Citrus Sinensis ID: 019685

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------
Protein Sequence
MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSFM
Secondary Structure (PSIPRED)
ccccccccccccccccccccccHHHHHHHHHHcHHHHHHHHHccccHHHHHHHHHcccccccccccccccHHHHHHHcccHHHHHHHHHHcccccccccccccHHHHHHHccHHHHHHHHHHccccccccccccccccccccccccccccEEcccccccccccEEEEccccEEEEEEEcccEEEEEEEcccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccccEEEcccccccEEEcccccccccEEcccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccHcccccccccEEEEEEHHHHccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHccccccccccccccccEEEEEccccEEEEEEcccccccccccHHHHHHHHHHHHHcccccEccEEEEEccccccEEEEEcccccEHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccccccHccccHHEEcccccccEEEEEEEEEcccccccccHccc
Coil and Loop (DISEMBL)
mssgnsspgdsttpckggatssadkQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDqslvhardydnrtplhvaSLHGWIDVAKCLIEYgadvnaqdrwkntpladaegakKFNMMELLNAhgglsygqngshfepkpvppplpnkcdweidpseldfsssaiigkgSFGEILKAYWRGTPVAIKRilpslsddrlVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKylkekgalspstAVNFALDIARGMaylhnepnviihrdlkprnvllvnssadhlkvgdfGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSFM
Flexible Loop (DISEMBL)
mssgnsspgdsttpckggatssadkqkekARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADvnaqdrwknTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNllvklrhpnIVQFlgavterkplMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSFM
Low Complexity Region (SEG)
MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEpkpvppplpNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSFM
Disordered region (IsUnstruct)
***********************************SLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL*********************CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSN****
Disordered Region (DISOPRED)
*********************************RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN*************************KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK**********TGETGSCEYLVSNCSFM
Disordered Region (DISEMBL)
*********************************RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSFM
Disordered Region (DISPRO)
**************CKGGATSSADK**EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG****************PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSFM
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSFM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	337	2.2.26 [Sep-21-2011]
P18160	2410	Dual specificity protein	yes	no	0.531	0.074	0.407	7e-29
Q54TM7	1288	Probable serine/threonine	no	no	0.554	0.145	0.405	1e-27
Q86AE1	527	Probable serine/threonine	no	no	0.510	0.326	0.377	1e-25
Q05609	821	Serine/threonine-protein	no	no	0.495	0.203	0.4	2e-25
Q9FPR3	933	Serine/threonine-protein	no	no	0.418	0.151	0.441	5e-25
Q7TQP6	835	Serine/threonine-protein	yes	no	0.798	0.322	0.307	7e-25
Q59H18	835	Serine/threonine-protein	yes	no	0.798	0.322	0.304	9e-25
Q5GIG6	834	Serine/threonine-protein	yes	no	0.798	0.322	0.307	9e-25
Q54N73	691	Seven transmembrane domai	no	no	0.442	0.215	0.439	2e-24
P42682	527	Tyrosine-protein kinase T	no	no	0.445	0.284	0.407	2e-24

>sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3

 Score =  128 bits (321), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 82/201 (40%), Positives = 113/201 (56%), Gaps = 22/201 (10%)

Query: 147  KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
            + ++EID +EL+F  +  IGKG FGE+ + YWR T VAIK I       +  +  F++EV
Sbjct: 2105 RSEYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEV 2162

Query: 207  NLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGAL---SPSTAVNFA 261
             +L KLRHPN+VQFLGA T        ++TE++ GG L ++L +   L   +P   +  A
Sbjct: 2163 GILSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLA 2222

Query: 262  LDIARGMAYLHNEPNVIIHRDLKPRNVLL----------VNSSAD-HLKVGDFGLSKLIK 310
            LDIA+GM YLH     I+HRDL  RN+LL          V+S  D   K+ DFGLS+L  
Sbjct: 2223 LDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM 2282

Query: 311  VQNSHDVYKMTGETGSCEYLV 331
             Q S    +MT   G   Y+ 
Sbjct: 2283 EQAS----QMTQSVGCIPYMA 2299

Essential for spore differentiation.
Dictyostelium discoideum (taxid: 44689)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  124 bits (310), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/202 (40%), Positives = 109/202 (53%), Gaps = 15/202 (7%)

Query: 130  QNGSHFEPKPVPPP----LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAI 185
            QN  H  P P  P     +    +WE+  SE+     A IG+G +G++ +  WRGT VA+
Sbjct: 820  QNKDHQFPVPTIPAKIIEVEKPFEWEVPLSEIAIG--ARIGRGGYGQVFRGSWRGTEVAV 877

Query: 186  KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHK- 244
            K +     + +L I D R EV+LL KLRHPNIV F+GA TE     ++TEYL  G L   
Sbjct: 878  KMLFNDNVNLKL-ISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI 936

Query: 245  YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
             L E   +     +    D ARGM YLH+   +IIHRDLK  N+L+ +S    +KV DFG
Sbjct: 937  LLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSW--QVKVADFG 994

Query: 305  LSKLIKVQNSHDVYK-MTGETG 325
            L+ +     SH   K M G TG
Sbjct: 995  LATV----KSHTFAKTMCGTTG 1012

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86AE1|Y9853_DICDI Probable serine/threonine-protein kinase DDB_G0271538 OS=Dictyostelium discoideum GN=DDB_G0271538 PE=3 SV=1

 Score =  117 bits (293), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/183 (37%), Positives = 113/183 (61%), Gaps = 11/183 (6%)

Query: 143 PLPNKCDWEIDPSELDFSSSAI---IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVI 199
           P   K + E D S LD+S   +   IG+GSFG++ KA + GT VA+K++   +S D    
Sbjct: 14  PKSTKEEDENDFSSLDYSDLFMDVEIGRGSFGQVQKASYFGTDVAVKQLSTLVSIDPDYF 73

Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTA 257
           +    E+ +L  +RHPNIVQ++GA       M++TEY++GGDLH+++K +G   +S +  
Sbjct: 74  KFMLREIKILKGMRHPNIVQYIGACCHEGRYMIVTEYIKGGDLHQFIKARGVSNISWTLR 133

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL---KVGDFGLSKLIKVQNS 314
           +  ALDIA   +YLH++   +I RDLK +N+ LV+   D L   KV DFG +++   +++
Sbjct: 134 MKLALDIASAFSYLHSKK--VIFRDLKAKNI-LVDEIGDGLYRAKVIDFGFARIFDGKDT 190

Query: 315 HDV 317
           +++
Sbjct: 191 NNL 193

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  117 bits (292), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 72/180 (40%), Positives = 103/180 (57%), Gaps = 13/180 (7%)

Query: 139 PVPPPLPNKCDWEI-------DPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPS 191
           P+  P+PN+ + E+       D    D +    IG GSFG + +A W G+ VA+K IL  
Sbjct: 524 PISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVK-ILME 582

Query: 192 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA 251
                  + +F  EV ++ +LRHPNIV F+GAVT+   L ++TEYL  G L++ L + GA
Sbjct: 583 QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 642

Query: 252 ---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
              L     ++ A D+A+GM YLHN    I+HRDLK  N+L+       +KV DFGLS+L
Sbjct: 643 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRL 700

Acts as a negative regulator in the ethylene response pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  115 bits (288), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 64/145 (44%), Positives = 90/145 (62%), Gaps = 4/145 (2%)

Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           IG GS+GE+  A W GT VA+K+ L         + +FR EV ++ +LRHPN+V FLGAV
Sbjct: 675 IGLGSYGEVYHADWHGTEVAVKKFL-DQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAV 733

Query: 225 TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283
           T    L ++TE+L  G L++ L + K  +     +  ALD+A GM  LH     I+HRDL
Sbjct: 734 TRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDL 793

Query: 284 KPRNVLLVNSSADHLKVGDFGLSKL 308
           K  N+L+ N+   ++KVGDFGLS+L
Sbjct: 794 KTPNLLVDNNW--NVKVGDFGLSRL 816

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7TQP6|TNI3K_RAT Serine/threonine-protein kinase TNNI3K OS=Rattus norvegicus GN=Tnni3k PE=2 SV=3

 Score =  114 bits (286), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 144/309 (46%), Gaps = 40/309 (12%)

Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--AQDRWKNTPLAD 107
           V+ LL+++   ++ R  D  T LH A  HG I + + L++ GAD+N  A D  +++   D
Sbjct: 322 VKFLLDQNAVNINHRGRDGHTGLHSACYHGHIRLVQFLLDNGADMNLVACDPSRSSGEKD 381

Query: 108 AEGA------KKFNMMELLNAHGGL--------SYGQNGSHFEPKPVPPPL-------PN 146
            +        K  + +  L  H            Y Q G       VP PL         
Sbjct: 382 EQTCLMWAYEKGHDAIVTLLKHYKRPQEELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKE 441

Query: 147 KCD-----------WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
           K D           + +  SE++F    IIG GSFG++ K   R   VAIKR   +    
Sbjct: 442 KADVLLLRAELPSRFHLQLSEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 499

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYLKE-KGALS 253
           +  +  F  EV++L +L HP +VQF+GA  +      ++T+Y+ GG L   L E K  L 
Sbjct: 500 KSDVDMFCREVSILCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILD 559

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
             + +  A+D+A+GM YLH+    IIHRDL   N+LL      H  V DFG S+ ++  +
Sbjct: 560 LQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQSLD 617

Query: 314 SHDVYKMTG 322
             ++ K  G
Sbjct: 618 EDNMTKQPG 626

May play a role in cardiac physiology.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q59H18|TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3

 Score =  114 bits (286), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 94/309 (30%), Positives = 145/309 (46%), Gaps = 40/309 (12%)

Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--AQDRWKNTPLAD 107
           V+ LL+++   ++ +  D  T LH A  HG I + + L++ GAD+N  A D  +++   D
Sbjct: 322 VKFLLDQNVININHQGRDGHTGLHSACYHGHIRLVQFLLDNGADMNLVACDPSRSSGEKD 381

Query: 108 AEGA------KKFNMMELLNAHGGL--------SYGQNGSHFEPKPVPPPL-------PN 146
            +        K  + +  L  H            Y Q G       VP PL         
Sbjct: 382 EQTCLMWAYEKGHDAIVTLLKHYKRPQDELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKE 441

Query: 147 KCD-----------WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
           K D           + +  SE++F    IIG GSFG++ K   R   VAIKR   +    
Sbjct: 442 KADILLLRAGLPSHFHLQLSEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 499

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALS 253
           +  +  F  EV++L +L HP ++QF+GA + +     ++T+Y+ GG L   L E K  L 
Sbjct: 500 KSDVDMFCREVSILCQLNHPCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILD 559

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
             + +  A+D+A+GM YLHN    IIHRDL   N+LL      H  V DFG S+ ++  +
Sbjct: 560 LQSKLIIAVDVAKGMEYLHNLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQSLD 617

Query: 314 SHDVYKMTG 322
             ++ K  G
Sbjct: 618 EDNMTKQPG 626

May play a role in cardiac physiology.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5GIG6|TNI3K_MOUSE Serine/threonine-protein kinase TNNI3K OS=Mus musculus GN=Tnni3k PE=2 SV=4

 Score =  114 bits (285), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 144/309 (46%), Gaps = 40/309 (12%)

Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN--AQDRWKNTPLAD 107
           V+ LL+++   ++ R  D  T LH A  HG I + + L++ GAD+N  A D  +++   D
Sbjct: 321 VKFLLDQNAVNINHRGRDGHTGLHSACYHGHIRLVQFLLDNGADMNLVACDPSRSSGEKD 380

Query: 108 AEGA------KKFNMMELLNAHGGL--------SYGQNGSHFEPKPVPPPL-------PN 146
            +        K  + +  L  H            Y Q G       VP PL         
Sbjct: 381 EQTCLMWAYEKGHDAIVTLLKHYKRPQDELPCNEYSQPGGDGSYVSVPSPLGKIKSMTKE 440

Query: 147 KCD-----------WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
           K D           + +  SE++F    IIG GSFG++ K   R   VAIKR   +    
Sbjct: 441 KADVLLLRAELPSRFHLQLSEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 498

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYLKE-KGALS 253
           +  +  F  EV++L +L HP +VQF+GA  +      ++T+Y+ GG L   L E K  L 
Sbjct: 499 KSDVDMFCREVSILCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILD 558

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
             + +  A+D+A+GM YLH+    IIHRDL   N+LL      H  V DFG S+ ++  +
Sbjct: 559 LQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQSLD 616

Query: 314 SHDVYKMTG 322
             ++ K  G
Sbjct: 617 EDNMTKQPG 625

May play a role in cardiac physiology.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54N73|7TMK1_DICDI Seven transmembrane domain-containing tyrosine-protein kinase 1 OS=Dictyostelium discoideum GN=7tmk1 PE=3 SV=1

 Score =  113 bits (283), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/157 (43%), Positives = 94/157 (59%), Gaps = 8/157 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIK---RILPSLSDDRLVIQDFRHEVNLLVKLRH 214
           +F    +IG+G FGE+ KA W+G  VA+K   R     +D       F  EV +L  LRH
Sbjct: 362 EFKFGQVIGEGYFGEVRKAVWKGAVVAVKILHRNSFRNTDGNKEENVFLKEVAILSILRH 421

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGAL---SPSTAVNFALDIARGMAYL 271
           PN++QFLG  +E     ++TEY+ GG L + L ++  L   +P  A N A+ IARGM YL
Sbjct: 422 PNVLQFLGVCSETNLNGIVTEYMGGGSLDRLLTDRYFLIKQNPILAWNMAISIARGMFYL 481

Query: 272 HN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           H+ +PN I+HRDL  +N+LL + S    KV DFGLSK
Sbjct: 482 HDWKPNPILHRDLSTKNILL-DESLTIAKVADFGLSK 517

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|P42682|TXK_MOUSE Tyrosine-protein kinase TXK OS=Mus musculus GN=Txk PE=1 SV=1

 Score =  113 bits (283), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/162 (40%), Positives = 95/162 (58%), Gaps = 12/162 (7%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEIDPSEL F     IG G FG +    WR   PVAIK    ++++  +  +DF  E  +
Sbjct: 264 WEIDPSELAFVKE--IGSGQFGVVHLGEWRAHIPVAIK----AINEGSMSEEDFIEEAKV 317

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARG 267
           ++KL H  +VQ  G   ++KPL ++TE++  G L  YL+E KG L  +  ++   DI  G
Sbjct: 318 MMKLSHSRLVQLYGVCIQQKPLYIVTEFMENGCLLDYLRERKGQLQKALLLSMCQDICEG 377

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           MAYL  E +  IHRDL  RN L+  SSA  +K+ DFG+++ +
Sbjct: 378 MAYL--ERSCYIHRDLAARNCLV--SSACVVKISDFGMARYV 415

Non-receptor tyrosine kinase that plays a redundant role with ITK in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of TXK to the cell membrane, where it is phosphorylated at Tyr-420. Phosphorylation leads to TXK full activation. Contributes also to signaling from many receptors and participates in multiple downstream pathways, including regulation of the actin cytoskekleton. Like ITK, can phosphorylate PLCG1, leading to its localization in lipid rafts and activation, followed by subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. With PARP1 and EEF1A1, TXK forms a complex that acts as a T-helper 1 (Th1) cell-specific transcription factor and binds the promoter of IFNG to directly regulate its transcription, and is thus involved importantly in Th1 cytokine production. Phosphorylates both PARP1 and EEF1A1. Phosphorylates also key sites in LCP2 leading to the up-regulation of Th1 preferred cytokine IL-2. Phosphorylates 'Tyr-201' of CTLA4 which leads to the association of PI-3 kinase with the CTLA4 receptor.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	337
255562954	431	protein kinase, putative [Ricinus commun	0.967	0.756	0.9	1e-165
225462932	435	PREDICTED: dual specificity protein kina	0.979	0.758	0.869	1e-163
356521649	421	PREDICTED: dual specificity protein kina	0.910	0.729	0.876	1e-161
449434754	446	PREDICTED: dual specificity protein kina	0.967	0.730	0.871	1e-161
449478377	446	PREDICTED: LOW QUALITY PROTEIN: dual spe	0.970	0.733	0.868	1e-160
15223025	438	VH1-interacting kinase [Arabidopsis thal	0.979	0.753	0.852	1e-159
116643246	449	flag-tagged protein kinase domain of put	0.979	0.734	0.852	1e-159
297844308	438	kinase family protein [Arabidopsis lyrat	0.979	0.753	0.852	1e-159
224101399	440	predicted protein [Populus trichocarpa]	0.916	0.702	0.915	1e-159
18700097	438	At1g14000/F7A19_9 [Arabidopsis thaliana]	0.979	0.753	0.852	1e-159

>gi|255562954|ref|XP_002522482.1| protein kinase, putative [Ricinus communis] gi|223538367|gb|EEF39974.1| protein kinase, putative [Ricinus communis]

 Score =  588 bits (1516), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 297/330 (90%), Positives = 313/330 (94%), Gaps = 4/330 (1%)

Query: 1   MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60
           MSSG SS G      +G    S+DKQKEKARVSRTS+ILWHAHQNDAAAVRKLLEED+SL
Sbjct: 1   MSSGTSSAGGE----RGPPPPSSDKQKEKARVSRTSMILWHAHQNDAAAVRKLLEEDRSL 56

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V ARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK NM+ELL
Sbjct: 57  VRARDYDSRTPLHVASLHGWIDVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHNMIELL 116

Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG 180
            ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKAYWRG
Sbjct: 117 KSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKAYWRG 176

Query: 181 TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
           TPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEYLRGG
Sbjct: 177 TPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEYLRGG 236

Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
           DLH+YLKEKGALSPSTA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS+ADHLKV
Sbjct: 237 DLHQYLKEKGALSPSTAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSNADHLKV 296

Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           GDFGLSKLIKVQNSHDVYKMTGETGS  Y+
Sbjct: 297 GDFGLSKLIKVQNSHDVYKMTGETGSYRYM 326

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225462932|ref|XP_002266329.1| PREDICTED: dual specificity protein kinase pyk1 isoform 1 [Vitis vinifera] gi|296087790|emb|CBI35046.3| unnamed protein product [Vitis vinifera]

 Score =  578 bits (1491), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 287/330 (86%), Positives = 310/330 (93%)

Query: 1   MSSGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60
           MS  + + G  ++    G   ++DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL
Sbjct: 1   MSCRDDNSGGHSSTSAAGKDKASDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL 60

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           VHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK +M+ELL
Sbjct: 61  VHARDYDSRTPLHVASLHGWIDVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHSMIELL 120

Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG 180
            ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+S+IIGKGSFGEILKA WRG
Sbjct: 121 KSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSSIIGKGSFGEILKACWRG 180

Query: 181 TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
           TPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT++KPLMLITEYLRGG
Sbjct: 181 TPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTDKKPLMLITEYLRGG 240

Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
           DLH+YLKEKG+LSPSTA+ FA+DIARGMAYLHNEPNVIIHRDLKPRNVLLVN+ ADHLKV
Sbjct: 241 DLHQYLKEKGSLSPSTAITFAMDIARGMAYLHNEPNVIIHRDLKPRNVLLVNTGADHLKV 300

Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           GDFGLSKLIKVQNSHDVYKMTGETGS  Y+
Sbjct: 301 GDFGLSKLIKVQNSHDVYKMTGETGSYRYM 330

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356521649|ref|XP_003529466.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max]

 Score =  572 bits (1475), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 269/307 (87%), Positives = 292/307 (95%)

Query: 24  DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV 83
           +K+KEK RVSRTSLILWHAHQNDA +VRKLL+ED SLV ARDYDNRTPLHVASLHGWIDV
Sbjct: 10  EKEKEKQRVSRTSLILWHAHQNDAGSVRKLLQEDPSLVKARDYDNRTPLHVASLHGWIDV 69

Query: 84  AKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPP 143
           A CLIE+GADVNAQDRWKNTPLADAEGAKK N++ELL +HGGLS+GQNGSHFEPKPV PP
Sbjct: 70  ATCLIEFGADVNAQDRWKNTPLADAEGAKKSNVIELLQSHGGLSFGQNGSHFEPKPVAPP 129

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFR 203
           LPNKCDWE++P+ELDFS+S  IGKGSFGEILKA+WRGTPVA+KRILPSLS+DRLVIQDFR
Sbjct: 130 LPNKCDWEVEPTELDFSNSVRIGKGSFGEILKAHWRGTPVAVKRILPSLSEDRLVIQDFR 189

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
           HEVNLLVKLRHPNIVQFLGAVT RKPLMLITEYLRGGDLH+YLKEKGALSP+TA+NF++D
Sbjct: 190 HEVNLLVKLRHPNIVQFLGAVTARKPLMLITEYLRGGDLHQYLKEKGALSPATAINFSMD 249

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
           I RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI VQ+SHDVYKMTGE
Sbjct: 250 IVRGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLITVQSSHDVYKMTGE 309

Query: 324 TGSCEYL 330
           TGS  Y+
Sbjct: 310 TGSYRYM 316

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449434754|ref|XP_004135161.1| PREDICTED: dual specificity protein kinase splA-like [Cucumis sativus]

 Score =  572 bits (1474), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 291/334 (87%), Positives = 313/334 (93%), Gaps = 8/334 (2%)

Query: 3   SGNSSPGDSTTPCKGG------ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE 56
           +G+ SPG  +T  +G       + +S +KQKEKARVSRTSLILWHAHQND +AVRKLLEE
Sbjct: 10  AGSPSPG--STGGRGNISSSSASGTSKEKQKEKARVSRTSLILWHAHQNDPSAVRKLLEE 67

Query: 57  DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116
           DQSLVHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK  M
Sbjct: 68  DQSLVHARDYDSRTPLHVASLHGWIDVAKCLIEHGADVNAQDRWKNTPLADAEGAKKHGM 127

Query: 117 MELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKA 176
           +ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKA
Sbjct: 128 IELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKA 187

Query: 177 YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
           YWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEY
Sbjct: 188 YWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEY 247

Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
           LRGGDLH+YLK+KG+LSP+TA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS AD
Sbjct: 248 LRGGDLHQYLKDKGSLSPATAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSGAD 307

Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           HLKVGDFGLSKLIKVQNSHDVYKMTGETGS  Y+
Sbjct: 308 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 341

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449478377|ref|XP_004155301.1| PREDICTED: LOW QUALITY PROTEIN: dual specificity protein kinase splA-like [Cucumis sativus]

 Score =  571 bits (1472), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 291/335 (86%), Positives = 313/335 (93%), Gaps = 8/335 (2%)

Query: 3   SGNSSPGDSTTPCKGG------ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE 56
           +G+ SPG  +T  +G       + +S +KQKEKARVSRTSLILWHAHQND +AVRKLLEE
Sbjct: 10  AGSPSPG--STGGRGNISSSSASGTSKEKQKEKARVSRTSLILWHAHQNDPSAVRKLLEE 67

Query: 57  DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNM 116
           DQSLVHARDYD+RTPLHVASLHGWIDVAKCLIE+GADVNAQDRWKNTPLADAEGAKK  M
Sbjct: 68  DQSLVHARDYDSRTPLHVASLHGWIDVAKCLIEHGADVNAQDRWKNTPLADAEGAKKHGM 127

Query: 117 MELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKA 176
           +ELL ++GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS+SAIIGKGSFGEILKA
Sbjct: 128 IELLKSYGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSNSAIIGKGSFGEILKA 187

Query: 177 YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
           YWRGTPVA+KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE+KPLMLITEY
Sbjct: 188 YWRGTPVAVKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTEKKPLMLITEY 247

Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
           LRGGDLH+YLK+KG+LSP+TA+NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS AD
Sbjct: 248 LRGGDLHQYLKDKGSLSPATAINFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSGAD 307

Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLV 331
           HLKVGDFGLSKLIKVQNSHDVYKMTGETGS  Y+ 
Sbjct: 308 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMA 342

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15223025|ref|NP_172853.1| VH1-interacting kinase [Arabidopsis thaliana] gi|5080776|gb|AAD39286.1|AC007576_9 Similar to protein kinases [Arabidopsis thaliana] gi|111074450|gb|ABH04598.1| At1g14000 [Arabidopsis thaliana] gi|332190976|gb|AEE29097.1| VH1-interacting kinase [Arabidopsis thaliana]

 Score =  567 bits (1461), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 284/333 (85%), Positives = 306/333 (91%), Gaps = 3/333 (0%)

Query: 1   MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
           MSS + + GD       G +    S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1   MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60

Query: 58  QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
            +LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K  M+
Sbjct: 61  PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120

Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
           ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180

Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
           WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240

Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
           RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LKVGDFGLSKLIKVQNSHDVYKMTGETGS  Y+
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 333

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116643246|gb|ABK06431.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct]

 Score =  567 bits (1460), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 284/333 (85%), Positives = 306/333 (91%), Gaps = 3/333 (0%)

Query: 1   MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
           MSS + + GD       G +    S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1   MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60

Query: 58  QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
            +LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K  M+
Sbjct: 61  PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120

Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
           ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180

Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
           WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240

Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
           RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LKVGDFGLSKLIKVQNSHDVYKMTGETGS  Y+
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 333

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

>gi|297844308|ref|XP_002890035.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297335877|gb|EFH66294.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  567 bits (1460), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 284/333 (85%), Positives = 306/333 (91%), Gaps = 3/333 (0%)

Query: 1   MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
           MSS + + GD       G +    S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1   MSSDSPASGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60

Query: 58  QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
            +LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K  M+
Sbjct: 61  PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120

Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
           ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180

Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
           WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240

Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
           RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPATAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LKVGDFGLSKLIKVQNSHDVYKMTGETGS  Y+
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 333

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224101399|ref|XP_002312262.1| predicted protein [Populus trichocarpa] gi|222852082|gb|EEE89629.1| predicted protein [Populus trichocarpa]

 Score =  566 bits (1459), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 283/309 (91%), Positives = 297/309 (96%)

Query: 22  SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI 81
           +A KQKEKARVSRTSLILWHAHQNDAAAVRKLLEED SLV ARDYD RTPLHVASLHGWI
Sbjct: 26  TAGKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDPSLVSARDYDKRTPLHVASLHGWI 85

Query: 82  DVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVP 141
           DVAKCLIE+GADVNAQDRWKNTPLADAEGAKK +M+ELL ++GGLSYGQNGSHFEPKPVP
Sbjct: 86  DVAKCLIEFGADVNAQDRWKNTPLADAEGAKKHSMIELLKSYGGLSYGQNGSHFEPKPVP 145

Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD 201
           PP PNKCDWEI+PSELDFS+S IIGKGSFGEILKA WRGTPVA+KRILPSLSDDRLVIQD
Sbjct: 146 PPQPNKCDWEIEPSELDFSNSNIIGKGSFGEILKASWRGTPVAVKRILPSLSDDRLVIQD 205

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
           FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH+YLKEKGALSPSTA+NFA
Sbjct: 206 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGALSPSTAINFA 265

Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
           LDIARGMA LHNEPNVI+HRDLKPRNVLLVNS+ADHLKVGDFGLSKLIKVQNSHDVYKMT
Sbjct: 266 LDIARGMACLHNEPNVIVHRDLKPRNVLLVNSNADHLKVGDFGLSKLIKVQNSHDVYKMT 325

Query: 322 GETGSCEYL 330
           GETGS  Y+
Sbjct: 326 GETGSYRYM 334

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18700097|gb|AAL77660.1| At1g14000/F7A19_9 [Arabidopsis thaliana]

 Score =  566 bits (1458), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 284/333 (85%), Positives = 306/333 (91%), Gaps = 3/333 (0%)

Query: 1   MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
           MSS + + GD       G +    S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct: 1   MSSDSPAAGDGGEQAAVGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60

Query: 58  QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
            +LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K  M+
Sbjct: 61  PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120

Query: 118 ELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
           ELL +HGGLSYGQNGSHFEPKPVPPP+P KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct: 121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180

Query: 178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
           WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct: 181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240

Query: 238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
           RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct: 241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LKVGDFGLSKLIKVQNSHDVYKMTGETGS  Y+
Sbjct: 301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 333

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	337
TAIR|locus:2014849	438	VIK "VH1-interacting kinase" [	0.979	0.753	0.828	3.1e-147
TAIR|locus:2117129	459	AT4G18950 [Arabidopsis thalian	0.818	0.601	0.430	1.5e-53
TAIR|locus:2098999	471	AT3G58760 [Arabidopsis thalian	0.792	0.566	0.444	3e-53
TAIR|locus:2045258	476	AT2G31800 [Arabidopsis thalian	0.798	0.565	0.389	1e-45
TAIR|locus:2044034	479	AT2G43850 [Arabidopsis thalian	0.813	0.572	0.390	2.1e-45
TAIR|locus:2080517	477	AT3G59830 [Arabidopsis thalian	0.851	0.601	0.382	1.5e-42
UNIPROTKB|F1P6V7	835	TNNI3K "Uncharacterized protei	0.501	0.202	0.376	4.9e-30
UNIPROTKB|A0JNG5	835	TNNI3K "TNNI3 interacting kina	0.501	0.202	0.376	4.9e-30
UNIPROTKB|F1P4W8	935	TNNI3K "Uncharacterized protei	0.501	0.180	0.370	7.2e-30
UNIPROTKB|Q59H18	835	TNNI3K "Serine/threonine-prote	0.501	0.202	0.370	1e-29

TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1438 (511.3 bits), Expect = 3.1e-147, P = 3.1e-147
 Identities = 276/333 (82%), Positives = 297/333 (89%)

Query:     1 MSSGNSSPGDSTTPCKGGAT---SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 57
             MSS + + GD       G +    S DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED
Sbjct:     1 MSSDSPAAGDGGEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED 60

Query:    58 QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
              +LVHARDYD RTPLHVASLHGWIDV KCL+E+GADVNAQDRWKNTPLADAEGA+K  M+
Sbjct:    61 PTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMI 120

Query:   118 ELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY 177
             ELL +HGGLSYGQNGSHFE          KCDWEI+P+ELDFS++A+IGKGSFGEI+KAY
Sbjct:   121 ELLKSHGGLSYGQNGSHFEPKPVPPPIPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAY 180

Query:   178 WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL 237
             WRGTPVA+KRILPSLSDDRLVIQDFRHEV+LLVKLRHPNIVQFLGAVTERKPLMLITEYL
Sbjct:   181 WRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYL 240

Query:   238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
             RGGDLH+YLKEKG L+P+TAVNFALDIARGM YLHNEPNVIIHRDLKPRNVLLVNSSADH
Sbjct:   241 RGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADH 300

Query:   298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             LKVGDFGLSKLIKVQNSHDVYKMTGETGS  Y+
Sbjct:   301 LKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYM 333

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009734 "auxin mediated signaling pathway" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0005829 "cytosol" evidence=RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)]

 Score = 554 (200.1 bits), Expect = 1.5e-53, P = 1.5e-53
 Identities = 127/295 (43%), Positives = 184/295 (62%)

Query:    38 ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
             +++ A++ D   +++L++      + RD D+RT LHVA+  G  DV + L++  A+V+ +
Sbjct:    47 LMYLANEGDIEGIKELIDSGID-ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPK 105

Query:    98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDPSEL 157
             DRW +TP ADA   K  +++++L  HG   +     H +            ++EI+PSEL
Sbjct:   106 DRWGSTPFADAIFYKNIDVIKILEIHGA-KHPMAPMHVKTAREVP------EYEINPSEL 158

Query:   158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLLVKLRHPN 216
             DF+ S  I KG++     A WRG  VA+K++    LSDD  V + F  E+ LL +LRHPN
Sbjct:   159 DFTQSKEITKGTY---CMAMWRGIQVAVKKLDDEVLSDDDQV-RKFHDELALLQRLRHPN 214

Query:   217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EP 275
             IVQFLGAVT+  P+M++TEYL  GDL + LK KG L P+TAV +ALDIARGM+YLH  + 
Sbjct:   215 IVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKGQLKPATAVRYALDIARGMSYLHEIKG 274

Query:   276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             + IIHRDL+P N+L  +S   HLKV DFG+SKL+ V+        T +  SC Y+
Sbjct:   275 DPIIHRDLEPSNILRDDSG--HLKVADFGVSKLVTVKEDKP---FTCQDISCRYI 324

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)]

 Score = 551 (199.0 bits), Expect = 3.0e-53, P = 3.0e-53
 Identities = 125/281 (44%), Positives = 171/281 (60%)

Query:    35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
             T  +++ A++ D   + K+L+   + V  RD D RT LHVA+  G  DV + L+  GA V
Sbjct:    50 TIRLMYLANEGDIDGINKMLDSGTN-VDYRDIDARTALHVAACQGRTDVVELLLSRGAKV 108

Query:    95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
             + +DRW +TPLADA   K  ++++LL  HG                        ++EI P
Sbjct:   109 DTKDRWGSTPLADAVYYKNHDVIKLLEKHGA-------KPTIAPMHVLTDKEVPEYEIHP 161

Query:   155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
             +ELDFS+S  I KG+F    KA WRG  VA+K     +  D   +  FR E+ LL K+RH
Sbjct:   162 TELDFSNSVKISKGTFN---KASWRGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRH 218

Query:   215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH-N 273
             PN+VQFLGAVT+  P+M++TEYL  GDL +YL  KG L P+ AV FAL+IARGM YLH +
Sbjct:   219 PNVVQFLGAVTQSTPMMIVTEYLPKGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEH 278

Query:   274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
             +P  IIH DL+P N+L  +S   HLKV DFG+SKL+ V+ +
Sbjct:   279 KPEAIIHCDLEPPNILRDDSG--HLKVADFGVSKLLVVKKT 317

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)]

 Score = 480 (174.0 bits), Expect = 1.0e-45, P = 1.0e-45
 Identities = 109/280 (38%), Positives = 162/280 (57%)

Query:    35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
             T  +L+ A + D   V+ LL+E    V++ D D RT LH+A+  G +DV K L+   A++
Sbjct:    76 TMQLLFVACRGDVEGVQDLLDEGID-VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANI 134

Query:    95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
             +A+DRW +T  ADA+     ++  +L A G     +                  ++E++P
Sbjct:   135 DARDRWGSTAAADAKYYGNMDVFNILKARGA----KVPKTKRTPMVVANPREVPEYELNP 190

Query:   155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
              EL    +  I KG + ++ K  W GT V++K +   L  D   I  F+HE+ L  K+RH
Sbjct:   191 QELQVRKADGISKGIY-QVAK--WNGTKVSVKILDKDLYKDSDTINAFKHELTLFEKVRH 247

Query:   215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN- 273
             PN+VQF+GAVT+  P+M+++EY   GDL  YL++KG LSP+  + FALDIARGM YLH  
Sbjct:   248 PNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQKKGRLSPAKVLRFALDIARGMNYLHEC 307

Query:   274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
             +P  +IH DLKP+N++L   S  HLKV  FGL    K+ +
Sbjct:   308 KPEPVIHCDLKPKNIML--DSGGHLKVAGFGLISFAKLSS 345

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)]

 Score = 477 (173.0 bits), Expect = 2.1e-45, P = 2.1e-45
 Identities = 112/287 (39%), Positives = 167/287 (58%)

Query:    35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
             T  +L+ A + D   + +LL+E    V++ D D RT LH+A+  G + V K L+   A++
Sbjct:    79 TMQLLFMASKGDVRGIEELLDEGID-VNSIDLDGRTALHIAACEGHLGVVKALLSRRANI 137

Query:    95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
             +A+DRW +T  ADA+     ++  LL A G     +     +            ++E++P
Sbjct:   138 DARDRWGSTAAADAKYYGNLDVYNLLKARGA----KVPKTRKTPMTVSNPREVPEYELNP 193

Query:   155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
              E+    S  I KG++ ++ K  W GT V++K +      D   I  FRHE+ LL K+RH
Sbjct:   194 LEVQVRKSDGISKGAY-QVAK--WNGTRVSVKILDKDSYSDPERINAFRHELTLLEKVRH 250

Query:   215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN- 273
             PN++QF+GAVT+  P+M++ EY   GDL  YL++KG LSPS A+ FALDIARGM YLH  
Sbjct:   251 PNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDIARGMNYLHEC 310

Query:   274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
             +P+ IIH DLKP+N+LL       LK+  FG+ +L K+  S D  K+
Sbjct:   311 KPDPIIHCDLKPKNILL--DRGGQLKISGFGMIRLSKI--SQDKAKV 353

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)]

 Score = 450 (163.5 bits), Expect = 1.5e-42, P = 1.5e-42
 Identities = 115/301 (38%), Positives = 164/301 (54%)

Query:    35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
             T  +L+ A + D   V +LL E    V++ D D RT LH+AS  G  DV K L+   A++
Sbjct:    77 TMQLLFMASKGDVNGVEELLNEGID-VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANI 135

Query:    95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEXXXXXXXXXNKCDWEIDP 154
             +A+DRW +T   DA+      +  LL A G  +        +            ++E++P
Sbjct:   136 DARDRWGSTAAVDAKYYGNVEVYNLLKARGAKAPKTR----KTPMTVGNPKEVPEYELNP 191

Query:   155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLR 213
              EL       I KG++ ++ K  W GT V++K     S SD   V   F +E+ LL K R
Sbjct:   192 LELQVRKVDGISKGTY-QVAK--WNGTRVSVKIFDKDSYSDPERV-NAFTNELTLLAKAR 247

Query:   214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
             HPNIVQF+GAVT+  P+M++ E    GDL  YL++KG LSPS A+ FALDIARGM YLH 
Sbjct:   248 HPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQKKGRLSPSKALRFALDIARGMNYLHE 307

Query:   274 -EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNSHDVYKMTGETGSCEYLV 331
              +P+ IIH +L P+N+LL       LK+  FGL KL K+ ++S  V     +     Y +
Sbjct:   308 CKPDPIIHCELMPKNILL--DRGGQLKISGFGLIKLSKIGEDSAKVVNHEAQIDKSNYYI 365

Query:   332 S 332
             +
Sbjct:   366 A 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

UNIPROTKB|F1P6V7 TNNI3K "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 272 (100.8 bits), Expect = 4.9e-30, Sum P(2) = 4.9e-30
 Identities = 67/178 (37%), Positives = 98/178 (55%)

Query:   155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
             SE++F    IIG GSFG++ K   R   VAIKR   +    +  +  F  EV++L +L H
Sbjct:   461 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNH 518

Query:   215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
             P I+QF+GA + +     ++T+Y+ GG L   L E K  L   + +  A+D+A+GM YLH
Sbjct:   519 PCIIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLH 578

Query:   273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             N    IIHRDL   N+LL      H  V DFG S+ ++   S D   MT + G+  ++
Sbjct:   579 NLTQPIIHRDLNSHNILLCEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWM 631

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|A0JNG5 TNNI3K "TNNI3 interacting kinase" [Bos taurus (taxid:9913)]

 Score = 272 (100.8 bits), Expect = 4.9e-30, Sum P(2) = 4.9e-30
 Identities = 67/178 (37%), Positives = 98/178 (55%)

Query:   155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
             SE++F    IIG GSFG++ K   R   VAIKR   +    +  +  F  EV++L +L H
Sbjct:   461 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNH 518

Query:   215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
             P I+QF+GA + +     ++T+Y+ GG L   L E K  L   + +  A+D+A+GM YLH
Sbjct:   519 PCIIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLH 578

Query:   273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             N    IIHRDL   N+LL      H  V DFG S+ ++   S D   MT + G+  ++
Sbjct:   579 NLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWM 631

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|F1P4W8 TNNI3K "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 271 (100.5 bits), Expect = 7.2e-30, Sum P(2) = 7.2e-30
 Identities = 66/178 (37%), Positives = 98/178 (55%)

Query:   155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
             SE++F    IIG GSFG++ K   R   VAIKR   +    +  +  F  EV++L +L H
Sbjct:   560 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNH 617

Query:   215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
             P ++QF+GA + +     ++T+Y+ GG L   L E K  L   + +  A+D+A+GM YLH
Sbjct:   618 PCVIQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRTLDLQSKLIIAVDVAKGMEYLH 677

Query:   273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             N    IIHRDL   N+LL      H  V DFG S+ ++   S D   MT + G+  ++
Sbjct:   678 NLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWM 730

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|Q59H18 TNNI3K "Serine/threonine-protein kinase TNNI3K" [Homo sapiens (taxid:9606)]

 Score = 270 (100.1 bits), Expect = 1.0e-29, Sum P(2) = 1.0e-29
 Identities = 66/178 (37%), Positives = 98/178 (55%)

Query:   155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
             SE++F    IIG GSFG++ K   R   VAIKR   +    +  +  F  EV++L +L H
Sbjct:   461 SEIEFHE--IIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCQLNH 518

Query:   215 PNIVQFLGA-VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLH 272
             P ++QF+GA + +     ++T+Y+ GG L   L E K  L   + +  A+D+A+GM YLH
Sbjct:   519 PCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLH 578

Query:   273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             N    IIHRDL   N+LL      H  V DFG S+ ++   S D   MT + G+  ++
Sbjct:   579 NLTQPIIHRDLNSHNILLYEDG--HAVVADFGESRFLQ---SLDEDNMTKQPGNLRWM 631

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0008022 "protein C-terminus binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0031013 "troponin I binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	337
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-55
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-47
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-39
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-32
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-32
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-31
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-30
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-28
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-28
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-27
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-27
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-26
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-25
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-24
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-24
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-23
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-21
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-20
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-18
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-17
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-17
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-17
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-15
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	4e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-15
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-15
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	5e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-14
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	1e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-12
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-12
PTZ00322	664	PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct	8e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-10
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	3e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-09
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	1e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-08
pfam00023	33	pfam00023, Ank, Ankyrin repeat	4e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-07
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	2e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	4e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-06
pfam13606	30	pfam13606, Ank_3, Ankyrin repeat	7e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-06
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	9e-06
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	9e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-05
pfam13857	56	pfam13857, Ank_5, Ankyrin repeats (many copies)	1e-05
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	2e-05
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-05
PHA02874	434	PHA02874, PHA02874, ankyrin repeat protein; Provis	6e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-05
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	2e-04
smart00248	30	smart00248, ANK, ankyrin repeats	2e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	3e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-04
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	4e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-04
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	7e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-04
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	8e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	9e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.002
PHA02874	434	PHA02874, PHA02874, ankyrin repeat protein; Provis	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	0.002
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.004
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	0.004
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  181 bits (463), Expect = 1e-55
 Identities = 64/167 (38%), Positives = 95/167 (56%), Gaps = 16/167 (9%)

Query: 164 IIGKGSFGEILKAYWRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
            +G+G+FGE+ K   +G        VA+K +    S+    I++F  E  ++ KL HPN+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNV 63

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPN 276
           V+ LG  TE +PL ++ EY+ GGDL  YL++ +  LS S  ++FAL IARGM YL ++  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN- 122

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
             IHRDL  RN L+       +K+ DFGLS+ +      D Y+  G 
Sbjct: 123 -FIHRDLAARNCLV--GENLVVKISDFGLSRDLY---DDDYYRKRGG 163

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  180 bits (459), Expect = 3e-55
 Identities = 67/168 (39%), Positives = 96/168 (57%), Gaps = 17/168 (10%)

Query: 164 IIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
            +G+G+FGE+ K   +G        VA+K +    S+    I++F  E  ++ KL HPNI
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNI 63

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEP 275
           V+ LG  TE +PLM++ EY+ GGDL  YL++     LS S  ++FAL IARGM YL ++ 
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
              IHRDL  RN L+       +K+ DFGLS+ +      D YK+ G 
Sbjct: 124 --FIHRDLAARNCLV--GENLVVKISDFGLSRDLY---DDDYYKVKGG 164

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  173 bits (440), Expect = 2e-52
 Identities = 61/167 (36%), Positives = 96/167 (57%), Gaps = 16/167 (9%)

Query: 165 IGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G+FGE+ K   +G      T VA+K +    S++    ++F  E +++ KL HPNIV
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSHPNIV 64

Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNV 277
           + LG  T+ +PL ++TEY+ GGDL  +L++ G  L+    +  AL IA+GM YL ++   
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN-- 122

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
            +HRDL  RN L+  +    +K+ DFGLS+ I      D Y+  G  
Sbjct: 123 FVHRDLAARNCLV--TENLVVKISDFGLSRDIY---EDDYYRKRGGG 164

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  168 bits (427), Expect = 2e-50
 Identities = 62/175 (35%), Positives = 94/175 (53%), Gaps = 23/175 (13%)

Query: 164 IIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
            +G+G+FGE+ K   +G     T VA+K +    S++    +DF  E  ++ KL HPN+V
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVV 59

Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKE---------KGALSPSTAVNFALDIARGMA 269
           + LG  TE +PL L+ EY+ GGDL  YL++         K  LS    ++FA+ IA+GM 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           YL ++    +HRDL  RN L+       +K+ DFGLS+ +      D Y+     
Sbjct: 120 YLASKK--FVHRDLAARNCLV--GEDLVVKISDFGLSRDV---YDDDYYRKKTGG 167

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  158 bits (403), Expect = 2e-47
 Identities = 63/169 (37%), Positives = 87/169 (51%), Gaps = 12/169 (7%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G FG +  A  +  G  VAIK I    S   L  ++   E+ +L KL HPNIV+  G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
              +   L L+ EY  GG L   LKE    LS    +   L I  G+ YLH+    IIHR
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHR 116

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLKP N+LL + +   +K+ DFGLSKL+    + D   +    G+  Y+
Sbjct: 117 DLKPENILLDSDN-GKVKLADFGLSKLL----TSDKSLLKTIVGTPAYM 160

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  160 bits (406), Expect = 2e-47
 Identities = 60/169 (35%), Positives = 88/169 (52%), Gaps = 13/169 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            +G+GSFG++  A  + T   VAIK I       +   +    E+ +L KL+HPNIV+  
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVI--KKKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
               +   L L+ EY  GGDL   LK++G LS   A  +   I   + YLH+    I+HR
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS--KGIVHR 121

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLKP N+LL      H+K+ DFGL++ +         K+T   G+ EY+
Sbjct: 122 DLKPENILLDEDG--HVKLADFGLARQL-----DPGEKLTTFVGTPEYM 163

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (403), Expect = 8e-47
 Identities = 65/169 (38%), Positives = 91/169 (53%), Gaps = 11/169 (6%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            +G GSFG + KA  +GT   VA+K +       +      R E+ +L +L HPNIV+ +
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLI 64

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            A  ++  L L+ EY  GGDL  YL   G LS   A   AL I RG+ YLH+    IIHR
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHR 122

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLKP N+LL  +    +K+ DFGL+K +   +S     +T   G+  Y+
Sbjct: 123 DLKPENILLDEN--GVVKIADFGLAKKLLKSSSS----LTTFVGTPWYM 165

Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  140 bits (354), Expect = 1e-39
 Identities = 68/173 (39%), Positives = 96/173 (55%), Gaps = 14/173 (8%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           W I+  EL   ++  IGKG FG+++   +RG  VA+K     L DD    Q F  E +++
Sbjct: 1   WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVK----CLKDDSTAAQAFLAEASVM 54

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
             LRHPN+VQ LG V +  PL ++TEY+  G L  YL+ +G   ++ +  + FALD+  G
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
           M YL  E    +HRDL  RNVL+  S     KV DFGL+K  +     D  K+
Sbjct: 115 MEYL--EEKNFVHRDLAARNVLV--SEDLVAKVSDFGLAK--EASQGQDSGKL 161

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (322), Expect = 6e-35
 Identities = 61/166 (36%), Positives = 85/166 (51%), Gaps = 17/166 (10%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G G FGE+    W G T VA+K + P         + F  E  +
Sbjct: 1   WEIPRESLKLERK--LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQI 54

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
           + KLRH  +VQ     +E +P+ ++TEY+  G L  +LK  E   L     V+ A  IA 
Sbjct: 55  MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIK 310
           GMAYL  E    IHRDL  RN+L+     ++L  K+ DFGL++LI+
Sbjct: 115 GMAYL--ESRNYIHRDLAARNILV----GENLVCKIADFGLARLIE 154

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  126 bits (318), Expect = 2e-34
 Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 9/157 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +++   ++G+GSFG +  A  + T   +A+K +     D    ++    E+ +L  L+HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59

Query: 216 NIVQFLGAVTERKPLML--ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           NIV++ G+  + +   L    EY+ GG L   LK+ G L       +   I  G+AYLH+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             N I+HRD+K  N+L+   S   +K+ DFG +K + 
Sbjct: 120 --NGIVHRDIKGANILV--DSDGVVKLADFGCAKRLG 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  121 bits (305), Expect = 1e-32
 Identities = 64/172 (37%), Positives = 91/172 (52%), Gaps = 16/172 (9%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WE    E  F+    +G G FGE+ +  W+    VAIK +    SDD L  QDF+ EV  
Sbjct: 1   WERPREE--FTLERKLGSGYFGEVWEGLWKNRVRVAIKILK---SDDLLKQQDFQKEVQA 55

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
           L +LRH +++      +  +P+ +ITE +  G L  +L+  E   L  ++ ++ A  +A 
Sbjct: 56  LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
           GMAYL  E    IHRDL  RN+L+        KV DFGL++LIK     DVY
Sbjct: 116 GMAYL--EEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIK----EDVY 159

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 6e-32
 Identities = 65/161 (40%), Positives = 91/161 (56%), Gaps = 14/161 (8%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
           IDPSEL F     +G G FG +    WRG   VAIK I   ++S+D     DF  E  ++
Sbjct: 1   IDPSELTFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-----DFIEEAKVM 53

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
           +KL HPN+VQ  G  T+++P+ ++TEY+  G L  YL+E KG L     ++   D+   M
Sbjct: 54  MKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAM 113

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E N  IHRDL  RN L+     + +KV DFGL++ +
Sbjct: 114 EYL--ESNGFIHRDLAARNCLV--GEDNVVKVSDFGLARYV 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  117 bits (294), Expect = 5e-31
 Identities = 61/160 (38%), Positives = 86/160 (53%), Gaps = 12/160 (7%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           I PSEL       IG G FG +   YW     VAIK I      +    +DF  E  +++
Sbjct: 1   IHPSELTLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMM 54

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 269
           KL HP +VQ  G  TER P+ L+ E++  G L  YL+ ++G  S  T +   LD+  GMA
Sbjct: 55  KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           YL  E + +IHRDL  RN L+  +    +KV DFG+++ +
Sbjct: 115 YL--ESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFV 150

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  116 bits (292), Expect = 1e-30
 Identities = 59/166 (35%), Positives = 88/166 (53%), Gaps = 20/166 (12%)

Query: 165 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRL--VIQDFRHEVNLLVKLRHPNI 217
           +G GSFG + +  W     +  PVA+K     L  D+L  ++ DF  E  ++  L H N+
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVK----CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEP 275
           ++  G V    PLM++TE    G L   L++   G    ST  ++A+ IA GM YL ++ 
Sbjct: 59  IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
              IHRDL  RN+LL  +S D +K+GDFGL + +    + D Y M 
Sbjct: 118 --FIHRDLAARNILL--ASDDKVKIGDFGLMRALP--QNEDHYVME 157

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 3e-30
 Identities = 61/164 (37%), Positives = 90/164 (54%), Gaps = 13/164 (7%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEID + +       +G G FGE+ +  W   TPVA+K + P   D     +DF  E  +
Sbjct: 1   WEIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQI 54

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
           + KLRHP ++Q     T  +P+ ++TE ++ G L +YL+     AL     ++ A  +A 
Sbjct: 55  MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAYL  E    IHRDL  RNVL+  ++    KV DFGL+++IK
Sbjct: 115 GMAYL--EAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIK 154

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  114 bits (287), Expect = 7e-30
 Identities = 51/152 (33%), Positives = 86/152 (56%), Gaps = 17/152 (11%)

Query: 165 IGKGSFGEILKAYWR----GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           IGKGSFG++     R    G    +K I L ++S+     +D  +EV +L KL HPNI++
Sbjct: 8   IGKGSFGKVYLV--RRKSDGKLYVLKEIDLSNMSEK--EREDALNEVKILKKLNHPNIIK 63

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGA----LSPSTAVNFALDIARGMAYLHNEP 275
           +  +  E+  L ++ EY  GGDL + +K++            +++ + +   + YLH+  
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-- 121

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             I+HRD+KP+N+ L  +S   +K+GDFG+SK
Sbjct: 122 RKILHRDIKPQNIFL--TSNGLVKLGDFGISK 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 8e-30
 Identities = 69/180 (38%), Positives = 95/180 (52%), Gaps = 22/180 (12%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSD-DRLVIQDFRHE 205
           IDPS    +   +IG G FGE+ +   +        VAIK +    SD  RL   DF  E
Sbjct: 1   IDPS--YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DFLTE 55

Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDI 264
            +++ +  HPNI++  G VT+ +P+M+ITEY+  G L K+L+E  G  +    V     I
Sbjct: 56  ASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGI 115

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTG 322
           A GM YL     V  HRDL  RN+ LVNS   +L  KV DFGLS+ +  ++S   Y   G
Sbjct: 116 ASGMKYLSEMNYV--HRDLAARNI-LVNS---NLVCKVSDFGLSRRL--EDSEATYTTKG 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  113 bits (284), Expect = 1e-29
 Identities = 63/161 (39%), Positives = 92/161 (57%), Gaps = 14/161 (8%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
           I+PSEL F     +G G FG +    WR    VAIK I   ++S++     DF  E  ++
Sbjct: 1   INPSELTFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-----DFIEEAKVM 53

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGM 268
           +KL HP +VQ  G  T++KPL ++TE++  G L  YL+++ G LS    ++   D+  GM
Sbjct: 54  MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E N  IHRDL  RN L+  SS   +KV DFG+++ +
Sbjct: 114 EYL--ERNSFIHRDLAARNCLV--SSTGVVKVSDFGMTRYV 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  112 bits (283), Expect = 2e-29
 Identities = 55/147 (37%), Positives = 81/147 (55%), Gaps = 12/147 (8%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IGKG FGE+ KA  +  G  VAIK I L S      +I     E+ +L K +HPNIV++ 
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN----EIQILKKCKHPNIVKYY 63

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF-ALDIARGMAYLHNEPNVIIH 280
           G+  ++  L ++ E+  GG L   LK        + + +   ++ +G+ YLH+  N IIH
Sbjct: 64  GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS--NGIIH 121

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RD+K  N+LL  S    +K+ DFGLS 
Sbjct: 122 RDIKAANILL-TSDG-EVKLIDFGLSA 146

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 1e-28
 Identities = 57/164 (34%), Positives = 87/164 (53%), Gaps = 18/164 (10%)

Query: 165 IGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQ--DFRHEVNLLVKLRHPNI 217
           +G G+FG ++K  +         VA+K    +L  + +     +F  E +++ +L HP I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVK----TLKQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V+ +G V + +PLML+ E    G L KYLK++  +  S     A  +A GMAYL  E   
Sbjct: 59  VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL--ESKH 115

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
            +HRDL  RNVLLVN      K+ DFG+S+ +   +  D Y+ T
Sbjct: 116 FVHRDLAARNVLLVNR--HQAKISDFGMSRALGAGS--DYYRAT 155

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  110 bits (276), Expect = 2e-28
 Identities = 55/166 (33%), Positives = 92/166 (55%), Gaps = 16/166 (9%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           WE++ +++       +G G +GE+ +  W+     VA+K    +L +D + +++F  E  
Sbjct: 1   WEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAVK----TLKEDTMEVEEFLKEAA 54

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIA 265
           ++ +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+
Sbjct: 55  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIK 310
             M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+ 
Sbjct: 115 SAMEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT 155

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 4e-28
 Identities = 56/160 (35%), Positives = 94/160 (58%), Gaps = 12/160 (7%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            +G+G++G + KA  +  G  VA+K+I     ++ +     R E++LL +L+HPNIV+ L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPNIVKLL 64

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
             +   + L L+ EY    DL KYL ++ G LSP+   +    + RG+AY H+  + I+H
Sbjct: 65  DVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS--HRILH 121

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV 317
           RDLKP+N+L+  +    LK+ DFGL++   +     +H+V
Sbjct: 122 RDLKPQNILI--NRDGVLKLADFGLARAFGIPLRTYTHEV 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  109 bits (274), Expect = 4e-28
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 8/152 (5%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKR--ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G GSFG + +      G   A+K   +       +  ++    E+ LL KL+HPNIVQ+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
           LG   E   L +  E + GG L K LK+ G+        +   I  G+ YLH+     +H
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD--RNTVH 125

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           RD+K  N+L+  +    +K+ DFG++K +   
Sbjct: 126 RDIKGANILVDTNGV--VKLADFGMAKQVVEF 155

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 5e-28
 Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 16/176 (9%)

Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
             E +     ++G G+FG + K  W         PVAIK +           ++   E  
Sbjct: 4   LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAY 61

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
           ++  + HP++V+ LG +     + LIT+ +  G L  Y++  K  +     +N+ + IA+
Sbjct: 62  VMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           GM+YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+ V      Y   G
Sbjct: 121 GMSYL--EEKRLVHRDLAARNVLV--KTPQHVKITDFGLAKLLDVDEKE--YHAEG 170

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 6e-28
 Identities = 51/156 (32%), Positives = 86/156 (55%), Gaps = 8/156 (5%)

Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           ++G+G+FG +   Y    G  +A+K++   P   + +  +     E+ LL  L+H  IVQ
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
           + G + + + L +  EY+ GG +   LK  GAL+ +    +   I  G+ YLH+  N+I+
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS--NMIV 126

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           HRD+K  N+L    SA ++K+GDFG SK ++   S 
Sbjct: 127 HRDIKGANIL--RDSAGNVKLGDFGASKRLQTICSS 160

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 2e-27
 Identities = 53/145 (36%), Positives = 82/145 (56%), Gaps = 8/145 (5%)

Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           IGKG+FG++ K   +  T VA+K    +L  D  + + F  E  +L +  HPNIV+ +G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD--LKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 224 VTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
             +++P+ ++ E + GG L  +L K+K  L+    +  +LD A GM YL  E    IHRD
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESKNCIHRD 118

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           L  RN L+     + LK+ DFG+S+
Sbjct: 119 LAARNCLV--GENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 2e-27
 Identities = 51/158 (32%), Positives = 85/158 (53%), Gaps = 9/158 (5%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           +IG+G+FG + K      G  VAIK+I          ++    E++LL  L+HPNIV+++
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           G++     L +I EY   G L + +K+ G    S    +   + +G+AYLH +   +IHR
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHR 123

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLS-KLIKV-QNSHDV 317
           D+K  N+L   +    +K+ DFG++ KL  V ++   V
Sbjct: 124 DIKAANILT--TKDGVVKLADFGVATKLNDVSKDDASV 159

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 3e-27
 Identities = 59/169 (34%), Positives = 90/169 (53%), Gaps = 12/169 (7%)

Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +GKGSFG++L    + T    A+K +       R  ++    E N+L ++ HP IV+   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           A    + L L+ EY  GG+L  +L ++G  S   A  +A +I   + YLH+    II+RD
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRD 118

Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LKP N+LL    AD H+K+ DFGL+K    + S +  +     G+ EYL
Sbjct: 119 LKPENILL---DADGHIKLTDFGLAK----ELSSEGSRTNTFCGTPEYL 160

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  107 bits (270), Expect = 3e-27
 Identities = 63/183 (34%), Positives = 92/183 (50%), Gaps = 36/183 (19%)

Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+G+FG++ K    G       T VAIK +  +      V Q+FR E  L+  L+HPNI
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYL----------------KEKGALSPSTAVNFA 261
           V  LG  T+ +P  ++ EYL  GDLH++L                  K +L  S  ++ A
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYK 319
           + IA GM YL +  +  +HRDL  RN L+     + L  K+ DFGLS+ I    S D Y+
Sbjct: 131 IQIAAGMEYLSS--HHFVHRDLAARNCLV----GEGLTVKISDFGLSRDIY---SADYYR 181

Query: 320 MTG 322
           +  
Sbjct: 182 VQS 184

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  107 bits (270), Expect = 3e-27
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 17/164 (10%)

Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG++    +       G  VA+K +  S  +      DF  E+ +L  L H NIV
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ--HRSDFEREIEILRTLDHENIV 69

Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G   +   + L LI EYL  G L  YL+  +  ++    + F+  I +GM YL ++ 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
              IHRDL  RN+L+   S D +K+ DFGL+K++      D Y 
Sbjct: 130 --YIHRDLAARNILV--ESEDLVKISDFGLAKVL--PEDKDYYY 167

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  109 bits (273), Expect = 4e-27
 Identities = 59/172 (34%), Positives = 85/172 (49%), Gaps = 10/172 (5%)

Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGA 223
           +G+GSFGE+  A      VA+K +   L      ++ F  E+ +L  L HP NIV+    
Sbjct: 8   LGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66

Query: 224 VTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
             +   L L+ EY+ GG L   LK+   KG LS S A+     I   + YLH     IIH
Sbjct: 67  FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIH 124

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIK--VQNSHDVYKMTGETGSCEYL 330
           RD+KP N+LL +     +K+ DFGL+KL+      S      +   G+  Y+
Sbjct: 125 RDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Length = 384

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  106 bits (267), Expect = 4e-27
 Identities = 64/174 (36%), Positives = 95/174 (54%), Gaps = 16/174 (9%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           W ++  EL    +  IGKG FG+++   +RG  VA+K I      +    Q F  E +++
Sbjct: 1   WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 53

Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
            +LRH N+VQ LG + E K  L ++TEY+  G L  YL+ +G   L     + F+LD+  
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
            M YL  E N  +HRDL  RNVL+  S  +  KV DFGL+K  +  ++ D  K+
Sbjct: 114 AMEYL--EANNFVHRDLAARNVLV--SEDNVAKVSDFGLTK--EASSTQDTGKL 161

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  104 bits (261), Expect = 2e-26
 Identities = 64/161 (39%), Positives = 92/161 (57%), Gaps = 12/161 (7%)

Query: 164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           ++GKG+FGE+ K   +  TPVA+K     L  + L I+ F  E  +L +  HPNIV+ +G
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-LKIK-FLSEARILKQYDHPNIVKLIG 59

Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
             T+R+P+ ++ E + GGD   +L K+K  L     V FALD A GMAYL  E    IHR
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESKNCIHR 117

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           DL  RN L+  ++   LK+ DFG+S+    Q    +Y  +G
Sbjct: 118 DLAARNCLVGENNV--LKISDFGMSR----QEDDGIYSSSG 152

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  103 bits (258), Expect = 9e-26
 Identities = 64/161 (39%), Positives = 88/161 (54%), Gaps = 14/161 (8%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
           IDP +L F     +G G FG +    WRG   VAIK I   S+S+D     +F  E  ++
Sbjct: 1   IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVM 53

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGM 268
           +KL H  +VQ  G  T+++P+ ++TEY+  G L  YL+E G    PS  +    D+  GM
Sbjct: 54  MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGM 113

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           AYL  E    IHRDL  RN  LV+     +KV DFGLS+ +
Sbjct: 114 AYL--ESKQFIHRDLAARNC-LVDDQGC-VKVSDFGLSRYV 150

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  103 bits (258), Expect = 9e-26
 Identities = 64/166 (38%), Positives = 93/166 (56%), Gaps = 14/166 (8%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHE 205
           EI PS +  +   +IG G FGE+ +   +        VAIK + P  ++ +   QDF  E
Sbjct: 1   EIHPSHI--TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSE 56

Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDI 264
            +++ +  H NI++  G VT+ KP M+ITEY+  G L KYL++  G  S    V     I
Sbjct: 57  ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A GM YL +   V  HRDL  RN+ LVNS+ +  KV DFGLS++++
Sbjct: 117 AAGMKYLSDMNYV--HRDLAARNI-LVNSNLE-CKVSDFGLSRVLE 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-25
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 30/191 (15%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS-DDRLVIQD 201
           WE+   ++       +G+GSFG + +   +G       T VAIK +  + S  +R+   +
Sbjct: 1   WELPREKITLIRE--LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI---E 55

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--------GALS 253
           F +E +++ +    ++V+ LG V+  +P +++ E +  GDL  YL+ +        G   
Sbjct: 56  FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 254 PST--AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           P+    +  A +IA GMAYL       +HRDL  RN ++  +    +K+GDFG+++ I  
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMV--AEDLTVKIGDFGMTRDI-- 169

Query: 312 QNSHDVYKMTG 322
               D Y+  G
Sbjct: 170 -YETDYYRKGG 179

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  100 bits (251), Expect = 1e-24
 Identities = 57/172 (33%), Positives = 80/172 (46%), Gaps = 30/172 (17%)

Query: 164 IIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
            +G+G FGE+  A  +G       T V +K +    + D  +  +FR E+++  KL H N
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKN 69

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA--------LSPSTAVNFALDIARG 267
           +V+ LG   E +P  +I EY   GDL ++L+  K          LS    V     IA G
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           M +L N     +HRDL  RN L+  SS   +KV    LSK        DVY 
Sbjct: 130 MDHLSN--ARFVHRDLAARNCLV--SSQREVKVSLLSLSK--------DVYN 169

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =   99 bits (249), Expect = 2e-24
 Identities = 61/164 (37%), Positives = 91/164 (55%), Gaps = 14/164 (8%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WE+    L       +G G FGE+   Y+ G T VAIK    SL    +  + F  E NL
Sbjct: 1   WEVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIK----SLKQGSMSPEAFLAEANL 54

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
           + +L+HP +V+ L AV  ++P+ +ITEY+  G L  +LK  E   L+ +  ++ A  IA 
Sbjct: 55  MKQLQHPRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMA++  E    IHRDL+  N+L+  S     K+ DFGL++LI+
Sbjct: 114 GMAFI--ERKNYIHRDLRAANILV--SETLCCKIADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 99.6 bits (249), Expect = 2e-24
 Identities = 55/165 (33%), Positives = 84/165 (50%), Gaps = 6/165 (3%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           I KG++G +  A  + T    AIK I  +    +  +     E ++L + + P +V+   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +   +K L L+ EYL GGDL   L+  G+L    A  +  +I   + YLH+  N IIHRD
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHS--NGIIHRD 118

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC 327
           LKP N+L+   S  HLK+ DFGLSK+  V+   ++     E    
Sbjct: 119 LKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.2 bits (248), Expect = 3e-24
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 38/174 (21%)

Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ---DFRH-----------EVNLL 209
            IGKGSFG + K         ++R     SD ++++    D+ +           EVN+L
Sbjct: 7   TIGKGSFGTVRK---------VRRK----SDGKILVWKEIDYGNMTEKEKQQLVSEVNIL 53

Query: 210 VKLRHPNIVQFLGAVTER--KPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALD 263
            +L+HPNIV++   + +R  + L ++ EY  GGDL     K  KE+  +           
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 264 IARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           +   +   HN     N ++HRDLKP N+ L   + +++K+GDFGL+K++   +S
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFL--DANNNVKLGDFGLAKILGHDSS 165

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.6 bits (246), Expect = 7e-24
 Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 9/152 (5%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  +  G  VAIK+I      + +     R E+ LL +L HPNI++ L 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
               +  L L+ E++   DL+K +K++   L  S   ++   + +G+A+ H+  + I+HR
Sbjct: 66  VFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--HGILHR 122

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
           DLKP N+L+  ++   LK+ DFGL++      
Sbjct: 123 DLKPENLLI--NTEGVLKLADFGLARSFGSPV 152

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 97.8 bits (243), Expect = 8e-24
 Identities = 56/161 (34%), Positives = 85/161 (52%), Gaps = 13/161 (8%)

Query: 165 IGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G+FGE+     R   TPVA+K    +L  D  +   F  E  +L +  HPNIV+ +G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIG 60

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
             T+++P+ ++ E ++GGD   +L+ +G  L     +    + A GM YL  E    IHR
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESKHCIHR 118

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           DL  RN L+   +   LK+ DFG+S+    +    VY  TG
Sbjct: 119 DLAARNCLVTEKNV--LKISDFGMSR----EEEDGVYASTG 153

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 98.3 bits (245), Expect = 9e-24
 Identities = 53/162 (32%), Positives = 81/162 (50%), Gaps = 23/162 (14%)

Query: 165 IGKGSFGEILKAYWRGT-------PVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +G G+FGE+ +  +RG         VA+K +    S  D+     DF  E  ++ K  H 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE----SDFLMEALIMSKFNHQ 69

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGM 268
           NIV+ +G   ER P  ++ E + GGDL  +L+E         +L+    +  A D+A+G 
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
            YL  E N  IHRD+  RN LL       + K+ DFG+++ I
Sbjct: 130 KYL--EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.9 bits (244), Expect = 1e-23
 Identities = 60/182 (32%), Positives = 93/182 (51%), Gaps = 32/182 (17%)

Query: 165 IGKGSFGEILKAYWR-GTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+G+FG++         P      VA+K +  + S+D    +DF  E  LL   +H NI
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENI 70

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK--------------EKGALSPSTAVNFALD 263
           V+F G  TE  P +++ EY+  GDL+K+L+                G L+ S  +  A+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTG 322
           IA GM YL ++  V  HRDL  RN L+     D + K+GDFG+S+ +    + D Y++ G
Sbjct: 131 IASGMVYLASQHFV--HRDLATRNCLV---GYDLVVKIGDFGMSRDVY---TTDYYRVGG 182

Query: 323 ET 324
            T
Sbjct: 183 HT 184

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 62/177 (35%), Positives = 87/177 (49%), Gaps = 24/177 (13%)

Query: 164 IIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            IG G++G +  A     G  VAIK+I     D     +  R E+ LL  LRH NI+  L
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLL 65

Query: 222 GAVTERKP-----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--NE 274
             +    P     + ++TE +   DLHK +K    L+      F   I RG+ YLH  N 
Sbjct: 66  DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN- 123

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLV 331
              +IHRDLKP N +LVNS+ D LK+ DFGL++ +        + +T      EY+V
Sbjct: 124 ---VIHRDLKPSN-ILVNSNCD-LKICDFGLARGVDPDEDEKGF-LT------EYVV 168

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 95.9 bits (239), Expect = 9e-23
 Identities = 52/138 (37%), Positives = 74/138 (53%), Gaps = 21/138 (15%)

Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242
           VA+K + P  SD+    +DF  EV +L +L  PNI + LG  T   PL +I EY+  GDL
Sbjct: 49  VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 243 HKYLKE-----------KGALSPSTAVNFALDIARGMAYL--HNEPNVIIHRDLKPRNVL 289
           +++L++             +LS ST +  A  IA GM YL   N     +HRDL  RN  
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNC- 161

Query: 290 LVNSSADHLKVGDFGLSK 307
           LV  +   +K+ DFG+S+
Sbjct: 162 LVGKNY-TIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 94.9 bits (236), Expect = 1e-22
 Identities = 49/147 (33%), Positives = 82/147 (55%), Gaps = 8/147 (5%)

Query: 163 AIIGKGSFGEILKA--YWRGTPVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
             +G G+F    +A     GT +A+K++     + S+   V++  R E+ L+ +L HP+I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           ++ LGA  E     L  E++ GG +   L + GA   +  +N+   + RG++YLH   N 
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE--NQ 123

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFG 304
           IIHRD+K  N LL++S+   L++ DFG
Sbjct: 124 IIHRDVKGAN-LLIDSTGQRLRIADFG 149

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 55/145 (37%), Positives = 77/145 (53%), Gaps = 11/145 (7%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IGKGSFGE+ KA  + T   VAIK I L    D+   I+D + E+  L + R P I ++ 
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE---IEDIQQEIQFLSQCRSPYITKYY 65

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           G+  +   L +I EY  GG     LK  G L  +       ++  G+ YLH E    IHR
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEGK--IHR 122

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLS 306
           D+K  N+LL +   D +K+ DFG+S
Sbjct: 123 DIKAANILL-SEEGD-VKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 94.3 bits (234), Expect = 2e-22
 Identities = 58/164 (35%), Positives = 89/164 (54%), Gaps = 13/164 (7%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    +       +G G FGE+   Y+   T VA+K + P      + +Q F  E NL
Sbjct: 1   WEIPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANL 54

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
           +  L+H  +V+    VT+ +P+ +ITEY+  G L  +LK  E G +     ++F+  IA 
Sbjct: 55  MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    IHRDL+  NVL+  S +   K+ DFGL+++I+
Sbjct: 115 GMAYI--ERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIE 154

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 94.4 bits (235), Expect = 3e-22
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 37/204 (18%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDR 196
           LP   +WE+    L  +    +G+G+FG+++KA   G         VA+K +    ++  
Sbjct: 1   LPLDPEWELPRDRL--TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58

Query: 197 LVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------ 249
           L   D   E+ ++  + +H NI+  LG  T+  PL ++ EY   G+L  +L+ +      
Sbjct: 59  LS--DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEY 116

Query: 250 ----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-L 298
                       L+    V+FA  +ARGM +L       IHRDL  RNVL+   + DH +
Sbjct: 117 ASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLV---TEDHVM 171

Query: 299 KVGDFGLSKLIKVQNSHDVYKMTG 322
           K+ DFGL++ I   +  D Y+ T 
Sbjct: 172 KIADFGLARDI---HHIDYYRKTT 192

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.4 bits (232), Expect = 4e-22
 Identities = 57/153 (37%), Positives = 84/153 (54%), Gaps = 12/153 (7%)

Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDD-----RLVIQDFRHEVNLLVKLRH 214
           A+IG GSFG +        G  +A+K++ LPS+S       R ++     E+ LL +L+H
Sbjct: 6   ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
            NIVQ+LG+  +   L +  EY+ GG +   L   GA   +   NF   I +G+ YLHN 
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              IIHRD+K  N+L+ N     +K+ DFG+SK
Sbjct: 126 G--IIHRDIKGANILVDNKGG--IKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 4e-22
 Identities = 58/161 (36%), Positives = 94/161 (58%), Gaps = 22/161 (13%)

Query: 162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---H 214
            A IG+G++G + KA  R    G  VA+K++   LS++ + +   R E+ LL +L    H
Sbjct: 4   LAEIGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEH 60

Query: 215 PNIVQFL----GAVTERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
           PNIV+ L    G  T+R+  L L+ E++   DL  YL +  K  L P T  +    + RG
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           + +LH+  + I+HRDLKP+N+L+  +S   +K+ DFGL+++
Sbjct: 120 VDFLHS--HRIVHRDLKPQNILV--TSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 93.7 bits (233), Expect = 5e-22
 Identities = 60/187 (32%), Positives = 88/187 (47%), Gaps = 38/187 (20%)

Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           IG+G+FG + +A   G       T VA+K +    S D  +  DF+ E  L+ +  HPNI
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDHPNI 70

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE----------------------KGALSPS 255
           V+ LG     KP+ L+ EY+  GDL+++L+                          LS +
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
             +  A  +A GMAYL       +HRDL  RN L+  +    +K+ DFGLS+ I    S 
Sbjct: 131 EQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGENMV--VKIADFGLSRNIY---SA 183

Query: 316 DVYKMTG 322
           D YK + 
Sbjct: 184 DYYKASE 190

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 93.0 bits (232), Expect = 5e-22
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 7/147 (4%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GS G + K   + T    A+K+I   +  D    +    E+  L     P +V+  G
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           A  +   + ++ EY+ GG L   LK+ G +        A  I +G+ YLH + + IIHRD
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH-IIHRD 125

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +KP N+L+  +S   +K+ DFG+SK++
Sbjct: 126 IKPSNLLI--NSKGEVKIADFGISKVL 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.0 bits (231), Expect = 7e-22
 Identities = 58/161 (36%), Positives = 88/161 (54%), Gaps = 12/161 (7%)

Query: 164 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +IG G FGE+ +        R   VAIK +    ++ +   +DF  E +++ +  HPNI+
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNII 68

Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNV 277
              G VT+ +P+M+ITE++  G L  +L++  G  +    V     IA GM YL +E N 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-SEMNY 127

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
            +HRDL  RN+ LVNS+    KV DFGLS+ ++   S   Y
Sbjct: 128 -VHRDLAARNI-LVNSNL-VCKVSDFGLSRFLEDDTSDPTY 165

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 92.9 bits (231), Expect = 7e-22
 Identities = 51/170 (30%), Positives = 88/170 (51%), Gaps = 16/170 (9%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
           D +    IG+G FG++ +  +         VA+K      S    V + F  E  ++ + 
Sbjct: 7   DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS--VREKFLQEAYIMRQF 64

Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYL 271
            HP+IV+ +G +TE  P+ ++ E    G+L  YL   K +L  ++ + ++  ++  +AYL
Sbjct: 65  DHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
            ++  V  HRD+  RNVL+  SS D +K+GDFGLS+ +        YK +
Sbjct: 124 ESKRFV--HRDIAARNVLV--SSPDCVKLGDFGLSRYL---EDESYYKAS 166

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 92.6 bits (231), Expect = 9e-22
 Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 17/159 (10%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH-----EVNLLV 210
           DF    IIG+GSF  ++ A  +      AIK +     D R +I++ +      E  +L 
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-----DKRQLIKEKKVKYVKIEKEVLT 56

Query: 211 KL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
           +L  HP I++      + + L  + EY   G+L +Y+++ G+L       +A +I   + 
Sbjct: 57  RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           YLH+    IIHRDLKP N+LL      H+K+ DFG +K+
Sbjct: 117 YLHS--KGIIHRDLKPENILL--DKDMHIKITDFGTAKV 151

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.3 bits (229), Expect = 1e-21
 Identities = 63/177 (35%), Positives = 91/177 (51%), Gaps = 15/177 (8%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           ID S +      +IG G FGE+          R  PVAIK +    ++ +   +DF  E 
Sbjct: 1   IDASCIKIEK--VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEA 56

Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIA 265
           +++ +  HPNI+   G VT+ KP+M++TEY+  G L  +L K  G  +    V     IA
Sbjct: 57  SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIA 116

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            GM YL +   V  HRDL  RN+ LVNS+    KV DFGLS++++  +    Y   G
Sbjct: 117 SGMKYLSDMGYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRVLE-DDPEAAYTTRG 168

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 92.6 bits (231), Expect = 1e-21
 Identities = 55/159 (34%), Positives = 84/159 (52%), Gaps = 11/159 (6%)

Query: 163 AIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           A IG+G++G++ KA  + T   VA+K+I      +   I   R E+ LL KLRHPNIV+ 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63

Query: 221 LGAVTERKP--LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNV 277
              VT +    + ++ EY+   DL   L       + S    +   +  G+ YLH+  N 
Sbjct: 64  KEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS--NG 120

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
           I+HRD+K  N+L+ N     LK+ DFGL++    +NS D
Sbjct: 121 ILHRDIKGSNILINNDG--VLKLADFGLARPYTKRNSAD 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 93.0 bits (231), Expect = 1e-21
 Identities = 57/161 (35%), Positives = 86/161 (53%), Gaps = 17/161 (10%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG +  A     G  VAIK+I+   S   L  + +R E+ LL  LRH NI+    
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76

Query: 223 A-VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
             ++  + +  +TE L G DLH+ L  +  L       F   I RG+ Y+H+    ++HR
Sbjct: 77  IFISPLEDIYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG--VVHR 132

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           DLKP N +L+N + D LK+ DFGL+   ++Q+      MTG
Sbjct: 133 DLKPSN-ILINENCD-LKICDFGLA---RIQDPQ----MTG 164

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 91.6 bits (228), Expect = 2e-21
 Identities = 49/147 (33%), Positives = 81/147 (55%), Gaps = 9/147 (6%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G+ G + KA  R T   VA+K++     +  +  Q  R E+  L   +HP +V+ L 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66

Query: 223 AVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
                   +L+ EY+   DL + L+ E+  L  +   ++   + +G+AY+H   N I+HR
Sbjct: 67  VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA--NGIMHR 123

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKL 308
           DLKP N+L+  S+   LK+ DFGL++L
Sbjct: 124 DLKPANLLI--SADGVLKIADFGLARL 148

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.7 bits (228), Expect = 3e-21
 Identities = 54/169 (31%), Positives = 91/169 (53%), Gaps = 16/169 (9%)

Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S ++    ++DF  E+ +L  L+H NIV
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH---LRDFEREIEILKSLQHDNIV 68

Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L L+ EYL  G L  YL K +  L     + +A  I +GM YL ++ 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              +HRDL  RN+L+ + +   +K+GDFGL+K++     +   +  GE+
Sbjct: 129 --YVHRDLATRNILVESEN--RVKIGDFGLTKVLPQDKEYYKVREPGES 173

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 91.2 bits (227), Expect = 3e-21
 Identities = 49/150 (32%), Positives = 82/150 (54%), Gaps = 11/150 (7%)

Query: 165 IGKGSFGEILKAYW--RGTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           IG G+FG++  A     G  +A+K  RI  +   D   I++   E+ +L  L+HPN+V++
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDN---DPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
            G    R+ + +  EY  GG L + L+    L       + L +  G+AYLH+  + I+H
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS--HGIVH 122

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           RD+KP N+ L ++    +K+GDFG +  +K
Sbjct: 123 RDIKPANIFLDHNGV--IKLGDFGCAVKLK 150

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.1 bits (224), Expect = 6e-21
 Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 6/149 (4%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           +IGKG+FG++     R T    A+K +      ++  +++  +E  +L +L HP +V   
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +  + + + L+ + L GGDL  +L +K   S      +  +I   + YLH+    IIHR
Sbjct: 67  YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS--KGIIHR 124

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           D+KP N+LL      H+ + DF ++  + 
Sbjct: 125 DIKPDNILLDEQG--HVHITDFNIATKVT 151

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.1 bits (223), Expect = 7e-21
 Identities = 60/164 (36%), Positives = 86/164 (52%), Gaps = 14/164 (8%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G G FGE+    W G T VA+K + P      +  + F  E  +
Sbjct: 1   WEIPRESLQLIKK--LGNGQFGEVWMGTWNGNTKVAVKTLKPG----TMSPESFLEEAQI 54

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
           + KLRH  +VQ L AV   +P+ ++TEY+  G L  +LK  E  AL     V+ A  +A 
Sbjct: 55  MKKLRHDKLVQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    IHRDL+  N+L+ +      K+ DFGL++LI+
Sbjct: 114 GMAYI--ERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.3 bits (225), Expect = 7e-21
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 12/166 (7%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP EL + +   IG+G+ GE+ KA  R T   VAIK++     +  L+I     E+ ++ 
Sbjct: 16  DPREL-YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN----EILIMK 70

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMA 269
             +HPNIV +  +      L ++ EY+ GG L   + +    ++         ++ +G+ 
Sbjct: 71  DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE 130

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           YLH+    +IHRD+K  N+LL  S    +K+ DFG +  +  + S 
Sbjct: 131 YLHS--QNVIHRDIKSDNILL--SKDGSVKLADFGFAAQLTKEKSK 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.7 bits (222), Expect = 8e-21
 Identities = 60/166 (36%), Positives = 88/166 (53%), Gaps = 18/166 (10%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P      +  + F  E  +
Sbjct: 1   WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQV 54

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK +    L     V+ A  IA 
Sbjct: 55  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+     ++L  KV DFGL++LI+
Sbjct: 114 GMAYV--ERMNYVHRDLRAANILV----GENLVCKVADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.2 bits (221), Expect = 1e-20
 Identities = 55/161 (34%), Positives = 87/161 (54%), Gaps = 16/161 (9%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           W ++  +L      IIG+G FG +L+  + G  VA+K I   ++      Q F  E  ++
Sbjct: 1   WLLNLQKLTLG--EIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-----AQAFLEETAVM 53

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTA--VNFALDIARG 267
            KL H N+V+ LG +     L ++ E +  G+L  +L+ +G    S    + F+LD+A G
Sbjct: 54  TKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSK 307
           M YL  E   ++HRDL  RN+L+   S D + KV DFGL++
Sbjct: 113 MEYL--ESKKLVHRDLAARNILV---SEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 62/181 (34%), Positives = 94/181 (51%), Gaps = 20/181 (11%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
           P  LP    WE   + L F     +G G+FG++++A   G         VA+K + P+  
Sbjct: 21  PTQLPYDLKWEFPRNNLSFGK--TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH 78

Query: 193 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA 251
           S +R   +    E+ ++  L  H NIV  LGA T   P+++ITEY   GDL  +L+ K  
Sbjct: 79  SSER---EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135

Query: 252 --LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
             L+    ++F+  +A+GMA+L       IHRDL  RNVLL +     +K+ DFGL++ I
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDI 191

Query: 310 K 310
            
Sbjct: 192 M 192

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.1 bits (221), Expect = 1e-20
 Identities = 58/182 (31%), Positives = 85/182 (46%), Gaps = 33/182 (18%)

Query: 164 IIGKGSFGEILKAYWRGT------------PVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
            +G G+FGE+    + GT             VA+K +    +D      +F  E +L+  
Sbjct: 2   FLGSGAFGEV----YEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSN 55

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------LSPSTAVNFALDI 264
             HPNIV+ LG     +P  +I E + GGDL  YL++          L+    ++  LD+
Sbjct: 56  FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMT 321
           A+G  YL  E    IHRDL  RN L+     D    +K+GDFGL++ I      D Y+  
Sbjct: 116 AKGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY---KSDYYRKE 170

Query: 322 GE 323
           GE
Sbjct: 171 GE 172

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 54/149 (36%), Positives = 78/149 (52%), Gaps = 10/149 (6%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G++G++ KA     G  VAIK I     DD  +IQ    E+++L + RHPNIV + G
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFG 67

Query: 223 AVTERKPLMLITEYLRGGDLHK-YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           +   R  L ++ EY  GG L   Y   +G LS         +  +G+AYLH      IHR
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--TGKIHR 125

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           D+K  N+LL  +    +K+ DFG+S  + 
Sbjct: 126 DIKGANILL--TEDGDVKLADFGVSAQLT 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 8/153 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH 214
           D      +G G+FG +     R      A+K + +P +   +   Q   +E  +L ++ H
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P I++      +++ L ++ EY+ GG+L  YL+  G  S ST + +A +I   + YLH++
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              I++RDLKP N+LL      H+K+ DFG +K
Sbjct: 121 E--IVYRDLKPENILL--DKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (219), Expect = 2e-20
 Identities = 55/153 (35%), Positives = 87/153 (56%), Gaps = 10/153 (6%)

Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           ++G+G+FGE+   Y    G  +A+K++   P   +    +     E+ LL  LRH  IVQ
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 220 FLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           + G +   E K L +  EY+ GG +   LK  GAL+ +    +   I +G++YLH+  N+
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS--NM 126

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           I+HRD+K  N+L    SA ++K+GDFG SK I+
Sbjct: 127 IVHRDIKGANIL--RDSAGNVKLGDFGASKRIQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 88.2 bits (218), Expect = 3e-20
 Identities = 55/164 (33%), Positives = 94/164 (57%), Gaps = 14/164 (8%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G G FGE+ +  Y + T VA+K + P      + ++ F  E N+
Sbjct: 1   WEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANV 54

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSP-STAVNFALDIAR 266
           +  L+H  +V+ L AV  ++P+ +ITE++  G L  +LK ++G+  P    ++F+  IA 
Sbjct: 55  MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMA++  E    IHRDL+  N+L+  S++   K+ DFGL+++I+
Sbjct: 114 GMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVIE 153

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 88.7 bits (221), Expect = 3e-20
 Identities = 50/155 (32%), Positives = 79/155 (50%), Gaps = 20/155 (12%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSD-DRLVIQDFRHEVNLLVKL-RHPNI 217
           +G G+FG +  A  +  G  VAIK++     S  +   L       EV  L KL  HPNI
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL------REVKSLRKLNEHPNI 60

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEP 275
           V+      E   L  + EY+ G +L++ +K  +    S S   +    I +G+A++H   
Sbjct: 61  VKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-- 117

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +   HRDLKP N+L+  S  + +K+ DFGL++ I+
Sbjct: 118 HGFFHRDLKPENLLV--SGPEVVKIADFGLAREIR 150

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 61/184 (33%), Positives = 92/184 (50%), Gaps = 36/184 (19%)

Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+G+FG++  A             VA+K +  +    R   QDF+ E  LL  L+H +I
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---------------GALSPSTAVNFAL 262
           V+F G  TE +PL+++ EY+R GDL+++L+                 G L+    +  A 
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKM 320
            IA GM YL +     +HRDL  RN L+       L  K+GDFG+S+ I    S D Y++
Sbjct: 130 QIASGMVYLASLH--FVHRDLATRNCLV----GQGLVVKIGDFGMSRDIY---STDYYRV 180

Query: 321 TGET 324
            G T
Sbjct: 181 GGRT 184

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 59/180 (32%), Positives = 97/180 (53%), Gaps = 27/180 (15%)

Query: 165 IGKGSFGEILKAY-WRGTPVAIKRILP--SLSDDRLVI-QDFRHEVNLLVKLRHPNIVQF 220
           +G+G+FG++  A  +  +P   K ++   +L D  L   +DF+ E  LL  L+H +IV+F
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDI 264
            G   +  PL+++ EY++ GDL+K+L+                 KG L  S  ++ A  I
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           A GM YL ++    +HRDL  RN L+  +    +K+GDFG+S+ +    S D Y++ G T
Sbjct: 133 ASGMVYLASQH--FVHRDLATRNCLVGANLL--VKIGDFGMSRDVY---STDYYRVGGHT 185

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 87.7 bits (217), Expect = 7e-20
 Identities = 59/187 (31%), Positives = 92/187 (49%), Gaps = 45/187 (24%)

Query: 164 IIGKGSFGEILKAY---WRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
            +G+G FG+++KA     +G    T VA+K +  + S   L  +D   E NLL ++ HP+
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL--RDLLSEFNLLKQVNHPH 64

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS--------------------- 255
           +++  GA ++  PL+LI EY + G L  +L+E   + PS                     
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 256 ---TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
                ++FA  I+RGM YL      ++HRDL  RNVL+       +K+ DFGLS+     
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRK--MKISDFGLSR----- 175

Query: 313 NSHDVYK 319
              DVY+
Sbjct: 176 ---DVYE 179

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 54/160 (33%), Positives = 88/160 (55%), Gaps = 10/160 (6%)

Query: 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKL 212
           +++    ++G+G+FG +   Y    G  +A K++   P   +    +     E+ LL  L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 213 RHPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +H  IVQ+ G + +R  K L +  EY+ GG +   LK  GAL+ S    +   I  GM+Y
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSY 121

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           LH+  N+I+HRD+K  N+L    SA ++K+GDFG SK ++
Sbjct: 122 LHS--NMIVHRDIKGANIL--RDSAGNVKLGDFGASKRLQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 87.2 bits (217), Expect = 1e-19
 Identities = 53/149 (35%), Positives = 86/149 (57%), Gaps = 12/149 (8%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G+G++  + KA  +  G  VAIK+I       + D +     R E+ LL +L+HPNI+ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVI 278
            L     +  + L+ E++   DL K +K+K   L+P+   ++ L   RG+ YLH+  N I
Sbjct: 67  LLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS--NWI 123

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +HRDLKP N+L+  +S   LK+ DFGL++
Sbjct: 124 LHRDLKPNNLLI--ASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 87.2 bits (217), Expect = 1e-19
 Identities = 50/159 (31%), Positives = 84/159 (52%), Gaps = 14/159 (8%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLV----IQDFRHEVNLLVK 211
           DF     +G GSFG ++    +G+    A+K     LS  ++V    ++   +E  +L  
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI----LSKAKIVKLKQVEHVLNEKRILQS 57

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           +RHP +V   G+  +   L L+ EY+ GG+L  +L++ G      A  +A  +   + YL
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           H+    I++RDLKP N+LL   S  ++K+ DFG +K +K
Sbjct: 118 HS--LDIVYRDLKPENLLL--DSDGYIKITDFGFAKRVK 152

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 53/147 (36%), Positives = 82/147 (55%), Gaps = 11/147 (7%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 221
           IG+G++G + KA  R     VA+KR+   L DD   +      E+ LL +L+H NIV+  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV--RLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
             +   K L L+ EY    DL KY     G + P    +F   + +G+A+ H+    ++H
Sbjct: 66  DVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLH 122

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLKP+N LL+N + + LK+ DFGL++
Sbjct: 123 RDLKPQN-LLINKNGE-LKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.4 bits (214), Expect = 2e-19
 Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 12/152 (7%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G++  + K   R T   VA+K I   L  +         E++L+ +L+H NIV+   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEI--HLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 223 AVTERKPLMLITEYLRGGDLHKYLK---EKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
            +     LML+ EY+   DL KY+     +GAL P+T  +F   + +G+A+ H   N ++
Sbjct: 66  VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVL 122

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           HRDLKP+N LL+N   + LK+ DFGL++   +
Sbjct: 123 HRDLKPQN-LLINKRGE-LKLADFGLARAFGI 152

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 51/148 (34%), Positives = 81/148 (54%), Gaps = 9/148 (6%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G++G +LK   + T   VAIK+   S  DD  V +    EV +L +LRH NIV    
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           A   +  L L+ EY+    L + L+   G L P    ++   + + +AY H+  + IIHR
Sbjct: 68  AFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHR 124

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           D+KP N+L+  S +  LK+ DFG ++ +
Sbjct: 125 DIKPENILV--SESGVLKLCDFGFARAL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 10/149 (6%)

Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG F  + KA     G  VA+K++      D    QD   E++LL +L HPN++++L 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 223 AVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYLHNEPNVI 278
           +  E   L ++ E    GDL    K+ K++  L P   +  + + +   + ++H++   I
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--I 127

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +HRD+KP NV +  +    +K+GD GL +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGR 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.1 bits (210), Expect = 4e-19
 Identities = 60/166 (36%), Positives = 88/166 (53%), Gaps = 18/166 (10%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P      ++ + F  E  +
Sbjct: 1   WEIPRESLRLDVK--LGQGCFGEVWMGTWNGTTKVAIKTLKPG----TMMPEAFLQEAQI 54

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 266
           + KLRH  +V     V+E +P+ ++TE++  G L  +LKE     L     V+ A  IA 
Sbjct: 55  MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIK 310
           GMAY+  E    IHRDL+  N+L+     D+L  K+ DFGL++LI+
Sbjct: 114 GMAYI--ERMNYIHRDLRAANILV----GDNLVCKIADFGLARLIE 153

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 85.5 bits (211), Expect = 5e-19
 Identities = 59/180 (32%), Positives = 96/180 (53%), Gaps = 30/180 (16%)

Query: 165 IGKGSFGEILKAY-WRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+G+FG++  A  +   P      VA+K +  +  + R   +DF  E  LL  L+H +I
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQHEHI 69

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------------LSPSTAVNFALDI 264
           V+F G   E  PL+++ EY++ GDL+K+L+  G              L+ S  ++ A  I
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           A GM YL ++    +HRDL  RN L+  +    +K+GDFG+S+ +    S D Y++ G T
Sbjct: 130 AAGMVYLASQH--FVHRDLATRNCLVGENLL--VKIGDFGMSRDVY---STDYYRVGGHT 182

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.1 bits (208), Expect = 7e-19
 Identities = 51/153 (33%), Positives = 88/153 (57%), Gaps = 14/153 (9%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPS---LSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           ++G+G+FG +     +     V IK+I P      D+RL  Q+   E  +L  L HPNI+
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQN---ECQVLKLLSHPNII 62

Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPN 276
           ++     E K LM++ EY  GG L +Y++++    L   T ++F + I   + ++H +  
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-- 120

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +I+HRDLK +N+LL +     +K+GDFG+SK++
Sbjct: 121 LILHRDLKTQNILL-DKHKMVVKIGDFGISKIL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 60/167 (35%), Positives = 93/167 (55%), Gaps = 22/167 (13%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP+   F    +IG+G++G++ KA  +  G  VAIK I+  + D+    ++ + E N+L 
Sbjct: 3   DPTG-IFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDE---EEEIKEEYNILR 57

Query: 211 KL-RHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNF 260
           K   HPNI  F GA  ++ P      L L+ E   GG   DL K L++KG       + +
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117

Query: 261 AL-DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            L +  RG+AYLH   N +IHRD+K +N+LL  ++   +K+ DFG+S
Sbjct: 118 ILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNA--EVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 84.2 bits (208), Expect = 8e-19
 Identities = 50/163 (30%), Positives = 86/163 (52%), Gaps = 10/163 (6%)

Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G+FG + K  ++       VA+K IL + ++D  +  +   E N++ +L +P IV+ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
           +G + E +  ML+ E    G L+K+L++   ++          ++ GM YL  E    +H
Sbjct: 62  IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL--EETNFVH 118

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
           RDL  RNVLLV  +  + K+ DFGLSK +    ++   K  G+
Sbjct: 119 RDLAARNVLLV--TQHYAKISDFGLSKALGADENYYKAKTHGK 159

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.0 bits (208), Expect = 9e-19
 Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 15/161 (9%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLR 213
           DF     +GKGS+G + K   R       A+K + L S+S      +D  +E+ +L  + 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKER--EDAVNEIRILASVN 57

Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAV-NFALDIARGMA 269
           HPNI+ +  A  +   L ++ EY   GDL K +   K+K  L P   +    + + RG+ 
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            LH     I+HRDLK  N+LLV +  D +K+GD G+SK++K
Sbjct: 118 ALHE--QKILHRDLKSANILLVAN--DLVKIGDLGISKVLK 154

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 84.6 bits (209), Expect = 1e-18
 Identities = 57/186 (30%), Positives = 93/186 (50%), Gaps = 37/186 (19%)

Query: 165 IGKGSFGEI-------LKAY-------WRGTP--VAIKRILPSLSDDRLVIQDFRHEVNL 208
           +G+G FGE+       L  +       + G P  VA+K +   ++  +    DF  E+ +
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKI 70

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN--------- 259
           + +L++PNI++ LG      PL +ITEY+  GDL+++L ++   S  T  N         
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 260 ---FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
               A+ IA GM YL +     +HRDL  RN L+ N     +K+ DFG+S+ +    S D
Sbjct: 131 LLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYT--IKIADFGMSRNLY---SGD 183

Query: 317 VYKMTG 322
            Y++ G
Sbjct: 184 YYRIQG 189

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 53/147 (36%), Positives = 84/147 (57%), Gaps = 10/147 (6%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  +  G  VA+K+I    ++D  V      E++LL +L HPNIV+ L 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 223 AVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
            V     L L+ E+L   DL KY+       L P    ++   + +G+AY H+  + ++H
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLH 122

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLKP+N LL++     LK+ DFGL++
Sbjct: 123 RDLKPQN-LLIDREGA-LKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 58/181 (32%), Positives = 93/181 (51%), Gaps = 28/181 (15%)

Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQ--DFRHEVNLLVKLRHPNIVQF 220
           +G+ +FG+I K   Y  G   A    + +L D     Q  +F+ E +L+ +L HPNIV  
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-----------------KEKGALSPSTAVNFALD 263
           LG VT+ +P+ ++ EYL  GDLH++L                   K +L     ++ A+ 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
           IA GM YL +  +  +H+DL  RN+L+      H+K+ D GLS+ I    S D Y++  +
Sbjct: 133 IAAGMEYLSS--HFFVHKDLAARNILI--GEQLHVKISDLGLSREIY---SADYYRVQPK 185

Query: 324 T 324
           +
Sbjct: 186 S 186

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 53/160 (33%), Positives = 85/160 (53%), Gaps = 9/160 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     IGKGSFG + K   +      A+K+I  S   +R   ++   E  +L KL   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS-KMNRREREEAIDEARVLAKLDSS 59

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAV-NFALDIARGMAYLHN 273
            I+++  +  ++  L ++ EY   GDLHK LK ++G   P   V  F + I  G+A+LH+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
               I+HRD+K  N+ L   + D++K+GD G++KL+    
Sbjct: 120 --KKILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNT 155

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 56/165 (33%), Positives = 86/165 (52%), Gaps = 20/165 (12%)

Query: 164 IIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRL------VIQDFRHEVNLLVKLRH 214
           +IGKG++G +  A     G  +A+K++ LP+    R       +++  R E+  L  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
            NIVQ+LG  T  + L +  EY+ GG +   L+  G         F   +  G+AYLH++
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 275 PNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVY 318
              I+HRDLK  N+L+    AD + K+ DFG+SK      S D+Y
Sbjct: 128 G--ILHRDLKADNLLV---DADGICKISDFGISK-----KSDDIY 162

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 53/159 (33%), Positives = 87/159 (54%), Gaps = 15/159 (9%)

Query: 164 IIGKGSFGE-ILKAYWR---GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           ++GKG+FGE  L  Y R    + V  K + L  LS+     +D  +E+ +L  L+HPNI+
Sbjct: 7   VLGKGAFGEATL--YRRTEDDSLVVWKEVNLTRLSEK--ERRDALNEIVILSLLQHPNII 62

Query: 219 QFLGAVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFAL-DIARGMAYLHNEPN 276
            +     +   L++  EY  GG L+ K +++KG L     V + L  I   ++Y+H    
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
            I+HRD+K  N+ L  + A  +K+GDFG+SK++  + S 
Sbjct: 122 -ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSM 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 83.0 bits (205), Expect = 3e-18
 Identities = 62/164 (37%), Positives = 87/164 (53%), Gaps = 17/164 (10%)

Query: 165 IGKGSFGE-ILKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG+  L  Y       G  VA+K +             ++ E+N+L  L H NIV
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIV 69

Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           ++ G  +E+  K L LI EY+  G L  YL  K  L+ +  + FA  I  GMAYLH++  
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLHSQH- 127

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
             IHRDL  RNVLL N     +K+GDFGL+K   V   H+ Y++
Sbjct: 128 -YIHRDLAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEYYRV 166

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 61/171 (35%), Positives = 85/171 (49%), Gaps = 27/171 (15%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL- 212
           D     +IG+G+FG++LKA  +        AIKR+    S D    +DF  E+ +L KL 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65

Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPST 256
            HPNI+  LGA   R  L L  EY   G+L  +L++                   LS   
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            ++FA D+ARGM YL  +    IHRDL  RN+L+  +     K+ DFGLS+
Sbjct: 126 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV--AKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 82.7 bits (204), Expect = 4e-18
 Identities = 53/155 (34%), Positives = 83/155 (53%), Gaps = 15/155 (9%)

Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG++    +       G  VA+K + P    +   I D + E+ +L  L H NIV
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 69

Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G  TE     + LI E+L  G L +YL + K  ++    + +A+ I +GM YL +  
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            V  HRDL  RNVL+ +     +K+GDFGL+K I+
Sbjct: 130 YV--HRDLAARNVLVESEHQ--VKIGDFGLTKAIE 160

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 82.3 bits (204), Expect = 4e-18
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 12/154 (7%)

Query: 156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           E  F     +G+GS+G + KA  +  G  VAIK ++P   D    +Q+   E+++L +  
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIK-VVPVEED----LQEIIKEISILKQCD 56

Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLH 272
            P IV++ G+  +   L ++ EY   G +   +K          +   L    +G+ YLH
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +  N  IHRD+K  N+LL  +     K+ DFG+S
Sbjct: 117 S--NKKIHRDIKAGNILL--NEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.3 bits (203), Expect = 5e-18
 Identities = 57/180 (31%), Positives = 88/180 (48%), Gaps = 29/180 (16%)

Query: 159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVK 211
           F+   ++GKG FG + +A  +        VA+K +   +  S D   I++F  E   + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD---IEEFLREAACMKE 57

Query: 212 LRHPNIVQFLGAVTERKPL------MLITEYLRGGDLHKYL------KEKGALSPSTAVN 259
             HPN+++ +G     +        M+I  +++ GDLH +L      +E   L   T V 
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           F +DIA GM YL ++    IHRDL  RN +L  +    + V DFGLSK I    S D Y+
Sbjct: 118 FMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMT--VCVADFGLSKKIY---SGDYYR 170

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.0 bits (203), Expect = 5e-18
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 15/149 (10%)

Query: 165 IGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+   +  A        VAIKRI   L   +  + + R EV  + +  HPN+V++  
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 223 AVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
           +      L L+  YL GG L    K    +G L  +       ++ +G+ YLH+  N  I
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQI 124

Query: 280 HRDLKPRNVLLVNSSADH--LKVGDFGLS 306
           HRD+K  N+LL     +   +K+ DFG+S
Sbjct: 125 HRDIKAGNILL----GEDGSVKIADFGVS 149

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 8/166 (4%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG+G+FGE+     + T    A+K +  S    R  I   R E ++L     P
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            IV+   +  + + L L+ EY+ GGDL   L  K      TA  +  ++   +  +H   
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
              IHRD+KP N+L+   +  H+K+ DFGL K  K+  + D     
Sbjct: 122 --FIHRDIKPDNILI--DADGHIKLADFGLCK--KMNKAKDREYYL 161

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 81.4 bits (201), Expect = 1e-17
 Identities = 58/160 (36%), Positives = 84/160 (52%), Gaps = 14/160 (8%)

Query: 156 ELDFSSS---AIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLV 210
           E ++  +    ++GKG++G +  A    T V  AIK I     D R V Q    E+ L  
Sbjct: 4   EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYV-QPLHEEIALHS 60

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSP--STAVNFALDIARG 267
            L+H NIVQ+LG+ +E     +  E + GG L   L+ K G L     T + +   I  G
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           + YLH+  N I+HRD+K  NV LVN+ +  +K+ DFG SK
Sbjct: 121 LKYLHD--NQIVHRDIKGDNV-LVNTYSGVVKISDFGTSK 157

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 38/199 (19%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSD--DRLVIQD 201
           EI+ S + F     +G+  FG++ K +  GT        VAIK    +L D  +  + ++
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK----TLKDKAEGPLREE 54

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--------------- 246
           F+HE  +  +L+HPNIV  LG VT+ +PL +I  Y    DLH++L               
Sbjct: 55  FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114

Query: 247 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
              K  L P+  V+    IA GM +L +    ++H+DL  RNVL+ +    ++K+ D GL
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKL--NVKISDLGL 170

Query: 306 SKLIKVQNSHDVYKMTGET 324
            + +    + D YK+ G +
Sbjct: 171 FREVY---AADYYKLMGNS 186

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 57/185 (30%), Positives = 88/185 (47%), Gaps = 25/185 (13%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
           NK  WE+ P    + + + +G G++G++  A+   T   VAIK++           + +R
Sbjct: 7   NKTVWEV-PDR--YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ LL  + H N++  L   T    L       L+T  L G DL+  +K +  LS    
Sbjct: 64  -ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQ-KLSDDHI 120

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
                 I RG+ Y+H+    IIHRDLKP N + VN   + LK+ DFGL++          
Sbjct: 121 QFLVYQILRGLKYIHSAG--IIHRDLKPSN-IAVNEDCE-LKILDFGLAR----HTDD-- 170

Query: 318 YKMTG 322
            +MTG
Sbjct: 171 -EMTG 174

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 47/149 (31%), Positives = 86/149 (57%), Gaps = 9/149 (6%)

Query: 165 IGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GSFG+  ++K+   G    IK I  S    +   ++ R EV +L  ++HPNIVQ+  
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQYQE 66

Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAV-NFALDIARGMAYLHNEPNVIIH 280
           +  E   L ++ +Y  GGDL+K +  ++G L P   + ++ + I   + ++H+    I+H
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILH 124

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           RD+K +N+ L       +K+GDFG+++++
Sbjct: 125 RDIKSQNIFLTKDGT--IKLGDFGIARVL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.1 bits (197), Expect = 3e-17
 Identities = 58/156 (37%), Positives = 83/156 (53%), Gaps = 10/156 (6%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP EL F+    IGKGSFGE+ K     T   VAIK I    ++D   I+D + E+ +L 
Sbjct: 1   DPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLS 57

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +   P + ++ G+  +   L +I EYL GG     L E G L  +       +I +G+ Y
Sbjct: 58  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDY 116

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           LH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 117 LHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 54/158 (34%), Positives = 85/158 (53%), Gaps = 17/158 (10%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
           DF+   ++GKGSFG+++ A  +GT    AIK     L  D ++IQD   E  ++ K    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VIIQDDDVECTMVEKRVLA 55

Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
              + P + Q          L  + EY+ GGDL  ++++ G      AV +A +IA G+ 
Sbjct: 56  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +LH++   II+RDLK  NV+L   +  H+K+ DFG+ K
Sbjct: 116 FLHSKG--IIYRDLKLDNVML--DAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 79.7 bits (197), Expect = 4e-17
 Identities = 50/146 (34%), Positives = 78/146 (53%), Gaps = 8/146 (5%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+ G + K   R T   +A+K I     ++ +  Q  R E+++L K   P IV F G
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILR-ELDILHKCNSPYIVGFYG 66

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           A      + +  EY+ GG L K LKE +G +        A+ + +G+ YLH +   IIHR
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK-IIHR 125

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           D+KP N+L+  +S   +K+ DFG+S 
Sbjct: 126 DVKPSNILV--NSRGQIKLCDFGVSG 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.7 bits (196), Expect = 4e-17
 Identities = 59/156 (37%), Positives = 83/156 (53%), Gaps = 10/156 (6%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP EL F+    IGKGSFGE+ K     T   VAIK I    ++D   I+D + E+ +L 
Sbjct: 1   DPEEL-FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLS 57

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +   P I ++ G+  +   L +I EYL GG     LK  G L  +       +I +G+ Y
Sbjct: 58  QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDY 116

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           LH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 117 LHSERK--IHRDIKAANVLL--SEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 53/172 (30%), Positives = 92/172 (53%), Gaps = 18/172 (10%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           ++ P    + + + IG+G++G +  A  +  G  VAIK+I P   + +   Q    E+ +
Sbjct: 2   DVGP---RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKI 56

Query: 209 LVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
           L + +H NI+  L      +      + ++ E +   DL+K +K +  LS      F   
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQ 114

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           I RG+ Y+H+  NV+ HRDLKP N LL+N++ D LK+ DFGL+++   ++ H
Sbjct: 115 ILRGLKYIHS-ANVL-HRDLKPSN-LLLNTNCD-LKICDFGLARIADPEHDH 162

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 52/153 (33%), Positives = 78/153 (50%), Gaps = 17/153 (11%)

Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL------RH 214
            ++GKGSFG++L A  +GT    A+K     L  D +++QD   E  +  K       +H
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVK----VLKKD-VILQDDDVECTMTEKRVLALAGKH 55

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P + Q       +  L  + EY+ GGDL  +++  G      A  +A +I  G+ +LH  
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              II+RDLK  NVLL   S  H+K+ DFG+ K
Sbjct: 116 G--IIYRDLKLDNVLL--DSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.5 bits (196), Expect = 5e-17
 Identities = 47/147 (31%), Positives = 83/147 (56%), Gaps = 10/147 (6%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HPNIV+ L 
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 66

Query: 223 AVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
            +     L L+ E+L   DL K++       +      ++   + +G+A+ H+  + ++H
Sbjct: 67  VIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLH 123

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLKP+N LL+N+    +K+ DFGL++
Sbjct: 124 RDLKPQN-LLINTEG-AIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.4 bits (196), Expect = 6e-17
 Identities = 48/148 (32%), Positives = 81/148 (54%), Gaps = 7/148 (4%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++G+GS+G ++K   +  G  VAIK+ L S  DD++V +    E+ +L +LRH N+V  +
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLES-EDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
                +K L L+ E++    L    K    L  S    +   I RG+ + H+  + IIHR
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS--HNIIHR 124

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           D+KP N+L+  S    +K+ DFG ++ +
Sbjct: 125 DIKPENILVSQSGV--VKLCDFGFARTL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 79.7 bits (197), Expect = 6e-17
 Identities = 53/156 (33%), Positives = 80/156 (51%), Gaps = 17/156 (10%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G+FGE+ KA     G  VA+K+IL     D   I   R E+ +L KL+HPN+V  + 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74

Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHN 273
              ER          + ++T Y+   DL   L+     L+ S    + L +  G+ YLH 
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE 133

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
             N I+HRD+K  N+L+ N     LK+ DFGL++  
Sbjct: 134 --NHILHRDIKAANILIDNQGI--LKIADFGLARPY 165

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.8 bits (195), Expect = 7e-17
 Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 18/157 (11%)

Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFR---H---EVNLLVKLRHPN 216
           +G G FG  E++K   +    A+K +       +  I +     H   E  +L +  HP 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           IV+      ++K + ++ EY  GG+L   L+++G     TA  +   +     YLHN   
Sbjct: 55  IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN--R 112

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
            II+RDLKP N+LL   S  ++K+ DFG +K +K   
Sbjct: 113 GIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQ 147

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 78.5 bits (193), Expect = 8e-17
 Identities = 55/156 (35%), Positives = 87/156 (55%), Gaps = 12/156 (7%)

Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G+FG + K  ++       VAIK +L +  +++ V  +   E  ++ +L +P IV+ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKN-ENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
           +G V E + LML+ E   GG L+K+L  +K  ++ S  V     ++ GM YL  E    +
Sbjct: 61  IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYL--EGKNFV 117

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           HRDL  RNVLLVN    + K+ DFGLSK +   +S+
Sbjct: 118 HRDLAARNVLLVNQH--YAKISDFGLSKALGADDSY 151

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 78.4 bits (193), Expect = 1e-16
 Identities = 45/150 (30%), Positives = 81/150 (54%), Gaps = 8/150 (5%)

Query: 164 IIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFR---HEVNLLVKLRHPNIVQ 219
           ++GKG++G +      +G  +A+K++    S+     +++     EV+LL  L+H NIVQ
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
           +LG   +   + +  E++ GG +   L   G L       +   I  G+AYLHN  N ++
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN--NCVV 124

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           HRD+K  NV+L+ +    +K+ DFG ++ +
Sbjct: 125 HRDIKGNNVMLMPNGI--IKLIDFGCARRL 152

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 1e-16
 Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 10/153 (6%)

Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           ++G+G+FG +   Y    G  +A+K++   P   +    +     E+ LL  L H  IVQ
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 220 FLGAV--TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           + G +     + L +  E++ GG +   LK  GAL+ +    +   I  G++YLH+  N+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS--NM 126

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           I+HRD+K  N+L    S  ++K+GDFG SK ++
Sbjct: 127 IVHRDIKGANIL--RDSVGNVKLGDFGASKRLQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 37/204 (18%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
           LP    WE     L       +G+G FG++++A   G           VA+K +  + +D
Sbjct: 1   LPLDPKWEFPRDRLVLGKP--LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58

Query: 195 DRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---- 249
             L   D   E+ L+ +  +H NI+  LG  T+  PL +I EY   G+L ++L+ +    
Sbjct: 59  KDLA--DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPG 116

Query: 250 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
                         LS    V+ A  +ARGM YL  E    IHRDL  RNVL+  +  + 
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESRRCIHRDLAARNVLV--TEDNV 172

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMT 321
           +K+ DFGL++ +   +  D YK T
Sbjct: 173 MKIADFGLARGV---HDIDYYKKT 193

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 78.2 bits (192), Expect = 1e-16
 Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 10/159 (6%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           +P E DF     IG G++G++ KA     G   AIK I     +D  V+Q    E+ ++ 
Sbjct: 6   NPQE-DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMK 61

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
             +H NIV + G+   R  L +  E+  GG L       G LS S     + +  +G+ Y
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           LH++    +HRD+K  N+LL ++   H+K+ DFG+S  I
Sbjct: 122 LHSKGK--MHRDIKGANILLTDNG--HVKLADFGVSAQI 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 11/155 (7%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           D++    IG+G++G + K   + T   VA+K+I    S++  V      E++LL +L+HP
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE-SEEEGVPSTAIREISLLKELQHP 59

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIARGMAYLH 272
           NIV     + +   L LI E+L   DL KYL    +   +      ++   I +G+ + H
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +    ++HRDLKP+N+L+ N     +K+ DFGL++
Sbjct: 119 SRR--VLHRDLKPQNLLIDNKGV--IKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 62/173 (35%), Positives = 86/173 (49%), Gaps = 31/173 (17%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVK 211
           D     +IG+G+FG++++A  +        AIK +    S +D R    DF  E+ +L K
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR----DFAGELEVLCK 58

Query: 212 L-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-------------KEKGALSPSTA 257
           L  HPNI+  LGA   R  L +  EY   G+L  +L             KE G  S  T+
Sbjct: 59  LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118

Query: 258 ---VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              + FA D+A GM YL  +    IHRDL  RNVL+  + A   K+ DFGLS+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS--KIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 53/162 (32%), Positives = 88/162 (54%), Gaps = 14/162 (8%)

Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +     ++G G+FG + K  W         PVAIK IL   +  +  ++ F  E  ++
Sbjct: 6   ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIM 63

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + HP++V+ LG V     + L+T+ +  G L  Y+ E K  +     +N+ + IA+GM
Sbjct: 64  ASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM 122

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            YL  E   ++HRDL  RNVL+   S +H+K+ DFGL++L++
Sbjct: 123 MYL--EERRLVHRDLAARNVLV--KSPNHVKITDFGLARLLE 160

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 29/177 (16%)

Query: 164 IIGKGSFGEILKAYWR---GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           I+G+G FG +++       G+   VA+K +   +      I++F  E   +    HPN++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFDHPNVM 64

Query: 219 QFLGAVTERKPL------MLITEYLRGGDLHKYL-KEKGALSP-----STAVNFALDIAR 266
           + +G   E   L      M+I  +++ GDLH +L   +    P      T + F +DIA 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK--VGDFGLSKLIKVQNSHDVYKMT 321
           GM YL N     IHRDL  RN +L     + +   V DFGLSK I    S D Y+  
Sbjct: 125 GMEYLSNRN--FIHRDLAARNCML----REDMTVCVADFGLSKKIY---SGDYYRQG 172

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 44/133 (33%), Positives = 70/133 (52%), Gaps = 18/133 (13%)

Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-----------KEK 249
           DF  E+ ++ +L+ PNI++ L       PL +ITEY+  GDL+++L            + 
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
             +S ST +  A  IA GM YL +     +HRDL  RN L+  +    +K+ DFG+S+ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYT--IKIADFGMSRNL 180

Query: 310 KVQNSHDVYKMTG 322
               S D Y++ G
Sbjct: 181 Y---SGDYYRIQG 190

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 3e-16
 Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 7/146 (4%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHE-VNLLVKLRHPNIVQFL 221
           I KG+FG +  A  R  G   AIK +  S    +  + + + E   ++++   P + +  
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +   +  L L+ EYL GGD    +K  G L    A  +  ++  G+  LH     IIHR
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHR 121

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           D+KP N+L+      HLK+ DFGLS+
Sbjct: 122 DIKPENLLI--DQTGHLKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 12/152 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ-- 219
            IG G++G +  A    +   VAIK+I P   D   + +    E+ +L   +H NI+   
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 220 --FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
                   + K + ++ + L   DLH  +     L+      F   + RG+ Y+H+    
Sbjct: 71  DILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN-- 127

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +IHRDLKP N LLVN     L++GDFG+++ +
Sbjct: 128 VIHRDLKPSN-LLVNEDC-ELRIGDFGMARGL 157

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 51/155 (32%), Positives = 70/155 (45%), Gaps = 11/155 (7%)

Query: 180 GTPVAIK--RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL-GAVTERKPLMLITEY 236
           G  VAIK  R   +  ++    + FR E  L  +L HPNIV  L         L  + EY
Sbjct: 3   GHEVAIKLLRTD-APEEEHQRAR-FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
           + G  L + L   GAL         L +   +A  HN    I+HRDLKP+N+++  +   
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHN--QGIVHRDLKPQNIMVSQTGVR 118

Query: 297 -HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            H KV DFG+  L+      DV  +T  T   E L
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTT---EVL 150

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.0 bits (189), Expect = 3e-16
 Identities = 56/156 (35%), Positives = 81/156 (51%), Gaps = 10/156 (6%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP EL F+    IGKGSFGE+ K     T   VAIK I    ++D   I+D + E+ +L 
Sbjct: 1   DPEEL-FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLS 57

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +   P + ++ G+  +   L +I EYL GG     L+  G            +I +G+ Y
Sbjct: 58  QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDY 116

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           LH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 117 LHSEKK--IHRDIKAANVLL--SEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 76.6 bits (188), Expect = 4e-16
 Identities = 50/151 (33%), Positives = 85/151 (56%), Gaps = 12/151 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           ++G+GSFG  L      +    A+K I LP  S     ++D R E  LL K++HPNIV F
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA---VEDSRKEAVLLAKMKHPNIVAF 63

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPS-TAVNFALDIARGMAYLHNEPNVI 278
             +      L ++ EY  GGDL + +K ++G L P  T + + + +  G+ ++H +   +
Sbjct: 64  KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--V 121

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +HRD+K +N+ L  +    +K+GDFG ++L+
Sbjct: 122 LHRDIKSKNIFLTQNG--KVKLGDFGSARLL 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 14/161 (8%)

Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 6   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 63

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 64  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+      H+K+ DFGL+KL+
Sbjct: 123 NYL--EERRLVHRDLAARNVLVKTP--QHVKITDFGLAKLL 159

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 6e-16
 Identities = 51/146 (34%), Positives = 75/146 (51%), Gaps = 10/146 (6%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GS+  + K   + T   VA+K I   L  +         E +LL  L+H NIV    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEI--RLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +  +K L L+ EYL   DL +Y+    G LS      F   + RG+AY H     ++HR
Sbjct: 71  IIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHR 127

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N+L+  S    LK+ DFGL++
Sbjct: 128 DLKPQNLLI--SERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 76.2 bits (187), Expect = 6e-16
 Identities = 46/151 (30%), Positives = 88/151 (58%), Gaps = 10/151 (6%)

Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHPNIVQF 220
            IG+GSFG+I  A  +    +   ++  +   ++ +++    + EV LL K++HPNIV F
Sbjct: 7   KIGEGSFGKIYLA--KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-KEKGAL-SPSTAVNFALDIARGMAYLHNEPNVI 278
             +  E   L ++ EY  GGDL K + +++G L S    +++ + I+ G+ ++H+    I
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--I 122

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +HRD+K +N+ L + +    K+GDFG+++ +
Sbjct: 123 LHRDIKSQNIFL-SKNGMVAKLGDFGIARQL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.2 bits (187), Expect = 6e-16
 Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 10/155 (6%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++GKGS+GE+     R  G    IK++    +  R   +    E  LL +L+HPNIV + 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYR 65

Query: 222 GAVT-ERKPLMLITEYLRGGDLHKYLKE-KGALSP-STAVNFALDIARGMAYLHNEPNVI 278
            +   E   L ++  +  GGDL+  LKE KG L P +  V + + IA  + YLH +   I
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--I 123

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
           +HRDLK +NV L  ++   +KVGD G++++++ Q 
Sbjct: 124 LHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQC 156

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 37/204 (18%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
           LP    WE    +L       +G+G FG+++ A   G           VA+K +    ++
Sbjct: 4   LPEDPRWEFSRDKLTLGKP--LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE 61

Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
             L   D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +    
Sbjct: 62  KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119

Query: 254 ----------PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
                     P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNV-- 175

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMT 321
           +K+ DFGL++ +   N+ D YK T
Sbjct: 176 MKIADFGLARDV---NNIDYYKKT 196

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.4 bits (188), Expect = 8e-16
 Identities = 52/147 (35%), Positives = 84/147 (57%), Gaps = 9/147 (6%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  R T   +A+K+I     D+ +     R E++LL +++H NIV+   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAVNFALDIARGMAYLHNEPNVIIH 280
            V   K L L+ EYL   DL K++      +  P     +   I RG+AY H+  + ++H
Sbjct: 69  VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLH 125

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLKP+N LL++   + LK+ DFGL++
Sbjct: 126 RDLKPQN-LLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.5 bits (188), Expect = 8e-16
 Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 30/165 (18%)

Query: 179 RGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY 236
           +G P  VA+K + P  + +     DF  EV +L +L+ PNI++ LG   +  PL +ITEY
Sbjct: 43  KGRPLLVAVKILRPDANKN--ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEY 100

Query: 237 LRGGDLHKYLKEKG-------------------ALSPSTAVNFALDIARGMAYLHNEPNV 277
           +  GDL+++L                       A+S S+ ++ AL IA GM YL +    
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            +HRDL  RN L+       +K+ DFG+S+ +    + D Y++ G
Sbjct: 159 FVHRDLATRNCLV--GENLTIKIADFGMSRNLY---AGDYYRIQG 198

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.1 bits (187), Expect = 9e-16
 Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 20/156 (12%)

Query: 164 IIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV---KLRH 214
           ++G G FG + K  W         PVAIK I      DR   Q F+   + ++    L H
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-----QDRSGRQTFQEITDHMLAMGSLDH 68

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHN 273
             IV+ LG +     L L+T+    G L  ++++ + +L P   +N+ + IA+GM YL  
Sbjct: 69  AYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL-- 125

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           E + ++HR+L  RN+LL   S   +++ DFG++ L+
Sbjct: 126 EEHRMVHRNLAARNILL--KSDSIVQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 37/204 (18%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
           LP    WE+    L       +G+G FG+++ A   G         T VA+K +    ++
Sbjct: 7   LPEDPRWEVPRDRLVLGKP--LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE 64

Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-- 251
             L   D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +    
Sbjct: 65  KDL--SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122

Query: 252 --------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
                         LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV-- 178

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMT 321
           +K+ DFGL++ I   +  D YK T
Sbjct: 179 MKIADFGLARDI---HHIDYYKKT 199

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 51/153 (33%), Positives = 72/153 (47%), Gaps = 19/153 (12%)

Query: 165 IGKGSFGEILKA-YWRGTPVA---IKRILPSLSDDRLVIQD-FRHEVNLLVKLRHPNIVQ 219
           IG G FG++L     RG   A   +K +  S + D    Q  F  EV    +L HPN++Q
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNE 274
            LG   E  P +L+ E+   GDL  YL+                  A ++A G+ +LH  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118

Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLS 306
               IH DL  RN  L   +AD  +K+GD+GL+
Sbjct: 119 -ADFIHSDLALRNCQL---TADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 10/163 (6%)

Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G F E+ +A       PVA+K++      D    QD   E++LL +L HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 271
           N++++L +  E   L ++ E    GDL    KY K++  L P   V  + + +   + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           H+    ++HRD+KP NV +  +    +K+GD GL +    + +
Sbjct: 123 HSRR--VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 52/151 (34%), Positives = 76/151 (50%), Gaps = 11/151 (7%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            IG+G++G + +A    +   VA+K++      D + I   R E+ LL+ LRHPNIV+  
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72

Query: 222 GAVTERK--PLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVI 278
             V  +    + L+ EY    DL   L         + V    L + RG+ YLH   N I
Sbjct: 73  EVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE--NFI 129

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           IHRDLK  N+LL +     LK+ DFGL++  
Sbjct: 130 IHRDLKVSNLLLTDKG--CLKIADFGLARTY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 37/204 (18%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
           LP    WE+  + L       +G+G FG+++ A   G           VA+K +    +D
Sbjct: 1   LPADPKWELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58

Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---- 249
             L   D   E+ ++  + +H NI+  LGA T+  PL ++ EY   G+L +YL+ +    
Sbjct: 59  KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPG 116

Query: 250 ------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
                         L+    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNV-- 172

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMT 321
           +K+ DFGL++   V N  D YK T
Sbjct: 173 MKIADFGLAR--DVHNI-DYYKKT 193

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 55/158 (34%), Positives = 83/158 (52%), Gaps = 17/158 (10%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
           DF+   ++GKGSFG+++ A  +GT    AIK     L  D +VIQD   E  ++ K    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 55

Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
              + P + Q          L  + EY+ GGDL  ++++ G      AV +A +I+ G+ 
Sbjct: 56  LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +LH     II+RDLK  NV+L   S  H+K+ DFG+ K
Sbjct: 116 FLHRRG--IIYRDLKLDNVML--DSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 58/170 (34%), Positives = 89/170 (52%), Gaps = 24/170 (14%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF-- 220
           +G GS G +  A        VA+K+I   L+D + V    R E+ ++ +L H NIV+   
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALR-EIKIIRRLDHDNIVKVYE 69

Query: 221 ------------LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
                       +G++TE   + ++ EY+   DL   L E+G LS   A  F   + RG+
Sbjct: 70  VLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGL 127

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
            Y+H+  NV+ HRDLKP NV  +N+    LK+GDFGL++++    SH  Y
Sbjct: 128 KYIHS-ANVL-HRDLKPANVF-INTEDLVLKIGDFGLARIVDPHYSHKGY 174

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)

Query: 165 IGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           IG+G++G + KA       G   AIK+          + Q    E+ LL +L+H N+V  
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 221 LGAV---TERKPLMLI--TEYLRGGDL-----HKYLKEKGALSPSTAVNFALDIARGMAY 270
           +       ++   +L    E+    DL          ++ ++ PS   +    I  G+ Y
Sbjct: 68  VEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLI 309
           LH+  N ++HRDLKP N+L++    +   +K+GD GL++L 
Sbjct: 124 LHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 53/154 (34%), Positives = 81/154 (52%), Gaps = 19/154 (12%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +IGKGS+G +  A     G  VAIK+I      +SD   +++    E+ LL  LRHP+IV
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62

Query: 219 QFLGAV-----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           +    +      E K + ++ E L   DLH+ +K    L+P     F   + R + Y+H 
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT 121

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
               + HRDLKP+N+ L N+    LK+ DFGL++
Sbjct: 122 --ANVFHRDLKPKNI-LANADCK-LKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 4e-15
 Identities = 50/165 (30%), Positives = 86/165 (52%), Gaps = 15/165 (9%)

Query: 164 IIGKGSFGEILKAYW--RGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH---PNI 217
           +IG+G++G + +      G  VA+K I L +  DD   + D + EV LL +LR    PNI
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD---VSDIQREVALLSQLRQSQPPNI 64

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
            ++ G+  +   L +I EY  GG + + L + G ++         ++   + Y+H     
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVG-- 121

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +IHRD+K  N+L+ N+   ++K+ DFG++ L+  QNS       G
Sbjct: 122 VIHRDIKAANILVTNTG--NVKLCDFGVAALL-NQNSSKRSTFVG 163

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 70.9 bits (174), Expect = 4e-15
 Identities = 38/86 (44%), Positives = 55/86 (63%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A  N    V KLL E+ + V+A+D D RTPLH+A+ +G +++ K L+E GADVNA+D
Sbjct: 11  LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARD 70

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHG 124
           +  NTPL  A      ++++LL  HG
Sbjct: 71  KDGNTPLHLAARNGNLDVVKLLLKHG 96

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 9/150 (6%)

Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIV 218
            ++GKGSFG+++ A  +GT    AIK +     L DD +        V L +   HP + 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRV-LALAWEHPFLT 59

Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
                   ++ L  + EYL GGDL  +++  G    + A  +A +I  G+ +LH     I
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK--KGI 117

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           I+RDLK  NVLL      H+K+ DFG+ K 
Sbjct: 118 IYRDLKLDNVLL--DKDGHIKIADFGMCKE 145

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.9 bits (181), Expect = 4e-15
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 10/163 (6%)

Query: 158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G F E+ +A     G PVA+K++      D     D   E++LL +L HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 271
           N++++  +  E   L ++ E    GDL    K+ K++  L P   V  + + +   + ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           H+    ++HRD+KP NV +  +    +K+GD GL +    + +
Sbjct: 123 HSRR--VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 50/153 (32%), Positives = 78/153 (50%), Gaps = 6/153 (3%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF +  +I  G++G +     + T    A+K+I       R  IQ    E ++L    +P
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +V    +   ++ L ++ EY+ GGD    LK  GAL    A  +  +    + YLHN  
Sbjct: 62  FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
             I+HRDLKP N+L+  +S  H+K+ DFGLSK+
Sbjct: 122 --IVHRDLKPDNLLI--TSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 6/157 (3%)

Query: 154 PSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           PS  +F     I +G+FG++            A+K +  +   ++ ++   + E + L  
Sbjct: 1   PSIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL 60

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
            + P IV    ++     + L+ EYL GGD+   L   G      AV +  ++A  + YL
Sbjct: 61  SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYL 120

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           H     IIHRDLKP N+L+ N    H+K+ DFGLSK+
Sbjct: 121 HRHG--IIHRDLKPDNMLISNEG--HIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 70.5 bits (173), Expect = 5e-15
 Identities = 36/87 (41%), Positives = 51/87 (58%), Gaps = 2/87 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           RT L    A       V+ LLE+    V+ARD D  TPLH+A+ +G +DV K L+++GAD
Sbjct: 41  RTPLH-LAAKNGHLEIVKLLLEKGAD-VNARDKDGNTPLHLAARNGNLDVVKLLLKHGAD 98

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELL 120
           VNA+D+   TPL  A       +++LL
Sbjct: 99  VNARDKDGRTPLHLAAKNGHLEVVKLL 125

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 56/158 (35%), Positives = 84/158 (53%), Gaps = 17/158 (10%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
           DF+   ++GKGSFG+++ A  +GT    AIK     L  D +VIQD   E  ++ K    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 55

Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
              + P + Q          L  + EY+ GGDL   +++ G      AV +A +IA G+ 
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +LH++   II+RDLK  NV+L   S  H+K+ DFG+ K
Sbjct: 116 FLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.2 bits (179), Expect = 7e-15
 Identities = 60/165 (36%), Positives = 85/165 (51%), Gaps = 27/165 (16%)

Query: 164 IIGKGSFGEILKAYWRGTPV----AIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIV 218
           +IG+G+FG++LKA  +   +    AIKR+    S D    +DF  E+ +L KL  HPNI+
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNII 59

Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFAL 262
             LGA   R  L L  EY   G+L  +L++                   LS    ++FA 
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           D+ARGM YL  +    IHRDL  RN+L+  +     K+ DFGLS+
Sbjct: 120 DVARGMDYLSQKQ--FIHRDLAARNILVGENYVA--KIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 8/153 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRL-VIQDFRHEVNLLVKLRH 214
           DF     +G GSFG +  A  +GT    AIK  L      ++  +Q    E ++L++L H
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-CLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P IV  + +  +   +  + E++ GG+L  +L++ G      A  +  ++     YLH++
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              II+RDLKP N+LL   +  H+KV DFG +K
Sbjct: 138 D--IIYRDLKPENLLL--DNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 51/177 (28%), Positives = 91/177 (51%), Gaps = 25/177 (14%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDF 202
           WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +F
Sbjct: 1   WEVAREKITMSRE--LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EF 56

Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSPS 255
            +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+            +P 
Sbjct: 57  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116

Query: 256 T---AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +    +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 117 SLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 169

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 49/148 (33%), Positives = 79/148 (53%), Gaps = 11/148 (7%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           I +G++G + +A  +  G  VA+K++      +   I   R E+N+L+KL+HPNIV    
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKE 71

Query: 223 AV--TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVII 279
            V  +    + ++ EY+   DL   ++  K     S      L +  G+A+LH+  N I+
Sbjct: 72  VVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD--NWIL 128

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           HRDLK  N+LL N     LK+ DFGL++
Sbjct: 129 HRDLKTSNLLLNNRGI--LKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 27/188 (14%)

Query: 165 IGKGSFGEILKAYWRGTP---VAIKRIL---PSLSDDRL----VIQDFRHEVNLLVK-LR 213
           +G G+FG + K   +      +A+K I    P+   D+      I D   EV ++ + LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 214 HPNIVQFLGAVTERKPLMLITEYLRG---GDLHKYLKEKGALSPSTAV-NFALDIARGMA 269
           HPNIV++     E   L ++ + + G   G+    LKEK        + N  + +   + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG---- 325
           YLH E   I+HRDL P N++L     D + + DFGL+K  K   S    K+T   G    
Sbjct: 128 YLHKEKR-IVHRDLTPNNIML--GEDDKVTITDFGLAKQ-KQPES----KLTSVVGTILY 179

Query: 326 SCEYLVSN 333
           SC  +V N
Sbjct: 180 SCPEIVKN 187

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 41/105 (39%), Positives = 61/105 (58%), Gaps = 4/105 (3%)

Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
           + E N+L  ++HP IV  + A      L LI EYL GG+L  +L+ +G     TA  +  
Sbjct: 48  KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +I+  + +LH +   II+RDLKP N+LL   +  H+K+ DFGL K
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILL--DAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 51/146 (34%), Positives = 79/146 (54%), Gaps = 10/146 (6%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GS+  + K   R  G  VA+K I  S+  +  V      E +LL  L+H NIV    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +  ++ L  + EY+   DL +Y+ +  G L P     F   + RG+AY+H +   I+HR
Sbjct: 71  IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHR 127

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N+L+  S    LK+ DFGL++
Sbjct: 128 DLKPQNLLI--SYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 7/147 (4%)

Query: 164 IIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
           +IGKGSFG++L A  +      A+K +       +   +    E N+L+K ++HP +V  
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
             +      L  + +Y+ GG+L  +L+ + +     A  +A +IA  + YLH+    II+
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIY 119

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLKP N+LL   S  H+ + DFGL K
Sbjct: 120 RDLKPENILL--DSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 70.7 bits (173), Expect = 4e-14
 Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 17/155 (10%)

Query: 165 IGKGSFGEIL----KAYWRGTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKGSFG +     K       + + + +P   L+ +  V  +   E  LL KL HP IV
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKLDHPAIV 65

Query: 219 QFLGAVTERKPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           +F  +  ER    +ITEY  G DL     +       LS +    + + +  G+ Y+H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              I+HRDLK +N+ L N   + LK+GDFG+S+L+
Sbjct: 126 R--ILHRDLKAKNIFLKN---NLLKIGDFGVSRLL 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 71.1 bits (174), Expect = 4e-14
 Identities = 51/156 (32%), Positives = 76/156 (48%), Gaps = 21/156 (13%)

Query: 165 IGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRH---EVNLLVKLRHPNI 217
           IG G FG+++     + +    V +K +  S S     +Q+      E      L+H N+
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-----VQEQMKFLEEAQPYRSLQHSNL 57

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLH 272
           +Q LG  TE  P +L+ E+   GDL  YL+     E     P+T    A +IA G+ +LH
Sbjct: 58  LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
              N  IH DL  RN LL  ++   +K+GD+GLS  
Sbjct: 118 K--NNFIHSDLALRNCLL--TADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.4 bits (172), Expect = 8e-14
 Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 14/163 (8%)

Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +     ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 6   ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVM 63

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             +  P + + LG +     + L+T+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 64  AGVGSPYVCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +YL  E   ++HRDL  RNVL+   S +H+K+ DFGL++L+ +
Sbjct: 123 SYL--EEVRLVHRDLAARNVLV--KSPNHVKITDFGLARLLDI 161

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 57/176 (32%), Positives = 88/176 (50%), Gaps = 22/176 (12%)

Query: 164 IIGKGSFGEI-----LKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHP 215
           ++G+GSFG++     +     G   A+K     L    L ++D    + E ++L ++ HP
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMK----VLKKATLKVRDRVRTKMERDILAEVNHP 58

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
            IV+   A      L LI ++LRGGDL   L  K  +     V F L ++A  + +LH+ 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSL 117

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
              II+RDLKP N+LL      H+K+ DFGLSK    ++     K     G+ EY+
Sbjct: 118 G--IIYRDLKPENILL--DEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYM 165

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 65.4 bits (160), Expect = 1e-13
 Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 3/83 (3%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
           A   +   V+ LLE+   +      D  T LH+A+ +G +++ K L+E+GADVNA+D+  
Sbjct: 5   AKNGNLELVKLLLEKGADV---NLGDTDTALHLAARNGNLEIVKLLLEHGADVNAKDKDG 61

Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
           NT L  A       +++LL  HG
Sbjct: 62  NTALHLAARNGNLEIVKLLLEHG 84

Length = 91

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 13/150 (8%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G +  A    T   VAIK+I  +  D+R+  +    E+ LL  L H N++    
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKD 71

Query: 223 AVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
            +          + ++ E L   DLH+ ++    LS      F   + RG+ Y+H+    
Sbjct: 72  IMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN-- 128

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           ++HRDLKP N LL+N++ D LK+ DFGL++
Sbjct: 129 VLHRDLKPSN-LLLNANCD-LKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 56/164 (34%), Positives = 74/164 (45%), Gaps = 7/164 (4%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP +L FS    IG GSFG +  A        VAIK++  S        QD   EV  L 
Sbjct: 12  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           KLRHPN +Q+ G         L+ EY  G         K  L             +G+AY
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           LH+    +IHRD+K  N+LL  S    +K+GDFG + ++   N 
Sbjct: 131 LHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPANX 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 49/148 (33%), Positives = 79/148 (53%), Gaps = 7/148 (4%)

Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQ 219
            +IGKGSFG++L A  +  G+  A+K +       +        E N+L+K L+HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
              +    + L  + +Y+ GG+L  +L+ +       A  +A ++A  + YLH+    II
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--II 118

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +RDLKP N+LL   S  H+ + DFGL K
Sbjct: 119 YRDLKPENILL--DSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 27/189 (14%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVN 207
           WEI   EL        G G+FG++ KA  + T +  A K I     ++   ++DF  E++
Sbjct: 7   WEI-IGEL--------GDGAFGKVYKAQHKETGLFAAAKIIQIESEEE---LEDFMVEID 54

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIA 265
           +L + +HPNIV    A      L ++ E+  GG L   +   E+G   P         + 
Sbjct: 55  ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML 113

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDV-----YK 319
             + +LH+  + +IHRDLK  N+LL  +    +K+ DFG+S K        D      Y 
Sbjct: 114 EALNFLHS--HKVIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYW 169

Query: 320 MTGETGSCE 328
           M  E  +CE
Sbjct: 170 MAPEVVACE 178

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 18/157 (11%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQF 220
            IG+G++G++ KA  +  G  VA+K+    + ++ +     R E++LL  L     IV+ 
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESIYIVRL 66

Query: 221 LGAV-TERKP----LMLITEYLRGGDLHKYLKEKG-----ALSPSTAVNFALDIARGMAY 270
           L     E K     L L+ EYL   DL K++   G      L   T  +F   + +G+A+
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            H     ++HRDLKP+N LLV+     LK+ D GL +
Sbjct: 126 CHKHG--VMHRDLKPQN-LLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 48/147 (32%), Positives = 82/147 (55%), Gaps = 7/147 (4%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
           +IGKGSFG++L A  +  G   A+K +   +  +R   +    E N+L+K ++HP +V  
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
             +    + L  + +++ GG+L  +L+ + +     A  +A +IA  + YLH+    I++
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVY 119

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLKP N+LL   S  H+ + DFGL K
Sbjct: 120 RDLKPENILL--DSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 21/161 (13%)

Query: 165 IGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G+G FG +++           VA+K +  ++   R  ++DF  E   + +  HPN+++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRL 65

Query: 221 LGAV---TERKPL---MLITEYLRGGDLHKYL------KEKGALSPSTAVNFALDIARGM 268
           +G      E +     ++I  +++ GDLH +L           L     V F  DIA GM
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL ++    IHRDL  RN +L N + + + V DFGLSK I
Sbjct: 126 EYLSSKS--FIHRDLAARNCML-NENMN-VCVADFGLSKKI 162

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 30/173 (17%)

Query: 165 IGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           IG G+FG +    W       G  VA+K+ +P++  + +  +    E+ +L   +H N+ 
Sbjct: 8   IGYGAFGVV----WSVTDPRDGKRVALKK-MPNVFQNLVSCKRVFRELKMLCFFKHDNV- 61

Query: 219 QFLGAVTERKP--------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
             L A+   +P        + ++TE ++  DLHK +     LS      F   I RG+ Y
Sbjct: 62  --LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
           LH+    I+HRD+KP N LLVNS+   LK+ DFGL+   +V+   +   MT E
Sbjct: 119 LHSAG--ILHRDIKPGN-LLVNSNC-VLKICDFGLA---RVEEPDESKHMTQE 164

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 57/179 (31%), Positives = 89/179 (49%), Gaps = 21/179 (11%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKR----ILPSLSDDRLVIQDFRHEVNLLVK 211
           DF     +G+G +G++  A  + T   VA+KR    +L  L++ R V+     E ++L  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT----ERDILTT 57

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
            +   +V+ L A  + + L L  EY+ GGD    L   G LS   A  +  ++   +  L
Sbjct: 58  TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           H      IHRDLKP N L+   ++ H+K+ DFGLSK I V  ++ V       GS +Y+
Sbjct: 118 HELG--YIHRDLKPENFLI--DASGHIKLTDFGLSKGI-VTYANSV------VGSPDYM 165

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 52/155 (33%), Positives = 82/155 (52%), Gaps = 22/155 (14%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVKLR-HPNI 217
           +GKG++G + KA  R T   VA+K+I  +  +      D    FR E+  L +L  HPNI
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA----TDAQRTFR-EIMFLQELGDHPNI 69

Query: 218 VQFLG---AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           V+ L    A  ++  + L+ EY+   DLH  ++    L           + + + Y+H+ 
Sbjct: 70  VKLLNVIKAENDKD-IYLVFEYMET-DLHAVIR-ANILEDVHKRYIMYQLLKALKYIHSG 126

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            NVI HRDLKP N+LL  +S   +K+ DFGL++ +
Sbjct: 127 -NVI-HRDLKPSNILL--NSDCRVKLADFGLARSL 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 15/151 (9%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD-----FRHEVNLLVKLRHPN 216
           ++GKGSFG++L A  +G     A+K    +L  D ++I D        +  L +   +P 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPF 57

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           +         ++ L  + E+L GGDL  ++++KG      A  +A +I  G+ +LH+   
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS--K 115

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            II+RDLK  NV+L      H+K+ DFG+ K
Sbjct: 116 GIIYRDLKLDNVML--DRDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 50/146 (34%), Positives = 78/146 (53%), Gaps = 10/146 (6%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GS+  + K   +  G  VA+K I   L ++         E +LL  L+H NIV    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVI--RLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 223 AVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +  ++ L L+ EY+   DL +Y+ K  G L P     F   + RG++Y+H     I+HR
Sbjct: 71  IIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR--YILHR 127

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N+L+  S    LK+ DFGL++
Sbjct: 128 DLKPQNLLI--SDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 48/146 (32%), Positives = 75/146 (51%), Gaps = 14/146 (9%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
           IG+G+F E+LKA  R  G   AIK +         V    R E+  L +L  HPNI++ +
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LR-EIQALRRLSPHPNILRLI 64

Query: 222 GAVTERKP--LMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
             + +RK   L L+ E L   +L++ +K  K  L      ++   + + + ++H   N I
Sbjct: 65  EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR--NGI 121

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFG 304
            HRD+KP N+L+     D LK+ DFG
Sbjct: 122 FHRDIKPENILI---KDDILKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 57/172 (33%), Positives = 79/172 (45%), Gaps = 23/172 (13%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP +L F+    IG GSFG +  A    T   VAIK++  S        QD   EV  L 
Sbjct: 12  DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGG-----DLHKYLKEKGALSPSTAVNFA---L 262
           +LRHPN +++ G         L+ EY  G      ++HK         P   V  A    
Sbjct: 71  QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK--------KPLQEVEIAAICH 122

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
              +G+AYLH+     IHRD+K  N+LL  +    +K+ DFG + L+   NS
Sbjct: 123 GALQGLAYLHSHER--IHRDIKAGNILL--TEPGTVKLADFGSASLVSPANS 170

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 14/151 (9%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            +G+G+ G + K   +  G   A+K I    + D L  Q  R E+ +    + P IV++ 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILR-ELEINKSCKSPYIVKYY 65

Query: 222 GAVTERKPLML--ITEYLRGGDL---HKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 275
           GA  +     +    EY  GG L   +K +K++G  +        A  + +G++YLH+  
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             IIHRD+KP N+LL  +    +K+ DFG+S
Sbjct: 126 --IIHRDIKPSNILL--TRKGQVKLCDFGVS 152

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 52/146 (35%), Positives = 76/146 (52%), Gaps = 10/146 (6%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G++  + K   + T   VA+K I   L  +         EV+LL  L+H NIV    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 281
            +   + L L+ EYL   DL +YL   G L     V  F   + RG++Y H     I+HR
Sbjct: 71  IIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHR 127

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N LL+N   + LK+ DFGL++
Sbjct: 128 DLKPQN-LLINEKGE-LKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 9/154 (5%)

Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           D+     +G G++G++ KA     G   A+K I     DD  +IQ    E+ ++ + +H 
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKHC 66

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NIV + G+   R+ L +  EY  GG L       G LS         +  +G+AYLH++ 
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              +HRD+K  N+LL ++    +K+ DFG++  I
Sbjct: 127 K--MHRDIKGANILLTDNG--DVKLADFGVAAKI 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 10/146 (6%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G++  + K   + T   VA+K I   L  +         EV+LL  L+H NIV    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 281
            V   K L L+ EYL   DL +Y+ + G +     V  F   I RG+AY H     ++HR
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHR 128

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N LL+N   + LK+ DFGL++
Sbjct: 129 DLKPQN-LLINERGE-LKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 33/165 (20%)

Query: 162 SAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
            A IG+G+FGE+ KA  + T   VA+K++L     +   I   R E+ +L  L+H N+V 
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN 75

Query: 220 FLGAVTERKPLM---------LITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIAR--- 266
            L  +   K            L+ E+    DL         L  +  V F L +I +   
Sbjct: 76  -LIEICRTKATPYNRYKGSFYLVFEFCEH-DL-------AGLLSNKNVKFTLSEIKKVMK 126

Query: 267 ----GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
               G+ Y+H   N I+HRD+K  N+L+       LK+ DFGL++
Sbjct: 127 MLLNGLYYIHR--NKILHRDMKAANILITKDGI--LKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 49/163 (30%), Positives = 87/163 (53%), Gaps = 19/163 (11%)

Query: 163 AIIGKGSFGEILKAY---WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPN 216
           A IG+G++G++ KA      G  VA+KR+     ++ + +   R EV +L  L    HPN
Sbjct: 7   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPN 65

Query: 217 IVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMA 269
           +V+     T         L L+ E++   DL  YL +  +  +   T  +    + RG+ 
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           +LH+  + ++HRDLKP+N+L+  +S+  +K+ DFGL+++   Q
Sbjct: 125 FLHS--HRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQ 163

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 18/171 (10%)

Query: 158 DFSSSAIIGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF S  +IG+G+FGE  +++    G   A+K++  S   ++  +   R E ++L +  +P
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF------ALDIARGMA 269
            +V+   +  +   L LI EYL GGD+   L +K   +      +      A+D    + 
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
           Y        IHRD+KP N+LL      H+K+ DFGL   +K  +  + Y++
Sbjct: 122 Y--------IHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRI 162

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.4 bits (165), Expect = 9e-13
 Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 7/147 (4%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GS+G + K   R  G  VAIK+ + S  DD ++ +    E+ +L +L+HPN+V  + 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVES-EDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
               ++ L L+ EY     L++  K    +             + + + H   +  IHRD
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRD 125

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +KP N+L+  +    +K+ DFG ++++
Sbjct: 126 VKPENILI--TKQGQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 7/147 (4%)

Query: 164 IIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQF 220
           +IGKGSFG++L A  +      A+K +       +   +    E N+L+K ++HP +V  
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
             +      L  + +Y+ GG+L  +L+ +       A  +A +IA  + YLH+    I++
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVY 119

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLKP N+LL   S  H+ + DFGL K
Sbjct: 120 RDLKPENILL--DSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 58/189 (30%), Positives = 93/189 (49%), Gaps = 17/189 (8%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLL 209
           ++DP+E+ +     +G G+FG++ KA  + T   A  +++ + S++ L  +D+  E+ +L
Sbjct: 7   DLDPNEV-WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMVEIEIL 63

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
               HP IV+ LGA      L ++ E+  GG +   + E  +G   P   V     +   
Sbjct: 64  ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEA 122

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDV-----YKMT 321
           + YLH+    IIHRDLK  NVLL       +K+ DFG+S K +K     D      Y M 
Sbjct: 123 LQYLHSMK--IIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDSFIGTPYWMA 178

Query: 322 GETGSCEYL 330
            E   CE +
Sbjct: 179 PEVVMCETM 187

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 47/164 (28%), Positives = 84/164 (51%), Gaps = 6/164 (3%)

Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF S  +IG+G+FGE+  ++    G   A+K +  +   ++  +   R E ++LV+    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +V+   +  +++ L LI E+L GGD+   L +K  LS      +  +    +  +H   
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
              IHRD+KP N+LL   +  H+K+ DFGL   +K  +  + Y+
Sbjct: 122 --FIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYR 161

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 8/151 (5%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +GKG  G +     +GT    A+K +       R  ++    E  +L  L HP +     
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
           +      L L+ +Y  GG+L + L+      LS   A  +A ++   + YLH     I++
Sbjct: 69  SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL--LGIVY 126

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           RDLKP N+LL  S   H+ + DF LSK   V
Sbjct: 127 RDLKPENILLHESG--HIMLSDFDLSKQSDV 155

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 18/162 (11%)

Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNI 217
           A IG G++G + KA     G  VA+K +    ++D L +   R EV LL +L    HPNI
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNI 64

Query: 218 VQFL----GAVTERK-PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAY 270
           V+ +     + T+R+  + L+ E++   DL  YL +     L   T  +      RG+ +
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           LH   N I+HRDLKP N+L+  +S   +K+ DFGL+++   Q
Sbjct: 124 LHA--NCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQ 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 21/168 (12%)

Query: 164 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +IGKG FG +          +    A+K  L  ++D   V Q F  E  ++    HPN++
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59

Query: 219 QFLGAV--TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
             LG    +E  PL+++  Y++ GDL  ++  E    +    + F L +A+GM YL ++ 
Sbjct: 60  SLLGICLPSEGSPLVVLP-YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI------KVQNSHDV 317
            V  HRDL  RN +L  S    +KV DFGL++ I       V N    
Sbjct: 119 FV--HRDLAARNCMLDESF--TVKVADFGLARDIYDKEYYSVHNHTGA 162

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 10/154 (6%)

Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV---KLR 213
           F   A++G+G FG++L A ++ T    AIK +       R  ++    E  +       R
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +V           +  + EY  GGDL  ++      S   AV +A  +  G+ YLH 
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHE 119

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             N I++RDLK  N+LL   +   +K+ DFGL K
Sbjct: 120 --NKIVYRDLKLDNLLL--DTEGFVKIADFGLCK 149

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 42/104 (40%), Positives = 58/104 (55%), Gaps = 6/104 (5%)

Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALD 263
           EV+LL  L+H NIV     +   K L L+ EYL   DL +YL + G       V  F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           + RG+ Y H     ++HRDLKP+N LL+N   + LK+ DFGL++
Sbjct: 113 LLRGLNYCHRRK--VLHRDLKPQN-LLINERGE-LKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 5/156 (3%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           ++   +L+  S    G G     +K    GT +A K +   +     V +    E+ ++ 
Sbjct: 1   DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMH 58

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           + R P IV F GA      + +  E++  G L +  K+ G +        A+ +  G+ Y
Sbjct: 59  ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           L+N    I+HRD+KP N+ LVN S   +K+ DFG+S
Sbjct: 119 LYNVHR-IMHRDIKPSNI-LVN-SRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 48/148 (32%), Positives = 67/148 (45%), Gaps = 14/148 (9%)

Query: 156 ELDFSS---SAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD  S     I+G G FGE+ +        R  PVAI  +    SD +   + F  E  
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEAL 58

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 266
            L +  H NIV+  G +T    +M++TEY+  G L  +L K +G L     +     +A 
Sbjct: 59  TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSS 294
           GM YL       +H+ L    V LVNS 
Sbjct: 119 GMKYLSEMG--YVHKGLAAHKV-LVNSD 143

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 3/149 (2%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF     +G G+ G + K   R + + + R L  L     +      E+ +L +   P I
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +  +     ++ + RG+ YL  + + 
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK-HK 120

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 121 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 27/178 (15%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGE----ILKAYWRGTP---VAIKRILPSLS-DDRLVIQD 201
           WE+   ++       +G+GSFG       +   +G     VA+K +  S S  +R+   +
Sbjct: 1   WEVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---E 55

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--------EKGALS 253
           F +E +++      ++V+ LG V++ +P +++ E +  GDL  YL+          G   
Sbjct: 56  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115

Query: 254 PS--TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           P+    +  A +IA GMAYL+ +    +HRDL  RN ++ +     +K+GDFG+++ I
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDI 169

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 53/155 (34%), Positives = 78/155 (50%), Gaps = 21/155 (13%)

Query: 165 IGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQ 219
           +G+G++G +  A    T     VAIK+I    S   L  +  R E+ LL   R H NI  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66

Query: 220 -------FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
                  F G   E    + + E L   DLH+ ++    L+ +   +F   I  G+ Y+H
Sbjct: 67  LYDMDIVFPGNFNE----LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +  NV+ HRDLKP N LLVN+  + LK+ DFGL++
Sbjct: 123 S-ANVL-HRDLKPGN-LLVNADCE-LKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 8/144 (5%)

Query: 165 IGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           +G G+FG++ KA  + T V A  +++ + S++ L  +D+  E+++L    HPNIV+ L A
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 70

Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
                 L ++ E+  GG +   + E +  L+              + YLH   N IIHRD
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRD 128

Query: 283 LKPRNVLLVNSSADHLKVGDFGLS 306
           LK  N+L        +K+ DFG+S
Sbjct: 129 LKAGNILFTLDG--DIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 27/186 (14%)

Query: 127 SYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVA 184
           S   + S   P      L          SEL+      IG G+ G + K   R T    A
Sbjct: 57  SSSSSASGSAP-SAAKSL----------SELE--RVNRIGSGAGGTVYKVIHRPTGRLYA 103

Query: 185 IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH- 243
           +K I  +  +D +  Q  R E+ +L  + HPN+V+          + ++ E++ GG L  
Sbjct: 104 LKVIYGN-HEDTVRRQICR-EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG 161

Query: 244 KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
            ++ ++  L+     + A  I  G+AYLH     I+HRD+KP N LL+N SA ++K+ DF
Sbjct: 162 THIADEQFLA-----DVARQILSGIAYLHRRH--IVHRDIKPSN-LLIN-SAKNVKIADF 212

Query: 304 GLSKLI 309
           G+S+++
Sbjct: 213 GVSRIL 218

Length = 353

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           ++GKGSFG++  A  +GT    AIK +     L DD +        V L +   HP +  
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTH 60

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  ++ L  + EYL GGDL  +++         A  +A +I  G+ +LH++   I+
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IV 118

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +RDLK  N+LL   +  H+K+ DFG+ K
Sbjct: 119 YRDLKLDNILL--DTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 65.1 bits (158), Expect = 6e-12
 Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 7/164 (4%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP +L F+    IG GSFG +  A    T   VAIK++  S        QD   EV  L 
Sbjct: 22  DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +++HPN +++ G         L+ EY  G         K  L             +G+AY
Sbjct: 81  RIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           LH+  + +IHRD+K  N+LL  +    +K+ DFG + +    NS
Sbjct: 141 LHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASIASPANS 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 13/174 (7%)

Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSLSDDRLV 198
           P   NK  +E      DF+    +G GSFG ++ A ++     PVAIKR   S    +  
Sbjct: 21  PKRKNKMKYE------DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74

Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
           +     E  +L  + HP  V   G+  +   L L+ E++ GG+   +L+           
Sbjct: 75  VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC 134

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
            +A  I     YL +    I++RDLKP N+LL       +K+ DFG +K++  +
Sbjct: 135 FYAAQIVLIFEYLQSLN--IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTR 184

Length = 340

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 65.5 bits (159), Expect = 6e-12
 Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 6/164 (3%)

Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF S  +IG+G+FGE+  ++    G   A+K +  +   ++  +   R E ++LV+    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +V+   +  ++  L LI E+L GGD+   L +K  L+      +  +    +  +H   
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
              IHRD+KP N+LL   S  H+K+ DFGL   +K  +  + Y+
Sbjct: 122 --FIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYR 161

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 10/147 (6%)

Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +GKG++G + K   R T V  A+K I   L + +        E+++L K   P IV F G
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFYG 66

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAVNF-ALDIARGMAYLHNEPNVII 279
           A      + +  EY+  G L K      A    P   +      + +G+ +L  E N II
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-II 125

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLS 306
           HRD+KP NVL+  +    +K+ DFG+S
Sbjct: 126 HRDVKPTNVLV--NGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.1 bits (158), Expect = 7e-12
 Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 3/149 (2%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LKE   +        ++ + RG+AYL  E + 
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR-EKHQ 124

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 125 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 151

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 7/151 (4%)

Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F    ++G+G++G +LK   + T   VAIK+   S  ++ +     R E+ +L  L+  N
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           IV+   A   R  L L+ EY+    L    +    + P    ++   + + + + H   N
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK--N 119

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            I+HRD+KP N+L+  S  D LK+ DFG ++
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 42/122 (34%), Positives = 55/122 (45%), Gaps = 6/122 (4%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
           A   DA   R LL       + RDYD RTPLH+A  +G + V + L+E+GAD    D+  
Sbjct: 90  AASGDAVGARILLTGGAD-PNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148

Query: 102 NTPLADAEGAKKFNMMELLNAHG--GLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDF 159
            TPL  AE      +++LL+ H       G N         PP L    D  I     DF
Sbjct: 149 KTPLELAEENGFREVVQLLSRHSQCHFELGANAKPDSFTGKPPSLE---DSPISSHHPDF 205

Query: 160 SS 161
           S+
Sbjct: 206 SA 207

Length = 664

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 124

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 125 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 151

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 16/169 (9%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     D      +G G++G +  A  R  G  VAIK++      +    + +R
Sbjct: 7   NKTIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY-----LRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T    L    ++       G DL K +K +  LS     
Sbjct: 64  -ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE-KLSEDRIQ 121

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                + +G+ Y+H     IIHRDLKP N L VN   + LK+ DFGL++
Sbjct: 122 FLVYQMLKGLKYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 10/168 (5%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKGSFG++++   R T    A+K I  +    R  +     E  +L ++  P IV    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +    + L L+  ++ GG+L  +L+ +G    S A  +  ++   +  LH + NVI +RD
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH-KFNVI-YRD 118

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LKP N+LL      H+ + DFGL KL    N  D  K     G+ EYL
Sbjct: 119 LKPENILL--DYQGHIALCDFGLCKL----NMKDDDKTNTFCGTPEYL 160

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 7/164 (4%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP E+ F     IG GSFG +  A    T   VA+K++  S        QD   EV  L 
Sbjct: 18  DPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L+HPN +++ G   +     L+ EY  G         K  L             +G+AY
Sbjct: 77  QLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 136

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           LH+  + +IHRD+K  N+LL  +    +K+ DFG +      NS
Sbjct: 137 LHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASKSSPANS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 6/151 (3%)

Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF +  +IGKG+FGE+  ++    G   A+K +L S    +  +   + E ++L +   P
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +V    +  + + L LI E+L GGDL   L +    S      +  +    +  +H   
Sbjct: 62  WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              IHRD+KP N+L+      H+K+ DFGLS
Sbjct: 122 --FIHRDIKPDNILI--DRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 17/152 (11%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVK------LRHP 215
           ++GKGSFG+++ A  +GT    AIK     L  D +++QD   +  +  K       +HP
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIK----VLKKD-VILQDDDVDCTMTEKRILALAAKHP 56

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +         +  L  + EY+ GGDL   ++         +  +A ++   + +LH   
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-- 114

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           + +I+RDLK  N+LL   +  H K+ DFG+ K
Sbjct: 115 HGVIYRDLKLDNILL--DAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 21/164 (12%)

Query: 159 FSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
            + S ++ +G+FG I               V +K +    S+ ++ +     E  LL  L
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLYGL 65

Query: 213 RHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLK-----EKG---ALSPSTAVNFALD 263
            H NI+  L    E  +P  ++  Y+  G+L  +L+     E     ALS    V+ A+ 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           IA GM+YLH     +IH+D+  RN ++       +K+ D  LS+
Sbjct: 126 IACGMSYLHKRG--VIHKDIAARNCVIDEEL--QVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 18/158 (11%)

Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRI------LPSLSDDRLVIQDFRH-----EVNLL 209
           A +G+G++G++ KAY    G  VAIK++           D +LV     H     E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
            +++H NI+  +    E   + L+ + +   DL K +  K  L+ S      L I  G+ 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLN 133

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            LH      +HRDL P N+ +  +S    K+ DFGL++
Sbjct: 134 VLHK--WYFMHRDLSPANIFI--NSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 46/140 (32%), Positives = 69/140 (49%), Gaps = 15/140 (10%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           +IGKG  GE+  AY       VA+K+I   LS++ L+ + F  E  +   L HP IV   
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLK---EKGALSP----STAVNFALDI----ARGMAY 270
              ++  P+     Y+ G  L   LK   +K +LS      T+V   L I       + Y
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 271 LHNEPNVIIHRDLKPRNVLL 290
           +H++   ++HRDLKP N+LL
Sbjct: 129 VHSKG--VLHRDLKPDNILL 146

Length = 932

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 13/170 (7%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +GKG FGE+     + T    A K++       R   Q   +E  +L K+    IV    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
           A   +  L L+   + GGDL  ++   G      + A+ +A  I  G+ +LH     I++
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--RIVY 118

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           RDLKP NVLL +    ++++ D GL+  +K        K+ G  G+  Y+
Sbjct: 119 RDLKPENVLLDDHG--NVRISDLGLAVELKGGK-----KIKGRAGTPGYM 161

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 23/184 (12%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 9   NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 66  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 123

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 124 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 172

Query: 319 KMTG 322
           +MTG
Sbjct: 173 EMTG 176

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 55.7 bits (135), Expect = 3e-10
 Identities = 24/68 (35%), Positives = 39/68 (57%), Gaps = 2/68 (2%)

Query: 32 VSRTSLILWHA-HQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
          +  T   L  A    +   V+ LLE     V+A+D D  T LH+A+ +G +++ K L+E+
Sbjct: 25 LGDTDTALHLAARNGNLEIVKLLLEHGAD-VNAKDKDGNTALHLAARNGNLEIVKLLLEH 83

Query: 91 GADVNAQD 98
          GAD+N +D
Sbjct: 84 GADINLKD 91

Length = 91

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 61.3 bits (148), Expect = 3e-10
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 37/181 (20%)

Query: 165 IGKGSFGEILKAYWRGTP-----VAIK-RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           IG G FGE+     + T       AI  R L      +LVI     EVN++ +L+H NIV
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-----EVNVMRELKHKNIV 75

Query: 219 QFLGAVTER--KPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           +++     +  + L ++ E+   GDL     K  K  G +     V+    +   +AY H
Sbjct: 76  RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135

Query: 273 N---EPN--VIIHRDLKPRNVLL---------VNSSADHL------KVGDFGLSKLIKVQ 312
           N    PN   ++HRDLKP+N+ L         + + A++L      K+GDFGLSK I ++
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195

Query: 313 N 313
           +
Sbjct: 196 S 196

Length = 1021

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 41/174 (23%)

Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F     IG+G++G++ KA  +  G  VA+K++      +   I   R E+ +L +L H N
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--------------LSPSTAVNFAL 262
           IV     VT+++            D   + K+KGA              L  S  V+F+ 
Sbjct: 68  IVNLKEIVTDKQ------------DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115

Query: 263 D--------IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           D        +  G+ Y H +    +HRD+K  N+LL N     +K+ DFGL++L
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKG--QIKLADFGLARL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 51/158 (32%), Positives = 74/158 (46%), Gaps = 25/158 (15%)

Query: 158 DFSSSAIIGKGSFGEI-LKAYWRGTPV-AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
           DF    +IG+G+FGE+ L  +     V A+K     LS   ++ +     F  E +++  
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL----LSKFEMIKRSDSAFFWEERDIMAH 99

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
                IVQ   A  + K L ++ EY+ GGDL   +      EK A   +  V  ALD   
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            M +        IHRD+KP N+LL    + HLK+ DFG
Sbjct: 160 SMGF--------IHRDVKPDNMLL--DKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 17/152 (11%)

Query: 165 IGKGSFGEILKAYWRGTPVAIKRI--LPSLSDDRLVIQ-DFRH---EVNLLVK---LRHP 215
           IGKG+FG++ +   + T    +RI  +  LS   +V + +  H   E N+LV+      P
Sbjct: 1   IGKGTFGQVYQVRKKDT----RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESP 56

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            IV    +      L L+T+Y+ GG+L  +L+++G  S   A  +  ++   + +LH   
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK-- 114

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             I++RDLKP N+LL   +  H+ + DFGLSK
Sbjct: 115 YDIVYRDLKPENILL--DATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 9/169 (5%)

Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++GKG+FG+++  K    G   A+K +   +   +  +     E  +L   RHP +    
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L  + EY  GG+L  +L  +   S   A  +  +I   + YLH+E NV ++R
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV-VYR 120

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLK  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 121 DLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYL 163

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 14/171 (8%)

Query: 164 IIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           ++GKG+FG+++    KA  R   + I R    ++ D   +     E  +L   RHP +  
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRHPFLTA 59

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
              A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+    ++
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VV 117

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           +RD+K  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 118 YRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKTFCGTPEYL 162

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 46/164 (28%), Positives = 85/164 (51%), Gaps = 18/164 (10%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           DP+ + F    ++G G++G++ K  + +   +A  +++    D+    ++ + E+N+L K
Sbjct: 3   DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKK 58

Query: 212 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 262
              H NI  + GA  ++ P      L L+ E+   G +   +K  KG  L          
Sbjct: 59  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +I RG+++LH     +IHRD+K +NVLL  ++   +K+ DFG+S
Sbjct: 119 EILRGLSHLHQHK--VIHRDIKGQNVLLTENA--EVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 21/166 (12%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DPS+  +     IGKG++G++ K   +  G+  A+K IL  + D   + ++   E N+L 
Sbjct: 15  DPSD-TWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHD---IDEEIEAEYNILK 69

Query: 211 KLR-HPNIVQFLGA-----VTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFA 261
            L  HPN+V+F G      V     L L+ E   GG   DL K   ++G       + + 
Sbjct: 70  ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129

Query: 262 LDIA-RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           L  A  G+ +LH   N  IHRD+K  N+LL       +K+ DFG+S
Sbjct: 130 LHEALMGLQHLHV--NKTIHRDVKGNNILLTTEGG--VKLVDFGVS 171

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 7/147 (4%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
           +IG+GS+ ++L    + T    A+K +   L +D   I   + E ++  +   HP +V  
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                    L  + EY+ GGDL  +++ +  L    A  ++ +I+  + YLH     II+
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIY 119

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLK  NVLL   S  H+K+ D+G+ K
Sbjct: 120 RDLKLDNVLL--DSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 14/149 (9%)

Query: 165 IGKGSFGE-ILKAYWRGTPVA---IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           IG G FG+ +L   +  T VA   +K +  + S       +F  + +    L+HPNI+Q 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQC 60

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV----NFALDIARGMAYLHNEPN 276
           LG   E  P +L+ EY   GDL  YL ++     ++ +      A +IA G+ ++H    
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
             +H DL  RN  L  +S   +KVGD+G+
Sbjct: 120 -FLHSDLALRNCFL--TSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 18/173 (10%)

Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQD-FRH---EVNLLVKLRHPNI 217
           ++GKG+FG+++  +    G   A+K     L  + ++ +D   H   E  +L   RHP +
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMK----ILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
                +      L  + EY  GG+L  +L  +   S   A  +  +I   + YLH+    
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           +++RDLK  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 116 VVYRDLKLENLML--DKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYL 162

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 48/164 (29%), Positives = 87/164 (53%), Gaps = 18/164 (10%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           DP+ + F    ++G G++G++ K  + +   +A  +++    D+    ++ + E+N+L K
Sbjct: 13  DPAGI-FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKK 68

Query: 212 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 262
              H NI  + GA  ++ P      L L+ E+   G +   +K  KG AL          
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +I RG+A+LH   + +IHRD+K +NVLL  ++   +K+ DFG+S
Sbjct: 129 EILRGLAHLH--AHKVIHRDIKGQNVLLTENA--EVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 8/152 (5%)

Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F    ++GKG FGE+     R T    A K++       R       +E  +L K+    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           +V    A   +  L L+   + GGDL  H Y   +       AV +A +I  G+  LH E
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              I++RDLKP N+LL +    H+++ D GL+
Sbjct: 122 R--IVYRDLKPENILLDDHG--HIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 10/171 (5%)

Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F    ++GKG FGE+     R T    A KR+       R       +E  +L K+    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           +V    A   +  L L+   + GGDL  H Y           A+ +A +I  G+  LH E
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
               ++RDLKP N+LL +    H+++ D GL+  +K+     +    G  G
Sbjct: 122 N--TVYRDLKPENILLDDYG--HIRISDLGLA--VKIPEGESIRGRVGTVG 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 58.6 bits (141), Expect = 7e-10
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 13/165 (7%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLL 209
           DP +  ++    IG+G+ G +  A     G  VAIK+I L       L+I    +E+ ++
Sbjct: 16  DPKK-KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII----NEILVM 70

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
            +L++PNIV FL +      L ++ EYL GG L   + E   +  +       +  + + 
Sbjct: 71  KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALE 129

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           +LH   N +IHRD+K  NVLL    +  +K+ DFG    I  + S
Sbjct: 130 FLH--ANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 10/169 (5%)

Query: 164 IIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++GKG+FG+++  +    G   A+K +   +   +  +     E  +L   RHP +    
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +   +  L  + EY+ GG+L  +L  +   S      +  +I   + YLH+    I++R
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS--GKIVYR 119

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLK  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 120 DLKLENLML--DKDGHIKITDFGLCK----EGITDAATMKTFCGTPEYL 162

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 8/156 (5%)

Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F    ++GKG FGE+     R  G   A K++       R       +E  +L K+    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           +V    A   +  L L+   + GGDL  H Y           AV +A +I  G+  LH E
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
              I++RDLKP N+LL      H+++ D GL+  I 
Sbjct: 122 R--IVYRDLKPENILL--DDYGHIRISDLGLAVEIP 153

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 16/151 (10%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
           IG+G+FG + K   +  GT +A+KRI    + D    +    +++++++    P IV+F 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 222 GAV-TERKPLM---LITEYLRGGDLHK--YLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           GA+  E    +   L+   L     +K  Y   K  +        A+   + + YL  E 
Sbjct: 70  GALFREGDCWICMELMDISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             IIHRD+KP N+LL  +   ++K+ DFG+S
Sbjct: 128 K-IIHRDVKPSNILLDRNG--NIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 7/150 (4%)

Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   +++G+G FGE+  ++    G   A+K +  S+   +  +  F  E ++L     P
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNE 274
            I Q   A  ++  L L+ EY  GGDL   L + +       A  +  ++   +  +H  
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
             V  HRD+KP NVL+      H+K+ DFG
Sbjct: 122 GYV--HRDIKPENVLI--DRTGHIKLADFG 147

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 12/153 (7%)

Query: 157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
            D     I+G G+ G + KAY       +A+K I   ++ +  + +    E+ +L K   
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDS 58

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P I+ F GA      + + TE++ GG L  Y      +        A+ + +G+ YL + 
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              I+HRD+KP N +LVN+    +K+ DFG+S 
Sbjct: 115 K--ILHRDVKPSN-MLVNTRG-QVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 25/158 (15%)

Query: 158 DFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 211
           D+    +IG+G+FGE+ L  +     V   ++L        SD       F  E +++  
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 99

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
              P +VQ   A  + K L ++ EY+ GGDL   +      EK A   +  V  ALD   
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 159

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            M         +IHRD+KP N+LL      HLK+ DFG
Sbjct: 160 SMG--------LIHRDVKPDNMLL--DKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 13/150 (8%)

Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-------DFRHEVNLLVKLRHPN 216
           IIG+G FGE+     R         +  L   R+ ++       + R  ++L+     P 
Sbjct: 1   IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           IV    A      L  I + + GGDLH +L + G  S      +A +I  G+ ++HN   
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR-- 116

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            +++RDLKP N+LL      H+++ D GL+
Sbjct: 117 FVVYRDLKPANILL--DEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-------DFRHEVNLLVKLRHPN 216
           IIG+G FGE+     R         +  L   R+ ++       + R  ++L+     P 
Sbjct: 1   IIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           IV    A      L  I + + GGDLH +L + G  S +    +A +I  G+ ++HN   
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR-- 116

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            +++RDLKP N+LL      H+++ D GL+
Sbjct: 117 FVVYRDLKPANILLDEHG--HVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 54/154 (35%), Positives = 80/154 (51%), Gaps = 20/154 (12%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFL 221
           IGKG++G++ K   +  G+  A+K IL  +SD   V ++   E N+L  L  HPN+V+F 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISD---VDEEIEAEYNILQSLPNHPNVVKFY 85

Query: 222 GAVTERK-----PLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDIAR-GMAYLH 272
           G   +        L L+ E   GG   +L K L   G       +++ L  A  G+ +LH
Sbjct: 86  GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           N  N IIHRD+K  N+LL       +K+ DFG+S
Sbjct: 146 N--NRIIHRDVKGNNILLTTEGG--VKLVDFGVS 175

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 40/118 (33%), Positives = 60/118 (50%), Gaps = 14/118 (11%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
           P  LP    WE     L F     +G G+FG++++A   G         VA+K +  S  
Sbjct: 24  PTQLPYNEKWEFPRDNLQFGK--TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH 81

Query: 193 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK 249
           +D+R   +    E+ +L  L +H NIV  LGA T   P+++ITEY   GDL  +L++K
Sbjct: 82  TDER---EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 33/103 (32%), Positives = 56/103 (54%), Gaps = 3/103 (2%)

Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           +PN ++   +VT  K  +LI +Y++ GDL   LK++G LS +        +   +  LH 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
             + IIH D+K  NVL  + + D + + D+GL K+I   + +D
Sbjct: 128 --HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCYD 167

Length = 267

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 25/158 (15%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 211
           D+    +IG+G+FGE+     + T  V   ++L        SD       F  E +++  
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 99

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
              P +VQ   A  + + L ++ EY+ GGDL   +      EK A   +  V  ALD   
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 159

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            M +        IHRD+KP N+LL  S   HLK+ DFG
Sbjct: 160 SMGF--------IHRDVKPDNMLLDKSG--HLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 26/185 (14%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+      ++S   +G G++G +  A  +  G  VAIK++      +    + +R
Sbjct: 7   NKTVWEL---PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63

Query: 204 HEVNLLVKLRHPNIVQFLGAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ LL  ++H N++  L   T      E +   L+  Y++  DL K +     LS    
Sbjct: 64  -ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKV 119

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
                 +  G+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H  
Sbjct: 120 QYLVYQMLCGLKYIHSAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR-------HAD 168

Query: 318 YKMTG 322
            +MTG
Sbjct: 169 AEMTG 173

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 44/148 (29%), Positives = 66/148 (44%), Gaps = 10/148 (6%)

Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +GKG FGE+     R T    A K++       R   +    E  +L K+    IV    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 223 AVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
           A   +  L L+   + GGDL  ++    +E        A  +   I  G+ +LH     I
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRI 118

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+RDLKP NVLL N    ++++ D GL+
Sbjct: 119 IYRDLKPENVLLDN--DGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 45/153 (29%), Positives = 78/153 (50%), Gaps = 21/153 (13%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRH---PN 216
           +G+G++G + K      GT +A+KRI   + S    RL++       +L + +R    P 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLM-------DLDISMRSVDCPY 61

Query: 217 IVQFLGAVTERKPLMLITEYLRGG--DLHKYLKEKGALSPSTAVN-FALDIARGMAYLHN 273
            V F GA+     + +  E +       +K + +KG   P   +   A+ I + + YLH+
Sbjct: 62  TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           + +VI HRD+KP NVL+  +    +K+ DFG+S
Sbjct: 122 KLSVI-HRDVKPSNVLI--NRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 17/152 (11%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK------LRHP 215
           ++GKGSFG+++ A  +  G   A+K     L  D +++QD   E  +  K        HP
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVK----VLKKD-VILQDDDVECTMTEKRILSLARNHP 56

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            + Q          L  + E++ GGDL  ++++      + A  +A +I   + +LH++ 
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             II+RDLK  NVLL +    H K+ DFG+ K
Sbjct: 117 --IIYRDLKLDNVLLDHEG--HCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 33/162 (20%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRIL--PSLSDDRLVIQDFRHEVNLL---------- 209
           IIG GSFG + +A    T   VAIK++L  P   +  L+I    + +N++          
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIA 265
            K    NI  FL  V E  P  +          HKY+K       AL       ++  + 
Sbjct: 133 FKKNEKNI--FLNVVMEFIPQTV----------HKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           R +AY+H++   I HRDLKP+N LL++ +   LK+ DFG +K
Sbjct: 181 RALAYIHSK--FICHRDLKPQN-LLIDPNTHTLKLCDFGSAK 219

Length = 440

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 7/147 (4%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQF 220
           +IG+GS+ ++L    + T    A+K I   L +D   I   + E ++      HP +V  
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                    L  + E++ GGDL  +++ +  L    A  ++ +I+  + +LH     II+
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIY 119

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLK  NVLL   +  H+K+ D+G+ K
Sbjct: 120 RDLKLDNVLL--DAEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 52.4 bits (126), Expect = 1e-08
 Identities = 28/58 (48%), Positives = 38/58 (65%)

Query: 63  ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           ARD D RTPLH+A+ +G ++V K L+E GADVNA+D    TPL  A       +++LL
Sbjct: 2   ARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLL 59

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 5/100 (5%)

Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           E ++L  + HP+I+Q  G  T  K   LI    +  DL+ YL  K  ++    +     +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            R + YLH   N IIHRD+K  N+  +N   D + +GDFG
Sbjct: 192 LRAIQYLHE--NRIIHRDIKAENI-FINHPGD-VCLGDFG 227

Length = 391

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 24/173 (13%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI---LPSLSDDRLVIQ 200
           NK  WE+ P    + +   +G G++G +  AY       VA+K++     SL   R   +
Sbjct: 7   NKTVWEV-PER--YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR 63

Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSP 254
           + R    LL  ++H N++  L   T          + L+T  L G DL+  +K +  LS 
Sbjct: 64  ELR----LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQ-KLSD 117

Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                    + RG+ Y+H+    IIHRDLKP NV  VN   + L++ DFGL++
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNV-AVNEDCE-LRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 12/153 (7%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IG+G+ G +  A     G  VAIK++ L       L+I    +E+ ++ + +HPNIV +L
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII----NEILVMRENKHPNIVNYL 82

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L ++ EYL GG L   + E   +          +  + + +LH+  N +IHR
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 139

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           D+K  N+LL    +  +K+ DFG    I  + S
Sbjct: 140 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 29/163 (17%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR----HEV 206
           DP      +   IG+GS G +  A  +  G  VA+K++        L  Q  R    +EV
Sbjct: 16  DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM-------DLRKQQRRELLFNEV 67

Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-----HKYLKEKGALSPSTAVNFA 261
            ++   +HPNIV+   +      L ++ E+L GG L     H  + E+   +   AV  A
Sbjct: 68  VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKA 127

Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
           L      ++LH +   +IHRD+K  ++LL  +S   +K+ DFG
Sbjct: 128 L------SFLHAQG--VIHRDIKSDSILL--TSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat

 Score = 48.3 bits (116), Expect = 4e-08
 Identities = 18/33 (54%), Positives = 26/33 (78%)

Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
          D  TPLH+A+ +G ++V K L+E GADVNA+D+
Sbjct: 1  DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 8/155 (5%)

Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F    ++GKG FGE+     R T    A K++       R       +E  +L K+    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           +V    A   +  L L+   + GGDL  H Y           A+ +A ++  G+  L  E
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              I++RDLKP N+LL +    H+++ D GL+  I
Sbjct: 122 R--IVYRDLKPENILLDDRG--HIRISDLGLAVQI 152

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 7/147 (4%)

Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
           +IG+GS+ ++L    +      A+K +   L  D   I   + E ++  +   +P +V  
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                    L L+ EY+ GGDL  +++ +  L    A  +A +I   + +LH     II+
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIY 119

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLK  NVLL   +  H+K+ D+G+ K
Sbjct: 120 RDLKLDNVLL--DADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 40/118 (33%), Positives = 57/118 (48%), Gaps = 14/118 (11%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSL- 192
           P  LP    WE   + L F     +G G+FG++++A   G         VA+K + PS  
Sbjct: 21  PTQLPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78

Query: 193 SDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK 249
             +R   +    E+ +L  L  H NIV  LGA T   P ++ITEY   GDL  +L+ K
Sbjct: 79  LTER---EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 50.3 bits (121), Expect = 2e-07
 Identities = 39/155 (25%), Positives = 62/155 (40%), Gaps = 29/155 (18%)

Query: 164 IIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRH--- 214
           +I KG+   I    + G    IK R+      P L D+R+  +  R+E  LL + R    
Sbjct: 1   LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPEL-DERIRRERTRNEARLLSRARKAGV 59

Query: 215 --PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +        +     ++ EY+ G  L   ++E              +I R +  LH
Sbjct: 60  NTPVVYDV-----DPDNKTIVMEYIEGKPLKDVIEEGN-------DELLREIGRLVGKLH 107

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                I+H DL   N+++     D L + DFGL K
Sbjct: 108 K--AGIVHGDLTTSNIIV---RDDKLYLIDFGLGK 137

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 51.3 bits (122), Expect = 2e-07
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IG+G+ G +  A     G  VAIK++ L       L+I    +E+ ++ + ++PNIV +L
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 82

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L ++ EYL GG L   + E   +          +  + + +LH+  N +IHR
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHS--NQVIHR 139

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           D+K  N+LL    +  +K+ DFG    I  + S
Sbjct: 140 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 8/106 (7%)

Query: 225 TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284
           T+ K L LI +Y+ GG+L  +L ++   + S    +  +I   + +LH     II+RD+K
Sbjct: 76  TDTK-LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIK 132

Query: 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             N+LL   S  H+ + DFGLSK    +     Y      G+ EY+
Sbjct: 133 LENILL--DSEGHVVLTDFGLSKEFLAEEEERAYSF---CGTIEYM 173

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 50.9 bits (121), Expect = 3e-07
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IG+G+ G +  A     G  VAI+++ L       L+I    +E+ ++ + ++PNIV +L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 83

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L ++ EYL GG L   + E   +          +  + + +LH+  N +IHR
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 140

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           D+K  N+LL    +  +K+ DFG    I  + S
Sbjct: 141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 21/158 (13%)

Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----------FRHEVNLLVKLRH 214
           +G+G+F  I K   R    +   I+    +  +V++           F    +L+ +L H
Sbjct: 3   LGQGTFTNIYKGVLR--VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHN 273
            ++V+  G V  R   +++ EY++ G L  +L +EK  +S    ++ A  +A  + YL  
Sbjct: 61  KHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL-- 117

Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLS 306
           E   ++H ++  +N+L+     +      +K+ D G+ 
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 50.2 bits (119), Expect = 4e-07
 Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 2/87 (2%)

Query: 41  HAHQNDAAAVRKLLE--EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           +  + +    + LLE   D  + + RD D  TPLH A+L+G  D+ + L+E GAD N+++
Sbjct: 118 NPPEGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRN 177

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGG 125
            +  T L  A    +  +++LL   G 
Sbjct: 178 SYGVTALDPAAKNGRIELVKLLLDKGL 204

Length = 235

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 46/150 (30%), Positives = 66/150 (44%), Gaps = 7/150 (4%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG+G+FGE+     + T  V   +IL       R     FR E ++LV     
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
            I     A  +   L L+ +Y  GGDL   L +     P     F L ++   +  +H  
Sbjct: 62  WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
             V  HRD+KP NVLL      H+++ DFG
Sbjct: 122 GYV--HRDIKPDNVLL--DKNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 28/101 (27%), Positives = 46/101 (45%), Gaps = 6/101 (5%)

Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALD 263
           E  LL  + HP++++    +     +  +       DL+ YL K    L    A+     
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV-SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
           I  G+ YLH +   IIHRD+K  N+ +  +  D + +GD G
Sbjct: 166 ILEGLRYLHAQR--IIHRDVKTENIFI--NDVDQVCIGDLG 202

Length = 357

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 16/154 (10%)

Query: 165 IGKGSFGEI--LKAYWRGTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG FGE+  ++    G   A K++    L   S +++ +     E  +L K+  P IV
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL----EKEILEKVNSPFIV 56

Query: 219 QFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
               A   +  L L+   + GGDL  H Y   +  L     ++++  I  G+ +LH+   
Sbjct: 57  NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD- 115

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            I++RD+KP NVLL      + ++ D GL+  +K
Sbjct: 116 -IVYRDMKPENVLL--DDQGNCRLSDLGLAVELK 146

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 39/114 (34%), Positives = 55/114 (48%), Gaps = 12/114 (10%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
           P  LP    WE+    L    +  +G G+FG +++A   G         VA+K +L S +
Sbjct: 23  PMQLPYDSAWEMPRDNLVLGRT--LGSGAFGRVVEATAHGLSHSQSTMKVAVK-MLKSTA 79

Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 246
                 Q    E+ ++  L  H NIV  LGA T+  P+ +ITEY R GDL  YL
Sbjct: 80  R-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 90/242 (37%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIK--RILPSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K  +   + S+ + ++ 
Sbjct: 2   WEFPRDRLKLGKP--LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMT 59

Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITE---------YLRG---------- 239
               E+ +L+ +  H N+V  LGA T+   PLM+I E         YLR           
Sbjct: 60  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRN 115

Query: 240 --------------------------GDLHKYLKEKGA----------------LSPSTA 257
                                          ++++K                  L+    
Sbjct: 116 KSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDL 175

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
           ++++  +ARGM +L +     IHRDL  RN+LL  ++   +K+ DFGL++        D+
Sbjct: 176 ISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNV--VKICDFGLAR--------DI 223

Query: 318 YK 319
           YK
Sbjct: 224 YK 225

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 41/130 (31%), Positives = 58/130 (44%), Gaps = 9/130 (6%)

Query: 192 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY----LK 247
           L+D+R      R E++ L    H  IV+          L+LI EY  GGDL+K     LK
Sbjct: 103 LNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161

Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           E               I   +  +H+    ++HRDLK  N+ L+ +    +K+GDFG SK
Sbjct: 162 EHLPFQEYEVGLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGI--IKLGDFGFSK 217

Query: 308 LIKVQNSHDV 317
                 S DV
Sbjct: 218 QYSDSVSLDV 227

Length = 478

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 11/155 (7%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP E    S   IG+GS G +  A  +  G  VA+K++       R ++ +   EV ++ 
Sbjct: 19  DPRE-YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMR 74

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
              H N+V    +      L ++ E+L GG L   +     ++        L + R ++Y
Sbjct: 75  DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSY 133

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
           LHN+   +IHRD+K  ++LL  +S   +K+ DFG 
Sbjct: 134 LHNQG--VIHRDIKSDSILL--TSDGRIKLSDFGF 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 9/151 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG+G+FGE+     + T    A+K +       R     FR E N+LV     
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
            I     A  +   L L+ +Y  GGDL   L +     P     F + ++   +  +H  
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121

Query: 275 PNVIIHRDLKPRNVLL-VNSSADHLKVGDFG 304
             V  HRD+KP NVLL +N    H+++ DFG
Sbjct: 122 HYV--HRDIKPDNVLLDMNG---HIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 14/180 (7%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIK----RIL--PSLSDDRLVIQDFRHEVNLLVK 211
           +F    ++G G++G++            K    ++L   +L      ++  R E N+L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 212 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +R  P +V    A      L LI +Y+ GG++  +L ++   S      ++ +I   + +
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LH     I++RD+K  N+LL   S  H+ + DFGLSK    +     Y   G     EY+
Sbjct: 121 LHKLG--IVYRDIKLENILL--DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI---EYM 173

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 38/129 (29%), Positives = 59/129 (45%), Gaps = 8/129 (6%)

Query: 203 RHEVNLLVKLRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
           R E  +L  +R  P +V    A      L LI +Y+ GG+L  +L ++          ++
Sbjct: 52  RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111

Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
            +I   + +LH     II+RD+K  N+LL   S  H+ + DFGLSK          Y   
Sbjct: 112 GEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFHEDEVERAYSF- 166

Query: 322 GETGSCEYL 330
              G+ EY+
Sbjct: 167 --CGTIEYM 173

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 20/151 (13%)

Query: 165 IGKGSFGEILKAYWRGTPVAIK-------RILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           I +G+  EI    + G    IK       R  P L D+R+  +  R E  ++ + R   +
Sbjct: 4   IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRH-PEL-DERIRRERTRREARIMSRARKAGV 61

Query: 218 -VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
            V  +  V     + ++ EY+ G    + LK+    +    +  + +I R +  LH+   
Sbjct: 62  NVPAVYFVDPENFI-IVMEYIEG----EPLKDLINSNGMEELELSREIGRLVGKLHS--A 114

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            IIH DL   N++L   S   + + DFGL++
Sbjct: 115 GIIHGDLTTSNMIL---SGGKIYLIDFGLAE 142

Length = 211

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 12/114 (10%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILK--AYW--RGTPV---AIKRILPSLS 193
           P  LP    WE     L      I+G G+FG++++  AY   R  PV   A+K + P+  
Sbjct: 23  PMQLPYDSRWEFPRDGLVLGR--ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR 80

Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL 246
                 Q    E+ ++  L  H NIV  LGA T+  P+ +ITEY   GDL  YL
Sbjct: 81  SSEK--QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 17/157 (10%)

Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV---QFL 221
           +G+G++G + KA  +      +  L  +    + +   R E+ LL +L+HPN++   +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKVF 67

Query: 222 GAVTERKPLMLITEYLRGGDLH--------KYLKEKGALSPSTAVNFALDIARGMAYLHN 273
            + ++RK + L+ +Y      H        K  K+   L  S   +    I  G+ YLH 
Sbjct: 68  LSHSDRK-VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH- 125

Query: 274 EPNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKL 308
             N ++HRDLKP N+L++    +   +K+ D G ++L
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 41/176 (23%), Positives = 79/176 (44%), Gaps = 13/176 (7%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           I+  ++D  +S +I +     I K  +    V I+         +++I    +E+  L +
Sbjct: 15  IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRR 74

Query: 212 LRHPNIVQFLG----AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
           +   NI++  G     V +   L LI EY   G L + L ++  LS  T ++ A+D  +G
Sbjct: 75  IDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKG 134

Query: 268 MAYLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
           +  L+   N+P    +++L   + L+  +    LK+   GL K++      +V  M
Sbjct: 135 LYNLYKYTNKP----YKNLTSVSFLVTENYK--LKIICHGLEKILSSPPFKNVNFM 184

Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 36/161 (22%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+ G +  AY    G  VAIK++     +     + +R E+ L+  + H NI+  L 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82

Query: 223 AVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR---------- 266
             T +K L       L+ E L   +L +             +   LD  R          
Sbjct: 83  VFTPQKSLEEFQDVYLVME-LMDANLCQ------------VIQMDLDHERMSYLLYQMLC 129

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           G+ +LH+    IIHRDLKP N+ +V S    LK+ DFGL++
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNI-VVKSDCT-LKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat

 Score = 41.9 bits (99), Expect = 7e-06
 Identities = 15/30 (50%), Positives = 24/30 (80%)

Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
          D  TPLH+A+ +G +++ K L+E+GAD+NA
Sbjct: 1  DGNTPLHLAARNGNLELVKLLLEHGADINA 30

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 6/143 (4%)

Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+FGE+       T    A+K +  +    R      + E ++L +  +  +V+   
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +  ++  L  + +Y+ GGD+   L   G      A  +  ++   +  +H      IHRD
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRD 126

Query: 283 LKPRNVLLVNSSADHLKVGDFGL 305
           +KP N+L+      H+K+ DFGL
Sbjct: 127 IKPDNILI--DRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 42.2 bits (100), Expect = 9e-06
 Identities = 16/38 (42%), Positives = 23/38 (60%)

Query: 68  NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
            RT LH A++ G +++ K L+E G D+N  D   NT L
Sbjct: 1   GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTAL 38

Length = 54

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 45.7 bits (109), Expect = 9e-06
 Identities = 41/153 (26%), Positives = 63/153 (41%), Gaps = 23/153 (15%)

Query: 163 AIIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
            +I +G+   I    + G P  +K RI      P L D++L  +  R E  +L K R   
Sbjct: 2   DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPEL-DEKLRRERTRREARILAKAREAG 60

Query: 217 I-VQFLGAVTERKPLMLIT-EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           + V  +  V       LI  EY+ G  L   L+E          +   ++ R +  LH  
Sbjct: 61  VPVPIVYDVDP--DNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK- 110

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              I+H DL   N++L   S   +   DFGL +
Sbjct: 111 -AGIVHGDLTTSNIIL---SGGRIYFIDFGLGE 139

Length = 204

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 14/164 (8%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GS G +  A  +  G  VA+K +       R ++ +   EV ++   +H N+V+   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +    + L ++ E+L+GG L   + +   L+          + + + YLH++   +IHRD
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQG--VIHRD 142

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
           +K  ++LL       +K+ DFG       Q S DV K     G+
Sbjct: 143 IKSDSILLTLDG--RVKLSDFGFC----AQISKDVPKRKSLVGT 180

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies)

 Score = 42.0 bits (99), Expect = 1e-05
 Identities = 18/53 (33%), Positives = 32/53 (60%)

Query: 53  LLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           LLE     ++A D +  TPLH+A+ +G +++ + L++ G D+N +D    T L
Sbjct: 1   LLEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53

Length = 56

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 44.8 bits (105), Expect = 2e-05
 Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 9/111 (8%)

Query: 23  ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG--- 79
            D+      +     +   A + D   V+ LL      V+A+D D  TPLH+A+L+G   
Sbjct: 62  VDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGAD-VNAKDADGDTPLHLAALNGNPP 120

Query: 80  --WIDVAKCLIEYGA---DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
              I+VAK L+E GA     N +D   NTPL  A      +++ELL   G 
Sbjct: 121 EGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGA 171

Length = 235

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 41.1 bits (97), Expect = 2e-05
 Identities = 15/55 (27%), Positives = 27/55 (49%), Gaps = 1/55 (1%)

Query: 34 RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
            + +   A       V+ LLE+    ++  D D  T LH+A+ +G ++V K L+
Sbjct: 1  GRTALHKAAISGRLELVKYLLEKGVD-INRTDEDGNTALHIAAENGNLEVLKLLL 54

Length = 54

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 42/156 (26%), Positives = 65/156 (41%), Gaps = 19/156 (12%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG+G+FGE+     +      A+K +       R     FR E ++LV   + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF-------ALDIARGM 268
            I     A  +   L L+ +Y  GGDL   L +     P     F       A+D    +
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            Y        +HRD+KP N+L+      H+++ DFG
Sbjct: 122 HY--------VHRDIKPDNILM--DMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 22/154 (14%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+ G +  A+    G  VA+K++     +     + +R E+ LL  + H NI+  L 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL---------HN 273
             T +K L    E+    D++  ++   A +    ++  LD  R M+YL         H 
Sbjct: 88  VFTPQKSL---EEF---QDVYLVMELMDA-NLCQVIHMELDHER-MSYLLYQMLCGIKHL 139

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
               IIHRDLKP N+++ +     LK+ DFGL++
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 15/135 (11%)

Query: 165 IGKGSFG----EILKAYWRGTPVAIKRI-LPSLSDDRLV-IQDFRHEVNLLVKLRHPNIV 218
           IGK         + K     T VA+K+I L S S + L  +Q    E+    +L+HPNI+
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPNIL 62

Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFAL-DIARGMAYLHNEP 275
            ++ +      L +++  +  G     LK      L P  A+ F L D+   + Y+H+  
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL-PELAIAFILKDVLNALDYIHS-- 119

Query: 276 NVIIHRDLKPRNVLL 290
              IHR +K  ++LL
Sbjct: 120 KGFIHRSVKASHILL 134

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 18/164 (10%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL--VIQDFRHE 205
           +  D ++L+      IG G+ G++ K  ++  G  +A+K++  + + +    ++ D    
Sbjct: 10  YPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD-- 65

Query: 206 VNLLVKLRH--PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
              +V   H  P IV+  G        + I   L    L K LK  +G +         +
Sbjct: 66  ---VVLKSHDCPYIVKCYGYFI-TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTV 121

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            I + + YL  +  VI HRD+KP N+LL ++S + +K+ DFG+S
Sbjct: 122 AIVKALHYLKEKHGVI-HRDVKPSNILL-DASGN-VKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 15/156 (9%)

Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           +G+G++G + KA  +         L  +    + +   R E+ LL +L+HPN++      
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67

Query: 225 TER--KPLMLITEYLRGGDLH--------KYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
                + + L+ +Y      H        K  K+   L      +    I  G+ YLH  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-- 125

Query: 275 PNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGLSKL 308
            N ++HRDLKP N+L++    +   +K+ D G ++L
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 35/151 (23%), Positives = 69/151 (45%), Gaps = 10/151 (6%)

Query: 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD----FRHEVNLLVKLRH 214
           F     +G G+FGE+  A  R         + +L    +++++     + E ++L +  +
Sbjct: 3   FVKIKTLGIGAFGEVCLA--RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
             +V+   +  ++  L  + +Y+ GGD+   L   G      A  +  ++   +  +H  
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
               IHRD+KP N+L+      H+K+ DFGL
Sbjct: 121 G--FIHRDIKPDNILI--DRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 17/111 (15%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIK--RILPSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K  +   + S+ R ++ 
Sbjct: 2   WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 59

Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEK 249
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+ K
Sbjct: 60  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 36/149 (24%), Positives = 67/149 (44%), Gaps = 6/149 (4%)

Query: 159 FSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F     +G G+FGE+  A    T    A+K +      +R  +   + E ++L +  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           +V+   +  ++  L  + +Y+ GGD+   L          A  +  ++   +  +H    
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG- 121

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
             IHRD+KP N+L+      H+K+ DFGL
Sbjct: 122 -FIHRDIKPDNILI--DLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 2/96 (2%)

Query: 29  KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
           K    +T   L +A +       K+L E  + V+  D +   P+H+A  H + D+ K L+
Sbjct: 120 KDAELKT--FLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLL 177

Query: 89  EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           E GA  N +D    +PL +A     +  ++LL  HG
Sbjct: 178 EKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHG 213

Length = 434

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 36/129 (27%), Positives = 60/129 (46%), Gaps = 8/129 (6%)

Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           E+++L  + H  I+  + A   +  + ++    +  DL  Y+   G L    A+     +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDVYKMTG- 322
              +AYLH     IIHRD+K  N+ L     ++  +GDFG + KL    ++   Y  +G 
Sbjct: 195 LEALAYLHGRG--IIHRDVKTENIFLDEP--ENAVLGDFGAACKLDAHPDTPQCYGWSGT 250

Query: 323 -ETGSCEYL 330
            ET S E L
Sbjct: 251 LETNSPELL 259

Length = 392

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 39.9 bits (94), Expect = 1e-04
 Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 2/49 (4%)

Query: 72  LHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           LH+A+ +G +++ K L+E GADVN  D   +T L  A       +++LL
Sbjct: 1   LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLL 47

Length = 91

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 26/71 (36%), Positives = 39/71 (54%), Gaps = 15/71 (21%)

Query: 252 LSPSTA---VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
            SP T    + ++  +ARGM +L +     IHRDL  RN+LL  S  + +K+ DFGL++ 
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLAR- 222

Query: 309 IKVQNSHDVYK 319
                  D+YK
Sbjct: 223 -------DIYK 226

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 23/67 (34%), Positives = 41/67 (61%), Gaps = 4/67 (5%)

Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           AL     ++F+  +A+GM++L ++    IHRDL  RN+LL +      K+ DFGL++ I+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRI--TKICDFGLARDIR 265

Query: 311 VQNSHDV 317
             +++ V
Sbjct: 266 NDSNYVV 272

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 17/111 (15%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRIL--PSLSDDRLVIQ 200
           WE     L      ++G G+FG++++A   G         VA+K +    + S+ + ++ 
Sbjct: 2   WEFPRDRLRLGK--VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMS 59

Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLKEK 249
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  +L+ K
Sbjct: 60  ----ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 31/160 (19%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEV 206
           +ID S   F   +++G+G+FG++++A+ R       V I R +P  +      +D + E+
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT------RDAKIEI 176

Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH------KY-------LKEKGALS 253
             + K+R  +         +R PLM I  Y +    H      KY       + + G  S
Sbjct: 177 QFMEKVRQAD-------PADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS 229

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293
                         + Y H E + ++H DLKP N+L+  S
Sbjct: 230 HRHLAQIIFQTGVALDYFHTELH-LMHTDLKPENILMETS 268

Length = 467

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 24/65 (36%), Positives = 37/65 (56%), Gaps = 1/65 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA-KKFNMMEL 119
           V+  D  N +PLH A  H    +   L+E GA  +A+D+  NTPL  + G  K +++++L
Sbjct: 194 VNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKL 253

Query: 120 LNAHG 124
           L  HG
Sbjct: 254 LLEHG 258

Length = 477

>gnl|CDD|197603 smart00248, ANK, ankyrin repeats

 Score = 37.6 bits (88), Expect = 2e-04
 Identities = 16/30 (53%), Positives = 24/30 (80%)

Query: 67 DNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
          D RTPLH+A+ +G ++V K L++ GAD+NA
Sbjct: 1  DGRTPLHLAAENGNLEVVKLLLDKGADINA 30

Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 37/159 (23%), Positives = 72/159 (45%), Gaps = 23/159 (14%)

Query: 165 IGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +G+G+F +I K   R          T V +K +  S    R   + F    +++ +L H 
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHK 59

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-- 273
           ++V   G        +++ EY++ G L  YLK+   L   +   + L++A+ +A+  +  
Sbjct: 60  HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS---WKLEVAKQLAWALHFL 116

Query: 274 EPNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLS 306
           E   + H ++  +NVLL+            +K+ D G+S
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 16/107 (14%)

Query: 204 HEVNLLVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTA 257
           HE  LL +L HP ++  L     G +T     +++ +Y    DL+ YL      L  +  
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLT----CLVLPKY--RSDLYTYLGARLRPLGLAQV 262

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
              A  +   + Y+H E   IIHRD+K  NV LVN   D + +GDFG
Sbjct: 263 TAVARQLLSAIDYIHGEG--IIHRDIKTENV-LVNGPED-ICLGDFG 305

Length = 461

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 26/80 (32%), Positives = 39/80 (48%)

Query: 44  QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103
           + D  AV +LL+  +        D  TPLH+A++   +D+ K LI  GAD +  +  K +
Sbjct: 78  EGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFS 137

Query: 104 PLADAEGAKKFNMMELLNAH 123
           PL  A        +ELL  H
Sbjct: 138 PLHLAVMMGDIKGIELLIDH 157

Length = 413

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GS G +  A  +  G  VA+K++       R ++ +   EV ++   +H N+V+   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +      L ++ E+L GG L   +     ++        L + + ++ LH +   +IHRD
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQG--VIHRD 141

Query: 283 LKPRNVLLVNSSADHLKVGDFGL 305
           +K  ++LL +     +K+ DFG 
Sbjct: 142 IKSDSILLTHDG--RVKLSDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 3/60 (5%)

Query: 50  VRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
           + KLL E    V+A+ Y    T LH  S+       K L+EYGAD+N+ + +K TPL+ A
Sbjct: 250 ILKLLLEHGVDVNAKSYILGLTALHS-SIKS-ERKLKLLLEYGADINSLNSYKLTPLSSA 307

Length = 477

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 4/90 (4%)

Query: 232 LITEYLRGGDLHKYLKEKGALSPSTAVNFA--LDIARGMAYLHNEPNVIIHRDLKPRNVL 289
           L+ +Y   GDL + +K +   + +   + A  L I   +A  H     +IHRD+K  N+L
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175

Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           L   S   +K+GDFG SK+     S DV +
Sbjct: 176 LC--SNGLVKLGDFGFSKMYAATVSDDVGR 203

Length = 496

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 38.9 bits (91), Expect = 7e-04
 Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 1/47 (2%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
           A   +   V+ LL+   + V+ARD D RTPLH+A+ +G ++V K L+
Sbjct: 81  ARNGNLDVVKLLLKHG-ADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 25/71 (35%), Positives = 36/71 (50%), Gaps = 4/71 (5%)

Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
                  + E  ALS    V F+  +A GM +L ++  V  HRDL  RNVL+       +
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV--HRDLAARNVLICEGKL--V 278

Query: 299 KVGDFGLSKLI 309
           K+ DFGL++ I
Sbjct: 279 KICDFGLARDI 289

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 29/73 (39%), Positives = 41/73 (56%), Gaps = 4/73 (5%)

Query: 39  LWHAHQNDAAA--VRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVN 95
           L HA Q  + +  V KLLE     V+A++    TPL++ + +G+  +  + LI  GADVN
Sbjct: 277 LHHASQAPSLSRLVPKLLERGAD-VNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVN 335

Query: 96  AQDRWKNTPLADA 108
           A DR   TPL  A
Sbjct: 336 AADRLYITPLHQA 348

Length = 682

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 40.6 bits (96), Expect = 9e-04
 Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 38/159 (23%)

Query: 164 IIGKGSFGEILKAYWRGTPVAIK-RI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +IGKG+  +I K  + G    IK R+      P L D+RL  +  R E  LL + R   +
Sbjct: 340 LIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPEL-DERLRTERTRAEARLLSEARRAGV 398

Query: 218 VQFLGAVTERKPLM---------LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
                      P++         ++ EY+ G DL   L+                +   +
Sbjct: 399 ---------PTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG--------NPELVRKVGEIV 441

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           A LH     I+H DL   N ++ +   D L + DFGL K
Sbjct: 442 AKLHK--AGIVHGDLTTSNFIVRD---DRLYLIDFGLGK 475

Length = 535

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           KL+HPNIV+ +G     K   LI EY+ G +L + L+    LS       A+ IA+ + +
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRF 795

Query: 271 LH--NEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
           LH    P V++  +L P  +++      HL++ 
Sbjct: 796 LHCRCSPAVVVG-NLSPEKIIIDGKDEPHLRLS 827

Length = 968

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 39.7 bits (92), Expect = 0.001
 Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 16/151 (10%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+ G +  AY       VAIK++     +     + +R E+ L+  + H NI+  L 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83

Query: 223 AVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
             T +K L       L+ E L   +L + ++ +  L           +  G+ +LH+   
Sbjct: 84  VFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG- 139

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            IIHRDLKP N+++ +     LK+ DFGL++
Sbjct: 140 -IIHRDLKPSNIVVKSDCT--LKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 25/78 (32%), Positives = 44/78 (56%), Gaps = 6/78 (7%)

Query: 240 GDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
            ++   L + G+  L+    ++F   +ARGM +L ++  V  HRDL  RNVLL  +    
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV--HRDLAARNVLL--AQGKI 275

Query: 298 LKVGDFGLSKLIKVQNSH 315
           +K+ DFGL++ I   +++
Sbjct: 276 VKICDFGLARDIMHDSNY 293

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 23/64 (35%), Positives = 35/64 (54%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+ +D + +T LH A   G ++  K L EYGADVN +D     P+  A     F++++LL
Sbjct: 117 VNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLL 176

Query: 121 NAHG 124
              G
Sbjct: 177 LEKG 180

Length = 434

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 14/150 (9%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+ G +  AY       VAIK++     +     + +R E+ L+  + H NI+  L 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 90

Query: 223 AVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
             T +K L     + I   L   +L + ++ +  L           +  G+ +LH+    
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG-- 146

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           IIHRDLKP N+++ +     LK+ DFGL++
Sbjct: 147 IIHRDLKPSNIVVKSDCT--LKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 26/65 (40%), Positives = 36/65 (55%), Gaps = 2/65 (3%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQDRW 100
           + +     VR LLE     V+A +    TPLH+   +   +DV K LI+ GADVNA+D+ 
Sbjct: 58  SSEKVKDIVRLLLEAGAD-VNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKV 116

Query: 101 KNTPL 105
             TPL
Sbjct: 117 GRTPL 121

Length = 471

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 11/132 (8%)

Query: 180 GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238
           GT V ++   L + +++ L     ++EV L    RHPNI+      T    L +I+ ++ 
Sbjct: 25  GTLVTVRITDLENCTEEHLKA--LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82

Query: 239 GGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
            G  +  LK      +S +   N      RG+ YLH   N  IHR++K  ++L+   S D
Sbjct: 83  YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILI---SGD 137

Query: 297 HLKVGDFGLSKL 308
            L V   GLS L
Sbjct: 138 GL-VSLSGLSHL 148

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 21/56 (37%), Positives = 32/56 (57%), Gaps = 3/56 (5%)

Query: 42  AHQNDAAAVRKLLEEDQSL-VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
           A +ND  A+++LL+  Q L V + D+   T L VA     +D+ + LI  GADV+ 
Sbjct: 630 AKRNDLTAMKELLK--QGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDK 683

Length = 823

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 24/71 (33%), Positives = 38/71 (53%), Gaps = 7/71 (9%)

Query: 61  VHARDYDNRTPLHVASLHGWI-----DVAKCLIEYGADVNAQDRWKNTPLADAEGAKK-- 113
           +++   +N TPLH  S   +      ++ K L+EYGA+VNA D    TPL  A   K   
Sbjct: 61  INSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNS 120

Query: 114 FNMMELLNAHG 124
           ++++E L  +G
Sbjct: 121 YSIVEYLLDNG 131

Length = 422

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	337
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.98
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.98
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.98
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.98
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.98
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.98
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.98
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
PHA03207	392	serine/threonine kinase US3; Provisional	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.95
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.95
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.95
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.95
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.95
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.95
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.94
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.94
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.94
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.94
PHA03210	501	serine/threonine kinase US3; Provisional	99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.94
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.94
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.94
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.94
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.94
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.94
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.94
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.94
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.94
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.94
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.94
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.94
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.94
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.94
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.94
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.94
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.94
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.94
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.94
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.94
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.93
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.93
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.93
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.93
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.93
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.93
PLN00009	294	cyclin-dependent kinase A; Provisional	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.93
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.93
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.93
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.93
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.93
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.93
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.93
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.93
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.93
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.92
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.92
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.92
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.92
PHA02882	294	putative serine/threonine kinase; Provisional	99.92
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.92
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.92
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.92
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.92
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.92
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.92
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.92
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.92
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.92
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.92
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.91
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.91
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.91
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.91
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.91
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.91
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.89
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.89
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.89
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.89
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.88
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.88
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.82
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.81
smart00090	237	RIO RIO-like kinase.	99.81
PHA02743	166	Viral ankyrin protein; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.76
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.76
PHA02884	300	ankyrin repeat protein; Provisional	99.75
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.73
PHA02741	169	hypothetical protein; Provisional	99.73
PHA02791	284	ankyrin-like protein; Provisional	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.71
PHA02741	169	hypothetical protein; Provisional	99.71
PHA02736	154	Viral ankyrin protein; Provisional	99.71
PHA02859	209	ankyrin repeat protein; Provisional	99.71
PHA02791	284	ankyrin-like protein; Provisional	99.71
KOG0508	615	consensus Ankyrin repeat protein [General function	99.69
PLN00181	793	protein SPA1-RELATED; Provisional	99.69
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.69
PHA02878	477	ankyrin repeat protein; Provisional	99.69
PHA02859	209	ankyrin repeat protein; Provisional	99.68
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.68
PHA02884	300	ankyrin repeat protein; Provisional	99.68
PHA02743	166	Viral ankyrin protein; Provisional	99.67
PHA02874	434	ankyrin repeat protein; Provisional	99.67
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.67
PHA02795	437	ankyrin-like protein; Provisional	99.67
PHA02946	446	ankyin-like protein; Provisional	99.67
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.66
PHA02798	489	ankyrin-like protein; Provisional	99.66
PF13857	56	Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A	99.66
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.66
PHA03095	471	ankyrin-like protein; Provisional	99.66
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.65
PHA02875	413	ankyrin repeat protein; Provisional	99.65
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.65
PHA02878	477	ankyrin repeat protein; Provisional	99.65
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.64
PHA03095	471	ankyrin-like protein; Provisional	99.63
PHA02917	661	ankyrin-like protein; Provisional	99.63
PHA02946	446	ankyin-like protein; Provisional	99.62
PHA02875	413	ankyrin repeat protein; Provisional	99.62
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.62
PHA03100	480	ankyrin repeat protein; Provisional	99.61
PHA03100	480	ankyrin repeat protein; Provisional	99.61
PHA02798	489	ankyrin-like protein; Provisional	99.61
KOG0508	615	consensus Ankyrin repeat protein [General function	99.6
PHA02989	494	ankyrin repeat protein; Provisional	99.6
PHA02989	494	ankyrin repeat protein; Provisional	99.59
PHA02874	434	ankyrin repeat protein; Provisional	99.59
PHA02876	682	ankyrin repeat protein; Provisional	99.58
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.58
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.57
KOG0514	452	consensus Ankyrin repeat protein [General function	99.56
PHA02730	672	ankyrin-like protein; Provisional	99.56
PHA02736	154	Viral ankyrin protein; Provisional	99.56
PHA02795	437	ankyrin-like protein; Provisional	99.55
PHA02792	631	ankyrin-like protein; Provisional	99.55
PHA02917	661	ankyrin-like protein; Provisional	99.55
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
PHA02730	672	ankyrin-like protein; Provisional	99.54
PHA02876	682	ankyrin repeat protein; Provisional	99.53
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.52
KOG0514	452	consensus Ankyrin repeat protein [General function	99.51
KOG0510	929	consensus Ankyrin repeat protein [General function	99.51
KOG0510	929	consensus Ankyrin repeat protein [General function	99.51
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.51
KOG3087	229	consensus Serine/threonine protein kinase [General	99.49
KOG1710	396	consensus MYND Zn-finger and ankyrin repeat protei	99.49
PF13637	54	Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A	99.49
PTZ00322	664	6-phosphofructo-2-kinase/fructose-2,6-biphosphatas	99.48
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.48
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.47
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.46
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.43
KOG0507	854	consensus CASK-interacting adaptor protein (caskin	99.43

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=296.11  Aligned_cols=171  Identities=35%  Similarity=0.623  Sum_probs=152.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+|++||+|+++  +..||||.+.+.... +...+.+..|+.+|+.++|||||+++++...++.+|+|||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            6888888999999999999986  789999999776543 3355778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CC---CcEEEEeccCceeeec
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SA---DHLKVGDFGLSKLIKV  311 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~---~~~kl~DFgla~~~~~  311 (337)
                      ||.||+|.++|+.++.+++..++.++.||+.||++||+++  ||||||||.|||+... ..   -.+||+|||+|+.+..
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            9999999999999999999999999999999999999977  9999999999999543 22   4699999999999875


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..     ...+.+|+|.|||||+++
T Consensus       168 ~~-----~a~tlcGSplYMAPEV~~  187 (429)
T KOG0595|consen  168 GS-----MAETLCGSPLYMAPEVIM  187 (429)
T ss_pred             hh-----HHHHhhCCccccCHHHHH
Confidence            42     356789999999999984

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-40  Score=283.62  Aligned_cols=171  Identities=32%  Similarity=0.537  Sum_probs=156.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..++||+|+||+||.++.+  ++.+|+|++.+.........+....|..+|..++||+||.++..|++.+.+|+|+|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld  105 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD  105 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence            7899999999999999999865  88999999988776666667888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+.||.|+.+|.+.+.+++..+..|+.+|+.||.|||++|  ||||||||+|||+  |..|+++|+|||||+..-..+. 
T Consensus       106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILL--d~~GHi~LtDFgL~k~~~~~~~-  180 (357)
T KOG0598|consen  106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILL--DEQGHIKLTDFGLCKEDLKDGD-  180 (357)
T ss_pred             ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeee--cCCCcEEEeccccchhcccCCC-
Confidence            9999999999999999999999999999999999999988  9999999999999  9999999999999986544332 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ...+.+||+.|||||+++
T Consensus       181 ---~t~tfcGT~eYmAPEil~  198 (357)
T KOG0598|consen  181 ---ATRTFCGTPEYMAPEILL  198 (357)
T ss_pred             ---ccccccCCccccChHHHh
Confidence               345689999999999986

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-39  Score=280.10  Aligned_cols=172  Identities=31%  Similarity=0.457  Sum_probs=151.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHH----HHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL----VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~----~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      .|...+.||+|+||.|-+|..+  |+.||||++.+.......    ......+|+++|++++||+||+++++|..+...|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            4677899999999999999875  889999999876544321    2334579999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceeee
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIK  310 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~~  310 (337)
                      |||||++||+|.+.+-.++.+.+.....+++|++.|+.|||++|  |+||||||+|||+..+ .+..+||+|||+|+...
T Consensus       253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g  330 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG  330 (475)
T ss_pred             EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhccc
Confidence            99999999999999999989999999999999999999999988  9999999999999544 45789999999999876


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..     ..+.+.+|||.|.|||+|.
T Consensus       331 ~~-----sfm~TlCGTpsYvAPEVl~  351 (475)
T KOG0615|consen  331 EG-----SFMKTLCGTPSYVAPEVLA  351 (475)
T ss_pred             cc-----eehhhhcCCccccChhhee
Confidence            33     2578899999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-38  Score=288.72  Aligned_cols=177  Identities=29%  Similarity=0.469  Sum_probs=162.2

Q ss_pred             cCCCCcCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          152 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      .++...+|...+.||+|||+.+|.+.+  .|..||+|++.+.........+...+|+.+.+.++|||||+++++|++.++
T Consensus        13 ~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n   92 (592)
T KOG0575|consen   13 EDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN   92 (592)
T ss_pred             ecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence            344446799999999999999999987  489999999988766666677889999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|||.|+|+.++|..+++.+..++|.+++.+++||+.||.|||+++  |||||||..|+|+  +...+|||+|||||..+
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL--~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFL--NENMNVKIGDFGLATQL  168 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheee--cCcCcEEecccceeeee
Confidence            9999999999999999998889999999999999999999999988  9999999999999  88889999999999999


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..++.    +..+.+|||.|+|||++.
T Consensus       169 e~~~E----rk~TlCGTPNYIAPEVl~  191 (592)
T KOG0575|consen  169 EYDGE----RKKTLCGTPNYIAPEVLN  191 (592)
T ss_pred             cCccc----ccceecCCCcccChhHhc
Confidence            86643    467789999999999985

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=264.55  Aligned_cols=168  Identities=31%  Similarity=0.514  Sum_probs=156.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||.|+||.|++++.+  |..+|+|++.+...-...+.+...+|.++|+.+.||+++++++.+.+...+|||||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            7888999999999999999876  88999999988766666677889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |++||.|+++++..+.+++..++.++.||+.||+|||+++  |++|||||+|||+  |..|++||+|||+|+.....   
T Consensus       125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLl--D~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLL--DQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeee--ccCCcEEEEeccceEEecCc---
Confidence            9999999999999999999999999999999999999988  9999999999999  99999999999999987753   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .-+.+|||.|+|||++.
T Consensus       198 ----T~TlCGTPeYLAPEii~  214 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQ  214 (355)
T ss_pred             ----EEEecCCccccChHHhh
Confidence                45689999999999985

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=264.59  Aligned_cols=298  Identities=28%  Similarity=0.384  Sum_probs=239.5

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+-|.|.-|+.|.+||++  ||..|+..+++.|++.|+.||+.|....||||+||.+||.++|+.||+..||+|+.+..|
T Consensus        23 tehdln~gddhgfsplhw--aakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehg  100 (448)
T KOG0195|consen   23 TEHDLNVGDDHGFSPLHW--AAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHG  100 (448)
T ss_pred             cccccccccccCcchhhh--hhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccC
Confidence            355778888999999977  999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCCC-------------------CCCCCCCCC-Cc-----------
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP-------------------VPPPLPNKC-DW-----------  150 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~~-------------------~~~~~~~~~-~~-----------  150 (337)
                      +||||+|+..|...+.+-|+..|+.....+....+|..                   .+...|.+. .|           
T Consensus       101 ntplhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdat  180 (448)
T KOG0195|consen  101 NTPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDAT  180 (448)
T ss_pred             CCchhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccc
Confidence            99999999999999999999999988777766666532                   222222221 22           


Q ss_pred             -----ccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          151 -----EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       151 -----~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                           .|+.+.++  ...+|.....|+.|+|+|.|..+++|++....... ....+|..|...++.+.||||+.+++++.
T Consensus       181 lsr~~gid~~~ln--l~tkl~e~hsgelwrgrwqgndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacn  257 (448)
T KOG0195|consen  181 LSRYTGIDVSSLN--LITKLAESHSGELWRGRWQGNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACN  257 (448)
T ss_pred             cccccCcchhhhh--hhhhhccCCCcccccccccCcchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhcc
Confidence                 22333222  23467788889999999999999999886554432 23467889999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCcEee-CCCCCCEEEecCCCCcEEEEe
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHR-DLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr-dlkp~Nil~~~~~~~~~kl~D  302 (337)
                      .+..+.++..||+.|||+.++++...  ++..++.+++.+|+.|++|||+.. +++-| -|.+..+++  |.+-+.+|+ 
T Consensus       258 sppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmi--dedltaris-  333 (448)
T KOG0195|consen  258 SPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMI--DEDLTARIS-  333 (448)
T ss_pred             CCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEe--cchhhhhee-
Confidence            99999999999999999999987543  678899999999999999999984 45555 689999999  555555553 


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+-+++.        ++..+..-.|.|||||.+.
T Consensus       334 mad~kfs--------fqe~gr~y~pawmspealq  359 (448)
T KOG0195|consen  334 MADTKFS--------FQEVGRAYSPAWMSPEALQ  359 (448)
T ss_pred             cccceee--------eeccccccCcccCCHHHHh
Confidence            1112211        1234455679999999874

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=278.93  Aligned_cols=180  Identities=44%  Similarity=0.699  Sum_probs=155.4

Q ss_pred             CCCcccCCCCcCccccceecccCceeEEEEEECCce-EEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~-vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      ...|.+++.++.+.  +.||+|+||+||++.|+|+. ||+|.+......... .+.|.+|+.+|.+++|||||+++|++.
T Consensus        33 ~~~~~i~~~~l~~~--~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~  109 (362)
T KOG0192|consen   33 LPEEEIDPDELPIE--EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACT  109 (362)
T ss_pred             ccceecChHHhhhh--hhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34566766665443  46999999999999999999 999999776555444 789999999999999999999999998


Q ss_pred             eCC-ceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-cEEEE
Q 019685          226 ERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVG  301 (337)
Q Consensus       226 ~~~-~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-~~kl~  301 (337)
                      .+. .+++||||+++|+|.+++..  ...++...++.++.||+.||.|||++++ ||||||||+|||+  +..+ ++||+
T Consensus       110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv--~~~~~~~KI~  186 (362)
T KOG0192|consen  110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILV--DLKGKTLKIA  186 (362)
T ss_pred             CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEE--cCCCCEEEEC
Confidence            887 79999999999999999987  5789999999999999999999999753 9999999999999  7887 99999


Q ss_pred             eccCceeeecccccceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+++......    .......||+.|||||+|.
T Consensus       187 DFGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~  217 (362)
T KOG0192|consen  187 DFGLSREKVISK----TSMTSVAGTYRWMAPEVLR  217 (362)
T ss_pred             CCccceeecccc----ccccCCCCCccccChhhhc
Confidence            999998766431    1344578999999999985

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=266.49  Aligned_cols=167  Identities=30%  Similarity=0.521  Sum_probs=150.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc-eEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-~~lv~  234 (337)
                      +++....||+|..|+||+++++  ++.+|+|.+....  +....+.+.+|+.+++.++|||||++||+|...+. ++|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            5566789999999999999987  7889999994432  34456788999999999999999999999999995 99999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |||++|||.++++..+.+++....+++.+|++||.|||. ++  ||||||||+|||+  +..|.|||||||.++.+.+. 
T Consensus       158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLv--NskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLV--NSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeee--ccCCCEEeccccccHHhhhh-
Confidence            999999999999988899999999999999999999996 66  9999999999999  89999999999999887654 


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ...+.+||..|||||-|.
T Consensus       233 -----~a~tfvGT~~YMsPERi~  250 (364)
T KOG0581|consen  233 -----IANTFVGTSAYMSPERIS  250 (364)
T ss_pred             -----hcccccccccccChhhhc
Confidence                 346789999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-38  Score=265.47  Aligned_cols=172  Identities=31%  Similarity=0.538  Sum_probs=148.8

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeee-eEEeCCc-eEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG-AVTERKP-LMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~-~~~~~~~-~~lv  233 (337)
                      +|++.+.||+|+||.||++..  +|..+|.|.+.-.. -+....+....|+.+|++++|||||++++ .+.+.+. ++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            789999999999999999876  48899999887333 34556688899999999999999999998 5555555 9999


Q ss_pred             EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC--CCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE--PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      ||||.+|+|.++|+.    +..+++..+++++.|++.||.+||++  +..|+||||||.||++  +..|.|||+|||+++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl--~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL--TANGVVKLGDFGLGR  176 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--cCCCceeeccchhHh
Confidence            999999999999963    44699999999999999999999993  3349999999999999  899999999999999


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+....+    ...+.+|||+||+||.|.
T Consensus       177 ~l~s~~t----fA~S~VGTPyYMSPE~i~  201 (375)
T KOG0591|consen  177 FLSSKTT----FAHSLVGTPYYMSPERIH  201 (375)
T ss_pred             HhcchhH----HHHhhcCCCcccCHHHHh
Confidence            9876532    456789999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-35  Score=263.54  Aligned_cols=177  Identities=34%  Similarity=0.605  Sum_probs=153.5

Q ss_pred             CCCcccCCCCcCccccceecccCceeEEEEEECCc-eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~-~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      ...|+++...+.+  .+.||+|.||.|+.|.++++ .|++|.+......    .+.|.+|+.+|++|+|++||++++++.
T Consensus       198 ~d~wei~r~~l~l--~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  198 RDPWEIPREELKL--IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             cCCeeecHHHHHH--HHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            6678888776655  56899999999999999987 8999998765322    367889999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      .+.++|||||||+.|+|.++|+.  ...+...+.+.++.|||+||+||.+++  +|||||.++||||  +.+..+||+||
T Consensus       272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV--~~~~~vKIsDF  347 (468)
T KOG0197|consen  272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILV--DEDLVVKISDF  347 (468)
T ss_pred             cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheee--ccCceEEEccc
Confidence            98899999999999999999986  456899999999999999999999987  9999999999999  88889999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+.+.++.   ++...+..-++.|.|||.|.
T Consensus       348 GLAr~~~d~~---Y~~~~~~kfPIkWtAPEa~~  377 (468)
T KOG0197|consen  348 GLARLIGDDE---YTASEGGKFPIKWTAPEALN  377 (468)
T ss_pred             ccccccCCCc---eeecCCCCCCceecCHHHHh
Confidence            9999554432   22445666789999999874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-35  Score=259.13  Aligned_cols=169  Identities=31%  Similarity=0.572  Sum_probs=158.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|.||.|-+|...  |+.||||.+++....+.+..-.+.+|+++|+.++||||+.+|++|+....+.||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            7888999999999999999864  99999999999888888778889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |..+|.|++++.+++.+++.+++.|++||..|+.|||..+  ++|||||.+|||+  |.++++||+|||++..+.+..  
T Consensus       134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILL--D~N~NiKIADFGLSNly~~~k--  207 (668)
T KOG0611|consen  134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILL--DQNNNIKIADFGLSNLYADKK--  207 (668)
T ss_pred             ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheee--cCCCCeeeeccchhhhhcccc--
Confidence            9999999999999999999999999999999999999966  9999999999999  899999999999998887653  


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ...+++|+|-|.+||++
T Consensus       208 ---fLqTFCGSPLYASPEIv  224 (668)
T KOG0611|consen  208 ---FLQTFCGSPLYASPEIV  224 (668)
T ss_pred             ---HHHHhcCCcccCCcccc
Confidence               45789999999999986

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.7e-35  Score=262.41  Aligned_cols=149  Identities=32%  Similarity=0.506  Sum_probs=140.4

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+....||+|+||.||+|+-+  |..+|+|++++..-....+.+..+.|-.+|....+|+||++|.+|++..++||||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            38899999999999999999864  8899999999887777778889999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ||++||++..+|...+.+++..+..|+.+++.|+.-||..|  +|||||||+|+||  |..|++||+|||||+-+
T Consensus       221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLi--D~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLI--DAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheee--cCCCCEeeccccccchh
Confidence            99999999999999999999999999999999999999988  9999999999999  99999999999998654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=264.90  Aligned_cols=176  Identities=30%  Similarity=0.489  Sum_probs=156.2

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      .+|..++.||.|+|++|++|+..  ++.+|||++.+.........+....|-.+|.+| .||.|++|+-.|++...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            48899999999999999999875  889999999877666555667778899999999 699999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      +||+++|+|.++|+..+.+++..++.|+.+|+.||+|||++|  ||||||||+|||+  |.++++||+|||.|+.+....
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILL--d~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILL--DKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeE--cCCCcEEEeeccccccCChhh
Confidence            999999999999999999999999999999999999999988  9999999999999  999999999999999986532


Q ss_pred             cc---------ceeeeeCCccccccccccccc
Q 019685          314 SH---------DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~---------~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..         ........+||..|.+||+|.
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~  260 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLN  260 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhc
Confidence            11         001125689999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=263.13  Aligned_cols=170  Identities=33%  Similarity=0.556  Sum_probs=149.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchH--HHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR--LVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l  232 (337)
                      .|...+.||+|+||.|+.|...  +..||+|++........  ...+.+.+|+.+++.++ ||||+++++++.....+|+
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            6888999999999999999874  88999997765422111  23355668999999999 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC-CcEEEEeccCceeee-
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLIK-  310 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~-~~~kl~DFgla~~~~-  310 (337)
                      ||||+.+|+|.+++...+.+.+.++..+++|++.|++|||++|  |+||||||+|||+  +.. +.+||+|||++.... 
T Consensus        98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENill--d~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILL--DGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEe--cCCCCCEEEeccccccccCC
Confidence            9999999999999999889999999999999999999999988  9999999999999  666 899999999999874 


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..+     .....+||+.|+|||+|.
T Consensus       174 ~~~-----~l~t~cGsp~Y~aPEvl~  194 (370)
T KOG0583|consen  174 EDG-----LLKTFCGSPAYAAPEVLS  194 (370)
T ss_pred             CCC-----cccCCCCCcccCCHHHhC
Confidence            221     467889999999999984

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-34  Score=251.81  Aligned_cols=178  Identities=24%  Similarity=0.399  Sum_probs=158.8

Q ss_pred             CCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      .....+|+..++||.|..+.||+|++.  +..||||++....++..  .+.+++|+..|+.++||||++++..|.....+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            344457888899999999999999985  78899999987776654  68899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          231 MLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      |+||.||.+||+.++++..  ..+++..+..|.+++++||.|||.+|  .||||||+.||||  +.+|.|||+|||.+..
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi--~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILI--DSDGTVKLADFGVSAS  175 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEE--cCCCcEEEcCceeeee
Confidence            9999999999999999863  45999999999999999999999988  9999999999999  8999999999999888


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.....+..+......|||.|||||+++
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~  203 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLM  203 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhh
Confidence            7766655555557889999999999964

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-35  Score=260.16  Aligned_cols=170  Identities=26%  Similarity=0.450  Sum_probs=149.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv  233 (337)
                      .|+..+.||+|.||.||+|+..  |+.||+|++.....+. ....-..+|+.+|+++.||||+++.+.....  ..+|||
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            6888999999999999999975  8889999997655433 2345567899999999999999999998776  689999


Q ss_pred             EeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      +|||+. +|.-++...+ .|++.++..||.|++.||.|||++|  |+|||||.+||||  |..|.+||+|||||+++...
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLi--dn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILI--DNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEE--cCCCCEEeccccceeeccCC
Confidence            999988 9998887643 6999999999999999999999988  9999999999999  89999999999999988765


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...   ..+..+-|..|+|||.|+
T Consensus       272 ~~~---~~T~rVvTLWYRpPELLL  292 (560)
T KOG0600|consen  272 GSA---PYTSRVVTLWYRPPELLL  292 (560)
T ss_pred             CCc---ccccceEEeeccChHHhc
Confidence            432   357788999999999986

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.4e-35  Score=247.26  Aligned_cols=170  Identities=24%  Similarity=0.444  Sum_probs=145.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+...++|+|+||.||+|+.+  |+.||||++..... ++...+-.++|+++|++++|+|+|.++++|.....+++|+|
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4677789999999999999975  89999999976543 34445566789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||+..-|.++=+-...+++..+..|+.|++.|+.|+|+++  +|||||||+|||+  ...|.+||||||+|+.+...+. 
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILi--t~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILI--TQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEE--ecCCcEEeccchhhHhhcCCcc-
Confidence            9988444444333456899999999999999999999977  9999999999999  8889999999999999885332 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ..+..+-|..|+|||.++
T Consensus       157 ---~YTDYVATRWYRaPELLv  174 (396)
T KOG0593|consen  157 ---NYTDYVATRWYRAPELLV  174 (396)
T ss_pred             ---hhhhhhhhhhccChhhhc
Confidence               235678899999999886

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.2e-35  Score=263.81  Aligned_cols=168  Identities=35%  Similarity=0.594  Sum_probs=153.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.+.+.||+|+||.||+|+-+  .+.||+|++.+.....+ ..+.+.+|+++++.++||||+.++++|+....+|+|+|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            6778889999999999999865  67899999987665443 46788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+.| +|+.++...+.++++.+..++.+++.||.|||+.+  |+|||+||.|||+  ++.+++|+||||+|+.+..... 
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl--~~~~~~KlcdFg~Ar~m~~~t~-  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILL--EKGGTLKLCDFGLARAMSTNTS-  155 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeee--cCCCceeechhhhhhhcccCce-
Confidence            9987 99999999999999999999999999999999976  9999999999999  8999999999999999887543 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ..+...|||.|||||..
T Consensus       156 ---vltsikGtPlYmAPElv  172 (808)
T KOG0597|consen  156 ---VLTSIKGTPLYMAPELV  172 (808)
T ss_pred             ---eeeeccCcccccCHHHH
Confidence               56888999999999975

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=248.60  Aligned_cols=172  Identities=30%  Similarity=0.557  Sum_probs=146.1

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC--ceEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLML  232 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~l  232 (337)
                      .+|...+.||+|+||.||++...  |...|||.+.....  . ..+.+.+|+.+|.+++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            36778899999999999999986  68999998865422  1 1577889999999999999999999755444  6999


Q ss_pred             EEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCceeee
Q 019685          233 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIK  310 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla~~~~  310 (337)
                      +|||+++|+|.+++...+ .+++..++.+.+||++||.|||++|  ||||||||+|||+  +. .+.+||+|||+++...
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl--~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILL--DPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEE--eCCCCeEEeccCccccccc
Confidence            999999999999999876 7999999999999999999999988  9999999999999  66 6899999999998876


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .. ...........||+.|||||++.
T Consensus       170 ~~-~~~~~~~~~~~Gtp~~maPEvi~  194 (313)
T KOG0198|consen  170 SK-GTKSDSELSVQGTPNYMAPEVIR  194 (313)
T ss_pred             cc-cccccccccccCCccccCchhhc
Confidence            41 11111245678999999999975

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=259.53  Aligned_cols=177  Identities=37%  Similarity=0.576  Sum_probs=150.6

Q ss_pred             cccCCCCcCccccceecccCceeEEEEEECC-ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      .++...+.+|.....||+|+||.||+|...+ ..||||.+.......   ..+|.+|+.++.+++|||+|+++|+|.+.+
T Consensus        68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~  144 (361)
T KOG1187|consen   68 DELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGG  144 (361)
T ss_pred             HHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence            3455556688888999999999999999875 899999886654431   355999999999999999999999999988


Q ss_pred             c-eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCC-CCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          229 P-LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEP-NVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       229 ~-~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~-~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      . .+||+||+++|+|.+++....  .++|...++|+.+++.||+|||... ++||||||||+|||+  |.++.+||+|||
T Consensus       145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL--D~~~~aKlsDFG  222 (361)
T KOG1187|consen  145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL--DEDFNAKLSDFG  222 (361)
T ss_pred             ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--CCCCCEEccCcc
Confidence            4 999999999999999998654  7999999999999999999999953 369999999999999  899999999999


Q ss_pred             Cceeeec-ccccceeeeeCC-ccccccccccccc
Q 019685          305 LSKLIKV-QNSHDVYKMTGE-TGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~-~~~~~~~~~~~~-~gt~~y~aPE~l~  336 (337)
                      +|+.... ..     ..... .||..|+|||++.
T Consensus       223 La~~~~~~~~-----~~~~~~~gt~gY~~PEy~~  251 (361)
T KOG1187|consen  223 LAKLGPEGDT-----SVSTTVMGTFGYLAPEYAS  251 (361)
T ss_pred             CcccCCcccc-----ceeeecCCCCccCChhhhc
Confidence            9966543 21     11222 8999999999874

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.3e-34  Score=237.23  Aligned_cols=169  Identities=33%  Similarity=0.557  Sum_probs=147.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|.||.||+|++.  |+.||+|++......+... ....+|+..|+.++|+||+.++++|.....+-+|+|
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5777889999999999999985  8899999997664443222 345679999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |++. +|..+|+.+. .+++.++..|+.++++||+|||++.  |+||||||.|+|+  +.+|.+||+|||+|+.+...+.
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLi--s~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLI--SSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEE--cCCCcEEeecccchhccCCCCc
Confidence            9976 9999998654 5899999999999999999999987  9999999999999  8999999999999999886653


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....+-|..|+|||.|+
T Consensus       157 ----~~~~~V~TRWYRAPELLf  174 (318)
T KOG0659|consen  157 ----IQTHQVVTRWYRAPELLF  174 (318)
T ss_pred             ----ccccceeeeeccChHHhc
Confidence                234458899999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=256.87  Aligned_cols=167  Identities=28%  Similarity=0.467  Sum_probs=146.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCC-ceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK-PLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~-~~~lv  233 (337)
                      +|...+.||.|.||.||+|...  +..||||.+.+......+  -.-++|+..|++++ ||||+++.+++.+.. .+|+|
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            7888999999999999999864  888999999776554322  22357999999999 999999999998887 89999


Q ss_pred             EeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||+. +|+++++.++ .++++.++.|+.||+.||+|+|.+|  +.|||+||+|||+  .....+||+|||+||.+...
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi--~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILI--SGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEe--cccceeEecccccccccccC
Confidence            999976 9999998754 5999999999999999999999987  9999999999999  66778999999999988755


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..     .+..+.|..|+|||+|+
T Consensus       164 pP-----YTeYVSTRWYRAPEvLL  182 (538)
T KOG0661|consen  164 PP-----YTEYVSTRWYRAPEVLL  182 (538)
T ss_pred             CC-----cchhhhcccccchHHhh
Confidence            32     46678999999999986

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-33  Score=241.17  Aligned_cols=169  Identities=28%  Similarity=0.431  Sum_probs=146.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv  233 (337)
                      +|+..+.|++|.||.||+|+++  +..||+|+++....... ..--.++|+.+|.+++|||||.+-++....  +.+|||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-FPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-CcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            6888999999999999999986  67899999976553322 223457799999999999999999987644  579999


Q ss_pred             EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||+. +|..++..- ..+...++..++.|+++|++|||...  |+||||||+|+|+  ...|.+||+|||+|+.+..+
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm--~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLL--SHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheee--ccCCcEEecccchhhhhcCC
Confidence            999988 999999864 47999999999999999999999987  9999999999999  88899999999999998765


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      -.    ..+..+-|..|+|||.|+
T Consensus       231 ~k----~~T~lVVTLWYRaPELLL  250 (419)
T KOG0663|consen  231 LK----PYTPLVVTLWYRAPELLL  250 (419)
T ss_pred             cc----cCcceEEEeeecCHHHhc
Confidence            32    467788999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=256.21  Aligned_cols=166  Identities=28%  Similarity=0.463  Sum_probs=148.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|.....||+|+.|.||.|...  ++.||+|.+.......   .+-+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            4677789999999999999864  7789999997665443   3677899999999999999999999988899999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |++||+|.+++... .+++.++..++++++.||.|||.+|  |+|||||.+|||+  +.+|.+||+|||++..+..... 
T Consensus       351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL--~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILL--TMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEe--ccCCcEEEeeeeeeeccccccC-
Confidence            99999999999754 4999999999999999999999988  9999999999999  8888999999999998876543 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         +..+.+|||+|||||++
T Consensus       425 ---KR~TmVGTPYWMAPEVv  441 (550)
T KOG0578|consen  425 ---KRSTMVGTPYWMAPEVV  441 (550)
T ss_pred             ---ccccccCCCCccchhhh
Confidence               56778999999999986

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-33  Score=257.73  Aligned_cols=174  Identities=29%  Similarity=0.440  Sum_probs=153.3

Q ss_pred             CCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCce
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL  230 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~  230 (337)
                      ....+|...++||+|+||.|+++..+  ++.+|||.+++...-.....+....|.+++.... ||+++.++.+|++.+.+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34447889999999999999999986  6689999998877666667788899999988886 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+||||+.||++..+ ...+.+++..+..|+..|+.||.|||++|  ||+||||.+|||+  |..|++||+|||+++...
T Consensus       445 ~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLL--D~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLL--DTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEE--cccCcEEecccccccccC
Confidence            999999999994443 34567999999999999999999999977  9999999999999  999999999999998866


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..+.    ...+.+|||.|||||+|.
T Consensus       520 ~~g~----~TsTfCGTpey~aPEil~  541 (694)
T KOG0694|consen  520 GQGD----RTSTFCGTPEFLAPEVLT  541 (694)
T ss_pred             CCCC----ccccccCChhhcChhhhc
Confidence            4433    467899999999999984

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=248.65  Aligned_cols=175  Identities=29%  Similarity=0.479  Sum_probs=142.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCch-----------HHHHHHHHHHHHHHHhCCCCCeeeeeeeE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----------RLVIQDFRHEVNLLVKLRHPNIVQFLGAV  224 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~  224 (337)
                      .|+..+.||+|.||.|-+|+..  ++.||+|++.+.....           ....+...+|+.+|++|.|||||+|+++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            6889999999999999999975  8899999986532221           11236788999999999999999999998


Q ss_pred             EeC--CceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          225 TER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       225 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                      .++  +.+|||+|||..|.+...-.....+++.+++.|+++++.||+|||.+|  ||||||||+|+|+  +.+|+|||+|
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl--~~~g~VKIsD  253 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLL--SSDGTVKISD  253 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEE--cCCCcEEeec
Confidence            765  579999999998877544322233899999999999999999999999  9999999999999  8889999999


Q ss_pred             ccCceeeecccccc-eeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHD-VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||.+.......... ........|||.|||||.+.
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~  288 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCS  288 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhc
Confidence            99998764332111 11345689999999999863

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-34  Score=232.54  Aligned_cols=177  Identities=33%  Similarity=0.523  Sum_probs=155.1

Q ss_pred             CCCCCcccCCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeee
Q 019685          145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG  222 (337)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~  222 (337)
                      +....|.++    +|+.++.||+|-||.||.|+.+  +..||+|++.+...........+.+|+++-+.++||||+++|+
T Consensus        14 ~~~~~~~l~----dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~   89 (281)
T KOG0580|consen   14 RATKTWTLD----DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG   89 (281)
T ss_pred             ccccccchh----hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh
Confidence            334456665    8899999999999999999986  5679999998766555455577889999999999999999999


Q ss_pred             eEEeCCceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEE
Q 019685          223 AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV  300 (337)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl  300 (337)
                      +|.+...+|+++||...|+++..+.+  ..++++..+..|+.|++.||.|+|.++  ||||||||+|+|+  +..+.+||
T Consensus        90 ~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLl--g~~~~lki  165 (281)
T KOG0580|consen   90 YFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLL--GSAGELKI  165 (281)
T ss_pred             heeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhcc--CCCCCeec
Confidence            99999999999999999999999984  456999999999999999999999977  9999999999999  88899999


Q ss_pred             EeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +|||.+..-...      +..+.+||.-|.+||+.
T Consensus       166 AdfGwsV~~p~~------kR~tlcgt~dyl~pEmv  194 (281)
T KOG0580|consen  166 ADFGWSVHAPSN------KRKTLCGTLDYLPPEMV  194 (281)
T ss_pred             cCCCceeecCCC------CceeeecccccCCHhhc
Confidence            999999664422      45678999999999985

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-32  Score=238.01  Aligned_cols=169  Identities=33%  Similarity=0.554  Sum_probs=145.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEeCC------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERK------  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~------  228 (337)
                      .|...+.||+|.||.||+|+.+  |+.||+|++.....+ ........+|+.+++.++|+| |+.+++++...+      
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            5777788999999999999975  889999999765432 112245578999999999999 999999998877      


Q ss_pred             ceEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          229 PLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      .+++|+||++. +|..++....    .++...+..+++||+.||+|||+++  |+||||||.||||  +..|.+||+|||
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi--~~~G~lKlaDFG  165 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLI--SSSGVLKLADFG  165 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEE--CCCCcEeeeccc
Confidence            79999999976 9999998754    5788899999999999999999987  9999999999999  889999999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +|+.+.-+..    ..+..++|..|+|||+++
T Consensus       166 lAra~~ip~~----~yt~evvTlWYRaPEvLl  193 (323)
T KOG0594|consen  166 LARAFSIPMR----TYTPEVVTLWYRAPEVLL  193 (323)
T ss_pred             hHHHhcCCcc----cccccEEEeeccCHHHhc
Confidence            9997664422    357788999999999975

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-32  Score=250.45  Aligned_cols=180  Identities=33%  Similarity=0.578  Sum_probs=153.0

Q ss_pred             CCCcccCCCCcCccccceecccCceeEEEEEEC---C--ce-EEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeee
Q 019685          147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---G--TP-VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF  220 (337)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---g--~~-vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~  220 (337)
                      ...|++.++...+.  +.||+|+||.||+|.++   +  .. ||+|..............++.+|+++|++++|||||++
T Consensus       149 r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  149 RQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            45699999988887  79999999999999875   1  13 78888765444456778999999999999999999999


Q ss_pred             eeeEEeCCceEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEE
Q 019685          221 LGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK  299 (337)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~k  299 (337)
                      ||+.....++++|||+|.||+|.++|+..+ .++..+...++.+.+.||+|||+++  +|||||..+|+|+  ...+.+|
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~--~~~~~vK  302 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLY--SKKGVVK  302 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHhee--cCCCeEE
Confidence            999999999999999999999999999876 4999999999999999999999987  9999999999999  7777899


Q ss_pred             EEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          300 VGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       300 l~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+|||+++.-....    .......-+.+|+|||.+.
T Consensus       303 ISDFGLs~~~~~~~----~~~~~~klPirWLAPEtl~  335 (474)
T KOG0194|consen  303 ISDFGLSRAGSQYV----MKKFLKKLPIRWLAPETLN  335 (474)
T ss_pred             eCccccccCCccee----eccccccCcceecChhhhc
Confidence            99999987543111    1112335679999999874

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.3e-32  Score=250.61  Aligned_cols=149  Identities=31%  Similarity=0.503  Sum_probs=133.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+|+|++.+...........+..|+.++..++|+||+++++.+.+...+|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            5778899999999999999875  78899999865433333445677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+++|+|.+++...+.+++..+..++.|++.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.+.
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi--~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEE--CCCCCEEEeeccCccccc
Confidence            9999999999988888999999999999999999999988  9999999999999  788899999999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=8.3e-32  Score=245.54  Aligned_cols=172  Identities=31%  Similarity=0.488  Sum_probs=153.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ..|+..+.||+|.||.||+|..+  |+.+|+|.+.+.........+...+|+.+|+++. ||||+.+++.|++...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            36888899999999999999875  7899999998776655445578899999999999 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC--CcEEEEeccCceeeec
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA--DHLKVGDFGLSKLIKV  311 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~--~~~kl~DFgla~~~~~  311 (337)
                      ||++.||.|++.|... .+++..+..++.||+.++.|||+.|  |+||||||+|+|+.....  +.+|++|||+|.....
T Consensus       115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            9999999999999876 4999999999999999999999988  999999999999965433  5799999999998876


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.     .....+||+.|+|||++.
T Consensus       192 ~~-----~~~~~~Gtp~y~APEvl~  211 (382)
T KOG0032|consen  192 GE-----RLHTIVGTPEYVAPEVLG  211 (382)
T ss_pred             Cc-----eEeeecCCccccCchhhc
Confidence            32     567899999999999975

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.98  E-value=8.4e-33  Score=252.52  Aligned_cols=179  Identities=34%  Similarity=0.574  Sum_probs=153.2

Q ss_pred             CCcccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC
Q 019685          148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER  227 (337)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  227 (337)
                      .+|+|..++.  .....||+|+||+||+|.|.| +||||++....... ...+.|.+|+.++++-+|.||+-+.|++-.+
T Consensus       385 ~~WeIp~~ev--~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  385 EEWEIPPEEV--LLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccCHHHh--hccceeccccccceeeccccc-ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            4677776654  556799999999999999986 78999997765544 4789999999999999999999999999877


Q ss_pred             CceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          228 KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      .. .||+.+|+|.+|+.+++- ..++.....+.|++||+.||.|||.++  |||||||..|||+  ..++.|||+||||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl--~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFL--HEDLKVKIGDFGLA  535 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEE--ccCCcEEEecccce
Confidence            66 999999999999999975 346888899999999999999999988  9999999999999  66689999999999


Q ss_pred             eeeecccccceeeeeCCcccccccccccccC
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSFM  337 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  337 (337)
                      ..-......  .......|..-|||||+|+|
T Consensus       536 tvk~~w~g~--~q~~qp~gsilwmAPEvIRm  564 (678)
T KOG0193|consen  536 TVKTRWSGE--QQLEQPHGSLLWMAPEVIRM  564 (678)
T ss_pred             eeeeeeccc--cccCCCccchhhhcHHHHhh
Confidence            776554221  13455679999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.4e-32  Score=253.25  Aligned_cols=169  Identities=30%  Similarity=0.477  Sum_probs=151.9

Q ss_pred             ccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |..++.||+|+-|.|-.|..  +|+.+|||++.+...........+.+|+-+|+.+.||||+++|+++++...+|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            55678999999999999986  4999999999876444444557788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++|.|++++-.++.+++.++.++++||+.|+.|||..+  |+||||||+|+|+  |..+.+||+|||+|..-..+.   
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLL--d~~~nIKIADFGMAsLe~~gk---  166 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLL--DVKNNIKIADFGMASLEVPGK---  166 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhh--hcccCEeeeccceeecccCCc---
Confidence            999999999999999999999999999999999999977  9999999999999  788889999999997654332   


Q ss_pred             eeeeeCCccccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l~  336 (337)
                        ...+.+|+|.|.|||+++
T Consensus       167 --lLeTSCGSPHYA~PEIV~  184 (786)
T KOG0588|consen  167 --LLETSCGSPHYAAPEIVS  184 (786)
T ss_pred             --cccccCCCcccCCchhhc
Confidence              467789999999999985

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.98  E-value=1.1e-31  Score=248.76  Aligned_cols=148  Identities=24%  Similarity=0.403  Sum_probs=133.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|...  ++.+|+|++.+...........+..|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            4777889999999999999875  77899999976543334455778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |+++|+|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+++||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili--~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILI--DLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEE--CCCCCEEEeeCcCCccc
Confidence            9999999999988888999999999999999999999987  9999999999999  78889999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.98  E-value=7.4e-32  Score=245.01  Aligned_cols=168  Identities=30%  Similarity=0.502  Sum_probs=148.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|..+  ++.+|+|++.+.........+.+.+|+.+++.++||||+++++++...+.+|++||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            7888999999999999999985  77899999865433333345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+.+++|.+++...+.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.....   
T Consensus        99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~---  171 (329)
T PTZ00263         99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLL--DNKGHVKVTDFGFAKKVPDR---  171 (329)
T ss_pred             CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE--CCCCCEEEeeccCceEcCCC---
Confidence            9999999999988888999999999999999999999987  9999999999999  88889999999999876432   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....||+.|+|||++.
T Consensus       172 ----~~~~~gt~~y~aPE~~~  188 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQ  188 (329)
T ss_pred             ----cceecCChhhcCHHHHc
Confidence                22357999999999863

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.98  E-value=1.1e-31  Score=243.41  Aligned_cols=165  Identities=27%  Similarity=0.418  Sum_probs=142.9

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD  241 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~  241 (337)
                      .||+|+||.||++...  ++.+|+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            6999999999999874  78899999875433333445667889999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeee
Q 019685          242 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT  321 (337)
Q Consensus       242 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~  321 (337)
                      |.+++...+.+++..+..++.||+.||.|||+.|  |+||||||+|||+  +..+.+||+|||+++.......    ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~----~~~  153 (323)
T cd05571          82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGA----TMK  153 (323)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE--CCCCCEEEeeCCCCcccccCCC----ccc
Confidence            9999988888999999999999999999999988  9999999999999  7888999999999975432221    234


Q ss_pred             CCccccccccccccc
Q 019685          322 GETGSCEYLVSNCSF  336 (337)
Q Consensus       322 ~~~gt~~y~aPE~l~  336 (337)
                      ...||+.|||||++.
T Consensus       154 ~~~gt~~y~aPE~~~  168 (323)
T cd05571         154 TFCGTPEYLAPEVLE  168 (323)
T ss_pred             ceecCccccChhhhc
Confidence            567999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.98  E-value=7.1e-33  Score=230.94  Aligned_cols=169  Identities=25%  Similarity=0.455  Sum_probs=149.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCC-----CCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPS-----LSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~-----~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~  229 (337)
                      .|...+.||.|..+.|.++..+  |++.++|++...     ........+....|+.+|+++. ||+|+++.+.|+.+..
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            4566678999999999998875  788999988432     2223445567788999999986 9999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +++|+|+|+.|.|+|++.+.-.+++..+++||+|+.+|+.|||.++  ||||||||+|||+  +.+.++||+|||+|..+
T Consensus        98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILl--ddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILL--DDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheee--ccccceEEeccceeecc
Confidence            9999999999999999999888999999999999999999999977  9999999999999  78889999999999998


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..+.     +....+|||+|+|||+|
T Consensus       174 ~~Ge-----kLrelCGTPgYLAPEti  194 (411)
T KOG0599|consen  174 EPGE-----KLRELCGTPGYLAPETI  194 (411)
T ss_pred             CCch-----hHHHhcCCCcccChhhe
Confidence            7664     56788999999999987

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=8.2e-32  Score=248.10  Aligned_cols=149  Identities=31%  Similarity=0.524  Sum_probs=134.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|++.............+.+|+.++..++||||+++++++.+...+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            6788899999999999999875  78899999865432233445677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+.
T Consensus        82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEeecccceecc
Confidence            9999999999988888999999999999999999999988  9999999999999  888999999999997654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-31  Score=247.74  Aligned_cols=148  Identities=30%  Similarity=0.492  Sum_probs=132.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.+.+.||+|+||.||++...  ++.||+|.+.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            5778899999999999999874  78899999865433233445678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll--~~~~~~kl~DfGla~~~  151 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILI--DRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--CCCCCEEEeeccccccc
Confidence            9999999999988788999999999999999999999988  9999999999999  78889999999999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1.5e-31  Score=247.93  Aligned_cols=148  Identities=24%  Similarity=0.407  Sum_probs=132.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|...  ++.+|+|.+.+...........+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            4778899999999999999875  67899999865433334455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |+++|+|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl--~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEEeECCCCccc
Confidence            9999999999988778999999999999999999999988  9999999999999  88899999999998543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-33  Score=251.75  Aligned_cols=167  Identities=31%  Similarity=0.435  Sum_probs=149.9

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ..|+..+.||.|+||.||.|++.  ...||||++.-.........++++.|++.|++++|||++.|-|+|......|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            35778889999999999999875  6679999998777777778899999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |||-| |-.|++.- +.++-+-++..|+.+.+.||+|||+.+  .||||||..|||+  ...|.|||+|||.|.....- 
T Consensus       106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILL--se~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILL--SEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEe--cCCCeeeeccccchhhcCch-
Confidence            99955 88888864 456889999999999999999999977  9999999999999  88899999999999776543 


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                             .+++|||+|||||+|+
T Consensus       180 -------nsFvGTPywMAPEVIL  195 (948)
T KOG0577|consen  180 -------NSFVGTPYWMAPEVIL  195 (948)
T ss_pred             -------hcccCCccccchhHhe
Confidence                   5589999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=7.8e-33  Score=250.77  Aligned_cols=172  Identities=32%  Similarity=0.504  Sum_probs=152.2

Q ss_pred             CCCCCCcccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeee
Q 019685          144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA  223 (337)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~  223 (337)
                      ......|+|++.++  ...+.||+|+.|.||+|++++..||||+++.          .-..++..|++|+||||+.+.|+
T Consensus       113 ~qq~e~WeiPFe~I--sELeWlGSGaQGAVF~Grl~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGV  180 (904)
T KOG4721|consen  113 QQQEELWEIPFEEI--SELEWLGSGAQGAVFLGRLHNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGV  180 (904)
T ss_pred             hhhhhhccCCHHHh--hhhhhhccCcccceeeeeccCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeee
Confidence            44566888887655  4567899999999999999999999998742          22347888999999999999999


Q ss_pred             EEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       224 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      |.....+|||||||..|-|..+|+....+++.....+..+|+.||.|||.+.  |||||||.-||||  ..+..|||+||
T Consensus       181 CtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLI--s~~d~VKIsDF  256 (904)
T KOG4721|consen  181 CTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILI--SYDDVVKISDF  256 (904)
T ss_pred             ecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEe--eccceEEeccc
Confidence            9999999999999999999999999999999999999999999999999966  9999999999999  77778999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |-++......     ....+.||..|||||+|.
T Consensus       257 GTS~e~~~~S-----TkMSFaGTVaWMAPEvIr  284 (904)
T KOG4721|consen  257 GTSKELSDKS-----TKMSFAGTVAWMAPEVIR  284 (904)
T ss_pred             cchHhhhhhh-----hhhhhhhhHhhhCHHHhh
Confidence            9998776542     467789999999999985

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=1.1e-31  Score=244.70  Aligned_cols=168  Identities=29%  Similarity=0.497  Sum_probs=146.7

Q ss_pred             CccccceecccCceeEEEEEEC---CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|.++   +..+|+|.+.+.........+.+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            6888899999999999999864   2579999886543333334567888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+...  
T Consensus       111 Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl--~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE--CCCCCEEEecCCCCeecCCC--
Confidence            99999999999988888999999999999999999999988  9999999999999  88899999999999876432  


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           .....||+.|||||++.
T Consensus       185 -----~~~~~gt~~y~aPE~~~  201 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILL  201 (340)
T ss_pred             -----cceecCChhhcCHHHHh
Confidence                 23457999999999874

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=1.9e-31  Score=246.70  Aligned_cols=148  Identities=24%  Similarity=0.404  Sum_probs=132.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||++...  ++.+|+|++.+...........+.+|+.+++.++|+||+++++.+.+.+.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            5788899999999999999875  78899999865432223344667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+|..+
T Consensus        82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill--~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEE--CCCCCEEEEeCCCCccc
Confidence            9999999999988888999999999999999999999988  9999999999999  88889999999998543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-33  Score=232.15  Aligned_cols=172  Identities=28%  Similarity=0.445  Sum_probs=148.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|++.++||+|.|+.|+++...  |+.+++|++........ ..+.+.+|+++.+.++||||+++.+.+......|||+|
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            5778889999999999998764  88899888865444332 45778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ++.|++|..-|-.+..+++..+..+++||+++|.|+|..+  |||||+||+|+++.+ +...-+||+|||+|..+..+  
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g--  166 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG--  166 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCc--
Confidence            9999999887766667899999999999999999999977  999999999999954 34446999999999888732  


Q ss_pred             cceeeeeCCcccccccccccccC
Q 019685          315 HDVYKMTGETGSCEYLVSNCSFM  337 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~~  337 (337)
                         ..+.+..|||.|||||++.+
T Consensus       167 ---~~~~G~~GtP~fmaPEvvrk  186 (355)
T KOG0033|consen  167 ---EAWHGFAGTPGYLSPEVLKK  186 (355)
T ss_pred             ---cccccccCCCcccCHHHhhc
Confidence               25788999999999999753

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.6e-32  Score=240.13  Aligned_cols=168  Identities=30%  Similarity=0.491  Sum_probs=147.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+|+|.+...........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            5777889999999999999986  78999999865433233345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.....   
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli--~~~~~~kl~Dfg~~~~~~~~---  154 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILL--DKEGHIKLTDFGFAKKLRDR---  154 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEEEecCcchhccCC---
Confidence            9999999999988888999999999999999999999987  9999999999999  78889999999999876432   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....||+.|+|||++.
T Consensus       155 ----~~~~~gt~~y~aPE~~~  171 (291)
T cd05612         155 ----TWTLCGTPEYLAPEVIQ  171 (291)
T ss_pred             ----cccccCChhhcCHHHHc
Confidence                23456999999999863

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-33  Score=244.35  Aligned_cols=170  Identities=31%  Similarity=0.493  Sum_probs=151.7

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ..|+..+.||+|+||.||+|.+.  ++.||+|++......+  ..++.+.|+.++.+++++||.++|+.+..+..+|++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            35777789999999999999985  7889999997665443  4688899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |||.||++.++++....+.+..+..++++++.||.|||+++  .+|||||+.|||+  ...|.+||+|||++-.+.....
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~--s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILL--SESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeE--eccCcEEEEecceeeeeechhh
Confidence            99999999999987777789999999999999999999988  9999999999999  6668999999999988775432


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          +..+++|||+|||||+|.
T Consensus       167 ----rr~tfvGTPfwMAPEVI~  184 (467)
T KOG0201|consen  167 ----RRKTFVGTPFWMAPEVIK  184 (467)
T ss_pred             ----ccccccccccccchhhhc
Confidence                347899999999999984

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=3.8e-31  Score=240.26  Aligned_cols=165  Identities=27%  Similarity=0.431  Sum_probs=143.2

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD  241 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~  241 (337)
                      .||+|+||.||++...  ++.+|+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            6899999999999875  78999999976543334445678889999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeee
Q 019685          242 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT  321 (337)
Q Consensus       242 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~  321 (337)
                      |.+++.....+++.++..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.......    ...
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll--~~~~~~kL~DfG~~~~~~~~~~----~~~  153 (328)
T cd05593          82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLML--DKDGHIKITDFGLCKEGITDAA----TMK  153 (328)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEE--CCCCcEEEecCcCCccCCCccc----ccc
Confidence            9999988778999999999999999999999987  9999999999999  7888999999999876432211    234


Q ss_pred             CCccccccccccccc
Q 019685          322 GETGSCEYLVSNCSF  336 (337)
Q Consensus       322 ~~~gt~~y~aPE~l~  336 (337)
                      ...||+.|+|||++.
T Consensus       154 ~~~gt~~y~aPE~~~  168 (328)
T cd05593         154 TFCGTPEYLAPEVLE  168 (328)
T ss_pred             cccCCcCccChhhhc
Confidence            567999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=2.9e-31  Score=240.48  Aligned_cols=166  Identities=26%  Similarity=0.419  Sum_probs=142.7

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      +.||+|+||.||++...  |+.||+|.+.............+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999874  7899999987643333334566778999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      +|..++.....+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......    ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~----~~  152 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA----TM  152 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--cCCCCEEecccHHhccccCCCC----cc
Confidence            99999988788999999999999999999999987  9999999999999  7888999999999875432211    23


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....||+.|+|||++.
T Consensus       153 ~~~~gt~~y~aPE~~~  168 (323)
T cd05595         153 KTFCGTPEYLAPEVLE  168 (323)
T ss_pred             ccccCCcCcCCccccc
Confidence            4567999999999873

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=3e-31  Score=244.54  Aligned_cols=172  Identities=25%  Similarity=0.403  Sum_probs=146.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++...  ++.+|+|.+.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            37888899999999999999985  6789999986533222333456778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++|+|.+++... .+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.......
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl--~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLL--DKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--CCCCCEEEEecccceecccCCc
Confidence            999999999999654 5899999999999999999999988  9999999999999  7888999999999987643221


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......||+.|||||++.
T Consensus       198 ---~~~~~~~gt~~Y~aPE~~~  216 (370)
T cd05621         198 ---VRCDTAVGTPDYISPEVLK  216 (370)
T ss_pred             ---eecccCCCCcccCCHHHHh
Confidence               1234567999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-31  Score=241.72  Aligned_cols=168  Identities=32%  Similarity=0.476  Sum_probs=148.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|...  ++.||+|++.+...........+..|+.++..++||||+++++++...+..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5788899999999999999985  78999999875433333345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++....    
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLI--DASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCCEEEEeCcCCccccc----
Confidence            9999999999988888999999999999999999999988  9999999999999  7888999999999976543    


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       154 ---~~~~~~gt~~y~aPE~~~  171 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLR  171 (333)
T ss_pred             ---ccCCcccCccccChhHhc
Confidence               234567999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=2e-33  Score=237.24  Aligned_cols=165  Identities=25%  Similarity=0.456  Sum_probs=147.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      -|.+...||+|+||.||+|+.+  |+.+|+|.+...     ...+++..|+.+|+++..|++|++||.|.....+|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            4788899999999999999875  899999988543     235788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||..|++.++++. +..+++.++..+++..++||+|||...  -||||||..|||+  +.+|++||+|||.|-.+.+.-.
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILL--NT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILL--NTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEE--cccchhhhhhccccchhhhhHH
Confidence            9999999999986 457999999999999999999999976  8999999999999  9999999999999987764321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          +..+..|||.|||||+|
T Consensus       185 ----KRNTVIGTPFWMAPEVI  201 (502)
T KOG0574|consen  185 ----KRNTVIGTPFWMAPEVI  201 (502)
T ss_pred             ----hhCccccCcccccHHHH
Confidence                45678899999999987

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-31  Score=238.76  Aligned_cols=164  Identities=30%  Similarity=0.448  Sum_probs=142.0

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      ||+|+||.||++...  ++.+|+|.+.+...........+..|+.++.+++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            689999999999875  678999998654333344456778899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeC
Q 019685          243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG  322 (337)
Q Consensus       243 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~  322 (337)
                      .+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.......    ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~----~~~~  152 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDD----KTNT  152 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEE--CCCCcEEEEECcccccCccCCC----cccc
Confidence            999988888999999999999999999999988  9999999999999  8888999999999976433221    2345


Q ss_pred             Cccccccccccccc
Q 019685          323 ETGSCEYLVSNCSF  336 (337)
Q Consensus       323 ~~gt~~y~aPE~l~  336 (337)
                      ..||+.|+|||++.
T Consensus       153 ~~gt~~y~aPE~~~  166 (312)
T cd05585         153 FCGTPEYLAPELLL  166 (312)
T ss_pred             ccCCcccCCHHHHc
Confidence            67999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=2.8e-32  Score=236.27  Aligned_cols=165  Identities=31%  Similarity=0.496  Sum_probs=139.4

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-----
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----  228 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----  228 (337)
                      ...|...+++|+|+||.||+|...  +..+|||+......       .-.+|+.+|+.+.|||||++.-+|....     
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            446888899999999999999875  67899999865432       2246999999999999999998885432     


Q ss_pred             ceEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          229 PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      .+.+||||++. +|.++++.    +..++.-.+.-++.||++||.|||+.|  |+||||||.|+|++ ...|.+||||||
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD-~~tg~LKicDFG  171 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVD-PDTGVLKICDFG  171 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEc-CCCCeEEeccCC
Confidence            46789999988 99999985    467899999999999999999999977  99999999999994 234899999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .|+.+..+..     ......|.+|+|||.|+
T Consensus       172 SAK~L~~~ep-----niSYicSRyYRaPELif  198 (364)
T KOG0658|consen  172 SAKVLVKGEP-----NISYICSRYYRAPELIF  198 (364)
T ss_pred             cceeeccCCC-----ceeEEEeccccCHHHHc
Confidence            9999987654     34556899999999886

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=6.4e-31  Score=238.49  Aligned_cols=166  Identities=27%  Similarity=0.417  Sum_probs=142.2

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      +.||+|+||.||++...  +..+|+|++.+...........+..|+.++..++||||+++++++.....+|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999874  7889999987644333344567788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      +|.+++.....+++..+..++.||+.||.|||+ .+  |+||||||+|||+  +.++.+||+|||+++.......    .
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~----~  152 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGA----T  152 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEE--CCCCCEEEecCCCCeecCCCCc----c
Confidence            999999887789999999999999999999997 67  9999999999999  8888999999999976432221    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|||||++.
T Consensus       153 ~~~~~gt~~y~aPE~~~  169 (325)
T cd05594         153 MKTFCGTPEYLAPEVLE  169 (325)
T ss_pred             cccccCCcccCCHHHHc
Confidence            34457999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=4.7e-31  Score=242.70  Aligned_cols=149  Identities=31%  Similarity=0.517  Sum_probs=133.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+|+|++.+...........+..|+.++..++||+|+++++.+.+.+.+|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5777889999999999999875  78899999865432233345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.|  |+||||||+|||+  +..+.+||+|||+++.+.
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli--~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEE--CCCCCEEEeeccCCcccc
Confidence            9999999999988888999999999999999999999988  9999999999999  888999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=233.08  Aligned_cols=170  Identities=28%  Similarity=0.426  Sum_probs=155.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...++||+|.||.|.+++.+  ++.+|+|++++...-.+.....-..|-++|+.++||++..+-..|+....+|+|||
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe  248 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME  248 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence            6888899999999999999875  88999999988777666677788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |..||.|+-++.....+++..++.+...|+.||.|||+++  ||.||||.+|+|+  |++|++||.|||+++.-..... 
T Consensus       249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlL--DkDGHIKitDFGLCKE~I~~g~-  323 (516)
T KOG0690|consen  249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLL--DKDGHIKITDFGLCKEEIKYGD-  323 (516)
T ss_pred             EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhhee--ccCCceEeeecccchhcccccc-
Confidence            9999999999988888999999999999999999999987  9999999999999  9999999999999986543322 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         +..+.+|||.|+|||+|
T Consensus       324 ---t~kTFCGTPEYLAPEVl  340 (516)
T KOG0690|consen  324 ---TTKTFCGTPEYLAPEVL  340 (516)
T ss_pred             ---eeccccCChhhcCchhh
Confidence               57889999999999997

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=1.5e-30  Score=231.81  Aligned_cols=169  Identities=27%  Similarity=0.426  Sum_probs=144.0

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |...+.||+|+||.||++...  ++.||+|.+.+...........+.+|+.++..++|++|+++++.+.+.+.++++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            566789999999999999874  889999998655433333345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||+  +..+.+||+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill--~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILL--DDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE--CCCCCEEEeeCCCcEEcCCCC-
Confidence            9999999888643  35899999999999999999999987  9999999999999  788899999999998764321 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|||||++.
T Consensus       157 ----~~~~~~g~~~y~aPE~~~  174 (285)
T cd05631         157 ----TVRGRVGTVGYMAPEVIN  174 (285)
T ss_pred             ----eecCCCCCCCccCHhhhc
Confidence                234567999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=1.1e-30  Score=241.05  Aligned_cols=172  Identities=24%  Similarity=0.402  Sum_probs=146.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++..+  ++.+|+|++.+...........+.+|+.+++.++||||+++++.+.....+|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            47889999999999999999885  6789999986433222333456778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++... .+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.......
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll--~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEE--CCCCCEEEEeCCceeEcCcCCc
Confidence            999999999998654 5889999999999999999999988  9999999999999  7888999999999987653321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......||+.|||||++.
T Consensus       198 ---~~~~~~~gt~~y~aPE~l~  216 (371)
T cd05622         198 ---VRCDTAVGTPDYISPEVLK  216 (371)
T ss_pred             ---ccccCcccCccccCHHHHh
Confidence               1234567999999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=237.69  Aligned_cols=172  Identities=26%  Similarity=0.407  Sum_probs=146.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||++...  ++.+|+|++.+.........+.+.+|..++..++|+||+++++++.+.+.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            5788899999999999999875  77899999865322233344667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++.. ...+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||++..+.....
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEE--CCCCCEEEEECCceeecCCCCC
Confidence            9999999999976 456899999999999999999999988  9999999999999  7888999999999977654321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......||+.|||||++.
T Consensus       158 ---~~~~~~~gt~~y~aPE~~~  176 (331)
T cd05597         158 ---VQSNVAVGTPDYISPEILQ  176 (331)
T ss_pred             ---ccccceeccccccCHHHHh
Confidence               1123346999999999874

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=1.4e-30  Score=236.83  Aligned_cols=172  Identities=26%  Similarity=0.390  Sum_probs=146.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++...  ++.+|+|.+.+...........+.+|..++..++|++|+++++++...+..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5788899999999999999875  67899998865332223344567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++|+|.+++.. ...+++..+..++.|++.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.+.....
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEE--cCCCCEEEEeccceeeccCCCc
Confidence            9999999999986 457899999999999999999999987  9999999999999  7888999999999987654321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......||+.|||||++.
T Consensus       158 ---~~~~~~~gt~~y~aPE~~~  176 (331)
T cd05624         158 ---VQSSVAVGTPDYISPEILQ  176 (331)
T ss_pred             ---eeeccccCCcccCCHHHHh
Confidence               1223457999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=1.7e-30  Score=235.66  Aligned_cols=171  Identities=29%  Similarity=0.425  Sum_probs=144.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|++.+.........+.+..|..++..+.| ++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4677889999999999999876  56899999875433233345677889999999986 56889999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--cCCCCEEEeecCcceecCCCCC
Confidence            99999999999988888999999999999999999999987  9999999999999  7888999999999875432211


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       157 ----~~~~~~gt~~y~aPE~~~  174 (324)
T cd05587         157 ----TTRTFCGTPDYIAPEIIA  174 (324)
T ss_pred             ----ceeeecCCccccChhhhc
Confidence                234567999999999874

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=1.4e-30  Score=236.82  Aligned_cols=172  Identities=26%  Similarity=0.425  Sum_probs=148.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+|+|.+.............+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            5778899999999999999875  78899999876543333455678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.+.....
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll--~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEE--CCCCCEEeccCCCCeECCCCCc
Confidence            99999999999875 67999999999999999999999987  9999999999999  8889999999999987654322


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......||+.|+|||++.
T Consensus       158 ---~~~~~~~gt~~y~aPE~~~  176 (330)
T cd05601         158 ---VNSKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             ---eeeecccCCccccCHHHhc
Confidence               1233457999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=1.6e-30  Score=236.31  Aligned_cols=166  Identities=26%  Similarity=0.407  Sum_probs=142.6

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.||+|+||.||++...  ++.||+|.+.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999875  778999999765444444456678899999888 599999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.......    .
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~~~----~  152 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGIRPGD----T  152 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEECcCccccccccCCC----c
Confidence            999999988888999999999999999999999988  9999999999999  7888999999999975322211    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|+|||++.
T Consensus       153 ~~~~~gt~~y~aPE~~~  169 (329)
T cd05588         153 TSTFCGTPNYIAPEILR  169 (329)
T ss_pred             cccccCCccccCHHHHc
Confidence            34567999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=1.4e-30  Score=240.24  Aligned_cols=171  Identities=26%  Similarity=0.402  Sum_probs=145.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+|+|.+.+...........+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            7888899999999999999875  77899999865332223334557789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++|+|.+++... .+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++....... 
T Consensus       124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl--~~~~~~kL~DfG~~~~~~~~~~-  197 (370)
T cd05596         124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMDANGM-  197 (370)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--cCCCCEEEEeccceeeccCCCc-
Confidence            99999999998653 5889999999999999999999987  9999999999999  8889999999999987643321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|||||++.
T Consensus       198 --~~~~~~~gt~~y~aPE~~~  216 (370)
T cd05596         198 --VRCDTAVGTPDYISPEVLK  216 (370)
T ss_pred             --ccCCCCCCCcCeECHHHhc
Confidence              1224567999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=2.4e-30  Score=235.14  Aligned_cols=166  Identities=27%  Similarity=0.424  Sum_probs=142.3

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.||+|+||.||++...  ++.+|+|++.+...........+..|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999875  678999999765444444556678899888776 699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|..++.....+++..+..++.||+.||.|||+++  |+||||||+||++  +.++.+||+|||+++.......    .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili--~~~~~~kL~DfG~~~~~~~~~~----~  152 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGD----T  152 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--CCCCCEEEeeCCccccccCCCC----c
Confidence            999999988888999999999999999999999987  9999999999999  8888999999999975432211    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|+|||++.
T Consensus       153 ~~~~~gt~~y~aPE~~~  169 (329)
T cd05618         153 TSTFCGTPNYIAPEILR  169 (329)
T ss_pred             cccccCCccccCHHHHc
Confidence            34467999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=2.5e-30  Score=234.37  Aligned_cols=171  Identities=29%  Similarity=0.425  Sum_probs=144.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|...+.||+|+||.||+|...  ++.+|+|.+.+..............|..++..+. |++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677889999999999999876  5689999987644333333455677888887775 899999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++|+|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEE--CCCCcEEEccCCCceecCCCCC
Confidence            99999999999988888999999999999999999999988  9999999999999  8888999999999976432221


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       157 ----~~~~~~gt~~y~aPE~~~  174 (323)
T cd05616         157 ----TTKTFCGTPDYIAPEIIA  174 (323)
T ss_pred             ----ccccCCCChhhcCHHHhc
Confidence                234567999999999874

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.7e-31  Score=239.65  Aligned_cols=169  Identities=28%  Similarity=0.516  Sum_probs=148.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc-eEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-~~lv~  234 (337)
                      +|...+++|+|+||.++.++.+  ++.+++|.+.-.....+.. +....|+.++++++|||||.+.+.|...+. ++|||
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            6888999999999999887765  6789999997665544433 466789999999999999999999999888 99999


Q ss_pred             eecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      +||+||++.+.|.+..  .++++.+..++.|++.|+.|||+..  |+|||||+.|||+  ..++.|||.|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifl--tk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFL--TKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhc--cccCceeecchhhhhhcCCc
Confidence            9999999999998643  5899999999999999999999866  9999999999999  78888999999999998876


Q ss_pred             cccceeeeeCCcccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .+    ...+..|||.||+||++
T Consensus       160 ~~----~a~tvvGTp~YmcPEil  178 (426)
T KOG0589|consen  160 DS----LASTVVGTPYYMCPEIL  178 (426)
T ss_pred             hh----hhheecCCCcccCHHHh
Confidence            43    34678899999999986

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=2.4e-30  Score=235.42  Aligned_cols=172  Identities=26%  Similarity=0.412  Sum_probs=145.2

Q ss_pred             CccccceecccCceeEEEEEE-----CCceEEEEEecCCCC-chHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~  230 (337)
                      +|++.+.||+|+||.||++..     .++.+|+|++.+... ......+.+..|+.++..++ |++|+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            467788999999999999875     367899999865322 12233456788999999995 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ++||||+++++|.+++.....+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili--~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILL--DSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEE--CCCCCEEEeeCcCCcccc
Confidence            999999999999999988888999999999999999999999988  9999999999999  788899999999998654


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....   ......||+.|||||++.
T Consensus       157 ~~~~~---~~~~~~gt~~y~aPE~~~  179 (332)
T cd05614         157 SEEKE---RTYSFCGTIEYMAPEIIR  179 (332)
T ss_pred             ccCCC---ccccccCCccccCHHHhc
Confidence            33211   223467999999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=239.43  Aligned_cols=175  Identities=29%  Similarity=0.478  Sum_probs=149.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  ++.||+|++.+...........+..|+.++..++||||+++++++.+.+.+|+|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            5788899999999999999986  88999999865433333345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||+.|  |+||||||+|||+  +..+.+||+|||+++.+......
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEeecCCCCccCcccCcc
Confidence            9999999999988788999999999999999999999987  9999999999999  88889999999999876543200


Q ss_pred             -------------------------ceeeeeCCccccccccccccc
Q 019685          316 -------------------------DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 -------------------------~~~~~~~~~gt~~y~aPE~l~  336 (337)
                                               .........||+.|+|||++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR  203 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence                                     001233457999999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=2.3e-30  Score=233.95  Aligned_cols=165  Identities=29%  Similarity=0.462  Sum_probs=138.3

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      .||+|+||.||+|...  ++.||+|.+...........+....|..++..+ +||||+++++++.....+|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6999999999999875  668999998654322223334555677776654 7999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      +|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......    ..
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~~----~~  153 (316)
T cd05592          82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLL--DKDGHIKIADFGMCKENMNGEG----KA  153 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEE--CCCCCEEEccCcCCeECCCCCC----cc
Confidence            99999988888999999999999999999999987  9999999999999  7888999999999976543221    23


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....||+.|+|||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (316)
T cd05592         154 STFCGTPDYIAPEILK  169 (316)
T ss_pred             ccccCCccccCHHHHc
Confidence            4567999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=3.4e-30  Score=234.39  Aligned_cols=172  Identities=24%  Similarity=0.393  Sum_probs=145.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++..+  ++.+|+|.+.+...........+..|+.++..++|++|+++++.+.+...+|+|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            5778899999999999999886  56799998864322223334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+.....
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili--~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEE--CCCCCEEEeecchheecccCCc
Confidence            9999999999976 456899999999999999999999988  9999999999999  7888999999999976543321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......||+.|||||++.
T Consensus       158 ---~~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         158 ---VQSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             ---ceecccccCccccCHHHHh
Confidence               1233457999999999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=2.7e-30  Score=234.01  Aligned_cols=165  Identities=25%  Similarity=0.405  Sum_probs=140.5

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      .||+|+||.||+|...  ++.+|+|.+.+...........+..|..++..+ +||||+++++++...+.+|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            6899999999999886  678999998654332333445677788888866 6999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      +|..++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......    ..
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill--~~~~~~kL~Dfg~~~~~~~~~~----~~  153 (321)
T cd05591          82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILL--DAEGHCKLADFGMCKEGILNGV----TT  153 (321)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEeecccceecccCCc----cc
Confidence            99999988888999999999999999999999988  9999999999999  8888999999999976433221    23


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....||+.|+|||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (321)
T cd05591         154 TTFCGTPDYIAPEILQ  169 (321)
T ss_pred             cccccCccccCHHHHc
Confidence            4567999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=2.5e-30  Score=234.40  Aligned_cols=171  Identities=29%  Similarity=0.434  Sum_probs=143.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|++.+.........+.+..|..++..+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999875  7789999987543322334466778888888886 578888999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill--~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVML--DSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEeccccccccCCCCc
Confidence            99999999999988888999999999999999999999988  9999999999999  7888999999999976433221


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       157 ----~~~~~~gt~~y~aPE~~~  174 (323)
T cd05615         157 ----TTRTFCGTPDYIAPEIIA  174 (323)
T ss_pred             ----cccCccCCccccCHHHHc
Confidence                234456999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=2.3e-30  Score=234.29  Aligned_cols=165  Identities=27%  Similarity=0.420  Sum_probs=140.2

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      .||+|+||.||++..+  ++.||+|.+.+...........+..|..++..+ +||||+++++++...+.+|+||||++++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            6999999999999875  678999998654332233445667788888876 5999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      +|.+++.....+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......    ..
T Consensus        82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli--~~~~~~kL~DfG~~~~~~~~~~----~~  153 (320)
T cd05590          82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFNGK----TT  153 (320)
T ss_pred             hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE--CCCCcEEEeeCCCCeecCcCCC----cc
Confidence            99999988888999999999999999999999988  9999999999999  7888999999999876432221    23


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....||+.|||||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (320)
T cd05590         154 STFCGTPDYIAPEILQ  169 (320)
T ss_pred             cccccCccccCHHHHc
Confidence            4567999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=3.3e-30  Score=233.65  Aligned_cols=166  Identities=32%  Similarity=0.472  Sum_probs=138.2

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.||+|+||.||++...  ++.||+|++.+...........+..|.. +++.++||||+++++.+...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999985  7899999986543322223344455554 56779999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......    .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~~----~  152 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILL--DSQGHVVLTDFGLCKEGIEHSK----T  152 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEE--CCCCcEEEeccCCCcccccCCC----c
Confidence            999999988888999999999999999999999988  9999999999999  7888999999999875433221    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|+|||++.
T Consensus       153 ~~~~~gt~~y~aPE~~~  169 (323)
T cd05575         153 TSTFCGTPEYLAPEVLR  169 (323)
T ss_pred             cccccCChhhcChhhhc
Confidence            34567999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=3.9e-30  Score=233.16  Aligned_cols=166  Identities=31%  Similarity=0.491  Sum_probs=140.4

Q ss_pred             ceecccCceeEEEEEE-----CCceEEEEEecCCCC-chHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          163 AIIGKGSFGEILKAYW-----RGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +.||+|+||.||++..     .++.+|+|.+..... ........+..|+.+++.++||||+++++.+...+.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999875     367899999865321 1122335567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++++|.+++...+.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEeeCcCCeecccCCC--
Confidence            999999999988888899999999999999999999987  9999999999999  8888999999999975433221  


Q ss_pred             eeeeeCCccccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l~  336 (337)
                        ......||+.|+|||++.
T Consensus       156 --~~~~~~gt~~y~aPE~~~  173 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILM  173 (323)
T ss_pred             --cccccCCCccccChhhcc
Confidence              223457999999999874

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=5.1e-30  Score=232.76  Aligned_cols=166  Identities=27%  Similarity=0.405  Sum_probs=142.6

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.||+|+||.||++...  ++.+|+|++.+.........+.+..|+.++.++ +||+|+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999875  678999999765444444556788899999888 499999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.......    .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~----~  152 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGD----T  152 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--eCCCCEEEeccccceeccCCCC----c
Confidence            999999988778999999999999999999999988  9999999999999  7788999999999975332211    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|+|||++.
T Consensus       153 ~~~~~gt~~y~aPE~~~  169 (327)
T cd05617         153 TSTFCGTPNYIAPEILR  169 (327)
T ss_pred             eecccCCcccCCHHHHC
Confidence            34567999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-31  Score=226.70  Aligned_cols=171  Identities=32%  Similarity=0.489  Sum_probs=146.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-----CCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-----RKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-----~~~~  230 (337)
                      .|...+.||+|+||.|+.+.++  |..||+|++.... ......++..+|+.+++.++|+||+.+++++..     -+.+
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            3444678999999999999886  8899999886432 334556888899999999999999999998855     3469


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+|+|+|+ .+|.+.|+....+++..+..++.|++.||.|+|+.+  |+||||||+|+|+  +.+..+||+|||+|+...
T Consensus       102 YiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~--n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLL--NADCDLKICDFGLARYLD  176 (359)
T ss_pred             EEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheee--ccCCCEEeccccceeecc
Confidence            99999994 599999998877999999999999999999999987  9999999999999  888899999999999886


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .. +. ...++..+-|..|.|||+++
T Consensus       177 ~~-~~-~~~mTeYVaTRWYRAPElll  200 (359)
T KOG0660|consen  177 KF-FE-DGFMTEYVATRWYRAPELLL  200 (359)
T ss_pred             cc-Cc-ccchhcceeeeeecCHHHHh
Confidence            53 11 12467888999999999975

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=4e-30  Score=233.27  Aligned_cols=166  Identities=33%  Similarity=0.495  Sum_probs=138.2

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.||+|+||.||++...  |+.+|+|++.+...........+..|.. +++.++||||+++++.+...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36899999999999875  7899999986543322223344555554 46778999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|..++.....+++..+..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||+++.......    .
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~----~  152 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILL--DSQGHVVLTDFGLCKEGIAQSD----T  152 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEEeecCCcccCCCCCC----C
Confidence            999999988888999999999999999999999988  9999999999999  8888999999999875432211    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|||||++.
T Consensus       153 ~~~~~gt~~y~aPE~~~  169 (325)
T cd05604         153 TTTFCGTPEYLAPEVIR  169 (325)
T ss_pred             cccccCChhhCCHHHHc
Confidence            34567999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.1e-30  Score=236.55  Aligned_cols=171  Identities=31%  Similarity=0.458  Sum_probs=154.1

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ...|...+.||+|.|+.|..++..  +..||+|.+.+...+... ...+.+|+++|..++|||||+++.+.+....+|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            336788899999999999999864  899999999887665543 34488899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |||+.+|.+++++...+.+.+.++..++.|+..|++|||+++  |||||||++|||+  +.+..+||+|||++..+....
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL--~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILL--DENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccc--ccccceeeeccccceeecccc
Confidence            999999999999999999999999999999999999999988  9999999999999  888889999999999887432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ...+.+|++.|.|||++.
T Consensus       210 -----~lqt~cgsppyAaPEl~~  227 (596)
T KOG0586|consen  210 -----MLQTFCGSPPYAAPELFN  227 (596)
T ss_pred             -----cccccCCCCCccChHhhc
Confidence                 467789999999999874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=232.97  Aligned_cols=166  Identities=30%  Similarity=0.476  Sum_probs=143.4

Q ss_pred             cceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      .++||+|.||+||-|..+  |+.||||++.+.....+. ...+++|+.+|+++.||.||.+.-.|++.+.+++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            378999999999998875  999999999876665443 37788999999999999999999999999999999999965


Q ss_pred             CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecccccc
Q 019685          240 GDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       240 ~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                       ++.+.|-  +.+.+++.....++.||+.||.|||-++  |+|.||||+|||+.+ +....+||||||+|+++....   
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---  721 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---  721 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence             6666653  5678999999999999999999999988  999999999999954 334589999999999987542   


Q ss_pred             eeeeeCCccccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .....+|||.|+|||+|.
T Consensus       722 --FRrsVVGTPAYLaPEVLr  739 (888)
T KOG4236|consen  722 --FRRSVVGTPAYLAPEVLR  739 (888)
T ss_pred             --hhhhhcCCccccCHHHHh
Confidence              346788999999999985

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=4.4e-30  Score=232.60  Aligned_cols=165  Identities=32%  Similarity=0.471  Sum_probs=137.4

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      .||+|+||.||+|...  ++.+|+|++.+...........+..|.. +++.++||||+++++.+...+..|+||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6999999999999985  7789999986543322223344555554 578899999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      +|...+.....+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.......    ..
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~----~~  153 (321)
T cd05603          82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEE----TT  153 (321)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEccCCCCccCCCCCC----cc
Confidence            99999987778999999999999999999999987  9999999999999  8888999999999875432211    23


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....||+.|+|||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (321)
T cd05603         154 STFCGTPEYLAPEVLR  169 (321)
T ss_pred             ccccCCcccCCHHHhc
Confidence            4457999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=5e-30  Score=232.63  Aligned_cols=165  Identities=32%  Similarity=0.473  Sum_probs=136.3

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      .||+|+||.||++...  ++.+|+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            6999999999999875  6789999986543222222234444444 567789999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      +|.+++.....+++..+..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||+++.......    ..
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili--~~~~~~kl~DfG~a~~~~~~~~----~~  153 (325)
T cd05602          82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNG----TT  153 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEEccCCCCcccccCCC----Cc
Confidence            99999988788999999999999999999999988  9999999999999  7888999999999976433221    23


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....||+.|||||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (325)
T cd05602         154 STFCGTPEYLAPEVLH  169 (325)
T ss_pred             ccccCCccccCHHHHc
Confidence            4567999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=1.2e-29  Score=225.73  Aligned_cols=175  Identities=21%  Similarity=0.281  Sum_probs=148.8

Q ss_pred             ccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----
Q 019685          151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----  226 (337)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----  226 (337)
                      .++..+.+......|++|+++.||+|.++|+.||+|.+...........+.+.+|+.++.+++||||+++++++.+    
T Consensus        14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   93 (283)
T PHA02988         14 CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD   93 (283)
T ss_pred             ecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence            3445555555557899999999999999999999999876554444456778899999999999999999999876    


Q ss_pred             CCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          227 RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      ...++++|||+++|+|.+++.....+++.....++.|++.||.|||+. +  ++||||||+|||+  +.++.+||+|||+
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill--~~~~~~kl~dfg~  169 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLV--TENYKLKIICHGL  169 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEE--CCCCcEEEcccch
Confidence            457899999999999999998888899999999999999999999984 6  8899999999999  7788999999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.....       .....|++.|+|||++.
T Consensus       170 ~~~~~~~-------~~~~~~~~~y~aPE~~~  193 (283)
T PHA02988        170 EKILSSP-------PFKNVNFMVYFSYKMLN  193 (283)
T ss_pred             Hhhhccc-------cccccCcccccCHHHhh
Confidence            9865432       12356889999999873

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4.4e-30  Score=225.37  Aligned_cols=148  Identities=29%  Similarity=0.425  Sum_probs=136.1

Q ss_pred             CccccceecccCceeEEEEEECC--ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g--~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|.-|.||++..++  ...|+|++.+..........+...|-.+|+.+.||+++.||..|+.....|++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            57788999999999999999985  6899999988776666777888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ||+||+|..+++.+  ..++++.++.|+.+|+.||+|||-.|  ||+|||||+||||  ..+|++-|+||.|+...
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILv--redGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILV--REDGHIMLSDFDLSLRC  229 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEE--ecCCcEEeeeccccccC
Confidence            99999999999764  45999999999999999999999998  9999999999999  88999999999987553

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=7.1e-30  Score=230.74  Aligned_cols=166  Identities=28%  Similarity=0.454  Sum_probs=138.6

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.||+|+||.||++..+  +..||+|.+.+..............|..++... +||+|+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999985  778999998654322122334566677777654 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......    .
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~----~  152 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVML--DRDGHIKIADFGMCKENVFGDN----R  152 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEE--CCCCCEEeCccCCCeecccCCC----c
Confidence            999999988888999999999999999999999987  9999999999999  7888999999999875432211    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|+|||++.
T Consensus       153 ~~~~~gt~~y~aPE~~~  169 (316)
T cd05620         153 ASTFCGTPDYIAPEILQ  169 (316)
T ss_pred             eeccCCCcCccCHHHHc
Confidence            34567999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=9.5e-31  Score=240.31  Aligned_cols=178  Identities=28%  Similarity=0.523  Sum_probs=148.0

Q ss_pred             ccCCCCcCccccceecccCceeEEEEEEC--CceEEEEEec-CCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC
Q 019685          151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER  227 (337)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~-~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  227 (337)
                      +.++...-......||+|+|-+||+|.+.  |-+||--.+. ..........++|..|+.+|+.|+||||+++|.+|.+.
T Consensus        34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence            34444444456679999999999999986  5566532221 11223455668999999999999999999999999876


Q ss_pred             Cc--eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          228 KP--LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       228 ~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      ..  +.+|+|++..|+|..|+++.+.++...+..|++||++||.|||++.++|||||||-+||||. ...|.|||+|.||
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin-G~~G~VKIGDLGL  192 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN-GNLGEVKIGDLGL  192 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc-CCcCceeecchhH
Confidence            55  88999999999999999999999999999999999999999999999999999999999993 4568999999999


Q ss_pred             ceeeecccccceeeeeCCcccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |.......      .....|||.|||||++
T Consensus       193 Atl~r~s~------aksvIGTPEFMAPEmY  216 (632)
T KOG0584|consen  193 ATLLRKSH------AKSVIGTPEFMAPEMY  216 (632)
T ss_pred             HHHhhccc------cceeccCccccChHHH
Confidence            99876542      3447899999999975

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=8.9e-30  Score=230.07  Aligned_cols=165  Identities=27%  Similarity=0.440  Sum_probs=138.2

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      .||+|+||.||+|...  ++.||+|.+................|..++... +||||+++++++.+.+.+|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            6999999999999975  678999998654322222334556677777764 7999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      +|.+++.....+++.++..++.|++.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.......    ..
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~----~~  153 (316)
T cd05619          82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILL--DTDGHIKIADFGMCKENMLGDA----KT  153 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEE--CCCCCEEEccCCcceECCCCCC----ce
Confidence            99999988778999999999999999999999987  9999999999999  7888999999999975432221    23


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....||+.|+|||++.
T Consensus       154 ~~~~gt~~y~aPE~~~  169 (316)
T cd05619         154 CTFCGTPDYIAPEILL  169 (316)
T ss_pred             eeecCCccccCHHHHc
Confidence            4567999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=1.3e-29  Score=226.05  Aligned_cols=168  Identities=30%  Similarity=0.503  Sum_probs=141.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|.+.......  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            6888899999999999999875  7789999886443221  22456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++ +|.+++...+ .+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLI--NEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEECcCcceeeccCCCc
Confidence            9975 9999887644 4789999999999999999999988  9999999999999  7888999999999976543321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+++.|+|||++.
T Consensus       159 ----~~~~~~~~~~y~aPE~~~  176 (288)
T cd07871         159 ----TYSNEVVTLWYRPPDVLL  176 (288)
T ss_pred             ----cccCceecccccChHHhc
Confidence                234567899999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=6.9e-30  Score=231.65  Aligned_cols=169  Identities=29%  Similarity=0.459  Sum_probs=139.6

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHH---HhCCCCCeeeeeeeEEeCCceEEE
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL---VKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l---~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      |.+.+.||+|+||.||++.+.  ++.||+|++.+.........+.+..|..++   +.++||||+++++++...+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456789999999999999875  788999998654322233345666666655   566799999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |||+++++|..++.. ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill--~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLL--DTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEE--CCCCcEEeCcccCCccCCCCC
Confidence            999999999988854 46999999999999999999999987  9999999999999  788899999999987543322


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......|++.|||||++.
T Consensus       156 ~----~~~~~~g~~~y~aPE~~~  174 (324)
T cd05589         156 D----RTSTFCGTPEFLAPEVLT  174 (324)
T ss_pred             C----cccccccCccccCHhHhc
Confidence            1    234567999999999863

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8e-30  Score=231.80  Aligned_cols=164  Identities=30%  Similarity=0.454  Sum_probs=136.4

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      ||+|+||.||+|...  ++.+|+|++.+..............|..++...   .||+|+++++.+.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            689999999999875  789999998653322222334455566666655   699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.......    .
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili--~~~~~~kl~Dfg~a~~~~~~~~----~  152 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILL--DATGHIALCDFGLSKANLTDNK----T  152 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEE--CCCCCEEEecCCcCcCCCCCCC----C
Confidence            999999988888999999999999999999999987  9999999999999  7788999999999976433221    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|||||++.
T Consensus       153 ~~~~~gt~~y~aPE~~~  169 (330)
T cd05586         153 TNTFCGTTEYLAPEVLL  169 (330)
T ss_pred             ccCccCCccccCHHHHc
Confidence            34567999999999874

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-31  Score=232.44  Aligned_cols=176  Identities=27%  Similarity=0.418  Sum_probs=155.6

Q ss_pred             cCCCCcCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          152 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      .+.....|..-++||+|+||.||-+..  +|+-+|.|++.+...+.+......++|-.++.++..++||.+-.+|++...
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            334455788889999999999998765  588999999977766666666777899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      +|+|+..|.||+|.-+|...+  .+++..++.|+.+|+.||.+||+++  ||.|||||+|||+  |..|+++|+|.|||.
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILL--Dd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILL--DDHGHVRISDLGLAV  335 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheee--ccCCCeEeeccceEE
Confidence            999999999999999987654  7999999999999999999999988  9999999999999  999999999999999


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+....     ...+.+||.+|||||++.
T Consensus       336 ei~~g~-----~~~~rvGT~GYMAPEvl~  359 (591)
T KOG0986|consen  336 EIPEGK-----PIRGRVGTVGYMAPEVLQ  359 (591)
T ss_pred             ecCCCC-----ccccccCcccccCHHHHc
Confidence            887654     245569999999999985

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=7.4e-30  Score=236.11  Aligned_cols=165  Identities=33%  Similarity=0.455  Sum_probs=143.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-C-----CCeeeeeeeEEeCCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H-----PNIVQFLGAVTERKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~Iv~~~~~~~~~~~  229 (337)
                      +|++.+.||+|.||+|.+|.+.  ++.||||+++..    +........|+.+|..++ |     -|+|+++++|...+.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            6789999999999999999875  789999998654    334466677999999997 4     389999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      +|||+|+++. +|+++|+.+.  .++...++.++.||+.||.+||..+  |||+||||+|||+..-....|||+|||.|.
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999999966 9999999754  5899999999999999999999977  999999999999987777799999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....       ......+..|+|||+|+
T Consensus       340 ~~~q~-------vytYiQSRfYRAPEVIL  361 (586)
T KOG0667|consen  340 FESQR-------VYTYIQSRFYRAPEVIL  361 (586)
T ss_pred             ccCCc-------ceeeeeccccccchhhc
Confidence            75532       23677899999999996

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.2e-29  Score=229.47  Aligned_cols=165  Identities=30%  Similarity=0.445  Sum_probs=140.7

Q ss_pred             ceecccCceeEEEEEE-----CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          163 AIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      +.||+|+||.||++..     .++.+|+|++.+.... ......+..|+.++++++||||+++++++...+.+|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            4799999999999875     3688999998653322 122345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccce
Q 019685          238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV  317 (337)
Q Consensus       238 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~  317 (337)
                      ++++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......   
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~~~~~~---  153 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEK---  153 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEE--CCCCcEEEeeccCCcccCCCCC---
Confidence            99999999988778999999999999999999999987  9999999999999  7888999999999986543321   


Q ss_pred             eeeeCCccccccccccccc
Q 019685          318 YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       318 ~~~~~~~gt~~y~aPE~l~  336 (337)
                       ......||+.|+|||++.
T Consensus       154 -~~~~~~g~~~y~aPE~~~  171 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVN  171 (318)
T ss_pred             -ceecccCChhhcCHHHHc
Confidence             234567999999999863

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=1.4e-29  Score=227.40  Aligned_cols=168  Identities=30%  Similarity=0.530  Sum_probs=141.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|..+  ++.+|+|.+.......  ....+.+|+.+++.++||||+++++++......|+|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            6888899999999999999985  7889999986543221  12456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+. ++|.+++... +.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.......
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~  158 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSH  158 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECCCCcceeccCCCc
Confidence            996 5888887653 56899999999999999999999988  9999999999999  7888999999999976543221


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       159 ----~~~~~~~~~~y~aPE~~~  176 (303)
T cd07869         159 ----TYSNEVVTLWYRPPDVLL  176 (303)
T ss_pred             ----cCCCCcccCCCCChHHHc
Confidence                234567899999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=243.50  Aligned_cols=167  Identities=26%  Similarity=0.425  Sum_probs=142.8

Q ss_pred             ccccceecccCceeEEEEEECC--ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~g--~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |.+...||.|+||.||+|..+.  -..|.|.+..   ......++++-|+.+|..|.||+||++++.|...+.+||+.||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            4556789999999999998763  3345666643   2345678999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |.||-...++-+ ...+++.++..+++|++.||.|||+++  |||||||..|||+  ..+|.++|+|||.+......-  
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~--TldGdirLADFGVSAKn~~t~--  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILL--TLDGDIRLADFGVSAKNKSTR--  184 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEE--EecCcEeeecccccccchhHH--
Confidence            999999888766 456999999999999999999999977  9999999999999  888899999999986654321  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .+...+.|||+|||||+.+
T Consensus       185 --qkRDsFIGTPYWMAPEVvm  203 (1187)
T KOG0579|consen  185 --QKRDSFIGTPYWMAPEVVM  203 (1187)
T ss_pred             --hhhccccCCcccccchhee
Confidence              2457789999999999875

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-29  Score=224.06  Aligned_cols=170  Identities=28%  Similarity=0.435  Sum_probs=144.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||++...  ++.||+|.+.............+.+|+.+++.++||||+++++.+.....+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677789999999999999875  78899999865443333334567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILL--DDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEE--CCCCCEEEeeCCCceecCCCC
Confidence            99999999888653  45899999999999999999999987  9999999999999  777899999999998764322


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......|++.|+|||++.
T Consensus       157 -----~~~~~~~~~~y~aPE~~~  174 (285)
T cd05605         157 -----TIRGRVGTVGYMAPEVVK  174 (285)
T ss_pred             -----ccccccCCCCccCcHHhc
Confidence                 123457899999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=3.4e-29  Score=225.01  Aligned_cols=171  Identities=32%  Similarity=0.541  Sum_probs=141.2

Q ss_pred             CccccceecccCceeEEEEEEC------------------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ  219 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~------------------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~  219 (337)
                      +|...+.||+|+||.||+|.+.                  +..||+|.+.....  ......+.+|+.++..++||||++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCeeE
Confidence            6777889999999999999753                  23699998865432  334567889999999999999999


Q ss_pred             eeeeEEeCCceEEEEeecCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEe
Q 019685          220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG-------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIH  280 (337)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH  280 (337)
                      +++++...+..+++|||+++++|.+++....                   .+++..+..++.||+.||.|||+.+  |+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence            9999999999999999999999999986421                   3577888999999999999999987  999


Q ss_pred             eCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       281 rdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||||+|||+  +..+.+||+|||+++.......  ........+++.|||||++.
T Consensus       162 ~dlkp~Nill--~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  213 (304)
T cd05096         162 RDLATRNCLV--GENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECIL  213 (304)
T ss_pred             cCcchhheEE--cCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHh
Confidence            9999999999  7788999999999987644321  11223445688999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=1.5e-29  Score=224.64  Aligned_cols=164  Identities=29%  Similarity=0.424  Sum_probs=139.4

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      ||+|+||.||++...  ++.+|+|.+.+.........+.+..|+.+++.++|+||+++.+++......|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            689999999999875  788999998654433333446678899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccccee
Q 019685          243 HKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY  318 (337)
Q Consensus       243 ~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~  318 (337)
                      .+++..    ...+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||++..+.....    
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~~----  152 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLL--DNDGNVRISDLGLAVELKDGQS----  152 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCccceecCCCCc----
Confidence            988753    345899999999999999999999987  9999999999999  7788999999999987654322    


Q ss_pred             eeeCCccccccccccccc
Q 019685          319 KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       319 ~~~~~~gt~~y~aPE~l~  336 (337)
                      ......||+.|+|||++.
T Consensus       153 ~~~~~~g~~~y~aPE~~~  170 (280)
T cd05608         153 KTKGYAGTPGFMAPELLQ  170 (280)
T ss_pred             cccccCCCcCccCHHHhc
Confidence            234467999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=1.7e-29  Score=230.36  Aligned_cols=171  Identities=29%  Similarity=0.527  Sum_probs=138.0

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC-C
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-K  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-~  228 (337)
                      +|++.+.||+|+||.||+|.+.       ++.||+|.+.....  ......+.+|+.++..+ +||||+++++++... .
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            6778889999999999999742       45799998864322  22346788999999999 799999999988754 4


Q ss_pred             ceEEEEeecCCCCHHHHHHhc-----------------------------------------------------------
Q 019685          229 PLMLITEYLRGGDLHKYLKEK-----------------------------------------------------------  249 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------------------  249 (337)
                      .++++|||+++|+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            689999999999999998742                                                           


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccc
Q 019685          250 ---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS  326 (337)
Q Consensus       250 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt  326 (337)
                         ..+++.++..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+.....  ........++
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~--~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~  239 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRKGSARLP  239 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEE--cCCCcEEEeecccccccccCcc--hhcccCCCCC
Confidence               13677888999999999999999987  9999999999999  7788999999999987643221  1122334567


Q ss_pred             cccccccccc
Q 019685          327 CEYLVSNCSF  336 (337)
Q Consensus       327 ~~y~aPE~l~  336 (337)
                      +.|||||++.
T Consensus       240 ~~y~aPE~~~  249 (338)
T cd05102         240 LKWMAPESIF  249 (338)
T ss_pred             ccccCcHHhh
Confidence            8999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=230.30  Aligned_cols=169  Identities=29%  Similarity=0.478  Sum_probs=149.4

Q ss_pred             ccccceecccCceeEEEEE--ECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |...+.||+|-|+.|-+|+  ++|..||||++.+...++.. ...+..|++.|+.++|||||++|++..+...+|+|+|+
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            6677899999999998886  47999999999887766543 35566799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      -.+|+|++||-+. ..+++..+.+|+.||+.|+.|+|...  +|||||||+||.+- .+-|.|||.|||++..+....  
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFF-EKlGlVKLTDFGFSNkf~PG~--  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFF-EKLGLVKLTDFGFSNKFQPGK--  173 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEe-eecCceEeeeccccccCCCcc--
Confidence            9999999998653 46999999999999999999999987  99999999998763 567899999999998876553  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         +..+.+|+..|-|||+|+
T Consensus       174 ---kL~TsCGSLAYSAPEILL  191 (864)
T KOG4717|consen  174 ---KLTTSCGSLAYSAPEILL  191 (864)
T ss_pred             ---hhhcccchhhccCchhhh
Confidence               578899999999999986

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=1.5e-29  Score=228.78  Aligned_cols=166  Identities=29%  Similarity=0.453  Sum_probs=140.6

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.||+|+||.||++...  ++.+|+|.+.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999885  678999998754333333445677888888887 599999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|.+++...+.+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||+++.......    .
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~----~  152 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLL--DSEGHIKIADFGMCKEGILGGV----T  152 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEE--CCCCcEEecccCCCeecCcCCC----c
Confidence            999999988878999999999999999999999987  9999999999999  7888999999999975432221    2


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....||+.|+|||++.
T Consensus       153 ~~~~~g~~~y~aPE~~~  169 (318)
T cd05570         153 TSTFCGTPDYIAPEILS  169 (318)
T ss_pred             ccceecCccccCHHHhc
Confidence            23456999999999874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=5.7e-29  Score=226.31  Aligned_cols=169  Identities=27%  Similarity=0.426  Sum_probs=146.6

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++...  +..+++|.+....  .....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            47888899999999999999986  6788999886542  2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+|||+  +.++.+||+|||+++.....  
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEE--cCCCcEEEccCccccccccc--
Confidence            9999999999998877899999999999999999999985 139999999999999  77889999999999766432  


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       158 ----~~~~~~g~~~y~aPE~~~  175 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQ  175 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhc
Confidence                223457999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.4e-29  Score=232.29  Aligned_cols=164  Identities=26%  Similarity=0.324  Sum_probs=140.9

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ...|++.+.||+|+||.||+|...  ++.||+|...         ...+.+|+.+++.++||||+++++++......+++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            347999999999999999999875  7789999642         13467899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      +|++. ++|.+++.....+++.+++.++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++......
T Consensus       162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll--~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFI--NHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEE--cCCCCEEEEeCCccccccccc
Confidence            99995 599999988778999999999999999999999987  9999999999999  788899999999997543221


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .   .......||+.|+|||++.
T Consensus       237 ~---~~~~~~~gt~~y~aPE~~~  256 (391)
T PHA03212        237 A---NKYYGWAGTIATNAPELLA  256 (391)
T ss_pred             c---cccccccCccCCCChhhhc
Confidence            1   1234567999999999874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-31  Score=253.68  Aligned_cols=172  Identities=28%  Similarity=0.416  Sum_probs=153.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.+.++||+|+||.|..++.+  ++.||+|++.+..--.......|..|-.+|...+.+-|+.++.+|++.+++|+|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            8999999999999999999886  67899999876433333334668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |++||+|-.++.....+++..++.|...|+.||.-||+.|  +|||||||+|||+  |..|++||+|||.+-.+..++. 
T Consensus       156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLl--d~~GHikLADFGsClkm~~dG~-  230 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLL--DKSGHIKLADFGSCLKMDADGT-  230 (1317)
T ss_pred             cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEe--cccCcEeeccchhHHhcCCCCc-
Confidence            9999999999998778999999999999999999999988  9999999999999  9999999999999988775542 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        ......+|||-|+|||+|.
T Consensus       231 --V~s~~aVGTPDYISPEvLq  249 (1317)
T KOG0612|consen  231 --VRSSVAVGTPDYISPEVLQ  249 (1317)
T ss_pred             --EEeccccCCCCccCHHHHH
Confidence              2467789999999999973

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=3.9e-29  Score=227.84  Aligned_cols=171  Identities=29%  Similarity=0.472  Sum_probs=141.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----Cce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~  230 (337)
                      +|++.+.||+|+||.||+|...  +..||+|.+...... ......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            4677889999999999999875  789999988643222 22335678899999999999999999987543     248


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++...
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILA--NADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCcEEEccCccccccc
Confidence            99999995 599999988778999999999999999999999988  9999999999999  888999999999998654


Q ss_pred             cccccceeeeeCCcccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...... .......||+.|+|||++
T Consensus       155 ~~~~~~-~~~~~~~~t~~y~aPE~~  178 (338)
T cd07859         155 NDTPTA-IFWTDYVATRWYRAPELC  178 (338)
T ss_pred             cccCcc-ccccCCCCCCCcCCHHHH
Confidence            332111 123456799999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=225.48  Aligned_cols=167  Identities=32%  Similarity=0.497  Sum_probs=142.0

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEeCC----ceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~~----~~~  231 (337)
                      ..+..++||+|.||.||+|.+.++.||||++...      ..+.|.+|-++.+.  ++|+||++++++-....    .+|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhccCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            3455678999999999999999999999998542      34677888887765  46999999999876655    799


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-------PNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-------~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      ||++|-+.|+|.++|+.+ .+++....+++..++.||+|||+.       .++|+|||||++||||  ..+++..|+|||
T Consensus       285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--K~DlTccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--KNDLTCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE--ccCCcEEeeccc
Confidence            999999999999999765 689999999999999999999973       2469999999999999  777889999999


Q ss_pred             CceeeecccccceeeeeCCcccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +|..+....+.  ....+.+||.+|||||+|
T Consensus       362 LAl~~~p~~~~--~d~~~qVGT~RYMAPEvL  390 (534)
T KOG3653|consen  362 LALRLEPGKPQ--GDTHGQVGTRRYMAPEVL  390 (534)
T ss_pred             eeEEecCCCCC--cchhhhhhhhhhcCHHHH
Confidence            99988754332  245669999999999987

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=7.2e-30  Score=232.18  Aligned_cols=170  Identities=32%  Similarity=0.575  Sum_probs=146.9

Q ss_pred             ccccceecccCceeEEEEEECC-ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          159 FSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~g-~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      ..+.+.||+|.||.|++|...+ ..||||.+++....  ....+|..|+.+|.+|+||||++++|+|..++++++++||+
T Consensus       540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             eehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            3456799999999999999886 89999999876443  23588999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          238 RGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       238 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +.|+|.+++.+.  ..+.......++.||+.||+||.+.+  +|||||.++|+|+  ++.+++||+|||+++.+-.++. 
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~y-  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLV--DGEFTIKIADFGMSRNLYSGDY-  692 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceee--cCcccEEecCcccccccccCCc-
Confidence            999999999876  33455667789999999999999977  9999999999999  9999999999999987665432 


Q ss_pred             ceee-eeCCcccccccccccccC
Q 019685          316 DVYK-MTGETGSCEYLVSNCSFM  337 (337)
Q Consensus       316 ~~~~-~~~~~gt~~y~aPE~l~~  337 (337)
                        +. ....+-+++|||||.|+|
T Consensus       693 --y~vqgr~vlpiRwmawEsill  713 (807)
T KOG1094|consen  693 --YRVQGRAVLPIRWMAWESILL  713 (807)
T ss_pred             --eeeecceeeeeeehhHHHHHh
Confidence              32 345567899999999975

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.96  E-value=3.2e-29  Score=223.22  Aligned_cols=171  Identities=26%  Similarity=0.435  Sum_probs=143.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||++..+  ++.+++|.+...... ....+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            5788899999999999999986  678999988654332 2234667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |++++.+..+......+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.+......
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEEeeccCcccccccccc
Confidence            9998777665555567999999999999999999999987  9999999999999  78889999999999876533211


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       157 ---~~~~~~~~~~y~aPE~~~  174 (287)
T cd07848         157 ---NYTEYVATRWYRSPELLL  174 (287)
T ss_pred             ---cccccccccccCCcHHHc
Confidence               223457899999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-30  Score=238.05  Aligned_cols=168  Identities=29%  Similarity=0.456  Sum_probs=142.7

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------ce
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------PL  230 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~~  230 (337)
                      |...+.||+|+||.||+++.+  |+.||||.+++....  ...+...+|+++|++++|+|||+++++-++..      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            344578999999999999975  999999999775532  23577889999999999999999999865543      46


Q ss_pred             EEEEeecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC--cEEEEeccC
Q 019685          231 MLITEYLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD--HLKVGDFGL  305 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~--~~kl~DFgl  305 (337)
                      .+|||||.+|||...+.+.   ..+++.+.+.++.+++.||.|||.+|  |+||||||.||++-...+|  .-||+|||.
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            8999999999999999753   35999999999999999999999966  9999999999998443333  579999999


Q ss_pred             ceeeecccccceeeeeCCcccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |+.++++.     ...+.+||+.|++||.+
T Consensus       171 Arel~d~s-----~~~S~vGT~~YLhPel~  195 (732)
T KOG4250|consen  171 ARELDDNS-----LFTSLVGTEEYLHPELY  195 (732)
T ss_pred             cccCCCCC-----eeeeecCchhhcChHHH
Confidence            99887663     57889999999999975

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=9.8e-29  Score=224.89  Aligned_cols=168  Identities=26%  Similarity=0.438  Sum_probs=145.2

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++...  +..+++|.+....  .......+.+|+.+++.++||||+++++++...+.+++||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            47888899999999999999986  6678888876542  2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+. +  |+||||||+|||+  +..+.+||+|||++..+... 
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEE--cCCCCEEEeeCCcchhhhhh-
Confidence            9999999999998877899999999999999999999974 5  9999999999999  77889999999999765432 


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......|++.|+|||++.
T Consensus       158 -----~~~~~~~~~~y~aPE~~~  175 (333)
T cd06650         158 -----MANSFVGTRSYMSPERLQ  175 (333)
T ss_pred             -----ccccCCCCccccCHHHhc
Confidence                 123457899999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=6.8e-30  Score=242.44  Aligned_cols=177  Identities=36%  Similarity=0.596  Sum_probs=148.0

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeee
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL  221 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~  221 (337)
                      ..+++.....|  .+.||+|.||+||+|...       .+.||||.++...  +.+...+|++|++++..++|||||+++
T Consensus       480 ~~~i~r~~i~~--~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLl  555 (774)
T KOG1026|consen  480 VLEIPRSDIVF--KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLL  555 (774)
T ss_pred             eeEechhheee--hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            33444444444  468999999999999875       2468999886543  334568999999999999999999999


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCC
Q 019685          222 GAVTERKPLMLITEYLRGGDLHKYLKEKG--------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN  287 (337)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~N  287 (337)
                      |++..++++|+|+|||..|||.+||+..+              .++..+.+.|+.||+.||.||-++.  +|||||..+|
T Consensus       556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRN  633 (774)
T KOG1026|consen  556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRN  633 (774)
T ss_pred             EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhh
Confidence            99999999999999999999999997421              2778899999999999999999977  9999999999


Q ss_pred             EEEecCCCCcEEEEeccCceeeecccccceeeee-CCccccccccccccc
Q 019685          288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT-GETGSCEYLVSNCSF  336 (337)
Q Consensus       288 il~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~-~~~gt~~y~aPE~l~  336 (337)
                      +||  ...-.|||+|||++|.+-..   ++++.. ...=+++|||||.|+
T Consensus       634 CLV--ge~l~VKIsDfGLsRdiYss---DYYk~~~~t~lPIRWMppEsIl  678 (774)
T KOG1026|consen  634 CLV--GENLVVKISDFGLSRDIYSS---DYYKVRGNTLLPIRWMPPESIL  678 (774)
T ss_pred             cee--ccceEEEecccccchhhhhh---hhhcccCCceeeeecCCHHHhh
Confidence            999  78889999999999876543   455554 556789999999986

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-29  Score=239.42  Aligned_cols=180  Identities=24%  Similarity=0.384  Sum_probs=146.9

Q ss_pred             cCCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeee-EEe-
Q 019685          152 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGA-VTE-  226 (337)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~-~~~-  226 (337)
                      +.....++++.+.|.+|||+.||.|...  |..+|+|++...   +....+...+|+.+|++|. |+|||.|++. ... 
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            3344456788899999999999999986  379999998654   4566788999999999998 9999999993 221 


Q ss_pred             -----CCceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEE
Q 019685          227 -----RKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK  299 (337)
Q Consensus       227 -----~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~k  299 (337)
                           .-.++|.||||.+|+|-+++..  ...|++.++++|+.|++.|+.+||.+.++|||||||-+||||  ..+|..|
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--s~~g~~K  186 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--SADGNYK  186 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE--cCCCCEE
Confidence                 1357999999999999999985  345999999999999999999999998999999999999999  8888999


Q ss_pred             EEeccCceeeeccc-c-c---ceeeeeCCccccccccccccc
Q 019685          300 VGDFGLSKLIKVQN-S-H---DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       300 l~DFgla~~~~~~~-~-~---~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||||.+......- + .   .+.......-|+.|+|||+|-
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID  228 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID  228 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHh
Confidence            99999886543221 1 0   111234456799999999973

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=1.6e-28  Score=233.72  Aligned_cols=171  Identities=25%  Similarity=0.312  Sum_probs=143.1

Q ss_pred             cCccccceecccCceeEEEEEEC---CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ..|...+.||+|+||.||+|...   +..+++|.+...   .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            35888899999999999999864   456888866432   233345678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |||+++|+|.+++..    ...+++.++..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.+
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll--~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFL--MPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEE--CCCCcEEEEeCcCceec
Confidence            999999999998754    345899999999999999999999987  9999999999999  78889999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......  .......||+.|||||++.
T Consensus       220 ~~~~~~--~~~~~~~gt~~y~aPE~~~  244 (478)
T PTZ00267        220 SDSVSL--DVASSFCGTPYYLAPELWE  244 (478)
T ss_pred             CCcccc--ccccccCCCccccCHhHhC
Confidence            543211  1234567999999999863

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=9.7e-29  Score=243.59  Aligned_cols=175  Identities=26%  Similarity=0.449  Sum_probs=145.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|.+.  ++.||+|++...........+++.+|+.+++.++||||+++++++.+.+..|++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            6888899999999999999875  78999999976555445556788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          236 YLRGGDLHKYLKEK-----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      |+++++|.+++...           ..++...+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILL--d~dg~vKLiDFG  158 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILL--GLFGEVVILDWG  158 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEE--cCCCCEEEEecC
Confidence            99999999998641           22456678899999999999999987  9999999999999  788899999999


Q ss_pred             Cceeeeccccc--------------ceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSH--------------DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +++........              .........||+.|||||++.
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~  204 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL  204 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc
Confidence            99876321110              001112356999999999863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=1.1e-28  Score=228.14  Aligned_cols=183  Identities=32%  Similarity=0.530  Sum_probs=144.7

Q ss_pred             CCCCCCcccCCCCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCC
Q 019685          144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHP  215 (337)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~  215 (337)
                      +|....|.++..  +|+..+.||+|+||.||+|.+.       +..||+|.+.....  ....+.+.+|+.++..+ +||
T Consensus        24 ~~~~~~~~~~~~--~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~Hp   99 (375)
T cd05104          24 LPYDHKWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHI   99 (375)
T ss_pred             CCCccccccchH--HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCc
Confidence            333444444433  5777899999999999999742       45799998864432  22346788899999999 799


Q ss_pred             CeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcC---------------------------------------------
Q 019685          216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG---------------------------------------------  250 (337)
Q Consensus       216 ~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------  250 (337)
                      ||+++++++......++||||+++|+|.+++....                                             
T Consensus       100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  179 (375)
T cd05104         100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV  179 (375)
T ss_pred             ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence            99999999999999999999999999999986421                                             


Q ss_pred             ------------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEE
Q 019685          251 ------------------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV  300 (337)
Q Consensus       251 ------------------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl  300 (337)
                                                    .+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill--~~~~~~kl  255 (375)
T cd05104         180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKI  255 (375)
T ss_pred             ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEE--ECCCcEEE
Confidence                                          3677888999999999999999987  9999999999999  67788999


Q ss_pred             EeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +|||+++........  .......+++.|+|||++.
T Consensus       256 ~DfG~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  289 (375)
T cd05104         256 CDFGLARDIRNDSNY--VVKGNARLPVKWMAPESIF  289 (375)
T ss_pred             ecCccceeccCcccc--cccCCCCCCcceeChhHhc
Confidence            999999876543211  1122344677899999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=8.9e-29  Score=228.51  Aligned_cols=183  Identities=31%  Similarity=0.495  Sum_probs=145.0

Q ss_pred             CCCCCCcccCCCCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCC
Q 019685          144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHP  215 (337)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~  215 (337)
                      +|....|.++..  +|+..+.||+|+||.||++.+.       +..||+|.+......  ...+.+.+|+.+++.+ +|+
T Consensus        27 ~~~~~~~~~~~~--~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~  102 (374)
T cd05106          27 LPYNEKWEFPRD--NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHK  102 (374)
T ss_pred             ccccccccccHH--HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCC
Confidence            343444554333  6777889999999999998853       246999988654332  2346788999999999 799


Q ss_pred             CeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhc----------------------------------------------
Q 019685          216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------------------------------------  249 (337)
Q Consensus       216 ~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------  249 (337)
                      ||+++++++.....+++||||+++|+|.+++...                                              
T Consensus       103 nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (374)
T cd05106         103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV  182 (374)
T ss_pred             ceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence            9999999999999999999999999999998642                                              


Q ss_pred             ------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          250 ------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       250 ------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                                              ..+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~--~~~~~~kL~DfGl  258 (374)
T cd05106         183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLL--TDGRVAKICDFGL  258 (374)
T ss_pred             ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEE--eCCCeEEEeecee
Confidence                                    13677889999999999999999987  9999999999999  7778999999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.+.....  ........+++.|||||++.
T Consensus       259 a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  287 (374)
T cd05106         259 ARDIMNDSN--YVVKGNARLPVKWMAPESIF  287 (374)
T ss_pred             eeeccCCcc--eeeccCCCCccceeCHHHhc
Confidence            987643321  11223344677899999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=7e-29  Score=227.69  Aligned_cols=164  Identities=27%  Similarity=0.500  Sum_probs=139.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++.+.  ++.|++|.+....  .......+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            5777889999999999999875  7899999986543  23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+.    ...++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+..... 
T Consensus       153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLI--NSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCEEEcccccceecccccc-
Confidence            9999998653    23567788899999999999999987  9999999999999  7888999999999987653321 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ......||+.|+|||++
T Consensus       224 ---~~~~~~gt~~y~aPE~~  240 (353)
T PLN00034        224 ---PCNSSVGTIAYMSPERI  240 (353)
T ss_pred             ---cccccccCccccCcccc
Confidence               22446799999999986

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=215.91  Aligned_cols=169  Identities=26%  Similarity=0.439  Sum_probs=144.0

Q ss_pred             cceecccCceeEEEEE--ECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEeecC
Q 019685          162 SAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .+.||+|+|+.|-.|.  .+|.++|||++.+.....   ..+..+|++++.+++ |+||++++++|++...+|+|||-|.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs---R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS---RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchH---HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            4689999999998776  469999999998774443   367889999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecccccc-
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHD-  316 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~~~~-  316 (337)
                      ||+|...|.++..+++.++.++..+|+.||.|||.+|  |.||||||+|||... +...-||||||.++.-+....+.. 
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            9999999999999999999999999999999999998  999999999999832 333458999999887665432221 


Q ss_pred             ee--eeeCCcccccccccccc
Q 019685          317 VY--KMTGETGSCEYLVSNCS  335 (337)
Q Consensus       317 ~~--~~~~~~gt~~y~aPE~l  335 (337)
                      ..  ...+.+|+..|||||+.
T Consensus       238 astP~L~tPvGSAEfMAPEVV  258 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVV  258 (463)
T ss_pred             CCCccccCcccchhhcchhHH
Confidence            11  35678899999999985

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=2.1e-28  Score=217.97  Aligned_cols=169  Identities=28%  Similarity=0.446  Sum_probs=143.5

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |+..+.||+|+||.||++.+.  ++.+|+|.+.+...........+..|+.+++.++|++|+.+++.+...+..|++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566789999999999999885  778999988765444333345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++...  ..+++.++..++.|++.||.|||+.+  |+||||||+||++  +..+.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEE--CCCCCEEEeeccceeecCCCc-
Confidence            9999999998653  35899999999999999999999987  9999999999999  778899999999997654332 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......|++.|+|||++.
T Consensus       157 ----~~~~~~g~~~y~aPE~~~  174 (285)
T cd05630         157 ----TIKGRVGTVGYMAPEVVK  174 (285)
T ss_pred             ----cccCCCCCccccChHHHc
Confidence                123457999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=221.90  Aligned_cols=169  Identities=31%  Similarity=0.498  Sum_probs=140.2

Q ss_pred             ccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEeCC----ceEE
Q 019685          159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PLML  232 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~~----~~~l  232 (337)
                      ....+.||+|.||+||+|.|+|..||||++.....      ..+.+|.++.+.  ++|+||+.++++-...+    .+||
T Consensus       213 I~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             eEEEEEecCccccceeeccccCCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            45567999999999999999999999999954321      445566666654  68999999998865443    5899


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-----C-CCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-----P-NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-----~-~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      |++|-+.|||+|+|.. ..++....++++..++.||++||..     | +.|.|||||+.|||+  .+++...|+|+|||
T Consensus       287 vTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--Kkn~~C~IADLGLA  363 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLA  363 (513)
T ss_pred             eeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE--ccCCcEEEeeceee
Confidence            9999999999999976 5799999999999999999999952     2 459999999999999  78889999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      -................+||.+|||||+|-
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLd  393 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLD  393 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhh
Confidence            877655433333456788999999999973

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=222.37  Aligned_cols=171  Identities=32%  Similarity=0.453  Sum_probs=149.0

Q ss_pred             CccccceecccCceeEEEEEECCc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|....+||+|+||.|.++..+|.  .+|||++++...-.....+--..|-++|.... -|++++++.+|++.+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            677788999999999999988754  58999998765443333455567888887765 789999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+.||+|.-.|++-+.+.++.+..++.+|+.||-|||++|  ||.||||.+||++  +.+|++||.|||+++.--.++ 
T Consensus       430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmL--d~eGHiKi~DFGmcKEni~~~-  504 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIFDG-  504 (683)
T ss_pred             EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEe--ccCCceEeeecccccccccCC-
Confidence            99999999999999999999999999999999999999998  9999999999999  999999999999998644332 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ....+.+|||.|+|||+|.
T Consensus       505 ---~TTkTFCGTPdYiAPEIi~  523 (683)
T KOG0696|consen  505 ---VTTKTFCGTPDYIAPEIIA  523 (683)
T ss_pred             ---cceeeecCCCcccccceEE
Confidence               2467789999999999984

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=2.5e-28  Score=217.39  Aligned_cols=169  Identities=28%  Similarity=0.428  Sum_probs=143.3

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |+..+.||+|+||.||++.+.  ++.+|+|.+.............+.+|+.+++.++|++|+.+++.+...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556678999999999999885  778999998665443333345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili--~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILL--DDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE--CCCCCEEEecCCcceecCCCC-
Confidence            9999999888653  35999999999999999999999988  9999999999999  777899999999997654321 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......|++.|+|||++.
T Consensus       157 ----~~~~~~g~~~~~aPE~~~  174 (285)
T cd05632         157 ----SIRGRVGTVGYMAPEVLN  174 (285)
T ss_pred             ----cccCCCCCcCccChHHhc
Confidence                123457999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=2.6e-28  Score=216.47  Aligned_cols=163  Identities=27%  Similarity=0.417  Sum_probs=136.9

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      ||+|+||.||++..+  |+.+++|.+................|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            689999999999875  789999998653332222234456699999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          243 HKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       243 ~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      .+++....  .+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||++.......     ..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili--~~~~~~~l~Dfg~~~~~~~~~-----~~  151 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGK-----TI  151 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEE--cCCCCEEEeeceeeeecCCCc-----ee
Confidence            98886533  4888999999999999999999987  9999999999999  778899999999998765432     23


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....|++.|+|||++.
T Consensus       152 ~~~~~~~~y~aPE~~~  167 (277)
T cd05607         152 TQRAGTNGYMAPEILK  167 (277)
T ss_pred             eccCCCCCccCHHHHc
Confidence            4467999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=3.2e-28  Score=226.14  Aligned_cols=183  Identities=31%  Similarity=0.532  Sum_probs=146.7

Q ss_pred             CCCCCCcccCCCCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CC
Q 019685          144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HP  215 (337)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~  215 (337)
                      +|..+.|+++..  +|.+.+.||+|+||.||+|.+.       +..||+|++.....  ....+.+.+|+.+++.+. ||
T Consensus        26 ~~~~~~~~~~~~--~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~Hp  101 (400)
T cd05105          26 LPYDSRWEFPRD--GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHL  101 (400)
T ss_pred             CCCCCceecccc--ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCC
Confidence            444556666544  6677889999999999999864       23599998865432  233467889999999996 99


Q ss_pred             CeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhc----------------------------------------------
Q 019685          216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------------------------------------  249 (337)
Q Consensus       216 ~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------  249 (337)
                      ||+++++++......|+||||+++|+|.+++...                                              
T Consensus       102 nIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (400)
T cd05105         102 NIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMK  181 (400)
T ss_pred             CeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccc
Confidence            9999999999999999999999999999988642                                              


Q ss_pred             --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcE
Q 019685          250 --------------------------------------------------GALSPSTAVNFALDIARGMAYLHNEPNVII  279 (337)
Q Consensus       250 --------------------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv  279 (337)
                                                                        ..+++.++..++.||+.||.|||+.+  |+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iv  259 (400)
T cd05105         182 QADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CV  259 (400)
T ss_pred             cccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence                                                              13677788899999999999999987  99


Q ss_pred             eeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       280 Hrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||||||+|||+  +..+.+||+|||+++........  .......+++.|||||.+.
T Consensus       260 H~dikp~Nill--~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  312 (400)
T cd05105         260 HRDLAARNVLL--AQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIF  312 (400)
T ss_pred             CCCCChHhEEE--eCCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhc
Confidence            99999999999  77788999999999876433211  1223455788999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=1.5e-28  Score=227.09  Aligned_cols=170  Identities=29%  Similarity=0.478  Sum_probs=143.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-----ce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~  230 (337)
                      +|+..+.||+|+||.||++...  ++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++....     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            4677889999999999999864  88999998865432 2234467888999999999999999999998776     78


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++...
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili--~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLV--NSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEE--CCCCCEEeccccceeecc
Confidence            99999996 589888877778999999999999999999999988  9999999999999  888899999999998764


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....   ......+|+.|+|||++.
T Consensus       155 ~~~~~---~~~~~~~~~~y~aPE~~~  177 (372)
T cd07853         155 PDESK---HMTQEVVTQYYRAPEILM  177 (372)
T ss_pred             cCccc---cCCCCCcCCCcCCHHHHc
Confidence            33221   234456899999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4.3e-28  Score=231.21  Aligned_cols=176  Identities=24%  Similarity=0.337  Sum_probs=145.0

Q ss_pred             CCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC---
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK---  228 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~---  228 (337)
                      ....+|.+.+.||+|+||.||++...  ++.||+|.+...... ......+.+|+.++..++|+||+++++.+....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34458999999999999999999864  889999998765443 334567788999999999999999988765332   


Q ss_pred             -----ceEEEEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEE
Q 019685          229 -----PLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK  299 (337)
Q Consensus       229 -----~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~k  299 (337)
                           .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++.+|
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl--~~~~~vk  183 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILL--CSNGLVK  183 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--eCCCCEE
Confidence                 368999999999999998752    45899999999999999999999987  9999999999999  7788999


Q ss_pred             EEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          300 VGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       300 l~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+|||+++.+.......  ......||+.|+|||++.
T Consensus       184 L~DFGls~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~  218 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDD--VGRTFCGTPYYVAPEIWR  218 (496)
T ss_pred             EEecccCeecccccccc--ccccccCCcceeCHHHhC
Confidence            99999998765432111  234567999999999874

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=5.1e-28  Score=213.13  Aligned_cols=167  Identities=28%  Similarity=0.466  Sum_probs=144.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||++...  ++.+++|.+......   ....+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            6888999999999999999874  778999988644322   23467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+  |+||||+|+||++  +..+.+||+|||+++.+..... 
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILL--TDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCCEEECcCccceeeccccc-
Confidence            9999999999987778999999999999999999999987  9999999999999  7788899999999987643321 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ......|++.|+|||.+
T Consensus       162 ---~~~~~~~~~~y~~PE~~  178 (267)
T cd06646         162 ---KRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             ---ccCccccCccccCHhHc
Confidence               22345689999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=4e-28  Score=213.90  Aligned_cols=169  Identities=25%  Similarity=0.435  Sum_probs=141.3

Q ss_pred             CccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|++.+.||+|+||.||+|.++     +..+++|.+.....  ......+.+|+.++.+++||||+++++++...+..++
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            6778889999999999999753     45789998865432  2334678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      ||||+++++|.+++... ..+++..++.++.||+.||+|||+++  ++||||||+||++  +.++.+|++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili--~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLV--NSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEE--cCCCcEEECCCcccccccc
Confidence            99999999999999764 56899999999999999999999987  9999999999999  7788999999998765432


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..   ........+++.|+|||.+
T Consensus       160 ~~---~~~~~~~~~~~~y~aPE~~  180 (266)
T cd05064         160 EA---IYTTMSGKSPVLWAAPEAI  180 (266)
T ss_pred             cc---hhcccCCCCceeecCHHHH
Confidence            21   1122234567899999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=6.1e-28  Score=212.56  Aligned_cols=171  Identities=27%  Similarity=0.501  Sum_probs=145.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|...  ++.+++|.+.............+.+|+.+++.++||||+++++++...+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            5778889999999999999874  78999998865443344455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       236 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.+  ++|+||||+||++  +.++.++|+|||++.....
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~--~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEE--cCCCCEEECccccceeccc
Confidence            9999999998853    334889999999999999999999987  9999999999999  7788899999999987654


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...    ......|++.|+|||.+.
T Consensus       159 ~~~----~~~~~~~~~~~~aPE~~~  179 (267)
T cd08228         159 KTT----AAHSLVGTPYYMSPERIH  179 (267)
T ss_pred             hhH----HHhcCCCCccccChhhhc
Confidence            321    223457899999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.96  E-value=5.3e-28  Score=215.82  Aligned_cols=168  Identities=30%  Similarity=0.519  Sum_probs=147.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++.+.  ++.+++|.+...........+.+.+|+.+++++.||||+++++.+......|++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            5778889999999999999875  78899998865443334455778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +.++.+||+|||+++.....   
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--CCCCCEEEeeCCCccccCCC---
Confidence            9999999999988888999999999999999999999987  9999999999999  77889999999999876533   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....|++.|+|||.+.
T Consensus       155 ----~~~~~~~~~y~aPE~~~  171 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIIL  171 (290)
T ss_pred             ----CCCCCCCccccChhhhc
Confidence                23456899999999763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=4.6e-28  Score=213.42  Aligned_cols=167  Identities=29%  Similarity=0.476  Sum_probs=145.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++...  ++.+++|.+.....   .....+.+|+.+++.++||||+++++.+...+..|++||
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            6788899999999999999874  77899998865432   223567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++.++..++.|++.||.|||+.+  |+|+||||+||++  +..+.+||+|||++........ 
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili--~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILL--TDNGHVKLADFGVSAQITATIA-  161 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECcceeeeEccCccc-
Confidence            9999999999988888999999999999999999999987  9999999999999  7888999999999876643211 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ......|++.|+|||++
T Consensus       162 ---~~~~~~~~~~y~aPE~~  178 (267)
T cd06645         162 ---KRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             ---ccccccCcccccChhhh
Confidence               23456799999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=3.4e-28  Score=213.07  Aligned_cols=169  Identities=34%  Similarity=0.556  Sum_probs=144.8

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |+..+.||+|+||.||++...  ++.+|+|.+........ ......+|+.+++.++||||+++++++......+++||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence            566789999999999999987  55799999977644332 223345599999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++++|.+++.....+++.++..++.||+.||.+||+.+  |+|+||||+||++  +..+.++|+|||.+.......   
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~--~~~~~~~l~Dfg~~~~~~~~~---  152 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILL--DENGEVKLIDFGSSVKLSENN---  152 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEE--STTSEEEESSGTTTEESTSTT---
T ss_pred             ccccccccccccccccccccccccccccccccccccccc--ccccccccccccc--ccccccccccccccccccccc---
Confidence            999999999987788999999999999999999999987  9999999999999  788899999999997652211   


Q ss_pred             eeeeeCCccccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l~  336 (337)
                       .......+++.|+|||++.
T Consensus       153 -~~~~~~~~~~~y~aPE~~~  171 (260)
T PF00069_consen  153 -ENFNPFVGTPEYMAPEVLQ  171 (260)
T ss_dssp             -SEBSSSSSSGGGSCHHHHT
T ss_pred             -ccccccccccccccccccc
Confidence             1355677999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=4.7e-29  Score=243.19  Aligned_cols=173  Identities=33%  Similarity=0.539  Sum_probs=140.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe---------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE---------  226 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~---------  226 (337)
                      +|+..+.||+||||.||+++.+  |+.||||++....  .........+|+.++++++|||||+|+.+|.+         
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            6888899999999999999975  9999999997765  33445677889999999999999999976532         


Q ss_pred             --------------------------------------------------------------------------------
Q 019685          227 --------------------------------------------------------------------------------  226 (337)
Q Consensus       227 --------------------------------------------------------------------------------  226 (337)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------CceEEEEeecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHcCC
Q 019685          227 ----------------------R--------KPLMLITEYLRGGDLHKYLKEKGAL-SPSTAVNFALDIARGMAYLHNEP  275 (337)
Q Consensus       227 ----------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~l~~lH~~~  275 (337)
                                            .        ..+||-||||+...+.++++.+-.. ....+++++++|++||.|+|++|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  0        2379999999997777777654333 47789999999999999999998


Q ss_pred             CCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee------cc--------cccceeeeeCCccccccccccccc
Q 019685          276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK------VQ--------NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       276 ~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~------~~--------~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        ||||||||.|||+  +..+.|||+|||+|+...      ..        .+......++.+||.-|+|||++-
T Consensus       718 --iIHRDLKP~NIFL--d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  718 --IIHRDLKPRNIFL--DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             --eeeccCCcceeEE--cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence              9999999999999  888899999999998822      00        011111356788999999999873

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=1.1e-27  Score=235.99  Aligned_cols=170  Identities=28%  Similarity=0.439  Sum_probs=149.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.+.+.||+|+||.||+|.+.  ++.||+|++.............+..|+.++..++||||+++++.+.....+|+|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            6888899999999999999987  88999999876544444455778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+.+++|.+++...+.+++..++.++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++....... 
T Consensus        85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl--~~~g~vkL~DFGls~~~~~~~~-  159 (669)
T cd05610          85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLI--SNEGHIKLTDFGLSKVTLNREL-  159 (669)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEE--cCCCCEEEEeCCCCccccCCcc-
Confidence            9999999999988778999999999999999999999987  9999999999999  7788999999999987654322 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ......+|+.|+|||..
T Consensus       160 ---~~~~~~~t~~~~~pe~~  176 (669)
T cd05610         160 ---NMMDILTTPSMAKPKND  176 (669)
T ss_pred             ---cccccccCccccCcccc
Confidence               23456789999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.95  E-value=4.8e-28  Score=228.02  Aligned_cols=163  Identities=29%  Similarity=0.438  Sum_probs=133.1

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-------
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-------  227 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-------  227 (337)
                      .+|...+.||+|+||.||+|...  ++.||+|.+....       ....+|+.+++.++||||+++++++...       
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            36889999999999999999874  7889999885432       2234699999999999999998876432       


Q ss_pred             -CceEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC-CcEEEE
Q 019685          228 -KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVG  301 (337)
Q Consensus       228 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~-~~~kl~  301 (337)
                       ..+++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.. +.+||+
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl--~~~~~~vkL~  213 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLI--DPNTHTLKLC  213 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEE--cCCCCceeee
Confidence             246799999975 78777652    456899999999999999999999988  9999999999999  544 479999


Q ss_pred             eccCceeeecccccceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+|+.+....     ......||+.|||||++.
T Consensus       214 DFGla~~~~~~~-----~~~~~~~t~~y~aPE~~~  243 (440)
T PTZ00036        214 DFGSAKNLLAGQ-----RSVSYICSRFYRAPELML  243 (440)
T ss_pred             ccccchhccCCC-----CcccCCCCcCccCHHHhc
Confidence            999998765432     223467899999999864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-30  Score=229.78  Aligned_cols=170  Identities=28%  Similarity=0.397  Sum_probs=155.6

Q ss_pred             CccccceecccCceeEEEEEECCce--EEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~--vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +++....||-|+||.|=++..+++.  +|+|++++...-+..+.+....|-++|..++.|+||++|..|.+..++|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            5667788999999999998887665  78999987766666677888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      -|-||.|+..++.++.+++..+..|+..+++|++|||++|  ||.|||||+|+++  +..|-+||.|||+|+.+....  
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllL--d~~Gy~KLVDFGFAKki~~g~--  574 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLL--DNRGYLKLVDFGFAKKIGSGR--  574 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheee--ccCCceEEeehhhHHHhccCC--
Confidence            9999999999999999999999999999999999999988  9999999999999  899999999999999988663  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         +.-+.+|||.|.|||+|+
T Consensus       575 ---KTwTFcGTpEYVAPEIIL  592 (732)
T KOG0614|consen  575 ---KTWTFCGTPEYVAPEIIL  592 (732)
T ss_pred             ---ceeeecCCcccccchhhh
Confidence               456789999999999986

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.95  E-value=2.3e-29  Score=213.45  Aligned_cols=174  Identities=25%  Similarity=0.437  Sum_probs=141.8

Q ss_pred             CccccceecccCceeEEEEEEC------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-CCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~  230 (337)
                      .|+....||+|.||.||+|.-+      ..++|+|.+......+. ......+|+.+++.++||||+.+..++.. +..+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            5677789999999999999643      23789998865432211 12445679999999999999999998876 7889


Q ss_pred             EEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC--CCCcEEEEec
Q 019685          231 MLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS--SADHLKVGDF  303 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~--~~~~~kl~DF  303 (337)
                      |+++||.+. +|.++|+-.     ..++...+..|+.||+.|+.|||+..  |+||||||.|||+.-+  ..|.|||+||
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence            999999988 999999742     35899999999999999999999987  9999999999999322  2389999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.+...- ...+.....+-|+.|+|||.|+
T Consensus       181 GlaR~~~~pl-kpl~s~d~VVVTiWYRAPELLL  212 (438)
T KOG0666|consen  181 GLARLFNNPL-KPLASLDPVVVTIWYRAPELLL  212 (438)
T ss_pred             cHHHHhhccc-cccccCCceEEEEEecChHHhc
Confidence            9999987652 2333567788999999999986

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-29  Score=247.83  Aligned_cols=180  Identities=28%  Similarity=0.469  Sum_probs=153.9

Q ss_pred             cCCCCcCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          152 IDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      +.....+|+....||.|.||.||.|..  +|...|+|.+...... ........+|..++..++|||+|++||+-...+.
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence            344455788889999999999999986  4788899988655443 3445677889999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ++|.||||++|+|.+++...+..++.....+..|++.|++|||+.|  ||||||||.|||+  +..|.+|++|||.|..+
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~L--d~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILL--DFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceee--ecCCcEEeecccceeEe
Confidence            9999999999999999987766777788889999999999999988  9999999999999  88889999999999998


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...............||+.|||||+|.
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhc
Confidence            766322222456788999999999985

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.95  E-value=9e-28  Score=216.29  Aligned_cols=168  Identities=31%  Similarity=0.505  Sum_probs=140.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++...  ++.+|+|.+.......  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            6888899999999999999875  6789999886543222  22456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++ +|.+++...+ .+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||+++.......
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEECccccceecCCCcc
Confidence            9976 8888886543 4889999999999999999999987  9999999999999  7888999999999976543321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+|+.|+|||++.
T Consensus       160 ----~~~~~~~~~~y~aPE~~~  177 (309)
T cd07872         160 ----TYSNEVVTLWYRPPDVLL  177 (309)
T ss_pred             ----ccccccccccccCCHHHh
Confidence                233456899999999863

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.95  E-value=1.1e-27  Score=213.55  Aligned_cols=168  Identities=30%  Similarity=0.532  Sum_probs=134.7

Q ss_pred             CccccceecccCceeEEEEEEC---CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEE-----e
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVT-----E  226 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~-----~  226 (337)
                      +|+..+.||+|+||.||+|...   ++.+|+|.+........ ....+.+|+.+++.+   +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            5778889999999999999873   56799998865433221 123445677666655   6999999999875     2


Q ss_pred             CCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          227 RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      ...+++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~--~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--cCCCCEEEcccc
Confidence            456899999997 5999998753  35899999999999999999999988  9999999999999  788899999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +++......     ......||+.|+|||++.
T Consensus       156 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  182 (290)
T cd07862         156 LARIYSFQM-----ALTSVVVTLWYRAPEVLL  182 (290)
T ss_pred             ceEeccCCc-----ccccccccccccChHHHh
Confidence            998765331     234567999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=1.2e-27  Score=220.04  Aligned_cols=166  Identities=27%  Similarity=0.387  Sum_probs=137.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------c
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------P  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~  229 (337)
                      +|+..+.||+|+||.||++...  +..+|+|.+...... ......+.+|+.+++.++||||+++++++....      .
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            7888999999999999999875  789999998654332 234467788999999999999999999886443      4


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+||||+++ +|.+.+..  .+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++..
T Consensus       101 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~--~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         101 VYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLARTA  173 (359)
T ss_pred             eEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEecCCCcccc
Confidence            7999999976 67766643  4888999999999999999999987  9999999999999  78889999999999765


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....     ......||+.|+|||++.
T Consensus       174 ~~~~-----~~~~~~~t~~y~aPE~~~  195 (359)
T cd07876         174 CTNF-----MMTPYVVTRYYRAPEVIL  195 (359)
T ss_pred             ccCc-----cCCCCcccCCCCCchhcc
Confidence            4321     234467899999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=2.3e-27  Score=213.59  Aligned_cols=166  Identities=28%  Similarity=0.461  Sum_probs=143.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  +..+++|.+....  .......+.+|+.++++++||||+++++++...+.++++||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            5788899999999999999875  6678888775432  23344668889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ .+  ++|+||||+|||+  +.++.+||+|||++......  
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEE--ecCCcEEEccCCCccccccc--
Confidence            99999999999887889999999999999999999997 46  9999999999999  77788999999998765432  


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......|++.|+|||.+
T Consensus       154 ----~~~~~~~~~~~~aPE~~  170 (308)
T cd06615         154 ----MANSFVGTRSYMSPERL  170 (308)
T ss_pred             ----ccccCCCCcCccChhHh
Confidence                12345789999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=1.7e-27  Score=215.13  Aligned_cols=171  Identities=29%  Similarity=0.596  Sum_probs=140.5

Q ss_pred             cCccccceecccCceeEEEEEEC--Cc----eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      .+|+..+.||+|+||.||+|.+.  +.    .|++|.+....  .....+++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            47888899999999999999863  33    38889886432  233456788999999999999999999988764 57


Q ss_pred             EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ++++||+.+|+|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill--~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEe--cCCCcEEEccccccccc
Confidence            8999999999999999864 45889999999999999999999987  9999999999999  77889999999999877


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......  .......+++.|+|||.+.
T Consensus       160 ~~~~~~--~~~~~~~~~~~y~apE~~~  184 (316)
T cd05108         160 GADEKE--YHAEGGKVPIKWMALESIL  184 (316)
T ss_pred             cCCCcc--eeccCCccceeecChHHhc
Confidence            643221  1223344578899999863

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=2.3e-27  Score=220.40  Aligned_cols=183  Identities=32%  Similarity=0.541  Sum_probs=146.0

Q ss_pred             CCCCCCcccCCCCcCccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CC
Q 019685          144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HP  215 (337)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~  215 (337)
                      .+....|+++..  +|...+.||+|+||.||+|.+.+       ..||+|++......  ...+.+..|+.++..+. ||
T Consensus        26 ~~~~~~~~~~~~--~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~  101 (401)
T cd05107          26 LPYDSAWEMPRD--NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHL  101 (401)
T ss_pred             CCCCCcceecHH--HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCC
Confidence            444556777665  45667899999999999998643       47999999654322  23456889999999998 99


Q ss_pred             CeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcC---------------------------------------------
Q 019685          216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG---------------------------------------------  250 (337)
Q Consensus       216 ~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------  250 (337)
                      ||+++++++...+..++||||+++|+|.+++...+                                             
T Consensus       102 niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (401)
T cd05107         102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM  181 (401)
T ss_pred             CeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence            99999999999999999999999999999996431                                             


Q ss_pred             -----------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 019685          251 -----------------------------------------------------ALSPSTAVNFALDIARGMAYLHNEPNV  277 (337)
Q Consensus       251 -----------------------------------------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~  277 (337)
                                                                           .+++..+..++.||+.||.|||+.+  
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--  259 (401)
T cd05107         182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--  259 (401)
T ss_pred             CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--
Confidence                                                                 2566778889999999999999977  


Q ss_pred             cEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       278 ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+||||||+|||+  +..+.+||+|||+++.+......  .......+++.|||||.+.
T Consensus       260 ivHrdlkp~NiLl--~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  314 (401)
T cd05107         260 CVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIF  314 (401)
T ss_pred             cCcccCCcceEEE--eCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhc
Confidence            9999999999999  67789999999999875432210  1123345788999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.5e-28  Score=224.01  Aligned_cols=148  Identities=24%  Similarity=0.416  Sum_probs=133.8

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      -|...+.||-|+||+|.+++-  +...+|+|.+.+...-.+.+......|-.+|....++.||+||..|++...+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            466778999999999999864  466799999877655455566778889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |++||++..+|-.-+-|.+..++.|+.++..|+++.|..|  +|||||||+||||  |.+|++||.||||+.-+
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILI--DrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILI--DRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEE--ccCCceeeeeccccccc
Confidence            9999999999998889999999999999999999999988  9999999999999  99999999999998654

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=193.41  Aligned_cols=169  Identities=32%  Similarity=0.547  Sum_probs=145.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|...+.||+|.||+||+++.+  +..||+|.++....+. .......+|+.+++.++|.|||++++.......+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            4566789999999999999875  6789999987654332 233556789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||.. +|..++.. ++.++.+.++.++.|++.||.|+|+++  ++||||||.|+||  +..|.+|++|||+++.+.-+- 
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnlli--n~ngelkladfglarafgipv-  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLI--NRNGELKLADFGLARAFGIPV-  155 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEe--ccCCcEEecccchhhhcCCce-
Confidence            9976 89888875 678999999999999999999999977  9999999999999  899999999999999876542 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......+-|..|.+|.+++
T Consensus       156 ---rcysaevvtlwyrppdvlf  174 (292)
T KOG0662|consen  156 ---RCYSAEVVTLWYRPPDVLF  174 (292)
T ss_pred             ---EeeeceeeeeeccCcceee
Confidence               2456678899999999874

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.4e-27  Score=236.35  Aligned_cols=173  Identities=27%  Similarity=0.457  Sum_probs=141.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv  233 (337)
                      +|.+...||+|+||.||++...  +..+++|.+...... ......+..|+.++..++||||++++++|...  ..+|||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            7889999999999999999886  667889988654433 23456788999999999999999999988543  568999


Q ss_pred             EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCcEeeCCCCCCEEEecC-----------
Q 019685          234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEP-----NVIIHRDLKPRNVLLVNS-----------  293 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~ivHrdlkp~Nil~~~~-----------  293 (337)
                      |||+++++|.++|..    .+.+++..++.|+.||+.||.|||+.+     .+||||||||+||||..+           
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            999999999999975    256999999999999999999999843     239999999999999431           


Q ss_pred             ----CCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          294 ----SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       294 ----~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ..+.+||+|||+++.+....     ......||+.|+|||++.
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~  214 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLL  214 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHh
Confidence                23458999999998764332     123457999999999874

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=9.5e-28  Score=223.15  Aligned_cols=165  Identities=22%  Similarity=0.381  Sum_probs=140.0

Q ss_pred             cCccccceecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      .+|.+.+.||+|+||.||++...    +..|++|.+...        ....+|+.+++.++||||+++++++......|+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            36899999999999999999764    456888877542        234579999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      +||++. ++|.+++.....+++.+++.++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.+...
T Consensus       164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill--~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFL--DEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--cCCCCEEEccCccccccCcc
Confidence            999986 589999977778999999999999999999999988  9999999999999  88889999999999776543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...  .......||+.|+|||++.
T Consensus       239 ~~~--~~~~~~~gt~~y~aPE~~~  260 (392)
T PHA03207        239 PDT--PQCYGWSGTLETNSPELLA  260 (392)
T ss_pred             ccc--ccccccccccCccCHhHhc
Confidence            211  1223567999999999874

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.5e-27  Score=206.44  Aligned_cols=174  Identities=30%  Similarity=0.542  Sum_probs=146.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCc--hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      +|...+.||+|++|.||++...  ++.+++|.+......  .......+.+|+.++++++||||+++++++......+++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            5778899999999999999864  789999988654322  222346788899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      +||+++++|.+++...+.+++..+..++.|++.||.|||+.+  |+||||+|+||++  +.++.++|+|||+++......
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv--~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccceeccccc
Confidence            999999999999988778999999999999999999999987  9999999999999  777899999999998764321


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .. ........|+..|+|||++.
T Consensus       159 ~~-~~~~~~~~~~~~y~aPE~~~  180 (263)
T cd06625         159 SS-GTGMKSVTGTPYWMSPEVIS  180 (263)
T ss_pred             cc-cccccCCCcCccccCcceec
Confidence            11 00113456889999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.95  E-value=2.5e-27  Score=207.50  Aligned_cols=168  Identities=33%  Similarity=0.583  Sum_probs=140.4

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||++.++ +..+++|.+......    ...+..|+.+++.++||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            4667789999999999999886 457899987543222    25678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++++|.+++.. .+.+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLV--SSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEE--cCCCeEEECCCCCccccCCCce-
Confidence            999999999975 346899999999999999999999987  9999999999999  7788999999999986543211 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......++..|+|||++.
T Consensus       156 --~~~~~~~~~~~y~aPE~~~  174 (256)
T cd05114         156 --TSSSGAKFPVKWSPPEVFN  174 (256)
T ss_pred             --eccCCCCCchhhCChhhcc
Confidence              1223345677899999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=2.2e-27  Score=214.44  Aligned_cols=166  Identities=23%  Similarity=0.420  Sum_probs=132.4

Q ss_pred             cceecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--CCceEEEEe
Q 019685          162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITE  235 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e  235 (337)
                      ...||+|+||.||+|...    ++.+|+|.+......     ....+|+.+++.++||||+++++++..  ...+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            358999999999999864    467999988654321     345679999999999999999998854  456899999


Q ss_pred             ecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec--CCCCcEEEEecc
Q 019685          236 YLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFG  304 (337)
Q Consensus       236 ~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~--~~~~~~kl~DFg  304 (337)
                      |+.+ +|.+++...         ..+++..+..++.||+.||.|||+.+  |+||||||+|||+..  +..+.+||+|||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            9865 898887532         24889999999999999999999988  999999999999943  345689999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +++.+..... .........||+.|||||++.
T Consensus       158 ~a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~  188 (317)
T cd07868         158 FARLFNSPLK-PLADLDPVVVTFWYRAPELLL  188 (317)
T ss_pred             ceeccCCCCc-cccccCCccccccccCCHHHc
Confidence            9987654321 111234567899999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.8e-27  Score=206.96  Aligned_cols=168  Identities=33%  Similarity=0.586  Sum_probs=141.1

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|++|.||++.+. ++.+++|.+.....    ..+.+.+|+.+++.++||||+++++++...+..|++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            5777889999999999999875 56799998865432    235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|||+++.......
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLV--GENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEE--cCCCCEEECCcceEEEccCCcc
Confidence            99999999997643  6899999999999999999999987  9999999999999  7788999999999987753211


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ....+...+..|+|||++.
T Consensus       159 ---~~~~~~~~~~~y~aPE~~~  177 (261)
T cd05068         159 ---EAREGAKFPIKWTAPEAAL  177 (261)
T ss_pred             ---cccCCCcCceeccCccccc
Confidence               1122333456899999764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=2.9e-27  Score=210.07  Aligned_cols=171  Identities=34%  Similarity=0.559  Sum_probs=142.2

Q ss_pred             CccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|+..+.||+|+||.||+|...+       ..+++|.+....  .......+.+|+.++..++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            67788899999999999998753       458899876443  233456788999999999999999999999988999


Q ss_pred             EEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC
Q 019685          231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS  294 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~  294 (337)
                      |++|||+++++|.+++...                ..+++..+..++.|++.||.|||+.+  |+|+||||+||++  +.
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~--~~  159 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV--GE  159 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEE--cC
Confidence            9999999999999999754                34788899999999999999999987  9999999999999  77


Q ss_pred             CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.+||+|||+++.....+.  ........+++.|+|||.+.
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAIL  199 (283)
T ss_pred             CCcEEECCCcceeecccccc--ccccCCCcccccccCHHHhc
Confidence            78999999999986543321  11234456789999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.3e-28  Score=235.92  Aligned_cols=170  Identities=35%  Similarity=0.641  Sum_probs=143.9

Q ss_pred             CccccceecccCceeEEEEEEC---Cc----eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR---GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~---g~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      ..+..+.||+|.||.||.|.+.   +.    .||+|.+.+..  +.+...+|.+|..+|+.++|||||+++|++.+....
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4455679999999999999875   32    37788775543  455678999999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          231 MLITEYLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      +|++|||++|+|..+|++.       ..++..+.+.++.||++|+.||++++  .|||||..+|+|+  +....|||+||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL--~~~r~VKIaDF  846 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLL--DERRVVKIADF  846 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheee--cccCcEEEccc
Confidence            9999999999999999875       34889999999999999999999987  9999999999999  77789999999


Q ss_pred             cCceeeecccccceeeeeCC-ccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGE-TGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~-~gt~~y~aPE~l~  336 (337)
                      |+|+.+...   +++..... .-+.+|||||.|+
T Consensus       847 GlArDiy~~---~yyr~~~~a~lPvkWm~PEsl~  877 (1025)
T KOG1095|consen  847 GLARDIYDK---DYYRKHGEAMLPVKWMPPESLK  877 (1025)
T ss_pred             chhHhhhhc---hheeccCccccceecCCHHHHh
Confidence            999955433   23344333 5568999999985

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.95  E-value=2.4e-27  Score=208.24  Aligned_cols=167  Identities=39%  Similarity=0.683  Sum_probs=137.9

Q ss_pred             ccceecccCceeEEEEEEC------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          161 SSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       161 ~~~~lg~G~~g~V~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ..+.||.|.||.||+|.+.      +..|+||.+...  ......+.+.+|+..+++++||||+++++++...+..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence            3568999999999999987      568999998543  22334688899999999999999999999999888899999


Q ss_pred             eecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||+++|+|.+++...  ..+++.....++.||+.||.|||+.+  |+|++|+++||++  +..+.+||+|||+++.....
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill--~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILL--DSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE--ETTTEEEEESTTTGEETTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccc--cccccccccccccccccccc
Confidence            999999999999886  67999999999999999999999987  9999999999999  77889999999999876322


Q ss_pred             cccceeeeeCCcccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .  .........+...|+|||.+
T Consensus       157 ~--~~~~~~~~~~~~~~~aPE~~  177 (259)
T PF07714_consen  157 S--KYKNDSSQQLPLRYLAPEVL  177 (259)
T ss_dssp             S--SEEESTTSESGGGGS-HHHH
T ss_pred             c--cccccccccccccccccccc
Confidence            1  11233456688999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=1.7e-27  Score=209.74  Aligned_cols=170  Identities=26%  Similarity=0.516  Sum_probs=145.4

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++..  .++.+++|.+.............+.+|+.+++.++||||+++++++...+..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            577788999999999999986  478999998865443344455778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       236 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |+++++|.+++..    ...+++..+..++.||+.||.|||+.+  ++|+||||+||++  +.++.++|+|||++..+..
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEECcchhhhcccc
Confidence            9999999999863    345899999999999999999999987  9999999999999  7788999999999887654


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...    ......|++.|+|||.+
T Consensus       159 ~~~----~~~~~~~~~~~~ape~~  178 (267)
T cd08229         159 KTT----AAHSLVGTPYYMSPERI  178 (267)
T ss_pred             CCc----ccccccCCcCccCHHHh
Confidence            321    22345689999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2.3e-27  Score=217.92  Aligned_cols=162  Identities=24%  Similarity=0.379  Sum_probs=137.0

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ...|.+.+.||+|+||.||+|...  +..||+|.....         ....|+.+++.++||||+++++++......++|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            347899999999999999999986  567888875332         224589999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||++. ++|.+++.. ...+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.....
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEecCccccccccC
Confidence            99995 488888865 456899999999999999999999987  9999999999999  78889999999999754322


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .     ......||+.|+|||++.
T Consensus       211 ~-----~~~~~~gt~~y~aPE~~~  229 (357)
T PHA03209        211 P-----AFLGLAGTVETNAPEVLA  229 (357)
T ss_pred             c-----ccccccccccccCCeecC
Confidence            1     234567999999999874

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=4.2e-27  Score=210.38  Aligned_cols=172  Identities=33%  Similarity=0.511  Sum_probs=143.5

Q ss_pred             cCccccceecccCceeEEEEEECC------------------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCee
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRG------------------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV  218 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g------------------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv  218 (337)
                      .+|++.+.||+|+||.||++....                  ..+++|.+......  ...+.+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCEe
Confidence            367888999999999999987642                  35788988654332  3457788999999999999999


Q ss_pred             eeeeeEEeCCceEEEEeecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCC
Q 019685          219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN  287 (337)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~N  287 (337)
                      ++++++......+++||++.+++|.+++....           .+++..+..++.|++.||.|||+.+  |+||||||+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~N  160 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRN  160 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhc
Confidence            99999999899999999999999999997654           6899999999999999999999987  9999999999


Q ss_pred             EEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       288 il~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |++  +..+.++|+|||+++........  .......+++.|||||.+.
T Consensus       161 ili--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  205 (296)
T cd05051         161 CLV--GKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVL  205 (296)
T ss_pred             eee--cCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhh
Confidence            999  77789999999999865433211  1223455678999999763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-28  Score=220.35  Aligned_cols=178  Identities=24%  Similarity=0.354  Sum_probs=150.0

Q ss_pred             CcccCCCCc-CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHH-----HHHHHHHHHHHhCC---CCCe
Q 019685          149 DWEIDPSEL-DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVI-----QDFRHEVNLLVKLR---HPNI  217 (337)
Q Consensus       149 ~~~~~~~~~-~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~-----~~~~~E~~~l~~l~---h~~I  217 (337)
                      .|+...... +|.....+|+|+||.|+.|.++  ...|++|.+.+...-.....     ...-.|+.+|..++   |+||
T Consensus       552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            444444333 7899999999999999999987  55789998876543221111     11236999999998   9999


Q ss_pred             eeeeeeEEeCCceEEEEee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          218 VQFLGAVTERKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       218 v~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      ++++++|++.+++||+||- -++.+|+++|..+..+++.++..|++||+.|+++||++|  |||||||-+|+.+  +..|
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenviv--d~~g  707 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIV--DSNG  707 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEE--ecCC
Confidence            9999999999999999996 456799999998889999999999999999999999998  9999999999999  8999


Q ss_pred             cEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      -+||+|||.|...+.+      .....+||..|.|||+|-
T Consensus       708 ~~klidfgsaa~~ksg------pfd~f~gtv~~aapevl~  741 (772)
T KOG1152|consen  708 FVKLIDFGSAAYTKSG------PFDVFVGTVDYAAPEVLG  741 (772)
T ss_pred             eEEEeeccchhhhcCC------CcceeeeeccccchhhhC
Confidence            9999999999887655      357789999999999873

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=2.9e-27  Score=208.27  Aligned_cols=174  Identities=27%  Similarity=0.526  Sum_probs=144.8

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCc---hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~---~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|+..+.||+|+||.||++..  .++.+++|.+......   .....+.+..|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            367778999999999999986  3788999988643322   12245778899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-cEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-~~kl~DFgla~~~~~  311 (337)
                      |+||+++++|.+++...+.+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+ .+||+|||++..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~--~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLI--DSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEEccccccccccc
Confidence            9999999999999988778999999999999999999999987  9999999999999  5554 599999999987754


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .............|+..|+|||.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~  180 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVL  180 (268)
T ss_pred             ccccCCccccccccccceeCHhHh
Confidence            321111112345689999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.95  E-value=4.5e-27  Score=205.56  Aligned_cols=170  Identities=32%  Similarity=0.489  Sum_probs=145.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|++|.||++...  ++.+++|.+...... ......+..|+.+++.++||||+++++++...+..|++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            3667789999999999999875  788999988654333 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.+||+|||+++.+....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili--~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--eCCCCEEEcccccceeccCcc
Confidence            99999999999764  46899999999999999999999987  9999999999999  777899999999998765432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......|++.|+|||++.
T Consensus       156 ~----~~~~~~~~~~y~aPE~~~  174 (256)
T cd08529         156 N----FANTIVGTPYYLSPELCE  174 (256)
T ss_pred             c----hhhccccCccccCHHHhc
Confidence            2    223456889999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=6.5e-27  Score=207.61  Aligned_cols=163  Identities=27%  Similarity=0.470  Sum_probs=139.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+.....  ......+.+|+.++.+++||||+++++.+...+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            4667789999999999999864  77899998865432  2344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|..+    ..+++..+..++.|++.||.|||+.+  |+|+||||+||++  +.++.+||+|||++..+...   
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill--~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLV--NTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEE--CCCCCEEEeeCCcceecccc---
Confidence            9999998654    34788899999999999999999987  9999999999999  78889999999999766433   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||..|+|||++.
T Consensus       149 ---~~~~~~~~~~y~aPE~~~  166 (279)
T cd06619         149 ---IAKTYVGTNAYMAPERIS  166 (279)
T ss_pred             ---cccCCCCChhhcCceeec
Confidence               234467999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=6.8e-27  Score=205.77  Aligned_cols=174  Identities=28%  Similarity=0.507  Sum_probs=143.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCC--CchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~--~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~  231 (337)
                      +|...+.||+|+||.||++...  +..|++|.+....  .......+.+.+|+.+++.++||||+++++++.+.  ..++
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            6778899999999999999874  7889999875432  22233457788999999999999999999988764  4688


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      ++|||+++++|.+++.....+++..+..++.|++.||.|||+.+  |+|+||||+||++  +.++.+||+|||+++....
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILR--DSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEe--cCCCCEEECcCcccccccc
Confidence            99999999999999987777899999999999999999999987  9999999999999  7788999999999986543


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .... ........|+..|+|||.+.
T Consensus       159 ~~~~-~~~~~~~~~~~~y~aPE~~~  182 (265)
T cd06652         159 ICLS-GTGMKSVTGTPYWMSPEVIS  182 (265)
T ss_pred             cccc-ccccccCCCCccccChhhhc
Confidence            2110 01223456899999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=6.9e-27  Score=205.83  Aligned_cols=170  Identities=33%  Similarity=0.564  Sum_probs=142.6

Q ss_pred             CccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|+..+.||+|+||.||+|.+.     ...+++|.+....  .......+.+|+.+++.++||||+++++.+...+..++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            6778889999999999999874     2368889876543  23345678889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +|||+++++|.+++... +.+++..+..++.|++.||.|||+.+  |+|+||||+||++  +.++.+||+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili--~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCCEEECccchhhcccc
Confidence            99999999999999763 46899999999999999999999977  9999999999999  7788999999999988753


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...  ........+++.|+|||.+
T Consensus       159 ~~~--~~~~~~~~~~~~y~~Pe~~  180 (266)
T cd05033         159 SEA--TYTTKGGKIPIRWTAPEAI  180 (266)
T ss_pred             ccc--ceeccCCCCCccccChhhh
Confidence            221  1122334567889999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=6.5e-27  Score=210.30  Aligned_cols=175  Identities=30%  Similarity=0.468  Sum_probs=145.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.|++|.+.............+.+|+.+++.++||||+++++.+.....++++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            5777889999999999999875  67899998866543334445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+  ++||||||+||++  +..+.+||+|||+++........
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll--~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEE--CCCCCEEEeeCCCccccCcCccc
Confidence            9999999999988788999999999999999999999987  9999999999999  78889999999998742111000


Q ss_pred             -----------ceeeeeCCccccccccccccc
Q 019685          316 -----------DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 -----------~~~~~~~~~gt~~y~aPE~l~  336 (337)
                                 .........+++.|+|||.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  189 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL  189 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhcc
Confidence                       000112346788999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.95  E-value=4.2e-27  Score=208.90  Aligned_cols=163  Identities=27%  Similarity=0.381  Sum_probs=133.6

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHH---HHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL---LVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~---l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .||+|+||.||++...  ++.+|+|.+.+...........+.+|..+   +....||+|+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875  78899998876543322222333444433   334469999999999999899999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccccee
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY  318 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~  318 (337)
                      +++|.+++...+.+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|||++.......     
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~--~~~~~~~l~dfg~~~~~~~~~-----  151 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK-----  151 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEE--CCCCCEEEccCCcceeccccC-----
Confidence            9999999988888999999999999999999999988  9999999999999  788899999999997654321     


Q ss_pred             eeeCCccccccccccccc
Q 019685          319 KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       319 ~~~~~~gt~~y~aPE~l~  336 (337)
                       .....|++.|+|||.+.
T Consensus       152 -~~~~~~~~~y~aPE~~~  168 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQ  168 (279)
T ss_pred             -ccCcCCCcCccCHHHhc
Confidence             23456999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-28  Score=228.02  Aligned_cols=176  Identities=35%  Similarity=0.599  Sum_probs=150.4

Q ss_pred             ccCCCCcCccccceecccCceeEEEEEEC--C---ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      +|+++.  ..+.++||.|.||+|++|+.+  |   ..||||.++....  ..+..+|+.|+.+|.++.||||++|.|+..
T Consensus       625 EId~s~--i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVT  700 (996)
T KOG0196|consen  625 EIDPSC--VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVT  700 (996)
T ss_pred             hcChhh--eEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence            444443  356789999999999999986  3   4699999876543  345688999999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      ....++||+|||++|+|..+|++ .++++..+..-+++.|+.||+||-+.+  +|||||..+|||+  +..-..|++|||
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILV--NsnLvCKVsDFG  776 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILV--NSNLVCKVSDFG  776 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheee--ccceEEEecccc
Confidence            99999999999999999999987 467999999999999999999999988  9999999999999  888889999999


Q ss_pred             CceeeecccccceeeeeCCcccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +++.+.++. ...+...+-.=+++|.|||.|
T Consensus       777 LSRvledd~-~~~ytt~GGKIPiRWTAPEAI  806 (996)
T KOG0196|consen  777 LSRVLEDDP-EAAYTTLGGKIPIRWTAPEAI  806 (996)
T ss_pred             ceeecccCC-CccccccCCccceeecChhHh
Confidence            999886654 333444444557899999987

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.95  E-value=4.8e-27  Score=205.72  Aligned_cols=168  Identities=32%  Similarity=0.564  Sum_probs=139.9

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||++.++ +..+++|.+......    ...+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            5778889999999999999876 447899987643322    24577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++++|.+++... ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~kl~dfg~~~~~~~~~~-  155 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLV--GEDNVVKVSDFGLARYVLDDQY-  155 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEE--CCCCcEEECCcccceecccccc-
Confidence            9999999999763 46899999999999999999999987  9999999999999  7788999999999976643211 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......++..|+|||.+.
T Consensus       156 --~~~~~~~~~~~y~~Pe~~~  174 (256)
T cd05059         156 --TSSQGTKFPVKWAPPEVFD  174 (256)
T ss_pred             --cccCCCCCCccccCHHHhc
Confidence              1122334556899999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.95  E-value=4.7e-27  Score=205.92  Aligned_cols=168  Identities=33%  Similarity=0.585  Sum_probs=141.5

Q ss_pred             CccccceecccCceeEEEEEECCc-eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~-~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|...+.||+|+||.||++.+.+. .+++|.+......    .+.+.+|+.+++.++||||+++++++.....++++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            567778999999999999988754 5999987643322    35688899999999999999999999988899999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +.+++|.+++... ..+++..++.++.||+.||.|||+.+  ++|+||||+||++  +.++.+||+|||+++....... 
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili--~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLV--DDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE--cCCCCEEECCCccceecCCCce-
Confidence            9999999999764 36899999999999999999999987  9999999999999  7788999999999987643321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......++..|+|||.+.
T Consensus       156 --~~~~~~~~~~~y~~pe~~~  174 (256)
T cd05113         156 --TSSVGSKFPVRWSPPEVLL  174 (256)
T ss_pred             --eecCCCccChhhCCHHHHh
Confidence              1223445678899999863

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=7.4e-27  Score=204.44  Aligned_cols=164  Identities=36%  Similarity=0.632  Sum_probs=143.6

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      +|+..+.||+|+||.||++...++.+++|.+.....    ..+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hccceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            677788999999999999999999999999865432    3567888999999999999999999999889999999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          238 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       238 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ++++|.+++....  .+++..+..++.|++.||.|||+.+  |+|+||||+||++  +..+.+||+|||+++.....   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili--~~~~~~~l~d~g~~~~~~~~---  155 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLV--SEDLVAKVSDFGLAKEASQG---  155 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEE--eCCCCEEEcccccccccccc---
Confidence            9999999998755  6899999999999999999999987  9999999999999  78889999999999876432   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....++..|+|||.+.
T Consensus       156 ----~~~~~~~~~~~ape~~~  172 (256)
T cd05039         156 ----QDSGKLPVKWTAPEALR  172 (256)
T ss_pred             ----cccCCCcccccCchhhc
Confidence                12334567899999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.7e-27  Score=215.75  Aligned_cols=178  Identities=24%  Similarity=0.332  Sum_probs=150.1

Q ss_pred             cccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeC
Q 019685          150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER  227 (337)
Q Consensus       150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~  227 (337)
                      ..|......|++.++||+||.+.||++... .+.+++|++..... +......|.+|+.+|.+++ |.+|++++++-..+
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            345556668999999999999999999876 45677777655444 3556789999999999998 99999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      +.+||||||- ..+|..+|++... ++...++.|..||+.++.++|.+|  |||.||||.|+|+   -.|.+||+|||+|
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLl---VkG~LKLIDFGIA  506 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLL---VKGRLKLIDFGIA  506 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEE---EeeeEEeeeechh
Confidence            9999999965 4599999987655 333578889999999999999988  9999999999998   5578999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..+..+....  .....+||+.|||||.|.
T Consensus       507 ~aI~~DTTsI--~kdsQvGT~NYMsPEAl~  534 (677)
T KOG0596|consen  507 NAIQPDTTSI--VKDSQVGTVNYMSPEALT  534 (677)
T ss_pred             cccCccccce--eeccccCcccccCHHHHh
Confidence            9988765432  356789999999999875

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6e-28  Score=223.55  Aligned_cols=164  Identities=35%  Similarity=0.519  Sum_probs=140.8

Q ss_pred             ceecccCceeEEEEEECCc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          163 AIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      -+||+|.||+||.|++...  ..|||.+.....   ...+-+.+|+.+-++++|.|||+++|.+.+++.+-|+||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            4799999999999998744  567887754432   23466778999999999999999999999999999999999999


Q ss_pred             CHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccce
Q 019685          241 DLHKYLKE-KGAL--SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV  317 (337)
Q Consensus       241 ~L~~~l~~-~~~~--~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~  317 (337)
                      ||.++++. -+++  ++..+-.|.+||++||.|||...  |||||||-+|||+. .-.|.+||+|||-++.+..-++   
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvN-TySGvlKISDFGTsKRLAginP---  731 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVN-TYSGVLKISDFGTSKRLAGINP---  731 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEe-eccceEEecccccchhhccCCc---
Confidence            99999986 3566  88899999999999999999976  99999999999983 5678999999999998875543   


Q ss_pred             eeeeCCccccccccccccc
Q 019685          318 YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       318 ~~~~~~~gt~~y~aPE~l~  336 (337)
                       ...+..||..|||||+|-
T Consensus       732 -~TETFTGTLQYMAPEvID  749 (1226)
T KOG4279|consen  732 -CTETFTGTLQYMAPEVID  749 (1226)
T ss_pred             -cccccccchhhhChHhhc
Confidence             345678999999999984

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=7.6e-27  Score=205.39  Aligned_cols=170  Identities=28%  Similarity=0.506  Sum_probs=145.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.+++|.+.............+.+|+.++++++|++|+++++.+...+..+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            6778889999999999999985  88999998865443344445778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       236 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |+++++|.+++..    ...+++.++..++.|++.||.|||+.+  |+|+||+|+||++  +.++.++|+|||+++.+..
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~--~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFI--TATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEE--CCCCcEEEeccceeeeccC
Confidence            9999999999864    245889999999999999999999987  9999999999999  7788999999999987654


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...    ......+++.|+|||.+
T Consensus       159 ~~~----~~~~~~~~~~y~apE~~  178 (267)
T cd08224         159 KTT----AAHSLVGTPYYMSPERI  178 (267)
T ss_pred             CCc----ccceecCCccccCHHHh
Confidence            322    12345688999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=2.9e-27  Score=222.56  Aligned_cols=165  Identities=25%  Similarity=0.359  Sum_probs=138.9

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ...|.+.+.||+|+||.||++...  ++.|++|....         ..+.+|+.++++++|+||+++++++...+..+++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            346888999999999999999986  67899985321         2356799999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||++. ++|.+++... ..+++.+++.++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.....
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl--~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLV--NGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEE--CCCCCEEEcccCCceecccc
Confidence            99995 5898888654 46999999999999999999999988  9999999999999  77889999999999876533


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....  ......||+.|||||++.
T Consensus       314 ~~~~--~~~~~~GT~~Y~APE~~~  335 (461)
T PHA03211        314 WSTP--FHYGIAGTVDTNAPEVLA  335 (461)
T ss_pred             cccc--cccccCCCcCCcCHHHHc
Confidence            2111  123467999999999874

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=2.4e-27  Score=217.64  Aligned_cols=166  Identities=26%  Similarity=0.381  Sum_probs=137.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------Cc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~  229 (337)
                      +|+..+.||+|+||.||++...  ++.+|+|.+...... ......+.+|+.+++.++||||+++++++...      ..
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            7888899999999999999864  788999988654332 23446677899999999999999999987543      34


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      .|++|||+++ ++.+.+..  .+++..+..++.|++.||.|||+.|  |+||||||+|||+  +.++.+||+|||+++..
T Consensus        97 ~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill--~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          97 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLARTA  169 (355)
T ss_pred             eEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE--CCCCCEEEeeCcccccC
Confidence            7999999976 77777653  4888999999999999999999988  9999999999999  78889999999999765


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....     ......||+.|+|||++.
T Consensus       170 ~~~~-----~~~~~~~t~~y~aPE~~~  191 (355)
T cd07874         170 GTSF-----MMTPYVVTRYYRAPEVIL  191 (355)
T ss_pred             CCcc-----ccCCccccCCccCHHHHc
Confidence            4321     234567899999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=1.8e-27  Score=208.49  Aligned_cols=170  Identities=26%  Similarity=0.462  Sum_probs=149.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+.+.........+.+.+|+.++++++||||+++++.+......++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4677889999999999999986  78999999976554444456788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+.+++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +.++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~--~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE--cCCCCEEEeecccccccCCCc--
Confidence            9999999999987778999999999999999999999977  9999999999999  788899999999987765432  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......|+..|+|||.+.
T Consensus       155 ---~~~~~~~~~~y~~PE~~~  172 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLC  172 (258)
T ss_pred             ---cccccCCChhhcCHHHHc
Confidence               234566899999999863

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6e-28  Score=213.59  Aligned_cols=179  Identities=28%  Similarity=0.448  Sum_probs=147.7

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchH----HHHHHHHHHHHHHHhCCCCCeeeeeeeEE-eCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDR----LVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~  230 (337)
                      +|....+||+|||+.||+|.+  ..+.||||+-..+..-..    ...+...+|.++-+.+.||.||++|++|. +...+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            577778999999999999986  377899997543332211    12344568999999999999999999985 55689


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~  309 (337)
                      |-|+|||+|.+|..+|+....+++.+++.|+.||+.||.||....++|||-||||.|||+.+ +..|.+||.|||+++++
T Consensus       544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM  623 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM  623 (775)
T ss_pred             eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence            99999999999999999998999999999999999999999998889999999999999954 34578999999999998


Q ss_pred             ecccccc---eeeeeCCccccccccccccc
Q 019685          310 KVQNSHD---VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~---~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .++....   ........||..|++||.++
T Consensus       624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFv  653 (775)
T KOG1151|consen  624 DDDSYNSVDGMELTSQGAGTYWYLPPECFV  653 (775)
T ss_pred             cCCccCcccceeeecccCceeeecCcceee
Confidence            7653221   11234566999999999985

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=7.2e-27  Score=207.56  Aligned_cols=167  Identities=26%  Similarity=0.435  Sum_probs=141.5

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |++.+.||+|+||.||++...  +..+++|.+....   ....+.+.+|+.+++.++||||+++++.+...+..|+|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            566788999999999999986  5677888774432   33456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++++|..++.. ...+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|||++........ 
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili--~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE--ccCCCEEEcccccccccccccc-
Confidence            999999998765 456899999999999999999999987  9999999999999  7788999999999976543211 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......+++.|+|||++.
T Consensus       159 ---~~~~~~~~~~y~aPE~~~  176 (282)
T cd06643         159 ---RRDSFIGTPYWMAPEVVM  176 (282)
T ss_pred             ---ccccccccccccCHhhcc
Confidence               234457899999999873

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.95  E-value=4.6e-27  Score=207.35  Aligned_cols=164  Identities=28%  Similarity=0.414  Sum_probs=131.9

Q ss_pred             eecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      .||+|+||.||+|...    ...+++|.+....  .......+.+|+.+++.++|+||+++++.+......|+||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            5899999999999753    3457777765432  233346678899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          240 GDLHKYLKEKG-----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       240 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ++|.+++....     ..++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQL--TADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEe--cCCCcEEEeccccccccccchh
Confidence            99999997642     2467788899999999999999987  9999999999999  7888999999999865433211


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                        ........+++.|+|||++
T Consensus       156 --~~~~~~~~~~~~y~aPE~~  174 (269)
T cd05042         156 --YITKDCHAVPLRWLAPELV  174 (269)
T ss_pred             --eeccCCCCCcccccCHHHH
Confidence              0112334567889999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=9.4e-27  Score=204.97  Aligned_cols=174  Identities=31%  Similarity=0.532  Sum_probs=145.2

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCch------HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      |.....||+|+||.||+|...  ++.+++|.+.......      ....+.+.+|+.+++.++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            566789999999999999874  6789999886543322      22346788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +++|||+++++|.+++...+.+++..+..++.|++.||.|||+.+  ++||||+|+||++  +..+.+||+|||+++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~--~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILV--DNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEE--cCCCCEEecccCCCcccc
Confidence            999999999999999988788999999999999999999999977  9999999999999  788899999999998775


Q ss_pred             cccccc--eeeeeCCccccccccccccc
Q 019685          311 VQNSHD--VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~--~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......  ........|++.|+|||.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~  185 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVK  185 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhc
Confidence            321110  01123356889999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=5e-27  Score=206.08  Aligned_cols=168  Identities=32%  Similarity=0.571  Sum_probs=141.3

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||+|... +..+++|.+.....    ..+.+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            6777889999999999999875 56789998754322    246788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++||||||+||++  +.++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLV--SESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEe--cCCCcEEECCCccceecCCCce
Confidence            9999999999753  45888899999999999999999977  9999999999999  7888999999999987654321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......++..|+|||.+.
T Consensus       159 ---~~~~~~~~~~~y~aPE~~~  177 (261)
T cd05072         159 ---TAREGAKFPIKWTAPEAIN  177 (261)
T ss_pred             ---eccCCCccceecCCHHHhc
Confidence               1123345678899999763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=6.9e-27  Score=207.15  Aligned_cols=171  Identities=28%  Similarity=0.460  Sum_probs=139.0

Q ss_pred             cCccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      .+|+..+.||+|+||.||+|.+.+       ..+++|.+....  .......+.+|+.+++.++||||+++++++.....
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            367888999999999999998643       468999875432  22334668899999999999999999999998899


Q ss_pred             eEEEEeecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEE
Q 019685          230 LMLITEYLRGGDLHKYLKEKG----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK  299 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~k  299 (337)
                      .++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+  ++||||||+||++  +.++.+|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~--~~~~~~~  159 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTVK  159 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEE--cCCCCEE
Confidence            999999999999999997522          2567788899999999999999977  9999999999999  7788999


Q ss_pred             EEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          300 VGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       300 l~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |+|||+++.+.....  ........+++.|||||++
T Consensus       160 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05062         160 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESL  193 (277)
T ss_pred             ECCCCCccccCCcce--eecCCCCccCHhhcChhHh
Confidence            999999976543221  0112233567899999986

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.8e-27  Score=216.22  Aligned_cols=165  Identities=28%  Similarity=0.490  Sum_probs=137.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------Cc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~  229 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+...... ......+.+|+.+++.++||||+++++++...      ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            6888899999999999999874  678999988654322 22345677899999999999999999887533      34


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      .|++++++ +++|.+++. ...+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++..
T Consensus        95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAV--NEDCELRILDFGLARQA  168 (343)
T ss_pred             EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEE--CCCCCEEEcCCccceec
Confidence            78999988 679988875 346999999999999999999999988  9999999999999  78889999999999865


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...       .....||+.|+|||++.
T Consensus       169 ~~~-------~~~~~~t~~y~aPE~~~  188 (343)
T cd07878         169 DDE-------MTGYVATRWYRAPEIML  188 (343)
T ss_pred             CCC-------cCCccccccccCchHhc
Confidence            432       23457899999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=5.2e-27  Score=210.81  Aligned_cols=167  Identities=38%  Similarity=0.585  Sum_probs=135.5

Q ss_pred             CccccceecccCceeEEEEEEC--Cce--EEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~--vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|++.+.||+|+||.||+|.++  +..  +++|.+....  .......+.+|+.++.++ +|+||+++++++...+..|+
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            6777889999999999999875  443  4666654322  233446788899999999 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          233 ITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      +|||+++++|.+++...+                .+++..++.++.||+.||+|||+.+  |+||||||+|||+  +.++
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili--~~~~  161 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENY  161 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe--cCCC
Confidence            999999999999997532                4788899999999999999999987  9999999999999  7788


Q ss_pred             cEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .+||+|||+++......     ......++..|+|||++
T Consensus       162 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~  195 (303)
T cd05088         162 VAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESL  195 (303)
T ss_pred             cEEeCccccCcccchhh-----hcccCCCcccccCHHHH
Confidence            99999999986432211     11222346789999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=7.6e-27  Score=207.50  Aligned_cols=171  Identities=30%  Similarity=0.504  Sum_probs=140.7

Q ss_pred             CccccceecccCceeEEEEEE------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      +|+..+.||+|+||.||+|..      .+..+++|.+.....  ......+.+|+.+++.++||||+++++++......|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            567778999999999999975      246789998864332  334467888999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC
Q 019685          232 LITEYLRGGDLHKYLKEK-----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS  294 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~  294 (337)
                      ++|||+.+++|.+++...                 ..+++..+..++.|++.||.|||+++  |+||||||+||++  +.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili--~~  159 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI--GE  159 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE--cC
Confidence            999999999999998532                 23778889999999999999999987  9999999999999  77


Q ss_pred             CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.+||+|||+++.......  ........++..|+|||++.
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05090         160 QLHVKISDLGLSREIYSADY--YRVQPKSLLPIRWMPPEAIM  199 (283)
T ss_pred             CCcEEeccccccccccCCcc--eecccCCCccceecChHHhc
Confidence            78899999999987643321  11234455678899999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-28  Score=209.38  Aligned_cols=171  Identities=26%  Similarity=0.408  Sum_probs=155.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|....+||+|+|+.|..++.+  .+.+|+|++++...++...+...+.|-.+..+.. ||++|.++.+|++...+++|.
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi  330 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI  330 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence            6888899999999999998875  6789999999888887777888899999988875 999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||++||+|.-.++..++++++.++.+..+|+.||.|||++|  ||.||||.+|+|+  |..|++||.|+|+++.--.+..
T Consensus       331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvll--daeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEE--ccCCceeecccchhhcCCCCCc
Confidence            99999999999998889999999999999999999999999  9999999999999  9999999999999986443322


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ...+.+|||.|+|||++.
T Consensus       407 ----~tstfcgtpnyiapeilr  424 (593)
T KOG0695|consen  407 ----TTSTFCGTPNYIAPEILR  424 (593)
T ss_pred             ----ccccccCCCcccchhhhc
Confidence                457789999999999984

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=6.8e-27  Score=207.86  Aligned_cols=169  Identities=30%  Similarity=0.496  Sum_probs=140.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|++|.||+|..+  ++.+++|.+...... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4677789999999999999875  788999988654322 2223567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       236 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |++ ++|.+++...   ..+++..+..++.||+.||.|||+.+  |+|+||+|+||++  +.++.+||+|||++......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEE--cCCCcEEECcccceeecCCC
Confidence            997 5898888642   45899999999999999999999987  9999999999999  78889999999999765432


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......+++.|+|||++.
T Consensus       155 ~~----~~~~~~~~~~y~aPE~~~  174 (285)
T cd07861         155 VR----VYTHEVVTLWYRAPEVLL  174 (285)
T ss_pred             cc----cccCCcccccccChHHhc
Confidence            11    234456789999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=7.7e-27  Score=204.33  Aligned_cols=166  Identities=37%  Similarity=0.632  Sum_probs=142.9

Q ss_pred             ceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          163 AIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      +.||+|+||.||++...     +..+++|.+.......  ..+.+.+|+.++..++|+||+++++++......+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            36899999999999886     6689999886554332  4578889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          238 RGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       238 ~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      ++++|.+++...         ..+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.+||+|||.+..
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili--~~~~~~~l~dfg~~~~  154 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLV--GEDLVVKISDFGLSRD  154 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEE--CCCCcEEEcccccccc
Confidence            999999999875         67999999999999999999999987  9999999999999  7778999999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......  ........+++.|+|||.+.
T Consensus       155 ~~~~~~--~~~~~~~~~~~~y~aPE~~~  180 (262)
T cd00192         155 VYDDDY--YRKKTGGKLPIRWMAPESLK  180 (262)
T ss_pred             cccccc--cccccCCCcCccccCHHHhc
Confidence            765421  11244566889999999763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.95  E-value=1.3e-26  Score=202.66  Aligned_cols=168  Identities=28%  Similarity=0.503  Sum_probs=143.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+.....  ....+.+..|+.+++.++|+||+++++.+...+.+|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4677889999999999999875  77899998854332  2244677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+|+||||+||++  +.++.++|+|||++.......
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFL--TQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE--CCCCcEEEcccCcceeecccc
Confidence            99999999998653  34889999999999999999999987  9999999999999  778899999999998765432


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .    ......|++.|+|||++
T Consensus       155 ~----~~~~~~~~~~~~aPE~~  172 (255)
T cd08219         155 A----YACTYVGTPYYVPPEIW  172 (255)
T ss_pred             c----ccccccCCccccCHHHH
Confidence            1    22346789999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=7.7e-27  Score=208.80  Aligned_cols=171  Identities=28%  Similarity=0.530  Sum_probs=140.3

Q ss_pred             CccccceecccCceeEEEEEECC----------------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG----------------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL  221 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g----------------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~  221 (337)
                      +|++.+.||+|+||.||++...+                ..+++|.+.....  ......+.+|+.+++.++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            67888999999999999987642                2488998865432  33456788999999999999999999


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEE
Q 019685          222 GAVTERKPLMLITEYLRGGDLHKYLKEKG------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL  289 (337)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil  289 (337)
                      +++......++||||+.+++|.+++....            .+++..+..++.|++.||.|||+.+  ++||||||+||+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil  161 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCL  161 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEE
Confidence            99999999999999999999999986432            3678889999999999999999987  999999999999


Q ss_pred             EecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       290 ~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +  +.++.+||+|||+++.......  ........+++.|+|||++.
T Consensus       162 l--~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  204 (295)
T cd05097         162 V--GNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESIL  204 (295)
T ss_pred             E--cCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhc
Confidence            9  7778899999999976543321  11123345678999999763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.95  E-value=5.1e-27  Score=216.24  Aligned_cols=167  Identities=25%  Similarity=0.368  Sum_probs=138.1

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------C
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~  228 (337)
                      .+|...+.||+|+||.||++...  ++.+|+|.+...... ......+.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-chhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            37888999999999999999875  778999988654332 23346677899999999999999999987543      3


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~  175 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLART  175 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEE--CCCCcEEEEeCCCccc
Confidence            57999999975 78777753  4788999999999999999999987  9999999999999  7888999999999976


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....     ......||+.|+|||++.
T Consensus       176 ~~~~~-----~~~~~~~t~~y~aPE~~~  198 (364)
T cd07875         176 AGTSF-----MMTPYVVTRYYRAPEVIL  198 (364)
T ss_pred             cCCCC-----cccCCcccCCcCCHHHHh
Confidence            54321     234567899999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=9.2e-27  Score=205.23  Aligned_cols=172  Identities=32%  Similarity=0.563  Sum_probs=142.1

Q ss_pred             CccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|...+.||+|+||.||+|...     +..+++|.+.....  ......+.+|+.+++.++||||+++++++...+..|+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            5777889999999999999863     23688888765432  2335678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +|||+++++|.+++... +.+++.++..++.|++.||.|||+.+  ++||||||+||++  +.++.+||+|||+++.+..
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili--~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEE--CCCCeEEeCCCCccccccc
Confidence            99999999999999764 46899999999999999999999987  9999999999999  7788999999999987754


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .... ........++..|+|||.+.
T Consensus       159 ~~~~-~~~~~~~~~~~~y~~pe~~~  182 (267)
T cd05066         159 DPEA-AYTTRGGKIPIRWTAPEAIA  182 (267)
T ss_pred             ccce-eeecCCCccceeecCHhHhc
Confidence            3221 11122333467899999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=5.8e-27  Score=209.78  Aligned_cols=168  Identities=33%  Similarity=0.527  Sum_probs=142.9

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCc--hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      |+..+.||+|+||.||+|...  ++.+++|.+......  .......+..|+.+++.++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            666789999999999999875  789999998765432  1223355678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+ +++|.+++.... .+++..+..++.||+.||.|||+.+  |+|+||+|+||++  +.++.+||+|||+++......
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill--~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLI--ASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEE--cCCCCEEEccceeeeeccCCC
Confidence            999 889999998765 7999999999999999999999988  9999999999999  778899999999998765432


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .    ......+++.|+|||.+
T Consensus       157 ~----~~~~~~~~~~y~aPE~~  174 (298)
T cd07841         157 R----KMTHQVVTRWYRAPELL  174 (298)
T ss_pred             c----cccccccceeeeCHHHH
Confidence            1    22344678899999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-26  Score=203.67  Aligned_cols=168  Identities=32%  Similarity=0.519  Sum_probs=145.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+......   ..+.+.+|+.+++.++||||+++++.+.....+|++||
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            6788889999999999999874  678999988654322   34778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++... ..+++.++..++.|++.||.|||+.+  |+|+||+|+||++  +.++.+||+|||++..+.....
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILL--TEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEE--CCCCCEEECccccchhhhhhhh
Confidence            99999999999775 68999999999999999999999987  9999999999999  7788999999999977654321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......++..|+|||.+.
T Consensus       157 ----~~~~~~~~~~y~~Pe~~~  174 (262)
T cd06613         157 ----KRKSFIGTPYWMAPEVAA  174 (262)
T ss_pred             ----ccccccCCccccCchhhc
Confidence                234467899999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=1e-26  Score=208.17  Aligned_cols=167  Identities=25%  Similarity=0.425  Sum_probs=143.1

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++...  ++.+++|.+......   ..+.+.+|+.+++.+.|+||+++++.+......|+||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            37888899999999999999864  788999988654332   2366788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++.. ..+++.++..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||++........
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill--~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--cCCCCEEECccccchhcccccc
Confidence            99999999999864 35889999999999999999999988  9999999999999  7788999999999876543321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......|++.|+|||.+
T Consensus       172 ----~~~~~~~~~~y~aPE~~  188 (296)
T cd06654         172 ----KRSTMVGTPYWMAPEVV  188 (296)
T ss_pred             ----ccCcccCCccccCHHHH
Confidence                12345789999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=1.2e-26  Score=202.72  Aligned_cols=164  Identities=30%  Similarity=0.547  Sum_probs=135.7

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGD  241 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~  241 (337)
                      .||+|+||.||+|...  ++.+++|.+....  .......+.+|+.+++.++||||+++++++......++||||+++++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            6899999999999874  7889999875432  23344678899999999999999999999999999999999999999


Q ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          242 LHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       242 L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      |.+++...+ .+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||++........  ....
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~--~~~~  153 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLV--TEKNVLKISDFGMSREEEDGVY--ASTG  153 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEE--cCCCcEEECccccCcccccccc--cccC
Confidence            999997644 5899999999999999999999987  9999999999999  7788999999999976543210  0011


Q ss_pred             eCCcccccccccccc
Q 019685          321 TGETGSCEYLVSNCS  335 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l  335 (337)
                      .....+..|+|||.+
T Consensus       154 ~~~~~~~~y~aPE~~  168 (252)
T cd05084         154 GMKQIPVKWTAPEAL  168 (252)
T ss_pred             CCCCCceeecCchhh
Confidence            112345679999976

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=7.8e-27  Score=207.49  Aligned_cols=170  Identities=25%  Similarity=0.445  Sum_probs=143.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+....||+|+||.||++..+  ++.+++|.+....... ...+.+.+|+.+++.++|+||+++++++......+++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            5777889999999999999885  7889999886443221 123557789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |++++.|..++.....+++..+..++.|++.||.|||+.+  |+|+||||+||++  +..+.+||+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILI--TKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEE--cCCCcEEECccccceecCCCcc-
Confidence            9999888888776667999999999999999999999987  9999999999999  7788999999999987754321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......++..|+|||++.
T Consensus       156 ---~~~~~~~~~~~~aPE~~~  173 (286)
T cd07847         156 ---DYTDYVATRWYRAPELLV  173 (286)
T ss_pred             ---cccCcccccccCCHHHHh
Confidence               123456789999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-26  Score=209.87  Aligned_cols=175  Identities=27%  Similarity=0.445  Sum_probs=146.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+.+...........+..|+.+++.++|+||+++++.+......|++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5778889999999999999875  68899999976655444456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||||+||++  +.++.++|+|||++.......
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEE--cCCCCEEEeecchhhcccccc
Confidence            99999999999753  46899999999999999999999987  9999999999999  777899999999987654321


Q ss_pred             ccce-------------------------eeeeCCccccccccccccc
Q 019685          314 SHDV-------------------------YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~-------------------------~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....                         .......||..|+|||++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  205 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS  205 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc
Confidence            1100                         0112346899999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=9.7e-27  Score=209.38  Aligned_cols=171  Identities=33%  Similarity=0.550  Sum_probs=139.4

Q ss_pred             CccccceecccCceeEEEEEECC---------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER  227 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g---------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~  227 (337)
                      +|.+.+.||+|+||.||++.+.+         ..+++|.+.....  ......+..|+.+++.+ +||||+++++++...
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            68888999999999999997632         4589998865432  22346678899999999 699999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEe
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV  291 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~  291 (337)
                      ...|+||||+++++|.+++....                .+++.+++.++.|++.||.|||+.+  ++||||||+||++ 
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill-  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV-  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEE-
Confidence            99999999999999999997532                3788899999999999999999987  9999999999999 


Q ss_pred             cCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       292 ~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                       +.++.+||+|||+++........  .......+++.|+|||++.
T Consensus       174 -~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  215 (307)
T cd05098         174 -TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALF  215 (307)
T ss_pred             -cCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhc
Confidence             77889999999999766432110  0112233567899999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=8.7e-28  Score=202.92  Aligned_cols=163  Identities=28%  Similarity=0.484  Sum_probs=134.0

Q ss_pred             Cccc-cceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe----CCc
Q 019685          158 DFSS-SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----RKP  229 (337)
Q Consensus       158 ~~~~-~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~----~~~  229 (337)
                      +|.+ ..+||-|-.|.|..|..+  ++.+|+|++.-.        ...++|+++--.. .|||||.++++|+.    ...
T Consensus        62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            4433 268999999999999875  788999987432        3345677764444 59999999998753    457


Q ss_pred             eEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCc
Q 019685          230 LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS  306 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla  306 (337)
                      +.+|||.++||.|++.|.+++.  +++.++..|++||+.|+.|||+.+  |.||||||+|+|.... .+..+||+|||+|
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccc
Confidence            8999999999999999998765  999999999999999999999987  9999999999999543 3457899999999


Q ss_pred             eeeecccccceeeeeCCcccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +.-....     ...+.+.||+|.|||++
T Consensus       212 K~t~~~~-----~L~TPc~TPyYvaPevl  235 (400)
T KOG0604|consen  212 KETQEPG-----DLMTPCFTPYYVAPEVL  235 (400)
T ss_pred             cccCCCc-----cccCCcccccccCHHHh
Confidence            8765432     46778899999999986

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=1.6e-26  Score=206.49  Aligned_cols=168  Identities=27%  Similarity=0.431  Sum_probs=143.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|++.+.||+|+||.||++...  +..+++|.+...   .....+.+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            5788899999999999999875  678999988543   23345778889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|..++.+ ...+++..+..++.|++.+|.|||+.+  |+||||||+||++  +.++.+||+|||++........
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLL--TLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEE--cCCCCEEEccCccceecccccc
Confidence            9999999988765 456899999999999999999999987  9999999999999  7788999999999876433211


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+++.|+|||.+.
T Consensus       166 ----~~~~~~~~~~y~aPE~~~  183 (292)
T cd06644         166 ----RRDSFIGTPYWMAPEVVM  183 (292)
T ss_pred             ----ccceecCCccccCceeec
Confidence                223456889999999873

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.95  E-value=7.4e-27  Score=205.38  Aligned_cols=167  Identities=30%  Similarity=0.579  Sum_probs=140.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|.++  ++.+++|.+....    .....+.+|+.+++.++||||+++++++.....++++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            4666789999999999999875  7789999876432    224678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||+.+  ++||||||+||++  +..+.+||+|||+++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE--cCCCcEEeCCCccccccccce
Confidence            99999999999753  35889999999999999999999987  9999999999999  778899999999998765432


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .   .......+++.|+|||.+
T Consensus       159 ~---~~~~~~~~~~~y~aPE~~  177 (263)
T cd05052         159 Y---TAHAGAKFPIKWTAPESL  177 (263)
T ss_pred             e---eccCCCCCccccCCHHHh
Confidence            1   112233456789999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=7.6e-27  Score=209.46  Aligned_cols=168  Identities=28%  Similarity=0.487  Sum_probs=141.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++..+  ++.|++|.+.......  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            6888899999999999999875  7789999886443221  22456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+.+ +|.+++... ..+++..+..++.||+.||.|||+.+  |+|+||||+||++  +.++.+||+|||+++.......
T Consensus        85 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          85 YLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEE--CCCCcEEECcCcchhccCCCCC
Confidence            9974 898888753 46889999999999999999999987  9999999999999  7788999999999976543321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+++.|+|||++.
T Consensus       160 ----~~~~~~~~~~y~~PE~~~  177 (301)
T cd07873         160 ----TYSNEVVTLWYRPPDILL  177 (301)
T ss_pred             ----cccccceeecccCcHHHh
Confidence                233456799999999863

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=1.4e-26  Score=203.68  Aligned_cols=174  Identities=26%  Similarity=0.513  Sum_probs=144.7

Q ss_pred             CccccceecccCceeEEEEEE-CCceEEEEEecCCCCc---hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW-RGTPVAIKRILPSLSD---DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~-~g~~vavK~l~~~~~~---~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      +|...+.||+|+||.||++.. .++.+++|.+......   .......+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            366778999999999999986 4778999988654322   223345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      +||+++++|.+++.....+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEE--CCCCeEEeccchhhHhhhhcc
Confidence            999999999999988778999999999999999999999987  9999999999999  788899999999987653211


Q ss_pred             cc--ceeeeeCCcccccccccccc
Q 019685          314 SH--DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~--~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..  .........|+..|+|||.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~  180 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVI  180 (265)
T ss_pred             ccccccccccccCCCccccChhhh
Confidence            10  00012345689999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=1.3e-26  Score=203.54  Aligned_cols=174  Identities=29%  Similarity=0.523  Sum_probs=148.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+...... ....+.+..|+.+++.++|+||+++++.+...+.+++++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            4677789999999999999874  788999998665443 3456788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.+||+|||++.........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~--~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEcccccccccCCCCCc
Confidence            9999999999988777899999999999999999999987  9999999999999  77889999999999887654322


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .........+++.|+|||++.
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~  176 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVIT  176 (264)
T ss_pred             ccccccCCcCCcCccChhhcc
Confidence            111123457889999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.95  E-value=6.5e-27  Score=208.33  Aligned_cols=168  Identities=31%  Similarity=0.504  Sum_probs=133.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEe-----C
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTE-----R  227 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~-----~  227 (337)
                      +|+..+.||+|+||.||+|..+  ++.+|+|.+........ ......+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4677889999999999999875  77899998865432221 112344566665554   79999999998764     2


Q ss_pred             CceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          228 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      ...+++|||+.+ +|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili--~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV--TSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECccCc
Confidence            458999999975 898888753  34899999999999999999999988  9999999999999  7888999999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++......     ......||+.|+|||++.
T Consensus       155 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~  180 (288)
T cd07863         155 ARIYSCQM-----ALTPVVVTLWYRAPEVLL  180 (288)
T ss_pred             cccccCcc-----cCCCccccccccCchHhh
Confidence            98765332     123456899999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=1.9e-26  Score=201.82  Aligned_cols=170  Identities=25%  Similarity=0.451  Sum_probs=144.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||.|+||.||.+...  ++.+++|.+....... .....+.+|+.++++++|+||+++++++.....++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            4778889999999988887764  7889999886543332 334677899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.+||+|||+++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~--~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEE--eCCCCEEECcCcceEEccccc
Confidence            99999999999764  45899999999999999999999987  9999999999999  777889999999998765443


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......|++.|+|||.+.
T Consensus       156 ~----~~~~~~~~~~y~ape~~~  174 (256)
T cd08221         156 S----MAETVVGTPYYMSPELCQ  174 (256)
T ss_pred             c----cccccCCCccccCHhhcC
Confidence            2    234456899999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=1.2e-26  Score=204.77  Aligned_cols=164  Identities=30%  Similarity=0.412  Sum_probs=133.3

Q ss_pred             eecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      .||+|+||.||+|.+.    +..+++|.+.....  ......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            6899999999999864    34688888765432  22335688899999999999999999999998999999999999


Q ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          240 GDLHKYLKEKG-----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       240 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ++|.+++....     ..++..+..++.|++.||.|||+.+  ++||||||+||++  +..+.+||+|||+++.......
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~--~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLL--TADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE--cCCCcEEECCccccccccCcce
Confidence            99999997422     3566778899999999999999987  9999999999999  7788999999999975432211


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                        ........+++.|+|||++
T Consensus       156 --~~~~~~~~~~~~y~aPE~~  174 (269)
T cd05087         156 --YVTPDQLWVPLRWIAPELV  174 (269)
T ss_pred             --eecCCCcCCcccccCHhHh
Confidence              1112345678899999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=1.6e-26  Score=205.56  Aligned_cols=173  Identities=31%  Similarity=0.526  Sum_probs=139.8

Q ss_pred             CcCccccceecccCceeEEEEEE------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--C
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--R  227 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~  227 (337)
                      +.+|+..+.||+|+||.||++.+      .+..|++|.+....   ....+.+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            34778889999999999999875      26789999875432   3345678899999999999999999997643  3


Q ss_pred             CceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          228 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      ..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili--~~~~~~~l~dfg~~  155 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILV--ESENRVKIGDFGLT  155 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEE--CCCCeEEECCCccc
Confidence            4689999999999999999764 46899999999999999999999987  9999999999999  77889999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +........ ........++..|+|||++.
T Consensus       156 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  184 (284)
T cd05081         156 KVLPQDKEY-YKVREPGESPIFWYAPESLT  184 (284)
T ss_pred             ccccCCCcc-eeecCCCCCceEeeCHHHhc
Confidence            876543221 11112223456799999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.2e-27  Score=206.93  Aligned_cols=167  Identities=28%  Similarity=0.429  Sum_probs=144.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||++...  +..+++|.+...   .....+.+..|+.+++.++||||+++++.+......|+|||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            5888899999999999999875  778999988543   23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.++|+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILL--TLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--CCCCCEEEccCccchhhccccc
Confidence            99999999998764 46899999999999999999999988  9999999999999  7888999999999876543321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......+++.|+|||.+
T Consensus       159 ----~~~~~~~~~~y~~PE~~  175 (280)
T cd06611         159 ----KRDTFIGTPYWMAPEVV  175 (280)
T ss_pred             ----ccceeecchhhcCHHHH
Confidence                22345689999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=9.9e-27  Score=207.51  Aligned_cols=171  Identities=26%  Similarity=0.412  Sum_probs=143.7

Q ss_pred             CccccceecccCceeEEEEEE-----CCceEEEEEecCCCCc-hHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~  230 (337)
                      +|+..+.||+|+||.||++..     +|..+++|.+...... .....+.+.+|+.++..+. |++|+++++.+.....+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778999999999999886     4788999988653221 2223466788999999995 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++||||+|+|||+  +.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEE--CCCCCEEEeeCccceecc
Confidence            999999999999999988778999999999999999999999987  9999999999999  778899999999998765


Q ss_pred             cccccceeeeeCCcccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .....   ......|+..|+|||.+
T Consensus       157 ~~~~~---~~~~~~~~~~y~aPE~~  178 (290)
T cd05613         157 EDEVE---RAYSFCGTIEYMAPDIV  178 (290)
T ss_pred             ccccc---ccccccCCcccCChhhc
Confidence            43211   22345689999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.95  E-value=1.3e-26  Score=203.50  Aligned_cols=163  Identities=29%  Similarity=0.443  Sum_probs=142.7

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      ||.|+||.||++...  ++.+++|.+.+.........+.+.+|+.+++.++||||+++++.+.+...+++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999987  789999998765544444557889999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeC
Q 019685          243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG  322 (337)
Q Consensus       243 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~  322 (337)
                      .+++.....+++..+..++.||+.||.|||+.+  ++|+||+|+||++  +.++.+||+|||+++......     ....
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv--~~~~~~~l~df~~~~~~~~~~-----~~~~  151 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQ-----KTWT  151 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE--cCCCCEEEeeCCcccccCccc-----cccc
Confidence            999988777999999999999999999999987  9999999999999  778899999999998765432     1233


Q ss_pred             Cccccccccccccc
Q 019685          323 ETGSCEYLVSNCSF  336 (337)
Q Consensus       323 ~~gt~~y~aPE~l~  336 (337)
                      ..+++.|+|||.+.
T Consensus       152 ~~~~~~~~~PE~~~  165 (262)
T cd05572         152 FCGTPEYVAPEIIL  165 (262)
T ss_pred             ccCCcCccChhHhc
Confidence            46889999999863

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=4.5e-27  Score=209.12  Aligned_cols=170  Identities=29%  Similarity=0.503  Sum_probs=145.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|.++  ++.+++|.+....... ...+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            5777889999999999999985  7889999876543322 334667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.++......+++.++..++.||+.||.|||+.+  |+|+||+|+||++  +.++.+||+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--CCCCcEEEEeeeeeeeccCCcc-
Confidence            9999999888776667999999999999999999999987  9999999999999  7788999999999987654321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......++..|+|||++.
T Consensus       156 ---~~~~~~~~~~y~aPE~~~  173 (286)
T cd07846         156 ---VYTDYVATRWYRAPELLV  173 (286)
T ss_pred             ---ccCcccceeeccCcHHhc
Confidence               233456899999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=1.2e-26  Score=206.92  Aligned_cols=170  Identities=31%  Similarity=0.530  Sum_probs=140.8

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|.+.+.||+|+||.||++...       +..+++|.+....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            6778889999999999999752       3457888775432   33456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc
Q 019685          231 MLITEYLRGGDLHKYLKEKG-------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH  297 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~  297 (337)
                      +++|||+++++|.+++...+             .+++..+..++.|++.||.|||+++  ++||||||+||++  +..+.
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili--~~~~~  158 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV--GENLL  158 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE--ccCCc
Confidence            99999999999999997543             3899999999999999999999987  9999999999999  78889


Q ss_pred             EEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       298 ~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +||+|||+++.+.....  ........+++.|+|||++.
T Consensus       159 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  195 (288)
T cd05093         159 VKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIM  195 (288)
T ss_pred             EEeccCCccccccCCce--eecCCCCCccccccCHHHhc
Confidence            99999999986643221  11223445688999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=2.6e-26  Score=202.28  Aligned_cols=175  Identities=31%  Similarity=0.550  Sum_probs=144.0

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCc--hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--Cce
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPL  230 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~  230 (337)
                      .+|+..+.||+|+||.||++...  +..+++|.+......  .......+.+|+.+++.++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888899999999999999864  788999988654322  223456788999999999999999999988653  568


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ++++||+++++|.+++.....+++.....++.|++.||.|||+.+  |+||||+|+||++  +..+.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~--~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEccCCCccccc
Confidence            999999999999999987777999999999999999999999977  9999999999999  778899999999998654


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...... .......++..|+|||.+.
T Consensus       158 ~~~~~~-~~~~~~~~~~~y~aPE~~~  182 (266)
T cd06651         158 TICMSG-TGIRSVTGTPYWMSPEVIS  182 (266)
T ss_pred             cccccC-CccccCCccccccCHHHhC
Confidence            321100 1123456899999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.95  E-value=1.1e-26  Score=206.04  Aligned_cols=163  Identities=28%  Similarity=0.391  Sum_probs=133.6

Q ss_pred             eecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHH---HHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV---NLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .||+|+||.||++...  ++.||+|.+.+...........+..|.   ..++...||+|+++++.+......++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4799999999999864  789999998765433222222233343   34445679999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccccee
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY  318 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~  318 (337)
                      +++|.+++...+.+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.+....     
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili--~~~~~~kl~dfg~~~~~~~~~-----  151 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKKK-----  151 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEE--CCCCCEEEccCcCccccCccC-----
Confidence            9999999987778999999999999999999999987  9999999999999  778899999999997654321     


Q ss_pred             eeeCCccccccccccccc
Q 019685          319 KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       319 ~~~~~~gt~~y~aPE~l~  336 (337)
                       .....|+..|+|||++.
T Consensus       152 -~~~~~~~~~y~aPE~~~  168 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQ  168 (278)
T ss_pred             -CcCcCCCcCCcCcHHhc
Confidence             23457999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=1.1e-26  Score=204.39  Aligned_cols=160  Identities=18%  Similarity=0.354  Sum_probs=130.3

Q ss_pred             eecccCceeEEEEEEC--------------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          164 IIGKGSFGEILKAYWR--------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--------------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      .||+|+||.||+|...              ...+++|.+....   ......+.+|+.++..++||||+++++++.....
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            6899999999999753              1247778765432   2234577889999999999999999999998889


Q ss_pred             eEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC-----CcEEEEec
Q 019685          230 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-----DHLKVGDF  303 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~-----~~~kl~DF  303 (337)
                      .+++|||+++++|..++.. ...+++..+..++.||+.||.|||+.+  |+||||||+|||+..+..     ..+|++||
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999998875 356899999999999999999999987  999999999999943221     13899999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |++.....        .....+++.|||||.+.
T Consensus       157 g~~~~~~~--------~~~~~~~~~y~aPE~~~  181 (262)
T cd05077         157 GIPITVLS--------RQECVERIPWIAPECVE  181 (262)
T ss_pred             CCCccccC--------cccccccccccChhhhc
Confidence            99865532        23346788999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=1.9e-26  Score=205.17  Aligned_cols=172  Identities=31%  Similarity=0.556  Sum_probs=142.1

Q ss_pred             CccccceecccCceeEEEEEEC------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--Cc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~  229 (337)
                      .|++.+.||+|+||.||++.+.      +..+++|.+.....  ......+.+|+.+++.++||||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            5678889999999999999742      66799998865432  33456788999999999999999999988765  56


Q ss_pred             eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+++|||+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~--~~~~~~~l~dfg~~~~  158 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV--ESEHQVKIGDFGLTKA  158 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEE--cCCCCEEECCCccccc
Confidence            89999999999999999764 35899999999999999999999987  9999999999999  7788999999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +...... ........++..|+|||++.
T Consensus       159 ~~~~~~~-~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         159 IETDKEY-YTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             cccCccc-eeecCCCCCCccccCHHHhc
Confidence            6543221 11223456788899999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=1.8e-26  Score=206.65  Aligned_cols=167  Identities=28%  Similarity=0.464  Sum_probs=143.7

Q ss_pred             cCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||.|+||.||++..  .++.+++|.+......   ..+.+.+|+.+++.++||||+++++.+.....+|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            3688889999999999999986  4789999988654322   2366788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++... .+++.++..++.|++.||.|||+.+  ++|+||||+||++  +.++.+||+|||++........
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili--~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLL--GMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEccCccchhcccccc
Confidence            999999999988653 5899999999999999999999987  9999999999999  7788999999999887654322


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......+++.|+|||.+
T Consensus       171 ----~~~~~~~~~~y~aPE~~  187 (296)
T cd06655         171 ----KRSTMVGTPYWMAPEVV  187 (296)
T ss_pred             ----cCCCcCCCccccCcchh
Confidence                12345689999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=1.3e-26  Score=206.99  Aligned_cols=177  Identities=30%  Similarity=0.576  Sum_probs=142.9

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeee
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF  220 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~  220 (337)
                      .|+++..  +|+..+.||+|+||.||++...+       ..+++|.+.....  ......+.+|+.++..+ +|+||+++
T Consensus         6 ~~~~~~~--~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~   81 (293)
T cd05053           6 EWELPRD--RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINL   81 (293)
T ss_pred             ccccCHh--HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            3444433  57778899999999999998642       4688898865432  22346688899999999 79999999


Q ss_pred             eeeEEeCCceEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCC
Q 019685          221 LGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK  284 (337)
Q Consensus       221 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlk  284 (337)
                      ++++...+.++++|||+++++|.+++...                ..+++..+..++.|++.||.|||+.+  |+|||||
T Consensus        82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlk  159 (293)
T cd05053          82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLA  159 (293)
T ss_pred             EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccc
Confidence            99999999999999999999999999642                35788999999999999999999977  9999999


Q ss_pred             CCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       285 p~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |+||++  +.++.+||+|||+++.+......  .......+++.|+|||.+
T Consensus       160 p~Nil~--~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~  206 (293)
T cd05053         160 ARNVLV--TEDHVMKIADFGLARDIHHIDYY--RKTTNGRLPVKWMAPEAL  206 (293)
T ss_pred             eeeEEE--cCCCeEEeCccccccccccccce--eccCCCCCCccccCHHHh
Confidence            999999  77889999999999876543211  112233456789999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=1.4e-26  Score=208.11  Aligned_cols=173  Identities=29%  Similarity=0.519  Sum_probs=140.9

Q ss_pred             CcCccccceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT  225 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~  225 (337)
                      ..+|.+.+.||+|+||.||++.+.         +..+++|.+.....  ......+.+|+.+++.+ +||||+++++.+.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            446788899999999999999752         23688888754322  23346788999999999 7999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEE
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL  289 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil  289 (337)
                      .....|++|||+.+++|.+++...                ..++..++..++.||+.||.|||+.+  |+||||||+||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence            999999999999999999999753                23677888999999999999999987  999999999999


Q ss_pred             EecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       290 ~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +  +..+.+||+|||+++.+......  .......+++.|+|||++.
T Consensus       170 i--~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  212 (304)
T cd05101         170 V--TENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALF  212 (304)
T ss_pred             E--cCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhc
Confidence            9  77889999999999876543211  1123345678899999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-27  Score=216.48  Aligned_cols=165  Identities=27%  Similarity=0.560  Sum_probs=141.0

Q ss_pred             ccceecccCceeEEEEEEC----Cc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          161 SSAIIGKGSFGEILKAYWR----GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       161 ~~~~lg~G~~g~V~~~~~~----g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ..+.||.|.||.||+|.+.    |.  -||||..+.+..  ....+.|+.|+.+|+.+.||||++++|++.+ .+.||||
T Consensus       393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            4578999999999999985    22  478887765433  2336889999999999999999999999875 5789999


Q ss_pred             eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++.|.|..+++.+ ..++......++.||+.||.|||+.+  .|||||..+|||+  ....-|||+|||+++.+.++ 
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLV--sSp~CVKLaDFGLSR~~ed~-  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILV--SSPQCVKLADFGLSRYLEDD-  544 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheee--cCcceeeecccchhhhcccc-
Confidence            999999999999864 45888899999999999999999987  9999999999999  66668999999999998765 


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                        .+++.....-++.|||||.|
T Consensus       545 --~yYkaS~~kLPIKWmaPESI  564 (974)
T KOG4257|consen  545 --AYYKASRGKLPIKWMAPESI  564 (974)
T ss_pred             --chhhccccccceeecCcccc
Confidence              34555666678999999986

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=2.2e-26  Score=201.65  Aligned_cols=165  Identities=27%  Similarity=0.496  Sum_probs=136.3

Q ss_pred             eecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      .||+|+||.||+|.++    +..+++|++.... ......+.+..|+.+++.++||||+++++++. ....+++|||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            5899999999999753    6789999875443 23345677889999999999999999999875 4567999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|.+++.....+++..+..++.|++.||.|||+++  |+||||||+||++  +.++.+||+|||+++........ ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill--~~~~~~kl~Dfg~~~~~~~~~~~-~~~  154 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALGADENY-YKA  154 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEE--cCCCeEEECCCccccccCCCCCe-eee
Confidence            999999987778999999999999999999999987  9999999999999  77789999999999876543221 111


Q ss_pred             eeCCcccccccccccc
Q 019685          320 MTGETGSCEYLVSNCS  335 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l  335 (337)
                      .....+++.|+|||.+
T Consensus       155 ~~~~~~~~~y~aPE~~  170 (257)
T cd05116         155 KTHGKWPVKWYAPECM  170 (257)
T ss_pred             cCCCCCCccccCHhHh
Confidence            2233456899999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=9.9e-27  Score=203.73  Aligned_cols=156  Identities=20%  Similarity=0.384  Sum_probs=130.1

Q ss_pred             eecccCceeEEEEEECCce------------EEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          164 IIGKGSFGEILKAYWRGTP------------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~g~~------------vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      .||+|+||.||++......            +++|.+.....    ....+.+|+.+++.++||||+++++++.. ...+
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            6899999999999986332            66666543321    14778889999999999999999999887 7789


Q ss_pred             EEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-------cEEEEec
Q 019685          232 LITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-------HLKVGDF  303 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-------~~kl~DF  303 (337)
                      +||||+++++|.+++.... .++...+..++.||+.||.|||+++  |+||||||+||++  +..+       .+||+||
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill--~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILV--ARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEE--ecCccccCCceeEEeCCC
Confidence            9999999999999998755 7899999999999999999999987  9999999999999  4444       7999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |++.....        .....++..|+|||++.
T Consensus       153 g~a~~~~~--------~~~~~~~~~y~aPE~~~  177 (259)
T cd05037         153 GIPITVLS--------REERVERIPWIAPECIR  177 (259)
T ss_pred             Cccccccc--------ccccccCCCccChhhhc
Confidence            99976543        12345678899999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.94  E-value=1.7e-26  Score=206.86  Aligned_cols=167  Identities=25%  Similarity=0.424  Sum_probs=143.4

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++...  ++.+++|.+......   ..+.+.+|+.+++.++|+||+++++.+......|+||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            37888899999999999999864  889999988654332   2366788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||++........
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili--~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEECcCccceEccCCcc
Confidence            99999999999864 45889999999999999999999987  9999999999999  7788999999999977643321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......+++.|+|||.+
T Consensus       171 ----~~~~~~~~~~y~aPE~~  187 (297)
T cd06656         171 ----KRSTMVGTPYWMAPEVV  187 (297)
T ss_pred             ----CcCcccCCccccCHHHH
Confidence                12345689999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=1.7e-26  Score=202.28  Aligned_cols=163  Identities=34%  Similarity=0.603  Sum_probs=138.1

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE-eCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~~lv~e~  236 (337)
                      +|...+.||+|+||.||++..++..+++|.+....     ..+.+.+|+.+++.++|++++++++++. ..+..+++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            67778899999999999999999999999885432     2356888999999999999999999754 55678999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++....  .+++..+..++.|++.||.|||+++  |+||||||+||++  +.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEE--cCCCcEEecCCccceeccccC-
Confidence            99999999997643  3788999999999999999999987  9999999999999  778899999999997654321 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                            ....++..|+|||++.
T Consensus       157 ------~~~~~~~~y~aPE~~~  172 (256)
T cd05082         157 ------DTGKLPVKWTAPEALR  172 (256)
T ss_pred             ------CCCccceeecCHHHHc
Confidence                  2334567899999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=2.3e-26  Score=201.73  Aligned_cols=165  Identities=30%  Similarity=0.520  Sum_probs=134.0

Q ss_pred             eecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      .||+|+||.||+|.++    +..+++|.+....  .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            4899999999999764    3468899886543  2334567889999999999999999999875 4578999999999


Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccccee
Q 019685          240 GDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY  318 (337)
Q Consensus       240 ~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~  318 (337)
                      ++|.+++.. ...+++..+..++.|++.||.|||+++  ++||||||+||++  +.++.+||+|||+++......... .
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~~~~-~  153 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLL--VNQHYAKISDFGLSKALGADDSYY-K  153 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEE--cCCCcEEeccCCccccccCCccce-e
Confidence            999999975 456899999999999999999999987  9999999999999  777899999999998665432211 1


Q ss_pred             eeeCCccccccccccccc
Q 019685          319 KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       319 ~~~~~~gt~~y~aPE~l~  336 (337)
                      ......+++.|+|||++.
T Consensus       154 ~~~~~~~~~~y~aPE~~~  171 (257)
T cd05115         154 ARSAGKWPLKWYAPECIN  171 (257)
T ss_pred             ccCCCCCCcccCCHHHHc
Confidence            122233467899999763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1e-26  Score=206.91  Aligned_cols=166  Identities=27%  Similarity=0.474  Sum_probs=142.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  +..+++|.+.....  ......+.+|+.++++++||||+++++.+...+..|+|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            5777889999999999999986  78899998864322  2234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       236 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+ .+  |+||||||+||++  +..+.+||+|||++..+..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV--NGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEE--CCCCCEEEeecCCcccccC
Confidence            99999999998763   368999999999999999999996 46  9999999999999  7788999999999976643


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .      ......+++.|+|||.+
T Consensus       156 ~------~~~~~~~~~~y~aPE~~  173 (286)
T cd06622         156 S------LAKTNIGCQSYMAPERI  173 (286)
T ss_pred             C------ccccCCCccCccCcchh
Confidence            2      12345688899999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.94  E-value=2.1e-26  Score=201.41  Aligned_cols=170  Identities=29%  Similarity=0.510  Sum_probs=146.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCC--chHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      +|+..+.||+|+||.||+|...  ++.+++|.+.....  ......+.+.+|+.+++.++|+||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3566789999999999999875  78899998855332  1233457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      +||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+|+||+|+||++  +.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~--~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEccCccceeccccc
Confidence            999999999999988777999999999999999999999987  9999999999999  778899999999998765432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......|++.|+|||.+.
T Consensus       157 -----~~~~~~~~~~y~~pe~~~  174 (258)
T cd06632         157 -----FAKSFKGSPYWMAPEVIA  174 (258)
T ss_pred             -----cccccCCCcceeCHHHhc
Confidence                 234566899999999763

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.94  E-value=2.1e-26  Score=205.28  Aligned_cols=170  Identities=27%  Similarity=0.445  Sum_probs=137.4

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|++.+.||+|+||.||+|..+       +..+++|.+.....  ......+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            6778889999999999998753       34789998754332  22335678899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEE
Q 019685          231 MLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV  300 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl  300 (337)
                      +++|||+++|+|.+++...          ...+...+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili--~~~~~~~L  160 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMV--AHDFTVKI  160 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEE--cCCCcEEE
Confidence            9999999999999999752          12456788899999999999999987  9999999999999  77889999


Q ss_pred             EeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +|||+++.+.....  ........++..|+|||.+
T Consensus       161 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~  193 (288)
T cd05061         161 GDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESL  193 (288)
T ss_pred             CcCCcccccccccc--ccccCCCcccccccCHHHh
Confidence            99999986543221  1112223457889999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.94  E-value=1.4e-26  Score=211.64  Aligned_cols=171  Identities=29%  Similarity=0.524  Sum_probs=137.0

Q ss_pred             CccccceecccCceeEEEEEE-------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC-C
Q 019685          158 DFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-K  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~-------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-~  228 (337)
                      +|.+.+.||+|+||.||+|.+       .++.||+|.+.....  ......+.+|+.++..+ +||||+++++++... .
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            688889999999999999974       256899999865432  22346788899999999 589999999987654 5


Q ss_pred             ceEEEEeecCCCCHHHHHHhcC----------------------------------------------------------
Q 019685          229 PLMLITEYLRGGDLHKYLKEKG----------------------------------------------------------  250 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------  250 (337)
                      .++++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6899999999999999986421                                                          


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeee
Q 019685          251 ---------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT  321 (337)
Q Consensus       251 ---------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~  321 (337)
                               .+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||+++.......  .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~--~~~~~  239 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPD--YVRKG  239 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEE--cCCCcEEEEecccccccccCcc--hhhcC
Confidence                     2567788899999999999999987  9999999999999  7788999999999987543211  11223


Q ss_pred             CCccccccccccccc
Q 019685          322 GETGSCEYLVSNCSF  336 (337)
Q Consensus       322 ~~~gt~~y~aPE~l~  336 (337)
                      ...+++.|+|||++.
T Consensus       240 ~~~~~~~y~aPE~~~  254 (343)
T cd05103         240 DARLPLKWMAPETIF  254 (343)
T ss_pred             CCCCCcceECcHHhc
Confidence            345678899999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=4.7e-27  Score=224.57  Aligned_cols=172  Identities=19%  Similarity=0.277  Sum_probs=132.5

Q ss_pred             cCccccceecccCceeEEEEEECC---ceEEEE--------------EecCCCCchHHHHHHHHHHHHHHHhCCCCCeee
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRG---TPVAIK--------------RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ  219 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g---~~vavK--------------~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~  219 (337)
                      .+|++.+.||+|+||.||+|..+.   ...+.|              .+.+...........+.+|+.+++.++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            378999999999999999987542   111212              111111112223456789999999999999999


Q ss_pred             eeeeEEeCCceEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC
Q 019685          220 FLGAVTERKPLMLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS  294 (337)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~  294 (337)
                      +++++...+..|+++|++.+ +|.+++...     .......+..++.||+.||.|||+++  ||||||||+|||+  +.
T Consensus       228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl--~~  302 (501)
T PHA03210        228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL--NC  302 (501)
T ss_pred             EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CC
Confidence            99999999999999999854 777776532     22345678889999999999999987  9999999999999  78


Q ss_pred             CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+.+||+|||+++.+.....   .......||+.|+|||++.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~  341 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILA  341 (501)
T ss_pred             CCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhc
Confidence            88999999999987754321   1223467999999999874

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.3e-26  Score=201.39  Aligned_cols=174  Identities=31%  Similarity=0.558  Sum_probs=143.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCC--chHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~  231 (337)
                      +|...+.||+|+||.||++...  +..+++|.+.....  ........+.+|+.++++++|+||+++++++...  ..++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            6788899999999999999874  78899998754321  2233456788999999999999999999998664  4588


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +++||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||||+||++  +.++.++|+|||+++....
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILR--DSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEECcccccccccc
Confidence            99999999999999987777899999999999999999999987  9999999999999  7788999999999987643


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..... .......++..|+|||.+.
T Consensus       159 ~~~~~-~~~~~~~~~~~y~aPE~~~  182 (264)
T cd06653         159 ICMSG-TGIKSVTGTPYWMSPEVIS  182 (264)
T ss_pred             ccccC-ccccccCCcccccCHhhhc
Confidence            21110 1123456899999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.94  E-value=3.4e-26  Score=200.19  Aligned_cols=170  Identities=31%  Similarity=0.511  Sum_probs=141.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-CCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~  234 (337)
                      .|+..+.||+|++|.||++...  ++.+++|.+...... ....+.+.+|+.+++.++|+|++++++.+.. ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            3677889999999999999875  678999988654332 2234667889999999999999999998764 34689999


Q ss_pred             eecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||+++++|.+++...  ..+++.++..++.|++.|+.|||+.+  |+|+||||+||++  +..+.++|+|||+++.+...
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~--~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFL--TRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEE--ecCCcEEEecccceEEeccc
Confidence            999999999999763  35899999999999999999999987  9999999999999  77889999999999877543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......+++.|+|||++.
T Consensus       156 ~~----~~~~~~~~~~y~aPE~~~  175 (257)
T cd08223         156 CD----MASTLIGTPYYMSPELFS  175 (257)
T ss_pred             CC----ccccccCCcCccChhHhc
Confidence            22    234566899999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=1e-26  Score=205.96  Aligned_cols=160  Identities=20%  Similarity=0.369  Sum_probs=129.9

Q ss_pred             eecccCceeEEEEEEC--------------------------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCe
Q 019685          164 IIGKGSFGEILKAYWR--------------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI  217 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--------------------------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~I  217 (337)
                      .||+|+||.||+|...                          ...+++|.+....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            6899999999998742                          1247778775432   2334677889999999999999


Q ss_pred             eeeeeeEEeCCceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC--
Q 019685          218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS--  294 (337)
Q Consensus       218 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~--  294 (337)
                      +++++++......++||||+++++|..++.. .+.+++..+..++.||+.||.|||+++  |+||||||+|||+....  
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999999999875 456899999999999999999999987  99999999999994321  


Q ss_pred             ---CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ---ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ---~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ...+|++|||++......        ....+++.|+|||.+.
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~  193 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVP  193 (274)
T ss_pred             cCccceeeecCCccccccccc--------cccccCCcccCchhhc
Confidence               234899999998644321        2245788899999763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.94  E-value=3.6e-26  Score=201.52  Aligned_cols=164  Identities=33%  Similarity=0.525  Sum_probs=137.0

Q ss_pred             ccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          161 SSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       161 ~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      ....||+|+||.||++.+.  +..+++|.+.....   ...+.+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   88 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP   88 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence            3458999999999999875  56799998754432   234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCceeeecccc
Q 019685          239 GGDLHKYLKEK-GAL--SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       239 ~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++|.+++... ..+  ++..+..++.||+.||.|||+.+  |+||||||+||++  +. .+.+||+|||++..+...+.
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCeEEEecchhheecccCCC
Confidence            99999999764 445  78888999999999999999987  9999999999999  44 56899999999976643321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......|++.|+|||++
T Consensus       165 ----~~~~~~~~~~~~aPE~~  181 (268)
T cd06624         165 ----CTETFTGTLQYMAPEVI  181 (268)
T ss_pred             ----ccccCCCCccccChhhh
Confidence                12334689999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.94  E-value=4.5e-27  Score=208.95  Aligned_cols=169  Identities=31%  Similarity=0.547  Sum_probs=140.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  |..+++|.+...... ......+.+|+.+++.++||||+++++++.+....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            3667789999999999999985  788999988653222 1223456779999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++ +|.+++.. ...+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||+++.......
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--cCCCcEEECccchhhccCCCCC
Confidence            9975 88887765 456899999999999999999999988  9999999999999  7788999999999986543321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+++.|+|||++.
T Consensus       155 ----~~~~~~~~~~y~aPE~~~  172 (284)
T cd07839         155 ----CYSAEVVTLWYRPPDVLF  172 (284)
T ss_pred             ----CcCCCccccCCcChHHHh
Confidence                234456789999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=2.4e-26  Score=203.01  Aligned_cols=173  Identities=29%  Similarity=0.482  Sum_probs=144.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCc-------hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-------DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      .|...+.||+|+||.||+|...  ++.+++|.+......       .....+.+..|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667789999999999999864  788999987532111       1112356788999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      ..++||||+.+++|.+++...+.+++..+..++.||+.||.|||+.+  ++|+||+|+||++  +..+.++|+|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~--~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLV--DADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEE--cCCCeEEEeecccccc
Confidence            99999999999999999988788999999999999999999999987  9999999999999  7788999999999976


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .......  .......|+..|+|||.+.
T Consensus       158 ~~~~~~~--~~~~~~~~~~~y~~PE~~~  183 (272)
T cd06629         158 SDDIYDN--DQNMSMQGSVFWMAPEVIH  183 (272)
T ss_pred             ccccccc--cccccccCCccccCHHHhc
Confidence            5432111  1223456899999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=1.6e-26  Score=204.83  Aligned_cols=162  Identities=30%  Similarity=0.452  Sum_probs=138.6

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      ||+|+||.||++...  ++.+++|.+.+...........+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865  788999988654433333445667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          243 HKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       243 ~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      .+++....  .+++.++..++.|++.||.|||+.+  ++|+||+|+||++  +.++.+||+|||++.......     ..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~--~~~~~~~l~dfg~~~~~~~~~-----~~  151 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGK-----KI  151 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEccCcchhhhccCC-----cc
Confidence            99997655  6899999999999999999999987  9999999999999  778899999999987654321     23


Q ss_pred             eCCcccccccccccc
Q 019685          321 TGETGSCEYLVSNCS  335 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l  335 (337)
                      ....++..|+|||++
T Consensus       152 ~~~~~~~~y~~PE~~  166 (277)
T cd05577         152 KGRAGTPGYMAPEVL  166 (277)
T ss_pred             ccccCCCCcCCHHHh
Confidence            445688999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.94  E-value=2.7e-26  Score=204.18  Aligned_cols=169  Identities=25%  Similarity=0.439  Sum_probs=138.9

Q ss_pred             CCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEE-----e
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVT-----E  226 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~-----~  226 (337)
                      ...+|++.+.||+|+||.||++...  ++.+++|.+.....    ....+..|+.+++.+ +||||+++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            3347888899999999999999874  77899998754221    125567899999998 6999999999874     3


Q ss_pred             CCceEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          227 RKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                      .+..+++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili--~~~~~~kl~d  167 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILL--TTEGGVKLVD  167 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEE--CCCCCEEEcc
Confidence            4568999999999999998753    245888999999999999999999987  9999999999999  7778899999


Q ss_pred             ccCceeeecccccceeeeeCCcccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||+++.+.....    ......|++.|+|||++
T Consensus       168 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~  196 (286)
T cd06638         168 FGVSAQLTSTRL----RRNTSVGTPFWMAPEVI  196 (286)
T ss_pred             CCceeecccCCC----ccccccCCCcccChhhh
Confidence            999987654321    23445699999999986

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.94  E-value=2.5e-26  Score=207.51  Aligned_cols=165  Identities=24%  Similarity=0.419  Sum_probs=131.1

Q ss_pred             ceecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--CCceEEEEee
Q 019685          163 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEY  236 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e~  236 (337)
                      ..||+|+||.||+|...    +..+|+|.+.....     ...+.+|+.+++.++||||+++++++..  ...+|++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            58999999999999864    46799998865432     1346789999999999999999998853  4578999999


Q ss_pred             cCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec--CCCCcEEEEeccC
Q 019685          237 LRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGL  305 (337)
Q Consensus       237 ~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~--~~~~~~kl~DFgl  305 (337)
                      +.+ +|.+++...         ..+++..+..++.||+.||.|||+.+  |+||||||+|||+..  +..+.+||+|||+
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            875 888887521         24788999999999999999999988  999999999999942  2456899999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.+..... .........||+.|+|||++.
T Consensus       159 a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~  188 (317)
T cd07867         159 ARLFNSPLK-PLADLDPVVVTFWYRAPELLL  188 (317)
T ss_pred             eeccCCCcc-cccccCcceecccccCcHHhc
Confidence            987654321 111234567899999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.7e-26  Score=207.69  Aligned_cols=165  Identities=20%  Similarity=0.288  Sum_probs=127.2

Q ss_pred             CcCccccceecccCceeEEEEEEC---CceEEEEEecCCCC--chHHHHHHHHHHHHHHHhCCCCCeee-eeeeEEeCCc
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQ-FLGAVTERKP  229 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~---g~~vavK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~-~~~~~~~~~~  229 (337)
                      ...|...+.||+|+||.||+|.++   ++.+|||.+.....  ........+.+|+.+++.++|+||+. +++.    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            337888999999999999999873   56679998754321  12334567899999999999999885 4432    45


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCC-CCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL-KPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdl-kp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .|+||||++|++|... ..   ..   ...++.|++.+|.|||+.|  |+|||| ||+|||+  +.++.+||+|||+|+.
T Consensus        93 ~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv--~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLM--GPDGEAAVIDFQLASV  161 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEE--cCCCCEEEEECcccee
Confidence            7999999999999632 11   11   1467899999999999988  999999 9999999  7778999999999998


Q ss_pred             eecccccce----eeeeCCcccccccccccc
Q 019685          309 IKVQNSHDV----YKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~----~~~~~~~gt~~y~aPE~l  335 (337)
                      +........    ....+..+++.|+|||++
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            765421111    012467789999999986

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.94  E-value=2.5e-26  Score=202.04  Aligned_cols=166  Identities=32%  Similarity=0.554  Sum_probs=137.6

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|++.+.||+|+||.||+|.+. ...+++|.+......    .+.+.+|+.+++.++||||+++++.+. ....+++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            5788889999999999999876 347899988653321    256788999999999999999999875 4568999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.+.....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill--~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEE--cCCCcEEeccCCceeecccccc
Confidence            9999999999753  35788999999999999999999987  9999999999999  7788899999999987654321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                         .......++..|+|||++
T Consensus       158 ---~~~~~~~~~~~y~~PE~~  175 (262)
T cd05071         158 ---TARQGAKFPIKWTAPEAA  175 (262)
T ss_pred             ---ccccCCcccceecCHhHh
Confidence               112344577889999976

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=2.8e-26  Score=201.34  Aligned_cols=166  Identities=31%  Similarity=0.568  Sum_probs=138.0

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|++.+.||+|+||.||++... +..+++|.+......    .+.+.+|+.++++++|++|+++++++. ....+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            5778889999999999999875 567899988654332    256888999999999999999999875 4568999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||++..+.....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili--~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV--GDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE--eCCceEEeCCceeeeeccCccc
Confidence            9999999999753  35899999999999999999999987  9999999999999  6778899999999987654321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                         .......++..|+|||.+
T Consensus       158 ---~~~~~~~~~~~y~aPE~~  175 (260)
T cd05070         158 ---TARQGAKFPIKWTAPEAA  175 (260)
T ss_pred             ---ccccCCCCCccccChHHH
Confidence               112334467789999976

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.94  E-value=1.3e-26  Score=211.21  Aligned_cols=171  Identities=30%  Similarity=0.534  Sum_probs=137.7

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC-C
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-K  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-~  228 (337)
                      +|++.+.||+|+||.||+|...       ++.|++|.+.....  ....+.+..|+.++.++ +|+||+++++++... .
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            5788899999999999999753       35799998864322  22346677899999999 699999999987644 5


Q ss_pred             ceEEEEeecCCCCHHHHHHhc-----------------------------------------------------------
Q 019685          229 PLMLITEYLRGGDLHKYLKEK-----------------------------------------------------------  249 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------------------  249 (337)
                      .++++|||+++++|.+++...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            689999999999999998642                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccc
Q 019685          250 --GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC  327 (337)
Q Consensus       250 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~  327 (337)
                        ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.+......  .......+++
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill--~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~  239 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDY--VRKGDARLPL  239 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEE--eCCCcEEEeccccchhcccCcch--hhccCCCCCc
Confidence              25788899999999999999999987  9999999999999  67789999999999876433211  1223445678


Q ss_pred             ccccccccc
Q 019685          328 EYLVSNCSF  336 (337)
Q Consensus       328 ~y~aPE~l~  336 (337)
                      .|||||++.
T Consensus       240 ~y~aPE~~~  248 (337)
T cd05054         240 KWMAPESIF  248 (337)
T ss_pred             cccCcHHhc
Confidence            899999763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.94  E-value=2e-26  Score=204.32  Aligned_cols=170  Identities=31%  Similarity=0.514  Sum_probs=141.7

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|.+.+.||+|+||.||+|...       +..+++|.+.....  ....+.+.+|+.+++.++|+||+++++++......
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            6778889999999999999763       35799998865433  22347889999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          231 MLITEYLRGGDLHKYLKEKG--------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      +++|||+++++|.+++...+              .+++..+..++.|++.||.|||+.+  ++||||||+||++  +.++
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili--~~~~  159 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV--GYDL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEE--cCCC
Confidence            99999999999999997542              3788899999999999999999987  9999999999999  7788


Q ss_pred             cEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .+||+|||+++.......  ........+++.|+|||++
T Consensus       160 ~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  196 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESI  196 (280)
T ss_pred             eEEECCcccceecccCcc--eecCCCCcccceecChhhh
Confidence            999999999976543211  1112344567899999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=1.1e-26  Score=203.75  Aligned_cols=169  Identities=32%  Similarity=0.560  Sum_probs=143.5

Q ss_pred             cCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .+|+..+.||+|+||.||+|.+. +..+++|.+.....   .....+..|+.+++.++|+||+++++++......+++||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            36888899999999999999986 57788998765432   234678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++...  ..+++..+..++.||+.||.|||+.+  |+|+||+|+||++  +.++.+||+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv--~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV--GEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEE--cCCceEEEccccchhhcCCcc
Confidence            99999999999753  35899999999999999999999987  9999999999999  778899999999998764332


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .......+++.|+|||.+.
T Consensus       159 ----~~~~~~~~~~~~~~PE~~~  177 (261)
T cd05148         159 ----YLSSDKKIPYKWTAPEAAS  177 (261)
T ss_pred             ----ccccCCCCceEecCHHHHc
Confidence                1223455778999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=2.9e-27  Score=190.06  Aligned_cols=168  Identities=23%  Similarity=0.455  Sum_probs=137.9

Q ss_pred             CccccceecccCceeEEEEE--ECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +......||+|++|.|-+.+  ..|+..|+|.+.....+ + ...+.+.|+.+..+. .+|++|.+||.+.+...+||.|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-Q-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-H-HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            45566789999999876554  46999999998765443 2 346677889886665 4999999999999999999999


Q ss_pred             eecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          235 EYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       235 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |.|.. ||..+.+    ..+.+++..+-+|+..|..||.|||++ ..+||||+||+|||+  +..|+||+||||++-.+.
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLI--n~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILI--NYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEE--ccCCcEEEcccccceeeh
Confidence            99855 8877755    356799999999999999999999997 459999999999999  999999999999998876


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.-     ..+...|...|||||.+.
T Consensus       201 dSi-----Akt~daGCkpYmaPEri~  221 (282)
T KOG0984|consen  201 DSI-----AKTMDAGCKPYMAPERIN  221 (282)
T ss_pred             hhh-----HHHHhcCCCccCChhhcC
Confidence            541     223356899999999874

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=1.5e-26  Score=219.92  Aligned_cols=170  Identities=19%  Similarity=0.335  Sum_probs=132.9

Q ss_pred             CCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC------CCeeeeeeeE
Q 019685          153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH------PNIVQFLGAV  224 (337)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h------~~Iv~~~~~~  224 (337)
                      +....+|.+.+.||+|+||.||+|...  ++.||||++....    ........|+.++..++|      .+++++++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            334567999999999999999999874  6789999985421    122344556766666644      4588898888


Q ss_pred             EeC-CceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCC--------
Q 019685          225 TER-KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSS--------  294 (337)
Q Consensus       225 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~--------  294 (337)
                      ... ..+|+|||++ +++|.+++...+.+++..+..++.||+.||.|||+ .+  ||||||||+|||+..+.        
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccc
Confidence            764 4689999988 67999999888889999999999999999999998 47  99999999999994321        


Q ss_pred             ------CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ------ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                            .+.+||+|||++.....       ......||+.|||||++.
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~  318 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVL  318 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhh
Confidence                  12599999998854322       234567999999999874

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=3.1e-26  Score=206.79  Aligned_cols=171  Identities=30%  Similarity=0.528  Sum_probs=138.8

Q ss_pred             CccccceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER  227 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~  227 (337)
                      +|...+.||+|+||.||++...         ...+++|.+.....  ......+..|+.+++.+ +||||+++++++...
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            6778899999999999999752         34688888765432  23356788899999999 599999999999988


Q ss_pred             CceEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEe
Q 019685          228 KPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV  291 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~  291 (337)
                      +..|++|||+.+++|.+++...                ..+++.++..++.||+.||.|||+.|  |+||||||+|||+ 
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill-  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLV-  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEE-
Confidence            9999999999999999999753                24788899999999999999999987  9999999999999 


Q ss_pred             cCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       292 ~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                       +.++.+||+|||+++.........  ......+++.|||||++.
T Consensus       168 -~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~  209 (314)
T cd05099         168 -TEDNVMKIADFGLARGVHDIDYYK--KTSNGRLPVKWMAPEALF  209 (314)
T ss_pred             -cCCCcEEEcccccccccccccccc--ccccCCCCccccCHHHHc
Confidence             778899999999998765332110  112233557899999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.4e-26  Score=202.21  Aligned_cols=170  Identities=30%  Similarity=0.603  Sum_probs=140.5

Q ss_pred             cCccccceecccCceeEEEEEEC--Cc----eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      .+|+..+.||+|+||.||+|.+.  +.    .+++|.+.....  ......+.+|+.+++.++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            36778889999999999999864  32    578887765433  3445778899999999999999999998877 788


Q ss_pred             EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +++|||+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||+++..
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~--~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEE--cCCCeEEECCCcccccc
Confidence            9999999999999999764 46899999999999999999999977  9999999999999  77889999999999877


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .....  ........+++.|+|||.+
T Consensus       160 ~~~~~--~~~~~~~~~~~~y~~PE~~  183 (279)
T cd05057         160 DVDEK--EYHAEGGKVPIKWMALESI  183 (279)
T ss_pred             cCccc--ceecCCCcccccccCHHHh
Confidence            53321  1122233456789999975

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.94  E-value=3.9e-26  Score=200.75  Aligned_cols=173  Identities=27%  Similarity=0.446  Sum_probs=145.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||++...  +..+++|++.......  ....+.+|+.+++.++|+||+++++.+...+..|++||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            5778889999999999999874  6789999886544332  45778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       236 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ++++++|.+++...   ..+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.+||+|||++..+...
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~--~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILL--GEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEE--cCCCCEEEcccchHHHhccC
Confidence            99999999999763   45899999999999999999999987  9999999999999  77788999999999877654


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ............|++.|+|||++.
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~  179 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVME  179 (267)
T ss_pred             ccccccccccccCChhhcChHHHc
Confidence            321111123446899999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.94  E-value=2.5e-26  Score=205.00  Aligned_cols=168  Identities=31%  Similarity=0.532  Sum_probs=138.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  ++.+++|.+.......  ....+.+|+.+++.++|+||+++++++......|+|||
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            6888899999999999999874  7899999986543221  12355689999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+. +++.+++.. ...+++..+..++.|++.||.|||+.+  |+|+||||+||++  +..+.+||+|||+++.......
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEE--cCCCcEEEeccccccccCCCCC
Confidence            996 577777654 345788889999999999999999987  9999999999999  7888999999999976543221


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+++.|+|||.+.
T Consensus       159 ----~~~~~~~~~~y~aPE~~~  176 (291)
T cd07870         159 ----TYSSEVVTLWYRPPDVLL  176 (291)
T ss_pred             ----CCCCccccccccCCceee
Confidence                123455789999999863

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.94  E-value=3.2e-26  Score=203.10  Aligned_cols=170  Identities=28%  Similarity=0.597  Sum_probs=139.4

Q ss_pred             CccccceecccCceeEEEEEEC--Cc----eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      +|+..+.||+|+||.||+|.+.  ++    .||+|.+.....  ......+.+|+.++..+.||||+++++++.. ...+
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            6778889999999999999863  44    478898865432  3344678889999999999999999998865 4578


Q ss_pred             EEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          232 LITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +++||+++|+|.+++.+. +.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~--~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLV--KSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEE--cCCCcEEECCCCceeecc
Confidence            999999999999999764 56899999999999999999999987  9999999999999  777889999999998775


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....  .......+++.|+|||.+.
T Consensus       161 ~~~~~--~~~~~~~~~~~y~~PE~~~  184 (279)
T cd05109         161 IDETE--YHADGGKVPIKWMALESIL  184 (279)
T ss_pred             cccce--eecCCCccchhhCCHHHhc
Confidence            43211  1123345678899999863

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.6e-26  Score=205.57  Aligned_cols=168  Identities=26%  Similarity=0.427  Sum_probs=145.0

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++...  ++.+++|.+.....  ....+.+.+|+.+++.++||||+++++.+...+.+++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            36788899999999999999876  78899998764322  234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++++|.+++...+.+++..+..++.+++.||.|||+ .+  ++||||+|+||++  +..+.++|+|||++...... 
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~--~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILV--NSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEE--CCCCcEEEccCCcccchhhh-
Confidence            999999999999887789999999999999999999997 46  9999999999999  77889999999998765332 


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......|+..|+|||++.
T Consensus       158 -----~~~~~~~~~~~~aPE~~~  175 (284)
T cd06620         158 -----IADTFVGTSTYMSPERIQ  175 (284)
T ss_pred             -----ccCccccCcccCCHHHHc
Confidence                 123457899999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=4.5e-26  Score=202.52  Aligned_cols=170  Identities=33%  Similarity=0.548  Sum_probs=137.1

Q ss_pred             ccccceecccCceeEEEEEE------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--Cce
Q 019685          159 FSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPL  230 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~  230 (337)
                      |...+.||+|+||.||++.+      .+..+++|.+.....  ......+.+|+.+++.++||||+++++++...  ..+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            37778999999999988754      256799998865422  23346778899999999999999999987653  458


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +++|||+++++|.+++... .+++.++..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.+.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLL--DNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEE--cCCCcEEEeecccccccC
Confidence            9999999999999999754 5999999999999999999999987  9999999999999  777899999999998765


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..... ........++..|+|||++.
T Consensus       159 ~~~~~-~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         159 EGHEY-YRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             Ccchh-hccCCCCCCCceeeCHhHhc
Confidence            43210 00112334677899999763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=2.7e-26  Score=204.71  Aligned_cols=170  Identities=33%  Similarity=0.577  Sum_probs=138.3

Q ss_pred             CccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|+..+.||+|+||.||+|....       ..+++|.+.....  ......+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            36677899999999999998642       3577787754432  23346788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCC
Q 019685          231 MLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR  286 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~  286 (337)
                      ++++||+.+++|.+++...                        ..+++..++.++.|++.||.|||+.+  |+||||||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~  156 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAAR  156 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhh
Confidence            9999999999999998642                        23678889999999999999999977  999999999


Q ss_pred             CEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       287 Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |||+  +.++.+||+|||+++.......  ........++..|+|||.+
T Consensus       157 nill--~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~apE~~  201 (290)
T cd05045         157 NVLV--AEGRKMKISDFGLSRDVYEEDS--YVKRSKGRIPVKWMAIESL  201 (290)
T ss_pred             eEEE--cCCCcEEeccccccccccCccc--hhcccCCCCCccccCHHHH
Confidence            9999  7778999999999986543321  1122334567889999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.94  E-value=2.3e-26  Score=205.14  Aligned_cols=168  Identities=32%  Similarity=0.526  Sum_probs=140.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|++|.||++..+  ++.|++|.+.......  ....+.+|+.+++.++|+||+++++++......++|||
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            6888899999999999999875  7889999986543221  12345679999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+.+ +|.+++... ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|||+++.......
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEE--cCCCCEEECccccccccCCCCc
Confidence            9985 999988753 46899999999999999999999987  9999999999999  7888999999999875432211


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+++.|+|||++.
T Consensus       159 ----~~~~~~~~~~~~aPE~~~  176 (291)
T cd07844         159 ----TYSNEVVTLWYRPPDVLL  176 (291)
T ss_pred             ----cccccccccccCCcHHhh
Confidence                123345789999999763

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.94  E-value=1.7e-26  Score=205.28  Aligned_cols=171  Identities=29%  Similarity=0.481  Sum_probs=140.6

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|...+.||+|+||.||+|...       +..+++|.+.....  ......+..|+.++..++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            4677789999999999999864       36799998864432  23446788899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC
Q 019685          231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS  294 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~  294 (337)
                      ++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~--~~  159 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLV--FD  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEe--cC
Confidence            9999999999999998532                24788889999999999999999987  9999999999999  77


Q ss_pred             CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.+||+|||+++.......  ........+++.|+|||.+.
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05091         160 KLNVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIM  199 (283)
T ss_pred             CCceEecccccccccccchh--eeeccCccCCccccCHHHHh
Confidence            78899999999987643321  11223445678999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.9e-26  Score=199.39  Aligned_cols=165  Identities=31%  Similarity=0.534  Sum_probs=136.6

Q ss_pred             ceecccCceeEEEEEEC--C---ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          163 AIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      +.||+|+||.||+|.+.  +   ..+++|.+......  ...+.+.+|+.+++.+.|+||+++++++. ....+++|||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            36899999999999874  2   56899988655433  34467889999999999999999999875 45689999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccce
Q 019685          238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV  317 (337)
Q Consensus       238 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~  317 (337)
                      ++++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||||+||++  +..+.+||+|||+++........ .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili--~~~~~~kl~df~~~~~~~~~~~~-~  152 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLL--VNRHQAKISDFGMSRALGAGSDY-Y  152 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEE--cCCCcEEeccccccceeecCCcc-c
Confidence            99999999988778999999999999999999999987  9999999999999  77889999999999877544321 1


Q ss_pred             eeeeCCcccccccccccc
Q 019685          318 YKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       318 ~~~~~~~gt~~y~aPE~l  335 (337)
                      .......++..|+|||.+
T Consensus       153 ~~~~~~~~~~~y~aPE~~  170 (257)
T cd05060         153 RATTAGRWPLKWYAPECI  170 (257)
T ss_pred             ccccCccccccccCHHHh
Confidence            112233456789999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=3.8e-26  Score=205.07  Aligned_cols=171  Identities=32%  Similarity=0.516  Sum_probs=141.8

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~  229 (337)
                      +|...+.||+|+||.||++...       +..+++|.+.....  ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            6788889999999999998752       34688898765432  23446788999999999 79999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      .|++|||+.+++|.+++....  .+++.++..++.|++.||.|||+.+  |+|+||||+||++  +..+.+||+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLL--THGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEE--cCCCeEEECCCcccc
Confidence            999999999999999997643  3899999999999999999999987  9999999999999  777899999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+......  .......+++.|+|||.+.
T Consensus       190 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~  216 (302)
T cd05055         190 DIMNDSNY--VVKGNARLPVKWMAPESIF  216 (302)
T ss_pred             cccCCCce--eecCCCCcccccCCHhhhc
Confidence            76543211  1123345688999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.94  E-value=2.8e-26  Score=202.46  Aligned_cols=167  Identities=26%  Similarity=0.458  Sum_probs=139.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC------C
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER------K  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~------~  228 (337)
                      .|+..+.||+|+||.||+|...  ++.+++|.+.....    ....+..|+.++..+ +|+||+++++++...      .
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            5777889999999999999875  67899998865432    125677899999998 699999999998653      3


Q ss_pred             ceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          229 PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      .+|++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili--~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL--TENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEE--CCCCCEEEccCCCc
Confidence            589999999999999999863  35899999999999999999999987  9999999999999  77889999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.......    ......|++.|+|||++.
T Consensus       159 ~~~~~~~~----~~~~~~g~~~y~aPE~~~  184 (272)
T cd06637         159 AQLDRTVG----RRNTFIGTPYWMAPEVIA  184 (272)
T ss_pred             eecccccc----cCCcccccccccCHhHhc
Confidence            86543221    234467899999999873

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=3.9e-26  Score=202.62  Aligned_cols=170  Identities=28%  Similarity=0.548  Sum_probs=137.2

Q ss_pred             CccccceecccCceeEEEEEEC--Cc----eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      +|+..+.||+|+||.||+|.+.  ++    .+++|.+....  ......++..|+..+..+.||||+++++++. ....+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence            6777889999999999999874  44    36667664322  2233467778888999999999999999875 45578


Q ss_pred             EEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          232 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +++||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+  ++||||||+||++  +.++.+||+|||+++...
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili--~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILL--KSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE--cCCCcEEEcCCccceecc
Confidence            99999999999999976 456899999999999999999999987  9999999999999  778899999999998764


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....  .......++..|+|||.+.
T Consensus       161 ~~~~~--~~~~~~~~~~~y~~pE~~~  184 (279)
T cd05111         161 PDDKK--YFYSEHKTPIKWMALESIL  184 (279)
T ss_pred             CCCcc--cccCCCCCcccccCHHHhc
Confidence            33211  1223456788999999863

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.94  E-value=3.8e-26  Score=202.07  Aligned_cols=169  Identities=33%  Similarity=0.516  Sum_probs=141.7

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|+....||+|+||.||+|..+       .+.+++|.+....  .......+.+|+.++++++|+||+++++++......
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            6778889999999999999864       3468888775432  222456788999999999999999999999988899


Q ss_pred             EEEEeecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          231 MLITEYLRGGDLHKYLKEKG---------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                      |+||||+++++|.+++....         .+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.++++
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili--~~~~~~~l~  159 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLV--SSQREVKVS  159 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEE--eCCCcEEEc
Confidence            99999999999999997654         6899999999999999999999987  9999999999999  778899999


Q ss_pred             eccCceeeecccccceeeeeCCcccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |||+++......   ........++..|+|||.+
T Consensus       160 ~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~  190 (275)
T cd05046         160 LLSLSKDVYNSE---YYKLRNALIPLRWLAPEAV  190 (275)
T ss_pred             ccccccccCccc---ccccCCceeEEeecChhhh
Confidence            999987543221   1233455678889999976

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=3.9e-26  Score=202.97  Aligned_cols=170  Identities=27%  Similarity=0.484  Sum_probs=144.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|.+.  ++.+++|.+....... .....+.+|+.+++.++||||+++++++......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            4677889999999999999874  7889999986544322 234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+ +++|.+++.. ...+++.++..++.||+.||.|||+.+  ++|+||||+||++  +..+.++|+|||++........
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~--~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEE--cCCCcEEEeeeeecccccCCCC
Confidence            99 9999999875 456899999999999999999999987  9999999999999  7788999999999987654422


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......|+..|+|||++.
T Consensus       155 ---~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07832         155 ---RLYSHQVATRWYRAPELLY  173 (286)
T ss_pred             ---CccccccCcccccCceeee
Confidence               1234467899999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=4.5e-26  Score=201.02  Aligned_cols=173  Identities=32%  Similarity=0.551  Sum_probs=141.1

Q ss_pred             CccccceecccCceeEEEEEEC--C---ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--G---TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g---~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|...+.||+|+||.||+|...  +   ..+++|.+....  .......+..|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            5677889999999999999875  2   258999886542  23345778999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +|||+++++|.+++.. .+.+++.++..++.|++.||.|||+.+  ++|+||||+||++  +..+.+||+|||+++....
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili--~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEE--cCCCcEEECCCcccccccc
Confidence            9999999999999976 356899999999999999999999987  9999999999999  7888999999999987654


Q ss_pred             cccccee-eeeCCccccccccccccc
Q 019685          312 QNSHDVY-KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~-~~~~~~gt~~y~aPE~l~  336 (337)
                      ....... .......+..|+|||.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~  184 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIA  184 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhc
Confidence            3221111 111112356899999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-26  Score=217.53  Aligned_cols=167  Identities=30%  Similarity=0.495  Sum_probs=142.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe-----CCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE-----RKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~-----~~~  229 (337)
                      -|++.++||.|.+|.||++...  ++..|+|++......+    ++...|.++++... |||++.++++|..     ++.
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            4667789999999999998754  8899999987654433    56677888888876 9999999999853     457


Q ss_pred             eEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          230 LMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      +|||||||.+||..|+++.  ...+.|+.+..|++.++.|+.+||...  ++|||+|=.|||+  +..+.|||+|||++.
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLL--T~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLL--TENAEVKLVDFGVSA  171 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEE--eccCcEEEeeeeeee
Confidence            9999999999999999975  346899999999999999999999965  9999999999999  888999999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .++..-    .+..+..|||.|||||++-
T Consensus       172 QldsT~----grRnT~iGtP~WMAPEVia  196 (953)
T KOG0587|consen  172 QLDSTV----GRRNTFIGTPYWMAPEVIA  196 (953)
T ss_pred             eeeccc----ccccCcCCCcccccceeee
Confidence            876432    2456788999999999973

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.94  E-value=4.4e-26  Score=206.97  Aligned_cols=170  Identities=15%  Similarity=0.254  Sum_probs=137.5

Q ss_pred             cceeccc--CceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          162 SAIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       162 ~~~lg~G--~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      .++||+|  +|+.||++..+  |+.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            4689999  78899999875  788999998655433 234466778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          238 RGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       238 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++.++++||+.+.........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~--~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEE--ecCCcEEEcccchhhcccccccc
Confidence            999999999653  45899999999999999999999987  9999999999999  77789999999865443322110


Q ss_pred             ce--e-eeeCCccccccccccccc
Q 019685          316 DV--Y-KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~--~-~~~~~~gt~~y~aPE~l~  336 (337)
                      ..  . ......++..|+|||++.
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~  181 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQ  181 (327)
T ss_pred             ccccccccccccceecccChHHhh
Confidence            00  0 112345788899999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.94  E-value=3.1e-26  Score=204.58  Aligned_cols=169  Identities=27%  Similarity=0.399  Sum_probs=141.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv  233 (337)
                      +|+..+.||+|+||.||+|.+.  ++.+++|.+...... ......+.+|+.+++.++||||+++++++...  ...|++
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            6788889999999999999986  778999988654332 22234567799999999999999999998877  889999


Q ss_pred             EeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |||+.+ +|.+++.... .+++..+..++.||+.||.|||+.+  |+|+||||+||++  +..+.+||+|||+++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLL--NNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEE--CCCCcEEEeecCceeeccCC
Confidence            999975 9999887643 5899999999999999999999987  9999999999999  77889999999999876543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......+++.|+|||.+.
T Consensus       160 ~~----~~~~~~~~~~~~aPE~~~  179 (293)
T cd07843         160 LK----PYTQLVVTLWYRAPELLL  179 (293)
T ss_pred             cc----ccccccccccccCchhhc
Confidence            21    223456789999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=2.2e-26  Score=207.57  Aligned_cols=172  Identities=27%  Similarity=0.458  Sum_probs=139.9

Q ss_pred             ccccceecccCceeEEEEEE----CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEE
Q 019685          159 FSSSAIIGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLML  232 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~l  232 (337)
                      |+..+.||+|+||.||+|..    .++.+|+|.+...........+.+.+|+.++..++||||+++++++...  ..+++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            66778999999999999997    4578999998764322222335677899999999999999999999888  78999


Q ss_pred             EEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC----CCcEEEEec
Q 019685          233 ITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS----ADHLKVGDF  303 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~----~~~~kl~DF  303 (337)
                      ||||+++ +|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.    .+.+||+||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~--~~~~~~~~~~kl~Df  156 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILV--MGEGPERGVVKIGDL  156 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEE--cCCCCccceEEECCC
Confidence            9999975 777776532     25889999999999999999999987  9999999999999  66    789999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.+...... ........+++.|+|||++.
T Consensus       157 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  188 (316)
T cd07842         157 GLARLFNAPLKP-LADLDPVVVTIWYRAPELLL  188 (316)
T ss_pred             ccccccCCCccc-ccccCCccccccccCHHHHh
Confidence            999876543221 11234557899999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=7.2e-26  Score=203.73  Aligned_cols=166  Identities=30%  Similarity=0.446  Sum_probs=141.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|...+.||+|+||.||++...  ++.|++|.+...........+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            5888889999999999999874  78899998865444444455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+.+ ++.+++.. ...+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +.++.+||+|||++......  
T Consensus        96 ~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~--~~~~~~kL~dfg~~~~~~~~--  168 (307)
T cd06607          96 YCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILL--TEPGTVKLADFGSASLVSPA--  168 (307)
T ss_pred             hhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE--CCCCCEEEeecCcceecCCC--
Confidence            9974 77777754 456899999999999999999999987  9999999999999  77889999999998765422  


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                            ....+++.|+|||++.
T Consensus       169 ------~~~~~~~~y~aPE~~~  184 (307)
T cd06607         169 ------NSFVGTPYWMAPEVIL  184 (307)
T ss_pred             ------CCccCCccccCceeee
Confidence                  2346888999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.94  E-value=3.4e-26  Score=204.28  Aligned_cols=170  Identities=31%  Similarity=0.527  Sum_probs=139.7

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|.....||+|+||.||++...       +..+++|.+....   ....+.+.+|+.+++.++|+||+++++++......
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            5677789999999999999753       3357778764332   23346788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC
Q 019685          231 MLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS  294 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~  294 (337)
                      ++||||+++++|.+++...                +.+++..++.++.||+.||.|||+++  |+||||||+||++  +.
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~--~~  158 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV--GA  158 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE--cc
Confidence            9999999999999999753                23788999999999999999999987  9999999999999  77


Q ss_pred             CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.+||+|||+++.......  ........+++.|+|||.+.
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  198 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIM  198 (291)
T ss_pred             CCcEEECCCCcccccCCCce--eecCCCCCcceeecChHHhc
Confidence            88999999999976543211  11234456789999999763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-27  Score=215.53  Aligned_cols=209  Identities=28%  Similarity=0.544  Sum_probs=165.1

Q ss_pred             hhHHHHHHhhcCCCCCCCCCCCCCCCC------CCCCCCCCCcccCCCCcCccccceecccCceeEEEEEEC--CceEEE
Q 019685          114 FNMMELLNAHGGLSYGQNGSHFEPKPV------PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAI  185 (337)
Q Consensus       114 ~~~v~~L~~~~a~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vav  185 (337)
                      ..+.+++-.+..-.++.-.....|.|.      =...|..+.|+++..++..  ...||-|.||.||.|.|+  ...|||
T Consensus       220 ~TLaELVHHHStvADGLittLhYPApK~nKptvygvSPn~DkWEmeRtdItM--khKLGGGQYGeVYeGvWKkyslTvAV  297 (1157)
T KOG4278|consen  220 RTLAELVHHHSTVADGLITTLHYPAPKKNKPTVYGVSPNADKWEMERTDITM--KHKLGGGQYGEVYEGVWKKYSLTVAV  297 (1157)
T ss_pred             hHHHHHHhhccccccceeEeeeccCccCCCCceeeecCCcchhhccchheee--eeccCCCcccceeeeeeeccceeeeh
Confidence            344555555554444433222222221      1124566788887766644  458999999999999998  457899


Q ss_pred             EEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHH
Q 019685          186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALD  263 (337)
Q Consensus       186 K~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~  263 (337)
                      |.++..    .-..++|+.|+.+|+.++|||+|+++|+|.....+|||+|||..|+|.++|++..  .++.-..+.++.|
T Consensus       298 KtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQ  373 (1157)
T KOG4278|consen  298 KTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQ  373 (1157)
T ss_pred             hhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHH
Confidence            988654    3356899999999999999999999999999999999999999999999998743  4677777888899


Q ss_pred             HHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       264 i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |..||+||..++  +|||||..+|.|+  .....||++||||++++..+.   ++...+..-++.|.|||.|
T Consensus       374 IsSaMeYLEkkn--FIHRDLAARNCLV--gEnhiVKvADFGLsRlMtgDT---YTAHAGAKFPIKWTAPEsL  438 (1157)
T KOG4278|consen  374 ISSAMEYLEKKN--FIHRDLAARNCLV--GENHIVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL  438 (1157)
T ss_pred             HHHHHHHHHHhh--hhhhhhhhhhccc--cccceEEeeccchhhhhcCCc---eecccCccCcccccCcccc
Confidence            999999999987  9999999999999  778889999999999987653   2345667788999999976

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=5.6e-26  Score=201.34  Aligned_cols=173  Identities=30%  Similarity=0.495  Sum_probs=138.9

Q ss_pred             CccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|...+.||+|+||.||+|.+.+       ..+++|.+.....  ......+..|+.+++.++|+||+++++++.+....
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            67788899999999999998854       4678887754332  23346788899999999999999999999988899


Q ss_pred             EEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEe
Q 019685          231 MLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGD  302 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~D  302 (337)
                      +++|||+++++|.+++...+       .+++..+..++.||+.||.|||+.+  ++||||||+||++..+. ...+||+|
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEecc
Confidence            99999999999999997643       4888999999999999999999987  99999999999994322 24699999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+++.+.....  .........++.|+|||++.
T Consensus       163 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  194 (277)
T cd05036         163 FGMARDIYRASY--YRKGGRAMLPIKWMPPEAFL  194 (277)
T ss_pred             CccccccCCccc--eecCCCCCccHhhCCHHHHh
Confidence            999987632211  01122334467899999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.94  E-value=3.7e-26  Score=201.54  Aligned_cols=164  Identities=29%  Similarity=0.423  Sum_probs=131.4

Q ss_pred             eecccCceeEEEEEEC-Cc---eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          164 IIGKGSFGEILKAYWR-GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~-g~---~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      .||+|+||.||++... +.   .+++|.+.....  ....+.+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            5899999999998753 22   355666544322  23457889999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          240 GDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       240 ~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ++|.+++...    ...++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||++........ 
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~--~~~~~~~l~Dfg~~~~~~~~~~-  154 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFL--TSDLTVKVGDYGIGPSRYKEDY-  154 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEE--cCCccEEecccccccccCcchh-
Confidence            9999999753    23566778899999999999999987  9999999999999  7788999999999864322110 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                       ........+++.|+|||++
T Consensus       155 -~~~~~~~~~~~~y~aPE~~  173 (268)
T cd05086         155 -IETEDDKCVPLRWLAPELV  173 (268)
T ss_pred             -hhcccCCcCcccccCchhc
Confidence             1122455688999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.8e-26  Score=201.52  Aligned_cols=170  Identities=28%  Similarity=0.483  Sum_probs=140.2

Q ss_pred             CccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|++.+.||+|+||.||++..++       ..+++|.+.....  ......+.+|+.++..++||||+++++++......
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            67778899999999999998752       5699998754432  22346778899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEE
Q 019685          231 MLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV  300 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl  300 (337)
                      +++|||+++++|.+++...          ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill--~~~~~~kl  160 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMV--AEDLTVKI  160 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEE--cCCCCEEE
Confidence            9999999999999999642          23678889999999999999999977  9999999999999  78889999


Q ss_pred             EeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +|||+++.+.....  ........++..|+|||.+
T Consensus       161 ~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05032         161 GDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESL  193 (277)
T ss_pred             CCcccchhhccCcc--cccCCCCCccccccCHHHH
Confidence            99999986643321  0112334568899999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.94  E-value=5.2e-26  Score=207.11  Aligned_cols=172  Identities=30%  Similarity=0.519  Sum_probs=139.2

Q ss_pred             cCccccceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE  226 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~  226 (337)
                      .+|++.+.||+|+||.||++.+.         ...+++|.+....  .......+.+|+.+++++ +||||+++++++..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            36788899999999999999753         1258889775432  223456788999999999 79999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEE
Q 019685          227 RKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL  290 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~  290 (337)
                      .+.+++++||+++++|.+++....                .++..++..++.|++.||.|||+.+  |+||||||+||++
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill  167 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLV  167 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEE
Confidence            999999999999999999997532                3677888999999999999999987  9999999999999


Q ss_pred             ecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       291 ~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        +.++.+||+|||+++........  .......++..|||||++.
T Consensus       168 --~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  209 (334)
T cd05100         168 --TEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALF  209 (334)
T ss_pred             --cCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhc
Confidence              77889999999999876532210  1122334567899999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=7e-26  Score=198.02  Aligned_cols=167  Identities=39%  Similarity=0.684  Sum_probs=141.3

Q ss_pred             cccceecccCceeEEEEEECC------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          160 SSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       160 ~~~~~lg~G~~g~V~~~~~~g------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ++.+.||.|+||.||++....      ..+++|.+......  .....+..|+.++..++|+||+++++.+...+..+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            456789999999999999864      77999998654332  2457888999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          234 TEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |||+++++|.+++.....  +++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.++|+|||+++....
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~--~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLV--GENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEE--ccCCeEEEcccCCceeccc
Confidence            999999999999976443  899999999999999999999987  9999999999999  7788999999999987654


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...   +......+++.|+|||.+
T Consensus       156 ~~~---~~~~~~~~~~~y~~Pe~~  176 (258)
T smart00219      156 DDY---YKKKGGKLPIRWMAPESL  176 (258)
T ss_pred             ccc---cccccCCCcccccChHHh
Confidence            421   112234478999999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=8.2e-26  Score=198.38  Aligned_cols=169  Identities=28%  Similarity=0.506  Sum_probs=147.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|++|.||++...  ++.+++|.+......  .....+.+|+..+..++|+||+++++.+...+..+++||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            5777889999999999999875  788999988665432  345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++.....+++..+..++.|++.||.|||+ .+  ++|+||+|+||++  +..+.++|+|||++........
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~--~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLI--NSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEE--CCCCCEEEccCccceecccCCC
Confidence            99999999999887889999999999999999999999 88  9999999999999  7888999999999987754332


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......++..|+|||.+.
T Consensus       156 ----~~~~~~~~~~y~~pE~~~  173 (264)
T cd06623         156 ----QCNTFVGTVTYMSPERIQ  173 (264)
T ss_pred             ----cccceeecccccCHhhhC
Confidence                123456889999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.94  E-value=9.2e-26  Score=196.71  Aligned_cols=164  Identities=35%  Similarity=0.586  Sum_probs=135.5

Q ss_pred             eecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      .||+|+||.||++... ++.+++|.+.....  ......+.+|+.+++.++||||+++++.+......++||||+++++|
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            6899999999999865 66789998765432  22345688899999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeee
Q 019685          243 HKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT  321 (337)
Q Consensus       243 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~  321 (337)
                      .+++... ..+++..+..++.|++.||.|+|+.+  ++|+||||+||++  +.++.+||+|||++........   ....
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~---~~~~  152 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIY---SSSG  152 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEE--cCCCeEEECCCccceecccccc---ccCC
Confidence            9998753 45889999999999999999999987  9999999999999  7788999999999976443211   0112


Q ss_pred             CCccccccccccccc
Q 019685          322 GETGSCEYLVSNCSF  336 (337)
Q Consensus       322 ~~~gt~~y~aPE~l~  336 (337)
                      ...+++.|+|||++.
T Consensus       153 ~~~~~~~y~aPE~~~  167 (250)
T cd05085         153 LKQIPIKWTAPEALN  167 (250)
T ss_pred             CCCCcccccCHHHhc
Confidence            234467899999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=5.8e-26  Score=203.36  Aligned_cols=168  Identities=35%  Similarity=0.536  Sum_probs=135.2

Q ss_pred             CccccceecccCceeEEEEEEC--Cc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|++.+.||+|+||.||+|..+  +.  .+++|.+....  .....+.+.+|+.++.++ +||||+++++++......|+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            5777889999999999999875  32  36777665322  223346788899999999 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          233 ITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      ++||+++++|.+++....                .+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill--~~~~  156 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV--GENL  156 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE--CCCC
Confidence            999999999999997532                4788899999999999999999987  9999999999999  7788


Q ss_pred             cEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+||+|||++.......     .......+..|+|||++.
T Consensus       157 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  191 (297)
T cd05089         157 ASKIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLN  191 (297)
T ss_pred             eEEECCcCCCcccccee-----ccCCCCcCccccCchhhc
Confidence            99999999986432110     112223356799999863

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.94  E-value=9.2e-26  Score=199.12  Aligned_cols=170  Identities=29%  Similarity=0.480  Sum_probs=137.0

Q ss_pred             ccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc----
Q 019685          159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----  229 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~----  229 (337)
                      |...+.||+|+||.||+|...     +..+|+|.+...... ......+..|+..++.++||||+++++.+.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            455678999999999999864     256999988654332 3345678899999999999999999998765443    


Q ss_pred             --eEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          230 --LMLITEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       230 --~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                        .++++||+++++|..++...      ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~  155 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCML--REDMTVCVA  155 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEE--CCCCeEEEC
Confidence              79999999999999998542      25889999999999999999999987  9999999999999  778899999


Q ss_pred             eccCceeeecccccceeeeeCCcccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |||+++........  .......++..|+|||++
T Consensus       156 dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~  187 (273)
T cd05035         156 DFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESL  187 (273)
T ss_pred             Cccceeeccccccc--cccccccCCccccCHhhc
Confidence            99999876543211  112223457789999976

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=8.5e-26  Score=199.07  Aligned_cols=172  Identities=35%  Similarity=0.608  Sum_probs=141.2

Q ss_pred             CccccceecccCceeEEEEEEC--Cc---eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~---~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|+..+.||+|+||.||++...  +.   .+++|.+.....  ....+.+..|+.+++.++||||+++++++...+..|+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            6777889999999999999874  32   588888755432  2334678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +|||+++++|.+++... +.+++.++..++.|++.||.|||+.+  ++||||||+||++  +.++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILV--NSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEE--cCCCcEEECCCccceeccc
Confidence            99999999999999764 57899999999999999999999987  9999999999999  7788999999999987654


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .... .........++.|+|||++.
T Consensus       160 ~~~~-~~~~~~~~~~~~y~~PE~~~  183 (268)
T cd05063         160 DPEG-TYTTSGGKIPIRWTAPEAIA  183 (268)
T ss_pred             cccc-ceeccCCCcCceecCHHHhh
Confidence            3221 11122233456899999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=6.3e-26  Score=199.04  Aligned_cols=168  Identities=32%  Similarity=0.556  Sum_probs=141.5

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|++.+.||+|+||.||++... ++.+++|.+......    .+.+.+|+.+++.++|+||+++++++......+++|||
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            6778889999999999999876 567899988654332    35688899999999999999999999988899999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||||+||++  +.++.+||+|||+++.+.....
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILV--GENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEE--cCCCCEEECccccceeccchhh
Confidence            9999999999764  36899999999999999999999987  9999999999999  7788999999999987653211


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......++..|+|||.+.
T Consensus       159 ---~~~~~~~~~~~y~~PE~~~  177 (261)
T cd05034         159 ---TAREGAKFPIKWTAPEAAN  177 (261)
T ss_pred             ---hhhhccCCCccccCHHHhc
Confidence               1123344567899999763

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=5.4e-26  Score=199.00  Aligned_cols=165  Identities=33%  Similarity=0.569  Sum_probs=138.5

Q ss_pred             eecccCceeEEEEEEC---Cc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          164 IIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~---g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .||+|++|.||++.+.   ++  .+++|.+......  ...+.+.+|+.++++++||||+++++.+.. ...+++|||++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            6899999999999874   22  5899988765443  456788899999999999999999999888 88999999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          239 GGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       239 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +.++.+||+|||+++.+...... 
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~--~~~~~~kl~dfg~~~~~~~~~~~-  153 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDH-  153 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEE--ecCCEEEeccccccccccccccc-
Confidence            999999997654  6899999999999999999999987  9999999999999  77789999999999887543221 


Q ss_pred             eeeeeCCccccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........++..|+|||.+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~  173 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLR  173 (257)
T ss_pred             eecccCCCCCceecCHHHhc
Confidence            11123456788999999763

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=7.7e-26  Score=198.50  Aligned_cols=166  Identities=32%  Similarity=0.552  Sum_probs=139.0

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||+|... ++.+++|.+......    ...+.+|+.+++.++|+||+++++++. ....+++|||
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            5777889999999999999875 678999988654432    256788999999999999999998864 5678999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +.+++|.+++...  ..+++.++..++.|++.||.|||+.+  ++||||||+||++  +.++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILV--SETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEE--cCCCCEEEccCcceeecCCCCc
Confidence            9999999998753  35889999999999999999999987  9999999999999  7788999999999977653221


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                         .......++..|+|||++
T Consensus       158 ---~~~~~~~~~~~y~~pe~~  175 (260)
T cd05067         158 ---TAREGAKFPIKWTAPEAI  175 (260)
T ss_pred             ---ccccCCcccccccCHHHh
Confidence               122344567899999976

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7e-26  Score=200.58  Aligned_cols=167  Identities=28%  Similarity=0.514  Sum_probs=142.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~l  232 (337)
                      .|+..+.||+|+||.||+|.+.  ++.+++|.+......  .....+.+|+.+++.++   |||++++++++......|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            3667789999999999999974  788999988654322  23456778999999986   9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      +|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILV--TNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEE--cCCCCEEEccCCceeecCCC
Confidence            9999999999999865 47899999999999999999999987  9999999999999  77889999999999877644


Q ss_pred             cccceeeeeCCcccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..    ......|+..|+|||++
T Consensus       155 ~~----~~~~~~~~~~y~aPE~~  173 (277)
T cd06917         155 SS----KRSTFVGTPYWMAPEVI  173 (277)
T ss_pred             cc----ccccccCCcceeCHHHh
Confidence            32    23445789999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.7e-26  Score=200.05  Aligned_cols=168  Identities=33%  Similarity=0.465  Sum_probs=144.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||.|+||.||++...  ++.+++|.+.....  ......+.+|+.+++.++|+||+++++++.....+|+|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            5777789999999999999875  77899998865432  2234667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++... .+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.++|+|||+++.+..... 
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILL--SEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--CCCCCEEEcccccceeeccccc-
Confidence            99999999999765 7899999999999999999999987  9999999999999  7788999999999988764421 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......+++.|+|||.+.
T Consensus       154 ---~~~~~~~~~~y~~PE~~~  171 (274)
T cd06609         154 ---KRNTFVGTPFWMAPEVIK  171 (274)
T ss_pred             ---ccccccCCccccChhhhc
Confidence               234457889999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=7.6e-26  Score=202.48  Aligned_cols=170  Identities=28%  Similarity=0.477  Sum_probs=138.6

Q ss_pred             CccccceecccCceeEEEEEEC------------------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR------------------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ  219 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~------------------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~  219 (337)
                      +|++.+.||+|+||.||++.+.                  +..+++|.+....  .......+.+|+.+++.++|+||++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence            5788899999999999998543                  2357888876442  2334567889999999999999999


Q ss_pred             eeeeEEeCCceEEEEeecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCE
Q 019685          220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV  288 (337)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Ni  288 (337)
                      +++++......+++|||+.+++|.+++....           .+++.++..++.|++.||.|||+.+  |+|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheE
Confidence            9999999999999999999999999997532           3667789999999999999999987  99999999999


Q ss_pred             EEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          289 LLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       289 l~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ++  +..+.+||+|||+++.+......  .......+++.|+|||.+
T Consensus       162 li--~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~  204 (296)
T cd05095         162 LV--GKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESI  204 (296)
T ss_pred             EE--cCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHH
Confidence            99  77889999999999866433210  112234457889999965

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=7.5e-26  Score=197.82  Aligned_cols=166  Identities=27%  Similarity=0.451  Sum_probs=144.0

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++...  ++.+++|.+....     ..+.+.+|+.+++.++|+||+++++.+.....+|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            36888889999999999999986  6789999885432     1578889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +.++.+||+|||++.......
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~--~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILL--NEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--CCCCcEEEcccccchhcccCc
Confidence            99999999999975 456899999999999999999999987  9999999999999  778899999999998765432


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .    ......++..|+|||++
T Consensus       154 ~----~~~~~~~~~~y~~PE~~  171 (256)
T cd06612         154 A----KRNTVIGTPFWMAPEVI  171 (256)
T ss_pred             c----ccccccCCccccCHHHH
Confidence            1    22345588999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=8.3e-26  Score=200.73  Aligned_cols=168  Identities=30%  Similarity=0.582  Sum_probs=140.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||.|++|.||+|...  +..+++|.+.......  ....+.+|+.++++++|+||+++++++...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            4777889999999999999985  7889999886543221  23456779999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          236 YLRGGDLHKYLKEK---GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       236 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |+++ +|.+++...   ..+++..+..++.|++.||.|||+.+  ++||||||+||++  +.++.+||+|||+++.....
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~--~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLI--NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE--CCCCcEEEeecchhhhhcCC
Confidence            9985 898888653   35899999999999999999999987  9999999999999  77889999999999765432


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......+++.|+|||++.
T Consensus       154 ~~----~~~~~~~~~~y~~PE~~~  173 (284)
T cd07836         154 VN----TFSNEVVTLWYRAPDVLL  173 (284)
T ss_pred             cc----ccccccccccccChHHhc
Confidence            11    223456789999999763

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=1.1e-25  Score=198.61  Aligned_cols=170  Identities=29%  Similarity=0.554  Sum_probs=138.7

Q ss_pred             cCccccceecccCceeEEEEEECC-----ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g-----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      .+|...+.||+|+||.||+|.+..     ..+++|.......  ....+.+.+|+.+++.+.||||+++++++.. ...|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            357778899999999999998642     3588887754432  3345678899999999999999999998865 5578


Q ss_pred             EEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          232 LITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+  ++|+||||+||++  +..+.+||+|||+++...
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLV--SSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEE--ecCCCeEEccCceeeecc
Confidence            9999999999999997643 5899999999999999999999977  9999999999999  777899999999998765


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....   .......+++.|+|||.+.
T Consensus       159 ~~~~---~~~~~~~~~~~y~aPE~~~  181 (270)
T cd05056         159 DESY---YKASKGKLPIKWMAPESIN  181 (270)
T ss_pred             cccc---eecCCCCccccccChhhhc
Confidence            4321   1222334567899999763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=1.1e-25  Score=197.56  Aligned_cols=166  Identities=32%  Similarity=0.570  Sum_probs=136.7

Q ss_pred             CccccceecccCceeEEEEEECC-ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g-~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|.+...||+|+||.||++.+.+ ..+++|.+.....    ..+.+.+|+.+++.++|+|++++++++. .+..+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            46777899999999999998764 4788998754332    2356788999999999999999998875 4568999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+.+  |+|+||||+||++  +.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill--~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILV--GDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEE--cCCCeEEECCCccceEccCCcc
Confidence            9999999999753  24788999999999999999999987  9999999999999  7888999999999987643321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                         .......++..|+|||.+
T Consensus       158 ---~~~~~~~~~~~y~~Pe~~  175 (260)
T cd05069         158 ---TARQGAKFPIKWTAPEAA  175 (260)
T ss_pred             ---cccCCCccchhhCCHHHh
Confidence               112334567889999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=5.7e-26  Score=198.63  Aligned_cols=162  Identities=31%  Similarity=0.592  Sum_probs=137.3

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      +|++.+.||+|+||.||++...++.+++|.+....     ....+.+|+.+++.++||||+++++++... ..+++|||+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            57788899999999999999889999999885432     235788899999999999999999988654 579999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          238 RGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       238 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      .+++|.+++....  .+++..+..++.|++.||.|||+.+  ++||||||+||++  +..+.+||+|||+++.....   
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili--~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILV--SEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEE--cCCCcEEECCCccceecccc---
Confidence            9999999997643  4789999999999999999999977  9999999999999  77889999999998764322   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+..|+|||++.
T Consensus       154 ----~~~~~~~~~y~~pe~~~  170 (254)
T cd05083         154 ----VDNSKLPVKWTAPEALK  170 (254)
T ss_pred             ----CCCCCCCceecCHHHhc
Confidence                12334567899999763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=7.2e-26  Score=201.03  Aligned_cols=170  Identities=32%  Similarity=0.534  Sum_probs=139.1

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|.....||+|+||.||++...       +..+++|.+....   ......+.+|+.+++.++|+||+++++++......
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            5667789999999999998642       4467888765432   23456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC
Q 019685          231 MLITEYLRGGDLHKYLKEKG---------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA  295 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~  295 (337)
                      +++|||+++++|.+++...+               .+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~--~~~  158 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV--GQG  158 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEE--cCC
Confidence            99999999999999997532               4788999999999999999999987  9999999999999  778


Q ss_pred             CcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       296 ~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.+||+|||+++.......  ........+++.|+|||.+.
T Consensus       159 ~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  197 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESIL  197 (280)
T ss_pred             CCEEECCCCceeEcCCCce--eecCCCccccccccCHHHhc
Confidence            8999999999976543221  01123344678999999763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=1.2e-25  Score=198.56  Aligned_cols=161  Identities=39%  Similarity=0.601  Sum_probs=130.7

Q ss_pred             eecccCceeEEEEEEC--Cc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          164 IIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~--g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .||+|+||.||++...  +.  .+++|.+....  .....+.+..|+.++.++ +||||+++++++...+..|++|||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            6899999999999875  33  45777765332  223346788899999999 69999999999999999999999999


Q ss_pred             CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          239 GGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       239 ~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                      +++|.+++....                .+++.++..++.|++.||+|||+.+  ++||||||+||++  +..+.+||+|
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili--~~~~~~kl~d  155 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENYVAKIAD  155 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEE--cCCCeEEECC
Confidence            999999997532                3788899999999999999999977  9999999999999  7888999999


Q ss_pred             ccCceeeecccccceeeeeCCcccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||+++......     .......++.|+|||++
T Consensus       156 fgl~~~~~~~~-----~~~~~~~~~~y~apE~~  183 (270)
T cd05047         156 FGLSRGQEVYV-----KKTMGRLPVRWMAIESL  183 (270)
T ss_pred             CCCccccchhh-----hccCCCCccccCChHHH
Confidence            99986432211     11223346789999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=1.2e-25  Score=199.28  Aligned_cols=167  Identities=31%  Similarity=0.486  Sum_probs=143.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|.+.  +..+++|.+.....  ......+.+|+.+++.+.||||+++++.+......|+|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            5677789999999999999874  67899998865432  2345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.. +.+++.++..++.|++.||.|||+.+  ++|+||+|+||++  +..+.++|+|||++..+..... 
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEE--cCCCCEEEcccccceeccCCcc-
Confidence            9999999999864 56899999999999999999999977  9999999999999  7788999999999987654321 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ......++..|+|||++
T Consensus       157 ---~~~~~~~~~~y~apE~~  173 (277)
T cd06640         157 ---KRNTFVGTPFWMAPEVI  173 (277)
T ss_pred             ---ccccccCcccccCHhHh
Confidence               12335688999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.94  E-value=1.2e-25  Score=196.58  Aligned_cols=168  Identities=34%  Similarity=0.605  Sum_probs=140.9

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||++.+. +..+++|.+......    ...+..|+.++++++||+|+++++++......+++|||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            5666789999999999999876 778999988654332    24678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++++|.+++... +.++++.+..++.|++.|+.|||+.+  ++|+||||+||++  +..+.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLV--GENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEE--cCCCeEEECCCcceeecccCcc-
Confidence            9999999999764 46899999999999999999999987  9999999999999  7788999999999976543211 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......++..|+|||.+.
T Consensus       156 --~~~~~~~~~~~~~aPe~~~  174 (256)
T cd05112         156 --TSSTGTKFPVKWSSPEVFS  174 (256)
T ss_pred             --cccCCCccchhhcCHhHhc
Confidence              1123344678899999763

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.94  E-value=2.4e-26  Score=205.35  Aligned_cols=165  Identities=25%  Similarity=0.428  Sum_probs=139.1

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |.....||+|+||.||++...  +..+++|.+....   ....+.+.+|+.+++.++|+||+++++.+...+..|++|||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            344567999999999999874  7789999875432   23346688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++++|.+++.. +.+++.++..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||++........  
T Consensus       101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill--~~~~~~kL~dfg~~~~~~~~~~--  173 (292)
T cd06658         101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILL--TSDGRIKLSDFGFCAQVSKEVP--  173 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE--cCCCCEEEccCcchhhcccccc--
Confidence            999999998854 46899999999999999999999987  9999999999999  7778999999999876543321  


Q ss_pred             eeeeeCCcccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l  335 (337)
                        ......|++.|+|||.+
T Consensus       174 --~~~~~~~~~~y~aPE~~  190 (292)
T cd06658         174 --KRKSLVGTPYWMAPEVI  190 (292)
T ss_pred             --cCceeecCccccCHHHH
Confidence              12345689999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.94  E-value=3.3e-26  Score=204.99  Aligned_cols=166  Identities=23%  Similarity=0.383  Sum_probs=139.9

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |.....||+|+||.||++...  ++.+++|.+......   ..+.+.+|+.++..++||||+++++.+...+..|+++||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            344457999999999999874  789999998543222   235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++++|.+++.. ..+++..+..++.|++.||.|||+.+  |+||||+|+||++  +.++.+||+|||++..+.....  
T Consensus       100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill--~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEE--ccCCcEEEeechhHhhcccccc--
Confidence            999999998754 46899999999999999999999987  9999999999999  7888999999999976543321  


Q ss_pred             eeeeeCCccccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l~  336 (337)
                        ......|++.|+|||++.
T Consensus       173 --~~~~~~~~~~y~aPE~~~  190 (297)
T cd06659         173 --KRKSLVGTPYWMAPEVIS  190 (297)
T ss_pred             --cccceecCccccCHHHHc
Confidence              234466899999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.1e-25  Score=194.57  Aligned_cols=169  Identities=28%  Similarity=0.554  Sum_probs=146.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|++|.||++...  ++.+++|.+...... ......+.+|+.++++++|+|++++++++...+..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            3667789999999999999875  678999998765433 2345788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.+  |+||||+|+||++  +..+.+||+|||++........ 
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILT--TKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEE--CCCCCEEEeccccceecCCCcc-
Confidence            9999999999988788999999999999999999999987  9999999999999  6778999999999987765432 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ......+++.|+|||.+
T Consensus       155 ---~~~~~~~~~~y~~pe~~  171 (254)
T cd06627         155 ---DDASVVGTPYWMAPEVI  171 (254)
T ss_pred             ---cccccccchhhcCHhhh
Confidence               12345689999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.94  E-value=6.3e-26  Score=201.85  Aligned_cols=171  Identities=30%  Similarity=0.492  Sum_probs=144.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.|++|.+...... ....+.+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            5778889999999999999885  678999988654332 2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |++++.+..++.....+++.++..++.||+.||.|||+.+  ++|+||+|+||++  +..+.+||+|||++.........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~--~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILV--SESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEEeeecccccCCCccc
Confidence            9998777766666667999999999999999999999987  9999999999999  77889999999999877654321


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......++..|+|||++.
T Consensus       157 ---~~~~~~~~~~~~~PE~~~  174 (288)
T cd07833         157 ---PLTDYVATRWYRAPELLV  174 (288)
T ss_pred             ---cccCcccccCCcCCchhc
Confidence               123456889999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.94  E-value=1.4e-25  Score=196.15  Aligned_cols=170  Identities=29%  Similarity=0.492  Sum_probs=142.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+....... ...+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            4677889999999999998874  7789999986543332 335778899999999999999999999998999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+++  |+|+||+|+||++.+ ..+.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~-~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDK-HKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC-CCCEEEEccCCCceecCCCc
Confidence            99999999999763  34899999999999999999999987  999999999999932 33468999999998765432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......|++.|+|||.+.
T Consensus       157 -----~~~~~~~~~~y~aPE~~~  174 (256)
T cd08220         157 -----KAYTVVGTPCYISPELCE  174 (256)
T ss_pred             -----cccccccCCcccCchhcc
Confidence                 123456899999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=1.4e-25  Score=196.85  Aligned_cols=170  Identities=29%  Similarity=0.492  Sum_probs=141.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--CCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv  233 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+...... ....+.+..|+.+++.++|+||+++++.+..  ....|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            4677789999999999999874  678999988654332 3345678889999999999999999997754  4568999


Q ss_pred             EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLH-----NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH-----~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||     +.+  |+|+||+|+||++  +..+.+||+|||
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili--~~~~~~kl~d~g  155 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFL--DANNNVKLGDFG  155 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEE--ecCCCEEEeccc
Confidence            999999999999975    356899999999999999999999     766  9999999999999  778899999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++........    ......+++.|+|||++.
T Consensus       156 ~~~~~~~~~~----~~~~~~~~~~~~~pE~~~  183 (265)
T cd08217         156 LAKILGHDSS----FAKTYVGTPYYMSPEQLN  183 (265)
T ss_pred             ccccccCCcc----cccccccCCCccChhhhc
Confidence            9987754421    134457899999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.94  E-value=1.1e-25  Score=196.95  Aligned_cols=169  Identities=27%  Similarity=0.497  Sum_probs=142.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.+|++...  ++.+++|.+....... ...+.+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            4677889999999999999874  7889999886543322 234678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+.+++|.+++....  .+++.++..++.|++.||.|||+.+  ++|+||+|+||++  +..+.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~--~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL--TKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEEeeccceeecCcch
Confidence            999999999997643  4789999999999999999999987  9999999999999  778899999999998765432


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .    ......|++.|+|||++
T Consensus       156 ~----~~~~~~~~~~~~~pe~~  173 (256)
T cd08218         156 E----LARTCIGTPYYLSPEIC  173 (256)
T ss_pred             h----hhhhccCCccccCHHHh
Confidence            1    12334588999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-25  Score=196.98  Aligned_cols=162  Identities=30%  Similarity=0.467  Sum_probs=134.1

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHH-HhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.||+|+||.||+|...  ++.+++|.+.+...........+..|..++ ...+|+||+++++.+...+..|+++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999874  789999988654332222233444555444 445799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK  319 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~  319 (337)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.+||+|||+++....        
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~--------  149 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLI--DQTGHLKLTDFGLSRNGLE--------  149 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCcEEEeecccceeccc--------
Confidence            999999988788999999999999999999999987  9999999999999  7788999999999875432        


Q ss_pred             eeCCccccccccccccc
Q 019685          320 MTGETGSCEYLVSNCSF  336 (337)
Q Consensus       320 ~~~~~gt~~y~aPE~l~  336 (337)
                      .....+++.|+|||.+.
T Consensus       150 ~~~~~~~~~y~~pe~~~  166 (260)
T cd05611         150 NKKFVGTPDYLAPETIL  166 (260)
T ss_pred             cccCCCCcCccChhhhc
Confidence            23356889999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-27  Score=192.66  Aligned_cols=176  Identities=23%  Similarity=0.336  Sum_probs=145.8

Q ss_pred             CCcCccccceecccCceeEEEEE--ECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----
Q 019685          155 SELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----  227 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----  227 (337)
                      .+.+|.+.+.||+|||+-||.+.  .+++.+|+|++.-..   ....+..++|++..++++||||++++++....     
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            44588999999999999999876  458899999986543   34457889999999999999999999876433     


Q ss_pred             CceEEEEeecCCCCHHHHHHh---c-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          228 KPLMLITEYLRGGDLHKYLKE---K-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~---~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      ...|+++.|...|+|.+.+..   . ..+++.+++.|+.+|++||.+||+..+++.||||||.|||+  ...+.++|.||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl--s~~~~~vl~D~  173 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL--SDSGLPVLMDL  173 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe--cCCCceEEEec
Confidence            348999999999999999974   2 35999999999999999999999987789999999999999  67889999999


Q ss_pred             cCceeeecc--ccc---ceeeeeCCcccccccccccc
Q 019685          304 GLSKLIKVQ--NSH---DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       304 gla~~~~~~--~~~---~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |.+....-.  ++.   ....+.....|.+|+|||.+
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf  210 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELF  210 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchhe
Confidence            998765321  111   12245677899999999986

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=3.6e-26  Score=202.55  Aligned_cols=168  Identities=33%  Similarity=0.480  Sum_probs=142.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|.+.  +..+++|.+.....  ....+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            4666788999999999999874  67899998864432  2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.. ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||++  +.++.+||+|||+++.+..... 
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i--~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEE--eCCCCEEEccccccccccCcch-
Confidence            9999999998864 46899999999999999999999987  9999999999999  6778999999999987654321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......|+..|+|||++.
T Consensus       157 ---~~~~~~~~~~y~aPE~~~  174 (277)
T cd06642         157 ---KRNTFVGTPFWMAPEVIK  174 (277)
T ss_pred             ---hhhcccCcccccCHHHhC
Confidence               123356889999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=1.6e-25  Score=198.68  Aligned_cols=172  Identities=31%  Similarity=0.536  Sum_probs=141.8

Q ss_pred             CccccceecccCceeEEEEEEC------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--CCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~  229 (337)
                      +|+..+.||+|+||.||++.+.      +..+++|.+......  ...+.+.+|+.+++.++|+||+++++++..  ...
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            5667789999999999999864      568999998755433  345788999999999999999999998877  557


Q ss_pred             eEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+  |+|+||||+||++  +.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~~~~  158 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILV--ESEDLVKISDFGLAKV  158 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEE--cCCCCEEEcccccccc
Confidence            899999999999999997644 5899999999999999999999987  9999999999999  7778999999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....... ........++..|+|||.+.
T Consensus       159 ~~~~~~~-~~~~~~~~~~~~~~~Pe~~~  185 (284)
T cd05038         159 LPEDKDY-YYVKEPGESPIFWYAPECLR  185 (284)
T ss_pred             cccCCcc-eeccCCCCCcccccCcHHHc
Confidence            7633211 11122334567799999763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=4.7e-26  Score=200.19  Aligned_cols=167  Identities=31%  Similarity=0.524  Sum_probs=144.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++..+  ++.+++|.+......  .....+.+|+.+++.++||||+++++.+...+..++++|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            4667789999999999999986  788999988665432  345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+ .+  ++|+||||+||++  +..+.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~--~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILV--NSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEE--CCCCCEEEeecccchhhHHHH
Confidence            99999999999875 678999999999999999999999 88  9999999999999  778899999999987664332


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .      ....++..|+|||.+.
T Consensus       156 ~------~~~~~~~~y~~PE~~~  172 (265)
T cd06605         156 A------KTFVGTSSYMAPERIQ  172 (265)
T ss_pred             h------hcccCChhccCHHHHc
Confidence            1      1267889999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.94  E-value=1.1e-25  Score=198.65  Aligned_cols=170  Identities=28%  Similarity=0.473  Sum_probs=134.6

Q ss_pred             cccceecccCceeEEEEEECC--c--eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------Cc
Q 019685          160 SSSAIIGKGSFGEILKAYWRG--T--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP  229 (337)
Q Consensus       160 ~~~~~lg~G~~g~V~~~~~~g--~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~  229 (337)
                      .+.+.||+|+||.||+|.+..  .  .+++|.+..... .....+.+..|+.+++.++|+||+++++.+...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            346789999999999998753  2  588888765433 234457788999999999999999999976432      24


Q ss_pred             eEEEEeecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          230 LMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      .+++|||+.+++|.+++..      ...+++..+..++.|++.||.|||+.+  |+||||||+|||+  +..+.+||+||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Df  156 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCML--NENMNVCVADF  156 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEE--cCCCCEEECCC
Confidence            7899999999999998742      124789999999999999999999977  9999999999999  77889999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.+.....  ........+++.|+|||.+.
T Consensus       157 g~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~  187 (272)
T cd05075         157 GLSKKIYNGDY--YRQGRIAKMPVKWIAIESLA  187 (272)
T ss_pred             CcccccCcccc--eecCCcccCCcccCCHHHcc
Confidence            99987654321  11122334678899999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=2.1e-25  Score=201.65  Aligned_cols=166  Identities=28%  Similarity=0.443  Sum_probs=141.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|...+.||+|+||.||++...  +..+++|.+.............+..|+.+++.++|||++++++++......|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999874  77899998865544444455678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+.+ +|.+++.. ...+++.++..++.|++.||.|||+.+  |+||||+|+||++  +.++.+||+|||++.....   
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~--~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL--TEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEE--CCCCCEEEecCCCccccCC---
Confidence            9975 78777754 456899999999999999999999987  9999999999999  7788999999999865432   


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           .....|++.|+|||.+.
T Consensus       178 -----~~~~~~~~~y~aPE~~~  194 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVIL  194 (317)
T ss_pred             -----cccccCCccccChhhhh
Confidence                 23456889999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=1.4e-25  Score=198.95  Aligned_cols=174  Identities=26%  Similarity=0.407  Sum_probs=141.5

Q ss_pred             CCcCccccceecccCceeEEEEEECC------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-C
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-R  227 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~g------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~  227 (337)
                      ...+|...+.||+|+||.||+|.+..      ..+++|.+....  .....+.+.+|+.+++.++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34478888999999999999998753      678888775432  23345778899999999999999999998665 5


Q ss_pred             CceEEEEeecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEE
Q 019685          228 KPLMLITEYLRGGDLHKYLKEK--------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK  299 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~k  299 (337)
                      ...++++||+.+++|.+++...        ..+++..+..++.|++.||.|||+.+  ++||||||+||++  +..+.+|
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~--~~~~~~k  157 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVI--DEELQVK  157 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEE--cCCCcEE
Confidence            6789999999999999999753        34889999999999999999999977  9999999999999  7778999


Q ss_pred             EEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          300 VGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       300 l~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+|||+++.+...+..  .......++..|+|||.+.
T Consensus       158 l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~  192 (280)
T cd05043         158 ITDNALSRDLFPMDYH--CLGDNENRPVKWMALESLV  192 (280)
T ss_pred             ECCCCCcccccCCceE--EeCCCCCcchhccCHHHHh
Confidence            9999999876433211  1123345678899999763

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=2.1e-25  Score=197.61  Aligned_cols=166  Identities=32%  Similarity=0.505  Sum_probs=141.5

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |+..+.||+|+||.||++...  +..+++|.+.....  ......+.+|+.++..++||||+++++.+......|+||||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            567789999999999999874  67899998754332  23446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++++|.+++.. ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||++  +..+.++|+|||++..+.....  
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i--~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEE--CCCCCEEEeecccceecccchh--
Confidence            999999999864 46899999999999999999999987  9999999999999  7788999999999987654321  


Q ss_pred             eeeeeCCcccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l  335 (337)
                        ......++..|+|||.+
T Consensus       157 --~~~~~~~~~~y~~PE~~  173 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVI  173 (277)
T ss_pred             --hhccccCCccccChhhh
Confidence              22345688999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=1.5e-25  Score=196.75  Aligned_cols=166  Identities=27%  Similarity=0.486  Sum_probs=131.9

Q ss_pred             eecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE-eCCceEEEEeec
Q 019685          164 IIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT-ERKPLMLITEYL  237 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~~lv~e~~  237 (337)
                      .||+|+||.||+|.+.     ...+++|.+....  .....+.+.+|+.+++.++||||+++++++. ..+..+++|||+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            6899999999999863     2468889874322  2334567888999999999999999999765 455689999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          238 RGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       238 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      .+++|.+++... ...++..+..++.|++.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.+.......
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili--~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEE--cCCCcEEECCccccccccCCccee
Confidence            999999999764 34677888899999999999999977  9999999999999  778899999999998654322111


Q ss_pred             eeeeeCCcccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l  335 (337)
                      ........+++.|+|||.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~  174 (262)
T cd05058         156 VHNHTGAKLPVKWMALESL  174 (262)
T ss_pred             ecccccCcCCccccChhHh
Confidence            1112344567899999976

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=1.3e-25  Score=200.82  Aligned_cols=168  Identities=26%  Similarity=0.431  Sum_probs=142.5

Q ss_pred             cCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|...+.||+|+||.||++..  .++.+++|.+.....   ...+.+.+|+.+++.++||||+++++.+...+..|+|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            3788889999999999999986  477899998854322   22366788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++... .+++.++..++.|++.||.|||+.+  ++|+||+|+||++  +.++.+||+|||++........
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili--~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEE--cCCCCEEEccCcceeccccccc
Confidence            999999999998653 5788999999999999999999987  9999999999999  7788999999999876654322


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......|++.|+|||.+.
T Consensus       171 ----~~~~~~~~~~y~~PE~~~  188 (293)
T cd06647         171 ----KRSTMVGTPYWMAPEVVT  188 (293)
T ss_pred             ----ccccccCChhhcCchhhc
Confidence                233456899999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.2e-25  Score=198.36  Aligned_cols=167  Identities=30%  Similarity=0.480  Sum_probs=140.9

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCC-----
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK-----  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~-----  228 (337)
                      .+|+..+.||+|++|.||+|..+  ++.+++|.+.....    ....+.+|+.+++++ .|+||+++++++....     
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            37888999999999999999985  67899998865432    236788999999999 5999999999987654     


Q ss_pred             -ceEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          229 -PLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       229 -~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                       .+|++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +.++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~--~~~~~~~l~d~  157 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILL--TKNAEVKLVDF  157 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE--ccCCeEEECCC
Confidence             48999999999999999864    346899999999999999999999987  9999999999999  77889999999


Q ss_pred             cCceeeecccccceeeeeCCcccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |++........    ......|++.|+|||++
T Consensus       158 ~~~~~~~~~~~----~~~~~~~~~~y~aPE~~  185 (275)
T cd06608         158 GVSAQLDSTLG----RRNTFIGTPYWMAPEVI  185 (275)
T ss_pred             ccceecccchh----hhcCccccccccCHhHh
Confidence            99976543321    23445689999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.94  E-value=7.1e-26  Score=198.65  Aligned_cols=168  Identities=33%  Similarity=0.514  Sum_probs=142.2

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      ||+|+||.||++...  ++.+++|.+...........+.+.+|+.+++.++||||+++++.+......|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999986  889999998765444445567888999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc----ee
Q 019685          243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD----VY  318 (337)
Q Consensus       243 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~----~~  318 (337)
                      .+++...+.+++..+..++.||+.||.|||+.+  ++|+||+|+||++  +.++.+||+|||++..........    ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEE--cCCCCEEEEecccchhcccCcccccccccc
Confidence            999988778999999999999999999999987  9999999999999  778899999999987654331100    01


Q ss_pred             eeeCCccccccccccccc
Q 019685          319 KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       319 ~~~~~~gt~~y~aPE~l~  336 (337)
                      ......++..|+|||.+.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~  174 (265)
T cd05579         157 EDKRIVGTPDYIAPEVIL  174 (265)
T ss_pred             cccCcccCccccCHHHhc
Confidence            224456889999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=2.5e-26  Score=201.47  Aligned_cols=160  Identities=23%  Similarity=0.382  Sum_probs=130.2

Q ss_pred             eecccCceeEEEEEECC---------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          164 IIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~g---------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .||+|+||.||+|....         ..+++|.+...   .....+.+..|+.+++.+.||||+++++++......++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            68999999999998642         23677766432   2233467788999999999999999999999989999999


Q ss_pred             eecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC------CcEEEEeccCce
Q 019685          235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA------DHLKVGDFGLSK  307 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~------~~~kl~DFgla~  307 (337)
                      ||+++++|.+++...+ .+++..+..++.||+.||.|||+.+  |+||||||+||++..+..      +.++++|||++.
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            9999999999997644 5899999999999999999999987  999999999999943321      137999999986


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....        ....+++.|+|||++.
T Consensus       157 ~~~~~--------~~~~~~~~y~aPE~~~  177 (258)
T cd05078         157 TVLPK--------EILLERIPWVPPECIE  177 (258)
T ss_pred             ccCCc--------hhccccCCccCchhcc
Confidence            54322        2346888999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=1.9e-25  Score=198.35  Aligned_cols=166  Identities=25%  Similarity=0.458  Sum_probs=135.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHH-HHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL-LVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|++.+.||+|+||.||++...  |+.||+|.+........  ...+..|+.. ++...||||+++++++...+..|++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            5778889999999999999885  78999998876533222  2344445554 56678999999999999999999999


Q ss_pred             eecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          235 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       235 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ||++ ++|.+++..    ...+++..+..++.||+.||.|||+. +  ++||||||+||++  +..+.+||+|||+++.+
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~--~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLI--NRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE--CCCCCEEEeeccccccc
Confidence            9997 588888764    23589999999999999999999986 6  9999999999999  78889999999999876


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....     ......|+..|+|||.+
T Consensus       155 ~~~~-----~~~~~~~~~~y~aPE~~  175 (283)
T cd06617         155 VDSV-----AKTIDAGCKPYMAPERI  175 (283)
T ss_pred             cccc-----ccccccCCccccChhhc
Confidence            4321     12335688999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=5.8e-26  Score=201.04  Aligned_cols=174  Identities=30%  Similarity=0.518  Sum_probs=147.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|...+.||+|+||.||++...  ++.+++|++.+...........+.+|+.++++++ ||||+++++.+...+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            5777889999999999999874  7899999987644433344567888999999999 999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |++++++|.+++...+.+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i--~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILL--DKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEE--CCCCCEEecCCccccccCCccc
Confidence            99999999999988878999999999999999999999987  9999999999999  7788999999999987654321


Q ss_pred             c----------------ceeeeeCCcccccccccccc
Q 019685          315 H----------------DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~----------------~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .                .........++..|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~  194 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL  194 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHh
Confidence            0                00123345688999999975

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.93  E-value=3.6e-25  Score=197.56  Aligned_cols=168  Identities=28%  Similarity=0.454  Sum_probs=139.3

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC-----
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-----  227 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~-----  227 (337)
                      ..+|+....||+|+||.||++...  ++.+++|.+.....    ....+..|+.+++.+ +||||+++++++...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            347888899999999999999874  77899998854321    235567789999988 799999999998654     


Q ss_pred             CceEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          228 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      +..|+||||+++++|.++++.    ...+++..++.++.|++.||.|||+.+  |+||||||+||++  +.++.+||+||
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili--~~~~~~kl~df  172 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILL--TTEGGVKLVDF  172 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--cCCCCEEEeec
Confidence            358999999999999998863    346899999999999999999999987  9999999999999  77888999999


Q ss_pred             cCceeeecccccceeeeeCCcccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |++........    ......|+..|+|||++
T Consensus       173 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~  200 (291)
T cd06639         173 GVSAQLTSTRL----RRNTSVGTPFWMAPEVI  200 (291)
T ss_pred             ccchhcccccc----cccCccCCccccChhhh
Confidence            99987653321    12345689999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=192.42  Aligned_cols=167  Identities=25%  Similarity=0.443  Sum_probs=140.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +.+....||+|+.|.|++++++  |...|||.+.....  ....++++..+.++.... .|+||+.+|+|.....+++.|
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N--kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC--HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            3455668999999999999987  58899999976543  345678888899887776 899999999999999999999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |.|.. .+..+++. .+.+++..+-++..-+++||.||-.+ ++|+|||+||+|||+  |..|.+||||||++-.+.+..
T Consensus       171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILl--De~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILL--DERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEE--ccCCCEEeecccccceeeccc
Confidence            98854 66677664 56799999999999999999999886 469999999999999  999999999999998876542


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                           ..+..-|.+.|||||-|
T Consensus       247 -----AhtrsAGC~~YMaPERi  263 (391)
T KOG0983|consen  247 -----AHTRSAGCAAYMAPERI  263 (391)
T ss_pred             -----ccccccCCccccCcccc
Confidence                 34566799999999976

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.93  E-value=1e-25  Score=200.24  Aligned_cols=169  Identities=30%  Similarity=0.528  Sum_probs=140.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|++|.||+|...  ++.+++|.+...... ......+.+|+.++++++||||+++++++......+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            3677889999999999999874  788999988644322 2233567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+. ++|.+++..  ...+++..+..++.|++.||+|||+.+  ++|+||+|+||++  +.++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill--~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEeeccchhhcccCc
Confidence            996 589998865  346899999999999999999999987  9999999999999  788899999999987664332


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......+++.|+|||++.
T Consensus       155 ~----~~~~~~~~~~y~aPE~~~  173 (284)
T cd07860         155 R----TYTHEVVTLWYRAPEILL  173 (284)
T ss_pred             c----ccccccccccccCCeEEe
Confidence            1    223445789999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-26  Score=218.04  Aligned_cols=169  Identities=30%  Similarity=0.499  Sum_probs=139.6

Q ss_pred             CccccceecccCcee-EEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGE-ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~-V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      -|...+.+|.|+.|+ ||+|.+.|++||||.+....      .....+|+..++... ||||+++++.-.++...||+.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            466678899999875 89999999999999986543      245578999999886 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec---CCCCcEEEEeccCcee
Q 019685          236 YLRGGDLHKYLKEKGA----LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKL  308 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~---~~~~~~kl~DFgla~~  308 (337)
                      +|.. +|.+++...+.    ......+.++.|+++||++||+.+  ||||||||.||||..   +...+++|+|||+++.
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            9966 99999976311    111445778899999999999987  999999999999954   3445899999999999


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +..+.++ +....+..||-+|+|||+|.
T Consensus       661 l~~~~sS-~~r~s~~sGt~GW~APE~L~  687 (903)
T KOG1027|consen  661 LAGGKSS-FSRLSGGSGTSGWQAPEQLR  687 (903)
T ss_pred             cCCCcch-hhcccCCCCcccccCHHHHh
Confidence            8866543 33467788999999999974

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.93  E-value=5e-26  Score=207.20  Aligned_cols=173  Identities=25%  Similarity=0.456  Sum_probs=142.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----CCce
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPL  230 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~  230 (337)
                      .+|+..+.||+|+||.||++...  +..|++|.+...... ......+.+|+.+++.++||||+++++++..    ...+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36788889999999999999875  889999988654322 2234667789999999999999999988753    3468


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ++||||+. ++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLV--NEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEecccccceeec
Confidence            99999996 599999987777999999999999999999999987  9999999999999  788899999999998765


Q ss_pred             cccccceeeeeCCcccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..............|+..|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~  183 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELL  183 (334)
T ss_pred             ccCcCCCcccccccccccccChHHh
Confidence            4332211122455789999999986

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.93  E-value=2.7e-25  Score=195.09  Aligned_cols=166  Identities=29%  Similarity=0.540  Sum_probs=138.1

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||++... +..+++|.+...    ......+.+|+.+++.++|+||+++++.+.. ...+++|||
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            6777889999999999999865 567888877543    2234678889999999999999999999887 778999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||||+||++  +..+.+||+|||++..+.....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV--SASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEE--cCCCcEEECCCcceeeccCCCc
Confidence            9999999999763  35788889999999999999999977  9999999999999  7888999999999977643321


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                         .......++..|+|||++
T Consensus       158 ---~~~~~~~~~~~y~~PE~~  175 (260)
T cd05073         158 ---TAREGAKFPIKWTAPEAI  175 (260)
T ss_pred             ---ccccCCcccccccCHhHh
Confidence               122334567889999976

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.93  E-value=1.8e-25  Score=200.94  Aligned_cols=172  Identities=26%  Similarity=0.424  Sum_probs=138.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-------  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-------  228 (337)
                      +|+....||+|+||.||+|...  ++.+++|.+....... .....+.+|+.+++.++||||+++++++....       
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            6888899999999999999875  7889999885433221 12234567999999999999999999876544       


Q ss_pred             -ceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          229 -PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       229 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                       ..++||||+.+ +|.+++... ..+++.++..++.||+.||.|||+.+  ++|+||||+||++  +..+.+||+|||++
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~  166 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILI--TKDGILKLADFGLA  166 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE--CCCCcEEECcCCCc
Confidence             35999999965 888887654 36899999999999999999999987  9999999999999  78889999999999


Q ss_pred             eeeecccccceeeeeCCcccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..................++..|+|||.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  195 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELL  195 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHh
Confidence            87654322111122345678999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.93  E-value=3e-25  Score=197.55  Aligned_cols=168  Identities=27%  Similarity=0.462  Sum_probs=145.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ..|+..+.||+|++|.||++.+.  +..+++|.+.....    ..+.+..|+.+++.++|+||+++++.+......|+++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            35778889999999999999986  78899999865432    3467788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||+.|  |+|+||+|+||++  +.++.+||+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILL--SKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEE--cCCCCEEECccchhhhhccch
Confidence            9999999999998876 7999999999999999999999977  9999999999999  778899999999987654332


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......+++.|+|||++.
T Consensus       171 ~----~~~~~~~~~~y~~PE~~~  189 (286)
T cd06614         171 S----KRNSVVGTPYWMAPEVIK  189 (286)
T ss_pred             h----hhccccCCcccCCHhHhc
Confidence            1    223456889999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.93  E-value=1.9e-25  Score=199.03  Aligned_cols=171  Identities=32%  Similarity=0.502  Sum_probs=140.0

Q ss_pred             cCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      .+|+....||+|+||.||++...       +..+++|.+.....  ......+.+|+.+++.+.||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            36788889999999999999863       46789998864332  2344678889999999999999999999999889


Q ss_pred             eEEEEeecCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCC
Q 019685          230 LMLITEYLRGGDLHKYLKEKG----------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN  287 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~N  287 (337)
                      .+++|||+++++|.+++....                      .+++.+++.++.|++.||.|||+.+  ++||||||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~n  160 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRN  160 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhh
Confidence            999999999999999997421                      3678888999999999999999987  9999999999


Q ss_pred             EEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       288 il~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |++  +.++.+||+|||+++.......  .........++.|+|||.+
T Consensus       161 il~--~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  204 (288)
T cd05050         161 CLV--GENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESI  204 (288)
T ss_pred             eEe--cCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHH
Confidence            999  7788999999999876543211  0112233456789999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.93  E-value=3e-25  Score=198.33  Aligned_cols=170  Identities=32%  Similarity=0.501  Sum_probs=137.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|++|.||++..+  ++.+++|.+...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5778889999999999999875  778999988554322 1233567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++ +|.+++....  .+++..+..++.||+.||.|||+.+  |+|+||+|+||+++. ..+.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~-~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEEC-CCCEEEEcccccccccCCCc
Confidence            9964 8888876543  3578888899999999999999987  999999999999932 34579999999997654321


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......+++.|+|||.+.
T Consensus       158 ~----~~~~~~~~~~y~~PE~~~  176 (294)
T PLN00009        158 R----TFTHEVVTLWYRAPEILL  176 (294)
T ss_pred             c----ccccCceeecccCHHHHh
Confidence            1    223456789999999763

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=2.6e-25  Score=197.61  Aligned_cols=169  Identities=31%  Similarity=0.481  Sum_probs=141.5

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEEE
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLIT  234 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~  234 (337)
                      |++.+.||+|+||.||++...  ++.+++|.+.... ........+.+|+.+++.++|+|++++++++...  ...++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            456778999999999999886  6889999997654 2223346678899999999999999999999887  7899999


Q ss_pred             eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++ +|.+++... ..+++..+..++.||+.||.|||+.+  ++|+||+|+||++  +.++.+||+|||++.......
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~--~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILI--NNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE--cCCCCEEEccccceeeccCCC
Confidence            99975 899888765 57999999999999999999999987  9999999999999  778899999999998775442


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..   ......++..|+|||.+.
T Consensus       155 ~~---~~~~~~~~~~y~~PE~~~  174 (287)
T cd07840         155 SA---DYTNRVITLWYRPPELLL  174 (287)
T ss_pred             cc---cccccccccccCCceeeE
Confidence            11   123456788999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.93  E-value=3.3e-25  Score=196.85  Aligned_cols=167  Identities=28%  Similarity=0.444  Sum_probs=138.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe------CC
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE------RK  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~------~~  228 (337)
                      .|+..+.||+|+||.||++...  ++.+++|.+....    .....+..|+.++..+ +|+||+++++++..      ..
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   92 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD   92 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence            6778889999999999999984  6789999875432    2235677899999988 59999999998853      45


Q ss_pred             ceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          229 PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      .+|++|||+.+++|.+++...  ..+++..+..++.||+.||.|||+.+  |+|+||+|+||++  +..+.++|+|||++
T Consensus        93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili--~~~~~~~l~dfg~~  168 (282)
T cd06636          93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLL--TENAEVKLVDFGVS  168 (282)
T ss_pred             EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCcch
Confidence            789999999999999999753  34888889999999999999999987  9999999999999  77888999999998


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........    ......|++.|+|||.+.
T Consensus       169 ~~~~~~~~----~~~~~~~~~~y~aPE~l~  194 (282)
T cd06636         169 AQLDRTVG----RRNTFIGTPYWMAPEVIA  194 (282)
T ss_pred             hhhhcccc----CCCcccccccccCHhhcC
Confidence            76543211    234466899999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.93  E-value=2.5e-25  Score=199.81  Aligned_cols=171  Identities=30%  Similarity=0.625  Sum_probs=137.7

Q ss_pred             cCccccceecccCceeEEEEEEC--Cc----eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      .+|+..+.||+|+||.||++.+.  +.    .+++|.+.....  ......+.+|+.+++.++||||+++++.+... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            36777889999999999999873  43    467887754332  22335688899999999999999999988654 46


Q ss_pred             EEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ++++||+++|+|.+++.... .+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|||+++..
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill--~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLV--KSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeee--cCCCceEEccccccccc
Confidence            79999999999999997643 5899999999999999999999987  9999999999999  77788999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......  .......++..|+|||.+.
T Consensus       160 ~~~~~~--~~~~~~~~~~~y~~PE~~~  184 (303)
T cd05110         160 EGDEKE--YNADGGKMPIKWMALECIH  184 (303)
T ss_pred             cCcccc--cccCCCccccccCCHHHhc
Confidence            543211  1223345678999999763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.93  E-value=4e-25  Score=196.79  Aligned_cols=167  Identities=23%  Similarity=0.408  Sum_probs=140.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|.....||+|++|.||++...  ++.+++|.+....   ....+.+.+|+.+++.+.||||+++++++...+..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            3455579999999999999864  6789999875332   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+.+++|.+++.. ..+++..+..++.|++.||.|||+.+  |+||||+|+||++  +.++.++|+|||++........ 
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILL--TSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEE--cCCCcEEEcccccchhhccCCc-
Confidence            9999999999876 56899999999999999999999987  9999999999999  7788999999999876543321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......|++.|+|||.+.
T Consensus       171 ---~~~~~~~~~~y~aPE~~~  188 (285)
T cd06648         171 ---RRKSLVGTPYWMAPEVIS  188 (285)
T ss_pred             ---ccccccCCccccCHHHhc
Confidence               223456899999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.93  E-value=2.5e-25  Score=197.61  Aligned_cols=168  Identities=33%  Similarity=0.552  Sum_probs=140.1

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |+..+.||+|++|.||++...  |..+++|.+....... .....+.+|+.+++.++||||+++++++......|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            456779999999999999874  8899999886543221 2235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          237 LRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       237 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ++ ++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +.++.++|+|||+++.......
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~--~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLI--DREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEE--cCCCcEEEeecccccccCCCcc
Confidence            95 59999987655  6899999999999999999999987  9999999999999  6788999999999976543211


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......+++.|+|||++.
T Consensus       155 ----~~~~~~~~~~~~aPE~~~  172 (283)
T cd07835         155 ----TYTHEVVTLWYRAPEILL  172 (283)
T ss_pred             ----ccCccccccCCCCCceee
Confidence                123446789999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-27  Score=197.37  Aligned_cols=167  Identities=27%  Similarity=0.416  Sum_probs=137.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHh-CCCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +.+....||.|.||.|++..++  |+..|||.++....  ....++++.|..+..+ -+.||||++||+...++..||.|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            4566788999999999998876  88999999976544  2334677888886554 45999999999999999999999


Q ss_pred             eecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          235 EYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       235 e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |+|.- ||..+.+     ++..+++...-.|..-.+.||.||-.. ..|||||+||+|||+  +..|.+||||||++-.+
T Consensus       143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILl--dr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILL--DRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEE--ecCCCEeeecccchHhH
Confidence            99954 7776654     345689998888988999999999875 349999999999999  89999999999999766


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...     ...+...|..+|||||-|
T Consensus       219 v~S-----iAkT~daGCrpYmAPERi  239 (361)
T KOG1006|consen  219 VDS-----IAKTVDAGCRPYMAPERI  239 (361)
T ss_pred             HHH-----HHhhhccCCccccChhcc
Confidence            543     234566799999999976

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.93  E-value=1.9e-25  Score=198.99  Aligned_cols=171  Identities=26%  Similarity=0.404  Sum_probs=142.3

Q ss_pred             CccccceecccCceeEEEEEEC-----CceEEEEEecCCCCc-hHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~  230 (337)
                      +|+..+.||+|+||.||++...     +..+++|.+.+.... .....+.+..|+.++..++ ||+|+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3667789999999999998753     567999988643221 2233456788999999995 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ++||||+.+++|.+++.....+++..+..++.|++.||.|||+.+  ++||||+|+||++  +.++.++|+|||+++.+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILL--DSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEE--CCCCCEEEEECccccccc
Confidence            999999999999999987777999999999999999999999977  9999999999999  777899999999987765


Q ss_pred             cccccceeeeeCCcccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .....   ......|++.|+|||.+
T Consensus       157 ~~~~~---~~~~~~~~~~y~aPE~~  178 (288)
T cd05583         157 AEEEE---RAYSFCGTIEYMAPEVI  178 (288)
T ss_pred             ccccc---ccccccCCccccCHHHh
Confidence            43211   12345689999999975

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.93  E-value=2.8e-25  Score=202.17  Aligned_cols=172  Identities=27%  Similarity=0.417  Sum_probs=138.2

Q ss_pred             CccccceecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe----CC
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE----RK  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~----~~  228 (337)
                      +|+..+.||+|+||.||++...    +..+|+|.+...... ....+.+.+|+.++++++ ||||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            3667789999999999999986    457999988643222 223466778999999995 9999999986532    24


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+|+++||+. ++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili--~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLV--NADCELKICDFGLARG  154 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEE--cCCCCEEeCcCCCcee
Confidence            5789999886 599999987778999999999999999999999988  9999999999999  7788999999999987


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +...............||+.|+|||.+
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~  181 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIM  181 (332)
T ss_pred             cccccccccccccCcccCccccCcHHH
Confidence            654322111123445789999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.93  E-value=2.3e-25  Score=200.55  Aligned_cols=169  Identities=33%  Similarity=0.507  Sum_probs=138.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv  233 (337)
                      +|+..+.||+|+||.||+|...  |+.|++|.+....... .......+|+.++++++|+||+++++++...  +.+++|
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            6888899999999999999975  7899999886443221 1123456799999999999999999998755  468999


Q ss_pred             EeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |||+.+ +|.+++.. ...+++.++..++.||+.||.|||+.+  ++||||||+||++  +..+.+||+|||+++.....
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLL--TDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECccceeeecCCc
Confidence            999975 88888875 356899999999999999999999988  9999999999999  77889999999999876543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......+++.|+|||++.
T Consensus       162 ~~----~~~~~~~~~~y~aPE~~~  181 (309)
T cd07845         162 AK----PMTPKVVTLWYRAPELLL  181 (309)
T ss_pred             cC----CCCcccccccccChhhhc
Confidence            21    123345688999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.93  E-value=3.1e-25  Score=203.54  Aligned_cols=166  Identities=27%  Similarity=0.388  Sum_probs=137.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------Cc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~  229 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+...... ......+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            6888899999999999999874  789999988654322 22345677899999999999999999987643      34


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      .|+||||+.+ +|.+.+...  +++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLARTA  168 (353)
T ss_pred             EEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEccCccceeC
Confidence            7999999965 888887654  889999999999999999999987  9999999999999  78889999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....     ......+++.|+|||.+.
T Consensus       169 ~~~~-----~~~~~~~~~~y~aPE~~~  190 (353)
T cd07850         169 GTSF-----MMTPYVVTRYYRAPEVIL  190 (353)
T ss_pred             CCCC-----CCCCCcccccccCHHHHh
Confidence            4321     233456889999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.93  E-value=3.4e-25  Score=198.00  Aligned_cols=169  Identities=28%  Similarity=0.459  Sum_probs=136.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCc-----
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKP-----  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~-----  229 (337)
                      +|+..+.||+|+||.||++.+.  ++.|++|.+...... ......+.+|+.+++.+. ||||+++++++.....     
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            5777889999999999999875  788999987554322 112356778999999996 6999999999877665     


Q ss_pred             eEEEEeecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEec
Q 019685          230 LMLITEYLRGGDLHKYLKEK-----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDF  303 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DF  303 (337)
                      .|++|||+++ +|.+++...     ..+++..+..++.||+.||.|||+.+  |+||||+|+||++  +. .+.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~--~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLV--DKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEE--ecCCCeEEEeec
Confidence            8999999986 898888642     34799999999999999999999987  9999999999999  55 778999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.+.....    ......+++.|+|||++.
T Consensus       156 g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~  184 (295)
T cd07837         156 GLGRAFSIPVK----SYTHEIVTLWYRAPEVLL  184 (295)
T ss_pred             ccceecCCCcc----ccCCcccccCCCChHHhh
Confidence            99986643211    123345788999999863

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=7.6e-25  Score=197.65  Aligned_cols=165  Identities=28%  Similarity=0.447  Sum_probs=139.3

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |...+.||+|+||.||+|...  +..+++|.+.............+..|+.+++.++|||++++++++.+....|++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555678999999999999874  788999988655444444556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +.+ ++.+++.. ...+++.++..++.||+.||.|||+.+  |+|+||+|+||++  +.++.+||+|||++....     
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili--~~~~~~kL~dfg~~~~~~-----  172 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILL--TEPGQVKLADFGSASKSS-----  172 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEE--CCCCCEEEeecCCCcccC-----
Confidence            964 78777764 456899999999999999999999987  9999999999999  777899999999985432     


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......|++.|+|||++.
T Consensus       173 ---~~~~~~~~~~y~aPE~~~  190 (313)
T cd06633         173 ---PANSFVGTPYWMAPEVIL  190 (313)
T ss_pred             ---CCCCccccccccChhhcc
Confidence               123456899999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.93  E-value=2e-25  Score=203.45  Aligned_cols=170  Identities=29%  Similarity=0.512  Sum_probs=138.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----Cce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~  230 (337)
                      +|++.+.||+|+||.||++...  ++.|++|.+....  .......+..|+.+++.++|+||+++++++...     ...
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            6888899999999999999874  7899999885432  222346677899999999999999999876543     357


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+++||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +..+.+||+|||+++...
T Consensus        84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--CCCCCEEECcccceeecc
Confidence            999999975 88888753 46899999999999999999999987  9999999999999  888899999999998765


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..... ........||+.|+|||++.
T Consensus       158 ~~~~~-~~~~~~~~~~~~y~aPE~~~  182 (336)
T cd07849         158 PEHDH-TGFLTEYVATRWYRAPEIML  182 (336)
T ss_pred             ccccc-cCCcCCcCcCCCccChHHhh
Confidence            43211 11223457899999999763

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=6.5e-25  Score=191.45  Aligned_cols=164  Identities=30%  Similarity=0.534  Sum_probs=136.8

Q ss_pred             eecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      .||+|+||.||++... ++.+++|.+......  .....+..|+.+++++.|+||+++++++......+++|||+.+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            6899999999999876 789999988654432  3456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeee
Q 019685          243 HKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT  321 (337)
Q Consensus       243 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~  321 (337)
                      .+++... ..+++..+..++.+++.||.|||+.+  ++||||+|+||++  +.++.+||+|||+++........  ....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~~--~~~~  153 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIYT--VSDG  153 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEE--cCCCcEEEeeccccccccCCcce--eccc
Confidence            9999753 45889999999999999999999977  9999999999999  78889999999999765422110  0112


Q ss_pred             CCcccccccccccc
Q 019685          322 GETGSCEYLVSNCS  335 (337)
Q Consensus       322 ~~~gt~~y~aPE~l  335 (337)
                      ....+..|+|||.+
T Consensus       154 ~~~~~~~y~~PE~~  167 (251)
T cd05041         154 LKQIPIKWTAPEAL  167 (251)
T ss_pred             cCcceeccCChHhh
Confidence            23346779999975

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.7e-25  Score=192.69  Aligned_cols=163  Identities=35%  Similarity=0.539  Sum_probs=143.0

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      ||+|+||.||++...  ++.+++|.+.............+..|+.+++.++||||+++++.+......+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999875  788999998776555445567888999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeC
Q 019685          243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG  322 (337)
Q Consensus       243 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~  322 (337)
                      .+++.....+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.++|+|||++........    ....
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~--~~~~~~~l~d~~~~~~~~~~~~----~~~~  152 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILL--DADGHIKLTDFGLAKELSSEGS----RTNT  152 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEE--cCCCcEEEeecCcceecccCCC----cccC
Confidence            999988778999999999999999999999977  9999999999999  7778999999999987654321    2345


Q ss_pred             Ccccccccccccc
Q 019685          323 ETGSCEYLVSNCS  335 (337)
Q Consensus       323 ~~gt~~y~aPE~l  335 (337)
                      ..++..|+|||.+
T Consensus       153 ~~~~~~~~~Pe~~  165 (250)
T cd05123         153 FCGTPEYLAPEVL  165 (250)
T ss_pred             CcCCccccChHHh
Confidence            6789999999976

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-27  Score=218.73  Aligned_cols=167  Identities=30%  Similarity=0.527  Sum_probs=148.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.....+|+|.||.||++++.  +...|+|.++....++-   .-.+.|+-+++.++||||+.|++.+.....+|++||
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCCccc---cccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            6788889999999999999985  78899998876655443   455679999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||.+|+|.+...-.+.+++.++...+++.+.||.|||+.|  -+|||||-.||++  ...|.+|+.|||.+..+...   
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanill--td~gDvklaDfgvsaqitat---  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILL--TDEGDVKLADFGVSAQITAT---  165 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceee--cccCceeecccCchhhhhhh---
Confidence            9999999999888889999999999999999999999988  9999999999999  88889999999999777542   


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                       +.+.....|||+|||||+-
T Consensus       166 -i~KrksfiGtpywmapEva  184 (829)
T KOG0576|consen  166 -IAKRKSFIGTPYWMAPEVA  184 (829)
T ss_pred             -hhhhhcccCCccccchhHH
Confidence             2245678899999999985

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.8e-28  Score=200.65  Aligned_cols=173  Identities=27%  Similarity=0.439  Sum_probs=138.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--------C
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------R  227 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--------~  227 (337)
                      .|+....||+|.||.||+|+.+  |+.|++|++.-...+.. ......+|+.++..++|+|++.+++.+..        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG-fpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC-CcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            5677789999999999999875  67788876643221111 12445679999999999999999887642        2


Q ss_pred             CceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          228 KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      ..+|+|+++|+. +|.-++... ..++..++.+++.++..||.|+|+..  |+|||+||+|+||  +.+|.+||+|||++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLI--t~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLI--TKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEE--cCCceEEeeccccc
Confidence            348999999987 999998764 56999999999999999999999966  9999999999999  88999999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.+...+...--..++.+-|..|++||.|+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllL  201 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLL  201 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhh
Confidence            888754322111345566799999999886

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.93  E-value=8.9e-25  Score=190.79  Aligned_cols=169  Identities=31%  Similarity=0.547  Sum_probs=145.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++.+.  +..+++|.+...... ......+..|+++++.++|+|++++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4677789999999999999986  788999988654332 2345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          236 YLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       236 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      ++++++|.+++...    ..+++..+..++.+++.||.|||+.+  ++|+||+|+||++  +..+.++|+|||++.....
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~--~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFL--TSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEE--cCCCcEEECCccceeeccc
Confidence            99999999999763    56899999999999999999999987  9999999999999  7778999999999987654


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...    ......|++.|+|||.+
T Consensus       156 ~~~----~~~~~~~~~~y~~pe~~  175 (258)
T cd08215         156 TVD----LAKTVVGTPYYLSPELC  175 (258)
T ss_pred             Ccc----eecceeeeecccChhHh
Confidence            321    23345789999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=1.2e-24  Score=189.95  Aligned_cols=172  Identities=28%  Similarity=0.520  Sum_probs=147.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv  233 (337)
                      +|...+.||+|++|.||+|...  +..+++|.+...... ....+.+.+|+.++++++|+||+++++.+...  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            3666789999999999999986  788999988665432 34567888999999999999999999999888  889999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      +||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.++|+|||.+.......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILV--DSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEE--cCCCCEEEcccccEEeccccc
Confidence            999999999999988778999999999999999999999977  9999999999999  778899999999998776543


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..  .......++..|+|||.+.
T Consensus       156 ~~--~~~~~~~~~~~y~~pE~~~  176 (260)
T cd06606         156 TG--EGTGSVRGTPYWMAPEVIR  176 (260)
T ss_pred             cc--ccccCCCCCccccCHhhhc
Confidence            21  0134567899999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=2.5e-25  Score=202.90  Aligned_cols=169  Identities=27%  Similarity=0.457  Sum_probs=140.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----Cce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~  230 (337)
                      +|...+.||+|+||.||++...  +..|++|.+....... .....+.+|+.+++.++|+||+++++++...     ...
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            6888899999999999999875  7899999886543222 2235667899999999999999999987644     348


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+++||+. ++|.+++...+.+++..+..++.|++.||.|||+.+  ++||||||+||++  +..+.+||+|||+++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLL--NANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEE--cCCCCEEECcCccccccC
Confidence            99999996 599999988788999999999999999999999987  9999999999999  778899999999998764


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....    ......++..|+|||.+.
T Consensus       160 ~~~~----~~~~~~~~~~y~aPE~~~  181 (337)
T cd07858         160 EKGD----FMTEYVVTRWYRAPELLL  181 (337)
T ss_pred             CCcc----cccccccccCccChHHHh
Confidence            3321    223456889999999764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=9.1e-25  Score=194.63  Aligned_cols=167  Identities=26%  Similarity=0.442  Sum_probs=138.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv  233 (337)
                      +|...+.||.|++|.||++...  ++.+++|.+......  .....+.+|+.+++.++||||+++++++...  ..+++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            4677789999999999999984  678999988654332  3446788899999999999999999988653  468999


Q ss_pred             EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||+.+  ++|+||+|+||++  +..+.++|+|||++...
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILL--TRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--ecCCeEEEeeccccccc
Confidence            999999999988753    345889999999999999999999987  9999999999999  67788999999998765


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....      .....++..|+|||.+.
T Consensus       156 ~~~~------~~~~~~~~~y~~pE~~~  176 (287)
T cd06621         156 VNSL------AGTFTGTSFYMAPERIQ  176 (287)
T ss_pred             cccc------cccccCCccccCHHHhc
Confidence            4321      12345788999999763

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=1.1e-24  Score=189.31  Aligned_cols=166  Identities=33%  Similarity=0.543  Sum_probs=144.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|++|.||++...  +..+++|.+.....   .....+.+|+.+++.++|++|+++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            3667789999999999999986  77899999865433   244778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.++|+|||.+........
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILL--TSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEE--ccCCeEEEeecccccccccccc
Confidence            99999999999775 57999999999999999999999977  9999999999999  7788999999999987764421


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                           .....++..|+|||.+
T Consensus       154 -----~~~~~~~~~~~~PE~~  169 (253)
T cd05122         154 -----RNTMVGTPYWMAPEVI  169 (253)
T ss_pred             -----ccceecCCcccCHHHH
Confidence                 2345688999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.93  E-value=5e-25  Score=200.66  Aligned_cols=171  Identities=26%  Similarity=0.390  Sum_probs=138.4

Q ss_pred             ccceecccCceeEEEEEEC--CceEEEEEecCCCCchHH-----------HHHHHHHHHHHHHhCCCCCeeeeeeeEEeC
Q 019685          161 SSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL-----------VIQDFRHEVNLLVKLRHPNIVQFLGAVTER  227 (337)
Q Consensus       161 ~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  227 (337)
                      ..+.||+|+||.||++...  ++.||+|.+.........           ....+.+|+.+++.++|+||+++++++...
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            4577999999999999865  788999988654322100           012467899999999999999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      +..+++|||+. ++|.+++.....+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.+||+|||+++
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill--~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFI--NSKGICKIADFGLAR  167 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEE--CCCCCEEECCcccee
Confidence            99999999997 599999987778999999999999999999999987  9999999999999  778899999999998


Q ss_pred             eeecccc----------cceeeeeCCccccccccccccc
Q 019685          308 LIKVQNS----------HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~----------~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .......          ..........+++.|+|||++.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  206 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM  206 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcc
Confidence            7652110          0001123345788999999863

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.93  E-value=7.8e-25  Score=193.10  Aligned_cols=152  Identities=26%  Similarity=0.397  Sum_probs=125.9

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEeecCCCC
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGD  241 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~  241 (337)
                      ||+|+||.||++..+  +..+++|.+.......        .|+.....+ +||||+++++.+...+..|+||||+++++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~   95 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD   95 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence            599999999999875  6788999875432211        122222222 69999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-cEEEEeccCceeeecccccceeee
Q 019685          242 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       242 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      |.+++.....+++.++..++.||+.||.|||+.+  ++||||||+||++  +..+ .++|+|||+++.....        
T Consensus        96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~~l~dfg~~~~~~~~--------  163 (267)
T PHA03390         96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLY--DRAKDRIYLCDYGLCKIIGTP--------  163 (267)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--eCCCCeEEEecCccceecCCC--------
Confidence            9999988778999999999999999999999988  9999999999999  5556 8999999998765432        


Q ss_pred             eCCccccccccccccc
Q 019685          321 TGETGSCEYLVSNCSF  336 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l~  336 (337)
                      ....+++.|+|||++.
T Consensus       164 ~~~~~~~~y~aPE~~~  179 (267)
T PHA03390        164 SCYDGTLDYFSPEKIK  179 (267)
T ss_pred             ccCCCCCcccChhhhc
Confidence            2346899999999863

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=7.6e-26  Score=209.80  Aligned_cols=168  Identities=30%  Similarity=0.566  Sum_probs=142.5

Q ss_pred             cccceecccCceeEEEEEEC---Cc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          160 SSSAIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       160 ~~~~~lg~G~~g~V~~~~~~---g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ...++||+|.||.|++|.|+   |+  .||||++.......  ...+|++|+.+|.+++|+|+++|||+..+ ..+.|||
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            44578999999999999997   33  58999997665443  56899999999999999999999999987 6789999


Q ss_pred             eecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |+++.|||.+.|+.  ...+.......|+.||+.||.||.+++  .|||||..+|+|+  -..-.|||+||||.+.+...
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlll--asprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLL--ASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhhee--cccceeeeecccceeccCCC
Confidence            99999999999986  345777888899999999999999988  9999999999999  56678999999999988765


Q ss_pred             cccceeee-eCCccccccccccccc
Q 019685          313 NSHDVYKM-TGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~-~~~~gt~~y~aPE~l~  336 (337)
                      +.  .|.+ ....-.+.|.|||.|.
T Consensus       266 ed--~Yvm~p~rkvPfAWCaPEsLr  288 (1039)
T KOG0199|consen  266 ED--MYVMAPQRKVPFAWCAPESLR  288 (1039)
T ss_pred             Cc--ceEecCCCcCcccccCHhHhc
Confidence            43  3333 3344678999999874

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=6.4e-25  Score=200.63  Aligned_cols=165  Identities=29%  Similarity=0.506  Sum_probs=137.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------c
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------P  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~  229 (337)
                      +|+..+.||+|+||.||++...  +..||+|.+..... .......+.+|+.+++.++||||+++++++....      .
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            6888899999999999999874  78899998865332 2333456788999999999999999999887543      3


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||++...
T Consensus        95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill--~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQT  168 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeeccccccc
Confidence            58999998 6799888864 46899999999999999999999987  9999999999999  77889999999999765


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...       .....+++.|+|||.+.
T Consensus       169 ~~~-------~~~~~~~~~y~aPE~~~  188 (343)
T cd07880         169 DSE-------MTGYVVTRWYRAPEVIL  188 (343)
T ss_pred             ccC-------ccccccCCcccCHHHHh
Confidence            432       23456789999999763

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.93  E-value=5.5e-25  Score=195.98  Aligned_cols=167  Identities=28%  Similarity=0.467  Sum_probs=136.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|...+.||+|+||.||++...  ++.+++|.+......  .....+..|+.++.++. |+||+++++++...+..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4566778999999999999875  788999988654332  33467888999999997 999999999999889999999


Q ss_pred             eecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          235 EYLRGGDLHKYLK-----EKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       235 e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      ||+.. ++.++..     ....+++..+..++.|++.||+|||+. +  |+||||||+||++  +..+.+||+|||+++.
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~  157 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILL--DRNGNIKLCDFGISGQ  157 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEE--ccCCcEEEeecchhHH
Confidence            99864 6655432     235689999999999999999999974 6  9999999999999  7778999999999976


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +....     ......|++.|+|||++.
T Consensus       158 ~~~~~-----~~~~~~~~~~y~aPE~~~  180 (288)
T cd06616         158 LVDSI-----AKTRDAGCRPYMAPERID  180 (288)
T ss_pred             hccCC-----ccccccCccCccCHHHhc
Confidence            54332     123446899999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=7.5e-25  Score=194.33  Aligned_cols=165  Identities=28%  Similarity=0.464  Sum_probs=134.9

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeC--CceEEE
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPLMLI  233 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~--~~~~lv  233 (337)
                      |+..+.||+|+||.||++...  ++.+++|.+........ . .....|+.++.++. |+||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-Q-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-h-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            456678999999999999874  78899998865432221 1 23346888888886 99999999999887  889999


Q ss_pred             EeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |||+++ +|.+.+.. ...+++.++..++.|++.||.|||+.+  |+||||+|+||++  +. +.+||+|||+++.+...
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l--~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILI--KD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE--cC-CCeEEEecccccccccC
Confidence            999975 88888875 356899999999999999999999987  9999999999999  56 89999999999876543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..     .....+++.|+|||.+.
T Consensus       153 ~~-----~~~~~~~~~y~aPE~~~  171 (282)
T cd07831         153 PP-----YTEYISTRWYRAPECLL  171 (282)
T ss_pred             CC-----cCCCCCCcccCChhHhh
Confidence            21     23356889999999763

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=1.4e-24  Score=191.45  Aligned_cols=170  Identities=27%  Similarity=0.490  Sum_probs=140.0

Q ss_pred             CccccceecccCceeEEEEEEC---CceEEEEEecCCCC-------chHHHHHHHHHHHHHHHh-CCCCCeeeeeeeEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLS-------DDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE  226 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~---g~~vavK~l~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~  226 (337)
                      +|++.+.||+|+||.||++...   ++.+++|.+.....       .......++..|+.++.. ++||||+++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            3677889999999999999985   46789998753221       123344567788888765 789999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          227 RKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                      .+..+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+ .+  ++|+||+|+||++  +..+.+||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~--~~~~~~~l~  156 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIML--GEDDKVTIT  156 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEE--CCCCcEEEe
Confidence            9999999999999999998743    3458999999999999999999996 56  9999999999999  788899999


Q ss_pred             eccCceeeecccccceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||++.......     ......|+..|+|||.+.
T Consensus       157 dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~  186 (269)
T cd08528         157 DFGLAKQKQPES-----KLTSVVGTILYSCPEIVK  186 (269)
T ss_pred             cccceeeccccc-----ccccccCcccCcChhhhc
Confidence            999998755432     234567899999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-27  Score=197.79  Aligned_cols=170  Identities=31%  Similarity=0.508  Sum_probs=142.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-----ce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~  230 (337)
                      +.+..+-||-|+||.||.+.+.  |+.|++|++..-. ..-...+++.+|+.++..++|.|++..+++.+-..     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3344567999999999998874  8899999875432 22334577888999999999999999998876543     47


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |+++|++.. +|..+|-....++...+.-+..||+.||.|||+.+  |+||||||.|+|+  +.+..+||||||+++.-.
T Consensus       133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLV--NSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLV--NSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEe--ccCceEEecccccccccc
Confidence            889998855 99999888888999999999999999999999987  9999999999999  889999999999998766


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .++.   ..++..+-|.+|.|||++|
T Consensus       208 ~d~~---~hMTqEVVTQYYRAPEiLM  230 (449)
T KOG0664|consen  208 QRDR---LNMTHEVVTQYYRAPELLM  230 (449)
T ss_pred             hhhh---hhhHHHHHHHHhccHHHhh
Confidence            5433   2456778899999999986

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=7e-25  Score=195.95  Aligned_cols=165  Identities=22%  Similarity=0.384  Sum_probs=138.8

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |.....||+|+||.||++...  +..+++|.+....   ......+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            334467999999999999874  7889999874332   22346688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++++|.+++. ...+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +.++.++|+|||++........  
T Consensus        99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv--~~~~~~~l~dfg~~~~~~~~~~--  171 (292)
T cd06657          99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP--  171 (292)
T ss_pred             CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCCEEEcccccceecccccc--
Confidence            99999999875 346899999999999999999999987  9999999999999  7778999999999876643321  


Q ss_pred             eeeeeCCcccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l  335 (337)
                        ......|++.|+|||.+
T Consensus       172 --~~~~~~~~~~y~~pE~~  188 (292)
T cd06657         172 --RRKSLVGTPYWMAPELI  188 (292)
T ss_pred             --cccccccCccccCHHHh
Confidence              22345689999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.92  E-value=6.5e-25  Score=200.10  Aligned_cols=172  Identities=28%  Similarity=0.479  Sum_probs=140.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC--CceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER--KPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~--~~~~l  232 (337)
                      +|+..+.||+|+||.||+|.+.  +..+++|.+....... .....+.+|+.+++++ +||||+++++++...  ...|+
T Consensus         8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            6888899999999999999875  7789999886543322 2335667899999999 899999999988653  36899


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||+.+ +|.+++... .+++.....++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.+...
T Consensus        87 v~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill--~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          87 VFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILL--NSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             Eeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCcEEEeeccchhccccc
Confidence            9999975 999988765 7889999999999999999999987  9999999999999  88889999999999876543


Q ss_pred             cccc-eeeeeCCccccccccccccc
Q 019685          313 NSHD-VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~-~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .... ........|++.|+|||++.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~  185 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILL  185 (337)
T ss_pred             cccccCcchhcccccccccCceeee
Confidence            2210 01223456899999999763

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.92  E-value=6.4e-25  Score=192.02  Aligned_cols=169  Identities=30%  Similarity=0.485  Sum_probs=140.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++..+  +..+++|.+....... ...+.+.+|+.+++.++|+||+++++.+......++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4677889999999999999985  6789999886532221 233567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-cEEEEeccCceeeecc
Q 019685          236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-~~kl~DFgla~~~~~~  312 (337)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||||+||++  +..+ .+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~--~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFL--SKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE--cCCCCeEEecccccchhccCC
Confidence            999999999997643  4789999999999999999999987  9999999999999  5553 5799999999876543


Q ss_pred             cccceeeeeCCcccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..    ......|++.|+|||++
T Consensus       156 ~~----~~~~~~~~~~~~ape~~  174 (257)
T cd08225         156 ME----LAYTCVGTPYYLSPEIC  174 (257)
T ss_pred             cc----cccccCCCccccCHHHH
Confidence            21    12334689999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.92  E-value=6.5e-25  Score=196.81  Aligned_cols=170  Identities=28%  Similarity=0.453  Sum_probs=138.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-------  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-------  228 (337)
                      +|+..+.||+|+||.||+|...  ++.+++|.+....... .....+.+|+.+++.++||||+++++++.+..       
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            6788899999999999999985  7789999886543221 12345678999999999999999999887654       


Q ss_pred             ---ceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          229 ---PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       229 ---~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                         .+++++||+++ ++.+++... ..+++..+..++.||+.||.|||+.+  |+|+||||+||++  +..+.+||+|||
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili--~~~~~~kl~dfg  161 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILL--NNKGQIKLADFG  161 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCcEEeCccc
Confidence               78999999986 777777643 46899999999999999999999977  9999999999999  788899999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++..+......   ......++..|+|||.+.
T Consensus       162 ~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~  190 (302)
T cd07864         162 LARLYNSEESR---PYTNKVITLWYRPPELLL  190 (302)
T ss_pred             ccccccCCccc---ccccceeccCccChHHhc
Confidence            99876544321   123345688999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.92  E-value=1.1e-24  Score=196.04  Aligned_cols=166  Identities=33%  Similarity=0.463  Sum_probs=140.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||++...  +..+++|.+............++.+|+.+++.++|+|++++++++......|+|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4777789999999999999974  67899998865433333445677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+. +++.+++.. ...+++..+..++.|++.||.|||+.+  ++||||+|+||++  +.++.+||+|||++......  
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEE--CCCCcEEECCcccceeecCc--
Confidence            996 588887754 446899999999999999999999987  9999999999999  77889999999998765432  


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                            ....+++.|+|||.+.
T Consensus       169 ------~~~~~~~~y~aPE~~~  184 (308)
T cd06634         169 ------NXFVGTPYWMAPEVIL  184 (308)
T ss_pred             ------ccccCCccccCHHHHh
Confidence                  2346889999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.92  E-value=1.6e-24  Score=193.77  Aligned_cols=177  Identities=16%  Similarity=0.206  Sum_probs=126.8

Q ss_pred             CCcCccccceecccCceeEEEEEECCc-----eEEEEEecCCCCchHHH--------HHHHHHHHHHHHhCCCCCeeeee
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLV--------IQDFRHEVNLLVKLRHPNIVQFL  221 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~g~-----~vavK~l~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~Iv~~~  221 (337)
                      ...+|.+.+.||+|+||.||+|.+.+.     .+++|............        ......+...+..+.|++|++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            334788999999999999999987533     45666432221111000        01122334455667899999999


Q ss_pred             eeEEeCC----ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc
Q 019685          222 GAVTERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH  297 (337)
Q Consensus       222 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~  297 (337)
                      ++.....    ..++++|++.. ++.+.+......++..+..++.|++.||.|||+.+  |+||||||+|||+  +..+.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill--~~~~~  164 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMV--DGNNR  164 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCc
Confidence            9765543    34778887644 77777766555788889999999999999999987  9999999999999  77889


Q ss_pred             EEEEeccCceeeecccccce---eeeeCCccccccccccccc
Q 019685          298 LKVGDFGLSKLIKVQNSHDV---YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       298 ~kl~DFgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~  336 (337)
                      +||+|||+|+.+........   .......||+.|+|||++.
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~  206 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN  206 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence            99999999987753321110   0123356999999999753

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=1e-24  Score=193.69  Aligned_cols=166  Identities=30%  Similarity=0.471  Sum_probs=138.7

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEe
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      |++.+.||+|+||.||+|...  ++.+++|.+.......  ......+|+..++.++ |+||+++++++...+..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            456778999999999999985  6789999886543321  1223456899999999 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+ +++|.+++....  .+++..+..++.|++.+|.|||+.+  ++|+||+|+||++  +..+.++|+|||+++......
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i--~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--cCCCCEEEeecccceeccCCC
Confidence            99 779999987654  6899999999999999999999977  9999999999999  778899999999998765432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......++..|+|||++.
T Consensus       154 -----~~~~~~~~~~~~aPE~~~  171 (283)
T cd07830         154 -----PYTDYVSTRWYRAPEILL  171 (283)
T ss_pred             -----CcCCCCCcccccCceeee
Confidence                 123456889999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.92  E-value=1.1e-24  Score=196.49  Aligned_cols=173  Identities=17%  Similarity=0.201  Sum_probs=139.5

Q ss_pred             ccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      +.+.+.+|.|+++.|+++..+++.+|+|.+...... ......+..|+.+++.++|+||+++++++...+..+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            344455666677777777777999999998764322 3345778999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc-
Q 019685          239 GGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH-  315 (337)
Q Consensus       239 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~-  315 (337)
                      +++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||.+......... 
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili--~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILL--SGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEE--ecCCceEEecCccceeeccccccc
Confidence            99999999763  45889999999999999999999987  9999999999999  77789999999998766432211 


Q ss_pred             --ceeeeeCCccccccccccccc
Q 019685          316 --DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 --~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .........++..|+|||++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~  181 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQ  181 (314)
T ss_pred             cccccccccccccccccCHHHhc
Confidence              001123456788999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=2.2e-24  Score=190.52  Aligned_cols=170  Identities=31%  Similarity=0.499  Sum_probs=135.4

Q ss_pred             ccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-----
Q 019685          159 FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----  228 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----  228 (337)
                      |.+.+.||+|+||.||+|.++     ++.+++|.+...... ....+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            455678999999999999863     578999988655433 334567889999999999999999999875432     


Q ss_pred             -ceEEEEeecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          229 -PLMLITEYLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       229 -~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                       ..++++||+.+++|.+++...      ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili--~~~~~~kl~  155 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCML--NENMTVCVA  155 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEE--cCCCCEEEC
Confidence             247889999999999887532      24788999999999999999999987  9999999999999  778899999


Q ss_pred             eccCceeeecccccceeeeeCCcccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |||+++.......  ........+++.|++||.+
T Consensus       156 dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~  187 (273)
T cd05074         156 DFGLSKKIYSGDY--YRQGCASKLPVKWLALESL  187 (273)
T ss_pred             cccccccccCCcc--eecCCCccCchhhcCHhHH
Confidence            9999987643221  1112334567889999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.92  E-value=6.5e-25  Score=199.44  Aligned_cols=172  Identities=31%  Similarity=0.485  Sum_probs=143.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-----ce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-----PL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-----~~  230 (337)
                      +|++.+.||+|+||.||+|...  ++.+++|.+..... .....+.+.+|+.+++.++|+||+++++++....     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4677889999999999999975  68899998865432 2234467888999999999999999999987765     78


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |++|||+.+ +|.+++.....+++..+..++.||+.||.|||+.|  |+|+||||+|||+  +..+.++|+|||++....
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili--~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILV--NSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEcccCceEeec
Confidence            999999974 89999987778999999999999999999999987  9999999999999  777899999999998776


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..... ........+++.|+|||++.
T Consensus       155 ~~~~~-~~~~~~~~~~~~y~aPE~~~  179 (330)
T cd07834         155 PDEDE-KGFLTEYVVTRWYRAPELLL  179 (330)
T ss_pred             ccccc-cccccccccccCcCCceeee
Confidence            54211 01234456899999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.92  E-value=8.2e-25  Score=192.79  Aligned_cols=165  Identities=31%  Similarity=0.539  Sum_probs=133.0

Q ss_pred             eecccCceeEEEEEECC--------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          164 IIGKGSFGEILKAYWRG--------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~g--------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .||+|+||.||++....        ..+++|.+.....  ......+.+|+.+++.++||||+++++++......+++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            68999999999998642        4688887754322  2234678889999999999999999999998899999999


Q ss_pred             ecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-----cEEEEec
Q 019685          236 YLRGGDLHKYLKEK-------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-----HLKVGDF  303 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-----~~kl~DF  303 (337)
                      |+++++|.+++...       ..+++.++..++.|++.||.|||+.+  ++|+||||+||++  +..+     .+||+||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~--~~~~~~~~~~~~l~df  155 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLV--SEKGYDADRVVKIGDF  155 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEE--ecCCCCCCcceEECCc
Confidence            99999999999642       23778899999999999999999987  9999999999999  4444     7999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++........  .......++..|+|||++.
T Consensus       156 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  186 (269)
T cd05044         156 GLARDIYKSDYY--RKEGEGLLPVRWMAPESLL  186 (269)
T ss_pred             cccccccccccc--ccCcccCCCccccCHHHHc
Confidence            999876433211  1122345678999999763

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.92  E-value=2e-24  Score=196.21  Aligned_cols=169  Identities=22%  Similarity=0.297  Sum_probs=134.9

Q ss_pred             ceeccc--CceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          163 AIIGKG--SFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       163 ~~lg~G--~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      ..||+|  +|+.||++..  .++.||+|.+....... ...+.+.+|+.+++.++||||+++++++......++++||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356766  8999999987  48899999986544333 345788899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          239 GGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       239 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+|++||+.+..........
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill--~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--eCCCcEEEechHHHhhhhccCccc
Confidence            99999999764  34889999999999999999999987  9999999999999  777899999998654332211100


Q ss_pred             --ee-eeeCCccccccccccccc
Q 019685          317 --VY-KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 --~~-~~~~~~gt~~y~aPE~l~  336 (337)
                        .. ......++..|||||++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~  181 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLR  181 (328)
T ss_pred             cccccccccccCccCccChhhhc
Confidence              00 011233567899999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.92  E-value=1.5e-24  Score=189.42  Aligned_cols=168  Identities=29%  Similarity=0.480  Sum_probs=142.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+....... .....+..|+.+++.++|+||+++++++......++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            3677789999999999999874  6789999886543322 334667789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       236 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.+||+|||+++....
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~--~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILL--VANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEE--ecCCcEEEeeccchhhhcc
Confidence            9999999999865    346899999999999999999999987  9999999999999  6678899999999977654


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .      ......+++.|+|||.+.
T Consensus       156 ~------~~~~~~~~~~~~~Pe~~~  174 (256)
T cd08530         156 N------MAKTQIGTPHYMAPEVWK  174 (256)
T ss_pred             C------CcccccCCccccCHHHHC
Confidence            3      123356889999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.92  E-value=3.7e-24  Score=190.25  Aligned_cols=167  Identities=32%  Similarity=0.543  Sum_probs=136.0

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEeCCc----
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERKP----  229 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~~----  229 (337)
                      |++.+.||+|+||.||++..+  ++.+++|.+....... .....+.+|+.++.++   .|+||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            456789999999999999985  7899999986543322 2234555677776665   59999999999988776    


Q ss_pred             -eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          230 -LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       230 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                       .+++|||+.+ +|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+||++  +..+.+||+|||++
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili--~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILV--TSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEE--ccCCCEEEeccCcc
Confidence             9999999975 8999887633  5899999999999999999999987  9999999999999  77789999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .......     ......+++.|+|||++.
T Consensus       155 ~~~~~~~-----~~~~~~~~~~~~~PE~~~  179 (287)
T cd07838         155 RIYSFEM-----ALTSVVVTLWYRAPEVLL  179 (287)
T ss_pred             eeccCCc-----ccccccccccccChHHhc
Confidence            8765432     123445889999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.92  E-value=3.3e-24  Score=194.72  Aligned_cols=167  Identities=32%  Similarity=0.536  Sum_probs=138.1

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-CCceEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLML  232 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~l  232 (337)
                      ..+|+..+.||.|+||.||++...  ++.+++|.+.+.... ....+.+..|+.+++.++||||+++++++.. ....|+
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            447888999999999999999865  778999988654322 2234667789999999999999999998865 457899


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ++||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+  |+||||+|+||++  +..+.+||+|||++......
T Consensus        88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili--~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILI--NENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeE--CCCCCEEeCccccccccCCC
Confidence            99998 5589888864 45788888999999999999999987  9999999999999  77889999999998754321


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                             .....+++.|+|||.+.
T Consensus       162 -------~~~~~~~~~y~aPE~~~  178 (328)
T cd07856         162 -------MTGYVSTRYYRAPEIML  178 (328)
T ss_pred             -------cCCCcccccccCceeee
Confidence                   23456789999999763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.92  E-value=2.9e-24  Score=196.45  Aligned_cols=165  Identities=28%  Similarity=0.484  Sum_probs=136.2

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------C
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~  228 (337)
                      .+|+..+.||+|+||.||++...  ++.||+|++...... ....+.+.+|+.++++++||||+++++++...      .
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            47888899999999999999864  788999988654322 22345677899999999999999999987543      3


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      ..|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll--~~~~~~kl~dfg~~~~  169 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARH  169 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEE--cCCCCEEEeccccccc
Confidence            478888877 6799888764 36899999999999999999999988  9999999999999  7788999999999876


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...       ......+++.|+|||.+
T Consensus       170 ~~~-------~~~~~~~~~~y~aPE~~  189 (345)
T cd07877         170 TDD-------EMTGYVATRWYRAPEIM  189 (345)
T ss_pred             ccc-------cccccccCCCccCHHHH
Confidence            432       12345688999999975

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=1.3e-24  Score=192.75  Aligned_cols=168  Identities=33%  Similarity=0.569  Sum_probs=141.1

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |+..+.||+|++|.||+|...  ++.+++|.+...... ....+.+..|+.+++.++|+||+++++++......++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            445678999999999999875  789999998765422 22345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++ +|.+++... ..+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +..+.+||+|||+++....... 
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~--~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEE--cCCCCEEEecCCcccccCCCcc-
Confidence            985 999999875 57999999999999999999999987  9999999999999  7788999999999987654321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......++..|+|||.+.
T Consensus       154 ---~~~~~~~~~~~~aPE~~~  171 (282)
T cd07829         154 ---TYTHEVVTLWYRAPEILL  171 (282)
T ss_pred             ---ccCccccCcCcCChHHhc
Confidence               223445678899999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.92  E-value=3.4e-24  Score=202.06  Aligned_cols=175  Identities=21%  Similarity=0.266  Sum_probs=128.0

Q ss_pred             CCcCccccceecccCceeEEEEEE------------------CCceEEEEEecCCCCchHH-----------HHHHHHHH
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYW------------------RGTPVAIKRILPSLSDDRL-----------VIQDFRHE  205 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~------------------~g~~vavK~l~~~~~~~~~-----------~~~~~~~E  205 (337)
                      +..+|...++||+|+||.||+|..                  .++.||||.+.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            344899999999999999999864                  2457999998543221110           01223447


Q ss_pred             HHHHHhCCCCCe-----eeeeeeEEe--------CCceEEEEeecCCCCHHHHHHhcC----------------------
Q 019685          206 VNLLVKLRHPNI-----VQFLGAVTE--------RKPLMLITEYLRGGDLHKYLKEKG----------------------  250 (337)
Q Consensus       206 ~~~l~~l~h~~I-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~----------------------  250 (337)
                      +.++.+++|.++     +++++++..        .+..|+|+||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776544     566666542        356899999999999999886421                      


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccc
Q 019685          251 --ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCE  328 (337)
Q Consensus       251 --~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~  328 (337)
                        .+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......   .......+|+.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl--~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~  375 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLV--TVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPR  375 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEE--CCCCcEEEEeCcCccccccCCc---cCccccCCCcc
Confidence              1345678889999999999999987  9999999999999  7778999999999976543211   11122345899


Q ss_pred             cccccccc
Q 019685          329 YLVSNCSF  336 (337)
Q Consensus       329 y~aPE~l~  336 (337)
                      |+|||++.
T Consensus       376 Y~aPE~l~  383 (507)
T PLN03224        376 YSPPEELV  383 (507)
T ss_pred             eeChhhhc
Confidence            99999875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.92  E-value=2.8e-24  Score=186.20  Aligned_cols=149  Identities=19%  Similarity=0.307  Sum_probs=126.4

Q ss_pred             cCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCHHHH
Q 019685          168 GSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY  245 (337)
Q Consensus       168 G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  245 (337)
                      |.++.||++.+.  ++.+++|.+....        .+..|...+....||||+++++.+......+++|||+++++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            889999999885  7889999986542        123345555566799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcc
Q 019685          246 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG  325 (337)
Q Consensus       246 l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~g  325 (337)
                      +.....+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.++++|||++......       .....+
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~df~~~~~~~~~-------~~~~~~  144 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDS-------CDGEAV  144 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEE--cCCCCEEEecccchhccccc-------cccCCc
Confidence            987777999999999999999999999988  9999999999999  78889999999988665432       234456


Q ss_pred             cccccccccc
Q 019685          326 SCEYLVSNCS  335 (337)
Q Consensus       326 t~~y~aPE~l  335 (337)
                      +..|+|||.+
T Consensus       145 ~~~y~aPE~~  154 (237)
T cd05576         145 ENMYCAPEVG  154 (237)
T ss_pred             CccccCCccc
Confidence            7889999976

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=4e-24  Score=191.32  Aligned_cols=167  Identities=24%  Similarity=0.436  Sum_probs=137.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||++.+.  ++.+++|.+......  .....+..|+.++.... ||||+++++++......|++|
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            6778889999999999999987  889999998654322  23355666777676665 999999999999999999999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||+.+ ++.+++.. ...+++..+..++.||+.||.|||+ .+  |+||||+|+||++  +.++.+||+|||++..+...
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill--~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILL--DASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEE--cCCCCEEECccccchhccCC
Confidence            99854 78777765 4568999999999999999999997 46  9999999999999  77889999999999776433


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .     ......+++.|+|||.+.
T Consensus       169 ~-----~~~~~~~~~~y~aPE~~~  187 (296)
T cd06618         169 K-----AKTRSAGCAAYMAPERID  187 (296)
T ss_pred             C-----cccCCCCCccccCHhhcC
Confidence            2     123346889999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.91  E-value=1.9e-24  Score=194.41  Aligned_cols=174  Identities=30%  Similarity=0.484  Sum_probs=137.8

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------  228 (337)
                      .+|+..+.||+|+||.||++...  ++.+++|.+........ ....+.+|+.+++.++||||+++++.+....      
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            37888999999999999999975  77899998865432221 1235578999999999999999999875433      


Q ss_pred             --ceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          229 --PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       229 --~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                        .+++++||+.+ ++...+.. ...+++..+..++.|++.||.|||+.+  |+|+||||+||++  +..+.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~--~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILI--DNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEECcCcc
Confidence              46999999975 77777654 446999999999999999999999988  9999999999999  7888999999999


Q ss_pred             ceeeecccccce-------eeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDV-------YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++..........       .......+++.|+|||.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL  199 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence            987643321100       1123456789999999763

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=4e-24  Score=207.87  Aligned_cols=181  Identities=36%  Similarity=0.656  Sum_probs=149.3

Q ss_pred             CCCCCcccCCCCcCccccceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-C
Q 019685          145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H  214 (337)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h  214 (337)
                      |....|+++...+.+..  .||+|.||.|++|...         ...||||.+......  ...+.+..|+.+|+.+. |
T Consensus       286 ~~~~~~e~~~~~l~~~~--~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H  361 (609)
T KOG0200|consen  286 PEDPKWEIPRENLKLGK--YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKH  361 (609)
T ss_pred             CcCCceeechhhccccc--eeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCC
Confidence            34447888888775544  9999999999999753         236889987655443  45688999999999997 9


Q ss_pred             CCeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 019685          215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVI  278 (337)
Q Consensus       215 ~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~i  278 (337)
                      +||+.++|++...+.+++|+||+..|+|.++++.++                .++..+.+.++.||+.||+||++..  +
T Consensus       362 ~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~  439 (609)
T KOG0200|consen  362 PNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--C  439 (609)
T ss_pred             cchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--c
Confidence            999999999999999999999999999999998765                3888899999999999999999987  9


Q ss_pred             EeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcc--ccccccccccc
Q 019685          279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG--SCEYLVSNCSF  336 (337)
Q Consensus       279 vHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~g--t~~y~aPE~l~  336 (337)
                      |||||..+|||+  .....+||+|||+|+.....+   .+......|  +..|||||.|.
T Consensus       440 vHRDLAaRNVLi--~~~~~~kIaDFGlar~~~~~~---~y~~~~~~~~LP~kWmApEsl~  494 (609)
T KOG0200|consen  440 VHRDLAARNVLI--TKNKVIKIADFGLARDHYNKD---YYRTKSSAGTLPVKWMAPESLF  494 (609)
T ss_pred             cchhhhhhhEEe--cCCCEEEEccccceeccCCCC---ceEecCCCCccceeecCHHHhc
Confidence            999999999999  666789999999998765432   233333443  45699999874

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=3.3e-24  Score=188.07  Aligned_cols=169  Identities=31%  Similarity=0.482  Sum_probs=135.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCc--hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      +|.+.+.||+|+||.||++.+.  +..+++|.+......  .......+..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            3667789999999999999876  344555555432211  112234566789999999999999999999988999999


Q ss_pred             EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +||+++++|.+++..    ...+++.++..++.|++.||.|||+.+  ++|+||+|+||++  + .+.+||+|||+++..
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili--~-~~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFL--K-NNLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEe--e-cCCEeecccCceeec
Confidence            999999999998864    346899999999999999999999987  9999999999999  3 356999999999876


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .....    ......|++.|+|||.+
T Consensus       156 ~~~~~----~~~~~~~~~~~~~pe~~  177 (260)
T cd08222         156 MGSCD----LATTFTGTPYYMSPEAL  177 (260)
T ss_pred             CCCcc----cccCCCCCcCccCHHHH
Confidence            54321    23345688999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=6.1e-24  Score=194.11  Aligned_cols=164  Identities=28%  Similarity=0.492  Sum_probs=134.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------c
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------P  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~  229 (337)
                      +|.....||+|+||.||+|...  ++.+|+|.+...... ......+.+|+.+++.++||||+++++++....      .
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            6888899999999999999864  789999988654322 223356778999999999999999999886543      4


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+++||+.. +|..++  ...+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++..
T Consensus        95 ~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll--~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAV--NEDCELKILDFGLARHA  167 (342)
T ss_pred             EEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEeeCCCCcCC
Confidence            6999999864 777665  235899999999999999999999987  9999999999999  78889999999998765


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...       .....+++.|+|||++.
T Consensus       168 ~~~-------~~~~~~~~~y~aPE~~~  187 (342)
T cd07879         168 DAE-------MTGYVVTRWYRAPEVIL  187 (342)
T ss_pred             CCC-------CCCceeeecccChhhhc
Confidence            321       23456789999999863

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.91  E-value=7.3e-24  Score=187.98  Aligned_cols=168  Identities=30%  Similarity=0.500  Sum_probs=140.9

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |+..+.||+|++|.||++...  ++.+++|.+....... .....+..|+.+++.++|++|+++++++......++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            455678999999999999874  7789999886544331 2346777899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++ +|.+++.. ...+++..+..++.|++.||.|||+.+  |+|+||+|+||++  +.++.+||+|||.+........ 
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili--~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLI--NTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEE--CCCCcEEEeeeeeeEecCCCcc-
Confidence            976 88888866 357899999999999999999999987  9999999999999  7788999999999987754421 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......++..|+|||.+.
T Consensus       154 ---~~~~~~~~~~~~~PE~~~  171 (283)
T cd05118         154 ---PYTHYVVTRWYRAPELLL  171 (283)
T ss_pred             ---cccCccCcccccCcHHHh
Confidence               123456889999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.91  E-value=7.1e-24  Score=193.70  Aligned_cols=170  Identities=28%  Similarity=0.456  Sum_probs=135.5

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-------
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-------  227 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-------  227 (337)
                      .+|...+.||.|+||.||+|..+  ++.|++|.+.....   ...+.+.+|+.+++.++||||+++++.+...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            47888999999999999999875  77899998855433   2346678899999999999999999876543       


Q ss_pred             -------CceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEE
Q 019685          228 -------KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV  300 (337)
Q Consensus       228 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl  300 (337)
                             ...|++|||+++ +|.+++.. ..+++..+..++.||+.||.|||+.|  |+||||||+||++.. ..+.+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~-~~~~~kl  156 (342)
T cd07854          82 VGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINT-EDLVLKI  156 (342)
T ss_pred             cccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcC-CCceEEE
Confidence                   357999999974 89888854 46899999999999999999999987  999999999999931 3457899


Q ss_pred             EeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +|||+++......... .......++..|+|||.+
T Consensus       157 ~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~  190 (342)
T cd07854         157 GDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLL  190 (342)
T ss_pred             CCcccceecCCccccc-cccccccccccccCHHHH
Confidence            9999997654321110 011234678999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.91  E-value=5.3e-24  Score=194.59  Aligned_cols=165  Identities=29%  Similarity=0.492  Sum_probs=138.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc-----
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~-----  229 (337)
                      .+|+....||+|++|.||++...  ++.+++|.+...... ......+.+|+.+++.++||||+++++++.....     
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            36888899999999999999985  678999988654322 2234567789999999999999999988766554     


Q ss_pred             -eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 -LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                       .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+  |+||||+|+||++  +.++.+||+|||++..
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill--~~~~~~kL~dfg~~~~  167 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAV--NEDCELKILDFGLARH  167 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--CCCCCEEEcccccccc
Confidence             89999998 5699999865 46899999999999999999999987  9999999999999  7788999999999976


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....       .....+++.|+|||.+
T Consensus       168 ~~~~-------~~~~~~~~~y~aPE~~  187 (343)
T cd07851         168 TDDE-------MTGYVATRWYRAPEIM  187 (343)
T ss_pred             cccc-------ccCCcccccccCHHHH
Confidence            5432       2345678899999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=9.7e-25  Score=205.65  Aligned_cols=172  Identities=31%  Similarity=0.586  Sum_probs=145.8

Q ss_pred             CcCccccceecccCceeEEEEEEC------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      +......++||+|+||.||+|.|-      .-+|++|++......  ....++..|+.+|..+.|||++++++++.... 
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            334556689999999999999983      347999988765443  34578999999999999999999999987665 


Q ss_pred             eEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      +.||++|++.|+|.++++. ++.+-....+.|+.||++||.|||.++  +|||||..+|||+  ....++||.|||+++.
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLV--ksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLV--KSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheee--cCCCeEEEEecchhhc
Confidence            8899999999999999986 457889999999999999999999988  9999999999999  7888999999999999


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +..+..+  +......-.+.|||=|.+.
T Consensus       848 l~~d~~e--y~~~~gK~pikwmale~i~  873 (1177)
T KOG1025|consen  848 LAPDEKE--YSAPGGKVPIKWMALESIR  873 (1177)
T ss_pred             cCccccc--ccccccccCcHHHHHHHhh
Confidence            8765432  3345556688999988874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.91  E-value=7.8e-24  Score=204.01  Aligned_cols=167  Identities=19%  Similarity=0.243  Sum_probs=117.4

Q ss_pred             CcCccccceecccCceeEEEEEEC------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeee------
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA------  223 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~------  223 (337)
                      ..+|...+.||+|+||.||+|.+.      +..||+|.+......     +....+  .+....+.++..++..      
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            347888999999999999999874      568999987543211     111111  1111222222222211      


Q ss_pred             EEeCCceEEEEeecCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCC
Q 019685          224 VTERKPLMLITEYLRGGDLHKYLKEKGA--------------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDL  283 (337)
Q Consensus       224 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdl  283 (337)
                      ......+++|+||+.+++|.+++.....                    .....+..++.||+.||.|||+++  |+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDL  281 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDV  281 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcC
Confidence            2345679999999999999999865321                    112345679999999999999987  999999


Q ss_pred             CCCCEEEecCC-CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          284 KPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       284 kp~Nil~~~~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+|||+  +. .+.+||+|||+|+.+.....   +......+++.|||||.+.
T Consensus       282 KP~NILl--~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~  330 (566)
T PLN03225        282 KPQNIIF--SEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYI  330 (566)
T ss_pred             CHHHEEE--eCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhh
Confidence            9999999  53 57899999999986643321   1234567899999999764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.5e-23  Score=174.75  Aligned_cols=142  Identities=22%  Similarity=0.157  Sum_probs=109.1

Q ss_pred             ceecccCceeEEEEEEC-CceEEEEEecCCCCchHH-----------------------HHHHHHHHHHHHHhCCCCCee
Q 019685          163 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRL-----------------------VIQDFRHEVNLLVKLRHPNIV  218 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~Iv  218 (337)
                      ..||+|+||.||+|... |+.||+|++.+.......                       .......|+..+..+.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            57999999999999874 889999999764321100                       012234599999999877764


Q ss_pred             eeeeeEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCCcEeeCCCCCCEEEecCCCCc
Q 019685          219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL-HNEPNVIIHRDLKPRNVLLVNSSADH  297 (337)
Q Consensus       219 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~ivHrdlkp~Nil~~~~~~~~  297 (337)
                      .......  ...+|||||++++++...+.....++...+..++.|++.+|.|+ |+.|  |+||||||+|||+  + ++.
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli--~-~~~  155 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLY--H-DGK  155 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--E-CCc
Confidence            4333222  23489999999887766544456789999999999999999999 7877  9999999999999  4 368


Q ss_pred             EEEEeccCceeeec
Q 019685          298 LKVGDFGLSKLIKV  311 (337)
Q Consensus       298 ~kl~DFgla~~~~~  311 (337)
                      ++|+|||+|.....
T Consensus       156 v~LiDFG~a~~~~~  169 (190)
T cd05147         156 LYIIDVSQSVEHDH  169 (190)
T ss_pred             EEEEEccccccCCC
Confidence            99999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.90  E-value=6e-24  Score=166.23  Aligned_cols=115  Identities=29%  Similarity=0.336  Sum_probs=98.8

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhC-CCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED-QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~-~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      .+..+|.+|+.||||||+  |+..+..+|++-|+.+ |+|||+.+..|.|+|||||.+|+.||+++|+++||.++++|++
T Consensus        61 ~nv~~ddkDdaGWtPlhi--a~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~  138 (226)
T KOG4412|consen   61 PNVKPDDKDDAGWTPLHI--AASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQ  138 (226)
T ss_pred             CCCCCCCccccCCchhhh--hhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccc
Confidence            345678889999999977  7777777877777777 9999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK  138 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~  138 (337)
                      |.||||.|+..|..+++++|+..++..+.++....+|.
T Consensus       139 ~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~TpL  176 (226)
T KOG4412|consen  139 GQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTPL  176 (226)
T ss_pred             cCchhHHHHhccchhhHHHHHhcCCCCCcccccCccHH
Confidence            99999999999999999999999987776665555543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.7e-22  Score=168.90  Aligned_cols=144  Identities=17%  Similarity=0.133  Sum_probs=112.0

Q ss_pred             cceecccCceeEEEEEEC-CceEEEEEecCCCCch-----------------------HHHHHHHHHHHHHHHhCCCCCe
Q 019685          162 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDD-----------------------RLVIQDFRHEVNLLVKLRHPNI  217 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~~I  217 (337)
                      ...||+|+||.||+|... |+.||+|++.+.....                       ......+..|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            357999999999999875 9999999987653210                       0112334678999999999887


Q ss_pred             eeeeeeEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCC
Q 019685          218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       218 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      .....+...  ..|+||||++++++.........++..+...++.|++.++.++|+ .|  |+||||||+||++  + ++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll--~-~~  154 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILY--H-DG  154 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEE--E-CC
Confidence            554443332  248999999987654432234568888999999999999999999 88  9999999999999  5 67


Q ss_pred             cEEEEeccCceeeecc
Q 019685          297 HLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~  312 (337)
                      .++|+|||+++.....
T Consensus       155 ~~~liDFG~a~~~~~~  170 (190)
T cd05145         155 KPYIIDVSQAVELDHP  170 (190)
T ss_pred             CEEEEEcccceecCCC
Confidence            8999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.89  E-value=1.2e-22  Score=209.37  Aligned_cols=158  Identities=25%  Similarity=0.387  Sum_probs=127.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|.....||+|+||.||+|...  +..||+|.+......       ...|+..+++++||||+++++++.+....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            4556678999999999999864  789999988543221       1235788999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++|+|.++++.   +++..+..++.||+.||+|||.. ..+|+||||||+||++  +..+.+++. ||........  
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~--~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE--CCCCceEEE-eccccccccC--
Confidence            9999999999963   78999999999999999999943 1349999999999999  666677765 6665433211  


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                            ....+|+.|||||++.
T Consensus       836 ------~~~~~t~~y~aPE~~~  851 (968)
T PLN00113        836 ------TKCFISSAYVAPETRE  851 (968)
T ss_pred             ------CCccccccccCccccc
Confidence                  2336899999999864

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.89  E-value=3.9e-23  Score=180.15  Aligned_cols=169  Identities=24%  Similarity=0.375  Sum_probs=138.1

Q ss_pred             CCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC--C----CeeeeeeeEE
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--P----NIVQFLGAVT  225 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~----~Iv~~~~~~~  225 (337)
                      ....+|.+...+|+|.||.|..+.+.  +..||+|+++.-    ....+..+-|++++.++.+  |    -++++.++|.
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            33558899999999999999999876  568999987532    2234556779999999942  2    4788888999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC----------
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS----------  293 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~----------  293 (337)
                      -.+..|||+|.+ |.|+++++.++.  .++...++.++.|++.++.|||+.+  ++|-||||+|||+.+.          
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCC
Confidence            999999999987 669999998754  5888999999999999999999977  9999999999999531          


Q ss_pred             --------CCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          294 --------SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       294 --------~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                              ....|||+|||.|......       ....+.|..|.|||+|+
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~-------hs~iVsTRHYRAPEViL  282 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEH-------HSTIVSTRHYRAPEVIL  282 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccC-------cceeeeccccCCchhee
Confidence                    1236999999999875543       25577899999999997

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.89  E-value=1.8e-23  Score=188.42  Aligned_cols=165  Identities=25%  Similarity=0.339  Sum_probs=139.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC------CCeeeeeeeEEeCCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH------PNIVQFLGAVTERKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h------~~Iv~~~~~~~~~~~  229 (337)
                      +|.+....|+|-|++|.+|.+.  |+.||||++..+..    .-+..+.|+++|.+|+.      -|+++|+..|...+.
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            7888889999999999999875  88999999976543    33566789999999952      389999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          230 LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      +|||+|.+.- +|.++++..+   .+....+..|+.|+..||..|-.+|  |+|.||||+|||+. .....+||||||.|
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVN-E~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVN-ESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEec-cCcceeeeccCccc
Confidence            9999998854 9999998755   3788899999999999999999977  99999999999994 34568999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......      ..+...-+..|.|||+|+
T Consensus       585 ~~~~en------eitPYLVSRFYRaPEIiL  608 (752)
T KOG0670|consen  585 SFASEN------EITPYLVSRFYRAPEIIL  608 (752)
T ss_pred             cccccc------cccHHHHHHhccCcceee
Confidence            876654      244556778999999986

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.89  E-value=1.6e-23  Score=171.08  Aligned_cols=162  Identities=23%  Similarity=0.438  Sum_probs=134.1

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCC--ceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK--PLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~--~~~l  232 (337)
                      +|++.+.+|+|.+++||.|+.  .+..+++|.+++-      ..+.+.+|+.+|..+. ||||+++++...++.  ..-+
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            789999999999999999984  4778999988653      3366789999999998 999999999987653  5689


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ++||+.+.+...+.   ..++..++..++.++++||.||||+|  |+|||+||.|++|+. ..-.++|+|||+|.++...
T Consensus       113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh-~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeech-hhceeeeeecchHhhcCCC
Confidence            99999887666554   35788899999999999999999999  999999999999942 3346999999999988765


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .     .-.-.+.+.+|--||.|+
T Consensus       187 ~-----eYnVRVASRyfKGPELLV  205 (338)
T KOG0668|consen  187 K-----EYNVRVASRYFKGPELLV  205 (338)
T ss_pred             c-----eeeeeeehhhcCCchhee
Confidence            3     233445678888899875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=9e-22  Score=168.20  Aligned_cols=168  Identities=35%  Similarity=0.621  Sum_probs=143.2

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |...+.||+|+++.||++...  ++.+++|.+......  ...+.+.+|+..++.++|+|++++++.+......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            345678999999999999986  588999998765433  2457888899999999999999999999988999999999


Q ss_pred             cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +.+++|.+++..... +++.....++.+++.++.+||+.+  ++|+||+|+||++  +..+.++|+|||++.........
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v--~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILL--GMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeeCceeeEecCcccc
Confidence            999999999987666 899999999999999999999987  9999999999999  66789999999999887654210


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                         ......++..|++||.+
T Consensus       155 ---~~~~~~~~~~~~~pe~~  171 (225)
T smart00221      155 ---LLKTVKGTPFYLAPEVL  171 (225)
T ss_pred             ---cccceeccCCcCCHhHh
Confidence               12345678899999975

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.88  E-value=2.1e-21  Score=163.54  Aligned_cols=161  Identities=40%  Similarity=0.680  Sum_probs=138.5

Q ss_pred             ecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       165 lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      ||+|++|.||++...  ++.+++|.+.......  ....+.+|+..++.++|++|+++++++......++++|++.+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999987  8899999986654322  346788999999999999999999999998999999999998999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCceeeecccccceeee
Q 019685          243 HKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       243 ~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                      .+++... ..+++..+..++.+++.++.+||+.+  ++|+||+|.||++  +. .+.++|+|||.+........    ..
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~--~~~~~~~~l~d~~~~~~~~~~~~----~~  150 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKS----LL  150 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEE--eCCCCcEEEecCCceEEccCCcc----hh
Confidence            9999865 56899999999999999999999987  9999999999999  65 68899999999987654321    13


Q ss_pred             eCCcccccccccccc
Q 019685          321 TGETGSCEYLVSNCS  335 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l  335 (337)
                      ....+...|++||.+
T Consensus       151 ~~~~~~~~~~~pe~~  165 (215)
T cd00180         151 KTIVGTPAYMAPEVL  165 (215)
T ss_pred             hcccCCCCccChhHh
Confidence            345688899999975

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.5e-23  Score=172.33  Aligned_cols=164  Identities=21%  Similarity=0.404  Sum_probs=134.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeee-eEEeCCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLG-AVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~-~~~~~~~~~lv  233 (337)
                      .|.+.+.||+|-||.+.++.++  .+.+++|.+.....    ...+|.+|...--.|. |.||+.-|+ +|+..+.+.++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            5888899999999999999987  45788898865433    3478888988776676 899998877 57888889999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      +||++.|+|.+-+.. ..+-+....+++.|+++|+.|||+++  +||||||.+||||-.....+|||||||+++....  
T Consensus       101 qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--  175 (378)
T ss_pred             eccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence            999999999888754 34788889999999999999999988  9999999999999555556999999999865432  


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                           ......-+..|.|||..
T Consensus       176 -----tV~~~~~~~~y~~pe~~  192 (378)
T KOG1345|consen  176 -----TVKYLEYVNNYHAPELC  192 (378)
T ss_pred             -----eehhhhhhcccCCcHHH
Confidence                 23444567788899875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.87  E-value=9.9e-23  Score=173.89  Aligned_cols=165  Identities=27%  Similarity=0.425  Sum_probs=134.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------Cc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------KP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~~  229 (337)
                      +|.....+|.|.- .|..+.+.  ++.|++|.+.....+ ....++..+|..++..++|+||++++.+|.-.      ..
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            6666677888887 56666553  889999988655444 33346677899999999999999999998533      35


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+|||+|.. +|..++..  .++-+.+..++.|++.|++|||+.|  |+||||||+||++  ..++.+||.|||+|+.-
T Consensus        96 ~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv--~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVV--NSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCccccee--cchhheeeccchhhccc
Confidence            8999999966 99988873  3677888999999999999999987  9999999999999  88899999999999754


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...     ...+..+.|..|.|||+++
T Consensus       169 ~~~-----~~mtpyVvtRyyrapevil  190 (369)
T KOG0665|consen  169 DTD-----FMMTPYVVTRYYRAPEVIL  190 (369)
T ss_pred             Ccc-----cccCchhheeeccCchhee
Confidence            322     3567778999999999985

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.5e-22  Score=184.73  Aligned_cols=163  Identities=28%  Similarity=0.450  Sum_probs=135.7

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ...|.....+|.|+|+.|..+...  ++..++|++.+...+       ..+|+.++...+ ||||+++.+.+.+....|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence            335677778999999999998875  788999998765222       234676666554 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |||++.++-+.+.+.....+. .++..|+.+|+.|+.|||++|  +|||||||+|||+. +..++++|+|||.++.....
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeec-CCCCcEEEEEechhhhCchh
Confidence            999999999988887665555 788899999999999999988  99999999999995 47789999999999877653


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                             ..+.+-|..|.|||++.
T Consensus       470 -------~~tp~~t~~y~APEvl~  486 (612)
T KOG0603|consen  470 -------CDTPALTLQYVAPEVLA  486 (612)
T ss_pred             -------hcccchhhcccChhhhc
Confidence                   34567789999999863

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.87  E-value=2.3e-21  Score=167.23  Aligned_cols=156  Identities=38%  Similarity=0.615  Sum_probs=135.5

Q ss_pred             CceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCCCCHHHHH
Q 019685          169 SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL  246 (337)
Q Consensus       169 ~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  246 (337)
                      +||.||++...  ++.+++|.+........  .+.+..|+..++.++|++|+++++.+......++++|++++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999986  58899999866543322  578889999999999999999999999889999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccc
Q 019685          247 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS  326 (337)
Q Consensus       247 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt  326 (337)
                      .....++...+..++.+++.++.|||+.+  ++|+||+|+||++  +..+.++|+|||.+.......     ......++
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~--~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~  149 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILL--DEDGHVKLADFGLARQLDPGG-----LLTTFVGT  149 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEE--CCCCcEEEccccceeeecccc-----ccccccCC
Confidence            87666899999999999999999999987  9999999999999  777899999999998776542     23456688


Q ss_pred             ccccccccc
Q 019685          327 CEYLVSNCS  335 (337)
Q Consensus       327 ~~y~aPE~l  335 (337)
                      +.|+|||.+
T Consensus       150 ~~~~~pE~~  158 (244)
T smart00220      150 PEYMAPEVL  158 (244)
T ss_pred             cCCCCHHHH
Confidence            999999975

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-21  Score=166.36  Aligned_cols=169  Identities=25%  Similarity=0.356  Sum_probs=139.0

Q ss_pred             CcCccccceecccCceeEEEEE--ECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ...|.+++.||+|+||.++.|.  +.+++||||.-.. ....    ..+..|.+..+.|. .+.|...|-+.+++.+-.|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc-cCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            3489999999999999999987  4699999996533 2222    34566888888886 7899999988888888899


Q ss_pred             EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec---CCCCcEEEEeccCcee
Q 019685          233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKL  308 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~---~~~~~~kl~DFgla~~  308 (337)
                      |+|++ |.||.|++.- .+.++..++..++.|++.-++|+|++.  +|.|||||+|+||..   .....+.|+|||+|+.
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            99988 7899999975 457999999999999999999999987  999999999999943   2234689999999999


Q ss_pred             eeccccc---ceeeeeCCccccccccc
Q 019685          309 IKVQNSH---DVYKMTGETGSCEYLVS  332 (337)
Q Consensus       309 ~~~~~~~---~~~~~~~~~gt~~y~aP  332 (337)
                      +.+....   ++.......||.+||+-
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             hcCccccccCccccccccccceeeeEe
Confidence            9876543   23345677899999984

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=5.4e-21  Score=160.97  Aligned_cols=143  Identities=20%  Similarity=0.256  Sum_probs=107.7

Q ss_pred             ccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeEEeCC---c-
Q 019685          159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-----RHPNIVQFLGAVTERK---P-  229 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~~~~~~~~~~---~-  229 (337)
                      +.....||+|+|+.||.-...+.. +||++......   ..+.+.+|+.+++.+     .||||+++++++++..   . 
T Consensus         4 L~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEECCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            344568999999999962222333 68887654322   236789999999999     5799999999998873   3 


Q ss_pred             eEEEEee--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHcCCCCcEeeCCCCCCEEEecC--CCCcEEEEe-c
Q 019685          230 LMLITEY--LRGGDLHKYLKEKGALSPSTAVNFALDIARGM-AYLHNEPNVIIHRDLKPRNVLLVNS--SADHLKVGD-F  303 (337)
Q Consensus       230 ~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l-~~lH~~~~~ivHrdlkp~Nil~~~~--~~~~~kl~D-F  303 (337)
                      +.+|+||  +.+++|.+++.+. .+++.  ..++.|++.++ .|||+.+  |+||||||+|||+...  ..+.++|+| |
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            3478999  5579999999653 46555  36688888888 8999987  9999999999999532  334799999 5


Q ss_pred             cCceeee
Q 019685          304 GLSKLIK  310 (337)
Q Consensus       304 gla~~~~  310 (337)
                      |....+.
T Consensus       155 G~~~~ip  161 (210)
T PRK10345        155 GESTFIP  161 (210)
T ss_pred             CCcceee
Confidence            6555533

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.86  E-value=7.2e-22  Score=154.61  Aligned_cols=113  Identities=27%  Similarity=0.278  Sum_probs=100.1

Q ss_pred             hhhhhhhc-cCCchhHHHHHhhCCHHHHHHHHH-hCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHc-CCCccccccc
Q 019685           24 DKQKEKAR-VSRTSLILWHAHQNDAAAVRKLLE-EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRW  100 (337)
Q Consensus        24 ~~~~~~~~-~~~~~~~~~~a~~~~~~~~~~lL~-~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~-ga~~~~~d~~  100 (337)
                      -+++.+++ +||||||+  ||..++.+++.+|+ +.+..+|.+|..||||||+||..|+.|+|+.|+.+ |+|+|+.++.
T Consensus        28 kSL~~r~dqD~Rt~LHw--a~S~g~~eiv~fLlsq~nv~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~  105 (226)
T KOG4412|consen   28 KSLNARDDQDGRTPLHW--ACSFGHVEIVYFLLSQPNVKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNG  105 (226)
T ss_pred             hhhhccccccCCceeee--eeecCchhHHHHHHhcCCCCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCC
Confidence            46667776 99999977  88888999999988 56788999999999999999999999999999988 9999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK  138 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~  138 (337)
                      |.|+||+|+.++..+++++|+.+|+.+...+.-..+|.
T Consensus       106 G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtpl  143 (226)
T KOG4412|consen  106 GQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPL  143 (226)
T ss_pred             CcceehhhhcCChhhHHHHHHhcCCCCcccccccCchh
Confidence            99999999999999999999999998776654444443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-20  Score=155.44  Aligned_cols=167  Identities=25%  Similarity=0.322  Sum_probs=133.6

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .|...+.||+|+||.+|.|..  .|..||+|.-......     ..+..|..+...+++ ..|+.+..+..+...-.+||
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            678889999999999999986  4889999976443222     345678889998884 67888888888888899999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~~~~  312 (337)
                      |++ |.||.+++.- .+.++..+++.++-|++.-++|+|.++  .|||||||+|+|..-+ ....+.++|||+|+.+.+.
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            988 8899999974 557999999999999999999999988  9999999999998321 2346899999999988654


Q ss_pred             ccc---ceeeeeCCccccccccc
Q 019685          313 NSH---DVYKMTGETGSCEYLVS  332 (337)
Q Consensus       313 ~~~---~~~~~~~~~gt~~y~aP  332 (337)
                      .+.   ++.......||.+|.+-
T Consensus       168 ~t~~HIpyre~r~ltGTaRYASi  190 (341)
T KOG1163|consen  168 RTRQHIPYREDRNLTGTARYASI  190 (341)
T ss_pred             cccccCccccCCccceeeeehhh
Confidence            332   12234556789998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=4.7e-20  Score=155.96  Aligned_cols=140  Identities=11%  Similarity=0.186  Sum_probs=116.3

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHH------HHHHHHHHHhCCCCCeeeeeeeEEeC----
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPNIVQFLGAVTER----  227 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~------~~~E~~~l~~l~h~~Iv~~~~~~~~~----  227 (337)
                      +|...+++|.|+||.||.....+..+++|.+.+.....+.....      +.+|+..+.++.|++|..+.+++...    
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~  111 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT  111 (232)
T ss_pred             ceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence            68888999999999999977778899999998776655555444      57899999999999999998886543    


Q ss_pred             ----CceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          228 ----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       228 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                          +..+++|||++|.+|.++..    +++    ....+++.+|..+|+.|  ++|||++|+||++  +.++ ++|+||
T Consensus       112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili--~~~g-i~liDf  178 (232)
T PRK10359        112 LRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIV--SKNG-LRIIDL  178 (232)
T ss_pred             ccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEE--eCCC-EEEEEC
Confidence                35899999999999988742    333    24568999999999988  9999999999999  6666 999999


Q ss_pred             cCceeee
Q 019685          304 GLSKLIK  310 (337)
Q Consensus       304 gla~~~~  310 (337)
                      |..+...
T Consensus       179 g~~~~~~  185 (232)
T PRK10359        179 SGKRCTA  185 (232)
T ss_pred             CCccccc
Confidence            9887664

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=9.6e-20  Score=154.91  Aligned_cols=139  Identities=24%  Similarity=0.418  Sum_probs=116.1

Q ss_pred             ceecccCceeEEEEEECCceEEEEEecCCCCch-----HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-----RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      +.||+|++|.||+|.+.+..+++|.........     ......+.+|+.++..+.|++|.....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            478999999999999999999999876543322     122346778999999999998887777777777889999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       238 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +|++|.+++....   + ....++.+++.+|.++|+.+  ++|+|++|+|||+  + .+.++|+|||.++...
T Consensus        82 ~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~--~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         82 EGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMIL--S-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             CCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEE--E-CCCEEEEECCcccCCC
Confidence            9999999986532   2 77889999999999999987  9999999999999  4 6789999999987643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.82  E-value=2.3e-19  Score=172.99  Aligned_cols=150  Identities=26%  Similarity=0.374  Sum_probs=120.1

Q ss_pred             CCcccCCCCc-CccccceecccCceeEEEEEECCceEEEEEecCCCCc-----hHHHHHHHHHHHHHHHhCCCCCeeeee
Q 019685          148 CDWEIDPSEL-DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFL  221 (337)
Q Consensus       148 ~~~~~~~~~~-~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~~~  221 (337)
                      ..|....... .|...+.||+|+||.||++.+.+..+++|........     .....+++.+|+.++..++|++++...
T Consensus       323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             eeeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            3455544433 3466789999999999999998877777654332211     122346788999999999999998887


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                      .+.......++||||+++++|.+++.        ....++.+++.+|.|||+.+  ++||||||+|||+  + .+.++|+
T Consensus       403 ~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl--~-~~~~~li  469 (535)
T PRK09605        403 IYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV--R-DDRLYLI  469 (535)
T ss_pred             EEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE--E-CCcEEEE
Confidence            77777778899999999999999885        34678999999999999987  9999999999999  3 4679999


Q ss_pred             eccCceeee
Q 019685          302 DFGLSKLIK  310 (337)
Q Consensus       302 DFgla~~~~  310 (337)
                      |||+++...
T Consensus       470 DFGla~~~~  478 (535)
T PRK09605        470 DFGLGKYSD  478 (535)
T ss_pred             eCcccccCC
Confidence            999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=9.5e-20  Score=164.84  Aligned_cols=171  Identities=23%  Similarity=0.314  Sum_probs=130.7

Q ss_pred             CccccceecccCceeEEEEEECCc---eEEEEEecCCCCchHHHHHHHHHHHHHHHhCC----CCCeeeeeeeE-EeCCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR----HPNIVQFLGAV-TERKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~---~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~----h~~Iv~~~~~~-~~~~~  229 (337)
                      .|.+.+.||+|+||.||.+.....   .+|+|..........   ..+..|..++..+.    .+++..+++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            688899999999999999997643   578887654322211   14566888888776    26899999988 47778


Q ss_pred             eEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-C--CcEEEEecc
Q 019685          230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-A--DHLKVGDFG  304 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~--~~~kl~DFg  304 (337)
                      .|+||+.+ |.+|.++....  +.++..++..++.|++.+|.+||+.|  ++||||||.|+.+.... .  ..+.|.|||
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            89999977 77999988653  57999999999999999999999988  99999999999994322 1  469999999


Q ss_pred             Cce--eeeccccc---ceee-eeCCccccccccccc
Q 019685          305 LSK--LIKVQNSH---DVYK-MTGETGSCEYLVSNC  334 (337)
Q Consensus       305 la~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~  334 (337)
                      +++  .+......   .... .....||.+|.++.+
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~  208 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINV  208 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHH
Confidence            998  43222211   0001 235669999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=2.1e-19  Score=151.47  Aligned_cols=135  Identities=26%  Similarity=0.395  Sum_probs=109.6

Q ss_pred             eecccCceeEEEEEECCceEEEEEecCCCCc-----hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .||+|+||.||++.+.+..+++|........     ......++.+|+.++..+.|+++.....++......+++|||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            4799999999999999999999987543321     12234667789999999998776555555556667899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |++|.+++.....       .++.+++.+|.+||+.+  ++|+|++|+||++  + .+.++++|||+++...
T Consensus        81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~--~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIV--R-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEE--E-CCcEEEEECCCCcCCC
Confidence            9999998754321       78899999999999988  9999999999999  5 6789999999987754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.82  E-value=1.5e-20  Score=166.08  Aligned_cols=139  Identities=26%  Similarity=0.423  Sum_probs=120.9

Q ss_pred             CccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~  231 (337)
                      .|...+.||.|.|+.||++.+.     .+.||+|.+......     .+..+|+++|..+. +.||+++.+++..++...
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            5777889999999999998753     568999988654332     56788999999997 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      +|+||++.....++...   ++..++..+++.++.||.++|..|  ||||||||+|+|.. ...+.-.|.|||+|.
T Consensus       112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n-~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYN-RRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccc-cccCCceEEechhHH
Confidence            99999999888888764   678999999999999999999988  99999999999984 345678899999997

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.1e-19  Score=147.94  Aligned_cols=135  Identities=20%  Similarity=0.141  Sum_probs=105.9

Q ss_pred             ccceecccCceeEEEEEECCceEEEEEecCCCCch-HHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEeecC
Q 019685          161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       161 ~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      +...|++|+||+|+.+...+.+++.+.+.....-. ......+.+|+.+|+++. |++|++++++    +..+++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            34689999999999887778888877664432211 112235789999999996 5889999886    34699999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCC-CCCCEEEecCCCCcEEEEeccCceeee
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL-KPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdl-kp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      |.+|.+.+..       ....++.|++.+|.++|++|  |+|||| ||+|||+  +.++.++|+|||+|....
T Consensus        82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv--~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLV--QEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEE--cCCCCEEEEECCCceecC
Confidence            9998765421       12357889999999999988  999999 7999999  777899999999998544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.81  E-value=7.3e-19  Score=157.84  Aligned_cols=173  Identities=34%  Similarity=0.549  Sum_probs=144.9

Q ss_pred             ccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCC-CeeeeeeeEEeCCceEEEEeec
Q 019685          159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP-NIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~-~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      |.....||.|+|+.||++... ..+++|.+.............+.+|+.++..+.|+ +|+++++.+......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            456678999999999999887 78899988776655444567889999999999988 7999999997777789999999


Q ss_pred             CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-cEEEEeccCceeeeccc
Q 019685          238 RGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       238 ~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-~~kl~DFgla~~~~~~~  313 (337)
                      .++++.+++....   .++......++.|++.++.|+|+.+  ++|||+||+||++  +..+ .++++|||+++......
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~--~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee--cCCCCeEEEeccCcceecCCCC
Confidence            9999998887664   7999999999999999999999988  9999999999999  6666 69999999998665433


Q ss_pred             ccce--eeeeCCccccccccccccc
Q 019685          314 SHDV--YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~--~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....  .......||..|+|||.+.
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~  181 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLL  181 (384)
T ss_pred             ccccccccccccccccccCCHHHhc
Confidence            2111  1246778999999999763

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=2.8e-19  Score=154.09  Aligned_cols=147  Identities=18%  Similarity=0.171  Sum_probs=110.8

Q ss_pred             CccccceecccCceeEEEEE-E--CCceEEEEEecCCCCch---------------------HHHHHHHHHHHHHHHhCC
Q 019685          158 DFSSSAIIGKGSFGEILKAY-W--RGTPVAIKRILPSLSDD---------------------RLVIQDFRHEVNLLVKLR  213 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~-~--~g~~vavK~l~~~~~~~---------------------~~~~~~~~~E~~~l~~l~  213 (337)
                      .|.+.+.||+|+||.||+|. .  .|+.||+|.+.......                     ......+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35667899999999999998 2  48999999986543110                     011234568999999997


Q ss_pred             CC--CeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEe
Q 019685          214 HP--NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV  291 (337)
Q Consensus       214 h~--~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~  291 (337)
                      +.  .++++++.    ...++||||+++.+|.........+...++..++.||+.++.+||+.| .|+||||||+||++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli-  182 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILV-  182 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEE-
Confidence            53  34444432    235899999999888766534445666777899999999999999953 39999999999999 


Q ss_pred             cCCCCcEEEEeccCceeeecc
Q 019685          292 NSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       292 ~~~~~~~kl~DFgla~~~~~~  312 (337)
                       + .+.++|+|||.+......
T Consensus       183 -~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      183 -H-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             -E-CCCEEEEEChhhhccCCc
Confidence             5 678999999999865543

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.77  E-value=1.1e-18  Score=142.33  Aligned_cols=109  Identities=21%  Similarity=0.190  Sum_probs=95.2

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHH---HHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHH-cCCCcc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAA---AVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIE-YGADVN   95 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~---~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~-~ga~~~   95 (337)
                      ..+++++.+|..|+|||++  |+.++..   +++++|++.|+++|.+| ..|+||||+|+..|+.+++++|+. .|++++
T Consensus        45 ~~g~~~~~~d~~g~t~Lh~--Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~  122 (166)
T PHA02743         45 GDGHLLHRYDHHGRQCTHM--VAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLG  122 (166)
T ss_pred             hcchhhhccCCCCCcHHHH--HHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCcc
Confidence            4567788899999999965  6665543   45789999999999998 589999999999999999999995 799999


Q ss_pred             ccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685           96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus        96 ~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .+|..|.||||+|+..++.+++++|+.++++....+
T Consensus       123 ~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~  158 (166)
T PHA02743        123 AINYQHETAYHIAYKMRDRRMMEILRANGAVCDDPL  158 (166)
T ss_pred             CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence            999999999999999999999999999998765443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=2.6e-18  Score=144.66  Aligned_cols=139  Identities=19%  Similarity=0.165  Sum_probs=106.5

Q ss_pred             ccccceecccCceeEEEEEEC-CceEEEEEecCCCCch-------------------HHHHHHHHHHHHHHHhCCCC--C
Q 019685          159 FSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDD-------------------RLVIQDFRHEVNLLVKLRHP--N  216 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~-------------------~~~~~~~~~E~~~l~~l~h~--~  216 (337)
                      |...+.||+|+||.||++... |+.++||++.......                   .........|+.++..+.++  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            556678999999999999874 8899999876532110                   01112356788888888776  4


Q ss_pred             eeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       217 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      ++..++    ....+++|||+++++|.++..      ......++.+++.++.++|+.+  |+||||+|+||++  +.++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill--~~~~  162 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILV--DDDE  162 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEE--cCCC
Confidence            444443    245689999999999876542      1345678899999999999987  9999999999999  7788


Q ss_pred             cEEEEeccCceeeec
Q 019685          297 HLKVGDFGLSKLIKV  311 (337)
Q Consensus       297 ~~kl~DFgla~~~~~  311 (337)
                      .++|+|||++.....
T Consensus       163 ~~~liDfg~~~~~~~  177 (198)
T cd05144         163 KIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEEECCccccCCC
Confidence            999999999966554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.76  E-value=1e-18  Score=161.26  Aligned_cols=113  Identities=26%  Similarity=0.235  Sum_probs=106.0

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      +.+++..|++|-|.||+  ||.+|..+|+++|+++|++||+.+ .-+.||||+||.+||..+|.+|+++|||++.+|.+|
T Consensus        68 g~~v~~~D~~g~tlLHW--AAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G  145 (600)
T KOG0509|consen   68 GESVNNPDREGVTLLHW--AAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQG  145 (600)
T ss_pred             CcCCCCCCcCCccceeH--HHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCC
Confidence            77889999999999977  999999999999999999999988 669999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      .||+|.|+..++.-++-+++.++++.+..+....+|
T Consensus       146 ~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTp  181 (600)
T KOG0509|consen  146 LTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTP  181 (600)
T ss_pred             CcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCH
Confidence            999999999999999999999999888777776665

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.76  E-value=3e-18  Score=133.44  Aligned_cols=106  Identities=32%  Similarity=0.445  Sum_probs=95.9

Q ss_pred             CCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhh
Q 019685           33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK  112 (337)
Q Consensus        33 ~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~  112 (337)
                      ...-+.+|+|..+...+|..+|.+..-.||.+|.+|+||||-|+++||.+||+.|+..||+.+.+-..||||||-|+...
T Consensus        62 dp~rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWn  141 (228)
T KOG0512|consen   62 DPIRLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWN  141 (228)
T ss_pred             CHHHHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhccc
Confidence            44567789899999999999998877789999999999999999999999999999999999999999999999999999


Q ss_pred             hhhHHHHHHhhcCCCCCCCCCCCCCC
Q 019685          113 KFNMMELLNAHGGLSYGQNGSHFEPK  138 (337)
Q Consensus       113 ~~~~v~~L~~~~a~~~~~~~~~~~~~  138 (337)
                      +.+++..|+.+|++.+.+.....+|.
T Consensus       142 N~~va~~LLqhgaDVnA~t~g~ltpL  167 (228)
T KOG0512|consen  142 NFEVAGRLLQHGADVNAQTKGLLTPL  167 (228)
T ss_pred             chhHHHHHHhccCcccccccccchhh
Confidence            99999999999999887765554443

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.75  E-value=5e-18  Score=149.44  Aligned_cols=111  Identities=23%  Similarity=0.181  Sum_probs=97.9

Q ss_pred             hhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC----CCCCcHHHHHHHcCCHHHHHHHHHcCCCcccc-ccc
Q 019685           26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD----YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ-DRW  100 (337)
Q Consensus        26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~----~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~-d~~  100 (337)
                      +..+|+.++|+++ |+|+..+..+++++|+++|+++|.++    ..|.||||+|+..|+.+++++|+++|||+|.+ +..
T Consensus        25 ~~~~d~~~~~~lL-~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~  103 (300)
T PHA02884         25 IKKKNKICIANIL-YSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEA  103 (300)
T ss_pred             hhccCcCCCCHHH-HHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCC
Confidence            4568899999995 46778888999999999999999874    58999999999999999999999999999986 568


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      |.||||.|+..++.+++++|+.+|++.+..+....+|
T Consensus       104 g~TpLh~Aa~~~~~eivklLL~~GAdin~kd~~G~Tp  140 (300)
T PHA02884        104 KITPLYISVLHGCLKCLEILLSYGADINIQTNDMVTP  140 (300)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            9999999999999999999999999888766555444

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.6e-17  Score=149.31  Aligned_cols=131  Identities=29%  Similarity=0.419  Sum_probs=110.0

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-----C---CCeeeeeeeEEe
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----H---PNIVQFLGAVTE  226 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~Iv~~~~~~~~  226 (337)
                      .+|.+.++||-|-|++||+|.+.  .+.||+|+.+..    +...+..+.|+.+|++++     |   ..||+|++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            47889999999999999999886  678999988543    234466778999999884     2   379999999865


Q ss_pred             C----CceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC
Q 019685          227 R----KPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS  293 (337)
Q Consensus       227 ~----~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~  293 (337)
                      .    ..+|||+|++ |-+|..+|..  .+.++...+..|++||+.||.|||.+ ++|||-||||+|||++.+
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLLCST  224 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeeeecc
Confidence            4    4699999998 5599999975  35699999999999999999999997 569999999999999543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=2.8e-17  Score=137.05  Aligned_cols=139  Identities=20%  Similarity=0.219  Sum_probs=98.0

Q ss_pred             cceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHH---------------------HHHHHHHHHhCCCC--Ce
Q 019685          162 SAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQD---------------------FRHEVNLLVKLRHP--NI  217 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~I  217 (337)
                      .+.||+|+||.||+|... ++.||||++.+...........                     ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            357999999999999887 8899999886543221111111                     13456666665533  24


Q ss_pred             eeeeeeEEeCCceEEEEeecCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCC
Q 019685          218 VQFLGAVTERKPLMLITEYLRGGDLHK-YLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSA  295 (337)
Q Consensus       218 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~  295 (337)
                      .+.++.    ...+++|||++++.+.. .+.... . ..++..++.+++.++.++|. .+  |+|+||||+||++  + +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili--~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILV--D-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEE--E-C
Confidence            444443    24589999999854321 121111 1 16678899999999999999 88  9999999999999  5 7


Q ss_pred             CcEEEEeccCceeeec
Q 019685          296 DHLKVGDFGLSKLIKV  311 (337)
Q Consensus       296 ~~~kl~DFgla~~~~~  311 (337)
                      +.++|+|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            8899999999976654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.73  E-value=3.8e-18  Score=132.87  Aligned_cols=97  Identities=31%  Similarity=0.267  Sum_probs=87.8

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      ..-+|.+|.++.||||.  |+.+|+.+++..|+..|++++++...||||||-||.+++.+++.+||++|||||++.+-..
T Consensus        87 an~vNtrD~D~YTpLHR--AaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~l  164 (228)
T KOG0512|consen   87 ANHVNTRDEDEYTPLHR--AAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLL  164 (228)
T ss_pred             cccccccccccccHHHH--HHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccc
Confidence            34578999999999966  9999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhhHH-HHHH
Q 019685          103 TPLADAEGAKKFNMM-ELLN  121 (337)
Q Consensus       103 t~l~~A~~~~~~~~v-~~L~  121 (337)
                      ||||.|+...+.... ++|+
T Consensus       165 tpLhlaa~~rn~r~t~~~Ll  184 (228)
T KOG0512|consen  165 TPLHLAAGNRNSRDTLELLL  184 (228)
T ss_pred             hhhHHhhcccchHHHHHHHh
Confidence            999999987665444 4444

>PHA02741 hypothetical protein; Provisional

Probab=99.73  E-value=9.9e-18  Score=137.34  Aligned_cols=105  Identities=20%  Similarity=0.206  Sum_probs=94.9

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCH----HHHHHHHHhCCCCccccCC-CCCcHHHHHHHcCCHHHHHHHHH-cCCCc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDA----AAVRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIE-YGADV   94 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~----~~~~~lL~~~~~~vn~~~~-~g~tpLh~A~~~g~~~~~~~Ll~-~ga~~   94 (337)
                      ..+++++.+|..|+|||++  |+.++.    .+++++|++.|+++|.++. +|+||||+|+..++.+++++|++ .|+++
T Consensus        48 ~~ga~in~~d~~g~T~Lh~--A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~  125 (169)
T PHA02741         48 CHAAALNATDDAGQMCIHI--AAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDL  125 (169)
T ss_pred             hhhhhhhccCCCCCcHHHH--HHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCC
Confidence            3468899999999999966  777665    5889999999999999985 89999999999999999999997 59999


Q ss_pred             cccccccccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685           95 NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus        95 ~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                      +.+|..|+|||+.|...++.+++++|.++++..
T Consensus       126 ~~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~~~  158 (169)
T PHA02741        126 HFCNADNKSPFELAIDNEDVAMMQILREIVATS  158 (169)
T ss_pred             CcCCCCCCCHHHHHHHCCCHHHHHHHHHHHHHh
Confidence            999999999999999999999999999887643

>PHA02791 ankyrin-like protein; Provisional

Probab=99.73  E-value=1.1e-17  Score=147.24  Aligned_cols=108  Identities=13%  Similarity=-0.007  Sum_probs=72.2

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCC-cHHHHHHHcCCHHHHHHHHHcCCCccccc-
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNR-TPLHVASLHGWIDVAKCLIEYGADVNAQD-   98 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~-tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d-   98 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.++..|+ ||||+|+..|+.+++++|+++|++.  .| 
T Consensus        82 ~~Gadvn~~d~~G~TpLh~--Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~--~d~  157 (284)
T PHA02791         82 FSGMDDSQFDDKGNTALYY--AVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST--FDL  157 (284)
T ss_pred             HCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcc--ccc
Confidence            3556777777777777755  7777777777777777777777666664 6666666666666666666665432  12 


Q ss_pred             cccccchhhhhhhhhhhHHHHHHhhcCCCCCCCC
Q 019685           99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      ..|.||||+|+..|+.+++++|+.+|++++..+.
T Consensus       158 ~~g~TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~  191 (284)
T PHA02791        158 AILLSCIHITIKNGHVDMMILLLDYMTSTNTNNS  191 (284)
T ss_pred             ccCccHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence            2366777777777777777777777776655443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=3.1e-18  Score=165.11  Aligned_cols=172  Identities=27%  Similarity=0.410  Sum_probs=132.5

Q ss_pred             cccceecccCceeEEEEEEC--CceEEEEEecC---CCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          160 SSSAIIGKGSFGEILKAYWR--GTPVAIKRILP---SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       160 ~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~---~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .....+|.|.+|.|+.+...  ......|....   ...........+..|+.+-..+.|+|++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34568999999977665542  22222232211   11112222233667777888899999988888777666666669


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |||++ +|+.++...+.++..++..++.|++.|++|+|+.|  |.|||+||+|+++  ...|.+||+|||.+..+.....
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~--~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLV--TENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEE--ecCCceEEeecCcceeeccCcc
Confidence            99999 99999988778999999999999999999999988  9999999999999  7888999999999988776544


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .......+.+|+-+|+|||++.
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~  497 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLT  497 (601)
T ss_pred             hhhhhhcCcccCCcCcCccccc
Confidence            4344678899999999999873

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=9.1e-17  Score=138.74  Aligned_cols=140  Identities=21%  Similarity=0.222  Sum_probs=107.1

Q ss_pred             cceec-ccCceeEEEEEECCceEEEEEecCCCC----------chHHHHHHHHHHHHHHHhCCCCCe--eeeeeeEEeC-
Q 019685          162 SAIIG-KGSFGEILKAYWRGTPVAIKRILPSLS----------DDRLVIQDFRHEVNLLVKLRHPNI--VQFLGAVTER-  227 (337)
Q Consensus       162 ~~~lg-~G~~g~V~~~~~~g~~vavK~l~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~I--v~~~~~~~~~-  227 (337)
                      ...|| .|+.|.||.+...+..+++|.+.....          ........+.+|+.++..++|++|  +..+++.... 
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            34687 899999999988899999998753211          011233567889999999998775  6677664332 


Q ss_pred             Cc---eEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          228 KP---LMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       228 ~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      ..   .++|||++++ .+|.+++.. ..+++.    .+.+|+.+|.+||+.|  |+||||||+|||+  +.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv--~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILL--DPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEE--cCCCCEEEEEC
Confidence            22   2599999997 699988864 345544    3578999999999988  9999999999999  66678999999


Q ss_pred             cCceeee
Q 019685          304 GLSKLIK  310 (337)
Q Consensus       304 gla~~~~  310 (337)
                      |.+....
T Consensus       187 g~~~~~~  193 (239)
T PRK01723        187 DRGELRT  193 (239)
T ss_pred             CCcccCC
Confidence            9987754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=4.7e-17  Score=130.16  Aligned_cols=135  Identities=21%  Similarity=0.220  Sum_probs=111.1

Q ss_pred             cceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEEeCCceEEEEeecCC
Q 019685          162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      .+.|++|.++.||++...+..+++|.......     ...+..|+..+..+++  ..+++++.+....+..+++|||+.+
T Consensus         3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             ceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35799999999999999888899998855432     3567889999999976  5899999888877889999999998


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-CCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          240 GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       240 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      .++..+       +......++.+++.++.++|... .+++|+|++|+||++  +..+.++++|||.++...
T Consensus        78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~--~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV--DDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE--ECCcEEEEEecccccCCC
Confidence            777544       44566778899999999999841 239999999999999  567889999999987543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.71  E-value=4.6e-17  Score=118.67  Aligned_cols=85  Identities=33%  Similarity=0.417  Sum_probs=78.2

Q ss_pred             HHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHH
Q 019685           40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL  119 (337)
Q Consensus        40 ~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~  119 (337)
                      |.|++.+..+++++|++.+.+++.    |.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..++.+++++
T Consensus         2 ~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~   77 (89)
T PF12796_consen    2 HIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKL   77 (89)
T ss_dssp             HHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHH
Confidence            458999999999999999998887    9999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCC
Q 019685          120 LNAHGGLSY  128 (337)
Q Consensus       120 L~~~~a~~~  128 (337)
                      |.++|++.+
T Consensus        78 Ll~~g~~~~   86 (89)
T PF12796_consen   78 LLEHGADVN   86 (89)
T ss_dssp             HHHTTT-TT
T ss_pred             HHHcCCCCC
Confidence            999988765

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>PHA02741 hypothetical protein; Provisional

Probab=99.71  E-value=2.1e-17  Score=135.44  Aligned_cols=108  Identities=21%  Similarity=0.167  Sum_probs=92.0

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHh------CCCCccccCCCCCcHHHHHHHcCC----HHHHHHHHHcCC
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE------DQSLVHARDYDNRTPLHVASLHGW----IDVAKCLIEYGA   92 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~------~~~~vn~~~~~g~tpLh~A~~~g~----~~~~~~Ll~~ga   92 (337)
                      ...++.+|..|+|+|++  |+..+..+++++|+.      .|+++|.+|..|+||||+|+..|+    .+++++|+++|+
T Consensus        11 ~~~~~~~~~~g~t~Lh~--Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~ga   88 (169)
T PHA02741         11 EEMIAEKNSEGENFFHE--AARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGA   88 (169)
T ss_pred             HHHhhccccCCCCHHHH--HHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCC
Confidence            34677888999999965  888887888777643      368999999999999999999999    589999999999


Q ss_pred             Ccccccc-ccccchhhhhhhhhhhHHHHHHh-hcCCCCCCCC
Q 019685           93 DVNAQDR-WKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNG  132 (337)
Q Consensus        93 ~~~~~d~-~g~t~l~~A~~~~~~~~v~~L~~-~~a~~~~~~~  132 (337)
                      ++|.+|. .|+||||+|+..++.+++++|+. .+++.+..+.
T Consensus        89 din~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~  130 (169)
T PHA02741         89 DINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNA  130 (169)
T ss_pred             CCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCC
Confidence            9999985 89999999999999999999997 4776654443

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.71  E-value=2e-17  Score=133.53  Aligned_cols=100  Identities=24%  Similarity=0.249  Sum_probs=89.1

Q ss_pred             hhhhhccCCchhHHHHHhhCCHH---HHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHH-cCCCccccccc
Q 019685           26 QKEKARVSRTSLILWHAHQNDAA---AVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQDRW  100 (337)
Q Consensus        26 ~~~~~~~~~~~~~~~~a~~~~~~---~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~-~ga~~~~~d~~  100 (337)
                      .+.+|..|+|||++  |+..+..   +++++|++.|+++|.+| .+|+||||+|+..|+.+++++|+. .|+++|.+|..
T Consensus        48 ~~~~d~~g~t~Lh~--a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~  125 (154)
T PHA02736         48 VLEYNRHGKQCVHI--VSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYA  125 (154)
T ss_pred             HHHhcCCCCEEEEe--ecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCC
Confidence            44568899999966  7766544   56889999999999998 599999999999999999999997 59999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                      |.||||+|+..++.+++++|+.+++..
T Consensus       126 g~tpL~~A~~~~~~~i~~~Ll~~ga~~  152 (154)
T PHA02736        126 FKTPYYVACERHDAKMMNILRAKGAQC  152 (154)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            999999999999999999999988754

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.71  E-value=3.3e-17  Score=138.76  Aligned_cols=110  Identities=21%  Similarity=0.163  Sum_probs=66.3

Q ss_pred             Cchhhhhhhhc-cCCchhHHHHHh--hCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHH--cCCHHHHHHHHHcCCCcc
Q 019685           21 SSADKQKEKAR-VSRTSLILWHAH--QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASL--HGWIDVAKCLIEYGADVN   95 (337)
Q Consensus        21 ~~~~~~~~~~~-~~~~~~~~~~a~--~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~--~g~~~~~~~Ll~~ga~~~   95 (337)
                      ..+++++.+++ .|+|||++ ++.  .++..+++++|+++|++||.+|.+|.||||+|+.  .++.+++++|+++|+++|
T Consensus        74 ~~gadvn~~~~~~g~TpLh~-a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin  152 (209)
T PHA02859         74 ENGADVNFKTRDNNLSALHH-YLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFL  152 (209)
T ss_pred             HCCCCCCccCCCCCCCHHHH-HHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcc
Confidence            44556666653 56666644 222  1235666666666666666666666666666654  346666666666666666


Q ss_pred             ccccccccchhh-hhhhhhhhHHHHHHhhcCCCCCCC
Q 019685           96 AQDRWKNTPLAD-AEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus        96 ~~d~~g~t~l~~-A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .+|..|.||||. |+..++.+++++|+.+|++.+..+
T Consensus       153 ~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d  189 (209)
T PHA02859        153 NKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETN  189 (209)
T ss_pred             cccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCC
Confidence            666666666664 344556666666666666555443

>PHA02791 ankyrin-like protein; Provisional

Probab=99.71  E-value=4.2e-17  Score=143.56  Aligned_cols=100  Identities=19%  Similarity=0.098  Sum_probs=91.4

Q ss_pred             hhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchh
Q 019685           27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA  106 (337)
Q Consensus        27 ~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~  106 (337)
                      +.+|.+|+|||++  |+..+..+++++|++.|+++|..+  |+||||+|+..|+.+++++|+++|+++|.+|..|+||||
T Consensus        24 ~~~D~~G~TpLh~--Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh   99 (284)
T PHA02791         24 FKADVHGHSALYY--AIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALY   99 (284)
T ss_pred             CCCCCCCCcHHHH--HHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHH
Confidence            4678899999966  889999999999999999998764  789999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhHHHHHHhhcCCCCCC
Q 019685          107 DAEGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus       107 ~A~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      +|+..++.+++++|+.++++....
T Consensus       100 ~Aa~~g~~eivk~Ll~~gadin~~  123 (284)
T PHA02791        100 YAVDSGNMQTVKLFVKKNWRLMFY  123 (284)
T ss_pred             HHHHcCCHHHHHHHHHCCCCcCcc
Confidence            999999999999999999876433

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.69  E-value=1.5e-17  Score=148.13  Aligned_cols=114  Identities=26%  Similarity=0.325  Sum_probs=95.6

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..++++|....-.-|||  .+||..|+.+++++|+++|+|++..|..|.|-||+||++||.+|+++|++.|||+|.++..
T Consensus       105 ~~ga~VN~tT~TNStPL--raACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~k  182 (615)
T KOG0508|consen  105 RRGASVNDTTRTNSTPL--RAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYK  182 (615)
T ss_pred             HhcCccccccccCCccH--HHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhccc
Confidence            34567776666666777  5689999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      |+|+||.|+..|+.+++++|+++++....... .++|
T Consensus       183 GNTALH~caEsG~vdivq~Ll~~ga~i~~d~~-GmtP  218 (615)
T KOG0508|consen  183 GNTALHDCAESGSVDIVQLLLKHGAKIDVDGH-GMTP  218 (615)
T ss_pred             CchHHHhhhhcccHHHHHHHHhCCceeeecCC-CCch
Confidence            99999999999999999999998887654433 4444

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.69  E-value=1e-17  Score=168.93  Aligned_cols=119  Identities=12%  Similarity=0.152  Sum_probs=84.6

Q ss_pred             CCeeeeeeeE-------EeCCceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCC
Q 019685          215 PNIVQFLGAV-------TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR  286 (337)
Q Consensus       215 ~~Iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~  286 (337)
                      +||.++++++       .....+++++|++ +++|.++|.. ...+++.+++.++.||+.||.|||++|  |+||||||+
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~  109 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPS  109 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCch
Confidence            4676777766       2334678888987 5599999975 345999999999999999999999988  999999999


Q ss_pred             CEEEec-----------------CCCCcEEEEeccCceeeecccccc------------eeeeeCCccccccccccccc
Q 019685          287 NVLLVN-----------------SSADHLKVGDFGLSKLIKVQNSHD------------VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       287 Nil~~~-----------------~~~~~~kl~DFgla~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||||..                 +..+.+|++|||+++.........            ........||+.|||||++.
T Consensus       110 NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  188 (793)
T PLN00181        110 CFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN  188 (793)
T ss_pred             hEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence            999932                 223456666777765432100000            00112246899999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.69  E-value=4.2e-17  Score=143.13  Aligned_cols=171  Identities=23%  Similarity=0.363  Sum_probs=138.2

Q ss_pred             CccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-CCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~  229 (337)
                      +++...++.+|.||.||+|+|+.       +.|.+|.+..+.  .+.+...+..|.-.+..+.|||+..+.++..+ ...
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            56677788999999999998752       345566664432  24456788899999999999999999998754 456


Q ss_pred             eEEEEeecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          230 LMLITEYLRGGDLHKYLKEK--------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                      .++++.++..|+|..++...        +.++..+...++.|++.|++|||+++  |||.||..+|.+|  +..-+|||+
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvI--dd~LqVklt  438 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVI--DDQLQVKLT  438 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhccee--hhheeEEec
Confidence            78888999999999999721        23677788889999999999999988  9999999999999  777899999


Q ss_pred             eccCceeeecccccceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |=.+++.+...+-.  ...++...+..|||||.|.
T Consensus       439 DsaLSRDLFP~DYh--cLGDnEnRPvkWMslEal~  471 (563)
T KOG1024|consen  439 DSALSRDLFPGDYH--CLGDNENRPVKWMSLEALQ  471 (563)
T ss_pred             cchhccccCccccc--ccCCCCCCcccccCHHHHh
Confidence            99999987755321  1346778899999999874

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.69  E-value=7.5e-17  Score=153.77  Aligned_cols=109  Identities=30%  Similarity=0.364  Sum_probs=100.4

Q ss_pred             Cchhhhhhhhcc-CCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARV-SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ..+++++.+|.. |+|||+.  |+.++..+++++|++.|+++|..|..|.||||+|+..|+.+++++|+++|+++|.+|.
T Consensus       155 ~~gadin~~~~~~g~tpLh~--A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~  232 (477)
T PHA02878        155 SYGADINMKDRHKGNTALHY--ATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDK  232 (477)
T ss_pred             HcCCCCCccCCCCCCCHHHH--HHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCC
Confidence            457788999988 9999966  8899999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccchhhhhhh-hhhhHHHHHHhhcCCCCCCC
Q 019685          100 WKNTPLADAEGA-KKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       100 ~g~t~l~~A~~~-~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .|.||||+|+.. ++.+++++|+.+|++.+..+
T Consensus       233 ~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~  265 (477)
T PHA02878        233 CGNTPLHISVGYCKDYDILKLLLEHGVDVNAKS  265 (477)
T ss_pred             CCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccC
Confidence            999999999976 68999999999999877554

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.68  E-value=1.6e-16  Score=134.60  Aligned_cols=104  Identities=17%  Similarity=0.158  Sum_probs=90.0

Q ss_pred             hhhhhccCCchhHHHHHhhC--CHHHHHHHHHhCCCCccccC-CCCCcHHHHHHHc---CCHHHHHHHHHcCCCcccccc
Q 019685           26 QKEKARVSRTSLILWHAHQN--DAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        26 ~~~~~~~~~~~~~~~~a~~~--~~~~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~---g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ++.+|..|.|||+.  |+.+  +..+++++|++.|+++|.++ ..|+||||+|+..   ++.+++++|+++||++|.+|.
T Consensus        44 ~n~~~~~g~TpLh~--a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~  121 (209)
T PHA02859         44 VNDCNDLYETPIFS--CLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDE  121 (209)
T ss_pred             hhccCccCCCHHHH--HHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCC
Confidence            56788899999966  5543  48899999999999999997 5899999998864   479999999999999999999


Q ss_pred             ccccchhhhhh--hhhhhHHHHHHhhcCCCCCCC
Q 019685          100 WKNTPLADAEG--AKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       100 ~g~t~l~~A~~--~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .|.||||.|+.  .++.+++++|+.+|++....+
T Consensus       122 ~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d  155 (209)
T PHA02859        122 DGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKD  155 (209)
T ss_pred             CCCCHHHHHHHhccCCHHHHHHHHHcCCCccccc
Confidence            99999999875  357899999999998876544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.68  E-value=3.9e-18  Score=158.11  Aligned_cols=160  Identities=28%  Similarity=0.370  Sum_probs=136.3

Q ss_pred             eecccCceeEEEEE-----ECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEeec
Q 019685          164 IIGKGSFGEILKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       164 ~lg~G~~g~V~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      ++|+|.||.|+.++     +.++.+++|.+.+......... ....|-.++..++ ||+++++...++.+..+++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            36899999998754     3477889998876544433222 5566788888888 999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccce
Q 019685          238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV  317 (337)
Q Consensus       238 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~  317 (337)
                      .+|+|...+.....+++.....+...++-+++++|+.+  |+|||+|++||++  +..|++++.|||+++..-..+    
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enill--d~~Ghi~~tdfglske~v~~~----  151 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLL--LLEGHIKLTDFGLSKEAVKEK----  151 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceee--cccCccccCCchhhhHhHhhh----
Confidence            99999999988888999999999999999999999988  9999999999999  999999999999998765442    


Q ss_pred             eeeeCCccccccccccccc
Q 019685          318 YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       318 ~~~~~~~gt~~y~aPE~l~  336 (337)
                          ..+||..|||||++.
T Consensus       152 ----~~cgt~eymApEI~~  166 (612)
T KOG0603|consen  152 ----IACGTYEYRAPEIIN  166 (612)
T ss_pred             ----hcccchhhhhhHhhh
Confidence                128999999999974

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.68  E-value=1.1e-16  Score=140.93  Aligned_cols=101  Identities=24%  Similarity=0.234  Sum_probs=90.2

Q ss_pred             CCchhhhhhh----hccCCchhHHHHHhhCCHHHHHHHHHhCCCCcccc-CCCCCcHHHHHHHcCCHHHHHHHHHcCCCc
Q 019685           20 TSSADKQKEK----ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHAR-DYDNRTPLHVASLHGWIDVAKCLIEYGADV   94 (337)
Q Consensus        20 ~~~~~~~~~~----~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~-~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~   94 (337)
                      ...|++++.+    +..|.|||++  |+..+..+++++|+++|++||.+ +..|.||||+|+..|+.+++++|+++||++
T Consensus        53 L~~GAdiN~~~~~sd~~g~TpLh~--Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAdi  130 (300)
T PHA02884         53 LKLGADPEAPFPLSENSKTNPLIY--AIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGADI  130 (300)
T ss_pred             HHCCCCccccCcccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCC
Confidence            3567888887    4589999966  88889999999999999999986 568999999999999999999999999999


Q ss_pred             cccccccccchhhhhhhhhhhHHHHHHh
Q 019685           95 NAQDRWKNTPLADAEGAKKFNMMELLNA  122 (337)
Q Consensus        95 ~~~d~~g~t~l~~A~~~~~~~~v~~L~~  122 (337)
                      |.+|..|.||||.|+..++..++.++..
T Consensus       131 n~kd~~G~TpL~~A~~~~~~~~~~~~~~  158 (300)
T PHA02884        131 NIQTNDMVTPIELALMICNNFLAFMICD  158 (300)
T ss_pred             CCCCCCCCCHHHHHHHhCChhHHHHhcC
Confidence            9999999999999999888888766653

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.67  E-value=1.6e-16  Score=129.61  Aligned_cols=118  Identities=21%  Similarity=0.227  Sum_probs=96.7

Q ss_pred             CCCCCchhhhhhhhccCCchhHHHHHhhCCHH---HHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHH---HHHHHHc
Q 019685           17 GGATSSADKQKEKARVSRTSLILWHAHQNDAA---AVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV---AKCLIEY   90 (337)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~---~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~---~~~Ll~~   90 (337)
                      ++....+.+++..+.++.++++ ++|..++..   +++++|++.|+++|.+|.+|+||||+||..|+.++   +++|+++
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~l~-~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~   82 (166)
T PHA02743          4 NGTAGNNLGAVEIDEDEQNTFL-RICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNM   82 (166)
T ss_pred             ccCcccchHHhhhccCCCcHHH-HHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHc
Confidence            3455678888889988888874 455666664   45557788999999999999999999999998654   8999999


Q ss_pred             CCCccccc-cccccchhhhhhhhhhhHHHHHHh-hcCCCCCCCCCCC
Q 019685           91 GADVNAQD-RWKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGSHF  135 (337)
Q Consensus        91 ga~~~~~d-~~g~t~l~~A~~~~~~~~v~~L~~-~~a~~~~~~~~~~  135 (337)
                      |+++|.+| ..|+||||+|+..++.+++++|+. .+++....+....
T Consensus        83 Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~  129 (166)
T PHA02743         83 GADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHE  129 (166)
T ss_pred             CCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCC
Confidence            99999998 589999999999999999999984 7877665544333

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.67  E-value=1.3e-16  Score=150.38  Aligned_cols=114  Identities=25%  Similarity=0.298  Sum_probs=103.0

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|.|||++  |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus       112 ~~g~d~n~~~~~g~T~Lh~--A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~  189 (434)
T PHA02874        112 DCGIDVNIKDAELKTFLHY--AIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNN  189 (434)
T ss_pred             HCcCCCCCCCCCCccHHHH--HHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCC
Confidence            3567788899999999965  88899999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      |.||||.|+..++.+++++|+..+++....+....+
T Consensus       190 g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~~g~T  225 (434)
T PHA02874        190 GESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFT  225 (434)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHhCCCCCcCCCCCCCC
Confidence            999999999999999999999999876655444333

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.67  E-value=3.9e-17  Score=162.45  Aligned_cols=111  Identities=27%  Similarity=0.229  Sum_probs=105.0

Q ss_pred             CCCCCCCCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCC
Q 019685           14 PCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD   93 (337)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~   93 (337)
                      ++......++++++.++..+.||||.  |+..++..++++|+++|+||+++++.|+||||.||..|+.+|+.+|+++||+
T Consensus       521 ~~~~~l~~~ga~v~~~~~r~~TpLh~--A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~  598 (1143)
T KOG4177|consen  521 KVAKILLEHGANVDLRTGRGYTPLHV--AVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGAS  598 (1143)
T ss_pred             HHHHHHhhcCCceehhcccccchHHH--HHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCC
Confidence            34555678899999999999999977  9999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccchhhhhhhhhhhHHHHHHhhcCC
Q 019685           94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus        94 ~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      +|..|.+|.|||++|...++.++++.+...++.
T Consensus       599 vna~d~~g~TpL~iA~~lg~~~~~k~l~~~~~~  631 (1143)
T KOG4177|consen  599 VNAADLDGFTPLHIAVRLGYLSVVKLLKVVTAT  631 (1143)
T ss_pred             CCcccccCcchhHHHHHhcccchhhHHHhccCc
Confidence            999999999999999999999999999998887

>PHA02795 ankyrin-like protein; Provisional

Probab=99.67  E-value=1.7e-16  Score=145.27  Aligned_cols=95  Identities=25%  Similarity=0.181  Sum_probs=86.3

Q ss_pred             cCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhh
Q 019685           32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA  111 (337)
Q Consensus        32 ~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~  111 (337)
                      .+.|+++.  |++++..+++++|+++|++||.+|.+|.||||+|+..|+.+++++|+++||++|.+|..|+||||.|+..
T Consensus       187 ~~~t~l~~--a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~  264 (437)
T PHA02795        187 IQYTRGFL--VDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDR  264 (437)
T ss_pred             hccchhHH--HHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHc
Confidence            45666644  8999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             h--------hhhHHHHHHhhcCCCC
Q 019685          112 K--------KFNMMELLNAHGGLSY  128 (337)
Q Consensus       112 ~--------~~~~v~~L~~~~a~~~  128 (337)
                      |        +.+++++|+.+++...
T Consensus       265 g~~~~~~~~~~eIvelLL~~gadI~  289 (437)
T PHA02795        265 GSVIARRETHLKILEILLREPLSID  289 (437)
T ss_pred             CCcccccccHHHHHHHHHhCCCCCC
Confidence            8        4689999999887543

>PHA02946 ankyin-like protein; Provisional

Probab=99.67  E-value=1.6e-16  Score=149.31  Aligned_cols=112  Identities=19%  Similarity=0.112  Sum_probs=93.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCC--HHHHHHHHHcCCCccc-c
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKCLIEYGADVNA-Q   97 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~--~~~~~~Ll~~ga~~~~-~   97 (337)
                      +.+++++.+|.+|+|||++  |+..+..+++++|+++|+++|.+|.+|+||||+|+..++  .+++++|+++||++|. .
T Consensus        60 ~~Gadvn~~d~~G~TpLh~--Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~  137 (446)
T PHA02946         60 HRGYSPNETDDDGNYPLHI--ASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSV  137 (446)
T ss_pred             HCcCCCCccCCCCCCHHHH--HHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCccccc
Confidence            5678889999999999966  888888999999999999999999999999999987664  7889999999999985 6


Q ss_pred             ccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCC
Q 019685           98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF  135 (337)
Q Consensus        98 d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~  135 (337)
                      |..|.|||+ |+..++.+++++|+..+++....+....
T Consensus       138 d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~  174 (446)
T PHA02946        138 DEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGK  174 (446)
T ss_pred             CCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCCC
Confidence            888999997 5566888888888888887665544333

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.66  E-value=2.2e-16  Score=159.42  Aligned_cols=112  Identities=22%  Similarity=0.195  Sum_probs=98.5

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHc----------------------
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH----------------------   78 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~----------------------   78 (337)
                      ..++++|.+|.+|+||||+  |+.+++.+++++|+++|+++|.+|.+|+||||+|+..                      
T Consensus       546 ~~G~d~n~~d~~G~TpLh~--Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~  623 (823)
T PLN03192        546 KAKLDPDIGDSKGRTPLHI--AASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAG  623 (823)
T ss_pred             HCCCCCCCCCCCCCCHHHH--HHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCc
Confidence            5577899999999999976  8899999999999999999999999999999866554                      


Q ss_pred             ---------CCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCC
Q 019685           79 ---------GWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH  134 (337)
Q Consensus        79 ---------g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~  134 (337)
                               |+.++++.|+++|+|+|.+|..|+||||.|+..++.+++++|+.+|++.+..+...
T Consensus       624 ~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g  688 (823)
T PLN03192        624 DLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD  688 (823)
T ss_pred             hHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence                     55566677888999999999999999999999999999999999999887665443

>PHA02798 ankyrin-like protein; Provisional

Probab=99.66  E-value=2.5e-16  Score=150.60  Aligned_cols=109  Identities=19%  Similarity=0.174  Sum_probs=98.8

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhh-----CCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcC---CHHHHHHHHHcC
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQ-----NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG---WIDVAKCLIEYG   91 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~-----~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g---~~~~~~~Ll~~g   91 (337)
                      ...|++++.+|..|.|||+.  |+.     .+..+++++|+++|+|||.+|.+|+||||+|+.++   +.+++++|+++|
T Consensus        58 l~~Gadvn~~d~~g~TpL~~--~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~G  135 (489)
T PHA02798         58 INLGANVNGLDNEYSTPLCT--ILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENG  135 (489)
T ss_pred             HHCCCCCCCCCCCCCChHHH--HHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcC
Confidence            46788999999999999966  443     36789999999999999999999999999999985   789999999999


Q ss_pred             CCccccccccccchhhhhhhhh---hhHHHHHHhhcCCCCCC
Q 019685           92 ADVNAQDRWKNTPLADAEGAKK---FNMMELLNAHGGLSYGQ  130 (337)
Q Consensus        92 a~~~~~d~~g~t~l~~A~~~~~---~~~v~~L~~~~a~~~~~  130 (337)
                      ||+|.+|..|.||||.|+..++   .+++++|+.+|++.+..
T Consensus       136 advn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~  177 (489)
T PHA02798        136 ADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH  177 (489)
T ss_pred             CCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence            9999999999999999999887   89999999999887654

>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A

Probab=99.66  E-value=6e-17  Score=106.75  Aligned_cols=55  Identities=42%  Similarity=0.484  Sum_probs=33.6

Q ss_pred             HHhCC-CCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhh
Q 019685           54 LEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA  108 (337)
Q Consensus        54 L~~~~-~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A  108 (337)
                      |++.| +++|.+|..|.||||+||..|+.+++++|++.|+|++.+|..|+||||+|
T Consensus         1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A   56 (56)
T PF13857_consen    1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA   56 (56)
T ss_dssp             -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred             CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence            45667 89999999999999999999999999999999999999999999999987

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.66  E-value=1.9e-16  Score=146.37  Aligned_cols=117  Identities=23%  Similarity=0.205  Sum_probs=102.9

Q ss_pred             CCchhhhhhhh-ccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccc
Q 019685           20 TSSADKQKEKA-RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD   98 (337)
Q Consensus        20 ~~~~~~~~~~~-~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d   98 (337)
                      .+.++++|... .-+-||||+  |+.+|+..++.+|+++|||++.+|.+|.||||+||..||.-+|-+||.+|+|+|.+|
T Consensus        98 i~~gadvn~~gG~l~stPLHW--Aar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D  175 (600)
T KOG0509|consen   98 ISHGADVNAIGGVLGSTPLHW--AARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRD  175 (600)
T ss_pred             HHcCCCccccCCCCCCCcchH--HHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcC
Confidence            46788999988 557788866  999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccchhhhhhhhhhhHHHHHHhhcCCCCCCC-CCCCCCC
Q 019685           99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN-GSHFEPK  138 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~-~~~~~~~  138 (337)
                      ..|.||||+|+.++....+..|+..++.....+ ....+|.
T Consensus       176 ~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~TpL  216 (600)
T KOG0509|consen  176 NNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTPL  216 (600)
T ss_pred             CCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCchH
Confidence            999999999999999887888888888766544 4455543

>PHA03095 ankyrin-like protein; Provisional

Probab=99.66  E-value=3.1e-16  Score=149.44  Aligned_cols=116  Identities=27%  Similarity=0.255  Sum_probs=98.1

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCC---HHHHHHHHHhCCCCccccCCCCCcHHHHHHHcC-CHHHHHHHHHcCCCcc
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQND---AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG-WIDVAKCLIEYGADVN   95 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~---~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g-~~~~~~~Ll~~ga~~~   95 (337)
                      ...+++++.++..|.|||+.  |+..+   ..+++++|++.|+++|.+|..|+||||+|+..| +.+++++|+++|+++|
T Consensus        34 l~~ga~vn~~~~~g~t~Lh~--a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in  111 (471)
T PHA03095         34 LAAGADVNFRGEYGKTPLHL--YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVN  111 (471)
T ss_pred             HHcCCCcccCCCCCCCHHHH--HHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCC
Confidence            35678888899999999966  55555   899999999999999999999999999999999 5999999999999999


Q ss_pred             ccccccccchhhhh--hhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685           96 AQDRWKNTPLADAE--GAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus        96 ~~d~~g~t~l~~A~--~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      .+|..|.||||.|+  ..++.+++++|+.+|++++..+....+|
T Consensus       112 ~~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g~tp  155 (471)
T PHA03095        112 AKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGMTP  155 (471)
T ss_pred             CCCCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCCCCH
Confidence            99999999999998  4567889999999998877655544443

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.65  E-value=3.2e-16  Score=152.87  Aligned_cols=115  Identities=14%  Similarity=0.024  Sum_probs=74.6

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCC--HHHHHHHHHhCCCCccccCCCCCcHHHHH-----------------------
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQND--AAAVRKLLEEDQSLVHARDYDNRTPLHVA-----------------------   75 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~--~~~~~~lL~~~~~~vn~~~~~g~tpLh~A-----------------------   75 (337)
                      +.|++++.+|..|+|||++  |+..+  ..+++++|++.|++||.+|..|+||||+|                       
T Consensus       200 e~GADVN~kD~~G~TPLH~--Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~  277 (764)
T PHA02716        200 NNGVNVNLQNNHLITPLHT--YLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNK  277 (764)
T ss_pred             HcCCCCCCCCCCCCCHHHH--HHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccc
Confidence            3556777777777777754  54444  34677777777777777777777777754                       


Q ss_pred             --------------HHcCCHHHHHHHHHcCCCccccccccccchhhhhh--hhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685           76 --------------SLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG--AKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus        76 --------------~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~--~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                                    |..|+.+++++|+++||++|.+|..|+||||+|+.  .++.+++++|+++|++.+..+....+|
T Consensus       278 ~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~G~TP  355 (764)
T PHA02716        278 VKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTV  355 (764)
T ss_pred             cccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCCCCCH
Confidence                          33466677777777777777777777777776653  345677777777777665555444443

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.65  E-value=4.5e-16  Score=145.88  Aligned_cols=102  Identities=24%  Similarity=0.151  Sum_probs=90.6

Q ss_pred             hhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhh
Q 019685           28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD  107 (337)
Q Consensus        28 ~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~  107 (337)
                      ..+.+|+|||++  |+..+..+++++|++.|+++|..+.+|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+
T Consensus        97 ~~~~~g~tpL~~--A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~  174 (413)
T PHA02875         97 VFYKDGMTPLHL--ATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLII  174 (413)
T ss_pred             cccCCCCCHHHH--HHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence            345678898866  888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          108 AEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       108 A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      |+..++.+++++|+.+|++.+..+
T Consensus       175 A~~~g~~eiv~~Ll~~ga~~n~~~  198 (413)
T PHA02875        175 AMAKGDIAICKMLLDSGANIDYFG  198 (413)
T ss_pred             HHHcCCHHHHHHHHhCCCCCCcCC
Confidence            999999999999999998876543

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.65  E-value=2.1e-16  Score=127.82  Aligned_cols=108  Identities=23%  Similarity=0.212  Sum_probs=99.2

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT  103 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t  103 (337)
                      ..+|..|+.|.|||++  |+..|+..++++|++.|+|++...++..|+|.+|+..|..+||++||..+.|+|..|-.|-|
T Consensus       151 n~VN~~De~GfTpLiW--Aaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgT  228 (296)
T KOG0502|consen  151 NKVNACDEFGFTPLIW--AAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGT  228 (296)
T ss_pred             ccccCccccCchHhHH--HHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCc
Confidence            4678889999999977  78888899999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhhhhhhhhHHHHHHhhcCCCCCCCCC
Q 019685          104 PLADAEGAKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       104 ~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      ||-+|+.-++.++++.|+..|++....+.+
T Consensus       229 pLlyAvrgnhvkcve~Ll~sGAd~t~e~ds  258 (296)
T KOG0502|consen  229 PLLYAVRGNHVKCVESLLNSGADVTQEDDS  258 (296)
T ss_pred             eeeeeecCChHHHHHHHHhcCCCccccccc
Confidence            999999999999999999999987655433

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.65  E-value=4e-16  Score=148.79  Aligned_cols=113  Identities=26%  Similarity=0.253  Sum_probs=101.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHc-CCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH-GWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~-g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|.||||+|+.. ++.+++++|+++|+++|.++.
T Consensus       189 ~~gad~n~~d~~g~tpLh~--A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~  266 (477)
T PHA02878        189 SYGANVNIPDKTNNSPLHH--AVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSY  266 (477)
T ss_pred             HCCCCCCCcCCCCCCHHHH--HHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCC
Confidence            4578899999999999976  8888999999999999999999999999999999975 799999999999999999986


Q ss_pred             -ccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          100 -WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       100 -~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                       .|.||||.|  .++.+++++|+.+|++++..+....+|
T Consensus       267 ~~g~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~Tp  303 (477)
T PHA02878        267 ILGLTALHSS--IKSERKLKLLLEYGADINSLNSYKLTP  303 (477)
T ss_pred             CCCCCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence             799999999  467889999999999988776655554

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.64  E-value=4.4e-16  Score=151.90  Aligned_cols=89  Identities=17%  Similarity=0.132  Sum_probs=77.8

Q ss_pred             Cch-hhhhhh-hccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCC--HHHHHHHHHcCCCccc
Q 019685           21 SSA-DKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKCLIEYGADVNA   96 (337)
Q Consensus        21 ~~~-~~~~~~-~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~--~~~~~~Ll~~ga~~~~   96 (337)
                      ..+ +++|.+ |..|+|||+..++...+..+++++|++.|++||.+|.+|.||||+|+..|+  .++|++|+++|||+|.
T Consensus       163 e~G~ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~  242 (764)
T PHA02716        163 DVGIVNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDM  242 (764)
T ss_pred             HCCCCCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCC
Confidence            456 889988 889999997522234467899999999999999999999999999999995  5999999999999999


Q ss_pred             cccccccchhhhh
Q 019685           97 QDRWKNTPLADAE  109 (337)
Q Consensus        97 ~d~~g~t~l~~A~  109 (337)
                      +|..|+||||.|+
T Consensus       243 kD~~G~TPLh~Ai  255 (764)
T PHA02716        243 KCVNGMSPIMTYI  255 (764)
T ss_pred             CCCCCCCHHHHHH
Confidence            9999999999764

>PHA03095 ankyrin-like protein; Provisional

Probab=99.63  E-value=5.5e-16  Score=147.78  Aligned_cols=103  Identities=21%  Similarity=0.158  Sum_probs=68.3

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCH--HHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDA--AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~--~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      .+++++.+|..|+||||+  |+..+.  ..++++|+..|+++|.+|..|+||||+|+..|+.+++++||++|||+|.+|.
T Consensus       211 ~g~~~~~~d~~g~tpLh~--Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~  288 (471)
T PHA03095        211 AGCDPAATDMLGNTPLHS--MATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSS  288 (471)
T ss_pred             cCCCCcccCCCCCCHHHH--HHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCC
Confidence            345566666667776644  443332  2455566667777777777777777777777777777777777777777777


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      .|.||||.|+..++.++++.|+..++.
T Consensus       289 ~g~tpl~~A~~~~~~~~v~~LL~~~~~  315 (471)
T PHA03095        289 DGNTPLSLMVRNNNGRAVRAALAKNPS  315 (471)
T ss_pred             CCCCHHHHHHHhCCHHHHHHHHHhCCC
Confidence            777777777777777777777666543

>PHA02917 ankyrin-like protein; Provisional

Probab=99.63  E-value=4.8e-16  Score=151.93  Aligned_cols=107  Identities=20%  Similarity=0.167  Sum_probs=94.6

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCC---CC-----------CcHHHHHHH--------
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY---DN-----------RTPLHVASL--------   77 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~---~g-----------~tpLh~A~~--------   77 (337)
                      .+.|++++.+|.+|+|||+.++|+.+++.+++++|+++|++||.+|.   .|           .||||+|+.        
T Consensus       123 l~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~~~~~~~t~L~~a~~~~~~~~~~  202 (661)
T PHA02917        123 VEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDYQPRNCGTVLHLYIISHLYSESD  202 (661)
T ss_pred             HHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccccccccccHHHHHHhhccccccc
Confidence            46899999999999999988777889999999999999999987653   34           599999986        


Q ss_pred             ---cCCHHHHHHHHHcCCCccccccccccchhhhhhhhhh--hHHHHHHhhcCCC
Q 019685           78 ---HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF--NMMELLNAHGGLS  127 (337)
Q Consensus        78 ---~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~--~~v~~L~~~~a~~  127 (337)
                         .++.+++++|+++|||+|.+|..|.||||+|+..++.  +++++|.+ |++.
T Consensus       203 ~~~~~~~eiv~~Li~~Gadvn~~d~~G~TpLh~A~~~g~~~~eivk~Li~-g~d~  256 (661)
T PHA02917        203 TRAYVRPEVVKCLINHGIKPSSIDKNYCTALQYYIKSSHIDIDIVKLLMK-GIDN  256 (661)
T ss_pred             ccccCcHHHHHHHHHCCCCcccCCCCCCcHHHHHHHcCCCcHHHHHHHHh-CCcc
Confidence               5689999999999999999999999999999999986  69999975 6543

>PHA02946 ankyin-like protein; Provisional

Probab=99.62  E-value=9e-16  Score=144.32  Aligned_cols=104  Identities=16%  Similarity=0.208  Sum_probs=63.0

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcC--CHHHHHHHHHcCCCcccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG--WIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g--~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      .+++++.+|..|+|||++++++.++..+++++|++.|+++|.+|.+|.||||+|+..|  +.+++++|++ |+++|.+|.
T Consensus       162 ~gad~~~~d~~G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~TpLH~Aa~~~~~~~~iv~lLl~-gadin~~d~  240 (446)
T PHA02946        162 IGFEARIVDKFGKNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGNTPLHIVCSKTVKNVDIINLLLP-STDVNKQNK  240 (446)
T ss_pred             ccccccccCCCCCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCCcHHHHHHHHc-CCCCCCCCC
Confidence            3455566666666666554444444455666666666666666666666666666654  5666666663 666666666


Q ss_pred             ccccchhhhhhhhh-hhHHHHHHhhcCC
Q 019685          100 WKNTPLADAEGAKK-FNMMELLNAHGGL  126 (337)
Q Consensus       100 ~g~t~l~~A~~~~~-~~~v~~L~~~~a~  126 (337)
                      .|.||||+|+..++ .+++++|+.+++.
T Consensus       241 ~G~TpLh~A~~~~~~~~~~~~Ll~~g~~  268 (446)
T PHA02946        241 FGDSPLTLLIKTLSPAHLINKLLSTSNV  268 (446)
T ss_pred             CCCCHHHHHHHhCChHHHHHHHHhCCCC
Confidence            66666666666655 3556666655543

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.62  E-value=8.2e-16  Score=144.11  Aligned_cols=107  Identities=20%  Similarity=0.180  Sum_probs=99.1

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.++..|+|||++  |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++||++|..+..
T Consensus       123 ~~gad~~~~~~~g~tpLh~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~  200 (413)
T PHA02875        123 ARGADPDIPNTDKFSPLHL--AVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKN  200 (413)
T ss_pred             hCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCC
Confidence            4577889999999999966  88888999999999999999999999999999999999999999999999999999988


Q ss_pred             cc-cchhhhhhhhhhhHHHHHHhhcCCCCC
Q 019685          101 KN-TPLADAEGAKKFNMMELLNAHGGLSYG  129 (337)
Q Consensus       101 g~-t~l~~A~~~~~~~~v~~L~~~~a~~~~  129 (337)
                      |. ||+|+|+..++.+++++|+.+|++.+.
T Consensus       201 ~~~t~l~~A~~~~~~~iv~~Ll~~gad~n~  230 (413)
T PHA02875        201 GCVAALCYAIENNKIDIVRLFIKRGADCNI  230 (413)
T ss_pred             CCchHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence            75 788999999999999999999998753

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.2e-15  Score=150.86  Aligned_cols=171  Identities=25%  Similarity=0.289  Sum_probs=125.4

Q ss_pred             CCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEeCCc
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKP  229 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~  229 (337)
                      .....|.+.+.||+|+||.||+|... |+.+|+|+-.+...-.-      ---..++.+|+   -+-|..+..++.-.+.
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            33446778899999999999999864 88999998766543211      00112233333   1244555555556667


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-----CCCCcEEEEecc
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-----SSADHLKVGDFG  304 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-----~~~~~~kl~DFg  304 (337)
                      -++|+||.+.|+|.+++...+.+++..+..+..|++.-++.||..+  |||+||||+|+||..     .....++|+|||
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecc
Confidence            7899999999999999998788999999999999999999999988  999999999999942     223469999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNC  334 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~  334 (337)
                      .|-.+..-..  .++.....+|-.+-.+|+
T Consensus       847 ~siDm~lfp~--~~~F~~~~~td~f~C~EM  874 (974)
T KOG1166|consen  847 RSIDMKLFPD--GTKFKAVWHTDLFDCIEM  874 (974)
T ss_pred             cceeeeEcCC--CcEEeeeeccccchhHHH
Confidence            9876654321  124555566666655554

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.61  E-value=1.9e-15  Score=144.46  Aligned_cols=109  Identities=20%  Similarity=0.285  Sum_probs=98.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHh--hCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcC--CHHHHHHHHHcCCCccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAH--QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG--WIDVAKCLIEYGADVNA   96 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~--~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g--~~~~~~~Ll~~ga~~~~   96 (337)
                      ..+++++.+|..|.|||++  |+  ..+..+++++|++.|++++..+..|.||||+|+..|  +.+++++|+++|+++|.
T Consensus        94 ~~ga~i~~~d~~g~tpL~~--A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~  171 (480)
T PHA03100         94 EYGANVNAPDNNGITPLLY--AISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINA  171 (480)
T ss_pred             HCCCCCCCCCCCCCchhhH--HHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCccc
Confidence            4567788888999999966  77  889999999999999999999999999999999999  99999999999999999


Q ss_pred             cccccccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685           97 QDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus        97 ~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      +|..|.||||.|+..++.+++++|+.+|++....+
T Consensus       172 ~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~  206 (480)
T PHA03100        172 KNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGD  206 (480)
T ss_pred             ccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCC
Confidence            99999999999999999999999999998776543

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.61  E-value=1.5e-15  Score=145.14  Aligned_cols=114  Identities=25%  Similarity=0.275  Sum_probs=80.7

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCC------CcHHHHHHHcCC--HHHHHHHHHcCC
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDN------RTPLHVASLHGW--IDVAKCLIEYGA   92 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g------~tpLh~A~~~g~--~~~~~~Ll~~ga   92 (337)
                      ..+++++.+|..|.|||++  |+..+..+++++|++.|++++..+..|      .||||+|+..|+  .+++++|+++|+
T Consensus       164 ~~g~din~~d~~g~tpL~~--A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~  241 (480)
T PHA03100        164 DKGVDINAKNRYGYTPLHI--AVEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGV  241 (480)
T ss_pred             HCCCCcccccCCCCCHHHH--HHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCC
Confidence            4456666667777777644  666666777777777777777766666      677777777777  777777777777


Q ss_pred             CccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685           93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus        93 ~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      ++|.+|..|.||||.|+..++.+++++|+.+|++++..+....+
T Consensus       242 din~~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n~~d~~g~t  285 (480)
T PHA03100        242 PINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDT  285 (480)
T ss_pred             CCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCc
Confidence            77777777888888887777778888877777766655444433

>PHA02798 ankyrin-like protein; Provisional

Probab=99.61  E-value=1.7e-15  Score=144.87  Aligned_cols=75  Identities=23%  Similarity=0.240  Sum_probs=61.4

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhC---CHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCC---HHHHHHHHHcCCCc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW---IDVAKCLIEYGADV   94 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~---~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~---~~~~~~Ll~~ga~~   94 (337)
                      ..|+++|.+|.+|+|||+.  |+.+   +..+++++|++.|+++|.+|.+|.||||+|+..|+   .+++++|+++|+++
T Consensus        97 ~~GadiN~~d~~G~TpLh~--a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadi  174 (489)
T PHA02798         97 ENGADINKKNSDGETPLYC--LLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDI  174 (489)
T ss_pred             HCCCCCCCCCCCcCcHHHH--HHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCc
Confidence            5678889999999999865  5544   47888888889999999999999999999998887   88888888887776


Q ss_pred             ccc
Q 019685           95 NAQ   97 (337)
Q Consensus        95 ~~~   97 (337)
                      |.+
T Consensus       175 n~~  177 (489)
T PHA02798        175 NTH  177 (489)
T ss_pred             ccc
Confidence            544

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.60  E-value=2.2e-15  Score=134.50  Aligned_cols=98  Identities=27%  Similarity=0.311  Sum_probs=91.8

Q ss_pred             HHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHH
Q 019685           39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME  118 (337)
Q Consensus        39 ~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~  118 (337)
                      +|+|+.-|+.+|+++|+++|++||.......|||--||+.||.|+|++|+++|||+++.|+.|.|-||+|+..|+.++++
T Consensus        88 LWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~q  167 (615)
T KOG0508|consen   88 LWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQ  167 (615)
T ss_pred             hhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHH
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCCCCC
Q 019685          119 LLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       119 ~L~~~~a~~~~~~~~~~~  136 (337)
                      +|++.|++.+.......+
T Consensus       168 yLle~gADvn~ks~kGNT  185 (615)
T KOG0508|consen  168 YLLEQGADVNAKSYKGNT  185 (615)
T ss_pred             HHHHhCCCcchhcccCch
Confidence            999999998865554444

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.60  E-value=2.4e-15  Score=143.95  Aligned_cols=106  Identities=15%  Similarity=0.175  Sum_probs=79.8

Q ss_pred             CchhhhhhhhccCCchhHHHHHhh------CCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHc---CCHHHHHHHHHcC
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQ------NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH---GWIDVAKCLIEYG   91 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~------~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~---g~~~~~~~Ll~~g   91 (337)
                      ..|+++|.++ .+.|||+.  |+.      .+..+++++|++.|+|+|.+|.+|.||||.|+..   |+.+++++|+++|
T Consensus        58 ~~GAdvn~~~-~~~tpL~~--a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~G  134 (494)
T PHA02989         58 DNGADVNYKG-YIETPLCA--VLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKG  134 (494)
T ss_pred             HcCCCccCCC-CCCCcHHH--HHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCC
Confidence            5677777765 45777753  433      2456788888888888888888888888877655   5788888888888


Q ss_pred             CCc-cccccccccchhhhhhh--hhhhHHHHHHhhcCCCCC
Q 019685           92 ADV-NAQDRWKNTPLADAEGA--KKFNMMELLNAHGGLSYG  129 (337)
Q Consensus        92 a~~-~~~d~~g~t~l~~A~~~--~~~~~v~~L~~~~a~~~~  129 (337)
                      ||+ +.+|..|.||||+|+..  ++.+++++|+.+|++++.
T Consensus       135 adin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~  175 (494)
T PHA02989        135 INVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE  175 (494)
T ss_pred             CCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence            888 78888888888887643  577888888888887654

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.59  E-value=3.3e-15  Score=143.05  Aligned_cols=36  Identities=14%  Similarity=0.155  Sum_probs=20.1

Q ss_pred             cccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCC
Q 019685           99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH  134 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~  134 (337)
                      ..|+||||+|+..++.+++++|++.|++++..+...
T Consensus       254 ~~G~TpL~~Aa~~~~~~~v~~LL~~Gadin~~d~~G  289 (494)
T PHA02989        254 KKGFNPLLISAKVDNYEAFNYLLKLGDDIYNVSKDG  289 (494)
T ss_pred             CCCCCHHHHHHHhcCHHHHHHHHHcCCCccccCCCC
Confidence            335566666666666666666666665555444333

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.59  E-value=4.6e-15  Score=139.91  Aligned_cols=111  Identities=26%  Similarity=0.291  Sum_probs=82.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCC-----------------------CCccccCCCCCcHHHHHHH
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQ-----------------------SLVHARDYDNRTPLHVASL   77 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~-----------------------~~vn~~~~~g~tpLh~A~~   77 (337)
                      ..+++++..+..|.|||+.  |+..+..+++++|++.|                       +++|.+|..|.||||+|+.
T Consensus        56 ~~Ga~~n~~~~~~~t~L~~--A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~~g~d~n~~~~~g~T~Lh~A~~  133 (434)
T PHA02874         56 KHGADINHINTKIPHPLLT--AIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCGIDVNIKDAELKTFLHYAIK  133 (434)
T ss_pred             HCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHHCcCCCCCCCCCCccHHHHHHH
Confidence            3456667777777777754  66666666666666554                       4466677788888888888


Q ss_pred             cCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCC
Q 019685           78 HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus        78 ~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      .|+.+++++|+++|+++|.+|..|.||||+|+..++.+++++|+.++++.+..+..
T Consensus       134 ~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~  189 (434)
T PHA02874        134 KGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNN  189 (434)
T ss_pred             CCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCC
Confidence            88888888888888888888888888888888888888888888887766544433

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.58  E-value=4.3e-15  Score=147.74  Aligned_cols=112  Identities=21%  Similarity=0.188  Sum_probs=67.7

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCC-HHHHHHHHHcCCCcccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~-~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      +++++.+|..|+|||++  |+..+..+++++|++.|++++..+..|.||||+|+..++ .+++++|+++|+++|.+|..|
T Consensus       365 gadin~~d~~G~TpLh~--Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G  442 (682)
T PHA02876        365 GANVNARDYCDKTPIHY--AAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDL  442 (682)
T ss_pred             CCCCccCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCC
Confidence            44555555555555543  555555555555555555555555555555555554443 345666666677777777777


Q ss_pred             ccchhhhhhhh-hhhHHHHHHhhcCCCCCCCCCCCC
Q 019685          102 NTPLADAEGAK-KFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       102 ~t~l~~A~~~~-~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      +||||+|+..+ +.+++++|+.+|++.+..+....+
T Consensus       443 ~TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~t  478 (682)
T PHA02876        443 STPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQY  478 (682)
T ss_pred             ChHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence            77777777655 567777777777776655544433

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.58  E-value=4.7e-15  Score=103.55  Aligned_cols=88  Identities=25%  Similarity=0.385  Sum_probs=75.8

Q ss_pred             HHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHH
Q 019685           39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME  118 (337)
Q Consensus        39 ~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~  118 (337)
                      .|....+...+|.+.. ..|-+||..- .|+|||||||.+|..++.++|+..||+++.+|++|.|||.-|...||.++|+
T Consensus         7 ~W~vkNG~~DeVk~~v-~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVk   84 (117)
T KOG4214|consen    7 AWNVKNGEIDEVKQSV-NEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVK   84 (117)
T ss_pred             hhhhccCcHHHHHHHH-HccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHH
Confidence            3555556666666666 5678888764 8999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCC
Q 019685          119 LLNAHGGLSY  128 (337)
Q Consensus       119 ~L~~~~a~~~  128 (337)
                      +|+..|++..
T Consensus        85 lLL~~GAdrt   94 (117)
T KOG4214|consen   85 LLLQNGADRT   94 (117)
T ss_pred             HHHHcCcccc
Confidence            9999998643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.57  E-value=5.4e-15  Score=124.36  Aligned_cols=108  Identities=27%  Similarity=0.307  Sum_probs=96.4

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      .+.|+.+|..+.-..|||++  |+..|+-++++.|++..+|||+.|..|.|||||||++|...+++-|+..||.+++-++
T Consensus        54 l~rgarvn~tnmgddtplhl--aaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~icnk  131 (448)
T KOG0195|consen   54 LSRGARVNSTNMGDDTPLHL--AAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVNICNK  131 (448)
T ss_pred             HhcccccccccCCCCcchhh--hhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceeeeccc
Confidence            46788899999999999987  7777777777777799999999999999999999999999999999999999999999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGLSYG  129 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~  129 (337)
                      +|.|||..|-......+.++..++|..++.
T Consensus       132 ~g~tpldkakp~l~~~l~e~aek~gq~~nr  161 (448)
T KOG0195|consen  132 KGMTPLDKAKPMLKNTLLEIAEKHGQSPNR  161 (448)
T ss_pred             CCCCchhhhchHHHHHHHHHHHHhCCCCCc
Confidence            999999999888777888888888876553

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.56  E-value=4.8e-15  Score=128.36  Aligned_cols=96  Identities=27%  Similarity=0.262  Sum_probs=54.8

Q ss_pred             hhhhhh-ccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHc-CCCccccccccc
Q 019685           25 KQKEKA-RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKN  102 (337)
Q Consensus        25 ~~~~~~-~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~-ga~~~~~d~~g~  102 (337)
                      |+|.|- ..|.|+|++  |...|..++++.|+..|+|||.+|.+|.|+|++||.+||+||+++||.. +.|+...|.+|.
T Consensus       331 nVNaKAsQ~gQTALML--AVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgS  408 (452)
T KOG0514|consen  331 DVNAKASQHGQTALML--AVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGS  408 (452)
T ss_pred             Ccchhhhhhcchhhhh--hhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCc
Confidence            444443 235555555  5555555666666566666666666666666666666666666665544 455555666666


Q ss_pred             cchhhhhhhhhhhHHHHHHh
Q 019685          103 TPLADAEGAKKFNMMELLNA  122 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~  122 (337)
                      |+|.+|...||.++.-+|..
T Consensus       409 TAl~IAleagh~eIa~mlYa  428 (452)
T KOG0514|consen  409 TALSIALEAGHREIAVMLYA  428 (452)
T ss_pred             hhhhhHHhcCchHHHHHHHH
Confidence            66666666666555555443

>PHA02730 ankyrin-like protein; Provisional

Probab=99.56  E-value=5.6e-15  Score=141.74  Aligned_cols=112  Identities=15%  Similarity=0.123  Sum_probs=92.5

Q ss_pred             CCCchhhhhhhhccCCchhHHHHHhhCCH---HHHHHHHHhCCC--CccccCCCCCcHHHH---HHHcC---------CH
Q 019685           19 ATSSADKQKEKARVSRTSLILWHAHQNDA---AAVRKLLEEDQS--LVHARDYDNRTPLHV---ASLHG---------WI   81 (337)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~---~~~~~lL~~~~~--~vn~~~~~g~tpLh~---A~~~g---------~~   81 (337)
                      ..+.|++++.+ ..|+||||. ||..++.   .+++++|+++|+  ++|.+|.+|.||||.   |+..+         ..
T Consensus       365 LIs~GAdIN~k-~~G~TpLH~-Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~  442 (672)
T PHA02730        365 MLDNGATMDKT-TDNNYPLHD-YFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILI  442 (672)
T ss_pred             HHHCCCCCCcC-CCCCcHHHH-HHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHH
Confidence            34678999985 789999965 3344433   899999999987  699999999999994   43332         23


Q ss_pred             HHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCC
Q 019685           82 DVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus        82 ~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      +++++|+++|||+|.+|..|.||||+|+..++.+++++|+.+|++.+..+.
T Consensus       443 ~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~  493 (672)
T PHA02730        443 DVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR  493 (672)
T ss_pred             HHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence            579999999999999999999999999999999999999999998876653

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.56  E-value=3.4e-15  Score=120.42  Aligned_cols=105  Identities=24%  Similarity=0.234  Sum_probs=81.8

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCC-------CccccCCCCCcHHHHHHHcCCH---HHHHHHHHcCC
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQS-------LVHARDYDNRTPLHVASLHGWI---DVAKCLIEYGA   92 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~-------~vn~~~~~g~tpLh~A~~~g~~---~~~~~Ll~~ga   92 (337)
                      ....+.+|..|+|||++  |+..+.  +++++...+.       .++..|.+|+||||+|+..|+.   +++++|+++|+
T Consensus         7 ~~~~~~~d~~g~tpLh~--A~~~g~--~~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~ga   82 (154)
T PHA02736          7 IIFASEPDIEGENILHY--LCRNGG--VTDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGA   82 (154)
T ss_pred             hhHHHhcCCCCCCHHHH--HHHhCC--HHHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCC
Confidence            44567788899999965  666554  3444433322       2345789999999999999986   46889999999


Q ss_pred             Cccccc-cccccchhhhhhhhhhhHHHHHHhh-cCCCCCCC
Q 019685           93 DVNAQD-RWKNTPLADAEGAKKFNMMELLNAH-GGLSYGQN  131 (337)
Q Consensus        93 ~~~~~d-~~g~t~l~~A~~~~~~~~v~~L~~~-~a~~~~~~  131 (337)
                      ++|.+| ..|+||||+|+..++.+++++|+.. +++.+..+
T Consensus        83 din~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~  123 (154)
T PHA02736         83 DINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILN  123 (154)
T ss_pred             CccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCcccc
Confidence            999998 5899999999999999999999874 66655444

>PHA02795 ankyrin-like protein; Provisional

Probab=99.55  E-value=8.4e-15  Score=134.26  Aligned_cols=116  Identities=12%  Similarity=-0.010  Sum_probs=97.4

Q ss_pred             CCCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCc-cccC-----CCCCcHHHHHHHcCCHHHHHHHHHcCC
Q 019685           19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV-HARD-----YDNRTPLHVASLHGWIDVAKCLIEYGA   92 (337)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~v-n~~~-----~~g~tpLh~A~~~g~~~~~~~Ll~~ga   92 (337)
                      ..+.|++++.+  ++.||++.  |+.++..+++++|+++|+++ |..+     ..+.||+|.|+.+++.|++++|+++||
T Consensus       137 LI~~GADIn~~--~~~t~lh~--A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GA  212 (437)
T PHA02795        137 MVDHGAVIYKI--ECLNAYFR--GICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIE  212 (437)
T ss_pred             HHHCCCCCCCC--CCCCHHHH--HHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcC
Confidence            35678888774  44777754  88888999999999999843 3322     347899999999999999999999999


Q ss_pred             CccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCC
Q 019685           93 DVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK  138 (337)
Q Consensus        93 ~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~  138 (337)
                      ++|.+|..|.||||+|+..++.+++++|+.+|++.+..+....+|.
T Consensus       213 DIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpL  258 (437)
T PHA02795        213 DINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCL  258 (437)
T ss_pred             CcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence            9999999999999999999999999999999999887776666553

>PHA02792 ankyrin-like protein; Provisional

Probab=99.55  E-value=1.1e-14  Score=138.39  Aligned_cols=107  Identities=14%  Similarity=0.114  Sum_probs=87.7

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHH---HHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccc
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAA---AVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA   96 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~---~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~   96 (337)
                      .+.|++++.+|.+|.+.+++|+|+.++..   +++++|++.|++||.+|..|+||||+|+..++.+++++|+++||++|.
T Consensus       359 Is~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GADIN~  438 (631)
T PHA02792        359 LKNGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGADINI  438 (631)
T ss_pred             HHcCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence            36788999999887655445557666554   457888899999999999999999999999999999999999999999


Q ss_pred             cccccccchhhhhh----------hhhhhHHHHHHhhcCC
Q 019685           97 QDRWKNTPLADAEG----------AKKFNMMELLNAHGGL  126 (337)
Q Consensus        97 ~d~~g~t~l~~A~~----------~~~~~~v~~L~~~~a~  126 (337)
                      +|..|.|||+.|..          ....+++++++.++..
T Consensus       439 kD~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~  478 (631)
T PHA02792        439 TTKYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPT  478 (631)
T ss_pred             cCCCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCC
Confidence            99999999999975          2235667778777643

>PHA02917 ankyrin-like protein; Provisional

Probab=99.55  E-value=1e-14  Score=142.62  Aligned_cols=105  Identities=15%  Similarity=0.081  Sum_probs=92.7

Q ss_pred             chhhhhhhhccCCchhHHHHHhhC-----------------------CHHHHHHHHHhCCCCccccCCCCCcHHHHHHHc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQN-----------------------DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLH   78 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~-----------------------~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~   78 (337)
                      .+++++.++++|+|||++  |+++                       +..+++++|++.|++||.+|..|+||||+|+..
T Consensus       385 ~ga~~~~~~~~G~TpL~~--a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~  462 (661)
T PHA02917        385 EGGDAVNHLDDGEIPIGH--LCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRY  462 (661)
T ss_pred             cCCCccccCCCCCChhHH--HHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHc
Confidence            567778888889999965  4422                       146678999999999999999999999999999


Q ss_pred             CCHHHHHHHHHcCCCccccccccccchhhhhh-hhhhhHHHHHHhhcCCCC
Q 019685           79 GWIDVAKCLIEYGADVNAQDRWKNTPLADAEG-AKKFNMMELLNAHGGLSY  128 (337)
Q Consensus        79 g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~-~~~~~~v~~L~~~~a~~~  128 (337)
                      ++.+++++|+++||++|.+|..|.||||+|.. .++.+++++++.++++..
T Consensus       463 ~~~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~  513 (661)
T PHA02917        463 NKQSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD  513 (661)
T ss_pred             CCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence            99999999999999999999999999999996 678999999999987543

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.54  E-value=1e-14  Score=145.46  Aligned_cols=112  Identities=37%  Similarity=0.438  Sum_probs=97.1

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP  104 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~  104 (337)
                      ..+...+.+-+++++  |..-+...+...++..|++++.++.+|+||||+||..|+.++|++||++|||++.+|+.|+||
T Consensus       499 ~~~~~~~~~l~~lhl--a~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TP  576 (1143)
T KOG4177|consen  499 NDNLDAKKGLTPLHL--AADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTP  576 (1143)
T ss_pred             ccCccchhccchhhh--hhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCCh
Confidence            344444556666655  666667777777888899999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCC
Q 019685          105 LADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK  138 (337)
Q Consensus       105 l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~  138 (337)
                      ||.|+..|+.+++++|.++|+.++..+....+|.
T Consensus       577 LH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL  610 (1143)
T KOG4177|consen  577 LHQAAQQGHNDIAELLLKHGASVNAADLDGFTPL  610 (1143)
T ss_pred             hhHHHHcChHHHHHHHHHcCCCCCcccccCcchh
Confidence            9999999999999999999999988777666654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=5.7e-14  Score=131.58  Aligned_cols=141  Identities=21%  Similarity=0.319  Sum_probs=97.8

Q ss_pred             ceecccCceeEEEEEEC-CceEEEEEecCCCCchHH---------------------------HH----------HHHHH
Q 019685          163 AIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRL---------------------------VI----------QDFRH  204 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~---------------------------~~----------~~~~~  204 (337)
                      +.||+|++|+||+|... |+.||||+..+.....-.                           ..          -++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999999985 899999998765321100                           00          02445


Q ss_pred             HHHHHHhCC-----CCCe--eeeeeeEEeCCceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHcCC
Q 019685          205 EVNLLVKLR-----HPNI--VQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIAR-GMAYLHNEP  275 (337)
Q Consensus       205 E~~~l~~l~-----h~~I--v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~-~l~~lH~~~  275 (337)
                      |+..+.+++     +++|  .+++.  ......++||||++|++|.++.... ...+   ...++.+++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence            666555542     3332  23332  2234569999999999998887532 1222   2345555555 467889977


Q ss_pred             CCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       276 ~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                        ++|+|++|.||++  +.++.++++|||++..+...
T Consensus       278 --~~H~D~hPgNilv--~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       278 --FFHADLHPGNIFV--LKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             --ceeCCCCcccEEE--CCCCcEEEEeCCCeeECCHH
Confidence              9999999999999  77789999999999887643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PHA02730 ankyrin-like protein; Provisional

Probab=99.54  E-value=1.7e-14  Score=138.36  Aligned_cols=102  Identities=15%  Similarity=0.064  Sum_probs=87.0

Q ss_pred             hhh-hhhccCCchhHHHHHhhCC---HHHHHHHHHhCCCCccccCCCCCcHHHHHHHcC--CHHHHHHHHHcCC--Cccc
Q 019685           25 KQK-EKARVSRTSLILWHAHQND---AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG--WIDVAKCLIEYGA--DVNA   96 (337)
Q Consensus        25 ~~~-~~~~~~~~~~~~~~a~~~~---~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g--~~~~~~~Ll~~ga--~~~~   96 (337)
                      +++ .+|.+|+||||+  |+.++   ..+++++|+++||+++++|..|+||||+||..+  +.|+|++|+++|+  +++.
T Consensus        32 ~in~~kd~~G~TaLh~--A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~  109 (672)
T PHA02730         32 NLSKHIDRRGNNALHC--YVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNEL  109 (672)
T ss_pred             chhhhcCCCCCcHHHH--HHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCccc
Confidence            455 788899999965  66554   589999999999999999999999999999976  7999999999965  5588


Q ss_pred             cccccccchhhhhh--hhhhhHHHHHHh-hcCCCC
Q 019685           97 QDRWKNTPLADAEG--AKKFNMMELLNA-HGGLSY  128 (337)
Q Consensus        97 ~d~~g~t~l~~A~~--~~~~~~v~~L~~-~~a~~~  128 (337)
                      .|..+.+||+.++.  .++.+++++|+. .+.++.
T Consensus       110 ~~~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~  144 (672)
T PHA02730        110 TSNINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPS  144 (672)
T ss_pred             ccccCCchHHHHHHhcCCcHHHHHHHHHhcCCChh
Confidence            88889999999888  888999999996 444544

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.53  E-value=2.1e-14  Score=142.86  Aligned_cols=105  Identities=28%  Similarity=0.215  Sum_probs=53.3

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCC-HHHHHHHHHhCCCCccccCCCCCcHHHHHHHc-CCHHHHHHHHHcCCCcccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQND-AAAVRKLLEEDQSLVHARDYDNRTPLHVASLH-GWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~-~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~-g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      .+++++.+|.+|+|||++  |+..+ ..+++++|+..|+++|..|..|.||||+|+.. ++.+++++|++.|+++|.+|.
T Consensus       296 ~gadin~~d~~g~TpLh~--Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~  373 (682)
T PHA02876        296 RGADVNAKNIKGETPLYL--MAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDY  373 (682)
T ss_pred             CCCCCCCcCCCCCCHHHH--HHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCC
Confidence            445555555555555533  33322 34445555555555555555555555555543 234555555555555555555


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGLSY  128 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~~~  128 (337)
                      .|.||||+|+..++.+++++|+.+|++..
T Consensus       374 ~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~  402 (682)
T PHA02876        374 CDKTPIHYAAVRNNVVIINTLLDYGADIE  402 (682)
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHCCCCcc
Confidence            55555555555555555555555554443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=3.5e-13  Score=108.20  Aligned_cols=136  Identities=24%  Similarity=0.383  Sum_probs=105.4

Q ss_pred             eecccCceeEEEEEECCceEEEEEecCCCCc-----hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .+.+|+-+.++.+.+.|.++++|.-.+....     .+....+..+|++++.+++--.|....=+..++....|+|||++
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~   82 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE   82 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence            5789999999999888888888865443332     23344567789999999875555555555566777889999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |..|.+++...       ...++..+-.-+.-||..|  |+|+||.++||++  .. +.+.++||||+..-..
T Consensus        83 G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl--~~-~~i~~IDfGLg~~s~~  143 (204)
T COG3642          83 GELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIIL--SG-GRIYFIDFGLGEFSDE  143 (204)
T ss_pred             ChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEE--eC-CcEEEEECCccccccc
Confidence            99999888654       2456777777788899977  9999999999999  33 3599999999986543

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.51  E-value=2e-14  Score=124.50  Aligned_cols=99  Identities=28%  Similarity=0.281  Sum_probs=82.4

Q ss_pred             hhhhhhccCCchhHHHHHhh---CCHHHHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQ---NDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~---~~~~~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ++|.+++.|+||.++-+-+.   -...++++-|...| |||++- ..|+|+|++|+.+|++++|+.||..|||||.+|.+
T Consensus       294 ~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdD  372 (452)
T KOG0514|consen  294 DVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDD  372 (452)
T ss_pred             cccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-CcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCC
Confidence            67888888999988844443   23445666664544 588764 46999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhc
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHG  124 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~  124 (337)
                      |.|+|+.|+.+||++++++|+...
T Consensus       373 GSTALMCA~EHGhkEivklLLA~p  396 (452)
T KOG0514|consen  373 GSTALMCAAEHGHKEIVKLLLAVP  396 (452)
T ss_pred             ccHHHhhhhhhChHHHHHHHhccC
Confidence            999999999999999999998754

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.51  E-value=2.8e-14  Score=135.09  Aligned_cols=108  Identities=25%  Similarity=0.239  Sum_probs=78.3

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCC-CCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcc---
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN---   95 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~-~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~---   95 (337)
                      ...|++++.++.++.||||+ ||..|....|.+||.+.| ...|..|-.|.||||+|+..||.+++++||++||+.+   
T Consensus       293 l~~Ga~I~~kn~d~~spLH~-AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~~  371 (929)
T KOG0510|consen  293 LGFGASINSKNKDEESPLHF-AAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNMS  371 (929)
T ss_pred             HHcCCcccccCCCCCCchHH-HHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhccc
Confidence            35677777788788888765 333344444455554233 3667778888888888888888888888888888766   


Q ss_pred             ccccccccchhhhhhhhhhhHHHHHHhhcCCCC
Q 019685           96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY  128 (337)
Q Consensus        96 ~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~  128 (337)
                      ..|.+|.||||.|+..|+...+++|+.+|++..
T Consensus       372 e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~  404 (929)
T KOG0510|consen  372 EADSDGNTALHLAAKYGNTSAVQKLISHGADIG  404 (929)
T ss_pred             ccccCCchhhhHHHHhccHHHHHHHHHcCCcee
Confidence            448888888888888888888888888888763

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.51  E-value=3.4e-14  Score=134.50  Aligned_cols=102  Identities=22%  Similarity=0.243  Sum_probs=94.4

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHH-cC-CCccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YG-ADVNAQDRWKN  102 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~-~g-a~~~~~d~~g~  102 (337)
                      -++..|++|-||||.  |+..|..+.++.|+..|++||.++.++.||||+||..|+.++|+-||+ .| ...|..|-.|.
T Consensus       265 lv~~~d~dg~tpLH~--a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~  342 (929)
T KOG0510|consen  265 LVNDEDNDGCTPLHY--AARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGM  342 (929)
T ss_pred             HhhcccccCCchHHH--HHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCC
Confidence            356788999999955  999999999999999999999999999999999999999999999998 55 57899999999


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSY  128 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~  128 (337)
                      ||||.|+..||..++++|++.||...
T Consensus       343 tpLHlaa~~gH~~v~qlLl~~GA~~~  368 (929)
T KOG0510|consen  343 TPLHLAAKSGHDRVVQLLLNKGALFL  368 (929)
T ss_pred             CchhhhhhcCHHHHHHHHHhcChhhh
Confidence            99999999999999999999999765

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.51  E-value=4.5e-14  Score=98.69  Aligned_cols=82  Identities=22%  Similarity=0.175  Sum_probs=72.2

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT  103 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t  103 (337)
                      .++|..- .|++||+.  |+..++.++.++|+..|++|+.+|++|-|||.-|+..||.++|++||++|||-..+-.+|.+
T Consensus        26 ~nVn~~~-ggR~plhy--AAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~~  102 (117)
T KOG4214|consen   26 LNVNEIY-GGRTPLHY--AADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGTA  102 (117)
T ss_pred             ccHHHHh-CCcccchH--hhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCchh
Confidence            4555554 78999954  99999999999999999999999999999999999999999999999999998888777777


Q ss_pred             chhhh
Q 019685          104 PLADA  108 (337)
Q Consensus       104 ~l~~A  108 (337)
                      .+..+
T Consensus       103 ~~eat  107 (117)
T KOG4214|consen  103 LIEAT  107 (117)
T ss_pred             HHhhc
Confidence            65543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.49  E-value=9e-13  Score=105.40  Aligned_cols=150  Identities=22%  Similarity=0.294  Sum_probs=112.9

Q ss_pred             ccceecccCceeEEEEEECCceEEEEEecCC-----CCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPS-----LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       161 ~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      ....|-+|+-+.|+++.+.|+..+||.-...     ..+.+....+..+|++.+.++.--.|....-++.+...-+|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            3467889999999999999999888865432     23344455677899999999875555555555677777899999


Q ss_pred             ecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCceeeec
Q 019685          236 YLRG-GDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       236 ~~~~-~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla~~~~~  311 (337)
                      |++| .++.+++.+..  ....+....++.+|-..+.-||..+  |+|+||..+||++.++. ...+.++|||++..-..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~~  168 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVSRL  168 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcccC
Confidence            9987 57788876532  2333334788999999999999977  99999999999995432 23468999999876544


Q ss_pred             c
Q 019685          312 Q  312 (337)
Q Consensus       312 ~  312 (337)
                      .
T Consensus       169 ~  169 (229)
T KOG3087|consen  169 P  169 (229)
T ss_pred             c
Confidence            3

>KOG1710 consensus MYND Zn-finger and ankyrin repeat protein [General function prediction only]

Probab=99.49  E-value=5.1e-14  Score=118.40  Aligned_cols=102  Identities=22%  Similarity=0.187  Sum_probs=93.2

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccc-cCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~-~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ++-.++|..|..|.++|.+  |+..|+.+.+++|++.|+|||. ++..++||||+||..|+.++.++|++.||.....|.
T Consensus        33 s~vr~vn~~D~sGMs~Lah--AaykGnl~~v~lll~~gaDvN~~qhg~~YTpLmFAALSGn~dvcrllldaGa~~~~vNs  110 (396)
T KOG1710|consen   33 STVRQVNQRDPSGMSVLAH--AAYKGNLTLVELLLELGADVNDKQHGTLYTPLMFAALSGNQDVCRLLLDAGARMYLVNS  110 (396)
T ss_pred             HHhhhhhccCCCcccHHHH--HHhcCcHHHHHHHHHhCCCcCcccccccccHHHHHHHcCCchHHHHHHhccCccccccc
Confidence            4455789999999999977  8999999999999999999997 567799999999999999999999999999999999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhc
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHG  124 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~  124 (337)
                      -|.|+-++|+.-|+.+.|.++..+-
T Consensus       111 vgrTAaqmAAFVG~H~CV~iINN~~  135 (396)
T KOG1710|consen  111 VGRTAAQMAAFVGHHECVAIINNHI  135 (396)
T ss_pred             hhhhHHHHHHHhcchHHHHHHhccc
Confidence            9999999999999999999887653

>PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A

Probab=99.49  E-value=4.1e-14  Score=92.62  Aligned_cols=53  Identities=42%  Similarity=0.603  Sum_probs=29.4

Q ss_pred             CCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHH
Q 019685           68 NRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL  120 (337)
Q Consensus        68 g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L  120 (337)
                      |.||||+||..|+.+++++|+++|+|+|.+|.+|.||||.|+..++.+++++|
T Consensus         1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~L   53 (54)
T PF13637_consen    1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFL   53 (54)
T ss_dssp             SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHH
T ss_pred             CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHH
Confidence            45666666666666666666666666666666666666666666666666555

...

>PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

Probab=99.48  E-value=1.3e-13  Score=135.58  Aligned_cols=83  Identities=34%  Similarity=0.500  Sum_probs=77.9

Q ss_pred             HHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHH
Q 019685           41 HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL  120 (337)
Q Consensus        41 ~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L  120 (337)
                      .|+..|..+.+++|++.|+++|.+|.+|+||||+||.+|+.+++++|+++||++|.+|..|.||||+|+..++.+++++|
T Consensus        88 ~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~L  167 (664)
T PTZ00322         88 QLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREVVQLL  167 (664)
T ss_pred             HHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHH
Confidence            35666667778888899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             Hhh
Q 019685          121 NAH  123 (337)
Q Consensus       121 ~~~  123 (337)
                      +.+
T Consensus       168 l~~  170 (664)
T PTZ00322        168 SRH  170 (664)
T ss_pred             HhC
Confidence            988

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.48  E-value=9.2e-14  Score=140.48  Aligned_cols=92  Identities=25%  Similarity=0.330  Sum_probs=80.4

Q ss_pred             CCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhh
Q 019685           33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK  112 (337)
Q Consensus        33 ~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~  112 (337)
                      ..++++  .|+..|+.++++.|++.|+++|..|.+|.||||+||..|+.+++++|+++|+|+|.+|..|+||||.|+..+
T Consensus       525 ~~~~L~--~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g  602 (823)
T PLN03192        525 MASNLL--TVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAK  602 (823)
T ss_pred             chhHHH--HHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhC
Confidence            345553  477777788888888999999999999999999999999999999999999999999999999999998888


Q ss_pred             hhhHHHHHHhhcCC
Q 019685          113 KFNMMELLNAHGGL  126 (337)
Q Consensus       113 ~~~~v~~L~~~~a~  126 (337)
                      +.+++++|...++.
T Consensus       603 ~~~iv~~L~~~~~~  616 (823)
T PLN03192        603 HHKIFRILYHFASI  616 (823)
T ss_pred             CHHHHHHHHhcCcc
Confidence            88888887765543

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.47  E-value=9.3e-14  Score=101.11  Aligned_cols=64  Identities=34%  Similarity=0.494  Sum_probs=57.7

Q ss_pred             CCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccc
Q 019685           33 SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD   98 (337)
Q Consensus        33 ~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d   98 (337)
                      |+||+++  |+.++..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|
T Consensus        26 ~~~~l~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n   89 (89)
T PF12796_consen   26 GNTALHY--AAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN   89 (89)
T ss_dssp             SSBHHHH--HHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred             CCCHHHH--HHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence            7788855  889999999999999999999999999999999999999999999999999999876

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.46  E-value=1e-13  Score=131.51  Aligned_cols=143  Identities=18%  Similarity=0.280  Sum_probs=93.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCch---------------------------H----HHHH----
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---------------------------R----LVIQ----  200 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~---------------------------~----~~~~----  200 (337)
                      +|+. +.||+|++|+||+|..+  |+.||||++.+.....                           .    ...+    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3554 67999999999999974  8999999998653211                           0    0111    


Q ss_pred             --HHHHHHHHHHhCC----CCCeeeeeeeEEe-CCceEEEEeecCCCCHHHHH--HhcC----CCCHHHHHHHHHHHHHH
Q 019685          201 --DFRHEVNLLVKLR----HPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYL--KEKG----ALSPSTAVNFALDIARG  267 (337)
Q Consensus       201 --~~~~E~~~l~~l~----h~~Iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~----~~~~~~~~~~~~~i~~~  267 (337)
                        ++.+|+..+.+++    +...+.+-.++.+ ....++||||+.|+++.++-  ...+    .+.+..+..++.|+.  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence              2344554444442    3333333333322 34568999999999998753  3322    133444444555554  


Q ss_pred             HHHHHcCCCCcEeeCCCCCCEEEecCCCC----cEEEEeccCceeeecc
Q 019685          268 MAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       268 l~~lH~~~~~ivHrdlkp~Nil~~~~~~~----~~kl~DFgla~~~~~~  312 (337)
                           ..|  ++|+|+||.||++  +.++    .++++|||+...++..
T Consensus       278 -----~~G--ffHaDpHPGNIlv--~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 -----RDG--FFHADMHPGNIFV--SYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----hCC--eeeCCCChHHeEE--ecCCCCCCeEEEEecceEEECCHH
Confidence                 355  9999999999999  5555    8999999999887654

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.46  E-value=5.1e-14  Score=114.11  Aligned_cols=107  Identities=20%  Similarity=0.198  Sum_probs=94.4

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      .+|++.+.--+...++|.+  |+.+|..+++++|+..+.|||..|-+|-|||-||+..||++|++.||..||+++..|..
T Consensus       181 ~~GAdp~~lgk~resALsL--At~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvrgnhvkcve~Ll~sGAd~t~e~ds  258 (296)
T KOG0502|consen  181 NSGADPDALGKYRESALSL--ATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVRGNHVKCVESLLNSGADVTQEDDS  258 (296)
T ss_pred             HcCCChhhhhhhhhhhHhH--HhcCChHHHHHHHHhcCCCcceeccCCCceeeeeecCChHHHHHHHHhcCCCccccccc
Confidence            4677888877888899988  99999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      |.+++..|...|+. +++.+++.-+....+
T Consensus       259 Gy~~mdlAValGyr-~Vqqvie~h~lkl~Q  287 (296)
T KOG0502|consen  259 GYWIMDLAVALGYR-IVQQVIEKHALKLCQ  287 (296)
T ss_pred             CCcHHHHHHHhhhH-HHHHHHHHHHHHHhh
Confidence            99999999999988 565555544444333

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.45  E-value=2.3e-12  Score=106.80  Aligned_cols=140  Identities=19%  Similarity=0.177  Sum_probs=99.4

Q ss_pred             ceecccCceeEEEEEEC--------CceEEEEEecCCCCc----------------------h-HHHHHHHHHHHHHHHh
Q 019685          163 AIIGKGSFGEILKAYWR--------GTPVAIKRILPSLSD----------------------D-RLVIQDFRHEVNLLVK  211 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--------g~~vavK~l~~~~~~----------------------~-~~~~~~~~~E~~~l~~  211 (337)
                      ..||.|--+.||.|...        +..+|+|+.+.....                      . ........+|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            46899999999999754        368999986422110                      0 0111123379999998


Q ss_pred             CCC--CCeeeeeeeEEeCCceEEEEeecCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HcCCCCcEeeCCCCCC
Q 019685          212 LRH--PNIVQFLGAVTERKPLMLITEYLRGGDLHK-YLKEKGALSPSTAVNFALDIARGMAYL-HNEPNVIIHRDLKPRN  287 (337)
Q Consensus       212 l~h--~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~ivHrdlkp~N  287 (337)
                      +..  -++++++++    ...+|||||+.+..+.. .++ ...++..+...+..+++.+|..| |..|  |||+||++.|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~N  155 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYN  155 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence            863  466677754    45689999997754422 232 22355566778889999999999 8877  9999999999


Q ss_pred             EEEecCCCCcEEEEeccCceeeecc
Q 019685          288 VLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       288 il~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |++  . ++.+.|+|||.+.....+
T Consensus       156 IL~--~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         156 MLW--H-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             EEE--E-CCcEEEEECCCceeCCCC
Confidence            999  3 467999999998765533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=5.4e-13  Score=109.19  Aligned_cols=130  Identities=18%  Similarity=0.145  Sum_probs=94.5

Q ss_pred             ceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEeCCceEEEEeecCCCC
Q 019685          163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLMLITEYLRGGD  241 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~lv~e~~~~~~  241 (337)
                      +.|+.|.++.||++...+..+++|........    ...+..|+.++..+.+.. +++++....  ...++|||+++|.+
T Consensus         4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEECCeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            46788999999999988999999987543211    123567888888876444 345555432  34589999999988


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC---CcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          242 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN---VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       242 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +.+.     ..   ....++.+++.+|..||+.+.   .++|+|++|.||++  + ++.++++|||.+..-
T Consensus        78 l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~--~-~~~~~liDf~~a~~~  137 (170)
T cd05151          78 LLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL--D-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE--E-CCeEEEEecccccCC
Confidence            7643     01   113456789999999999751   14999999999999  4 567999999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=2.8e-13  Score=119.69  Aligned_cols=119  Identities=27%  Similarity=0.373  Sum_probs=90.4

Q ss_pred             CCCCeeeeeeeEEe---------------------------CCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 019685          213 RHPNIVQFLGAVTE---------------------------RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA  265 (337)
Q Consensus       213 ~h~~Iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~  265 (337)
                      +|||||++.++|.+                           +..+|+||..... +|.+++..+ ..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            69999999988743                           3358999998866 999998643 467788888999999


Q ss_pred             HHHHHHHcCCCCcEeeCCCCCCEEEecCCC--CcEEEEeccCceeeecccccceee--eeCCcccccccccccc
Q 019685          266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSA--DHLKVGDFGLSKLIKVQNSHDVYK--MTGETGSCEYLVSNCS  335 (337)
Q Consensus       266 ~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~--~~~kl~DFgla~~~~~~~~~~~~~--~~~~~gt~~y~aPE~l  335 (337)
                      +|+.|||.+|  |.|||+|++|||+.-+.+  ..+.|+|||.+-..+...-+-.+.  ....-|+-.-||||+.
T Consensus       352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            9999999988  999999999999954444  467889999875443322111111  1234588899999985

>KOG0507 consensus CASK-interacting adaptor protein (caskin) and related proteins with ankyrin repeats and SAM domain [Signal transduction mechanisms]

Probab=99.43  E-value=1.1e-13  Score=130.16  Aligned_cols=116  Identities=23%  Similarity=0.202  Sum_probs=106.5

Q ss_pred             CCCCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccc
Q 019685           18 GATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ   97 (337)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~   97 (337)
                      ..+....++|.+|-+|.|.|++  |+.+++.++.++|++..+.++.+|..|.+|||+||..|+.|++++||.++..+|.+
T Consensus        34 ~~~trsds~n~qd~~gfTalhh--a~Lng~~~is~llle~ea~ldl~d~kg~~plhlaaw~g~~e~vkmll~q~d~~na~  111 (854)
T KOG0507|consen   34 FFTTRSDSHNLQDYSGFTLLHH--AVLNGQNQISKLLLDYEALLDLCDTKGILPLHLAAWNGNLEIVKMLLLQTDILNAV  111 (854)
T ss_pred             CCCCCCccccccCccchhHHHH--HHhcCchHHHHHHhcchhhhhhhhccCcceEEehhhcCcchHHHHHHhcccCCCcc
Confidence            3456678899999999999977  99999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCC
Q 019685           98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF  135 (337)
Q Consensus        98 d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~  135 (337)
                      +..|.||||.|+..++.+++.+|+.+++++...+++.-
T Consensus       112 ~~e~~tplhlaaqhgh~dvv~~Ll~~~adp~i~nns~~  149 (854)
T KOG0507|consen  112 NIENETPLHLAAQHGHLEVVFYLLKKNADPFIRNNSKE  149 (854)
T ss_pred             cccCcCccchhhhhcchHHHHHHHhcCCCccccCcccc
Confidence            99999999999999999999999999999886665443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	337
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-24
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-23
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-22
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-22
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-21
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-21
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-21
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-14
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-13
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-13
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-13
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-13
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
1n0r_A	126	4ank: A Designed Ankyrin Repeat Protein With Four I		4e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
1n0q_A	93	3ank: A Designed Ankyrin Repeat Protein With Three		4e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-08
3zu7_B	169	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
3twu_A	167	Crystal Structure Of Arc4 From Human Tankyrase 2 In		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
4gpm_A	169	Crystal Structure Of Engineered Protein. Northeast		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-08
3twq_A	175	Crystal Structure Of Arc4 From Human Tankyrase 2 (A		3e-08
3twr_A	165	Crystal Structure Of Arc4 From Human Tankyrase 2 In		3e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-08
4dui_A	169	Darpin D1 Binding To Tubulin Beta Chain (not In Com		5e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-08
4drx_E	169	Gtp-Tubulin In Complex With A Darpin Length = 169		8e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
3utm_A	351	Crystal Structure Of A Mouse Tankyrase-Axin Complex		2e-07
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-07
3zuv_B	136	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-07
2y0b_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4_		3e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-07
2bkg_A	166	Crystal Structure Of E3_19 An Designed Ankyrin Repe		4e-07
2p2c_P	169	Inhibition Of Caspase-2 By A Designed Ankyrin Repea		5e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-07
4hqd_A	169	Crystal Structure Of Engineered Protein. Northeast		5e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-07
2xeh_A	157	Structural Determinants For Improved Thermal Stabil		6e-07
2xee_A	157	Structural Determinants For Improved Thermal Stabil		6e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-06
2v4h_C	136	Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13		1e-06
4f6r_D	169	Tubulin:stathmin-Like Domain Complex Length = 169		1e-06
2xzt_G	136	Caspase-3 In Complex With Darpin-3.4_i78s Length =		1e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-06
2zgg_A	92	Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-06
1mj0_A	166	Sank E3_5: An Artificial Ankyrin Repeat Protein Len		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
2xzd_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
2bkk_B	169	Crystal Structure Of Aminoglycoside Phosphotransfer		2e-06
4grg_A	135	Crystal Structure Of Ige Complexed With E2_79, An A		3e-06
2l6b_A	115	Nrc Consensus Ankyrin Repeat Protein Solution Struc		3e-06
3q9u_C	158	In Silico And In Vitro Co-Evolution Of A High Affin		3e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-06
4hb5_A	169	Crystal Structure Of Engineered Protein. Northeast		4e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-06
2qyj_A	166	Crystal Structure Of A Designed Full Consensus Anky		5e-06
3hg0_D	136	Crystal Structure Of A Darpin In Complex With Orf49		5e-06
1svx_A	169	Crystal Structure Of A Designed Selected Ankyrin Re		5e-06
4atz_D	154	Ad5 Knob In Complex With A Designed Ankyrin Repeat		6e-06
2v5q_C	167	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-06
2zgd_A	110	Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom		8e-06
2jab_A	136	A Designed Ankyrin Repeat Protein Evolved To Picomo		8e-06
2y1l_E	169	Caspase-8 In Complex With Darpin-8.4 Length = 169		8e-06
3noc_D	169	Designed Ankyrin Repeat Protein (Darpin) Binders To		8e-06
4gmr_A	169	Crystal Structure Of Engineered Protein. Northeast		1e-05
2j8s_D	169	Drug Export Pathway Of Multidrug Exporter Acrb Reve		1e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-05
3hra_A	201	Crystal Structure Of Ef0377 An Ankyrin Repeat Prote		1e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
2xen_A	91	Structural Determinants For Improved Thermal Stabil		2e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 66/162 (40%), Positives = 97/162 (59%), Gaps = 8/162 (4%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLL 209
           ++D    D +    IG GSFG + +A W G+ VA+K ++      +R  + +F  EV ++
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER--VNEFLREVAIM 88
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIAR 266
            +LRHPNIV F+GAVT+   L ++TEYL  G L++ L + GA   L     ++ A D+A+
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           GM YLHN    I+HRDLK  N+L+       +KV DFGLS+L
Sbjct: 149 GMNYLHNRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/162 (40%), Positives = 97/162 (59%), Gaps = 8/162 (4%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLL 209
           ++D    D +    IG GSFG + +A W G+ VA+K ++      +R  + +F  EV ++
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER--VNEFLREVAIM 88
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIAR 266
            +LRHPNIV F+GAVT+   L ++TEYL  G L++ L + GA   L     ++ A D+A+
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           GM YLHN    I+HR+LK  N+L+       +KV DFGLS+L
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRL 188

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/162 (38%), Positives = 89/162 (54%), Gaps = 12/162 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 208
           W IDPSEL F     IG G FG +   YW     VAIK I     +  +  +DF  E  +
Sbjct: 3   WVIDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEV 56
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           ++KL HP +VQ  G   E+ P+ L+TE++  G L  YL+ ++G  +  T +   LD+  G
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           MAYL  E   +IHRDL  RN L+  +    +KV DFG+++ +
Sbjct: 117 MAYL--EEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFV 154

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/166 (41%), Positives = 94/166 (56%), Gaps = 13/166 (7%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIK--RILPSLSDDRLVIQDFRHEVNL 208
           EID +EL      IIG G FG++ +A+W G  VA+K  R  P   D    I++ R E  L
Sbjct: 3   EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPD-EDISQTIENVRQEAKL 59
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
              L+HPNI+   G   +   L L+ E+ RGG L++ L  K  + P   VN+A+ IARGM
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGM 118
Query: 269 AYLHNEPNV-IIHRDLKPRNVLLVNS------SADHLKVGDFGLSK 307
            YLH+E  V IIHRDLK  N+L++        S   LK+ DFGL++
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 61/162 (37%), Positives = 88/162 (54%), Gaps = 12/162 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNL 208
           W IDPSEL F     IG G FG +   YW     VAIK I     +  +  +DF  E  +
Sbjct: 5   WVIDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEV 58
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           ++KL HP +VQ  G   E+ P+ L+ E++  G L  YL+ ++G  +  T +   LD+  G
Sbjct: 59  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 118
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           MAYL  E   +IHRDL  RN L+  +    +KV DFG+++ +
Sbjct: 119 MAYL--EEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFV 156

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/161 (39%), Positives = 89/161 (55%), Gaps = 14/161 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
           IDPSEL F     IG G FG +   YW     VAIK I   S+S+D     DF  E  ++
Sbjct: 24  IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-----DFIEEAEVM 76
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGM 268
           +KL HP +VQ  G   E+ P+ L+ E++  G L  YL+ ++G  +  T +   LD+  GM
Sbjct: 77  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 136
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           AYL  E   +IHRDL  RN L+  +    +KV DFG+++ +
Sbjct: 137 AYL--EEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFV 173

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           IDPSEL F     IG G FG +   YW     VAIK I     +  +  +DF  E  +++
Sbjct: 2   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMM 55
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 269
           KL HP +VQ  G   E+ P+ L+ E++  G L  YL+ ++G  +  T +   LD+  GMA
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           YL  E   +IHRDL  RN L+  +    +KV DFG+++ +
Sbjct: 116 YL--EEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFV 151

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           IDPSEL F     IG G FG +   YW     VAIK I     +  +  +DF  E  +++
Sbjct: 4   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMM 57
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 269
           KL HP +VQ  G   E+ P+ L+ E++  G L  YL+ ++G  +  T +   LD+  GMA
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           YL  E   +IHRDL  RN L+  +    +KV DFG+++ +
Sbjct: 118 YL--EEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFV 153

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/160 (37%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           IDPSEL F     IG G FG +   YW     VAIK I     +  +  +DF  E  +++
Sbjct: 4   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMM 57
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGMA 269
           KL HP +VQ  G   E+ P+ L+ E++  G L  YL+ ++G  +  T +   LD+  GMA
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           YL  E   +IHRDL  RN L+  +    +KV DFG+++ +
Sbjct: 118 YL--EEASVIHRDLAARNCLVGENQV--IKVSDFGMTRFV 153

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/161 (38%), Positives = 89/161 (55%), Gaps = 14/161 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           W ++  EL    +  IGKG FG+++   +RG  VA+K I      +    Q F  E +++
Sbjct: 16  WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 68
Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
            +LRH N+VQ LG + E K  L ++TEY+  G L  YL+ +G   L     + F+LD+  
Sbjct: 69  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            M YL  E N  +HRDL  RNVL+  S  +  KV DFGL+K
Sbjct: 129 AMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 165

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/161 (38%), Positives = 89/161 (55%), Gaps = 14/161 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           W ++  EL    +  IGKG FG+++   +RG  VA+K I      +    Q F  E +++
Sbjct: 188 WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 240
Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
            +LRH N+VQ LG + E K  L ++TEY+  G L  YL+ +G   L     + F+LD+  
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            M YL  E N  +HRDL  RNVL+  S  +  KV DFGL+K
Sbjct: 301 AMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 337

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/161 (38%), Positives = 89/161 (55%), Gaps = 14/161 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           W ++  EL    +  IGKG FG+++   +RG  VA+K I      +    Q F  E +++
Sbjct: 1   WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 53
Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
            +LRH N+VQ LG + E K  L ++TEY+  G L  YL+ +G   L     + F+LD+  
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            M YL  E N  +HRDL  RNVL+  S  +  KV DFGL+K
Sbjct: 114 AMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 150

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/161 (38%), Positives = 89/161 (55%), Gaps = 14/161 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           W ++  EL    +  IGKG FG+++   +RG  VA+K I      +    Q F  E +++
Sbjct: 7   WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 59
Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
            +LRH N+VQ LG + E K  L ++TEY+  G L  YL+ +G   L     + F+LD+  
Sbjct: 60  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 119
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            M YL  E N  +HRDL  RNVL+  S  +  KV DFGL+K
Sbjct: 120 AMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 156

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/183 (36%), Positives = 100/183 (54%), Gaps = 21/183 (11%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           ID  E++     ++G+G+FG + KA WR   VAIK+I  S S+ +  I + R     L +
Sbjct: 6   IDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-ESESERKAFIVELRQ----LSR 58
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST---AVNFALDIARGM 268
           + HPNIV+  GA     P+ L+ EY  GG L+  L     L   T   A+++ L  ++G+
Sbjct: 59  VNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 269 AYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC 327
           AYLH+ +P  +IHRDLKP N+LLV +    LK+ DFG +  I+         MT   GS 
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLV-AGGTVLKICDFGTACDIQTH-------MTNNKGSA 168
Query: 328 EYL 330
            ++
Sbjct: 169 AWM 171

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/183 (36%), Positives = 100/183 (54%), Gaps = 21/183 (11%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           ID  E++     ++G+G+FG + KA WR   VAIK+I  S S+ +  I + R     L +
Sbjct: 5   IDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-ESESERKAFIVELRQ----LSR 57
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST---AVNFALDIARGM 268
           + HPNIV+  GA     P+ L+ EY  GG L+  L     L   T   A+++ L  ++G+
Sbjct: 58  VNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 269 AYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC 327
           AYLH+ +P  +IHRDLKP N+LLV +    LK+ DFG +  I+         MT   GS 
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLV-AGGTVLKICDFGTACDIQTH-------MTNNKGSA 167
Query: 328 EYL 330
            ++
Sbjct: 168 AWM 170

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G FGE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 6   WEMERT--DITMKHKLGGGQFGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 61
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  +S    +  A  I+  
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 122 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 159

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 8   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  +S    +  A  I+  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 161

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 8   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  +S    +  A  I+  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 161

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 6   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 61
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  +S    +  A  I+  
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 122 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 159

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 13  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 68
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  +S    +  A  I+  
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 128
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 166

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/167 (38%), Positives = 94/167 (56%), Gaps = 15/167 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRH 204
           EI PS +  +   +IG G FGE+ K   + +      PVAIK +    ++ + V  DF  
Sbjct: 40  EIHPSCV--TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLG 95
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALD 263
           E  ++ +  H NI++  G +++ KP+M+ITEY+  G L K+L+EK G  S    V     
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           IA GM YL N   V  HRDL  RN+ LVNS+    KV DFGLS++++
Sbjct: 156 IAAGMKYLANMNYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRVLE 198

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVN 207
           WEIDP +L F     +G G FG +    WRG   VAIK I   S+S+D     +F  E  
Sbjct: 3   WEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAK 55
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
           +++ L H  +VQ  G  T+++P+ +ITEY+  G L  YL+E +        +    D+  
Sbjct: 56  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 115
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            M YL  E    +HRDL  RN L+ +     +KV DFGLS+ +
Sbjct: 116 AMEYL--ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYV 154

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVN 207
           WEIDP +L F     +G G FG +    WRG   VAIK I   S+S+D     +F  E  
Sbjct: 4   WEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAK 56
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
           +++ L H  +VQ  G  T+++P+ +ITEY+  G L  YL+E +        +    D+  
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 116
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            M YL  E    +HRDL  RN L+ +     +KV DFGLS+ +
Sbjct: 117 AMEYL--ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYV 155

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVN 207
           WEIDP +L F     +G G FG +    WRG   VAIK I   S+S+D     +F  E  
Sbjct: 10  WEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAK 62
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
           +++ L H  +VQ  G  T+++P+ +ITEY+  G L  YL+E +        +    D+  
Sbjct: 63  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 122
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            M YL  E    +HRDL  RN L+ +     +KV DFGLS+ +
Sbjct: 123 AMEYL--ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYV 161

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVN 207
           WEIDP +L F     +G G FG +    WRG   VAIK I   S+S+D     +F  E  
Sbjct: 4   WEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAK 56
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
           +++ L H  +VQ  G  T+++P+ +ITEY+  G L  YL+E +        +    D+  
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 116
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            M YL  E    +HRDL  RN L+ +     +KV DFGLS+ +
Sbjct: 117 AMEYL--ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYV 155

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVN 207
           WEIDP +L F     +G G FG +    WRG   VAIK I   S+S+D     +F  E  
Sbjct: 19  WEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAK 71
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
           +++ L H  +VQ  G  T+++P+ +ITEY+  G L  YL+E +        +    D+  
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            M YL  E    +HRDL  RN L+ +     +KV DFGLS+ +
Sbjct: 132 AMEYL--ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYV 170

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVN 207
           WEIDP +L F     +G G FG +    WRG   VAIK I   S+S+D     +F  E  
Sbjct: 19  WEIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAK 71
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIAR 266
           +++ L H  +VQ  G  T+++P+ +ITEY+  G L  YL+E +        +    D+  
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            M YL  E    +HRDL  RN L+ +     +KV DFGLS+ +
Sbjct: 132 AMEYL--ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYV 170

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 21  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 76
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 77  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 136
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 137 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 174

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 10  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 65
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 126 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 163

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 10  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 65
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 126 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 163

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 8   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 123
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 161

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 13  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 68
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 166

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 10  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 65
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 66  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 126 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 163

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 13  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 68
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 166

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 13  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 68
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 166

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 9   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 64
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 125 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 162

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 92/167 (55%), Gaps = 12/167 (7%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE 205
           N   WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E
Sbjct: 211 NYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKE 266
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALD 263
             ++ +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  +S    +  A  
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           I+  M YL  E    IHR+L  RN L+     +HL KV DFGLS+L+
Sbjct: 327 ISSAMEYL--EKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLM 368

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 12  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 67
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 127
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 128 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 165

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 91/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 8   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 123
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 161

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 90/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 8   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +I E++  G+L  YL+E  +  +S    +  A  I+  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 161

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 90/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 8   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 63
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +I E++  G+L  YL+E  +  +S    +  A  I+  
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 124 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 161

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 90/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 6   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 61
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +I E++  G+L  YL+E  +  +S    +  A  I+  
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 122 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 159

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 87/161 (54%), Gaps = 13/161 (8%)
Query: 165 IGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G+FGE+     R   T VA+K    +L  D  +   F  E  +L +  HPNIV+ +G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIG 179
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
             T+++P+ ++ E ++GGD   +L+ +GA L   T +    D A GM YL  E    IHR
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL--ESKCCIHR 237
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           DL  RN L+   +   LK+ DFG+S+    + +  VY  +G
Sbjct: 238 DLAARNCLVTEKNV--LKISDFGMSR----EEADGVYAASG 272

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 91/167 (54%), Gaps = 14/167 (8%)
Query: 150 WEIDPSELDFSSSAII---GKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHE 205
           W+ D  E+   S  ++   G G FGE+   Y+   T VA+K + P      + +Q F  E
Sbjct: 3   WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEE 58
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALD 263
            NL+  L+H  +V+    VT  +P+ +ITEY+  G L  +LK  E G +     ++F+  
Sbjct: 59  ANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 118
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           IA GMAY+  E    IHRDL+  NVL+  S +   K+ DFGL+++I+
Sbjct: 119 IAEGMAYI--ERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIE 161

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 92/167 (55%), Gaps = 12/167 (7%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE 205
           N   WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E
Sbjct: 250 NYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKE 305
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALD 263
             ++ +++HPN+VQ LG  T   P  +ITE++  G+L  YL+E  +  ++    +  A  
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 365
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           I+  M YL  E    IHR+L  RN L+     +HL KV DFGLS+L+
Sbjct: 366 ISSAMEYL--EKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLM 407

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 90/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 9   WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 64
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +I E++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 65  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 125 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 162

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 90/163 (55%), Gaps = 12/163 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+ +  W+   + +   + +L +D + +++F  E  ++
Sbjct: 13  WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 68
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  +I E++  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 69  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 128
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+     +HL KV DFGLS+L+
Sbjct: 129 MEYL--EKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLM 166

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 54/146 (36%), Positives = 81/146 (55%), Gaps = 9/146 (6%)
Query: 165 IGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G+FGE+     R   T VA+K    +L  D  +   F  E  +L +  HPNIV+ +G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIG 179
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
             T+++P+ ++ E ++GGD   +L+ +GA L   T +    D A GM YL  E    IHR
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL--ESKCCIHR 237
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DL  RN L+   +   LK+ DFG+S+
Sbjct: 238 DLAARNCLVTEKNV--LKISDFGMSR 261

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/160 (38%), Positives = 91/160 (56%), Gaps = 10/160 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WEI+ SE+  S+   IG GSFG + K  W G  VA+K IL  +       Q FR+EV +L
Sbjct: 31  WEIEASEVMLSTR--IGSGSFGTVYKGKWHGD-VAVK-ILKVVDPTPEQFQAFRNEVAVL 86
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARGM 268
            K RH NI+ F+G +T +  L ++T++  G  L+K+L  ++        ++ A   A+GM
Sbjct: 87  RKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 145
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
            YLH +   IIHRD+K  N+ L       +K+GDFGL+ +
Sbjct: 146 DYLHAKN--IIHRDMKSNNIFL--HEGLTVKIGDFGLATV 181

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 89/162 (54%), Gaps = 10/162 (6%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           WE++ +  D +    +G G +GE+    W+   + +   + +L +D + +++F  E  ++
Sbjct: 27  WEMERT--DITMKHKLGGGQYGEVYVGVWKKYSLTVA--VKTLKEDTMEVEEFLKEAAVM 82
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
            +++HPN+VQ LG  T   P  ++TEY+  G+L  YL+E  +  ++    +  A  I+  
Sbjct: 83  KEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSA 142
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           M YL  E    IHRDL  RN L+  +    +KV DFGLS+L+
Sbjct: 143 MEYL--EKKNFIHRDLAARNCLVGENHV--VKVADFGLSRLM 180

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 13/164 (7%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    +       +G G FGE+   Y+   T VA+K + P      + +Q F  E NL
Sbjct: 7   WEIPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLKPG----TMSVQAFLEEANL 60
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
           +  L+H  +V+    VT+ +P+ +ITE++  G L  +LK  E G +     ++F+  IA 
Sbjct: 61  MKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 120
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    IHRDL+  NVL+  S +   K+ DFGL+++I+
Sbjct: 121 GMAYI--ERKNYIHRDLRAANVLV--SESLMCKIADFGLARVIE 160

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/148 (35%), Positives = 81/148 (54%), Gaps = 12/148 (8%)
Query: 165 IGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G FG +    W+G   VA+K I   S+S+D     +F  E   ++KL HP +V+F G
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-----EFFQEAQTMMKLSHPKLVKFYG 70
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
             ++  P+ ++TEY+  G L  YL+  G  L PS  +    D+  GMA+L  E +  IHR
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQFIHR 128
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           DL  RN L+       +KV DFG+++ +
Sbjct: 129 DLAARNCLVDRDLC--VKVSDFGMTRYV 154

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/154 (38%), Positives = 88/154 (57%), Gaps = 8/154 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           D     ++GKG FG+ +K   R T  V + + L  +  D    + F  EV ++  L HPN
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP-STAVNFALDIARGMAYLHNEP 275
           +++F+G + + K L  ITEY++GG L   +K   +  P S  V+FA DIA GMAYLH+  
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS-- 126
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
             IIHRDL   N L+  +   ++ V DFGL++L+
Sbjct: 127 MNIIHRDLNSHNCLVRENK--NVVVADFGLARLM 158

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILP-SLSDDRLVIQDFRHEVNLL 209
           IDP +L F     +G G FG +    WRG   VAIK I   S+S+D     +F  E  ++
Sbjct: 1   IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-----EFIEEAKVM 53
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
           + L H  +VQ  G  T+++P+ +ITEY+  G L  YL+E +        +    D+   M
Sbjct: 54  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E    +HRDL  RN L+ +     +KV DFGLS+ +
Sbjct: 114 EYL--ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYV 150

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 149 DWEIDPSELD-----FSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQD 201
           D+ ID S  D     F   + +G+G+   + +   +GT  P A+K +L    D ++V   
Sbjct: 40  DYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK-VLKKTVDKKIV--- 95
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
            R E+ +L++L HPNI++          + L+ E + GG+L   + EKG  S   A +  
Sbjct: 96  -RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKM 320
             I   +AYLH   N I+HRDLKP N+L    + D  LK+ DFGLSK+++    H V   
Sbjct: 155 KQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE----HQVLMK 208
Query: 321 T--GETGSC-EYLVSNCSF 336
           T  G  G C   ++  C++
Sbjct: 209 TVCGTPGYCAPEILRGCAY 227

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/176 (34%), Positives = 95/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 6   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 61
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   ARG
Sbjct: 62  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 120
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L   +   +K+GDFGL+ +  +   SH   +++G
Sbjct: 121 MDYLHAKS--IIHRDLKSNNIFLHEDNT--VKIGDFGLATVKSRWSGSHQFEQLSG 172

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 18  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 73
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T +  L ++T++  G  L+ +L   +        ++ A   ARG
Sbjct: 74  LRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL-SKLIKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L   +   +K+GDFGL ++  +   SH   +++G
Sbjct: 133 MDYLHAKS--IIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSG 184

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 18  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 73
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T  + L ++T++  G  L+ +L   +        ++ A   ARG
Sbjct: 74  LRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL-SKLIKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L   +   +K+GDFGL ++  +   SH   +++G
Sbjct: 133 MDYLHAKS--IIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSG 184

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/179 (33%), Positives = 91/179 (50%), Gaps = 20/179 (11%)
Query: 165 IGKGSFGEILKAYWRG--TPVAIKRILPS------LSDDRLVIQDFR----HEVNLLVKL 212
           +G G++GE+L    +   +  AIK I  S       SDD   I+ F     +E++LL  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
            HPNI++      ++K   L+TE+  GG+L + +  +       A N    I  G+ YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 273 NEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
                I+HRD+KP N+LL N +S  ++K+ DFGLS       S D YK+    G+  Y+
Sbjct: 164 KHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF----SKD-YKLRDRLGTAYYI 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G G FGE+    W G T VAIK + P      +  + F  E  +
Sbjct: 4   WEIPRESLQLIKR--LGNGQFGEVWMGTWNGNTKVAIKTLKPG----TMSPESFLEEAQI 57
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIAR 266
           + KL+H  +VQ    V+E +P+ ++TEY+  G L  +LK  E  AL     V+ A  +A 
Sbjct: 58  MKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 116
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    IHRDL+  N+L+ N      K+ DFGL++LI+
Sbjct: 117 GMAYI--ERMNYIHRDLRSANILVGNGLI--CKIADFGLARLIE 156

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/153 (35%), Positives = 84/153 (54%), Gaps = 12/153 (7%)
Query: 164 IIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +IG G FGE+          R  PVAIK +    ++ +   +DF  E +++ +  HPNI+
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNII 86
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNV 277
              G VT+ KP+M++TEY+  G L  +LK+  G  +    V     I+ GM YL +   V
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             HRDL  RN+L+  +S    KV DFGLS++++
Sbjct: 147 --HRDLAARNILI--NSNLVCKVSDFGLSRVLE 175

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 87/164 (53%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P      +  + F  E  +
Sbjct: 179 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQV 232
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 292 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 331

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 87/164 (53%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P      +  + F  E  +
Sbjct: 262 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQV 315
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 375 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 414

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 87/164 (53%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P      +  + F  E  +
Sbjct: 179 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQV 232
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 292 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 331

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/166 (36%), Positives = 87/166 (52%), Gaps = 14/166 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHE 205
           EID S +      +IG G FGE+          R   VAIK +    +D +   +DF  E
Sbjct: 10  EIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSE 65
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDI 264
            +++ +  HPNI+   G VT+ KP+M+ITEY+  G L  +L K  G  +    V     I
Sbjct: 66  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI 125
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             GM YL +   V  HRDL  RN+ LVNS+    KV DFG+S++++
Sbjct: 126 GSGMKYLSDMSYV--HRDLAARNI-LVNSNL-VCKVSDFGMSRVLE 167

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/166 (36%), Positives = 87/166 (52%), Gaps = 14/166 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHE 205
           EID S +      +IG G FGE+          R   VAIK +    +D +   +DF  E
Sbjct: 4   EIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSE 59
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDI 264
            +++ +  HPNI+   G VT+ KP+M+ITEY+  G L  +L K  G  +    V     I
Sbjct: 60  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI 119
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             GM YL +   V  HRDL  RN+ LVNS+    KV DFG+S++++
Sbjct: 120 GSGMKYLSDMSYV--HRDLAARNI-LVNSNL-VCKVSDFGMSRVLE 161

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P      +  + F  E  +
Sbjct: 180 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPG----NMSPEAFLQEAQV 233
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 234 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 292
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL +LI+
Sbjct: 293 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLGRLIE 332

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/166 (36%), Positives = 87/166 (52%), Gaps = 14/166 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHE 205
           EID S +      +IG G FGE+          R   VAIK +    +D +   +DF  E
Sbjct: 25  EIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSE 80
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDI 264
            +++ +  HPNI+   G VT+ KP+M+ITEY+  G L  +L K  G  +    V     I
Sbjct: 81  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGI 140
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             GM YL +   V  HRDL  RN+ LVNS+    KV DFG+S++++
Sbjct: 141 GSGMKYLSDMSAV--HRDLAARNI-LVNSNL-VCKVSDFGMSRVLE 182

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 3   WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 56
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 57  MKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 115
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 116 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 155

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 13  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 66
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 126 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 165

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 6   WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 59
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 60  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 118
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 119 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 158

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 4   WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 57
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 58  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 116
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 117 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 156

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 2   WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 55
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 56  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 114
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 115 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 154

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 89/172 (51%), Gaps = 15/172 (8%)
Query: 156 ELDFSSSAI---IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           E+D S   I   IG G FGE+   +      R   VAIK +    ++ +   +DF  E +
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEAS 86
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIAR 266
           ++ +  HPN++   G VT+  P+M+ITE++  G L  +L++  G  +    V     IA 
Sbjct: 87  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 146
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
           GM YL +   V  HRDL  RN+ LVNS+    KV DFGLS+ ++   S   Y
Sbjct: 147 GMKYLADMNYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRFLEDDTSDPTY 194

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 96/180 (53%), Gaps = 30/180 (16%)
Query: 165 IGKGSFGEILKA-YWRGTP------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+G+FG++  A  +   P      VA+K +  +  + R   +DF  E  LL  L+H +I
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQHEHI 77
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------------LSPSTAVNFALDI 264
           V+F G   E  PL+++ EY++ GDL+K+L+  G              L+ S  ++ A  I
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           A GM YL ++    +HRDL  RN L+  +    +K+GDFG+S+ +    S D Y++ G T
Sbjct: 138 AAGMVYLASQH--FVHRDLATRNCLVGENLL--VKIGDFGMSRDVY---STDYYRVGGHT 190

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 13  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 66
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 126 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 165

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 10  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 63
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ +  IA 
Sbjct: 64  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIAS 122
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 123 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 162

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 13  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 66
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + K+RH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 67  MKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 126 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 165

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 17  EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 70
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 71  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 130 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 170

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 10  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 63
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ +  IA 
Sbjct: 64  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIAS 122
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 123 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 162

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/164 (37%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 13  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 66
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL   N+L+  +     KV DFGL++LI+
Sbjct: 126 GMAYV--ERMNYVHRDLAAANILVGENLV--CKVADFGLARLIE 165

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 13  EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 66
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 67  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 126 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 166

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 15  EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 68
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 69  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 128 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 168

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 2   EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 55
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 56  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 114
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 115 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 155

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 13  EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 66
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 67  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 126 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 166

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 12  EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 65
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 66  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 124
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 125 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 165

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 7   EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 61  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 120 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 160

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 7   EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 61  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 120 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 160

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 8   EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 61
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 62  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 120
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 121 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 161

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 90/182 (49%), Gaps = 32/182 (17%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+G+FG++  A             VA+K +  +    R   QDF+ E  LL  L+H +I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHI 105
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE---------------KGALSPSTAVNFAL 262
           V+F G  TE +PL+++ EY+R GDL+++L+                 G L     +  A 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            +A GM YL       +HRDL  RN L+       +K+GDFG+S+ I    S D Y++ G
Sbjct: 166 QVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV--VKIGDFGMSRDI---YSTDYYRVGG 218
Query: 323 ET 324
            T
Sbjct: 219 RT 220

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P      +  + F  E  +
Sbjct: 179 WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGT----MSPEAFLQEAQV 232
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++ EY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 233 MKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 292 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 331

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 16  EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 69
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 70  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 129 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 169

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 7   EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 61  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 120 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 160

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 90/165 (54%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 9   EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 62
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 63  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 122 EGMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 162

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 90/182 (49%), Gaps = 32/182 (17%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+G+FG++  A             VA+K +  +    R   QDF+ E  LL  L+H +I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHI 76
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE---------------KGALSPSTAVNFAL 262
           V+F G  TE +PL+++ EY+R GDL+++L+                 G L     +  A 
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            +A GM YL       +HRDL  RN L+       +K+GDFG+S+ I    S D Y++ G
Sbjct: 137 QVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV--VKIGDFGMSRDI---YSTDYYRVGG 189
Query: 323 ET 324
            T
Sbjct: 190 RT 191

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 90/182 (49%), Gaps = 32/182 (17%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+G+FG++  A             VA+K +  +    R   QDF+ E  LL  L+H +I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHI 82
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE---------------KGALSPSTAVNFAL 262
           V+F G  TE +PL+++ EY+R GDL+++L+                 G L     +  A 
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            +A GM YL       +HRDL  RN L+       +K+GDFG+S+ I    S D Y++ G
Sbjct: 143 QVAAGMVYLAGLH--FVHRDLATRNCLVGQGLV--VKIGDFGMSRDI---YSTDYYRVGG 195
Query: 323 ET 324
            T
Sbjct: 196 RT 197

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/176 (36%), Positives = 90/176 (51%), Gaps = 16/176 (9%)
Query: 156 ELDFSSSAI---IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD S   I   IG G FGE+          R   VAIK +    ++ +   +DF  E +
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR--RDFLCEAS 96
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 266
           ++ +  HPN+V   G VT  KP+M++ E++  G L  +L K  G  +    V     IA 
Sbjct: 97  IMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAA 156
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           GM YL +   V  HRDL  RN+ LVNS+    KV DFGLS++I+  +   VY  TG
Sbjct: 157 GMRYLADMGYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRVIE-DDPEAVYTTTG 207

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 86/164 (52%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P      +  + F  E  +
Sbjct: 13  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQV 66
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++ EY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 126 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 165

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 97/180 (53%), Gaps = 27/180 (15%)
Query: 165 IGKGSFGEILKA-YWRGTPVAIKRILP--SLSDDRLVI-QDFRHEVNLLVKLRHPNIVQF 220
           +G+G+FG++  A  +  +P   K ++   +L D  L   +DF+ E  LL  L+H +IV+F
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDI 264
            G   +  PL+++ EY++ GDL+K+L+                 KG L  S  ++ A  I
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           A GM YL ++    +HRDL  RN L+   +   +K+GDFG+S+ +    S D Y++ G T
Sbjct: 143 ASGMVYLASQH--FVHRDLATRNCLV--GANLLVKIGDFGMSRDV---YSTDYYRVGGHT 195

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 13  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 66
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++ EY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 126 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 165

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 13  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 66
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++ EY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 126 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 165

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 69
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 130 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 169

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 86
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 87  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 146
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 147 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 186

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 30  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 85
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 86  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 144
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL+ +  +   SH   +++G
Sbjct: 145 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSG 196

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 7   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 62
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 63  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 121
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL+ +  +   SH   +++G
Sbjct: 122 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSG 173

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 29  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 84
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 85  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 143
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL+ +  +   SH   +++G
Sbjct: 144 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSG 195

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/164 (36%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-VAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G+G FGE+    W GT  VAIK + P         + F  E  +
Sbjct: 13  WEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQV 66
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGA-LSPSTAVNFALDIAR 266
           + KLRH  +VQ    V+E +P+ ++ EY+  G L  +LK E G  L     V+ A  IA 
Sbjct: 67  MKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAY+  E    +HRDL+  N+L+  +     KV DFGL++LI+
Sbjct: 126 GMAYV--ERMNYVHRDLRAANILVGENLV--CKVADFGLARLIE 165

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 7   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 62
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 63  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 121
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL+ +  +   SH   +++G
Sbjct: 122 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSG 173

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 85/171 (49%), Gaps = 27/171 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL- 212
           D     +IG+G+FG++LKA  +        AIKR+    S D    +DF  E+ +L KL 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 83
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPST 256
            HPNI+  LGA   R  L L  EY   G+L  +L++                   LS   
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            ++FA D+ARGM YL  +    IHRDL  RN+L+  +     K+ DFGLS+
Sbjct: 144 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV--AKIADFGLSR 190

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +     +HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 159 GMKYLSDMG--FVHRDLAARNI-LINSNL-VCKVSDFGLSRVLE 198

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 4   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 59
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 60  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 118
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL+ +  +   SH   +++G
Sbjct: 119 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSG 170

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 88/165 (53%), Gaps = 14/165 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 3   EWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 56
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 57  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 115
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHR+L+  N+L+  S     K+ DFGL++LI+
Sbjct: 116 EGMAFI--EERNYIHRNLRAANILV--SDTLSCKIADFGLARLIE 156

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 85/171 (49%), Gaps = 27/171 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL- 212
           D     +IG+G+FG++LKA  +        AIKR+    S D    +DF  E+ +L KL 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 73
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPST 256
            HPNI+  LGA   R  L L  EY   G+L  +L++                   LS   
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            ++FA D+ARGM YL  +    IHRDL  RN+L+  +     K+ DFGLS+
Sbjct: 134 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV--AKIADFGLSR 180

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 2   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 57
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 58  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL+ +  +   SH   +++G
Sbjct: 117 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSG 168

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 159 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 198

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 159 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 198

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 10/175 (5%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +    ++GKGSFGE++  K    G   A+K I       +   +    EV LL +L HPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           I++      ++    L+ E   GG+L   +  +   S   A      +  G+ Y+H   N
Sbjct: 112 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK--N 169
Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            I+HRDLKP N+LL + S D ++++ DFGLS   +        KM  + G+  Y+
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYI 219

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 94/164 (57%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G G FGE+  A Y + T VA+K + P      + ++ F  E N+
Sbjct: 183 WEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANV 236
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSP-STAVNFALDIAR 266
           +  L+H  +V+ L AV  ++P+ +ITE++  G L  +LK ++G+  P    ++F+  IA 
Sbjct: 237 MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMA++  E    IHRDL+  N+L+  S++   K+ DFGL+++I+
Sbjct: 296 GMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVIE 335

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 10/175 (5%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +    ++GKGSFGE++  K    G   A+K I       +   +    EV LL +L HPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           I++      ++    L+ E   GG+L   +  +   S   A      +  G+ Y+H   N
Sbjct: 111 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK--N 168
Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            I+HRDLKP N+LL + S D ++++ DFGLS   +        KM  + G+  Y+
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYI 218

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 96
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 97  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 156
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 157 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 196

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 159 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 198

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 159 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 198

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/172 (34%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 156 ELDFSSSAI---IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           E+D S   I   IG G FGE+   +      R   VAIK +    ++ +   +DF  E +
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEAS 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIAR 266
           ++ +  HPN++   G VT+  P+M+ITE++  G L  +L++  G  +    V     IA 
Sbjct: 61  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 120
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
           GM YL +   V  HR L  RN+ LVNS+    KV DFGLS+ ++   S   Y
Sbjct: 121 GMKYLADMNYV--HRALAARNI-LVNSNL-VCKVSDFGLSRFLEDDTSDPTY 168

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 30  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 85
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 86  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 144
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL-SKLIKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL ++  +   SH   +++G
Sbjct: 145 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSG 196

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 10/175 (5%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +    ++GKGSFGE++  K    G   A+K I       +   +    EV LL +L HPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           I++      ++    L+ E   GG+L   +  +   S   A      +  G+ Y+H   N
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK--N 145
Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            I+HRDLKP N+LL + S D ++++ DFGLS   +        KM  + G+  Y+
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYI 195

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 87/171 (50%), Gaps = 11/171 (6%)
Query: 163 AIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
            ++GKGSFGE+LK   R T    A+K I  + + ++      R EV LL KL HPNI++ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKL 86
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
              + +     ++ E   GG+L   + ++   S   A      +  G+ Y+H     I+H
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVH 144
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           RDLKP N+LL +   D  +K+ DFGLS   + QN+    KM    G+  Y+
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNT----KMKDRIGTAYYI 190

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 93/176 (52%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 2   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 57
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T  + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 58  LRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL-IKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL+ +  +   SH   +++G
Sbjct: 117 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSG 168

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 22  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 77
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 78  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 136
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL-SKLIKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL ++  +   SH   +++G
Sbjct: 137 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSG 188

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 11/176 (6%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +L   +     +Q F++EV +
Sbjct: 2   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVK-MLNVTAPTPQQLQAFKNEVGV 57
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T+ + L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 58  LRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL-SKLIKVQNSHDVYKMTG 322
           M YLH +   IIHRDLK  N+ L       +K+GDFGL ++  +   SH   +++G
Sbjct: 117 MDYLHAKS--IIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSG 168

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 38/199 (19%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSD--DRLVIQD 201
           EI  S + F     +G+  FG++ K +  G         VAIK    +L D  +  + ++
Sbjct: 22  EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIK----TLKDKAEGPLREE 75
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--------------- 246
           FRHE  L  +L+HPN+V  LG VT+ +PL +I  Y   GDLH++L               
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 247 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
              K AL P   V+    IA GM YL +  + ++H+DL  RNVL+ +    ++K+ D GL
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKL--NVKISDLGL 191
Query: 306 SKLIKVQNSHDVYKMTGET 324
            + +    + D YK+ G +
Sbjct: 192 FREV---YAADYYKLLGNS 207

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 90/174 (51%), Gaps = 14/174 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHE 205
           EID S +      +IG G FGE+ +   +      + VAIK +    ++ +   ++F  E
Sbjct: 10  EIDVSYVKIEE--VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSE 65
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDI 264
            +++ +  HPNI++  G VT   P+M++TE++  G L  +L+   G  +    V     I
Sbjct: 66  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGI 125
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
           A GM YL     V  HRDL  RN+ LVNS+    KV DFGLS+ ++  +S   Y
Sbjct: 126 ASGMRYLAEMSYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRFLEENSSDPTY 175

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 94/164 (57%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G G FGE+  A Y + T VA+K + P      + ++ F  E N+
Sbjct: 10  WEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANV 63
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSP-STAVNFALDIAR 266
           +  L+H  +V+ L AV  ++P+ +ITE++  G L  +LK ++G+  P    ++F+  IA 
Sbjct: 64  MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 122
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMA++  E    IHRDL+  N+L+  S++   K+ DFGL+++I+
Sbjct: 123 GMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVIE 162

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 38/199 (19%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSD--DRLVIQD 201
           EI  S + F     +G+  FG++ K +  G         VAIK    +L D  +  + ++
Sbjct: 5   EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIK----TLKDKAEGPLREE 58
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--------------- 246
           FRHE  L  +L+HPN+V  LG VT+ +PL +I  Y   GDLH++L               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 247 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
              K AL P   V+    IA GM YL +  + ++H+DL  RNVL+ +    ++K+ D GL
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKL--NVKISDLGL 174
Query: 306 SKLIKVQNSHDVYKMTGET 324
            + +    + D YK+ G +
Sbjct: 175 FREV---YAADYYKLLGNS 190

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 88/171 (51%), Gaps = 11/171 (6%)
Query: 163 AIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
            ++GKGSFGE+LK   R T    A+K I  + + ++      R EV LL KL HPNI++ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKL 86
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
              + +     ++ E   GG+L   + ++   S   A      +  G+ Y+H   + I+H
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVH 144
Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           RDLKP N+LL +   D  +K+ DFGLS   + QN+    KM    G+  Y+
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNT----KMKDRIGTAYYI 190

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 90/175 (51%), Gaps = 11/175 (6%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           ++   ++GKGSFGE+LK   R T    A+K I  + + ++      R EV LL KL HPN
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPN 82
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           I++    + +     ++ E   GG+L   + ++   S   A      +  G+ Y+H   +
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--H 140
Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            I+HRDLKP N+LL +   D  +K+ DFGLS   + QN+    KM    G+  Y+
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNT----KMKDRIGTAYYI 190

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 89/164 (54%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGL+++++
Sbjct: 159 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLARVLE 198

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 10/175 (5%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +    ++GKGSFGE++  K    G   A+K I       +   +    EV LL +L HPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           I++      ++    L+ E   GG+L   +  +   S   A      +  G+ Y+H   N
Sbjct: 94  IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK--N 151
Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            I+HRDLKP N+LL + S D ++++ DFGLS   +        KM  + G+  Y+
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYI 201

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/172 (34%), Positives = 91/172 (52%), Gaps = 15/172 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHE 205
           EID S +      +IG G FGE+ +   +      + VAIK +    ++ +   ++F  E
Sbjct: 12  EIDVSYVKIEE--VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSE 67
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDI 264
            +++ +  HPNI++  G VT   P+M++TE++  G L  +L+   G  +    V     I
Sbjct: 68  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGI 127
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
           A GM YL     V  HRDL  RN+ LVNS+    KV DFGLS+ ++ +NS D
Sbjct: 128 ASGMRYLAEMSYV--HRDLAARNI-LVNSNL-VCKVSDFGLSRFLE-ENSSD 174

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 90/181 (49%), Gaps = 18/181 (9%)
Query: 151 EIDPSELD---FSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQD 201
           E+DP+  +         +G+G FG++    +       G  VA+K + P    +   I D
Sbjct: 12  EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IAD 69
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYL-KEKGALSPSTAV 258
            + E+ +L  L H NIV++ G  TE     + LI E+L  G L +YL K K  ++    +
Sbjct: 70  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
            +A+ I +GM YL +   V  HRDL  RNVL+   S   +K+GDFGL+K I+        
Sbjct: 130 KYAVQICKGMDYLGSRQYV--HRDLAARNVLV--ESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 319 K 319
           K
Sbjct: 186 K 186

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 82/161 (50%), Gaps = 11/161 (6%)
Query: 165 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G GSFG + +  W     +   VA+K + P +      + DF  EVN +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
             G V    P+ ++TE    G L   L K +G     T   +A+ +A GM YL  E    
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL--ESKRF 142
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           IHRDL  RN+LL  ++ D +K+GDFGL + +   + H V +
Sbjct: 143 IHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQ 181

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/171 (35%), Positives = 87/171 (50%), Gaps = 27/171 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL- 212
           D     +IG+G+FG++LKA  +        AIKR+    S D    +DF  E+ +L KL 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 80
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV------------ 258
            HPNI+  LGA   R  L L  EY   G+L  +L++   L   P+ A+            
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 259 --NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             +FA D+ARGM YL  +    IHR+L  RN+L+  +     K+ DFGLS+
Sbjct: 141 LLHFAADVARGMDYLSQKQ--FIHRNLAARNILVGENYV--AKIADFGLSR 187

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 88/164 (53%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGL ++++
Sbjct: 159 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLGRVLE 198

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 81
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 82  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 141
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 142 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 186

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 74
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 135 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 179

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 79
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 80  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 139
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 140 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 184

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 77
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 138 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 105
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 164
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 165 -RYIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 210

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           E D      +G GSFG + +  W     +   VA+K + P +      + DF  EVN + 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMA 269
            L H N+++  G V    P+ ++TE    G L   L K +G     T   +A+ +A GM 
Sbjct: 67  SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           YL  E    IHRDL  RN+LL  ++ D +K+GDFGL + +   + H V +
Sbjct: 126 YL--ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQ 171

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 73
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 133
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 134 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 178

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 72
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 73  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 132
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 133 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 177

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 80
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 81  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 140
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 141 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 185

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 92
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 153 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 197

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 82/161 (50%), Gaps = 11/161 (6%)
Query: 165 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G GSFG + +  W     +   VA+K + P +      + DF  EVN +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
             G V    P+ ++TE    G L   L K +G     T   +A+ +A GM YL  E    
Sbjct: 80  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL--ESKRF 136
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           IHRDL  RN+LL  ++ D +K+GDFGL + +   + H V +
Sbjct: 137 IHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQ 175

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 74
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 135 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 179

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 92/162 (56%), Gaps = 14/162 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WEI    L       +G G FGE+  A Y + T VA+K + P      + ++ F  E N+
Sbjct: 177 WEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANV 230
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSP-STAVNFALDIAR 266
           +  L+H  +V+ L AV  ++P+ +ITE++  G L  +LK ++G+  P    ++F+  IA 
Sbjct: 231 MKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 289
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           GMA++  E    IHRDL+  N+L+  S++   K+ DFGL+++
Sbjct: 290 GMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARV 327

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 92
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 152
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 153 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 197

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 78
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 137
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 138 -RYIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 183

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 82/161 (50%), Gaps = 11/161 (6%)
Query: 165 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G GSFG + +  W     +   VA+K + P +      + DF  EVN +  L H N+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
             G V    P+ ++TE    G L   L K +G     T   +A+ +A GM YL  E    
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL--ESKRF 142
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           IHRDL  RN+LL  ++ D +K+GDFGL + +   + H V +
Sbjct: 143 IHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQ 181

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 88/164 (53%), Gaps = 14/164 (8%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           WE+    L       +G G  GE+   Y+ G T VA+K    SL    +    F  E NL
Sbjct: 8   WEVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEANL 61
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIAR 266
           + +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA 
Sbjct: 62  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMA++  E    IHRDL+  N+L+ ++ +   K+ DFGL++LI+
Sbjct: 121 GMAFI--EERNYIHRDLRAANILVSDTLS--CKIADFGLARLIE 160

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 82/161 (50%), Gaps = 11/161 (6%)
Query: 165 IGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G GSFG + +  W     +   VA+K + P +      + DF  EVN +  L H N+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
             G V    P+ ++TE    G L   L K +G     T   +A+ +A GM YL  E    
Sbjct: 80  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL--ESKRF 136
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           IHRDL  RN+LL  ++ D +K+GDFGL + +   + H V +
Sbjct: 137 IHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQ 175

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 77
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI E+L  G L +YL K K  +     + +   I +GM YL  + 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 138 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           E D      +G GSFG + +  W     +   VA+K + P +      + DF  EVN + 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMA 269
            L H N+++  G V    P+ ++TE    G L   L K +G     T   +A+ +A GM 
Sbjct: 67  SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           YL  E    IHRDL  RN+LL  ++ D +K+GDFGL + +   + H V +
Sbjct: 126 YL--ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQ 171

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           E D      +G GSFG + +  W     +   VA+K + P +      + DF  EVN + 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMA 269
            L H N+++  G V    P+ ++TE    G L   L K +G     T   +A+ +A GM 
Sbjct: 67  SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           YL  E    IHRDL  RN+LL  ++ D +K+GDFGL + +   + H V +
Sbjct: 126 YL--ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQ 171

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 39/197 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKA---YWRG----TPVAIKRILPSLSDDRLVIQDF 202
           WE     L    +  +G+G FG+++KA   + +G    T VA+K +  + S   L  +D 
Sbjct: 18  WEFPRKNLVLGKT--LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL--RDL 73
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------------- 248
             E N+L ++ HP++++  GA ++  PL+LI EY + G L  +L+E              
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 249 ----------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
                     + AL+    ++FA  I++GM YL      ++HRDL  RN+L+  +    +
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILV--AEGRKM 189
Query: 299 KVGDFGLSKLIKVQNSH 315
           K+ DFGLS+ +  ++S+
Sbjct: 190 KISDFGLSRDVYEEDSY 206

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 74
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 135 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 88/164 (53%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 69
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TE +  G L  +L++  A  +    V     IA 
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 130 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 169

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 6   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G+++K L++           +  +
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 122 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 160

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 6   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G+++K L++           +  +
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITE 121
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 122 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 160

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 96/182 (52%), Gaps = 30/182 (16%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDF 202
           WE   + L F  +  +G G+FG++++A   G         VA+K +  +   D    +  
Sbjct: 41  WEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EAL 96
Query: 203 RHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG---------AL 252
             E+ ++  L +H NIV  LGA T   P+++ITEY   GDL  +L+ K          A+
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 253 SPSTA-----VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           + STA     ++F+  +A+GMA+L ++    IHRD+  RNVLL N      K+GDFGL++
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHV--AKIGDFGLAR 212
Query: 308 LI 309
            I
Sbjct: 213 DI 214

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 5/151 (3%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +    ++GKGSFGE++  K    G   A+K I       +   +    EV LL +L HPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           I +      ++    L+ E   GG+L   +  +   S   A      +  G+ Y H   N
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK--N 145
Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLS 306
            I+HRDLKP N+LL + S D ++++ DFGLS
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 83/156 (53%), Gaps = 15/156 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG++    +       G  VA+K + P    +   I D + E+ +L  L H NIV
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 74
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G  TE     + LI E+L  G L +YL K K  ++    + +A+ I +GM YL +  
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
            V  HRDL  RNVL+   S   +K+GDFGL+K I+ 
Sbjct: 135 YV--HRDLAARNVLV--ESEHQVKIGDFGLTKAIET 166

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 88/164 (53%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TE +  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 159 GMKYLSDMGAV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 198

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 75
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL K K  +     + +   I +GM YL  + 
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 135
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHR+L  RN+L+ N   + +K+GDFGL+K++     +   K  GE+
Sbjct: 136 --YIHRNLATRNILVENE--NRVKIGDFGLTKVLPQDKEYYKVKEPGES 180

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 39/196 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKA---YWRG----TPVAIKRILPSLSDDRLVIQDF 202
           WE     L    +  +G+G FG+++KA   + +G    T VA+K +  + S   L  +D 
Sbjct: 18  WEFPRKNLVLGKT--LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL--RDL 73
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------------- 248
             E N+L ++ HP++++  GA ++  PL+LI EY + G L  +L+E              
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 249 ----------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
                     + AL+    ++FA  I++GM YL      ++HRDL  RN+L+  +    +
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MSLVHRDLAARNILV--AEGRKM 189
Query: 299 KVGDFGLSKLIKVQNS 314
           K+ DFGLS+ +  ++S
Sbjct: 190 KISDFGLSRDVYEEDS 205

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 88/164 (53%), Gaps = 15/164 (9%)
Query: 156 ELD---FSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ELD    S   ++G G FGE+     +        VAIK +    ++ +   +DF  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEAS 98
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIAR 266
           ++ +  HPNI++  G VT+ KP+M++TE +  G L  +L++  A  +    V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GM YL +   V  HRDL  RN+ L+NS+    KV DFGLS++++
Sbjct: 159 GMKYLSDMGYV--HRDLAARNI-LINSNL-VCKVSDFGLSRVLE 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 39/196 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKA---YWRG----TPVAIKRILPSLSDDRLVIQDF 202
           WE     L    +  +G+G FG+++KA   + +G    T VA+K +  + S   L  +D 
Sbjct: 18  WEFPRKNLVLGKT--LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL--RDL 73
Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------------- 248
             E N+L ++ HP++++  GA ++  PL+LI EY + G L  +L+E              
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 249 ----------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
                     + AL+    ++FA  I++GM YL      ++HRDL  RN+L+  +    +
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILV--AEGRKM 189
Query: 299 KVGDFGLSKLIKVQNS 314
           K+ DFGLS+ +  ++S
Sbjct: 190 KISDFGLSRDVYEEDS 205

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 89/162 (54%), Gaps = 14/162 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +     ++G G+FG + K  W         PVAIK IL   +  +  ++ F  E  ++
Sbjct: 14  ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIM 71
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + HP++V+ LG V     + L+T+ +  G L +Y+ E K  +     +N+ + IA+GM
Sbjct: 72  ASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGM 130
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            YL  E   ++HRDL  RNVL+   S +H+K+ DFGL++L++
Sbjct: 131 MYL--EERRLVHRDLAARNVLV--KSPNHVKITDFGLARLLE 168

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 89/162 (54%), Gaps = 14/162 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +     ++G G+FG + K  W         PVAIK IL   +  +  ++ F  E  ++
Sbjct: 37  ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK-ILNETTGPKANVE-FMDEALIM 94
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + HP++V+ LG V     + L+T+ +  G L +Y+ E K  +     +N+ + IA+GM
Sbjct: 95  ASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGM 153
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            YL  E   ++HRDL  RNVL+   S +H+K+ DFGL++L++
Sbjct: 154 MYL--EERRLVHRDLAARNVLV--KSPNHVKITDFGLARLLE 191

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 95/184 (51%), Gaps = 16/184 (8%)
Query: 160 SSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           S + I+G G FG++ K      G  +A K I      D+   ++ ++E++++ +L H N+
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANL 148
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           +Q   A   +  ++L+ EY+ GG+L  + + E   L+    + F   I  G+ ++H    
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ--M 206
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL---VSN 333
            I+H DLKP N+L VN  A  +K+ DFGL++  K +      K+    G+ E+L   V N
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----KLKVNFGTPEFLAPEVVN 261
Query: 334 CSFM 337
             F+
Sbjct: 262 YDFV 265

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 90/192 (46%), Gaps = 46/192 (23%)
Query: 165 IGKGSFGEILKA-------YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           IG+G+FG + +A       Y   T VA+K +    S D  +  DF+ E  L+ +  +PNI
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNI 112
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF----------------- 260
           V+ LG     KP+ L+ EY+  GDL+++L+   ++SP T  +                  
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLR---SMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 261 ----------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
                     A  +A GMAYL       +HRDL  RN L+  +    +K+ DFGLS+ I 
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMV--VKIADFGLSRNIY 225
Query: 311 VQNSHDVYKMTG 322
              S D YK  G
Sbjct: 226 ---SADYYKADG 234

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 92/182 (50%), Gaps = 30/182 (16%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDF 202
           WE   + L F  +  +G G+FG++++A   G         VA+K +  +   D    +  
Sbjct: 41  WEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EAL 96
Query: 203 RHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------------ 249
             E+ ++  L +H NIV  LGA T   P+++ITEY   GDL  +L+ K            
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 250 --GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
               LS    ++F+  +A+GMA+L ++    IHRD+  RNVLL N      K+GDFGL++
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVA--KIGDFGLAR 212
Query: 308 LI 309
            I
Sbjct: 213 DI 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  +    ++DF  E+ +L  L+H NIV
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIV 77
Query: 219 QFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L LI EYL  G L  YL+     +     + +   I +GM YL  + 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR 137
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              IHRDL  RN+L+ N   + +K+GDFGL+K++         K  GE+
Sbjct: 138 --YIHRDLATRNILVENE--NRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GS+GE+  A  +GT +  A K+I     +D   +  F+ E+ ++  L HPNI++   
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
              +   + L+ E   GG+L + +  K     S A     D+   +AY H     + HRD
Sbjct: 91  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRD 148
Query: 283 LKPRNVLLVNSSADH-LKVGDFGLSKLIK 310
           LKP N L +  S D  LK+ DFGL+   K
Sbjct: 149 LKPENFLFLTDSPDSPLKLIDFGLAARFK 177

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG + +   R  G   A K ++     D+  +   R E+  +  LRHP +V    
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV---RKEIQTMSVLRHPTLVNLHD 115
Query: 223 AVTERKPLMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           A  +   +++I E++ GG+L  K   E   +S   AV +   + +G+ ++H   N  +H 
Sbjct: 116 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHL 173
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCE 328
           DLKP N++     ++ LK+ DFGL+  +  + S  V   T E  + E
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 8/149 (5%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GS+GE+  A  +GT +  A K+I     +D   +  F+ E+ ++  L HPNI++   
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
              +   + L+ E   GG+L + +  K     S A     D+   +AY H     + HRD
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK--LNVAHRD 131
Query: 283 LKPRNVLLVNSSADH-LKVGDFGLSKLIK 310
           LKP N L +  S D  LK+ DFGL+   K
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAARFK 160

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 7   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 62
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 63  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 121
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 122 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 165

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 4   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFL 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 119 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 162

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 19  KRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 134
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 135 ANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 172

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 384 DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFL 439
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 499 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 542

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 32  DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 87
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 88  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 146
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 147 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 190

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG + +   R  G   A K ++     D+  +   R E+  +  LRHP +V    
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV---RKEIQTMSVLRHPTLVNLHD 221
Query: 223 AVTERKPLMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           A  +   +++I E++ GG+L  K   E   +S   AV +   + +G+ ++H   N  +H 
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHL 279
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCE 328
           DLKP N++     ++ LK+ DFGL+  +  + S  V   T E  + E
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 28  KRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 144 ANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 181

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 6   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 61
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 62  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 120
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 121 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 164

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 9   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 64
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 124 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 167

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/189 (32%), Positives = 96/189 (50%), Gaps = 18/189 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQD--FRHEVNLLVKLRH 214
           +FS+  I+G+G FG++ K     GT VA+KR    L ++R    +  F+ EV ++    H
Sbjct: 39  NFSNKNILGRGGFGKVYKGRLADGTLVAVKR----LKEERXQGGELQFQTEVEMISMAVH 94
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS----TAVNFALDIARGMAY 270
            N+++  G        +L+  Y+  G +   L+E+    P          AL  ARG+AY
Sbjct: 95  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 154
Query: 271 LHN--EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG--S 326
           LH+  +P  IIHRD+K  N+LL         VGDFGL+KL+  ++ H    + G  G  +
Sbjct: 155 LHDHCDPK-IIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIA 211
Query: 327 CEYLVSNCS 335
            EYL +  S
Sbjct: 212 PEYLSTGKS 220

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 1   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 56
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 57  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 116 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 159

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 4   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFL 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 119 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 162

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 384 DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFL 439
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  S+ D +K+GDFGLS+ ++
Sbjct: 499 QLSTALAYL--ESKRFVHRDIAARNVLV--SATDCVKLGDFGLSRYME 542

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A  +     +A+K +  S  +   V    R E+ +   LRHP
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++      +RK + L+ E+   G+L+K L++ G      +  F  ++A  + Y H   
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-- 133
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +IHRD+KP N+L+       LK+ DFG S
Sbjct: 134 RKVIHRDIKPENLLM--GYKGELKIADFGWS 162

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 4   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFL 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  S+ D +K+GDFGLS+ ++
Sbjct: 119 QLSTALAYL--ESKRFVHRDIAARNVLV--SATDCVKLGDFGLSRYME 162

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 28  KRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 144 ANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 181

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 6   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 122 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 160

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   +GT        IK+   S S   +  ++   EVN+L ++RHPNI+ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH++   I 
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IA 137
Query: 280 HRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNS 314
           H DLKP N++L++ +  +  +K+ DFG++  I+  N 
Sbjct: 138 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 174

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 165 IGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   +GT        IK+   S S   +  ++   EVN+L ++RHPNI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH++   I 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IA 130
Query: 280 HRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQN 313
           H DLKP N++L++ +  +  +K+ DFG++  I+  N
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 2   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 118 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 156

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 4   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 60  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 118
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++
Sbjct: 119 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME 162

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 6   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 122 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 160

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 4   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 120 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 158

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 3   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 58
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 119 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 157

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 91/178 (51%), Gaps = 26/178 (14%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDF 202
           WE   + L F  +  +G G+FG++++A   G         VA+K +  +   D    +  
Sbjct: 41  WEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EAL 96
Query: 203 RHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------A 251
             E+ ++  L +H NIV  LGA T   P+++ITEY   GDL  +L+ K            
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           L     ++F+  +A+GMA+L ++    IHRD+  RNVLL N      K+GDFGL++ I
Sbjct: 157 LELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHV--AKIGDFGLARDI 210

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 91/178 (51%), Gaps = 26/178 (14%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDF 202
           WE   + L F  +  +G G+FG++++A   G         VA+K +  +   D    +  
Sbjct: 33  WEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EAL 88
Query: 203 RHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------A 251
             E+ ++  L +H NIV  LGA T   P+++ITEY   GDL  +L+ K            
Sbjct: 89  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           L     ++F+  +A+GMA+L ++    IHRD+  RNVLL N      K+GDFGL++ I
Sbjct: 149 LELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVA--KIGDFGLARDI 202

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 93/161 (57%), Gaps = 11/161 (6%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           IG+G++G + KA    G   A+K+I     D+ +     R E+++L +L+H NIV+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +  +K L+L+ E+L   DL K L   +G L   TA +F L +  G+AY H+    ++HRD
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDVYKM 320
           LKP+N LL+N   + LK+ DFGL++   +   + +H+V  +
Sbjct: 126 LKPQN-LLINREGE-LKIADFGLARAFGIPVRKYTHEVVTL 164

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 2   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 118 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 156

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 2   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 118 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 156

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 93/161 (57%), Gaps = 11/161 (6%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           IG+G++G + KA    G   A+K+I     D+ +     R E+++L +L+H NIV+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +  +K L+L+ E+L   DL K L   +G L   TA +F L +  G+AY H+    ++HRD
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDVYKM 320
           LKP+N LL+N   + LK+ DFGL++   +   + +H+V  +
Sbjct: 126 LKPQN-LLINREGE-LKIADFGLARAFGIPVRKYTHEVVTL 164

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/145 (37%), Positives = 86/145 (59%), Gaps = 8/145 (5%)
Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           IG+G++G + KA    G   A+K+I     D+ +     R E+++L +L+H NIV+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +  +K L+L+ E+L   DL K L   +G L   TA +F L +  G+AY H+    ++HRD
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRD 125
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LKP+N LL+N   + LK+ DFGL++
Sbjct: 126 LKPQN-LLINREGE-LKIADFGLAR 148

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 6   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 121
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 122 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 160

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 2   KRQWALE----DFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 118 ANALSYCHSKK--VIHRDIKPENLLL--GSAGELKIADFGWS 155

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A  + +   +A+K +  +  +   V    R EV +   LRHP
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++  G   +   + LI EY   G +++ L++           +  ++A  ++Y H++ 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 131 -RVIHRDIKPENLLL--GSAGELKIADFGWS 158

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 7/157 (4%)
Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    ++GKGSF  + +A     G  VAIK I         ++Q  ++EV +  +L+HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNE 274
           +I++      +   + L+ E    G++++YLK +    S + A +F   I  GM YLH+ 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
              I+HRDL   N+LL  +   ++K+ DFGL+  +K+
Sbjct: 132 G--ILHRDLTLSNLLLTRNM--NIKIADFGLATQLKM 164

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 14/174 (8%)
Query: 151 EIDPSELDFSSSAI------IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQD 201
           EI P E+      +      +G G+FG + K Y++          +IL + ++D  +  +
Sbjct: 5   EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
              E N++ +L +P IV+ +G + E +  ML+ E    G L+KYL++   +     +   
Sbjct: 65  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 123
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
             ++ GM YL  E +  +HRDL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 124 HQVSMGMKYL--EESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENY 173

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 7/173 (4%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           +W+I   +L+     +IGKG FG++    W G  VAI R++    D+   ++ F+ EV  
Sbjct: 27  EWDIPFEQLEIGE--LIGKGRFGQVYHGRWHGE-VAI-RLIDIERDNEDQLKAFKREVMA 82
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARG 267
             + RH N+V F+GA      L +IT   +G  L+  +++ K  L  +     A +I +G
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
           M YLH +   I+H+DLK +NV   N        G F +S +++     D  ++
Sbjct: 143 MGYLHAKG--ILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRI 193

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 14/174 (8%)
Query: 151 EIDPSELDFSSSAI------IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQD 201
           EI P E+      +      +G G+FG + K Y++          +IL + ++D  +  +
Sbjct: 13  EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 72
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
              E N++ +L +P IV+ +G + E +  ML+ E    G L+KYL++   +     +   
Sbjct: 73  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 131
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
             ++ GM YL  E +  +HRDL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 132 HQVSMGMKYL--EESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENY 181

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A  + +   +A+K +  +  +   V    R EV +   LRHP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++  G   +   + LI EY   G +++ L++           +  ++A  ++Y H++ 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 128 -RVIHRDIKPENLLL--GSAGELKIADFGWS 155

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A  + +   +A+K +  +  +   V    R EV +   LRHP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++  G   +   + LI EY   G +++ L++           +  ++A  ++Y H++ 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 128 -RVIHRDIKPENLLL--GSAGELKIADFGWS 155

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 1   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 117 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 155

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A  +     +A+K +  S  +   V    R E+ +   LRHP
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++      +RK + L+ E+   G+L+K L++ G      +  F  ++A  + Y H   
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-- 132
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +IHRD+KP N+L+       LK+ DFG S
Sbjct: 133 RKVIHRDIKPENLLM--GYKGELKIADFGWS 161

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 2   KRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 118 ANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 155

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 14/174 (8%)
Query: 151 EIDPSELDFSSSAI------IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQD 201
           EI P E+      +      +G G+FG + K Y++          +IL + ++D  +  +
Sbjct: 15  EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 74
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
              E N++ +L +P IV+ +G + E +  ML+ E    G L+KYL++   +     +   
Sbjct: 75  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 133
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
             ++ GM YL  E +  +HRDL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 134 HQVSMGMKYL--EESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENY 183

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 14/174 (8%)
Query: 151 EIDPSELDFSSSAI------IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQD 201
           EI P E+      +      +G G+FG + K Y++          +IL + ++D  +  +
Sbjct: 15  EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 74
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
              E N++ +L +P IV+ +G + E +  ML+ E    G L+KYL++   +     +   
Sbjct: 75  LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 133
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
             ++ GM YL  E +  +HRDL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 134 HQVSMGMKYL--EESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENY 183

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
           +K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 5   SKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 60
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 120
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 121 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 159

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 4   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 120 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 158

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ KL H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKLNHQNI 96
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 156 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 194

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 4   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 120 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 158

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVI---QDFRHEVNLLVKLRHPNIVQFL 221
           IG+GSF  + K     T   ++     L D +L     Q F+ E   L  L+HPNIV+F 
Sbjct: 34  IGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 222 ----GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
                 V  +K ++L+TE    G L  YLK           ++   I +G+ +LH     
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           IIHRDLK  N+ +   +   +K+GD GL+ L
Sbjct: 152 IIHRDLKCDNIFITGPTGS-VKIGDLGLATL 181

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ KL H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKLNHQNI 110
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 170 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/145 (37%), Positives = 84/145 (57%), Gaps = 8/145 (5%)
Query: 165 IGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           +G+G++G + KA   +G  VA+KRI     D+ +     R E++LL +L HPNIV  +  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +   + L L+ E++   DL K L E K  L  S    +   + RG+A+ H   + I+HRD
Sbjct: 88  IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRD 144
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LKP+N LL+NS    LK+ DFGL++
Sbjct: 145 LKPQN-LLINSDG-ALKLADFGLAR 167

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           +G G+FG + K Y++          +IL + ++D  +  +   E N++ +L +P IV+ +
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           G + E +  ML+ E    G L+KYL++   +     +     ++ GM YL  E +  +HR
Sbjct: 73  G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFVHR 129
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           DL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 130 DLAARNVLLV--TQHYAKISDFGLSKALRADENY 161

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 89/169 (52%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  D +   +DF+ E+ +L  L    IV
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 87
Query: 219 QFLGAV--TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L L+ EYL  G L  +L + +  L  S  + ++  I +GM YL +  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              +HRDL  RN+L+   S  H+K+ DFGL+KL+ +   + V +  G++
Sbjct: 146 RRCVHRDLAARNILV--ESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/145 (37%), Positives = 84/145 (57%), Gaps = 8/145 (5%)
Query: 165 IGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           +G+G++G + KA   +G  VA+KRI     D+ +     R E++LL +L HPNIV  +  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +   + L L+ E++   DL K L E K  L  S    +   + RG+A+ H   + I+HRD
Sbjct: 88  IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRD 144
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LKP+N LL+NS    LK+ DFGL++
Sbjct: 145 LKPQN-LLINSDG-ALKLADFGLAR 167

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 2   KRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 118 ANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 155

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 1   KRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 56
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 116
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 117 ANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 154

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 2   KRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 118 ANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 155

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 14/174 (8%)
Query: 151 EIDPSELDFSSSAI------IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQD 201
           EI P E+      +      +G G+FG + K Y++          +IL + ++D  +  +
Sbjct: 357 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 416
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
              E N++ +L +P IV+ +G + E +  ML+ E    G L+KYL++   +     +   
Sbjct: 417 LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 475
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
             ++ GM YL  E +  +HRDL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 476 HQVSMGMKYL--EESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENY 525

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 45/125 (36%), Positives = 68/125 (54%), Gaps = 4/125 (3%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242
           VAIK I     +    ++ F  EV+   +L H NIV  +    E     L+ EY+ G  L
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
            +Y++  G LS  TA+NF   I  G+ + H+    I+HRD+KP+N+L+   S   LK+ D
Sbjct: 99  SEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILI--DSNKTLKIFD 154
Query: 303 FGLSK 307
           FG++K
Sbjct: 155 FGIAK 159

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 14/174 (8%)
Query: 151 EIDPSELDFSSSAI------IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQD 201
           EI P E+      +      +G G+FG + K Y++          +IL + ++D  +  +
Sbjct: 358 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 417
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
              E N++ +L +P IV+ +G + E +  ML+ E    G L+KYL++   +     +   
Sbjct: 418 LLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELV 476
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
             ++ GM YL  E +  +HRDL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 477 HQVSMGMKYL--EESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENY 526

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 6/151 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A    R   +A+K +  +  +   V    R EV +   LRHP
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++  G   +   + LI EY   G +++ L++           +  ++A  ++Y H++ 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 124
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 125 -RVIHRDIKPENLLL--GSAGELKIADFGWS 152

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           +G G+FG + K Y++          +IL + ++D  +  +   E N++ +L +P IV+ +
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           G + E +  ML+ E    G L+KYL++   +     +     ++ GM YL  E +  +HR
Sbjct: 75  G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFVHR 131
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           DL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 132 DLAARNVLLV--TQHYAKISDFGLSKALRADENY 163

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRH 204
           K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R 
Sbjct: 2   KRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 57
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           A  ++Y H++   +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 118 ANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 155

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 89/169 (52%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  D +   +DF+ E+ +L  L    IV
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 75
Query: 219 QFLGAV--TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L L+ EYL  G L  +L + +  L  S  + ++  I +GM YL +  
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-- 133
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              +HRDL  RN+L+   S  H+K+ DFGL+KL+ +   + V +  G++
Sbjct: 134 RRCVHRDLAARNILV--ESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           ++    IG+G++G +  AY   R T VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPF--EHQTYCQRTLREIQILLRFRHEN 102
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           ++     L A T E    + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQ-QLSNDHICYFLYQILRGLKYIH 161
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++   ++ H
Sbjct: 162 SAN--VLHRDLKPSN-LLINTTCD-LKICDFGLARIADPEHDH 200

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 94/191 (49%), Gaps = 39/191 (20%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDF 202
           WE   + L F  +  +G G+FG++++A   G         VA+K +  +   D    +  
Sbjct: 26  WEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EAL 81
Query: 203 RHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--GALSPSTA-- 257
             E+ ++  L +H NIV  LGA T   P+++ITEY   GDL  +L+ K    L PS A  
Sbjct: 82  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPG 141
Query: 258 -------------------VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
                              ++F+  +A+GMA+L ++    IHRD+  RNVLL N      
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVA-- 197
Query: 299 KVGDFGLSKLI 309
           K+GDFGL++ I
Sbjct: 198 KIGDFGLARDI 208

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 89/169 (52%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  D +   +DF+ E+ +L  L    IV
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 74
Query: 219 QFLGAV--TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R+ L L+ EYL  G L  +L + +  L  S  + ++  I +GM YL +  
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-- 132
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              +HRDL  RN+L+   S  H+K+ DFGL+KL+ +   + V +  G++
Sbjct: 133 RRCVHRDLAARNILV--ESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 16/168 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
           D   + I+G+G FGE+ +  +         VA+K      + D    + F  E  ++  L
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNL 70
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYL 271
            HP+IV+ +G + E +P  +I E    G+L  YL + K +L   T V ++L I + MAYL
Sbjct: 71  DHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
             E    +HRD+  RN+L+  +S + +K+GDFGLS+ I+     D YK
Sbjct: 130 --ESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYIE---DEDYYK 170

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 87/168 (51%), Gaps = 16/168 (9%)
Query: 165 IGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVI----QDFRHEVNLLVKLRHPNIV 218
           IGKG FG + K       + VAIK ++   S+    +    Q+F+ EV ++  L HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 219 QFLGAVTERKPLMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           +  G +    P  ++ E++  GDL H+ L +   +  S  +   LDIA G+ Y+ N+   
Sbjct: 87  KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 278 IIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMTG 322
           I+HRDL+  N+ L +   +     KV DFGLS+    Q+ H V  + G
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLG 188

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 11/157 (7%)
Query: 165 IGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G G F  + K   +GT          KR L S S   +  ++   EVN+L ++RHPNI+
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXS-SRRGVSREEIEREVNILREIRHPNII 92
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
                   +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH++   I
Sbjct: 93  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--I 150
Query: 279 IHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQN 313
            H DLKP N++L++ +  +  +K+ DFG++  I+  N
Sbjct: 151 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 187

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           +G G+FG + K Y++          +IL + ++D  +  +   E N++ +L +P IV+ +
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           G + E +  ML+ E    G L+KYL++   +     +     ++ GM YL  E +  +HR
Sbjct: 79  G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFVHR 135
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           DL  RNVLLV  +  + K+ DFGLSK ++   ++
Sbjct: 136 DLAARNVLLV--TQHYAKISDFGLSKALRADENY 167

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 32/184 (17%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDF 202
           WE   + L F  +  +G G+FG++++A   G         VA+K +  +   D    +  
Sbjct: 41  WEFPRNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK--EAL 96
Query: 203 RHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------------ 249
             E+ ++  L +H NIV  LGA T   P+++ITEY   GDL  +L+ K            
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 250 ----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
                 LS    ++F+  +A+GMA+L ++    IHRD+  RNVLL N      K+GDFGL
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHV--AKIGDFGL 212
Query: 306 SKLI 309
           ++ I
Sbjct: 213 ARDI 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 16/168 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
           D   + I+G+G FGE+ +  +         VA+K      + D    + F  E  ++  L
Sbjct: 9   DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNL 66
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYL 271
            HP+IV+ +G + E +P  +I E    G+L  YL + K +L   T V ++L I + MAYL
Sbjct: 67  DHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
             E    +HRD+  RN+L+  +S + +K+GDFGLS+ I+     D YK
Sbjct: 126 --ESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYIE---DEDYYK 166

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A  + +   +A+K +  +  +   V    R EV +   LRHP
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++  G   +   + LI EY   G +++ L++           +  ++A  ++Y H++ 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +IHRD+KP N+LL   SA  LK+ DFG S
Sbjct: 131 -RVIHRDIKPENLLL--GSAGELKIADFGWS 158

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 89/168 (52%), Gaps = 16/168 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
           D   + I+G+G FGE+ +  +         VA+K      + D    + F  E  ++  L
Sbjct: 25  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNL 82
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYL 271
            HP+IV+ +G + E +P  +I E    G+L  YL + K +L   T V ++L I + MAYL
Sbjct: 83  DHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
             E    +HRD+  RN+L+  +S + +K+GDFGLS+ I+     D YK
Sbjct: 142 --ESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYIE---DEDYYK 182

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 83/158 (52%), Gaps = 17/158 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
           DF+   ++GKGSFG+++ A  +GT    AIK     L  D +VIQD   E  ++ K    
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIK----ILKKD-VVIQDDDVECTMVEKRVLA 74
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
              + P + Q          L  + EY+ GGDL  ++++ G      AV +A +I+ G+ 
Sbjct: 75  LLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF 134
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +LH     II+RDLK  NV+L   S  H+K+ DFG+ K
Sbjct: 135 FLHK--RGIIYRDLKLDNVML--DSEGHIKIADFGMCK 168

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 88/178 (49%), Gaps = 15/178 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHE 205
           EI+ S +      IIG G  GE+     R       PVAIK +    ++ +   +DF  E
Sbjct: 45  EIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSE 100
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDI 264
            +++ +  HPNI++  G VT  +  M++TEY+  G L  +L+   G  +    V     +
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
             GM YL +   V  HRDL  RNVL+ ++     KV DFGLS++++  +    Y  TG
Sbjct: 161 GAGMRYLSDLGYV--HRDLAARNVLVDSNLV--CKVSDFGLSRVLE-DDPDAAYTTTG 213

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
           +K  W ++    DF     +GKG FG +  A  R +   +A+K +  +  +   V    R
Sbjct: 5   SKRQWTLE----DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLR 60
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITE 120
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   S   LK+ DFG S
Sbjct: 121 LANALSYCHSK--RVIHRDIKPENLLL--GSNGELKIADFGWS 159

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 91/164 (55%), Gaps = 15/164 (9%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 102
Query: 217 IVQF-----LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           I+          + + K + L+T +L G DL+K LK +  LS      F   I RG+ Y+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 160
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           H+    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 161 HSAN--VLHRDLKPSN-LLLNTTXD-LKICDFGLARVADPDHDH 200

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 3   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 58
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 118
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ +FG S
Sbjct: 119 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIANFGWS 157

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
           +K  W ++    DF     +GKG FG +  A  R +   +A+K +  +  +   V    R
Sbjct: 5   SKRQWTLE----DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLR 60
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITE 120
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   S   LK+ DFG S
Sbjct: 121 LANALSYCHSK--RVIHRDIKPENLLL--GSNGELKIADFGWS 159

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 110
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 170 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 95
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 155 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 113
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 173 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 211

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 136
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 196 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 8/149 (5%)
Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           +G G+FG + K Y++          +IL + ++D  +  +   E N++ +L +P IV+ +
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           G + E +  ML+ E    G L+KYL++   +     +     ++ GM YL  E +  +HR
Sbjct: 79  G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFVHR 135
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           DL  RNVLLV  +  + K+ DFGLSK ++
Sbjct: 136 DLAARNVLLV--TQHYAKISDFGLSKALR 162

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 71
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 72  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 131 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 167

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 112
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 172 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 210

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 122
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 182 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 220

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/183 (31%), Positives = 88/183 (48%), Gaps = 30/183 (16%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 95
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMT-GETGSC 327
           YL  E N  IHRD+  RN LL       + K+GDFG+++        D+Y+ +    G C
Sbjct: 155 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--------DIYRASYYRKGGC 204
Query: 328 EYL 330
             L
Sbjct: 205 AML 207

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 96
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 156 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 194

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHE 205
           EI+ S +      IIG G  GE+     R       PVAIK +    ++ +   +DF  E
Sbjct: 45  EIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSE 100
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALDI 264
            +++ +  HPNI++  G VT  +  M++TEY+  G L  +L+   G  +    V     +
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             GM YL +   V  HRDL  RNVL+ ++     KV DFGLS++++
Sbjct: 161 GAGMRYLSDLGYV--HRDLAARNVLVDSNLV--CKVSDFGLSRVLE 202

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVA-----IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T +      IK+     S   +  ++   EV++L ++ HPNI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  R  ++LI E + GG+L  +L +K +LS   A +F   I  G+ YLH +   I 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IA 137
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIK 310
           H DLKP N++L+  N    H+K+ DFGL+  I+
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 87
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 147 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 185

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 81/146 (55%), Gaps = 9/146 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  R T   VA+KR+     DD  V      E+ LL +L+H NIV+   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +   K L L+ E+    DL KY     G L P    +F   + +G+ + H+    ++HR
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHR 125
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N LL+N + + LK+ DFGL++
Sbjct: 126 DLKPQN-LLINRNGE-LKLADFGLAR 149

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 71
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 72  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 131 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 167

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 20  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 77
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 78  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 136
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 137 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 173

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 96
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 156 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDI 194

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 74
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 75  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 133
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 134 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 170

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 39  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 96
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 97  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 155
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 156 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 192

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 24  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 81
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 82  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 140
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 141 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 177

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDEL-DFLMEALIISKFNHQNI 102
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 162 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 200

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           ++     IGKG+F ++  A     G  VA+K I+     +   +Q    EV ++  L HP
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVK-IIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NIV+    +   K L L+ EY  GG++  YL   G +    A      I   + Y H + 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK- 133
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
             I+HRDLK  N+LL      ++K+ DFG S    V N  D +
Sbjct: 134 -YIVHRDLKAENLLL--DGDMNIKIADFGFSNEFTVGNKLDTF 173

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR 203
            K  W ++    DF     +GKG FG +  A  + +   +A+K +  +  +   V    R
Sbjct: 4   KKRQWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
            EV +   LRHPNI++  G   +   + LI EY   G +++ L++           +  +
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +A  ++Y H++   +IHRD+KP N+LL   SA  LK+ +FG S
Sbjct: 120 LANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIANFGWS 158

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/157 (36%), Positives = 83/157 (52%), Gaps = 10/157 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL 209
           +DP EL F+    IGKGSFGE+ K     T   VAIK I   L +    I+D + E+ +L
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVL 59
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
            +   P + ++ G+  +   L +I EYL GG     L E G L  +       +I +G+ 
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLD 118
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           YLH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 119 YLHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVA 151

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 74
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 75  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 133
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 134 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 170

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 73
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 74  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 132
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 133 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 169

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/157 (36%), Positives = 83/157 (52%), Gaps = 10/157 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL 209
           +DP EL F+    IGKGSFGE+ K     T   VAIK I   L +    I+D + E+ +L
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVL 59
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
            +   P + ++ G+  +   L +I EYL GG     L E G L  +       +I +G+ 
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLD 118
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           YLH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 119 YLHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVA 151

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 71
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 72  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 131 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 167

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 74
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 75  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 133
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 134 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 170

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 21  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 78
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 79  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 137
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 138 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 174

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 65
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 66  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 125 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 161

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/157 (36%), Positives = 83/157 (52%), Gaps = 10/157 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL 209
           +DP EL F+    IGKGSFGE+ K     T   VAIK I   L +    I+D + E+ +L
Sbjct: 23  MDPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVL 79
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
            +   P + ++ G+  +   L +I EYL GG     L E G L  +       +I +G+ 
Sbjct: 80  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLD 138
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           YLH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 139 YLHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVA 171

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 16/179 (8%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVI----QDFRH---EVNLLVK 211
           F    ++GKG +G++ +   + T     +I       + +I    +D  H   E N+L +
Sbjct: 19  FELLRVLGKGGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           ++HP IV  + A      L LI EYL GG+L   L+ +G     TA  +  +I+  + +L
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           H +   II+RDLKP N++L  +   H+K+ DFGL K    ++ HD        G+ EY+
Sbjct: 138 HQKG--IIYRDLKPENIML--NHQGHVKLTDFGLCK----ESIHDGTVTHTFCGTIEYM 188

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 16/179 (8%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVI----QDFRH---EVNLLVK 211
           F    ++GKG +G++ +   + T     +I       + +I    +D  H   E N+L +
Sbjct: 19  FELLRVLGKGGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           ++HP IV  + A      L LI EYL GG+L   L+ +G     TA  +  +I+  + +L
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           H +   II+RDLKP N++L  +   H+K+ DFGL K    ++ HD        G+ EY+
Sbjct: 138 HQKG--IIYRDLKPENIML--NHQGHVKLTDFGLCK----ESIHDGTVTHXFCGTIEYM 188

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 13  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 68
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 129 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 182

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 13  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 68
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 69  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 129 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 182

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 9   EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 64
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 65  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 125 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 178

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 12  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 67
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 128 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 181

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 10  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 65
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 126 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 179

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 6   EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 61
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 122 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 175

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VAIK I+     +   +Q    EV ++  L HPNIV+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L LI EY  GG++  YL   G +    A +    I   + Y H +   I+HRD
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRD 136
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL    AD ++K+ DFG S    V    D +
Sbjct: 137 LKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTF 170

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 16/169 (9%)
Query: 165 IGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +GKG+FG +    +       G  VA+K++  S  D +   +DF+ E+ +L  L    IV
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 71
Query: 219 QFLGAV--TERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEP 275
           ++ G      R  L L+ EYL  G L  +L + +  L  S  + ++  I +GM YL +  
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-- 129
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
              +HRDL  RN+L+   S  H+K+ DFGL+KL+ +     V +  G++
Sbjct: 130 RRCVHRDLAARNILV--ESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 4   EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 59
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 60  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 119
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 120 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 173

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 165 IGKGSFGEILKAYWRGTP-------VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FGE+ +    G P       VA+K  LP +  ++  + DF  E  ++ K  H NI
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVYSEQDEL-DFLMEALIISKFNHQNI 110
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL--------DIARGMA 269
           V+ +G   +  P  ++ E + GGDL  +L+E     PS   + A+        DIA G  
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           YL  E N  IHRD+  RN LL       + K+GDFG+++ I
Sbjct: 170 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 12  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 67
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 68  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 128 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 181

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VAIK I+     +   +Q    EV ++  L HPNIV+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L LI EY  GG++  YL   G +    A +    I   + Y H +   I+HRD
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRD 139
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL    AD ++K+ DFG S    V    D +
Sbjct: 140 LKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAF 173

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VA+ RI+     +   +Q    EV ++  L HPNIV+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L L+ EY  GG++  YL   G +    A      I   + Y H +   I+HRD
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK--FIVHRD 138
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL    AD ++K+ DFG S      N  D +
Sbjct: 139 LKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTF 172

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 8/162 (4%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG + +  +R     I   +  L    ++   ++   E  ++ +L +P IV+ +G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNEPNVIIHR 281
            V + + LML+ E   GG LHK+L  K    P + V   L  ++ GM YL  E    +HR
Sbjct: 78  -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL--EEKNFVHR 134
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
           DL  RNVLLVN    + K+ DFGLSK +   +S+   +  G+
Sbjct: 135 DLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGK 174

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 82/156 (52%), Gaps = 10/156 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP EL F+    IGKGSFGE+ K     T   VAIK I   L +    I+D + E+ +L 
Sbjct: 19  DPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLS 75
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +   P + ++ G+  +   L +I EYL GG     L E G L  +       +I +G+ Y
Sbjct: 76  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDY 134
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           LH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 135 LHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVA 166

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 19  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 74
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 188

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/157 (37%), Positives = 83/157 (52%), Gaps = 10/157 (6%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL 209
           +DP EL F+    IGKGSFGE+ K     T   VAIK I   L +    I+D + E+ +L
Sbjct: 15  VDPEEL-FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQEITVL 71
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
            +   P I ++ G+  +   L +I EYL GG     LK  G L  +       +I +G+ 
Sbjct: 72  SQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLD 130
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           YLH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 131 YLHSERK--IHRDIKAANVLL--SEQGDVKLADFGVA 163

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 41  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 96
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 97  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 156
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 157 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 210

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 90/173 (52%), Gaps = 20/173 (11%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +     ++G G FG + K  W         PV IK I     +D+   Q F+   + +
Sbjct: 30  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-----EDKSGRQSFQAVTDHM 84
Query: 210 V---KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIA 265
           +    L H +IV+ LG +     L L+T+YL  G L  ++++ +GAL P   +N+ + IA
Sbjct: 85  LAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 143
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
           +GM YL  E + ++HR+L  RNVLL   S   ++V DFG++ L+   +   +Y
Sbjct: 144 KGMYYL--EEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLLPPDDKQLLY 192

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 90/173 (52%), Gaps = 20/173 (11%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +     ++G G FG + K  W         PV IK I     +D+   Q F+   + +
Sbjct: 12  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-----EDKSGRQSFQAVTDHM 66
Query: 210 V---KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIA 265
           +    L H +IV+ LG +     L L+T+YL  G L  ++++ +GAL P   +N+ + IA
Sbjct: 67  LAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
           +GM YL  E + ++HR+L  RNVLL   S   ++V DFG++ L+   +   +Y
Sbjct: 126 KGMYYL--EEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLLPPDDKQLLY 174

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 19  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 74
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 134
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN ++       +K+GDFG+++ I
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI 188

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 92/187 (49%), Gaps = 14/187 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +F +  I+G+G FG++ K     G  VA+KR+    +    +   F+ EV ++    H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRN 88
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS----TAVNFALDIARGMAYLH 272
           +++  G        +L+  Y+  G +   L+E+    P          AL  ARG+AYLH
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 273 N--EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG--SCE 328
           +  +P  IIHRD+K  N+LL         VGDFGL+KL+  ++ H    + G  G  + E
Sbjct: 149 DHCDPK-IIHRDVKAANILL--DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE 205
Query: 329 YLVSNCS 335
           YL +  S
Sbjct: 206 YLSTGKS 212

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VA+K I+     +   +Q    EV ++  L HPNIV+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L L+ EY  GG++  YL   G +    A      I   + Y H +   I+HRD
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK--FIVHRD 138
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL    AD ++K+ DFG S      N  D +
Sbjct: 139 LKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTF 172

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VA+K I+     +   +Q    EV ++  L HPNIV+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L L+ EY  GG++  YL   G +    A      I   + Y H +   I+HRD
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK--FIVHRD 138
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL    AD ++K+ DFG S      N  D +
Sbjct: 139 LKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTF 172

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 86/168 (51%), Gaps = 16/168 (9%)
Query: 165 IGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVI----QDFRHEVNLLVKLRHPNIV 218
           IGKG FG + K       + VAIK ++   S+    +    Q+F+ EV ++  L HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 219 QFLGAVTERKPLMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           +  G +    P  ++ E++  GDL H+ L +   +  S  +   LDIA G+ Y+ N+   
Sbjct: 87  KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 278 IIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMTG 322
           I+HRDL+  N+ L +   +     KV DFG S+    Q+ H V  + G
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLG 188

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +F    +IG G FG++ K   R G  VA+KR  P  S      +     ++     RHP+
Sbjct: 40  NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC---RHPH 96
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI----ARGMAYLH 272
           +V  +G   ER  ++LI +Y+  G+L ++L      + S +    L+I    ARG+ YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                IIHRD+K  N+LL  +     K+ DFG+SK
Sbjct: 157 TR--AIIHRDVKSINILLDENFVP--KITDFGISK 187

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +F    +IG G FG++ K   R G  VA+KR  P  S      +     ++     RHP+
Sbjct: 40  NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC---RHPH 96
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI----ARGMAYLH 272
           +V  +G   ER  ++LI +Y+  G+L ++L      + S +    L+I    ARG+ YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                IIHRD+K  N+LL  +     K+ DFG+SK
Sbjct: 157 TR--AIIHRDVKSINILLDENFVP--KITDFGISK 187

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VA+K I+     +   +Q    EV ++  L HPNIV+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L L+ EY  GG++  YL   G +    A      I   + Y H +   I+HRD
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK--FIVHRD 138
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL    AD ++K+ DFG S      N  D +
Sbjct: 139 LKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAF 172

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 23  WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 78
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYN 138
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 194
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   +  D YK T
Sbjct: 195 GLARDI---HHIDYYKKT 209

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    +++ L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 202 GLARDI---NNIDYYKKT 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 11  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 68
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA GM
Sbjct: 69  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGM 127
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 128 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 164

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 38/196 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPS--LSDDRLVIQ 200
           WE   + L F  +  +G G+FG++++A   G         VA+K + PS  L++   ++ 
Sbjct: 18  WEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------GALS 253
               E+ +L  L  H NIV  LGA T   P ++ITEY   GDL  +L+ K         S
Sbjct: 76  ----ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 254 PST------------AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
           P+              ++F+  +A+GMA+L ++    IHRDL  RN+LL +      K+ 
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRIT--KIC 187
Query: 302 DFGLSKLIKVQNSHDV 317
           DFGL++ IK  +++ V
Sbjct: 188 DFGLARDIKNDSNYVV 203

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 84/158 (53%), Gaps = 17/158 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
           DF+   ++GKGSFG+++ +  +GT    A+K     L  D +VIQD   E  ++ K    
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKD-VVIQDDDVECTMVEKRVLA 396
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
              + P + Q          L  + EY+ GGDL  ++++ G      AV +A +IA G+ 
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +L ++   II+RDLK  NV+L   S  H+K+ DFG+ K
Sbjct: 457 FLQSK--GIIYRDLKLDNVML--DSEGHIKIADFGMCK 490

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 15  WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 70
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 71  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 130
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 131 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 186
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   +  D YK T
Sbjct: 187 GLARDI---HHIDYYKKT 201

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 8   WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 63
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 123
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 179
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   +  D YK T
Sbjct: 180 GLARDI---HHIDYYKKT 194

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 12  WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 67
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 68  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 127
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 128 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 183
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   +  D YK T
Sbjct: 184 GLARDI---HHIDYYKKT 198

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 23  WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 78
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 138
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 194
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   +  D YK T
Sbjct: 195 GLARDI---HHIDYYKKT 209

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 87/173 (50%), Gaps = 26/173 (15%)
Query: 164 IIGKGSFGEILKAYWR---GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           I+G+G FG +++   +   GT   VA+K +    S  R  I++F  E   +    HPN++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR-EIEEFLSEAACMKDFSHPNVI 99
Query: 219 QFLGAVTER------KPLMLITEYLRGGDLHKYL----KEKGA--LSPSTAVNFALDIAR 266
           + LG   E       KP M+I  +++ GDLH YL     E G   +   T + F +DIA 
Sbjct: 100 RLLGVCIEMSSQGIPKP-MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
           GM YL N     +HRDL  RN +L +     + V DFGLSK I    S D Y+
Sbjct: 159 GMEYLSNRN--FLHRDLAARNCMLRDDMT--VCVADFGLSKKI---YSGDYYR 204

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVA-----IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T +      IK+     S   +  +D   EV++L +++HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH+    I 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IA 136
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 76/147 (51%), Gaps = 6/147 (4%)
Query: 165 IGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG++   K    G  VA+K +         V+   R E+  L   RHP+I++   
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            ++    + ++ EY+ GG+L  Y+ + G L    +      I  G+ Y H   ++++HRD
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR--HMVVHRD 141
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLI 309
           LKP NVLL   +  + K+ DFGLS ++
Sbjct: 142 LKPENVLL--DAHMNAKIADFGLSNMM 166

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 35/197 (17%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---TPVAIKRILPSLSD--DRLVIQDFRH 204
           WE     L+F    ++G G+FG+++ A   G   T V+I+  +  L +  D    +    
Sbjct: 40  WEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS 97
Query: 205 EVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-------------- 249
           E+ ++ +L  H NIV  LGA T   P+ LI EY   GDL  YL+ K              
Sbjct: 98  ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 250 ---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
                      L+    + FA  +A+GM +L  E    +HRDL  RNVL+ +     +K+
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKV--VKI 213
Query: 301 GDFGLSKLIKVQNSHDV 317
            DFGL++ I   +++ V
Sbjct: 214 CDFGLARDIMSDSNYVV 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 23  WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 78
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 138
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 194
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   +  D YK T
Sbjct: 195 GLARDI---HHIDYYKKT 209

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 86/168 (51%), Gaps = 16/168 (9%)
Query: 165 IGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVI----QDFRHEVNLLVKLRHPNIV 218
           IGKG FG + K       + VAIK ++   S+    +    Q+F+ EV ++  L HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 219 QFLGAVTERKPLMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           +  G +    P  ++ E++  GDL H+ L +   +  S  +   LDIA G+ Y+ N+   
Sbjct: 87  KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPP 144
Query: 278 IIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKVQNSHDVYKMTG 322
           I+HRDL+  N+ L +   +     KV DF LS+    Q+ H V  + G
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLG 188

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVA-----IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T +      IK+     S   +  +D   EV++L +++HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH+    I 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IA 136
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 16  WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 71
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 72  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 131
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 132 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 187
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   +  D YK T
Sbjct: 188 GLARDI---HHIDYYKKT 202

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVA-----IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T +      IK+     S   +  +D   EV++L +++HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH+    I 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IA 136
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VA+ RI+     +   +Q    EV ++  L HPNIV+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L L+ EY  GG++  YL   G +    A      I   + Y H +   I+HRD
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK--FIVHRD 138
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL    AD ++K+ DFG S      N  D +
Sbjct: 139 LKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEF 172

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 10/163 (6%)
Query: 158 DFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G F E+ +A     G PVA+K++      D     D   E++LL +L HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLH---KYLKEKGALSPSTAV-NFALDIARGMAYL 271
           N++++  +  E   L ++ E    GDL    K+ K++  L P   V  + + +   + ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           H+    ++HRD+KP NV +  +    +K+GD GL +    + +
Sbjct: 153 HSR--RVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT 191

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 84/158 (53%), Gaps = 17/158 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
           DF+   ++GKGSFG+++ +  +GT    A+K     L  D +VIQD   E  ++ K    
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKD-VVIQDDDVECTMVEKRVLA 75
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
              + P + Q          L  + EY+ GGDL  ++++ G      AV +A +IA G+ 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +L ++   II+RDLK  NV+L   S  H+K+ DFG+ K
Sbjct: 136 FLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCK 169

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 38/196 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPS--LSDDRLVIQ 200
           WE   + L F  +  +G G+FG++++A   G         VA+K + PS  L++   ++ 
Sbjct: 41  WEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------GALS 253
               E+ +L  L  H NIV  LGA T   P ++ITEY   GDL  +L+ K         S
Sbjct: 99  ----ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 254 PST------------AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
           P+              ++F+  +A+GMA+L ++    IHRDL  RN+LL +      K+ 
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRIT--KIC 210
Query: 302 DFGLSKLIKVQNSHDV 317
           DFGL++ IK  +++ V
Sbjct: 211 DFGLARHIKNDSNYVV 226

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 38/196 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPS--LSDDRLVIQ 200
           WE   + L F  +  +G G+FG++++A   G         VA+K + PS  L++   ++ 
Sbjct: 34  WEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 91
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------GALS 253
               E+ +L  L  H NIV  LGA T   P ++ITEY   GDL  +L+ K         S
Sbjct: 92  ----ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 147
Query: 254 PST------------AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
           P+              ++F+  +A+GMA+L ++    IHRDL  RN+LL +      K+ 
Sbjct: 148 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRIT--KIC 203
Query: 302 DFGLSKLIKVQNSHDV 317
           DFGL++ IK  +++ V
Sbjct: 204 DFGLARDIKNDSNYVV 219

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 15  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 72
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 73  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGM 131
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 132 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 168

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 38/196 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPS--LSDDRLVIQ 200
           WE   + L F  +  +G G+FG++++A   G         VA+K + PS  L++   ++ 
Sbjct: 36  WEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 93
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------GALS 253
               E+ +L  L  H NIV  LGA T   P ++ITEY   GDL  +L+ K         S
Sbjct: 94  ----ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 149
Query: 254 PST------------AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
           P+              ++F+  +A+GMA+L ++    IHRDL  RN+LL +      K+ 
Sbjct: 150 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRIT--KIC 205
Query: 302 DFGLSKLIKVQNSHDV 317
           DFGL++ IK  +++ V
Sbjct: 206 DFGLARDIKNDSNYVV 221

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 86/151 (56%), Gaps = 13/151 (8%)
Query: 165 IGKGSFGE--ILKAYWRGTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           IG+GSFG+  ++K+   G    IK I  S   S +R   ++ R EV +L  ++HPNIVQ+
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER---EESRREVAVLANMKHPNIVQY 88
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAV-NFALDIARGMAYLHNEPNVI 278
             +  E   L ++ +Y  GGDL K +  +KG L     + ++ + I   + ++H+    I
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--I 146
Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +HRD+K +N+ L       +++GDFG+++++
Sbjct: 147 LHRDIKSQNIFLTKDGT--VQLGDFGIARVL 175

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 4/116 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 118 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 88/164 (53%), Gaps = 12/164 (7%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G++GE+ KA    T   VAIKRI     ++ +     R EV+LL +L+H NI++   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +     L LI EY    DL KY+ +   +S     +F   +  G+ + H+     +HRD
Sbjct: 101 VIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRD 157
Query: 283 LKPRNVLLVNSSADH---LKVGDFGLSKLIKV---QNSHDVYKM 320
           LKP+N+LL  S A     LK+GDFGL++   +   Q +H++  +
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 38/196 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPS--LSDDRLVIQ 200
           WE   + L F  +  +G G+FG++++A   G         VA+K + PS  L++   ++ 
Sbjct: 41  WEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------GALS 253
               E+ +L  L  H NIV  LGA T   P ++ITEY   GDL  +L+ K         S
Sbjct: 99  ----ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 254 PST------------AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
           P+              ++F+  +A+GMA+L ++    IHRDL  RN+LL +      K+ 
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRIT--KIC 210
Query: 302 DFGLSKLIKVQNSHDV 317
           DFGL++ IK  +++ V
Sbjct: 211 DFGLARDIKNDSNYVV 226

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 4/116 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 64  WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 119
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 235
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   +  D YK T
Sbjct: 236 GLARDI---HHIDYYKKT 250

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 4/116 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 81/146 (55%), Gaps = 9/146 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  R T   VA+KR+     DD  V      E+ LL +L+H NIV+   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +   K L L+ E+    DL KY     G L P    +F   + +G+ + H+    ++HR
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHR 125
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N LL+N + + LK+ +FGL++
Sbjct: 126 DLKPQN-LLINRNGE-LKLANFGLAR 149

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 92/178 (51%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +G       T VAIK +  + S    +  +
Sbjct: 6   EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--E 61
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------KGALSP 254
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+           L+P
Sbjct: 62  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 255 ---STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              S  +  A +IA GMAYL+   N  +HRDL  RN  +       +K+GDFG+++ I
Sbjct: 122 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCXVAEDFT--VKIGDFGMTRDI 175

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 4/116 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 4/116 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 118 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/116 (34%), Positives = 64/116 (55%), Gaps = 4/116 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVA-----IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T +      IK+     S   +  +D   EV++L +++HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH+    I 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IA 136
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVA-----IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T +      IK+     S   +  +D   EV++L +++HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH+    I 
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IA 136
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQN 313
           H DLKP N++L+  N     +K+ DFGL+  I   N
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 7/147 (4%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GSFG++  A  Y     VA+K I   L     +      E++ L  LRHP+I++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +T    ++++ EY  GG+L  Y+ EK  ++      F   I   + Y H     I+HRD
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRD 133
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLI 309
           LKP N+LL ++   ++K+ DFGLS ++
Sbjct: 134 LKPENLLLDDNL--NVKIADFGLSNIM 158

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 64/117 (54%), Gaps = 4/117 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQNS 314
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N 
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VA+K I+     +   +Q    EV ++  L HPNIV+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L L+ EY  GG++  YL   G +    A      I   + Y H +   I+HRD
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK--FIVHRD 131
Query: 283 LKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL    AD ++K+ DFG S      N  D +
Sbjct: 132 LKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTF 165

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 74
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 75  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 133
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 134 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 170

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 15  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 72
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 73  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 131
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 132 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 168

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 73
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 74  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 132
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 133 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 169

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 64/117 (54%), Gaps = 4/117 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQNS 314
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N 
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 90/186 (48%), Gaps = 34/186 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE+    L       +G+G+FG+++ A   G         T VA+K +    ++  L   
Sbjct: 23  WELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--S 78
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-------- 251
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFN 138
Query: 252 --------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   LS    V+ A  +ARGM YL ++    IHRDL  RNVL+   +   +K+ DF
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV--MKIADF 194
Query: 304 GLSKLI 309
           GL++ I
Sbjct: 195 GLARDI 200

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 71
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 72  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 131 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 167

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/117 (34%), Positives = 64/117 (54%), Gaps = 4/117 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           +D   EV++L +++HPN++        +  ++LI E + GG+L  +L EK +L+   A  
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQNS 314
           F   I  G+ YLH+    I H DLKP N++L+  N     +K+ DFGL+  I   N 
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNL 208
           DPS+  F    ++G+GSFG++ L     G+       +  L    L ++D    + E ++
Sbjct: 23  DPSQ--FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
           LV++ HP IV+   A      L LI ++LRGGDL   L ++   +      +  ++A  +
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            +LH+    II+RDLKP N+LL      H+K+ DFGLSK
Sbjct: 141 DHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSK 175

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    ++  L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 202 GLARDI---NNIDYYKKT 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 75
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 76  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 134
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 135 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 171

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 79/169 (46%), Gaps = 10/169 (5%)
Query: 165 IGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G++GE+L  K    G   AIK I  S             EV +L +L HPNI++   
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
              +++   L+ E  RGG+L   +  +   S   A      +  G  YLH     I+HRD
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN--IVHRD 129
Query: 283 LKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LKP N+LL + S D L K+ DFGLS   +V       KM    G+  Y+
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGG-----KMKERLGTAYYI 173

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    ++  L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 202 GLARDI---NNIDYYKKT 216

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNL 208
           DPS+  F    ++G+GSFG++ L     G+       +  L    L ++D    + E ++
Sbjct: 22  DPSQ--FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
           LV++ HP IV+   A      L LI ++LRGGDL   L ++   +      +  ++A  +
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            +LH+    II+RDLKP N+LL      H+K+ DFGLSK
Sbjct: 140 DHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSK 174

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+FG   +++       VA+K I    + D    ++ + E+     LRHPNIV+F  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +     L +I EY  GG+L++ +   G  S   A  F   +  G++Y H+    I HRD
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRD 141
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LK  N LL  S A  LK+ DFG SK
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSK 166

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G FG+++ A   G           VA+K +    ++  L   
Sbjct: 22  WEFPRDKLTLGKP--LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 77
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 78  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 137
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 138 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 193
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 194 GLARDI---NNIDYYKKT 208

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           + +  ++G+GS+G ++K   +  G  VAIK+ L S  DD++V +    E+ LL +LRH N
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQLRHEN 85
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           +V  L    ++K   L+ E++    L         L       +   I  G+ + H+  +
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--H 143
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            IIHRD+KP N+L+  S    +K+ DFG ++ +
Sbjct: 144 NIIHRDIKPENILVSQSGV--VKLCDFGFARTL 174

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G FG+++ A   G           VA+K +    ++  L   
Sbjct: 19  WEFPRDKLTLGKP--LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 74
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 75  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 134
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 135 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 190
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 191 GLARDI---NNIDYYKKT 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    ++  L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 202 GLARDI---NNIDYYKNT 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 73
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 74  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 132
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFG +KL+
Sbjct: 133 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLL 169

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G FG+++ A   G           VA+K +    ++  L   
Sbjct: 17  WEFPRDKLTLGKP--LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 72
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 73  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 132
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 133 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLTARNVLVTENNV--MKIADF 188
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 189 GLARDI---NNIDYYKKT 203

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 92/186 (49%), Gaps = 14/186 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNL 208
           DPS+  F    ++G+GSFG++ L     G+       +  L    L ++D    + E ++
Sbjct: 22  DPSQ--FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
           LV++ HP IV+   A      L LI ++LRGGDL   L ++   +      +  ++A  +
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCE 328
            +LH+    II+RDLKP N+LL      H+K+ DFGLSK   + +    Y      G+ E
Sbjct: 140 DHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKE-SIDHEKKAYSF---CGTVE 191
Query: 329 YLVSNC 334
           Y+    
Sbjct: 192 YMAPEV 197

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++  G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 21  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 78
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 79  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 137
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 138 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 174

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 21  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 78
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 79  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 137
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFG +KL+
Sbjct: 138 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLL 174

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++  G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 14  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 71
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 72  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 131 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 167

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 71
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 72  ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFG +KL+
Sbjct: 131 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLL 167

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 87
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 146
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 147 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 185

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 88
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 147
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 148 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 186

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 79
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 138
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 139 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 177

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 86
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 145
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 146 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 184

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G+FG + +  +R       VAIK +      ++   ++   E  ++ +L +P IV+ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNEPNVII 279
           +G V + + LML+ E   GG LHK+L  K    P + V   L  ++ GM YL  E    +
Sbjct: 402 IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL--EEKNFV 458
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
           HR+L  RNVLLVN    + K+ DFGLSK +   +S+   +  G+
Sbjct: 459 HRNLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGK 500

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 80
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 139
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 140 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 178

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 80
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 139
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 140 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 178

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLN 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 124 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 169

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GSFG++  AY    G  VA+K I   +     +      E++ L  LRHP+I++   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +  +  ++++ EY  G +L  Y+ ++  +S   A  F   I   + Y H     I+HRD
Sbjct: 82  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRD 138
Query: 283 LKPRNVLLVNSSADHL--KVGDFGLSKLI 309
           LKP N+LL     +HL  K+ DFGLS ++
Sbjct: 139 LKPENLLL----DEHLNVKIADFGLSNIM 163

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 86
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 145
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 146 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 184

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 149 DWEIDPSELDFS-----SSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQD 201
           D E D  E D+         ++GKG++G +   +       +AIK I      D    Q 
Sbjct: 9   DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQP 65
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GAL--SPSTAV 258
              E+ L   L+H NIVQ+LG+ +E   + +  E + GG L   L+ K G L  +  T  
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            +   I  G+ YLH+  N I+HRD+K  NV L+N+ +  LK+ DFG SK
Sbjct: 126 FYTKQILEGLKYLHD--NQIVHRDIKGDNV-LINTYSGVLKISDFGTSK 171

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 87
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 146
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 147 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 185

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G FG+++ A   G           VA+K +    ++  L   
Sbjct: 76  WEFPRDKLTLGKP--LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 131
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 247
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 248 GLARDI---NNIDYYKKT 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GSFG++  AY    G  VA+K I   +     +      E++ L  LRHP+I++   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +  +  ++++ EY  G +L  Y+ ++  +S   A  F   I   + Y H     I+HRD
Sbjct: 81  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRD 137
Query: 283 LKPRNVLLVNSSADHL--KVGDFGLSKLI 309
           LKP N+LL     +HL  K+ DFGLS ++
Sbjct: 138 LKPENLLL----DEHLNVKIADFGLSNIM 162

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAI  +  + S      ++   E  ++
Sbjct: 48  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPK--ANKEILDEAYVM 105
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LIT+ +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 106 ASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 164
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 165 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 201

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 84
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 143
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 144 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 182

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 90
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 149
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 150 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 188

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 82
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 141
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 142 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 180

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 82
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 141
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 142 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 180

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    ++  L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +++ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MRIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 202 GLARDI---NNIDYYKKT 216

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 5/166 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH     
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IG 124
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
           I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 125 ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 168

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 5/166 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH     
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IG 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
           I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 126 ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 169

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 86
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 145
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 146 SAN--VLHRDLKPSN-LLLNTTXD-LKICDFGLARVADPDHDH 184

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 102
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIH 161
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 162 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 200

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 5/166 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH     
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IG 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
           I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 126 ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 169

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 5/166 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH     
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IG 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
           I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 126 ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 169

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 5/166 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH     
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IG 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
           I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 126 ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 169

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 11/176 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVK-LRH 214
           DF    +IGKGSFG++L A  +   V  A+K +       +   +    E N+L+K ++H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P +V    +      L  + +Y+ GG+L  +L+ +       A  +A +IA  + YLH+ 
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
              I++RDLKP N+LL   S  H+ + DFGL K    +N       +   G+ EYL
Sbjct: 159 --NIVYRDLKPENILL--DSQGHIVLTDFGLCK----ENIEHNSTTSTFCGTPEYL 206

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 86
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH-LSNDHICYFLYQILRGLKYIH 145
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 146 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 184

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 168

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +G GSFG +  +++   G   A+K +   +      ++    E  +L  + HP
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            I++  G   + + + +I +Y+ GG+L   L++        A  +A ++   + YLH++ 
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
             II+RDLKP N+LL  +   H+K+ DFG +K +
Sbjct: 127 --IIYRDLKPENILLDKNG--HIKITDFGFAKYV 156

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 168

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYXQRTLREIKILLRFRHEN 86
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 145
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 146 SAN--VLHRDLKPSN-LLLNTTXD-LKICDFGLARVADPDHDH 184

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GSFG++  AY    G  VA+K I   +     +      E++ L  LRHP+I++   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +  +  ++++ EY  G +L  Y+ ++  +S   A  F   I   + Y H     I+HRD
Sbjct: 76  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRD 132
Query: 283 LKPRNVLLVNSSADHL--KVGDFGLSKLI 309
           LKP N+LL     +HL  K+ DFGLS ++
Sbjct: 133 LKPENLLL----DEHLNVKIADFGLSNIM 157

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 168

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 168

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 7/156 (4%)
Query: 165 IGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VA+K I+     +   +Q    EV +   L HPNIV+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVK-IIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L L+ EY  GG++  YL   G      A      I   + Y H +   I+HRD
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQK--FIVHRD 138
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
           LK  N+LL   +  ++K+ DFG S      N  D +
Sbjct: 139 LKAENLLL--DADXNIKIADFGFSNEFTFGNKLDAF 172

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAI++I P   + +   Q    E+ +L++ RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPF--EHQTYCQRTLREIKILLRFRHEN 86
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 145
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 146 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 184

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GSFG++  AY    G  VA+K I   +     +      E++ L  LRHP+I++   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +  +  ++++ EY  G +L  Y+ ++  +S   A  F   I   + Y H     I+HRD
Sbjct: 72  VIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRD 128
Query: 283 LKPRNVLLVNSSADHL--KVGDFGLSKLI 309
           LKP N+LL     +HL  K+ DFGLS ++
Sbjct: 129 LKPENLLL----DEHLNVKIADFGLSNIM 153

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 124 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 169

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 10/169 (5%)
Query: 165 IGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G++GE+L  K    G   AIK I  S             EV +L +L HPNI++   
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
              +++   L+ E  RGG+L   +  +   S   A      +  G  YLH   + I+HRD
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK--HNIVHRD 146
Query: 283 LKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LKP N+LL + S D L K+ DFGLS   +V       KM    G+  Y+
Sbjct: 147 LKPENLLLESKSRDALIKIVDFGLSAHFEVGG-----KMKERLGTAYYI 190

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 124 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 169

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 2   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 122 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 167

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 168

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 82
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 141
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 142 SAN--VLHRDLKPSN-LLLNTTXD-LKICDFGLARVADPDHDH 180

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 168

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXG 168

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXG 168

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 4   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 124 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXG 169

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 82
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 141
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 142 SAN--VLHRDLKPSN-LLLNTTXD-LKICDFGLARVADPDHDH 180

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 77/147 (52%), Gaps = 7/147 (4%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GS+G + K   R  G  VAIK+ L S  DD ++ +    E+ +L +L+HPN+V  L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
               ++ L L+ EY     LH+  + +  +      +      + + + H   +  IHRD
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRD 127
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +KP N+L+   S   +K+ DFG ++L+
Sbjct: 128 VKPENILITKHSV--IKLCDFGFARLL 152

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 87/167 (52%), Gaps = 14/167 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +     ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 16  ETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVM 73
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             +  P + + LG +     + L+T+ +  G L  +++E +G L     +N+ + IA+GM
Sbjct: 74  AGVGSPYVSRLLG-ICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGM 132
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +YL  E   ++HRDL  RNVL+   S +H+K+ DFGL++L+ +  + 
Sbjct: 133 SYL--EDVRLVHRDLAARNVLV--KSPNHVKITDFGLARLLDIDETE 175

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L++ RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHEN 82
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 141
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 142 SAN--VLHRDLKPSN-LLLNTTXD-LKIXDFGLARVADPDHDH 180

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 78/155 (50%), Gaps = 19/155 (12%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRH-EVNLLVKLRHPNIVQFLGA 223
           +GKG +GE+ +  W G  VA+K I  S  +       FR  E+   V LRH NI+ F+ +
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVK-IFSSRDEQSW----FRETEIYNTVLLRHDNILGFIAS 70
Query: 224 -VTERKP---LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE----- 274
            +T R     L LIT Y   G L+ +L ++  L P  A+  A+  A G+A+LH E     
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFL-QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 275 -PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
               I HRD K RNVL+   S     + D GL+ +
Sbjct: 130 GKPAIAHRDFKSRNVLV--KSNLQCCIADLGLAVM 162

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 87/164 (53%), Gaps = 17/164 (10%)
Query: 165 IGKGSFGEI-LKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG++ L  Y       G  VA+K +             ++ E+++L  L H +I+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEHII 79
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           ++ G   ++  K L L+ EY+  G L  YL  + ++  +  + FA  I  GMAYLH++  
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHSQH- 137
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
             IHR+L  RNVLL N     +K+GDFGL+K   V   H+ Y++
Sbjct: 138 -YIHRNLAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEYYRV 176

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXG 168

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 90/163 (55%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L+  RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLAFRHEN 84
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 143
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N+++D LK+ DFGL+++    + H
Sbjct: 144 SAN--VLHRDLKPSN-LLLNTTSD-LKICDFGLARVADPDHDH 182

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 89/163 (54%), Gaps = 13/163 (7%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +++ + IG+G++G +  AY       VAIK+I P   + +   Q    E+ +L+  RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLAFRHEN 84
Query: 217 IV---QFLGAVT-ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           I+     + A T E+   + I + L   DL+K LK +  LS      F   I RG+ Y+H
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-LSNDHICYFLYQILRGLKYIH 143
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +    ++HRDLKP N LL+N++ D LK+ DFGL+++    + H
Sbjct: 144 SAN--VLHRDLKPSN-LLLNTTCD-LKICDFGLARVADPDHDH 182

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           D+E D +        ++GKG++G +   +       +AIK I      D    Q    E+
Sbjct: 4   DYEYDEN----GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEI 56
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GAL--SPSTAVNFALD 263
            L   L+H NIVQ+LG+ +E   + +  E + GG L   L+ K G L  +  T   +   
Sbjct: 57  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 116
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           I  G+ YLH+  N I+HRD+K  NV L+N+ +  LK+ DFG SK
Sbjct: 117 ILEGLKYLHD--NQIVHRDIKGDNV-LINTYSGVLKISDFGTSK 157

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 19/173 (10%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G G++GE+L    + T V  AIK I    + + S+ +L+      EV +L  L HPNI+
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL-----EEVAVLKLLDHPNIM 99
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
           +      +++   L+ E  +GG+L   +  +   +   A      +  G+ YLH     I
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--I 157
Query: 279 IHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           +HRDLKP N+LL +   D L K+ DFGLS + + Q      KM    G+  Y+
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-----KMKERLGTAYYI 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G++GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMXG 168

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKGSFG++  A ++ T    AIK +     L DD +        V L +   
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWE 77
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +         ++ L  + EYL GGDL  +++       S A  +A +I  G+ +LH+
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +   I++RDLK  N+LL      H+K+ DFG+ K
Sbjct: 138 KG--IVYRDLKLDNILL--DKDGHIKIADFGMCK 167

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    ++  L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I  Y   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 202 GLARDI---NNIDYYKKT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 73
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 74  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 132
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFG +KL+
Sbjct: 133 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLL 169

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++  G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 21  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 78
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 79  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 137
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+
Sbjct: 138 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL 174

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 73
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 74  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 132
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFG +KL+
Sbjct: 133 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLL 169

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 14/161 (8%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           E +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVM 75
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGM 268
             + +P++ + LG +     + LI + +  G L  Y++E K  +     +N+ + IA+GM
Sbjct: 76  ASVDNPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 134
Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            YL  E   ++HRDL  RNVL+   +  H+K+ DFG +KL+
Sbjct: 135 NYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGRAKLL 171

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 165 IGKGSFGEI-LKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG++ L  Y       G  VA+K +             ++ E+++L  L H +I+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEHII 79
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           ++ G   ++  K L L+ EY+  G L  YL  + ++  +  + FA  I  GMAYLH +  
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQH- 137
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
             IHR+L  RNVLL N     +K+GDFGL+K   V   H+ Y++
Sbjct: 138 -YIHRNLAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEYYRV 176

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 31/169 (18%)
Query: 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
           +DF    +IG G FG++ KA  R  G    IKR+       +   +    EV  L KL H
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDH 63
Query: 215 PNIVQFLG----------------AVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPST 256
            NIV + G                + ++ K L +  E+   G L ++++++    L    
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
           A+     I +G+ Y+H++   +I+RDLKP N+ LV++    +K+GDFGL
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTK--QVKIGDFGL 168

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           IGKG FGE+ +  WRG  VA+K  + S  ++R   ++   E+   V LRH NI+ F+ A 
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 67
Query: 225 TERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
            +       L L+++Y   G L  YL  +  ++    +  AL  A G+A+LH E      
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              I HRDLK +N+L+  +      + D GL+
Sbjct: 127 KPAIAHRDLKSKNILVKKNGT--CCIADLGLA 156

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           IGKG FGE+ +  WRG  VA+K  + S  ++R   ++   E+   V LRH NI+ F+ A 
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 72
Query: 225 TERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
            +       L L+++Y   G L  YL  +  ++    +  AL  A G+A+LH E      
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              I HRDLK +N+L+  +      + D GL+
Sbjct: 132 KPAIAHRDLKSKNILVKKNGT--CCIADLGLA 161

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           IGKG FGE+ +  WRG  VA+K  + S  ++R   ++   E+   V LRH NI+ F+ A 
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 69
Query: 225 TERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
            +       L L+++Y   G L  YL  +  ++    +  AL  A G+A+LH E      
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              I HRDLK +N+L+  +      + D GL+
Sbjct: 129 KPAIAHRDLKSKNILVKKNGT--CCIADLGLA 158

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    ++  L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I  Y   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D YK T
Sbjct: 202 GLARDI---NNIDYYKKT 216

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           IGKG FGE+ +  WRG  VA+K  + S  ++R   ++   E+   V LRH NI+ F+ A 
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 66
Query: 225 TERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
            +       L L+++Y   G L  YL  +  ++    +  AL  A G+A+LH E      
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              I HRDLK +N+L+  +      + D GL+
Sbjct: 126 KPAIAHRDLKSKNILVKKNGT--CCIADLGLA 155

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           IGKG FGE+ +  WRG  VA+K  + S  ++R   ++   E+   V LRH NI+ F+ A 
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 92
Query: 225 TERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
            +       L L+++Y   G L  YL  +  ++    +  AL  A G+A+LH E      
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              I HRDLK +N+L+  +      + D GL+
Sbjct: 152 KPAIAHRDLKSKNILVKKNGT--CCIADLGLA 181

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 83/153 (54%), Gaps = 11/153 (7%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDR--LVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG++     R +   ++R++ +++ DR  + ++    E+ +L  L HPNI++   
Sbjct: 30  LGSGAFGDVHLVEERSS--GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 223 AVTERKPLMLITEYLRGGDLHKYL---KEKG-ALSPSTAVNFALDIARGMAYLHNEPNVI 278
              +   + ++ E   GG+L + +   + +G ALS          +   +AY H++   +
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--V 145
Query: 279 IHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLIK 310
           +H+DLKP N+L  ++S    +K+ DFGL++L K
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    ++  L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D  K T
Sbjct: 202 GLARDI---NNIDXXKKT 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPS--LSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKGSFG++  A ++ T    AIK +     L DD +        V L +   
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWE 76
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +         ++ L  + EYL GGDL  +++       S A  +A +I  G+ +LH+
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +   I++RDLK  N+LL      H+K+ DFG+ K
Sbjct: 137 KG--IVYRDLKLDNILL--DKDGHIKIADFGMCK 166

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
           WE    +L       +G+G+FG+++ A   G           VA+K +    ++  L   
Sbjct: 30  WEFPRDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL--S 85
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS------ 253
           D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +          
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 254 ----PSTAVNF------ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
               P   + F         +ARGM YL ++    IHRDL  RNVL+  ++   +K+ DF
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV--MKIADF 201
Query: 304 GLSKLIKVQNSHDVYKMT 321
           GL++ I   N+ D  K T
Sbjct: 202 GLARDI---NNIDXXKKT 216

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 164 IIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +IGKG+F  + +   R T     V I  +    S   L  +D + E ++   L+HP+IV+
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEP 275
            L   +    L ++ E++ G DL   + ++       S + A ++   I   + Y H+  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 276 NVIIHRDLKPRNVLLVN-SSADHLKVGDFGLS 306
           N IIHRD+KP NVLL +  ++  +K+GDFG++
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVA 180

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 14/154 (9%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFL 221
           IG GS+ E  +   + T +  A+K I  S  D          E+ +L++  +HPNI+   
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS-------EEIEILLRYGQHPNIITLK 87
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
               + K + L+TE +RGG+L   +  +   S   A      I + + YLH++   ++HR
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG--VVHR 145
Query: 282 DLKPRNVLLVNSSA--DHLKVGDFGLSKLIKVQN 313
           DLKP N+L V+ S   + L++ DFG +K ++ +N
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           IGKG FGE+ +  WRG  VA+K  + S  ++R   ++   E+   V LRH NI+ F+ A 
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVK--IFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105
Query: 225 TERK----PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
            +       L L+++Y   G L  YL  +  ++    +  AL  A G+A+LH E      
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              I HRDLK +N+L+  +      + D GL+
Sbjct: 165 KPAIAHRDLKSKNILVKKNGT--CCIADLGLA 194

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 75/163 (46%), Gaps = 7/163 (4%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP +L FS    IG GSFG +  A        VAIK++  S        QD   EV  L 
Sbjct: 51  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           KLRHPN +Q+ G         L+ EY  G         K  L             +G+AY
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
           LH+  + +IHRD+K  N+LL  S    +K+GDFG + ++   N
Sbjct: 170 LHS--HNMIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPAN 208

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++G G+F E++ A  + T   VAIK I     + +       +E+ +L K++HPNIV   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALD 82
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
                   L LI + + GG+L   + EKG  +   A      +   + YLH+    I+HR
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHR 140
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKL 308
           DLKP N+L  +   D  + + DFGLSK+
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 64/113 (56%), Gaps = 4/113 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           ++   EV++L ++ H N++        R  ++LI E + GG+L  +L +K +LS   A +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIK 310
           F   I  G+ YLH +   I H DLKP N++L+  N    H+K+ DFGL+  I+
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++G G+F E++ A  + T   VAIK I     + +       +E+ +L K++HPNIV   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALD 82
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
                   L LI + + GG+L   + EKG  +   A      +   + YLH+    I+HR
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHR 140
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKL 308
           DLKP N+L  +   D  + + DFGLSK+
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 82/160 (51%), Gaps = 12/160 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP-----VAIKRILPSLSDDRLVIQDFRHEVN 207
           DPS   F    ++G+GSFG++        P      A+K +  +    R  ++  + E +
Sbjct: 26  DPSH--FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERD 82
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
           +L  + HP +V+   A      L LI ++LRGGDL   L ++   +      +  ++A G
Sbjct: 83  ILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALG 142
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           + +LH+    II+RDLKP N+LL      H+K+ DFGLSK
Sbjct: 143 LDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSK 178

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 64/113 (56%), Gaps = 4/113 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           ++   EV++L ++ H N++        R  ++LI E + GG+L  +L +K +LS   A +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIK 310
           F   I  G+ YLH +   I H DLKP N++L+  N    H+K+ DFGL+  I+
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 9/153 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVA-----IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T +      IK+     S   +  ++   EV++L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  R  ++LI E + GG+L  +L +K +LS   A +F   I  G+ YLH +   I 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IA 137
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIK 310
           H DLKP N++L+  N    H+K+ DFGL+  I+
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 75/163 (46%), Gaps = 7/163 (4%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP +L FS    IG GSFG +  A        VAIK++  S        QD   EV  L 
Sbjct: 12  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           KLRHPN +Q+ G         L+ EY  G         K  L             +G+AY
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
           LH+  + +IHRD+K  N+LL  S    +K+GDFG + ++   N
Sbjct: 131 LHS--HNMIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPAN 169

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 90/180 (50%), Gaps = 18/180 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 85
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++     +     G+ +Y+
Sbjct: 146 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQA--RANAFVGTAQYV 199

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 5/170 (2%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           P   D+     +G+G+ GE+  A  R T  A+   +  +       ++ + E+ +   L 
Sbjct: 3   PFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           H N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMTG 322
               I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  KM G
Sbjct: 123 --IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERLLNKMCG 168

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 64/113 (56%), Gaps = 4/113 (3%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           ++   EV++L ++ H N++        R  ++LI E + GG+L  +L +K +LS   A +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLV--NSSADHLKVGDFGLSKLIK 310
           F   I  G+ YLH +   I H DLKP N++L+  N    H+K+ DFGL+  I+
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 9/153 (5%)
Query: 165 IGKGSFGEILKAYWRGTPVA-----IKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T +      IK+     S   +  ++   EV++L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  R  ++LI E + GG+L  +L +K +LS   A +F   I  G+ YLH +   I 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IA 137
Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIK 310
           H DLKP N++L+  N    H+K+ DFGL+  I+
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++G G+F E++ A  + T   VAIK I     + +       +E+ +L K++HPNIV   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALD 82
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
                   L LI + + GG+L   + EKG  +   A      +   + YLH+    I+HR
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHR 140
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKL 308
           DLKP N+L  +   D  + + DFGLSK+
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++G G+F E++ A  + T   VAIK I     + +       +E+ +L K++HPNIV   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPNIVALD 82
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
                   L LI + + GG+L   + EKG  +   A      +   + YLH+    I+HR
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHR 140
Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKL 308
           DLKP N+L  +   D  + + DFGLSK+
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 92
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 93  RLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 152
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 153 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 193

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 20/172 (11%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKA--YWRGTPVAIKRILPSLSD-DRLVIQDFRHEVNL 208
           ++  EL      ++ +G F  + +A     G   A+KR+L +  + +R +IQ    EV  
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ----EVCF 78
Query: 209 LVKLR-HPNIVQFLGAV--------TERKPLMLITEYLRGG--DLHKYLKEKGALSPSTA 257
           + KL  HPNIVQF  A         T +   +L+TE  +G   +  K ++ +G LS  T 
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +       R + ++H +   IIHRDLK  N+LL N     +K+ DFG +  I
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTI 188

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 85
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 146 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 186

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+FG   +++       VA+K I      D    ++ + E+     LRHPNIV+F  
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREIINHRSLRHPNIVRFKE 81
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +     L ++ EY  GG+L + +   G  S   A  F   +  G++Y H     + HRD
Sbjct: 82  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRD 139
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LK  N LL  S A  LK+ DFG SK
Sbjct: 140 LKLENTLLDGSPAPRLKICDFGYSK 164

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG---AVTERKPL-MLITEYLR 238
           VA+K +   L+ D      FR E      L HP IV       A T   PL  ++ EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVD 99
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
           G  L   +  +G ++P  A+    D  + + + H   N IIHRD+KP N+++  S+ + +
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMI--SATNAV 155
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           KV DFG+++ I   + + V +     G+ +YL
Sbjct: 156 KVMDFGIARAI-ADSGNSVTQTAAVIGTAQYL 186

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 16/159 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 84
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++
Sbjct: 145 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVL 179

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 87
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 148 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 188

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 16/159 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 84
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 85  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 144
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++
Sbjct: 145 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVL 179

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 85
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 146 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 186

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 87
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 148 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 188

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 88
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 149 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 189

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 87
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 148 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 188

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 88
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 89  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 148
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 149 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 189

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 16/159 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 69
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 70  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 129
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++
Sbjct: 130 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVL 164

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 14/172 (8%)
Query: 165 IGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           +G G+FG++ KA  + T V A  +++ + S++ L  +D+  E+++L    HPNIV+ L A
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 102
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
                 L ++ E+  GG +   + E +  L+ S            + YLH+  N IIHRD
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRD 160
Query: 283 LKPRNVLLVNSSADHLKVGDFGLS----KLIKVQNSH--DVYKMTGETGSCE 328
           LK  N+L        +K+ DFG+S    + I+ ++S     Y M  E   CE
Sbjct: 161 LKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 210

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG---AVTERKPL-MLITEYLR 238
           VA+K +   L+ D      FR E      L HP IV       A T   PL  ++ EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
           G  L   +  +G ++P  A+    D  + + + H   N IIHRD+KP N+L+  S+ + +
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANILI--SATNAV 155
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           KV DFG+++ I   + + V +     G+ +YL
Sbjct: 156 KVVDFGIARAI-ADSGNSVXQTAAVIGTAQYL 186

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 87/172 (50%), Gaps = 14/172 (8%)
Query: 165 IGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           +G G+FG++ KA  + T V A  +++ + S++ L  +D+  E+++L    HPNIV+ L A
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 102
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
                 L ++ E+  GG +   + E +  L+ S            + YLH+  N IIHRD
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRD 160
Query: 283 LKPRNVLLVNSSADHLKVGDFGLS----KLIKVQNSH--DVYKMTGETGSCE 328
           LK  N+L        +K+ DFG+S    + I+ ++S     Y M  E   CE
Sbjct: 161 LKAGNILFTLDG--DIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCE 210

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 87
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 148 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 188

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G FG + K Y   T VA+K++  +  ++ + L  Q F  E+ ++ K +H N+V+ LG
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK-QQFDQEIKVMAKCQHENLVELLG 97
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPST---AVNFALDIARGMAYLHNEPNVII 279
             ++   L L+  Y+  G L   L       P +       A   A G+ +LH   N  I
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHI 155
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           HRD+K  N+LL    A   K+ DFGL++
Sbjct: 156 HRDIKSANILL--DEAFTAKISDFGLAR 181

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G FG + K Y   T VA+K++  +  ++ + L  Q F  E+ ++ K +H N+V+ LG
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK-QQFDQEIKVMAKCQHENLVELLG 97
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPST---AVNFALDIARGMAYLHNEPNVII 279
             ++   L L+  Y+  G L   L       P +       A   A G+ +LH   N  I
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHI 155
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           HRD+K  N+LL    A   K+ DFGL++
Sbjct: 156 HRDIKSANILL--DEAFTAKISDFGLAR 181

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 90
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 91  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 150
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 151 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 191

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 87
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 148 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 188

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 122 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 177
Query: 326 SCEY 329
            C+Y
Sbjct: 178 GCKY 181

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 326 SCEY 329
            C+Y
Sbjct: 177 GCKY 180

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 66
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 125 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 180
Query: 326 SCEY 329
            C+Y
Sbjct: 181 GCKY 184

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 120 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 326 SCEY 329
            C+Y
Sbjct: 176 GCKY 179

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 14/154 (9%)
Query: 165 IGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFL 221
           IG GS+ E  +   + T +  A+K I  S  D          E+ +L++  +HPNI+   
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPS-------EEIEILLRYGQHPNIITLK 87
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
               + K + L+TE +RGG+L   +  +   S   A      I + + YLH++   ++HR
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG--VVHR 145
Query: 282 DLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQN 313
           DLKP N+L V+ S +   L++ DFG +K ++ +N
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 326 SCEY 329
            C+Y
Sbjct: 177 GCKY 180

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G FG + K Y   T VA+K++  +  ++ + L  Q F  E+ ++ K +H N+V+ LG
Sbjct: 33  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK-QQFDQEIKVMAKCQHENLVELLG 91
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPST---AVNFALDIARGMAYLHNEPNVII 279
             ++   L L+  Y+  G L   L       P +       A   A G+ +LH   N  I
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHI 149
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           HRD+K  N+LL    A   K+ DFGL++
Sbjct: 150 HRDIKSANILL--DEAFTAKISDFGLAR 175

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 64
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 124
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 125 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 165

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 120 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 326 SCEY 329
            C+Y
Sbjct: 176 GCKY 179

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 128 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 326 SCEY 329
            C+Y
Sbjct: 184 GCKY 187

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 155

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 65
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 125
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 126 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 166

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 63
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 124 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 164

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 155

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 122 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 156

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 62
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 122
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 123 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 163

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 123 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 157

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 124 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 158

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG---AVTERKPL-MLITEYLR 238
           VA+K +   L+ D      FR E      L HP IV       A T   PL  ++ EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
           G  L   +  +G ++P  A+    D  + + + H   N IIHRD+KP N+++  S+ + +
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMI--SATNAV 155
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           KV DFG+++ I   + + V +     G+ +YL
Sbjct: 156 KVMDFGIARAI-ADSGNSVTQTAAVIGTAQYL 186

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           D +    +GKG +GE+ +  W+G  VA+K  + S  D++   ++   E+   V LRH NI
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQGENVAVK--IFSSRDEKSWFRE--TELYNTVMLRHENI 64
Query: 218 VQFLGA-VTER---KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           + F+ + +T R     L LIT Y   G L+ YL +   L   + +   L IA G+A+LH 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 274 E------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
           E         I HRDLK +N+L+  +      + D GL+ +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAVM 162

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 155

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 122 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 156

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 124 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 158

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 123 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 157

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 120 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 154

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 22/186 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           D+     IG GS+G   K   +    + + + L   S      Q    EVNLL +L+HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 217 IVQFLGAVTER--KPLMLITEYLRGGDL----------HKYLKEKGALSPSTAVNFALDI 264
           IV++   + +R    L ++ EY  GGDL           +YL E+  L   T +  AL  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
               +   +  + ++HRDLKP NV L      ++K+GDFGL++++    +HD        
Sbjct: 127 CHRRS---DGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARIL----NHDTSFAKAFV 177
Query: 325 GSCEYL 330
           G+  Y+
Sbjct: 178 GTPYYM 183

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 66
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 125 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 159

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           D+     IG GS+G   K   +    + + + L   S      Q    EVNLL +L+HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 217 IVQFLGAVTER--KPLMLITEYLRGGDL----------HKYLKEKGALSPSTAVNFALDI 264
           IV++   + +R    L ++ EY  GGDL           +YL E+  L   T +  AL  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
               +   +  + ++HRDLKP NV L      ++K+GDFGL++++
Sbjct: 127 CHRRS---DGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARIL 166

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+FG   +++       VA+K I         +  + + E+     LRHPNIV+F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI----ERGEKIAANVKREIINHRSLRHPNIVRFKE 82
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +     L ++ EY  GG+L + +   G  S   A  F   +  G++Y H     + HRD
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--MQVCHRD 140
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LK  N LL  S A  LK+ DFG SK
Sbjct: 141 LKLENTLLDGSPAPRLKICDFGYSK 165

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 155

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 120 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 154

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG---AVTERKPL-MLITEYLR 238
           VA+K +   L+ D      FR E      L HP IV       A T   PL  ++ EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
           G  L   +  +G ++P  A+    D  + + + H   N IIHRD+KP N+++  S+ + +
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMI--SATNAV 155
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           KV DFG+++ I   + + V +     G+ +YL
Sbjct: 156 KVMDFGIARAI-ADSGNSVTQTAAVIGTAQYL 186

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+FG   +++       VA+K I      D    ++ + E+     LRHPNIV+F  
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKID----ENVKREIINHRSLRHPNIVRFKE 82
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +     L ++ EY  GG+L + +   G  S   A  F   +  G++Y H     + HRD
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA--MQVAHRD 140
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LK  N LL  S A  LK+ DFG SK
Sbjct: 141 LKLENTLLDGSPAPRLKIADFGYSK 165

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           D+     IG GS+G   K   +    + + + L   S      Q    EVNLL +L+HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 217 IVQFLGAVTER--KPLMLITEYLRGGDL----------HKYLKEKGALSPSTAVNFALDI 264
           IV++   + +R    L ++ EY  GGDL           +YL E+  L   T +  AL  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
               +   +  + ++HRDLKP NV L      ++K+GDFGL++++
Sbjct: 127 CHRRS---DGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARIL 166

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG---AVTERKPL-MLITEYLR 238
           VA+K +   L+ D      FR E      L HP IV       A T   PL  ++ EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
           G  L   +  +G ++P  A+    D  + + + H   N IIHRD+KP N+++  S+ + +
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMI--SATNAV 155
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           KV DFG+++ I   + + V +     G+ +YL
Sbjct: 156 KVMDFGIARAI-ADSGNSVTQTAAVIGTAQYL 186

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 155

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   R + + + R L  L     +      E+ +L +   P I
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LKE   +        ++ + RG+AYL  E + 
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR-EKHQ 135
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 136 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 162

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 128 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 162

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 17/154 (11%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA- 223
           +GKG +GE+ +  W+G  VA+K  + S  D++   ++   E+   V LRH NI+ F+ + 
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVK--IFSSRDEKSWFRE--TELYNTVMLRHENILGFIASD 100
Query: 224 VTER---KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
           +T R     L LIT Y   G L+ YL +   L   + +   L IA G+A+LH E      
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
              I HRDLK +N+L+  +      + D GL+ +
Sbjct: 160 KPAIAHRDLKSKNILVKKNG--QCCIADLGLAVM 191

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 89/159 (55%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP N+L+    A  +K+ DFGL++   V
Sbjct: 122 S--HRVLHRDLKPENLLINTEGA--IKLADFGLARAFGV 156

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 17/164 (10%)
Query: 165 IGKGSFGEI-LKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG++ L  Y       G  VA+K +             ++ E+++L  L H +I+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEHII 96
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           ++ G   +     L L+ EY+  G L  YL  + ++  +  + FA  I  GMAYLH +  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQH- 154
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
             IHRDL  RNVLL N     +K+GDFGL+K   V   H+ Y++
Sbjct: 155 -YIHRDLAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEXYRV 193

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 17/164 (10%)
Query: 165 IGKGSFGEI-LKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG++ L  Y       G  VA+K +         +   ++ E+ +L  L H +IV
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ--LRSGWQREIEILRTLYHEHIV 74
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           ++ G   ++  K + L+ EY+  G L  YL  +  +  +  + FA  I  GMAYLH +  
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP-RHCVGLAQLLLFAQQICEGMAYLHAQH- 132
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
             IHR L  RNVLL N     +K+GDFGL+K   V   H+ Y++
Sbjct: 133 -YIHRALAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEYYRV 171

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 87/183 (47%), Gaps = 29/183 (15%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSL--SDDRLVIQDFRHEVNL 208
           E  F+   ++GKG FG + +A  +        VA+K +   +  S D   I++F  E   
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD---IEEFLREAAC 78
Query: 209 LVKLRHPNIVQFLGAVTE-----RKPL-MLITEYLRGGDLHKYL------KEKGALSPST 256
           + +  HP++ + +G         R P+ M+I  +++ GDLH +L      +    L   T
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
            V F +DIA GM YL +     IHRDL  RN +L       + V DFGLS+ I    S D
Sbjct: 139 LVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMT--VCVADFGLSRKI---YSGD 191
Query: 317 VYK 319
            Y+
Sbjct: 192 YYR 194

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 17/164 (10%)
Query: 165 IGKGSFGEI-LKAY-----WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
           +G+G FG++ L  Y       G  VA+K +         +   ++ E+ +L  L H +IV
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQ--LRSGWQREIEILRTLYHEHIV 73
Query: 219 QFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           ++ G   ++  K + L+ EY+  G L  YL  +  +  +  + FA  I  GMAYLH +  
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP-RHCVGLAQLLLFAQQICEGMAYLHAQH- 131
Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
             IHR L  RNVLL N     +K+GDFGL+K   V   H+ Y++
Sbjct: 132 -YIHRALAARNVLLDNDRL--VKIGDFGLAK--AVPEGHEYYRV 170

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 8/144 (5%)
Query: 165 IGKGSFGEILKAYWRGTPV-AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           +G G+FG++ KA  + T V A  +++ + S++ L  +D+  E+++L    HPNIV+ L A
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 102
Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
                 L ++ E+  GG +   + E +  L+ S            + YLH+  N IIHRD
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD--NKIIHRD 160
Query: 283 LKPRNVLLVNSSADHLKVGDFGLS 306
           LK  N+L        +K+ DFG+S
Sbjct: 161 LKAGNILFTLDG--DIKLADFGVS 182

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 89/159 (55%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP N+L+    A  +K+ DFGL++   V
Sbjct: 123 S--HRVLHRDLKPENLLINTEGA--IKLADFGLARAFGV 157

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 17/154 (11%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA- 223
           +GKG +GE+ +  W+G  VA+K  + S  D++   ++   E+   V LRH NI+ F+ + 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVK--IFSSRDEKSWFRE--TELYNTVMLRHENILGFIASD 71
Query: 224 VTER---KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
           +T R     L LIT Y   G L+ YL +   L   + +   L IA G+A+LH E      
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
              I HRDLK +N+L+  +      + D GL+ +
Sbjct: 131 KPAIAHRDLKSKNILVKKNG--QCCIADLGLAVM 162

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRH-EVNLLVKLRHPNIVQFLGA 223
           IGKG +GE+    WRG  VA+K    +          FR  E+   V +RH NI+ F+ A
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVKVFFTTEEASW-----FRETEIYQTVLMRHENILGFIAA 99
Query: 224 ----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE----- 274
                     L LIT+Y   G L+ YLK    L   + +  A     G+ +LH E     
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 275 -PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDV 317
               I HRDLK +N+L+  +      + D GL+ K I   N  D+
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDI 201

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF   + A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 85
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G+L KY+++ G+   +    +  +I   + Y
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 146 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 186

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG---AVTERKPL-MLITEYLR 238
           VA+K +   L+ D      FR E      L HP IV       A T   PL  ++ EY+ 
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 116
Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
           G  L   +  +G ++P  A+    D  + + + H   N IIHRD+KP N+++  S+ + +
Sbjct: 117 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMI--SATNAV 172
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           KV DFG+++ I   + + V +     G+ +YL
Sbjct: 173 KVMDFGIARAI-ADSGNSVTQTAAVIGTAQYL 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 89/159 (55%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP N+L+    A  +K+ DFGL++   V
Sbjct: 122 S--HRVLHRDLKPENLLINTEGA--IKLADFGLARAFGV 156

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 89/159 (55%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP N+L+    A  +K+ DFGL++   V
Sbjct: 124 S--HRVLHRDLKPENLLINTEGA--IKLADFGLARAFGV 158

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 99/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+++ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 326 SCEY 329
            C+Y
Sbjct: 177 GCKY 180

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 6/151 (3%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A  + +   VA+K +  S  +   V    R E+ +   L HP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++      +R+ + LI EY   G+L+K L++              ++A  + Y H + 
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +IHRD+KP N+LL        K+ DFG S
Sbjct: 144 --VIHRDIKPENLLLGLKGEL--KIADFGWS 170

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 44/187 (23%)
Query: 157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
           +DF    +IG G FG++ KA  R  G    I+R+       +   +    EV  L KL H
Sbjct: 12  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-------KYNNEKAEREVKALAKLDH 64
Query: 215 PNIVQFLG-----------------------------AVTERKPLMLITEYLRGGDLHKY 245
            NIV + G                             + ++ K L +  E+   G L ++
Sbjct: 65  VNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 246 LKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
           ++++    L    A+     I +G+ Y+H++   +IHRDLKP N+ LV++    +K+GDF
Sbjct: 125 IEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LIHRDLKPSNIFLVDTK--QVKIGDF 180
Query: 304 GLSKLIK 310
           GL   +K
Sbjct: 181 GLVTSLK 187

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 165 IGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG+  I +    G  VA+K +         V+   + E+  L   RHP+I++   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            ++      ++ EY+ GG+L  Y+ + G +    A      I   + Y H   ++++HRD
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR--HMVVHRD 136
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLI 309
           LKP NVLL   +  + K+ DFGLS ++
Sbjct: 137 LKPENVLL--DAHMNAKIADFGLSNMM 161

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 165 IGKGSFGE--ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG+  I +    G  VA+K +         V+   + E+  L   RHP+I++   
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            ++      ++ EY+ GG+L  Y+ + G +    A      I   + Y H   ++++HRD
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR--HMVVHRD 136
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLI 309
           LKP NVLL   +  + K+ DFGLS ++
Sbjct: 137 LKPENVLL--DAHMNAKIADFGLSNMM 161

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 93/182 (51%), Gaps = 15/182 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   +++G+G++G +  A  +  G  VAIK+I P   D  L       E+ +L   +H 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHE 69
Query: 216 NIVQFLGAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           NI+           E    + I + L   DLH+ +  +  LS      F     R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVL 128
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG-ETGSCEYL 330
           H   + +IHRDLKP N LL+NS+ D LKV DFGL+++I  +++ D  + TG ++G  EY+
Sbjct: 129 HG--SNVIHRDLKPSN-LLINSNCD-LKVCDFGLARIID-ESAADNSEPTGQQSGMTEYV 183
Query: 331 VS 332
            +
Sbjct: 184 AT 185

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKGSFG++       T    A+K +      +R  +++   E+ ++  L HP +V    
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +  + + + ++ + L GGDL  +L++       T   F  ++   + YL N+   IIHRD
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ--RIIHRD 140
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +KP N+LL      H+ + DF ++ ++
Sbjct: 141 MKPDNILL--DEHGHVHITDFNIAAML 165

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 18/170 (10%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           W I+    D+    +IG G+   +  AY   +   VAIKRI  +L   +  + +   E+ 
Sbjct: 10  WSINRD--DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQ 65
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEK-----GALSPSTAVN 259
            + +  HPNIV +  +   +  L L+ + L GG   D+ K++  K     G L  ST   
Sbjct: 66  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              ++  G+ YLH   N  IHRD+K  N+LL    +  +++ DFG+S  +
Sbjct: 126 ILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGS--VQIADFGVSAFL 171

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 78/146 (53%), Gaps = 10/146 (6%)
Query: 165 IGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G++  + K   + T   VA+K I   L  +         EV+LL  L+H NIV    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN-FALDIARGMAYLHNEPNVIIHR 281
            +   K L L+ EYL   DL +YL + G +     V  F   + RG+AY H +   ++HR
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHR 124
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N LL+N   + LK+ DFGL++
Sbjct: 125 DLKPQN-LLINERGE-LKLADFGLAR 148

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFR---HEVNLLVKLRHPNIVQFL 221
           +GKG+F  + +   + T +     +  ++  +L  +DF+    E  +  KL+HPNIV+  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            ++ E     L+ + + GG+L + +  +   S + A +    I   +AY H+  N I+HR
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS--NGIVHR 152
Query: 282 DLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
           +LKP N+LL + +    +K+ DFGL+  I+V +S   +   G  G
Sbjct: 153 NLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 195

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 144
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 145 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 171

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 79/156 (50%), Gaps = 10/156 (6%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP EL F+    IGKGSFGE+ K     T   VAIK I   L +    I+D + E+ +L 
Sbjct: 20  DPEEL-FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLS 76
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +     + ++ G+  +   L +I EYL GG     L+  G            +I +G+ Y
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDY 135
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           LH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 136 LHSEKK--IHRDIKAANVLL--SEQGDVKLADFGVA 167

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRH---------EV 206
           ++  S  +G G+ GE+  A+ R T   VAIK I    S  +  I   R          E+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKII----SKRKFAIGSAREADPALNVETEI 66
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
            +L KL HP I++ +    + +   ++ E + GG+L   +     L  +T   +   +  
Sbjct: 67  EILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
            + YLH   N IIHRDLKP NVLL +   D L K+ DFG SK++
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFR---HEVNLLVKLRHPNIVQFL 221
           +GKG+F  + +   + T +     +  ++  +L  +DF+    E  +  KL+HPNIV+  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            ++ E     L+ + + GG+L + +  +   S + A +    I   +AY H+  N I+HR
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS--NGIVHR 129
Query: 282 DLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
           +LKP N+LL + +    +K+ DFGL+  I+V +S   +   G  G
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFR-----HEVNLLV 210
           DF    I+G+GSF  ++ A    T    AIK     + + R +I++ +      E +++ 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIK-----ILEKRHIIKENKVPYVTRERDVMS 87
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +L HP  V+      + + L     Y + G L KY+++ G+   +    +  +I   + Y
Sbjct: 88  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEY 147
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LH +   IIHRDLKP N+LL  +   H+++ DFG +K++  ++  
Sbjct: 148 LHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ 188

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRH---------EV 206
           ++  S  +G G+ GE+  A+ R T   VAIK I    S  +  I   R          E+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKII----SKRKFAIGSAREADPALNVETEI 66
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
            +L KL HP I++ +    + +   ++ E + GG+L   +     L  +T   +   +  
Sbjct: 67  EILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
            + YLH   N IIHRDLKP NVLL +   D L K+ DFG SK++
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRH---------EV 206
           ++  S  +G G+ GE+  A+ R T   VAIK I    S  +  I   R          E+
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKII----SKRKFAIGSAREADPALNVETEI 72
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
            +L KL HP I++ +    + +   ++ E + GG+L   +     L  +T   +   +  
Sbjct: 73  EILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
            + YLH   N IIHRDLKP NVLL +   D L K+ DFG SK++
Sbjct: 132 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 173

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 152
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 153 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 179

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRH---------EV 206
           ++  S  +G G+ GE+  A+ R T   VAIK I    S  +  I   R          E+
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKII----SKRKFAIGSAREADPALNVETEI 65
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
            +L KL HP I++ +    + +   ++ E + GG+L   +     L  +T   +   +  
Sbjct: 66  EILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
            + YLH   N IIHRDLKP NVLL +   D L K+ DFG SK++
Sbjct: 125 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 166

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRH---------EV 206
           ++  S  +G G+ GE+  A+ R T   VAIK I    S  +  I   R          E+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKII----SKRKFAIGSAREADPALNVETEI 66
Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
            +L KL HP I++ +    + +   ++ E + GG+L   +     L  +T   +   +  
Sbjct: 67  EILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
            + YLH   N IIHRDLKP NVLL +   D L K+ DFG SK++
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL-REKHK 128
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 129 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 155

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFR---HEVNLLVKLRHPNIVQFL 221
           +GKG+F  + +   + T +     +  ++  +L  +DF+    E  +  KL+HPNIV+  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            ++ E     L+ + + GG+L + +  +   S + A +    I   +AY H+  N I+HR
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS--NGIVHR 129
Query: 282 DLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
           +LKP N+LL + +    +K+ DFGL+  I+V +S   +   G  G
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 18/170 (10%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           W I+    D+    +IG G+   +  AY   +   VAIKRI  +L   +  + +   E+ 
Sbjct: 5   WSINRD--DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQ 60
Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEK-----GALSPSTAVN 259
            + +  HPNIV +  +   +  L L+ + L GG   D+ K++  K     G L  ST   
Sbjct: 61  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 120
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
              ++  G+ YLH   N  IHRD+K  N+LL    +  +++ DFG+S  +
Sbjct: 121 ILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGS--VQIADFGVSAFL 166

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFR---HEVNLLVKLRHPNIVQFL 221
           +GKG+F  + +   + T +     +  ++  +L  +DF+    E  +  KL+HPNIV+  
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            ++ E     L+ + + GG+L + +  +   S + A +    I   +AY H+  N I+HR
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS--NGIVHR 128
Query: 282 DLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
           +LKP N+LL + +    +K+ DFGL+  I+V +S   +   G  G
Sbjct: 129 NLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 171

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 126 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 152

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 126 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 152

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 126 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 152

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 187
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 188 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 214

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLRH 214
           F    ++G G+F E+     R  G   A+K I   P+  D  L      +E+ +L K++H
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL-----ENEIAVLKKIKH 65
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
            NIV             L+ + + GG+L   + E+G  +   A      +   + YLH  
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE- 124
Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKL 308
            N I+HRDLKP N+L +    +  + + DFGLSK+
Sbjct: 125 -NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     IG GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GGD+  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      ++KV DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIKVADFGFAKRVK 192

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 126 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 152

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 98/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+ +I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 121 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 326 SCEY 329
            C+Y
Sbjct: 177 GCKY 180

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 98/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+ +I      + +     R E++LL +L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 120 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 326 SCEY 329
            C+Y
Sbjct: 176 GCKY 179

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     IG GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GGD+  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      ++KV DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIKVADFGFAKRVK 192

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 83/164 (50%), Gaps = 11/164 (6%)
Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG + +   + T      K I      D+  +   ++E++++ +L HP ++    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISIMNQLHHPKLINLHD 115
Query: 223 AVTERKPLMLITEYLRGGDLH-KYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           A  ++  ++LI E+L GG+L  +   E   +S +  +N+      G+ ++H   + I+H 
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHL 173
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
           D+KP N++     A  +K+ DFGL+  +   N  ++ K+T  T 
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATA 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 85/158 (53%), Gaps = 17/158 (10%)
Query: 156 ELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLV 210
           +LDF     +G+G F  + KA  + T   VAIK+I     S + D +     R E+ LL 
Sbjct: 14  KLDF-----LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQ 67
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMA 269
           +L HPNI+  L A   +  + L+ +++   DL   +K+    L+PS    + L   +G+ 
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           YLH   + I+HRDLKP N+LL  +    LK+ DFGL+K
Sbjct: 127 YLHQ--HWILHRDLKPNNLLLDENGV--LKLADFGLAK 160

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 18/162 (11%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV------NFALDIARGMA 269
           NIV+ L  +     L L+ E+     LH+ LK+    S  T +      ++   + +G+A
Sbjct: 63  NIVKLLDVIHTENKLYLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           + H+  + ++HRDLKP N+L+    A  +K+ DFGL++   V
Sbjct: 118 FCHS--HRVLHRDLKPENLLINTEGA--IKLADFGLARAFGV 155

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 89/159 (55%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL  ++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLH-QDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 124 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 158

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 3/149 (2%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           DF   + +G G+ G + K   + + + + R L  L     +      E+ +L +   P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           V F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  E + 
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           I+HRD+KP N+ LVNS  + +K+ DFG+S
Sbjct: 126 IMHRDVKPSNI-LVNSRGE-IKLCDFGVS 152

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 159 FSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNL--LVKLR 213
           +   A IG+G++G++ KA      G  VA+KR+     ++ + +   R    L  L    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 214 HPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIAR 266
           HPN+V+     T         L L+ E++   DL  YL +  +  +   T  +    + R
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           G+ +LH+  + ++HRDLKP+N+L+  +S+  +K+ DFGL+++   Q
Sbjct: 132 GLDFLHS--HRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQ 173

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 90/159 (56%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E++   DL K++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 124 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 158

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 89/159 (55%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL  ++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 123 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 157

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 80/147 (54%), Gaps = 22/147 (14%)
Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF--------------LGAVTERK 228
           VAIK+I+  L+D + V    R E+ ++ +L H NIV+               +G++TE  
Sbjct: 39  VAIKKIV--LTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95
Query: 229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNV 288
            + ++ EY+   DL   L E+G L    A  F   + RG+ Y+H+    ++HRDLKP N 
Sbjct: 96  SVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPAN- 150
Query: 289 LLVNSSADHLKVGDFGLSKLIKVQNSH 315
           L +N+    LK+GDFGL++++    SH
Sbjct: 151 LFINTEDLVLKIGDFGLARIMDPHYSH 177

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 158 DFSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F    ++GKG+FG+++  K    G   A+K +   +   +  +     E  +L   RHP
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +     +      L  + EY  GG+L  +L  +   S   A  +  +I   + YLH+E 
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           NV ++RDLK  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 269 NV-VYRDLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYL 316

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 159 FSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNL--LVKLR 213
           +   A IG+G++G++ KA      G  VA+KR+     ++ + +   R    L  L    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 214 HPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIAR 266
           HPN+V+     T         L L+ E++   DL  YL +  +  +   T  +    + R
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           G+ +LH+  + ++HRDLKP+N+L+  +S+  +K+ DFGL+++   Q
Sbjct: 132 GLDFLHS--HRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQ 173

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 93/182 (51%), Gaps = 15/182 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   +++G+G++G +  A  +  G  VAIK+I P   D  L       E+ +L   +H 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHE 69
Query: 216 NIVQFLGAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           NI+           E    + I + L   DLH+ +  +  LS      F     R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVL 128
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG-ETGSCEYL 330
           H   + +IHRDLKP N LL+NS+ D LKV DFGL+++I  +++ D  + TG ++G  E++
Sbjct: 129 HG--SNVIHRDLKPSN-LLINSNCD-LKVCDFGLARIID-ESAADNSEPTGQQSGMVEFV 183
Query: 331 VS 332
            +
Sbjct: 184 AT 185

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 158 DFSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F    ++GKG+FG+++  K    G   A+K +   +   +  +     E  +L   RHP
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +     +      L  + EY  GG+L  +L  +   S   A  +  +I   + YLH+E 
Sbjct: 212 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           NV ++RDLK  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 272 NV-VYRDLKLENLML--DKDGHIKITDFGLCK----EGIKDGATMKTFCGTPEYL 319

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 17/189 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           ++DP+E+ +     +G G+FG++ KA  + T  +A  +++ + S++ L  +D+  E+ +L
Sbjct: 14  DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYIVEIEIL 70
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
               HP IV+ LGA      L ++ E+  GG +   + E  +G   P   V     +   
Sbjct: 71  ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEA 129
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDV-----YKMT 321
           + +LH+    IIHRDLK  NVL+  +    +++ DFG+S K +K     D      Y M 
Sbjct: 130 LNFLHS--KRIIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 185
Query: 322 GETGSCEYL 330
            E   CE +
Sbjct: 186 PEVVMCETM 194

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 149 DWEIDPSEL--DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRH 204
           D  + P  L  ++  S  +G G+ GE+  A+ R T   VAI+ I    S  +  I   R 
Sbjct: 125 DQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII----SKRKFAIGSARE 180
Query: 205 ---------EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
                    E+ +L KL HP I++ +    + +   ++ E + GG+L   +     L  +
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEA 239
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           T   +   +   + YLH   N IIHRDLKP NVLL +   D L K+ DFG SK++
Sbjct: 240 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 17/189 (8%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           ++DP+E+ +     +G G+FG++ KA  + T  +A  +++ + S++ L  +D+  E+ +L
Sbjct: 6   DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYIVEIEIL 62
Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARG 267
               HP IV+ LGA      L ++ E+  GG +   + E  +G   P   V     +   
Sbjct: 63  ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEA 121
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS-KLIKVQNSHDV-----YKMT 321
           + +LH+    IIHRDLK  NVL+  +    +++ DFG+S K +K     D      Y M 
Sbjct: 122 LNFLHS--KRIIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA 177
Query: 322 GETGSCEYL 330
            E   CE +
Sbjct: 178 PEVVMCETM 186

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 89/159 (55%), Gaps = 12/159 (7%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E+L   DL  ++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V
Sbjct: 124 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV 158

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+FG   +++       VA+K I      D    ++ + E+     LRHPNIV+F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREIINHRSLRHPNIVRFKE 82
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +     L ++ EY  GG+L + +   G  S   A  F   +  G++Y H     + HRD
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--MQVCHRD 140
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LK  N LL  S A  LK+  FG SK
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGYSK 165

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 84/175 (48%), Gaps = 21/175 (12%)
Query: 149 DWEIDPSEL--DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRH 204
           D  + P  L  ++  S  +G G+ GE+  A+ R T   VAI+ I    S  +  I   R 
Sbjct: 139 DQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII----SKRKFAIGSARE 194
Query: 205 ---------EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
                    E+ +L KL HP I++ +    + +   ++ E + GG+L   +     L  +
Sbjct: 195 ADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEA 253
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLI 309
           T   +   +   + YLH   N IIHRDLKP NVLL +   D L K+ DFG SK++
Sbjct: 254 TCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 306

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 45/197 (22%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 13  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+ITE+ + G+L  YL+           
Sbjct: 71  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 182
Query: 303 FGLSKLIKVQNSHDVYK 319
           FGL++        D+YK
Sbjct: 183 FGLAR--------DIYK 191

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 8/145 (5%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+FG   +++       VA+K I      D    ++ + E+     LRHPNIV+F  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREIINHRSLRHPNIVRFKE 82
Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +     L ++ EY  GG+L + +   G  S   A  F   +  G++Y H     + HRD
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--MQVCHRD 140
Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LK  N LL  S A  LK+  FG SK
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGYSK 165

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 158 DFSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F    ++GKG+FG+++  K    G   A+K +   +   +  +     E  +L   RHP
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +     +      L  + EY  GG+L  +L  +   S   A  +  +I   + YLH+E 
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 128
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           NV ++RDLK  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 129 NV-VYRDLKLENLMLDKDG--HIKITDFGLCK----EGIKDGATMKXFCGTPEYL 176

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 72/143 (50%), Gaps = 15/143 (10%)
Query: 165 IGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 221
           +G+GSFGE+  ++    G   A+K++       RL +  FR  E+     L  P IV   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-------RLEV--FRAEELMACAGLTSPRIVPLY 151
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           GAV E   + +  E L GG L + +KE+G L    A+ +      G+ YLH+    I+H 
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHS--RRILHG 209
Query: 282 DLKPRNVLLVNSSADHLKVGDFG 304
           D+K  NVLL +S   H  + DFG
Sbjct: 210 DVKADNVLL-SSDGSHAALCDFG 231

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 158 DFSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F    ++GKG+FG+++  K    G   A+K +   +   +  +     E  +L   RHP
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +     +      L  + EY  GG+L  +L  +   S   A  +  +I   + YLH+E 
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 129
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           NV ++RDLK  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 130 NV-VYRDLKLENLMLDKDG--HIKITDFGLCK----EGIKDGATMKXFCGTPEYL 177

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 45/197 (22%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 13  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+ITE+ + G+L  YL+           
Sbjct: 71  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 182
Query: 303 FGLSKLIKVQNSHDVYK 319
           FGL++        D+YK
Sbjct: 183 FGLAR--------DIYK 191

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 158 DFSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F    ++GKG+FG+++  K    G   A+K +   +   +  +     E  +L   RHP
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +     +      L  + EY  GG+L  +L  +   S   A  +  +I   + YLH+E 
Sbjct: 71  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 130
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           NV ++RDLK  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 131 NV-VYRDLKLENLMLDKDG--HIKITDFGLCK----EGIKDGATMKXFCGTPEYL 178

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 166 GKGSFGEILKAYWRGTPVAIKRI--LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           G+G FG + K Y   T VA+K++  +  ++ + L  Q F  E+ +  K +H N+V+ LG 
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK-QQFDQEIKVXAKCQHENLVELLGF 89
Query: 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPST---AVNFALDIARGMAYLHNEPNVIIH 280
            ++   L L+  Y   G L   L       P +       A   A G+ +LH   N  IH
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHE--NHHIH 147
Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RD+K  N+LL    A   K+ DFGL++
Sbjct: 148 RDIKSANILL--DEAFTAKISDFGLAR 172

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 72/143 (50%), Gaps = 15/143 (10%)
Query: 165 IGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 221
           +G+GSFGE+  ++    G   A+K++       RL +  FR  E+     L  P IV   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-------RLEV--FRAEELMACAGLTSPRIVPLY 132
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           GAV E   + +  E L GG L + +KE+G L    A+ +      G+ YLH+    I+H 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHS--RRILHG 190
Query: 282 DLKPRNVLLVNSSADHLKVGDFG 304
           D+K  NVLL +S   H  + DFG
Sbjct: 191 DVKADNVLL-SSDGSHAALCDFG 212

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++       +G+GSFG + +   R        T VA+K +  S S    +  +
Sbjct: 8   EWEVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--E 63
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--------KGALS 253
           F +E +++      ++V+ LG V++ +P +++ E +  GDL  YL+          G   
Sbjct: 64  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 123
Query: 254 PS--TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           P+    +  A +IA GMAYL+ +    +HRDL  RN ++ +     +K+GDFG+++ I
Sbjct: 124 PTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDI 177

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++       +G+GSFG + +   R        T VA+K +  S S    +  +
Sbjct: 11  EWEVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--E 66
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--------KGALS 253
           F +E +++      ++V+ LG V++ +P +++ E +  GDL  YL+          G   
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 254 PS--TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           P+    +  A +IA GMAYL+ +    +HRDL  RN ++ +     +K+GDFG+++ I
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDI 180

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 159 FSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNL--LVKLR 213
           +   A IG+G++G++ KA      G  VA+KR+     ++ + +   R    L  L    
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 214 HPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIAR 266
           HPN+V+     T         L L+ E++   DL  YL +  +  +   T  +    + R
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           G+ +LH+  + ++HRDLKP+N+L+  +S+  +K+ DFGL+++   Q
Sbjct: 132 GLDFLHS--HRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQ 173

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++       +G+GSFG + +   R        T VA+K +  S S    +  +
Sbjct: 11  EWEVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--E 66
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--------KGALS 253
           F +E +++      ++V+ LG V++ +P +++ E +  GDL  YL+          G   
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 254 PS--TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           P+    +  A +IA GMAYL+ +    +HRDL  RN ++ +     +K+GDFG+++ I
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDI 180

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 97/194 (50%), Gaps = 30/194 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   A++G+G+FG+++KA         AIK+I    ++++L       EV LL  L H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKL--STILSEVMLLASLNHQ 62
Query: 216 NIVQFLGAVTER----KP---------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
            +V++  A  ER    KP         L +  EY   G L+  +  +  L+      + L
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRL 121
Query: 263 --DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
              I   ++Y+H++   IIHRDLKP N+ +  S   ++K+GDFGL+K   V  S D+ K+
Sbjct: 122 FRQILEALSYIHSQG--IIHRDLKPMNIFIDESR--NVKIGDFGLAK--NVHRSLDILKL 175
Query: 321 TGET--GSCEYLVS 332
             +   GS + L S
Sbjct: 176 DSQNLPGSSDNLTS 189

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++       +G+GSFG + +   R        T VA+K +  S S    +  +
Sbjct: 11  EWEVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--E 66
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--------KGALS 253
           F +E +++      ++V+ LG V++ +P +++ E +  GDL  YL+          G   
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 254 PS--TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           P+    +  A +IA GMAYL+ +    +HRDL  RN ++ +     +K+GDFG+++ I
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDI 180

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 41/193 (21%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L+      +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 22  WEFPRDRLNLGKP--LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS 79
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 80  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
Query: 249 --KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ DFGL+
Sbjct: 136 LYKDFLTLEHLICYSFQVAKGMEFLASRKX--IHRDLAARNILL--SEKNVVKICDFGLA 191
Query: 307 KLIKVQNSHDVYK 319
           +        D+YK
Sbjct: 192 R--------DIYK 196

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++       +G+GSFG + +   R        T VA+K +  S S    +  +
Sbjct: 11  EWEVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--E 66
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--------KGALS 253
           F +E +++      ++V+ LG V++ +P +++ E +  GDL  YL+          G   
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 254 PS--TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           P+    +  A +IA GMAYL+ +    +HRDL  RN ++ +     +K+GDFG+++ I
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDI 180

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 37/187 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 13  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+ITE+ + G+L  YL+           
Sbjct: 71  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 182
Query: 303 FGLSKLI 309
           FGL++ I
Sbjct: 183 FGLARDI 189

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 65/117 (55%), Gaps = 5/117 (4%)
Query: 200 QDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
           +D   E+ +L++  +HPNI+       + K + ++TE ++GG+L   +  +   S   A 
Sbjct: 60  RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA--DHLKVGDFGLSKLIKVQN 313
                I + + YLH +   ++HRDLKP N+L V+ S   + +++ DFG +K ++ +N
Sbjct: 120 AVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 41/193 (21%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L+      +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 22  WEFPRDRLNLGKP--LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS 79
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 80  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
Query: 249 --KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ DFGL+
Sbjct: 136 LYKDFLTLEHLIXYSFQVAKGMEFLASRKX--IHRDLAARNILL--SEKNVVKIXDFGLA 191
Query: 307 KLIKVQNSHDVYK 319
           +        D+YK
Sbjct: 192 R--------DIYK 196

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/179 (32%), Positives = 89/179 (49%), Gaps = 21/179 (11%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           +  +G FG + KA      VA+K I P    D+   Q+  +EV  L  ++H NI+QF+GA
Sbjct: 31  VKARGRFGCVWKAQLLNEYVAVK-IFPI--QDKQSWQN-EYEVYSLPGMKHENILQFIGA 86
Query: 224 ----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNV- 277
                +    L LIT +   G L  +LK    +S +   + A  +ARG+AYLH + P + 
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 278 ------IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
                 I HRD+K +NVLL N+      + DFGL+  +K +         G+ G+  Y+
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLA--LKFEAGKSAGDTHGQVGTRRYM 200

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 23/162 (14%)
Query: 165 IGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G+GSFG + +   R        T VA+K +  S S    +  +F +E +++      ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCHHV 81
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKE--------KGALSPS--TAVNFALDIARG 267
           V+ LG V++ +P +++ E +  GDL  YL+          G   P+    +  A +IA G
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           MAYL+ +    +HRDL  RN ++ +     +K+GDFG+++ I
Sbjct: 142 MAYLNAKK--FVHRDLAARNCMVAHDFT--VKIGDFGMTRDI 179

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 18/183 (9%)
Query: 164 IIGKGSFGEILKAYWRGT---------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR- 213
           +IG+G    + +   R T          V  +R+ P   ++  V +  R E ++L ++  
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE--VREATRRETHILRQVAG 158
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP+I+  + +      + L+ + +R G+L  YL EK ALS     +    +   +++LH 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSN 333
             N I+HRDLKP N+LL ++    +++ DFG S    ++    + ++ G  G     +  
Sbjct: 219 --NNIVHRDLKPENILLDDNM--QIRLSDFGFS--CHLEPGEKLRELCGTPGYLAPEILK 272
Query: 334 CSF 336
           CS 
Sbjct: 273 CSM 275

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     IG GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      ++KV DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIKVADFGFAKRVK 192

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 98/184 (53%), Gaps = 19/184 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      + +     R E++LL +L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS--PSTAV-NFALDIARGMAYLH 272
           NIV+ L  +     L L+ E++   DL  ++ +  AL+  P   + ++   + +G+A+ H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVH-QDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV---QNSHDV----YKMTGETG 325
           +  + ++HRDLKP+N+L+    A  +K+ DFGL++   V     +H+V    Y+      
Sbjct: 120 S--HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 326 SCEY 329
            C+Y
Sbjct: 176 GCKY 179

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 18/171 (10%)
Query: 148 CDWE-----IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-- 200
           C W+     I  +  DFS   IIG+G FGE+     R         +  L   R+ ++  
Sbjct: 174 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQG 231
Query: 201 -----DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
                + R  ++L+     P IV    A      L  I + + GGDLH +L + G  S +
Sbjct: 232 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA 291
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
               +A +I  G+ ++HN    +++RDLKP N+LL      H+++ D GL+
Sbjct: 292 DMRFYAAEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLA 338

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G++G +  A  R  G  VAIK+I P+  D     +    E+ +L   +H NI+    
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 223 AVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
            +    P      + +   L   DLH+ +     L+      F   + RG+ Y+H+    
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS--AQ 179
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
           +IHRDLKP N LLVN + + LK+GDFG+++ +    +   Y MT
Sbjct: 180 VIHRDLKPSN-LLVNENCE-LKIGDFGMARGLCTSPAEHQYFMT 221

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 93/186 (50%), Gaps = 36/186 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L+      +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 23  WEFPRDRLNLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 80
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 81  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 136
Query: 249 -----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ DF
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICDF 192
Query: 304 GLSKLI 309
           GL++ I
Sbjct: 193 GLARDI 198

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 18/171 (10%)
Query: 148 CDWE-----IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-- 200
           C W+     I  +  DFS   IIG+G FGE+     R         +  L   R+ ++  
Sbjct: 175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQG 232
Query: 201 -----DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
                + R  ++L+     P IV    A      L  I + + GGDLH +L + G  S +
Sbjct: 233 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA 292
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
               +A +I  G+ ++HN    +++RDLKP N+LL      H+++ D GL+
Sbjct: 293 DMRFYAAEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLA 339

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
           S   F     +G G++  + K   +  G  VA+K +   L  +         E++L+ +L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV--KLDSEEGTPSTAIREISLMKEL 60
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA------LSPSTAVNFALDIAR 266
           +H NIV+    +     L L+ E++   DL KY+  +        L  +    F   + +
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           G+A+ H   N I+HRDLKP+N LL+N     LK+GDFGL++
Sbjct: 120 GLAFCHE--NKILHRDLKPQN-LLINKRG-QLKLGDFGLAR 156

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 18/171 (10%)
Query: 148 CDWE-----IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-- 200
           C W+     I  +  DFS   IIG+G FGE+     R         +  L   R+ ++  
Sbjct: 175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQG 232
Query: 201 -----DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
                + R  ++L+     P IV    A      L  I + + GGDLH +L + G  S +
Sbjct: 233 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA 292
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
               +A +I  G+ ++HN    +++RDLKP N+LL      H+++ D GL+
Sbjct: 293 DMRFYAAEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLA 339

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 18/171 (10%)
Query: 148 CDWE-----IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ-- 200
           C W+     I  +  DFS   IIG+G FGE+     R         +  L   R+ ++  
Sbjct: 175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQG 232
Query: 201 -----DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
                + R  ++L+     P IV    A      L  I + + GGDLH +L + G  S +
Sbjct: 233 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA 292
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
               +A +I  G+ ++HN    +++RDLKP N+LL      H+++ D GL+
Sbjct: 293 DMRFYAAEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLA 339

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G++G +  A  R  G  VAIK+I P+  D     +    E+ +L   +H NI+    
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 223 AVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
            +    P      + +   L   DLH+ +     L+      F   + RG+ Y+H+    
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS--AQ 178
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
           +IHRDLKP N LLVN + + LK+GDFG+++ +    +   Y MT
Sbjct: 179 VIHRDLKPSN-LLVNENCE-LKIGDFGMARGLCTSPAEHQYFMT 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   +++G+G++G +  A  +  G  VAIK+I P   D  L       E+ +L   +H 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHE 69
Query: 216 NIVQFLGAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           NI+           E    + I + L   DLH+ +  +  LS      F     R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVL 128
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           H   + +IHRDLKP N LL+NS+ D LKV DFGL+++I
Sbjct: 129 HG--SNVIHRDLKPSN-LLINSNCD-LKVCDFGLARII 162

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 23  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 80
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 81  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 139
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 140 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 194

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 64/117 (54%), Gaps = 5/117 (4%)
Query: 200 QDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
           +D   E+ +L++  +HPNI+       + K + ++TE  +GG+L   +  +   S   A 
Sbjct: 60  RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREAS 119
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA--DHLKVGDFGLSKLIKVQN 313
                I + + YLH +   ++HRDLKP N+L V+ S   + +++ DFG +K ++ +N
Sbjct: 120 AVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 25  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 82
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 141
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 142 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 196

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 25  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 82
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 141
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 142 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 196

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 24  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 81
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 82  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 140
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 141 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 195

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 43  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 100
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 101 IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 159
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 160 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 214

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 20  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 77
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 137 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 191

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 89/175 (50%), Gaps = 18/175 (10%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--- 213
           +   A IG G++G + KA     G  VA+K +     ++ L I   R EV LL +L    
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFE 64
Query: 214 HPNIVQFLGAV----TERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIAR 266
           HPN+V+ +       T+R+  + L+ E++   DL  YL +     L   T  +      R
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
           G+ +LH   N I+HRDLKP N+L+  +S   +K+ DFGL+++   Q + D   +T
Sbjct: 124 GLDFLHA--NCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALDPVVVT 174

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 44  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 101
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 102 IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 160
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 161 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 215

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 22  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 79
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 139 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 193

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSFG-----EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G FG      +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 17  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 74
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 75  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 133
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +  + V+  TG
Sbjct: 134 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTG 188

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 45/197 (22%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 22  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 80  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 191
Query: 303 FGLSKLIKVQNSHDVYK 319
           FGL++        D+YK
Sbjct: 192 FGLAR--------DIYK 200

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++       +G+GSFG + +   R        T VA+K +  S S    +  +
Sbjct: 12  EWEVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--E 67
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--------KGALS 253
           F +E +++      ++V+ LG V++ +P +++ E +  GDL  YL+          G   
Sbjct: 68  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 127
Query: 254 PS--TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           P+    +  A +IA GMAYL+ +    +HR+L  RN ++ +     +K+GDFG+++ I
Sbjct: 128 PTLQEMIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFT--VKIGDFGMTRDI 181

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 45/197 (22%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 59  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 116
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 117 ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 172
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 173 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 228
Query: 303 FGLSKLIKVQNSHDVYK 319
           FGL++        D+YK
Sbjct: 229 FGLAR--------DIYK 237

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 45/197 (22%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 24  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 81
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 82  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKE 137
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 138 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 193
Query: 303 FGLSKLIKVQNSHDVYK 319
           FGL++        D+YK
Sbjct: 194 FGLAR--------DIYK 202

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 45/197 (22%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 22  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 80  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 191
Query: 303 FGLSKLIKVQNSHDVYK 319
           FGL++        D+YK
Sbjct: 192 FGLAR--------DIYK 200

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++       +G+GSFG + +   R        T VA+K +  S S    +  +
Sbjct: 11  EWEVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--E 66
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE--------KGALS 253
           F +E +++      ++V+ LG V++ +P +++ E +  GDL  YL+          G   
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 254 PS--TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           P+    +  A +IA GMAYL+ +    +HR+L  RN ++ +     +K+GDFG+++ I
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFT--VKIGDFGMTRDI 180

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 35/185 (18%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 24  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS 81
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 82  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKP 137
Query: 249 ----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
               K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ DFG
Sbjct: 138 EDLYKDFLTLEHLIXYSFQVAKGMEFLASRKX--IHRDLAARNILL--SEKNVVKICDFG 193
Query: 305 LSKLI 309
           L++ I
Sbjct: 194 LARDI 198

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +G+G FG + +A  +      AIKRI   L +  L  +    EV  L KL HP
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEHP 63
Query: 216 NIVQFLGAVTER------KP------LMLITEYLRGGDLHKYLKEKGALSP---STAVNF 260
            IV++  A  E+      +P      L +  +  R  +L  ++  +  +     S  ++ 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
            L IA  + +LH++   ++HRDLKP N+    +  D +KVGDFGL
Sbjct: 124 FLQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKVGDFGL 164

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 37/187 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 13  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 71  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 182
Query: 303 FGLSKLI 309
           FGL++ I
Sbjct: 183 FGLARDI 189

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 9/160 (5%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           ID  +L+F +   + +   GE+ K  W+G  + +K +L          +DF  E   L  
Sbjct: 7   IDFKQLNFLTK--LNENHSGELWKGRWQGNDIVVK-VLKVRDWSTRKSRDFNEECPRLRI 63
Query: 212 LRHPNIVQFLGAVTERKPL---MLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIAR 266
             HPN++  LGA  +  P     LIT ++  G L+  L E     +  S AV FALD+AR
Sbjct: 64  FSHPNVLPVLGA-CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           GMA+LH    +I    L  R+V++       + + D   S
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           F     +G G+F E++ A  + T    A+K I   +L      I++   E+ +L K++H 
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIEN---EIAVLRKIKHE 80
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NIV           L L+ + + GG+L   + EKG  +   A      +   + YLH   
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMG 140
Query: 276 NVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKL 308
             I+HRDLKP N+L  +   +  + + DFGLSK+
Sbjct: 141 --IVHRDLKPENLLYYSQDEESKIMISDFGLSKM 172

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 165 IGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G FG +L+  W     G  VAIK+    LS      + +  E+ ++ KL HPN+V  
Sbjct: 23  LGTGGFGYVLR--WIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPNVVSA 78
Query: 221 ------LGAVTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYL 271
                 L  +      +L  EY  GGDL KYL +      L          DI+  + YL
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSK 307
           H   N IIHRDLKP N++L       + K+ D G +K
Sbjct: 139 HE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 173

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 165 IGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G FG +L+  W     G  VAIK+    LS      + +  E+ ++ KL HPN+V  
Sbjct: 22  LGTGGFGYVLR--WIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPNVVSA 77
Query: 221 ------LGAVTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYL 271
                 L  +      +L  EY  GGDL KYL +      L          DI+  + YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSK 307
           H   N IIHRDLKP N++L       + K+ D G +K
Sbjct: 138 HE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSF-----GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G F     G +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 24  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 81
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 82  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 140
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM YL ++    +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 141 VAKGMKYLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEXXSVHNKTG 195

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 16/187 (8%)
Query: 128 YGQNGSHFEXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAI 185
           Y Q+ +  E         NK  WE+     + S    +G G++G +  A+    G  VA+
Sbjct: 19  YFQSNASQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAV 75
Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGG 240
           K++           + +R E+ LL  ++H N++  L   T  + L     + +  +L G 
Sbjct: 76  KKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 134
Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
           DL+  +K +  L+          I RG+ Y+H+    IIHRDLKP N L VN   + LK+
Sbjct: 135 DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKI 189
Query: 301 GDFGLSK 307
            DFGL++
Sbjct: 190 LDFGLAR 196

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 21  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 78  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 135
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 136 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTAD 184
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 185 EMTGYVATRWY 195

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 21  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 78  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 135
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 136 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTAD 184
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 185 EMTGYVATRWY 195

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 7/153 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 214
           DF    +IG+GS+ ++L    + T    A+K +   L +D   I   + E ++  +   H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P +V           L  + EY+ GGDL  +++ +  L    A  ++ +I+  + YLH  
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 140
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              II+RDLK  NVLL   S  H+K+ D+G+ K
Sbjct: 141 G--IIYRDLKLDNVLL--DSEGHIKLTDYGMCK 169

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 37/187 (19%)
Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRIL--PSLSDDRLVIQ 200
           WE     L       +G+G+FG++++A   G         VA+K +    + S+ R ++ 
Sbjct: 22  WEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 201 DFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKE---------- 248
               E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+           
Sbjct: 80  ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 249 ------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
                 K  L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + +K+ D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICD 191
Query: 303 FGLSKLI 309
           FGL++ I
Sbjct: 192 FGLARDI 198

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 21  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 78  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 135
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 136 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTAD 184
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 185 EMTGYVATRWY 195

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 158 DFSSSAIIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKG+FG+++    KA  R   + I R    ++ D   +     E  +L   R
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTR 66
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +     A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 126
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               +++RD+K  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 127 RD--VVYRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKTFCGTPEYL 175

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 158 DFSSSAIIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKG+FG+++    KA  R   + I R    ++ D   +     E  +L   R
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTR 68
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +     A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 128
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               +++RD+K  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 129 RD--VVYRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKXFCGTPEYL 177

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 158 DFSSSAIIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKG+FG+++    KA  R   + I R    ++ D   +     E  +L   R
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTR 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +     A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               +++RD+K  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 124 RD--VVYRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKTFCGTPEYL 172

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 158 DFSSSAIIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKG+FG+++    KA  R   + I R    ++ D   +     E  +L   R
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTR 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +     A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               +++RD+K  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 124 RD--VVYRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKXFCGTPEYL 172

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V +++  H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKEIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY  GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      ++KV DFGL+K +K
Sbjct: 159 SLD--LIYRDLKPENLMI--DQQGYIKVTDFGLAKRVK 192

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 16/182 (8%)
Query: 133 SHFEXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILP 190
           SH E         NK  WE+      + + + +G G++G +  +Y    G  +A+K++  
Sbjct: 30  SHKERPTFYRQELNKTIWEVPER---YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR 86
Query: 191 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKY 245
                    + +R E+ LL  ++H N++  L   T    L     + +  +L G DL+  
Sbjct: 87  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNI 145
Query: 246 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
           +K +  L+          I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL
Sbjct: 146 VKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGL 200
Query: 306 SK 307
           ++
Sbjct: 201 AR 202

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 8/160 (5%)
Query: 152 IDPSEL-DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNL 208
           +DP  L DF    +IG+GS+ ++L    + T    A+K +   L +D   I   + E ++
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 209 LVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
             +   HP +V           L  + EY+ GGDL  +++ +  L    A  ++ +I+  
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           + YLH     II+RDLK  NVLL   S  H+K+ D+G+ K
Sbjct: 123 LNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCK 158

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 158 DFSSSAIIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKG+FG+++    KA  R   + I R    ++ D   +     E  +L   R
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTR 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +     A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               +++RD+K  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 124 RD--VVYRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKTFCGTPEYL 172

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 158 DFSSSAIIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKG+FG+++    KA  R   + I R    ++ D   +     E  +L   R
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTR 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +     A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               +++RD+K  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 124 RD--VVYRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKXFCGTPEYL 172

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 14/177 (7%)
Query: 158 DFSSSAIIGKGSFGEIL----KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR 213
           DF    ++GKG+FG+++    KA  R   + I R    ++ D   +     E  +L   R
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTR 63
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HP +     A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               +++RD+K  N++L      H+K+ DFGL K    +   D   M    G+ EYL
Sbjct: 124 RD--VVYRDIKLENLMLDKDG--HIKITDFGLCK----EGISDGATMKXFCGTPEYL 172

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 11/152 (7%)
Query: 164 IIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +IGKG F  + +   R T     V I  +    S   L  +D + E ++   L+HP+IV+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEP 275
            L   +    L ++ E++ G DL   + ++       S + A ++   I   + Y H+  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148
Query: 276 NVIIHRDLKPRNVLLVN-SSADHLKVGDFGLS 306
           N IIHRD+KP  VLL +  ++  +K+G FG++
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 165 IGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 221
           +G+GSFGE+  +K    G   A+K++       RL +  FR  E+     L  P IV   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEV--FRVEELVACAGLSSPRIVPLY 116
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           GAV E   + +  E L GG L + +K+ G L    A+ +      G+ YLH     I+H 
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT--RRILHG 174
Query: 282 DLKPRNVLLVNSSADHLKVGDFG 304
           D+K  NVLL +S      + DFG
Sbjct: 175 DVKADNVLL-SSDGSRAALCDFG 196

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 11/152 (7%)
Query: 164 IIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +IGKG F  + +   R T     V I  +    S   L  +D + E ++   L+HP+IV+
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEP 275
            L   +    L ++ E++ G DL   + ++       S + A ++   I   + Y H+  
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 150
Query: 276 NVIIHRDLKPRNVLLVN-SSADHLKVGDFGLS 306
           N IIHRD+KP  VLL +  ++  +K+G FG++
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 182

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN  ++ LK+ DFGL +       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDSE-LKILDFGLCR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+ P    + + A +G G++G +  A+    G  VA+K++           + +R
Sbjct: 24  NKTIWEV-PER--YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 80
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 81  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 138
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 139 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 187
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 188 EMTGYVATRWY 198

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 7/153 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 214
           DF    +IG+GS+ ++L    + T    A+K +   L +D   I   + E ++  +   H
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P +V           L  + EY+ GGDL  +++ +  L    A  ++ +I+  + YLH  
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 125
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              II+RDLK  NVLL   S  H+K+ D+G+ K
Sbjct: 126 G--IIYRDLKLDNVLL--DSEGHIKLTDYGMCK 154

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDXE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 80/148 (54%), Gaps = 12/148 (8%)
Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
           +GKG++G + K+  R  G  VA+K+I  +  +     + FR E+ +L +L  H NIV  L
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 222 GAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
             +     + + L+ +Y+   DLH  ++    L P         + + + YLH+    ++
Sbjct: 76  NVLRADNDRDVYLVFDYMET-DLHAVIR-ANILEPVHKQYVVYQLIKVIKYLHS--GGLL 131
Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           HRD+KP N+LL  ++  H+KV DFGLS+
Sbjct: 132 HRDMKPSNILL--NAECHVKVADFGLSR 157

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 96/194 (49%), Gaps = 30/194 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   A++G+G+FG+++KA         AIK+I    ++++L       EV LL  L H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKL--STILSEVMLLASLNHQ 62
Query: 216 NIVQFLGAVTER----KP---------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
            +V++  A  ER    KP         L +  EY     L+  +  +  L+      + L
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN-LNQQRDEYWRL 121
Query: 263 --DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
              I   ++Y+H++   IIHRDLKP N+ +  S   ++K+GDFGL+K   V  S D+ K+
Sbjct: 122 FRQILEALSYIHSQG--IIHRDLKPMNIFIDESR--NVKIGDFGLAK--NVHRSLDILKL 175
Query: 321 TGET--GSCEYLVS 332
             +   GS + L S
Sbjct: 176 DSQNLPGSSDNLTS 189

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 26  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR 82
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 83  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 140
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 141 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 189
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 190 EMTGYVATRWY 200

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 211
           D+    +IG+G+FGE+     + T  V   ++L        SD       F  E +++  
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 130
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
              P +VQ   A  + + L ++ EY+ GGDL   +      EK A   +  V  ALD   
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            M +        IHRD+KP N+LL  S   HLK+ DFG
Sbjct: 191 SMGF--------IHRDVKPDNMLLDKSG--HLKLADFG 218

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 165 IGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 221
           +G+GSFGE+  +K    G   A+K++       RL +  FR  E+     L  P IV   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEV--FRVEELVACAGLSSPRIVPLY 132
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           GAV E   + +  E L GG L + +K+ G L    A+ +      G+ YLH     I+H 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT--RRILHG 190
Query: 282 DLKPRNVLLVNSSADHLKVGDFG 304
           D+K  NVLL +S      + DFG
Sbjct: 191 DVKADNVLL-SSDGSRAALCDFG 212

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 132 GSHF--EXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKR 187
           GSH   E         NK  WE+     + S    +G G++G +  A+    G  VA+K+
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKK 74
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDL 242
           +           + +R E+ LL  ++H N++  L   T  + L     + +  +L G DL
Sbjct: 75  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 133
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
           +  +K +  L+          I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D
Sbjct: 134 NNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILD 188
Query: 303 FGLSKLIKVQNSHDVYKMTGETGSCEY 329
           FGL++       H   +MTG   +  Y
Sbjct: 189 FGLAR-------HTDDEMTGYVATRWY 208

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 16  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 72
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 73  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 130
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN  ++ LK+ DFGL++       H   
Sbjct: 131 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDSE-LKILDFGLAR-------HTDD 179
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 180 EMTGYVATRWY 190

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 211
           D+    +IG+G+FGE+     + T  V   ++L        SD       F  E +++  
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 130
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
              P +VQ   A  + + L ++ EY+ GGDL   +      EK A   +  V  ALD   
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            M +        IHRD+KP N+LL  S   HLK+ DFG
Sbjct: 191 SMGF--------IHRDVKPDNMLLDKSG--HLKLADFG 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 132 GSHF--EXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKR 187
           GSH   E         NK  WE+     + S    +G G++G +  A+    G  VA+K+
Sbjct: 17  GSHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKK 73
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDL 242
           +           + +R E+ LL  ++H N++  L   T  + L     + +  +L G DL
Sbjct: 74  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 132
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
           +  +K +  L+          I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D
Sbjct: 133 NNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILD 187
Query: 303 FGLSKLIKVQNSHDVYKMTGETGSCEY 329
           FGL++       H   +MTG   +  Y
Sbjct: 188 FGLAR-------HTDDEMTGYVATRWY 207

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 20  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 76
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 77  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 134
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 135 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 183
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 184 EMTGYVATRWY 194

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 51  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 106
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 166
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 167 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 213

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--- 213
           +   A IG G++G + KA     G  VA+K +     ++ L I   R EV LL +L    
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFE 64
Query: 214 HPNIVQFLGAV----TERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIAR 266
           HPN+V+ +       T+R+  + L+ E++   DL  YL +     L   T  +      R
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           G+ +LH   N I+HRDLKP N+L+  +S   +K+ DFGL+++   Q
Sbjct: 124 GLDFLHA--NCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQ 165

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 20  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 76
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 77  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 134
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN  ++ LK+ DFGL++       H   
Sbjct: 135 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDSE-LKILDFGLAR-------HTDD 183
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 184 EMTGYVATRWY 194

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 211
           D+    +IG+G+FGE+     + T  V   ++L        SD       F  E +++  
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 125
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
              P +VQ   A  + + L ++ EY+ GGDL   +      EK A   +  V  ALD   
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            M +        IHRD+KP N+LL  S   HLK+ DFG
Sbjct: 186 SMGF--------IHRDVKPDNMLLDKSG--HLKLADFG 213

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--- 213
           +   A IG G++G + KA     G  VA+K +     ++ L I   R EV LL +L    
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFE 64
Query: 214 HPNIVQFLGAV----TERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIAR 266
           HPN+V+ +       T+R+  + L+ E++   DL  YL +     L   T  +      R
Sbjct: 65  HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           G+ +LH   N I+HRDLKP N+L+  +S   +K+ DFGL+++   Q
Sbjct: 124 GLDFLHA--NCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQ 165

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 31  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 86
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 87  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 146
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 193

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGXVATRWY 188

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 132 GSHF--EXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKR 187
           GSH   E         NK  WE+     + S    +G G++G +  A+    G  VA+K+
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKK 74
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDL 242
           +           + +R E+ LL  ++H N++  L   T  + L     + +  +L G DL
Sbjct: 75  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 133
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
           +  +K +  L+          I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D
Sbjct: 134 NNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILD 188
Query: 303 FGLSKLIKVQNSHDVYKMTGETGSCEY 329
           FGL++       H   +MTG   +  Y
Sbjct: 189 FGLAR-------HTDDEMTGYVATRWY 208

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 17/158 (10%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--- 212
           +F    ++GKGSFG+++ A  +  G   A+K     L  D +++QD   E  +  K    
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVK----VLKKD-VILQDDDVECTMTEKRILS 78
Query: 213 ---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
               HP + Q          L  + E++ GGDL  ++++      + A  +A +I   + 
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +LH++   II+RDLK  NVLL +    H K+ DFG+ K
Sbjct: 139 FLHDKG--IIYRDLKLDNVLLDHEG--HCKLADFGMCK 172

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 165 IGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFR-HEVNLLVKLRHPNIVQFL 221
           +G+GSFGE+  +K    G   A+K++       RL +  FR  E+     L  P IV   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEV--FRVEELVACAGLSSPRIVPLY 130
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           GAV E   + +  E L GG L + +K+ G L    A+ +      G+ YLH     I+H 
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT--RRILHG 188
Query: 282 DLKPRNVLLVNSSADHLKVGDFG 304
           D+K  NVLL +S      + DFG
Sbjct: 189 DVKADNVLL-SSDGSRAALCDFG 210

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    IG G++G +  A+    G  VA+K++           + +R
Sbjct: 19  NKTIWEVPERYQNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 75
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 76  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 133
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 134 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDXE-LKILDFGLAR-------HTDD 182
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 183 EMTGYVATRWY 193

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 7/153 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 214
           DF    +IG+GS+ ++L    + T    A++ +   L +D   I   + E ++  +   H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P +V           L  + EY+ GGDL  +++ +  L    A  ++ +I+  + YLH  
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              II+RDLK  NVLL   S  H+K+ D+G+ K
Sbjct: 173 G--IIYRDLKLDNVLL--DSEGHIKLTDYGMCK 201

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 16  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 72
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 73  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 130
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 131 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 179
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 180 EMTGYVATRWY 190

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 132 GSHF--EXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKR 187
           GSH   E         NK  WE+     + S    +G G++G +  A+    G  VA+K+
Sbjct: 17  GSHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKK 73
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDL 242
           +           + +R E+ LL  ++H N++  L   T  + L     + +  +L G DL
Sbjct: 74  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 132
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
           +  +K +  L+          I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D
Sbjct: 133 NNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILD 187
Query: 303 FGLSKLIKVQNSHDVYKMTGETGSCEY 329
           FGL++       H   +MTG   +  Y
Sbjct: 188 FGLAR-------HTDDEMTGYVATRWY 207

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 26  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 82
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 83  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 140
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 141 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 189
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 190 EMTGYVATRWY 200

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 26  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 82
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 83  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 140
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 141 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 189
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 190 EMTGYVATRWY 200

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 20  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 76
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 77  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 134
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 135 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 183
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 184 EMTGYVATRWY 194

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 25  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 81
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 82  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 139
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 140 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 188
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 189 EMTGYVATRWY 199

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 16  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 72
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 73  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 130
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 131 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 179
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 180 EMTGYVATRWY 190

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 20  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 76
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 77  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 134
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 135 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 183
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 184 EMTGYVATRWY 194

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 37  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 93
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 94  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 151
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 152 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 200
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 201 EMTGYVATRWY 211

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 12  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 68
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 69  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 126
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 127 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 175
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 176 EMTGYVATRWY 186

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 21  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 78  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 135
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 136 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 184
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 185 EMTGYVATRWY 195

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 10  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 66
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 67  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 124
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 125 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 173
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 174 EMTGYVATRWY 184

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 19  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 75
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 76  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 133
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 134 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 182
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 183 EMTGYVATRWY 193

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 132 GSHF--EXXXXXXXXXNKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKR 187
           GSH   E         NK  WE+     + S    +G G++G +  A+    G  VA+K+
Sbjct: 18  GSHMSQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKK 74
Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDL 242
           +           + +R E+ LL  ++H N++  L   T  + L     + +  +L G DL
Sbjct: 75  LSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 133
Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
           +  +K +  L+          I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D
Sbjct: 134 NNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILD 188
Query: 303 FGLSK 307
           FGL++
Sbjct: 189 FGLAR 193

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 193

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V +++  H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKEIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY  GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      +++V DFGL+K +K
Sbjct: 159 SLD--LIYRDLKPENLMI--DQQGYIQVTDFGLAKRVK 192

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 19  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 75
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 76  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 133
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 134 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 182
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 183 EMTGYVATRWY 193

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 11  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 67
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 68  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 125
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 126 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 174
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 175 EMTGYVATRWY 185

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 13  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 69
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 70  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 127
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 128 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 176
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 177 EMTGYVATRWY 187

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 11  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 67
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 68  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 125
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 126 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 174
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 175 EMTGYVATRWY 185

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 193

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 16  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 72
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 73  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 130
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 131 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 179
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 180 EMTGYVATRWY 190

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 17  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 72
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 73  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 132
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 133 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DEQGYIQVTDFGFAKRVK 179

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 25  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 81
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 82  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 139
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 140 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDXE-LKILDFGLAR-------HTDD 188
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 189 EMTGYVATRWY 199

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 19  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 75
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 76  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 133
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 134 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDXE-LKILDFGLAR-------HTDD 182
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 183 EMTGYVATRWY 193

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSF-----GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G F     G +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 26  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 83
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 84  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 142
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM +L ++    +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 143 VAKGMKFLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTG 197

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSF-----GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G F     G +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 25  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 82
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 141
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM +L ++    +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 142 VAKGMKFLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTG 196

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 84
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 85  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 145 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 178

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSF-----GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G F     G +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 25  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 82
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 83  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 141
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM +L ++    +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 142 VAKGMKFLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTG 196

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+++      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLII--DQQGYIQVTDFGFAKRVK 192

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 10  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 66
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 67  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 124
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   
Sbjct: 125 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDD 173
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 174 EMTGYVATRWY 184

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR 173

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSF-----GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G F     G +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 84  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 141
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 200
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM +L ++    +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 201 VAKGMKFLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTG 255

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR 173

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSF-----GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G F     G +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 23  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 80
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 81  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 139
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM +L ++    +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 140 VAKGMKFLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTG 194

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSF-----GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G F     G +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 30  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 87
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 88  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 146
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM +L ++    +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 147 VAKGMKFLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTG 201

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 193

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 86/164 (52%), Gaps = 18/164 (10%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           DP+ + F    ++G G++G++ K  + +   +A  +++    D+    ++ + E+N+L K
Sbjct: 21  DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKK 76
Query: 212 L-RHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLKE-KG-ALSPSTAVNFAL 262
              H NI  + GA  ++ P      L L+ E+   G +   +K  KG  L          
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +I RG+++LH   + +IHRD+K +NVLL  ++   +K+ DFG+S
Sbjct: 137 EILRGLSHLHQ--HKVIHRDIKGQNVLLTENA--EVKLVDFGVS 176

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 152 IDPSELDFSSSAIIGKGSF-----GEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           I PS L    + +IG+G F     G +L    +    A+K  L  ++D   V Q F  E 
Sbjct: 26  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ-FLTEG 83
Query: 207 NLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGGDLHKYLK-EKGALSPSTAVNFALD 263
            ++    HPN++  LG    +E  PL+++  Y++ GDL  +++ E    +    + F L 
Sbjct: 84  IIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 142
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           +A+GM +L ++    +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 143 VAKGMKFLASKK--FVHRDLAARNCMLDEKFT--VKVADFGLARDMLDKEFDSVHNKTG 197

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 30/194 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   A++G+G+FG+++KA         AIK+I  +      ++     EV LL  L H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS----EVXLLASLNHQ 62
Query: 216 NIVQFLGAVTER----KP---------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
            +V++  A  ER    KP         L +  EY     L+  +  +  L+      + L
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN-LNQQRDEYWRL 121
Query: 263 --DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
              I   ++Y+H++   IIHR+LKP N+ +  S   ++K+GDFGL+K   V  S D+ K+
Sbjct: 122 FRQILEALSYIHSQG--IIHRNLKPXNIFIDESR--NVKIGDFGLAK--NVHRSLDILKL 175
Query: 321 TGET--GSCEYLVS 332
             +   GS + L S
Sbjct: 176 DSQNLPGSSDNLTS 189

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY  GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      ++KV DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK 192

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 193

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 29/160 (18%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL--LVKLRHPNIVQFL 221
           +IG+G +G + K      PVA+K    S ++     Q+F +E N+  +  + H NI +F+
Sbjct: 20  LIGRGRYGAVYKGSLDERPVAVKVF--SFANR----QNFINEKNIYRVPLMEHDNIARFI 73
Query: 222 GA---VTE--RKPLMLITEYLRGGDLHKYLKEKGALSPS---TAVNFALDIARGMAYLHN 273
                VT   R   +L+ EY   G L KYL    +L  S   ++   A  + RG+AYLH 
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 274 E-------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           E          I HRDL  RNVL+ N       + DFGLS
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLS 167

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 180 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 213

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 10  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 66
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 67  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 124
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++
Sbjct: 125 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR 169

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 151
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 152 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 185

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 193

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G  +   A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 11/153 (7%)
Query: 161 SSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNI 217
           S  +IGKG FG +    Y       I+  + SLS   +   ++ F  E  L+  L HPN+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 218 VQFLGAVTERKPL-MLITEYLRGGDLHKYLKEKGALSPSTA--VNFALDIARGMAYLHNE 274
           +  +G +   + L  ++  Y+  GDL ++++     +P+    ++F L +ARGM YL  +
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGMEYLAEQ 143
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
               +HRDL  RN +L  S    +KV DFGL++
Sbjct: 144 K--FVHRDLAARNCMLDESFT--VKVADFGLAR 172

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY  GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      ++KV DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK 193

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 51  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 106
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G      A  
Sbjct: 107 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF 166
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 167 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 213

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G      A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 81/156 (51%), Gaps = 13/156 (8%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ F     +G+GS+G + KA  +  G  VAIK++ P  SD    +Q+   E++++ +
Sbjct: 27  PEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESD----LQEIIKEISIMQQ 80
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAY 270
              P++V++ G+  +   L ++ EY   G +   ++ +   L+            +G+ Y
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           LH      IHRD+K  N+LL  ++  H K+ DFG++
Sbjct: 141 LHFMRK--IHRDIKAGNILL--NTEGHAKLADFGVA 172

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G      A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D+GL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDYGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/77 (46%), Positives = 50/77 (64%), Gaps = 2/77 (2%)
Query: 29  KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
           K +  RT L L  A +N    V KLL E  + V+A+D + RTPLH+A+ +G ++V K L+
Sbjct: 31  KDKNGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLL 88
Query: 89  EYGADVNAQDRWKNTPL 105
           E GADVNA+D+   TPL
Sbjct: 89  EAGADVNAKDKNGRTPL 105

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 88/169 (52%), Gaps = 33/169 (19%)
Query: 161 SSAIIGKGSFGEIL-KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIV 218
           S  I+G GS G ++ +  ++G PVA+KR+L    D  L+      E+ LL +   HPN++
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM------EIKLLTESDDHPNVI 72
Query: 219 QFLGAVTERKPLMLITEY--LRGGDL-------HKYLKEKGALSPSTAVNFALDIARGMA 269
           ++  + T  + L +  E   L   DL        + LK +   +P   ++    IA G+A
Sbjct: 73  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP---ISLLRQIASGVA 129
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSS---------ADHLK--VGDFGLSK 307
           +LH+    IIHRDLKP+N+L+  SS         A++L+  + DFGL K
Sbjct: 130 HLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 30  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 85
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G      A  
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF 145
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 25/158 (15%)
Query: 158 DFSSSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSL-----SDDRLVIQDFRHEVNLLVK 211
           D+    +IG+G+FGE+ L  +     V   ++L        SD       F  E +++  
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAF 131
Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-----EKGALSPSTAVNFALDIAR 266
              P +VQ   A  + K L ++ EY+ GGDL   +      EK A   +  V  ALD   
Sbjct: 132 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            M         +IHRD+KP N+LL      HLK+ DFG
Sbjct: 192 SMG--------LIHRDVKPDNMLL--DKHGHLKLADFG 219

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 18/171 (10%)
Query: 150 WEI---DPSELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDF 202
           WE    + ++LD F     +G GSFG ++  K    G   A+K     L   ++V ++  
Sbjct: 25  WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQI 80
Query: 203 RHEVN---LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
            H +N   +L  +  P +V+   +  +   L ++ EY+ GG++  +L+  G      A  
Sbjct: 81  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF 140
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +A  I     YLH+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 141 YAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 187

>pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 54/88 (61%), Gaps = 2/88 (2%)
Query: 33  SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
            RT L L  A +N    V KLL E  + V+A+D + RTPLH+A+ +G ++V K L+E GA
Sbjct: 2   GRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
Query: 93  DVNAQDRWKNTPLADAEGAKKFNMMELL 120
           DVNA+D+   TPL  A       +++LL
Sbjct: 60  DVNAKDKNGRTPLHLAARNGHLEVVKLL 87

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 87/169 (51%), Gaps = 33/169 (19%)
Query: 161 SSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIV 218
           S  I+G GS G +  +  ++G PVA+KR+L    D  L+      E+ LL +   HPN++
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM------EIKLLTESDDHPNVI 72
Query: 219 QFLGAVTERKPLMLITEY--LRGGDL-------HKYLKEKGALSPSTAVNFALDIARGMA 269
           ++  + T  + L +  E   L   DL        + LK +   +P   ++    IA G+A
Sbjct: 73  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP---ISLLRQIASGVA 129
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSS---------ADHLK--VGDFGLSK 307
           +LH+    IIHRDLKP+N+L+  SS         A++L+  + DFGL K
Sbjct: 130 HLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 78/169 (46%), Gaps = 16/169 (9%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
            K  WE+     D      +G G++G +  A     G  VAIK++      +    + +R
Sbjct: 17  TKTAWEVRAVYRDLQP---VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY-----LRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  +RH N++  L   T  + L   T++       G DL K +K +  L      
Sbjct: 74  -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQ 131
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                + +G+ Y+H     IIHRDLKP N L VN   + LK+ DFGL++
Sbjct: 132 FLVYQMLKGLRYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLAR 176

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 81/169 (47%), Gaps = 26/169 (15%)
Query: 156 ELD-FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRIL--PSLSDDRL-VIQDFRHEVNLL 209
           E+D F    + G+G+FG +   K    G  VAIK+++  P   +  L ++QD       L
Sbjct: 21  EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD-------L 73
Query: 210 VKLRHPNIVQ---FLGAVTERKP----LMLITEYLRGGDLHK----YLKEKGALSPSTAV 258
             L HPNIVQ   +   + ER      L ++ EY+    LH+    Y + + A  P    
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIK 132
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            F   + R +  LH     + HRD+KP NV LVN +   LK+ DFG +K
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNV-LVNEADGTLKLCDFGSAK 180

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY  GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLMI--DQQGYIQVTDFGFAKRVK 192

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G      A  +A  I     YLH
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 193

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G      A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G      A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 30/184 (16%)
Query: 156 ELDFSSSAIIGKGSFGEIL-KAYWRGTPVAIKRILP---SLSDDRLVIQDFRHEVNLLVK 211
           ++ F    ++G G+ G I+ +  +    VA+KRILP   S +D          EV LL +
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---------REVQLLRE 73
Query: 212 L-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIAR 266
              HPN++++     +R+    I   L    L +Y+++K      L P T +        
Sbjct: 74  SDEHPNVIRYFCTEKDRQ-FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ---QTTS 129
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK----VGDFGLSKLIKVQNSHDVYKMTG 322
           G+A+LH+    I+HRDLKP N+L+   +A H K    + DFGL K + V   H   + +G
Sbjct: 130 GLAHLHSLN--IVHRDLKPHNILISMPNA-HGKIKAMISDFGLCKKLAV-GRHSFSRRSG 185
Query: 323 ETGS 326
             G+
Sbjct: 186 VPGT 189

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 45  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 97
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 98  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 158 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 199

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 18/171 (10%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLV--------IQD 201
           E+   +  ++    I  GS+G +       G PVAIKR+  ++SD R V         + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTE-RKPLM----LITEYLRGGDLHKYLKEKGALSPST 256
              E+ LL    HPNI+          +P M    L+TE +R         ++  +SP  
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              F   I  G+  LH     ++HRDL P N+LL ++  + + + DF L++
Sbjct: 136 IQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN--NDITICDFNLAR 182

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 88/169 (52%), Gaps = 33/169 (19%)
Query: 161 SSAIIGKGSFGEIL-KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIV 218
           S  I+G GS G ++ +  ++G PVA+KR+L    D  L+      E+ LL +   HPN++
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM------EIKLLTESDDHPNVI 90
Query: 219 QFLGAVTERKPLMLITEY--LRGGDL-------HKYLKEKGALSPSTAVNFALDIARGMA 269
           ++  + T  + L +  E   L   DL        + LK +   +P   ++    IA G+A
Sbjct: 91  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP---ISLLRQIASGVA 147
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSS---------ADHLK--VGDFGLSK 307
           +LH+    IIHRDLKP+N+L+  SS         A++L+  + DFGL K
Sbjct: 148 HLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 103
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 164 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 205

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 83/172 (48%), Gaps = 22/172 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRI---LPSLSDDRLVIQ 200
           NK  WE+ P  L       +G G++G +  AY       VA+K++     SL   R   +
Sbjct: 20  NKTVWEV-PQRL--QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR 76
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPS 255
           + R    LL  L+H N++  L   T    +     + +   L G DL+  +K + ALS  
Sbjct: 77  ELR----LLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ-ALSDE 131
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                   + RG+ Y+H+    IIHRDLKP NV  VN  ++ L++ DFGL++
Sbjct: 132 HVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNV-AVNEDSE-LRILDFGLAR 179

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 18/171 (10%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLV--------IQD 201
           E+   +  ++    I  GS+G +       G PVAIKR+  ++SD R V         + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTE-RKPLM----LITEYLRGGDLHKYLKEKGALSPST 256
              E+ LL    HPNI+          +P M    L+TE +R         ++  +SP  
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              F   I  G+  LH     ++HRDL P N+LL ++  + + + DF L++
Sbjct: 136 IQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN--NDITICDFNLAR 182

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 88/169 (52%), Gaps = 33/169 (19%)
Query: 161 SSAIIGKGSFGEIL-KAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIV 218
           S  I+G GS G ++ +  ++G PVA+KR+L    D  L+      E+ LL +   HPN++
Sbjct: 37  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM------EIKLLTESDDHPNVI 90
Query: 219 QFLGAVTERKPLMLITEY--LRGGDL-------HKYLKEKGALSPSTAVNFALDIARGMA 269
           ++  + T  + L +  E   L   DL        + LK +   +P   ++    IA G+A
Sbjct: 91  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP---ISLLRQIASGVA 147
Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSS---------ADHLK--VGDFGLSK 307
           +LH+    IIHRDLKP+N+L+  SS         A++L+  + DFGL K
Sbjct: 148 HLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 103
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 164 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 205

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 158 DFSSSAIIGKGSFGEI--LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG+G+F E+  +K    G   A+K +       R  +  FR E ++LV     
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
            I Q   A  +   L L+ EY  GGDL   L + G   P+    F L +I   +  +H  
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
             V  HRD+KP N+LL      H+++ DFG
Sbjct: 182 GYV--HRDIKPDNILL--DRCGHIRLADFG 207

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P + +   +  +   L ++ EY  GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      ++KV DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK 193

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P + +   +  +   L ++ EY  GG++  +L+  G  S   A  +A  I     YLH
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      ++KV DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK 193

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY+ GG++  +L+  G      A  +A  I     YLH
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 151
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 152 SLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 185

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 55  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 107
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 108 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 168 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 209

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P +V+   +  +   L ++ EY  GG++  +L+  G      A  +A  I     YLH
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      ++KV DFG +K +K
Sbjct: 159 SLD--LIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK 192

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 53  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 105
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 106 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 166 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 96  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 148
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 149 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 209 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 250

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 28/165 (16%)
Query: 159 FSSSAIIGKGSFGEIL-------------KAYWRGTPVAIKRILPSLSDDRLVIQDFRHE 205
           F     +G GSFG ++             K   +   V +K+I  +L++ R+     +  
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI-----QQA 98
Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
           VN       P +V+   +  +   L ++ EY  GG++  +L+  G  S   A  +A  I 
Sbjct: 99  VNF------PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
               YLH+    +I+RDLKP N+L+      ++KV DFG +K +K
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLI--DQQGYIKVADFGFAKRVK 193

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 22  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 74
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 75  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 135 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 176

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 23/190 (12%)
Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRH 204
           K  WE+     + S    +G G++G +  A+    G  VA+K++           + +R 
Sbjct: 11  KTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR- 66
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K    L+      
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CAKLTDDHVQF 125
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
               I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL++       H   +
Sbjct: 126 LIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLAR-------HTDDE 174
Query: 320 MTGETGSCEY 329
           MTG   +  Y
Sbjct: 175 MTGYVATRWY 184

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 30  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 82
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 83  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 143 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 184

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 25  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 77
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 78  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 138 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 179

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 36  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 88
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 89  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 149 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 190

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 81
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 142 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 183

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 81
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 142 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 183

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 84/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 69
Query: 212 LRHPNIVQ---FLGAVTERKPLM---LITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K ++   L+ +Y+          Y + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 130 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 171

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 69
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 130 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 171

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 21  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 73
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 74  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 134 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 175

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 69
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 130 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 171

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+  FGL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILGFGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 69
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 130 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 171

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++   L D R        E+ ++ K
Sbjct: 18  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFK----NRELQIMRK 70
Query: 212 LRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFAL 262
           L H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       +  
Sbjct: 71  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 131 QLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 172

>pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 5/80 (6%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+A D    TPLH+A+  G  ++ + L+++GADVNA+D    TPL  A   
Sbjct: 31  RILMANGADVNAHDDQGSTPLHLAAWIGHPEIVEVLLKHGADVNARDTDGWTPLHLAADN 90
Query: 112 KKFNMMELLNAHGGLSYGQN 131
               ++E+L     L YG +
Sbjct: 91  GHLEIVEVL-----LKYGAD 105

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 83/172 (48%), Gaps = 22/172 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRI---LPSLSDDRLVIQ 200
           NK  WE+ P  L       +G G++G +  AY       VA+K++     SL   R   +
Sbjct: 20  NKTVWEV-PQRL--QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR 76
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPS 255
           + R    LL  L+H N++  L   T    +     + +   L G DL+  +K + ALS  
Sbjct: 77  ELR----LLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ-ALSDE 131
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                   + RG+ Y+H+    IIHRDLKP NV  VN  ++ L++ DFGL++
Sbjct: 132 HVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNV-AVNEDSE-LRILDFGLAR 179

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DF L++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFYLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
           DW+I P   +     +IG GS+G + +AY       VAIK+IL  + +D +  +    E+
Sbjct: 48  DWQI-PDRYEIRH--LIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREI 103
Query: 207 NLLVKLRHPNIVQFLGAV----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
            +L +L H ++V+ L  V     E+   + +   +   D  K  +    L+         
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY 163
Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           ++  G+ Y+H+    I+HRDLKP N L+    +  +KV DFGL++ +
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVNQDCS--VKVCDFGLARTV 206

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D GL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDAGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|3TWU|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human Mcl1 Length = 167

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 13/134 (9%)
Query: 1   MSSGNSSP----------GDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAV 50
           M SGNS            GD  T  K     S + +  + R  +++ + + A  N  + V
Sbjct: 3   MGSGNSEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGR--QSTPLHFAAGYNRVSVV 60
Query: 51  RKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110
             LL+     VHA+D     PLH A  +G  +VA+ L+++GA VN  D WK TPL +A  
Sbjct: 61  EYLLQHGAD-VHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAA 119
Query: 111 AKKFNMMELLNAHG 124
             K+ + +LL  HG
Sbjct: 120 KGKYEICKLLLQHG 133

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 22/172 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRI---LPSLSDDRLVIQ 200
           NK  WE+ P  L       +G G++G +  AY       VA+K++     SL   R   +
Sbjct: 12  NKTVWEV-PQRL--QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR 68
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPS 255
           + R    LL  L+H N++  L   T    +     + +   L G DL+  +K + ALS  
Sbjct: 69  ELR----LLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ-ALSDE 123
Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                   + RG+ Y+H+    IIHRDLKP NV  VN   + L++ DFGL++
Sbjct: 124 HVQFLVYQLLRGLKYIHSAG--IIHRDLKPSNV-AVNEDCE-LRILDFGLAR 171

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 61/114 (53%), Gaps = 7/114 (6%)
Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKP--LMLITEYLRGGDLHKYLKEKGALSPST 256
           I+    E+ +L KL HPN+V+ +  + +     L ++ E +  G + +    K  LS   
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQ 138
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A  +  D+ +G+ YLH +   IIHRD+KP N+L+      H+K+ DFG+S   K
Sbjct: 139 ARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV--GEDGHIKIADFGVSNEFK 188

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D GL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDRGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 23/166 (13%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH-EVNLLV 210
           P E+ ++ + +IG GSFG + +A     G  VAIK++L          + F++ E+ ++ 
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 211 KLRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFA 261
           KL H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 129 YQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 171

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 159 FSSSAIIGKGSFGEIL--KAYWRGTPVAIKRILPSLSDDRLV-IQDFRHEVN---LLVKL 212
           F     +G GSFG ++  K    G   A+K     L   ++V ++   H +N   +L  +
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P + +   +  +   L ++ EY  GG++  +L+  G      A  +A  I     YLH
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +    +I+RDLKP N+++      ++KV DFG +K +K
Sbjct: 160 SLD--LIYRDLKPENLMI--DQQGYIKVTDFGFAKRVK 193

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 23/191 (12%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+     + S    +G G++G +  A+    G  VA+K++           + +R
Sbjct: 14  NKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 70
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL-----MLITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L     + +  +L G DL+  +K +  L+     
Sbjct: 71  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQ 128
Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N L VN   + LK+ D GL++       H   
Sbjct: 129 FLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDGGLAR-------HTDD 177
Query: 319 KMTGETGSCEY 329
           +MTG   +  Y
Sbjct: 178 EMTGYVATRWY 188

>pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/87 (42%), Positives = 47/87 (54%)
Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L HA +N    V KLL    + V+A+D D RTPLH A+ +G  +V K LI  GADVN  D
Sbjct: 74  LHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSD 133
Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGG 125
               TPL  A       +++LL   GG
Sbjct: 134 SDGRTPLDLAREHGNEEVVKLLEKQGG 160

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 21/169 (12%)
Query: 159 FSSSAIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDR--LVIQDFRHEVNLLVKLR 213
           +   A IG G++G + KA     G  VA+K + +P+       L I   R EV LL +L 
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLE 69
Query: 214 ---HPNIVQFLGAV----TERK-PLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALD 263
              HPN+V+ +       T+R+  + L+ E++   DL  YL +     L   T  +    
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
             RG+ +LH   N I+HRDLKP N+L+  +S   +K+ DFGL+++   Q
Sbjct: 129 FLRGLDFLHA--NCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQ 173

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLRHPNIVQFL 221
           +GKG+F  + +      P   +     ++  +L  +D      E  +   L+HPNIV+  
Sbjct: 12  LGKGAFSVVRRCM--KIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 69
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +++E     L+ + + GG+L + +  +   S + A +    I   + + H   N I+HR
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL--NGIVHR 127
Query: 282 DLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLKP N+LL + S    +K+ DFGL+  I+VQ     +   G  G+  YL
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAW--FGFAGTPGYL 173

>pdb|3TWQ|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 (Apo Form) Length = 175

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 50/91 (54%)
Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           R S  L  A   +  +V + L +  + VHA+D     PLH A  +G  +VA+ L+++GA 
Sbjct: 45  RQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAV 104
Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           VN  D WK TPL +A    K+ + +LL  HG
Sbjct: 105 VNVADLWKFTPLHEAAAKGKYEICKLLLQHG 135

>pdb|3TWR|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human 3bp2 Length = 165

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 50/91 (54%)
Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           R S  L  A   +  +V + L +  + VHA+D     PLH A  +G  +VA+ L+++GA 
Sbjct: 41  RQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAV 100
Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           VN  D WK TPL +A    K+ + +LL  HG
Sbjct: 101 VNVADLWKFTPLHEAAAKGKYEICKLLLQHG 131

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 86/177 (48%), Gaps = 12/177 (6%)
Query: 161 SSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNI 217
           +S ++G+G++ ++  A     G   A+K I       R  +  FR EV  L + + + NI
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV--FR-EVETLYQCQGNKNI 73
Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           ++ +    +     L+ E L+GG +  +++++   +   A     D+A  + +LH +   
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG-- 131
Query: 278 IIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSH---DVYKMTGETGSCEYL 330
           I HRDLKP N+L  +      +K+ DF L   +K+ NS       ++T   GS EY+
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 67/132 (50%), Gaps = 7/132 (5%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           Q    E  +   L+HPNIV+   +++E     L+ + + GG+L + +  +   S + A +
Sbjct: 48  QKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH 107
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVY 318
               I   + + H   N I+HRDLKP N+LL + S    +K+ DFGL+  I+VQ     +
Sbjct: 108 CIQQILESVNHCHL--NGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAW 163
Query: 319 KMTGETGSCEYL 330
              G  G+  YL
Sbjct: 164 --FGFAGTPGYL 173

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 31/167 (18%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +   A IG+G+FGE+ KA  R  G  VA+K++L     +   I   R E+ +L  L+H N
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHEN 78
Query: 217 IVQFLGAV-TERKP-------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIAR- 266
           +V  +    T+  P       + L+ ++    DL       G LS +  V F L +I R 
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDL------AGLLS-NVLVKFTLSEIKRV 130
Query: 267 ------GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                 G+ Y+H   N I+HRD+K  NVL+       LK+ DFGL++
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV--LKLADFGLAR 173

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 10/171 (5%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F    ++GKG FGE+     R T    A K++       R       +E  +L K+    
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           +V    A   +  L L+   + GGDL  H Y   +     + AV +A +I  G+  LH E
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
              I++RDLKP N+LL +    H+++ D GL+  + V     +    G  G
Sbjct: 306 --RIVYRDLKPENILLDDHG--HIRISDLGLA--VHVPEGQTIKGRVGTVG 350

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 9/160 (5%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           ID  +L+F +   + +   GE+ K  W+G  + +K +L          +DF  E   L  
Sbjct: 7   IDFKQLNFLTK--LNENHSGELWKGRWQGNDIVVK-VLKVRDWSTRKSRDFNEECPRLRI 63
Query: 212 LRHPNIVQFLGAVTERKPL---MLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIAR 266
             HPN++  LGA  +  P     LIT +   G L+  L E     +  S AV FALD AR
Sbjct: 64  FSHPNVLPVLGAC-QSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXAR 122
Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           G A+LH    +I    L  R+V +       +   D   S
Sbjct: 123 GXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFS 162

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 31/167 (18%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +   A IG+G+FGE+ KA  R  G  VA+K++L     +   I   R E+ +L  L+H N
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHEN 78
Query: 217 IVQFLGAV-TERKP-------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIAR- 266
           +V  +    T+  P       + L+ ++           +   L  +  V F L +I R 
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRV 130
Query: 267 ------GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                 G+ Y+H   N I+HRD+K  NVL+       LK+ DFGL++
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV--LKLADFGLAR 173

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 23/166 (13%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH-EVNLLV 210
           P E+ ++ + +IG GSFG + +A     G  VAIK++L          + F++ E+ ++ 
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 211 KLRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFA 261
           KL H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 129 YQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 171

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 10/171 (5%)
Query: 159 FSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           F    ++GKG FGE+     R T    A K++       R       +E  +L K+    
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 217 IVQFLGAVTERKPLMLITEYLRGGDL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           +V    A   +  L L+   + GGDL  H Y   +     + AV +A +I  G+  LH E
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
              I++RDLKP N+LL +    H+++ D GL+  + V     +    G  G
Sbjct: 306 --RIVYRDLKPENILLDDHG--HIRISDLGLA--VHVPEGQTIKGRVGTVG 350

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 23/166 (13%)
Query: 154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH-EVNLLV 210
           P E+ ++ + +IG GSFG + +A     G  VAIK++L          + F++ E+ ++ 
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 211 KLRHPNIVQ---FLGAVTERKP---LMLITEYLRGGDL---HKYLKEKGALSPSTAVNFA 261
           KL H NIV+   F  +  E+K    L L+ +Y+          Y + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             + R +AY+H+    I HRD+KP+N+LL   +A  LK+ DFG +K
Sbjct: 129 YQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 171

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 31/167 (18%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +   A IG+G+FGE+ KA  R  G  VA+K++L     +   I   R E+ +L  L+H N
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHEN 78
Query: 217 IVQFLGAV-TERKP-------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIAR- 266
           +V  +    T+  P       + L+ ++           +   L  +  V F L +I R 
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRV 130
Query: 267 ------GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                 G+ Y+H   N I+HRD+K  NVL+       LK+ DFGL++
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV--LKLADFGLAR 173

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 3/96 (3%)
Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           HPNIV+      ++    L+ E L GG+L + +K+K   S + A      +   ++++H+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 274 EPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKL 308
               ++HRDLKP N+L  + + +  +K+ DFG ++L
Sbjct: 125 VG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158

>pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 27/64 (42%), Positives = 41/64 (64%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D    TPLH+A+L G +++ + L+++GADVNA D W +TPL  A       ++E+L
Sbjct: 73  VNAIDIXGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVL 132
Query: 121 NAHG 124
             HG
Sbjct: 133 LKHG 136

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 31/167 (18%)
Query: 159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +   A IG+G+FGE+ KA  R  G  VA+K++L     +   I   R E+ +L  L+H N
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHEN 77
Query: 217 IVQFLGAV-TERKP-------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIAR- 266
           +V  +    T+  P       + L+ ++           +   L  +  V F L +I R 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNVLVKFTLSEIKRV 129
Query: 267 ------GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                 G+ Y+H   N I+HRD+K  NVL+       LK+ DFGL++
Sbjct: 130 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGV--LKLADFGLAR 172

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 51/214 (23%)
Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLV------IQDFRHEVNLLVKLRHPNIV 218
           IG+GS+G +  A    T     R +  ++ +++       ++  + EV L+ KL HPNI 
Sbjct: 34  IGQGSYGVVRVAIENQTRAI--RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKE--------------KGALSPSTAVN----- 259
           +      + + + L+ E   GG L   L                K  + P    N     
Sbjct: 92  RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 260 ---------------------FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
                                    I   + YLHN+   I HRD+KP N L   + +  +
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEI 209
Query: 299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVS 332
           K+ DFGLSK     N+ + Y MT + G+  Y V+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGT-PYFVA 242

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           S  ++G G  G++L+ + R T    K  L  L D     Q+  H          P+IV  
Sbjct: 14  SKQVLGLGVNGKVLECFHRRT--GQKCALKLLYDSPKARQEVDHHWQ---ASGGPHIVCI 68
Query: 221 LGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
           L         ++ L++I E + GG+L   ++E+G  A +   A     DI   + +LH+ 
Sbjct: 69  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 127
Query: 275 PNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSK 307
            + I HRD+KP N+L  +   D  LK+ DFG +K
Sbjct: 128 -HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           S  ++G G  G++L+ + R T    K  L  L D     Q+  H          P+IV  
Sbjct: 33  SKQVLGLGVNGKVLECFHRRT--GQKCALKLLYDSPKARQEVDHHWQ---ASGGPHIVCI 87
Query: 221 LGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
           L         ++ L++I E + GG+L   ++E+G  A +   A     DI   + +LH+ 
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 146
Query: 275 PNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSK 307
            + I HRD+KP N+L  +   D  LK+ DFG +K
Sbjct: 147 -HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

>pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 27/64 (42%), Positives = 41/64 (64%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D    TPLH+A+L G +++ + L+++GADVNA D W +TPL  A       ++E+L
Sbjct: 73  VNAIDIMGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVL 132
Query: 121 NAHG 124
             HG
Sbjct: 133 LKHG 136

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 10/176 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVA--IKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           D+     +GKG+F  +++   + TP      +I+ +        Q    E  +   L+HP
Sbjct: 32  DYQLFEELGKGAFS-VVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NIV+   +++E     L+ + + GG+L + +  +   S + A +    I   + ++H   
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD 150
Query: 276 NVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             I+HRDLKP N+LL +      +K+ DFGL+  I+VQ     +   G  G+  YL
Sbjct: 151 --IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAW--FGFAGTPGYL 200

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 9/113 (7%)
Query: 199 IQDFRH----EVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
           +Q+ R     EV++L K+  HPNI+Q            L+ + ++ G+L  YL EK  LS
Sbjct: 50  VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS 109
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
                     +   +  LH     I+HRDLKP N+LL +    ++K+ DFG S
Sbjct: 110 EKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM--NIKLTDFGFS 158

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 9/113 (7%)
Query: 199 IQDFRH----EVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
           +Q+ R     EV++L K+  HPNI+Q            L+ + ++ G+L  YL EK  LS
Sbjct: 63  VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS 122
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
                     +   +  LH     I+HRDLKP N+LL +    ++K+ DFG S
Sbjct: 123 EKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM--NIKLTDFGFS 171

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 9/113 (7%)
Query: 199 IQDFRH----EVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
           +Q+ R     EV++L K+  HPNI+Q            L+ + ++ G+L  YL EK  LS
Sbjct: 63  VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS 122
Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
                     +   +  LH     I+HRDLKP N+LL +    ++K+ DFG S
Sbjct: 123 EKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM--NIKLTDFGFS 171

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+  +   + S   +G G++G +  A  +  G  VAIK++      +    + +R
Sbjct: 16  NKTAWELPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ LL  ++H N++  L   T    L       L+  +++  DL K +  K   S    
Sbjct: 73  -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK--FSEEKI 128
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                 + +G+ Y+H+    ++HRDLKP N L VN   + LK+ DFGL++
Sbjct: 129 QYLVYQMLKGLKYIHSAG--VVHRDLKPGN-LAVNEDCE-LKILDFGLAR 174

>pdb|3UTM|A Chain A, Crystal Structure Of A Mouse Tankyrase-Axin Complex Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 44/76 (57%)
Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAE 109
           + +LL +  + VHA+D     PLH A  +G  +V + L+++GA VNA D W+ TPL +A 
Sbjct: 73  IVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAA 132
Query: 110 GAKKFNMMELLNAHGG 125
              +  +  LL +HG 
Sbjct: 133 SKNRVEVCSLLLSHGA 148

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL 209
           +D  E+D    ++IGKGSFG+++KAY R     VAIK I     + +  +   + EV LL
Sbjct: 53  MDRYEID----SLIGKGSFGQVVKAYDRVEQEWVAIKII----KNKKAFLNQAQIEVRLL 104
Query: 210 VKL-RHPN-----IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFA 261
             + +H       IV        R  L L+ E L   +L+  L+      +S +    FA
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +   + +L      IIH DLKP N+LL N     +K+ DFG S
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>pdb|3ZUV|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 136

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/64 (42%), Positives = 41/64 (64%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D D  TPLH+A+  G +++ + L++YGADVNA+D +  TPL  A       ++E+L
Sbjct: 40  VNALDEDGLTPLHLAAQLGHLEIVEVLLKYGADVNAEDNFGITPLHLAAIRGHLEIVEVL 99
Query: 121 NAHG 124
             HG
Sbjct: 100 LKHG 103

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL 209
           +D  E+D    ++IGKGSFG+++KAY R     VAIK I     + +  +   + EV LL
Sbjct: 34  MDRYEID----SLIGKGSFGQVVKAYDRVEQEWVAIKII----KNKKAFLNQAQIEVRLL 85
Query: 210 VKL-RHPN-----IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFA 261
             + +H       IV        R  L L+ E L   +L+  L+      +S +    FA
Sbjct: 86  ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFA 144
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +   + +L      IIH DLKP N+LL N     +K+ DFG S
Sbjct: 145 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 189

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 20/164 (12%)
Query: 156 ELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
           E+ +++  +IG GSFG + +A       VAIK++L    D R        E+ ++  ++H
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFK----NRELQIMRIVKH 91
Query: 215 PNIVQ---FLGAVTERKP---LMLITEYLRGGDLHK---YLKEKGALSPSTAVNFALDIA 265
           PN+V    F  +  ++K    L L+ EY+          Y K K  +       +   + 
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           R +AY+H+    I HRD+KP+N LL++  +  LK+ DFG +K++
Sbjct: 152 RSLAYIHS--IGICHRDIKPQN-LLLDPPSGVLKLIDFGSAKIL 192

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLL 209
           +D  E+D    ++IGKGSFG+++KAY R     VAIK I     + +  +   + EV LL
Sbjct: 53  MDRYEID----SLIGKGSFGQVVKAYDRVEQEWVAIKII----KNKKAFLNQAQIEVRLL 104
Query: 210 VKL-RHPN-----IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFA 261
             + +H       IV        R  L L+ E L   +L+  L+      +S +    FA
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +   + +L      IIH DLKP N+LL N     +K+ DFG S
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSS 208

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+  +   + S   +G G++G +  A  +  G  VAIK++      +    + +R
Sbjct: 34  NKTAWELPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 90
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPL------MLITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ LL  ++H N++  L   T    L       L+  +++  DL K +  +   S    
Sbjct: 91  -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGME--FSEEKI 146
Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                 + +G+ Y+H+    ++HRDLKP N L VN   + LK+ DFGL++
Sbjct: 147 QYLVYQMLKGLKYIHSAG--VVHRDLKPGN-LAVNEDCE-LKILDFGLAR 192

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 65/132 (49%), Gaps = 7/132 (5%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           Q    E  +   L+HPNIV+   +++E     LI + + GG+L + +  +   S + A +
Sbjct: 66  QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH 125
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDVY 318
               I    A LH     ++HRDLKP N+LL +      +K+ DFGL+  I+V+     +
Sbjct: 126 CIQQILE--AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAW 181
Query: 319 KMTGETGSCEYL 330
              G  G+  YL
Sbjct: 182 --FGFAGTPGYL 191

>pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 45/73 (61%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+A D    TPLH+A+  G +++ + L+++GADVNA+D W  TPL  A   
Sbjct: 31  RILMANGADVNAMDDAGVTPLHLAAKRGHLEIVEVLLKHGADVNARDIWGRTPLHLAATV 90
Query: 112 KKFNMMELLNAHG 124
               ++E+L  +G
Sbjct: 91  GHLEIVEVLLEYG 103

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP------ 215
           +IGKGSFG+++KAY       VA+K +     +++   +    E+ +L  LR        
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
           N++  L   T R  + +  E L   +L++ +K+      S      FA  I + +  LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             N IIH DLKP N+LL       +KV DFG S
Sbjct: 219 --NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP------ 215
           +IGKGSFG+++KAY       VA+K +     +++   +    E+ +L  LR        
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
           N++  L   T R  + +  E L   +L++ +K+      S      FA  I + +  LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             N IIH DLKP N+LL       +KV DFG S
Sbjct: 219 --NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/64 (39%), Positives = 40/64 (62%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D+   TPLH+A+  G +++ + L++YGADVNA D   +TPL  A       ++E+L
Sbjct: 73  VNALDFSGSTPLHLAAKRGHLEIVEVLLKYGADVNADDTIGSTPLHLAADTGHLEIVEVL 132
Query: 121 NAHG 124
             +G
Sbjct: 133 LKYG 136

>pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 27/73 (36%), Positives = 45/73 (61%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+A D+   TPLH+A+  G +++ + L++YGADVNA D +  TPL  A   
Sbjct: 31  RILMANGADVNATDWLGHTPLHLAAKTGHLEIVEVLLKYGADVNAWDNYGATPLHLAADN 90
Query: 112 KKFNMMELLNAHG 124
               ++E+L  HG
Sbjct: 91  GHLEIVEVLLKHG 103

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 66  TSQVLGLGINGKVLQIFNKRT--QEKFALKXLQD----CPKARREVELHWRASQCPHIVR 119
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 120 IVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS 179
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

>pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 45/87 (51%)
Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L +A +     + KLL    + V+A+D D RTPLH A+  G  ++ K LI  GADVN  D
Sbjct: 74  LHYAAKEGHKEIVKLLISKGADVNAKDSDGRTPLHYAAKEGHKEIVKLLISKGADVNTSD 133
Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGG 125
               TPL  A       +++LL   GG
Sbjct: 134 SDGRTPLDLAREHGNEEIVKLLEKQGG 160

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IG+G+ G +  A     G  VAI+++ L       L+I    +E+ ++ + ++PNIV +L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 83
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L ++ EYL GG L   + E   +          +  + + +LH+  N +IHR
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 140
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           D+K  N+LL    +  +K+ DFG    I  + S
Sbjct: 141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IG+G+ G +  A     G  VAI+++ L       L+I    +E+ ++ + ++PNIV +L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 83
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L ++ EYL GG L   + E   +          +  + + +LH+  N +IHR
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 140
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           D+K  N+LL    +  +K+ DFG    I  + S
Sbjct: 141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 11/160 (6%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           +IG+GS+G +  AY + T   VAIK++   + +D +  +    E+ +L +L+   I++  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 222 GAVTERKPL----MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
             +     L    + I   +   DL K  K    L+         ++  G  ++H     
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG-- 149
Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
           IIHRDLKP N LL    +  +KV DFGL++ I  +   ++
Sbjct: 150 IIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNI 187

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IG+G+ G +  A     G  VAI+++ L       L+I    +E+ ++ + ++PNIV +L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 83
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L ++ EYL GG L   + E   +          +  + + +LH+  N +IHR
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 140
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           D+K  N+LL    +  +K+ DFG    I  + S
Sbjct: 141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171

>pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 33/45 (73%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           V+A+D D  TPLH+A+  G +++ + L++ GADVNAQD++  TP 
Sbjct: 94  VNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAQDKFGKTPF 138

>pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 33/45 (73%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           V+A+D D  TPLH+A+  G +++ + L++ GADVNAQD++  TP 
Sbjct: 94  VNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAQDKFGKTPF 138

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 149 DWEIDPSELD-FSSSAIIGKGSFGEIL-------KAYWRGTPVAIKRILPSLSDDRLVIQ 200
           D  +DP  +  +     +GKG F +         K  + G  V    +L     +++   
Sbjct: 17  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST- 75
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
               E+ +   L +P++V F G   +   + ++ E  R   L +  K + A++   A  F
Sbjct: 76  ----EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 131
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
                +G+ YLHN  N +IHRDLK  N L +N   D +K+GDFGL+  I+
Sbjct: 132 MRQTIQGVQYLHN--NRVIHRDLKLGN-LFLNDDMD-VKIGDFGLATKIE 177

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 149 DWEIDPSELD-FSSSAIIGKGSFGEIL-------KAYWRGTPVAIKRILPSLSDDRLVIQ 200
           D  +DP  +  +     +GKG F +         K  + G  V    +L     +++   
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST- 91
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
               E+ +   L +P++V F G   +   + ++ E  R   L +  K + A++   A  F
Sbjct: 92  ----EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
                +G+ YLHN  N +IHRDLK  N L +N   D +K+GDFGL+  I+
Sbjct: 148 MRQTIQGVQYLHN--NRVIHRDLKLGN-LFLNDDMD-VKIGDFGLATKIE 193

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 12/153 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IG+G+ G +  A     G  VAI+++ L       L+I    +E+ ++ + ++PNIV +L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 84
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L ++ EYL GG L   + E   +          +  + + +LH+  N +IHR
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 141
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           D+K  N+LL    +  +K+ DFG    I  + S
Sbjct: 142 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 172

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 149 DWEIDPSELD-FSSSAIIGKGSFGEIL-------KAYWRGTPVAIKRILPSLSDDRLVIQ 200
           D  +DP  +  +     +GKG F +         K  + G  V    +L     +++   
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST- 91
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
               E+ +   L +P++V F G   +   + ++ E  R   L +  K + A++   A  F
Sbjct: 92  ----EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
                +G+ YLHN  N +IHRDLK  N L +N   D +K+GDFGL+  I+
Sbjct: 148 MRQTIQGVQYLHN--NRVIHRDLKLGN-LFLNDDMD-VKIGDFGLATKIE 193

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/195 (21%), Positives = 88/195 (45%), Gaps = 31/195 (15%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSL----------SDDRLVIQ----DFR 203
           D+     + +G F +I+         A+K+   SL          ++D++ I+    DF+
Sbjct: 32  DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91
Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
           +E+ ++  +++   +   G +T    + +I EY+    + K+ +    L  +      + 
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 264 IAR--------GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           + +          +Y+HNE N I HRD+KP N+L+       +K+ DFG S+ +  +   
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM--DKNGRVKLSDFGESEYMVDK--- 205
Query: 316 DVYKMTGETGSCEYL 330
              K+ G  G+ E++
Sbjct: 206 ---KIKGSRGTYEFM 217

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 149 DWEIDPSELD-FSSSAIIGKGSFGEIL-------KAYWRGTPVAIKRILPSLSDDRLVIQ 200
           D  +DP  +  +     +GKG F +         K  + G  V    +L     +++   
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST- 91
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
               E+ +   L +P++V F G   +   + ++ E  R   L +  K + A++   A  F
Sbjct: 92  ----EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
                +G+ YLHN  N +IHRDLK  N L +N   D +K+GDFGL+  I+
Sbjct: 148 MRQTIQGVQYLHN--NRVIHRDLKLGN-LFLNDDMD-VKIGDFGLATKIE 193

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 20  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 73
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 74  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 133
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 134 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 173

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 20  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 73
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 74  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 133
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 134 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 173

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 36  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 89
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 90  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 149
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 150 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 189

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 22  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 75
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 175

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 28  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 81
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 82  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 141
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 142 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 181

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 27  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 80
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 81  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 140
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 141 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 180

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 26  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 79
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 80  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 139
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 140 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 179

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 66  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 119
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 21  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 74
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 75  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 134
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 135 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 174

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 22  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 75
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 175

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 72  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 125
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 126 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 185
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNS 314
               I HRD+KP N+L  +   +  LK+ DFG +K     NS
Sbjct: 186 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 225

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 65/132 (49%), Gaps = 7/132 (5%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           Q    E  +   L+HPNIV+   +++E     LI + + GG+L + +  +   S + A +
Sbjct: 55  QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH 114
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDVY 318
               I    A LH     ++HR+LKP N+LL +      +K+ DFGL+  I+V+     +
Sbjct: 115 CIQQILE--AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAW 170
Query: 319 KMTGETGSCEYL 330
              G  G+  YL
Sbjct: 171 --FGFAGTPGYL 180

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 164 IIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP------ 215
           +IGKG FG+++KAY       VA+K +     +++   +    E+ +L  LR        
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
           N++  L   T R  + +  E L   +L++ +K+      S      FA  I + +  LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             N IIH DLKP N+LL       +KV DFG S
Sbjct: 219 --NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 33/45 (73%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           V+A D D  TPLH+A+L G +++ + L+++GADVNAQD++  T  
Sbjct: 73  VNAHDNDGSTPLHLAALFGHLEIVEVLLKHGADVNAQDKFGKTAF 117

>pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 21/54 (38%), Positives = 39/54 (72%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           ++L  + + V+A D   +TPLH+A++ G +++ + L+++GADVNA D+  +TPL
Sbjct: 31  RILMANGADVNAEDDSGKTPLHLAAIKGHLEIVEVLLKHGADVNAADKMGDTPL 84

>pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 44/73 (60%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+A D    TPLH+A+  G +++ + L+++GADVNA D W  TPL  A   
Sbjct: 31  RILMANGADVNAMDDAGVTPLHLAAKRGHLEIVEVLLKHGADVNASDSWGRTPLHLAATV 90
Query: 112 KKFNMMELLNAHG 124
               ++E+L  +G
Sbjct: 91  GHLEIVEVLLEYG 103

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 82/184 (44%), Gaps = 14/184 (7%)
Query: 158 DFSSSAIIGKGSFGEI-----LKAYWRGTPVAIKRIL-PSLSDDRLVIQDFRHEVNLLVK 211
           +F    ++G G++G++     +  +  G   A+K +   ++       +  R E  +L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 212 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +R  P +V    A      L LI +Y+ GG+L  +L ++   +      +  +I   + +
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LH     II+RD+K  N+LL   S  H+ + DFGLSK      +   Y      G+ EY+
Sbjct: 175 LHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDF---CGTIEYM 227
Query: 331 VSNC 334
             + 
Sbjct: 228 APDI 231

>pdb|2ZGG|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 92

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 22/45 (48%), Positives = 32/45 (71%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           V A+D +  TPLH+A+ +G ++V K L+E GADVNAQD++  T  
Sbjct: 32  VAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVNAQDKFGKTAF 76

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 17/180 (9%)
Query: 157 LDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
           LDF    ++G+G FGE+     + T    A K++       R   Q    E  +L K+  
Sbjct: 188 LDFR---VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAY 270
             IV    A   +  L L+   + GGD+  ++    ++        A+ +   I  G+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LH     II+RDLKP NVLL +    ++++ D GL+  +K   +    K  G  G+  ++
Sbjct: 305 LHQ--RNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQT----KTKGYAGTPGFM 356

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 17/180 (9%)
Query: 157 LDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
           LDF    ++G+G FGE+     + T    A K++       R   Q    E  +L K+  
Sbjct: 188 LDFR---VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAY 270
             IV    A   +  L L+   + GGD+  ++    ++        A+ +   I  G+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LH     II+RDLKP NVLL +    ++++ D GL+  +K   +    K  G  G+  ++
Sbjct: 305 LHQ--RNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQT----KTKGYAGTPGFM 356

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 17/180 (9%)
Query: 157 LDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
           LDF    ++G+G FGE+     + T    A K++       R   Q    E  +L K+  
Sbjct: 188 LDFR---VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAY 270
             IV    A   +  L L+   + GGD+  ++    ++        A+ +   I  G+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LH     II+RDLKP NVLL +    ++++ D GL+  +K   +    K  G  G+  ++
Sbjct: 305 LHQ--RNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQT----KTKGYAGTPGFM 356

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 7/132 (5%)
Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVN 259
           Q    E  +   L+H NIV+   +++E     L+ + + GG+L + +  +   S + A +
Sbjct: 48  QKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH 107
Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSHDVY 318
               I    A LH     ++HRDLKP N+LL +      +K+ DFGL+  I+VQ     +
Sbjct: 108 CIQQILE--AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAW 163
Query: 319 KMTGETGSCEYL 330
              G  G+  YL
Sbjct: 164 --FGFAGTPGYL 173

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 17/180 (9%)
Query: 157 LDFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
           LDF    ++G+G FGE+     + T    A K++       R   Q    E  +L K+  
Sbjct: 188 LDFR---VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAY 270
             IV    A   +  L L+   + GGD+  ++    ++        A+ +   I  G+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LH     II+RDLKP NVLL +    ++++ D GL+  +K   +    K  G  G+  ++
Sbjct: 305 LHQ--RNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAGQT----KTKGYAGTPGFM 356

>pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/73 (36%), Positives = 44/73 (60%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+A D D  TPLH+A+ +G +++ + L++ GADVNA D    TPL  A   
Sbjct: 31  RILMANGADVNATDNDGYTPLHLAASNGHLEIVEVLLKNGADVNASDLTGITPLHLAAAT 90
Query: 112 KKFNMMELLNAHG 124
               ++E+L  HG
Sbjct: 91  GHLEIVEVLLKHG 103

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 9/151 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG+G+FGE+     + T    A+K +       R     FR E ++LV     
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
            I     A  +   L L+ +Y  GGDL   L +     P     F + ++   +  +H  
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 210
Query: 275 PNVIIHRDLKPRNVLL-VNSSADHLKVGDFG 304
             V  HRD+KP NVLL VN    H+++ DFG
Sbjct: 211 HYV--HRDIKPDNVLLDVNG---HIRLADFG 236

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 161 SSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +S ++G G  G++L+ + + T    K  L  L D        R EV L  +    P+IV+
Sbjct: 22  TSQVLGLGINGKVLQIFNKRT--QEKFALKMLQD----CPKARREVELHWRASQCPHIVR 75
Query: 220 FLGAVTE----RKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHN 273
            +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+
Sbjct: 76  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 274 EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSK 307
               I HRD+KP N+L  +   +  LK+ DFG +K
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 9/151 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG+G+FGE+     + T    A+K +       R     FR E ++LV     
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
            I     A  +   L L+ +Y  GGDL   L +     P     F + ++   +  +H  
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 194
Query: 275 PNVIIHRDLKPRNVLL-VNSSADHLKVGDFG 304
             V  HRD+KP NVLL VN    H+++ DFG
Sbjct: 195 HYV--HRDIKPDNVLLDVNG---HIRLADFG 220

>pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 44/73 (60%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+A D    TPLH+A+  G +++ + L+++GADVNA D W  TPL  A   
Sbjct: 31  RILMANGADVNAMDDAGVTPLHLAAKRGHLEIVEVLLKHGADVNASDIWGRTPLHLAATV 90
Query: 112 KKFNMMELLNAHG 124
               ++E+L  +G
Sbjct: 91  GHLEIVEVLLEYG 103

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 202 FRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
           FR EV +L + + H N+++ +    E     L+ E +RGG +  ++ ++   +   A   
Sbjct: 58  FR-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV 116
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSH---D 316
             D+A  + +LHN+   I HRDLKP N+L  + +    +K+ DFGL   IK+        
Sbjct: 117 VQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIS 174
Query: 317 VYKMTGETGSCEYL 330
             ++    GS EY+
Sbjct: 175 TPELLTPCGSAEYM 188

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           ++    +IG+GS+G +  AY +     VAIK++   + +D +  +    E+ +L +L+  
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKV-NRMFEDLIDCKRILREITILNRLKSD 87
Query: 216 NIVQFLGAVTERKPL----MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
            I++    +     L    + I   +   DL K  K    L+         ++  G  ++
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           H     IIHRDLKP N LL    +  +K+ DFGL++ I
Sbjct: 148 HESG--IIHRDLKPANCLLNQDCS--VKICDFGLARTI 181

>pdb|2BKK|B Chain B, Crystal Structure Of Aminoglycoside Phosphotransferase Aph (3')-Iiia In Complex With The Inhibitor Ar_3a Length = 169

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 43/73 (58%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+A D+   TPLH+   +G +++ + L++Y ADVNA D+   TPL  A   
Sbjct: 31  RILMANGADVNANDWFGITPLHLVVNNGHLEIIEVLLKYAADVNASDKSGWTPLHLAAYR 90
Query: 112 KKFNMMELLNAHG 124
               ++E+L  +G
Sbjct: 91  GHLEIVEVLLKYG 103

>pdb|4GRG|A Chain A, Crystal Structure Of Ige Complexed With E2_79, An Anti-Ige Inhibitor Length = 135

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/73 (36%), Positives = 44/73 (60%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+A DY   TPLH+A++ G +++ + L++ GADVNA      TPL  A  A
Sbjct: 31  RILTANGADVNANDYWGHTPLHLAAMLGHLEIVEVLLKNGADVNATGNTGRTPLHLAAWA 90
Query: 112 KKFNMMELLNAHG 124
               ++E+L  HG
Sbjct: 91  DHLEIVEVLLKHG 103

>pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 47/78 (60%), Gaps = 1/78 (1%)
Query: 47  AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA 106
           A  V+KLL +    V+AR  D  TPLH+A+ +G  ++ K L+  GADVNA+ +  NTP  
Sbjct: 22  AEEVKKLLSKGAD-VNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEH 80
Query: 107 DAEGAKKFNMMELLNAHG 124
            A+      +++LL+A G
Sbjct: 81  LAKKNGHHEIVKLLDAKG 98

>pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/64 (40%), Positives = 41/64 (64%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D    TPLH+A+  G +++ + L+++GADVNA DR   TPL  A  + +  ++E+L
Sbjct: 65  VNASDSAGITPLHLAAYDGHLEIVEVLLKHGADVNAYDRAGWTPLHLAALSGQLEIVEVL 124
Query: 121 NAHG 124
             HG
Sbjct: 125 LKHG 128

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 61/143 (42%), Gaps = 8/143 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG G FG + K   R  G   AIKR    L+         R      V  +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYL 271
           ++V++  A  E   +++  EY  GG L   + E          +   +  L + RG+ Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 272 HNEPNVIIHRDLKPRNVLLVNSS 294
           H+    ++H D+KP N+ +  +S
Sbjct: 132 HSMS--LVHMDIKPSNIFISRTS 152

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           IG+G+ G +  A     G  VAI+++ L       L+I    +E+ ++ + ++PNIV +L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENKNPNIVNYL 84
Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +      L ++ EYL GG L   + E   +          +  + + +LH+  N +IHR
Sbjct: 85  DSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS--NQVIHR 141
Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           ++K  N+LL       +K+ DFG    I  + S
Sbjct: 142 NIKSDNILL--GMDGSVKLTDFGFCAQITPEQS 172

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 61/143 (42%), Gaps = 8/143 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG G FG + K   R  G   AIKR    L+         R      V  +H 
Sbjct: 10  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYL 271
           ++V++  A  E   +++  EY  GG L   + E          +   +  L + RG+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 272 HNEPNVIIHRDLKPRNVLLVNSS 294
           H+    ++H D+KP N+ +  +S
Sbjct: 130 HSMS--LVHMDIKPSNIFISRTS 150

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 61/143 (42%), Gaps = 8/143 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG G FG + K   R  G   AIKR    L+         R      V  +H 
Sbjct: 10  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 69
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYL 271
           ++V++  A  E   +++  EY  GG L   + E          +   +  L + RG+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 272 HNEPNVIIHRDLKPRNVLLVNSS 294
           H+    ++H D+KP N+ +  +S
Sbjct: 130 HSMS--LVHMDIKPSNIFISRTS 150

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 61/143 (42%), Gaps = 8/143 (5%)
Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG G FG + K   R  G   AIKR    L+         R      V  +H 
Sbjct: 8   EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 67
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYL 271
           ++V++  A  E   +++  EY  GG L   + E          +   +  L + RG+ Y+
Sbjct: 68  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 272 HNEPNVIIHRDLKPRNVLLVNSS 294
           H+    ++H D+KP N+ +  +S
Sbjct: 128 HSMS--LVHMDIKPSNIFISRTS 148

>pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 48/96 (50%)
Query: 30  ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
           A+ S     L +A +N    + KLL    +  +A+D D RTPLH A+ +G  ++ K L+ 
Sbjct: 65  AKDSDGRTPLHYAAENGHKEIVKLLLSKGADPNAKDSDGRTPLHYAAENGHKEIVKLLLS 124
Query: 90  YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
            GAD N  D    TPL  A       +++LL   GG
Sbjct: 125 KGADPNTSDSDGRTPLDLAREHGNEEIVKLLEKQGG 160

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 24/181 (13%)
Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           I  +G FG + KA      VA+K I P    D+   Q  R E+     ++H N++QF+ A
Sbjct: 22  IKARGRFGCVWKAQLMNDFVAVK-IFPL--QDKQSWQSER-EIFSTPGMKHENLLQFIAA 77
Query: 224 VTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE----- 274
                     L LIT +   G L  YLK    ++ +   + A  ++RG++YLH +     
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLK-GNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 275 -----PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEY 329
                P+ I HRD K +NVLL +     L   DFGL+  ++ +         G+ G+  Y
Sbjct: 137 GEGHKPS-IAHRDFKSKNVLLKSDLTAVL--ADFGLA--VRFEPGKPPGDTHGQVGTRRY 191
Query: 330 L 330
           +
Sbjct: 192 M 192

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 80/151 (52%), Gaps = 17/151 (11%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH---PNIVQ 219
           +G+G++G  E ++    G  +A+KRI  +++      +  R  ++L + +R    P  V 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ----EQKRLLMDLDISMRTVDCPFTVT 70
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAV-NFALDIARGMAYLHNEP 275
           F GA+     + +  E L    L K+ K+   KG   P   +   A+ I + + +LH++ 
Sbjct: 71  FYGALFREGDVWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +VI HRD+KP NVL+  ++   +K+ DFG+S
Sbjct: 130 SVI-HRDVKPSNVLI--NALGQVKMCDFGIS 157

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 80/151 (52%), Gaps = 17/151 (11%)
Query: 165 IGKGSFG--EILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH---PNIVQ 219
           +G+G++G  E ++    G  +A+KRI  +++      +  R  ++L + +R    P  V 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ----EQKRLLMDLDISMRTVDCPFTVT 114
Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAV-NFALDIARGMAYLHNEP 275
           F GA+     + +  E L    L K+ K+   KG   P   +   A+ I + + +LH++ 
Sbjct: 115 FYGALFREGDVWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           +VI HRD+KP NVL+  ++   +K+ DFG+S
Sbjct: 174 SVI-HRDVKPSNVLI--NALGQVKMCDFGIS 201

>pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 24/60 (40%), Positives = 39/60 (65%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A+D D  TPLH+A+  G +++ + L++ GADVNA+D+   TPL  A       ++E+L
Sbjct: 40  VNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVL 99

>pdb|3HG0|D Chain D, Crystal Structure Of A Darpin In Complex With Orf49 From Lactococcal Phage Tp901-1 Length = 136

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 23/67 (34%), Positives = 43/67 (64%)
Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A  ND   + ++L ++ + V+A D    TPLH+ +++G +++ + L+++GADVNAQD
Sbjct: 51  LHLAAMNDHLEIVEVLLKNGADVNAIDAIGETPLHLVAMYGHLEIVEVLLKHGADVNAQD 110
Query: 99  RWKNTPL 105
           ++  T  
Sbjct: 111 KFGKTAF 117

>pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 21/56 (37%), Positives = 40/56 (71%)
Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           + ++L ++ + V+A D D  TPLH+A+  G++++ + L+++GADVNAQD++  T  
Sbjct: 95  IVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEVLLKHGADVNAQDKFGKTAF 150

>pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/64 (40%), Positives = 40/64 (62%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D +  TPLH+A+  G +++ + L++YGADVNA+D    TPL  A       ++E+L
Sbjct: 61  VNAVDTNGTTPLHLAASLGHLEIVEVLLKYGADVNAKDATGITPLYLAAYWGHLEIVEVL 120
Query: 121 NAHG 124
             HG
Sbjct: 121 LKHG 124

>pdb|2V5Q|C Chain C, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 167

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 25/64 (39%), Positives = 39/64 (60%)
Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V A D    TPLH+A++ G +++ + L++YGADVNA D   +TPL  A       ++E+L
Sbjct: 73  VDAADVYGFTPLHLAAMTGHLEIVEVLLKYGADVNAFDMTGSTPLHLAADEGHLEIVEVL 132
Query: 121 NAHG 124
             +G
Sbjct: 133 LKYG 136

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP E   ++   IG+GS G +  A  +  G  VA+K++       R ++ +   EV ++ 
Sbjct: 42  DPREY-LANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMR 97
Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
              H N+V    +      L ++ E+L GG L   +     ++        L + R ++Y
Sbjct: 98  DYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSY 156
Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
           LHN+   +IHRD+K  ++LL  +S   +K+ DFG 
Sbjct: 157 LHNQG--VIHRDIKSDSILL--TSDGRIKLSDFGF 187

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 55
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E +    DL  ++ E+GAL    
Sbjct: 56  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL 115
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 116 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 166

>pdb|2ZGD|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 110

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 22/54 (40%), Positives = 36/54 (66%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           ++L  + + V A+D +  TPLH+A+ +G ++V K L+E GADV AQD++  T  
Sbjct: 41  RILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAF 94

>pdb|2JAB|A Chain A, A Designed Ankyrin Repeat Protein Evolved To Picomolar Affinity To Her2 Length = 136

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 52/86 (60%), Gaps = 2/86 (2%)
Query: 35  TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
           T L L  AH +    + ++L ++ + V+A D    TPLH+A+  G +++A+ L+++GADV
Sbjct: 49  TPLYLATAHGH--LEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADV 106
Query: 95  NAQDRWKNTPLADAEGAKKFNMMELL 120
           NAQD++  T    + G    ++ E+L
Sbjct: 107 NAQDKFGKTAFDISIGNGNEDLAEIL 132

>pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 20/56 (35%), Positives = 39/56 (69%)
Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           + ++L ++ + V+A D +  TPLH+A++ G +++ + L++ GADVNAQD++  T  
Sbjct: 95  IVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAF 150

>pdb|3NOC|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 45/73 (61%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA 111
           ++L  + + V+ARD+   TPLH+A+  G +++ + L++ GADVNA+D    TPL  A   
Sbjct: 31  RILMANGADVNARDFTGWTPLHLAAHFGHLEIVEVLLKNGADVNAKDSLGVTPLHLAARR 90
Query: 112 KKFNMMELLNAHG 124
               ++E+L  +G
Sbjct: 91  GHLEIVEVLLKNG 103

>pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 48/96 (50%)
Query: 30  ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
           A+ S     L  A +N    V KLL    +  +A+D D +TPLH+A+ +G  +V K L+ 
Sbjct: 65  AKDSDGKTPLHLAAENGHKEVVKLLLSQGADPNAKDSDGKTPLHLAAENGHKEVVKLLLS 124
Query: 90  YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
            GAD N  D    TPL  A       +++LL   GG
Sbjct: 125 QGADPNTSDSDGRTPLDLAREHGNEEVVKLLEKQGG 160

>pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 21/56 (37%), Positives = 40/56 (71%)
Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           + ++L ++ + V+A+D +  TPLH+A+  G +++ + L++YGADVNAQD++  T  
Sbjct: 95  IVEVLLKNGADVNAKDDNGITPLHLAANRGHLEIVEVLLKYGADVNAQDKFGKTAF 150

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 200 QDFR----HEVNLLVKLRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--L 252
           QD R    HE+ +L   +  P ++           ++LI EY  GG++      + A  +
Sbjct: 69  QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 253 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLI 309
           S +  +     I  G+ YLH   N I+H DLKP+N+LL +      +K+ DFG+S+ I
Sbjct: 129 SENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           E+++   L H ++V F G   +   + ++ E  R   L +  K + AL+   A  +   I
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             G  YLH   N +IHRDLK  N L +N   + +K+GDFGL+
Sbjct: 125 VLGCQYLHR--NRVIHRDLKLGN-LFLNEDLE-VKIGDFGLA 162

>pdb|3HRA|A Chain A, Crystal Structure Of Ef0377 An Ankyrin Repeat Protein Length = 201

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/67 (34%), Positives = 41/67 (61%)
Query: 38  ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
           +L  A+Q D   V+++L++    V   D +  TPL++A  +  I++AK LI+ GAD+N Q
Sbjct: 9   LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68
Query: 98  DRWKNTP 104
           +   ++P
Sbjct: 69  NSISDSP 75

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 202 FRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
           FR EV +L + + H N+++ +    E     L+ E +RGG +  ++ ++   +   A   
Sbjct: 58  FR-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV 116
Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNSH---D 316
             D+A  + +LHN+   I HRDLKP N+L  + +    +K+ DF L   IK+        
Sbjct: 117 VQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 317 VYKMTGETGSCEYL 330
             ++    GS EY+
Sbjct: 175 TPELLTPCGSAEYM 188

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           E+++   L H ++V F G   +   + ++ E  R   L +  K + AL+   A  +   I
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             G  YLH   N +IHRDLK  N L +N   + +K+GDFGL+
Sbjct: 127 VLGCQYLHR--NRVIHRDLKLGN-LFLNEDLE-VKIGDFGLA 164

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 62/113 (54%), Gaps = 9/113 (7%)
Query: 201 DFRHEVNLLVKLRHPNIVQFLGAV--TERKPLMLITEYLRGG--DLHKYLKEKGALSPST 256
           + + E+ LL +LRH N++Q +  +   E++ + ++ EY   G  ++   + EK       
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQ 110
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           A  +   +  G+ YLH++   I+H+D+KP N+LL  ++   LK+   G+++ +
Sbjct: 111 AHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLL--TTGGTLKISALGVAEAL 159

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           E+++   L H ++V F G   +   + ++ E  R   L +  K + AL+   A  +   I
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 130
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             G  YLH   N +IHRDLK  N L +N   + +K+GDFGL+
Sbjct: 131 VLGCQYLHR--NRVIHRDLKLGN-LFLNEDLE-VKIGDFGLA 168

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           E+++   L H ++V F G   +   + ++ E  R   L +  K + AL+   A  +   I
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             G  YLH   N +IHRDLK  N L +N   + +K+GDFGL+
Sbjct: 127 VLGCQYLHR--NRVIHRDLKLGN-LFLNEDLE-VKIGDFGLA 164

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           E+++   L H ++V F G   +   + ++ E  R   L +  K + AL+   A  +   I
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             G  YLH   N +IHRDLK  N L +N   + +K+GDFGL+
Sbjct: 149 VLGCQYLHR--NRVIHRDLKLGN-LFLNEDLE-VKIGDFGLA 186

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           E+++   L H ++V F G   +   + ++ E  R   L +  K + AL+   A  +   I
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             G  YLH   N +IHRDLK  N L +N   + +K+GDFGL+
Sbjct: 151 VLGCQYLHR--NRVIHRDLKLGN-LFLNEDLE-VKIGDFGLA 188

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 65/150 (43%), Gaps = 7/150 (4%)
Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG+G+FGE+     +      A+K +       R     FR E ++LV     
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL-DIARGMAYLHNE 274
            I     A  +   L L+ +Y  GGDL   L +     P     F L ++   +  +H  
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
             V  HRD+KP N+L+      H+++ DFG
Sbjct: 195 HYV--HRDIKPDNILM--DMNGHIRLADFG 220

>pdb|2XEN|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module Length = 91

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 21/52 (40%), Positives = 37/52 (71%)
Query: 52  KLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT 103
           ++L  + + V+A+D D  TPLH+A+  G +++ + L++ GADVNAQD++  T
Sbjct: 19  RILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAQDKFGKT 70

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 45  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 98
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 159 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 209

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 71
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 132 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 182

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 71
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 132 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 182

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 71
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 132 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 182

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 70
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 131 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 181

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 37  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 90
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 91  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 151 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 201

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 84
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 145 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 195

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 70
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 131 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 181

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 84
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 145 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 195

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 83
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 144 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 194

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 83
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 144 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 194

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRH---- 204
           E +P E  +    ++G G FG +          PVAIK +      DR  I D+      
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV----EKDR--ISDWGELPNG 84
Query: 205 -----EVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRG-GDLHKYLKEKGALSPST 256
                EV LL K+      +++ L         +LI E      DL  ++ E+GAL    
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           A +F   +   + + HN    ++HRD+K  N+ L++ +   LK+ DFG   L+K
Sbjct: 145 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENI-LIDLNRGELKLIDFGSGALLK 195
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	337
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-75
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-72
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-71
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-71
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-68
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-67
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-63
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-62
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-54
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-53
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-53
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-53
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-53
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-52
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-52
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-52
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-52
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-52
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-52
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-51
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-51
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-51
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-51
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-51
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-51
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-50
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-50
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-50
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-49
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-49
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-49
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-49
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-49
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-49
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-49
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-49
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-49
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-49
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-49
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-48
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-48
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-48
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-48
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-48
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-48
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-47
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-47
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-47
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-47
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-47
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-47
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-47
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-47
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-46
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-46
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-46
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-46
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-46
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-46
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-46
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-45
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-45
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-37
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-34
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-33
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-33
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-33
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-33
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-33
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-33
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-33
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-33
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-33
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-33
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-33
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-33
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-33
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-32
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-32
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-32
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-32
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-31
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-31
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-31
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-31
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-30
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-30
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-30
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-30
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-29
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-28
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-28
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-27
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-27
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-26
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-26
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-26
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-26
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-26
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-25
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-25
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-25
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-25
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-23
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-23
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-22
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-22
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-22
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-22
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-22
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-21
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-21
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-19
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	8e-18
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	4e-16
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	3e-12
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	1e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-17
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-17
3v30_A	172	DNA-binding protein rfxank; structural genomics co	1e-16
3v30_A	172	DNA-binding protein rfxank; structural genomics co	3e-14
3v30_A	172	DNA-binding protein rfxank; structural genomics co	1e-12
3v30_A	172	DNA-binding protein rfxank; structural genomics co	8e-09
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	3e-16
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	8e-15
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	4e-14
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	5e-09
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	7e-09
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	5e-16
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	2e-13
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	3e-11
3hra_A	201	Ankyrin repeat family protein; structural protein;	1e-15
3hra_A	201	Ankyrin repeat family protein; structural protein;	4e-12
3hra_A	201	Ankyrin repeat family protein; structural protein;	5e-12
3hra_A	201	Ankyrin repeat family protein; structural protein;	1e-11
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-15
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	6e-15
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	4e-13
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	4e-12
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	9e-11
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	9e-10
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	9e-05
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	7e-04
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	2e-15
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	3e-12
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	4e-11
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	5e-11
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	9e-11
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	2e-10
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	5e-04
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	3e-15
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	2e-14
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	1e-13
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	9e-09
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	3e-04
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	3e-15
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-14
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	4e-14
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-12
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-11
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-08
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-06
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-05
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	6e-15
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	2e-14
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	3e-11
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	6e-15
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	1e-12
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	2e-10
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	1e-06
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	7e-15
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	1e-12
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	4e-11
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	6e-11
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	9e-11
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	5e-10
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	3e-05
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	7e-05
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	8e-15
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	1e-14
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-13
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	7e-13
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	2e-09
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-08
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	9e-08
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	9e-15
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	8e-13
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	2e-12
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	4e-10
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	7e-10
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	3e-09
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	2e-14
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-13
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	4e-13
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	4e-12
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	3e-07
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-06
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-14
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-14
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	5e-14
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	5e-11
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-10
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	2e-14
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	7e-14
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	2e-12
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	4e-12
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	2e-11
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	3e-10
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	3e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-14
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	3e-14
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	4e-14
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	5e-12
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	2e-08
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	3e-14
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	3e-12
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	5e-08
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	3e-14
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	7e-14
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	1e-13
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	3e-13
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	8e-13
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	6e-11
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	2e-06
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	3e-14
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	7e-14
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-13
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	3e-13
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	3e-13
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	5e-13
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	8e-13
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	8e-13
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-12
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	5e-12
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	7e-12
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-08
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	4e-14
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-13
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	1e-12
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	1e-09
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	4e-14
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	2e-13
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	3e-12
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	9e-09
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	4e-14
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	2e-13
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	9e-09
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	6e-08
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	1e-06
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	5e-14
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	4e-13
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	1e-10
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	5e-14
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	1e-13
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	3e-13
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	4e-13
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	1e-11
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	6e-08
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	7e-14
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	1e-13
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	6e-13
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	7e-14
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	4e-12
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	4e-06
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	8e-14
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	2e-13
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	5e-12
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	2e-07
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	8e-14
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	2e-12
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	3e-11
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	8e-14
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	8e-13
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	6e-12
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-11
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	3e-11
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	6e-11
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	4e-10
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	3e-08
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-07
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	9e-14
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	2e-10
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	3e-10
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	6e-10
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	8e-10
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	1e-09
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	9e-06
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	1e-13
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	1e-12
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	1e-11
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	1e-10
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	4e-07
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-13
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	8e-13
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-11
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	3e-10
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-09
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-08
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-07
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-13
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-13
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	2e-12
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	2e-11
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	6e-11
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	9e-11
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	4e-10
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	1e-13
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-13
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	5e-09
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	1e-08
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	3e-06
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-05
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	2e-13
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	4e-13
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	4e-13
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	3e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-13
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	4e-13
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	6e-13
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	1e-12
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	3e-12
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	1e-04
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	6e-13
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	5e-12
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	1e-04
2rfa_A	232	Transient receptor potential cation channel subfa	6e-13
2rfa_A	232	Transient receptor potential cation channel subfa	8e-12
2rfa_A	232	Transient receptor potential cation channel subfa	1e-08
2rfa_A	232	Transient receptor potential cation channel subfa	7e-08
2rfa_A	232	Transient receptor potential cation channel subfa	3e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-13
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-12
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-12
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	5e-12
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	8e-12
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	9e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-12
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	1e-12
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	6e-12
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	2e-10
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	1e-09
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	2e-08
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	2e-12
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	4e-12
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	2e-11
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	6e-11
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	1e-04
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	3e-12
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	3e-12
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	4e-12
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	2e-11
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	3e-09
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	5e-08
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	7e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-12
2pnn_A	273	Transient receptor potential cation channel subfa	4e-12
2pnn_A	273	Transient receptor potential cation channel subfa	6e-08
2pnn_A	273	Transient receptor potential cation channel subfa	1e-07
2pnn_A	273	Transient receptor potential cation channel subfa	4e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-12
2etb_A	256	Transient receptor potential cation channel subfam	6e-12
2etb_A	256	Transient receptor potential cation channel subfam	2e-08
2etb_A	256	Transient receptor potential cation channel subfam	2e-08
2etb_A	256	Transient receptor potential cation channel subfam	3e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-11
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	1e-10
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	2e-09
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	5e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-10
3jxi_A	260	Vanilloid receptor-related osmotically activated p	1e-09
3jxi_A	260	Vanilloid receptor-related osmotically activated p	4e-09
3jxi_A	260	Vanilloid receptor-related osmotically activated p	9e-06
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	1e-09
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	1e-05
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	1e-05
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	4e-09
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	9e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	4e-07
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	3e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-05
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	3e-05
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	3e-04
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	5e-05

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  232 bits (595), Expect = 4e-75
 Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 12/196 (6%)

Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR 196
                    +  D +I   +L+      IG GSFG + +A W G+ VA+K ++       
Sbjct: 19  ENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE 76

Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA---LS 253
             + +F  EV ++ +LRHPNIV F+GAVT+   L ++TEYL  G L++ L + GA   L 
Sbjct: 77  R-VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
               ++ A D+A+GM YLHN    I+HR+LK  N+L+       +KV DFGLS+L     
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLK---- 189

Query: 314 SHDVYKMTGETGSCEY 329
           +          G+ E+
Sbjct: 190 ASTFLSSKSAAGTPEW 205

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  225 bits (575), Expect = 2e-72
 Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 21/197 (10%)

Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRL--- 197
             P      +  +E+++     IGKG FG + K       + VAIK ++   S+      
Sbjct: 7   EFPKSRLPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64

Query: 198 -VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPS 255
              Q+F+ EV ++  L HPNIV+  G +    P  ++ E++  GDL+  L  +   +  S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122

Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKVQ 312
             +   LDIA G+ Y+ N+   I+HRDL+  N+ L +   +     KV DFGLS+     
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---- 178

Query: 313 NSHDVYKMTGETGSCEY 329
               V+ ++G  G+ ++
Sbjct: 179 ---SVHSVSGLLGNFQW 192

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  224 bits (572), Expect = 1e-71
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 11/196 (5%)

Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR 196
           P+          +W+I   +L+     +IGKG FG++    W G  VAI+ I     D+ 
Sbjct: 15  PRKASQTSIFLQEWDIPFEQLEIGE--LIGKGRFGQVYHGRWHGE-VAIRLIDIE-RDNE 70

Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPS 255
             ++ F+ EV    + RH N+V F+GA      L +IT   +G  L+  +   K  L  +
Sbjct: 71  DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN 130

Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV-QNS 314
                A +I +GM YLH +   I+H+DLK +NV   N     + + DFGL  +  V Q  
Sbjct: 131 KTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAG 185

Query: 315 HDVYKMTGETGSCEYL 330
               K+  + G   +L
Sbjct: 186 RREDKLRIQNGWLCHL 201

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  221 bits (565), Expect = 4e-71
 Identities = 69/188 (36%), Positives = 99/188 (52%), Gaps = 17/188 (9%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR-LVIQDFRHEVNL 208
            EID +EL      IIG G FG++ +A+W G  VA+K       +D    I++ R E  L
Sbjct: 2   LEIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
              L+HPNI+   G   +   L L+ E+ RGG L++ L  K  + P   VN+A+ IARGM
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGM 118

Query: 269 AYLHNE-PNVIIHRDLKPRNVLLVNSSADH------LKVGDFGLSKLIKVQNSHDVYKMT 321
            YLH+E    IIHRDLK  N+L++    +       LK+ DFGL++       H   KM+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-----HRTTKMS 173

Query: 322 GETGSCEY 329
              G+  +
Sbjct: 174 A-AGAYAW 180

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  216 bits (551), Expect = 2e-68
 Identities = 63/184 (34%), Positives = 98/184 (53%), Gaps = 21/184 (11%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
             ID  E++     ++G+G+FG + KA WR   VAIK+I    S+     + F  E+  L
Sbjct: 3   HMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQIE---SES--ERKAFIVELRQL 55

Query: 210 VKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIAR 266
            ++ HPNIV+  GA     P+ L+ EY  GG L+  L   +     + + A+++ L  ++
Sbjct: 56  SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113

Query: 267 GMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
           G+AYLH+ +P  +IHRDLKP N LL+ +    LK+ DFG +  I+         MT   G
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPN-LLLVAGGTVLKICDFGTACDIQTH-------MTNNKG 165

Query: 326 SCEY 329
           S  +
Sbjct: 166 SAAW 169

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  212 bits (541), Expect = 2e-67
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 18/185 (9%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
              ID  +L+F +   + +   GE+ K  W+G  + +K +       R   +DF  E   
Sbjct: 4   HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60

Query: 209 LVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDI 264
           L    HPN++  LGA          LIT ++  G L+  L       +  S AV FALD+
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           ARGMA+LH    +I    L  R+V++        ++    +            ++  G  
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDED--MTARISMADVKF---------SFQSPGRM 169

Query: 325 GSCEY 329
            +  +
Sbjct: 170 YAPAW 174

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  201 bits (513), Expect = 8e-63
 Identities = 58/164 (35%), Positives = 89/164 (54%), Gaps = 12/164 (7%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVN 207
               PS+L      ++GKG FG+ +K   R T   + +K ++    + +   + F  EV 
Sbjct: 5   RIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVK 59

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIAR 266
           ++  L HPN+++F+G + + K L  ITEY++GG L   +         S  V+FA DIA 
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           GMAYLH+    IIHRDL   N  LV  +  ++ V DFGL++L+ 
Sbjct: 120 GMAYLHSMN--IIHRDLNSHN-CLVREN-KNVVVADFGLARLMV 159

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (509), Expect = 2e-62
 Identities = 59/182 (32%), Positives = 91/182 (50%), Gaps = 12/182 (6%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +  +    +  +Q F++EV +
Sbjct: 18  DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ-LQAFKNEVGV 73

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T    L ++T++  G  L+ +L   +        ++ A   ARG
Sbjct: 74  LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC 327
           M YLH +   IIHRDLK  N+ L     + +K+GDFGL+      +     +    +GS 
Sbjct: 133 MDYLHAKS--IIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSGSH--QFEQLSGSI 186

Query: 328 EY 329
            +
Sbjct: 187 LW 188

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  189 bits (483), Expect = 4e-58
 Identities = 49/191 (25%), Positives = 73/191 (38%), Gaps = 19/191 (9%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
                  ++       IGKG +GE+    WRG  VA+K    +             E+  
Sbjct: 31  VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWF----RETEIYQ 84

Query: 209 LVKLRHPNIVQFLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
            V +RH NI+ F+ A  +       L LIT+Y   G L+ YLK    L   + +  A   
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143

Query: 265 ARGMAYLHNEP------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
             G+ +LH E         I HRDLK +N+L+         + D GL+       +    
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAVKFISDTNEVDI 201

Query: 319 KMTGETGSCEY 329
                 G+  Y
Sbjct: 202 PPNTRVGTKRY 212

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (455), Expect = 3e-54
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 21/178 (11%)

Query: 164 IIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE--VNLLVKLRHPNIVQFL 221
            +GKG +GE+ +  W+G  VA+K             + +  E  +   V LRH NI+ F+
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFI 68

Query: 222 GAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-- 275
            +          L LIT Y   G L+ YL+    L   + +   L IA G+A+LH E   
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 276 ----NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEY 329
                 I HRDLK +N+L+  +      + D GL+ +     +          G+  Y
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (455), Expect = 7e-54
 Identities = 50/191 (26%), Positives = 72/191 (37%), Gaps = 19/191 (9%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
                   +       IGKG FGE+ +  WRG  VA+K                  E+  
Sbjct: 36  VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERS----WFREAEIYQ 89

Query: 209 LVKLRHPNIVQFLGAVT----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
            V LRH NI+ F+ A          L L+++Y   G L  YL  +  ++    +  AL  
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALST 148

Query: 265 ARGMAYLHNEPN------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
           A G+A+LH E         I HRDLK +N+L+         + D GL+            
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAVRHDSATDTIDI 206

Query: 319 KMTGETGSCEY 329
                 G+  Y
Sbjct: 207 APNHRVGTKRY 217

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  177 bits (450), Expect = 1e-53
 Identities = 57/185 (30%), Positives = 87/185 (47%), Gaps = 16/185 (8%)

Query: 145 PNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLV 198
           P +     I   +L       +G GSFG + +  W         VA+K + P +      
Sbjct: 7   PLQSLTCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64

Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTA 257
           + DF  EVN +  L H N+++  G V    P+ ++TE    G L   L++ +G     T 
Sbjct: 65  MDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
             +A+ +A GM YL  E    IHRDL  RN+LL  ++ D +K+GDFGL + +   +  D 
Sbjct: 124 SRYAVQVAEGMGYL--ESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQND--DH 177

Query: 318 YKMTG 322
           Y M  
Sbjct: 178 YVMQE 182

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  176 bits (449), Expect = 3e-53
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 21/212 (9%)

Query: 123 HGGLSYGQNGSHFEPKPVPPPLPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG- 180
           H          +   +          D  + +   L F     +GKG+FG +    +   
Sbjct: 8   HHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPL 65

Query: 181 -----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI 233
                  VA+K++  S  +     +DF  E+ +L  L+H NIV++ G      R+ L LI
Sbjct: 66  QDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122

Query: 234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN 292
            EYL  G L  YL++ K  +     + +   I +GM YL       IHRDL  RN+L+  
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILV-- 178

Query: 293 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
            + + +K+GDFGL+K++      + YK+    
Sbjct: 179 ENENRVKIGDFGLTKVLP--QDKEYYKVKEPG 208

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  178 bits (453), Expect = 4e-53
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 115 NMMELLNAH----GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSF 170
           ++  L++        L+            +   +P    W ++  +L       IG+G+F
Sbjct: 77  SIPLLIDHLLSTQQPLTKK------SGVVLHRAVPKD-KWVLNHEDLVLGE--QIGRGNF 127

Query: 171 GEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK 228
           GE+     R   T VA+K    +L  D  +   F  E  +L +  HPNIV+ +G  T+++
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185

Query: 229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287
           P+ ++ E ++GGD   +L+ +G  L   T +    D A GM YL ++    IHRDL  RN
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARN 243

Query: 288 VLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
            L+  +  + LK+ DFG+S+         VY  +G   
Sbjct: 244 CLV--TEKNVLKISDFGMSREEA----DGVYAASGGLR 275

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  175 bits (446), Expect = 6e-53
 Identities = 55/195 (28%), Positives = 89/195 (45%), Gaps = 19/195 (9%)

Query: 139 PVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR------GTPVAIKRILPSL 192
               P         +   L       +G+G FG++    +       G  VA+K + P  
Sbjct: 5   SEKKPATEVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62

Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-K 249
             + +   D + E+ +L  L H NIV++ G  TE     + LI E+L  G L +YL + K
Sbjct: 63  GGNHI--ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120

Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
             ++    + +A+ I +GM YL       +HRDL  RNVL+   S   +K+GDFGL+K I
Sbjct: 121 NKINLKQQLKYAVQICKGMDYL--GSRQYVHRDLAARNVLV--ESEHQVKIGDFGLTKAI 176

Query: 310 KVQNSHDVYKMTGET 324
             +   + Y +  + 
Sbjct: 177 --ETDKEYYTVKDDR 189

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  173 bits (441), Expect = 2e-52
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 14/184 (7%)

Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLV 198
            +  K +  +D   L       +G G+FG + K Y++       VA+K IL + ++D  +
Sbjct: 5   EIRPK-EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVK-ILKNEANDPAL 61

Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
             +   E N++ +L +P IV+ +G     +  ML+ E    G L+KYL++   +     +
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                ++ GM YL  E +  +HRDL  RNVLL   +  + K+ DFGLSK ++     + Y
Sbjct: 121 ELVHQVSMGMKYL--EESNFVHRDLAARNVLL--VTQHYAKISDFGLSKALRADE--NYY 174

Query: 319 KMTG 322
           K   
Sbjct: 175 KAQT 178

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  173 bits (440), Expect = 2e-52
 Identities = 60/188 (31%), Positives = 86/188 (45%), Gaps = 17/188 (9%)

Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDD 195
             P    L     WEIDP +L F     +G G FG +    WRG   VAIK I      +
Sbjct: 7   NAPSTAGLG-YGSWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE 63

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
                +F  E  +++ L H  +VQ  G  T+++P+ +ITEY+  G L  YL+E +     
Sbjct: 64  ----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119

Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
              +    D+   M YL  E    +HRDL  RN L+  +    +KV DFGLS+ +     
Sbjct: 120 QQLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVL---- 171

Query: 315 HDVYKMTG 322
            D Y  + 
Sbjct: 172 DDEYTSSV 179

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  173 bits (441), Expect = 3e-52
 Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 20/184 (10%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFR 203
            + +   L F     +GKG+FG +    +          VA+K++  S  +     +DF 
Sbjct: 5   TQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFE 59

Query: 204 HEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNF 260
            E+ +L  L+H NIV++ G      R+ L LI EYL  G L  YL++ K  +     + +
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119

Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
              I +GM YL       IHRDL  RN+L+   + + +K+GDFGL+K++      + +K+
Sbjct: 120 TSQICKGMEYL--GTKRYIHRDLATRNILV--ENENRVKIGDFGLTKVLP--QDKEFFKV 173

Query: 321 TGET 324
               
Sbjct: 174 KEPG 177

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  174 bits (443), Expect = 3e-52
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 22/202 (10%)

Query: 132 GSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAI 185
           G H           +      +   L + S   +GKG+FG +    +          VA+
Sbjct: 2   GHHHHHHAQLYACQDP--TIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAV 57

Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGDLH 243
           K++  S  D +   +DF+ E+ +L  L    IV++ G      R+ L L+ EYL  G L 
Sbjct: 58  KQLQHSGPDQQ---RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114

Query: 244 KYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD 302
            +L+  +  L  S  + ++  I +GM YL       +HRDL  RN+L+   S  H+K+ D
Sbjct: 115 DFLQRHRARLDASRLLLYSSQICKGMEYL--GSRRCVHRDLAARNILV--ESEAHVKIAD 170

Query: 303 FGLSKLIKVQNSHDVYKMTGET 324
           FGL+KL+      D Y +    
Sbjct: 171 FGLAKLL--PLDKDYYVVREPG 190

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  172 bits (439), Expect = 3e-52
 Identities = 62/163 (38%), Positives = 86/163 (52%), Gaps = 12/163 (7%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           W IDPSEL F     IG G FG +   YW     VAIK I      +    +DF  E  +
Sbjct: 3   WVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEV 56

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARG 267
           ++KL HP +VQ  G   E+ P+ L+TE++  G L  YL+  +G  +  T +   LD+  G
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           MAYL  E   +IHRDL  RN L+       +KV DFG+++ + 
Sbjct: 117 MAYL--EEACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVL 155

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  172 bits (438), Expect = 6e-52
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 18/185 (9%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQD 201
            PN   WE++ +++       +G G +GE+ +  W+     VA+K +     +     ++
Sbjct: 2   SPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EE 55

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVN 259
           F  E  ++ +++HPN+VQ LG  T   P  +ITE++  G+L  YL+   +  +S    + 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 115

Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
            A  I+  M YL  E    IHRDL  RN L+       +KV DFGLS+L+      D Y 
Sbjct: 116 MATQISSAMEYL--EKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMT----GDTYT 167

Query: 320 MTGET 324
                
Sbjct: 168 AHAGA 172

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  171 bits (435), Expect = 1e-51
 Identities = 54/175 (30%), Positives = 84/175 (48%), Gaps = 16/175 (9%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNL 208
            E+   E+       +G G FG +    W+G   VA+K I      +     +F  E   
Sbjct: 3   MELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQT 56

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARG 267
           ++KL HP +V+F G  ++  P+ ++TEY+  G L  YL+  G  L PS  +    D+  G
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           MA+L  E +  IHRDL  RN L+       +KV DFG+++ +      D Y  + 
Sbjct: 117 MAFL--ESHQFIHRDLAARNCLV--DRDLCVKVSDFGMTRYVL----DDQYVSSV 163

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  171 bits (435), Expect = 1e-51
 Identities = 62/184 (33%), Positives = 90/184 (48%), Gaps = 22/184 (11%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ 200
                 +  W ++  EL       IGKG FG+++   +RG  VA+K I    +      Q
Sbjct: 7   AQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-----Q 59

Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLKEKG--ALSPSTA 257
            F  E +++ +LRH N+VQ LG + E K  L ++TEY+  G L  YL+ +G   L     
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL 119

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
           + F+LD+   M YL  E N  +HRDL  RNVL+  S  +  KV DFGL+K        + 
Sbjct: 120 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK--------EA 167

Query: 318 YKMT 321
               
Sbjct: 168 SSTQ 171

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  176 bits (449), Expect = 2e-51
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 24/220 (10%)

Query: 115 NMMELLNAHGGLSYG--QNGSHFEPKPVPPPLPNKC----DWEIDPSELDFSSSAIIGKG 168
            + EL++ H  ++ G      +  PK   P +         WE++ +++       +G G
Sbjct: 174 TLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGG 231

Query: 169 SFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE 226
            +GE+ +  W+     VA+K +     +     ++F  E  ++ +++HPN+VQ LG  T 
Sbjct: 232 QYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNLVQLLGVCTR 287

Query: 227 RKPLMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK 284
             P  +ITE++  G+L  YL+   +  +S    +  A  I+  M YL  E    IHR+L 
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFIHRNLA 345

Query: 285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
            RN L+       +KV DFGLS+L+      D Y      
Sbjct: 346 ARNCLV--GENHLVKVADFGLSRLMT----GDTYTAHAGA 379

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  171 bits (435), Expect = 6e-51
 Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 29/200 (14%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVN- 207
           +  +D   L      +IG+G +G + K      PVA+K +    +      Q+F +E N 
Sbjct: 7   EPSLDLDNLKLLE--LIGRGRYGAVYKGSLDERPVAVK-VFSFANR-----QNFINEKNI 58

Query: 208 -LLVKLRHPNIVQFLGAVTE-----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
             +  + H NI +F+          R   +L+ EY   G L KYL         ++   A
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLA 117

Query: 262 LDIARGMAYLHNEPN-------VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI----K 310
             + RG+AYLH E          I HRDL  RNVL+ N       + DFGLS  +     
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRL 175

Query: 311 VQNSHDVYKMTGETGSCEYL 330
           V+   +      E G+  Y+
Sbjct: 176 VRPGEEDNAAISEVGTIRYM 195

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  174 bits (443), Expect = 6e-51
 Identities = 63/192 (32%), Positives = 91/192 (47%), Gaps = 22/192 (11%)

Query: 136 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD 195
           E          +  W ++  EL       IGKG FG+++   +RG  VA+K I    +  
Sbjct: 174 EGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA- 230

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLKEKG--AL 252
               Q F  E +++ +LRH N+VQ LG + E K  L ++TEY+  G L  YL+ +G   L
Sbjct: 231 ----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286

Query: 253 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
                + F+LD+   M YL  E N  +HRDL  RNVL+  S  +  KV DFGL+K     
Sbjct: 287 GGDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTK----- 337

Query: 313 NSHDVYKMTGET 324
              +        
Sbjct: 338 ---EASSTQDTG 346

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  170 bits (433), Expect = 9e-51
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 19/186 (10%)

Query: 145 PNKCDWE-IDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRL 197
           PN+     +  +E       ++G G+FG + K  W         PVAIK +  + S    
Sbjct: 4   PNQALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-- 59

Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPST 256
             ++   E  ++  + +P++ + LG       + LIT+ +  G L  Y++E K  +    
Sbjct: 60  ANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
            +N+ + IA+GM YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+       
Sbjct: 119 LLNWCVQIAKGMNYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL--GAEEK 172

Query: 317 VYKMTG 322
            Y   G
Sbjct: 173 EYHAEG 178

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  169 bits (430), Expect = 3e-50
 Identities = 58/188 (30%), Positives = 87/188 (46%), Gaps = 15/188 (7%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
           P         EI+ S +      IIG G  GE+     R       PVAIK +    ++ 
Sbjct: 35  PGRAGRSFTREIEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
           +   +DF  E +++ +  HPNI++  G VT  +  M++TEY+  G L  +L+   G  + 
Sbjct: 93  QR--RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150

Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
              V     +  GM YL       +HRDL  RNVL+   S    KV DFGLS++++  + 
Sbjct: 151 MQLVGMLRGVGAGMRYL--SDLGYVHRDLAARNVLV--DSNLVCKVSDFGLSRVLE-DDP 205

Query: 315 HDVYKMTG 322
              Y  TG
Sbjct: 206 DAAYTTTG 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  166 bits (423), Expect = 8e-50
 Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 18/180 (10%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 9   DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 64

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++ + +A 
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++       YK + 
Sbjct: 124 QLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME---DSTYYKASK 176

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  167 bits (424), Expect = 9e-50
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 35/203 (17%)

Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRL 197
                  I   ++       +G+G+FG++  A             VA+K +       R 
Sbjct: 5   SGIHVQHIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR- 61

Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK---------- 247
             +DF+ E  LL  L+H +IV+F G   +  PL+++ EY++ GDL+K+L+          
Sbjct: 62  --KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119

Query: 248 ------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
                  KG L  S  ++ A  IA GM YL       +HRDL  RN L+   +   +K+G
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLV--GANLLVKIG 175

Query: 302 DFGLSKLIKVQNSHDVYKMTGET 324
           DFG+S+ +    S D Y++ G T
Sbjct: 176 DFGMSRDV---YSTDYYRVGGHT 195

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  167 bits (426), Expect = 1e-49
 Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 26/196 (13%)

Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRL 197
                 E+    +       +G G+FGE+ +    G         VA+K +    S+   
Sbjct: 20  SISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 77

Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK-------EKG 250
              DF  E  ++ K  H NIV+ +G   +  P  ++ E + GGDL  +L+       +  
Sbjct: 78  --LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135

Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKL 308
           +L+    ++ A DIA G  YL  E N  IHRD+  RN  L+         K+GDFG+++ 
Sbjct: 136 SLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNC-LLTCPGPGRVAKIGDFGMARD 192

Query: 309 IKVQNSHDVYKMTGET 324
           I        Y+  G  
Sbjct: 193 I---YRASYYRKGGCA 205

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  166 bits (423), Expect = 1e-49
 Identities = 56/180 (31%), Positives = 93/180 (51%), Gaps = 18/180 (10%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
            + I   ++  +   I+G+G FGE+ +  +         VA+K      + D    + F 
Sbjct: 6   QYGIAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFM 61

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
            E  ++  L HP+IV+ +G + E +P  +I E    G+L  YL+  K +L   T V ++L
Sbjct: 62  SEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            I + MAYL  E    +HRD+  RN+L+  +S + +K+GDFGLS+ I+     D YK + 
Sbjct: 121 QICKAMAYL--ESINCVHRDIAVRNILV--ASPECVKLGDFGLSRYIE---DEDYYKASV 173

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  166 bits (422), Expect = 2e-49
 Identities = 42/187 (22%), Positives = 81/187 (43%), Gaps = 26/187 (13%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQ 200
            +I   +L F+    +G+G+F +I K   R          T V +K +  +  +     +
Sbjct: 3   HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---E 57

Query: 201 DFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVN 259
            F    +++ KL H ++V   G        +L+ E+++ G L  YLK+ K  ++    + 
Sbjct: 58  SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117

Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL------KVGDFGLSKLIKVQN 313
            A  +A  M +L  E N +IH ++  +N+LL+             K+ D G+S  +    
Sbjct: 118 VAKQLAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--- 172

Query: 314 SHDVYKM 320
             D+ + 
Sbjct: 173 PKDILQE 179

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  166 bits (423), Expect = 2e-49
 Identities = 55/182 (30%), Positives = 84/182 (46%), Gaps = 19/182 (10%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFR 203
                +EL      ++G G FG + K  W         PV IK I           Q   
Sbjct: 8   RIFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVT 63

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFAL 262
             +  +  L H +IV+ LG       L L+T+YL  G L  ++++ +GAL P   +N+ +
Sbjct: 64  DHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            IA+GM YL  E + ++HR+L  RNVLL   S   ++V DFG++ L+      D   +  
Sbjct: 123 QIAKGMYYL--EEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLL---PPDDKQLLYS 175

Query: 323 ET 324
           E 
Sbjct: 176 EA 177

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  167 bits (424), Expect = 3e-49
 Identities = 63/192 (32%), Positives = 94/192 (48%), Gaps = 16/192 (8%)

Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPS 191
              P     K   EI PS +      +IG G FGE+ K   +        PVAIK +   
Sbjct: 27  GSDPNQAVLKFTTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG 84

Query: 192 LSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KG 250
            ++ +    DF  E  ++ +  H NI++  G +++ KP+M+ITEY+  G L K+L+E  G
Sbjct: 85  YTEKQR--VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG 142

Query: 251 ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             S    V     IA GM YL       +HRDL  RN+L+  +S    KV DFGLS++++
Sbjct: 143 EFSVLQLVGMLRGIAAGMKYL--ANMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLE 198

Query: 311 VQNSHDVYKMTG 322
             +    Y  +G
Sbjct: 199 -DDPEATYTTSG 209

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  164 bits (418), Expect = 5e-49
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 15/179 (8%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSLSDDRLVIQDFRH 204
              +    L  +    +G G+FG + +  +R       VAIK +           ++   
Sbjct: 3   KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 59

Query: 205 EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALD 263
           E  ++ +L +P IV+ +G     + LML+ E   GG LHK+L  ++  +  S        
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
           ++ GM YL  E    +HRDL  RNVLL   +  + K+ DFGLSK +   +    Y    
Sbjct: 119 VSMGMKYL--EEKNFVHRDLAARNVLL--VNRHYAKISDFGLSKALGADD--SYYTARS 171

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  165 bits (420), Expect = 6e-49
 Identities = 57/195 (29%), Positives = 84/195 (43%), Gaps = 25/195 (12%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           +       L      +  +G FG + KA      VA+K I P             +EV  
Sbjct: 18  NLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVK-IFPIQDKQS---WQNEYEVYS 71

Query: 209 LVKLRHPNIVQFLGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           L  ++H NI+QF+GA          L LIT +   G L  +LK    +S +   + A  +
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETM 130

Query: 265 ARGMAYLHNEPN--------VIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSH 315
           ARG+AYLH +           I HRD+K +NVLL  N +A    + DFGL+   +   S 
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA---CIADFGLALKFEAGKSA 187

Query: 316 DVYKMTGETGSCEYL 330
                 G+ G+  Y+
Sbjct: 188 GD--THGQVGTRRYM 200

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  166 bits (423), Expect = 6e-49
 Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 26/200 (13%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
                     E+    +       +G G+FGE+ +    G         VA+K +    S
Sbjct: 57  GKTSSISDLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114

Query: 194 DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK------ 247
           +      DF  E  ++ K  H NIV+ +G   +  P  ++ E + GGDL  +L+      
Sbjct: 115 EQDE--LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172

Query: 248 -EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL--KVGDFG 304
            +  +L+    ++ A DIA G  YL  E N  IHRD+  RN  L+         K+GDFG
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYL--EENHFIHRDIAARNC-LLTCPGPGRVAKIGDFG 229

Query: 305 LSKLIKVQNSHDVYKMTGET 324
           +++ I        Y+  G  
Sbjct: 230 MARDIY---RAGYYRKGGCA 246

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  165 bits (420), Expect = 7e-49
 Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 43/232 (18%)

Query: 124 GGLSYGQNGSHFEPKPV---------PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEIL 174
           G +  G + S  E K           P    + C   I   ++       +G+G+FG++ 
Sbjct: 1   GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVF 58

Query: 175 KAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227
            A             VA+K +  +    R   QDF+ E  LL  L+H +IV+F G  TE 
Sbjct: 59  LAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHIVRFFGVCTEG 115

Query: 228 KPLMLITEYLRGGDLHKYLKE---------------KGALSPSTAVNFALDIARGMAYLH 272
           +PL+++ EY+R GDL+++L+                 G L     +  A  +A GM YL 
Sbjct: 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL- 174

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
                 +HRDL  RN L+       +K+GDFG+S+ I    S D Y++ G T
Sbjct: 175 -AGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRDI---YSTDYYRVGGRT 220

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  165 bits (420), Expect = 7e-49
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 20/201 (9%)

Query: 131 NGSHFEPKPVPPPLPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPV 183
           +  H     +        D        L       +G+G FG++    +          V
Sbjct: 6   HHHHHHHGALEVLFQGPGDPTVFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMV 63

Query: 184 AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITEYLRGGD 241
           A+K +             ++ E+++L  L H +I+++ G   +     L L+ EY+  G 
Sbjct: 64  AVKALKADAGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121

Query: 242 LHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG 301
           L  YL  + ++  +  + FA  I  GMAYL       IHRDL  RNVLL   +   +K+G
Sbjct: 122 LRDYLP-RHSIGLAQLLLFAQQICEGMAYL--HAQHYIHRDLAARNVLL--DNDRLVKIG 176

Query: 302 DFGLSKLIKVQNSHDVYKMTG 322
           DFGL+K +     H+ Y++  
Sbjct: 177 DFGLAKAVP--EGHEYYRVRE 195

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  165 bits (419), Expect = 8e-49
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 43/223 (19%)

Query: 129 GQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------T 181
           G N  + +P  +P        WE   + L F     +G G+FG++++A   G        
Sbjct: 1   GNNYVYIDPTQLPYDH----KWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAM 54

Query: 182 PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG 240
            VA+K + PS        +    E+ +L  L  H NIV  LGA T   P ++ITEY   G
Sbjct: 55  TVAVKMLKPSAHLTER--EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 112

Query: 241 DLHKYLKEK------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           DL  +L+ K                   AL     ++F+  +A+GMA+L       IHRD
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRD 170

Query: 283 LKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYKMTGET 324
           L  RN+LL   +   + K+ DFGL++ I    +   Y + G  
Sbjct: 171 LAARNILL---THGRITKICDFGLARDI---KNDSNYVVKGNA 207

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  165 bits (419), Expect = 1e-48
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 32/211 (15%)

Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPV 183
           N  +F    V  P     +WE+   ++  S    +G+GSFG + +   +G       T V
Sbjct: 5   NPEYFSAADVYVPD----EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRV 58

Query: 184 AIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLH 243
           AIK +  + S       +F +E +++ +    ++V+ LG V++ +P ++I E +  GDL 
Sbjct: 59  AIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 116

Query: 244 KYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS 293
            YL+               S S  +  A +IA GMAYL    N  +HRDL  RN ++  +
Sbjct: 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL--NANKFVHRDLAARNCMV--A 172

Query: 294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
               +K+GDFG+++ I      D Y+  G+ 
Sbjct: 173 EDFTVKIGDFGMTRDI---YETDYYRKGGKG 200

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  163 bits (415), Expect = 1e-48
 Identities = 57/165 (34%), Positives = 87/165 (52%), Gaps = 14/165 (8%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+ G T VA+K    SL    +    F  E N
Sbjct: 7   EWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVK----SLKQGSMSPDAFLAEAN 60

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+  P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 61  LMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            GMA++  E    IHRDL+  N+L+  S     K+ DFGL++LI+
Sbjct: 120 EGMAFI--EERNYIHRDLRAANILV--SDTLSCKIADFGLARLIE 160

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  163 bits (415), Expect = 2e-48
 Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 34/198 (17%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDF 202
            EI  S + F     +G+  FG++ K +  G         VAIK +           ++F
Sbjct: 4   KEISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR--EEF 59

Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-------------- 248
           RHE  L  +L+HPN+V  LG VT+ +PL +I  Y   GDLH++L                
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 249 --KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             K AL P   V+    IA GM YL    + ++H+DL  RNVL+      ++K+ D GL 
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLV--YDKLNVKISDLGLF 175

Query: 307 KLIKVQNSHDVYKMTGET 324
           + +    + D YK+ G +
Sbjct: 176 REV---YAADYYKLLGNS 190

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  171 bits (434), Expect = 2e-48
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 21/246 (8%)

Query: 86  CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG-GLSYGQNGSHFEPKPVPPP- 143
           C +  GA  +   R +           K    E        +S  +   + E        
Sbjct: 318 CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY 377

Query: 144 -LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRL 197
            +P+  D+EI    ++      IG+G FG++ +  +         VAIK      SD   
Sbjct: 378 TMPSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435

Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPST 256
             + F  E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +L+  K +L  ++
Sbjct: 436 --EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLAS 492

Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 316
            + +A  ++  +AYL  E    +HRD+  RNVL+  SS D +K+GDFGLS+ ++      
Sbjct: 493 LILYAYQLSTALAYL--ESKRFVHRDIAARNVLV--SSNDCVKLGDFGLSRYME---DST 545

Query: 317 VYKMTG 322
            YK + 
Sbjct: 546 YYKASK 551

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  165 bits (419), Expect = 3e-48
 Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 15/188 (7%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
           P    ++   E+D + +      ++G G FGE+     +        VAIK +    ++ 
Sbjct: 31  PTQTVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 88

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSP 254
           +   +DF  E +++ +  HPNI++  G VT+ KP+M++TEY+  G L  +L++     + 
Sbjct: 89  QR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146

Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
              V     IA GM YL       +HRDL  RN+L+  +S    KV DFGL ++++  + 
Sbjct: 147 IQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILI--NSNLVCKVSDFGLGRVLE-DDP 201

Query: 315 HDVYKMTG 322
              Y   G
Sbjct: 202 EAAYTTRG 209

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  166 bits (423), Expect = 5e-48
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 14/177 (7%)

Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDD 195
               P     K  WEI    L       +G G FGE+  A +   T VA+K + P     
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV 227

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK--EKGALS 253
               + F  E N++  L+H  +V+    VT+ +P+ +ITE++  G L  +LK  E     
Sbjct: 228 ----EAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQP 282

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
               ++F+  IA GMA++  E    IHRDL+  N+L+  S++   K+ DFGL+++I+
Sbjct: 283 LPKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILV--SASLVCKIADFGLARVIE 335

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  165 bits (420), Expect = 1e-47
 Identities = 70/219 (31%), Positives = 101/219 (46%), Gaps = 24/219 (10%)

Query: 114 FNMMELLNAH-----GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKG 168
           FN ++ L A+      GL +         KP    L  K  WEI    L       +G+G
Sbjct: 139 FNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGL-AKDAWEIPRESLRLEV--KLGQG 195

Query: 169 SFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER 227
            FGE+    W G T VAIK    +L    +  + F  E  ++ KLRH  +VQ    V+E 
Sbjct: 196 CFGEVWMGTWNGTTRVAIK----TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250

Query: 228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKP 285
           +P+ ++TEY+  G L  +LK +    L     V+ A  IA GMAY+  E    +HRDL+ 
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYVHRDLRA 308

Query: 286 RNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
            N+L+        KV DFGL++LI+     + Y      
Sbjct: 309 ANILV--GENLVCKVADFGLARLIE----DNEYTARQGA 341

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  162 bits (411), Expect = 1e-47
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 44/214 (20%)

Query: 143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDD 195
            +     WE     L       +G+G FG+++KA           T VA+K +  + S  
Sbjct: 11  KILEDPKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK------ 249
            L  +D   E N+L ++ HP++++  GA ++  PL+LI EY + G L  +L+E       
Sbjct: 69  EL--RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126

Query: 250 ------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
                              AL+    ++FA  I++GM YL      ++HRDL  RN+L+ 
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILV- 183

Query: 292 NSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGET 324
             +    +K+ DFGLS+ +      D Y    + 
Sbjct: 184 --AEGRKMKISDFGLSRDV---YEEDSYVKRSQG 212

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  162 bits (411), Expect = 1e-47
 Identities = 55/185 (29%), Positives = 90/185 (48%), Gaps = 17/185 (9%)

Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLV 198
           PN+    I   E +F    ++G G+FG + K  W         PVAIK +  + S     
Sbjct: 4   PNQALLRILK-ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--A 60

Query: 199 IQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTA 257
            ++   E  ++  + +P++ + LG       + LIT+ +  G L  Y++E K  +     
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYL 119

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
           +N+ + IA+GM YL  E   ++HRDL  RNVL+   +  H+K+ DFGL+KL+        
Sbjct: 120 LNWCVQIAKGMNYL--EDRRLVHRDLAARNVLV--KTPQHVKITDFGLAKLL--GAEEKE 173

Query: 318 YKMTG 322
           Y   G
Sbjct: 174 YHAEG 178

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  161 bits (409), Expect = 2e-47
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 17/200 (8%)

Query: 134 HFEPKPVPPPLPNK-CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKR 187
           H +   + P L        I PS L    + +IG+G FG +               A+K 
Sbjct: 1   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK- 59

Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL 246
            L  ++D    +  F  E  ++    HPN++  LG     +   +++  Y++ GDL  ++
Sbjct: 60  SLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118

Query: 247 -KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
             E    +    + F L +A+GM YL       +HRDL  RN +L       +KV DFGL
Sbjct: 119 RNETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCML--DEKFTVKVADFGL 174

Query: 306 SKLIKVQNSHDVYKMTGETG 325
           ++ +      + Y +  +TG
Sbjct: 175 ARDM---YDKEYYSVHNKTG 191

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  161 bits (409), Expect = 2e-47
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 26/213 (12%)

Query: 128 YGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TP 182
           +  + S   P+          D  ID + L      I+G+G FG +++   +        
Sbjct: 7   HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLK 64

Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYL 237
           VA+K +    S  R + ++F  E   +    HPN+++ LG   E         M+I  ++
Sbjct: 65  VAVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123

Query: 238 RGGDLHKYLK------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
           + GDLH YL           +   T + F +DIA GM YL       +HRDL  RN +L 
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCML- 180

Query: 292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
                 + V DFGLSK I    S D Y+     
Sbjct: 181 -RDDMTVCVADFGLSKKI---YSGDYYRQGRIA 209

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  161 bits (409), Expect = 3e-47
 Identities = 67/215 (31%), Positives = 94/215 (43%), Gaps = 36/215 (16%)

Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIK 186
              H        P P      +D +++ F    +IG+G+FG++LKA  +        AIK
Sbjct: 2   KKHHHHHHGKNNPDPTI-YPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIK 58

Query: 187 RILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 245
           R+    S D    +DF  E+ +L KL  HPNI+  LGA   R  L L  EY   G+L  +
Sbjct: 59  RMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116

Query: 246 LKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 289
           L++                   LS    ++FA D+ARGM YL       IHRDL  RN+L
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNIL 174

Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           +        K+ DFGLS+        +VY      
Sbjct: 175 V--GENYVAKIADFGLSR------GQEVYVKKTMG 201

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  161 bits (410), Expect = 3e-47
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 42/218 (19%)

Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILP 190
           +      P     E   + +++     IG+G+FG + +A   G       T VA+K +L 
Sbjct: 30  RMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLK 86

Query: 191 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK- 249
             +   +   DF+ E  L+ +  +PNIV+ LG     KP+ L+ EY+  GDL+++L+   
Sbjct: 87  EEASADM-QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 145

Query: 250 -----------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR 286
                                    LS +  +  A  +A GMAYL       +HRDL  R
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATR 203

Query: 287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           N L+       +K+ DFGLS+ I    S D YK  G  
Sbjct: 204 NCLV--GENMVVKIADFGLSRNI---YSADYYKADGND 236

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  161 bits (409), Expect = 4e-47
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 35/207 (16%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLS 193
           P  LP    WE   + L F     +G G+FG++++A   G         VA+K +  +  
Sbjct: 32  PTQLPYNEKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89

Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-- 250
            D    +    E+ ++  L +H NIV  LGA T   P+++ITEY   GDL  +L+ K   
Sbjct: 90  ADEK--EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147

Query: 251 ------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
                         S    ++F+  +A+GMA+L       IHRD+  RNVLL   +  H+
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLL---TNGHV 202

Query: 299 -KVGDFGLSKLIKVQNSHDVYKMTGET 324
            K+GDFGL++ I    +   Y + G  
Sbjct: 203 AKIGDFGLARDI---MNDSNYIVKGNA 226

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  164 bits (417), Expect = 1e-46
 Identities = 63/192 (32%), Positives = 90/192 (46%), Gaps = 19/192 (9%)

Query: 137 PKPVPPP-LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSD 194
           P   P      K  WEI    L       +G+G FGE+    W G T VAIK    +L  
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIK----TLKP 301

Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--AL 252
             +  + F  E  ++ KLRH  +VQ    V+E +P+ ++TEY+  G L  +LK +    L
Sbjct: 302 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL 360

Query: 253 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
                V+ A  IA GMAY+  E    +HRDL+  N+L+        KV DFGL++LI+  
Sbjct: 361 RLPQLVDMAAQIASGMAYV--ERMNYVHRDLRAANILV--GENLVCKVADFGLARLIE-- 414

Query: 313 NSHDVYKMTGET 324
              + Y      
Sbjct: 415 --DNEYTARQGA 424

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  160 bits (406), Expect = 1e-46
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 43/230 (18%)

Query: 123 HGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-- 180
           H    + Q+           P   K  WE    +L       +G+G+FG+++ A   G  
Sbjct: 5   HHHHHHSQDPMLAGVSEYELPEDPK--WEFPRDKLTLGK--PLGEGAFGQVVMAEAVGID 60

Query: 181 -------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML 232
                    VA+K +    ++  L   D   E+ ++  + +H NI+  LGA T+  PL +
Sbjct: 61  KDKPKEAVTVAVKMLKDDATEKDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118

Query: 233 ITEYLRGGDLHKYLK----------------EKGALSPSTAVNFALDIARGMAYLHNEPN 276
           I EY   G+L +YL+                 +  ++    V+    +ARGM YL     
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQ 176

Query: 277 VIIHRDLKPRNVLLVNSSADHL--KVGDFGLSKLIKVQNSHDVYKMTGET 324
             IHRDL  RNVL+     ++   K+ DFGL++ I   N+ D YK T   
Sbjct: 177 KCIHRDLAARNVLV----TENNVMKIADFGLARDI---NNIDYYKKTTNG 219

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  160 bits (407), Expect = 1e-46
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 39/208 (18%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSD 194
           LP    WE    +L       +G+G FG+++ A   G           VA+K +    ++
Sbjct: 70  LPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127

Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK------ 247
             L   D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+      
Sbjct: 128 KDL--SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185

Query: 248 ----------EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
                      +  ++    V+    +ARGM YL       IHRDL  RNVL+   + ++
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLV---TENN 240

Query: 298 -LKVGDFGLSKLIKVQNSHDVYKMTGET 324
            +K+ DFGL++ I   N+ D YK T   
Sbjct: 241 VMKIADFGLARDI---NNIDYYKKTTNG 265

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  160 bits (406), Expect = 2e-46
 Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 14/230 (6%)

Query: 101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNK-CDWEIDPSELDF 159
                  +      ++ +   +      G N  H +   + P L        I PS L  
Sbjct: 32  PGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIV 91

Query: 160 SSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH 214
             + +IG+G FG +               A+K  L  ++D    +  F  E  ++    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIG-EVSQFLTEGIIMKDFSH 149

Query: 215 PNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLH 272
           PN++  LG     +   +++  Y++ GDL  ++  E    +    + F L +A+GM +L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL- 208

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
                 +HRDL  RN +L       +KV DFGL++ +  +    V+  TG
Sbjct: 209 -ASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSVHNKTG 255

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  159 bits (405), Expect = 4e-46
 Identities = 66/242 (27%), Positives = 103/242 (42%), Gaps = 44/242 (18%)

Query: 115 NMMELLNAHGGLSYGQNGSHFEPKPVPPP-----LPNKCDWEIDPSELDFSSSAIIGKGS 169
            M    + H          +   + +        LP    WE+    L       +G+G+
Sbjct: 24  GMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGA 81

Query: 170 FGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQ 219
           FG+++ A   G         T VA+K +    ++  L   D   E+ ++  + +H NI+ 
Sbjct: 82  FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL--SDLISEMEMMKMIGKHKNIIN 139

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALD 263
            LGA T+  PL +I EY   G+L +YL+ +                  LS    V+ A  
Sbjct: 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTG 322
           +ARGM YL       IHRDL  RNVL+   + D+ +K+ DFGL++ I   +  D YK T 
Sbjct: 200 VARGMEYL--ASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDI---HHIDYYKKTT 251

Query: 323 ET 324
             
Sbjct: 252 NG 253

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  157 bits (399), Expect = 5e-46
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 16/193 (8%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDD 195
              L    D  I    +   S  +IGKG FG +    +          AIK  L  +++ 
Sbjct: 5   SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK-SLSRITEM 63

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-LMLITEYLRGGDLHKYLK-EKGALS 253
           +  ++ F  E  L+  L HPN++  +G +   +    ++  Y+  GDL ++++  +   +
Sbjct: 64  Q-QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
               ++F L +ARGM YL       +HRDL  RN +L    +  +KV DFGL++ I    
Sbjct: 123 VKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCML--DESFTVKVADFGLARDI---L 175

Query: 314 SHDVYKMTGETGS 326
             + Y +     +
Sbjct: 176 DREYYSVQQHRHA 188

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  158 bits (401), Expect = 8e-46
 Identities = 62/245 (25%), Positives = 96/245 (39%), Gaps = 48/245 (19%)

Query: 112 KKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFG 171
           +     +L       S      + + +     L     WE     L+F    ++G G+FG
Sbjct: 6   QFRYESQLQMVQVTGSSDNEYFYVDFREYEYDL----KWEFPRENLEFGK--VLGSGAFG 59

Query: 172 EILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGA 223
           +++ A   G         VA+K +           +    E+ ++ +L  H NIV  LGA
Sbjct: 60  KVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMTQLGSHENIVNLLGA 117

Query: 224 VTERKPLMLITEYLRGGDLHKYLKEK-----------------------GALSPSTAVNF 260
            T   P+ LI EY   GDL  YL+ K                         L+    + F
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177

Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL-KVGDFGLSKLIKVQNSHDVYK 319
           A  +A+GM +L  E    +HRDL  RNVL+   +   + K+ DFGL++ I    S   Y 
Sbjct: 178 AYQVAKGMEFL--EFKSCVHRDLAARNVLV---THGKVVKICDFGLARDI---MSDSNYV 229

Query: 320 MTGET 324
           + G  
Sbjct: 230 VRGNA 234

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  156 bits (397), Expect = 2e-45
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 27/193 (13%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFR 203
           D  I   +       ++GKG FG + +A  +        VA+K +L +       I++F 
Sbjct: 17  DVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVK-MLKADIIASSDIEEFL 73

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLK------EKGA 251
            E   + +  HP++ + +G     +        M+I  +++ GDLH +L           
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133

Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           L   T V F +DIA GM YL       IHRDL  RN +L  +    + V DFGLS+ I  
Sbjct: 134 LPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCML--AEDMTVCVADFGLSRKI-- 187

Query: 312 QNSHDVYKMTGET 324
             S D Y+    +
Sbjct: 188 -YSGDYYRQGCAS 199

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  155 bits (393), Expect = 5e-45
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 40/215 (18%)

Query: 136 EPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRI 188
           E     P   +K  WE     L       +G+G+FG++++A   G         VA+K +
Sbjct: 10  EHCERLPYDASK--WEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65

Query: 189 LPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER-KPLMLITEYLRGGDLHKYL 246
               +      +    E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL
Sbjct: 66  KEGATHSEH--RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123

Query: 247 KE----------------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL 290
           +                 K  L+    + ++  +A+GM +L       IHRDL  RN+LL
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILL 181

Query: 291 VNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGET 324
              S  + +K+ DFGL++ I        Y   G+ 
Sbjct: 182 ---SEKNVVKICDFGLARDI---YKDPDYVRKGDA 210

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  155 bits (394), Expect = 5e-43
 Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 16/191 (8%)

Query: 137 PKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG----TPVAIKRILPSL 192
           P   P  L +K    +    L  +    +G G+FG + +  +R       VAIK +    
Sbjct: 318 PFSDPEELKDK-KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT 375

Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGA 251
                  ++   E  ++ +L +P IV+ +G     + LML+ E   GG LHK+L   +  
Sbjct: 376 EKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE 432

Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
           +  S        ++ GM YL  E    +HR+L  RNVLL   +  + K+ DFGLSK +  
Sbjct: 433 IPVSNVAELLHQVSMGMKYL--EEKNFVHRNLAARNVLL--VNRHYAKISDFGLSKALGA 488

Query: 312 QNSHDVYKMTG 322
            +    Y    
Sbjct: 489 DD--SYYTARS 497

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (355), Expect = 9e-40
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 10/174 (5%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVN 207
            +            IG+GSF  + K         VA   +    L+      Q F+ E  
Sbjct: 20  GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER--QRFKEEAE 77

Query: 208 LLVKLRHPNIVQFLGA----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
           +L  L+HPNIV+F  +    V  +K ++L+TE +  G L  YLK    +      ++   
Sbjct: 78  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 137

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
           I +G+ +LH     IIHRDLK  N+  +      +K+GD GL+ L +   +  V
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNI-FITGPTGSVKIGDLGLATLKRASFAKAV 190

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (340), Expect = 3e-37
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 15/177 (8%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH 214
            F   + +G GS+GE+ K   +  G   A+KR +      +        EV    K+ +H
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHN 273
           P  V+   A  E   L L TE   G  L ++ +  GA L  +    +  D    +A+LH+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               ++H D+KP N+ L        K+GDFGL   +    + +V +     G   Y+
Sbjct: 176 --QGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYM 223

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  134 bits (340), Expect = 3e-37
 Identities = 43/205 (20%), Positives = 89/205 (43%), Gaps = 27/205 (13%)

Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR- 179
           +   G+  G    +F+   V         + I            IG G   ++ +     
Sbjct: 6   HHSSGVDLGTENLYFQSMSV-----KGRIYSIL---------KQIGSGGSSKVFQVLNEK 51

Query: 180 GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQFLGAVTERKPLMLITEY 236
               AIK +  +L + D   +  +R+E+  L KL+  +  I++        + + ++ E 
Sbjct: 52  KQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 109

Query: 237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
               DL+ +LK+K ++ P    ++  ++   +  +H   + I+H DLKP N L+V+    
Sbjct: 110 -GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVDGM-- 164

Query: 297 HLKVGDFGLSKLIKVQNSHDVYKMT 321
            LK+ DFG++  ++  ++  V K +
Sbjct: 165 -LKLIDFGIANQMQ-PDTTSVVKDS 187

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  134 bits (339), Expect = 4e-37
 Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 12/192 (6%)

Query: 131 NGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI 188
            G    P P   P           +  +F     IG+G F E+ +A     G PVA+K++
Sbjct: 6   QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65

Query: 189 -LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK 247
            +  L D +    D   E++LL +L HPN++++  +  E   L ++ E    GDL + +K
Sbjct: 66  QIFDLMDAKA-RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124

Query: 248 EKGA----LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF 303
                   +   T   + + +   + ++H+    ++HRD+KP NV +  ++   +K+GD 
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFI--TATGVVKLGDL 180

Query: 304 GLSKLIKVQNSH 315
           GL +    + + 
Sbjct: 181 GLGRFFSSKTTA 192

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  135 bits (341), Expect = 4e-37
 Identities = 42/152 (27%), Positives = 79/152 (51%), Gaps = 11/152 (7%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
            IG+GSFG+ +       G    IK I +  +S      ++ R EV +L  ++HPNIVQ+
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER--EESRREVAVLANMKHPNIVQY 88

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVI 278
             +  E   L ++ +Y  GGDL K +             +++ + I   + ++H+    I
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKI 146

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +HRD+K +N+ L  +    +++GDFG+++++ 
Sbjct: 147 LHRDIKSQNIFL--TKDGTVQLGDFGIARVLN 176

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  133 bits (337), Expect = 6e-37
 Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 24/193 (12%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   A++G+G+FG+++KA         AIK+I    ++++  +     EV LL  L H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEK--LSTILSEVMLLASLNHQ 62

Query: 216 NIVQFLGAVTERKP-------------LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFA 261
            +V++  A  ER+              L +  EY   G L+  +  +             
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
             I   ++Y+H+    IIHRDLKP N+ +    + ++K+GDFGL+K +            
Sbjct: 123 RQILEALSYIHS--QGIIHRDLKPMNIFI--DESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 322 GETGSCEYLVSNC 334
              GS + L S  
Sbjct: 179 NLPGSSDNLTSAI 191

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (335), Expect = 8e-37
 Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 17/170 (10%)

Query: 154 PSELD-FSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLL 209
           PS  + +     IG GS+G   K   +  G  +  K +   S+++     Q    EVNLL
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLL 59

Query: 210 VKLRHPNIVQFLGAVTERKP--LMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALD 263
            +L+HPNIV++   + +R    L ++ EY  GGDL   + +    +  L     +     
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 264 IARGMAYLHNE---PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           +   +   H      + ++HRDLKP NV L      ++K+GDFGL++++ 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLARILN 167

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  133 bits (337), Expect = 2e-36
 Identities = 38/161 (23%), Positives = 79/161 (49%), Gaps = 13/161 (8%)

Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQF 220
           IG G   ++ +         AIK +  +L + D   +  +R+E+  L KL+  +  I++ 
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                  + + ++ E     DL+ +LK+K ++ P    ++  ++   +  +H   + I+H
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVH 131

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
            DLKP N L+V+     LK+ DFG++  ++  ++  V K +
Sbjct: 132 SDLKPANFLIVD---GMLKLIDFGIANQMQ-PDTTSVVKDS 168

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  129 bits (327), Expect = 1e-35
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 27/195 (13%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRH 214
           DF     +G+G FG + +A  +      AIKRI LP+    R   +    EV  L KL H
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR---EKVMREVKALAKLEH 62

Query: 215 PNIVQFLGAVTERKP------------LMLITEYLRGGDLHKYLKEKGALSP---STAVN 259
           P IV++  A  E+              L +  +  R  +L  ++  +  +     S  ++
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
             L IA  + +LH+    ++HRDLKP N+    +  D +KVGDFGL   +      +   
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMD--QDEEEQT 176

Query: 320 MTGETGSCEYLVSNC 334
           +     +        
Sbjct: 177 VLTPMPAYARHTGQV 191

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (327), Expect = 2e-35
 Identities = 37/193 (19%), Positives = 66/193 (34%), Gaps = 17/193 (8%)

Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKR 187
            +  H                 +      +     +G+G F  +        G   A+KR
Sbjct: 2   GSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR 61

Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----LMLITEYLRGGDLH 243
           IL     DR   ++ + E ++     HPNI++ +      +       L+  + + G L 
Sbjct: 62  ILCHEQQDR---EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 244 KYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299
             ++        L+    +   L I RG+  +H +     HRDLKP N+LL         
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL--GDEGQPV 174

Query: 300 VGDFGLSKLIKVQ 312
           + D G      + 
Sbjct: 175 LMDLGSMNQACIH 187

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  131 bits (331), Expect = 2e-35
 Identities = 38/161 (23%), Positives = 79/161 (49%), Gaps = 13/161 (8%)

Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPN--IVQF 220
           IG G   ++ +         AIK +  +L + D   +  +R+E+  L KL+  +  I++ 
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                  + + ++ E     DL+ +LK+K ++ P    ++  ++   +  +H   + I+H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ--HGIVH 178

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
            DLKP N L+V+     LK+ DFG++  ++  ++  V K +
Sbjct: 179 SDLKPANFLIVDGM---LKLIDFGIANQMQ-PDTTSVVKDS 215

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  128 bits (324), Expect = 3e-35
 Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 33/185 (17%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    +IG G FG++ KA  R  G    IKR+       +   +    EV  L KL H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHV 64

Query: 216 NIVQFLGA----------------VTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTA 257
           NIV + G                  ++ K L +  E+   G L ++++++    L    A
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
           +     I +G+ Y+H+    +I+RDLKP N+ L       +K+GDFGL   +K  N    
Sbjct: 125 LELFEQITKGVDYIHS--KKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLK--NDGKR 178

Query: 318 YKMTG 322
            +  G
Sbjct: 179 TRSKG 183

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (320), Expect = 3e-34
 Identities = 41/156 (26%), Positives = 67/156 (42%), Gaps = 13/156 (8%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           I+G+G+   + +   +  G   AIK          +       E  +L KL H NIV+  
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHKNIVKLF 73

Query: 222 GAVTERKP--LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPN 276
               E      +LI E+   G L+  L+E      L  S  +    D+  GM +L    N
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--N 131

Query: 277 VIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIK 310
            I+HR++KP N++ V         K+ DFG ++ ++
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  128 bits (323), Expect = 6e-34
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 19/195 (9%)

Query: 141 PPPLPNKCDWE---IDPSELDFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDR 196
           P    +  D E   +   ++ F    ++G G+ G I+    +    VA+KRILP      
Sbjct: 5   PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---- 60

Query: 197 LVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSP 254
                   EV LL +   HPN++++     +R+   +  E      L +Y+++K  A   
Sbjct: 61  --FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLG 117

Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIKV 311
              +        G+A+LH+    I+HRDLKP N+L+   +A       + DFGL K +  
Sbjct: 118 LEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA- 174

Query: 312 QNSHDVYKMTGETGS 326
              H   + +G  G+
Sbjct: 175 VGRHSFSRRSGVPGT 189

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  126 bits (318), Expect = 1e-33
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 20/209 (9%)

Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELD-----FSSSAIIGKGSFGEILKAYWRGT--P 182
           Q+ S       P       D+ ID S  D     F   + +G+G+   + +   +GT  P
Sbjct: 21  QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80

Query: 183 VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL 242
            A+K +        +  +  R E+ +L++L HPNI++          + L+ E + GG+L
Sbjct: 81  YALKVL-----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135

Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVG 301
              + EKG  S   A +    I   +AYLH   N I+HRDLKP N+L    + D  LK+ 
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIA 193

Query: 302 DFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DFGLSK+++ Q       M    G+  Y 
Sbjct: 194 DFGLSKIVEHQV-----LMKTVCGTPGYC 217

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  124 bits (314), Expect = 1e-33
 Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 13/171 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
            +GKG+F  + +   + T    A K I    LS      Q    E  +  KL+HPNIV+ 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVRL 70

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
             ++ E     L+ + + GG+L + +  +   S + A +    I   +AY H+  N I+H
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS--NGIVH 128

Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           R+LKP N+LL + +    +K+ DFGL+  +            G  G+  YL
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----AWHGFAGTPGYL 174

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  126 bits (318), Expect = 1e-33
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 14/173 (8%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI---LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T    A K I       S   +  ++   EV++L ++ HPNI+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  R  ++LI E + GG+L  +L +K +LS   A +F   I  G+ YLH     I 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKIA 137

Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           H DLKP N++L++ +    H+K+ DFGL+  I+        +     G+ E++
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFV 185

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  125 bits (315), Expect = 1e-33
 Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 14/174 (8%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
            +G G F  + K   + T    A K I       S   +  ++   EV++L ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 219 QFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVI 278
                   R  ++LI E + GG+L  +L +K +LS   A +F   I  G+ YLH     I
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT--KKI 136

Query: 279 IHRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            H DLKP N++L++ +    H+K+ DFGL+  I+        +     G+ E++
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFV 185

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  124 bits (313), Expect = 2e-33
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 14/173 (8%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   +GT    A K I     S S   +  ++   EVN+L ++RHPNI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH+    I 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS--KRIA 130

Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           H DLKP N++L++ +     +K+ DFG++  I+  N     +     G+ E++
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-----EFKNIFGTPEFV 178

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  123 bits (312), Expect = 2e-33
 Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 13/170 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            IG+GS+GE+  A  +GT    A K+I     +D   +  F+ E+ ++  L HPNI++  
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLY 72

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
               +   + L+ E   GG+L + +  K     S A     D+   +AY H     + HR
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK--LNVAHR 130

Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLKP N L +  S D  LK+ DFGL+   K         M  + G+  Y+
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-----MMRTKVGTPYYV 175

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  127 bits (320), Expect = 2e-33
 Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 16/174 (9%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+ GE+  A+ R T   VAI+ I         + +     +   E+ +L KL HP I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
           ++            ++ E + GG+L   +     L  +T   +   +   + YLH   N 
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--NG 259

Query: 278 IIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           IIHRDLKP NVLL +   D  +K+ DFG SK++      +   M    G+  YL
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-----ETSLMRTLCGTPTYL 308

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (312), Expect = 2e-33
 Identities = 47/198 (23%), Positives = 73/198 (36%), Gaps = 37/198 (18%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKL-R 213
           +F     IG G FG + K   R  G   AIKR   P         Q+   EV     L +
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD--EQNALREVYAHAVLGQ 69

Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMA 269
           H ++V++  A  E   +++  EY  GG L   + E          +   +  L + RG+ 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 270 YLHNEPNVIIHRDLKPRNVLL-----------------VNSSADHLKVGDFGLSKLIKVQ 312
           Y+H+    ++H D+KP N+ +                   S+    K+GD G    I   
Sbjct: 130 YIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187

Query: 313 NSHDVYKMTGETGSCEYL 330
                     E G   +L
Sbjct: 188 QV--------EEGDSRFL 197

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  124 bits (314), Expect = 2e-33
 Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 14/157 (8%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
           +F    +IG G FG++ K   R G  VA+KR  P   +    I++F  E+  L   RHP+
Sbjct: 40  NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP---ESSQGIEEFETEIETLSFCRHPH 96

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMAYLH 272
           +V  +G   ER  ++LI +Y+  G+L ++L        ++S    +   +  ARG+ YLH
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156

Query: 273 NEPNVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKL 308
                IIHRD+K  N+LL  N      K+ DFG+SK 
Sbjct: 157 TRA--IIHRDVKSINILLDENFVP---KITDFGISKK 188

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (317), Expect = 2e-33
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 15/157 (9%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           I+G+G+   + +   +  G   AIK     S      V      E  +L KL H NIV+ 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLNHKNIVKL 72

Query: 221 LGAVTERKP--LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEP 275
                E      +LI E+   G L+  L+E      L  S  +    D+  GM +L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-- 130

Query: 276 NVIIHRDLKPRNVLLVNSSADH--LKVGDFGLSKLIK 310
           N I+HR++KP N++ V         K+ DFG ++ ++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  123 bits (311), Expect = 4e-33
 Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 14/170 (8%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++G G+F E+     R T    A+K I  S +          +E+ +L K++H NIV   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHENIVTLE 72

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
                     L+ + + GG+L   + E+G  +   A      +   + YLH   N I+HR
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE--NGIVHR 130

Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLKP N+L +    +  + + DFGLSK+ +         M+   G+  Y+
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNG------IMSTACGTPGYV 174

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  123 bits (311), Expect = 6e-33
 Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 14/173 (8%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRIL---PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   + T    A K I       S   +  +D   EV++L +++HPN++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH+    I 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS--LQIA 136

Query: 280 HRDLKPRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           H DLKP N++L++ +     +K+ DFGL+  I   N     +     G+ E++
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFV 184

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  124 bits (313), Expect = 6e-33
 Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 13/176 (7%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
             S + I+G G FG++ K     T   +A K I      D+   ++ ++E++++ +L H 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNE 274
           N++Q   A   +  ++L+ EY+ GG+L   + ++   L+    + F   I  G+ ++H  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
              I+H DLKP N+L VN  A  +K+ DFGL++  K +      K+    G+ E+L
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----KLKVNFGTPEFL 255

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  127 bits (320), Expect = 7e-33
 Identities = 48/204 (23%), Positives = 90/204 (44%), Gaps = 13/204 (6%)

Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKR 187
            N  ++         P   + + D     +     +G G+FG + +   R T    A K 
Sbjct: 130 SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189

Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDL-HKYL 246
           ++     D+   +  R E+  +  LRHP +V    A  +   +++I E++ GG+L  K  
Sbjct: 190 VMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246

Query: 247 KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            E   +S   AV +   + +G+ ++H   N  +H DLKP N++     ++ LK+ DFGL+
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304

Query: 307 KLIKVQNSHDVYKMTGETGSCEYL 330
             +  +       +   TG+ E+ 
Sbjct: 305 AHLDPKQ-----SVKVTTGTAEFA 323

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  123 bits (310), Expect = 7e-33
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 11/155 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
            +G G+ GE+  A+ R T   VAIK I         + +     +   E+ +L KL HP 
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           I++            ++ E + GG+L   +     L  +T   +   +   + YLH   N
Sbjct: 77  IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE--N 133

Query: 277 VIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIK 310
            IIHRDLKP NVLL +   D  +K+ DFG SK++ 
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  123 bits (311), Expect = 1e-32
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 16/206 (7%)

Query: 132 GSHFEPKPVPPPLPNKCDWEIDPSELDFSSS----AIIGKGSFGEILKAYWRGT--PVAI 185
           G H         +    ++ ++ S   FS +      +GKG+F  + +   + T    A 
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNAST-KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59

Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY 245
           K I       R   Q    E  +  KL+HPNIV+   ++ E     L+ + + GG+L + 
Sbjct: 60  KIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118

Query: 246 LKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFG 304
           +  +   S + A +    I   +AY H+  N I+HR+LKP N+LL + +    +K+ DFG
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFG 176

Query: 305 LSKLIKVQNSHDVYKMTGETGSCEYL 330
           L+  +            G  G+  YL
Sbjct: 177 LAIEVNDSE-----AWHGFAGTPGYL 197

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  121 bits (305), Expect = 2e-32
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 11/157 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++GKG++G +           +AIK I     D R   Q    E+ L   L+H NIVQ+L
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRY-SQPLHEEIALHKHLKHKNIVQYL 85

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAV--NFALDIARGMAYLHNEPNVI 278
           G+ +E   + +  E + GG L   L+ K G L  +      +   I  G+ YLH+  N I
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQI 143

Query: 279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +HRD+K  NV L+N+ +  LK+ DFG SK +   N  
Sbjct: 144 VHRDIKGDNV-LINTYSGVLKISDFGTSKRLAGINPC 179

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  126 bits (317), Expect = 2e-32
 Identities = 50/159 (31%), Positives = 71/159 (44%), Gaps = 16/159 (10%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            +G G FG +L+   +  G  VAIK+    LS      + +  E+ ++ KL HPN+V   
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKKLNHPNVVSAR 78

Query: 222 ------GAVTERKPLMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLH 272
                   +      +L  EY  GGDL KYL +      L          DI+  + YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 273 NEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIK 310
              N IIHRDLKP N++L         K+ D G +K + 
Sbjct: 139 E--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  121 bits (307), Expect = 2e-32
 Identities = 56/169 (33%), Positives = 87/169 (51%), Gaps = 20/169 (11%)

Query: 158 DFSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRL--VIQDFRHEVNLLVKLRH 214
           +FS+  I+G+G FG++ K     GT VA+KR    L ++R       F+ EV ++    H
Sbjct: 31  NFSNKNILGRGGFGKVYKGRLADGTLVAVKR----LKEERTQGGELQFQTEVEMISMAVH 86

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP----STAVNFALDIARGMAY 270
            N+++  G        +L+  Y+  G +   L+E+    P          AL  ARG+AY
Sbjct: 87  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146

Query: 271 LHNEPNV-IIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKVQNSH 315
           LH+  +  IIHRD+K  N+LL     D      VGDFGL+KL+  +++H
Sbjct: 147 LHDHCDPKIIHRDVKAANILL-----DEEFEAVVGDFGLAKLMDYKDTH 190

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (314), Expect = 2e-32
 Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 10/170 (5%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++GKGSFGE++    + T    A+K I       +   +    EV LL +L HPNI++  
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
               ++    L+ E   GG+L   +  +   S   A      +  G+ Y+H   N I+HR
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK--NKIVHR 150

Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLKP N+LL + S D ++++ DFGLS   +        KM  + G+  Y+
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYI 195

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  121 bits (306), Expect = 3e-32
 Identities = 32/169 (18%), Positives = 74/169 (43%), Gaps = 14/169 (8%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G FG + +     +      K +    +D        + E+++L   RH NI+    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHE 68

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           +    + L++I E++ G D+ + +      L+    V++   +   + +LH+  + I H 
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--HNIGHF 126

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           D++P N++     +  +K+ +FG ++ +K  +            + EY 
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-----NFRLLFTAPEYY 170

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  120 bits (303), Expect = 4e-32
 Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 13/171 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           ++GKGSFGE+LK   R T    A+K I   S  +          EV LL KL HPNI++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKL 86

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
              + +     ++ E   GG+L   + ++   S   A      +  G+ Y+H   + I+H
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVH 144

Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           RDLKP N+LL +   D  +K+ DFGLS   +        KM    G+  Y+
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYI 190

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (305), Expect = 5e-32
 Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 15/169 (8%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHE 205
           D+E        +    +G+GSFGE+ +   + T    A+K++ L     +         E
Sbjct: 50  DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---------E 100

Query: 206 VNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
           +     L  P IV   GAV E   + +  E L GG L + +K+ G L    A+ +     
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
            G+ YLH     I+H D+K  NVLL +S      + DFG +  ++    
Sbjct: 161 EGLEYLHT--RRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGL 206

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  122 bits (309), Expect = 7e-32
 Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 12/171 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRIL-PSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
            +GKG+F  + +          A   I    LS      Q    E  +   L+HPNIV+ 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD--HQKLEREARICRLLKHPNIVRL 75

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
             +++E     LI + + GG+L + +  +   S + A +    I   + + H     ++H
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ--MGVVH 133

Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           R+LKP N+LL +      +K+ DFGL+  ++ +         G  G+  YL
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ----AWFGFAGTPGYL 180

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (307), Expect = 1e-31
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 29/188 (15%)

Query: 159 FSSSAIIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPN 216
             S  I+G GS G ++    ++G PVA+KR+L               E+ LL +   HPN
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPN 70

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST-------AVNFALDIARGMA 269
           ++++  + T  + L +  E     +L   ++ K     +         ++    IA G+A
Sbjct: 71  VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADH-----------LKVGDFGLSKLIKVQNSHDVY 318
           +LH+    IIHRDLKP+N+L+  SS              + + DFGL K +    S    
Sbjct: 130 HLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 319 KMTGETGS 326
            +   +G+
Sbjct: 188 NLNNPSGT 195

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  120 bits (304), Expect = 2e-31
 Identities = 38/169 (22%), Positives = 80/169 (47%), Gaps = 13/169 (7%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG + +   + T      K I      D+      ++E++++ +L HP ++    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHD 115

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           A  ++  ++LI E+L GG+L   +  +   +S +  +N+      G+ ++H   + I+H 
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE--HSIVHL 173

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           D+KP N++     A  +K+ DFGL+  +          +   T + E+ 
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTATAEFA 217

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  118 bits (298), Expect = 2e-31
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 16/173 (9%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G G+FG++     R +     IK I    S     ++    E+ +L  L HPNI++   
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVI 278
              +   + ++ E   GG+L + +        ALS          +   +AY H+    +
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHV 145

Query: 279 IHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           +H+DLKP N+L  ++S    +K+ DFGL++L K          T   G+  Y+
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-----HSTNAAGTALYM 193

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (299), Expect = 3e-31
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 18/155 (11%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
           + +G F  + +A     G   A+KR+L +  +     +    EV  + KL  HPNIVQF 
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92

Query: 222 GAVTERKPLM-------LITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYL 271
            A +  K          L+   L  G L ++LK+   +G LS  T +       R + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           H +   IIHRDLK  N+LL  S+   +K+ DFG +
Sbjct: 153 HRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSA 185

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  118 bits (298), Expect = 4e-31
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 19/171 (11%)

Query: 155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQ---DFRHEVNLLVK 211
                     +G+G FG + K Y   T VA+K+   +   D    +    F  E+ ++ K
Sbjct: 29  ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK--LAAMVDITTEELKQQFDQEIKVMAK 86

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP---STAVNFALDIARGM 268
            +H N+V+ LG  ++   L L+  Y+  G L   L       P         A   A G+
Sbjct: 87  CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSAD---HLKVGDFGLSKLIKV-QNSH 315
            +LH      IHRD+K  N+LL     D     K+ DFGL++  +    + 
Sbjct: 147 NFLHENH--HIHRDIKSANILL-----DEAFTAKISDFGLARASEKFAQTV 190

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  117 bits (296), Expect = 4e-31
 Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 12/167 (7%)

Query: 145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPS-LSDDRLVIQD 201
             K  + ID    DF     +GKG FG +  A  +     +A+K +  S L  + +  Q 
Sbjct: 6   MPKRKFTID----DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ- 60

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
            R E+ +   LRHPNI++      +RK + L+ E+   G+L+K L++ G      +  F 
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120

Query: 262 LDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
            ++A  + Y H     +IHRD+KP N+L+       LK+ DFG S  
Sbjct: 121 EELADALHYCHE--RKVIHRDIKPENLLM--GYKGELKIADFGWSVH 163

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  117 bits (295), Expect = 5e-31
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 6/153 (3%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +GKG FG +  A  + +   +A+K +  +  +   V    R EV +   LRHP
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           NI++  G   +   + LI EY   G +++ L++           +  ++A  ++Y H+  
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-- 127

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL 308
             +IHRD+KP N+LL   SA  LK+ DFG S  
Sbjct: 128 KRVIHRDIKPENLLL--GSAGELKIADFGWSVH 158

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  120 bits (304), Expect = 8e-31
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 20/180 (11%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI----------LPSLSDDRLVIQDFRHEVNLLVK 211
            +G G++GE+L    +      AIK I               +     ++  +E++LL  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           L HPNI++      ++K   L+TE+  GG+L + +  +       A N    I  G+ YL
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYL 162

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           H   + I+HRD+KP N+LL N ++  ++K+ DFGLS            K+    G+  Y+
Sbjct: 163 HK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-----KLRDRLGTAYYI 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (303), Expect = 8e-31
 Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 25/213 (11%)

Query: 134 HFEPKPVPPPLPNKCDWEIDPSELDFSSSA------------IIGKGSFGEILKAYWRGT 181
           H                ++  +   F +S              +G G++GE+L    + T
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 182 --PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR 238
               AIK I   S+S           EV +L  L HPNI++      +++   L+ E  +
Sbjct: 62  HVERAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119

Query: 239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-H 297
           GG+L   +  +   +   A      +  G+ YLH   + I+HRDLKP N+LL +   D  
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDAL 177

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           +K+ DFGLS + + Q      KM    G+  Y+
Sbjct: 178 IKIVDFGLSAVFENQK-----KMKERLGTAYYI 205

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  120 bits (302), Expect = 1e-30
 Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 13/171 (7%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           ++GKGSFGE+LK   R T    A+K I   S  +          EV LL KL HPNI++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKL 86

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
              + +     ++ E   GG+L   + ++   S   A      +  G+ Y+H   + I+H
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK--HNIVH 144

Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           RDLKP N+LL +   D  +K+ DFGLS   +        KM    G+  Y+
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYI 190

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  116 bits (292), Expect = 2e-30
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 18/176 (10%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI------LPSLSDDRLVIQDFRHEVNLLVKL-RH 214
           I+G+G    + +   + T    A+K I        S  + + + +    EV++L K+  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           PNI+Q            L+ + ++ G+L  YL EK  LS          +   +  LH  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK- 142

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
              I+HRDLKP N+LL +    ++K+ DFG S  +         K+    G+  YL
Sbjct: 143 -LNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGE-----KLREVCGTPSYL 190

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  116 bits (293), Expect = 3e-30
 Identities = 33/168 (19%), Positives = 69/168 (41%), Gaps = 25/168 (14%)

Query: 165 IGKGSFGEILKAYWRGTPVAIK--------------RILPSLSDDRLVIQDFRHEVNLLV 210
           + +G F +I+         A+K              +        +    DF++E+ ++ 
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR---- 266
            +++   +   G +T    + +I EY+    + K+ +    L  +      + + +    
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158

Query: 267 ----GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
                 +Y+HNE N I HRD+KP N+L+       +K+ DFG S+ + 
Sbjct: 159 SVLNSFSYIHNEKN-ICHRDVKPSNILM--DKNGRVKLSDFGESEYMV 203

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  116 bits (292), Expect = 4e-30
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 15/176 (8%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +IGKG F  + +   R T    A+K +  +   S   L  +D + E ++   L+HP+IV+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEP 275
            L   +    L ++ E++ G DL   + ++       S + A ++   I   + Y H+  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148

Query: 276 NVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           N IIHRD+KP  VLL +      +K+G FG++  +            G  G+  ++
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL----VAGGRVGTPHFM 200

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  114 bits (289), Expect = 5e-30
 Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 18/182 (9%)

Query: 138 KPVPPPLPNKCDWEIDPSEL-DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILP--SL 192
           K +P  L       +DP     +     +GKG F +  +     T    A K I+P   L
Sbjct: 2   KEIPEVL-------VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLL 53

Query: 193 SDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGAL 252
                  +    E+++   L H ++V F G   +   + ++ E  R   L +  K + AL
Sbjct: 54  LKPHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL 112

Query: 253 SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ 312
           +   A  +   I  G  YLH   N +IHRDLK  N+ L  +    +K+GDFGL+  ++  
Sbjct: 113 TEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYD 168

Query: 313 NS 314
             
Sbjct: 169 GE 170

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  115 bits (290), Expect = 5e-30
 Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 12/174 (6%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
           ++G+G+   +       T    A+K I       R        EV +L + + H N+++ 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
           +    E     L+ E +RGG +  ++ ++   +   A     D+A  + +LHN    I H
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN--KGIAH 134

Query: 281 RDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSH---DVYKMTGETGSCEYL 330
           RDLKP N+L  + +    +K+ DF L   IK+          ++    GS EY+
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  116 bits (292), Expect = 6e-30
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 17/175 (9%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRI-----LPSLSDDRLVIQDFRHEVNLLVKLR-HP 215
           +IG+G    + +   R T    A+K +       S      V +  R E ++L ++  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           +I+  + +      + L+ + +R G+L  YL EK ALS     +    +   +++LH   
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-- 218

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           N I+HRDLKP N+LL ++    +++ DFG S  ++        K+    G+  YL
Sbjct: 219 NNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLEPGE-----KLRELCGTPGYL 266

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  115 bits (290), Expect = 7e-30
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 11/179 (6%)

Query: 141 PPPLPNKCDWEIDPSEL-DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILP--SLSDD 195
            PP     +  +DP     +     +GKG F +  +     T    A K I+P   L   
Sbjct: 24  APPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKP 82

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPS 255
               +    E+++   L H ++V F G   +   + ++ E  R   L +  K + AL+  
Sbjct: 83  HQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP 141

Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
            A  +   I  G  YLH   N +IHRDLK  N+ L  +    +K+GDFGL+  ++    
Sbjct: 142 EARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGE 196

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  113 bits (286), Expect = 2e-29
 Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 16/171 (9%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQF 220
            +G+GSF    K   + +    A+K I       + +  + + E+  L     HPNIV+ 
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKII------SKRMEANTQKEITALKLCEGHPNIVKL 71

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                ++    L+ E L GG+L + +K+K   S + A      +   ++++H+    ++H
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD--VGVVH 129

Query: 281 RDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           RDLKP N+L  + + +  +K+ DFG ++L    N      +     +  Y 
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ----PLKTPCFTLHYA 176

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  113 bits (285), Expect = 3e-29
 Identities = 50/148 (33%), Positives = 71/148 (47%), Gaps = 7/148 (4%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IGKG+F ++  A     G  VAIK I+     +   +Q    EV ++  L HPNIV+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L LI EY  GG++  YL   G +    A +    I   + Y H     I+HRD
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRD 139

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           LK  N+LL   +  ++K+ DFG S    
Sbjct: 140 LKAENLLL--DADMNIKIADFGFSNEFT 165

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  113 bits (284), Expect = 5e-29
 Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 12/184 (6%)

Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKR 187
             G+       P  +           +  +     +G+G++GE+ KA    T   VAIKR
Sbjct: 8   HMGTLEAQTQGPGSMSVSAAPSATSID-RYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66

Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK 247
           I     ++ +     R EV+LL +L+H NI++    +     L LI EY    DL KY+ 
Sbjct: 67  IRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMD 124

Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDF 303
           +   +S     +F   +  G+ + H+     +HRDLKP+N LL++ S       LK+GDF
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQN-LLLSVSDASETPVLKIGDF 181

Query: 304 GLSK 307
           GL++
Sbjct: 182 GLAR 185

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (280), Expect = 8e-29
 Identities = 48/147 (32%), Positives = 73/147 (49%), Gaps = 6/147 (4%)

Query: 163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
             +G G    +  A        VAIK I     +    ++ F  EV+   +L H NIV  
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
           +    E     L+ EY+ G  L +Y++  G LS  TA+NF   I  G+ + H+    I+H
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD--MRIVH 134

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RD+KP+N+L+   S   LK+ DFG++K
Sbjct: 135 RDIKPQNILI--DSNKTLKIFDFGIAK 159

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  112 bits (283), Expect = 9e-29
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 14/156 (8%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
            IG GS+    +   + T    A+K I     D      D   E+ +L++  +HPNI+  
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKR--DPTEEIEILLRYGQHPNIITL 81

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                + K + ++TE ++GG+L   +  +   S   A      I + + YLH     ++H
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA--QGVVH 139

Query: 281 RDLKPRNVLLVNSSADH--LKVGDFGLSKLIKVQNS 314
           RDLKP N+L V+ S +   +++ DFG +K ++ +N 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (282), Expect = 1e-28
 Identities = 33/209 (15%), Positives = 75/209 (35%), Gaps = 30/209 (14%)

Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTP-------VAIKRILPSLSD 194
           P +  K ++++    +      ++G+G+F ++ +A               +K   P+   
Sbjct: 52  PAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW 109

Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--- 251
           +  +       +  L        ++F  A   +   +L+ E    G L   +        
Sbjct: 110 EFYIG---TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166

Query: 252 --LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD---------HLKV 300
             +     ++FA+ +   +  +H+    IIH D+KP N +L N   +          L +
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224

Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSCEY 329
            D G S  +K+     +   T +  +  +
Sbjct: 225 IDLGQSIDMKLFPKGTI--FTAKCETSGF 251

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  111 bits (281), Expect = 1e-28
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 18/174 (10%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRH-PNIVQ 219
           +G+G F  + +   + T    A K +       D R    +  HE+ +L   +  P ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR---AEILHEIAVLELAKSCPRVIN 93

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
                     ++LI EY  GG++      +    +S +  +     I  G+ YLH   N 
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NN 151

Query: 278 IIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           I+H DLKP+N+LL +      +K+ DFG+S+ I         ++    G+ EYL
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-----ELREIMGTPEYL 200

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  111 bits (280), Expect = 2e-28
 Identities = 51/210 (24%), Positives = 78/210 (37%), Gaps = 46/210 (21%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPS--LSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           IG+GS+G +  A    T    AIK +  +     +   ++  + EV L+ KL HPNI + 
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------------------ 250
                + + + L+ E   GG L   L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 251 ----------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
                             N    I   + YLHN    I HRD+KP N L   + +  +K+
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKL 211

Query: 301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            DFGLSK     N+ + Y MT + G+  ++
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (276), Expect = 3e-28
 Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 11/155 (7%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +GKGSF  + +A    T   VAIK ++   ++    +V +  ++EV +  +L+HP+I++ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILEL 76

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVII 279
                +   + L+ E    G++++YLK +    S + A +F   I  GM YLH+  + I+
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS--HGIL 134

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
           HRDL   N+LL  +   ++K+ DFGL+  +K+ + 
Sbjct: 135 HRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHE 167

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  111 bits (279), Expect = 4e-28
 Identities = 50/148 (33%), Positives = 70/148 (47%), Gaps = 8/148 (5%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG G+FG       +     VA+K I         + ++ + E+     LRHPNIV+F  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI----ERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +     L +I EY  GG+L++ +   G  S   A  F   +  G++Y H+    I HRD
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS--MQICHRD 141

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           LK  N LL  S A  LK+ DFG SK   
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSV 169

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (274), Expect = 1e-27
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 12/159 (7%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GS+G + K   R T   VAIK+ L S  D  +     R E+ +L +L+HPN+V  L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
               ++ L L+ EY     +   L   +  +      +      + + + H   +  IHR
Sbjct: 70  VFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK--HNCIHR 126

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDV 317
           D+KP N +L+      +K+ DFG ++L+   +     +V
Sbjct: 127 DVKPEN-ILITKH-SVIKLCDFGFARLLTGPSDYYDDEV 163

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  108 bits (271), Expect = 1e-27
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 8/151 (5%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G++GE+  A  R T   VA+K I+             + E+ +   L H N+V+F G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
              E     L  EY  GG+L   ++    +    A  F   +  G+ YLH     I HRD
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRD 130

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
           +KP N+LL     D+LK+ DFGL+ + +  N
Sbjct: 131 IKPENLLL--DERDNLKISDFGLATVFRYNN 159

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  110 bits (276), Expect = 1e-27
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 28/169 (16%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDRLVIQDFRH---EVNL 208
           +  E+ +++  +IG GSFG + +A    +  VAIK++L          QD R    E+ +
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----------QDKRFKNRELQI 85

Query: 209 LVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYL----KEKGALSPSTAV 258
           +  ++HPN+V                 L L+ EY+    +++      K K  +      
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIK 144

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            +   + R +AY+H+    I HRD+KP+N LL++  +  LK+ DFG +K
Sbjct: 145 LYMYQLLRSLAYIHS--IGICHRDIKPQN-LLLDPPSGVLKLIDFGSAK 190

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  108 bits (273), Expect = 2e-27
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 12/159 (7%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+GS+G ++K   + T   VAIK+ L S  D  +     R E+ LL +LRH N+V  L 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
              ++K   L+ E++    +   L+     L       +   I  G+ + H+  + IIHR
Sbjct: 92  VCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--HNIIHR 148

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDV 317
           D+KP N +LV+ S   +K+ DFG ++ +         +V
Sbjct: 149 DIKPEN-ILVSQS-GVVKLCDFGFARTLAAPGEVYDDEV 185

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (270), Expect = 3e-27
 Identities = 61/172 (35%), Positives = 87/172 (50%), Gaps = 12/172 (6%)

Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRI-LPSLSD 194
            PV   LP   + + DP EL F+    IGKGSFGE+ K     T   VAIK I L    D
Sbjct: 4   SPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62

Query: 195 DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP 254
           +   I+D + E+ +L +   P + ++ G+  +   L +I EYL GG     L+       
Sbjct: 63  E---IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET 119

Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             A     +I +G+ YLH+E    IHRD+K  NVLL  S    +K+ DFG++
Sbjct: 120 QIAT-ILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVA 166

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  108 bits (271), Expect = 3e-27
 Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 13/199 (6%)

Query: 121 NAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR- 179
           + H        GSH  P             E +P E  +    ++G G FG +       
Sbjct: 7   HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVS 66

Query: 180 -GTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKPLML 232
              PVAIK +    +    +     +    EV LL K+      +++ L         +L
Sbjct: 67  DNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVL 125

Query: 233 ITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV 291
           I E      DL  ++ E+GAL    A +F   +   + + HN    ++HRD+K  N +L+
Sbjct: 126 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDEN-ILI 182

Query: 292 NSSADHLKVGDFGLSKLIK 310
           + +   LK+ DFG   L+K
Sbjct: 183 DLNRGELKLIDFGSGALLK 201

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  106 bits (268), Expect = 3e-27
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 10/150 (6%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G+FG++     +  G  VA+K IL    +    +V +  R E+  L   RHP+I++ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL 76

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
              ++      ++ EY+ GG+L  Y+ + G +    A      I   + Y H   ++++H
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR--HMVVH 134

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           RDLKP NVLL   +  + K+ DFGLS ++ 
Sbjct: 135 RDLKPENVLL--DAHMNAKIADFGLSNMMS 162

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  107 bits (270), Expect = 4e-27
 Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 8/151 (5%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G++GE+  A  R     VA+K I+             + E+ +   L H N+V+F G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
              E     L  EY  GG+L   ++    +    A  F   +  G+ YLH     I HRD
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRD 130

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQN 313
           +KP N+LL     D+LK+ DFGL+ + +  N
Sbjct: 131 IKPENLLL--DERDNLKISDFGLATVFRYNN 159

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  106 bits (267), Expect = 7e-27
 Identities = 55/158 (34%), Positives = 90/158 (56%), Gaps = 11/158 (6%)

Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           IG+G++G + KA    G   A+K+I     D+ +     R E+++L +L+H NIV+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68

Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +  +K L+L+ E+L   DL K L   +G L   TA +F L +  G+AY H+    ++HRD
Sbjct: 69  IHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRD 125

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDV 317
           LKP+N LL+N     LK+ DFGL++   +     +H++
Sbjct: 126 LKPQN-LLINREG-ELKIADFGLARAFGIPVRKYTHEI 161

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  106 bits (267), Expect = 1e-26
 Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 6/147 (4%)

Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
            ++G+G  G++ +A    R   VA+K +  +LS D +     + E     +L+ P++V  
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                    L +    + G DL   L+ +G L+P  AV     I   +   H       H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA--AGATH 157

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RD+KP N+L+  S+ D   + DFG++ 
Sbjct: 158 RDVKPENILV--SADDFAYLVDFGIAS 182

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  106 bits (266), Expect = 1e-26
 Identities = 51/146 (34%), Positives = 81/146 (55%), Gaps = 9/146 (6%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  R T   VA+KR+     D+ +     R E+ LL +L+H NIV+   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
            +   K L L+ E+    DL KY     G L P    +F   + +G+ + H+    ++HR
Sbjct: 69  VLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHR 125

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSK 307
           DLKP+N LL+N +   LK+ +FGL++
Sbjct: 126 DLKPQN-LLINRNG-ELKLANFGLAR 149

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  106 bits (266), Expect = 1e-26
 Identities = 55/145 (37%), Positives = 83/145 (57%), Gaps = 8/145 (5%)

Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           +G+G++G + KA    G  VA+KRI     D+ +     R E++LL +L HPNIV  +  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87

Query: 224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           +   + L L+ E++   DL K L E K  L  S    +   + RG+A+ H   + I+HRD
Sbjct: 88  IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRD 144

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           LKP+N LL+NS    LK+ DFGL++
Sbjct: 145 LKPQN-LLINSDG-ALKLADFGLAR 167

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  105 bits (265), Expect = 1e-26
 Identities = 47/147 (31%), Positives = 83/147 (56%), Gaps = 10/147 (6%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  + T   VA+K+I      + +     R E++LL +L HPNIV+ L 
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIH 280
            +     L L+ E+L   DL K++       +      ++   + +G+A+ H+  + ++H
Sbjct: 70  VIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLH 126

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSK 307
           RDLKP+N LL+N+    +K+ DFGL++
Sbjct: 127 RDLKPQN-LLINTEG-AIKLADFGLAR 151

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  107 bits (270), Expect = 1e-26
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 29/171 (16%)

Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---EVNL 208
           P E+ ++ + +IG GSFG + +A     G  VAIK++L          QD R    E+ +
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFKNRELQI 100

Query: 209 LVKLRHPNIVQFLGAVTERKP------LMLITEYLRGGDLHKYLK----EKGALSPSTAV 258
           + KL H NIV+                L L+ +Y+    +++  +     K  L      
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVK 159

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
            +   + R +AY+H+    I HRD+KP+N LL++     LK+ DFG +K +
Sbjct: 160 LYMYQLFRSLAYIHS--FGICHRDIKPQN-LLLDPDTAVLKLCDFGSAKQL 207

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  105 bits (264), Expect = 2e-26
 Identities = 50/179 (27%), Positives = 75/179 (41%), Gaps = 34/179 (18%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIK-----------------------RILPSLSDDRLVI 199
           IGKGS+G +  AY     T  A+K                                R  I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 200 QDFRHEVNLLVKLRHPNIVQF---LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST 256
           +    E+ +L KL HPN+V+    L    E   L ++ E +  G + +       LS   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPVMEVPT-LKPLSEDQ 138

Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           A  +  D+ +G+ YLH     IIHRD+KP N+L+      H+K+ DFG+S   K  ++ 
Sbjct: 139 ARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLV--GEDGHIKIADFGVSNEFKGSDAL 193

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  106 bits (266), Expect = 2e-26
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 11/150 (7%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G+GSFG++  A        VA+K  +    L    + ++  R E++ L  LRHP+I++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK-FISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL 74

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
              +T    ++++ EY  GG+L  Y+ EK  ++      F   I   + Y H   + I+H
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR--HKIVH 131

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           RDLKP N+LL      ++K+ DFGLS ++ 
Sbjct: 132 RDLKPENLLL--DDNLNVKIADFGLSNIMT 159

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  105 bits (265), Expect = 2e-26
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 26/176 (14%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
           ++G G  G++L+ + R T    A+K +      D       R EV+   +    P+IV  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL-----YDS---PKARQEVDHHWQASGGPHIVCI 87

Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
           L         ++ L++I E + GG+L   ++E+G  A +   A     DI   + +LH+ 
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS- 146

Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEY 329
            + I HRD+KP N+L  +   D  LK+ DFG +K            +     +  Y
Sbjct: 147 -HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN------ALQTPCYTPYY 195

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  106 bits (267), Expect = 3e-26
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 25/176 (14%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
           ++G G  G++L+ + + T    A+K +      D       R EV L  +  + P+IV+ 
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRI 120

Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
           +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+ 
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 179

Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEY 329
              I HRD+KP N+L  +   +  LK+ DFG +K     N      +T    +  Y
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-----SLTTPCYTPYY 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  106 bits (266), Expect = 3e-26
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 20/171 (11%)

Query: 151 EIDPSELD-FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           E    E+D F    + G+G+FG +     +  G  VAIK+++    D R   ++ +  + 
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQ-IMQ 71

Query: 208 LLVKLRHPNIVQ---FLGAVTERKP----LMLITEYLRGGDLHKYLK----EKGALSPST 256
            L  L HPNIVQ   +   + ER      L ++ EY+    LH+  +     + A  P  
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130

Query: 257 AVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              F   + R +  LH     + HRD+KP N +LVN +   LK+ DFG +K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEADGTLKLCDFGSAK 180

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  105 bits (263), Expect = 3e-26
 Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 18/155 (11%)

Query: 163 AIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
            I+G G   E+               VA+K +   L+ D      FR E      L HP 
Sbjct: 18  EILGFGGMSEV----HLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 217 IVQFL--GAVTERKPLM--LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           IV     G        +  ++ EY+ G  L   +  +G ++P  A+    D  + + + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              N IIHRD+KP N+++  S+ + +KV DFG+++
Sbjct: 134 Q--NGIIHRDVKPANIMI--SATNAVKVMDFGIAR 164

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  107 bits (268), Expect = 4e-26
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 10/150 (6%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G+FG++        G  VA+K IL    +    +V +  R E+  L   RHP+I++ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL 81

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
              ++    + ++ EY+ GG+L  Y+ + G L    +      I  G+ Y H   ++++H
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR--HMVVH 139

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           RDLKP NVLL   +  + K+ DFGLS ++ 
Sbjct: 140 RDLKPENVLL--DAHMNAKIADFGLSNMMS 167

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  105 bits (263), Expect = 4e-26
 Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 15/157 (9%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRI----LPSLSDDRLVIQDFRHEVNLLVKLR----H 214
           +GKG FG +   +       VAIK I    +   S     +     EV LL K+     H
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97

Query: 215 PNIVQFLGAVTERKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
           P +++ L     ++  ML+ E  L   DL  Y+ EKG L    +  F   +   + + H+
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
               ++HRD+K  N +L++      K+ DFG   L+ 
Sbjct: 158 --RGVVHRDIKDEN-ILIDLRRGCAKLIDFGSGALLH 191

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (263), Expect = 4e-26
 Identities = 34/154 (22%), Positives = 66/154 (42%), Gaps = 12/154 (7%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIK-----RILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           +G G+FG +  A  +     V +K     ++L     +   +     E+ +L ++ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 218 VQFLGAVTERKPLMLITE-YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           ++ L     +    L+ E +  G DL  ++     L    A      +   + YL     
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL--K 149

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
            IIHRD+K  N+++  +    +K+ DFG +  ++
Sbjct: 150 DIIHRDIKDENIVI--AEDFTIKLIDFGSAAYLE 181

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  105 bits (264), Expect = 4e-26
 Identities = 50/155 (32%), Positives = 79/155 (50%), Gaps = 24/155 (15%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---------EVNLLVKLR 213
           +G+G F  + KA  +     VAIK+I       +L  +             E+ LL +L 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKI-------KLGHRSEAKDGINRTALREIKLLQELS 70

Query: 214 HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLH 272
           HPNI+  L A   +  + L+ +++   DL   +K+    L+PS    + L   +G+ YLH
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
              + I+HRDLKP N LL++ +   LK+ DFGL+K
Sbjct: 130 Q--HWILHRDLKPNN-LLLDENG-VLKLADFGLAK 160

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (263), Expect = 6e-26
 Identities = 58/186 (31%), Positives = 78/186 (41%), Gaps = 14/186 (7%)

Query: 130 QNGSHFEPKPVPPPLPNKCDWEI-------DPSELDFSSSAIIGKGSFGEILKAYWRGT- 181
                 +P P      +  D ++       DP +L FS    IG GSFG +  A      
Sbjct: 21  YFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL-FSDLREIGHGSFGAVYFARDVRNS 79

Query: 182 -PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
             VAIK++  S        QD   EV  L KLRHPN +Q+ G         L+ EY  G 
Sbjct: 80  EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 139

Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV 300
                   K  L             +G+AYLH+    +IHRD+K  N+LL  S    +K+
Sbjct: 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKL 195

Query: 301 GDFGLS 306
           GDFG +
Sbjct: 196 GDFGSA 201

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  103 bits (259), Expect = 1e-25
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 11/168 (6%)

Query: 142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVI 199
                    ++DP+E+ +     +G G+FG++ KA  + T    A K I     ++   +
Sbjct: 5   SREYEHVRRDLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---L 60

Query: 200 QDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAV 258
           +D+  E+ +L    HP IV+ LGA      L ++ E+  GG +   + E    L+     
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
                +   + +LH+    IIHRDLK  NVL+  +    +++ DFG+S
Sbjct: 121 VVCRQMLEALNFLHS--KRIIHRDLKAGNVLM--TLEGDIRLADFGVS 164

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  104 bits (260), Expect = 4e-25
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 20/196 (10%)

Query: 130 QNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKR 187
           Q   H   KP         DW+I      +    +IG GS+G + +AY +     VAIK+
Sbjct: 29  QRKQHHSSKPTASMPRPHSDWQIPD---RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK 85

Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL-----GAVTERKPLMLITEYLRGGDL 242
           IL    D     +  R E+ +L +L H ++V+ L       V +   L ++ E     D 
Sbjct: 86  ILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF 143

Query: 243 HKYLKEKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKV 300
            K  +    L+         ++  G+ Y+H       I+HRDLKP N  LVN     +KV
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG----ILHRDLKPAN-CLVNQDCS-VKV 197

Query: 301 GDFGLSKLIKVQNSHD 316
            DFGL++ +    + +
Sbjct: 198 CDFGLARTVDYPENGN 213

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  101 bits (254), Expect = 4e-25
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 20/154 (12%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
           ++G G  G++L+ + + T    A+K +      D       R EV L  +  + P+IV+ 
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-----QDC---PKARREVELHWRASQCPHIVRI 76

Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
           +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+ 
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 135

Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSK 307
              I HRD+KP N+L  +   +  LK+ DFG +K
Sbjct: 136 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  102 bits (256), Expect = 4e-25
 Identities = 54/165 (32%), Positives = 83/165 (50%), Gaps = 25/165 (15%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQD------FRHEVNLLVKLRHPN 216
           +G+G++  + K   + T   VA+K I       RL  ++       R EV+LL  L+H N
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIR-EVSLLKDLKHAN 61

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEP 275
           IV     +   K L L+ EYL   DL +YL + G  ++      F   + RG+AY H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-- 118

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDV 317
             ++HRDLKP+N LL+N     LK+ DFGL++   +      ++V
Sbjct: 119 QKVLHRDLKPQN-LLINERG-ELKLADFGLARAKSIPTKTYDNEV 161

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  102 bits (256), Expect = 5e-25
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 7/160 (4%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
               +  + DF   + +G G+ G + K      G  +A K I   L     +      E+
Sbjct: 25  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIREL 82

Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
            +L +   P IV F GA      + +  E++ GG L + LK+ G +        ++ + +
Sbjct: 83  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           G+ YL  +   I+HRD+KP N+L+  +S   +K+ DFG+S
Sbjct: 143 GLTYLREKHK-IMHRDVKPSNILV--NSRGEIKLCDFGVS 179

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (253), Expect = 8e-25
 Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 30/173 (17%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEV 206
           W I+    D+    +IG G+   +  AY   +   VAIKRI L         + +   E+
Sbjct: 10  WSINRD--DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEI 64

Query: 207 NLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALD 263
             + +  HPNIV +  +   +  L L+ + L GG   D+ K++  KG           LD
Sbjct: 65  QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-----LD 119

Query: 264 ---IA-------RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
              IA        G+ YLH   N  IHRD+K  N+LL       +++ DFG+S
Sbjct: 120 ESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILL--GEDGSVQIADFGVS 168

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  100 bits (252), Expect = 8e-25
 Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 11/156 (7%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP +  ++    IG+G+ G +  A    T   VAI+++       + +I +   E+ ++ 
Sbjct: 17  DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMR 72

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           + ++PNIV +L +      L ++ EYL GG L   + E        A     +  + + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           LH+    +IHRD+K  N+LL       +K+ DFG  
Sbjct: 132 LHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFC 163

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  100 bits (251), Expect = 2e-24
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 28/193 (14%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           N   +++      +     +G G  G +  A        VAIK+I   L+D + V    R
Sbjct: 3   NIHGFDLGS---RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALR 57

Query: 204 HEVNLLVKLRHPNIVQFL--------------GAVTERKPLMLITEYLRGGDLHKYLKEK 249
            E+ ++ +L H NIV+                G++TE   + ++ EY+   DL   L+ +
Sbjct: 58  -EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE-Q 114

Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           G L    A  F   + RG+ Y+H+    ++HRDLKP N L +N+    LK+GDFGL++++
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPAN-LFINTEDLVLKIGDFGLARIM 171

Query: 310 KVQNSHDVYKMTG 322
               SH  + ++ 
Sbjct: 172 DPHYSHKGH-LSE 183

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (250), Expect = 2e-24
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 11/156 (7%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP  L   S   IG+GS G +  A  + +   VA+K +       R ++ +   EV ++ 
Sbjct: 42  DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMR 97

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
             +H N+V+   +    + L ++ E+L+GG L   + +   L+          + + +AY
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAY 156

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           LH +   +IHRD+K  ++LL  +    +K+ DFG  
Sbjct: 157 LHAQG--VIHRDIKSDSILL--TLDGRVKLSDFGFC 188

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 98.8 bits (247), Expect = 6e-24
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 32/171 (18%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRI-------LPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +G G++  + K   + T   VA+K +        PS +         R E++L+ +L+H 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--------IR-EISLMKELKHE 63

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMA 269
           NIV+    +     L L+ E++   DL KY+           L  +    F   + +G+A
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN---SHDV 317
           + H   N I+HRDLKP+N LL+N     LK+GDFGL++   +     S +V
Sbjct: 123 FCHE--NKILHRDLKPQN-LLINKRG-QLKLGDFGLARAFGIPVNTFSSEV 169

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 98.2 bits (245), Expect = 9e-24
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 17/159 (10%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
            P E+ F     +G+GS+G + KA  + T   VAIK++   +  D   +Q+   E++++ 
Sbjct: 26  QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESD---LQEIIKEISIMQ 79

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDIARG 267
           +   P++V++ G+  +   L ++ EY   G   D+ +       L+            +G
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKG 137

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
           + YLH      IHRD+K  N+LL  ++  H K+ DFG++
Sbjct: 138 LEYLHFMR--KIHRDIKAGNILL--NTEGHAKLADFGVA 172

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 22/170 (12%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP+ + F    ++G G++G++ K     T    AIK ++    D+    ++ + E+N+L 
Sbjct: 21  DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDE---EEEIKQEINMLK 75

Query: 211 KL-RHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNF 260
           K   H NI  + GA  ++ P      L L+ E+   G   DL K  K         A   
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-I 134

Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             +I RG+++LH   + +IHRD+K +NVLL  +    +K+ DFG+S  + 
Sbjct: 135 CREILRGLSHLHQ--HKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLD 180

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 99.5 bits (248), Expect = 3e-23
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 25/157 (15%)

Query: 165 IGKGSFGEILKAYWRGT-------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           I  G  G I    +          PV +K ++ S   D         E   L ++ HP+I
Sbjct: 88  IAHGGLGWI----YLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSI 141

Query: 218 VQFLGAVTERKPLM-----LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
           VQ    V            ++ EY+ G  L +       L  + A+ + L+I   ++YLH
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLH 199

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
           +    +++ DLKP N++L   + + LK+ D G    I
Sbjct: 200 SIG--LVYNDLKPENIML---TEEQLKLIDLGAVSRI 231

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 98.3 bits (245), Expect = 4e-23
 Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 20/198 (10%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV 206
           +  +     ++    +IG+GS+G +  AY +     VAIK++     D     +  R E+
Sbjct: 21  NVHVPD---NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EI 76

Query: 207 NLLVKLRHPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
            +L +L+   I++    +      +   L ++ E     DL K  K    L+        
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135

Query: 262 LDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
            ++  G  ++H       IIHRDLKP N  L+N     +KV DFGL++ I  +   ++  
Sbjct: 136 YNLLLGENFIHESG----IIHRDLKPAN-CLLNQDCS-VKVCDFGLARTINSEKDTNIVN 189

Query: 320 MTGETGSCEYLVSNCSFM 337
              E         N    
Sbjct: 190 DLEENEEPGPHNKNLKKQ 207

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 19/170 (11%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+  +   + S   +G G++G +  A  +  G  VAIK++      +    + +R
Sbjct: 16  NKTAWELPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ LL  ++H N++  L   T    L       L+  ++   DL K +  K   S    
Sbjct: 73  -ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKI 128

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
                 + +G+ Y+H+    ++HRDLKP N L VN   + LK+ DFGL++
Sbjct: 129 QYLVYQMLKGLKYIHSAG--VVHRDLKPGN-LAVNEDCE-LKILDFGLAR 174

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.9 bits (242), Expect = 4e-23
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 17/170 (10%)

Query: 165 IGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G+FGE+ KA  R T   VA+K++L     +   I   R E+ +L  L+H N+V  + 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 83

Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHN 273
               +          + L+ ++    DL   L       + S        +  G+ Y+H 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGE 323
             N I+HRD+K  NVL+       LK+ DFGL++   +  +    + T  
Sbjct: 143 --NKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNR 188

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 29/204 (14%)

Query: 134 HFEPKPVPPPLP------NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAI 185
           H     +               +++ P    +++ + IG+G++G +  AY       VAI
Sbjct: 1   HHHHHHMAAAAAAGPEMVRGQVFDVGP---RYTNLSYIGEGAYGMVCSAYDNLNKVRVAI 57

Query: 186 KRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYLRGG 240
           K+I P         +  R E+ +L++ RH NI+     +          + ++ + +   
Sbjct: 58  KKISP-FEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ET 114

Query: 241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHL 298
           DL+K LK    LS      F   I RG+ Y+H  N    ++HRDLKP N LL+N++ D L
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSAN----VLHRDLKPSN-LLLNTTCD-L 167

Query: 299 KVGDFGLSKLIKVQNSHDVYKMTG 322
           K+ DFGL+++    + H  + +T 
Sbjct: 168 KICDFGLARVADPDHDHTGF-LTE 190

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.4 bits (238), Expect = 9e-23
 Identities = 40/155 (25%), Positives = 76/155 (49%), Gaps = 16/155 (10%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILP--SLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G+GS+G++ +          A+K IL    L        + + E+ LL +LRH N++Q 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 221 ---LGAVTERKPLMLITEYLRGG--DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
              L    ++K + ++ EY   G  ++   + EK       A  +   +  G+ YLH+  
Sbjct: 72  VDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHS-- 127

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             I+H+D+KP N+LL  ++   LK+   G+++ + 
Sbjct: 128 QGIVHKDIKPGNLLL--TTGGTLKISALGVAEALH 160

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 24/194 (12%)

Query: 124 GGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-- 181
           G  +  + G+       PPP P K   E      DF    I+G+GSF  ++ A    T  
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPE------DFKFGKILGEGSFSTVVLARELATSR 56

Query: 182 PVAIKRILPSLSDDRLVIQ--DFRH---EVNLLVKLRHPNIVQFLGAV-TERKPLMLITE 235
             AIK IL    + R +I+     +   E +++ +L HP  V+       + K L     
Sbjct: 57  EYAIK-IL----EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYFGLS 110

Query: 236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA 295
           Y + G+L KY+++ G+   +    +  +I   + YLH     IIHRDLKP N+LL  +  
Sbjct: 111 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILL--NED 166

Query: 296 DHLKVGDFGLSKLI 309
            H+++ DFG +K++
Sbjct: 167 MHIQITDFGTAKVL 180

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 95.9 bits (239), Expect = 1e-22
 Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 18/169 (10%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
            K  WE+      +     +G G++G +  A     G  VAIK++      +    + +R
Sbjct: 17  TKTAWEVRA---VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ LL  +RH N++  L   T  + L       L+  ++ G DL K +K +  L     
Sbjct: 74  -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRI 130

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
                 + +G+ Y+H     IIHRDLKP N L VN   + LK+ DFGL+
Sbjct: 131 QFLVYQMLKGLRYIHAAG--IIHRDLKPGN-LAVNEDCE-LKILDFGLA 175

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 25/148 (16%), Positives = 48/148 (32%), Gaps = 16/148 (10%)

Query: 163 AIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN 216
              G     +     W+         VA+  + P       V+Q+       L ++  P 
Sbjct: 37  IFHGGVPPLQF----WQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN 276
           + + L  V  R   +++ E++RGG L +      + SP  A+     +A      H    
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG- 149

Query: 277 VIIHRDLKPRNVLLVNSSADHLKVGDFG 304
            +      P  V +  S    + +    
Sbjct: 150 -VALSIDHPSRVRV--SIDGDVVLAYPA 174

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 34/162 (20%), Positives = 68/162 (41%), Gaps = 8/162 (4%)

Query: 148 CDWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHE 205
                     D  +   +G G+ G++ K      G  +A+K++    S ++   +    +
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMD 73

Query: 206 VNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDI 264
           +++++K    P IVQ  G       + +  E +         + +G +         + I
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            + + YL  +   +IHRD+KP N+LL       +K+ DFG+S
Sbjct: 134 VKALYYLKEKHG-VIHRDVKPSNILL--DERGQIKLCDFGIS 172

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 43/177 (24%), Positives = 70/177 (39%), Gaps = 25/177 (14%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRH 204
                 +      ++    I  GS+G +       G PVAIKR+  +   D   +     
Sbjct: 14  IAELHAMQS---PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRV-FNTVSDGRTVNILSD 69

Query: 205 ---------EVNLLVKLRHPNIVQFLGAVTERKP-----LMLITEYLRGGDLHKYLK-EK 249
                    E+ LL    HPNI+         +      L L+TE +   DL + +  ++
Sbjct: 70  SFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR 128

Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             +SP     F   I  G+  LH     ++HRDL P N +L+  + D + + DF L+
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHE--AGVVHRDLHPGN-ILLADNND-ITICDFNLA 181

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.0 bits (236), Expect = 3e-22
 Identities = 30/162 (18%), Positives = 63/162 (38%), Gaps = 16/162 (9%)

Query: 153 DPSELDFSSSAIIGKG--SFGEILKAY--WRGTPVAIKRI-LPSLSDDRLVIQDFRHEVN 207
                 +    +IGKG      +  A     G  V ++RI L + S++   +   + E++
Sbjct: 22  PEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM--VTFLQGELH 78

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDI 264
           +     HPNIV +         L ++T ++  G   DL       G ++          +
Sbjct: 79  VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGV 137

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            + + Y+H+     +HR +K  ++L+  S    + +     +
Sbjct: 138 LKALDYIHH--MGYVHRSVKASHILI--SVDGKVYLSGLRSN 175

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 19/198 (9%)

Query: 147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH 204
           + D  +      +     +GKG++G + K+  R  G  VA+K+I  +  +     + FR 
Sbjct: 2   RVDRHVLR---KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR- 57

Query: 205 EVNLLVKLR-HPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFA 261
           E+ +L +L  H NIV  L  +     + + L+ +Y+   DLH  ++    L P       
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVV 115

Query: 262 LDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYK 319
             + + + YLH       ++HRD+KP N +L+N+    +KV DFGLS+            
Sbjct: 116 YQLIKVIKYLHSGG----LLHRDMKPSN-ILLNAECH-VKVADFGLSRSFVNIRRVTNNI 169

Query: 320 MTGETGSCEYLVSNCSFM 337
                 + E    +   +
Sbjct: 170 PLSINENTENFDDDQPIL 187

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 19/169 (11%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
               + +      + +   IG G+ G +  AY       VAIK++     +     + +R
Sbjct: 17  GDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR 73

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ L+  + H NI+  L   T +K L       ++ E +   +L + ++ +  L     
Sbjct: 74  -ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERM 129

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
                 +  G+ +LH+    IIHRDLKP N ++V S    LK+ DFGL+
Sbjct: 130 SYLLYQMLCGIKHLHS--AGIIHRDLKPSN-IVVKSDCT-LKILDFGLA 174

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 93.5 bits (233), Expect = 8e-22
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 22/197 (11%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD 201
           +P +  + I     DF   +++G+G++G +  A  +  G  VAIK+I P        ++ 
Sbjct: 1   MPKRIVYNISS---DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRT 56

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVT-----ERKPLMLITEYLRGGDLHKYLKEKGALSPST 256
            R E+ +L   +H NI+                + +I E +   DLH+ +  +  LS   
Sbjct: 57  LR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDH 113

Query: 257 AVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
              F     R +  LH  N    +IHRDLKP N LL+NS+ D LKV DFGL+++I    +
Sbjct: 114 IQYFIYQTLRAVKVLHGSN----VIHRDLKPSN-LLINSNCD-LKVCDFGLARIIDESAA 167

Query: 315 HDVYKMTGETGSCEYLV 331
            +      ++G  E++ 
Sbjct: 168 DNSEPTGQQSGMVEFVA 184

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 93.1 bits (232), Expect = 9e-22
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 16/157 (10%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD-FRH---EVNLLVK 211
           DF    ++GKG+FG+++    + T    A+K     L  + ++ +D   H   E  +L  
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMK----ILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 212 LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
            RHP +     A  T  + L  + EY  GG+L  +L  +   +   A  +  +I   + Y
Sbjct: 62  TRHPFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           LH+    +++RD+K  N++L      H+K+ DFGL K
Sbjct: 121 LHS--RDVVYRDIKLENLML--DKDGHIKITDFGLCK 153

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 94.4 bits (235), Expect = 9e-22
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 15/157 (9%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD-FRH---EVNLLVK 211
           +F    ++GKG+FG+++    + T    A+K     L  + +V +D   H   E  +L  
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 212 LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
            RHP +     +  T  + L  + EY  GG+L  +L  +   S   A  +  +I   + Y
Sbjct: 205 SRHPFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 263

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           LH+E N +++RDLK  N++L      H+K+ DFGL K
Sbjct: 264 LHSEKN-VVYRDLKLENLML--DKDGHIKITDFGLCK 297

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 19/169 (11%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
               + +      + +   IG G+ G +  AY       VAIK++     +     + +R
Sbjct: 54  GDSTFTVLK---RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 110

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ L+  + H NI+  L   T +K L       L+ E +   +L + ++ +  L     
Sbjct: 111 -ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERM 166

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
                 +  G+ +LH+    IIHRDLKP N ++V S    LK+ DFGL+
Sbjct: 167 SYLLYQMLCGIKHLHSAG--IIHRDLKPSN-IVVKSDCT-LKILDFGLA 211

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 18/177 (10%)

Query: 140 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRL 197
           +PP      D   D     F     IGKGSFG++       T    A+K     ++  + 
Sbjct: 2   MPPVFDENEDVNFD----HFEILRAIGKGSFGKVCIVQKNDTKKMYAMK----YMNKQKC 53

Query: 198 VIQD-FRH---EVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALS 253
           V ++  R+   E+ ++  L HP +V    +  + + + ++ + L GGDL  +L++     
Sbjct: 54  VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK 113

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             T   F  ++   + YL N    IIHRD+KP N+LL      H+ + DF ++ ++ 
Sbjct: 114 EETVKLFICELVMALDYLQN--QRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLP 166

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 20/192 (10%)

Query: 131 NGSHFEPKPVPPPLPNKCDWEIDP----SELDFSSSAIIGKGSFGEILKAYWRGTPV--A 184
           + + F              W+       ++  F    ++GKG FGE+     R T    A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213

Query: 185 IKRILPSLSDDRLVIQD----FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGG 240
            K     L   R+  +       +E  +L K+    +V    A   +  L L+   + GG
Sbjct: 214 CK----KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269

Query: 241 DL--HKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL 298
           DL  H Y   +     + AV +A +I  G+  LH     I++RDLKP N+LL      H+
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILL--DDHGHI 325

Query: 299 KVGDFGLSKLIK 310
           ++ D GL+  + 
Sbjct: 326 RISDLGLAVHVP 337

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 93.2 bits (231), Expect = 1e-21
 Identities = 21/204 (10%), Positives = 41/204 (20%), Gaps = 38/204 (18%)

Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDD 195
              P       D  +   E        +  G    +            A+K       + 
Sbjct: 43  TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP-------------------------- 229
           R  ++          +L   +  +         P                          
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 230 LMLITEYLRG------GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283
            +L+              L      +G             + R  A L +    ++H   
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHF 220

Query: 284 KPRNVLLVNSSADHLKVGDFGLSK 307
            P N+ +       L +GD     
Sbjct: 221 TPDNLFI--MPDGRLMLGDVSALW 242

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 27/159 (16%)

Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G+G++G + KA  +        A+K+I        + +   R E+ LL +L+HPN++  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACR-EIALLRELKHPNVISL 83

Query: 221 LGAVTER--KPLMLITEYLRGGDLHKYLKEKGA---------LSPSTAVNFALDIARGMA 269
                    + + L+ +Y    DL   +K   A         L      +    I  G+ 
Sbjct: 84  QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGL 305
           YLH   N ++HRDLKP N +LV         +K+ D G 
Sbjct: 143 YLHA--NWVLHRDLKPAN-ILVMGEGPERGRVKIADMGF 178

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.4 bits (230), Expect = 1e-21
 Identities = 39/167 (23%), Positives = 74/167 (44%), Gaps = 18/167 (10%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEV 206
            W+    +L       IG+G++G + K      G  +A+KRI  ++ +     +    ++
Sbjct: 16  HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDL 71

Query: 207 NLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPST------AVN 259
           +++++    P IVQF GA+       +  E +      K+ K   ++             
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGK- 129

Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
             L   + + +L      IIHRD+KP N+LL    + ++K+ DFG+S
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILL--DRSGNIKLCDFGIS 173

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 15/157 (9%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
           DF    +IG+G+FGE+     +      A+K     L+   ++ +     FR E ++LV 
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMK----ILNKWEMLKRAETACFREERDVLVN 130

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAY 270
                I     A  +   L L+ +Y  GGDL   L K +  L    A  +  ++   +  
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +H      +HRD+KP N+L+      H+++ DFG   
Sbjct: 191 VHQ--LHYVHRDIKPDNILM--DMNGHIRLADFGSCL 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 18/169 (10%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+      + + + +G G++G +  A+    G  VA+K++           + +R
Sbjct: 21  NKTIWEVPE---RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 77

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM------LITEYLRGGDLHKYLKEKGALSPSTA 257
            E+ LL  ++H N++  L   T  + L       L+T  + G DL+  +K +  L+    
Sbjct: 78  -ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHV 134

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
                 I RG+ Y+H+    IIHRDLKP N L VN   + LK+ DFGL+
Sbjct: 135 QFLIYQILRGLKYIHSAD--IIHRDLKPSN-LAVNEDCE-LKILDFGLA 179

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 91.8 bits (229), Expect = 3e-21
 Identities = 54/161 (33%), Positives = 83/161 (51%), Gaps = 20/161 (12%)

Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLVIQDFRH---EVNLL 209
            F    ++G+GSFG++    K          A+K     L    L ++D      E ++L
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK----VLKKATLKVRDRVRTKMERDIL 80

Query: 210 VKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
           V++ HP IV+   A  TE K L LI ++LRGGDL   L ++   +      +  ++A  +
Sbjct: 81  VEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKL 308
            +LH+    II+RDLKP N+LL     + H+K+ DFGLSK 
Sbjct: 140 DHLHS--LGIIYRDLKPENILL---DEEGHIKLTDFGLSKE 175

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 15/157 (9%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
           DF    +IG+G+F E+     + T    A+K     ++   ++ +     FR E ++LV 
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMK----IMNKWDMLKRGEVSCFREERDVLVN 117

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAY 270
                I Q   A  +   L L+ EY  GGDL   L + G  +    A  +  +I   +  
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +H      +HRD+KP N+LL      H+++ DFG   
Sbjct: 178 VHR--LGYVHRDIKPDNILL--DRCGHIRLADFGSCL 210

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 35/162 (21%), Positives = 77/162 (47%), Gaps = 13/162 (8%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           E+   +L+      +G+G++G + K      G  +A+KRI    + +    +    ++++
Sbjct: 3   EVKADDLEPIME--LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDI 58

Query: 209 LVKL-RHPNIVQFLGAVTERKPLMLITEYLRGG---DLHKYLKEKGALSPSTAVNFALDI 264
            ++    P  V F GA+     + +  E +         + + +   +        A+ I
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            + + +LH++ + +IHRD+KP NVL+  ++   +K+ DFG+S
Sbjct: 119 VKALEHLHSKLS-VIHRDVKPSNVLI--NALGQVKMCDFGIS 157

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 61/191 (31%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRH---EVNLLVKLRHPNIV 218
            +G GSFG + + +    G   A+K++L          QD R+   E++++  L H NI+
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVL----------QDPRYKNRELDIMKVLDHVNII 63

Query: 219 QFL--------------------------------------GAVTERKPLMLITEYLRGG 240
           + +                                         ++ K L +I EY+   
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PD 122

Query: 241 DLHK----YLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD 296
            LHK    +++   ++  +    +   + R + ++H+    I HRD+KP+N LLVNS  +
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQN-LLVNSKDN 179

Query: 297 HLKVGDFGLSK 307
            LK+ DFG +K
Sbjct: 180 TLKLCDFGSAK 190

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 91.1 bits (227), Expect = 4e-21
 Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 19/156 (12%)

Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIV 218
           IG+G++G++ KA      G  VA+KR+     ++ + +   R EV +L  L    HPN+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77

Query: 219 QFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYL 271
           +     T  +      L L+ E++   DL  YL +     +   T  +    + RG+ +L
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           H+  + ++HRDLKP+N +LV SS   +K+ DFGL++
Sbjct: 137 HS--HRVVHRDLKPQN-ILVTSSG-QIKLADFGLAR 168

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 91.5 bits (228), Expect = 4e-21
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 23/161 (14%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
           DF    ++GKGSFG++  A ++ T    AIK    +L  D +++ D   +V         
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIK----ALKKDVVLMDD---DVECTMVEKRV 70

Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
           L +   HP +        T+   L  + EYL GGDL  +++       S A  +A +I  
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           G+ +LH+    I++RDLK  N+LL      H+K+ DFG+ K
Sbjct: 130 GLQFLHS--KGIVYRDLKLDNILL--DKDGHIKIADFGMCK 166

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 14/159 (8%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLV----IQDFRHEVNLLVK 211
            F     +G GSFG ++    + +    A+K     L   ++V    I+   +E  +L  
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMK----ILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           +  P +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YL
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           H+    +I+RDLKP N+L+      +++V DFG +K +K
Sbjct: 158 HS--LDLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVK 192

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 90.7 bits (226), Expect = 4e-21
 Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 21/158 (13%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLV---IQDFRHEVNLLVKLR---HPN 216
           IG G++G + KA     G  VA+K +             I   R EV LL +L    HPN
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPN 75

Query: 217 IVQFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMA 269
           +V+ +      +      + L+ E++   DL  YL +     L   T  +      RG+ 
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           +LH   N I+HRDLKP N +LV S    +K+ DFGL++
Sbjct: 135 FLHA--NCIVHRDLKPEN-ILVTSGG-TVKLADFGLAR 168

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 45/183 (24%), Positives = 75/183 (40%), Gaps = 22/183 (12%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
            F    ++G+G FGE+     + T    A K     L+  RL  +        E  +L K
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACK----KLNKKRLKKRKGYQGAMVEKKILAK 241

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDL----HKYLKEKGALSPSTAVNFALDIARG 267
           +    IV    A   +  L L+   + GGD+    +   ++        A+ +   I  G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC 327
           + +LH     II+RDLKP NVLL      ++++ D GL+     +      K  G  G+ 
Sbjct: 302 LEHLHQ--RNIIYRDLKPENVLL--DDDGNVRISDLGLAV----ELKAGQTKTKGYAGTP 353

Query: 328 EYL 330
            ++
Sbjct: 354 GFM 356

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 90.7 bits (226), Expect = 6e-21
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 14/159 (8%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
           DF     +G GSFG +     R      A+K     L  + +V          E  +L  
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMK----VLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           + HP I++  G   + + + +I +Y+ GG+L   L++        A  +A ++   + YL
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
           H+    II+RDLKP N+LL      H+K+ DFG +K + 
Sbjct: 123 HS--KDIIYRDLKPENILL--DKNGHIKITDFGFAKYVP 157

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
           D+    +IG+G+FGE+     + T    A+K     LS   ++ +     F  E +++  
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK----LLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
              P +VQ   A  + + L ++ EY+ GGDL   +     +    A  +  ++   +  +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAI 184

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           H+     IHRD+KP N+LL    + HLK+ DFG   
Sbjct: 185 HS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTCM 216

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 22/162 (13%)

Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLV--IQDFRH---EVN 207
            F    ++GKG +G++    K     T    A+K     L    +V   +D  H   E N
Sbjct: 18  CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMK----VLKKAMIVRNAKDTAHTKAERN 73

Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
           +L +++HP IV  + A  T  K L LI EYL GG+L   L+ +G     TA  +  +I+ 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM 132

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSK 307
            + +LH     II+RDLKP N++L   +   H+K+ DFGL K
Sbjct: 133 ALGHLHQ--KGIIYRDLKPENIML---NHQGHVKLTDFGLCK 169

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 30/200 (15%)

Query: 125 GLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSEL------DFSSSAIIGKGSFGEILKAYW 178
           G+S  Q        P PPP P++    + PS        DF    +IGKGSFG++L A  
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQ-QINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARH 59

Query: 179 RGTPV--AIKRILPSLSDDRLVIQDFRHEVN--------LLVKLRHPNIVQFLGAV-TER 227
           +   V  A+K     L     +++  + E          LL  ++HP +V    +  T  
Sbjct: 60  KAEEVFYAVK----VLQKK-AILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112

Query: 228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRN 287
           K L  + +Y+ GG+L  +L+ +       A  +A +IA  + YLH+    I++RDLKP N
Sbjct: 113 K-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPEN 169

Query: 288 VLLVNSSADHLKVGDFGLSK 307
           +LL   S  H+ + DFGL K
Sbjct: 170 ILL--DSQGHIVLTDFGLCK 187

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 17/159 (10%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVI-QDFRH---EVNLLVK 211
           DFS   IIG+G FGE+       T    A+K     L   R+ + Q       E  +L  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMKQGETLALNERIMLSL 245

Query: 212 L---RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
           +     P IV    A      L  I + + GGDLH +L + G  S +    +A +I  G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            ++HN    +++RDLKP N+LL      H+++ D GL+ 
Sbjct: 306 EHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLAC 340

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
           DF    +IG+GS+ ++L    + T    A+K     +  + +   +     + E ++  +
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK----VVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 212 -LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
              HP +V       TE + L  + EY+ GGDL  +++ +  L    A  ++ +I+  + 
Sbjct: 66  ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           YLH     II+RDLK  NVLL   S  H+K+ D+G+ K
Sbjct: 125 YLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK 158

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 51/161 (31%), Positives = 83/161 (51%), Gaps = 23/161 (14%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
           DF+   ++GKGSFG+++ +  +GT    A+K     L  D ++  D   +V         
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKDVVIQDD---DVECTMVEKRV 73

Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
           L +  + P + Q      T  + L  + EY+ GGDL  ++++ G      AV +A +IA 
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           G+ +L +    II+RDLK  NV+L   S  H+K+ DFG+ K
Sbjct: 133 GLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCK 169

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTPV--AIKRILPSLSDDRLVIQD----FRHEVNLLVK 211
           DF    +IG+GS+ ++L    + T    A++     +  + +   +     + E ++  +
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR----VVKKELVNDDEDIDWVQTEKHVFEQ 108

Query: 212 -LRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA 269
              HP +V       TE + L  + EY+ GGDL  +++ +  L    A  ++ +I+  + 
Sbjct: 109 ASNHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           YLH     II+RDLK  NVLL   S  H+K+ D+G+ K
Sbjct: 168 YLHE--RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCK 201

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 51/161 (31%), Positives = 83/161 (51%), Gaps = 23/161 (14%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
           DF+   ++GKGSFG+++ +  +GT    A+K     L  D ++  D   +V         
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVK----ILKKDVVIQDD---DVECTMVEKRV 394

Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
           L +  + P + Q      T  + L  + EY+ GGDL  ++++ G      AV +A +IA 
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
           G+ +L +    II+RDLK  NV+L   S  H+K+ DFG+ K
Sbjct: 454 GLFFLQS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCK 490

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 44/241 (18%), Positives = 79/241 (32%), Gaps = 72/241 (29%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKR------------------ILPSLSDDRL 197
           DF     +G+G FG + +A  +      AIKR                   L  L    +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 198 V-------------------------------------IQDFRHEVNLLVKLRHPNIVQF 220
           V                                     +     ++  +      N V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSP---STAVNFALDIARGMAYLHNEPNV 277
           L   + +  L +  +  R  +L  ++  + +L        ++  + IA  + +LH+    
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KG 184

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK--------VQNSHDVYKMTGETGSCEY 329
           ++HRDLKP N+    +  D +KVGDFGL   +         +         TG+ G+  Y
Sbjct: 185 LMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 330 L 330
           +
Sbjct: 243 M 243

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 28/229 (12%), Positives = 63/229 (27%), Gaps = 44/229 (19%)

Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
                  P + + E+           ++G+      L+A  +  G    +     +    
Sbjct: 59  SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 118

Query: 196 RLVIQDFRHEVNLLVKLR----------------------HPNIVQFLGAVTERKPLMLI 233
              I+  + EV  L  LR                       P   + +    + + + ++
Sbjct: 119 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 178

Query: 234 TEYL-----------RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
           + +             G  L  +     +L     +   L + R +A LH+    ++H  
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTY 236

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET-GSCEYL 330
           L+P +++L       + +  F                  G      E  
Sbjct: 237 LRPVDIVL--DQRGGVFLTGFEHLVRD----GASAVSPIGRGFAPPETT 279

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 89.2 bits (221), Expect = 3e-20
 Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 20/161 (12%)

Query: 144 LPNKCD-WEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDD 195
           LP     WE     L       +G+G+FG++++A   G         VA+K +    +  
Sbjct: 10  LPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67

Query: 196 RLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKGALS 253
               +    E+ +L+ +  H N+V  LGA T+   PLM+I E+ + G+L  YL+ K    
Sbjct: 68  --EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNE 124

Query: 254 PSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294
                       +G  Y+       I  DLK R   + +S 
Sbjct: 125 FVPYKTKGARFRQGKDYVGA-----IPVDLKRRLDSITSSQ 160

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 7/77 (9%)

Query: 248 EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            K  L+    + ++  +A+GM +L       IHRDL  RN+LL  S  + +K+ DFGL++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILL--SEKNVVKICDFGLAR 241

Query: 308 LIKVQNSHDVYKMTGET 324
            I        Y   G+ 
Sbjct: 242 DI---YKDPDYVRKGDA 255

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 36/165 (21%), Positives = 73/165 (44%), Gaps = 20/165 (12%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           +  +W       D+     +G+G + E+ +A        V +K + P +   ++     R
Sbjct: 28  HVVEWGNQD---DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKI----KR 79

Query: 204 HEVNLLVKLR-HPNIVQFLGAVT--ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNF 260
            E+ +L  LR  PNI+     V     +   L+ E++   D  +  +    L+      +
Sbjct: 80  -EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFY 135

Query: 261 ALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
             +I + + Y H+    I+HRD+KP N ++++     L++ D+GL
Sbjct: 136 MYEILKALDYCHS--MGIMHRDVKPHN-VMIDHEHRKLRLIDWGL 177

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 23/161 (14%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVIQDFRHEVN-------- 207
           +F    ++GKGSFG+++ A  + T    A+K     L  D ++  D   +V         
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVK----VLKKDVILQDD---DVECTMTEKRI 76

Query: 208 LLVKLRHPNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
           L +   HP + Q      T  + L  + E++ GGDL  ++++      + A  +A +I  
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            + +LH+    II+RDLK  NVLL      H K+ DFG+ K
Sbjct: 136 ALMFLHD--KGIIYRDLKLDNVLL--DHEGHCKLADFGMCK 172

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 27/205 (13%), Positives = 57/205 (27%), Gaps = 39/205 (19%)

Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
                  P + + E+           ++G+      L+A  +  G    +     +    
Sbjct: 54  SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113

Query: 196 RLVIQDFRHEVNLLVKLR-------------------------HPNIVQFLGAVTERK-- 228
              I+  + EV  L  LR                            +++      +    
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173

Query: 229 ------PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
                 P M       G  L  +     +L     +   L + R +A LH+    ++H  
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTY 231

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSK 307
           L+P +++L       + +  F    
Sbjct: 232 LRPVDIVL--DQRGGVFLTGFEHLV 254

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 77.8 bits (193), Expect = 8e-18
 Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L    + + D  +V  LL+      + +D+   TPLH A  HG + V + L+++ A 
Sbjct: 11  ETLLH-IASIKGDIPSVEYLLQNGSD-PNVKDHAGWTPLHEACNHGHLKVVELLLQHKAL 68

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           VN      ++PL DA      ++++LL ++G
Sbjct: 69  VNTTGYQNDSPLHDAAKNGHVDIVKLLLSYG 99

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 73.2 bits (181), Expect = 4e-16
 Identities = 18/64 (28%), Positives = 33/64 (51%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+   Y N +PLH A+ +G +D+ K L+ YGA  NA + +   P+   +     +++ L 
Sbjct: 69  VNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLP 128

Query: 121 NAHG 124
             + 
Sbjct: 129 EKNE 132

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 62.4 bits (153), Expect = 3e-12
 Identities = 15/43 (34%), Positives = 24/43 (55%)

Query: 63  ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
             ++   T LH+AS+ G I   + L++ G+D N +D    TPL
Sbjct: 5   FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPL 47

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 40.5 bits (96), Expect = 1e-04
 Identities = 3/36 (8%), Positives = 9/36 (25%), Gaps = 1/36 (2%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
            +A +     P+          +     +     +A
Sbjct: 102 RNAVNIFGLRPVDYTDDESMKSLLLLPEK-NESSSA 136

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 23/163 (14%)

Query: 158 DFSSSAIIGKGSFGEIL---KAYWRGTPV--AIKRILPSLSDDRLVIQ--DFRH---EVN 207
           +F    ++G G++G++    K     T    A+K     L    +V +     H   E  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK----VLKKATIVQKAKTTEHTRTERQ 110

Query: 208 LLVKLRH-PNIVQFLGAV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
           +L  +R  P +V    A  TE K L LI +Y+ GG+L  +L ++   +      +  +I 
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSK 307
             + +LH     II+RD+K  N+LL    ++ H+ + DFGLSK
Sbjct: 170 LALEHLHK--LGIIYRDIKLENILL---DSNGHVVLTDFGLSK 207

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 50/162 (30%), Positives = 74/162 (45%), Gaps = 33/162 (20%)

Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVI---QDFRH----EVNLLVKLR 213
            +IGKGSFG+++KAY       VA+K           ++   + F      E+ +L  LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK-----------MVRNEKRFHRQAAEEIRILEHLR 151

Query: 214 H------PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDI 264
                   N++  L   T R  + +  E L   +L++ +K+   +G  S      FA  I
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-FSLPLVRKFAHSI 209

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS 306
            + +  LH   N IIH DLKP N+LL       +KV DFG S
Sbjct: 210 LQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 49/159 (30%), Positives = 70/159 (44%), Gaps = 29/159 (18%)

Query: 163 AIIGKGSFGEILKAYWRGTP--VAIKRILPSLSDDRLVI---QDFRH----EVNLLVKLR 213
           ++IGKGSFG+++KAY R     VAIK           +I   + F +    EV LL  + 
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK-----------IIKNKKAFLNQAQIEVRLLELMN 108

Query: 214 HP------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIA 265
                    IV        R  L L+ E L   +L+  L+      +S +    FA  + 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG 304
             + +L      IIH DLKP N+LL N     +K+ DFG
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 75.5 bits (187), Expect = 1e-16
 Identities = 20/72 (27%), Positives = 36/72 (50%), Gaps = 1/72 (1%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
             S+    A Q +   +++ L +  +LV+  D    TPL  AS  G I+  + L+E+GAD
Sbjct: 3   SLSIH-QLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61

Query: 94  VNAQDRWKNTPL 105
            +   + + + L
Sbjct: 62  PHILAKERESAL 73

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 68.6 bits (169), Expect = 3e-14
 Identities = 13/64 (20%), Positives = 27/64 (42%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           ++  D++  TPL  A     +   + L+  GAD+  +     TP+  A       + +++
Sbjct: 95  INIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVI 154

Query: 121 NAHG 124
             H 
Sbjct: 155 ENHI 158

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 64.4 bits (158), Expect = 1e-12
 Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 6/73 (8%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
            T L+ +    N    V  LL    D   +        TP+ +A   G+  V + +  + 
Sbjct: 103 GTPLL-YAVRGNHVKCVEALLARGAD---LTTEADSGYTPMDLAVALGYRKVQQVIENHI 158

Query: 92  ADVNAQDRWKNTP 104
             +   +     P
Sbjct: 159 LKLFQSNLVPADP 171

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 53.2 bits (129), Expect = 8e-09
 Identities = 11/39 (28%), Positives = 17/39 (43%), Gaps = 1/39 (2%)

Query: 68  NRTPLHVASLHGWIDVAKCLIEYGAD-VNAQDRWKNTPL 105
           +   +H  +  G +D  K  +  G + VN  D    TPL
Sbjct: 2   DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPL 40

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 74.8 bits (185), Expect = 3e-16
 Identities = 21/72 (29%), Positives = 34/72 (47%), Gaps = 1/72 (1%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
              +      + +A AVR  L+  ++ ++  D    +PLH A   G   V + LI  GA 
Sbjct: 6   MDDIFTQ-CREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGAR 64

Query: 94  VNAQDRWKNTPL 105
           +N  +R  +TPL
Sbjct: 65  INVMNRGDDTPL 76

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 70.5 bits (174), Expect = 8e-15
 Identities = 17/66 (25%), Positives = 29/66 (43%), Gaps = 4/66 (6%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
           ++A +     PLH A   G   VA+ L+  GA V+  +++   P+  A A   +   + E
Sbjct: 98  INAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLREL--LRE 155

Query: 119 LLNAHG 124
                G
Sbjct: 156 RAEKMG 161

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 68.6 bits (169), Expect = 4e-14
 Identities = 22/64 (34%), Positives = 37/64 (57%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           ++  +  + TPLH+A+ HG  D+ + L++Y AD+NA +   N PL  A    +  + E L
Sbjct: 65  INVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDL 124

Query: 121 NAHG 124
            A+G
Sbjct: 125 VANG 128

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 54.0 bits (131), Expect = 5e-09
 Identities = 7/48 (14%), Positives = 14/48 (29%), Gaps = 6/48 (12%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
           V   +     P+  A       + +   + G ++N        P  D 
Sbjct: 131 VSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNR------IPYKDT 172

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 53.6 bits (130), Expect = 7e-09
 Identities = 10/61 (16%), Positives = 21/61 (34%), Gaps = 1/61 (1%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
             +    +      G     +  ++    D+N  D    +PL  A    +  ++E+L   
Sbjct: 2   SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61

Query: 124 G 124
           G
Sbjct: 62  G 62

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 72.4 bits (179), Expect = 5e-16
 Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 6/77 (7%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
               + W     D   V+  + +  D   V+      R PLH A+  G +++ + L+  G
Sbjct: 8   DKEFM-WALKNGDLDEVKDYVAKGED---VNRTLEGGRKPLHYAADCGQLEILEFLLLKG 63

Query: 92  ADVNAQDRWKNTPLADA 108
           AD+NA D+   TPL  A
Sbjct: 64  ADINAPDKHHITPLLSA 80

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 65.1 bits (160), Expect = 2e-13
 Identities = 13/48 (27%), Positives = 19/48 (39%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
           ++A D  + TPL  A   G +   K L+  GAD   +     T     
Sbjct: 66  INAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEAT 113

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 58.9 bits (144), Expect = 3e-11
 Identities = 14/62 (22%), Positives = 20/62 (32%)

Query: 63  ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNA 122
                       A  +G +D  K  +  G DVN        PL  A    +  ++E L  
Sbjct: 2   PLGSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLL 61

Query: 123 HG 124
            G
Sbjct: 62  KG 63

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 73.6 bits (182), Expect = 1e-15
 Identities = 27/89 (30%), Positives = 49/89 (55%), Gaps = 4/89 (4%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A+Q D   V+++L++    V   D +  TPL++A  +  I++AK LI+ GAD+N Q+
Sbjct: 10  LEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQN 69

Query: 99  RWKNTPL--ADAEGAKKFNMMELLNAHGG 125
              ++P   A A+G  +  ++  +  H  
Sbjct: 70  SISDSPYLYAGAQGRTE--ILAYMLKHAT 96

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 63.6 bits (156), Expect = 4e-12
 Identities = 22/106 (20%), Positives = 41/106 (38%), Gaps = 6/106 (5%)

Query: 23  ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASL----- 77
                +  R    +LI   A +     V+ LLE+ +  +  ++    T L  A       
Sbjct: 96  TPDLNKHNRYGGNALI-PAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGN 154

Query: 78  HGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
             + D+ K L+E GAD + +D    T +  A       + ++L  +
Sbjct: 155 QLYQDIVKLLMENGADQSIKDNSGRTAMDYANQKGYTEISKILAQY 200

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 63.2 bits (155), Expect = 5e-12
 Identities = 14/61 (22%), Positives = 22/61 (36%)

Query: 64  RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
           + Y+    L  A+      V + L +    V+  D   NTPL  A       + + L   
Sbjct: 2   KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61

Query: 124 G 124
           G
Sbjct: 62  G 62

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 62.1 bits (152), Expect = 1e-11
 Identities = 18/84 (21%), Positives = 35/84 (41%), Gaps = 3/84 (3%)

Query: 23  ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWID 82
           AD    +  +S +  + +   Q     +  +L+     ++  +      L  A+  G ID
Sbjct: 63  ADI-NLQNSISDSPYL-YAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHID 120

Query: 83  VAKCLIEYG-ADVNAQDRWKNTPL 105
             K L+E G  D++ Q+ +  T L
Sbjct: 121 NVKLLLEDGREDIDFQNDFGYTAL 144

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 74.5 bits (184), Expect = 2e-15
 Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 2/85 (2%)

Query: 42  AHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
                   +  LL        +  ++   +T LH+A++ G     + L   GA V   +R
Sbjct: 17  VIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAER 76

Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
             +T L  A   +      +L    
Sbjct: 77  GGHTALHLACRVRAHTCACVLLQPR 101

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 73.0 bits (180), Expect = 6e-15
 Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 1/87 (1%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
              +  N         E+ +  + A +YD  TPLHVA +H   ++ + L + GAD+N  +
Sbjct: 129 AVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPE 188

Query: 99  R-WKNTPLADAEGAKKFNMMELLNAHG 124
                TPL  A  A+  +++ELL   G
Sbjct: 189 PTCGRTPLHLAVEAQAASVLELLLKAG 215

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 67.6 bits (166), Expect = 4e-13
 Identities = 22/67 (32%), Positives = 31/67 (46%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A +  AA+V +LL +  +   AR Y  RTPL  A L     +A+ L  +GA      
Sbjct: 196 LHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDG 255

Query: 99  RWKNTPL 105
             K +P 
Sbjct: 256 GDKLSPC 262

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 64.9 bits (159), Expect = 4e-12
 Identities = 21/65 (32%), Positives = 30/65 (46%), Gaps = 1/65 (1%)

Query: 61  VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
           ++  +    RTPLH+A       V + L++ GAD  A+     TPL  A       +  L
Sbjct: 184 LNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARL 243

Query: 120 LNAHG 124
           L AHG
Sbjct: 244 LRAHG 248

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 60.6 bits (148), Expect = 9e-11
 Identities = 12/86 (13%), Positives = 23/86 (26%), Gaps = 5/86 (5%)

Query: 42  AHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
           A   +A+ V KL         V   +    T LH+A        A  L++          
Sbjct: 53  AILGEASTVEKLYAAGAG---VLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDAS 109

Query: 100 WKNTPLADAEGAKKFNMMELLNAHGG 125
                 +        +    +++   
Sbjct: 110 DTYLTQSQDCTPDTSHAPAAVDSQPN 135

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 57.6 bits (140), Expect = 9e-10
 Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 3/65 (4%)

Query: 63  ARDYDNRTPLHVASLHGWIDVAKCLIEYGAD---VNAQDRWKNTPLADAEGAKKFNMMEL 119
               D  T LH+A +H        L+ + A    ++ Q+    T L  A    + + +E 
Sbjct: 4   YVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEK 63

Query: 120 LNAHG 124
           L A G
Sbjct: 64  LYAAG 68

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 42.5 bits (101), Expect = 9e-05
 Identities = 17/96 (17%), Positives = 30/96 (31%), Gaps = 13/96 (13%)

Query: 42  AHQNDAAAVRKLLE---------EDQSLVHARDYDNRTPLHVASLH----GWIDVAKCLI 88
                      LL+          D  L  ++D    T    A++        +      
Sbjct: 86  CRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDE 145

Query: 89  EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           ++   + A++   +TPL  A   K   M+ LL   G
Sbjct: 146 DWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAG 181

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 39.8 bits (94), Expect = 7e-04
 Identities = 5/31 (16%), Positives = 7/31 (22%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
                 D  +P   +      D      EY 
Sbjct: 251 EPEDGGDKLSPCSSSGSDSDSDNRDEGDEYD 281

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 71.3 bits (176), Expect = 3e-15
 Identities = 28/64 (43%), Positives = 39/64 (60%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           VHA+D     PLH A  +G  +VA+ L+++GA VN  D WK TPL +A    K+ + +LL
Sbjct: 68  VHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLL 127

Query: 121 NAHG 124
             HG
Sbjct: 128 LQHG 131

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 69.0 bits (170), Expect = 2e-14
 Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 3/65 (4%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA-EGAKKFNMMEL 119
           V+  D    TPLH A+  G  ++ K L+++GAD   ++R  NTPL    +G     + +L
Sbjct: 101 VNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVKDGDTD--IQDL 158

Query: 120 LNAHG 124
           L    
Sbjct: 159 LRGDA 163

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 66.6 bits (164), Expect = 1e-13
 Identities = 26/83 (31%), Positives = 41/83 (49%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
           A   D   V+KL           +    TPLH A+ +  + V + L+++GADV+A+D+  
Sbjct: 16  AKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGG 75

Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
             PL +A     + + ELL  HG
Sbjct: 76  LVPLHNACSYGHYEVAELLVKHG 98

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 53.2 bits (129), Expect = 9e-09
 Identities = 14/61 (22%), Positives = 27/61 (44%), Gaps = 1/61 (1%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
           + +    L  A+  G ++  K L      +    +  ++TPL  A G  + +++E L  H
Sbjct: 5   NSEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQH 64

Query: 124 G 124
           G
Sbjct: 65  G 65

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 39.7 bits (94), Expect = 3e-04
 Identities = 8/32 (25%), Positives = 12/32 (37%), Gaps = 1/32 (3%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
              ++ D  TPL +    G  D+   L    A
Sbjct: 134 PTKKNRDGNTPLDLVK-DGDTDIQDLLRGDAA 164

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 1/97 (1%)

Query: 28  EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
                 +  L L  A   +   +  LL       HA D    TPLH+A+ +  + + + L
Sbjct: 19  LTGEYKKDEL-LEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLL 77

Query: 88  IEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           +++GADV+A+D+    PL +A     + + ELL  HG
Sbjct: 78  LQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHG 114

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 72.9 bits (180), Expect = 1e-14
 Identities = 26/64 (40%), Positives = 38/64 (59%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           VHA+D     PLH A  +G  +V + L+++GA VNA D W+ TPL +A    +  +  LL
Sbjct: 84  VHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLL 143

Query: 121 NAHG 124
            +HG
Sbjct: 144 LSHG 147

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 71.4 bits (176), Expect = 4e-14
 Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 3/93 (3%)

Query: 34  RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
            T+L       H         LL +  + V+ ++ D  TPLHVA+     DV + L ++G
Sbjct: 212 ETALHCAVASLHPKRKQVAELLLRKG-ANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHG 270

Query: 92  ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           A +NA D    T L  A  A       LL ++G
Sbjct: 271 AKMNALDSLGQTALHRAALAGHLQTCRLLLSYG 303

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 66.7 bits (164), Expect = 1e-12
 Identities = 14/64 (21%), Positives = 25/64 (39%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D    TPLH A+    ++V   L+ +GAD    +    + +  A   +    +   
Sbjct: 117 VNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYE 176

Query: 121 NAHG 124
               
Sbjct: 177 FKGH 180

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 13/45 (28%), Positives = 22/45 (48%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           ++A D   +T LH A+L G +   + L+ YG+D +       T  
Sbjct: 273 MNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAA 317

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 54.4 bits (132), Expect = 1e-08
 Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 1/65 (1%)

Query: 61  VHARDYDNRTPLHVASLHG-WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
                   +  L  A+  G    +   L     + +A D  K+TPL  A G  +  +++L
Sbjct: 17  AVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQL 76

Query: 120 LNAHG 124
           L  HG
Sbjct: 77  LLQHG 81

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 47.9 bits (115), Expect = 2e-06
 Identities = 9/88 (10%), Positives = 20/88 (22%), Gaps = 24/88 (27%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEY---------------------GADVNAQDR 99
               +   ++ + +A      +      +                            Q +
Sbjct: 150 PTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQ 209

Query: 100 WKNTPL---ADAEGAKKFNMMELLNAHG 124
              T L     +   K+  + ELL   G
Sbjct: 210 SHETALHCAVASLHPKRKQVAELLLRKG 237

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 4/48 (8%), Positives = 13/48 (27%), Gaps = 7/48 (14%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
                    T   + +     +  + ++     +   D   +  L +A
Sbjct: 306 PSIISLQGFTAAQMGN-----EAVQQILSESTPMRTSD--VDYRLLEA 346

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 70.5 bits (174), Expect = 6e-15
 Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 2/90 (2%)

Query: 35  TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
             L    A + D   VR+LL  +     A +   +T L V    G   +A  L++ GA  
Sbjct: 4   DRL-SGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASP 61

Query: 95  NAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           N QD    +P+ DA      + +++L  HG
Sbjct: 62  NVQDTSGTSPVHDAARTGFLDTLKVLVEHG 91

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 68.6 bits (169), Expect = 2e-14
 Identities = 21/65 (32%), Positives = 33/65 (50%), Gaps = 4/65 (6%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
            + +D    +P+H A+  G++D  K L+E+GADVN  D     P+  A  EG     ++ 
Sbjct: 61  PNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTA--VVS 118

Query: 119 LLNAH 123
            L A 
Sbjct: 119 FLAAE 123

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 60.1 bits (147), Expect = 3e-11
 Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 1/63 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+  D     P+H+A   G   V   L    +D++ +D    TPL  A      +++++L
Sbjct: 94  VNVPDGTGALPIHLAVQEGHTAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDIL 152

Query: 121 NAH 123
             H
Sbjct: 153 QGH 155

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 71.9 bits (177), Expect = 6e-15
 Identities = 18/91 (19%), Positives = 36/91 (39%), Gaps = 1/91 (1%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T+L  W  H      V  L  +    ++ ++    T LH A+  G+ D+ + L+  GA 
Sbjct: 107 STALY-WACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGAR 165

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            + ++  K      A  A   ++++      
Sbjct: 166 TDLRNIEKKLAFDMATNAACASLLKKKQGTD 196

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 65.3 bits (160), Expect = 1e-12
 Identities = 15/87 (17%), Positives = 28/87 (32%), Gaps = 5/87 (5%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
            W         +          V  +      PLH A+  G +   +  ++    VN  D
Sbjct: 49  WWKGTSKGRTGLIPSN-----YVAEQAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLD 103

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGG 125
           +  +T L  A      +++E+L     
Sbjct: 104 KAGSTALYWACHGGHKDIVEMLFTQPN 130

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 5/50 (10%), Positives = 14/50 (28%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG 110
              R+ + +    +A+      + K      A     +        D++ 
Sbjct: 166 TDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDSDL 215

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 48.0 bits (115), Expect = 1e-06
 Identities = 4/47 (8%), Positives = 8/47 (17%)

Query: 62  HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
                  +  +  A           L     D+       +T     
Sbjct: 6   PKPVKPGQVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKG 52

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 72.9 bits (180), Expect = 7e-15
 Identities = 25/83 (30%), Positives = 43/83 (51%), Gaps = 1/83 (1%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
           A      ++R L+ +  + V+    D+ +PLH A L G +   K L+++GA VN      
Sbjct: 67  AIHGHQLSLRNLISQGWA-VNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADW 125

Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
           +TPL +A  +  ++ + LL  HG
Sbjct: 126 HTPLFNACVSGSWDCVNLLLQHG 148

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 66.4 bits (163), Expect = 1e-12
 Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 1/77 (1%)

Query: 48  AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD 107
                +      L+      + +P+H A++HG     + LI  G  VN       +PL +
Sbjct: 40  RDFPGIRLLSNPLM-GDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHE 98

Query: 108 AEGAKKFNMMELLNAHG 124
           A      + +++L  HG
Sbjct: 99  ACLGGHLSCVKILLKHG 115

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 61.7 bits (151), Expect = 4e-11
 Identities = 20/85 (23%), Positives = 31/85 (36%), Gaps = 7/85 (8%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
                 A V+KLLE     V+       +PLH        ++A  L+++GAD  A++   
Sbjct: 198 CENQQRACVKKLLESGAD-VNQGK-GQDSPLHAVVRTASEELACLLMDFGADTQAKNAEG 255

Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
             P+     E          L   G
Sbjct: 256 KRPVELVPPESPLA---QLFLEREG 277

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 61.4 bits (150), Expect = 6e-11
 Identities = 21/85 (24%), Positives = 38/85 (44%), Gaps = 6/85 (7%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
                 + V+ LL+   + V+    D  TPL  A + G  D    L+++GA V  +    
Sbjct: 100 CLGGHLSCVKILLKHG-AQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPESD-L 157

Query: 102 NTPLADAEGAKK--FNMMELLNAHG 124
            +P+ +A  A++     +  L A+G
Sbjct: 158 ASPIHEA--ARRGHVECVNSLIAYG 180

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 60.6 bits (148), Expect = 9e-11
 Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 1/86 (1%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           +  A +         L      +  +     TPL++A  +      K L+E GADVN Q 
Sbjct: 161 IHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QG 219

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHG 124
           + +++PL          +  LL   G
Sbjct: 220 KGQDSPLHAVVRTASEELACLLMDFG 245

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 58.7 bits (143), Expect = 5e-10
 Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 1/64 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V     D  +P+H A+  G ++    LI YG +++ +     TPL  A   ++   ++ L
Sbjct: 151 VQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKL 209

Query: 121 NAHG 124
              G
Sbjct: 210 LESG 213

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 44.0 bits (105), Expect = 3e-05
 Identities = 8/58 (13%), Positives = 21/58 (36%), Gaps = 1/58 (1%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
           L    +  +  +  LL +  +   A++ + + P+ +      +     L   GA +  
Sbjct: 226 LHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVPPESPL-AQLFLEREGASLPK 282

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 42.9 bits (102), Expect = 7e-05
 Identities = 7/64 (10%), Positives = 20/64 (31%), Gaps = 10/64 (15%)

Query: 74  VASLHGWIDVAKCLIEYGADVNAQDRWK-----NTPLADAEGAKKFNMMELLNAHGGLSY 128
           + S H     +  L+  G+ + + D  +     + P    +          L ++  +  
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPG-----IRLLSNPLMGD 55

Query: 129 GQNG 132
             + 
Sbjct: 56  AVSD 59

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 72.9 bits (180), Expect = 8e-15
 Identities = 22/85 (25%), Positives = 32/85 (37%), Gaps = 4/85 (4%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
             +      R+ L               T LHVA+  G+ +V K LI+   DVN +D   
Sbjct: 173 EERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDG 232

Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
            TPL  A   G +      +L  + 
Sbjct: 233 WTPLHAAAHWGKE--EACRILVENL 255

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 72.5 bits (179), Expect = 1e-14
 Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 1/83 (1%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
               D   V +LLE     ++  + D  T LH A +   +D+ K L+E GA++N  D   
Sbjct: 48  CSSGDTEEVLRLLERGAD-INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEG 106

Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
             PL  A      ++ E L + G
Sbjct: 107 WIPLHAAASCGYLDIAEYLISQG 129

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 67.5 bits (166), Expect = 4e-13
 Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
           V+ +DYD  TPLH A+  G  +  + L+E   D+ A ++   T    AD +      + E
Sbjct: 225 VNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDILGY--LEE 282

Query: 119 LLNAHG 124
           L     
Sbjct: 283 LQKKQN 288

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 67.1 bits (165), Expect = 7e-13
 Identities = 23/68 (33%), Positives = 35/68 (51%), Gaps = 7/68 (10%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME-- 118
           ++  D +   PLH A+  G++D+A+ LI  GA V A +   +TPL  AE   +  M E  
Sbjct: 99  INQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAE---EEAMEELL 155

Query: 119 --LLNAHG 124
              +N  G
Sbjct: 156 QNEVNRQG 163

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 57.1 bits (139), Expect = 2e-09
 Identities = 17/98 (17%), Positives = 32/98 (32%), Gaps = 3/98 (3%)

Query: 27  KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
           K      + +  L       +    +     +     +  D+      A   G  +    
Sbjct: 2   KMADAKQKRNEQL--KRWIGSETDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLR 58

Query: 87  LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           L+E GAD+N  +    T L  A      +M++ L  +G
Sbjct: 59  LLERGADINYANVDGLTALHQACIDDNVDMVKFLVENG 96

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 52.9 bits (128), Expect = 4e-08
 Identities = 15/81 (18%), Positives = 27/81 (33%), Gaps = 4/81 (4%)

Query: 46  DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           D A    + E  Q+ V+ +  D              D  + L     +     +   T L
Sbjct: 144 DIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTAL 203

Query: 106 --ADAEGAKKFNMMELLNAHG 124
             A A+G  +  +++LL    
Sbjct: 204 HVAAAKGYTE--VLKLLIQAR 222

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 51.7 bits (125), Expect = 9e-08
 Identities = 6/64 (9%), Positives = 13/64 (20%), Gaps = 1/64 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           +   D   +    +    G     +  +        +       LA          +  L
Sbjct: 1   MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDT-EEVLRL 59

Query: 121 NAHG 124
              G
Sbjct: 60  LERG 63

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 71.8 bits (177), Expect = 9e-15
 Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 6/95 (6%)

Query: 34  RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
            + L L   H  +     V + ++ D + ++ ++   +TPLH+A +    ++A+ L+  G
Sbjct: 9   DSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAG 68

Query: 92  ADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
            D   +D   NTPL  A  +G      + +L    
Sbjct: 69  CDPELRDFRGNTPLHLACEQGCL--ASVGVLTQSC 101

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 66.0 bits (162), Expect = 8e-13
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 6/89 (6%)

Query: 42  AHQNDAAAVRKLLE-----EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA 96
             Q   A+V  L +        S++ A +Y+  T LH+AS+HG++ + + L+  GADVNA
Sbjct: 86  CEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNA 145

Query: 97  QDRWK-NTPLADAEGAKKFNMMELLNAHG 124
           Q+     T L  A   +  +++ LL   G
Sbjct: 146 QEPCNGRTALHLAVDLQNPDLVSLLLKCG 174

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 64.9 bits (159), Expect = 2e-12
 Identities = 18/65 (27%), Positives = 28/65 (43%), Gaps = 1/65 (1%)

Query: 61  VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
           V+A++  N RT LH+A      D+   L++ GADVN       +P     G     + + 
Sbjct: 143 VNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQ 202

Query: 120 LNAHG 124
           L    
Sbjct: 203 LGQLT 207

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 58.3 bits (142), Expect = 4e-10
 Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 6/70 (8%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD------VNAQDRWKNTPLADAEGAKKF 114
              RD+   TPLH+A   G +     L +          + A +   +T L  A      
Sbjct: 71  PELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYL 130

Query: 115 NMMELLNAHG 124
            ++ELL + G
Sbjct: 131 GIVELLVSLG 140

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 57.6 bits (140), Expect = 7e-10
 Identities = 10/75 (13%), Positives = 21/75 (28%), Gaps = 2/75 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           RT+L        +   V  LL+     V+   Y   +P  +        + + L +   +
Sbjct: 152 RTALH-LAVDLQNPDLVSLLLKCGAD-VNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 209

Query: 94  VNAQDRWKNTPLADA 108
                       +  
Sbjct: 210 NLQMLPESEDEESYD 224

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 55.6 bits (135), Expect = 3e-09
 Identities = 16/67 (23%), Positives = 28/67 (41%), Gaps = 4/67 (5%)

Query: 62  HARDYDNRTPLHVASLHGW----IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
                D  + LH+A +H      ++V + +    A +N Q+  + TPL  A    +  + 
Sbjct: 2   QQLTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIA 61

Query: 118 ELLNAHG 124
           E L   G
Sbjct: 62  EALLGAG 68

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 71.0 bits (175), Expect = 2e-14
 Identities = 20/83 (24%), Positives = 34/83 (40%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
              +     + L+    + + AR +D  TPL +A+      + + LI   ADVNA D   
Sbjct: 98  VSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLG 157

Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
            + L  A      +   +L  +G
Sbjct: 158 KSALHWAAAVNNVDAAVVLLKNG 180

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 68.6 bits (169), Expect = 1e-13
 Identities = 21/92 (22%), Positives = 42/92 (45%), Gaps = 2/92 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           +++L  W A  N+  A   LL+   +    ++    TPL +A+  G  + AK L+++ A+
Sbjct: 158 KSALH-WAAAVNNVDAAVVLLKNG-ANKDMQNNREETPLFLAAREGSYETAKVLLDHFAN 215

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
            +  D     P   A+     +++ LL+    
Sbjct: 216 RDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 67.1 bits (165), Expect = 4e-13
 Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 4/88 (4%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
               ++  A +   + +  SL +  D    T LH+A+ +   D AK L+E  AD N QD 
Sbjct: 29  SEEEEDAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDN 88

Query: 100 WKNTPL--ADAEGAKKFNMMELLNAHGG 125
              TPL  A +  A+   + ++L  +  
Sbjct: 89  MGRTPLHAAVSADAQG--VFQILIRNRA 114

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 64.4 bits (158), Expect = 4e-12
 Identities = 20/66 (30%), Positives = 35/66 (53%), Gaps = 4/66 (6%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMME 118
           V+A D   ++ LH A+    +D A  L++ GA+ + Q+  + TPL  A  EG+ +    +
Sbjct: 150 VNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYE--TAK 207

Query: 119 LLNAHG 124
           +L  H 
Sbjct: 208 VLLDHF 213

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 50.2 bits (121), Expect = 3e-07
 Identities = 20/78 (25%), Positives = 26/78 (33%), Gaps = 14/78 (17%)

Query: 61  VHARDYDNRTPLHVASLHGW-------------IDVAKCLIEYGADV-NAQDRWKNTPLA 106
           V+ R  D  TPL +AS  G                V    I  GA + N  DR   T L 
Sbjct: 3   VNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETALH 62

Query: 107 DAEGAKKFNMMELLNAHG 124
            A    + +  + L    
Sbjct: 63  LAARYSRSDAAKRLLEAS 80

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 48.2 bits (116), Expect = 1e-06
 Identities = 6/37 (16%), Positives = 12/37 (32%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
               D+ +R P  +A      D+ + L       +  
Sbjct: 216 RDITDHMDRLPRDIAQERMHHDIVRLLDLEHHHHHHH 252

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 69.0 bits (170), Expect = 2e-14
 Identities = 18/72 (25%), Positives = 34/72 (47%), Gaps = 2/72 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
             S+    A Q +   +   +E++   ++  D +  TPL  A+ HG I V + L++ GAD
Sbjct: 4   SLSVH-QLAAQGEMLYLATRIEQENV-INHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61

Query: 94  VNAQDRWKNTPL 105
                + + + L
Sbjct: 62  PQLLGKGRESAL 73

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 69.0 bits (170), Expect = 2e-14
 Identities = 26/93 (27%), Positives = 37/93 (39%), Gaps = 6/93 (6%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
            T L+ W A     A V  LL+   D            + L +A   G+ D+ K L++ G
Sbjct: 37  FTPLM-WAAAHGQIAVVEFLLQNGAD---PQLLGKGRESALSLACSKGYTDIVKMLLDCG 92

Query: 92  ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            DVN  D    TPL  A        +++L   G
Sbjct: 93  VDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESG 125

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 67.8 bits (167), Expect = 5e-14
 Identities = 18/91 (19%), Positives = 36/91 (39%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            ++L      +     V+ LL+     V+  D++  TPL  A     +   K L+E GAD
Sbjct: 70  ESALS-LACSKGYTDIVKMLLDCGVD-VNEYDWNGGTPLLYAVHGNHVKCVKMLLESGAD 127

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
              +       +  A      ++ +++ +H 
Sbjct: 128 PTIETDSGYNSMDLAVALGYRSVQQVIESHL 158

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 59.3 bits (145), Expect = 5e-11
 Identities = 10/39 (25%), Positives = 14/39 (35%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
            N   +H  +  G +      IE    +N  D    TPL
Sbjct: 2   ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPL 40

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 58.2 bits (142), Expect = 2e-10
 Identities = 12/68 (17%), Positives = 23/68 (33%), Gaps = 6/68 (8%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
            T L+ +  H N    V+ LLE   D              + +A   G+  V + +  + 
Sbjct: 103 GTPLL-YAVHGNHVKCVKMLLESGAD---PTIETDSGYNSMDLAVALGYRSVQQVIESHL 158

Query: 92  ADVNAQDR 99
             +    +
Sbjct: 159 LKLLQNIK 166

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 70.6 bits (174), Expect = 2e-14
 Identities = 20/88 (22%), Positives = 32/88 (36%), Gaps = 7/88 (7%)

Query: 42  AHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
             Q +  AV +L+   Q     +   +   +TPLH+A +     V + L+  GA   A D
Sbjct: 17  VVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALD 76

Query: 99  RWKNTPL--ADAEGAKKFNMMELLNAHG 124
           R   T    A    +     +  L    
Sbjct: 77  RHGQTAAHLACEHRSPT--CLRALLDSA 102

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 69.0 bits (170), Expect = 7e-14
 Identities = 16/64 (25%), Positives = 31/64 (48%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A+ Y   + LH AS  G + + + L+  GAD + ++   +TPL  A   +  +++   
Sbjct: 176 VNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRGK 235

Query: 121 NAHG 124
               
Sbjct: 236 ATRP 239

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 65.2 bits (160), Expect = 2e-12
 Identities = 18/65 (27%), Positives = 33/65 (50%), Gaps = 1/65 (1%)

Query: 61  VHARDYDN-RTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
           + A D  + R+PL  A  +  + + + L+++GA+VNAQ    ++ L  A G     ++  
Sbjct: 142 IDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRT 201

Query: 120 LNAHG 124
           L   G
Sbjct: 202 LVRSG 206

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 64.0 bits (157), Expect = 4e-12
 Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 6/88 (6%)

Query: 42  AHQNDAAAVRKLLE---EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
                   +R LL+        + AR+YD  T LHVA      +  + L+E GAD++A D
Sbjct: 87  CEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVD 146

Query: 99  RWKN--TPLADAEGAKKFNMMELLNAHG 124
             K+  +PL  A      +M++LL  HG
Sbjct: 147 I-KSGRSPLIHAVENNSLSMVQLLLQHG 173

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 62.1 bits (152), Expect = 2e-11
 Identities = 17/69 (24%), Positives = 30/69 (43%), Gaps = 4/69 (5%)

Query: 60  LVHARDYDNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFN 115
           +    D D  TPLH+A + G +     L+      G +++  +  + TPL  A      +
Sbjct: 1   MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60

Query: 116 MMELLNAHG 124
           ++ LL   G
Sbjct: 61  VVRLLVTAG 69

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 58.6 bits (143), Expect = 3e-10
 Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 4/68 (5%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA----DVNAQDRWKNTPLADAEGAKKFNM 116
             A D   +T  H+A  H      + L++  A    D+ A++    T L  A   +    
Sbjct: 72  PMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQET 131

Query: 117 MELLNAHG 124
           ++LL   G
Sbjct: 132 VQLLLERG 139

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 46.7 bits (112), Expect = 3e-06
 Identities = 9/32 (28%), Positives = 13/32 (40%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
              ++  N TPL VA     ID+ +      A
Sbjct: 209 SSLKNCHNDTPLMVARSRRVIDILRGKATRPA 240

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 3e-14
 Identities = 42/234 (17%), Positives = 67/234 (28%), Gaps = 52/234 (22%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLV------IQDFR 203
           +              IG+G FGE+ +     TPVAIK I+     D +        ++  
Sbjct: 13  FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIK-IIAIEGPDLVNGSHQKTFEEIL 71

Query: 204 HEVNLLVKL---------RHPNIVQFLGA--VTERKP----------------------- 229
            E+ +  +L         R    +       V    P                       
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 230 -----LMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283
                L ++ E+  GG DL +   +    S +TA +    +   +A          HRDL
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLR-FEHRDL 188

Query: 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSFM 337
              NVLL        K+      K   + +      +   T S         F 
Sbjct: 189 HWGNVLL--KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFC 240

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 67.9 bits (167), Expect = 3e-14
 Identities = 13/45 (28%), Positives = 23/45 (51%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           +H     +   L  A+  G ++  + L+E GAD NA +R+   P+
Sbjct: 5   IHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPI 49

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 67.5 bits (166), Expect = 4e-14
 Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 6/89 (6%)

Query: 39  LWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVN 95
           +       A     LL    +    +  D    T P+H A+  G++D    L   GA ++
Sbjct: 49  IQVMMMGSAQVAELLLLHGAE---PNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLD 105

Query: 96  AQDRWKNTPLADAEGAKKFNMMELLNAHG 124
             D W   P+  AE     ++   L+A  
Sbjct: 106 VCDAWGRLPVDLAEEQGHRDIARYLHAAT 134

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 61.7 bits (151), Expect = 5e-12
 Identities = 26/94 (27%), Positives = 40/94 (42%), Gaps = 8/94 (8%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
              L    A +     VR+LLE   D    +A +   R P+ V    G   VA+ L+ +G
Sbjct: 13  DAGLA-TAAARGQVETVRQLLEAGAD---PNALNRFGRRPIQVMM-MGSAQVAELLLLHG 67

Query: 92  ADVNAQDRWKNT-PLADAEGAKKFNMMELLNAHG 124
           A+ N  D    T P+ DA      + + +L+  G
Sbjct: 68  AEPNCADPATLTRPVHDAAREGFLDTLVVLHRAG 101

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 50.9 bits (123), Expect = 2e-08
 Identities = 9/33 (27%), Positives = 14/33 (42%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           +   D   R P+ +A   G  D+A+ L     D
Sbjct: 104 LDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD 136

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 66.6 bits (164), Expect = 3e-14
 Identities = 33/74 (44%), Positives = 45/74 (60%), Gaps = 6/74 (8%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
           RT L    A       V+ LLE   D   V+A+D + RTPLH+A+ +G ++V K L+E G
Sbjct: 3   RTPLH-LAARNGHLEVVKLLLEAGAD---VNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58

Query: 92  ADVNAQDRWKNTPL 105
           ADVNA+D+   TPL
Sbjct: 59  ADVNAKDKNGRTPL 72

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 61.2 bits (150), Expect = 3e-12
 Identities = 25/58 (43%), Positives = 37/58 (63%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           + RTPLH+A+ +G ++V K L+E GADVNA+D+   TPL  A       +++LL   G
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 49.3 bits (119), Expect = 5e-08
 Identities = 24/54 (44%), Positives = 35/54 (64%)

Query: 39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
          L  A +N    V KLL E  + V+A+D + RTPLH+A+ +G ++V K L+E GA
Sbjct: 39 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 92

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 70.1 bits (173), Expect = 3e-14
 Identities = 25/91 (27%), Positives = 43/91 (47%), Gaps = 1/91 (1%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L    A +     V+ LL   Q  V+ +D    TP+  A+ +  +D+ K L+  G+D
Sbjct: 78  STCLH-LAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSD 136

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           +N +D  +N  L  A  +   ++ E+L A  
Sbjct: 137 INIRDNEENICLHWAAFSGCVDIAEILLAAK 167

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 69.0 bits (170), Expect = 7e-14
 Identities = 16/64 (25%), Positives = 30/64 (46%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
                 + R+PLH A+  G +D+   L++ GA+++     + TPL +A        ++ L
Sbjct: 4   FKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYL 63

Query: 121 NAHG 124
              G
Sbjct: 64  IKAG 67

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 68.2 bits (168), Expect = 1e-13
 Identities = 13/64 (20%), Positives = 26/64 (40%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           +HA +    +PLH+A+     D     +   +DV  +++   TPL  A    +      +
Sbjct: 170 LHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQM 229

Query: 121 NAHG 124
           +   
Sbjct: 230 SKAL 233

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 67.1 bits (165), Expect = 3e-13
 Identities = 15/64 (23%), Positives = 33/64 (51%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           ++ RD +    LH A+  G +D+A+ L+    D++A +   ++PL  A    +++ + L 
Sbjct: 137 INIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLF 196

Query: 121 NAHG 124
            +  
Sbjct: 197 LSRD 200

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 66.3 bits (163), Expect = 8e-13
 Identities = 18/64 (28%), Positives = 33/64 (51%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           +     D RTPL  A+ +  ++  K LI+ GA V+ +D   +T L  A     + +++ L
Sbjct: 37  IDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYL 96

Query: 121 NAHG 124
            ++G
Sbjct: 97  LSNG 100

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 60.5 bits (148), Expect = 6e-11
 Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 1/65 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMEL 119
           V  +D +  T LH+A+  G  +V + L+  G  DVN QD    TP+  A   K  ++++L
Sbjct: 70  VDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKL 129

Query: 120 LNAHG 124
           L + G
Sbjct: 130 LLSKG 134

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 47.4 bits (114), Expect = 2e-06
 Identities = 9/33 (27%), Positives = 16/33 (48%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           V  ++ +  TPL  ASL+  +  A  + +   D
Sbjct: 203 VTLKNKEGETPLQCASLNSQVWSALQMSKALQD 235

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 72.1 bits (178), Expect = 3e-14
 Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L L  A Q   A +  LL   Q+  +  +    TPLH+ +  G + VA  LI++G  
Sbjct: 246 VTPLHL--AAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVM 303

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           V+A  R   TPL  A       +++ L  H 
Sbjct: 304 VDATTRMGYTPLHVASHYGNIKLVKFLLQHQ 334

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 71.0 bits (175), Expect = 7e-14
 Identities = 25/91 (27%), Positives = 35/91 (38%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L    A          LLE D    +A   +  TPLHVA  H  +D+ K L+  G  
Sbjct: 147 FTPLH-VAAKYGKVRVAELLLERDAH-PNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGS 204

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            ++      TPL  A    +  +   L  +G
Sbjct: 205 PHSPAWNGYTPLHIAAKQNQVEVARSLLQYG 235

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 70.2 bits (173), Expect = 1e-13
 Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 5/85 (5%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
            H N+   V+ LL    S  H+  ++  TPLH+A+    ++VA+ L++YG   NA+    
Sbjct: 187 VHHNNLDIVKLLLPRGGS-PHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQG 245

Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
            TPL  A  EG  +  M+ LL +  
Sbjct: 246 VTPLHLAAQEGHAE--MVALLLSKQ 268

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 5/85 (5%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
           +       V+ LL+   S  +  +    TPLH+A+  G  +VAK L++  A VNA+ +  
Sbjct: 22  SFMGHLPIVKNLLQRGAS-PNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDD 80

Query: 102 NTPL--ADAEGAKKFNMMELLNAHG 124
            TPL  A   G     M++LL  + 
Sbjct: 81  QTPLHCAARIGHTN--MVKLLLENN 103

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L L    Q     V  +L +   +V A      TPLHVAS +G I + K L+++ AD
Sbjct: 279 LTPLHL--VAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQAD 336

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           VNA+ +   +PL  A      +++ LL  +G
Sbjct: 337 VNAKTKLGYSPLHQAAQQGHTDIVTLLLKNG 367

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 68.3 bits (168), Expect = 5e-13
 Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L    A        + LL+   + V+A+  D++TPLH A+  G  ++ K L+E  A+
Sbjct: 48  ETPLH-MAARAGHTEVAKYLLQNK-AKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNAN 105

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            N      +TPL  A        +  L    
Sbjct: 106 PNLATTAGHTPLHIAAREGHVETVLALLEKE 136

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 67.9 bits (167), Expect = 8e-13
 Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L    A +     V  LLE+ ++          TPLHVA+ +G + VA+ L+E  A 
Sbjct: 114 HTPLH-IAAREGHVETVLALLEK-EASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAH 171

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            NA  +   TPL  A      ++++LL   G
Sbjct: 172 PNAAGKNGLTPLHVAVHHNNLDIVKLLLPRG 202

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 67.9 bits (167), Expect = 8e-13
 Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L    +H  +   V+ LL+   + V+A+     +PLH A+  G  D+   L++ GA 
Sbjct: 312 YTPLH-VASHYGNIKLVKFLLQHQ-ADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGAS 369

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            N       TPLA A+     ++ ++L    
Sbjct: 370 PNEVSSDGTTPLAIAKRLGYISVTDVLKVVT 400

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 67.5 bits (166), Expect = 1e-12
 Identities = 24/91 (26%), Positives = 36/91 (39%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           +T L    A       V+ LLE + +  +       TPLH+A+  G ++    L+E  A 
Sbjct: 81  QTPLH-CAARIGHTNMVKLLLENN-ANPNLATTAGHTPLHIAAREGHVETVLALLEKEAS 138

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
                +   TPL  A    K  + ELL    
Sbjct: 139 QACMTKKGFTPLHVAAKYGKVRVAELLLERD 169

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 65.2 bits (160), Expect = 5e-12
 Identities = 19/64 (29%), Positives = 27/64 (42%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
                    TPLHVAS  G + + K L++ GA  N  +    TPL  A  A    + + L
Sbjct: 7   GGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYL 66

Query: 121 NAHG 124
             + 
Sbjct: 67  LQNK 70

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 64.8 bits (159), Expect = 7e-12
 Identities = 16/64 (25%), Positives = 28/64 (43%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
            +A      TPLH+A+  G  ++   L+   A+ N  ++   TPL          + ++L
Sbjct: 238 ANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 297

Query: 121 NAHG 124
             HG
Sbjct: 298 IKHG 301

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 54.8 bits (133), Expect = 1e-08
 Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 4/71 (5%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL---IEYGADVNAQD 98
           A Q     V  LL+   S  +    D  TPL +A   G+I V   L    +  + V   D
Sbjct: 352 AQQGHTDIVTLLLKNGAS-PNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 410

Query: 99  RWKNTPLADAE 109
           + + +     +
Sbjct: 411 KHRMSFPETVD 421

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 69.8 bits (172), Expect = 4e-14
 Identities = 22/96 (22%), Positives = 38/96 (39%), Gaps = 4/96 (4%)

Query: 32  VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
           +S   L      +N+   V++LL    SL+  +D D R PLH +      ++   L+   
Sbjct: 1   MSNYPLH-QACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKM 59

Query: 92  ADVNAQDRWKN---TPLADAEGAKKFNMMELLNAHG 124
            +VN  D   +   TP   A       +++ L    
Sbjct: 60  ENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRP 95

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 67.9 bits (167), Expect = 2e-13
 Identities = 20/64 (31%), Positives = 31/64 (48%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           ++       T LH+A    W +V++ LIE GA V  +D++   PL  A       ++ELL
Sbjct: 100 LNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELL 159

Query: 121 NAHG 124
              G
Sbjct: 160 CGLG 163

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 65.5 bits (161), Expect = 1e-12
 Identities = 21/97 (21%), Positives = 35/97 (36%), Gaps = 5/97 (5%)

Query: 28  EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
            K + ++  L    A       +  L    +S V+ +D    TPL  A   G  D A  L
Sbjct: 135 IKDKFNQIPLH-RAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLL 193

Query: 88  IE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
           +E YGA+ +  D         A    +  + +    +
Sbjct: 194 VEKYGAEYDLVDNKGAKAEDVA--LNE-QVKKFFLNN 227

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 56.7 bits (138), Expect = 1e-09
 Identities = 19/64 (29%), Positives = 27/64 (42%), Gaps = 2/64 (3%)

Query: 63  ARDYDNRTPLHVASLHGWIDVAKCLIE--YGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
             D    TP H+A   G ++V K L +     D+N       T L  A G K F + + L
Sbjct: 67  YPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFL 126

Query: 121 NAHG 124
             +G
Sbjct: 127 IENG 130

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 67.8 bits (167), Expect = 4e-14
 Identities = 25/64 (39%), Positives = 38/64 (59%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
             AR   +RTPLH+A+  G  ++ + L+++GADVNA+D  K T L  A       ++ELL
Sbjct: 60  RDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELL 119

Query: 121 NAHG 124
             +G
Sbjct: 120 IKYG 123

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 66.3 bits (163), Expect = 2e-13
 Identities = 18/45 (40%), Positives = 27/45 (60%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           V+A+D    T LH A+ H   +V + LI+YGADV+ Q ++  T  
Sbjct: 93  VNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAF 137

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 62.8 bits (154), Expect = 3e-12
 Identities = 18/60 (30%), Positives = 31/60 (51%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           D+   +PLH+A+ +G     + L+  G   +A+ +   TPL  A      N++E+L  HG
Sbjct: 31  DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHG 90

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 52.8 bits (128), Expect = 9e-09
 Identities = 16/58 (27%), Positives = 22/58 (37%), Gaps = 1/58 (1%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           D    L  A+  G  D  + L+  GA     D    +PL  A     F+  E+L   G
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFSTTEVLLRAG 57

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 68.7 bits (169), Expect = 4e-14
 Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 6/93 (6%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
            T      A + D  A+ +LLE+ D   V A D + RT L   +  G     + L E GA
Sbjct: 45  ETPWW-TAARKADEQALSQLLEDRD---VDAVDENGRTALLFVAGLGSDKCVRLLAEAGA 100

Query: 93  DVNAQD-RWKNTPLADAEGAKKFNMMELLNAHG 124
           D++ +D R   T L  A G  +  ++E L   G
Sbjct: 101 DLDHRDMRGGLTALHMAAGYVRPEVVEALVELG 133

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 67.1 bits (165), Expect = 2e-13
 Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 7/94 (7%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEY 90
           RT+L+ + A       VR L E   D   +  RD     T LH+A+ +   +V + L+E 
Sbjct: 77  RTALL-FVAGLGSDKCVRLLAEAGAD---LDHRDMRGGLTALHMAAGYVRPEVVEALVEL 132

Query: 91  GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           GAD+  +D    T L  A    K          G
Sbjct: 133 GADIEVEDERGLTALELAREILKTTPKGNPMQFG 166

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 53.3 bits (129), Expect = 9e-09
 Identities = 16/92 (17%), Positives = 27/92 (29%), Gaps = 4/92 (4%)

Query: 33  SRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
              ++      ++  +          + V +      TP   A+          L+E   
Sbjct: 12  GEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEY---ETPWWTAARKADEQALSQLLE-DR 67

Query: 93  DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           DV+A D    T L    G      + LL   G
Sbjct: 68  DVDAVDENGRTALLFVAGLGSDKCVRLLAEAG 99

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 51.0 bits (123), Expect = 6e-08
 Identities = 12/67 (17%), Positives = 21/67 (31%), Gaps = 6/67 (8%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
            T+L    A       V  L+E   D   +   D    T L +A            +++G
Sbjct: 111 LTALH-MAAGYVRPEVVEALVELGAD---IEVEDERGLTALELAREILKTTPKGNPMQFG 166

Query: 92  ADVNAQD 98
             +  + 
Sbjct: 167 RRIGLEK 173

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 47.1 bits (113), Expect = 1e-06
 Identities = 8/51 (15%), Positives = 15/51 (29%), Gaps = 4/51 (7%)

Query: 56  EDQSLVHAR-DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           E   ++ +R   +      +    G            ADV ++     TP 
Sbjct: 1   EVNKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPW 48

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 67.4 bits (166), Expect = 5e-14
 Identities = 25/64 (39%), Positives = 38/64 (59%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A+D    TPL++A+ HG +++ + L++ GADVNA D    TPL  A       + E+L
Sbjct: 40  VNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVL 99

Query: 121 NAHG 124
             HG
Sbjct: 100 LKHG 103

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 64.7 bits (159), Expect = 4e-13
 Identities = 23/63 (36%), Positives = 39/63 (61%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D    TPLH+A+  G +++A+ L+++GADVNAQD++  T    + G    ++ E+L
Sbjct: 73  VNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEIL 132

Query: 121 NAH 123
              
Sbjct: 133 QKL 135

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 57.8 bits (141), Expect = 1e-10
 Identities = 20/58 (34%), Positives = 29/58 (50%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           D    L  A+  G  D  + L+  GADVNA+D +  TPL  A       ++E+L  +G
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNG 70

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 69.4 bits (171), Expect = 5e-14
 Identities = 20/83 (24%), Positives = 34/83 (40%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
              +     + L+    + + AR +D  TPL +A+      + + LI   ADVNA D   
Sbjct: 66  VSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLG 125

Query: 102 NTPLADAEGAKKFNMMELLNAHG 124
            + L  A      +   +L  +G
Sbjct: 126 KSALHWAAAVNNVDAAVVLLKNG 148

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 68.6 bits (169), Expect = 1e-13
 Identities = 14/64 (21%), Positives = 30/64 (46%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
              ++    TPL +A+  G  + AK L+++ A+ +  D     P   A+     +++ LL
Sbjct: 151 KDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLL 210

Query: 121 NAHG 124
           + + 
Sbjct: 211 DEYN 214

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 67.0 bits (165), Expect = 3e-13
 Identities = 23/76 (30%), Positives = 35/76 (46%)

Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAE 109
           +   + +  SL +  D    T LH+A+ +   D AK L+E  AD N QD    TPL  A 
Sbjct: 7   ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66

Query: 110 GAKKFNMMELLNAHGG 125
            A    + ++L  +  
Sbjct: 67  SADAQGVFQILIRNRA 82

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 66.7 bits (164), Expect = 4e-13
 Identities = 18/64 (28%), Positives = 32/64 (50%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D   ++ LH A+    +D A  L++ GA+ + Q+  + TPL  A     +   ++L
Sbjct: 118 VNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVL 177

Query: 121 NAHG 124
             H 
Sbjct: 178 LDHF 181

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 62.4 bits (153), Expect = 1e-11
 Identities = 29/103 (28%), Positives = 42/103 (40%), Gaps = 3/103 (2%)

Query: 23  ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWID 82
           A    +  R   T+L    A  + + A ++LLE      + +D   RTPLH A       
Sbjct: 15  ASLHNQTDRTGETALH-LAARYSRSDAAKRLLEASAD-ANIQDNMGRTPLHAAVSADAQG 72

Query: 83  VAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           V + LI   A D++A+     TPL  A       M+E L    
Sbjct: 73  VFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSH 115

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 51.6 bits (125), Expect = 6e-08
 Identities = 9/38 (23%), Positives = 15/38 (39%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
               D+ +R P  +A      D+ + L EY    + Q 
Sbjct: 184 RDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQL 221

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 66.2 bits (163), Expect = 7e-14
 Identities = 21/45 (46%), Positives = 30/45 (66%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           V+AR  D  TPLH+A+ +G  ++ K L+  GADVNA+ +  NTP 
Sbjct: 35  VNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPE 79

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 65.5 bits (161), Expect = 1e-13
 Identities = 17/45 (37%), Positives = 24/45 (53%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           V+AR  D  TP H+A  +G  ++ K L   GADVNA+    +   
Sbjct: 68  VNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHHH 112

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 63.6 bits (156), Expect = 6e-13
 Identities = 24/60 (40%), Positives = 33/60 (55%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
             D  TPLH A+ +G  +  K L+  GADVNA+ +  NTPL  A       +++LL A G
Sbjct: 6   SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKG 65

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 68.8 bits (169), Expect = 7e-14
 Identities = 24/99 (24%), Positives = 37/99 (37%), Gaps = 3/99 (3%)

Query: 28  EKARVSRTSLILWH--AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
           +  R     L+L    A   +   V++ ++E        + +  T LH A       +  
Sbjct: 13  KARRARLNPLVLLLDAALTGELEVVQQAVKEMND-PSQPNEEGITALHNAICGANYSIVD 71

Query: 86  CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            LI  GA+VN+ D    TPL  A       +   L  HG
Sbjct: 72  FLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHG 110

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 64.2 bits (157), Expect = 4e-12
 Identities = 13/67 (19%), Positives = 25/67 (37%), Gaps = 3/67 (4%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKK--FNMM 117
           V++ D    TPLH A+      +   L+++GA + A       T     +  ++   +  
Sbjct: 80  VNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCA 139

Query: 118 ELLNAHG 124
             L    
Sbjct: 140 TYLADVE 146

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 46.5 bits (111), Expect = 4e-06
 Identities = 12/67 (17%), Positives = 20/67 (29%), Gaps = 6/67 (8%)

Query: 61  VHARD-YDNRTPLHVASLH--GWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMM 117
           + A    D  T       +  G+ D A  L +    +   +      L D   + +    
Sbjct: 113 IFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDY--SAE-FGD 169

Query: 118 ELLNAHG 124
           EL    G
Sbjct: 170 ELSFREG 176

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 66.2 bits (163), Expect = 8e-14
 Identities = 28/64 (43%), Positives = 42/64 (65%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A+D + RTPLH+A+ +G ++V K L+E GADVNA+D+   TPL  A       +++LL
Sbjct: 61  VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLL 120

Query: 121 NAHG 124
              G
Sbjct: 121 LEAG 124

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 65.1 bits (160), Expect = 2e-13
 Identities = 24/45 (53%), Positives = 35/45 (77%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           V+A+D + RTPLH+A+ +G ++V K L+E GADVNA+D+   TPL
Sbjct: 28  VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPL 72

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 61.2 bits (150), Expect = 5e-12
 Identities = 25/58 (43%), Positives = 37/58 (63%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           + RTPLH+A+ +G ++V K L+E GADVNA+D+   TPL  A       +++LL   G
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 48.1 bits (116), Expect = 2e-07
 Identities = 16/32 (50%), Positives = 25/32 (78%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
           V+A+D + RTPLH+A+ +G ++V K L+E GA
Sbjct: 94  VNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 67.1 bits (165), Expect = 8e-14
 Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 6/100 (6%)

Query: 39  LWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVN 95
           +       A     LL    +    +  D    T P+H A+  G++D    L   GA ++
Sbjct: 49  IQVMMMGSARVAELLLLHGAE---PNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLD 105

Query: 96  AQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF 135
            +D W   P+  AE     ++   L A  G + G N +  
Sbjct: 106 VRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARI 145

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 63.3 bits (155), Expect = 2e-12
 Identities = 26/99 (26%), Positives = 40/99 (40%), Gaps = 8/99 (8%)

Query: 29  KARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
               S   L    A +     VR LLE   +    +A +   R P+ V    G   VA+ 
Sbjct: 8   SMEPSADWLA-TAAARGRVEEVRALLEAGAN---PNAPNSYGRRPIQVMM-MGSARVAEL 62

Query: 87  LIEYGADVNAQDRWKNT-PLADAEGAKKFNMMELLNAHG 124
           L+ +GA+ N  D    T P+ DA      + + +L+  G
Sbjct: 63  LLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAG 101

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 59.8 bits (146), Expect = 3e-11
 Identities = 10/43 (23%), Positives = 21/43 (48%)

Query: 63  ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           +    +   L  A+  G ++  + L+E GA+ NA + +   P+
Sbjct: 7   SSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPI 49

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 70.3 bits (173), Expect = 8e-14
 Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 4/87 (4%)

Query: 42  AHQNDAAAVRKLLEEDQSL----VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
               +  A+  +++   S     +   +    + LH A L  W DVA   +E G DVN +
Sbjct: 181 MEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNME 240

Query: 98  DRWKNTPLADAEGAKKFNMMELLNAHG 124
           D     PL  +  A    + + L    
Sbjct: 241 DNEHTVPLYLSVRAAMVLLTKELLQKT 267

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 18/64 (28%), Positives = 27/64 (42%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
               D +N   +HVA+  G  D  + LIE G     Q+R+  T L  A      +  + L
Sbjct: 13  RIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYL 72

Query: 121 NAHG 124
            + G
Sbjct: 73  ASVG 76

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 64.9 bits (159), Expect = 6e-12
 Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 10/105 (9%)

Query: 29  KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW--IDVAKC 86
                +        ++ D   V ++        H +    +T LH     G   +++ K 
Sbjct: 107 AKERGQMPES--LLNECDEREVNEIG------SHVKHCKGQTALHWCVGLGPEYLEMIKI 158

Query: 87  LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131
           L++ GA   A+D+   TPL  A   +    ++L+           
Sbjct: 159 LVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLR 203

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 7/64 (10%), Positives = 15/64 (23%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V          +  A+     +V + L E   +V              +      +  + 
Sbjct: 283 VLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMK 342

Query: 121 NAHG 124
            A  
Sbjct: 343 LAPS 346

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 15/64 (23%), Positives = 24/64 (37%), Gaps = 2/64 (3%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
              ++    T LH+A   G +D AK L   G   +        P+  A  A K +++  L
Sbjct: 46  PTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWHGQ--KPIHLAVMANKTDLVVAL 103

Query: 121 NAHG 124
               
Sbjct: 104 VEGA 107

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 61.8 bits (151), Expect = 6e-11
 Identities = 12/82 (14%), Positives = 21/82 (25%), Gaps = 2/82 (2%)

Query: 28  EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
               V    +    A       V +LL+E    V                     V +  
Sbjct: 285 PDRVVWLDFVPA--AADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMK 342

Query: 88  IEYGADVNAQDRWKNTPLADAE 109
           +   A V  + R +    A ++
Sbjct: 343 LAPSAPVRTRSRSRARSSAVSK 364

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 59.1 bits (144), Expect = 4e-10
 Identities = 10/69 (14%), Positives = 23/69 (33%), Gaps = 5/69 (7%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEY-----GADVNAQDRWKNTPLADAEGAKKFN 115
             A+D  + TPL  A      +    +++         ++  ++  N+ L  A      +
Sbjct: 166 PTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWED 225

Query: 116 MMELLNAHG 124
           +       G
Sbjct: 226 VAMRFVEMG 234

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 53.3 bits (129), Expect = 3e-08
 Identities = 12/83 (14%), Positives = 26/83 (31%), Gaps = 23/83 (27%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGAD---------------------VNAQDRWKNT 103
            +  + P+H+A +    D+   L+E   +                      + +     T
Sbjct: 81  LWHGQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSHVKHCKGQT 140

Query: 104 PL--ADAEGAKKFNMMELLNAHG 124
            L      G +   M+++L   G
Sbjct: 141 ALHWCVGLGPEYLEMIKILVQLG 163

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 50.6 bits (122), Expect = 2e-07
 Identities = 12/77 (15%), Positives = 26/77 (33%), Gaps = 13/77 (16%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIE-------------YGADVNAQDRWKNTPLAD 107
           V+  D ++  PL+++     + + K L++              G  V          +  
Sbjct: 237 VNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPA 296

Query: 108 AEGAKKFNMMELLNAHG 124
           A    K  +++LL    
Sbjct: 297 AADPSKQEVLQLLQEKL 313

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 68.7 bits (168), Expect = 9e-14
 Identities = 23/87 (26%), Positives = 40/87 (45%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
              A+      +++ +  D+SL    D D+RT LH A   G  ++ + L++ G  VN +D
Sbjct: 11  CNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKD 70

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGG 125
               +PL  A  A    +++ L   G 
Sbjct: 71  DAGWSPLHIAASAGXDEIVKALLVKGA 97

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 59.1 bits (143), Expect = 2e-10
 Identities = 20/65 (30%), Positives = 33/65 (50%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+ +D    +PLH+A+  G  ++ K L+  GA VNA ++   TPL  A    +  +  +L
Sbjct: 66  VNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVML 125

Query: 121 NAHGG 125
              G 
Sbjct: 126 LEGGA 130

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 22/86 (25%), Positives = 39/86 (45%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A       + K L    + V+A + +  TPLH A+     ++A  L+E GA+ +A+D
Sbjct: 77  LHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 136

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHG 124
            +  T +  A       M+ +L  + 
Sbjct: 137 HYDATAMHRAAAKGNLKMVHILLFYK 162

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 57.6 bits (139), Expect = 6e-10
 Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 2/86 (2%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           +  A       +  +L   ++  + +D +  TPLH+A     ++ AK L+  GA +  ++
Sbjct: 143 MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIEN 202

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHG 124
           + + TPL  A+G     ++    A G
Sbjct: 203 KEEKTPLQVAKGGL--GLILKRLAEG 226

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 57.2 bits (138), Expect = 8e-10
 Identities = 10/58 (17%), Positives = 21/58 (36%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            N    ++A      ++ + ++   +     D+   T L  A  A    ++E L   G
Sbjct: 6   SNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLG 63

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 56.8 bits (137), Expect = 1e-09
 Identities = 26/99 (26%), Positives = 43/99 (43%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L +A   +   +  +L E  +   A+D+ + T +H A+  G + +   L+ Y A  N QD
Sbjct: 110 LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQD 169

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
              NTPL  A   ++    + L   G   Y +N     P
Sbjct: 170 TEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTP 208

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 45.2 bits (107), Expect = 9e-06
 Identities = 10/57 (17%), Positives = 22/57 (38%), Gaps = 2/57 (3%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95
           L  A   +     K L    + ++  + + +TPL VA     + +    +  G + +
Sbjct: 176 LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAKGG--LGLILKRLAEGEEAS 230

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 67.0 bits (165), Expect = 1e-13
 Identities = 19/64 (29%), Positives = 30/64 (46%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
              +D      +H A+  G++D  + L+E+ ADVN +D   N PL  A       ++E L
Sbjct: 63  PDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFL 122

Query: 121 NAHG 124
             H 
Sbjct: 123 VKHT 126

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 63.9 bits (157), Expect = 1e-12
 Identities = 16/65 (24%), Positives = 34/65 (52%), Gaps = 1/65 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA-DVNAQDRWKNTPLADAEGAKKFNMMEL 119
           V+  D +   PLH+A+  G + V + L+++ A +V  ++   +T    A    +  ++ L
Sbjct: 96  VNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSL 155

Query: 120 LNAHG 124
           + A+G
Sbjct: 156 MQANG 160

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 61.2 bits (150), Expect = 1e-11
 Identities = 17/64 (26%), Positives = 31/64 (48%), Gaps = 1/64 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A++   RT L V    G  ++A+ L+  GA+ + +DR     + DA  A   + ++ L
Sbjct: 31  VNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTL 89

Query: 121 NAHG 124
               
Sbjct: 90  LEFQ 93

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 58.5 bits (143), Expect = 1e-10
 Identities = 13/59 (22%), Positives = 23/59 (38%), Gaps = 3/59 (5%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL-ADAEGAKKFNMMELLNAHG 124
                L  A+  G ++    L++   +VNAQ+ +  T L     G  +  +   L   G
Sbjct: 4   PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKLGNPE--IARRLLLRG 60

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 48.1 bits (116), Expect = 4e-07
 Identities = 14/59 (23%), Positives = 23/59 (38%), Gaps = 1/59 (1%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
              L    A +     V  L++   S V  R++   T   +A L+G  +V   +   GA
Sbjct: 104 NLPLH-LAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 1/91 (1%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           RT+L  + A  ++   V+ L+ E  S    +D D +TP+ +A+  G I+V   LI+ GA 
Sbjct: 280 RTALH-YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGAS 338

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           V A D   +T    A+     N++++ +   
Sbjct: 339 VEAVDATDHTARQLAQANNHHNIVDIFDRCR 369

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 67.7 bits (166), Expect = 8e-13
 Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 8/94 (8%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSL-------VHARDYDNRTPLHVASLHGWIDVAKC 86
           RT L  W A  + A     L+  +          V+A D D  TPL +A L     +   
Sbjct: 126 RTVLH-WIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAY 184

Query: 87  LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           L++ GAD    ++ + + L  A   + F MM  +
Sbjct: 185 LMKAGADPTIYNKSERSALHQAAANRDFGMMVYM 218

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 24/103 (23%), Positives = 47/103 (45%), Gaps = 14/103 (13%)

Query: 34  RTSLIL--WHAHQNDAAAVRKLLE-------EDQSLVHARDYDNRTPLHVASLHGWIDVA 84
            T+L++   +  ++  A+ + L+E       +  +   +  Y  RT LH A+    + + 
Sbjct: 236 MTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIV 295

Query: 85  KCLI-EYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
           K L+ E G++ + QD    TP+  A  EG  +  ++  L   G
Sbjct: 296 KYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIE--VVMYLIQQG 336

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 15/70 (21%), Positives = 25/70 (35%), Gaps = 6/70 (8%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIE---YGADVNAQDRWKNTPL---ADAEGAKKF 114
               +   R+ LH A+ +    +   ++       D+   DR   T L   A  EG  + 
Sbjct: 192 PTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQV 251

Query: 115 NMMELLNAHG 124
              +LL   G
Sbjct: 252 ASAKLLVEKG 261

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 13/101 (12%), Positives = 26/101 (25%), Gaps = 14/101 (13%)

Query: 25  KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVA 84
           K  +    S+ SL L  ++       R  L           + +  P      +G   + 
Sbjct: 29  KNHQSITSSQHSL-LEASYDGYIKRQRNEL----------QHYSLYPNPQGYGNGNDFLG 77

Query: 85  KCLIEYGADVNAQDRWKNTPL-ADAEGAKKFNMMELLNAHG 124
                        +      L  +A G+    + E +    
Sbjct: 78  DFNHTNLQIPTEPEPESPIKLHTEAAGSYA--ITEPITRES 116

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 25/94 (26%), Positives = 38/94 (40%), Gaps = 10/94 (10%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI--------EY 90
           L        A    +  E  ++       NRT LH  + +   + ++ LI          
Sbjct: 98  LHTEAAGSYAITEPITRESVNI--IDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAA 155

Query: 91  GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           GADVNA D  +NTPL  A  A++  ++  L   G
Sbjct: 156 GADVNAMDCDENTPLMLAVLARRRRLVAYLMKAG 189

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 5/34 (14%), Positives = 11/34 (32%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV 94
           V A D  + T   +A  +   ++         + 
Sbjct: 339 VEAVDATDHTARQLAQANNHHNIVDIFDRCRPER 372

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 69.0 bits (170), Expect = 1e-13
 Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 3/94 (3%)

Query: 34  RTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-Y 90
           R +LI     +  +D  A+  LL +  + V+ R    +TPL +A     + + + L+E  
Sbjct: 183 RNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQE 242

Query: 91  GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
             ++N  D    T L  A   K   + ELL   G
Sbjct: 243 HIEINDTDSDGKTALLLAVELKLKKIAELLCKRG 276

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 69.0 bits (170), Expect = 1e-13
 Identities = 17/64 (26%), Positives = 28/64 (43%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
              R  +  TP  +A++ G + + K  +  GADVN  D +  T   +A    K   ++ L
Sbjct: 65  PVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFL 124

Query: 121 NAHG 124
              G
Sbjct: 125 YKRG 128

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 65.6 bits (161), Expect = 2e-12
 Identities = 23/91 (25%), Positives = 38/91 (41%), Gaps = 1/91 (1%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
              LI       D   V++LLE   ++    +    TPLH A      D+ + L+ +GAD
Sbjct: 6   NHLLI-KAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGAD 64

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
              + +   TP   A  A    +++L  + G
Sbjct: 65  PVLRKKNGATPFLLAAIAGSVKLLKLFLSKG 95

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 62.5 bits (153), Expect = 2e-11
 Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 1/65 (1%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           +T LI     +     V++LLE++   ++  D D +T L +A       +A+ L + GA 
Sbjct: 220 KTPLI-LAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAS 278

Query: 94  VNAQD 98
            +  D
Sbjct: 279 TDCGD 283

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 61.3 bits (150), Expect = 6e-11
 Identities = 25/96 (26%), Positives = 41/96 (42%), Gaps = 5/96 (5%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----WIDVAKCLIE 89
            T+L+   A +     ++ LL+E  + V+A D   R  L  A L         +   L++
Sbjct: 149 ATALM-DAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLD 207

Query: 90  YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
           +GADVN +     TPL  A   K   +++ L     
Sbjct: 208 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEH 243

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 60.6 bits (148), Expect = 9e-11
 Identities = 18/75 (24%), Positives = 32/75 (42%), Gaps = 10/75 (13%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK----------NTPLADAEG 110
           V+  D+   T    A+++G +   K L + GA+VN + + K           T L DA  
Sbjct: 98  VNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAE 157

Query: 111 AKKFNMMELLNAHGG 125
                ++++L    G
Sbjct: 158 KGHVEVLKILLDEMG 172

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 58.6 bits (143), Expect = 4e-10
 Identities = 19/61 (31%), Positives = 33/61 (54%), Gaps = 1/61 (1%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKKFNMMELLNAH 123
             ++   L  A  +  +D+ + L+E GA+VN Q+     TPL +A    + +++ELL  H
Sbjct: 2   AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61

Query: 124 G 124
           G
Sbjct: 62  G 62

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 27/94 (28%), Positives = 39/94 (41%), Gaps = 7/94 (7%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEY 90
           RT+L+ + A       VR L E   D   +  RD     T LH+A+ +   +V + L+E 
Sbjct: 78  RTALL-FVAGLGSDKCVRLLAEAGAD---LDHRDMRGGLTALHMAAGYVRPEVVEALVEL 133

Query: 91  GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           GAD+  +D    T L  A    K          G
Sbjct: 134 GADIEVEDERGLTALELAREILKTTPKGNPMQFG 167

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 6/93 (6%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
            T      A + D  A+ +LLE+ D   V A D + RT L   +  G     + L E GA
Sbjct: 46  ETPWW-TAARKADEQALSQLLEDRD---VDAVDENGRTALLFVAGLGSDKCVRLLAEAGA 101

Query: 93  DVNAQD-RWKNTPLADAEGAKKFNMMELLNAHG 124
           D++ +D R   T L  A G  +  ++E L   G
Sbjct: 102 DLDHRDMRGGLTALHMAAGYVRPEVVEALVELG 134

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 54.9 bits (133), Expect = 5e-09
 Identities = 17/104 (16%), Positives = 33/104 (31%), Gaps = 9/104 (8%)

Query: 23  ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGW 80
           AD      R   T+L    A       V  L+E   D   +   D    T L +A     
Sbjct: 101 ADLDHRDMRGGLTALH-MAAGYVRPEVVEALVELGAD---IEVEDERGLTALELAREILK 156

Query: 81  IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
                  +++G  +  +       + + +  +   + E++   G
Sbjct: 157 TTPKGNPMQFGRRIGLEK---VINVLEGQVFEYAEVDEIVEKRG 197

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 53.8 bits (130), Expect = 1e-08
 Identities = 16/86 (18%), Positives = 26/86 (30%), Gaps = 4/86 (4%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
                ++  +          + V +   +  TP   A+          L+E   DV+A D
Sbjct: 19  YLIEWKDGHSPSWVPSSYIAADVVS---EYETPWWTAARKADEQALSQLLE-DRDVDAVD 74

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHG 124
               T L    G      + LL   G
Sbjct: 75  ENGRTALLFVAGLGSDKCVRLLAEAG 100

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 46.8 bits (112), Expect = 3e-06
 Identities = 11/74 (14%), Positives = 23/74 (31%), Gaps = 12/74 (16%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           +      + A V +++E+            +   ++       D       + A+  A+D
Sbjct: 178 VLEGQVFEYAEVDEIVEKRG--------KGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD 229

Query: 99  RWKNTPL--ADAEG 110
                 L  A AE 
Sbjct: 230 --YEDGLEYAVAES 241

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 44.1 bits (105), Expect = 2e-05
 Identities = 6/39 (15%), Positives = 10/39 (25%), Gaps = 3/39 (7%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
           +      +    G            ADV ++     TP 
Sbjct: 14  EGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPW 49

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 66.2 bits (163), Expect = 2e-13
 Identities = 21/63 (33%), Positives = 38/63 (60%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D +  TPLH+A++ G +++ + L++ GADVNAQD++  T    +      ++ E+L
Sbjct: 106 VNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEIL 165

Query: 121 NAH 123
              
Sbjct: 166 QKL 168

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 65.8 bits (162), Expect = 4e-13
 Identities = 24/64 (37%), Positives = 38/64 (59%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D    TPLH+A+ +G +++ + L++ GADVNA D    TPL  A       ++E+L
Sbjct: 40  VNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVL 99

Query: 121 NAHG 124
             +G
Sbjct: 100 LKNG 103

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 65.5 bits (161), Expect = 4e-13
 Identities = 24/64 (37%), Positives = 39/64 (60%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+A D+   TPL +A+L G +++ + L++ GADVNA D   +TPL  A       ++E+L
Sbjct: 73  VNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVL 132

Query: 121 NAHG 124
             +G
Sbjct: 133 LKNG 136

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 60.5 bits (148), Expect = 3e-11
 Identities = 22/65 (33%), Positives = 31/65 (47%), Gaps = 4/65 (6%)

Query: 62  HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMEL 119
           H    D    L  A+  G  D  + L+  GADVNA+D    TPL  A   G  +  ++E+
Sbjct: 8   HHHGSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLE--IVEV 65

Query: 120 LNAHG 124
           L  +G
Sbjct: 66  LLKNG 70

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 44/185 (23%), Positives = 71/185 (38%), Gaps = 23/185 (12%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRI------LPSLSD-----DRLVIQDFRHEVNLLVK 211
           IG G FG I  A+   +    A   +         L        R+  +D   +     +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 212 LRHPNIVQFLG----AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
           L +  I  F G        R    ++ E L G DL K   + G    ST +   + +   
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDV 163

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM---TGET 324
           + Y+H   N  +H D+K  N+LL   + D + + D+GLS       +H  Y+     G  
Sbjct: 164 LEYIHE--NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221

Query: 325 GSCEY 329
           G+ E+
Sbjct: 222 GTIEF 226

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 65.9 bits (162), Expect = 4e-13
 Identities = 20/60 (33%), Positives = 35/60 (58%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+ R+ +  TPL VAS +G  ++ K L+E GAD++A+D    T  A A    +  ++++ 
Sbjct: 127 VNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIF 186

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 65.5 bits (161), Expect = 6e-13
 Identities = 20/65 (30%), Positives = 30/65 (46%)

Query: 60  LVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
           L + RD  NRTPL VA + G  +    L+E    +  +D   +T L  A    +  + E 
Sbjct: 27  LRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEK 86

Query: 120 LNAHG 124
           L + G
Sbjct: 87  LLSKG 91

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 64.7 bits (159), Expect = 1e-12
 Identities = 17/64 (26%), Positives = 29/64 (45%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           +  +D +  T L  A  +  + +A+ L+  G++VN +D    TPL  +       M   L
Sbjct: 61  LEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFL 120

Query: 121 NAHG 124
             HG
Sbjct: 121 LEHG 124

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 63.6 bits (156), Expect = 3e-12
 Identities = 18/64 (28%), Positives = 37/64 (57%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V+ +D+  +TPL  + + G+ +++  L+E+GA+VN ++    TPL  A    +  +++ L
Sbjct: 94  VNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKL 153

Query: 121 NAHG 124
              G
Sbjct: 154 LELG 157

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 41.6 bits (99), Expect = 1e-04
 Identities = 9/32 (28%), Positives = 12/32 (37%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGA 92
           + ARD    T    A + G  +V K   E   
Sbjct: 160 ISARDLTGLTAEASARIFGRQEVIKIFTEVRR 191

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 63.4 bits (155), Expect = 6e-13
 Identities = 23/60 (38%), Positives = 37/60 (61%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           V A+D +  TPLH+A+ +G ++V K L+E GADV AQD++  T    +      ++ E+L
Sbjct: 50  VAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNGNEDLAEIL 109

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 60.7 bits (148), Expect = 5e-12
 Identities = 19/60 (31%), Positives = 28/60 (46%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
             D    L  A+  G  D  + L+  GADV A+D+  +TPL  A       +++LL   G
Sbjct: 21  GSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAG 80

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 40.3 bits (95), Expect = 1e-04
 Identities = 5/31 (16%), Positives = 10/31 (32%), Gaps = 3/31 (9%)

Query: 75  ASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
            S H     +  L+  G+ + +        L
Sbjct: 1   GSSHHHHHHSSGLVPRGSHMGSDL---GKKL 28

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 66.5 bits (163), Expect = 6e-13
 Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 5/88 (5%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV-----NA 96
           A +ND  A+ KLL+ +   VH R     T LH+A+L+  ++ A  L+E   ++      +
Sbjct: 11  AKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTS 70

Query: 97  QDRWKNTPLADAEGAKKFNMMELLNAHG 124
           +     T L  A   +  N++  L A G
Sbjct: 71  ELYEGQTALHIAVINQNVNLVRALLARG 98

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 63.0 bits (154), Expect = 8e-12
 Identities = 23/68 (33%), Positives = 32/68 (47%), Gaps = 4/68 (5%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKF--NM 116
            H   Y    PL  A+  G  ++ + LIE+GAD+ AQD   NT L     +  K F   M
Sbjct: 114 PHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQM 173

Query: 117 MELLNAHG 124
             LL ++ 
Sbjct: 174 YNLLLSYD 181

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 51.5 bits (124), Expect = 7e-08
 Identities = 14/74 (18%), Positives = 21/74 (28%), Gaps = 10/74 (13%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVA----KCLIEYGADVNA------QDRWKNTPLADAEG 110
           + A+D    T LH+  L      A      L+ Y    +        +    TP   A  
Sbjct: 147 IRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQGLTPFKLAGV 206

Query: 111 AKKFNMMELLNAHG 124
                M + L    
Sbjct: 207 EGNIVMFQHLMQKR 220

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 49.5 bits (119), Expect = 3e-07
 Identities = 11/56 (19%), Positives = 21/56 (37%), Gaps = 1/56 (1%)

Query: 70  TPLHVASLHGWID-VAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           +PL +A+    +  ++K L   G +V+ +     T L  A          +L    
Sbjct: 5   SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAA 60

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 32/145 (22%), Positives = 60/145 (41%), Gaps = 24/145 (16%)

Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRH-- 214
             +G G+FG +L           A+K ++ +       I+ +      E ++L K+++  
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVK-VVRN-------IKKYTRSAKIEADILKKIQNDD 92

Query: 215 ---PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMA 269
               NIV++ G       + LI E L G  L++ +               + ++I + + 
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSS 294
           YL      + H DLKP N+LL +  
Sbjct: 152 YLRK--MSLTHTDLKPENILLDDPY 174

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 65.9 bits (162), Expect = 1e-12
 Identities = 28/92 (30%), Positives = 41/92 (44%), Gaps = 2/92 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGA 92
            T L+ W A++  +    +LL      V+  D Y   T LH A L G   V   L+E GA
Sbjct: 143 MTPLM-WAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201

Query: 93  DVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           +V+AQ+    + L  A+  K   M+  L    
Sbjct: 202 NVDAQNIKGESALDLAKQRKNVWMINHLQEAR 233

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 65.5 bits (161), Expect = 1e-12
 Identities = 24/106 (22%), Positives = 40/106 (37%), Gaps = 9/106 (8%)

Query: 23  ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGW 80
           A   +    ++ T L  W   Q   + V +L++   D       D +  + +H+A+  G 
Sbjct: 66  AIVDQLGGDLNSTPLH-WATRQGHLSMVVQLMKYGAD---PSLIDGEGCSCIHLAAQFGH 121

Query: 81  IDVAKCLIEYGADVNAQDRWKNTPL--ADAEGAKKFNMMELLNAHG 124
             +   LI  G DV+  D+   TPL  A        +   LL    
Sbjct: 122 TSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSV-DPTRLLLTFN 166

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 64.0 bits (157), Expect = 5e-12
 Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 7/94 (7%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
              ++            R+L+E   D   V   D +N T LH A+++  ID+ K  I  G
Sbjct: 10  TWDIV-KATQYGIYERCRELVEAGYD---VRQPDKENVTLLHWAAINNRIDLVKYYISKG 65

Query: 92  ADVNAQDR-WKNTPLADAEGAKKFNMMELLNAHG 124
           A V+       +TPL  A      +M+  L  +G
Sbjct: 66  AIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYG 99

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 63.2 bits (155), Expect = 8e-12
 Identities = 11/43 (25%), Positives = 19/43 (44%)

Query: 63  ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL 105
             D  +   +  A+ +G  +  + L+E G DV   D+   T L
Sbjct: 4   HIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLL 46

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 51.3 bits (124), Expect = 9e-08
 Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 2/65 (3%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T+L  W     +   +  LLE   + V A++    + L +A     + +   L E    
Sbjct: 178 NTALH-WAVLAGNTTVISLLLEAG-ANVDAQNIKGESALDLAKQRKNVWMINHLQEARQA 235

Query: 94  VNAQD 98
               +
Sbjct: 236 KGYDN 240

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 39/174 (22%), Positives = 66/174 (37%), Gaps = 43/174 (24%)

Query: 163 AIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRHP 215
             +G+G+FG++++          VA+K I+ +       +  +      E+ +L  L   
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVK-IVKN-------VDRYCEAARSEIQVLEHLNTT 71

Query: 216 ------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
                   VQ L        + ++ E L G   + ++KE G            A  I + 
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------LKVGDFG 304
           + +LH+  N + H DLKP N+L V S                     +KV DFG
Sbjct: 131 VNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 65.3 bits (160), Expect = 1e-12
 Identities = 18/64 (28%), Positives = 28/64 (43%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
               + +  T LH A   G  ++ K L+++G +VNA D    TPL  A       + + L
Sbjct: 63  PSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFL 122

Query: 121 NAHG 124
              G
Sbjct: 123 VESG 126

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 63.8 bits (156), Expect = 6e-12
 Identities = 19/67 (28%), Positives = 25/67 (37%), Gaps = 3/67 (4%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ---DRWKNTPLADAEGAKKFNMM 117
           V+A D D  TPLH A+    + V K L+E GA V A    D        +          
Sbjct: 96  VNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCS 155

Query: 118 ELLNAHG 124
           + L    
Sbjct: 156 QFLYGVQ 162

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 58.8 bits (143), Expect = 2e-10
 Identities = 13/60 (21%), Positives = 24/60 (40%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           +      L  +SL G  D+ + +I    D +  +    T L +A  A    +++ L   G
Sbjct: 34  NPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFG 93

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 57.2 bits (139), Expect = 1e-09
 Identities = 16/93 (17%), Positives = 26/93 (27%), Gaps = 6/93 (6%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
            T L    A  N+    + L+E       +   D             G+   ++ L    
Sbjct: 104 WTPLH-CAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQ 162

Query: 92  ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
             +   ++     L D E     N  EL    G
Sbjct: 163 EKMGIMNKGVIYALWDYE---PQNDDELPMKEG 192

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 53.4 bits (129), Expect = 2e-08
 Identities = 7/60 (11%), Positives = 17/60 (28%), Gaps = 1/60 (1%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           +   +  L               I +G  V          L D+    +F++++ +    
Sbjct: 2   EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 63.9 bits (156), Expect = 2e-12
 Identities = 14/99 (14%), Positives = 32/99 (32%), Gaps = 12/99 (12%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDV------AKCLIEYGA 92
           L + +      +   L    + + +R  +  T        G  D+       K  +E GA
Sbjct: 46  LRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105

Query: 93  DVNAQDRWKNTPLADA------EGAKKFNMMELLNAHGG 125
           D+ A  +     +         +  +   + +L+ +  G
Sbjct: 106 DITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSG 144

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 63.2 bits (154), Expect = 4e-12
 Identities = 12/105 (11%), Positives = 33/105 (31%), Gaps = 17/105 (16%)

Query: 34  RTSLIL--WHAHQN---DAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKC 86
            T           +        +  LE+  D   + A     +  +     + ++D  + 
Sbjct: 76  TTLFFPLFQGGGNDITGTTELCKIFLEKGAD---ITALYKPYKIVVFKNIFNYFVDENEM 132

Query: 87  -------LIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
                    + G  +  +D+W  T L   +  +K   ++++  + 
Sbjct: 133 IPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYI 177

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 60.8 bits (148), Expect = 2e-11
 Identities = 6/70 (8%), Positives = 21/70 (30%), Gaps = 5/70 (7%)

Query: 34  RTSLIL--WHAHQNDAAA---VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI 88
           +  +    ++   ++       + +  +    +  +D    T L            K + 
Sbjct: 115 KIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMME 174

Query: 89  EYGADVNAQD 98
           +Y    N ++
Sbjct: 175 DYIKKYNLKE 184

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 59.7 bits (145), Expect = 6e-11
 Identities = 12/101 (11%), Positives = 29/101 (28%), Gaps = 8/101 (7%)

Query: 32  VSRTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
           +S    +   A         +L E+  +      +       L   +      ++  LI 
Sbjct: 4   MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63

Query: 90  YGADVNAQDRWKNTPLADA------EGAKKFNMMELLNAHG 124
            GAD+ ++ +   T           +      + ++    G
Sbjct: 64  KGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKG 104

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 41.2 bits (97), Expect = 1e-04
 Identities = 9/65 (13%), Positives = 19/65 (29%), Gaps = 3/65 (4%)

Query: 63  ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN---TPLADAEGAKKFNMMEL 119
           +        +  A++ G  +    L E G +        N     L +     ++ +   
Sbjct: 1   SNAMSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMF 60

Query: 120 LNAHG 124
           L   G
Sbjct: 61  LINKG 65

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 65.2 bits (160), Expect = 3e-12
 Identities = 12/84 (14%), Positives = 27/84 (32%), Gaps = 4/84 (4%)

Query: 41  HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
             +   +  ++  L          D    +  + A     + +   L+  GA  N  +  
Sbjct: 6   RINTWKSKQLKSFLSSKD--TFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE-- 61

Query: 101 KNTPLADAEGAKKFNMMELLNAHG 124
              PL  A   +   ++++L   G
Sbjct: 62  NEFPLHQAATLEDTKIVKILLFSG 85

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 64.9 bits (159), Expect = 3e-12
 Identities = 15/59 (25%), Positives = 23/59 (38%)

Query: 66  YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            +N  PLH A+      + K L+  G D +  D   NT L  A  +     ++L     
Sbjct: 60  LENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKN 118

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 64.9 bits (159), Expect = 4e-12
 Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 8/94 (8%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           +TS        ND + V   L   +           + +H+   +G +D+   L++Y   
Sbjct: 130 KTSFY-HAVMLNDVSIVSYFLS--EIPSTFDLAILLSCIHITIKNGHVDMMILLLDYMTS 186

Query: 94  VNAQDRWKNTPL---ADAEGAKKFNMMELLNAHG 124
            N  +     P    A      +  M++ L  + 
Sbjct: 187 TNTNNSLLFIPDIKLAIDNKDIE--MLQALFKYD 218

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 62.9 bits (154), Expect = 2e-11
 Identities = 8/65 (12%), Positives = 18/65 (27%), Gaps = 1/65 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKKFNMMEL 119
               D    T L+ A   G +   K  ++    +    +    T    A      +++  
Sbjct: 88  DSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSY 147

Query: 120 LNAHG 124
             +  
Sbjct: 148 FLSEI 152

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 56.4 bits (137), Expect = 3e-09
 Identities = 6/45 (13%), Positives = 15/45 (33%)

Query: 70  TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114
           +      L    ++AK +IE   +  +    K+  +       + 
Sbjct: 223 SANLENVLLDDAEIAKMIIEKHVEYKSDSYTKDLDIVKNNKLDEI 267

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 52.5 bits (127), Expect = 5e-08
 Identities = 10/87 (11%), Positives = 25/87 (28%), Gaps = 2/87 (2%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ 97
           L++A  +      KL  +    +        +T  + A +   + +    +         
Sbjct: 99  LYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPS-TFD 157

Query: 98  DRWKNTPLADAEGAKKFNMMELLNAHG 124
                + +         +MM LL  + 
Sbjct: 158 LAILLSCIHITIKNGHVDMMILLLDYM 184

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 51.8 bits (125), Expect = 7e-08
 Identities = 5/41 (12%), Positives = 18/41 (43%), Gaps = 1/41 (2%)

Query: 61  VHARDYDNRTP-LHVASLHGWIDVAKCLIEYGADVNAQDRW 100
            +  +     P + +A  +  I++ + L +Y  ++ + +  
Sbjct: 187 TNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIYSANLE 227

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 38/174 (21%), Positives = 68/174 (39%), Gaps = 43/174 (24%)

Query: 163 AIIGKGSFGEILKAYWRGT---PVAIKRILPSLSDDRLVIQDFRH----EVNLLVKLRHP 215
             +G+G+FG++++          VA+K I+ +       +  +R     E+N+L K++  
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALK-IIRN-------VGKYREAARLEINVLKKIKEK 76

Query: 216 ------NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARG 267
                   V           + +  E L G +  ++LKE            + A  +   
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----------------LKVGDFG 304
           + +LH   N + H DLKP N+L VNS  +                  ++V DFG
Sbjct: 136 LRFLHE--NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 19/104 (18%), Positives = 32/104 (30%), Gaps = 12/104 (11%)

Query: 23  ADKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSL----------VHARDYDNRT 70
            D + +     +T L+    + H      +  LL+  +                 Y  +T
Sbjct: 44  TDSEFKDPETGKTCLLKAMLNLHNGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQT 103

Query: 71  PLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF 114
            LH+A     + +   L+E GADV A                 F
Sbjct: 104 ALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYF 147

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 52.1 bits (125), Expect = 6e-08
 Identities = 13/51 (25%), Positives = 22/51 (43%), Gaps = 3/51 (5%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPLADA 108
                Y    PL +A+    + + K L++     AD++A+D   NT L   
Sbjct: 141 GRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHAL 191

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 12/78 (15%), Positives = 23/78 (29%), Gaps = 7/78 (8%)

Query: 28  EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
           E A  +  +     +  N+   +   L     L    +    TPL +A+  G I V   +
Sbjct: 193 EVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYI 252

Query: 88  IEYGADVNAQDRWKNTPL 105
           ++                
Sbjct: 253 LQREIHE-------PECR 263

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 20/101 (19%), Positives = 30/101 (29%), Gaps = 18/101 (17%)

Query: 42  AHQNDAAAVRKLLEEDQSL--VHARDYDNRTPLHVASLHG----------------WIDV 83
           A  N  A V+ LL+       + ARD    T LH                       + +
Sbjct: 156 ACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILIL 215

Query: 84  AKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
              L          +R   TPLA A  + K  ++  +    
Sbjct: 216 GAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQRE 256

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.8 bits (158), Expect = 5e-12
 Identities = 27/188 (14%), Positives = 55/188 (29%), Gaps = 26/188 (13%)

Query: 165 IGKGSFGEI----------LKAYWRGTPVAIK-------RILPSLSDDRLVIQDFRHEVN 207
             + + G +            +  +    ++K                R       ++  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 208 LLVKLRHPNIVQFLG-AVTERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDI 264
            L       I   +G  V + K   L+   L G  L   L    K  LS  + +  A  +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168

Query: 265 ARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM---T 321
              + +LH   N  +H ++   N+ +       + +  +G +        H  Y     +
Sbjct: 169 LDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226

Query: 322 GETGSCEY 329
              G  E+
Sbjct: 227 PHEGDLEF 234

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 64.0 bits (156), Expect = 6e-12
 Identities = 23/128 (17%), Positives = 44/128 (34%), Gaps = 25/128 (19%)

Query: 23  ADKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSL----------VHARDYDNRT 70
            D    +    +T L+    +      A +  LL+ D+                 Y   +
Sbjct: 33  TDSAYTEGSTGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHS 92

Query: 71  PLHVASLHGWIDVAKCLIEYGADVNAQDR-------------WKNTPLADAEGAKKFNMM 117
            LH+A     +   K L+E GADV+ +               +   PL+ A   K+++++
Sbjct: 93  ALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVV 152

Query: 118 ELLNAHGG 125
             L  +  
Sbjct: 153 TYLLENPH 160

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 11/72 (15%), Positives = 21/72 (29%), Gaps = 5/72 (6%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           + A +    + L +    G + +   L          +    TPL  A    K  +   +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240

Query: 121 NAHGGLSYGQNG 132
                L    +G
Sbjct: 241 -----LQREFSG 247

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 14/48 (29%), Positives = 18/48 (37%), Gaps = 3/48 (6%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPL 105
                Y    PL +A+     DV   L+E     A + A D   NT L
Sbjct: 129 QGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVL 176

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 10/71 (14%), Positives = 26/71 (36%), Gaps = 2/71 (2%)

Query: 26  QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
                    ++L++     +    +   L     L    ++   TPL +A+  G I++ +
Sbjct: 181 MIADNSPENSALVI--HMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFR 238

Query: 86  CLIEYGADVNA 96
            +++      A
Sbjct: 239 HILQREFSGAA 249

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 36/167 (21%), Positives = 63/167 (37%), Gaps = 29/167 (17%)

Query: 163 AIIGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR------- 213
             +G G F  +  A      T VA+K I+          +    E+ LL ++        
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYT---EAAEDEIKLLQRVNDADNTKE 80

Query: 214 ----HPNIVQFLGAVTERKPLM----LITEYLRGGDLHKYLK--EKGALSPSTAVNFALD 263
                 +I++ L     + P      ++ E L G +L   +K  E   +        +  
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLL----VNSSADHLKVGDFGLS 306
           +  G+ Y+H     IIH D+KP NVL+       +   +K+ D G +
Sbjct: 140 LLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 40/156 (25%), Positives = 64/156 (41%), Gaps = 13/156 (8%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFL 221
           IG GSFGEI           VAIK         +L      +E  +   L+    I    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL-----LYESKIYRILQGGTGIPNVR 69

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
               E    +L+ + L G  L          LS  T +  A  +   + ++H+     +H
Sbjct: 70  WFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--KSFLH 126

Query: 281 RDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSH 315
           RD+KP N L+ +   A+ + + DFGL+K  +  ++H
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 40/161 (24%), Positives = 61/161 (37%), Gaps = 23/161 (14%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKR-----ILPSLSDDRLVIQDFRHEVNLLVKLRH-PN 216
           IG GSFG+I        G  VAIK        P L            E  +   ++    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL----------HIESKIYKMMQGGVG 66

Query: 217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEP 275
           I        E    +++ E L G  L           S  T +  A  +   + Y+H+  
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-- 123

Query: 276 NVIIHRDLKPRNVLL-VNSSADHLKVGDFGLSKLIKVQNSH 315
              IHRD+KP N L+ +    + + + DFGL+K  +   +H
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 40/195 (20%), Positives = 67/195 (34%), Gaps = 40/195 (20%)

Query: 165 IGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI 217
           IG+G FG I  A            P  +K  +    +  L       E+    +   P  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVK--VEPSDNGPL-----FTELKFYQRAAKPEQ 95

Query: 218 VQFLGAVTERKPL-------------------MLITEYLRGGDLHKYLKEKG-ALSPSTA 257
           +Q      + K L                    +I +   G DL K  +      S  T 
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTV 154

Query: 258 VNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
           +  +L I   + Y+H   +  +H D+K  N+LL   + D + + D+GL+     +  H  
Sbjct: 155 LQLSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 318 YKM---TGETGSCEY 329
           Y         G+ E+
Sbjct: 213 YAADPKRCHDGTIEF 227

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 15/84 (17%), Positives = 33/84 (39%)

Query: 22  SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWI 81
           +   Q                 ++       L     ++++A+D +  T L++A+  G I
Sbjct: 237 NRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNI 296

Query: 82  DVAKCLIEYGADVNAQDRWKNTPL 105
            +   L++YGAD    ++    P+
Sbjct: 297 SIVDALLDYGADPFIANKSGLRPV 320

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 13/64 (20%), Positives = 24/64 (37%), Gaps = 4/64 (6%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA----EGAKKFNMMELL 120
           D    TPLH  +    +++ K L+++G++    D    + L  A              LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187

Query: 121 NAHG 124
           +   
Sbjct: 188 DYLY 191

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 40.4 bits (94), Expect = 5e-04
 Identities = 12/76 (15%), Positives = 20/76 (26%), Gaps = 6/76 (7%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----WIDVAKCLIE 89
            T L  W     +   V+ L++   +     D    + L  A               L  
Sbjct: 132 NTPLH-WLTSIANLELVKHLVKHGSN-RLYGDNMGESCLVKAVKSVNNYDSGTFEALLDY 189

Query: 90  YGADVNAQDRWKNTPL 105
               +  +D    T L
Sbjct: 190 LYPCLILEDSMNRTIL 205

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 38/158 (24%), Positives = 60/158 (37%), Gaps = 15/158 (9%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
           IG G+FGE+      +    VAIK     L   +        E     +L     I Q  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVY 71

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
                 K   ++ E L G  L           S  T +  A+ +   M Y+H++   +I+
Sbjct: 72  YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK--NLIY 128

Query: 281 RDLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSH 315
           RD+KP N L+    N +   + + DF L+K      + 
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.8 bits (140), Expect = 9e-10
 Identities = 39/158 (24%), Positives = 59/158 (37%), Gaps = 15/158 (9%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFL 221
           IG+GSFG I +         VAIK         R      R E      L     I    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
               E    +L+ + L G  L   L   G   S  T    A  +   +  +H     +++
Sbjct: 73  YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVY 129

Query: 281 RDLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSH 315
           RD+KP N L+    + +A+ + V DFG+ K  +   + 
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 26/127 (20%)

Query: 24  DKQKEKARVSRTSLIL--WHAHQNDAAAVRKLLE------EDQSLVHA----RDYDNRTP 71
           D++  +    +T L     +        +  LL+        +  +++      Y  +T 
Sbjct: 37  DEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTA 96

Query: 72  LHVASLHGWIDVAKCLIEYGADVNAQDR--------------WKNTPLADAEGAKKFNMM 117
           LH+A         + L+E GADV+AQ R              +   PL+ A    + +++
Sbjct: 97  LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156

Query: 118 ELLNAHG 124
             L  +G
Sbjct: 157 HYLTENG 163

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 55.6 bits (134), Expect = 4e-09
 Identities = 19/93 (20%), Positives = 25/93 (26%), Gaps = 10/93 (10%)

Query: 62  HARDYDNRTPLHVASLHGWIDVAKCLIEYG---ADVNAQDRWKNTPL--ADAEGAKKFNM 116
               Y    PL +A+      +   L E G   AD+  QD   NT L    A        
Sbjct: 134 GGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTREN 193

Query: 117 MELLNAHGG--LSYGQNGSHFEPKPVPPPLPNK 147
            + +       L          P      L N 
Sbjct: 194 TKFVTKMYDLLLIKCAKL---FPDTNLEALLNN 223

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 45.5 bits (108), Expect = 9e-06
 Identities = 11/45 (24%), Positives = 19/45 (42%)

Query: 54  LEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  D +L    + D  +PL +A+  G I + + +I       A  
Sbjct: 211 LFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAAH 255

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 3/67 (4%)

Query: 41  HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
               +    +  LL  D  +V     +N     +A+ +G + V   L E           
Sbjct: 102 TGCSSALDTLCLLLTSD-EIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQ 160

Query: 101 KN--TPL 105
                  
Sbjct: 161 AENYHAF 167

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 13/114 (11%), Positives = 27/114 (23%), Gaps = 7/114 (6%)

Query: 15  CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL----VHARDYDNRT 70
              G      K +          ++    +     +R LL                D   
Sbjct: 262 NPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 321

Query: 71  PLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            L +A   G       L+   + +       N  + +  G    ++  +   H 
Sbjct: 322 LLRLALRLGNQGACALLLSIPSVLALTKA-NNYYINETGGR--LDLRAVALEHH 372

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 9/59 (15%), Positives = 18/59 (30%), Gaps = 3/59 (5%)

Query: 50  VRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD--RWKNTPL 105
           + +L E   + + A    +N     +A+ +G + V   L E                  
Sbjct: 144 LNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAF 202

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 21/119 (17%), Positives = 36/119 (30%), Gaps = 1/119 (0%)

Query: 3   SGNSSPGDSTTPCKGGATSSADKQKEKARVSRTSLILW-HAHQNDAAAVRKLLEEDQSLV 61
                 G       G   +             T+L L   +    +  +   L ++   +
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198

Query: 62  HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
             +     T LH   L    +  K L+   A +   +    TPL  A+  K  +  ELL
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELL 257

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 48.8 bits (116), Expect = 9e-07
 Identities = 10/61 (16%), Positives = 22/61 (36%), Gaps = 3/61 (4%)

Query: 67  DNRTPLHVASLHG---WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
            + T LH+A        + +   L++   +++ Q    +T L           ++LL   
Sbjct: 168 PDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRG 227

Query: 124 G 124
            
Sbjct: 228 K 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 2e-08
 Identities = 59/341 (17%), Positives = 101/341 (29%), Gaps = 89/341 (26%)

Query: 27  KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-NRTPLHVASLHGWIDVAK 85
             K  VS T  + W         V+K +EE    V   +Y    +P+           + 
Sbjct: 56  MSKDAVSGTLRLFWTLLSKQEEMVQKFVEE----VLRINYKFLMSPIKTEQ----RQPSM 107

Query: 86  CLIEYGADVNAQDRWKNTPLADAEGAKKFN------MMELLNA------------HGGLS 127
               Y   +  +DR  N    D +   K+N       ++L  A             G L 
Sbjct: 108 MTRMY---IEQRDRLYN----DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160

Query: 128 YGQN-------------------------GSHFEPKPVPPPLPNKCDWEIDP---SELDF 159
            G+                           +   P+ V   L     ++IDP   S  D 
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-YQIDPNWTSRSDH 219

Query: 160 SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNI 217
           SS+  +   S    L+   +  P   +  L  L +  +      F     +L+  R   +
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKP--YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277

Query: 218 VQFLGAVTERKPLMLITEYLRGG---D-----LHKYLKEKGALSPSTAVN---FALD-IA 265
             FL A T     +   ++       D     L KYL  +    P   +      L  IA
Sbjct: 278 TDFLSAATTTHISL---DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334

Query: 266 RGMAYLHNEPNVII---HRDLKPRNVLLVNSSADHLKVGDF 303
                + +         H +      ++  SS + L+  ++
Sbjct: 335 ---ESIRDGLATWDNWKHVNCDKLTTII-ESSLNVLEPAEY 371

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 18/60 (30%), Positives = 25/60 (41%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           + A+  D  T LH A+L+   D  K L++  A V   +    T L  A         ELL
Sbjct: 219 LDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELL 278

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 14/74 (18%), Positives = 27/74 (36%), Gaps = 3/74 (4%)

Query: 67  DNRTPLHVASLHGW---IDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
                LH+A        + +   +I+ G  ++A+    NT L  A    + + ++LL   
Sbjct: 189 PEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKG 248

Query: 124 GGLSYGQNGSHFEP 137
             L    N +    
Sbjct: 249 RALVGTVNEAGETA 262

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 35/151 (23%), Positives = 59/151 (39%), Gaps = 22/151 (14%)

Query: 165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----HPN- 216
           +G G F  +  ++       VA+K ++ S        +    E+ LL  +R      PN 
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYT---ETALDEIRLLKSVRNSDPNDPNR 100

Query: 217 --IVQFLGAVTERKP----LMLITEYLRGGDLHKYLK--EKGALSPSTAVNFALDIARGM 268
             +VQ L            + ++ E L G  L K++       L           + +G+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLK 299
            YLH +   IIH D+KP N+LL  +     +
Sbjct: 160 DYLHTKCR-IIHTDIKPENILLSVNEQYIRR 189

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 32/165 (19%), Positives = 56/165 (33%), Gaps = 22/165 (13%)

Query: 150 WEIDPSELDFSS-SAIIGKGSFGEILKAYWRGTPVAIKRIL------PSLSDDRLVIQDF 202
           W  +           +IGKG+  +I +  +    V IK  +        L D+ +     
Sbjct: 328 WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERL-DENIRKSRT 386

Query: 203 RHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFAL 262
             E   L  ++   I        +     ++  Y+ G      +++         ++ A 
Sbjct: 387 AREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDN--------LDIAY 438

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
            I   +  LH   N +IH DL   N +        L + DFGL K
Sbjct: 439 KIGEIVGKLHK--NDVIHNDLTTSNFIF----DKDLYIIDFGLGK 477

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 9/108 (8%)

Query: 39  LWHA-HQNDAAAVRKLLEEDQSL-----VHARDYDNRTPLHVASLH---GWIDVAKCLIE 89
           LW A    D  +V +     Q                  LH+A        + +   +I+
Sbjct: 136 LWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQ 195

Query: 90  YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
            G  ++A+    NT L  A    + + ++LL     L    N +    
Sbjct: 196 NGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETA 243

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 18/60 (30%), Positives = 25/60 (41%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           + A+  D  T LH A+L+   D  K L++  A V   +    T L  A         ELL
Sbjct: 200 LDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELL 259

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 43.6 bits (102), Expect = 5e-05
 Identities = 33/155 (21%), Positives = 54/155 (34%), Gaps = 14/155 (9%)

Query: 6   SSPGDSTTPCKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD 65
             P    T     A  +        + + T LI      N   A    L ++ + V+  D
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLI-QATAANSLLACE-FLLQNGANVNQAD 265

Query: 66  YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
              R PLH A++ G   +A   ++ GAD+ A+D     PL  A      +++ LL     
Sbjct: 266 SAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR---- 321

Query: 126 LSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFS 160
           L+  +     + +          D        DFS
Sbjct: 322 LAKMREAEAAQGQAG--------DETYLDIFRDFS 348

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	337
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.98
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.98
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.98
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.98
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.98
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.98
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.98
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.98
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.98
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.98
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.98
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.98
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.98
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
3niz_A	311	Rhodanese family protein; structural genomics, str	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.95
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.95
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.89
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.88
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.83
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.83
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.83
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.83
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.82
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.82
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.81
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.81
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.81
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.81
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.8
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.8
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.79
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.79
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.79
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.79
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.79
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.79
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.79
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.79
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.79
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.78
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.78
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.78
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.78
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.78
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.78
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.78
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.78
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.77
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.77
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.77
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.77
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.77
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.77
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.77
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.76
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.76
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.76
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.76
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.75
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.75
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.75
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.75
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.75
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.75
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.74
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.74
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.74
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.74
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.74
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.74
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.74
2rfa_A	232	Transient receptor potential cation channel subfa	99.74
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.74
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.73
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.73
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.73
2pnn_A	273	Transient receptor potential cation channel subfa	99.73
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.73
2rfa_A	232	Transient receptor potential cation channel subfa	99.73
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.73
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.73
2etb_A	256	Transient receptor potential cation channel subfam	99.72
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.72
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.72
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.72
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.72
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.72
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.72
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.72
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.71
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.71
2etb_A	256	Transient receptor potential cation channel subfam	99.71
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.71
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.71
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.71
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.71
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.71
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.71
2pnn_A	273	Transient receptor potential cation channel subfa	99.71
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.71
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.71
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.7
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.7
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.7
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.7
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.7
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.69
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.69
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.69
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.69
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.69
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.68
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.68
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.67
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.66
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.66
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.64
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.62
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.6
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.59
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.59
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.59
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.59
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.57
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.56
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.48
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.38
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.35
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.18
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.12
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.9
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.78
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.43
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.31
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.29
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.02
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.9
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.79
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.75
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.58
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.49
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.86
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.73
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.29
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.96
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.65

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.3e-44  Score=316.20  Aligned_cols=173  Identities=26%  Similarity=0.463  Sum_probs=153.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|++.+.........+.+.+|+.+++.++|||||++++++++.+.+|||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            6999999999999999999985  88999999975433223335678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||+||+|.+++...+.+++.++..|+.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+|+.+......
T Consensus       113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl--~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEECCTTTTC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEE--cCCCCEEEEEcCCceecCCCCCc
Confidence            9999999999998889999999999999999999999988  9999999999999  88899999999999987644321


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        ....+.+||+.|||||++.
T Consensus       189 --~~~~~~~GTp~YmAPEvl~  207 (311)
T 4aw0_A          189 --ARANSFVGTAQYVSPELLT  207 (311)
T ss_dssp             --CCBCCCCSCGGGCCHHHHH
T ss_pred             --ccccCcccCcccCCHHHHc
Confidence              1345678999999999873

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.2e-42  Score=302.84  Aligned_cols=169  Identities=30%  Similarity=0.546  Sum_probs=136.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|..+  |+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            7899999999999999999875  88999999987655544455778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+ +|+|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++++||+|||+|+......  
T Consensus        94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~~~--  166 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLL--DEHLNVKIADFGLSNIMTDGN--  166 (275)
T ss_dssp             CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE--CTTCCEEECCSSCC---------
T ss_pred             CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEE--CCCCCEEEeecCCCeecCCCC--
Confidence            99 6799999998889999999999999999999999988  9999999999999  888999999999998765432  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ...+..||+.|||||++.
T Consensus       167 ---~~~~~~GT~~Y~APE~~~  184 (275)
T 3hyh_A          167 ---FLKTSCGSPNYAAPEVIS  184 (275)
T ss_dssp             -----------CTTSCHHHHS
T ss_pred             ---ccCCeeECcccCChhhhc
Confidence               245678999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-42  Score=312.48  Aligned_cols=170  Identities=26%  Similarity=0.481  Sum_probs=144.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|.++  |+.||||++.+..... ...+.+.+|+.+++.++|||||++++++.+.+.+|||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            7899999999999999999986  8899999997765543 345789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+||+|.++|...  ..+++.+++.|+.||+.||.|||++|  ||||||||+|||+  +.++.+||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFL--TKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEE--CTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEE--CCCCCEEEcccccceeecCCc
Confidence            99999999999754  34789999999999999999999988  9999999999999  888999999999999876432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    .....+||+.|||||++.
T Consensus       180 ~----~~~~~~GT~~YmAPE~l~  198 (350)
T 4b9d_A          180 E----LARACIGTPYYLSPEICE  198 (350)
T ss_dssp             H----HHHHHHSCCTTCCHHHHT
T ss_pred             c----cccccCCCccccCHHHHC
Confidence            1    234567999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-42  Score=310.18  Aligned_cols=167  Identities=22%  Similarity=0.375  Sum_probs=148.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|.++  |+.||||++.......   .+.+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5888999999999999999986  8899999996543332   2567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||++|+|.+++.. +.+++.++..|+.||+.||.|||+++  ||||||||+|||+  +.+|.+||+|||+|+.+..... 
T Consensus       152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEE--CCCCCEEEecCcCceecCCCCC-
Confidence            9999999999975 56999999999999999999999988  9999999999999  8889999999999998765432 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .....+||+.|||||++.
T Consensus       226 ---~~~~~~GTp~YmAPEvl~  243 (346)
T 4fih_A          226 ---RRKSLVGTPYWMAPELIS  243 (346)
T ss_dssp             ---CBCCCCSCGGGCCHHHHT
T ss_pred             ---cccccccCcCcCCHHHHC
Confidence               345678999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-41  Score=300.99  Aligned_cols=169  Identities=28%  Similarity=0.467  Sum_probs=145.6

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----CCceEE
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPLML  232 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~l  232 (337)
                      |...+.||+|+||.||+|.++  +..||+|.+...... ....+.+.+|+.++++++|||||++++++.+    ...+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            356678999999999999986  778999998765443 3345789999999999999999999999875    345899


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla~~~~~  311 (337)
                      |||||++|+|.+++...+.+++..+..++.||+.||.|||+++.+||||||||+|||+  +. ++.+||+|||+|+....
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl--~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE--SSTTSCEEECCTTGGGGCCT
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE--ECCCCCEEEEeCcCCEeCCC
Confidence            9999999999999998889999999999999999999999976669999999999999  53 68999999999986443


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .      ...+.+||+.|||||++.
T Consensus       185 ~------~~~~~~GTp~YmAPE~~~  203 (290)
T 3fpq_A          185 S------FAKAVIGTPEFMAPEMYE  203 (290)
T ss_dssp             T------SBEESCSSCCCCCGGGGG
T ss_pred             C------ccCCcccCccccCHHHcC
Confidence            2      234578999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-41  Score=304.80  Aligned_cols=168  Identities=27%  Similarity=0.399  Sum_probs=143.1

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ..|...+.||+|+||.||+|.++  |+.||||++......        .+|+.+++.++|||||++++++.+.+.+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35777889999999999999986  889999999764332        35999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-cEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-~~kl~DFgla~~~~~~~  313 (337)
                      |||+||+|.++|+..+.+++.++..|+.||+.||.|||+++  ||||||||+|||+  +.+| ++||+|||+|+.+....
T Consensus       130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLL--SSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEE--CTTSCCEEECCCTTCEEC----
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEE--eCCCCEEEEeeCCCCeEccCCC
Confidence            99999999999998889999999999999999999999988  9999999999999  7666 69999999999876542


Q ss_pred             cc-ceeeeeCCccccccccccccc
Q 019685          314 SH-DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~-~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .. ........+||+.|||||++.
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~  229 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVM  229 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHT
T ss_pred             cccceecCCccccCccccCHHHHC
Confidence            21 111234567999999999874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=301.12  Aligned_cols=179  Identities=35%  Similarity=0.554  Sum_probs=146.6

Q ss_pred             CCCcccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 019685          147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE  226 (337)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  226 (337)
                      ...|+|+.+++.  ..+.||+|+||.||+|.+++ .||||++..... .....+.|.+|+.++++++|||||++++++. 
T Consensus        28 ~~~Wei~~~~l~--l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-  102 (307)
T 3omv_A           28 SYYWEIEASEVM--LSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-  102 (307)
T ss_dssp             -CCCBCCTTSCC--EEEECCCCSSSEEEEEESSS-EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred             CcCcEEcHHHeE--EeeEEeeCCCcEEEEEEECC-cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-
Confidence            457999887654  46799999999999998765 699998865433 3445688999999999999999999999875 


Q ss_pred             CCceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          227 RKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      .+.+|||||||++|+|.++|... ..+++.++..|+.||+.||.|||+++  ||||||||+|||+  +.++.+||+|||+
T Consensus       103 ~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl--~~~~~~Ki~DFGl  178 (307)
T 3omv_A          103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFL--HEGLTVKIGDFGL  178 (307)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEE--ETTEEEEECCCSS
T ss_pred             CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEE--CCCCcEEEeeccC
Confidence            45689999999999999999764 57999999999999999999999987  9999999999999  7788999999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+........  .......||+.|||||++.
T Consensus       179 a~~~~~~~~~--~~~~~~~GT~~ymAPE~l~  207 (307)
T 3omv_A          179 ATVKSRWSGS--QQVEQPTGSVLWMAPEVIR  207 (307)
T ss_dssp             CBC--------------CCCCTTSCCHHHHH
T ss_pred             ceecccCCcc--eeecccccCCCccCHHHhh
Confidence            9876543221  1345678999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=311.86  Aligned_cols=167  Identities=22%  Similarity=0.375  Sum_probs=149.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|.++  |+.||||++.......   .+.+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            5889999999999999999986  8899999997654433   2567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||+||+|.+++.. +.+++.++..|+.||+.||.|||++|  ||||||||+||||  +.+|.+||+|||+|+.+..... 
T Consensus       229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl--~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEE--CTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE--cCCCCEEEecCccceECCCCCc-
Confidence            9999999999965 46999999999999999999999988  9999999999999  8889999999999998765432 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .....+||+.|||||++.
T Consensus       303 ---~~~~~~GTp~YmAPEvl~  320 (423)
T 4fie_A          303 ---RRKSLVGTPYWMAPELIS  320 (423)
T ss_dssp             ---CBCCCEECTTTCCHHHHT
T ss_pred             ---cccccccCcCcCCHHHHC
Confidence               345678999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.9e-42  Score=306.15  Aligned_cols=170  Identities=31%  Similarity=0.442  Sum_probs=142.1

Q ss_pred             CccccceecccCceeEEEEEE-----CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~-----~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|++.+.||+|+||.||+|..     .++.||+|++.+...... ....+.+|+.++++++|||||++++++.+.+.+||
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            699999999999999999986     256899999876433221 12357789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |||||+||+|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl--~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILL--DEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEE--cCCCCEEecccccceeccCC
Confidence            9999999999999998889999999999999999999999988  9999999999999  88899999999999876543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ...+.+||+.|||||++.
T Consensus       180 ~~----~~~~~~GT~~YmAPE~~~  199 (304)
T 3ubd_A          180 EK----KAYSFCGTVEYMAPEVVN  199 (304)
T ss_dssp             -C----CCCSCCCCGGGCCHHHHH
T ss_pred             Cc----cccccccCcccCCHHHhc
Confidence            32    345678999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-41  Score=298.73  Aligned_cols=170  Identities=30%  Similarity=0.520  Sum_probs=144.8

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|...+.||+|+||.||+|.+.       +..||||.+...   .....+.|.+|+.+|++++|||||++++++.+.+.+
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            6777889999999999999864       567999999653   234457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc
Q 019685          231 MLITEYLRGGDLHKYLKEK-------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH  297 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~  297 (337)
                      |||||||++|+|.++|...             ..+++.+++.++.||+.||.|||+++  ||||||||+|||+  +.++.
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl--~~~~~  166 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV--GENLL  166 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGC
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEE--CCCCc
Confidence            9999999999999999753             35899999999999999999999987  9999999999999  78889


Q ss_pred             EEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       298 ~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +||+|||+|+.....+.  ........||+.|||||++.
T Consensus       167 ~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~  203 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIM  203 (299)
T ss_dssp             EEECCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHH
T ss_pred             EEECCcccceecCCCCc--eeecCceecChhhcCHHHHc
Confidence            99999999987654322  11223456999999999873

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-40  Score=296.56  Aligned_cols=170  Identities=31%  Similarity=0.511  Sum_probs=144.5

Q ss_pred             ccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          159 FSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      ++..+.||+|+||.||+|.+.       ++.||||.+......  ...+.|.+|+.++++++|||||+++|++.+.+.++
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            445678999999999999873       568999998654322  23478999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC
Q 019685          232 LITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA  295 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~  295 (337)
                      ||||||++|+|.++|...                ..+++.++..++.||+.||.|||+++  ||||||||+|||+  +.+
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl--~~~  181 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLV--YDK  181 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEE--CCC
Confidence            999999999999999642                35899999999999999999999987  9999999999999  888


Q ss_pred             CcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       296 ~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.+||+|||+|+.+...+..  .......||+.|||||++.
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~  220 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYY--KLLGNSLLPIRWMAPEAIM  220 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCB--CSSSSSCBCGGGCCHHHHH
T ss_pred             CCEEECCcccceeccCCCce--eEecccccCCcccCHHHHh
Confidence            89999999999877544321  1245678999999999873

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.5e-40  Score=294.40  Aligned_cols=173  Identities=30%  Similarity=0.519  Sum_probs=135.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-------  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-------  228 (337)
                      +|+..+.||+|+||.||+|.++  |+.||||.+....  .....+.+.+|+.+|+.++|||||++++++.+.+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            5788899999999999999986  8899999986543  3344578899999999999999999999987654       


Q ss_pred             -----ceEEEEeecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEE
Q 019685          229 -----PLMLITEYLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV  300 (337)
Q Consensus       229 -----~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl  300 (337)
                           .+|+|||||++|+|.+++.....   .++..++.++.||+.||.|||+++  ||||||||+|||+  +.++.+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl--~~~~~vKl  159 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKV  159 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEE--CCCCcEEE
Confidence                 37999999999999999987654   345668899999999999999988  9999999999999  88889999


Q ss_pred             EeccCceeeecccccc--------eeeeeCCccccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHD--------VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +|||+|+.+.......        .....+.+||+.|||||++.
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~  203 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH  203 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHT
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence            9999999876542211        11234567999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=298.76  Aligned_cols=170  Identities=32%  Similarity=0.536  Sum_probs=138.9

Q ss_pred             CccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|...+.||+|+||.||+|.++       ++.||||.+...   .....+.|.+|+.+|++++|||||++++++.+.+.+
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            5677789999999999999874       567999999653   234557899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC
Q 019685          231 MLITEYLRGGDLHKYLKEK---------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA  295 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~  295 (337)
                      |||||||++|+|.+++...               +.+++.+++.|+.||+.||.|||+++  ||||||||+|||+  +.+
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl--~~~  194 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV--GQG  194 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE--CCC
Confidence            9999999999999999753               35899999999999999999999987  9999999999999  788


Q ss_pred             CcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          296 DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       296 ~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.+||+|||+|+.+...+.  ........||+.|||||++.
T Consensus       195 ~~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~  233 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESIL  233 (329)
T ss_dssp             TEEEECCCC------------------CCCCGGGCCHHHHT
T ss_pred             CcEEEcccccceeccCCCc--ceecCcccccccccChhhhc
Confidence            8999999999987754322  11234577999999999874

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.6e-40  Score=291.97  Aligned_cols=172  Identities=29%  Similarity=0.426  Sum_probs=138.6

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC----ceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~lv  233 (337)
                      +|...+.||+|+||.||+|.++|+.||||++....    .....+..|+..+..++|||||++++++.+.+    .+|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            56677899999999999999999999999985431    11223345666677889999999999987654    57999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC------CCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      ||||++|+|.++++.. .++++.+.+++.|++.||.|||++      ..+||||||||+|||+  +.++.+||+|||+|+
T Consensus        80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl--~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE--CCCCCEEEEeCCCCc
Confidence            9999999999999754 689999999999999999999986      1149999999999999  888999999999999


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .................||+.|||||++.
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~  185 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLD  185 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHT
T ss_pred             cccCCCCceeeecccccccccccCHHHhc
Confidence            87654332212234568999999999873

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=294.46  Aligned_cols=173  Identities=27%  Similarity=0.476  Sum_probs=147.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe------CCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~~  229 (337)
                      +|++.+.||+|+||.||+|.++  |+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++..      .+.
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            6999999999999999999985  889999999765433 3345778899999999999999999998754      357


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|||||||+ |+|.+++...+.+++.++..|+.||+.||.|||++|  ||||||||+|||+  +..+.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~--~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLV--NENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCcccccc--CCCCCEEEeecceeeec
Confidence            899999996 589999988889999999999999999999999988  9999999999999  88899999999999877


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ............+.+||+.|||||+++
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~  235 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELML  235 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHT
T ss_pred             ccCccccccccccceeChHhcCHHHhc
Confidence            543222222346678999999999874

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.3e-39  Score=292.21  Aligned_cols=179  Identities=29%  Similarity=0.538  Sum_probs=149.3

Q ss_pred             CCcccCCCCcCccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC-CCeee
Q 019685          148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQ  219 (337)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~  219 (337)
                      +.|+|+.+  +|+..+.||+|+||.||+|.+.+       +.||||.+.....  ....+.+.+|+.+|.+++| ||||+
T Consensus        57 ~~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           57 SKWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             HHHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            35777754  56778899999999999998753       4699999875443  3345789999999999975 89999


Q ss_pred             eeeeEEeC-CceEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeC
Q 019685          220 FLGAVTER-KPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD  282 (337)
Q Consensus       220 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrd  282 (337)
                      +++++... +.+|||||||++|+|.++|+..                ..+++.++..++.||+.||.|||+++  |||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRD  210 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  210 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCc
Confidence            99998664 5789999999999999999752                23789999999999999999999987  99999


Q ss_pred             CCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       283 lkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+|||+  +.++.+||+|||+|+.+.....  ........||+.|||||++.
T Consensus       211 LK~~NILl--~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~  260 (353)
T 4ase_A          211 LAARNILL--SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIF  260 (353)
T ss_dssp             CSGGGEEE--CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHH
T ss_pred             cCccceee--CCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHh
Confidence            99999999  7888999999999987654322  22345667999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.2e-39  Score=309.11  Aligned_cols=173  Identities=28%  Similarity=0.404  Sum_probs=148.5

Q ss_pred             CCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCch---HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      .+-.+|++.++||+|+||.||+|..+  |+.||+|++.+.....   .........++.+++.++|||||+++++|++.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            34448999999999999999999985  8899999996532211   112222334566777889999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+|||||||+||+|.++|...+.+++..+..|+.||+.||.|||++|  ||||||||+|||+  +.+|++||+|||+|+.
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILl--d~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEE--eCCCCEEecccceeee
Confidence            99999999999999999999889999999999999999999999988  9999999999999  8889999999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +...      ...+.+||+.|||||+|.
T Consensus       342 ~~~~------~~~t~~GTp~YmAPEvl~  363 (689)
T 3v5w_A          342 FSKK------KPHASVGTHGYMAPEVLQ  363 (689)
T ss_dssp             CSSC------CCCSCCSCGGGCCHHHHS
T ss_pred             cCCC------CCCCccCCcCccCHHHHh
Confidence            7543      235678999999999984

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-36  Score=277.60  Aligned_cols=167  Identities=19%  Similarity=0.306  Sum_probs=139.1

Q ss_pred             CccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~  231 (337)
                      .|++.+.||+|+||.||+|..+     ++.||+|.+.+...     ..++.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            6899999999999999999863     56899999865432     24567899999998 5999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC-CcEEEEeccCceeee
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLIK  310 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~-~~~kl~DFgla~~~~  310 (337)
                      +||||+++++|.+++.   .+++.++..++.||+.||.|||++|  |+||||||+|||+  +.+ +.+||+|||+|+...
T Consensus        97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl--~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLY--NRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCCTTCEECT
T ss_pred             EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEE--eCCCCeEEECcCCCCcccC
Confidence            9999999999999984   5999999999999999999999988  9999999999999  444 789999999998754


Q ss_pred             cccccc------------------------eeeeeCCccccccccccccc
Q 019685          311 VQNSHD------------------------VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~------------------------~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......                        .......+||+.|||||++.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~  219 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT  219 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHT
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence            321100                        00134457999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9e-37  Score=294.37  Aligned_cols=169  Identities=24%  Similarity=0.506  Sum_probs=149.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|..+  |+.||+|++.....   ...+.+.+|+.+|+.++||||+++++++.+...+|||||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            7899999999999999999986  88999999865432   234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+||+|.++|.. .+.+++.++..++.||+.||.|||+++  |+||||||+|||+..+..+.+||+|||+|+.+.... 
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            9999999999964 457999999999999999999999988  999999999999954456899999999999876542 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....+||+.|||||++.
T Consensus       312 ----~~~~~~GT~~y~APEv~~  329 (573)
T 3uto_A          312 ----SVKVTTGTAEFAAPEVAE  329 (573)
T ss_dssp             ----EEEEECSSGGGCCHHHHT
T ss_pred             ----ceeeeEECccccCHHHhC
Confidence                244568999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-34  Score=260.57  Aligned_cols=171  Identities=26%  Similarity=0.422  Sum_probs=149.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            7888999999999999999985  88999999865322122234667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++|+|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++....... 
T Consensus        86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~~-  160 (337)
T 1o6l_A           86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTC-
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEE--CCCCCEEEeeccchhhcccCCC-
Confidence            9999999999988888999999999999999999999988  9999999999999  8889999999999986443221 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       161 ---~~~~~~gt~~y~aPE~~~  178 (337)
T 1o6l_A          161 ---TMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             ---CBCCCEECGGGCCGGGGS
T ss_pred             ---cccccccChhhCChhhhc
Confidence               345678999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-34  Score=265.33  Aligned_cols=172  Identities=27%  Similarity=0.422  Sum_probs=149.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      .+|+..+.||+|+||.||+|..+  ++.+|+|++.+.........+.+..|..++.++ +||||+++++++.+.+.+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            37899999999999999999986  678999999776554444456678899998876 799999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |||+++|+|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++++||+|||+++......
T Consensus       132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl--~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTT
T ss_pred             EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEE--CCCCCEEEeecceeeecccCC
Confidence            999999999999998888999999999999999999999988  9999999999999  888999999999998643322


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......||+.|+|||++.
T Consensus       208 ~----~~~~~~gt~~Y~aPE~l~  226 (396)
T 4dc2_A          208 D----TTSTFCGTPNYIAPEILR  226 (396)
T ss_dssp             C----CBCCCCBCGGGCCHHHHT
T ss_pred             C----ccccccCCcccCCchhhc
Confidence            1    345678999999999874

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-34  Score=262.36  Aligned_cols=170  Identities=26%  Similarity=0.415  Sum_probs=144.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|++.+.........+.+..|..++..+ +||||+++++++.+.+.+|+||
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            7889999999999999999986  789999998654322233446678899999988 5999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++++||+|||+++.......
T Consensus       104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl--~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLL--DHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCC---
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEE--CCCCCEEEccccceeecccCCc
Confidence            99999999999998888999999999999999999999988  9999999999999  8889999999999986443221


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......||+.|+|||++
T Consensus       180 ----~~~~~~gt~~y~aPE~~  196 (353)
T 3txo_A          180 ----TTATFCGTPDYIAPEIL  196 (353)
T ss_dssp             ----------CCGGGCCHHHH
T ss_pred             ----cccccCCCcCeEChhhc
Confidence                34566899999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.1e-34  Score=257.84  Aligned_cols=171  Identities=27%  Similarity=0.429  Sum_probs=152.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|++.+.........+.+.+|..++..+ +||||+++++++.+...+|+||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            7889999999999999999986  788999999876655556667888999999988 7999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++++||+|||+++.......
T Consensus        90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCGGGCBCSCCTTC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--CCCCCEEEEeccccccccCCCC
Confidence            99999999999988888999999999999999999999988  9999999999999  8889999999999986433221


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       166 ----~~~~~~gt~~y~aPE~~~  183 (345)
T 3a8x_A          166 ----TTSTFCGTPNYIAPEILR  183 (345)
T ss_dssp             ----CBCCCCSCGGGCCHHHHT
T ss_pred             ----cccccCCCccccCccccC
Confidence                245678999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.2e-34  Score=256.39  Aligned_cols=169  Identities=32%  Similarity=0.499  Sum_probs=151.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  |+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            7899999999999999999974  889999999765443 3345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++.++..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++......  
T Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~--  168 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLL--DADMNIKIADFGFSNEFTVGG--  168 (328)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSTTCCGGGSSSC--
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEE--cCCCCEEEeeccCceecCCCC--
Confidence            9999999999988888999999999999999999999988  9999999999999  888999999999998765432  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       169 ---~~~~~~gt~~y~aPE~~~  186 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQ  186 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHH
T ss_pred             ---ccccccCCcceeCccccc
Confidence               245678999999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.9e-34  Score=263.41  Aligned_cols=171  Identities=25%  Similarity=0.448  Sum_probs=151.0

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++...  ++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            37899999999999999999986  6789999986543222223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+.+|+|.+++.....+++..+..++.||+.||.|||+.|  |+||||||+|||+  +..+.+||+|||+++.+.... 
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~-  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRET-  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTC-
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEE--CCCCCEEEeccceeeeccCCC-
Confidence            99999999999998888999999999999999999999988  9999999999999  888999999999998775432 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       170 ----~~~~~~gt~~Y~aPE~~~  187 (384)
T 4fr4_A          170 ----QITTMAGTKPYMAPEMFS  187 (384)
T ss_dssp             ----CBCCCCSCGGGCCGGGTC
T ss_pred             ----ceeccCCCccccCCeeec
Confidence                345678999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-33  Score=250.42  Aligned_cols=172  Identities=29%  Similarity=0.473  Sum_probs=147.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+...........+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   91 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME   91 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence            7899999999999999999875  78999999877666666667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++  |+||||||+|||+  +.++.+||+|||+++....... 
T Consensus        92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~-  166 (294)
T 4eqm_A           92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILI--DSNKTLKIFDFGIAKALSETSL-  166 (294)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCSSSTTC------
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCCEEEEeCCCccccccccc-
Confidence            9999999999998888999999999999999999999988  9999999999999  8888999999999987654321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|+|||++.
T Consensus       167 --~~~~~~~gt~~y~aPE~~~  185 (294)
T 4eqm_A          167 --TQTNHVLGTVQYFSPEQAK  185 (294)
T ss_dssp             ----------CCSSCCHHHHH
T ss_pred             --cccCccccCccccCHhHhc
Confidence              1234567999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.8e-34  Score=267.69  Aligned_cols=173  Identities=24%  Similarity=0.380  Sum_probs=148.2

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||+|..+  ++.||+|++.+...........+.+|..++..++||||+++++++.+.+.+|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            47889999999999999999986  6789999986422111111234788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+|+......
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl--~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTS
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeE--cCCCCEEEcchhhhhhcccCC
Confidence            99999999999987 467999999999999999999999988  9999999999999  888999999999998765443


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .   .......||+.|||||++.
T Consensus       230 ~---~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          230 T---VQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             C---EECCSCCSCGGGCCHHHHH
T ss_pred             C---cccccccCCcCeeChHHHh
Confidence            2   1334568999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.9e-34  Score=258.48  Aligned_cols=173  Identities=28%  Similarity=0.439  Sum_probs=148.4

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ..+|...+.||+|+||.||+|..+  ++.||+|.+.+.........+.+..|..++..+ +||||+++++++.+.+.+|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            347899999999999999999985  788999998653211112235677888888876 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||+++|+|.+++...+.+++..+..++.||+.||.|||++|  |+||||||+|||+  +.++++||+|||+++.....
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL--DKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEE--CCCCCEEEeEChhhhhcccC
Confidence            9999999999999998888999999999999999999999988  9999999999999  88899999999999865433


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......||+.|+|||++.
T Consensus       172 ~~----~~~~~~gt~~y~aPE~~~  191 (345)
T 1xjd_A          172 DA----KTNTFCGTPDYIAPEILL  191 (345)
T ss_dssp             TC----CBCCCCSCGGGCCHHHHT
T ss_pred             CC----cccCCCCCcccCChhhhc
Confidence            21    245678999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-34  Score=254.88  Aligned_cols=168  Identities=27%  Similarity=0.499  Sum_probs=148.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  |+.||+|++.+.........+.+.+|..+++.++||||+++++++.+...+|+|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            7888999999999999999985  88999999865322222234667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.....   
T Consensus        87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC---
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEE--cCCCCEEEeecCcceecCCc---
Confidence            9999999999998888999999999999999999999988  9999999999999  88899999999999875432   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....||+.|+|||++.
T Consensus       160 ----~~~~~gt~~y~aPE~~~  176 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVS  176 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHT
T ss_pred             ----cccccCCccccCHhHhc
Confidence                24567999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-34  Score=263.67  Aligned_cols=173  Identities=27%  Similarity=0.399  Sum_probs=148.7

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++..+  ++.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            37889999999999999999985  8899999986432212222345788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++|+|.+++...+ .+++..++.++.||+.||.|||+++  |+||||||+|||+  +..+++||+|||+++......
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl--d~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTS
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeee--cCCCCEEEeechhheeccCCC
Confidence            9999999999998754 7999999999999999999999988  9999999999999  888999999999998776442


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .   .......||+.|||||++.
T Consensus       217 ~---~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          217 T---VRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             C---EECSSCCSCGGGCCHHHHH
T ss_pred             c---cccceeccccCcCCHHHHh
Confidence            2   1234568999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.2e-33  Score=259.36  Aligned_cols=174  Identities=31%  Similarity=0.455  Sum_probs=141.9

Q ss_pred             CCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHH-HHhCCCCCeeeeeeeEEeCCceE
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL-LVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~-l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      ...+|+..+.||+|+||.||+|..+  ++.||+|++.+...........+..|..+ ++.++||||+++++++.+.+.+|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3347999999999999999999986  67899999976554444444566677776 56788999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +||||+++|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||+  +.++++||+|||+++....
T Consensus       116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL--DSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCBCGGGBC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--CCCCCEEEeeCcccccccc
Confidence            99999999999999998888999999999999999999999988  9999999999999  8889999999999986433


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...    ......||+.|+|||++.
T Consensus       192 ~~~----~~~~~~gt~~y~aPE~~~  212 (373)
T 2r5t_A          192 HNS----TTSTFCGTPEYLAPEVLH  212 (373)
T ss_dssp             CCC----CCCSBSCCCCCCCHHHHT
T ss_pred             CCC----ccccccCCccccCHHHhC
Confidence            221    345678999999999874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.4e-33  Score=246.74  Aligned_cols=168  Identities=24%  Similarity=0.425  Sum_probs=147.6

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||+|...  ++.||+|.+.......   .+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            37889999999999999999864  7899999986544333   356788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++... .+++..+..++.|++.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTC
T ss_pred             ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE--CCCCCEEEeeCCCceecCCccc
Confidence            999999999999764 6999999999999999999999988  9999999999999  8888999999999987764432


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       172 ----~~~~~~gt~~y~aPE~~~  189 (297)
T 3fxz_A          172 ----KRSTMVGTPYWMAPEVVT  189 (297)
T ss_dssp             ----CBCCCCSCGGGCCHHHHH
T ss_pred             ----ccCCccCCcCccChhhhc
Confidence                345568999999999863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.6e-33  Score=256.68  Aligned_cols=168  Identities=27%  Similarity=0.421  Sum_probs=148.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||++...  ++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            7889999999999999999985  78999999865322222234678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||++|  |+||||||+|||+  +.++.+||+|||+++.....   
T Consensus       122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC---
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEE--CCCCCEEEcccccceeccCC---
Confidence            9999999999998888999999999999999999999988  9999999999999  88899999999999876432   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....||+.|+|||++.
T Consensus       195 ----~~~~~gt~~y~aPE~~~  211 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIIL  211 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHT
T ss_pred             ----cccccCCccccCHHHhc
Confidence                23567999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.3e-33  Score=249.71  Aligned_cols=174  Identities=37%  Similarity=0.612  Sum_probs=142.0

Q ss_pred             CcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      ..+|++.+.||+|+||.||+|.++++.||+|++...... ....+.+.+|+.++++++||||+++++++.....+++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            447888999999999999999999999999998765443 3445788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          236 YLRGGDLHKYLKEKGA---LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |+++++|.+++...+.   +++..++.++.||+.||.|||+++.+|+||||||+|||+  +.++.+||+|||+++.....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE--CTTCCEEECCCC--------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE--eCCCcEEECCCCCCcccccc
Confidence            9999999999986543   999999999999999999999965559999999999999  88889999999999865433


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......||+.|+|||++.
T Consensus       193 ~~----~~~~~~gt~~y~aPE~~~  212 (309)
T 3p86_A          193 FL----SSKSAAGTPEWMAPEVLR  212 (309)
T ss_dssp             -------------CCTTSCHHHHT
T ss_pred             cc----ccccCCCCccccChhhhc
Confidence            21    234567999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.5e-34  Score=263.69  Aligned_cols=172  Identities=24%  Similarity=0.398  Sum_probs=146.9

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||+|..+  ++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            37889999999999999999986  7789999985421111111234678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++|+|.+++.. ..+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+++||+|||+++.......
T Consensus       149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl--~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCTTSE
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeE--CCCCCEEEeccceeEeeccCCc
Confidence            99999999999975 46999999999999999999999988  9999999999999  8889999999999987654321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .......||+.|||||++.
T Consensus       224 ---~~~~~~~gt~~Y~APE~l~  242 (410)
T 3v8s_A          224 ---VRCDTAVGTPDYISPEVLK  242 (410)
T ss_dssp             ---EECCSCCSCGGGCCHHHHH
T ss_pred             ---ccccCCcCCccccCHHHhh
Confidence               2345678999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-33  Score=257.41  Aligned_cols=171  Identities=27%  Similarity=0.416  Sum_probs=148.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|+||
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~  100 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  100 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence            7889999999999999999986  678999998653221222346678899999888 6999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||+  +.++++||+|||+++.......
T Consensus       101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A          101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEE--cCCCcEEEEeCCcccccccCCc
Confidence            99999999999998888999999999999999999999988  9999999999999  8889999999999986433221


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       177 ----~~~~~~gt~~y~aPE~~~  194 (353)
T 2i0e_A          177 ----TTKTFCGTPDYIAPEIIA  194 (353)
T ss_dssp             ----CBCCCCSCGGGCCHHHHT
T ss_pred             ----ccccccCCccccChhhhc
Confidence                245678999999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.1e-33  Score=254.29  Aligned_cols=171  Identities=30%  Similarity=0.473  Sum_probs=148.8

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchH---HHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      ..|...+.||+|+||.||+|...  |+.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            36889999999999999999986  88999999976543211   12367889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC----cEEEEeccCce
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSK  307 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~----~~kl~DFgla~  307 (337)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||+.|  |+||||||+|||+  +..+    .+||+|||+++
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll--~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML--LDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCTTSSSCCEEECCCSSCE
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--eCCCCCccCEEEEecCCce
Confidence            99999999999999988888999999999999999999999988  9999999999999  5444    79999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+....     ......||+.|+|||++.
T Consensus       168 ~~~~~~-----~~~~~~gt~~y~aPE~~~  191 (361)
T 2yab_A          168 EIEDGV-----EFKNIFGTPEFVAPEIVN  191 (361)
T ss_dssp             ECCTTC-----CCCCCCSCGGGCCHHHHT
T ss_pred             EcCCCC-----ccccCCCCccEECchHHc
Confidence            776432     235567999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-32  Score=258.14  Aligned_cols=172  Identities=24%  Similarity=0.363  Sum_probs=149.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  |+.+|+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            6888899999999999999875  889999998765543 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+.+|+|.+++...+.+++..+..++.||+.||.|||++|  |+||||||+|||+..+ ..+.+||+|||+++.......
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            9999999999998888999999999999999999999988  9999999999999432 457899999999987764432


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       169 ----~~~~~~gt~~Y~APE~l~  186 (444)
T 3soa_A          169 ----AWFGFAGTPGYLSPEVLR  186 (444)
T ss_dssp             ----BCCCSCSCGGGCCHHHHT
T ss_pred             ----eeecccCCcccCCHHHhc
Confidence                245678999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-32  Score=248.74  Aligned_cols=171  Identities=30%  Similarity=0.476  Sum_probs=138.6

Q ss_pred             CccccceecccCceeEEEEEE-----CCceEEEEEecCCCCc-hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      +|+..+.||+|+||.||++..     .++.+|+|++.+.... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            788999999999999999986     4788999999765322 2223456788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++|  |+||||||+|||+  +.++.+||+|||+++....
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIML--NHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEE--CTTSCEEECCCSCC-----
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEE--CCCCcEEEEeCCccccccc
Confidence            99999999999999988888999999999999999999999988  9999999999999  8888999999999976543


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...    ......||+.|+|||++.
T Consensus       174 ~~~----~~~~~~gt~~y~aPE~~~  194 (327)
T 3a62_A          174 DGT----VTHTFCGTIEYMAPEILM  194 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHT
T ss_pred             CCc----cccccCCCcCccCHhhCc
Confidence            321    234567999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.7e-33  Score=253.60  Aligned_cols=169  Identities=30%  Similarity=0.508  Sum_probs=146.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.+.+.||+|+||.||+|.+.  ++.||+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            7889999999999999999984  78999999864322211123567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+ +|+|.+++...+.+++.++..++.||+.||.|||+.|  |+||||||+|||+  +..+.+||+|||+++......  
T Consensus        90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLL--DDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEE--CTTCCEEECCSSCTBTTTTSB--
T ss_pred             CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEE--cCCCCEEEEEeccceeccCCc--
Confidence            99 6799999988888999999999999999999999988  9999999999999  888899999999998765432  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       163 ---~~~~~~gt~~y~aPE~~~  180 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVIN  180 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSC
T ss_pred             ---ccccccCCcCcCCHHHHc
Confidence               234567999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4e-32  Score=243.29  Aligned_cols=172  Identities=34%  Similarity=0.581  Sum_probs=146.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++.+.  ++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            7888899999999999999986  788999988543   34456788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++.. ...+++.++..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLV--RENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--CTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEE--CCCCCEEEeecccceecccccc
Confidence            9999999999987 567999999999999999999999988  9999999999999  8888999999999988754322


Q ss_pred             cce----------eeeeCCccccccccccccc
Q 019685          315 HDV----------YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~----------~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...          .......||+.|+|||++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN  195 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHT
T ss_pred             cccccccccccccccccccCCCcceeCHHHhc
Confidence            110          0112567999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.8e-32  Score=250.94  Aligned_cols=171  Identities=31%  Similarity=0.428  Sum_probs=139.8

Q ss_pred             CCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ...+|...+.||+|+||.||++...  ++.||+|++.......    +.+.+|+.+++.++||||+++++++.....+|+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            3447999999999999999999985  7889999997644332    457789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||++|  |+||||||+|||+..+..+.+||+|||+++.....
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999999999988888999999999999999999999988  99999999999994434445999999999754332


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .     ......||+.|+|||++.
T Consensus       172 ~-----~~~~~~gt~~y~aPE~~~  190 (361)
T 3uc3_A          172 S-----QPKSTVGTPAYIAPEVLL  190 (361)
T ss_dssp             --------------CTTSCHHHHH
T ss_pred             C-----CCCCCcCCCCcCChhhhc
Confidence            2     234567999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-32  Score=246.41  Aligned_cols=168  Identities=18%  Similarity=0.320  Sum_probs=146.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  ++.+|+|.+....    .....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            7888999999999999999986  7789999886432    234567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++... ..+++.++..++.||+.||.|||+.|  |+||||||+|||+..+.++.+||+|||+++.+.... 
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            99999999999764 36999999999999999999999988  999999999999944337899999999998876442 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       159 ----~~~~~~gt~~y~aPE~~~  176 (321)
T 1tki_A          159 ----NFRLLFTAPEYYAPEVHQ  176 (321)
T ss_dssp             ----EEEEEESCGGGSCHHHHT
T ss_pred             ----ccccccCChhhcCcHHhc
Confidence                234567999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.8e-33  Score=248.94  Aligned_cols=174  Identities=27%  Similarity=0.470  Sum_probs=142.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc----eE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----LM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~----~~  231 (337)
                      +|+..+.||+|+||.||+|.+.  ++.||+|++.............+.+|+.+++.++||||+++++++.....    .|
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            7889999999999999999974  78999999987666666667789999999999999999999999876654    39


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +||||+++++|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+..
T Consensus        93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--ETTSCEEECCCSCC-----
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEE--cCCCCEEEeeccCcccccc
Confidence            99999999999999998888999999999999999999999988  9999999999999  7778999999999987754


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .... ........||+.|+|||++.
T Consensus       169 ~~~~-~~~~~~~~gt~~y~aPE~~~  192 (311)
T 3ork_A          169 SGNS-VTQTAAVIGTAQYLSPEQAR  192 (311)
T ss_dssp             --------------CCTTCCHHHHH
T ss_pred             cccc-cccccccCcCcccCCHHHhc
Confidence            3221 11234567999999999863

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.4e-32  Score=250.10  Aligned_cols=171  Identities=27%  Similarity=0.438  Sum_probs=149.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            6888999999999999999986  789999999765443 3345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++.....+++.++..++.||+.||.|||+.+  |+||||||+|||+..+ ..+.+||+|||+++...... 
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-  185 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  185 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence            9999999999988788999999999999999999999988  9999999999999432 23569999999998765432 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       186 ----~~~~~~gt~~y~aPE~~~  203 (362)
T 2bdw_A          186 ----AWHGFAGTPGYLSPEVLK  203 (362)
T ss_dssp             ----SCCCSCSCTTTCCHHHHT
T ss_pred             ----ccccCCCCccccCHHHHc
Confidence                234578999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-32  Score=264.10  Aligned_cols=172  Identities=28%  Similarity=0.447  Sum_probs=148.9

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ..+|...+.||+|+||.||+|...  |+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            347889999999999999999985  889999998653222222235678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          234 TEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |||+++|+|.+++...+  .+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++++||+|||+++.+..
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILl--d~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILL--DDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEE--eCCCCeEEEecccceeccc
Confidence            99999999999998654  3999999999999999999999988  9999999999999  8889999999999987754


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..     ......||+.|+|||++.
T Consensus       339 ~~-----~~~~~~GT~~Y~APEvl~  358 (576)
T 2acx_A          339 GQ-----TIKGRVGTVGYMAPEVVK  358 (576)
T ss_dssp             TC-----CEECCCSCGGGCCHHHHT
T ss_pred             Cc-----cccccCCCccccCHHHHc
Confidence            32     234568999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.98  E-value=3.6e-33  Score=262.64  Aligned_cols=172  Identities=26%  Similarity=0.408  Sum_probs=139.7

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||+|...  ++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            36889999999999999999975  7899999986543223334466788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+ .+  |+||||||+|||+  +.++.+||+|||+++......
T Consensus       228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEE--CSSSCEEECCCCCCCTTCC--
T ss_pred             eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEE--CCCCCEEEccCCCceeccCCC
Confidence            999999999999888889999999999999999999998 88  9999999999999  888899999999998643322


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......||+.|+|||++.
T Consensus       304 ~----~~~~~~gt~~y~aPE~~~  322 (446)
T 4ejn_A          304 A----TMKTFCGTPEYLAPEVLE  322 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHH
T ss_pred             c----ccccccCCccccCHhhcC
Confidence            1    345678999999999863

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.98  E-value=3e-32  Score=246.04  Aligned_cols=170  Identities=29%  Similarity=0.501  Sum_probs=147.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCch---HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      .|...+.||+|+||.||+|...  ++.||+|.+.......   ....+.+.+|+.+++.++||||+++++++......++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            5888999999999999999986  7899999986543321   1124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC----cEEEEeccCcee
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL  308 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~----~~kl~DFgla~~  308 (337)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+    .+||+|||+++.
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll--~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--SCSSSSSCCEEECCCTTCEE
T ss_pred             EEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEE--ecCCCCCCCEEEEECCCCeE
Confidence            9999999999999988788999999999999999999999988  9999999999999  5555    799999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....     ......||+.|+|||++.
T Consensus       168 ~~~~~-----~~~~~~gt~~y~aPE~~~  190 (326)
T 2y0a_A          168 IDFGN-----EFKNIFGTPEFVAPEIVN  190 (326)
T ss_dssp             CCTTS-----CCCCCCSCTTTCCHHHHT
T ss_pred             CCCCC-----ccccccCCcCcCCceeec
Confidence            75432     234567999999999863

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.98  E-value=5.7e-32  Score=244.09  Aligned_cols=174  Identities=31%  Similarity=0.516  Sum_probs=145.7

Q ss_pred             CCcCccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      ...+|.+.+.||+|+||.||+|.+.     +..||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            3457888999999999999999984     34599999865432  3345788999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .|+||||+++++|.+++... +.+++.++..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLV--DSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCSSCEE
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE--CCCCCEEECCCCcccc
Confidence            99999999999999999754 57999999999999999999999988  9999999999999  8888999999999988


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....... ........+|+.|+|||++
T Consensus       201 ~~~~~~~-~~~~~~~~~t~~y~aPE~~  226 (325)
T 3kul_A          201 LEDDPDA-AYTTTGGKIPIRWTAPEAI  226 (325)
T ss_dssp             CC----C-CEECC---CCGGGSCHHHH
T ss_pred             cccCccc-eeeccCCCCcccccCHhHh
Confidence            7654321 1233455678899999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.98  E-value=4.3e-32  Score=241.02  Aligned_cols=169  Identities=30%  Similarity=0.535  Sum_probs=145.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+....... .....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            6888999999999999999985  7889999997654332 334677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++ ++.+.+.. .+.+++..+..++.||+.||.|||++|  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECCSCCS
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEeecccceecCCccc
Confidence            9986 66665544 667999999999999999999999988  9999999999999  8888999999999987654322


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       157 ----~~~~~~~t~~y~aPE~~~  174 (292)
T 3o0g_A          157 ----CYSAEVVTLWYRPPDVLF  174 (292)
T ss_dssp             ----CCCSCCSCGGGCCHHHHT
T ss_pred             ----cccCCccccCCcChHHHc
Confidence                345567899999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.98  E-value=1.6e-32  Score=247.43  Aligned_cols=171  Identities=29%  Similarity=0.472  Sum_probs=146.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|++......  ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            7889999999999999999886  788999998654332  223667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.....+++.++..++.||+.||.|||+.|  |+||||||+|||+  +..+.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEE--eCCCCEEEEEeeccceeccCCcc
Confidence            9999999999987778999999999999999999999988  9999999999999  88889999999999876543221


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|+|||++.
T Consensus       162 --~~~~~~~gt~~y~aPE~~~  180 (323)
T 3tki_A          162 --RLLNKMCGTLPYVAPELLK  180 (323)
T ss_dssp             --CCBCSCCSCGGGSCHHHHH
T ss_pred             --cccCCCccCcCccCcHHhc
Confidence              1234678999999999873

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.98  E-value=9.9e-32  Score=243.49  Aligned_cols=174  Identities=25%  Similarity=0.361  Sum_probs=153.7

Q ss_pred             CCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ...+|...+.||+|+||.||++.+.  ++.+++|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4457999999999999999999986  67899999876655455566788999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||+++++|.+++.....+++.+++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.....
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEE--cCCCCEEEeeccCceecccC
Confidence            9999999999999988888999999999999999999999988  9999999999999  78889999999999877543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......||+.|+|||++.
T Consensus       195 ~~----~~~~~~gt~~y~aPE~~~  214 (335)
T 2owb_A          195 GE----RKKVLCGTPNYIAPEVLS  214 (335)
T ss_dssp             TC----CBCCCCSCCSSCCHHHHH
T ss_pred             cc----cccccCCCccccCHHHhc
Confidence            22    234567999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.98  E-value=1.6e-32  Score=262.29  Aligned_cols=172  Identities=26%  Similarity=0.415  Sum_probs=148.8

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|...+.||+|+||.||+|..+  |+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            47888999999999999999985  8899999986543222223467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          235 EYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       235 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ||+++|+|.+++...    ..+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+.
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl--~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLL--DDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCEECC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEE--eCCCCEEEeecceeeecc
Confidence            999999999999763    35999999999999999999999988  9999999999999  888999999999998876


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....    ......||+.|||||++.
T Consensus       341 ~~~~----~~~~~~GT~~Y~APE~l~  362 (543)
T 3c4z_A          341 AGQT----KTKGYAGTPGFMAPELLL  362 (543)
T ss_dssp             TTCC----CBCCCCSCTTTSCHHHHT
T ss_pred             CCCc----ccccccCCccccChhhhc
Confidence            4422    234468999999999874

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.98  E-value=1e-32  Score=260.63  Aligned_cols=170  Identities=28%  Similarity=0.509  Sum_probs=149.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  |+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            7889999999999999999985  88999999865322222234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++.++..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++......  
T Consensus        97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll--~~~~~vkL~DFG~a~~~~~~~--  170 (476)
T 2y94_A           97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGE--  170 (476)
T ss_dssp             CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE--CTTCCEEECCCSSCEECCTTC--
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEE--ecCCCeEEEeccchhhccccc--
Confidence            9999999999988888999999999999999999999988  9999999999999  888899999999998765432  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       171 ---~~~~~~gt~~y~aPE~~~  188 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVIS  188 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHT
T ss_pred             ---cccccCCCcCeEChhhcc
Confidence               234567999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.98  E-value=7.2e-32  Score=243.34  Aligned_cols=173  Identities=29%  Similarity=0.502  Sum_probs=141.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC-------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-------  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~-------  228 (337)
                      +|+..+.||+|+||.||+|.+.  ++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+..       
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            5788899999999999999985  88999999865432  223477899999999999999999999986543       


Q ss_pred             --------------------------------------------------ceEEEEeecCCCCHHHHHHhcCC---CCHH
Q 019685          229 --------------------------------------------------PLMLITEYLRGGDLHKYLKEKGA---LSPS  255 (337)
Q Consensus       229 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~  255 (337)
                                                                        .+++||||+++++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              28999999999999999986543   5566


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc--------eeeeeCCcccc
Q 019685          256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD--------VYKMTGETGSC  327 (337)
Q Consensus       256 ~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~--------~~~~~~~~gt~  327 (337)
                      .++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.........        ........||+
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEE--eCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            78999999999999999988  9999999999999  788899999999998876542110        01234567999


Q ss_pred             ccccccccc
Q 019685          328 EYLVSNCSF  336 (337)
Q Consensus       328 ~y~aPE~l~  336 (337)
                      .|+|||++.
T Consensus       241 ~y~aPE~~~  249 (332)
T 3qd2_B          241 LYMSPEQIH  249 (332)
T ss_dssp             GGSCHHHHH
T ss_pred             CccChHHhc
Confidence            999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.98  E-value=5.6e-32  Score=247.97  Aligned_cols=173  Identities=18%  Similarity=0.259  Sum_probs=145.7

Q ss_pred             cCCCCcCccccceecccCceeEEEEE-------ECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC---CCCeeeee
Q 019685          152 IDPSELDFSSSAIIGKGSFGEILKAY-------WRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFL  221 (337)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~V~~~~-------~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~  221 (337)
                      +.....+|...+.||+|+||.||+|.       ..++.||+|++....      ...+..|+.++..++   |+||++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            44455678999999999999999994       247899999986542      245677888888887   89999999


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC--
Q 019685          222 GAVTERKPLMLITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS--  294 (337)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~--  294 (337)
                      +++...+..|+||||+++|+|.+++..     ...+++..++.++.||+.||.|||+++  |+||||||+|||+  +.  
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll--~~~~  209 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFIL--GNGF  209 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CGGG
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEe--cccc
Confidence            999999999999999999999999974     356999999999999999999999988  9999999999999  55  


Q ss_pred             ---------CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ---------ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ---------~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                               .+.+||+|||+|+.+......  .......||+.|||||++.
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~  258 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKG--TIFTAKCETSGFQCVEMLS  258 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTT--EEECCSSCTTSCCCHHHHT
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCC--ceeeeecCCCCCCChHHhc
Confidence                     789999999999876533211  2456678999999999874

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.98  E-value=7.4e-32  Score=247.61  Aligned_cols=172  Identities=30%  Similarity=0.522  Sum_probs=145.9

Q ss_pred             cCccccceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE  226 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~  226 (337)
                      .+|...+.||+|+||.||+|.+.         +..||+|.+....  .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            47888899999999999999863         3469999986543  334567889999999999 79999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEE
Q 019685          227 RKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL  290 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~  290 (337)
                      .+.+|+||||+++|+|.+++....                .+++.+++.++.||+.||.|||+++  |+||||||+|||+
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll  236 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV  236 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEE
Confidence            999999999999999999998643                4789999999999999999999988  9999999999999


Q ss_pred             ecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       291 ~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        +.++.+||+|||+++.+.....  ........+|+.|+|||++.
T Consensus       237 --~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~  278 (370)
T 2psq_A          237 --TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALF  278 (370)
T ss_dssp             --CTTCCEEECCCSSCEETTCCCT--TCTTTTTTSCGGGCCHHHHH
T ss_pred             --CCCCCEEEccccCCcccCcccc--eecccCCCcccceECHhHhc
Confidence              8889999999999987654321  11234456789999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.98  E-value=6.2e-32  Score=249.25  Aligned_cols=169  Identities=22%  Similarity=0.441  Sum_probs=146.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|++.+.||+|+||.||+|...  ++.+|+|++.....   .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            6889999999999999999985  78899999865432   234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++... ..+++.++..++.||+.||.|||+++  |+||||||+|||+..+..+.+||+|||+++...... 
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            99999999999754 36999999999999999999999988  999999999999954456789999999998775432 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       206 ----~~~~~~gt~~y~aPE~~~  223 (387)
T 1kob_A          206 ----IVKVTTATAEFAAPEIVD  223 (387)
T ss_dssp             ----CEEEECSSGGGCCHHHHT
T ss_pred             ----ceeeeccCCCccCchhcc
Confidence                223457999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.98  E-value=4.4e-32  Score=256.04  Aligned_cols=174  Identities=27%  Similarity=0.457  Sum_probs=135.6

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----Cc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~  229 (337)
                      .+|++.+.||+|+||.||+|.+.  ++.||||++..... .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            47999999999999999999875  78999999866433 344567889999999999999999999998433     56


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++..
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl--~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLV--NQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTCCEEECCCTTCBCT
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEE--CCCCCEeecccccchhc
Confidence            899999985 699999988888999999999999999999999988  9999999999999  88889999999999876


Q ss_pred             ecccccc-----------------------eeeeeCCccccccccccccc
Q 019685          310 KVQNSHD-----------------------VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .......                       .......+||+.|+|||+++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  256 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL  256 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence            4321100                       01245567899999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.98  E-value=6.3e-32  Score=243.43  Aligned_cols=171  Identities=30%  Similarity=0.426  Sum_probs=145.2

Q ss_pred             CCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc----e
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----L  230 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~----~  230 (337)
                      ...+|+..+.||+|+||.||+|.+.++.||+|++....    ........|+.+++.++||||+++++++.....    +
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             chhhchhhheecccCceEEEEEEECCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            34478889999999999999999999999999985432    223455668999999999999999999987543    6


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCcEeeCCCCCCEEEecCCCCcEEE
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE----------PNVIIHRDLKPRNVLLVNSSADHLKV  300 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~----------~~~ivHrdlkp~Nil~~~~~~~~~kl  300 (337)
                      ++||||+++++|.+++... .+++..+..++.||+.||.|||+.          +  |+||||||+|||+  +..+.+||
T Consensus        98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill--~~~~~~kL  172 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLL--KNNLTACI  172 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEE--CTTCCEEE
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEE--CCCCeEEE
Confidence            9999999999999999764 599999999999999999999997          7  9999999999999  88889999


Q ss_pred             EeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +|||+++.+......  .......||+.|+|||++.
T Consensus       173 ~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~  206 (322)
T 3soc_A          173 ADFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLE  206 (322)
T ss_dssp             CCCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHT
T ss_pred             ccCCcccccccccCc--cccccCccCccccCHhhcc
Confidence            999999887654321  1234467999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.97  E-value=2.7e-32  Score=248.85  Aligned_cols=173  Identities=25%  Similarity=0.446  Sum_probs=143.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCc--hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD--DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~--~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      .|+..+.||+|+||.||+|..+  ++.||+|++......  .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            6888999999999999999875  789999998532110  001236788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCcee
Q 019685          234 TEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKL  308 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~  308 (337)
                      |||+++++|.+++...    ..+++..+..++.||+.||.|||+++  |+||||||+|||+..+ ..+.+||+|||+++.
T Consensus       105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            9999999999888642    24899999999999999999999988  9999999999999432 234599999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......    ......||+.|+|||++.
T Consensus       183 ~~~~~~----~~~~~~gt~~y~aPE~~~  206 (351)
T 3c0i_A          183 LGESGL----VAGGRVGTPHFMAPEVVK  206 (351)
T ss_dssp             CCTTSC----BCCCCCSCGGGCCHHHHT
T ss_pred             ecCCCe----eecCCcCCcCccCHHHHc
Confidence            764321    234567999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=2.6e-31  Score=245.57  Aligned_cols=178  Identities=15%  Similarity=0.257  Sum_probs=151.9

Q ss_pred             CCCcCccccceeccc--CceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          154 PSELDFSSSAIIGKG--SFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G--~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      +...+|++.+.||+|  +||.||+|...  ++.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            344489999999999  99999999986  889999999765433 3456778899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      +|+||||+++++|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILI--SVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCGGGCE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--cCCCCEEEcccccce
Confidence            99999999999999999875  67999999999999999999999988  9999999999999  888899999999987


Q ss_pred             eeecccccce---eeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDV---YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..........   .......||+.|+|||++.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  208 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ  208 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHS
T ss_pred             eeccccccccccccccccccccccccCHHHHh
Confidence            7654321110   0123357999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=2.8e-32  Score=268.20  Aligned_cols=172  Identities=27%  Similarity=0.411  Sum_probs=148.5

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      .+|+..+.||+|+||.||+|...  ++.||||++.+.........+.+..|..++..+ +||+|+++++++.+.+.+|||
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            37888999999999999999986  678999998653221222345677899999887 599999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |||+++|+|.+++...+.+++..++.|+.||+.||.|||+++  ||||||||+|||+  +.++++||+|||+++......
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl--~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEE--CSSSCEEECCCTTCEECCCTT
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEE--cCCCcEEEeecceeeccccCC
Confidence            999999999999998888999999999999999999999988  9999999999999  888999999999998654332


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......||+.|||||++.
T Consensus       497 ~----~~~~~~GT~~Y~APE~l~  515 (674)
T 3pfq_A          497 V----TTKTFCGTPDYIAPEIIA  515 (674)
T ss_dssp             C----CBCCCCSCSSSCCHHHHT
T ss_pred             c----ccccccCCCcccCHhhhc
Confidence            2    345678999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=7.5e-32  Score=247.81  Aligned_cols=174  Identities=30%  Similarity=0.535  Sum_probs=135.9

Q ss_pred             CCcCccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      ...+|...+.||+|+||.||+|...     +..||+|.+....  .....+.+.+|+.++++++||||+++++++...+.
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            3447889999999999999999864     5679999986543  23445789999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .++||||+++++|.+++...+ .+++.+++.++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILI--NSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCC-----
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEE--cCCCCEEECcCccccc
Confidence            999999999999999998654 6999999999999999999999988  9999999999999  8888999999999987


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....... ........+|+.|+|||++
T Consensus       197 ~~~~~~~-~~~~~~~~~~~~y~aPE~~  222 (373)
T 2qol_A          197 LEDDPEA-AYTTRGGKIPIRWTSPEAI  222 (373)
T ss_dssp             ------------------CTTSCHHHH
T ss_pred             cccCCcc-ceeccCCCcCCCccChhhh
Confidence            7643221 1122334568899999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=2.2e-31  Score=233.36  Aligned_cols=170  Identities=29%  Similarity=0.558  Sum_probs=147.6

Q ss_pred             CCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ...+|+..+.||+|+||.||++.++ +..||+|.+.......    +.+.+|+.++..++||||+++++++...+..++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            3447888999999999999999887 4579999987654332    5678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |||+++++|.+++...+ .+++..++.++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV--DRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEE--CTTCCEEECCTTCEEECCTT
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEE--CCCCCEEEccCccceecchh
Confidence            99999999999998754 5999999999999999999999988  9999999999999  88889999999999876544


Q ss_pred             cccceeeeeCCcccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..   .......+|+.|+|||++
T Consensus       158 ~~---~~~~~~~~~~~y~aPE~~  177 (268)
T 3sxs_A          158 QY---VSSVGTKFPVKWSAPEVF  177 (268)
T ss_dssp             CE---EECCSCCCCGGGCCHHHH
T ss_pred             hh---hcccCCCcCcccCCHHHH
Confidence            21   234566788899999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=2.5e-31  Score=236.27  Aligned_cols=174  Identities=25%  Similarity=0.361  Sum_probs=153.4

Q ss_pred             CCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ...+|...+.||+|+||.||++...  ++.+++|.+...........+.+.+|+.+++.++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            3347899999999999999999986  77899999876655555566788999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||+++++|.+++.....+++.++..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEE--cCCCCEEEEeccCceecccC
Confidence            9999999999999988888999999999999999999999988  9999999999999  78889999999999876543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......||+.|+|||++.
T Consensus       169 ~~----~~~~~~~~~~y~aPE~~~  188 (294)
T 2rku_A          169 GE----RKKVLCGTPNYIAPEVLS  188 (294)
T ss_dssp             TC----CBCCCCSCCSSCCHHHHT
T ss_pred             cc----ccccccCCCCcCCcchhc
Confidence            22    234567999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=7.2e-32  Score=240.25  Aligned_cols=170  Identities=29%  Similarity=0.488  Sum_probs=140.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCch-----------------------HHHHHHHHHHHHHHHhC
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-----------------------RLVIQDFRHEVNLLVKL  212 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~-----------------------~~~~~~~~~E~~~l~~l  212 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|++.......                       ....+.+.+|+.+++.+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            7889999999999999999875  7889999986543211                       11235688999999999


Q ss_pred             CCCCeeeeeeeEEe--CCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEE
Q 019685          213 RHPNIVQFLGAVTE--RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL  290 (337)
Q Consensus       213 ~h~~Iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~  290 (337)
                      +||||+++++++..  ...+|+||||+++++|.+++. ...+++.++..++.||+.||.|||+.+  |+||||||+|||+
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV  170 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEE
Confidence            99999999999986  567999999999999988653 456999999999999999999999988  9999999999999


Q ss_pred             ecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       291 ~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        +.++.+||+|||+++.......    ......||+.|+|||++.
T Consensus       171 --~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~  210 (298)
T 2zv2_A          171 --GEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLS  210 (298)
T ss_dssp             --CTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCC
T ss_pred             --CCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhc
Confidence              8888999999999987654322    245568999999999874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=245.63  Aligned_cols=167  Identities=29%  Similarity=0.499  Sum_probs=139.7

Q ss_pred             cccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          160 SSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       160 ~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      ...+.||+|+||.||+|...  |+.||+|++.....   ...+.+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            34568999999999999875  78999999876432   33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          238 RGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       238 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      ++++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||+..+..+.+||+|||+++.+....   
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---  243 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---  243 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence            999999988754 46999999999999999999999988  999999999999966667899999999998875442   


Q ss_pred             eeeeeCCccccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l~  336 (337)
                        ......||+.|+|||++.
T Consensus       244 --~~~~~~gt~~y~aPE~~~  261 (373)
T 2x4f_A          244 --KLKVNFGTPEFLAPEVVN  261 (373)
T ss_dssp             --BCCCCCSSCTTCCHHHHT
T ss_pred             --ccccccCCCcEeChhhcc
Confidence              234457999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=1.3e-33  Score=255.84  Aligned_cols=168  Identities=22%  Similarity=0.230  Sum_probs=134.8

Q ss_pred             cCccccceecccCceeEEEEEECCceEEEEEecCCCCc-----hHHHHHHHHHHHHHHHhCC---------CCCeeeeee
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLR---------HPNIVQFLG  222 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~Iv~~~~  222 (337)
                      .+|+..+.||+|+||.||+|.++++.||+|++......     .....+.+.+|+.+++.++         ||||+++.+
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~   99 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS   99 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred             ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence            47888999999999999999999999999999765321     1222366778888888875         666666666


Q ss_pred             eE-----------------Ee-------------CCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019685          223 AV-----------------TE-------------RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH  272 (337)
Q Consensus       223 ~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH  272 (337)
                      .+                 ..             .+.+|+||||+++|++.+.+.. ..+++..++.++.||+.||.|||
T Consensus       100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH  178 (336)
T 2vuw_A          100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAE  178 (336)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence            53                 22             6789999999999976666533 56899999999999999999999


Q ss_pred             -cCCCCcEeeCCCCCCEEEecCC------------------CCcEEEEeccCceeeecccccceeeeeCCcccccccccc
Q 019685          273 -NEPNVIIHRDLKPRNVLLVNSS------------------ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSN  333 (337)
Q Consensus       273 -~~~~~ivHrdlkp~Nil~~~~~------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE  333 (337)
                       +++  |+||||||+|||+..+.                  ...+||+|||+|+.....         ...||+.|||||
T Consensus       179 ~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~~y~aPE  247 (336)
T 2vuw_A          179 ASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCCCTTCSG
T ss_pred             HhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEeecccChh
Confidence             877  99999999999994332                  128999999999876532         237999999999


Q ss_pred             ccc
Q 019685          334 CSF  336 (337)
Q Consensus       334 ~l~  336 (337)
                      ++.
T Consensus       248 ~~~  250 (336)
T 2vuw_A          248 LFT  250 (336)
T ss_dssp             GGC
T ss_pred             hhc
Confidence            874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=1.2e-31  Score=238.72  Aligned_cols=169  Identities=29%  Similarity=0.469  Sum_probs=140.5

Q ss_pred             cCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEeC----Cce
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTER----KPL  230 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~----~~~  230 (337)
                      .+|+..+.||+|+||.||+|.++++.||+|++....      ...+..|.+++..  ++||||+++++++...    ..+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            378889999999999999999999999999985431      2445556666666  7899999999986543    458


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--------NEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                      |+||||+++++|.++++ ...+++..+..++.||+.||.|||        +.+  |+||||||+|||+  +.++.+||+|
T Consensus        82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill--~~~~~~kl~D  156 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILV--KKNGQCCIAD  156 (301)
T ss_dssp             EEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEE--CTTSCEEECC
T ss_pred             EEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEE--cCCCCEEEee
Confidence            99999999999999995 456999999999999999999999        866  9999999999999  7888999999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+++.................||+.|+|||++.
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  190 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD  190 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhc
Confidence            9999887654332222234458999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=2.7e-31  Score=238.12  Aligned_cols=168  Identities=26%  Similarity=0.345  Sum_probs=138.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHH-hCCCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV-KLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|.+.  ++.||||++.......... .....|+..+. ..+||||+++++++.+.+.+|+||
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            6888999999999999999985  8899999987654444433 34444555544 458999999999999999999999


Q ss_pred             eecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+ +++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++......
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEE--CCCCCEEEccceeeeecccCC
Confidence            999 56999988764 46999999999999999999999987  9999999999999  788899999999998765432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......||+.|+|||++.
T Consensus       212 -----~~~~~~gt~~y~aPE~~~  229 (311)
T 3p1a_A          212 -----AGEVQEGDPRYMAPELLQ  229 (311)
T ss_dssp             --------CCCCCGGGCCGGGGG
T ss_pred             -----CCcccCCCccccCHhHhc
Confidence                 234567999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.97  E-value=8.7e-32  Score=241.37  Aligned_cols=170  Identities=32%  Similarity=0.499  Sum_probs=142.9

Q ss_pred             cCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .+|+..+.||+|+||.||+|.+. ++.||+|.+...... ......+.+|+.+++.++||||+++++++.....+++|||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            47899999999999999999985 788999998654332 2234677899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++ +|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLI--NSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEETTSCCC
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEE--CCCCCEEEccCcCceecCCCcc
Confidence            9985 888888764 45999999999999999999999988  9999999999999  8888999999999987653321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       175 ----~~~~~~~t~~y~aPE~~~  192 (311)
T 3niz_A          175 ----SYTHEVVTLWYRAPDVLM  192 (311)
T ss_dssp             -------CCCCCCTTCCHHHHT
T ss_pred             ----cccCCcccCCcCCHHHhc
Confidence                345567899999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=2.7e-31  Score=239.22  Aligned_cols=167  Identities=25%  Similarity=0.369  Sum_probs=145.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|...+.||+|+||.||+|...  |+.||||++.......   .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            3566678999999999999975  8899999987654332   3667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.. ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++....... 
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~-  196 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKDVP-  196 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSSSC-
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--CCCCcEEEeeeeeeeecccCcc-
Confidence            9999999999864 46999999999999999999999987  9999999999999  7888999999999987754322 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       197 ---~~~~~~gt~~y~aPE~~~  214 (321)
T 2c30_A          197 ---KRKSLVGTPYWMAPEVIS  214 (321)
T ss_dssp             ---CBCCCCSCGGGCCHHHHT
T ss_pred             ---ccccccCCccccCHhhhc
Confidence               234567999999999863

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=3e-31  Score=250.00  Aligned_cols=176  Identities=30%  Similarity=0.536  Sum_probs=147.4

Q ss_pred             CCCcccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      ...|+++..  +|...+.||+|+||.||+|.++ +..||||.+......    .+.+.+|+.+++.++||||+++++++.
T Consensus       180 ~~~~~i~~~--~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~  253 (454)
T 1qcf_A          180 KDAWEIPRE--SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT  253 (454)
T ss_dssp             TTCSBCCGG--GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccceeechH--HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            345665543  5777889999999999999986 678999999764432    467899999999999999999999886


Q ss_pred             eCCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                       .+.+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+||
T Consensus       254 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DF  328 (454)
T 1qcf_A          254 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV--SASLVCKIADF  328 (454)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE--CTTCCEEECST
T ss_pred             -CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEE--CCCCcEEEeeC
Confidence             66789999999999999999753  36899999999999999999999988  9999999999999  78889999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.......   .......+|+.|+|||++.
T Consensus       329 G~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~  358 (454)
T 1qcf_A          329 GLARVIEDNEY---TAREGAKFPIKWTAPEAIN  358 (454)
T ss_dssp             TGGGGBCCHHH---HTTCSSSSCGGGSCHHHHH
T ss_pred             CCceEcCCCce---eccCCCcccccccCHHHhc
Confidence            99987653311   1234456789999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.8e-31  Score=244.77  Aligned_cols=182  Identities=32%  Similarity=0.558  Sum_probs=150.9

Q ss_pred             CCCCCcccCCCCcCccccceecccCceeEEEEEECC---------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CC
Q 019685          145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH  214 (337)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g---------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h  214 (337)
                      |....|++..  .+|...+.||+|+||.||+|.+.+         ..||+|++....  .......+.+|+.+++.+ +|
T Consensus        59 ~~~~~~~i~~--~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h  134 (382)
T 3tt0_A           59 PEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKH  134 (382)
T ss_dssp             CCCTTTBCCG--GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCC
T ss_pred             ccCcccccch--hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCC
Confidence            3334454433  378888999999999999998632         469999986653  234457888999999999 89


Q ss_pred             CCeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 019685          215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVI  278 (337)
Q Consensus       215 ~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~i  278 (337)
                      |||+++++++...+..++||||+++++|.+++....                .+++.+++.++.||+.||.|||+.+  |
T Consensus       135 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i  212 (382)
T 3tt0_A          135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--C  212 (382)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             chhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--E
Confidence            999999999999999999999999999999998643                4899999999999999999999988  9


Q ss_pred             EeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       279 vHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +||||||+|||+  +.++.+||+|||+++........  .......+|+.|+|||++.
T Consensus       213 vH~Dlkp~NIll--~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~  266 (382)
T 3tt0_A          213 IHRDLAARNVLV--TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALF  266 (382)
T ss_dssp             CCSCCCGGGEEE--CTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHH
T ss_pred             ecCCCCcceEEE--cCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhc
Confidence            999999999999  78889999999999876543211  1234566889999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=1.7e-31  Score=250.18  Aligned_cols=174  Identities=26%  Similarity=0.428  Sum_probs=144.7

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----Cc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~  229 (337)
                      .+|...+.||+|+||.||+|.+.  ++.||+|++..... .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            37999999999999999999986  77899999976433 344567889999999999999999999998766     56


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+||||+++ +|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl--~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLL--NQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEE--CCCCCEEEccCCCcccc
Confidence            8999999864 99999988888999999999999999999999988  9999999999999  88899999999999887


Q ss_pred             ecccccce------------------eeeeCCccccccccccccc
Q 019685          310 KVQNSHDV------------------YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........                  .......||+.|+|||+++
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  224 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL  224 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence            54321100                  1236678999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=3e-31  Score=237.55  Aligned_cols=170  Identities=26%  Similarity=0.454  Sum_probs=143.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+..... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            6888999999999999999986  78999998866543 34445778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.|  |+||||||+||++  +.++.+||+|||+++....... 
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILI--TKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEE--cCCCCEEEeeCCCchhccCccc-
Confidence            9999999999988788999999999999999999999988  9999999999999  8888999999999987654321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       158 ---~~~~~~~~~~y~aPE~~~  175 (311)
T 4agu_A          158 ---YYDDEVATRWYRSPELLV  175 (311)
T ss_dssp             -----------GGGCCHHHHH
T ss_pred             ---ccCCCcCCccccChHHHh
Confidence               234567999999999863

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=9.2e-32  Score=237.25  Aligned_cols=170  Identities=30%  Similarity=0.493  Sum_probs=144.5

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||+|...  +..+|+|.+.............+.+|+.+++.++||||+++++++.+....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            37899999999999999999886  6689999986533222223466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||++......  
T Consensus        89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili--~~~~~~~l~Dfg~~~~~~~~--  162 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL--GSAGELKIADFGWSVHAPSS--  162 (279)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEE--CTTSCEEECSCCEESCC-----
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEE--cCCCCEEEEeccccccCCcc--
Confidence            99999999999988888999999999999999999999987  9999999999999  88889999999998655432  


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       163 ----~~~~~~~~~~y~aPE~~~  180 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIE  180 (279)
T ss_dssp             ---------CCCCTTCCHHHHT
T ss_pred             ----cccccCCCCCccCHhHhc
Confidence                234567999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.97  E-value=1.3e-31  Score=240.96  Aligned_cols=168  Identities=27%  Similarity=0.529  Sum_probs=132.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+.......  ..+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            6888899999999999999875  7899999986543221  22567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          236 YLRGGDLHKYLKEK------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       236 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |+++ +|.+++...      ..+++..+..++.||+.||.|||++|  |+||||||+|||+  +.++.+||+|||+++..
T Consensus        84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLI--NKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCSSCEET
T ss_pred             ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEE--cCCCCEEECcCccceec
Confidence            9984 999998753      35899999999999999999999988  9999999999999  88889999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....    ......||+.|+|||++.
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~  181 (317)
T 2pmi_A          159 GIPVN----TFSSEVVTLWYRAPDVLM  181 (317)
T ss_dssp             TSCCC----CCCCCCSCCTTCCHHHHT
T ss_pred             CCCcc----cCCCCcccccccCchHhh
Confidence            53321    234567999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=2.3e-31  Score=241.74  Aligned_cols=165  Identities=25%  Similarity=0.489  Sum_probs=141.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|..+  ++.||+|++.+....       ..+|+.++.++ +||||+++++++.+...+|+||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            6888899999999999999986  788999999765432       23577777777 6999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC--CCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS--ADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~--~~~~kl~DFgla~~~~~~  312 (337)
                      ||+++|+|.+++...+.+++.++..++.||+.||.|||+.|  |+||||||+|||+.++.  .+.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999999988888999999999999999999999988  99999999999984322  235999999999877544


Q ss_pred             cccceeeeeCCcccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..    ......||+.|+|||++
T Consensus       174 ~~----~~~~~~gt~~y~aPE~~  192 (342)
T 2qr7_A          174 NG----LLMTPCYTANFVAPEVL  192 (342)
T ss_dssp             TC----CBCCSSCCSSCCCHHHH
T ss_pred             CC----ceeccCCCccccCHHHh
Confidence            32    23556899999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=2.1e-31  Score=235.39  Aligned_cols=176  Identities=30%  Similarity=0.559  Sum_probs=146.9

Q ss_pred             CCcccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 019685          148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE  226 (337)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  226 (337)
                      ..|.++  ..+|+..+.||+|+||.||++.+. +..||+|.+.......    +.+.+|+.++..++||||+++++++..
T Consensus        17 ~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           17 GSWEID--PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             CTTBCC--GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCccCC--HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            455543  336888899999999999999987 4579999997654432    567889999999999999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          227 RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      .+..++||||+++++|.+++.. ...+++.++..++.|++.||.|||+++  |+||||||+||++  +.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili--~~~~~~kl~Dfg~  166 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGL  166 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEE--CTTSCEEECSTTG
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEE--cCCCCEEEccccc
Confidence            9999999999999999999986 457999999999999999999999988  9999999999999  8888999999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.......   .......+|+.|+|||++.
T Consensus       167 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~  194 (283)
T 3gen_A          167 SRYVLDDEY---TSSVGSKFPVRWSPPEVLM  194 (283)
T ss_dssp             GGGBCCHHH---HSTTSTTSCGGGCCHHHHH
T ss_pred             ccccccccc---ccccCCccCcccCCHHHhc
Confidence            987654321   1234566789999999863

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=2.5e-31  Score=253.76  Aligned_cols=173  Identities=30%  Similarity=0.526  Sum_probs=144.7

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchH----------HHHHHHHHHHHHHHhCCCCCeeeeeeeE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR----------LVIQDFRHEVNLLVKLRHPNIVQFLGAV  224 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~Iv~~~~~~  224 (337)
                      .+|.+.+.||+|+||.||+|...  ++.+|+|++.+......          ...+.+.+|+.+++.++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            37899999999999999999985  67899999876433211          2246788999999999999999999999


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEec
Q 019685          225 TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDF  303 (337)
Q Consensus       225 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DF  303 (337)
                      .+...+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+..+. ...+||+||
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            999999999999999999999988888999999999999999999999988  99999999999993322 136999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++......     ......||+.|+|||++.
T Consensus       194 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~  221 (504)
T 3q5i_A          194 GLSSFFSKDY-----KLRDRLGTAYYIAPEVLK  221 (504)
T ss_dssp             TTCEECCTTS-----CBCCCCSCTTTCCHHHHT
T ss_pred             CCCEEcCCCC-----ccccccCCcCCCCHHHhc
Confidence            9998776442     245567999999999863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=2.1e-31  Score=239.85  Aligned_cols=176  Identities=32%  Similarity=0.543  Sum_probs=150.0

Q ss_pred             ccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      ++.....+|+..+.||+|+||.||+|.++ ++.||+|.+......   ..+.+.+|+.+++.++||||+++++++...+.
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            44455568999999999999999999976 789999988665432   34678899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          230 LMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      .++||||+++++|.+++....    .+++..++.++.||+.||.|||+++  |+||||||+||++  +.++.+||+|||+
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILL--DENFVPKITDFGI  185 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEE--CTTCCEEECCCTT
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEE--CCCCCEEEeeccc
Confidence            999999999999999986532    4899999999999999999999987  9999999999999  8888999999999


Q ss_pred             ceeeecccccceeeeeCCcccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ++........  .......||+.|+|||++
T Consensus       186 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~  213 (321)
T 2qkw_B          186 SKKGTELDQT--HLSTVVKGTLGYIDPEYF  213 (321)
T ss_dssp             CEECSSSSCC--CCBCCCEEETTTCCHHHH
T ss_pred             cccccccccc--ccccccCCCccccCHHHh
Confidence            9875433211  123445699999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=3.2e-31  Score=237.44  Aligned_cols=172  Identities=23%  Similarity=0.374  Sum_probs=144.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++...  ++.||+|++...........+.+.+|+.+++.++||||+++++++...+..|++||
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            7889999999999999999975  78899999976655555566888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++.++..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||++........ 
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~-  189 (309)
T 2h34_A          115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKL-  189 (309)
T ss_dssp             CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSCCC----------
T ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEE--cCCCCEEEecCccCcccccccc-
Confidence            9999999999998888999999999999999999999988  9999999999999  7888999999999987654321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|+|||++.
T Consensus       190 --~~~~~~~~~~~y~aPE~~~  208 (309)
T 2h34_A          190 --TQLGNTVGTLYYMAPERFS  208 (309)
T ss_dssp             ---------CCGGGCCGGGTC
T ss_pred             --ccccccCCCcCccCHHHHc
Confidence              1234567999999999873

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=5.2e-31  Score=250.86  Aligned_cols=175  Identities=30%  Similarity=0.587  Sum_probs=149.5

Q ss_pred             CCcccCCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      ..|++..  .+|...+.||+|+||.||+|.+.  +..||||.+......    .+.+.+|+.++++++||||+++++++.
T Consensus       213 ~~~~~~~--~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~  286 (495)
T 1opk_A          213 DKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCT  286 (495)
T ss_dssp             SCCBCCG--GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccCH--HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            4555543  35778889999999999999987  778999998764332    367889999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      ....+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+||
T Consensus       287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DF  362 (495)
T 1opk_A          287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLV--GENHLVKVADF  362 (495)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGGGCEEECCT
T ss_pred             cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEE--CCCCcEEEeec
Confidence            999999999999999999999863  35899999999999999999999988  9999999999999  77889999999


Q ss_pred             cCceeeecccccceeeeeCCcccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |+++......   ........+|+.|+|||++
T Consensus       363 G~a~~~~~~~---~~~~~~~~~~~~y~aPE~~  391 (495)
T 1opk_A          363 GLSRLMTGDT---YTAHAGAKFPIKWTAPESL  391 (495)
T ss_dssp             TCEECCTTCC---EECCTTCCCCGGGCCHHHH
T ss_pred             ccceeccCCc---eeecCCCcCCcceeCHhHH
Confidence            9998765332   1223456678999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=2.9e-31  Score=239.49  Aligned_cols=163  Identities=25%  Similarity=0.407  Sum_probs=125.3

Q ss_pred             cceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEeecC
Q 019685          162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .+.||+|+||.||+|...  ++.||+|++.+.      ....+.+|+.+++.+. ||||+++++++.+....|+||||++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            368999999999999986  789999998542      2356678999999998 9999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCceeeecccccce
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQNSHDV  317 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla~~~~~~~~~~~  317 (337)
                      +++|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+..+. ...+||+|||+++.......   
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---  164 (325)
T 3kn6_A           90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---  164 (325)
T ss_dssp             SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---
Confidence            9999999998888999999999999999999999988  99999999999994322 23799999999987654322   


Q ss_pred             eeeeCCccccccccccccc
Q 019685          318 YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       318 ~~~~~~~gt~~y~aPE~l~  336 (337)
                       ......||+.|+|||++.
T Consensus       165 -~~~~~~~t~~y~aPE~~~  182 (325)
T 3kn6_A          165 -PLKTPCFTLHYAAPELLN  182 (325)
T ss_dssp             -------------------
T ss_pred             -cccccCCCcCccCHHHhc
Confidence             345567899999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=5.2e-32  Score=245.35  Aligned_cols=170  Identities=22%  Similarity=0.362  Sum_probs=146.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchH-----HHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR-----LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|...+.||+|+||.||+|...  ++.||+|.+........     .....+.+|+.+++.++||||+++++++...+.+
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            6888999999999999999874  78899999876542211     1224566799999999999999999999999999


Q ss_pred             EEEEeecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          231 MLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ++||||+..| +|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+
T Consensus       105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVI--AEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEE--cCCCcEEEeecccceEC
Confidence            9999998766 99999998888999999999999999999999988  9999999999999  78889999999999877


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....     ......||+.|+|||++.
T Consensus       181 ~~~~-----~~~~~~gt~~y~aPE~~~  202 (335)
T 3dls_A          181 ERGK-----LFYTFCGTIEYCAPEVLM  202 (335)
T ss_dssp             CTTC-----CBCEECSCGGGCCHHHHT
T ss_pred             CCCC-----ceeccCCCccccChhhhc
Confidence            6542     223456999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=2.8e-31  Score=236.31  Aligned_cols=181  Identities=25%  Similarity=0.450  Sum_probs=148.5

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEECC-----ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeee
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA  223 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~  223 (337)
                      .+.+.+...+|+..+.||+|+||.||+|.+..     ..+++|.+....  .....+.+.+|+.++++++||||++++++
T Consensus        17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            34566777789999999999999999998642     247888886532  34456788999999999999999999998


Q ss_pred             E-EeCCceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          224 V-TERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       224 ~-~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                      + ...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++  |+||||||+||++  +.++.+||+
T Consensus        95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~  170 (298)
T 3f66_A           95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCML--DEKFTVKVA  170 (298)
T ss_dssp             ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEEC
T ss_pred             EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEE--CCCCCEEEC
Confidence            5 455678999999999999999976 345899999999999999999999988  9999999999999  888899999


Q ss_pred             eccCceeeecccccceeeeeCCcccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |||+++.................+|+.|+|||++
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL  204 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHH
T ss_pred             cccccccccccchhccccccCCCCCccccChHHh
Confidence            9999987765433222345567789999999976

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=2e-31  Score=233.78  Aligned_cols=167  Identities=32%  Similarity=0.603  Sum_probs=145.3

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||++.+. ++.||+|.+.......    +.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            6788899999999999999984 7789999997654432    5688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++++|.+++... ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++....... 
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEE--cCCCCEEecccccccccccccc-
Confidence            9999999999754 45899999999999999999999988  9999999999999  7778999999999987654321 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                        .......+|+.|+|||++
T Consensus       162 --~~~~~~~~~~~y~aPE~~  179 (269)
T 4hcu_A          162 --TSSTGTKFPVKWASPEVF  179 (269)
T ss_dssp             --HSTTSTTCCGGGCCHHHH
T ss_pred             --ccccCcccccccCCHHHh
Confidence              123456678899999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=3.4e-31  Score=241.21  Aligned_cols=165  Identities=33%  Similarity=0.464  Sum_probs=145.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|...+.||+|+||.||+|...  ++.||+|.+...........+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            5788899999999999999964  88999999977655555566789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+. |+|.+++.. ...+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.....  
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSSB--
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--CCCCCEEEeeccCceecCCC--
Confidence            997 588888864 567999999999999999999999988  9999999999999  77889999999999765432  


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                            ....||+.|+|||++
T Consensus       208 ------~~~~gt~~y~aPE~~  222 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVI  222 (348)
T ss_dssp             ------CCCCSCGGGCCHHHH
T ss_pred             ------CcccCCcceeCHhhh
Confidence                  345799999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=5e-31  Score=248.21  Aligned_cols=170  Identities=34%  Similarity=0.612  Sum_probs=143.8

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      .|+++..  +|...+.||+|+||.||++.++++.||||.+....     ..+.+.+|+.++++++||||+++++++....
T Consensus       187 ~~~i~~~--~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  259 (450)
T 1k9a_A          187 GWALNMK--ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK  259 (450)
T ss_dssp             TCBCCGG--GEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred             ccccChH--HeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence            4555433  67778899999999999999999999999997543     2367889999999999999999999987655


Q ss_pred             -ceEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          229 -PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       229 -~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                       .+|+||||+++|+|.+++...+.  +++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+
T Consensus       260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~DfG~  335 (450)
T 1k9a_A          260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGL  335 (450)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTSCEEECCCTT
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEE--CCCCCEEEeeCCC
Confidence             79999999999999999987543  799999999999999999999988  9999999999999  7888999999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.....       .....+++.|+|||++.
T Consensus       336 a~~~~~~-------~~~~~~~~~y~aPE~~~  359 (450)
T 1k9a_A          336 TKEASST-------QDTGKLPVKWTAPEALR  359 (450)
T ss_dssp             CEECC-------------CCCTTTSCHHHHH
T ss_pred             ccccccc-------ccCCCCCcceeCHHHhc
Confidence            9854322       22346789999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=1.1e-31  Score=238.01  Aligned_cols=169  Identities=33%  Similarity=0.537  Sum_probs=141.4

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||+|... ++.+|+|.+...... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            6888899999999999999986 789999998654322 11235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++ +|.+++... +.+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++....... 
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEEeECccccccCcccc-
Confidence            986 999998764 57999999999999999999999988  9999999999999  8888999999999987643221 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       156 ---~~~~~~~t~~y~aPE~~~  173 (288)
T 1ob3_A          156 ---KYTHEIVTLWYRAPDVLM  173 (288)
T ss_dssp             ---------CCCTTCCHHHHT
T ss_pred             ---ccccccccccccCchhee
Confidence               234567899999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=2.6e-31  Score=253.04  Aligned_cols=171  Identities=28%  Similarity=0.463  Sum_probs=143.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|..+  +..+|+|++.+...... ....+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999985  77899999876432221 23667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+... ..+.+||+|||+++...... 
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-  193 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-  193 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence            9999999999988888999999999999999999999988  9999999999999432 24569999999998876442 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       194 ----~~~~~~gt~~y~aPE~l~  211 (494)
T 3lij_A          194 ----KMKERLGTAYYIAPEVLR  211 (494)
T ss_dssp             ----CBCCCCSCTTTCCHHHHT
T ss_pred             ----cccccCCCcCeeCHHHHc
Confidence                245567999999999863

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=3.3e-31  Score=240.43  Aligned_cols=175  Identities=31%  Similarity=0.486  Sum_probs=147.8

Q ss_pred             CCCCcCccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          153 DPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      .....+|...+.||+|+||.||+|.+.+       +.||+|.+.....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3444578889999999999999999864       6899999875432  344578899999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEee
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKEK------------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHR  281 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr  281 (337)
                      ..+..|+||||+++++|.+++...                        ..+++.+++.++.||+.||.|||+++  |+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~  198 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR  198 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecC
Confidence            999999999999999999999763                        46899999999999999999999988  9999


Q ss_pred             CCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       282 dlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||||+|||+  +.++.+||+|||+++.......  ........+|+.|+|||++
T Consensus       199 Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~  248 (343)
T 1luf_A          199 DLATRNCLV--GENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESI  248 (343)
T ss_dssp             CCSGGGEEE--CGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHH
T ss_pred             CCCcceEEE--CCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhh
Confidence            999999999  7788999999999987644321  1123456789999999976

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=7.4e-32  Score=256.22  Aligned_cols=171  Identities=29%  Similarity=0.532  Sum_probs=149.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  ++.||+|++.+.........+.+.+|+.++++++||||+++++++...+.+|+|||
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  106 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE  106 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            6888999999999999999985  78999999976544333345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+.+++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+.. +..+.+||+|||+++.+.... 
T Consensus       107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-  183 (484)
T 3nyv_A          107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-  183 (484)
T ss_dssp             CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-
Confidence            9999999999988888999999999999999999999988  999999999999943 346789999999998765432 


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......||+.|+|||++
T Consensus       184 ----~~~~~~gt~~y~aPE~~  200 (484)
T 3nyv_A          184 ----KMKDKIGTAYYIAPEVL  200 (484)
T ss_dssp             ----SHHHHTTGGGTCCHHHH
T ss_pred             ----ccccCCCCccccCceee
Confidence                23445799999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=243.27  Aligned_cols=168  Identities=30%  Similarity=0.478  Sum_probs=131.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ..|...+.||+|+||.||+|.+.  ++.||+|.+....     ..+.+.+|+.+++.++||||+++++++......++||
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            36888999999999999999986  6789999986542     2356778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++++|.+++...+.+++.++..++.||+.||.|||+.+  |+||||||+|||+.. +..+.+||+|||+++......
T Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999999999988888999999999999999999999988  999999999999943 237899999999998765432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......||+.|+|||++.
T Consensus       206 -----~~~~~~gt~~y~aPE~~~  223 (349)
T 2w4o_A          206 -----LMKTVCGTPGYCAPEILR  223 (349)
T ss_dssp             ------------CGGGSCHHHHT
T ss_pred             -----ccccccCCCCccCHHHhc
Confidence                 234567999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=1.8e-31  Score=245.65  Aligned_cols=178  Identities=30%  Similarity=0.515  Sum_probs=148.2

Q ss_pred             CCcccCCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      ..|.++..  +|...+.||+|+||.||+|.+.  ++.||+|.+....  .....+.+.+|+.+++.++||||+++++++.
T Consensus       107 ~~~~~~~~--~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          107 DKWVLNHE--DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             CTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccEEchH--HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            35555443  6778889999999999999985  7889999986543  2334567889999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      ..+.+|+||||+++++|.+++...+ .+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~--~~~~~~kl~DfG  258 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLV--TEKNVLKISDFG  258 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCGG
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEE--cCCCcEEECcCC
Confidence            9999999999999999999998654 5999999999999999999999988  9999999999999  788899999999


Q ss_pred             CceeeecccccceeeeeCCcccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +++.......  ........+++.|+|||++
T Consensus       259 ~s~~~~~~~~--~~~~~~~~~~~~y~aPE~~  287 (377)
T 3cbl_A          259 MSREEADGVY--AASGGLRQVPVKWTAPEAL  287 (377)
T ss_dssp             GCEECTTSEE--ECCSSCCEEEGGGSCHHHH
T ss_pred             CceecCCCce--eecCCCCCCCcCcCCHhHh
Confidence            9986543210  0011223468899999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=6.3e-31  Score=231.55  Aligned_cols=168  Identities=29%  Similarity=0.502  Sum_probs=147.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  +..+++|.+.......   .+.+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            6888899999999999999986  5678999986644333   3678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++.....+++..+..++.|++.||.|||+++  |+||||||+||++.. +..+.+||+|||++....... 
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            9999999999988888999999999999999999999988  999999999999943 345789999999998766442 


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......||+.|+|||++
T Consensus       164 ----~~~~~~~t~~y~aPE~~  180 (277)
T 3f3z_A          164 ----MMRTKVGTPYYVSPQVL  180 (277)
T ss_dssp             ----CBCCCCSCTTTCCHHHH
T ss_pred             ----chhccCCCCCccChHHh
Confidence                23456799999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=1.9e-31  Score=240.50  Aligned_cols=176  Identities=31%  Similarity=0.515  Sum_probs=148.7

Q ss_pred             ccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      ++.....+|+..+.||+|+||.||+|... ++.||+|.+.......  ....+.+|+.+++.++||||+++++++.....
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence            45556668999999999999999999875 7889999986543221  12357889999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcC---CCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          230 LMLITEYLRGGDLHKYLKEKG----ALSPSTAVNFALDIARGMAYLHNE---PNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                      .++||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +  |+||||||+|||+  +.++.+||+|
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~--~~~~~~kl~D  177 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILL--DEEFEAVVGD  177 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEE--CTTCCEEECC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEE--CCCCCEEecc
Confidence            999999999999999998643    389999999999999999999997   7  9999999999999  7888999999


Q ss_pred             ccCceeeecccccceeeeeCCcccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||+++.......   .......||+.|+|||++
T Consensus       178 fg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~  207 (326)
T 3uim_A          178 FGLAKLMDYKDT---HVTTAVRGTIGHIAPEYL  207 (326)
T ss_dssp             CSSCEECCSSSS---CEECCCCSCGGGCCHHHH
T ss_pred             CccccccCcccc---cccccccCCcCccCHHHh
Confidence            999987754332   134456699999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=2.2e-31  Score=236.68  Aligned_cols=173  Identities=30%  Similarity=0.533  Sum_probs=140.5

Q ss_pred             CCcCccccceecccCceeEEEEEE------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--  226 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--  226 (337)
                      ...+|+..+.||+|+||.||+|.+      .++.||+|++...   .....+.+.+|+.+++.++||||+++++++..  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            344788999999999999999985      3778999998643   23445778999999999999999999999854  


Q ss_pred             CCceEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          227 RKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      ...+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV--ENENRVKIGDFGL  160 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCCS
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEE--cCCCeEEEccCcc
Confidence            356899999999999999998754 4999999999999999999999987  9999999999999  6778999999999


Q ss_pred             ceeeecccccceeeeeCCcccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ++....... .........+|+.|+|||++
T Consensus       161 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~  189 (295)
T 3ugc_A          161 TKVLPQDKE-FFKVKEPGESPIFWYAPESL  189 (295)
T ss_dssp             CC--------------CTTCGGGGCCHHHH
T ss_pred             cccccCCcc-eeeeccCCCCccceeCcHHh
Confidence            987754321 11123445688899999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=9.5e-31  Score=231.17  Aligned_cols=172  Identities=27%  Similarity=0.430  Sum_probs=148.4

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||+|...  ++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            37889999999999999999886  789999998665433 334577889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++++|.+.+.....+++..+..++.|++.||.|||+.+  |+||||||+||++..+. .+.+||+|||++.......
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            99999999999988888999999999999999999999988  99999999999993322 2449999999997765432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......||+.|+|||++.
T Consensus       163 -----~~~~~~~~~~y~aPE~~~  180 (284)
T 3kk8_A          163 -----AWHGFAGTPGYLSPEVLK  180 (284)
T ss_dssp             -----BCCCSCSCGGGCCHHHHT
T ss_pred             -----cccCCCCCcCCcCchhhc
Confidence                 234567999999999863

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=4.2e-31  Score=237.86  Aligned_cols=170  Identities=29%  Similarity=0.463  Sum_probs=147.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchH---HHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      .|+..+.||+|+||.||+|...  ++.||+|.+........   ...+.+.+|+.+++.++||||+++++++......++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            6888999999999999999985  78999999876443221   124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC----cEEEEeccCcee
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL  308 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~----~~kl~DFgla~~  308 (337)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+    .+||+|||+++.
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~--~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCTTSSSCCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEE--ecCCCCcCCEEEccCcccee
Confidence            9999999999999988888999999999999999999999988  9999999999999  5555    799999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....     ......||+.|+|||++.
T Consensus       169 ~~~~~-----~~~~~~gt~~y~aPE~~~  191 (321)
T 2a2a_A          169 IEDGV-----EFKNIFGTPEFVAPEIVN  191 (321)
T ss_dssp             CCTTC-----CCCCCCSCGGGCCHHHHT
T ss_pred             cCccc-----cccccCCCCCccCccccc
Confidence            76432     234567999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=5.3e-31  Score=241.50  Aligned_cols=169  Identities=27%  Similarity=0.482  Sum_probs=148.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCc-----hHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~  229 (337)
                      +|...+.||+|+||.||+|...  |+.||||++......     .....+.+.+|+.++..+ +||||+++++++.....
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            5778899999999999999985  889999998765421     122346678999999999 79999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      .|+||||+++++|.+++.....+++..+..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||++..+
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~--~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILL--DDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE--CCCCCEEEEecCccccc
Confidence            9999999999999999988888999999999999999999999988  9999999999999  88889999999999877


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....     ......||+.|+|||++
T Consensus       251 ~~~~-----~~~~~~gt~~y~aPE~~  271 (365)
T 2y7j_A          251 EPGE-----KLRELCGTPGYLAPEIL  271 (365)
T ss_dssp             CTTC-----CBCCCCSCGGGCCHHHH
T ss_pred             CCCc-----ccccCCCCCCccChhhc
Confidence            6432     23557899999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=1.9e-31  Score=235.05  Aligned_cols=171  Identities=31%  Similarity=0.530  Sum_probs=132.4

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.+.+.||+|+||.||+|..  .++.||+|.+...........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            788899999999999999997  488999999854322111224678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||++........
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEE--CTTCCEEECCCTTCEECC----
T ss_pred             cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE--cCCCCEEEEeecceeeccCCCC
Confidence            99999999999875 56999999999999999999999988  9999999999999  7888999999999987654322


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       168 ----~~~~~~~~~~y~aPE~~~  185 (278)
T 3cok_A          168 ----KHYTLCGTPNYISPEIAT  185 (278)
T ss_dssp             ----------------------
T ss_pred             ----cceeccCCCCcCCcchhc
Confidence                233467999999999863

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=6.5e-31  Score=236.39  Aligned_cols=171  Identities=26%  Similarity=0.368  Sum_probs=144.6

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC--ceE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLM  231 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~  231 (337)
                      ..+|...+.||+|+||.||+|.+.  ++.||+|++.......  ..+.+.+|+.+++.++||||+++++++....  ..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            347889999999999999999986  7899999986533222  2466788999999999999999999988765  789


Q ss_pred             EEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec--CCCCcEEEEeccCc
Q 019685          232 LITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGLS  306 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~--~~~~~~kl~DFgla  306 (337)
                      +||||+++++|.+++....   .+++.+++.++.||+.||.|||+.+  |+||||||+|||+..  +..+.+||+|||++
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999998643   3999999999999999999999988  999999999998732  34557999999999


Q ss_pred             eeeecccccceeeeeCCcccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +......     ......||+.|+|||++
T Consensus       164 ~~~~~~~-----~~~~~~gt~~y~aPE~~  187 (319)
T 4euu_A          164 RELEDDE-----QFVSLYGTEEYLHPDMY  187 (319)
T ss_dssp             EECCTTC-----CBCCCCSCGGGCCHHHH
T ss_pred             eecCCCC-----ceeecccCCCccCHHHh
Confidence            8776543     23456799999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.3e-32  Score=247.23  Aligned_cols=173  Identities=25%  Similarity=0.394  Sum_probs=147.3

Q ss_pred             cCccccceecccCceeEEEEEE-----CCceEEEEEecCCCCc-hHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~  229 (337)
                      .+|...+.||+|+||.||++..     .++.||+|++.+.... .....+.+.+|+.++..+ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            3789999999999999999987     4789999998643211 111224566799999999 59999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +++||||+++++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--CCCCcEEEeeCCCCeec
Confidence            9999999999999999998888999999999999999999999988  9999999999999  88889999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......   ......||+.|+|||++.
T Consensus       210 ~~~~~~---~~~~~~gt~~y~aPE~~~  233 (355)
T 1vzo_A          210 VADETE---RAYDFCGTIEYMAPDIVR  233 (355)
T ss_dssp             CGGGGG---GGCGGGSCCTTCCHHHHT
T ss_pred             ccCCCC---cccCcccCcCccChhhhc
Confidence            543221   234467999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2.6e-31  Score=234.96  Aligned_cols=169  Identities=30%  Similarity=0.508  Sum_probs=147.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  ++.|++|.+.............+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            7888999999999999999986  67899999854322222223678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||++......   
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~---  167 (284)
T 2vgo_A           95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLM--GYKGELKIADFGWSVHAPSL---  167 (284)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECSSS---
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEE--cCCCCEEEecccccccCccc---
Confidence            9999999999988888999999999999999999999988  9999999999999  78889999999999765432   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       168 ---~~~~~~~~~~y~aPE~~~  185 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIE  185 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHT
T ss_pred             ---ccccccCCCCcCCHHHhc
Confidence               234567999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=2.4e-31  Score=252.85  Aligned_cols=171  Identities=30%  Similarity=0.524  Sum_probs=146.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.+.+.||+|+||.||+|...  ++.||+|++.+..... .....+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            6888999999999999999986  8899999985432111 123677899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+.+++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+.. +..+.+||+|||+++...... 
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-  178 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-  178 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence            9999999999988888999999999999999999999988  999999999999943 235679999999998765432 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       179 ----~~~~~~gt~~y~aPE~~~  196 (486)
T 3mwu_A          179 ----KMKDRIGTAYYIAPEVLR  196 (486)
T ss_dssp             -------CCTTGGGGCCGGGGG
T ss_pred             ----ccCCCcCCCCCCCHHHhC
Confidence                245567999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=1.4e-30  Score=230.87  Aligned_cols=176  Identities=27%  Similarity=0.439  Sum_probs=148.2

Q ss_pred             cCCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe---
Q 019685          152 IDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE---  226 (337)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~---  226 (337)
                      +......|...+.||+|+||.||+|.+.  +..|++|.+...... ....+.+.+|+.+++.++||||+++++++..   
T Consensus        21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            4444556788889999999999999985  667999988655443 3346788999999999999999999998865   


Q ss_pred             -CCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEecc
Q 019685          227 -RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFG  304 (337)
Q Consensus       227 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFg  304 (337)
                       ...+++||||+++++|.+++.....+++..+..++.||+.||.|||+.+.+|+||||||+|||+  + ..+.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE--ECCCCCEEEeeCC
Confidence             3558999999999999999988888999999999999999999999965559999999999999  5 67799999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++......      ......||+.|+|||++.
T Consensus       178 ~~~~~~~~------~~~~~~~t~~y~aPE~~~  203 (290)
T 1t4h_A          178 LATLKRAS------FAKAVIGTPEFMAPEMYE  203 (290)
T ss_dssp             GGGGCCTT------SBEESCSSCCCCCGGGGG
T ss_pred             Cccccccc------ccccccCCcCcCCHHHHh
Confidence            99755433      224457999999999763

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=3.1e-31  Score=242.13  Aligned_cols=172  Identities=28%  Similarity=0.492  Sum_probs=143.8

Q ss_pred             CcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER  227 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~  227 (337)
                      ..+|...+.||+|+||.||+|.+.       ++.||+|.+.....  ....+.+.+|+.++..+ +||||+++++++...
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            447888999999999999999853       46899999965432  33457789999999999 699999999998875


Q ss_pred             C-ceEEEEeecCCCCHHHHHHhcCC-------------------------------------------------------
Q 019685          228 K-PLMLITEYLRGGDLHKYLKEKGA-------------------------------------------------------  251 (337)
Q Consensus       228 ~-~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------  251 (337)
                      + .+++||||+++|+|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            5 48999999999999999976432                                                       


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeee
Q 019685          252 -----------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM  320 (337)
Q Consensus       252 -----------~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~  320 (337)
                                 +++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+.....  ....
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~--~~~~  252 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNVVKICDFGLARDIYKDPD--YVRK  252 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCCGGGSCTTSCTT--CEEC
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEE--cCCCcEEEEeccceeeeccccc--chhc
Confidence                       889999999999999999999988  9999999999999  7788999999999987643321  1234


Q ss_pred             eCCcccccccccccc
Q 019685          321 TGETGSCEYLVSNCS  335 (337)
Q Consensus       321 ~~~~gt~~y~aPE~l  335 (337)
                      ....||+.|+|||++
T Consensus       253 ~~~~~t~~y~aPE~~  267 (359)
T 3vhe_A          253 GDARLPLKWMAPETI  267 (359)
T ss_dssp             --CEECGGGCCHHHH
T ss_pred             cccCCCceeEChhhh
Confidence            567789999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=8.3e-31  Score=246.83  Aligned_cols=175  Identities=34%  Similarity=0.580  Sum_probs=140.8

Q ss_pred             CCCcccCCCCcCccccceecccCceeEEEEEECC-ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      ...|+++..  +|...+.||+|+||.||+|.+.+ ..||||.+......    .+.+.+|+.++++++||||+++++++.
T Consensus       176 ~~~~~i~~~--~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~  249 (452)
T 1fmk_A          176 KDAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS  249 (452)
T ss_dssp             TTCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccChh--HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            345665543  57778899999999999999974 57999998765432    357889999999999999999999986


Q ss_pred             eCCceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      . +..|+||||+++|+|.+++..  ...+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+||
T Consensus       250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill--~~~~~~kl~Df  324 (452)
T 1fmk_A          250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADF  324 (452)
T ss_dssp             S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCC
T ss_pred             C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEE--CCCCCEEECCC
Confidence            6 678999999999999999964  346999999999999999999999988  9999999999999  77889999999


Q ss_pred             cCceeeecccccceeeeeCCcccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |+++.......   .......+|+.|+|||++
T Consensus       325 G~a~~~~~~~~---~~~~~~~~~~~y~aPE~~  353 (452)
T 1fmk_A          325 GLARLIEDNEY---TARQGAKFPIKWTAPEAA  353 (452)
T ss_dssp             CTTC-----------------CCGGGSCHHHH
T ss_pred             ccceecCCCce---ecccCCcccccccCHhHH
Confidence            99987654321   123455678999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=8.4e-31  Score=237.21  Aligned_cols=175  Identities=34%  Similarity=0.555  Sum_probs=139.4

Q ss_pred             CCcCccccceecccCceeEEEEEECC------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~g------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      ...+|...+.||+|+||.||+|.+..      ..||+|.+....  .......+.+|+.+++.++||||+++++++...+
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            34467888999999999999998752      249999986543  2334567889999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      ..++||||+++++|.+++... ..+++.+++.++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC--
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEE--CCCCcEEECCCCcch
Confidence            999999999999999999864 56999999999999999999999988  9999999999999  788899999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........ ........+|+.|+|||++.
T Consensus       196 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  223 (333)
T 1mqb_A          196 VLEDDPEA-TYTTSGGKIPIRWTAPEAIS  223 (333)
T ss_dssp             ----------------CCCGGGSCHHHHH
T ss_pred             hhcccccc-ccccCCCCccccccCchhcc
Confidence            77543221 11233445788999999863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=1.9e-30  Score=231.18  Aligned_cols=172  Identities=31%  Similarity=0.563  Sum_probs=143.3

Q ss_pred             cCccccceecccCceeEEEEEE------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--C
Q 019685          157 LDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--K  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~  228 (337)
                      ..|+..+.||+|+||.||+|.+      .++.||+|.+......  ...+.+.+|+.+++.++||||+++++++...  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            3588889999999999999985      3788999998754322  2346788999999999999999999999876  6


Q ss_pred             ceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          229 PLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      .+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV--ESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEE--cCCCCEEECcccccc
Confidence            68999999999999999965 456999999999999999999999988  9999999999999  677899999999998


Q ss_pred             eeecccccceeeeeCCcccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....... .........||+.|+|||++
T Consensus       175 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~  201 (302)
T 4e5w_A          175 AIETDKE-YYTVKDDRDSPVFWYAPECL  201 (302)
T ss_dssp             ECCTTCC-EEECCCCTTCCGGGCCHHHH
T ss_pred             cccCCCc-ceeccCCCCCCccccCCeee
Confidence            8765432 11234556789999999976

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=3.4e-31  Score=233.03  Aligned_cols=170  Identities=26%  Similarity=0.488  Sum_probs=140.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  ++.|++|.+...........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            7888999999999999999985  88999999864322222234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++...+.+++..+..++.||+.||.|||+.+  |+|+||||+||++  +.++.+||+|||++.......  
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~~~~--  165 (276)
T 2h6d_A           92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLL--DAHMNAKIADFGLSNMMSDGE--  165 (276)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEE--CTTSCEEECCCCGGGCCCC----
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEE--CCCCCEEEeecccccccCCCc--
Confidence            9999999999988888999999999999999999999988  9999999999999  788899999999998765432  


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       166 ---~~~~~~~~~~y~aPE~~~  183 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVIS  183 (276)
T ss_dssp             --------------CCTGGGT
T ss_pred             ---ceecccCCccccCHHHHc
Confidence               234557999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.2e-31  Score=244.65  Aligned_cols=182  Identities=25%  Similarity=0.453  Sum_probs=138.9

Q ss_pred             CCcccCCCCcCccccceecccCceeEEEEEEC---C--ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeee
Q 019685          148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---G--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG  222 (337)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---g--~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~  222 (337)
                      ..+.+++....|...+.||+|+||.||+|.+.   +  ..+++|.+....  .....+.+.+|+.+++.++||||+++++
T Consensus        80 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~  157 (373)
T 3c1x_A           80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLG  157 (373)
T ss_dssp             TTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred             cccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            34566777778888999999999999999863   2  357888886432  2334578899999999999999999999


Q ss_pred             eEE-eCCceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEE
Q 019685          223 AVT-ERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKV  300 (337)
Q Consensus       223 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl  300 (337)
                      ++. ..+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||
T Consensus       158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll--~~~~~~kL  233 (373)
T 3c1x_A          158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKV  233 (373)
T ss_dssp             EECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEE
T ss_pred             EEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEE--CCCCCEEE
Confidence            865 456789999999999999999864 45889999999999999999999988  9999999999999  88889999


Q ss_pred             EeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +|||+++.+...............+|+.|+|||++
T Consensus       234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  268 (373)
T 3c1x_A          234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL  268 (373)
T ss_dssp             CCC---------------------CCGGGSCHHHH
T ss_pred             eeccccccccccccccccccCCCCCcccccChHHh
Confidence            99999987654332222234556788999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=1.5e-30  Score=229.87  Aligned_cols=168  Identities=27%  Similarity=0.489  Sum_probs=143.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+........ ....+.+|+..+..+ +||||+++++++...+..++||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            6888899999999999999985  88999999876544333 346778899999999 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-----------------
Q 019685          235 EYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-----------------  293 (337)
Q Consensus       235 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-----------------  293 (337)
                      ||+++++|.+++...    ..+++.++..++.||+.||.|||+++  |+||||||+|||+..+                 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            999999999999764    66999999999999999999999988  9999999999999321                 


Q ss_pred             CCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          294 SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       294 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....+||+|||++......        ....||+.|+|||++.
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~aPE~~~  203 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP--------QVEEGDSRFLANEVLQ  203 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS--------CCCCCCGGGCCHHHHT
T ss_pred             CceEEEEcccccccccCCc--------cccCCCccccChhHhc
Confidence            3447999999999876533        2345999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=2e-30  Score=231.68  Aligned_cols=171  Identities=28%  Similarity=0.464  Sum_probs=146.3

Q ss_pred             ccccceecccCceeEEEEEECCceEEEEEecCCCC-chHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLS-DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~-~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      |...+.||+|+||.||+|..+++.+++|.+..... ......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            44457999999999999999999999999865432 22334577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          238 RGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       238 ~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ++++|.+++..   ...+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++.......
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILL--DEAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECCSCSS
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEE--cCCCcEEEeecccccccccccc
Confidence            99999999974   345899999999999999999999988  9999999999999  8888999999999987654322


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .  .......||+.|+|||++
T Consensus       189 ~--~~~~~~~g~~~y~aPE~~  207 (307)
T 2nru_A          189 T--VMTSRIVGTTAYMAPEAL  207 (307)
T ss_dssp             C--EECSSCCSCGGGCCHHHH
T ss_pred             c--ccccccCCCcCcCChHHh
Confidence            1  123456799999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7e-31  Score=237.59  Aligned_cols=168  Identities=29%  Similarity=0.481  Sum_probs=137.5

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEeC----CceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTER----KPLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~----~~~~  231 (337)
                      +|+..+.||+|+||.||+|.++++.||+|++....      ...+..|..++..  ++||||+++++++...    ..+|
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            68889999999999999999999999999985321      1334445555554  4899999999999877    6799


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE--------PNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      +||||+++++|.+++... .+++..++.++.|++.||.|||+.        +  |+||||||+|||+  +.++.+||+||
T Consensus       112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill--~~~~~~kl~Df  186 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILV--KKNGTCCIADL  186 (337)
T ss_dssp             EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEE--CTTSCEEECCC
T ss_pred             EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEE--CCCCCEEEEeC
Confidence            999999999999999654 699999999999999999999997        6  9999999999999  78889999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.+...............||+.|+|||++.
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  219 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD  219 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcc
Confidence            999877654322211234567999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=7.1e-31  Score=232.46  Aligned_cols=169  Identities=27%  Similarity=0.487  Sum_probs=140.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++...  +..+|+|.+.......  ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            6888999999999999999975  7789999986643322  23678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeee
Q 019685          236 YLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       236 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~  310 (337)
                      |+++++|.+++..    ...+++..+..++.||+.||.|||+.+  |+||||||+||++.. +..+.+||+|||+++.+.
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999999864    357999999999999999999999988  999999999999943 335789999999998765


Q ss_pred             cccccceeeeeCCcccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...     ......||+.|+|||++
T Consensus       179 ~~~-----~~~~~~~t~~y~aPE~~  198 (285)
T 3is5_A          179 SDE-----HSTNAAGTALYMAPEVF  198 (285)
T ss_dssp             -------------CTTGGGCCHHHH
T ss_pred             Ccc-----cCcCcccccCcCChHHh
Confidence            432     23456799999999976

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=1.1e-30  Score=233.86  Aligned_cols=173  Identities=29%  Similarity=0.536  Sum_probs=147.2

Q ss_pred             CCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER  227 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  227 (337)
                      ...+|...+.||+|+||.||+|...       +..||+|.+....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            3457888999999999999999862       3679999986543  234557889999999999999999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCC
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKGA------------------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDL  283 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdl  283 (337)
                      +..++||||+++++|.+++.....                        +++.+++.++.||+.||.|||+++  |+||||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~di  176 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDL  176 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cccccc
Confidence            999999999999999999986433                        889999999999999999999988  999999


Q ss_pred             CCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       284 kp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||+||++  +.++.+||+|||+++.......  ........+|+.|+|||++
T Consensus       177 kp~NIli--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  224 (314)
T 2ivs_A          177 AARNILV--AEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESL  224 (314)
T ss_dssp             SGGGEEE--ETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHH
T ss_pred             chheEEE--cCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhh
Confidence            9999999  7778999999999987654322  1123445678999999976

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=2.1e-30  Score=232.02  Aligned_cols=172  Identities=26%  Similarity=0.503  Sum_probs=138.0

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|...+.||+|+||.||+|...  ++.||+|.+.............+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            37899999999999999999974  8899999997655555556678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          235 EYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       235 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ||+++++|.+++..    ...+++..++.++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++...
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~--~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFI--TATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCC-------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEE--cCCCCEEEEeccceeeec
Confidence            99999999999974    356899999999999999999999988  9999999999999  788899999999998765


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....    ......|++.|+|||++.
T Consensus       188 ~~~~----~~~~~~~~~~y~aPE~~~  209 (310)
T 2wqm_A          188 SKTT----AAHSLVGTPYYMSPERIH  209 (310)
T ss_dssp             ---------------CCSSCCHHHHT
T ss_pred             CCCc----cccccCCCeeEeChHHhC
Confidence            4321    234567999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=1.4e-30  Score=233.63  Aligned_cols=171  Identities=24%  Similarity=0.403  Sum_probs=137.8

Q ss_pred             Cccc-cceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEE
Q 019685          158 DFSS-SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~-~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      .|.+ .+.||+|+||.||+|...  ++.||+|++.......   ...+.+|+.++.++ +||||+++++++...+.+|+|
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            5666 368999999999999874  8899999997654332   36778899999885 699999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc---EEEEeccCceeee
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH---LKVGDFGLSKLIK  310 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~---~kl~DFgla~~~~  310 (337)
                      |||+++++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.   +||+|||+++...
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~--~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILC--EHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--SCSSSSCSEEECCTTCCC---
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEE--ccCCCcCceEEEEccCccccc
Confidence            999999999999988888999999999999999999999988  9999999999999  54444   9999999998765


Q ss_pred             cccccc---eeeeeCCcccccccccccc
Q 019685          311 VQNSHD---VYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       311 ~~~~~~---~~~~~~~~gt~~y~aPE~l  335 (337)
                      ......   ........||+.|+|||++
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~  193 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVV  193 (316)
T ss_dssp             ----------------CCSGGGCCHHHH
T ss_pred             cCCccccccccccccccCCcCccChHHh
Confidence            332110   0122345699999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=1e-30  Score=241.56  Aligned_cols=172  Identities=28%  Similarity=0.487  Sum_probs=134.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCC--ceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK--PLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~--~~~l  232 (337)
                      +|+..+.||+|+||.||+|.+.  ++.||+|++...... ......+.+|+.++..+. ||||+++++++...+  .+|+
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            6888999999999999999875  889999998654333 344567788999999998 999999999997544  6899


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||+|+.+...
T Consensus        89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILL--NAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEESSSC
T ss_pred             EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEE--cCCCCEEecCCccccccccc
Confidence            999997 499999875 47999999999999999999999988  9999999999999  88899999999999876431


Q ss_pred             cc-----------------cceeeeeCCccccccccccccc
Q 019685          313 NS-----------------HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~-----------------~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..                 ..........||+.|+|||++.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL  203 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence            10                 0011234568999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=5.4e-31  Score=238.05  Aligned_cols=169  Identities=24%  Similarity=0.311  Sum_probs=143.4

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|...+.||+|+||.||+|..  .++.||+|++......     +.+.+|+.+++.+ +||||+++++++......++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            788899999999999999996  4889999998654322     3567899999999 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc-----EEEEeccCcee
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSKL  308 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~-----~kl~DFgla~~  308 (337)
                      ||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.     +||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill--~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLI--GRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CCGGGTCTTSEEECCCTTCEE
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeee--ccCCCCCCceEEEEEccccee
Confidence            999 8899999986 467999999999999999999999988  9999999999999  66665     99999999988


Q ss_pred             eecccccc---eeeeeCCccccccccccccc
Q 019685          309 IKVQNSHD---VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~---~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.......   ........||+.|+|||++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  190 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHL  190 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHc
Confidence            75443211   11235678999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=6.7e-31  Score=230.55  Aligned_cols=172  Identities=35%  Similarity=0.656  Sum_probs=133.7

Q ss_pred             cCccccceecccCceeEEEEEECCceEEEEEecCCCCch-HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .+|+..+.||+|+||.||+|.+.++.+|+|++....... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            478889999999999999999999999999986543322 2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCC-CcEeeCCCCCCEEEecC------CCCcEEEEeccCcee
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPN-VIIHRDLKPRNVLLVNS------SADHLKVGDFGLSKL  308 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~ivHrdlkp~Nil~~~~------~~~~~kl~DFgla~~  308 (337)
                      |+++++|.+++. ...+++..+..++.|++.||.|||+++. +|+||||||+||++..+      ..+.+||+|||+++.
T Consensus        87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            999999999985 4579999999999999999999999752 28899999999999321      267899999999987


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .....      .....||+.|+|||++
T Consensus       166 ~~~~~------~~~~~~~~~y~aPE~~  186 (271)
T 3dtc_A          166 WHRTT------KMSAAGAYAWMAPEVI  186 (271)
T ss_dssp             ----------------CCGGGSCHHHH
T ss_pred             ccccc------ccCCCCccceeCHHHh
Confidence            65432      2345799999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=8.2e-31  Score=242.30  Aligned_cols=172  Identities=22%  Similarity=0.357  Sum_probs=144.6

Q ss_pred             CcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEEeCCceEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ..+|.+.+.||+|+||.||++... ++.||||++...... ....+.+.+|+.++..++  ||||+++++++.....+|+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            346999999999999999999876 788999998765443 345678899999999997  5999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||| +.+++|.+++.....+++.++..++.||+.||.|||+.+  |+||||||+|||+  + ++.+||+|||+++.+...
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll--~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEE--S-SSCEEECCCSSSCCC---
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEE--E-CCeEEEEecCccccccCC
Confidence            999 567899999998888999999999999999999999988  9999999999999  4 478999999999877543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...  .......||+.|+|||++.
T Consensus       208 ~~~--~~~~~~~gt~~y~aPE~~~  229 (390)
T 2zmd_A          208 TTS--VVKDSQVGAVNYMPPEAIK  229 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHH
T ss_pred             Ccc--ccCCCCCcCCCccChHHhh
Confidence            211  1234567999999999873

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=9.7e-32  Score=244.21  Aligned_cols=177  Identities=28%  Similarity=0.396  Sum_probs=140.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCC--chHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLS--DDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~--~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      +|+..+.||+|+||.||+|...  +..+|+|++.+...  ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            6888999999999999999885  67899999864321  1122347788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHc
Q 019685          234 TEYLRGGDLHKYLKE----------------------------------------KGALSPSTAVNFALDIARGMAYLHN  273 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~  273 (337)
                      |||+++++|.+++..                                        ...+++..+..++.||+.||.|||+
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  186 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN  186 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            999999999998841                                        0113567788999999999999999


Q ss_pred             CCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       274 ~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+  |+||||||+|||+..+..+.+||+|||+++.+...............||+.|+|||++.
T Consensus       187 ~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  247 (345)
T 3hko_A          187 QG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN  247 (345)
T ss_dssp             TT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred             CC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence            88  99999999999994444448999999999877554332223345678999999999873

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=6.2e-31  Score=239.00  Aligned_cols=174  Identities=21%  Similarity=0.360  Sum_probs=144.1

Q ss_pred             CCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC--CCeeeeeeeEEeCCc
Q 019685          153 DPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH--PNIVQFLGAVTERKP  229 (337)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~~~~~  229 (337)
                      ......|++.+.||+|+||.||++... ++.||+|++...... ....+.+.+|+.++..++|  |||+++++++.....
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            344557999999999999999999875 778999998765433 3455788999999999986  999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+||| +.+++|.+++.....+++.++..++.||+.||.|||+.+  |+||||||+|||+  + ++.+||+|||+++.+
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll--~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--E-TTEEEECCCSSSCCC
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEE--E-CCcEEEeeccccccc
Confidence            999999 557799999998888999999999999999999999988  9999999999999  3 468999999999877


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ......  .......||+.|+|||++
T Consensus       158 ~~~~~~--~~~~~~~gt~~y~aPE~~  181 (343)
T 3dbq_A          158 QPDTTS--VVKDSQVGTVNYMPPEAI  181 (343)
T ss_dssp             --------------CCCCSSCCHHHH
T ss_pred             Cccccc--ccCCCCcCCcCcCCHHHH
Confidence            543221  123456799999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=2e-31  Score=248.61  Aligned_cols=171  Identities=29%  Similarity=0.441  Sum_probs=135.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCc-----hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|...+.||+|+||.||+|...  ++.||+|++.+....     .......+.+|+.++++++||||+++++++. .+..
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~  214 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY  214 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence            6888899999999999999885  679999998654221     1122335788999999999999999999975 4558


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~  309 (337)
                      |+||||+++++|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+..+ ..+.+||+|||+++..
T Consensus       215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            999999999999999988788999999999999999999999988  9999999999999332 2346999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....     ......||+.|+|||++.
T Consensus       293 ~~~~-----~~~~~~gt~~y~aPE~~~  314 (419)
T 3i6u_A          293 GETS-----LMRTLCGTPTYLAPEVLV  314 (419)
T ss_dssp             C----------------CTTCCTTTTC
T ss_pred             CCCc-----cccccCCCCCccCceeee
Confidence            5432     234567999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=1.2e-30  Score=230.36  Aligned_cols=170  Identities=29%  Similarity=0.513  Sum_probs=143.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCch---HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|+..+.||+|+||.||++...  ++.+++|.+.......   ....+.+.+|+.+++.++||||+++++++......++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            5788899999999999999986  7899999986543321   1124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC----cEEEEeccCcee
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL  308 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~----~~kl~DFgla~~  308 (337)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+    .+||+|||++..
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--SCSSSSSCCEEECCCTTCEE
T ss_pred             EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEE--ecCCCCCCceEEEeccccee
Confidence            9999999999999988888999999999999999999999988  9999999999999  5544    799999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....     ......||+.|+|||++.
T Consensus       162 ~~~~~-----~~~~~~~~~~y~aPE~~~  184 (283)
T 3bhy_A          162 IEAGN-----EFKNIFGTPEFVAPEIVN  184 (283)
T ss_dssp             CC-------------CCCGGGCCHHHHT
T ss_pred             ccCCC-----cccccCCCcCccCcceec
Confidence            65432     234567999999999863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=2.7e-31  Score=240.07  Aligned_cols=171  Identities=32%  Similarity=0.485  Sum_probs=137.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  ++.||+|++...... ....+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE  113 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence            7899999999999999999875  789999998655332 2334667789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec---CCCCcEEEEeccCceeeecc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~---~~~~~~kl~DFgla~~~~~~  312 (337)
                      |+++ +|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+..   +..+.+||+|||+++.....
T Consensus       114 ~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          114 YAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             CCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             cCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            9985 99999998888999999999999999999999988  999999999999942   23446999999999876533


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......||+.|+|||++.
T Consensus       191 ~~----~~~~~~~t~~y~aPE~~~  210 (329)
T 3gbz_A          191 IR----QFTHEIITLWYRPPEILL  210 (329)
T ss_dssp             -------------CCTTCCHHHHT
T ss_pred             cc----ccCCCcCCccccCHHHhc
Confidence            21    345567899999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=9.2e-31  Score=236.67  Aligned_cols=170  Identities=28%  Similarity=0.477  Sum_probs=143.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            7888999999999999999986  789999998665433 3445677899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+..... 
T Consensus       105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~-  179 (331)
T 4aaa_A          105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGE-  179 (331)
T ss_dssp             CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEE--cCCCcEEEEeCCCceeecCCcc-
Confidence            9999999988877778999999999999999999999988  9999999999999  8888999999999987654322 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       180 ---~~~~~~~t~~y~aPE~~~  197 (331)
T 4aaa_A          180 ---VYDDEVATRWYRAPELLV  197 (331)
T ss_dssp             -------CCCCCTTCCHHHHT
T ss_pred             ---ccCCCcCCccccCccccc
Confidence               234567999999999863

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.3e-31  Score=256.64  Aligned_cols=161  Identities=17%  Similarity=0.147  Sum_probs=126.8

Q ss_pred             ecccCceeEEEEE--ECCceEEEEEecCCCCc-------hHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEE
Q 019685          165 IGKGSFGEILKAY--WRGTPVAIKRILPSLSD-------DRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       165 lg~G~~g~V~~~~--~~g~~vavK~l~~~~~~-------~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      ...|++|.+..++  +.|+.+++|++.+....       .....+++.+|+.+|+++. |+||+++++++++.+.+||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            3455555544433  35899999999764321       1334567999999999995 999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||++|++|.++|...+.+++.   .|+.||+.||.|+|++|  ||||||||+|||+  +.+|.+||+|||+|+.......
T Consensus       322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL--~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMV--DARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEE--CTTSCEEECCCTTEESCC---C
T ss_pred             ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEE--CCCCCEEEeecccCeeCCCCCc
Confidence            999999999999988888765   47899999999999988  9999999999999  8889999999999987764432


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ...+.+||+.|||||++.
T Consensus       395 ----~~~t~vGTp~YmAPE~l~  412 (569)
T 4azs_A          395 ----WPTNLVQSFFVFVNELFA  412 (569)
T ss_dssp             ----CSHHHHHHHHHHHHHHC-
T ss_pred             ----cccCceechhhccHHHhC
Confidence                345578999999999873

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=8.2e-31  Score=229.67  Aligned_cols=167  Identities=25%  Similarity=0.376  Sum_probs=146.2

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--CceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|.++++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++...  ...++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            7888899999999999999999999999999765433 33457789999999999999999999999877  78899999


Q ss_pred             ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++....  .+++.++..++.||+.||.|||+++.+|+||||||+||++  +.++.++|+|||++....   
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~l~~~~~~~~~~---  164 (271)
T 3kmu_A           90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDMTARISMADVKFSFQ---  164 (271)
T ss_dssp             CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE--CTTSCEEEEGGGSCCTTS---
T ss_pred             ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE--cCCcceeEEeccceeeec---
Confidence            999999999998754  4899999999999999999999976669999999999999  788899999999875432   


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                            .....||+.|+|||++.
T Consensus       165 ------~~~~~~t~~y~aPE~~~  181 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQ  181 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHH
T ss_pred             ------ccCccCCccccChhhhc
Confidence                  23457899999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=1e-30  Score=234.02  Aligned_cols=180  Identities=32%  Similarity=0.501  Sum_probs=150.1

Q ss_pred             CCCCcccCCCCcCccccceecccCceeEEEEEE-------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCe
Q 019685          146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNI  217 (337)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~I  217 (337)
                      ....|++.  ..+|...+.||+|+||.||+|.+       .++.||+|.+.....  ....+.+.+|+.+++++ +||||
T Consensus        14 ~~~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i   89 (313)
T 1t46_A           14 YDHKWEFP--RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNI   89 (313)
T ss_dssp             CCGGGBCC--GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CccccccC--hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCe
Confidence            33444443  34788889999999999999985       256899999875432  33457789999999999 89999


Q ss_pred             eeeeeeEEeCCceEEEEeecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcE
Q 019685          218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------ALSPSTAVNFALDIARGMAYLHNEPNVII  279 (337)
Q Consensus       218 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~iv  279 (337)
                      +++++++...+..++||||+++++|.+++....                  .+++..++.++.||+.||.|||+.+  |+
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~  167 (313)
T 1t46_A           90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CI  167 (313)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            999999999999999999999999999998643                  3899999999999999999999988  99


Q ss_pred             eeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       280 Hrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||||||+||++  +.++.+||+|||+++.......  ........||+.|+|||++
T Consensus       168 H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  219 (313)
T 1t46_A          168 HRDLAARNILL--THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESI  219 (313)
T ss_dssp             CSCCSGGGEEE--ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHH
T ss_pred             cCCCccceEEE--cCCCCEEEcccccccccccccc--ceeccCCCCcceeeChHHh
Confidence            99999999999  7778999999999987654422  1123456688999999976

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=1.1e-30  Score=242.25  Aligned_cols=164  Identities=28%  Similarity=0.480  Sum_probs=130.0

Q ss_pred             Ccccc-ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHH-HhCCCCCeeeeeeeEEe----CCc
Q 019685          158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTE----RKP  229 (337)
Q Consensus       158 ~~~~~-~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~----~~~  229 (337)
                      +|... +.||+|+||.||++...  ++.||+|++...        ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            56554 68999999999999986  788999998532        3456788876 45579999999999875    567


Q ss_pred             eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCc
Q 019685          230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS  306 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla  306 (337)
                      +|+||||+++|+|.+++...+  .+++.++..++.||+.||.|||+.+  |+||||||+|||++.+ ..+.+||+|||++
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            899999999999999998643  5999999999999999999999987  9999999999999321 1688999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +......     ......||+.|+|||++.
T Consensus       212 ~~~~~~~-----~~~~~~gt~~y~aPE~~~  236 (400)
T 1nxk_A          212 KETTSHN-----SLTTPCYTPYYVAPEVLG  236 (400)
T ss_dssp             EECC----------------CTTCCGGGSC
T ss_pred             cccCCCC-----ccccCCCCCCccCHhhcC
Confidence            8765432     235677999999999873

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.1e-30  Score=232.30  Aligned_cols=182  Identities=26%  Similarity=0.429  Sum_probs=150.9

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEEC--Cc---eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeee
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA  223 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~---~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~  223 (337)
                      ++.++.....|...+.||+|+||.||+|.+.  +.   .+++|.+....  .....+.+.+|+.+++.++||||++++++
T Consensus        13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   90 (298)
T 3pls_A           13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGI   90 (298)
T ss_dssp             GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            4556666677888899999999999999863  22   68999886532  33456788999999999999999999999


Q ss_pred             EEeCCce-EEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          224 VTERKPL-MLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       224 ~~~~~~~-~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                      +...+.. +++|||+.+++|.+++.. ...+++..+..++.|++.||.|||+++  |+||||||+||++  +.++.+||+
T Consensus        91 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili--~~~~~~kl~  166 (298)
T 3pls_A           91 MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCML--DESFTVKVA  166 (298)
T ss_dssp             ECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEEC
T ss_pred             EecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCcEEeC
Confidence            9876655 999999999999999986 456899999999999999999999988  9999999999999  888899999


Q ss_pred             eccCceeeecccccceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+++.+...............+|+.|+|||.+.
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  201 (298)
T 3pls_A          167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQ  201 (298)
T ss_dssp             CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT
T ss_pred             cCCCcccccCCcccccccCcCCCCCccccChhhhc
Confidence            99999876543322222345567899999999863

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=4.5e-31  Score=242.14  Aligned_cols=173  Identities=28%  Similarity=0.422  Sum_probs=143.3

Q ss_pred             cCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      .+|...+.||+|+||.||+|.+.       +..||+|.+.....  ......+.+|+.+++.++||||+++++++.....
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            36888999999999999999853       45799999864332  3344678889999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEE
Q 019685          230 LMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVG  301 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~  301 (337)
                      .|+||||+++++|.+++....       .+++.+++.++.||+.||.|||+++  |+||||||+|||+..+ ....+||+
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999998642       4899999999999999999999988  9999999999999321 33459999


Q ss_pred             eccCceeeecccccceeeeeCCcccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |||+++.+......  .......||+.|+|||++
T Consensus       227 DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~  258 (367)
T 3l9p_A          227 DFGMARDIYRAGYY--RKGGCAMLPVKWMPPEAF  258 (367)
T ss_dssp             CCHHHHHHHHHSSC--TTCCGGGSCGGGCCHHHH
T ss_pred             CCcccccccccccc--ccCCCcCCcccEECHHHh
Confidence            99999866433211  123445689999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=2.3e-30  Score=230.32  Aligned_cols=170  Identities=26%  Similarity=0.416  Sum_probs=149.0

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCc------hHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeC
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD------DRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER  227 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~------~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~  227 (337)
                      .+|...+.||+|+||.||+|...  ++.||+|.+......      .....+.+.+|+.+++++. ||||+++++++...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            37889999999999999999985  788999998654321      1233467789999999996 99999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      ...++||||+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILL--DDDMNIKLTDFGFSC  172 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEE--cCCCcEEEecccchh
Confidence            999999999999999999998888999999999999999999999988  9999999999999  888899999999998


Q ss_pred             eeecccccceeeeeCCcccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ......     ......||+.|+|||++
T Consensus       173 ~~~~~~-----~~~~~~~~~~y~aPE~~  195 (298)
T 1phk_A          173 QLDPGE-----KLREVCGTPSYLAPEII  195 (298)
T ss_dssp             ECCTTC-----CBCCCCSCGGGCCHHHH
T ss_pred             hcCCCc-----ccccccCCccccCHHHh
Confidence            765432     23456799999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=3.3e-31  Score=234.68  Aligned_cols=165  Identities=23%  Similarity=0.374  Sum_probs=141.0

Q ss_pred             cCccccceecccCceeEEEEEEC--C-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--G-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER  227 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  227 (337)
                      .+|...+.||+|+||.||+|.+.  +       ..|++|.+.....   ...+.+.+|+.+++.++||||+++++++...
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            37888999999999999999875  3       4699998865332   2346788999999999999999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc--------E
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH--------L  298 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~--------~  298 (337)
                      +..++||||+++++|.+++..... +++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.        +
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILL--IREEDRKTGNPPFI  160 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--EECCBGGGTBCCEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEE--ecCCccccccccee
Confidence            999999999999999999987554 999999999999999999999988  9999999999999  44444        9


Q ss_pred             EEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       299 kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+|||++......        ....||+.|+|||++.
T Consensus       161 kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~  190 (289)
T 4fvq_A          161 KLSDPGISITVLPK--------DILQERIPWVPPECIE  190 (289)
T ss_dssp             EECCCCSCTTTSCH--------HHHHHTTTTSCHHHHH
T ss_pred             eeccCcccccccCc--------cccCCcCcccCHHHhC
Confidence            99999999655432        2345889999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=5.7e-31  Score=248.52  Aligned_cols=166  Identities=27%  Similarity=0.382  Sum_probs=135.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------c
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------P  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~  229 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|++..... .....+.+.+|+.+++.++||||+++++++....      .
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            6888999999999999999875  78999999975432 3345577889999999999999999999986553      4


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||+++..
T Consensus       142 ~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll--~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCCC---
T ss_pred             EEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEE--eCCCCEEEEEEEeeeec
Confidence            6999999976 5777764  34899999999999999999999988  9999999999999  88889999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....     ......||+.|+|||++.
T Consensus       215 ~~~~-----~~~~~~gt~~y~aPE~~~  236 (464)
T 3ttj_A          215 GTSF-----MMTPYVVTRYYRAPEVIL  236 (464)
T ss_dssp             --CC-----CC----CCCTTCCHHHHT
T ss_pred             CCCc-----ccCCCcccccccCHHHHc
Confidence            5432     245578999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=2.8e-30  Score=233.72  Aligned_cols=181  Identities=29%  Similarity=0.531  Sum_probs=149.5

Q ss_pred             CCCCCcccCCCCcCccccceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CC
Q 019685          145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH  214 (337)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h  214 (337)
                      |....|++.  ..+|...+.||+|+||.||+|.+.         +..||+|++....  .......+.+|+.+++.+ +|
T Consensus        25 ~~~~~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h  100 (334)
T 2pvf_A           25 PEDPKWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKH  100 (334)
T ss_dssp             CCCTTTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCC
T ss_pred             CCCccccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcC
Confidence            333444433  347888899999999999999863         4579999986543  234457788999999999 89


Q ss_pred             CCeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 019685          215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVI  278 (337)
Q Consensus       215 ~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~i  278 (337)
                      |||+++++++...+.+|+||||+++++|.+++....                .+++.+++.++.||+.||.|||+.+  |
T Consensus       101 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i  178 (334)
T 2pvf_A          101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--C  178 (334)
T ss_dssp             TTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred             CCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence            999999999999999999999999999999998643                3889999999999999999999988  9


Q ss_pred             EeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       279 vHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +||||||+|||+  +.++.+||+|||+++.......  ........+|+.|+|||++
T Consensus       179 vH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  231 (334)
T 2pvf_A          179 IHRDLAARNVLV--TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEAL  231 (334)
T ss_dssp             ECSCCSGGGEEE--CTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHH
T ss_pred             eCCCCccceEEE--cCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHh
Confidence            999999999999  8888999999999987654321  1123445678999999976

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=7.4e-31  Score=239.93  Aligned_cols=168  Identities=26%  Similarity=0.440  Sum_probs=147.5

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|+..+.||+|+||.||++.+.  +..||+|++....  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            37889999999999999999986  7889999987653  2344577899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+. +  |+||||||+|||+  +.++.+||+|||+++..... 
T Consensus       111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEE--CTTCCEEECCCCCCHHHHHH-
T ss_pred             ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEE--CCCCCEEEEECCCCcccccc-
Confidence            9999999999999888899999999999999999999995 7  9999999999999  78889999999999766433 


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           ......||+.|+|||++.
T Consensus       186 -----~~~~~~gt~~y~aPE~~~  203 (360)
T 3eqc_A          186 -----MANSFVGTRSYMSPERLQ  203 (360)
T ss_dssp             -----C----CCCCTTCCHHHHT
T ss_pred             -----cccCCCCCCCeECHHHHc
Confidence                 234567999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=7.8e-31  Score=238.97  Aligned_cols=173  Identities=26%  Similarity=0.437  Sum_probs=144.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--------C
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------R  227 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--------~  227 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|++....... .....+.+|+.+++.++||||+++++++..        .
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            7899999999999999999985  7899999986544322 123466789999999999999999999876        3


Q ss_pred             CceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          228 KPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      +.+|+||||+++ +|.+.+.. ...+++.++..++.||+.||.|||++|  |+||||||+|||+  +.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLI--TRDGVLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEE--cCCCCEEEccchhc
Confidence            468999999986 78777765 356999999999999999999999988  9999999999999  88889999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.+...............||+.|+|||++.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  201 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLL  201 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHT
T ss_pred             ccccccccccccccCCcccccCccCchhhc
Confidence            887644332222446678999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=1.3e-30  Score=230.19  Aligned_cols=171  Identities=28%  Similarity=0.522  Sum_probs=132.7

Q ss_pred             CCcCccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      ...+|+..+.||+|+||.||+|.+.     +..+++|.+....  .....+.+.+|+.+++.++||||+++++++. .+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            3447888999999999999999874     3458899876533  3345578899999999999999999999874 567


Q ss_pred             eEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECC------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEE--CCCCCEEECccccccc
Confidence            899999999999999998654 6999999999999999999999988  9999999999999  6678999999999987


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ......   .......+|+.|+|||++
T Consensus       166 ~~~~~~---~~~~~~~~~~~y~aPE~~  189 (281)
T 1mp8_A          166 MEDSTY---YKASKGKLPIKWMAPESI  189 (281)
T ss_dssp             ----------------CCGGGCCHHHH
T ss_pred             cCcccc---cccccCCCcccccChhhc
Confidence            754321   123445678899999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.2e-30  Score=237.00  Aligned_cols=172  Identities=29%  Similarity=0.478  Sum_probs=143.4

Q ss_pred             CcCccccceecccCceeEEEEEE-------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYW-------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER  227 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~-------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~  227 (337)
                      ..+|...+.||+|+||.||+|.+       .+..||+|.+.....  ....+.+.+|+.++..+ +||||+++++++...
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            34788889999999999999986       245799999865432  22346788999999999 899999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCC
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKG-----------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK  284 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlk  284 (337)
                      +..++||||+++++|.+++....                       .+++..++.++.||+.||.|||+.|  |+|||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dik  199 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLA  199 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCS
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence            99999999999999999997643                       2789999999999999999999988  9999999


Q ss_pred             CCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          285 PRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       285 p~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |+|||+  +.++.+||+|||+++.......  ........||+.|+|||++
T Consensus       200 p~NIll--~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~  246 (344)
T 1rjb_A          200 ARNVLV--THGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESL  246 (344)
T ss_dssp             GGGEEE--ETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHH
T ss_pred             hhhEEE--cCCCcEEeCCCccCcccccCcc--ceeccCccCccCccCHHHh
Confidence            999999  7788999999999987654422  1223456688999999976

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.7e-30  Score=238.21  Aligned_cols=166  Identities=28%  Similarity=0.487  Sum_probs=138.2

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------  228 (337)
                      .+|...+.||+|+||.||+|...  |+.||+|++..... .....+.+.+|+.+++.++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            47889999999999999999975  88999999865443 3445577889999999999999999999987653      


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEE--cCCCCEEEEeeecccc
Confidence            469999999 7799999976 56999999999999999999999988  9999999999999  8888999999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....       .....||+.|+|||++.
T Consensus       178 ~~~~-------~~~~~~t~~y~aPE~~~  198 (367)
T 1cm8_A          178 ADSE-------MTGYVVTRWYRAPEVIL  198 (367)
T ss_dssp             CCSS-------CCSSCSCGGGCCTHHHH
T ss_pred             cccc-------cCcCcCCCCcCCHHHHh
Confidence            5432       34567999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=1.9e-31  Score=245.54  Aligned_cols=168  Identities=13%  Similarity=0.179  Sum_probs=136.5

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHH---HHHHhCCCCCeeeee-------ee
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEV---NLLVKLRHPNIVQFL-------GA  223 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~---~~l~~l~h~~Iv~~~-------~~  223 (337)
                      ..+|...+.||+|+||.||+|.+.  |+.||||++...........+.+.+|+   .+++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            347888999999999999999964  889999999755443344557888999   555566899999998       66


Q ss_pred             EEeCC-----------------ceEEEEeecCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHcCCCCcE
Q 019685          224 VTERK-----------------PLMLITEYLRGGDLHKYLKEKGALSP-------STAVNFALDIARGMAYLHNEPNVII  279 (337)
Q Consensus       224 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~~i~~~l~~lH~~~~~iv  279 (337)
                      +...+                 ..|++|||+ +|+|.+++...+.+++       ..++.++.||+.||.|||+++  |+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv  228 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LV  228 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            65543                 289999999 5799999987554555       778889999999999999988  99


Q ss_pred             eeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       280 Hrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||||||+|||+  +.++.+||+|||+++....       ......| +.|+|||++.
T Consensus       229 HrDikp~NIll--~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~  275 (377)
T 3byv_A          229 HTYLRPVDIVL--DQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEA  275 (377)
T ss_dssp             CSCCCGGGEEE--CTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHH
T ss_pred             cCCCCHHHEEE--cCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhc
Confidence            99999999999  7888999999999985332       2345677 9999999873

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=1.2e-30  Score=231.01  Aligned_cols=174  Identities=30%  Similarity=0.589  Sum_probs=149.1

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE  226 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  226 (337)
                      .|++  ...+|+..+.||+|+||.||+|.+.  +..||+|.+.....    ..+.+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~~--~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A            7 KWEM--ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             TTBC--CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccc--cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4444  3447888899999999999999987  77899999865432    34678899999999999999999999999


Q ss_pred             CCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          227 RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      ....++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~~l~Dfg  156 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFG  156 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEE--CGGGCEEECCCC
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEE--cCCCCEEEccCc
Confidence            99999999999999999999864  34899999999999999999999988  9999999999999  778899999999


Q ss_pred             CceeeecccccceeeeeCCcccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +++.......   .......+|+.|+|||++
T Consensus       157 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~  184 (288)
T 3kfa_A          157 LSRLMTGDTY---TAHAGAKFPIKWTAPESL  184 (288)
T ss_dssp             GGGTSCSSSS---EEETTEEECGGGCCHHHH
T ss_pred             cceeccCCcc---ccccCCccccCcCChhhh
Confidence            9987654322   234556688999999976

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=1.6e-30  Score=234.12  Aligned_cols=173  Identities=29%  Similarity=0.498  Sum_probs=129.6

Q ss_pred             CcCccccceecccCceeEEEEEECC-----ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~g-----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      ..+|+..+.||+|+||.||+|.+..     ..||+|.+....... ...+.+.+|+.+++.++||||+++++++......
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            3478899999999999999998752     279999986654332 3457889999999999999999999999876654


Q ss_pred             ------EEEEeecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcE
Q 019685          231 ------MLITEYLRGGDLHKYLKEKG------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL  298 (337)
Q Consensus       231 ------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~  298 (337)
                            ++||||+++++|.+++....      .+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli--~~~~~~  176 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCML--AEDMTV  176 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEE--cCCCCE
Confidence                  99999999999999996532      5899999999999999999999988  9999999999999  788899


Q ss_pred             EEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       299 kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||+|||+++........  .......+|+.|+|||++
T Consensus       177 kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~  211 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYY--RQGCASKLPVKWLALESL  211 (323)
T ss_dssp             EECCCCC-------------------CCGGGCCHHHH
T ss_pred             EEeeccccccccccccc--cccccccCcccccCchhh
Confidence            99999999876543211  123455678999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=2.1e-30  Score=248.90  Aligned_cols=176  Identities=34%  Similarity=0.581  Sum_probs=147.0

Q ss_pred             CCCcccCCCCcCccccceecccCceeEEEEEECC-ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      ...|++...  +|+..+.||+|+||.||+|.+.+ ..||||.+......    .+.+.+|+.+|+.++||||+++++++.
T Consensus       259 ~~~~~i~~~--~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~  332 (535)
T 2h8h_A          259 KDAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS  332 (535)
T ss_dssp             TTCSBCCGG--GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccceecchh--hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345666543  56778899999999999999974 57999999765432    357889999999999999999999986


Q ss_pred             eCCceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      . +.+|+||||+++++|.+++..  ...+++.+++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+||
T Consensus       333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll--~~~~~~kl~DF  407 (535)
T 2h8h_A          333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADF  407 (535)
T ss_dssp             S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECCT
T ss_pred             e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEE--cCCCcEEEccc
Confidence            6 678999999999999999974  346899999999999999999999988  9999999999999  77789999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.+.....   .......+++.|+|||++.
T Consensus       408 G~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~  437 (535)
T 2h8h_A          408 GLARLIEDNEY---TARQGAKFPIKWTAPEAAL  437 (535)
T ss_dssp             TSTTTCCCHHH---HTTCSTTSCGGGSCHHHHH
T ss_pred             ccceecCCCce---ecccCCcCcccccCHHHhc
Confidence            99987653311   1234556789999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=1.9e-30  Score=228.18  Aligned_cols=171  Identities=29%  Similarity=0.472  Sum_probs=148.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.|++|.+......  ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            6788899999999999999985  789999998654332  234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||++.........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEE--ccCCCEEEeeCCCccccCCCcch
Confidence            9999999999977777999999999999999999999988  9999999999999  78889999999999876543211


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|+|||++.
T Consensus       162 --~~~~~~~~~~~y~aPE~~~  180 (276)
T 2yex_A          162 --RLLNKMCGTLPYVAPELLK  180 (276)
T ss_dssp             --CCBCCCCSCGGGCCGGGGT
T ss_pred             --hcccCCccccCccChHHHh
Confidence              1234567999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=5.5e-30  Score=226.67  Aligned_cols=168  Identities=33%  Similarity=0.534  Sum_probs=141.4

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHH----HHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVI----QDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~----~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      .+|+..+.||+|+||.||+|.+.  ++.||+|.+...........    +.+.+|+.+++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            47888999999999999999984  78899999866544322221    67889999999999999999999986554  


Q ss_pred             EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc-----EEEEecc
Q 019685          231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFG  304 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~-----~kl~DFg  304 (337)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+.+|+||||||+|||+  +..+.     +||+|||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~--~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL--QSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE--SCCCTTCSCCEEECCCT
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE--eccCCCCceeEEeCCCC
Confidence            7999999999999988754 46999999999999999999999965559999999999999  55554     9999999


Q ss_pred             CceeeecccccceeeeeCCcccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +++....       ......||+.|+|||++
T Consensus       175 ~~~~~~~-------~~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          175 LSQQSVH-------SVSGLLGNFQWMAPETI  198 (287)
T ss_dssp             TCBCCSS-------CEECCCCCCTTSCGGGS
T ss_pred             ccccccc-------cccccCCCccccCchhh
Confidence            9975432       23557799999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=2.7e-30  Score=233.58  Aligned_cols=181  Identities=30%  Similarity=0.520  Sum_probs=149.4

Q ss_pred             CCCCCcccCCCCcCccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCC
Q 019685          145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPN  216 (337)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~  216 (337)
                      +....|++.  ..+|...+.||+|+||.||+|...+       ..|++|.+.....  ....+.+.+|+.+++.+ +|||
T Consensus        36 ~~~~~~~~~--~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~  111 (333)
T 2i1m_A           36 PYNEKWEFP--RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHEN  111 (333)
T ss_dssp             CCCGGGBCC--TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cccccccCC--HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCC
Confidence            333445444  3467888999999999999999752       3699999865432  33457788999999999 7999


Q ss_pred             eeeeeeeEEeCCceEEEEeecCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeC
Q 019685          217 IVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD  282 (337)
Q Consensus       217 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrd  282 (337)
                      |+++++++...+..++||||+++++|.+++...              ..+++..++.++.||+.||.|||+.+  |+|||
T Consensus       112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~D  189 (333)
T 2i1m_A          112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRD  189 (333)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred             eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCC
Confidence            999999999999999999999999999999752              35799999999999999999999987  99999


Q ss_pred             CCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       283 lkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |||+|||+  +.++.+||+|||+++.......  ........||+.|+|||++
T Consensus       190 lkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  238 (333)
T 2i1m_A          190 VAARNVLL--TNGHVAKIGDFGLARDIMNDSN--YIVKGNARLPVKWMAPESI  238 (333)
T ss_dssp             CSGGGCEE--EGGGEEEBCCCGGGCCGGGCTT--SEECSSCEECGGGSCHHHH
T ss_pred             cccceEEE--CCCCeEEECccccccccccccc--eeecCCCCCCccccCHHHh
Confidence            99999999  6778999999999987654322  1233456788999999976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=4.7e-30  Score=234.57  Aligned_cols=166  Identities=22%  Similarity=0.360  Sum_probs=142.6

Q ss_pred             cCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-----CCCeeeeeeeEEeCCc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----HPNIVQFLGAVTERKP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~Iv~~~~~~~~~~~  229 (337)
                      .+|.+.+.||+|+||.||+|.+  .++.||+|++...    ......+..|+.+++.++     ||||+++++++...+.
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            3789999999999999999998  4788999998642    334466778999999986     9999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec---------------
Q 019685          230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---------------  292 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~---------------  292 (337)
                      .++||||+ +++|.+++....  .+++..+..++.||+.||.|||+++  |+||||||+|||+..               
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccc
Confidence            99999999 889999998654  5999999999999999999999988  999999999999932               


Q ss_pred             --------CCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          293 --------SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       293 --------~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                              ...+.+||+|||+++.....       .....||+.|+|||++.
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~  232 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVIL  232 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHT
T ss_pred             cccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHc
Confidence                    12778999999999864432       24567999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=5.9e-30  Score=230.09  Aligned_cols=170  Identities=29%  Similarity=0.505  Sum_probs=143.2

Q ss_pred             CccccceecccCceeEEEEEE------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC--Cc
Q 019685          158 DFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER--KP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~  229 (337)
                      .|+..+.||+|+||.||++.+      .++.||+|++....  .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            348889999999999999876      36789999997653  234457789999999999999999999999874  57


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +++||||+++++|.+++... .+++..++.++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++..
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL--DNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCGGGCEEC
T ss_pred             EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEE--cCCCCEEECCccccccc
Confidence            89999999999999999654 4999999999999999999999988  9999999999999  78889999999999887


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..... .........+|+.|+|||++
T Consensus       185 ~~~~~-~~~~~~~~~~~~~y~aPE~~  209 (318)
T 3lxp_A          185 PEGHE-YYRVREDGDSPVFWYAPECL  209 (318)
T ss_dssp             CTTCS-EEEC---CCCCGGGCCHHHH
T ss_pred             ccccc-ccccccCCCCCceeeChHHh
Confidence            65422 11123456689999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=5.3e-30  Score=228.62  Aligned_cols=168  Identities=32%  Similarity=0.506  Sum_probs=147.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|...  ++.||+|.+.......  ..+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            5888999999999999999875  7889999986654332  34678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++++|.+++.. +.+++..+..++.||+.||.|||+.+  |+||||||+||++  +..+.+||+|||++........ 
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECBTTBC-
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEE--CCCCCEEEeecccceecCcccc-
Confidence            9999999999864 56999999999999999999999988  9999999999999  7888999999999987754321 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|+|||++.
T Consensus       175 ---~~~~~~~~~~y~aPE~~~  192 (303)
T 3a7i_A          175 ---KRNTFVGTPFWMAPEVIK  192 (303)
T ss_dssp             ---CBCCCCSCGGGCCHHHHT
T ss_pred             ---ccCccCCCcCccCHHHHh
Confidence               234567999999999863

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=3.1e-30  Score=232.71  Aligned_cols=173  Identities=29%  Similarity=0.495  Sum_probs=146.1

Q ss_pred             CCcCccccceecccCceeEEEEEE------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE--e
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT--E  226 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--~  226 (337)
                      ...+|+..+.||+|+||.||+|.+      .++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.  .
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            344788999999999999999985      36789999986542   334577899999999999999999999886  4


Q ss_pred             CCceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          227 RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       227 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      ...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV--ESEAHVKIADFGL  173 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCGGG
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEE--CCCCCEEEccccc
Confidence            5568999999999999999986 456999999999999999999999988  9999999999999  6778999999999


Q ss_pred             ceeeecccccceeeeeCCcccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ++....... .........||+.|+|||++
T Consensus       174 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~  202 (327)
T 3lxl_A          174 AKLLPLDKD-YYVVREPGQSPIFWYAPESL  202 (327)
T ss_dssp             CEECCTTCS-EEECSSCCCSCGGGSCHHHH
T ss_pred             ceecccCCc-cceeeccCCccccccCHHHh
Confidence            987754432 11123455689999999976

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=237.69  Aligned_cols=180  Identities=23%  Similarity=0.298  Sum_probs=140.1

Q ss_pred             CCCcCccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHH--------HHHHHHHHHHHHHhCCCCCeeee
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRL--------VIQDFRHEVNLLVKLRHPNIVQF  220 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~Iv~~  220 (337)
                      ....+|...+.||+|+||.||+|.+.     +..+|+|.+.........        ....+.+|+..+..++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            44557999999999999999999984     568999998765332111        11235678889999999999999


Q ss_pred             eeeEEe----CCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          221 LGAVTE----RKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       221 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      ++++..    ....|+||||+ +++|.+++...+.+++.+++.++.||+.||.|||+++  |+||||||+|||+..+..+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTT
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCC
Confidence            999887    67899999999 8999999987778999999999999999999999987  9999999999999544444


Q ss_pred             cEEEEeccCceeeeccccccee---eeeCCccccccccccccc
Q 019685          297 HLKVGDFGLSKLIKVQNSHDVY---KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~~~~~~~---~~~~~~gt~~y~aPE~l~  336 (337)
                      .+||+|||+++.+.........   ......||+.|+|||++.
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  233 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK  233 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhc
Confidence            9999999999887644221111   124567999999999863

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=2.4e-30  Score=237.04  Aligned_cols=180  Identities=21%  Similarity=0.283  Sum_probs=141.7

Q ss_pred             CCCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHH--------HHHHHHHHHHHHhCCCCCee
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLV--------IQDFRHEVNLLVKLRHPNIV  218 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~Iv  218 (337)
                      ....+|.+.+.||+|+||.||+|.+.       ++.||+|.+..........        ......|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            44557999999999999999999874       3679999986543211111        11234566677888999999


Q ss_pred             eeeeeEEeC----CceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC
Q 019685          219 QFLGAVTER----KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS  293 (337)
Q Consensus       219 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~  293 (337)
                      ++++++...    ...|+||||+ +++|.+++... ..+++.+++.++.||+.||.|||+++  |+||||||+|||+..+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence            999998765    4589999999 99999999875 57999999999999999999999988  9999999999999533


Q ss_pred             CCCcEEEEeccCceeeeccccccee---eeeCCccccccccccccc
Q 019685          294 SADHLKVGDFGLSKLIKVQNSHDVY---KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       294 ~~~~~kl~DFgla~~~~~~~~~~~~---~~~~~~gt~~y~aPE~l~  336 (337)
                      ..+.+||+|||+++.+.........   ......||+.|||||++.
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  234 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN  234 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC
Confidence            7889999999999887654321111   123456999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=4e-30  Score=233.13  Aligned_cols=168  Identities=29%  Similarity=0.473  Sum_probs=143.7

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHh--CCCCCeeeeeeeEEeCC----ceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK--LRHPNIVQFLGAVTERK----PLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~--l~h~~Iv~~~~~~~~~~----~~~  231 (337)
                      +|...+.||+|+||.||++.++++.||+|++...      ....+.+|..++..  ++||||+++++++....    .++
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             cEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            6888899999999999999999999999998542      12556778888887  78999999999998775    789


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH--------NEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      +||||+++++|.+++.. ..+++.+++.++.|++.||.|||        +.+  |+||||||+|||+  +.++.+||+||
T Consensus       117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll--~~~~~~kL~Df  191 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILV--KKNGTCCIADL  191 (342)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEE--CTTSCEEECCC
T ss_pred             EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEE--CCCCCEEEEEC
Confidence            99999999999999975 46899999999999999999999        766  9999999999999  78889999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.................||+.|+|||++.
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  224 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD  224 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHT
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhc
Confidence            999887654322111235567999999999864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=3.7e-30  Score=228.39  Aligned_cols=173  Identities=28%  Similarity=0.494  Sum_probs=141.6

Q ss_pred             CcCccccc-eecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          156 ELDFSSSA-IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       156 ~~~~~~~~-~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      ..+|...+ .||+|+||.||+|.+.    ++.|++|.+..... .....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            34677777 9999999999999653    56899999875533 233457789999999999999999999998 56778


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEE--eCCCcEEEccCCcceeec
Confidence            999999999999999998888999999999999999999999988  9999999999999  677899999999998775


Q ss_pred             cccccceeeeeCCcccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..... ........+|+.|+|||++
T Consensus       169 ~~~~~-~~~~~~~~~~~~y~aPE~~  192 (291)
T 1xbb_A          169 ADENY-YKAQTHGKWPVKWYAPECI  192 (291)
T ss_dssp             TTCSE-EEC----CCCGGGCCHHHH
T ss_pred             cCCCc-ccccccCCCCceeeChHHh
Confidence            44321 1122344578999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=2.5e-30  Score=230.98  Aligned_cols=168  Identities=27%  Similarity=0.455  Sum_probs=143.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||++...  ++.||+|.+......   ..+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            6888899999999999999985  889999998754322   23567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+  |+||||||+||++.. +..+.+||+|||+++.....  
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--  162 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--  162 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence            9999999999988888999999999999999999999988  999999999999832 35678999999999765432  


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       163 ----~~~~~~~~~~y~aPE~~~  180 (304)
T 2jam_A          163 ----IMSTACGTPGYVAPEVLA  180 (304)
T ss_dssp             ----TTHHHHSCCCBCCTTTBS
T ss_pred             ----ccccccCCCCccChHHhc
Confidence                123356899999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=7.2e-31  Score=236.72  Aligned_cols=168  Identities=29%  Similarity=0.491  Sum_probs=135.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|...+.||+|+||.||+|...  ++.||+|.+......  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            6888899999999999999985  788999998643321  111234579999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++ +|.+++...+ .+++..+..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEE--CTTCCEEECSSSEEECC-----
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEE--CCCCCEEEccCcccccccCCcc
Confidence            9975 9999987654 5899999999999999999999988  9999999999999  8888999999999986654321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       156 ----~~~~~~~t~~y~aPE~~~  173 (324)
T 3mtl_A          156 ----TYDNEVVTLWYRPPDILL  173 (324)
T ss_dssp             -----------CGGGCCHHHHT
T ss_pred             ----ccccccCcccccChhhhc
Confidence                344567899999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.1e-30  Score=240.14  Aligned_cols=171  Identities=26%  Similarity=0.368  Sum_probs=144.2

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC--ceE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK--PLM  231 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~--~~~  231 (337)
                      ..+|...+.||+|+||.||+|.+.  ++.||+|++.......  ..+.+.+|+.+++.++||||+++++++....  ..+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            347899999999999999999986  7899999986533221  2366778999999999999999999988765  689


Q ss_pred             EEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec--CCCCcEEEEeccCc
Q 019685          232 LITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFGLS  306 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~--~~~~~~kl~DFgla  306 (337)
                      +||||+++++|.+++....   .+++..++.++.||+.||.|||+++  |+||||||+|||+..  +..+.+||+|||++
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999997543   3999999999999999999999988  999999999999732  34556999999999


Q ss_pred             eeeecccccceeeeeCCcccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +......     ......||+.|+|||++
T Consensus       164 ~~~~~~~-----~~~~~~gt~~y~aPE~~  187 (396)
T 4eut_A          164 RELEDDE-----QFVSLYGTEEYLHPDMY  187 (396)
T ss_dssp             EECCCGG-----GSSCSSSCCTTCCHHHH
T ss_pred             eEccCCC-----ccccccCCccccCHHHh
Confidence            8775442     23456799999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=3.3e-30  Score=225.55  Aligned_cols=167  Identities=33%  Similarity=0.612  Sum_probs=145.0

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|...+.||+|+||.||++.+. ++.|++|.+.......    +.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            6788899999999999999985 6789999997654332    5688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++++|.+++... ..+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+++....... 
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE--CCCCCEEEcccccccccccccc-
Confidence            9999999999864 46899999999999999999999988  9999999999999  7788999999999987643211 


Q ss_pred             ceeeeeCCcccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l  335 (337)
                        .......+|+.|+|||++
T Consensus       160 --~~~~~~~~~~~y~aPE~~  177 (267)
T 3t9t_A          160 --TSSTGTKFPVKWASPEVF  177 (267)
T ss_dssp             --HSTTSTTCCGGGCCHHHH
T ss_pred             --cccccccccccccChhhh
Confidence              123456688999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=6.5e-30  Score=230.32  Aligned_cols=171  Identities=26%  Similarity=0.445  Sum_probs=140.0

Q ss_pred             CCCcCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEe----
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTE----  226 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~----  226 (337)
                      ....+|+..+.||+|+||.||+|.+  .++.||+|.+......    .+.+.+|+.+++.+ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3445789999999999999999998  4889999998654332    25678899999998 79999999999976    


Q ss_pred             --CCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          227 --RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       227 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                        ...+|+||||+++++|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~--~~~~~~kl~D  172 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL--TENAEVKLVD  172 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTCCEEECC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEE--cCCCCEEEee
Confidence              45789999999999999999864  46999999999999999999999988  9999999999999  7888999999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||++........    ......||+.|+|||++.
T Consensus       173 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          173 FGVSAQLDRTVG----RRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             CTTTC-----------------CCGGGCCHHHHC
T ss_pred             CcCceecCcCcc----ccccccCCccccChhhhc
Confidence            999987653321    234557999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=1.3e-30  Score=234.64  Aligned_cols=170  Identities=29%  Similarity=0.447  Sum_probs=138.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCc-----hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSD-----DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|.+.+.||+|+||.||+|...  ++.||+|.+......     .......+.+|+.+++.++||||+++++++.... .
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence            6888899999999999999985  678999998654321     1122345788999999999999999999987654 8


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~  309 (337)
                      |+||||+++++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+..+ ..+.+||+|||+++..
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence            999999999999999988788999999999999999999999988  9999999999999322 1335999999999876


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....     ......||+.|+|||++
T Consensus       168 ~~~~-----~~~~~~gt~~y~aPE~~  188 (322)
T 2ycf_A          168 GETS-----LMRTLCGTPTYLAPEVL  188 (322)
T ss_dssp             CCCH-----HHHHHHSCCTTCCHHHH
T ss_pred             cccc-----ccccccCCcCccCchhh
Confidence            5331     12345689999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.4e-30  Score=237.01  Aligned_cols=171  Identities=31%  Similarity=0.487  Sum_probs=140.1

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCch--HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      .+|...+.||+|+||.||+|.+.  |+.||+|.+.......  ......+.+|+.+++.++||||+++++++......++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            47899999999999999999985  7899999986533221  1122467789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      ||||+++ +|.+++... ..+++..+..++.|++.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+..
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL--DENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCCGGGSTTTS
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEE--cCCCCEEEEecccceeccC
Confidence            9999986 898888764 35899999999999999999999988  9999999999999  8888999999999987654


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...    ......||+.|+|||++.
T Consensus       165 ~~~----~~~~~~~t~~y~aPE~~~  185 (346)
T 1ua2_A          165 PNR----AYTHQVVTRWYRAPELLF  185 (346)
T ss_dssp             CCC----CCCCSCCCCTTCCHHHHT
T ss_pred             Ccc----cCCcccccccccCchHhh
Confidence            321    235567999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=6.7e-30  Score=229.86  Aligned_cols=172  Identities=28%  Similarity=0.453  Sum_probs=145.5

Q ss_pred             CcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      ..+|...+.||+|+||.||+|.+.       ++.||+|.+.....  ......+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            347888999999999999999865       56799999865432  334567889999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcE
Q 019685          229 PLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHL  298 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~  298 (337)
                      ..++||||+++++|.+++...          ..+++..++.++.||+.||.|||+++  |+||||||+||++  +.++.+
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli--~~~~~~  177 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTV  177 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE--CTTCCE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEE--cCCCeE
Confidence            999999999999999999752          35689999999999999999999988  9999999999999  788899


Q ss_pred             EEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          299 KVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       299 kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||+|||+++.......  ........+|+.|+|||++
T Consensus       178 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  212 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESL  212 (322)
T ss_dssp             EECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHH
T ss_pred             EECcCccccccccccc--cccccCCCCCCCccChhhh
Confidence            9999999987654321  1123445678999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=1.1e-29  Score=227.58  Aligned_cols=168  Identities=25%  Similarity=0.457  Sum_probs=142.4

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ..+|+..+.||+|+||.||+|...  |+.||+|.+.....     .+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            347889999999999999999986  78999999865432     25678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |||+++++|.+++.. ...+++..+..++.||+.||.|||+.+  |+|+||||+||++  +.++.+||+|||++......
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILL--NTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECBTT
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEE--CCCCCEEEeecccchhhhhh
Confidence            999999999999974 567999999999999999999999988  9999999999999  78889999999999876543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..    ......||+.|+|||++.
T Consensus       179 ~~----~~~~~~~~~~y~aPE~~~  198 (314)
T 3com_A          179 MA----KRNTVIGTPFWMAPEVIQ  198 (314)
T ss_dssp             BS----CBCCCCSCGGGCCHHHHS
T ss_pred             cc----ccCccCCCCCccChhhcC
Confidence            22    234567999999999863

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=2.1e-30  Score=234.48  Aligned_cols=168  Identities=30%  Similarity=0.488  Sum_probs=134.3

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHH--HHhCCCCCeeeeeeeEEe-----CCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL--LVKLRHPNIVQFLGAVTE-----RKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~--l~~l~h~~Iv~~~~~~~~-----~~~~  230 (337)
                      +|+..+.||+|+||.||+|..+++.||+|++....      ...+..|..+  +..++||||+++++.+..     ...+
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            78889999999999999999999999999985432      1233334444  455889999999986532     2357


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE---------PNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---------~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                      ++||||+++++|.+++... ..++..+..++.||+.||.|||+.         +  |+||||||+|||+  +.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill--~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLV--KNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEE--CTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEE--cCCCcEEEe
Confidence            9999999999999999754 458899999999999999999997         7  9999999999999  788899999


Q ss_pred             eccCceeeeccccc----ceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSH----DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+++.+......    .........||+.|+|||++.
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  201 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE  201 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHT
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhc
Confidence            99999877543210    111234567999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=3.5e-30  Score=227.30  Aligned_cols=162  Identities=33%  Similarity=0.594  Sum_probs=140.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe---------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE---------  226 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~---------  226 (337)
                      +|+..+.||+|+||.||+|.+.  ++.||+|.+....       +.+.+|+.+++.++||||+++++++..         
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            6888899999999999999986  8899999986542       345679999999999999999998854         


Q ss_pred             -------CCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc
Q 019685          227 -------RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH  297 (337)
Q Consensus       227 -------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~  297 (337)
                             ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+||++  +..+.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFL--VDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEE--cCCCC
Confidence                   44589999999999999999754  56999999999999999999999988  9999999999999  67789


Q ss_pred             EEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       298 ~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +||+|||+++......     ......||+.|+|||++
T Consensus       161 ~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~  193 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQI  193 (284)
T ss_dssp             EEECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHH
T ss_pred             EEECcchhheeccccc-----cccccCCcccccChhhh
Confidence            9999999998765432     23456799999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=2.5e-30  Score=233.49  Aligned_cols=171  Identities=30%  Similarity=0.591  Sum_probs=136.0

Q ss_pred             CcCccccceecccCceeEEEEEEC--Cce----EEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~----vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      ..+|+..+.||+|+||.||+|.+.  ++.    |++|.+.....  ....+.+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            347889999999999999999874  443    57777654322  223467889999999999999999999998754 


Q ss_pred             eEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .++++||+.+++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCTTHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEE--CCCCCEEEccCcceeE
Confidence            7899999999999999987 456999999999999999999999988  9999999999999  6778999999999987


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ......  ........+|+.|+|||++
T Consensus       167 ~~~~~~--~~~~~~~~~t~~y~aPE~~  191 (327)
T 3poz_A          167 LGAEEK--EYHAEGGKVPIKWMALESI  191 (327)
T ss_dssp             HTTTCC---------CCCGGGSCHHHH
T ss_pred             ccCCcc--cccccCCCccccccChHHh
Confidence            654322  1123455678999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1e-29  Score=225.14  Aligned_cols=170  Identities=28%  Similarity=0.510  Sum_probs=142.0

Q ss_pred             Cccccc-eecccCceeEEEEEE----CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSA-IIGKGSFGEILKAYW----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~-~lg~G~~g~V~~~~~----~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|.... .||+|+||.||+|.+    .+..||+|.+....  .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            455555 899999999999986    36689999987643  334567889999999999999999999998 4567999


Q ss_pred             EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      ||||+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL--VNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--EETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEE--cCCCCEEECcccceeeecc
Confidence            99999999999999754 45999999999999999999999988  9999999999999  6778999999999987754


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .... ........+|+.|+|||++
T Consensus       163 ~~~~-~~~~~~~~~~~~y~aPE~~  185 (287)
T 1u59_A          163 DDSY-YTARSAGKWPLKWYAPECI  185 (287)
T ss_dssp             CSCE-ECCCCSSCCCGGGCCHHHH
T ss_pred             Ccce-eeccccccccccccCHHHh
Confidence            3221 1123445678999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=2.2e-30  Score=231.76  Aligned_cols=170  Identities=29%  Similarity=0.464  Sum_probs=137.5

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCch--HHHHHHHHHHHHHHHhC---CCCCeeeeeeeEEeCC-
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKL---RHPNIVQFLGAVTERK-  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~~~~-  228 (337)
                      .+|+..+.||+|+||.||+|...  ++.||+|.+.......  ......+.+|+.+++.+   +||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            37899999999999999999964  7899999986432110  01113445566666555   5999999999997765 


Q ss_pred             ----ceEEEEeecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          229 ----PLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       229 ----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                          .++++|||+.+ +|.+++.....  +++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~--~~~~~~kl~D  163 (308)
T 3g33_A           89 DREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV--TSGGTVKLAD  163 (308)
T ss_dssp             SSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEE--CTTSCEEECS
T ss_pred             CCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE--cCCCCEEEee
Confidence                48999999975 99999987543  999999999999999999999988  9999999999999  8888999999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+++......     ......||+.|+|||++.
T Consensus       164 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~  192 (308)
T 3g33_A          164 FGLARIYSYQM-----ALTPVVVTLWYRAPEVLL  192 (308)
T ss_dssp             CSCTTTSTTCC-----CSGGGGCCCSSCCHHHHH
T ss_pred             CccccccCCCc-----ccCCccccccccCchHHc
Confidence            99998765332     234567999999999873

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=1e-29  Score=225.61  Aligned_cols=166  Identities=31%  Similarity=0.465  Sum_probs=138.8

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      |.....||+|+||.||+|.+.  +..|++|.+.....   ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            334458999999999999974  77899999865432   2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCceeeecc
Q 019685          237 LRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       237 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla~~~~~~  312 (337)
                      +++++|.+++....   .+++..+..++.||+.||.|||+.+  |+||||||+||++  +. .+.+||+|||+++.....
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLI--NTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEE--ECCCCCEEEeecccccccCCC
Confidence            99999999998642   4678889999999999999999988  9999999999999  54 679999999999876543


Q ss_pred             cccceeeeeCCcccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..    ......||+.|+|||++
T Consensus       177 ~~----~~~~~~~~~~y~aPE~~  195 (295)
T 2clq_A          177 NP----CTETFTGTLQYMAPEII  195 (295)
T ss_dssp             --------CCCCCCGGGCCHHHH
T ss_pred             CC----cccccCCCccccChhhh
Confidence            21    23456799999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=4.1e-30  Score=227.96  Aligned_cols=171  Identities=32%  Similarity=0.527  Sum_probs=133.4

Q ss_pred             cCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      .+|++.+.||+|+||.||++.+.+ .+++|.+..... .....+.+.+|+.+++.++||||++++++. .....++||||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            368888999999999999998765 599999866543 344567889999999999999999999954 55678999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++++|.+++.. ...+++..++.++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL--HEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETTTEEEECCCC-----------
T ss_pred             cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEE--CCCCCEEEccceecccccccccc
Confidence            999999999964 346999999999999999999999988  9999999999999  77789999999999876542211


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|+|||++.
T Consensus       177 --~~~~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          177 --HQFEQLSGSILWMAPEVIR  195 (289)
T ss_dssp             ---------CCCTTCCHHHHC
T ss_pred             --ccccccCCCccccCchhhc
Confidence              1234567999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=6.5e-30  Score=226.36  Aligned_cols=170  Identities=23%  Similarity=0.376  Sum_probs=132.0

Q ss_pred             CCcCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ...+|+..+.||+|+||.||+|..  .++.||+|.+...... ......+.++...++.++||||+++++++...+..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            344788999999999999999998  4889999998765332 3333445556666888899999999999999999999


Q ss_pred             EEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          233 ITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      ||||+++ +|.+++..    ...+++..+..++.||+.||.|||++ +  |+||||||+||++  +..+.+||+|||+++
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLI--NALGQVKMCDFGISG  158 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEE--CTTCCEEBCCC----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE--CCCCCEEEeecCCcc
Confidence            9999975 88887754    45799999999999999999999997 7  9999999999999  788899999999998


Q ss_pred             eeecccccceeeeeCCcccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ......     ......||+.|+|||++
T Consensus       159 ~~~~~~-----~~~~~~~t~~y~aPE~~  181 (290)
T 3fme_A          159 YLVDDV-----AKDIDAGCKPYMAPERI  181 (290)
T ss_dssp             ----------------CCCCCCSCHHHH
T ss_pred             cccccc-----cccccCCCccccChhhc
Confidence            765432     23345799999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=1.4e-29  Score=225.18  Aligned_cols=169  Identities=24%  Similarity=0.322  Sum_probs=143.1

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|...+.||+|+||.||+|..  .++.||+|++......     +.+.+|+.++..+ +|++|+++++++......++||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            688999999999999999996  4889999988654322     3467799999999 6999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc-----EEEEeccCcee
Q 019685          235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH-----LKVGDFGLSKL  308 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~-----~kl~DFgla~~  308 (337)
                      ||+ +++|.+++...+ .+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.     +||+|||+++.
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~--~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLI--GRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CCSSSTTTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEe--ccCCCCCCCeEEEEECccccc
Confidence            999 889999998754 5999999999999999999999988  9999999999999  55554     99999999988


Q ss_pred             eecccccc---eeeeeCCccccccccccccc
Q 019685          309 IKVQNSHD---VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~---~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........   ........||+.|+|||++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  191 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHL  191 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             cccccccccccccCccCCCCCcccCCchhhc
Confidence            76543211   11235567999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=5.1e-30  Score=236.43  Aligned_cols=165  Identities=27%  Similarity=0.419  Sum_probs=136.7

Q ss_pred             CCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----  227 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----  227 (337)
                      ...+|...+.||+|+||.||+|...  ++.||+|++......       ..+|+.+++.++||||+++++++...     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            4457999999999999999999874  789999998654322       23699999999999999999998443     


Q ss_pred             ---------------------------------CceEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 019685          228 ---------------------------------KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAY  270 (337)
Q Consensus       228 ---------------------------------~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~  270 (337)
                                                       ..+++||||+++ +|.+.+..    ...+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             348999999985 88777653    4679999999999999999999


Q ss_pred             HHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          271 LHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       271 lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+.|  |+||||||+|||+  + .++.+||+|||+++......     ......||+.|+|||++.
T Consensus       157 LH~~g--i~H~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~  214 (383)
T 3eb0_A          157 IHSLG--ICHRDIKPQNLLV--NSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELML  214 (383)
T ss_dssp             HHTTT--EECSCCCGGGEEE--ETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHT
T ss_pred             HHHCc--CccCccCHHHEEE--cCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhc
Confidence            99988  9999999999999  5 46789999999998775443     234567899999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=7.3e-30  Score=224.97  Aligned_cols=173  Identities=31%  Similarity=0.558  Sum_probs=144.8

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER  227 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  227 (337)
                      +|++..  .+|+..+.||+|+||.||+|... +..|++|.+......    .+.+.+|+.+++.++||||+++++++. .
T Consensus         7 ~~~v~~--~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   79 (279)
T 1qpc_A            7 EWEVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-Q   79 (279)
T ss_dssp             TTBCCG--GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             hcccCH--HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence            444433  36888899999999999999987 458999998654432    357889999999999999999999876 4


Q ss_pred             CceEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+||++  +.++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~--~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV--SDTLSCKIADFGL  155 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTT
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEE--cCCCCEEECCCcc
Confidence            56899999999999999996532  6999999999999999999999988  9999999999999  7888999999999


Q ss_pred             ceeeecccccceeeeeCCcccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ++.......   .......+++.|+|||++
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~  182 (279)
T 1qpc_A          156 ARLIEDNEY---TAREGAKFPIKWTAPEAI  182 (279)
T ss_dssp             CEECSSSCE---ECCTTCCCCTTTSCHHHH
T ss_pred             cccccCccc---ccccCCCCccCccChhhh
Confidence            987654321   123455678899999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=2.2e-30  Score=233.66  Aligned_cols=172  Identities=30%  Similarity=0.539  Sum_probs=138.7

Q ss_pred             CcCccccceecccCceeEEEEEEC--Cce----EEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~----vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      ..+|+..+.||+|+||.||+|.+.  ++.    +++|.+......  .....+.+|+.+++.++||||+++++++. ...
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            347889999999999999999975  443    777776443221  11245677999999999999999999886 566


Q ss_pred             eEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .++||||+.+++|.+++... +.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLL--KSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEE--SSSSCEEECSCSGGGG
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEE--CCCCeEEECCCCcccc
Confidence            89999999999999999764 57999999999999999999999988  9999999999999  8888999999999988


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +......  .......||+.|+|||++.
T Consensus       165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~  190 (325)
T 3kex_A          165 LPPDDKQ--LLYSEAKTPIKWMALESIH  190 (325)
T ss_dssp             SCCCTTC--CC-----CCTTTSCHHHHH
T ss_pred             cCccccc--ccccCCCCcccccChHHhc
Confidence            7544321  1234567888999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=3.8e-30  Score=229.29  Aligned_cols=167  Identities=26%  Similarity=0.438  Sum_probs=139.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|.+.  ++.+++|.+......   ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            6888999999999999999986  788999988654322   24678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++.. ...+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||++........
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTSCEEECCCHHHHHHHHHHH
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEE--CCCCCEEEEECCCCcccccccc
Confidence            9999999999876 456999999999999999999999988  9999999999999  7888999999999865432211


Q ss_pred             cceeeeeCCcccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l  335 (337)
                          ......||+.|+|||++
T Consensus       173 ----~~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          173 ----KRDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             ----C-----CCGGGCCHHHH
T ss_pred             ----ccccccCChhhcCCeee
Confidence                23446799999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=4e-30  Score=230.09  Aligned_cols=161  Identities=36%  Similarity=0.642  Sum_probs=132.4

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      +|+..+.||+|+||.||++.+.++.||+|.+...     ...+.+.+|+.+++.++||||+++++++.  +..++||||+
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            6788899999999999999999999999998543     13467889999999999999999999876  4589999999


Q ss_pred             CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHc---CCCCcEeeCCCCCCEEEecCCCCc-EEEEeccCceeee
Q 019685          238 RGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHN---EPNVIIHRDLKPRNVLLVNSSADH-LKVGDFGLSKLIK  310 (337)
Q Consensus       238 ~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~~~ivHrdlkp~Nil~~~~~~~~-~kl~DFgla~~~~  310 (337)
                      ++++|.+++....   .+++..++.++.|++.||.|||+   ++  |+||||||+|||+  +.++. +||+|||++....
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll--~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEE--ETTTTEEEECCCCC-----
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEE--eCCCCEEEEcccccccccc
Confidence            9999999998654   37889999999999999999999   66  9999999999999  55555 7999999997654


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..       .....||+.|+|||++.
T Consensus       158 ~~-------~~~~~gt~~y~aPE~~~  176 (307)
T 2eva_A          158 TH-------MTNNKGSAAWMAPEVFE  176 (307)
T ss_dssp             --------------CCTTSSCHHHHT
T ss_pred             cc-------cccCCCCCceEChhhhC
Confidence            32       23456999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.96  E-value=9.9e-31  Score=237.82  Aligned_cols=169  Identities=22%  Similarity=0.439  Sum_probs=147.3

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchH--------------HHHHHHHHHHHHHHhCCCCCeeeeeee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDR--------------LVIQDFRHEVNLLVKLRHPNIVQFLGA  223 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~Iv~~~~~  223 (337)
                      +|...+.||+|+||.||+|...++.||+|.+........              ...+.+.+|+.+++.++||||++++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  111 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI  111 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred             ceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            789999999999999999999999999999854321110              112678899999999999999999999


Q ss_pred             EEeCCceEEEEeecCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCC
Q 019685          224 VTERKPLMLITEYLRGGDLHKY------LKE--KGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSS  294 (337)
Q Consensus       224 ~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~  294 (337)
                      +...+..++||||+++++|.++      +..  ...+++..+..++.||+.||.|||+ .|  |+||||||+||++  +.
T Consensus       112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~--~~  187 (348)
T 2pml_X          112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM--DK  187 (348)
T ss_dssp             EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEE--CT
T ss_pred             EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEE--cC
Confidence            9999999999999999999998      655  4679999999999999999999999 88  9999999999999  88


Q ss_pred             CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 ~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.+||+|||++......      ......||+.|+|||++.
T Consensus       188 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~  223 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFS  223 (348)
T ss_dssp             TSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGS
T ss_pred             CCcEEEeccccccccccc------cccCCCCCcCccCchhhc
Confidence            889999999999876543      345677999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=1.1e-29  Score=233.31  Aligned_cols=166  Identities=26%  Similarity=0.375  Sum_probs=133.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------c
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------P  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------~  229 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|++...... ....+.+.+|+.+++.++||||+++++++....      .
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            7889999999999999999875  788999998764433 345577889999999999999999999987654      6


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      .|+||||+++ +|.+++.  ..+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCCCC----
T ss_pred             eEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEE--cCCCCEEEEEeeccccc
Confidence            8999999975 8888885  35899999999999999999999988  9999999999999  78889999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....     ......||+.|+|||++.
T Consensus       178 ~~~~-----~~~~~~gt~~y~aPE~~~  199 (371)
T 2xrw_A          178 GTSF-----MMTPYVVTRYYRAPEVIL  199 (371)
T ss_dssp             -----------------CTTCCHHHHT
T ss_pred             cccc-----ccCCceecCCccCHHHhc
Confidence            5331     234567999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=4.4e-30  Score=250.98  Aligned_cols=166  Identities=28%  Similarity=0.517  Sum_probs=135.2

Q ss_pred             ceecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          163 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      +.||+|+||.||+|.+.    ++.||||++...... ....+.+.+|+.+++.++||||+++++++.. +.+++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            47999999999999763    567999998654332 2334778999999999999999999998864 56899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccccee
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY  318 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~  318 (337)
                      +++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+...... ..
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl--~~~~~~kL~DFGla~~~~~~~~~-~~  527 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENY-YK  527 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCTTHHHHTTC-------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEE--eCCCCEEEEEcCCccccccCccc-cc
Confidence            9999999998888999999999999999999999988  9999999999999  67789999999999876543211 11


Q ss_pred             eeeCCcccccccccccc
Q 019685          319 KMTGETGSCEYLVSNCS  335 (337)
Q Consensus       319 ~~~~~~gt~~y~aPE~l  335 (337)
                      ......+|+.|+|||++
T Consensus       528 ~~~~~~~t~~y~APE~~  544 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECI  544 (635)
T ss_dssp             -------CGGGSCHHHH
T ss_pred             cccCCCCceeeeChhhh
Confidence            23445678999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=1e-29  Score=224.34  Aligned_cols=170  Identities=31%  Similarity=0.529  Sum_probs=139.9

Q ss_pred             CcCccccceecccCceeEEEEEECC-----ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~g-----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      ..+|...+.||+|+||.||+|.+.+     ..|++|.+.....  ....+.+.+|+.+++.++||||+++++++.. +..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            3478889999999999999998642     2499998876532  3345788999999999999999999999865 457


Q ss_pred             EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      |+||||+++++|.+++... ..+++..+..++.||+.||.|||+++  |+||||||+||++  +.++.+||+|||+++..
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV--ASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--EETTEEEECCCCGGGCC
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEE--CCCCcEEeCccCCCccc
Confidence            9999999999999999765 45999999999999999999999988  9999999999999  66789999999999876


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .....   .......+|+.|+|||++
T Consensus       164 ~~~~~---~~~~~~~~~~~y~aPE~~  186 (281)
T 3cc6_A          164 EDEDY---YKASVTRLPIKWMSPESI  186 (281)
T ss_dssp             ------------CCCCCGGGCCHHHH
T ss_pred             ccccc---cccccCCCCcceeCchhh
Confidence            54321   123456678999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=4.2e-30  Score=226.49  Aligned_cols=163  Identities=34%  Similarity=0.597  Sum_probs=134.7

Q ss_pred             cCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-CceEEEEe
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-KPLMLITE  235 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-~~~~lv~e  235 (337)
                      .+|+..+.||+|+||.||++.++++.||+|.+....     ..+.+.+|+.+++.++||||+++++++... +..++|||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            478889999999999999999999999999986542     236788999999999999999999987544 57899999


Q ss_pred             ecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEKGA--LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+++++|.+++...+.  +++..+..++.|++.||.|||+++  |+||||||+||++  +.++.+||+|||+++..... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCEEECCCCC--------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEE--eCCCcEEEeecccccccccc-
Confidence            9999999999976543  899999999999999999999988  9999999999999  78889999999999765432 


Q ss_pred             ccceeeeeCCcccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                            .....+++.|+|||++
T Consensus       171 ------~~~~~~~~~y~aPE~~  186 (278)
T 1byg_A          171 ------QDTGKLPVKWTAPEAL  186 (278)
T ss_dssp             -----------CCTTTSCHHHH
T ss_pred             ------ccCCCccccccCHHHh
Confidence                  2234678999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=2.3e-29  Score=230.45  Aligned_cols=171  Identities=30%  Similarity=0.500  Sum_probs=144.5

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----Cc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~  229 (337)
                      .+|+..+.||+|+||.||+|...  ++.||+|.+....  .....+.+.+|+.++..++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            37999999999999999999875  7789999986533  334457788999999999999999999998655     36


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      .|+||||+.+ +|.+++.. +.+++.++..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||+++..
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEE--CCCCCEEEEeCcceEec
Confidence            8999999975 99999865 46999999999999999999999988  9999999999999  88889999999999877


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....... .......||+.|+|||++.
T Consensus       179 ~~~~~~~-~~~~~~~gt~~y~aPE~~~  204 (364)
T 3qyz_A          179 DPDHDHT-GFLTEYVATRWYRAPEIML  204 (364)
T ss_dssp             CGGGCBC-CTTCCCCSCGGGCCHHHHH
T ss_pred             CCCCCcc-ccccccccccCCCCCHHhc
Confidence            6442211 1134568999999999863

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=5e-30  Score=235.11  Aligned_cols=166  Identities=28%  Similarity=0.485  Sum_probs=125.6

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------C
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------K  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------~  228 (337)
                      .+|+..+.||+|+||.||+|...  |+.||+|++..... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            37889999999999999999875  78999999865433 334557788999999999999999999998654      5


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||+.|  |+||||||+|||+  +.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll--~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEE--CCCCCEEEeecccccc
Confidence            689999998 6799999865 57999999999999999999999988  9999999999999  8888999999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....       .....||+.|+|||++.
T Consensus       182 ~~~~-------~~~~~~t~~y~aPE~~~  202 (367)
T 2fst_X          182 TADE-------MTGYVATRWYRAPEIML  202 (367)
T ss_dssp             ----------------CCCTTCCHHHHT
T ss_pred             cccc-------CCCcCcCcCccChHHHc
Confidence            5432       34567999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=7.7e-30  Score=234.25  Aligned_cols=167  Identities=13%  Similarity=0.099  Sum_probs=126.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC--CCCCeeeee-------eeEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL--RHPNIVQFL-------GAVTE  226 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l--~h~~Iv~~~-------~~~~~  226 (337)
                      .|...+.||+|+||.||+|.+.  ++.||+|++...........+.+.+|+.++..+  +||||++++       +++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            5888999999999999999975  788999999887665555667788885544444  699988755       44433


Q ss_pred             C-----------------CceEEEEeecCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHcCCCCcEeeC
Q 019685          227 R-----------------KPLMLITEYLRGGDLHKYLKEK-GALSPSTA------VNFALDIARGMAYLHNEPNVIIHRD  282 (337)
Q Consensus       227 ~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~~~~~i~~~l~~lH~~~~~ivHrd  282 (337)
                      .                 ..+|+||||++ ++|.+++... ..+++...      ..++.||+.||.|||+++  |+|||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrD  219 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGH  219 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCc
Confidence            3                 23899999998 7999999863 33444455      577799999999999988  99999


Q ss_pred             CCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       283 lkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+|||+  +.++.+||+|||+++.....       .....+|+.|+|||++.
T Consensus       220 ikp~NIll--~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~  264 (371)
T 3q60_A          220 FTPDNLFI--MPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLN  264 (371)
T ss_dssp             CSGGGEEE--CTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHT
T ss_pred             CCHHHEEE--CCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhcc
Confidence            99999999  88889999999999865422       22566779999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=6.8e-30  Score=229.04  Aligned_cols=172  Identities=28%  Similarity=0.492  Sum_probs=144.5

Q ss_pred             CcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeC
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTER  227 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~  227 (337)
                      ..+|...+.||+|+||.||+|.+.       ++.||+|.+.....  ....+.+.+|+.++..+ +||||+++++++...
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            447888999999999999999852       46899999875432  33456788999999999 699999999998765


Q ss_pred             C-ceEEEEeecCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEE
Q 019685          228 K-PLMLITEYLRGGDLHKYLKEKGA----------------LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL  290 (337)
Q Consensus       228 ~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~  290 (337)
                      + .+++||||+++++|.+++.....                +++..+..++.||+.||.|||+.+  |+||||||+||++
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~  181 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL  181 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEE
Confidence            4 59999999999999999986543                789999999999999999999987  9999999999999


Q ss_pred             ecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          291 VNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       291 ~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                        +..+.+||+|||+++.......  ........||+.|+|||++
T Consensus       182 --~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~  222 (316)
T 2xir_A          182 --SEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETI  222 (316)
T ss_dssp             --CGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHH
T ss_pred             --CCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhh
Confidence              7788999999999987654321  1234456789999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=227.91  Aligned_cols=174  Identities=20%  Similarity=0.309  Sum_probs=142.3

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----CCc
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKP  229 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~  229 (337)
                      ..+|+..+.||+|+||.||++...  ++.||+|.+...   .....+.+.+|+.+++.++||||+++++++..    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            347899999999999999999974  889999988653   23445778899999999999999999999863    347


Q ss_pred             eEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          230 LMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      .|+||||+.+++|.+++..    ...+++.+++.++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~dfg~  180 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILL--GDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCSS
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE--cCCCCEEEEecCc
Confidence            8999999999999999975    356999999999999999999999987  9999999999999  7888999999999


Q ss_pred             ceeeeccccc-----ceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSH-----DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++........     .........||+.|+|||++.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  216 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS  216 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhc
Confidence            8765432110     000123345799999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.6e-29  Score=226.68  Aligned_cols=173  Identities=29%  Similarity=0.515  Sum_probs=144.2

Q ss_pred             CCcCccccceecccCceeEEEEEE------CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYW------RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~------~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      ...+|+..+.||+|+||.||++.+      .++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            344788899999999999999985      37789999987642   234577899999999999999999999886543


Q ss_pred             --ceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          229 --PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       229 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                        .+++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli--~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV--ENENRVKIGDFGL  191 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTT
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEE--cCCCcEEEecCcc
Confidence              789999999999999999875 45999999999999999999999987  9999999999999  6678999999999


Q ss_pred             ceeeecccccceeeeeCCcccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ++....... .........+++.|+|||++
T Consensus       192 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~  220 (326)
T 2w1i_A          192 TKVLPQDKE-YYKVKEPGESPIFWYAPESL  220 (326)
T ss_dssp             CEECCSSCS-EEECSSCCSCCGGGCCHHHH
T ss_pred             hhhcccccc-ccccccCCCCceeEECchhh
Confidence            987754422 11112345678899999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.9e-30  Score=231.30  Aligned_cols=172  Identities=27%  Similarity=0.385  Sum_probs=138.4

Q ss_pred             CCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchH---HHHHHHHHHHHHHHhC----CCCCeeeeeeeE
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKL----RHPNIVQFLGAV  224 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~Iv~~~~~~  224 (337)
                      ....+|...+.||+|+||.||+|...  ++.||+|.+........   .....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            33457999999999999999999874  78899999865543221   1223455789988888    899999999999


Q ss_pred             EeCCceEEEEee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEe
Q 019685          225 TERKPLMLITEY-LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGD  302 (337)
Q Consensus       225 ~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~D  302 (337)
                      ...+..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||+.+  |+||||||+||++  + .++.+||+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~--~~~~~~~kl~d  183 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILI--DLRRGCAKLID  183 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEE--ETTTTEEEECC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEE--eCCCCeEEEEE
Confidence            999999999999 789999999998888999999999999999999999987  9999999999999  5 677899999


Q ss_pred             ccCceeeecccccceeeeeCCcccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ||+++.....      ......||+.|+|||++
T Consensus       184 fg~~~~~~~~------~~~~~~~~~~y~aPE~~  210 (312)
T 2iwi_A          184 FGSGALLHDE------PYTDFDGTRVYSPPEWI  210 (312)
T ss_dssp             CSSCEECCSS------CBCCCCSCTTTSCHHHH
T ss_pred             cchhhhcccC------cccccCCcccccCceee
Confidence            9999877543      23456799999999976

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.96  E-value=2.3e-29  Score=227.16  Aligned_cols=161  Identities=22%  Similarity=0.424  Sum_probs=139.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEe--CCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTE--RKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~--~~~~~l  232 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|++....      .+.+.+|+.+++.++ ||||+++++++..  ....++
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            6889999999999999999874  7899999986432      256788999999998 9999999999987  567899


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-cEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-~~kl~DFgla~~~~~  311 (337)
                      ||||+.+++|.+++.   .+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++ .+||+|||+++....
T Consensus       111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~--~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCCTTCEECCT
T ss_pred             EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEE--cCCCCEEEEEeCCCceEcCC
Confidence            999999999999884   3899999999999999999999988  9999999999999  5444 899999999987654


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..     ......||+.|+|||++.
T Consensus       184 ~~-----~~~~~~~~~~y~aPE~~~  203 (330)
T 3nsz_A          184 GQ-----EYNVRVASRYFKGPELLV  203 (330)
T ss_dssp             TC-----CCCSCCSCGGGCCHHHHT
T ss_pred             CC-----ccccccccccccChhhhc
Confidence            42     234567999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=8.3e-30  Score=225.79  Aligned_cols=174  Identities=30%  Similarity=0.536  Sum_probs=134.5

Q ss_pred             CcCccccceecccCceeEEEEEEC---Cc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR---GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~---g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      ..+|+..+.||+|+||.||+|.+.   ++  .|++|++...........+.+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            447889999999999999999863   22  58999887654444455678899999999999999999999987655 8


Q ss_pred             EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili--~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEE--cCCCCEEEccccccccc
Confidence            9999999999999999764 56999999999999999999999987  9999999999999  67789999999999887


Q ss_pred             ecccccceeeeeCCcccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ...... ........+|+.|+|||++
T Consensus       172 ~~~~~~-~~~~~~~~~~~~y~aPE~~  196 (291)
T 1u46_A          172 PQNDDH-YVMQEHRKVPFAWCAPESL  196 (291)
T ss_dssp             CC-CCE-EEC-----CCGGGCCHHHH
T ss_pred             cccccc-hhhhccCCCCceeeCchhh
Confidence            544321 1123445688899999986

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.96  E-value=9.4e-30  Score=226.44  Aligned_cols=169  Identities=30%  Similarity=0.530  Sum_probs=141.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccc-hhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            6888899999999999999985  789999988654322 1223567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+. ++|.+++...  ..+++..+..++.||+.||.|||+.|  |+||||||+||++  +.++.+||+|||+++......
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~~~~~  157 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV  157 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECSTTHHHHHCCCS
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHeEE--cCCCCEEECcchhhhhccCCc
Confidence            997 5999999865  46899999999999999999999988  9999999999999  888899999999997764332


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......||+.|+|||++.
T Consensus       158 ~----~~~~~~~~~~y~aPE~~~  176 (299)
T 2r3i_A          158 R----TYTHEVVTLWYRAPEILL  176 (299)
T ss_dssp             B----CTTSCBCCCTTCCHHHHT
T ss_pred             c----ccCcccccccccCcHHhh
Confidence            1    234457899999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=227.93  Aligned_cols=171  Identities=30%  Similarity=0.596  Sum_probs=134.0

Q ss_pred             CcCccccceecccCceeEEEEEEC--Cce----EEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTP----VAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP  229 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~----vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  229 (337)
                      ..+|+..+.||+|+||.||+|.+.  ++.    +++|.+......  ...+.+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            347899999999999999999974  444    467766543322  23467889999999999999999999998654 


Q ss_pred             eEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .++++|++.+++|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~--~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCTTC---
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEE--cCCCCEEEccCcceeE
Confidence            8899999999999999986 456999999999999999999999988  9999999999999  6778999999999987


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .......  .......+|+.|+|||++
T Consensus       167 ~~~~~~~--~~~~~~~~t~~y~aPE~~  191 (327)
T 3lzb_A          167 LGAEEKE--YHAEGGKVPIKWMALESI  191 (327)
T ss_dssp             ---------------CCCGGGSCHHHH
T ss_pred             ccCcccc--ccccCCCccccccCHHHH
Confidence            7543221  123455678999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.96  E-value=8.1e-30  Score=230.12  Aligned_cols=169  Identities=25%  Similarity=0.421  Sum_probs=139.1

Q ss_pred             Ccccc-ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEE
Q 019685          158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       158 ~~~~~-~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      .|.+. +.||+|+||.||+|...  ++.||+|++....... .....+.+|+.++..+. ||||+++++++...+..++|
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            34554 78999999999999986  8899999986543322 12367888999999996 69999999999999999999


Q ss_pred             EeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC---CCcEEEEeccCcee
Q 019685          234 TEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS---ADHLKVGDFGLSKL  308 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~---~~~~kl~DFgla~~  308 (337)
                      |||+++++|.+++..  ...+++.++..++.||+.||.|||++|  |+||||||+|||+  +.   .+.+||+|||+++.
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~--~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILL--SSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--SCBTTBCCEEECCGGGCEE
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEE--ecCCCCCcEEEeeCccccc
Confidence            999999999999854  356999999999999999999999988  9999999999999  54   67999999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....     ......||+.|+|||++.
T Consensus       184 ~~~~~-----~~~~~~gt~~y~aPE~~~  206 (327)
T 3lm5_A          184 IGHAC-----ELREIMGTPEYLAPEILN  206 (327)
T ss_dssp             C--------------CCCGGGCCHHHHT
T ss_pred             cCCcc-----ccccccCCcCccCCeeec
Confidence            75432     234567999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=1.2e-29  Score=228.97  Aligned_cols=167  Identities=38%  Similarity=0.589  Sum_probs=137.9

Q ss_pred             CccccceecccCceeEEEEEEC--Cce--EEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTP--VAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~--vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|...+.||+|+||.||+|...  +..  +++|.+.....  ....+.+.+|+.+++.+ +||||+++++++...+..|+
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc--hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            7888899999999999999875  554  48888864322  23346788999999999 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          233 ITEYLRGGDLHKYLKEKG----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      ||||+++++|.+++....                .+++.+++.++.||+.||.|||+++  |+||||||+|||+  +.++
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~~~~  179 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENY  179 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGGG
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEE--cCCC
Confidence            999999999999997653                6899999999999999999999988  9999999999999  7788


Q ss_pred             cEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .+||+|||+++......     ......+++.|+|||++
T Consensus       180 ~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~  213 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESL  213 (327)
T ss_dssp             CEEECCTTCEESSCEEC-----CC----CCTTTCCHHHH
T ss_pred             eEEEcccCcCccccccc-----cccCCCCCccccChhhh
Confidence            99999999997543221     22345678999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=3.2e-30  Score=232.11  Aligned_cols=172  Identities=27%  Similarity=0.405  Sum_probs=145.5

Q ss_pred             CCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchH---HHHHHHHHHHHHHHhCC--CCCeeeeeeeEEe
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLR--HPNIVQFLGAVTE  226 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~  226 (337)
                      ....+|+..+.||+|+||.||+|...  ++.||+|.+........   .....+.+|+.+++.++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34457999999999999999999874  78899999865432210   11234567899999996  5999999999999


Q ss_pred             CCceEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEecc
Q 019685          227 RKPLMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFG  304 (337)
Q Consensus       227 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFg  304 (337)
                      .+..++|||++.+ ++|.+++...+.+++..+..++.||+.||.|||+.+  |+||||||+|||+  + ..+.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll--~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILI--DLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEE--eCCCCCEEEeeCc
Confidence            9999999999976 899999998888999999999999999999999988  9999999999999  5 56789999999


Q ss_pred             CceeeecccccceeeeeCCcccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +++.....      ......||+.|+|||++
T Consensus       196 ~~~~~~~~------~~~~~~gt~~y~aPE~~  220 (320)
T 3a99_A          196 SGALLKDT------VYTDFDGTRVYSPPEWI  220 (320)
T ss_dssp             TCEECCSS------CBCCCCSCGGGSCHHHH
T ss_pred             cccccccc------cccCCCCCccCCChHHh
Confidence            99876543      23456799999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=2e-29  Score=224.25  Aligned_cols=171  Identities=29%  Similarity=0.488  Sum_probs=137.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe---------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE---------  226 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~---------  226 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+..    .....+.+.+|+.+++.++||||+++++++.+         
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            5788899999999999999974  88999999853    23445778899999999999999999998765         


Q ss_pred             ----CCceEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          227 ----RKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       227 ----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                          ....|+||||+++++|.+++.... .+++..++.++.||+.||.|||+++  |+||||||+||++  +.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~--~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFI--DESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEE--cCCCCEEEe
Confidence                456899999999999999998643 5788999999999999999999988  9999999999999  888899999


Q ss_pred             eccCceeeeccccc----------ceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSH----------DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+++........          .........||+.|+|||++.
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  203 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD  203 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHT
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCccccc
Confidence            99999876432100          001234567999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=1.7e-29  Score=235.69  Aligned_cols=164  Identities=29%  Similarity=0.420  Sum_probs=135.3

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------  227 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------  227 (337)
                      ..+|...+.||+|+||.||+|.+.  ++.||||++.....       ...+|+.+++.++||||+++++++...      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            347899999999999999999985  88999999865422       223699999999999999999988542      


Q ss_pred             CceEEEEeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEe
Q 019685          228 KPLMLITEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGD  302 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~D  302 (337)
                      ..+++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+++  |+||||||+|||+  +. .+.+||+|
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl--~~~~~~~kl~D  200 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL--DPDTAVLKLCD  200 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEE--ETTTTEEEECC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEE--eCCCCeEEecc
Confidence            237899999986 77766642    457999999999999999999999988  9999999999999  53 35789999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+++.+....     ......||+.|+|||++.
T Consensus       201 FG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~  229 (420)
T 1j1b_A          201 FGSAKQLVRGE-----PNVSYICSRYYRAPELIF  229 (420)
T ss_dssp             CTTCEECCTTC-----CCCSCCSCTTSCCHHHHT
T ss_pred             chhhhhcccCC-----CceeeeeCCCcCCHHHHc
Confidence            99998765432     234567899999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=2.6e-29  Score=225.15  Aligned_cols=175  Identities=29%  Similarity=0.455  Sum_probs=134.1

Q ss_pred             CCCcCccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          154 PSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       154 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      ....+|...+.||+|+||.||+|.+.     +..||+|.+...... ....+.+.+|+.+++.++||||+++++++....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            34457888999999999999999864     337999998655433 334577899999999999999999999987654


Q ss_pred             -----ceEEEEeecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc
Q 019685          229 -----PLMLITEYLRGGDLHKYLKE------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH  297 (337)
Q Consensus       229 -----~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~  297 (337)
                           ..++||||+++++|.+++..      ...+++..++.++.||+.||.|||+.+  |+||||||+||++  +.++.
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli--~~~~~  185 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCML--RDDMT  185 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEE--CTTSC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEE--cCCCc
Confidence                 35999999999999999953      245999999999999999999999987  9999999999999  78889


Q ss_pred             EEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       298 ~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +||+|||+++.+.....  ........+++.|+|||++
T Consensus       186 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  221 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDY--YRQGRIAKMPVKWIAIESL  221 (313)
T ss_dssp             EEECSCSCC------------------CCGGGSCHHHH
T ss_pred             EEEeecCcceecccccc--cCcccccCCCccccCchhh
Confidence            99999999987654321  1123445678999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=1.5e-29  Score=228.60  Aligned_cols=179  Identities=29%  Similarity=0.439  Sum_probs=132.4

Q ss_pred             ccCCCCcCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEE--
Q 019685          151 EIDPSELDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVT--  225 (337)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~--  225 (337)
                      .+.....+|+..+.||+|+||.||+|.+  .++.||+|.+...   .....+.+.+|+.++..+. ||||+++++++.  
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            3445556899999999999999999998  4789999988544   2334567889999999996 999999999984  


Q ss_pred             ------eCCceEEEEeecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          226 ------ERKPLMLITEYLRGGDLHKYLKE---KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       226 ------~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                            ....++++|||+. |+|.+++..   .+.+++.+++.++.||+.||.|||+.+.+|+||||||+|||+  +.++
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~--~~~~  175 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQG  175 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--CTTS
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--CCCC
Confidence                  3345899999996 699998865   456999999999999999999999965559999999999999  7888


Q ss_pred             cEEEEeccCceeeecccccce--------eeeeCCcccccccccccc
Q 019685          297 HLKVGDFGLSKLIKVQNSHDV--------YKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~l  335 (337)
                      .+||+|||+++..........        .......||+.|+|||++
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  222 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII  222 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC------------------------------
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence            999999999987654321110        012245699999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=4.3e-30  Score=228.85  Aligned_cols=173  Identities=26%  Similarity=0.457  Sum_probs=127.7

Q ss_pred             cCccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|...+.||+|+||.||++..  +++.||+|.+.....  ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3788899999999999999986  478999998865432  223467788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          235 EYLRGGDLHKYLKE--------KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       235 e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      ||+++++|.+++..        ...+++..+..++.||+.||.|||+.+  |+||||||+||++  +.++.+||+|||++
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~--~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILL--GEDGSVQIADFGVS  168 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--CTTCCEEECCCHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEE--cCCCCEEEEeccch
Confidence            99999999999974        345899999999999999999999988  9999999999999  78889999999999


Q ss_pred             eeeecccccc-eeeeeCCcccccccccccc
Q 019685          307 KLIKVQNSHD-VYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       307 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~l  335 (337)
                      +......... ........||+.|+|||++
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVM  198 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHH
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHh
Confidence            7765432110 0122445799999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.96  E-value=5.9e-30  Score=225.50  Aligned_cols=173  Identities=28%  Similarity=0.454  Sum_probs=142.7

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--CCceEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLML  232 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~l  232 (337)
                      .+|+..+.||+|+||.||++...  ++.+++|.+...... ....+.+.+|+.+++.++||||+++++++..  ...+|+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            47889999999999999999985  788999998765443 3345788999999999999999999998754  567999


Q ss_pred             EEeecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCC---CCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          233 ITEYLRGGDLHKYLKEK----GALSPSTAVNFALDIARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.+   .+|+||||||+||++  +..+.+||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~--~~~~~~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE--CSSSCEEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE--cCCCCEEEecCch
Confidence            99999999999999753    34999999999999999999999954   239999999999999  7888999999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++.......    ......||+.|+|||++.
T Consensus       163 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~  189 (279)
T 2w5a_A          163 ARILNHDTS----FAKTFVGTPYYMSPEQMN  189 (279)
T ss_dssp             HHHC---CH----HHHHHHSCCTTCCHHHHH
T ss_pred             heeeccccc----cccccCCCccccChHHhc
Confidence            987654321    123456899999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=5.2e-29  Score=226.87  Aligned_cols=172  Identities=29%  Similarity=0.474  Sum_probs=141.8

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----Cc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~  229 (337)
                      .+|...+.||+|+||.||+|...  ++.||+|.+....  .......+.+|+.+++.++||||+++++++...     ..
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            47889999999999999999986  8899999986432  344456788999999999999999999987654     67


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      .|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++..
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLI--NSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--cCCCcEEEEeccccccc
Confidence            899999997 599999875 56999999999999999999999988  9999999999999  88889999999999877


Q ss_pred             ecccccce------eeeeCCccccccccccccc
Q 019685          310 KVQNSHDV------YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~------~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........      .......||+.|+|||++.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVML  195 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHH
T ss_pred             ccccccccCccccccchhhccccccccCCeeec
Confidence            54321100      0123457899999999863

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=2.8e-29  Score=223.99  Aligned_cols=172  Identities=22%  Similarity=0.419  Sum_probs=141.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCch-HHHHHHHHHHHHHHHhCCCCCeeeeeeeE--EeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD-RLVIQDFRHEVNLLVKLRHPNIVQFLGAV--TERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--~~~~~~~l  232 (337)
                      +|.+.+.||+|+||.||++...  ++.+++|.+....... ......+.+|+.+++.++||||+++++++  ......|+
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            6888999999999999999984  7789999986432111 12346788999999999999999999998  44567999


Q ss_pred             EEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          233 ITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      ||||++++ |.+++..  ...+++..+..++.||+.||.|||+++  |+||||||+||++  +.++.+||+|||++....
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~--~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLL--TTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEECC
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEE--cCCCcEEeeccccccccC
Confidence            99999875 8787765  346999999999999999999999988  9999999999999  788899999999998765


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....  .......||+.|+|||++.
T Consensus       161 ~~~~~--~~~~~~~~~~~y~aPE~~~  184 (305)
T 2wtk_C          161 PFAAD--DTCRTSQGSPAFQPPEIAN  184 (305)
T ss_dssp             TTCSS--CEECCCCSCGGGCCHHHHT
T ss_pred             ccccc--cccccCCCCCCCcChhhcc
Confidence            43221  1234567999999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=1.7e-29  Score=223.69  Aligned_cols=171  Identities=30%  Similarity=0.524  Sum_probs=145.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|.+.+.||+|+||.||+|...  ++.|++|++....... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            6888899999999999999985  7899999986543321 124678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~~~~~~  314 (337)
                      |+++++|.+++.....+++..+..++.||+.||.|||+.+  |+||||||+||++..+ ..+.+||+|||+++...... 
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-  178 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-  178 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence            9999999999988788999999999999999999999988  9999999999999432 24579999999998765432 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       179 ----~~~~~~~~~~y~aPE~~~  196 (287)
T 2wei_A          179 ----KMKDRIGTAYYIAPEVLR  196 (287)
T ss_dssp             ----SCSCHHHHHTTCCHHHHT
T ss_pred             ----ccccccCcccccChHHhc
Confidence                123456899999999763

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.2e-29  Score=247.17  Aligned_cols=165  Identities=29%  Similarity=0.504  Sum_probs=133.0

Q ss_pred             eecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecCC
Q 019685          164 IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      .||+|+||.||+|.++    +..||||.+......  ...+.+.+|+.+++.++||||+++++++.. +.+++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            7999999999999874    456999998765322  234778999999999999999999999876 569999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccccee
Q 019685          240 GDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY  318 (337)
Q Consensus       240 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~  318 (337)
                      |+|.+++... ..+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+...... ..
T Consensus       420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl--~~~~~vkL~DFGla~~~~~~~~~-~~  494 (613)
T 2ozo_A          420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL--VNRHYAKISDFGLSKALGADDSY-YT  494 (613)
T ss_dssp             CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCSTTTTCC--------
T ss_pred             CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEE--cCCCcEEEeeccCcccccCCCce-ee
Confidence            9999999754 45999999999999999999999988  9999999999999  67789999999999876543221 11


Q ss_pred             eeeCCccccccccccccc
Q 019685          319 KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       319 ~~~~~~gt~~y~aPE~l~  336 (337)
                      ......+|+.|+|||++.
T Consensus       495 ~~~~~~~~~~y~APE~~~  512 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECIN  512 (613)
T ss_dssp             -------CCTTSCHHHHH
T ss_pred             eccCCCCccceeCHhhhc
Confidence            223345678999999863

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=234.48  Aligned_cols=166  Identities=23%  Similarity=0.421  Sum_probs=123.5

Q ss_pred             cceecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--CCceEEEEe
Q 019685          162 SAIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLITE  235 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv~e  235 (337)
                      .++||+|+||.||+|..+    ++.||+|.+......     ..+.+|+.+++.++||||+++++++..  ...+|+|||
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e  100 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD  100 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence            458999999999999964    678999998654332     456789999999999999999999954  668999999


Q ss_pred             ecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec--CCCCcEEEEecc
Q 019685          236 YLRGGDLHKYLKEK---------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN--SSADHLKVGDFG  304 (337)
Q Consensus       236 ~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~--~~~~~~kl~DFg  304 (337)
                      |+.+ +|.+++...         ..+++..++.++.||+.||.|||+.+  |+||||||+|||+..  +..+.+||+|||
T Consensus       101 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A          101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             CCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             CCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            9975 888887532         14899999999999999999999988  999999999999943  345789999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +++.+..... .........||+.|+|||++.
T Consensus       178 ~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~  208 (405)
T 3rgf_A          178 FARLFNSPLK-PLADLDPVVVTFWYRAPELLL  208 (405)
T ss_dssp             CCC-----------------CCCTTCCHHHHT
T ss_pred             CceecCCCCc-ccccCCCceecCcccCchhhc
Confidence            9987754321 111345578999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=2.4e-29  Score=226.93  Aligned_cols=174  Identities=28%  Similarity=0.421  Sum_probs=140.5

Q ss_pred             CcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      ..+|...+.||+|+||.||+|.+.       +..||+|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            347889999999999999999842       5679999986433  2334567889999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEE
Q 019685          229 PLMLITEYLRGGDLHKYLKEKG-------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKV  300 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl  300 (337)
                      ..|+||||+++++|.+++....       .+++..++.++.||+.||.|||+.+  |+||||||+|||+..+ ....+||
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999998653       4889999999999999999999988  9999999999999321 3456999


Q ss_pred             EeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          301 GDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       301 ~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      +|||+++.......  ........||+.|+|||++
T Consensus       185 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~  217 (327)
T 2yfx_A          185 GDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAF  217 (327)
T ss_dssp             CCCHHHHHHHC--------CCGGGSCGGGCCHHHH
T ss_pred             Cccccccccccccc--cccCCCcCCCcceeCHhHh
Confidence            99999976543221  1123345689999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=2.9e-29  Score=232.27  Aligned_cols=163  Identities=27%  Similarity=0.436  Sum_probs=134.5

Q ss_pred             cCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc------
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP------  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~------  229 (337)
                      .+|...+.||+|+||.||+|... +..+|+|++......       ..+|+.+++.++||||+++++++...+.      
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            37999999999999999999985 556888888654322       2359999999999999999999865443      


Q ss_pred             eEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEecc
Q 019685          230 LMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFG  304 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFg  304 (337)
                      +++||||+++ ++.+.+.    ....+++..+..++.||+.||.|||+++  |+||||||+|||+  + ..+.+||+|||
T Consensus       113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill--~~~~~~~kL~DFG  187 (394)
T 4e7w_A          113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLL--DPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--ETTTTEEEECCCT
T ss_pred             EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEE--cCCCCcEEEeeCC
Confidence            8899999987 4444433    2567999999999999999999999988  9999999999999  5 67899999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +++......     ......||+.|+|||++.
T Consensus       188 ~a~~~~~~~-----~~~~~~~t~~y~aPE~~~  214 (394)
T 4e7w_A          188 SAKILIAGE-----PNVSYICSRYYRAPELIF  214 (394)
T ss_dssp             TCEECCTTC-----CCCSSCSCGGGCCHHHHT
T ss_pred             CcccccCCC-----CCcccccCcCccCHHHHc
Confidence            998875443     234567899999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=4.3e-29  Score=229.30  Aligned_cols=164  Identities=26%  Similarity=0.485  Sum_probs=138.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce-----
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL-----  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~-----  230 (337)
                      +|...+.||+|+||.||+|.+.  ++.||+|++...... ....+.+.+|+.+++.++||||+++++++......     
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            7888899999999999999875  789999999765433 34567888999999999999999999999877654     


Q ss_pred             -EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          231 -MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                       |+||||+. ++|.+++.  ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++..
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll--~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV--NEDCELKILDFGLARHA  194 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECSTTCC---
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEE--CCCCCEEEEecCccccc
Confidence             99999997 58888773  34999999999999999999999988  9999999999999  88889999999999865


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...       .....||+.|+|||++.
T Consensus       195 ~~~-------~~~~~~t~~y~aPE~~~  214 (371)
T 4exu_A          195 DAE-------MTGYVVTRWYRAPEVIL  214 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHS
T ss_pred             ccC-------cCCcccCccccCHHHhc
Confidence            432       34567899999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.96  E-value=6.4e-29  Score=232.36  Aligned_cols=164  Identities=29%  Similarity=0.407  Sum_probs=138.8

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC------CCCCeeeeeeeEEeCC
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL------RHPNIVQFLGAVTERK  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l------~h~~Iv~~~~~~~~~~  228 (337)
                      .+|++.+.||+|+||.||+|...  ++.||||++...    ......+.+|+.++..+      +|+||+++++++...+
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            36899999999999999999875  688999998643    23345667788887776      5779999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc--EEEEecc
Q 019685          229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH--LKVGDFG  304 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~--~kl~DFg  304 (337)
                      .+++||||+. ++|.+++....  .+++..+..++.||+.||.|||+++  |+||||||+|||+  +..+.  +||+|||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl--~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILL--KQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEE--SSTTSCCEEECCCT
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEE--ccCCCcceEEeecc
Confidence            9999999996 59999998653  4999999999999999999999987  9999999999999  55555  9999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +++....       ......||+.|+|||++.
T Consensus       248 ~a~~~~~-------~~~~~~gt~~y~aPE~~~  272 (429)
T 3kvw_A          248 SSCYEHQ-------RVYTYIQSRFYRAPEVIL  272 (429)
T ss_dssp             TCEETTC-------CCCSSCSCGGGCCHHHHH
T ss_pred             cceecCC-------cccccCCCCCccChHHHh
Confidence            9976432       234567999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=3e-29  Score=224.89  Aligned_cols=177  Identities=21%  Similarity=0.350  Sum_probs=143.8

Q ss_pred             ccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEEeC
Q 019685          151 EIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTER  227 (337)
Q Consensus       151 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~  227 (337)
                      .+.....+|...+.||+|+||.||++... ++.||+|.+...... ....+.+.+|+.++..++  ||||+++++++...
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            34455567999999999999999999875 778999998665433 345678899999999997  59999999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      ...+++|| +.+++|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+  + ++.+||+|||+++
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~--~-~~~~kL~Dfg~~~  174 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI--V-DGMLKLIDFGIAN  174 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--E-TTEEEECCCSSSC
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE--E-CCeEEEeeccccc
Confidence            99999999 567899999998888999999999999999999999988  9999999999999  3 3789999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........  .......||+.|+|||++.
T Consensus       175 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~  201 (313)
T 3cek_A          175 QMQPDTTS--VVKDSQVGTVNYMPPEAIK  201 (313)
T ss_dssp             C----------------CCGGGCCHHHHT
T ss_pred             cccCcccc--ccccCCCCCCCcCCHHHHh
Confidence            77543221  1234567999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.96  E-value=2.6e-29  Score=229.81  Aligned_cols=169  Identities=28%  Similarity=0.487  Sum_probs=133.9

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCc--------hHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD--------DRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-  227 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-  227 (337)
                      +|...+.||+|+||.||+|... ++.||+|++......        .....+.+.+|+.+++.++||||+++++++... 
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE  102 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred             ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence            7888999999999999999875 788999998543221        233457889999999999999999999998542 


Q ss_pred             ----CceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          228 ----KPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       228 ----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                          ..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+.+||+|
T Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~--~~~~~~kl~D  177 (362)
T 3pg1_A          103 EPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILL--ADNNDITICD  177 (362)
T ss_dssp             TTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECC
T ss_pred             CCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEE--cCCCCEEEEe
Confidence                35899999998 5888888754 36999999999999999999999988  9999999999999  7888999999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+++......     ......||+.|+|||++.
T Consensus       178 fg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~  206 (362)
T 3pg1_A          178 FNLAREDTADA-----NKTHYVTHRWYRAPELVM  206 (362)
T ss_dssp             TTC--------------------CGGGCCHHHHT
T ss_pred             cCccccccccc-----ccceecccceecCcHHhc
Confidence            99997654332     234567999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=230.49  Aligned_cols=171  Identities=17%  Similarity=0.264  Sum_probs=140.9

Q ss_pred             CCCCcCccccceecccCceeEEEEEEC----------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeee---
Q 019685          153 DPSELDFSSSAIIGKGSFGEILKAYWR----------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ---  219 (337)
Q Consensus       153 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~---  219 (337)
                      +....+|...+.||+|+||.||+|...          ++.||+|.+...        +.+.+|+.+++.++||||++   
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~  109 (352)
T 2jii_A           38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWK  109 (352)
T ss_dssp             CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred             cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhh
Confidence            344568999999999999999999874          578999998653        35678999999999999887   


Q ss_pred             ------------eeeeEEe-CCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCC
Q 019685          220 ------------FLGAVTE-RKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLK  284 (337)
Q Consensus       220 ------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlk  284 (337)
                                  +++++.. ....|+||||+ +++|.+++...  ..+++.+++.++.||+.||.|||+++  |+|||||
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dik  186 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVT  186 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCC
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCC
Confidence                        5666665 67889999999 89999999875  67999999999999999999999988  9999999


Q ss_pred             CCCEEEecCCCC--cEEEEeccCceeeeccccccee---eeeCCccccccccccccc
Q 019685          285 PRNVLLVNSSAD--HLKVGDFGLSKLIKVQNSHDVY---KMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       285 p~Nil~~~~~~~--~~kl~DFgla~~~~~~~~~~~~---~~~~~~gt~~y~aPE~l~  336 (337)
                      |+|||+  +.++  .+||+|||+++.+.........   ......||+.|+|||++.
T Consensus       187 p~NIl~--~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  241 (352)
T 2jii_A          187 AENIFV--DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK  241 (352)
T ss_dssp             GGGEEE--ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT
T ss_pred             HHHEEE--cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc
Confidence            999999  5555  8999999999887654321110   124457999999999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=2.9e-29  Score=247.74  Aligned_cols=162  Identities=27%  Similarity=0.396  Sum_probs=137.9

Q ss_pred             cCccccceecccCceeEEEEEEC---CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc----
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP----  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~----  229 (337)
                      .+|++.+.||+|+||.||++.+.   ++.||||.+....  .......+.+|+.++..++||||+++++++...+.    
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            37899999999999999999974   6889999886532  33455678899999999999999999999987765    


Q ss_pred             -eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 -LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                       .|+||||+++++|.+++..  .+++.+++.++.||+.||.|||++|  |+||||||+|||+  +. +.+||+|||+++.
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll--~~-~~~kl~DFG~a~~  230 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIML--TE-EQLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CS-SCEEECCCTTCEE
T ss_pred             eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEE--eC-CcEEEEecccchh
Confidence             7999999999999998754  6999999999999999999999988  9999999999999  44 4899999999987


Q ss_pred             eecccccceeeeeCCcccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....        ....||+.|+|||++
T Consensus       231 ~~~~--------~~~~gt~~y~aPE~~  249 (681)
T 2pzi_A          231 INSF--------GYLYGTPGFQAPEIV  249 (681)
T ss_dssp             TTCC--------SCCCCCTTTSCTTHH
T ss_pred             cccC--------CccCCCccccCHHHH
Confidence            6432        346799999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=1.1e-28  Score=223.06  Aligned_cols=165  Identities=24%  Similarity=0.408  Sum_probs=139.9

Q ss_pred             CccccceecccCceeEEEEEE---CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCC------CeeeeeeeEEeCC
Q 019685          158 DFSSSAIIGKGSFGEILKAYW---RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP------NIVQFLGAVTERK  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~------~Iv~~~~~~~~~~  228 (337)
                      +|++.+.||+|+||.||+|..   .++.||+|++...    ....+.+.+|+.+++.++|+      +|+++++++...+
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            789999999999999999987   3778999998542    23456778899998888655      5999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC------------
Q 019685          229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS------------  294 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~------------  294 (337)
                      ..++||||+ +++|.+++...+  .+++..+..++.||+.||.|||+++  |+||||||+|||+..+.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccc
Confidence            999999999 789999998765  5899999999999999999999988  99999999999993322            


Q ss_pred             -----CCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          295 -----ADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       295 -----~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                           .+.+||+|||+++.....       .....||+.|+|||++.
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~  207 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVIL  207 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHT
T ss_pred             cccccCCCceEeeCcccccCccc-------cccccCCccccChHHhh
Confidence                 668999999999764322       34567999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=1.2e-28  Score=223.42  Aligned_cols=163  Identities=27%  Similarity=0.471  Sum_probs=118.1

Q ss_pred             Ccccc-ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----CCce
Q 019685          158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPL  230 (337)
Q Consensus       158 ~~~~~-~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~  230 (337)
                      +|.+. +.||+|+||.||+|...  ++.||+|++...    .   ....+....++.++||||+++++++..    ...+
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            67774 46999999999999986  889999998542    1   112223334667789999999999876    4458


Q ss_pred             EEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCce
Q 019685          231 MLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSK  307 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~  307 (337)
                      ++||||+++++|.+++....  .+++.+++.++.||+.||.|||+++  |+||||||+|||+..+ ..+.+||+|||+++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            99999999999999998753  5999999999999999999999988  9999999999999432 25569999999998


Q ss_pred             eeecccccceeeeeCCcccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .....      ......||+.|+|||++
T Consensus       180 ~~~~~------~~~~~~~t~~y~aPE~~  201 (336)
T 3fhr_A          180 ETTQN------ALQTPCYTPYYVAPEVL  201 (336)
T ss_dssp             EC--------------------------
T ss_pred             ecccc------ccccCCCCcCccChhhh
Confidence            76533      23456789999999986

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.7e-29  Score=242.26  Aligned_cols=173  Identities=18%  Similarity=0.233  Sum_probs=126.9

Q ss_pred             CcccCCCCcCc-cccceecccCceeEEEEEECCceEEEEEecCCCCch-----HHHHHHHHHHHHHHHhCCCCCeeeeee
Q 019685          149 DWEIDPSELDF-SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDD-----RLVIQDFRHEVNLLVKLRHPNIVQFLG  222 (337)
Q Consensus       149 ~~~~~~~~~~~-~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~Iv~~~~  222 (337)
                      .|..+.....+ ...+.||+|+||.||++...++.+++|.........     ....+++.+|+.++++++||||+++..
T Consensus       327 ~w~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~  406 (540)
T 3en9_A          327 NWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYI  406 (540)
T ss_dssp             CCC------------------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCE
T ss_pred             cccccccccccCCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEE
Confidence            44443333333 445689999999999998889999999876544322     222456899999999999999996666


Q ss_pred             eEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       223 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                      ++...+..|+||||+++++|.+++..        +..++.|++.||.|||+++  |+||||||+|||+  +.  .+||+|
T Consensus       407 ~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl--~~--~~kL~D  472 (540)
T 3en9_A          407 FDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIF--DK--DLYIID  472 (540)
T ss_dssp             EEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEE--SS--SEEECC
T ss_pred             EEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEE--CC--eEEEEE
Confidence            66677788999999999999999865        5689999999999999988  9999999999999  55  899999


Q ss_pred             ccCceeeecccccce---eeeeCCcccccccccccc
Q 019685          303 FGLSKLIKVQNSHDV---YKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       303 Fgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~l  335 (337)
                      ||+++..........   .......||+.|||||++
T Consensus       473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~  508 (540)
T 3en9_A          473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIW  508 (540)
T ss_dssp             CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             CccCEECCCccccccchhhhhhhhcCCCCcCCHHHH
Confidence            999998765422110   012356799999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=6.2e-29  Score=226.99  Aligned_cols=165  Identities=28%  Similarity=0.411  Sum_probs=125.9

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP------  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~------  229 (337)
                      +|.+.+.||+|+||.||+|...  ++.||+|.+.......    .....++..+..++||||+++++++.....      
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            7888999999999999999986  7899999886543222    345667888888999999999999876443      


Q ss_pred             -eEEEEeecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--cCCCCcEeeCCCCCCEEEecCC-CCcEEEE
Q 019685          230 -LMLITEYLRGGDLHKYLK----EKGALSPSTAVNFALDIARGMAYLH--NEPNVIIHRDLKPRNVLLVNSS-ADHLKVG  301 (337)
Q Consensus       230 -~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~  301 (337)
                       +++||||+++ +|.+.+.    ....+++..+..++.|++.||.|||  +.+  |+||||||+|||+  +. ++.+||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll--~~~~~~~kl~  174 (360)
T 3e3p_A          100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLV--NEADGTLKLC  174 (360)
T ss_dssp             EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEE--ETTTTEEEEC
T ss_pred             eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEE--eCCCCcEEEe
Confidence             8999999987 5555443    3456899999999999999999999  866  9999999999999  54 7899999


Q ss_pred             eccCceeeecccccceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+++......     ......||+.|+|||++.
T Consensus       175 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~  204 (360)
T 3e3p_A          175 DFGSAKKLSPSE-----PNVAYICSRYYRAPELIF  204 (360)
T ss_dssp             CCTTCBCCCTTS-----CCCSTTSCGGGCCHHHHT
T ss_pred             eCCCceecCCCC-----CcccccCCcceeCHHHHc
Confidence            999998776443     234567899999999873

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=2e-28  Score=220.85  Aligned_cols=169  Identities=24%  Similarity=0.430  Sum_probs=125.4

Q ss_pred             CCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHH-HHHhCCCCCeeeeeeeEEeCCceE
Q 019685          155 SELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN-LLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      ...+|...+.||+|+||.||+|...  ++.||+|.+......  .....+..|+. +++.++||||+++++++...+..+
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            3447888899999999999999986  889999999765322  23344555555 677789999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccC
Q 019685          232 LITEYLRGGDLHKYLKE-----KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGL  305 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgl  305 (337)
                      +||||+++ +|.+++..     ...+++..+..++.|++.||.|||+. +  |+||||||+|||+  +.++.+||+|||+
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll--~~~~~~kl~Dfg~  172 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILL--DRSGNIKLCDFGI  172 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEE--ETTTEEEECCCSS
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEE--cCCCCEEEccCCC
Confidence            99999986 88888763     45789999999999999999999997 7  9999999999999  7788999999999


Q ss_pred             ceeeecccccceeeeeCCcccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ++......     ......||+.|+|||++
T Consensus       173 ~~~~~~~~-----~~~~~~gt~~y~aPE~~  197 (327)
T 3aln_A          173 SGQLVDSI-----AKTRDAGCRPYMAPERI  197 (327)
T ss_dssp             SCC---------------------------
T ss_pred             ceeccccc-----ccccCCCCccccCceee
Confidence            98765432     22344799999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=1.3e-28  Score=241.42  Aligned_cols=169  Identities=28%  Similarity=0.529  Sum_probs=138.6

Q ss_pred             cCccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      .+|+..+.||+|+||.||+|.+.     +..+++|.+....  .....+.+.+|+.+++.++||||+++++++. .+..|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            46778899999999999999874     3458888876532  3345578899999999999999999999885 46789


Q ss_pred             EEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          232 LITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +||||+++++|.+++.... .+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl--~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEE--eCCCCEEEEecCCCeecC
Confidence            9999999999999998654 6899999999999999999999988  9999999999999  677899999999998765


Q ss_pred             cccccceeeeeCCcccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ....   .......+|+.|||||++
T Consensus       543 ~~~~---~~~~~~~~t~~y~aPE~~  564 (656)
T 2j0j_A          543 DSTY---YKASKGKLPIKWMAPESI  564 (656)
T ss_dssp             C-------------CCGGGCCHHHH
T ss_pred             CCcc---eeccCCCCCcceeCHHHh
Confidence            4321   123445678999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=7.9e-29  Score=228.99  Aligned_cols=164  Identities=23%  Similarity=0.378  Sum_probs=137.0

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC--------CCCeeeeeeeEE-
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--------HPNIVQFLGAVT-  225 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~Iv~~~~~~~-  225 (337)
                      .+|.+.+.||+|+||.||+|...  ++.||+|++...    ....+.+.+|+.+++.++        |+||+++++++. 
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            37899999999999999999875  788999998643    334567888999999885        788999999987 


Q ss_pred             ---eCCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCC---
Q 019685          226 ---ERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSAD---  296 (337)
Q Consensus       226 ---~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~---  296 (337)
                         ....+|+||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ |  |+||||||+|||+  +.++   
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll--~~~~~~~  187 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL--SVNEQYI  187 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEE--CCCHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeE--eccchhh
Confidence               456799999999 55777766543  4699999999999999999999997 7  9999999999999  5443   


Q ss_pred             ----------------------------------------------cEEEEeccCceeeecccccceeeeeCCccccccc
Q 019685          297 ----------------------------------------------HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL  330 (337)
Q Consensus       297 ----------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~  330 (337)
                                                                    .+||+|||+++.....       .....||+.|+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~  260 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYR  260 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGC
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCccc
Confidence                                                          7999999999876532       34567999999


Q ss_pred             cccccc
Q 019685          331 VSNCSF  336 (337)
Q Consensus       331 aPE~l~  336 (337)
                      |||++.
T Consensus       261 aPE~~~  266 (397)
T 1wak_A          261 SLEVLI  266 (397)
T ss_dssp             CHHHHH
T ss_pred             CChhhc
Confidence            999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=7.7e-29  Score=226.00  Aligned_cols=164  Identities=26%  Similarity=0.478  Sum_probs=137.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCc------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKP------  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~------  229 (337)
                      +|...+.||+|+||.||+|...  |+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.....      
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            6888999999999999999875  88999999876543 33455778899999999999999999999987654      


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+||||+. ++|.+++.  ..+++..+..++.||+.||.|||++|  |+||||||+||++  +.++.+||+|||+++..
T Consensus       104 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~--~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV--NEDCELKILDFGLARHA  176 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE--CTTCCEEECSTTCTTC-
T ss_pred             EEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeE--CCCCcEEEeecccccCC
Confidence            499999997 48888774  35899999999999999999999988  9999999999999  78889999999999765


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...       .....||+.|+|||++.
T Consensus       177 ~~~-------~~~~~~t~~y~aPE~~~  196 (353)
T 3coi_A          177 DAE-------MTGYVVTRWYRAPEVIL  196 (353)
T ss_dssp             --------------CCSBCCSCHHHHS
T ss_pred             CCC-------ccccccCcCcCCHHHHh
Confidence            432       34567899999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=2.6e-28  Score=224.93  Aligned_cols=167  Identities=31%  Similarity=0.413  Sum_probs=140.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CC-----CeeeeeeeEEeCCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HP-----NIVQFLGAVTERKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~Iv~~~~~~~~~~~  229 (337)
                      +|...+.||+|+||.||+|...  ++.||+|++...    ......+..|+.++..++ |+     +|+++++++...+.
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            7889999999999999999876  778999998642    234466778888888875 54     49999999999999


Q ss_pred             eEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      .|+||||+.+ +|.+++...  ..+++..+..++.||+.||.|||++..+|+||||||+|||+..+..+.+||+|||+++
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            9999999965 999999865  4599999999999999999999963234999999999999965567889999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....       .....||+.|+|||++.
T Consensus       210 ~~~~~-------~~~~~~t~~y~aPE~~~  231 (382)
T 2vx3_A          210 QLGQR-------IYQYIQSRFYRSPEVLL  231 (382)
T ss_dssp             ETTCC-------CCSSCSCGGGCCHHHHT
T ss_pred             ecccc-------cccccCCccccChHHHc
Confidence            76432       34567999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=1.4e-28  Score=220.64  Aligned_cols=170  Identities=28%  Similarity=0.475  Sum_probs=133.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE----------
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT----------  225 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~----------  225 (337)
                      +|...+.||+|+||.||+|...  ++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.          
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            7888999999999999999986  789999988643   2345577889999999999999999999873          


Q ss_pred             ----eCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          226 ----ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       226 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                          .....|+||||++ ++|.+++.. +.+++..+..++.||+.||.|||+++  |+||||||+||+++ ..++.+||+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~kl~  163 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFIN-TEDLVLKIG  163 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTTEEEEC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCeEEEc
Confidence                3467899999998 599999854 56999999999999999999999988  99999999999993 145689999


Q ss_pred             eccCceeeecccccceeeeeCCccccccccccccc
Q 019685          302 DFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       302 DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+++........ ........+|+.|+|||++.
T Consensus       164 Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  197 (320)
T 2i6l_A          164 DFGLARIMDPHYSH-KGHLSEGLVTKWYRSPRLLL  197 (320)
T ss_dssp             CCTTCBCC---------CCCGGGSCCTTCCHHHHH
T ss_pred             cCccccccCCCccc-ccccccccccccccCcHHhc
Confidence            99999876533211 01234456799999999763

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=227.00  Aligned_cols=179  Identities=29%  Similarity=0.492  Sum_probs=141.4

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      .|+++.  .+|+..+.||+|+||.||+|.+.+ .+++|.+....... ...+.+.+|+.+++.++||||+++++++....
T Consensus        27 ~~~i~~--~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           27 EWDIPF--EQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GSSSCC--SCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccCCH--HHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            444443  367888999999999999999875 58999886543221 12245677999999999999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          229 PLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      .++++|||+++++|.+++...+ .+++..+..++.||+.||.|||+++  |+||||||+||++  + ++.+||+|||+++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~--~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFY--D-NGKVVITDFGLFS  177 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEE--C---CCEECCCSCCC
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEE--e-CCCEEEeecCCcc
Confidence            9999999999999999997654 6999999999999999999999988  9999999999999  5 5789999999987


Q ss_pred             eeeccccc-ceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSH-DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........ .........||+.|+|||++.
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  207 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIR  207 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHS
T ss_pred             ccccccccccccccccCCCcccccChHHhh
Confidence            65422111 111234556999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=5.3e-29  Score=232.98  Aligned_cols=172  Identities=26%  Similarity=0.466  Sum_probs=134.6

Q ss_pred             CCcCccccceecccCcee-EEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEE
Q 019685          155 SELDFSSSAIIGKGSFGE-ILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       155 ~~~~~~~~~~lg~G~~g~-V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      ...+|...+.||+|+||. ++++...++.||||++.+....      .+.+|+.+++.+ +||||+++++++.+....|+
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            344688889999999998 5556667999999999654332      245699999999 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec---CCCCcEEEEeccCcee
Q 019685          233 ITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKL  308 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~---~~~~~~kl~DFgla~~  308 (337)
                      ||||+. ++|.+++.... ..++..+..++.||+.||.|||+++  |+||||||+|||+..   +....+||+|||+++.
T Consensus        96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            999996 49999997643 4566677899999999999999988  999999999999932   2334688999999988


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...... .........||+.|+|||++.
T Consensus       173 ~~~~~~-~~~~~~~~~gt~~y~APE~l~  199 (432)
T 3p23_A          173 LAVGRH-SFSRRSGVPGTEGWIAPEMLS  199 (432)
T ss_dssp             C-------------CCSCTTSCCGGGTS
T ss_pred             ccCCCc-ceeeccccCCCcCccChhhhh
Confidence            764321 111345577999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.95  E-value=1e-28  Score=222.47  Aligned_cols=170  Identities=29%  Similarity=0.528  Sum_probs=138.1

Q ss_pred             CcCccccceecccCceeEEEEEEC---CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC---CCCCeeeeeeeEE----
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL---RHPNIVQFLGAVT----  225 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l---~h~~Iv~~~~~~~----  225 (337)
                      ..+|+..+.||+|+||.||+|...   ++.||+|.+........ ....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            347999999999999999999973   67899998864332111 112344566666555   8999999999987    


Q ss_pred             -eCCceEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          226 -ERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       226 -~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                       .....++||||+. ++|.+++....  .+++..+..++.||+.||.|||+.|  |+||||||+||++  +.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili--~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEE--cCCCCEEEec
Confidence             4567899999998 59999998643  4999999999999999999999988  9999999999999  8888999999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+++......     ......||+.|+|||++.
T Consensus       164 fg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  192 (326)
T 1blx_A          164 FGLARIYSFQM-----ALTSVVVTLWYRAPEVLL  192 (326)
T ss_dssp             CCSCCCCCGGG-----GGCCCCCCCTTCCHHHHT
T ss_pred             CcccccccCCC-----CccccccccceeCHHHHh
Confidence            99998765432     234567999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.95  E-value=4.5e-28  Score=215.16  Aligned_cols=171  Identities=24%  Similarity=0.333  Sum_probs=139.5

Q ss_pred             CccccceecccCceeEEEEEE--CCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeE-EeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYW--RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-~~~~~~~lv~  234 (337)
                      +|...+.||+|+||.||+|..  .++.||+|++......     ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            788999999999999999996  4889999998654432     3577899999999987766655544 6667889999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEe-cCCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~-~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||+ +++|.+++.. ...+++.++..++.||+.||.|||+++  |+||||||+|||+. .+..+.+||+|||+++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            999 8899999974 457999999999999999999999988  99999999999992 125678999999999887654


Q ss_pred             cccc---eeeeeCCccccccccccccc
Q 019685          313 NSHD---VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~---~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....   ........||+.|+|||++.
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~  188 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHL  188 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHT
T ss_pred             ccccccccccccccccccccCChhhhc
Confidence            3211   11234567999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=5.8e-29  Score=233.05  Aligned_cols=170  Identities=28%  Similarity=0.428  Sum_probs=127.2

Q ss_pred             CccccceecccCceeEEEE-EECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKA-YWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~-~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|...+.||+|+||.||.+ ...|+.||||.+....      .+.+.+|+.++..+ +||||+++++++.....+|+|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            3555688999999999654 4568999999985431      24567899999876 79999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-----------CCCc
Q 019685          236 YLRGGDLHKYLKEKGAL-------SPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-----------SADH  297 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-----------~~~~  297 (337)
                      |+. ++|.+++......       ++..++.++.||+.||.|||+++  |+||||||+|||+..+           ..+.
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence            996 5999999765432       23345789999999999999988  9999999999999432           3458


Q ss_pred             EEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       298 ~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +||+|||+++.................||+.|+|||++.
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  205 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLE  205 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHS
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhc
Confidence            999999999987654322111234567999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.95  E-value=5.6e-28  Score=228.55  Aligned_cols=171  Identities=26%  Similarity=0.326  Sum_probs=141.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|.+.+.||+|+||.||+|.+.  ++.||||++......     ..+..|+.+++.++| ++|..+..++......++||
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            6888999999999999999975  889999987654332     346789999999986 56666666777788899999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||+ +++|.+++.. ...+++.+++.++.||+.||.|||+++  |+||||||+|||+.. +..+.+||+|||+++.+...
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            999 8899999985 557999999999999999999999988  999999999999931 25678999999999887654


Q ss_pred             cccc---eeeeeCCccccccccccccc
Q 019685          313 NSHD---VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~---~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....   ........||+.|+|||++.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~  186 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHL  186 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             ccccccccccccccCCCccccCHHHhc
Confidence            3211   11234678999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.95  E-value=5.2e-28  Score=214.65  Aligned_cols=171  Identities=24%  Similarity=0.330  Sum_probs=137.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeE-EeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV-TERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-~~~~~~~lv~  234 (337)
                      +|+..+.||+|+||.||+|...  ++.||+|.+......     ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            6888999999999999999964  789999986543322     3467799999999987766665554 6677889999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEe-cCCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV-NSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~-~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||+ +++|.+++.. ...+++.++..++.||+.||.|||+++  |+||||||+|||+. .+..+.+||+|||+++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            999 8899999985 457999999999999999999999988  99999999999992 235578999999999887654


Q ss_pred             cccc---eeeeeCCccccccccccccc
Q 019685          313 NSHD---VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~---~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....   ........||+.|+|||++.
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~  188 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHL  188 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHT
T ss_pred             ccCccCCCCcccccCCCccccchHHhc
Confidence            3211   11234567999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=7e-28  Score=216.11  Aligned_cols=169  Identities=24%  Similarity=0.390  Sum_probs=126.5

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      -.+|+..+.||+|+||.||+|.+.  ++.||+|.+...... ....+.+.++..+++.++||||+++++++...+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            347888899999999999999985  889999999765432 22334455555678888999999999999999999999


Q ss_pred             EeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          234 TEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |||+ ++.+..+... ...+++..+..++.||+.||.|||+. +  |+||||||+||++  +.++.+||+|||+++....
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILL--DERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEE--CTTSCEEECCCTTC-----
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEE--CCCCCEEEEECCCchhccC
Confidence            9999 5566666554 46799999999999999999999995 7  9999999999999  8888999999999977654


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      ..     ......||+.|+|||++
T Consensus       178 ~~-----~~~~~~~~~~y~aPE~~  196 (318)
T 2dyl_A          178 DK-----AKDRSAGCAAYMAPERI  196 (318)
T ss_dssp             --------------CCTTCCHHHH
T ss_pred             Cc-----cccccCCCccccChhhc
Confidence            32     23445799999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=1.1e-27  Score=217.96  Aligned_cols=166  Identities=23%  Similarity=0.393  Sum_probs=138.4

Q ss_pred             cCccccceecccCceeEEEEEEC--C-ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCC------eeeeeeeEEeC
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--G-TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN------IVQFLGAVTER  227 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g-~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~------Iv~~~~~~~~~  227 (337)
                      .+|++.+.||+|+||.||+|...  + +.||+|++...    ....+.+.+|+.+++.++|++      ++.+++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            37899999999999999999975  3 68999998643    234467788999998887655      89999999999


Q ss_pred             CceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-------------
Q 019685          228 KPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-------------  292 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-------------  292 (337)
                      +..++||||+ ++++.+++...  ..+++.++..++.||+.||.|||+++  |+||||||+|||+..             
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccc
Confidence            9999999999 56777777654  36999999999999999999999988  999999999999932             


Q ss_pred             ----CCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          293 ----SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       293 ----~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          +..+.+||+|||+++.....       .....||+.|+|||++.
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~  212 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVIL  212 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHT
T ss_pred             cccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeee
Confidence                24678999999999764332       34567999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=6.1e-28  Score=221.36  Aligned_cols=166  Identities=22%  Similarity=0.343  Sum_probs=139.2

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-----------CCCeeeeeee
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----------HPNIVQFLGA  223 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~Iv~~~~~  223 (337)
                      .+|...+.||+|+||.||+|...  ++.||+|++...    ....+.+.+|+.+++.++           ||||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            47899999999999999999974  789999998643    233466788999888876           8899999999


Q ss_pred             EEeCC----ceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEec----
Q 019685          224 VTERK----PLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVN----  292 (337)
Q Consensus       224 ~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~----  292 (337)
                      +...+    .++++||++ +++|.+++...  ..+++..+..++.||+.||.|||++ +  |+||||||+|||+..    
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETT
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCC
Confidence            87654    789999999 88999999863  4599999999999999999999997 7  999999999999943    


Q ss_pred             CCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          293 SSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       293 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +..+.+||+|||+++.....       .....||+.|+|||++.
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~  208 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLL  208 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHH
T ss_pred             cCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHh
Confidence            23347999999999876432       34457999999999863

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=2.8e-28  Score=236.44  Aligned_cols=170  Identities=31%  Similarity=0.455  Sum_probs=142.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe------CCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~~  229 (337)
                      +|.+.+.||+|+||.||+|...  |+.||+|.+....  .....+.+.+|+.+++.++||||+++++++..      .+.
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            6888999999999999999874  7899999886543  23445778999999999999999999998755      667


Q ss_pred             eEEEEeecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccC
Q 019685          230 LMLITEYLRGGDLHKYLKEKG---ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGL  305 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgl  305 (337)
                      .|+||||+++++|.+++....   .+++..++.++.||+.||.|||+.|  |+||||||+||++..+. ...+||+|||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            899999999999999998643   5899999999999999999999988  99999999999994322 22499999999


Q ss_pred             ceeeecccccceeeeeCCccccccccccccc
Q 019685          306 SKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       306 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ++......     ......||+.|+|||++.
T Consensus       171 a~~~~~~~-----~~~~~~gt~~Y~APE~l~  196 (676)
T 3qa8_A          171 AKELDQGE-----LCTEFVGTLQYLAPELLE  196 (676)
T ss_dssp             CCBTTSCC-----CCCCCCSCCTTCSSCSSC
T ss_pred             cccccccc-----ccccccCCcccCChHHhc
Confidence            98765432     234567999999999864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=6.6e-27  Score=207.11  Aligned_cols=145  Identities=17%  Similarity=0.159  Sum_probs=130.5

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      .+|++.+.||+|+||.||+|.+.  ++.||+|++...........+.+.+|+.++..++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            47999999999999999999986  7899999998776665666788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      ||+++++|.+++..  ...+.++..++.||+.||.|||++|  |+||||||+|||+  +.++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll--~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRV--SIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE--ETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEE--cCCCCEEEEeccccC
Confidence            99999999999954  2467788999999999999999988  9999999999999  778899999877653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=1.5e-25  Score=199.49  Aligned_cols=144  Identities=30%  Similarity=0.532  Sum_probs=123.6

Q ss_pred             Ccccc-ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHH-HhCCCCCeeeeeeeEEe----CCc
Q 019685          158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRHPNIVQFLGAVTE----RKP  229 (337)
Q Consensus       158 ~~~~~-~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l-~~l~h~~Iv~~~~~~~~----~~~  229 (337)
                      +|... +.||+|+||.||++...  ++.||+|.+...        ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            56665 77999999999999984  789999998532        3456788877 66689999999999877    677


Q ss_pred             eEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCC-CCcEEEEeccCc
Q 019685          230 LMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS-ADHLKVGDFGLS  306 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~-~~~~kl~DFgla  306 (337)
                      +++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+  |+||||||+|||+..+. .+.+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999998754  5999999999999999999999988  99999999999993211 678999999999


Q ss_pred             eeeec
Q 019685          307 KLIKV  311 (337)
Q Consensus       307 ~~~~~  311 (337)
                      +....
T Consensus       168 ~~~~~  172 (299)
T 3m2w_A          168 KETTG  172 (299)
T ss_dssp             EECTT
T ss_pred             ccccc
Confidence            87653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.93  E-value=2.2e-26  Score=214.15  Aligned_cols=166  Identities=14%  Similarity=0.181  Sum_probs=124.4

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC-CCee---------------
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIV---------------  218 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv---------------  218 (337)
                      ..|...+.||+|+||.||+|.+.  |+.||||++...........+.+.+|+.++..++| ++..               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            35777889999999999999986  89999999875444333345778899999999987 2211               


Q ss_pred             e------eeeeEEe-----CCceEEEEeecCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEe
Q 019685          219 Q------FLGAVTE-----RKPLMLITEYLRGGDLHKYLKE-------KGALSPSTAVNFALDIARGMAYLHNEPNVIIH  280 (337)
Q Consensus       219 ~------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH  280 (337)
                      .      +..++..     ....+++|+++ +++|.+++..       ...+++..++.++.||+.||.|||+++  |+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiH  234 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVH  234 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence            1      1111111     22457777765 6799999852       223677888999999999999999988  999


Q ss_pred             eCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCcccccccccccc
Q 019685          281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       281 rdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      |||||+|||+  +.++.+||+|||+++.....       .....| +.|||||++
T Consensus       235 rDiKp~NILl--~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          235 TYLRPVDIVL--DQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             SCCCGGGEEE--CTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHH
T ss_pred             CCcccceEEE--ecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhh
Confidence            9999999999  88889999999999765432       345667 999999987

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=7.7e-25  Score=193.23  Aligned_cols=136  Identities=19%  Similarity=0.206  Sum_probs=108.2

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchH---------------HHHHHHHHHHHHHHhCCCCCeeeee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDR---------------LVIQDFRHEVNLLVKLRHPNIVQFL  221 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~Iv~~~  221 (337)
                      .|...+.||+|+||.||+|.+. |+.||+|.+........               .....+.+|+.+++.++  | ++++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            4556689999999999999985 78999999864322110               23567889999999999  4 6666


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEE
Q 019685          222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVG  301 (337)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~  301 (337)
                      +++.. +..|+||||+++++|.+ +.      ......++.||+.||.|||+.|  |+||||||+|||+  + ++.+||+
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl--~-~~~vkl~  234 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV--S-EEGIWII  234 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--E-TTEEEEC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEE--E-CCcEEEE
Confidence            65543 56799999999999987 42      1334579999999999999988  9999999999999  5 7899999


Q ss_pred             eccCceee
Q 019685          302 DFGLSKLI  309 (337)
Q Consensus       302 DFgla~~~  309 (337)
                      |||+|+..
T Consensus       235 DFG~a~~~  242 (282)
T 1zar_A          235 DFPQSVEV  242 (282)
T ss_dssp             CCTTCEET
T ss_pred             ECCCCeEC
Confidence            99999643

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.89  E-value=2.3e-23  Score=169.65  Aligned_cols=107  Identities=36%  Similarity=0.394  Sum_probs=52.8

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      ++++|.+|..|+||+++  |+..+..+++++|++.|++++.+|.+|+||||+||..|+.+++++|+++|+|+|.+|..|+
T Consensus        27 Gadvn~~d~~g~t~l~~--a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~  104 (169)
T 4gpm_A           27 GADVNASDSDGRTPLHH--AAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGR  104 (169)
T ss_dssp             TCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             CCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCC
Confidence            44445555555554433  4444444444444455555555555555555555555555555555555555555555555


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      ||||+|+..++.+++++|+.+|++++..+
T Consensus       105 TpLh~A~~~g~~~~v~~Ll~~gad~~~~d  133 (169)
T 4gpm_A          105 TPLHHAAENGHKEVVKLLISKGADVNTSD  133 (169)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCCccccC
Confidence            55555555555555555555444444333

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.88  E-value=5.6e-23  Score=167.40  Aligned_cols=105  Identities=38%  Similarity=0.430  Sum_probs=97.0

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|++||.+|.+|+||||+||..|+.+++++|+++||+++.+|..
T Consensus        58 ~~gad~~~~d~~g~TpLh~--A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~  135 (169)
T 4gpm_A           58 SKGADVNAKDSDGRTPLHH--AAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSD  135 (169)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             hcccchhhhccCCCCHHHH--HHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence            4577899999999999966  89999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                      |+|||++|+..++.+++++|+++||+.
T Consensus       136 G~TpL~~A~~~g~~~iv~~Ll~~GA~i  162 (169)
T 4gpm_A          136 GRTPLDLAREHGNEEVVKLLEKQGGWL  162 (169)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHTC----
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCc
Confidence            999999999999999999999999865

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.86  E-value=4.2e-22  Score=145.53  Aligned_cols=93  Identities=42%  Similarity=0.541  Sum_probs=86.6

Q ss_pred             cCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhh
Q 019685           32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA  111 (337)
Q Consensus        32 ~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~  111 (337)
                      +|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..
T Consensus         1 ~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~   78 (93)
T 1n0q_A            1 NGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN   78 (93)
T ss_dssp             --CCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCcHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc
Confidence            47899866  8888888999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhHHHHHHhhcCC
Q 019685          112 KKFNMMELLNAHGGL  126 (337)
Q Consensus       112 ~~~~~v~~L~~~~a~  126 (337)
                      ++.+++++|+.+|++
T Consensus        79 ~~~~~~~~Ll~~ga~   93 (93)
T 1n0q_A           79 GHLEVVKLLLEAGAY   93 (93)
T ss_dssp             TCHHHHHHHHHTTCC
T ss_pred             CCHHHHHHHHHcCCC
Confidence            999999999998863

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1.2e-21  Score=170.69  Aligned_cols=140  Identities=18%  Similarity=0.209  Sum_probs=106.7

Q ss_pred             ccccceecccCceeEEEEEE--CCce--EEEEEecCCCCc---------------------hHHHHHHHHHHHHHHHhCC
Q 019685          159 FSSSAIIGKGSFGEILKAYW--RGTP--VAIKRILPSLSD---------------------DRLVIQDFRHEVNLLVKLR  213 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~--~g~~--vavK~l~~~~~~---------------------~~~~~~~~~~E~~~l~~l~  213 (337)
                      |...+.||+|+||.||+|.+  .|+.  ||||++......                     .......+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            55678999999999999998  6888  999987543211                     1122246788999999998


Q ss_pred             CCCe--eeeeeeEEeCCceEEEEeecCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-cCCCCcEeeCCCC
Q 019685          214 HPNI--VQFLGAVTERKPLMLITEYLRG-G----DLHKYLKEKGALSPSTAVNFALDIARGMAYLH-NEPNVIIHRDLKP  285 (337)
Q Consensus       214 h~~I--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~ivHrdlkp  285 (337)
                      |+++  +.+++.    ...++||||+.+ |    +|.++...   .++..+..++.|++.||.||| +.|  |+||||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp  199 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSE  199 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCST
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCH
Confidence            7754  334432    357899999942 3    67666432   235577899999999999999 877  99999999


Q ss_pred             CCEEEecCCCCcEEEEeccCceeeec
Q 019685          286 RNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       286 ~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +|||+  +.  .++|+|||+|.....
T Consensus       200 ~NILl--~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          200 YNIMY--ID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             TSEEE--SS--SEEECCCTTCEETTS
T ss_pred             HHEEE--cC--cEEEEECcccccCCC
Confidence            99999  55  899999999987643

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.83  E-value=1.2e-20  Score=147.94  Aligned_cols=111  Identities=24%  Similarity=0.252  Sum_probs=98.6

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT  103 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t  103 (337)
                      +|. .+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus         2 ~d~-~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t   78 (137)
T 3c5r_A            2 IDP-FTNHRGETLLHI--ASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDS   78 (137)
T ss_dssp             --C-CCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCC
T ss_pred             CCC-CcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCC
Confidence            344 578889999966  88888888899999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       104 ~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      |||+|+..++.+++++|+.++++.+..+....+|
T Consensus        79 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  112 (137)
T 3c5r_A           79 PLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRP  112 (137)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence            9999999999999999999998877665554443

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.83  E-value=2.6e-21  Score=155.33  Aligned_cols=115  Identities=22%  Similarity=0.304  Sum_probs=94.8

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCc-HHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRT-PLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~t-pLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ..+++++.+|..|+|||++  |+ .+..+++++|++.|+++|.+|..|+| |||+|+..|+.+++++|+++|+++|.+|.
T Consensus        33 ~~g~~~~~~~~~g~t~L~~--A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~  109 (156)
T 1bi7_B           33 EAGANPNAPNSYGRRPIQV--MM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDA  109 (156)
T ss_dssp             TTTCCTTCCCSSSCCTTTS--SC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCT
T ss_pred             HcCCCCCCCCCCCCCHHHH--HH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCCHHHHHHHHHcCCCCcccCC
Confidence            4467888999999999966  65 78889999999999999999999999 99999999999999999999999999999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK  138 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~  138 (337)
                      .|+||||+|+..++.+++++|+.+|++....+....++.
T Consensus       110 ~g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~~  148 (156)
T 1bi7_B          110 WGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDAA  148 (156)
T ss_dssp             TCCCHHHHHHHHTCHHHHHHHSSCC--------------
T ss_pred             CCCCHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCccc
Confidence            999999999999999999999999998876665544443

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.83  E-value=2.7e-21  Score=146.88  Aligned_cols=107  Identities=31%  Similarity=0.330  Sum_probs=96.9

Q ss_pred             hhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhh
Q 019685           28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD  107 (337)
Q Consensus        28 ~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~  107 (337)
                      .+|.+|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus         4 ~~d~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~   81 (115)
T 2l6b_A            4 WGSKDGNTPLHN--AAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHL   81 (115)
T ss_dssp             CCSCSSCCHHHH--HHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHH
T ss_pred             ccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHH
Confidence            367889999966  888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685          108 AEGAKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       108 A~~~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      |+..++.+++++|+++|++.+..+....+
T Consensus        82 A~~~~~~~~~~~Ll~~ga~~n~~~~~~~~  110 (115)
T 2l6b_A           82 AKKNGHHEIVKLLDAKGADVNARSWGSSH  110 (115)
T ss_dssp             HHTTTCHHHHHHHHTTSSSHHHHSCCCC-
T ss_pred             HHHCCCHHHHHHHHHcCCCCCcCCccccc
Confidence            99999999999999999987766544433

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.83  E-value=5e-21  Score=149.99  Aligned_cols=106  Identities=21%  Similarity=0.172  Sum_probs=62.7

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc-cc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW-KN  102 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~-g~  102 (337)
                      ++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+. |+.+++++|+++|+++|.+|.. |.
T Consensus         3 ~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~   79 (136)
T 1d9s_A            3 PGIHMLGGSSDAGLAT--AAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLT   79 (136)
T ss_dssp             CCCSCCCCCCSCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTB
T ss_pred             CCccCCCCCCccHHHH--HHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCC
Confidence            3455555566665544  555555555555556666666666666666666666 6666666666666666666666 56


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      ||||+|+..++.+++++|+.++++.+..+.
T Consensus        80 t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~  109 (136)
T 1d9s_A           80 RPVHDAAREGFLDTLVVLHRAGARLDVCDA  109 (136)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHTCCCCCCCSS
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCCCCccCC
Confidence            666666666666666666666655544433

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.82  E-value=5.5e-21  Score=149.73  Aligned_cols=103  Identities=22%  Similarity=0.291  Sum_probs=97.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCC-CCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-NRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~-g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ..+++++.+|..|+|||++  |+. +..+++++|++.|+++|.+|.. |+||||+|+..|+.+++++|+++|++++.+|.
T Consensus        33 ~~g~~~~~~~~~g~t~L~~--A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~  109 (136)
T 1d9s_A           33 EAGADPNALNRFGRRPIQV--MMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDA  109 (136)
T ss_dssp             HTTCCTTCCCTTCCTTTTT--STT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCCSS
T ss_pred             HcCCCcCCcCCCCCCHHHH--HHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCC
Confidence            4567889999999999976  888 9999999999999999999999 99999999999999999999999999999999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      .|.||||+|+..++.+++++|+++|++
T Consensus       110 ~g~tpl~~A~~~~~~~~~~~Ll~~Gad  136 (136)
T 1d9s_A          110 WGRLPVDLAEEQGHRDIARYLHAATGD  136 (136)
T ss_dssp             SSSCHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence            999999999999999999999998874

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.82  E-value=1.8e-20  Score=146.75  Aligned_cols=97  Identities=30%  Similarity=0.410  Sum_probs=48.9

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT  103 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t  103 (337)
                      ++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        38 ~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  115 (136)
T 2jab_A           38 ADVNAKDEYGLTPLYL--ATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKT  115 (136)
T ss_dssp             CCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             CCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcCCCCCC
Confidence            3444444455555433  44444444455555555555555555555555555555555555555555555555555555


Q ss_pred             chhhhhhhhhhhHHHHHHh
Q 019685          104 PLADAEGAKKFNMMELLNA  122 (337)
Q Consensus       104 ~l~~A~~~~~~~~v~~L~~  122 (337)
                      |||+|+..++.+++++|++
T Consensus       116 pl~~A~~~~~~~~~~~Ll~  134 (136)
T 2jab_A          116 AFDISIGNGNEDLAEILQK  134 (136)
T ss_dssp             HHHHHHHTTCHHHHHHHHH
T ss_pred             HHHHHHHCCCHHHHHHHHH
Confidence            5555555555555555444

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.81  E-value=5.6e-20  Score=150.84  Aligned_cols=112  Identities=26%  Similarity=0.251  Sum_probs=98.3

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      +.+++.+|..|+|||++  |+..+..+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|+++|.+|..|.
T Consensus        29 ~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~  106 (179)
T 3f6q_A           29 ENDLNQGDDHGFSPLHW--ACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGN  106 (179)
T ss_dssp             TSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             cccccccCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence            45677888899999866  8888888999999999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      ||||+|+..++.+++++|+.++++.+..+....+
T Consensus       107 t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t  140 (179)
T 3f6q_A          107 VPLHYACFWGQDQVAEDLVANGALVSICNKYGEM  140 (179)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCC
T ss_pred             CHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCC
Confidence            9999999999999999999999887665544443

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.81  E-value=5.8e-20  Score=141.23  Aligned_cols=102  Identities=24%  Similarity=0.240  Sum_probs=90.4

Q ss_pred             ccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhh
Q 019685           31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG  110 (337)
Q Consensus        31 ~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~  110 (337)
                      ..+.||+++  |+..+..+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+.
T Consensus         5 ~~~~~~l~~--A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~   82 (123)
T 3aaa_C            5 SMCDKEFMW--ALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVY   82 (123)
T ss_dssp             --CHHHHHH--HHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred             cccchHHHH--HHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence            345677755  888888888888999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhHHHHHHhhcCCCCCCCCCC
Q 019685          111 AKKFNMMELLNAHGGLSYGQNGSH  134 (337)
Q Consensus       111 ~~~~~~v~~L~~~~a~~~~~~~~~  134 (337)
                      .++.+++++|+.++++.+..+...
T Consensus        83 ~~~~~~v~~Ll~~ga~~~~~~~~g  106 (123)
T 3aaa_C           83 EGHVSCVKLLLSKGADKTVKGPDG  106 (123)
T ss_dssp             HTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             cCCHHHHHHHHHcCCCCCCcCCCC
Confidence            999999999999998776554433

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.81  E-value=6.3e-20  Score=151.71  Aligned_cols=109  Identities=14%  Similarity=0.120  Sum_probs=92.6

Q ss_pred             hhhhh-ccCCchhHHHHHhhCCH----HHHHHHHHhCCCCccccCCCCCcHHHHHHHcCC------HHHHHHHHHcCCCc
Q 019685           26 QKEKA-RVSRTSLILWHAHQNDA----AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW------IDVAKCLIEYGADV   94 (337)
Q Consensus        26 ~~~~~-~~~~~~~~~~~a~~~~~----~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~------~~~~~~Ll~~ga~~   94 (337)
                      .+.++ ..|+|||++  |+.++.    .+++++|++.|++||.+|.+|+||||+|+..|+      .+++++|+++|||+
T Consensus        30 ~~~~~~~~g~T~Lh~--A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadi  107 (186)
T 3t8k_A           30 YEDKESVLKSNILYD--VLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADI  107 (186)
T ss_dssp             SSCHHHHHTTTHHHH--HTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCS
T ss_pred             cccccccCCCCHHHH--HHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCC
Confidence            44555 779999965  766653    359999999999999999999999999999997      68899999999999


Q ss_pred             cccccccc-cchhhhhh-----hhhhhHHHHHHh-hcCCCCCCCCCCCC
Q 019685           95 NAQDRWKN-TPLADAEG-----AKKFNMMELLNA-HGGLSYGQNGSHFE  136 (337)
Q Consensus        95 ~~~d~~g~-t~l~~A~~-----~~~~~~v~~L~~-~~a~~~~~~~~~~~  136 (337)
                      |.+|..|. ||||+|+.     .++.+++++|+. +|++.+..+....+
T Consensus       108 n~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~T  156 (186)
T 3t8k_A          108 TALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLT  156 (186)
T ss_dssp             SSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCC
T ss_pred             CccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCC
Confidence            99999999 99999998     455679999999 99988766654443

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.81  E-value=9.8e-20  Score=147.21  Aligned_cols=113  Identities=31%  Similarity=0.398  Sum_probs=101.7

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      +.+.+..+..|+|||++  |+..+..+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|+++|.+|.+|.
T Consensus        32 ~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  109 (165)
T 3twr_A           32 SVNCRDIEGRQSTPLHF--AAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKF  109 (165)
T ss_dssp             TTTCCCTTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred             CCCccccccCCCCHHHH--HHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCC
Confidence            35566677788999966  8899999999999999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      ||||+|+..++.+++++|+.++++.+..+....+|
T Consensus       110 t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~  144 (165)
T 3twr_A          110 TPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTP  144 (165)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCh
Confidence            99999999999999999999998877665544443

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.80  E-value=1.1e-19  Score=147.71  Aligned_cols=109  Identities=28%  Similarity=0.353  Sum_probs=100.2

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|.|||++  |+..+..+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        35 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~  112 (169)
T 2y1l_E           35 ANGADVNAEDASGWTPLHL--AAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDME  112 (169)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HCCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCC
Confidence            3466788889999999966  88888999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      |.||||+|+..++.+++++|++++++.+..+
T Consensus       113 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  143 (169)
T 2y1l_E          113 GHTPLHLAAMFGHLEIVEVLLKNGADVNAQD  143 (169)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence            9999999999999999999999998765444

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.80  E-value=6.9e-20  Score=160.48  Aligned_cols=118  Identities=23%  Similarity=0.214  Sum_probs=86.2

Q ss_pred             CCCchhhhhhhhccCCchhHHHHHhhCCHHHHHH---------------------------------HHHhCCCCccccC
Q 019685           19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRK---------------------------------LLEEDQSLVHARD   65 (337)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~---------------------------------lL~~~~~~vn~~~   65 (337)
                      ....++++|.+|.+|+|||++  |+..+..++++                                 +|++.|+++|.+|
T Consensus        72 Ll~~Gadvn~~d~~G~TpLh~--A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d  149 (269)
T 4b93_B           72 VPASGLGVNVTSQDGSSPLHV--AALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKD  149 (269)
T ss_dssp             ---CCCCTTCCCTTSCCHHHH--HHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCC
T ss_pred             HHHCCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCC
Confidence            345678888888888888855  66655554444                                 4455566677777


Q ss_pred             CCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCC
Q 019685           66 YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPK  138 (337)
Q Consensus        66 ~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~  138 (337)
                      ..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..++.+++++|+.+|++++..+....+|.
T Consensus       150 ~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL  222 (269)
T 4b93_B          150 LSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAV  222 (269)
T ss_dssp             TTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCSG
T ss_pred             CCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence            7888888888888888888888888888888888888888888888888888888888887766655544443

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.79  E-value=2e-19  Score=146.39  Aligned_cols=106  Identities=24%  Similarity=0.205  Sum_probs=95.3

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT  103 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t  103 (337)
                      ..++.+|..|+|||++  |+..+..+++++|++.|+++|..|..|.||||+|+..|+.+++++|+++|+++|.+|..|.|
T Consensus        27 ~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  104 (172)
T 3v30_A           27 NLVNKPDERGFTPLIW--ASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGT  104 (172)
T ss_dssp             GGGGCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCC
T ss_pred             ccccCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCC
Confidence            3477888899999866  88888899999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          104 PLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       104 ~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      |||+|+..++.+++++|+.++++.+..+
T Consensus       105 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~~  132 (172)
T 3v30_A          105 PLLYAVRGNHVKCVEALLARGADLTTEA  132 (172)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCccccC
Confidence            9999999999999999999988765443

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.79  E-value=1.8e-19  Score=145.96  Aligned_cols=108  Identities=21%  Similarity=0.246  Sum_probs=99.0

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+++++.+|..|+|||++  |+..+..+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|+++|.+|..|
T Consensus        25 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g  102 (167)
T 3v31_A           25 QENVINHTDEEGFTPLMW--AAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNG  102 (167)
T ss_dssp             HSSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTS
T ss_pred             cCCCcCCCCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCC
Confidence            356688889999999966  888888999999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .||||.|+..++.+++++|+.++++.+..+
T Consensus       103 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  132 (167)
T 3v31_A          103 GTPLLYAVHGNHVKCVKMLLESGADPTIET  132 (167)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence            999999999999999999999988765444

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.79  E-value=1.6e-19  Score=149.81  Aligned_cols=108  Identities=26%  Similarity=0.342  Sum_probs=89.7

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+++++.+|..|+|||++  |+..+..+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|+++|.+|..|
T Consensus        57 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g  134 (192)
T 2rfm_A           57 NFDKLEDKDIEGSTALIW--AVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEG  134 (192)
T ss_dssp             HHCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTC
T ss_pred             hccccccccccCccHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence            456677778888888865  788888888888888888888888888888888888888888888888888888888888


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .||||+|+..++.+++++|+.++++.+..+
T Consensus       135 ~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~  164 (192)
T 2rfm_A          135 ETPLIVASKYGRSEIVKKLLELGADISARD  164 (192)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCTTCBC
T ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCCCCcC
Confidence            888888888888888888888887655443

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.79  E-value=1.1e-19  Score=148.00  Aligned_cols=109  Identities=19%  Similarity=0.200  Sum_probs=100.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus        57 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  134 (172)
T 3v30_A           57 EWGADPHILAKERESALSL--ASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADS  134 (172)
T ss_dssp             HHTCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HcCCCchhhcccCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence            3567888899999999966  89999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      |.||||+|+..++.+++++|+.+++.....+
T Consensus       135 g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~  165 (172)
T 3v30_A          135 GYTPMDLAVALGYRKVQQVIENHILKLFQSN  165 (172)
T ss_dssp             SCCHHHHHHHHTCHHHHHHHHHHHHHHSCC-
T ss_pred             CCCHHHHHHHhCcHHHHHHHHHHHHHHhccc
Confidence            9999999999999999999999987655443

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.79  E-value=3.7e-19  Score=145.91  Aligned_cols=107  Identities=21%  Similarity=0.202  Sum_probs=100.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        60 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  137 (179)
T 3f6q_A           60 MRGARINVMNRGDDTPLHL--AASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKY  137 (179)
T ss_dssp             HTTCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTT
T ss_pred             HcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccC
Confidence            3467888899999999966  88889999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYG  129 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~  129 (337)
                      |.|||+.|+..++.+++++|.+++++...
T Consensus       138 g~tpl~~A~~~~~~~~~~~L~~~g~~~~~  166 (179)
T 3f6q_A          138 GEMPVDKAKAPLRELLRERAEKMGQNLNR  166 (179)
T ss_dssp             SCCGGGGSCHHHHHHHHHHHHHTTCCCSC
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHhhcCccc
Confidence            99999999999999999999999987653

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.79  E-value=2.6e-19  Score=142.95  Aligned_cols=102  Identities=30%  Similarity=0.319  Sum_probs=93.8

Q ss_pred             hhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhh
Q 019685           29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA  108 (337)
Q Consensus        29 ~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A  108 (337)
                      .|..|+|||++  |+..+..+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+|
T Consensus        30 ~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A  107 (153)
T 1awc_B           30 TDWLGTSPLHL--AAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWA  107 (153)
T ss_dssp             CCTTCCCHHHH--HHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHH
T ss_pred             cCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence            46779999966  8888889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhHHHHHHhhcCCCCCCCC
Q 019685          109 EGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus       109 ~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      +..++.+++++|+.++++.+..+.
T Consensus       108 ~~~~~~~~v~~Ll~~ga~~~~~~~  131 (153)
T 1awc_B          108 TEHNHQEVVELLIKYGADVHTQSK  131 (153)
T ss_dssp             HHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHcCCHHHHHHHHHcCCCccccCC
Confidence            999999999999999987665443

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.79  E-value=1.6e-19  Score=145.39  Aligned_cols=109  Identities=22%  Similarity=0.262  Sum_probs=89.9

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+.+++.+|..|+|||++  |+. +..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..
T Consensus        26 ~~~~~~~~~~~~g~t~L~~--A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~  102 (162)
T 1ihb_A           26 QNNVNVNAQNGFGRTALQV--MKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNE  102 (162)
T ss_dssp             TSCCCTTCCCTTSCCHHHH--CCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             hCCCCccccCccCccHHHH--HHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence            3456777788888888855  777 7788888888888888888888899999999888999999988888888888888


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCC-CCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLS-YGQNG  132 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~-~~~~~  132 (337)
                      |.||||+|+..++.+++++|+.+++.. ...+.
T Consensus       103 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~  135 (162)
T 1ihb_A          103 GNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNH  135 (162)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCT
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCC
Confidence            899999988888888888888888763 43333

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.79  E-value=4e-19  Score=151.87  Aligned_cols=110  Identities=16%  Similarity=0.065  Sum_probs=97.1

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccc-cc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD-RW  100 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d-~~  100 (337)
                      .+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.++ ..
T Consensus        43 ~g~~~~~~d~~g~tpLh~--A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~  120 (229)
T 2vge_A           43 EMNDPSQPNEEGITALHN--AICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSD  120 (229)
T ss_dssp             HSSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSST
T ss_pred             cCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCC
Confidence            456788889999999966  888888999999999999999999999999999999999999999999999999986 69


Q ss_pred             cccchhhh--hhhhhhhHHHHHHhhcCCCCCCCCC
Q 019685          101 KNTPLADA--EGAKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       101 g~t~l~~A--~~~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      |+||||+|  +..++.+++++|+.+|++.+..+..
T Consensus       121 g~tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~~  155 (229)
T 2vge_A          121 GATAFEKCDPYREGYADCATYLADVEQSMGLMNSG  155 (229)
T ss_dssp             TCCTGGGCCTTSTTHHHHHHHHHHHHHHTTTSGGG
T ss_pred             CCCHHHHHHHHhcChHHHHHHHHHcCCCcccccCC
Confidence            99999999  8899999999999998877655433

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.79  E-value=1.5e-19  Score=158.96  Aligned_cols=100  Identities=20%  Similarity=0.166  Sum_probs=92.2

Q ss_pred             hhhhhccCCchhHHHHHhhC---CHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           26 QKEKARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        26 ~~~~~~~~~~~~~~~~a~~~---~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      ++..|..|+|||++  |+..   +..+++++|++.|+++|.+|.+|+||||+||..|+.+++++|+++|||+|.+|..|.
T Consensus       162 l~~~~~~g~t~Lh~--A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~  239 (278)
T 1dcq_A          162 LANGHEPDETALHL--AVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGE  239 (278)
T ss_dssp             CSSCSSTTCBHHHH--HHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             ccccccCCCCcchH--HHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCC
Confidence            34447889999966  6665   889999999999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                      ||||+|+..++.+++++|+.+++..
T Consensus       240 tpL~~A~~~~~~~~v~~Ll~~ga~~  264 (278)
T 1dcq_A          240 TPLDIAKRLKHEHCEELLTQALSGR  264 (278)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            9999999999999999999999853

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.78  E-value=2.7e-19  Score=144.04  Aligned_cols=104  Identities=21%  Similarity=0.194  Sum_probs=94.8

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCC-cccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-VNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~-~~~~d~   99 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|++ ++.+|.
T Consensus        58 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~  135 (162)
T 1ihb_A           58 LRGANPDLKDRTGFAVIHD--AARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNH  135 (162)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCT
T ss_pred             HcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCC
Confidence            3467888899999999966  8888889999999999999999999999999999999999999999999998 699999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      .|.||||+|+..++.+++++|+++|++
T Consensus       136 ~g~t~l~~A~~~~~~~~~~~Ll~~GAd  162 (162)
T 1ihb_A          136 KGDTACDLARLYGRNEVVSLMQANGAG  162 (162)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence            999999999999999999999999873

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.78  E-value=3e-19  Score=156.59  Aligned_cols=118  Identities=25%  Similarity=0.238  Sum_probs=101.7

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCC-CCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-NRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~-g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ..+.+++.+|..|+|||++  |+..+..+++++|++.|+++|..+.. |+||||+|+..|+.+++++|+++|+++|.+|.
T Consensus       146 ~~~~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~  223 (282)
T 1oy3_D          146 DWRLQLEAENYDGHTPLHV--AVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMY  223 (282)
T ss_dssp             CGGGGTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             hhhhcCCCcCCCCcCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCccccc
Confidence            3456788999999999966  88888999999999999999999854 99999999999999999999999999999999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPV  140 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~~~  140 (337)
                      .|.||||+|+..++.+++++|+.+|++++..+....+|...
T Consensus       224 ~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~  264 (282)
T 1oy3_D          224 GGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSS  264 (282)
T ss_dssp             TSCCHHHHHHTSSCHHHHHHHHHTTCCCCCCC---------
T ss_pred             CCCCHHHHHHHcCCcHHHHHHHHcCCCcCcCCCcccccccc
Confidence            99999999999999999999999999988777766665443

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.78  E-value=2.8e-19  Score=137.31  Aligned_cols=103  Identities=39%  Similarity=0.511  Sum_probs=89.0

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+.+++.+|..|.|||++  |+..+..+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        24 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g  101 (126)
T 1n0r_A           24 AGADVNAKDKNGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNG  101 (126)
T ss_dssp             HTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             cCCCCCCcCCCCCcHHHH--HHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccCCCC
Confidence            345667778888888865  777788888888889999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      .|||++|+..++.+++++|+++|++
T Consensus       102 ~t~l~~A~~~~~~~~~~~Ll~~Gad  126 (126)
T 1n0r_A          102 RTPLHLAARNGHLEVVKLLLEAGAY  126 (126)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHHTCC
T ss_pred             CCHHHHHHHcCcHHHHHHHHHcCCC
Confidence            9999999999999999999888863

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.78  E-value=2.1e-19  Score=140.65  Aligned_cols=99  Identities=29%  Similarity=0.344  Sum_probs=90.2

Q ss_pred             ccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhh
Q 019685           31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG  110 (337)
Q Consensus        31 ~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~  110 (337)
                      ..+.||+++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+.
T Consensus        12 ~~~~t~l~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~   89 (136)
T 2jab_A           12 SDLGKKLLE--AARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAF   89 (136)
T ss_dssp             CHHHHHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred             ccccHHHHH--HHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence            345677755  888888889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhHHHHHHhhcCCCCCCC
Q 019685          111 AKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       111 ~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .++.+++++|+.++++.+..+
T Consensus        90 ~~~~~~v~~Ll~~g~~~~~~~  110 (136)
T 2jab_A           90 IGHLEIAEVLLKHGADVNAQD  110 (136)
T ss_dssp             HTCHHHHHHHHHTTCCTTCCC
T ss_pred             cCCHHHHHHHHHcCCCCcCcC
Confidence            999999999999998765444

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.78  E-value=1.8e-19  Score=138.46  Aligned_cols=94  Identities=18%  Similarity=0.192  Sum_probs=85.6

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+.+++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        29 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  106 (123)
T 3aaa_C           29 KGEDVNRTLEGGRKPLHY--AADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDG  106 (123)
T ss_dssp             TTCCTTSCCTTSSCHHHH--HHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             cCCCcCccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCC
Confidence            456788889999999966  889999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHH
Q 019685          102 NTPLADAEGAKKFNMM  117 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v  117 (337)
                      .|||++|...+..+++
T Consensus       107 ~t~l~~A~~~~~~~ll  122 (123)
T 3aaa_C          107 LTAFEATDNQAIKALL  122 (123)
T ss_dssp             CCHHHHCCCHHHHHHH
T ss_pred             CCHHHHhCCHHHHHHh
Confidence            9999999766555543

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.78  E-value=3.6e-19  Score=143.86  Aligned_cols=102  Identities=25%  Similarity=0.302  Sum_probs=93.8

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus        63 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  140 (165)
T 3twr_A           63 QHGADVHAKDKGGLVPLHN--ACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRD  140 (165)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             hcCCCCCccCCCCCCHHHH--HHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCC
Confidence            3467888899999999966  88999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGG  125 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a  125 (337)
                      |.|||++|.. ++.+++++|...|+
T Consensus       141 g~t~l~~a~~-~~~~i~~~L~~~gA  164 (165)
T 3twr_A          141 GNTPLDLVKD-GDTDIQDLLRGDAA  164 (165)
T ss_dssp             SCCTGGGSCT-TCHHHHHHHHTC--
T ss_pred             CCChhHhHhc-CChHHHHHHhhccc
Confidence            9999999877 88999999998775

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.78  E-value=3.2e-19  Score=134.42  Aligned_cols=98  Identities=27%  Similarity=0.358  Sum_probs=83.2

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      .........|.+|+|+|++  |+..+..+++++|++.|+++|.+|..|.||||+||..|+.+++++|+++|+++|.+|..
T Consensus        12 ~~~~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~   89 (110)
T 2zgd_A           12 GLVPRGSHMGSDLGKKLLE--AARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKF   89 (110)
T ss_dssp             C---------CCHHHHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             CCCCcccccCCccchHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccC
Confidence            3345566677889999865  77777888888899999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHH
Q 019685          101 KNTPLADAEGAKKFNMMELL  120 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L  120 (337)
                      |+||||+|+..++.+++++|
T Consensus        90 g~tpl~~A~~~~~~~~~~~L  109 (110)
T 2zgd_A           90 GKTAFDISIDNGNEDLAEIL  109 (110)
T ss_dssp             SCCHHHHHHHHTCHHHHHHH
T ss_pred             CCcHHHHHHHcCCHHHHHHh
Confidence            99999999999999999887

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.78  E-value=5e-19  Score=141.59  Aligned_cols=105  Identities=23%  Similarity=0.263  Sum_probs=92.7

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      +.+++.+|..|+|||++   +..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|+
T Consensus        26 ~~~~~~~~~~g~t~L~~---~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  102 (156)
T 1bd8_A           26 LVHPDALNRFGKTALQV---MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGA  102 (156)
T ss_dssp             CCCTTCCCTTSCCHHHH---SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSC
T ss_pred             CcCccccCCCCCcHHHH---HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCC
Confidence            34677788899999854   556778888888899999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      ||||+|+..++.+++++|+.. ++.+..+
T Consensus       103 t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~  130 (156)
T 1bd8_A          103 LPIHLAVQEGHTAVVSFLAAE-SDLHRRD  130 (156)
T ss_dssp             CHHHHHHHHTCHHHHHHHHTT-SCTTCCC
T ss_pred             cHHHHHHHhChHHHHHHHHhc-cCCCCcC
Confidence            999999999999999999987 6554433

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.77  E-value=1.5e-19  Score=141.61  Aligned_cols=102  Identities=25%  Similarity=0.377  Sum_probs=91.5

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+++++.+|..|+|||++  |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        32 ~g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  109 (137)
T 3c5r_A           32 NGSDPNVKDHAGWTPLHE--ACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFG  109 (137)
T ss_dssp             TTCCSCCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             cCCCCCcCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCC
Confidence            456788889999999966  889999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGG  125 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a  125 (337)
                      .|||++|+..+..++++++.+..+
T Consensus       110 ~tpl~~A~~~~~~~~l~~l~~~~~  133 (137)
T 3c5r_A          110 LRPVDYTDDESMKSLLLLPEKNES  133 (137)
T ss_dssp             CCGGGGCCCHHHHHHHSCC-----
T ss_pred             CCHHHHHhhccHHHHHhhcccccc
Confidence            999999999999999888776553

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.77  E-value=3.5e-19  Score=155.98  Aligned_cols=114  Identities=22%  Similarity=0.206  Sum_probs=68.5

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      ...++..|..+.|||+. ++..++...++++|++.|++||.+|.+|+||||+||..|+.+++++|++.|++++.++..|.
T Consensus        42 ~~~~~~~~~~~~t~L~~-a~~~~~~~~~v~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~  120 (269)
T 4b93_B           42 EDTVSAADPEFCHPLCQ-CPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQA  120 (269)
T ss_dssp             ----------------------------------CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCC
T ss_pred             cccccccCccCCCHHHH-HHHhCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCC
Confidence            34567778889999965 44456666788899999999999999999999999999999999999998888888888888


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      ||++.|+..++.+++++|+.++++++..+....+|
T Consensus       121 t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~Tp  155 (269)
T 4b93_B          121 VPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTP  155 (269)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCH
T ss_pred             CccccccccChHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            88888888888888888887777776655544443

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.77  E-value=4e-19  Score=141.84  Aligned_cols=98  Identities=28%  Similarity=0.385  Sum_probs=92.0

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus        55 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  132 (153)
T 1awc_B           55 RAGVSRDARTKVDRTPLHM--AASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKF  132 (153)
T ss_dssp             TTTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HcCCCCCCCCCCCCCHHHH--HHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence            3466788899999999966  88888899999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHH
Q 019685          101 KNTPLADAEGAKKFNMMELL  120 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L  120 (337)
                      |.|||++|+..++.+++++|
T Consensus       133 g~t~l~~A~~~~~~~i~~~L  152 (153)
T 1awc_B          133 CKTAFDISIDNGNEDLAEIL  152 (153)
T ss_dssp             SCCHHHHHHHTTCHHHHHHH
T ss_pred             CCCHHHHHHHcCCHHHHHHh
Confidence            99999999999999999987

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.77  E-value=4.8e-19  Score=150.38  Aligned_cols=109  Identities=20%  Similarity=0.156  Sum_probs=98.0

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHc-CCCccccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDRWKN  102 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~-ga~~~~~d~~g~  102 (337)
                      .-++.++..|.|||++  |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++ |+++|.+|..|+
T Consensus        64 ~~v~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~  141 (222)
T 3ehr_A           64 NYVAEQAESIDNPLHE--AAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGD  141 (222)
T ss_dssp             HHHHHHEEEESCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSC
T ss_pred             hhcccccccccccccc--ccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCC
Confidence            3466778889999966  7887888888888899999999999999999999999999999999999 999999999999


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGSH  134 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~  134 (337)
                      ||||+|+..++.+++++|+.+|++.+..+...
T Consensus       142 tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  173 (222)
T 3ehr_A          142 TALHAAAWKGYADIVQLLLAKGARTDLRNIEK  173 (222)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTS
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCCCccccCCC
Confidence            99999999999999999999999876555443

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.77  E-value=6.5e-19  Score=143.10  Aligned_cols=102  Identities=25%  Similarity=0.385  Sum_probs=95.1

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        68 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~  145 (169)
T 2y1l_E           68 KNGADVNAVDHAGMTPLRL--AALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKF  145 (169)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HcCCCCCccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence            3466788889999999966  88999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhc
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHG  124 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~  124 (337)
                      |.|||++|+..++.+++++|++.|
T Consensus       146 g~t~l~~A~~~~~~~~~~~L~~~G  169 (169)
T 2y1l_E          146 GKTAFDISIDNGNEDLAEILQKLN  169 (169)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHTC-
T ss_pred             CCCHHHHHHHhCCHHHHHHHHHcC
Confidence            999999999999999999998764

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.77  E-value=6.6e-19  Score=140.87  Aligned_cols=100  Identities=20%  Similarity=0.225  Sum_probs=93.8

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++ ++++.+|..
T Consensus        56 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~  132 (156)
T 1bd8_A           56 KQGASPNVQDTSGTSPVHD--AARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDAR  132 (156)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCCTT
T ss_pred             HCCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcCCC
Confidence            4467888999999999966  8889999999999999999999999999999999999999999999999 999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhh
Q 019685          101 KNTPLADAEGAKKFNMMELLNAH  123 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~  123 (337)
                      |.|||++|+..++.+++++|+++
T Consensus       133 g~t~l~~A~~~~~~~~v~~Ll~~  155 (156)
T 1bd8_A          133 GLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             SCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             CCCHHHHHHHcCcHHHHHHHHhh
Confidence            99999999999999999999864

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.77  E-value=5.6e-19  Score=145.49  Aligned_cols=104  Identities=24%  Similarity=0.155  Sum_probs=92.9

Q ss_pred             hhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccc-cccccch
Q 019685           27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD-RWKNTPL  105 (337)
Q Consensus        27 ~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d-~~g~t~l  105 (337)
                      ...+..|+|||++  |+..+..+++++|++ |+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+| ..|+|||
T Consensus        38 ~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL  114 (183)
T 3deo_A           38 ADVVSEYETPWWT--AARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTAL  114 (183)
T ss_dssp             HHHHHHHHHHHHH--HHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHH
T ss_pred             ccCCCCCCCHHHH--HHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHH
Confidence            3446778898865  888888888888888 99999999999999999999999999999999999999998 8999999


Q ss_pred             hhhhhhhhhhHHHHHHhhcCCCCCCCCC
Q 019685          106 ADAEGAKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       106 ~~A~~~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      |+|+..++.+++++|+.++++.+..+..
T Consensus       115 ~~A~~~~~~~~v~~Ll~~ga~~~~~d~~  142 (183)
T 3deo_A          115 HMAAGYVRPEVVEALVELGADIEVEDER  142 (183)
T ss_dssp             HHHHHTTCHHHHHHHHHHTCCTTCCCTT
T ss_pred             HHHHhcCcHHHHHHHHHcCCCCcCCCCC
Confidence            9999999999999999999877655433

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.76  E-value=7.3e-19  Score=151.13  Aligned_cols=111  Identities=19%  Similarity=0.203  Sum_probs=87.6

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ...+++++.. ..+.|||+.  |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|.
T Consensus        25 l~~g~~~~~~-~~~~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~  101 (239)
T 1ycs_B           25 IAHGMRVKFN-PLPLALLLD--SSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADS  101 (239)
T ss_dssp             -------------CHHHHHH--HHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCT
T ss_pred             hccCCCcccC-chhhHHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCC
Confidence            4566666643 556777755  7777778888888899999999999999999999999999999999999999999999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      .|+||||+|+..++.+++++|+.++++.+..+..
T Consensus       102 ~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  135 (239)
T 1ycs_B          102 DGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYS  135 (239)
T ss_dssp             TCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSS
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCC
Confidence            9999999999999999999999999887655543

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.76  E-value=4.9e-19  Score=150.30  Aligned_cols=109  Identities=16%  Similarity=0.177  Sum_probs=90.9

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhC-CCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEED-QSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~-~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ..+++++.+|..|+|||++  |+..++.+++++|++. |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|.
T Consensus        94 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~  171 (222)
T 3ehr_A           94 DNRVGVNGLDKAGSTALYW--ACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNI  171 (222)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCT
T ss_pred             hCCCCccccCCCCCCHHHH--HHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccC
Confidence            3567788899999999966  8889999999999998 999999999999999999999999999999999999999999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .|.|||++|+..++.++++.+...++.....+
T Consensus       172 ~g~t~l~~A~~~~~~~~l~~l~~~~~~~~~~~  203 (222)
T 3ehr_A          172 EKKLAFDMATNAACASLLKKKQGTDAVRTLSN  203 (222)
T ss_dssp             TSCCHHHHCCSHHHHHHHC-------------
T ss_pred             CCCCHHHHhcchhHHHHHHHHhccchhhhccc
Confidence            99999999999999999999999888655433

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.76  E-value=9.4e-19  Score=145.09  Aligned_cols=101  Identities=25%  Similarity=0.270  Sum_probs=94.9

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        90 ~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  167 (192)
T 2rfm_A           90 KGSNVNTKDFSGKTPLMW--SIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTG  167 (192)
T ss_dssp             HTCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTS
T ss_pred             CCCCCCCCCCCCCcHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCC
Confidence            456788889999999966  888888899999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhc
Q 019685          102 NTPLADAEGAKKFNMMELLNAHG  124 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~  124 (337)
                      .|||++|+..++.+++++|.+++
T Consensus       168 ~t~l~~A~~~~~~~~v~~Ll~~~  190 (192)
T 2rfm_A          168 LTAEASARIFGRQEVIKIFTEVR  190 (192)
T ss_dssp             CBHHHHHHHTTCHHHHHHHHHHH
T ss_pred             CCHHHHHHHhCcHHHHHHHHhcc
Confidence            99999999999999999998865

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.75  E-value=5.8e-19  Score=141.48  Aligned_cols=103  Identities=22%  Similarity=0.187  Sum_probs=91.3

Q ss_pred             hhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccccc-ch
Q 019685           27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT-PL  105 (337)
Q Consensus        27 ~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t-~l  105 (337)
                      +..+..|.|||++  |+..+..+++++|++.|+++|..|..|+||||+|+ .|+.+++++|+++|+++|.+|..|.| ||
T Consensus         6 ~~~~~~~~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL   82 (156)
T 1bi7_B            6 GSSMEPSADWLAT--AAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPV   82 (156)
T ss_dssp             ----CCSTTHHHH--HHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHH
T ss_pred             cCCCccchHHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHH
Confidence            4556788999866  88888889999999999999999999999999995 99999999999999999999999999 99


Q ss_pred             hhhhhhhhhhHHHHHHhhcCCCCCCCC
Q 019685          106 ADAEGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus       106 ~~A~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      |+|+..++.+++++|+.++++.+..+.
T Consensus        83 ~~A~~~~~~~~v~~Ll~~ga~~~~~d~  109 (156)
T 1bi7_B           83 HDAAREGFLDTLVVLHRAGARLDVRDA  109 (156)
T ss_dssp             HHHHHHTCHHHHHHHHHHTCCSSCCCT
T ss_pred             HHHHHCCCHHHHHHHHHcCCCCcccCC
Confidence            999999999999999999987765543

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.75  E-value=1.3e-19  Score=149.89  Aligned_cols=104  Identities=13%  Similarity=0.102  Sum_probs=92.0

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCH------HHHHHHHHhCCCCccccCCCCC-cHHHHHHHcC-----CHHHHHHH
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDA------AAVRKLLEEDQSLVHARDYDNR-TPLHVASLHG-----WIDVAKCL   87 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~------~~~~~lL~~~~~~vn~~~~~g~-tpLh~A~~~g-----~~~~~~~L   87 (337)
                      ...++++|.+|..|+||||+  |+..+.      .+++++|+++|++||.+|..|+ ||||+|+..+     +.+++++|
T Consensus        62 l~~Gadvn~~d~~g~TpLh~--a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~L  139 (186)
T 3t8k_A           62 INKGADIKSRTKEGTTLFFP--LFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLI  139 (186)
T ss_dssp             HHTTCCSSCCCTTCCCTHHH--HHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHH
T ss_pred             HHCCCCCCCCCCCCCcHHHH--HHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHH
Confidence            35789999999999999976  544332      6889999999999999999999 9999999954     46799999


Q ss_pred             HH-cCCCccccccccccchhhhhhhhhhhHHHHHHhhcC
Q 019685           88 IE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG  125 (337)
Q Consensus        88 l~-~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a  125 (337)
                      ++ +|||+|.+|..|.||||+|+..++.+++++|..+..
T Consensus       140 l~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~  178 (186)
T 3t8k_A          140 FSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIK  178 (186)
T ss_dssp             HTSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHH
T ss_pred             HHhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHH
Confidence            99 999999999999999999999999999999987654

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.75  E-value=2.4e-18  Score=146.16  Aligned_cols=112  Identities=25%  Similarity=0.182  Sum_probs=97.2

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcC-CCccccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQDRWKN  102 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~g-a~~~~~d~~g~  102 (337)
                      .+++.+|..|+|||++  |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++| +++|.+|..|+
T Consensus        98 ~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~  175 (228)
T 2dzn_A           98 PDLNKITNQGVTCLHL--AVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGW  175 (228)
T ss_dssp             CCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSC
T ss_pred             cccccCCcCCCCHHHH--HHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCC
Confidence            6677788889999865  88888889999999999999999999999999999999999999999999 89999999999


Q ss_pred             cchhhhhhhhhhhHHHHHH-hhcCCCCCCCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLN-AHGGLSYGQNGSHFEP  137 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~-~~~a~~~~~~~~~~~~  137 (337)
                      ||||+|+..++.+++++|+ .+|++.+..+....+|
T Consensus       176 t~L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~  211 (228)
T 2dzn_A          176 TPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKA  211 (228)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBG
T ss_pred             CHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcH
Confidence            9999999999999999998 8888876655444433

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.75  E-value=3.5e-18  Score=146.25  Aligned_cols=101  Identities=24%  Similarity=0.168  Sum_probs=74.7

Q ss_pred             hhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCC-CCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccc
Q 019685           26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY-DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP  104 (337)
Q Consensus        26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~-~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~  104 (337)
                      ++.++..|+|||++  |+..+..+++++|++.|+++|.++. .|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus       110 ~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  187 (236)
T 1ikn_D          110 LKATNYNGHTCLHL--ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSP  187 (236)
T ss_dssp             GGCCCTTCCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCG
T ss_pred             hhccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCH
Confidence            45566667777755  6667777777777777777777776 77777777777777777777777777777777777777


Q ss_pred             hhhhhhhhhhhHHHHHHhhcCCCC
Q 019685          105 LADAEGAKKFNMMELLNAHGGLSY  128 (337)
Q Consensus       105 l~~A~~~~~~~~v~~L~~~~a~~~  128 (337)
                      |++|+..++.+++++|+.+|++..
T Consensus       188 l~~A~~~~~~~~~~~Ll~~ga~~~  211 (236)
T 1ikn_D          188 YQLTWGRPSTRIQQQLGQLTLENL  211 (236)
T ss_dssp             GGGCTTSSCHHHHHHHHTTSCGGG
T ss_pred             HHHHHccCchHHHHHHHHcchhhh
Confidence            777777777777777777777543

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.75  E-value=6.7e-19  Score=151.36  Aligned_cols=109  Identities=23%  Similarity=0.096  Sum_probs=99.4

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ...+++++.+|..|+|||++  |+..++.+++++|++.|+++|.+|.+|+||||+||..|+.+++++|+++|++++.+|.
T Consensus        57 l~~g~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~  134 (239)
T 1ycs_B           57 IYEVDDPSLPNDEGITALHN--AVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTY  134 (239)
T ss_dssp             TSTTSSCCCCCTTSCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCS
T ss_pred             HHcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecC
Confidence            34566889999999999966  8888889999999999999999999999999999999999999999999999999998


Q ss_pred             ccc-cchhhh--hhhhhhhHHHHHHhhcCCCCCC
Q 019685          100 WKN-TPLADA--EGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus       100 ~g~-t~l~~A--~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      .|. ||||.|  +..++.+++++|+.++++....
T Consensus       135 ~~~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~  168 (239)
T 1ycs_B          135 SDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIM  168 (239)
T ss_dssp             SSCCCHHHHCCSSSTTCCCHHHHHHHHHHHTTTT
T ss_pred             CCCcchHHHHHHhhhccHHHHHHHHHhhhccccc
Confidence            887 999999  7789999999999998876543

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.75  E-value=3.4e-18  Score=131.20  Aligned_cols=98  Identities=40%  Similarity=0.506  Sum_probs=90.3

Q ss_pred             cCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhh
Q 019685           32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA  111 (337)
Q Consensus        32 ~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~  111 (337)
                      +|+|||++  |+..+..+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||.|+..
T Consensus         1 ~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~   78 (126)
T 1n0r_A            1 NGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN   78 (126)
T ss_dssp             CCCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCccHHHH--HHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHc
Confidence            47898866  8888888899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhHHHHHHhhcCCCCCCC
Q 019685          112 KKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       112 ~~~~~v~~L~~~~a~~~~~~  131 (337)
                      ++.+++++|+.++++....+
T Consensus        79 ~~~~~~~~Ll~~g~~~~~~~   98 (126)
T 1n0r_A           79 GHLEVVKLLLEAGADVNAKD   98 (126)
T ss_dssp             TCHHHHHHHHHTTCCTTCCC
T ss_pred             ChHHHHHHHHHcCCCCcccC
Confidence            99999999999988765443

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.74  E-value=3.6e-18  Score=145.46  Aligned_cols=104  Identities=24%  Similarity=0.272  Sum_probs=62.7

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      +++++.+|..|+|||++  |+..+..+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|+++|.+|..|.
T Consensus        96 g~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  173 (231)
T 3aji_A           96 GAHVNAVNQNGCTPLHY--AASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGN  173 (231)
T ss_dssp             TCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSC
T ss_pred             CCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccCCCCC
Confidence            34455555556666544  5555555566666666666666666666666666666666666666666666666666666


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSY  128 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~  128 (337)
                      ||||+|+..++.+++++|+++|++.+
T Consensus       174 t~L~~A~~~~~~~~v~~Ll~~ga~~~  199 (231)
T 3aji_A          174 TPLHLACDEERVEEAKFLVTQGASIY  199 (231)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCSC
T ss_pred             CHHHHHHHCCCHHHHHHHHHCCCCCC
Confidence            66666666666666666666655544

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.74  E-value=1.5e-18  Score=149.79  Aligned_cols=103  Identities=24%  Similarity=0.145  Sum_probs=92.4

Q ss_pred             hhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccc-cccccchhh
Q 019685           29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD-RWKNTPLAD  107 (337)
Q Consensus        29 ~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d-~~g~t~l~~  107 (337)
                      .+..|.|||++  |+..+..+++++|++ |+++|.+|..|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+
T Consensus        41 ~~~~g~t~L~~--A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~  117 (244)
T 3ui2_A           41 VVSEYETPWWT--AARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHM  117 (244)
T ss_dssp             HHHHHHHHHHH--HHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHH
T ss_pred             cccCCCCHHHH--HHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHH
Confidence            34578898865  888888888888888 99999999999999999999999999999999999999998 889999999


Q ss_pred             hhhhhhhhHHHHHHhhcCCCCCCCCCC
Q 019685          108 AEGAKKFNMMELLNAHGGLSYGQNGSH  134 (337)
Q Consensus       108 A~~~~~~~~v~~L~~~~a~~~~~~~~~  134 (337)
                      |+..++.+++++|+.++++.+..+...
T Consensus       118 A~~~g~~~~v~~Ll~~ga~~~~~d~~g  144 (244)
T 3ui2_A          118 AAGYVRPEVVEALVELGADIEVEDERG  144 (244)
T ss_dssp             HHHTTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred             HHHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence            999999999999999998876555433

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.74  E-value=1.7e-18  Score=150.08  Aligned_cols=105  Identities=23%  Similarity=0.211  Sum_probs=73.5

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP  104 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~  104 (337)
                      +++.++..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|.||
T Consensus       116 ~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  193 (253)
T 1yyh_A          116 DLDARMHDGTTPLIL--AARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETP  193 (253)
T ss_dssp             CTTCCCTTCCCHHHH--HHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             CccccCCCCCcHHHH--HHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence            455566667776644  666666666777777777777777777777777777777777777777777777777777777


Q ss_pred             hhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          105 LADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       105 l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      ||+|+..++.+++++|+++|++....+
T Consensus       194 L~~A~~~~~~~~v~~Ll~~ga~~~~~d  220 (253)
T 1yyh_A          194 LFLAAREGSYETAKVLLDHFANRDITD  220 (253)
T ss_dssp             HHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHHCCCHHHHHHHHHcCCCccccc
Confidence            777777777777777777776654433

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.74  E-value=2.2e-18  Score=151.38  Aligned_cols=98  Identities=26%  Similarity=0.267  Sum_probs=71.5

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHH-cCCCcccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQDRWKNT  103 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~-~ga~~~~~d~~g~t  103 (337)
                      +.+..|..|+|||++  |+..+..+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|++ .|+++|.+|..|.|
T Consensus       175 ~~~~~~~~g~tpLh~--A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~T  252 (276)
T 4hbd_A          175 INAKASQAGQTALML--AVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGST  252 (276)
T ss_dssp             TTCCCTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSCC
T ss_pred             CccccCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCCC
Confidence            444555667777755  666667777777777777777777777777777777777777777777 67777777777777


Q ss_pred             chhhhhhhhhhhHHHHHHhhc
Q 019685          104 PLADAEGAKKFNMMELLNAHG  124 (337)
Q Consensus       104 ~l~~A~~~~~~~~v~~L~~~~  124 (337)
                      |||+|+..++.+++++|+++.
T Consensus       253 pL~~A~~~g~~~iv~~Ll~~~  273 (276)
T 4hbd_A          253 ALMVALDAGQSEIASMLYSRM  273 (276)
T ss_dssp             HHHHHHHHTCHHHHHHHHHHC
T ss_pred             HHHHHHHcCCHHHHHHHHhcc
Confidence            777777777777777777654

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.74  E-value=1.4e-18  Score=154.67  Aligned_cols=96  Identities=22%  Similarity=0.147  Sum_probs=90.3

Q ss_pred             hhccCCchhHHHHHhhC---CHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccch
Q 019685           29 KARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL  105 (337)
Q Consensus        29 ~~~~~~~~~~~~~a~~~---~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l  105 (337)
                      +|..|+|||++  |+..   +..+++++|++.|++||.+|.+|+||||+|+..|+.+++++||++||+++.+|..|.|||
T Consensus       186 ~~~~g~t~Lh~--A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL  263 (301)
T 2b0o_E          186 AQAPEELVLHL--AVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETAL  263 (301)
T ss_dssp             SCSCEECHHHH--HHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHH
T ss_pred             cCCCCccHHHH--HHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence            57889999966  7664   788999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHHHhhcCC
Q 019685          106 ADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       106 ~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      ++|+..++.+++++|+.++++
T Consensus       264 ~~A~~~~~~~iv~~Ll~~ga~  284 (301)
T 2b0o_E          264 DIARKKHHKECEELLEQAQAG  284 (301)
T ss_dssp             HHHHHHTCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHhcCC
Confidence            999999999999999998875

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.74  E-value=2.1e-18  Score=139.62  Aligned_cols=104  Identities=18%  Similarity=0.164  Sum_probs=96.6

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|..|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        57 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~  134 (167)
T 3v31_A           57 QNGADPQLLGKGRESALSL--ACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDS  134 (167)
T ss_dssp             HTTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HcCCCCCCcCCCCCcHHHH--HHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence            3466788889999999966  88888899999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      |.|||++|+..++.+++++|.++++.
T Consensus       135 g~t~l~~A~~~~~~~~~~~L~~~~~~  160 (167)
T 3v31_A          135 GYNSMDLAVALGYRSVQQVIESHLLK  160 (167)
T ss_dssp             SCCHHHHHHHHTCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHcCcHHHHHHHHHHHHH
Confidence            99999999999999999999988754

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.74  E-value=1.8e-18  Score=147.74  Aligned_cols=107  Identities=20%  Similarity=0.130  Sum_probs=93.0

Q ss_pred             hccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhh
Q 019685           30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAE  109 (337)
Q Consensus        30 ~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~  109 (337)
                      +..+.|+|+.  |+..+..+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+
T Consensus        18 ~~~~~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~   95 (229)
T 2vge_A           18 RLNPLVLLLD--AALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAA   95 (229)
T ss_dssp             TSCHHHHHHH--HHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred             ccchhHHHHH--HHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            3445566644  88888888888888999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhHHHHHHhhcCCCCCCC-CCCCCCC
Q 019685          110 GAKKFNMMELLNAHGGLSYGQN-GSHFEPK  138 (337)
Q Consensus       110 ~~~~~~~v~~L~~~~a~~~~~~-~~~~~~~  138 (337)
                      ..++.+++++|+.++++.+..+ ....+|.
T Consensus        96 ~~g~~~~v~~Ll~~ga~~~~~~~~~g~tpL  125 (229)
T 2vge_A           96 SCNDTVICMALVQHGAAIFATTLSDGATAF  125 (229)
T ss_dssp             HTTCHHHHHHHHTTTCCTTCCCSSTTCCTG
T ss_pred             HcCCHHHHHHHHHcCCCcccccCCCCCCHH
Confidence            9999999999999999877654 2444443

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.74  E-value=3.9e-18  Score=145.45  Aligned_cols=107  Identities=22%  Similarity=0.333  Sum_probs=93.9

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCc-----cccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLV-----HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ   97 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~v-----n~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~   97 (337)
                      +++++.+|..|+|||++  |+..+..+++++|++.|+++     +..|..|+||||+|+..|+.+++++|+++|++++.+
T Consensus        27 g~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~  104 (232)
T 2rfa_A           27 GCEVHQRGAMGETALHI--AALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSAR  104 (232)
T ss_dssp             CSCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             CCCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcc
Confidence            67788889999999866  88888899999999999877     677889999999999999999999999999999988


Q ss_pred             cc-------------ccccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685           98 DR-------------WKNTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus        98 d~-------------~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      +.             .|.||||+|+..++.+++++|+++|++.+..+
T Consensus       105 ~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d  151 (232)
T 2rfa_A          105 ATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQD  151 (232)
T ss_dssp             CCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             cCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Confidence            66             79999999999999999999999988765444

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.74  E-value=5.4e-18  Score=143.62  Aligned_cols=106  Identities=23%  Similarity=0.205  Sum_probs=67.9

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP  104 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~  104 (337)
                      +++.++..|+||+++  |+..+..+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|+++|.+|..|.||
T Consensus        84 ~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~  161 (223)
T 2f8y_A           84 DLDARMHDGTTPLIL--AARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETP  161 (223)
T ss_dssp             CTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred             CcccCCCCCCcHHHH--HHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCH
Confidence            455555666666644  555556666666666666666666666666666666666666666666666666666666666


Q ss_pred             hhhhhhhhhhhHHHHHHhhcCCCCCCCC
Q 019685          105 LADAEGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus       105 l~~A~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      ||+|+..++.+++++|+.++++.+..+.
T Consensus       162 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~  189 (223)
T 2f8y_A          162 LFLAAREGSYETAKVLLDHFANRDITDH  189 (223)
T ss_dssp             HHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCccccc
Confidence            6666666666666666666665554443

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.73  E-value=3.3e-18  Score=140.84  Aligned_cols=91  Identities=25%  Similarity=0.253  Sum_probs=83.7

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      +++++.+|..|+|||++  |+..++.+++++|++.|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        66 ~~~~~~~d~~g~t~L~~--A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g  143 (183)
T 3deo_A           66 DRDVDAVDENGRTALLF--VAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERG  143 (183)
T ss_dssp             TSCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTS
T ss_pred             cCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCCCC
Confidence            67889999999999966  888888899999999999999998 899999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhh
Q 019685          102 NTPLADAEGAKKFN  115 (337)
Q Consensus       102 ~t~l~~A~~~~~~~  115 (337)
                      .||||+|+..++.+
T Consensus       144 ~tpl~~A~~~~~~~  157 (183)
T 3deo_A          144 LTALELAREILKTT  157 (183)
T ss_dssp             CCHHHHHHHHHHTC
T ss_pred             CCHHHHHHHhccCc
Confidence            99999998765443

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.73  E-value=6.2e-18  Score=143.22  Aligned_cols=113  Identities=26%  Similarity=0.222  Sum_probs=87.2

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCC-CccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQS-LVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~-~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      .+++++.+|..|+|||++  |+..+..+++++|++.+. +++..+..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        47 ~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~  124 (223)
T 2f8y_A           47 ASADANIQDNMGRTPLHA--AVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDL  124 (223)
T ss_dssp             TTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTT
T ss_pred             cCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCC
Confidence            456677777788888755  777777777777777766 77778888888888888888888888888888888888888


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      |.||||+|+..++.+++++|+.++++.+..+....+
T Consensus       125 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  160 (223)
T 2f8y_A          125 GKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREET  160 (223)
T ss_dssp             SCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred             CCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcC
Confidence            888888888888888888888887776665544444

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=6e-18  Score=153.66  Aligned_cols=143  Identities=13%  Similarity=0.068  Sum_probs=98.6

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCc---------------hHH----HHHHHHHHHHHHHhCCCCCe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD---------------DRL----VIQDFRHEVNLLVKLRHPNI  217 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~---------------~~~----~~~~~~~E~~~l~~l~h~~I  217 (337)
                      -|.+...||+|+||.||+|... |+.||||+++.....               ...    ..-....|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4678899999999999999875 889999987542110               000    00112346666666654433


Q ss_pred             eeeeeeEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-
Q 019685          218 VQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-  296 (337)
Q Consensus       218 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-  296 (337)
                      ....-+..  ...+|||||++|++|.++.      ..+....++.||+.+|.|||+.|  ||||||||.|||+.+++++ 
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCcc
Confidence            22111111  2347999999998886543      22345678899999999999987  9999999999999544322 


Q ss_pred             -------cEEEEeccCceeee
Q 019685          297 -------HLKVGDFGLSKLIK  310 (337)
Q Consensus       297 -------~~kl~DFgla~~~~  310 (337)
                             .+.|+||+-+....
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccceEEEEeCCcccCC
Confidence                   38999999876543

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.73  E-value=8.1e-18  Score=144.06  Aligned_cols=111  Identities=24%  Similarity=0.239  Sum_probs=98.7

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT  103 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t  103 (337)
                      +++.+|..|+||+++  |+..+..+++++|++.|++++..+ ..|.||||+|+..|+.+++++|+++|+++|.+|..|.|
T Consensus       108 ~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  185 (241)
T 1k1a_A          108 DLEARNYDGLTALHV--AVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSS  185 (241)
T ss_dssp             CTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCB
T ss_pred             cccccCcCCCcHHHH--HHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence            567778889999866  888888999999999999999988 78999999999999999999999999999999999999


Q ss_pred             chhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          104 PLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       104 ~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      |||+|+..++.+++++|+++|++++..+....+|
T Consensus       186 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  219 (241)
T 1k1a_A          186 ALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTP  219 (241)
T ss_dssp             HHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred             HHHHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCH
Confidence            9999999999999999999999877665544444

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.73  E-value=6.2e-18  Score=144.73  Aligned_cols=113  Identities=26%  Similarity=0.324  Sum_probs=74.0

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCC------ccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL------VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADV   94 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~------vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~   94 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|++      ++..|..|.||||+|+..|+.+++++|+++|+++
T Consensus        66 ~~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~  143 (236)
T 1ikn_D           66 GAGCDPELRDFRGNTPLHL--ACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADV  143 (236)
T ss_dssp             SCCCCSCCCCTTCCCHHHH--HHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCT
T ss_pred             HcCCCCCCcCCCCCCHHHH--HHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            3455666666666666644  5665666666666666653      4556666777777777777777777777777777


Q ss_pred             ccccc-ccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCC
Q 019685           95 NAQDR-WKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF  135 (337)
Q Consensus        95 ~~~d~-~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~  135 (337)
                      |.+|. .|.||||+|+..++.+++++|+.+|++.+..+....
T Consensus       144 ~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~  185 (236)
T 1ikn_D          144 NAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGY  185 (236)
T ss_dssp             TCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCC
T ss_pred             CCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCC
Confidence            77766 677777777777777777777777766554444333

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.73  E-value=1.8e-18  Score=151.42  Aligned_cols=102  Identities=22%  Similarity=0.198  Sum_probs=93.9

Q ss_pred             chhhhhhhhc--------------cCCchhHHHHHhhCCHHHHHHHHHh---CCCCccccCCCCCcHHHHHHHcCC----
Q 019685           22 SADKQKEKAR--------------VSRTSLILWHAHQNDAAAVRKLLEE---DQSLVHARDYDNRTPLHVASLHGW----   80 (337)
Q Consensus        22 ~~~~~~~~~~--------------~~~~~~~~~~a~~~~~~~~~~lL~~---~~~~vn~~~~~g~tpLh~A~~~g~----   80 (337)
                      .+++++.++.              .|+|||++  |+..+..+++++|++   .|+++|.+|.+|+||||+|+..|+    
T Consensus       123 ~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~--A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~  200 (273)
T 2pnn_A          123 NGADVQAAANGDFFKKTKGRPGFYFGELPLSL--AACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVD  200 (273)
T ss_dssp             TTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHH--HHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHH
T ss_pred             CCCCcCccccccccccccccccccCCCCHHHH--HHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchh
Confidence            4566666665              79999966  888999999999999   999999999999999999999998    


Q ss_pred             -----HHHHHHHHHcCCCcc-------ccccccccchhhhhhhhhhhHHHHHHhhcC
Q 019685           81 -----IDVAKCLIEYGADVN-------AQDRWKNTPLADAEGAKKFNMMELLNAHGG  125 (337)
Q Consensus        81 -----~~~~~~Ll~~ga~~~-------~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a  125 (337)
                           .+++++|+++|+++|       .+|..|+||||+|+..++.+++++|+.+|+
T Consensus       201 ~~~~~~~~v~~Ll~~ga~~n~~~~~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga  257 (273)
T 2pnn_A          201 NTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREI  257 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhhhhcccccccccccCCCCCCHHHHHHHhChHHHHHHHHHCCC
Confidence                 899999999999997       589999999999999999999999999998

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.73  E-value=5e-18  Score=146.41  Aligned_cols=101  Identities=23%  Similarity=0.225  Sum_probs=93.0

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      +++++.+|..|+|||++  |+..++.+++++|++.|+++|.+| ..|+||||+|+..|+.+++++|+++|+++|.+|..|
T Consensus        67 ~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g  144 (244)
T 3ui2_A           67 DRDVDAVDENGRTALLF--VAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERG  144 (244)
T ss_dssp             TCCTTCBCTTSCBHHHH--HHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred             CCCCCCcCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Confidence            67889999999999976  888888899999999999999998 889999999999999999999999999999999999


Q ss_pred             ccchhhhh----------------hhhhhhHHHHHHhhcC
Q 019685          102 NTPLADAE----------------GAKKFNMMELLNAHGG  125 (337)
Q Consensus       102 ~t~l~~A~----------------~~~~~~~v~~L~~~~a  125 (337)
                      .||||+|+                ..++.+++++|..+..
T Consensus       145 ~t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~  184 (244)
T 3ui2_A          145 LTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVF  184 (244)
T ss_dssp             CCHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHE
T ss_pred             CcHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhcc
Confidence            99999987                5688899999987653

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.73  E-value=1.1e-17  Score=142.68  Aligned_cols=99  Identities=27%  Similarity=0.238  Sum_probs=91.5

Q ss_pred             hhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCC-------------CCCcHHHHHHHcCCHHHHHHHHHcCCC
Q 019685           27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY-------------DNRTPLHVASLHGWIDVAKCLIEYGAD   93 (337)
Q Consensus        27 ~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~-------------~g~tpLh~A~~~g~~~~~~~Ll~~ga~   93 (337)
                      +.+|..|+|||++  |+..+..+++++|++.|++++..+.             .|.||||+|+..|+.+++++|+++|++
T Consensus        69 ~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~  146 (232)
T 2rfa_A           69 TSELYEGQTALHI--AVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGAD  146 (232)
T ss_dssp             CSTTTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCC
T ss_pred             cccCCCCcCHHHH--HHHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCC
Confidence            5567789999966  9999999999999999999998765             799999999999999999999999999


Q ss_pred             ccccccccccchhhhhhhhhhhHH----HHHHhhcCCC
Q 019685           94 VNAQDRWKNTPLADAEGAKKFNMM----ELLNAHGGLS  127 (337)
Q Consensus        94 ~~~~d~~g~t~l~~A~~~~~~~~v----~~L~~~~a~~  127 (337)
                      +|.+|..|+||||+|+..++.+++    ++|+.++++.
T Consensus       147 ~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~  184 (232)
T 2rfa_A          147 IRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD  184 (232)
T ss_dssp             TTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSC
T ss_pred             CCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCch
Confidence            999999999999999999999888    9999998865

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.73  E-value=8.5e-18  Score=151.81  Aligned_cols=108  Identities=31%  Similarity=0.361  Sum_probs=99.8

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+.+++.+|..|+|||++  |+..++.+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|++++.+|.+|
T Consensus        47 ~~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g  124 (351)
T 3utm_A           47 LNVNCHASDGRKSTPLHL--AAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQ  124 (351)
T ss_dssp             TTTTCCCSSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred             cCCCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCC
Confidence            466778888999999966  999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .||||+|+..++.+++++|+.+++++...+
T Consensus       125 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  154 (351)
T 3utm_A          125 FTPLHEAASKNRVEVCSLLLSHGADPTLVN  154 (351)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence            999999999999999999999998765444

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.73  E-value=3.2e-18  Score=148.65  Aligned_cols=99  Identities=25%  Similarity=0.232  Sum_probs=90.4

Q ss_pred             hhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC--------------CCCCcHHHHHHHcCCHHHHHHHHH---
Q 019685           27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD--------------YDNRTPLHVASLHGWIDVAKCLIE---   89 (337)
Q Consensus        27 ~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~--------------~~g~tpLh~A~~~g~~~~~~~Ll~---   89 (337)
                      +.+|..|+|||++  |+..++.+++++|++.|+++|..+              ..|+||||+|+..|+.+++++|++   
T Consensus        87 ~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~  164 (260)
T 3jxi_A           87 RDVYYRGQTALHI--AIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGH  164 (260)
T ss_dssp             CCSSEESBCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSS
T ss_pred             cccccCCCCHHHH--HHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccc
Confidence            3445589999966  999999999999999999999998              689999999999999999999999   


Q ss_pred             cCCCccccccccccchhhhhhhhh---------hhHHHHHHhhcCCC
Q 019685           90 YGADVNAQDRWKNTPLADAEGAKK---------FNMMELLNAHGGLS  127 (337)
Q Consensus        90 ~ga~~~~~d~~g~t~l~~A~~~~~---------~~~v~~L~~~~a~~  127 (337)
                      +|+++|.+|..|+||||+|+..++         .+++++|+.+|++.
T Consensus       165 ~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~  211 (260)
T 3jxi_A          165 KQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKL  211 (260)
T ss_dssp             CCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCccc
Confidence            999999999999999999997766         68999999999876

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.72  E-value=6.6e-18  Score=146.38  Aligned_cols=97  Identities=26%  Similarity=0.225  Sum_probs=89.7

Q ss_pred             hhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCC-------------CCcHHHHHHHcCCHHHHHHHHH---cCC
Q 019685           29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYD-------------NRTPLHVASLHGWIDVAKCLIE---YGA   92 (337)
Q Consensus        29 ~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~-------------g~tpLh~A~~~g~~~~~~~Ll~---~ga   92 (337)
                      +|..|+|||++  |+..+..+++++|++.|+++|..|..             |.||||+|+..|+.+++++|++   +|+
T Consensus        86 ~d~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga  163 (256)
T 2etb_A           86 EFYQGHSALHI--AIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPA  163 (256)
T ss_dssp             TTTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCC
T ss_pred             ccccCCCHHHH--HHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCC
Confidence            34679999966  99999999999999999999999886             9999999999999999999999   999


Q ss_pred             Cccccccccccchhhhhh--hhhhh-------HHHHHHhhcCCC
Q 019685           93 DVNAQDRWKNTPLADAEG--AKKFN-------MMELLNAHGGLS  127 (337)
Q Consensus        93 ~~~~~d~~g~t~l~~A~~--~~~~~-------~v~~L~~~~a~~  127 (337)
                      ++|.+|..|+||||+|+.  .++.+       ++++|+.+|++.
T Consensus       164 ~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~  207 (256)
T 2etb_A          164 SLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARL  207 (256)
T ss_dssp             CTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCc
Confidence            999999999999999998  67777       999999999876

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.72  E-value=7.3e-18  Score=153.66  Aligned_cols=103  Identities=23%  Similarity=0.269  Sum_probs=88.1

Q ss_pred             Cchhhhhhhh--ccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccc
Q 019685           21 SSADKQKEKA--RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD   98 (337)
Q Consensus        21 ~~~~~~~~~~--~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d   98 (337)
                      ..+++++.++  ..|+|||++  |+..+..+++++|++.|++||..|..|+||||+|+..|+.+++++||++||+++.+|
T Consensus       221 ~~Gadvn~~~~~~~g~TpLh~--Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~~d  298 (368)
T 3jue_A          221 AHGADVNWVNGGQDNATPLIQ--ATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARD  298 (368)
T ss_dssp             HTTCCTTCCCTTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             HcCCCCCccccccCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCCcC
Confidence            3456777777  778888865  778888888888889999999999999999999999999999999999999999999


Q ss_pred             cccccchhhhhhhhhhhHHHHHHhhcC
Q 019685           99 RWKNTPLADAEGAKKFNMMELLNAHGG  125 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~~~~v~~L~~~~a  125 (337)
                      ..|.||||+|+..++.+++++|+.++.
T Consensus       299 ~~G~TpL~~A~~~g~~~iv~lLl~~~~  325 (368)
T 3jue_A          299 SEGRDPLTIAMETANADIVTLLRLAKM  325 (368)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHHHC
T ss_pred             CCCCCHHHHHHHCCCHHHHHHHHHcCC
Confidence            999999999999999999998887764

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.72  E-value=6.1e-18  Score=158.03  Aligned_cols=111  Identities=27%  Similarity=0.303  Sum_probs=91.1

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+++.+.+|..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|
T Consensus       267 ~~~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~g  344 (437)
T 1n11_A          267 KQANGNLGNKSGLTPLHL--VAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLG  344 (437)
T ss_dssp             TTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTS
T ss_pred             cCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCCCCC
Confidence            455677777888888865  777777888888888888888888888888888888888888888888888888888888


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSH  134 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~  134 (337)
                      .||||+|+..++.+++++|+++|++++..+...
T Consensus       345 ~t~L~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g  377 (437)
T 1n11_A          345 YSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDG  377 (437)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSS
T ss_pred             CCHHHHHHHCChHHHHHHHHHCcCCCCCCCCCC
Confidence            888888888888888888888888766554433

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.72  E-value=8e-18  Score=147.84  Aligned_cols=106  Identities=25%  Similarity=0.154  Sum_probs=82.0

Q ss_pred             hhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCC-Cc--------------------------------------cccCC
Q 019685           26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQS-LV--------------------------------------HARDY   66 (337)
Q Consensus        26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~-~v--------------------------------------n~~~~   66 (337)
                      +|.+|.+|+|||++  |+..+..+++++|++.|+ ++                                      +..|.
T Consensus       104 ~n~~d~~g~T~Lh~--A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~  181 (276)
T 4hbd_A          104 VNIADSNGNTALHY--SVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQ  181 (276)
T ss_dssp             HTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTT
T ss_pred             CcCCCCCCCCHHHH--HHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCC
Confidence            55566666666644  555555556666666555 44                                      44455


Q ss_pred             CCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHHHh-hcCCCCCCCCC
Q 019685           67 DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNA-HGGLSYGQNGS  133 (337)
Q Consensus        67 ~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~-~~a~~~~~~~~  133 (337)
                      .|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..++.+++++|+. .+++.+..+..
T Consensus       182 ~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~  249 (276)
T 4hbd_A          182 AGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRD  249 (276)
T ss_dssp             TCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTT
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCC
Confidence            68899999999999999999999999999999999999999999999999999998 78776654433

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.72  E-value=9e-18  Score=156.88  Aligned_cols=111  Identities=25%  Similarity=0.217  Sum_probs=87.0

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      +.+++++..+..|+|||++  |+..|..+++++|++.|+++|..|..|.||||+||..|+.+++++|+++|+++|.+|..
T Consensus         2 ~~g~~~~~~~~~g~t~L~~--Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~   79 (437)
T 1n11_A            2 SPGISGGGGGESGLTPLHV--ASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKD   79 (437)
T ss_dssp             -------------CCHHHH--HHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTT
T ss_pred             CCCCCccccCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCC
Confidence            4577888889999999866  88888888888888999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      |.||||+|+..|+.+++++|+.++++++..+..
T Consensus        80 g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~  112 (437)
T 1n11_A           80 DQTPLHCAARIGHTNMVKLLLENNANPNLATTA  112 (437)
T ss_dssp             SCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTT
T ss_pred             CCCHHHHHHHCCCHHHHHHHHhCCCCCCCCCCC
Confidence            999999999999999999999998876655443

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.72  E-value=1.2e-17  Score=142.21  Aligned_cols=106  Identities=25%  Similarity=0.284  Sum_probs=72.4

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP  104 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~  104 (337)
                      ..+.+|..|+|||++  |+..+..+++++|++.|++++..|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus        32 ~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~  109 (231)
T 3aji_A           32 LATRTDQDSRTALHW--ACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTP  109 (231)
T ss_dssp             GGGCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             hhhcCCCCCCCHHHH--HHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCH
Confidence            345556667776654  666666666666667777777777777777777777777777777777777777777777777


Q ss_pred             hhhhhhhhhhhHHHHHHhhcCCCCCCCC
Q 019685          105 LADAEGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus       105 l~~A~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      ||.|+..++.+++++|+.++++....+.
T Consensus       110 L~~A~~~~~~~~~~~Ll~~g~~~~~~~~  137 (231)
T 3aji_A          110 LHYAASKNRHEIAVMLLEGGANPDAKDH  137 (231)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence            7777777777777777776666554443

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.72  E-value=1.4e-17  Score=142.47  Aligned_cols=105  Identities=21%  Similarity=0.250  Sum_probs=70.4

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNT  103 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t  103 (337)
                      .+++.+|..|+||+++  |+..+..+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|+++|.+|..|.|
T Consensus       102 ~~~~~~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t  179 (237)
T 3b7b_A          102 MDVNCQDDGGWTPMIW--ATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDS  179 (237)
T ss_dssp             CCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCC
T ss_pred             CCcccCCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence            3455556666666644  66666666666666777777766667777777777777777777777777777777777777


Q ss_pred             chhhhhhhhhhhHHHHHHhhcCCCCCC
Q 019685          104 PLADAEGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus       104 ~l~~A~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      |||+|+..++.+++++|+.+|++....
T Consensus       180 ~L~~A~~~~~~~~v~~Ll~~gad~~~~  206 (237)
T 3b7b_A          180 PLHIAARENRYDCVVLFLSRDSDVTLK  206 (237)
T ss_dssp             HHHHHHHTTCHHHHHHHHTTTCCTTCC
T ss_pred             HHHHHHHhCCHhHHHHHHHcCCCCCcc
Confidence            777777777777777777666655433

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.72  E-value=1.5e-17  Score=151.77  Aligned_cols=104  Identities=14%  Similarity=-0.002  Sum_probs=92.6

Q ss_pred             hhhhhccCCchhHHHHHhhCC--HHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCC-----ccccc
Q 019685           26 QKEKARVSRTSLILWHAHQND--AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-----VNAQD   98 (337)
Q Consensus        26 ~~~~~~~~~~~~~~~~a~~~~--~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~-----~~~~d   98 (337)
                      .+.+|..|+|||++  |+..+  ..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++     +|.+|
T Consensus       131 ~~~~~~~g~t~L~~--A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~  208 (364)
T 3ljn_A          131 SHVKHCKGQTALHW--CVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYAN  208 (364)
T ss_dssp             TEEEEESCCCHHHH--HHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCC
T ss_pred             cccCCCCCCCHHHH--HHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccC
Confidence            33488889999966  88888  89999999999999999999999999999999999999999999998     99999


Q ss_pred             cccccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685           99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      ..|.||||+|+..++.+++++|+.+|++.+..+
T Consensus       209 ~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d  241 (364)
T 3ljn_A          209 KQGNSHLHWAILINWEDVAMRFVEMGIDVNMED  241 (364)
T ss_dssp             TTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCC
T ss_pred             CCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999999999988765444

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.71  E-value=1.8e-17  Score=138.02  Aligned_cols=104  Identities=17%  Similarity=0.225  Sum_probs=93.7

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHH-HcCCCcccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI-EYGADVNAQDRWK  101 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll-~~ga~~~~~d~~g  101 (337)
                      +.+++.+|..|+|||++  |+..+..+++++|++.|+++|..|..|+||||+|+..|+.+++++|+ ..+++++.+|..|
T Consensus        29 ~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g  106 (201)
T 3hra_A           29 TYQVDEVDTEGNTPLNI--AVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYG  106 (201)
T ss_dssp             TCCTTCCCTTSCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTS
T ss_pred             CCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCC
Confidence            34778888999999966  88888899999999999999999999999999999999999999999 6678999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhc-CCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHG-GLSY  128 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~-a~~~  128 (337)
                      .||||.|+..++.+++++|+..+ ++.+
T Consensus       107 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~  134 (201)
T 3hra_A          107 GNALIPAAEKGHIDNVKLLLEDGREDID  134 (201)
T ss_dssp             CCSHHHHHHTTCHHHHHHHHHHCCCCTT
T ss_pred             CcHHHHHHHcCCHHHHHHHHHcCCCCcC
Confidence            99999999999999999999988 5444

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.71  E-value=9.4e-18  Score=151.40  Aligned_cols=106  Identities=24%  Similarity=0.239  Sum_probs=54.8

Q ss_pred             hhhhhhhhccCCchhHHHHHh--hCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHc-CCCcccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAH--QNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY-GADVNAQDR   99 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~--~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~-ga~~~~~d~   99 (337)
                      +++++.+|..|+|++++.+.+  .++...++++|++.|+++|.+|.+|+||||+|+..|+.++++.|++. |+++|.+|.
T Consensus       192 gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~  271 (337)
T 4g8k_A          192 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDS  271 (337)
T ss_dssp             CCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCT
T ss_pred             CCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCC
Confidence            445555555555555432211  22334455555555555555555555555555555555555555543 455555555


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGLSY  128 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~~~  128 (337)
                      .|+||||+|+..++.+++++|+++|++++
T Consensus       272 ~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n  300 (337)
T 4g8k_A          272 DGKTALLLAVELKLKKIAELLCKRGASTD  300 (337)
T ss_dssp             TSCBHHHHHHHTTCHHHHHHHHTTSCSST
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence            55555555555555555555555555444

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.71  E-value=5e-18  Score=147.14  Aligned_cols=105  Identities=19%  Similarity=0.135  Sum_probs=95.7

Q ss_pred             Cchhhhhhhhcc-------------CCchhHHHHHhhCCHHHHHHHHHh---CCCCccccCCCCCcHHHHHHH--cCCHH
Q 019685           21 SSADKQKEKARV-------------SRTSLILWHAHQNDAAAVRKLLEE---DQSLVHARDYDNRTPLHVASL--HGWID   82 (337)
Q Consensus        21 ~~~~~~~~~~~~-------------~~~~~~~~~a~~~~~~~~~~lL~~---~~~~vn~~~~~g~tpLh~A~~--~g~~~   82 (337)
                      ..+++++.+|..             |+|||++  |+..+..+++++|++   .|+++|.+|.+|+||||+|+.  .++.+
T Consensus       111 ~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~--A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~  188 (256)
T 2etb_A          111 ENGADVHLRACGRFFQKHQGTCFYFGELPLSL--AACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPE  188 (256)
T ss_dssp             HTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHH--HHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHH
T ss_pred             HcCCCCCcccccccccccccccccCCCCHHHH--HHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCch
Confidence            346677777765             9999966  888899999999999   999999999999999999999  88998


Q ss_pred             -------HHHHHHHcCCCc-------cccccccccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685           83 -------VAKCLIEYGADV-------NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus        83 -------~~~~Ll~~ga~~-------~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                             ++++|+++|+++       |.+|..|+||||+|+..++.+++++|+++++..
T Consensus       189 ~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~  247 (256)
T 2etb_A          189 NSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSG  247 (256)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHcCCCcccccccccccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCC
Confidence                   999999999999       999999999999999999999999999988643

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.71  E-value=6.3e-18  Score=154.18  Aligned_cols=105  Identities=22%  Similarity=0.236  Sum_probs=98.9

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCC-----ccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL-----VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN   95 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~-----vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~   95 (337)
                      ..+++++.+|..|+|||++  |+..++.+++++|++.|++     +|..|..|+||||+||..|+.+++++|+++|||+|
T Consensus       161 ~~ga~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~  238 (364)
T 3ljn_A          161 QLGASPTAKDKADETPLMR--AMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVN  238 (364)
T ss_dssp             HHTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCTT
T ss_pred             HcCCCCcccCCCCCCHHHH--HHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCC
Confidence            4577889999999999966  9999999999999999998     99999999999999999999999999999999999


Q ss_pred             ccccccccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685           96 AQDRWKNTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus        96 ~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                      .+|..|.||||+|+..++.+++++|+.+++..
T Consensus       239 ~~d~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~  270 (364)
T 3ljn_A          239 MEDNEHTVPLYLSVRAAMVLLTKELLQKTDVF  270 (364)
T ss_dssp             CCCTTSCCHHHHHHHTCCHHHHHHHHHHSCHH
T ss_pred             CCCCCCCCHHHHHHHhChHHHHHHHHHcCCch
Confidence            99999999999999999999999999998764

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.71  E-value=5e-18  Score=149.86  Aligned_cols=103  Identities=17%  Similarity=0.077  Sum_probs=92.7

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP  104 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~  104 (337)
                      +++.+|..|+|||++  |+..+..+++++|++.|+++|..|  |+||||+||..|+.+++++|+++|+++|.+|..|.||
T Consensus        23 ~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~   98 (285)
T 3kea_A           23 DTFKADVHGHSASYY--AIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTA   98 (285)
T ss_dssp             TTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             CCCccCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcH
Confidence            578888999999966  888888999999999999999884  8999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          105 LADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       105 l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      ||+|+..++.+++++|+.++++.+..+
T Consensus        99 L~~A~~~g~~~~v~~Ll~~ga~~~~~~  125 (285)
T 3kea_A           99 LYYAVDSGNMQTVKLFVKKNWRLMFYG  125 (285)
T ss_dssp             HHHHHHTTCHHHHHHHHHHCGGGGGCS
T ss_pred             HHHHHHcCCHHHHHHHHhcCCCCCccC
Confidence            999999999999999999988765443

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.71  E-value=1.6e-17  Score=147.12  Aligned_cols=72  Identities=29%  Similarity=0.374  Sum_probs=35.2

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA   96 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~   96 (337)
                      +++++.+|..|+|||++  |+..++.+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|++++.
T Consensus        63 g~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~  134 (299)
T 1s70_B           63 GADINYANVDGLTALHQ--ACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGA  134 (299)
T ss_dssp             CCCTTCBCTTCCBHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTC
T ss_pred             CCCCcccCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCC
Confidence            33444444455555433  4444444455555555555555555555555555555555555555554444443

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.71  E-value=9.7e-18  Score=145.21  Aligned_cols=119  Identities=24%  Similarity=0.134  Sum_probs=90.1

Q ss_pred             CCCCCCchhhhhh-hhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCC-C
Q 019685           16 KGGATSSADKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGA-D   93 (337)
Q Consensus        16 ~~~~~~~~~~~~~-~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga-~   93 (337)
                      -......+++++. .|..|+|||++  |+..+..+++++|++.|+++|..|..|+||||+|+..|+.+++++|+++|+ +
T Consensus        39 v~~Ll~~g~~~~~~~d~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~  116 (253)
T 1yyh_A           39 ISDFIYQGASLHNQTDRTGETALHL--AARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATD  116 (253)
T ss_dssp             -------------CCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSC
T ss_pred             HHHHHHccCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            3344556666654 47888998865  888888888888889999999999999999999999999999999998887 8


Q ss_pred             ccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685           94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus        94 ~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      ++.+|..|.||||+|+..++.+++++|+.++++.+..+....+
T Consensus       117 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t  159 (253)
T 1yyh_A          117 LDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKS  159 (253)
T ss_dssp             TTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCB
T ss_pred             ccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCC
Confidence            8888888999999999888899999888888877665554444

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.71  E-value=1.8e-17  Score=137.98  Aligned_cols=110  Identities=18%  Similarity=0.250  Sum_probs=97.4

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHH-hCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcC-CCccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLE-EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQD   98 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~-~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~g-a~~~~~d   98 (337)
                      ..+++++.+|..|+||+++  |+..+..+++++|+ ..+++++..|..|.||||+|+..|+.+++++|+++| +++|.+|
T Consensus        60 ~~g~~~~~~~~~g~t~l~~--A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  137 (201)
T 3hra_A           60 DRGADINLQNSISDSPYLY--AGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQN  137 (201)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCC
T ss_pred             HcCCCCCCCCCCCCCHHHH--HHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCC
Confidence            4567888899999999966  88888888888888 678899999999999999999999999999999999 9999999


Q ss_pred             cccccchhhhhhhhh-----hhHHHHHHhhcCCCCCCCC
Q 019685           99 RWKNTPLADAEGAKK-----FNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~-----~~~v~~L~~~~a~~~~~~~  132 (337)
                      ..|.||||.|+..+.     .+++++|+++|++.+..+.
T Consensus       138 ~~g~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~  176 (201)
T 3hra_A          138 DFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDN  176 (201)
T ss_dssp             TTSCCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCT
T ss_pred             CCCCCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCC
Confidence            999999999998776     8999999999987765543

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.71  E-value=1.4e-17  Score=149.83  Aligned_cols=115  Identities=19%  Similarity=0.042  Sum_probs=86.3

Q ss_pred             Cchhhhhh-hhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCC-------------------
Q 019685           21 SSADKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-------------------   80 (337)
Q Consensus        21 ~~~~~~~~-~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~-------------------   80 (337)
                      ..++++|. +|..|+|||++  |+..++.+++++|++.|+++|.+|.+|+||||+|+..|+                   
T Consensus       118 ~~g~dvn~~~d~~g~TpLh~--Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~  195 (327)
T 1sw6_A          118 NTQLNLNIPVDEHGNTPLHW--LTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLI  195 (327)
T ss_dssp             TSCCCSCSCCSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGG
T ss_pred             hcCCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhcccc
Confidence            44577888 88999999966  888888999999999999999999889999888888655                   


Q ss_pred             ----------------------HHHHHHHHHcCC---------------------------------------------C
Q 019685           81 ----------------------IDVAKCLIEYGA---------------------------------------------D   93 (337)
Q Consensus        81 ----------------------~~~~~~Ll~~ga---------------------------------------------~   93 (337)
                                            .+++++|++.++                                             +
T Consensus       196 ~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~  275 (327)
T 1sw6_A          196 LEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANM  275 (327)
T ss_dssp             EECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHT
T ss_pred             CCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhC
Confidence                                  344555554422                                             4


Q ss_pred             ccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685           94 VNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus        94 ~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      +|.+|..|+||||+|+..++.+++++|+.+|++++..+....+|
T Consensus       276 ~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~Tp  319 (327)
T 1sw6_A          276 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP  319 (327)
T ss_dssp             TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred             CCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence            66667777777777777777888888887777766555444443

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.71  E-value=1.4e-17  Score=145.72  Aligned_cols=98  Identities=22%  Similarity=0.198  Sum_probs=91.0

Q ss_pred             hhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCC--------------CCCcHHHHHHHcCCHHHHHHHHH---cC
Q 019685           29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDY--------------DNRTPLHVASLHGWIDVAKCLIE---YG   91 (337)
Q Consensus        29 ~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~--------------~g~tpLh~A~~~g~~~~~~~Ll~---~g   91 (337)
                      +|..|+|||++  |+..+..+++++|++.|+++|..+.              .|.||||+|+..|+.+++++|++   +|
T Consensus        97 ~d~~g~tpL~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~g  174 (273)
T 2pnn_A           97 SYYKGQTALHI--AIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQP  174 (273)
T ss_dssp             TTTTTCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCC
T ss_pred             ccCCCCCHHHH--HHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCC
Confidence            56789999976  8999999999999999999999987              79999999999999999999999   99


Q ss_pred             CCccccccccccchhhhhhhhh---------hhHHHHHHhhcCCCC
Q 019685           92 ADVNAQDRWKNTPLADAEGAKK---------FNMMELLNAHGGLSY  128 (337)
Q Consensus        92 a~~~~~d~~g~t~l~~A~~~~~---------~~~v~~L~~~~a~~~  128 (337)
                      +++|.+|..|+||||+|+..++         .+++++|+.++++.+
T Consensus       175 ad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n  220 (273)
T 2pnn_A          175 ADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLH  220 (273)
T ss_dssp             CCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             CCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcc
Confidence            9999999999999999999887         789999999988764

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.71  E-value=1.7e-17  Score=145.31  Aligned_cols=70  Identities=34%  Similarity=0.478  Sum_probs=39.2

Q ss_pred             ccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc-ccccchhhhhhhhhhhHHHHHHhhcCCCCCC
Q 019685           61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR-WKNTPLADAEGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus        61 vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~-~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      ++.+|..|.||||+|+..|+.+++++|+++|+++|.++. .|.||||+|+..++.+++++|+.+|++++..
T Consensus       151 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~  221 (282)
T 1oy3_D          151 LEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTAR  221 (282)
T ss_dssp             TTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             CCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCccc
Confidence            444455555555555555555555555555555555553 2556666665555556666555555554433

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.71  E-value=2.2e-17  Score=146.13  Aligned_cols=96  Identities=23%  Similarity=0.254  Sum_probs=68.0

Q ss_pred             cCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhh
Q 019685           32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA  111 (337)
Q Consensus        32 ~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~  111 (337)
                      ++.|+|+.  |+..|..+++++|++.|+++|..|.+|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..
T Consensus        39 ~~~t~l~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~  116 (299)
T 1s70_B           39 DDGAVFLA--ACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASC  116 (299)
T ss_dssp             CHHHHHHH--HHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHH
T ss_pred             CCccHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHc
Confidence            44455533  6666666666666677777777777777777777777777777777777777777777777777777777


Q ss_pred             hhhhHHHHHHhhcCCCCC
Q 019685          112 KKFNMMELLNAHGGLSYG  129 (337)
Q Consensus       112 ~~~~~v~~L~~~~a~~~~  129 (337)
                      ++.+++++|+.++++...
T Consensus       117 g~~~~v~~Ll~~g~~~~~  134 (299)
T 1s70_B          117 GYLDIAEYLISQGAHVGA  134 (299)
T ss_dssp             TCHHHHHHHHHTTCCTTC
T ss_pred             CCHHHHHHHHhCCCCCCC
Confidence            777777777777665543

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.70  E-value=7.4e-18  Score=146.31  Aligned_cols=104  Identities=16%  Similarity=0.104  Sum_probs=94.4

Q ss_pred             chhhhhhhh--------------ccCCchhHHHHHhhCCHHHHHHHHHh---CCCCccccCCCCCcHHHHHHHcCC----
Q 019685           22 SADKQKEKA--------------RVSRTSLILWHAHQNDAAAVRKLLEE---DQSLVHARDYDNRTPLHVASLHGW----   80 (337)
Q Consensus        22 ~~~~~~~~~--------------~~~~~~~~~~~a~~~~~~~~~~lL~~---~~~~vn~~~~~g~tpLh~A~~~g~----   80 (337)
                      .+++++.++              ..|+|||++  |+..+..+++++|++   .|+++|.+|..|+||||+|+..|+    
T Consensus       115 ~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~--A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~  192 (260)
T 3jxi_A          115 KGADVHAQARGRFFQPKDEGGYFYFGELPLSL--AACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRE  192 (260)
T ss_dssp             TTCCTTCCCEECCCSSSCCCCSCCSCSSHHHH--HHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHH
T ss_pred             CCCCcCccccccccCcccccccccCCCCHHHH--HHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchh
Confidence            456666666              579999976  888899999999999   999999999999999999999888    


Q ss_pred             -----HHHHHHHHHcCCCc-------cccccccccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685           81 -----IDVAKCLIEYGADV-------NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus        81 -----~~~~~~Ll~~ga~~-------~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                           .+++++|+++|+++       +.+|..|+||||+|+..++.+++++|+++++..
T Consensus       193 ~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~  251 (260)
T 3jxi_A          193 NTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIAD  251 (260)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCcccccccchhhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCc
Confidence                 79999999999999       789999999999999999999999999998754

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.70  E-value=1.1e-17  Score=143.14  Aligned_cols=102  Identities=23%  Similarity=0.335  Sum_probs=89.9

Q ss_pred             chhhhhhhh-ccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           22 SADKQKEKA-RVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        22 ~~~~~~~~~-~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      .+++++.++ ..|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..
T Consensus       138 ~g~~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  215 (241)
T 1k1a_A          138 RGADIDAVDIKSGRSPLIH--AVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCH  215 (241)
T ss_dssp             TTCCTTCCCTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             cCCCcccccccCCCcHHHH--HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCcCCC
Confidence            456677777 789999966  88999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGG  125 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a  125 (337)
                      |.|||++|+..++.++++.|...++
T Consensus       216 g~tpl~~A~~~~~~~i~~~l~~~~a  240 (241)
T 1k1a_A          216 NDTPLMVARSRRVIDILRGKATRPA  240 (241)
T ss_dssp             SCCTTTTCSSHHHHHHHTC------
T ss_pred             CCCHHHHHHhcCcHHHHhhhccCCC
Confidence            9999999999999999998876553

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.70  E-value=2.7e-17  Score=144.01  Aligned_cols=106  Identities=24%  Similarity=0.227  Sum_probs=94.3

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCH----HHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHH-cCCCcccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDA----AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQ   97 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~----~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~-~ga~~~~~   97 (337)
                      +++++.+|..|+||+++  |+..+.    .+++++|++.|+++|.+|..|.||||+|+..|+.+++++|++ .|+++|.+
T Consensus       172 ~~~~~~~~~~g~t~l~~--a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~  249 (285)
T 1wdy_A          172 GADVNACDNMGRNALIH--ALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDT  249 (285)
T ss_dssp             CCCTTCCCTTSCCHHHH--HHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCC
T ss_pred             CCCCCccCCCCCCHHHH--HHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhccCCCcccc
Confidence            66778888899999865  665555    889999999999999999999999999999999999999998 89999999


Q ss_pred             ccccccchhhhhhhhhhhHHHHHHhhcCCCCCC
Q 019685           98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus        98 d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      |..|.||||+|+..++.+++++|+++|++++..
T Consensus       250 ~~~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~  282 (285)
T 1wdy_A          250 DSDGKTALLLAVELKLKKIAELLCKRGASTDCG  282 (285)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCS
T ss_pred             CCCCCcHHHHHHHcCcHHHHHHHHHcCCCCCcc
Confidence            999999999999999999999999999876543

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.70  E-value=3.2e-17  Score=144.61  Aligned_cols=102  Identities=25%  Similarity=0.222  Sum_probs=95.3

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP  104 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~  104 (337)
                      ..+.+|..|+|||++  |+..+..+++++|++.|+++|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||
T Consensus        51 ~~~~~~~~g~t~L~~--Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~  128 (285)
T 3d9h_A           51 PLMGDAVSDWSPMHE--AAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTP  128 (285)
T ss_dssp             TTCSSSCCSCCHHHH--HHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCH
T ss_pred             cccCCCccCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            356788999999966  888888999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhhHHHHHHhhcCCCC
Q 019685          105 LADAEGAKKFNMMELLNAHGGLSY  128 (337)
Q Consensus       105 l~~A~~~~~~~~v~~L~~~~a~~~  128 (337)
                      ||+|+..++.+++++|+.++++..
T Consensus       129 L~~A~~~~~~~~v~~Ll~~g~~~~  152 (285)
T 3d9h_A          129 LFNACVSGSWDCVNLLLQHGASVQ  152 (285)
T ss_dssp             HHHHHHHTCHHHHHHHHHTTCCSS
T ss_pred             HHHHHHcCHHHHHHHHHHCCCCCC
Confidence            999999999999999999987654

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.69  E-value=5e-17  Score=137.99  Aligned_cols=94  Identities=27%  Similarity=0.365  Sum_probs=59.0

Q ss_pred             hhccCCchhHHHHHhhCCHHHHHHHHHhCC--CCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchh
Q 019685           29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQ--SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA  106 (337)
Q Consensus        29 ~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~--~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~  106 (337)
                      ++..|+|||++  |+..+..+++++|++.|  ++++..|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus        68 ~~~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~  145 (228)
T 2dzn_A           68 PDDSGWTPFHI--ACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLH  145 (228)
T ss_dssp             CCTTSCCHHHH--HHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHH
T ss_pred             CCCCCCCHHHH--HHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHH
Confidence            44556666644  55555556666666665  566666666666666666666666666666666666666666666666


Q ss_pred             hhhhhhhhhHHHHHHhhc
Q 019685          107 DAEGAKKFNMMELLNAHG  124 (337)
Q Consensus       107 ~A~~~~~~~~v~~L~~~~  124 (337)
                      +|+..++.+++++|+..+
T Consensus       146 ~A~~~~~~~~v~~Ll~~g  163 (228)
T 2dzn_A          146 RAASVGSLKLIELLCGLG  163 (228)
T ss_dssp             HHHHTTCHHHHHHHHTTT
T ss_pred             HHHHcCCHHHHHHHHhcC
Confidence            666666666666666655

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.69  E-value=8.1e-17  Score=145.35  Aligned_cols=105  Identities=29%  Similarity=0.256  Sum_probs=95.1

Q ss_pred             hhccCCchhHHHHHhhC---CHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccch
Q 019685           29 KARVSRTSLILWHAHQN---DAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL  105 (337)
Q Consensus        29 ~~~~~~~~~~~~~a~~~---~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l  105 (337)
                      .+..|.|||++  |+..   +..+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|..|+|||
T Consensus       207 ~~~~~~t~L~~--A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t~L  284 (351)
T 3utm_A          207 QPQSHETALHC--AVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTAL  284 (351)
T ss_dssp             CTTTCCCHHHH--HHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred             CCCCCCCHHHH--HHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence            45678899865  7666   779999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHHHhhcCCCCCCCCCCC
Q 019685          106 ADAEGAKKFNMMELLNAHGGLSYGQNGSHF  135 (337)
Q Consensus       106 ~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~  135 (337)
                      |+|+..++.+++++|+.+|+++...+....
T Consensus       285 ~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~  314 (351)
T 3utm_A          285 HRAALAGHLQTCRLLLSYGSDPSIISLQGF  314 (351)
T ss_dssp             HHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HHHHHcCcHHHHHHHHHcCCCCCCcCCCCC
Confidence            999999999999999999998766554443

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.69  E-value=5.2e-17  Score=146.51  Aligned_cols=101  Identities=20%  Similarity=0.245  Sum_probs=88.8

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHh-CCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~-~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++ .|++||.+|.+|+||||+||..|+.++|++||++|||+|.+  
T Consensus       227 ~~gad~n~~d~~g~t~L~~--a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~--  302 (337)
T 4g8k_A          227 DHGADVNVRGERGKTPLIL--AVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG--  302 (337)
T ss_dssp             HTTCCTTCCCGGGCCHHHH--HHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC--
T ss_pred             HCCCCCCCcCCCCCCHHHH--HHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC--
Confidence            4577889999999999965  777777777777666 58999999999999999999999999999999999999865  


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGGLSY  128 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a~~~  128 (337)
                         +|||.|+..++.+++++|+++||+++
T Consensus       303 ---~~L~~A~~~~~~~iv~~Ll~~GA~~d  328 (337)
T 4g8k_A          303 ---DLVMTARRNYDHSLVKVLLSHGAKED  328 (337)
T ss_dssp             ---CHHHHHHHTTCHHHHHHHHHTTCCC-
T ss_pred             ---CHHHHHHHcCCHHHHHHHHHCcCCCC
Confidence               59999999999999999999999765

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.69  E-value=3.3e-17  Score=144.53  Aligned_cols=102  Identities=12%  Similarity=-0.019  Sum_probs=93.6

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+++++.+  +|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        53 ~g~~~~~~--~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g  128 (285)
T 3kea_A           53 AGALKNLL--ENEFPLHQ--AATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTG  128 (285)
T ss_dssp             TTGGGSCC--TTCCHHHH--HTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSSSG
T ss_pred             CCCCCCCC--CCCCHHHH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCCCC
Confidence            45666666  48999966  999999999999999999999999999999999999999999999999999999999999


Q ss_pred             -ccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685          102 -NTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus       102 -~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                       .||||.|+..++.+++++|+.+++..
T Consensus       129 ~~t~L~~A~~~~~~~~v~~Ll~~g~~~  155 (285)
T 3kea_A          129 WKTSFYHAVMLNDVSIVSYFLSEIPST  155 (285)
T ss_dssp             GGSHHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred             CCCHHHHHHHcCCHHHHHHHHhCCCcc
Confidence             79999999999999999999988643

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.68  E-value=6e-17  Score=142.88  Aligned_cols=106  Identities=21%  Similarity=0.161  Sum_probs=96.5

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+++++.+|.+|+|||++  |+..+..+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+ .|
T Consensus        81 ~g~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~-~g  157 (285)
T 3d9h_A           81 QGWAVNIITADHVSPLHE--ACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DL  157 (285)
T ss_dssp             TTCCSCEECTTCCCHHHH--HHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSC-TT
T ss_pred             CCCCCCCcCCCCCCHHHH--HHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCC-CC
Confidence            456788899999999976  999999999999999999999999999999999999999999999999999998655 49


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      .||||+|+..++.+++++|+.++++.+..
T Consensus       158 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~  186 (285)
T 3d9h_A          158 ASPIHEAARRGHVECVNSLIAYGGNIDHK  186 (285)
T ss_dssp             SCHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCCCCc
Confidence            99999999999999999999998865543

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.68  E-value=9.4e-17  Score=137.21  Aligned_cols=107  Identities=28%  Similarity=0.330  Sum_probs=65.3

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcC-CCcccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQDRWK  101 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~g-a~~~~~d~~g  101 (337)
                      +++++.++..|+|||++  |+..+..+++++|++.|++++..+..|.||||+|+..|+.+++++|+++| ++++.+|..|
T Consensus        34 g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g  111 (237)
T 3b7b_A           34 GANIDTCSEDQRTPLME--AAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGG  111 (237)
T ss_dssp             TCCTTCCCTTCCCHHHH--HHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTS
T ss_pred             CCCcCccCCCCCCHHHH--HHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCC
Confidence            44555555666666644  55555666666666666666666666666666666666666666666665 5666666666


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQN  131 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~  131 (337)
                      .||||.|+..++.+++++|+.++++.+..+
T Consensus       112 ~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~  141 (237)
T 3b7b_A          112 WTPMIWATEYKHVDLVKLLLSKGSDINIRD  141 (237)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCCCccC
Confidence            666666666666666666666665554443

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.67  E-value=7.3e-17  Score=147.84  Aligned_cols=98  Identities=27%  Similarity=0.326  Sum_probs=89.3

Q ss_pred             hhhhccCCchhHHHHHhhCCHHHHHHHHHhCC-CCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccch
Q 019685           27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPL  105 (337)
Q Consensus        27 ~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~-~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l  105 (337)
                      +.+|..|+|||++  |+..+..+++++|++.+ +++|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|..|.|||
T Consensus       273 ~~~d~~g~t~Lh~--A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l  350 (373)
T 2fo1_E          273 DSEKYKGRTALHY--AAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTAR  350 (373)
T ss_dssp             SSSSCCCCCTHHH--HHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHH
T ss_pred             CcccccCCCHHHH--HHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHH
Confidence            3467789999966  88888889999998765 99999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHHHhhcCC
Q 019685          106 ADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       106 ~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      ++|+..++.+++++|..+++.
T Consensus       351 ~~A~~~g~~~iv~~Ll~~~a~  371 (373)
T 2fo1_E          351 QLAQANNHHNIVDIFDRCRPE  371 (373)
T ss_dssp             HHHHHTTCHHHHHHHHTTC--
T ss_pred             HHHHHcCCHHHHHHHHhcCcc
Confidence            999999999999999988763

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.66  E-value=1.3e-16  Score=146.15  Aligned_cols=107  Identities=24%  Similarity=0.294  Sum_probs=95.8

Q ss_pred             hhhhhhhccCCchhHHHHHhhCC---HHHHHHHHHhCCCCccc--------cCCCCCcHHHHHHHcCCHHHHHHHHHcC-
Q 019685           24 DKQKEKARVSRTSLILWHAHQND---AAAVRKLLEEDQSLVHA--------RDYDNRTPLHVASLHGWIDVAKCLIEYG-   91 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~---~~~~~~lL~~~~~~vn~--------~~~~g~tpLh~A~~~g~~~~~~~Ll~~g-   91 (337)
                      ++++.+|..|+|||++  |+..+   ..+++++|++.|+++|.        .|..|+||||+||..|+.+++++|+++| 
T Consensus       226 ~~~~~~d~~g~t~L~~--A~~~~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~  303 (373)
T 2fo1_E          226 GDIEELDRNGMTALMI--VAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKG  303 (373)
T ss_dssp             HTTSCCCTTSCCHHHH--HHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSC
T ss_pred             cChhhcCCCCCCHHHH--HHHhCCcchHHHHHHHHHCCCCcccccccccCcccccCCCHHHHHHHhCCHHHHHHHHHhcC
Confidence            6788889999999965  66655   99999999999999886        6779999999999999999999999886 


Q ss_pred             CCccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCC
Q 019685           92 ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus        92 a~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      +++|.+|..|.||||+|+..++.+++++|+.+|++.+..+.
T Consensus       304 ~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~  344 (373)
T 2fo1_E          304 SNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDA  344 (373)
T ss_dssp             CCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCS
T ss_pred             CCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCC
Confidence            99999999999999999999999999999999987765543

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.66  E-value=2e-16  Score=138.47  Aligned_cols=105  Identities=22%  Similarity=0.199  Sum_probs=95.6

Q ss_pred             hhhhhhh-hccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           23 ADKQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        23 ~~~~~~~-~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      +.+++.+ +..|+|||++  |+..+..+++++|++.|++++..|.+|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        28 g~~~~~~~~~~g~t~L~~--A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g  105 (285)
T 1wdy_A           28 GANVNFQEEEGGWTPLHN--AVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYG  105 (285)
T ss_dssp             TCCTTCCCTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTC
T ss_pred             CCCcccccCCCCCcHHHH--HHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCccc
Confidence            4556656 6778999866  999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYG  129 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~  129 (337)
                      .||||.|+..++.+++++|+.++++...
T Consensus       106 ~t~L~~A~~~~~~~~~~~Ll~~g~~~~~  133 (285)
T 1wdy_A          106 FTAFMEAAVYGKVKALKFLYKRGANVNL  133 (285)
T ss_dssp             CBHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred             CCHHHHHHHhCCHHHHHHHHHhCCCccc
Confidence            9999999999999999999999886543

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.64  E-value=2.8e-16  Score=143.19  Aligned_cols=99  Identities=20%  Similarity=0.153  Sum_probs=88.1

Q ss_pred             CCchhHHHHHhhC-CHHHHHHHHHhCCCCccccC--CCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhh
Q 019685           33 SRTSLILWHAHQN-DAAAVRKLLEEDQSLVHARD--YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAE  109 (337)
Q Consensus        33 ~~~~~~~~~a~~~-~~~~~~~lL~~~~~~vn~~~--~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~  109 (337)
                      +.|+|  |.|+.. +..+++++|++.|+++|..+  ..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+
T Consensus       199 ~~t~L--~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~  276 (368)
T 3jue_A          199 PGALL--FRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHAT  276 (368)
T ss_dssp             HHHHH--HHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             CCcHH--HHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH
Confidence            34555  347776 88888888889999999998  89999999999999999999999999999999999999999999


Q ss_pred             hhhhhhHHHHHHhhcCCCCCCCCC
Q 019685          110 GAKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       110 ~~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      ..++.+++++|+.++++.+..+..
T Consensus       277 ~~g~~~~v~~LL~~Gad~~~~d~~  300 (368)
T 3jue_A          277 ILGHTGLACLFLKRGADLGARDSE  300 (368)
T ss_dssp             HHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HcCcHHHHHHHHHCcCCCCCcCCC
Confidence            999999999999999887655433

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.62  E-value=1e-15  Score=130.50  Aligned_cols=107  Identities=21%  Similarity=0.167  Sum_probs=88.6

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      .+++++.+|..|.|||++  |+..+..+++++|++.|++++..+ ..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        31 ~g~~~~~~~~~g~t~L~~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~  108 (240)
T 3eu9_A           31 AGYDVRQPDKENVTLLHW--AAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGE  108 (240)
T ss_dssp             TTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             cCCCcCCCCCCCCCHHHH--HHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCCC
Confidence            456677778888888865  888888888888888888887654 44889999999999999999999999999988889


Q ss_pred             cccchhhhhhhhhhhHHHHHHhhcCCCCCC
Q 019685          101 KNTPLADAEGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      |.||||.|+..++.+++++|+.++++....
T Consensus       109 g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~  138 (240)
T 3eu9_A          109 GCSCIHLAAQFGHTSIVAYLIAKGQDVDMM  138 (240)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             CCCHHHHHHHcCHHHHHHHHHhcCCCcccc
Confidence            999999999999999999998887765443

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E*

Probab=99.60  E-value=1.4e-15  Score=144.66  Aligned_cols=99  Identities=18%  Similarity=0.096  Sum_probs=88.0

Q ss_pred             HHHHhhCCHHHHHHHHHhCCCCcccc------CCCCCcHHHHHHH---cCCHHHHHHHHHcCCCccccccccccchhhhh
Q 019685           39 LWHAHQNDAAAVRKLLEEDQSLVHAR------DYDNRTPLHVASL---HGWIDVAKCLIEYGADVNAQDRWKNTPLADAE  109 (337)
Q Consensus        39 ~~~a~~~~~~~~~~lL~~~~~~vn~~------~~~g~tpLh~A~~---~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~  109 (337)
                      +|.|+..+..++++.|++.|+++|..      |..|+||||+|+.   .|+.+++++||++|||+|.+|..|+||||+|+
T Consensus       136 L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpLh~A~  215 (497)
T 3lvq_E          136 LWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAA  215 (497)
T ss_dssp             HHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHHHHHT
T ss_pred             HHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHHHHHH
Confidence            45577777777777777999999987      8899999999966   99999999999999999999999999999999


Q ss_pred             hhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685          110 GAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus       110 ~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      ..++.+++++|+.+|++.+..+....+|
T Consensus       216 ~~g~~~~v~~Ll~~ga~~~~~d~~g~tp  243 (497)
T 3lvq_E          216 LYNQPDCLKLLLKGRALVGTVNEAGETA  243 (497)
T ss_dssp             TTTCHHHHHHHHHTCCCCSCCCTTCCCH
T ss_pred             HcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence            9999999999999999988777666554

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.59  E-value=1.2e-15  Score=130.03  Aligned_cols=101  Identities=24%  Similarity=0.208  Sum_probs=50.1

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCC-HHHHHHHHHcCCCcccccc-ccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-IDVAKCLIEYGADVNAQDR-WKN  102 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~-~~~~~~Ll~~ga~~~~~d~-~g~  102 (337)
                      +++.+|..|+||++.  |+..+..+++++|++.|++++..|..|.||||+|+..++ .+++++|++.|++++..+. .|.
T Consensus       101 ~~~~~~~~g~t~l~~--A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~~~g~  178 (240)
T 3eu9_A          101 DPSLIDGEGCSCIHL--AAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKN  178 (240)
T ss_dssp             CTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCTTTCC
T ss_pred             CCcccCCCCCCHHHH--HHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhccCCC
Confidence            344444445554433  444444455555555555555555555555555554433 4455555555555555444 455


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                      ||||.|+..++.+++++|+.++++.
T Consensus       179 t~L~~A~~~~~~~~v~~Ll~~g~~~  203 (240)
T 3eu9_A          179 TALHWAVLAGNTTVISLLLEAGANV  203 (240)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHHTCCT
T ss_pred             cHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            5555555555555555555554443

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.59  E-value=7.5e-16  Score=138.56  Aligned_cols=87  Identities=22%  Similarity=0.238  Sum_probs=75.8

Q ss_pred             hhhhhhhccCCchhHHHHHhh----CCHHHHHHHHHhCCC----------------------------------------
Q 019685           24 DKQKEKARVSRTSLILWHAHQ----NDAAAVRKLLEEDQS----------------------------------------   59 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~----~~~~~~~~lL~~~~~----------------------------------------   59 (337)
                      ++++.+|..|+|||++  |+.    .+..+++++|++.++                                        
T Consensus       192 ~~~~~~d~~g~tpLh~--A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~  269 (327)
T 1sw6_A          192 PCLILEDSMNRTILHH--IIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLK  269 (327)
T ss_dssp             GGGGEECTTCCCHHHH--HHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHH
T ss_pred             ccccCCCCCCCCHHHH--HHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHH
Confidence            5788889999999966  666    778888888877642                                        


Q ss_pred             -----CccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhh
Q 019685           60 -----LVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK  112 (337)
Q Consensus        60 -----~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~  112 (337)
                           ++|.+|.+|+||||+||..|+.++|++|+++|||+|.+|..|+||||+|+..|
T Consensus       270 ~Ll~~~~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~~~g  327 (327)
T 1sw6_A          270 WIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGAGLE  327 (327)
T ss_dssp             HHHHHTTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTCC--
T ss_pred             HHHHhCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcC
Confidence                 58889999999999999999999999999999999999999999999998754

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.59  E-value=6.9e-16  Score=116.72  Aligned_cols=83  Identities=33%  Similarity=0.358  Sum_probs=75.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++||++|.++..
T Consensus        30 ~~g~~~~~~d~~g~t~L~~--A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~n~~~~~  107 (115)
T 2l6b_A           30 SKGADVNARSKDGNTPLHL--AAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWG  107 (115)
T ss_dssp             TTTCCSSCCCSSSCCTTHH--HHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTSSSHHHHSCC
T ss_pred             HcCCCCCCcCCCCCCHHHH--HHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCcc
Confidence            4567888899999999966  88999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccch
Q 019685          101 KNTPL  105 (337)
Q Consensus       101 g~t~l  105 (337)
                      |.||-
T Consensus       108 ~~~~~  112 (115)
T 2l6b_A          108 SSHHH  112 (115)
T ss_dssp             CC---
T ss_pred             ccccc
Confidence            99884

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.59  E-value=3.2e-15  Score=131.29  Aligned_cols=97  Identities=14%  Similarity=0.007  Sum_probs=82.3

Q ss_pred             HHHhhCCHHHHHHHHHhCCCCc------cccCCCCCcHHHHHHHc---CCHHHHHHHHHcCCCccccccccccchhhhhh
Q 019685           40 WHAHQNDAAAVRKLLEEDQSLV------HARDYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADAEG  110 (337)
Q Consensus        40 ~~a~~~~~~~~~~lL~~~~~~v------n~~~~~g~tpLh~A~~~---g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~  110 (337)
                      +.|+..+..+.+..+++.|+++      +..|..|+||||+||..   |+.+++++|+++||++|.+|..|+||||+|+.
T Consensus       135 ~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~  214 (278)
T 1dcq_A          135 CEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCL  214 (278)
T ss_dssp             HHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHH
T ss_pred             hhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHH
Confidence            4466555555666666889984      45588999999999999   89999999999999999999999999999999


Q ss_pred             hhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685          111 AKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       111 ~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      .++.+++++|+.+|++++..+....+
T Consensus       215 ~g~~~~v~~Ll~~gad~~~~d~~g~t  240 (278)
T 1dcq_A          215 TDNAECLKLLLRGKASIEIANESGET  240 (278)
T ss_dssp             TTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             cCCHHHHHHHHHcCCCCCCccCCCCC
Confidence            99999999999999987766554443

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.57  E-value=3.4e-15  Score=132.69  Aligned_cols=94  Identities=18%  Similarity=0.095  Sum_probs=81.6

Q ss_pred             HHHhhCCHHHHHHHHHhCCCCccc------cCCCCCcHHHHHHHc---CCHHHHHHHHHcCCCccccccccccchhhhhh
Q 019685           40 WHAHQNDAAAVRKLLEEDQSLVHA------RDYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADAEG  110 (337)
Q Consensus        40 ~~a~~~~~~~~~~lL~~~~~~vn~------~~~~g~tpLh~A~~~---g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~  110 (337)
                      +.|+..+..+.++.|++.|+++|.      .|..|+||||+|+..   |+.+++++|+++|+++|.+|..|.||||+|+.
T Consensus       156 ~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~  235 (301)
T 2b0o_E          156 WTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAAL  235 (301)
T ss_dssp             HHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHH
T ss_pred             hhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence            335555555555566699999998      689999999999997   89999999999999999999999999999999


Q ss_pred             hhhhhHHHHHHhhcCCCCCCCCC
Q 019685          111 AKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       111 ~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      .++.+++++|+.+|++++..+..
T Consensus       236 ~g~~~~v~~Ll~~gad~~~~d~~  258 (301)
T 2b0o_E          236 YNQPDCLKLLLKGRALVGTVNEA  258 (301)
T ss_dssp             TTCHHHHHHHHHTTCCCSCCCTT
T ss_pred             cCCHHHHHHHHHcCCCCCCcCCC
Confidence            99999999999999987655543

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.56  E-value=5e-15  Score=107.56  Aligned_cols=71  Identities=39%  Similarity=0.506  Sum_probs=66.2

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCC
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD   93 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~   93 (337)
                      ..+++++.+|..|+|||++  |+..+..+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++||+
T Consensus        23 ~~g~~~n~~d~~g~t~L~~--A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~Ll~~ga~   93 (93)
T 1n0q_A           23 EAGADVNAKDKNGRTPLHL--AARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY   93 (93)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred             HcCCCCcccCCCCCCHHHH--HHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence            3567889999999999966  9999999999999999999999999999999999999999999999999986

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.48  E-value=2.5e-15  Score=137.30  Aligned_cols=92  Identities=16%  Similarity=0.085  Sum_probs=78.0

Q ss_pred             ccCCchhHHHHHhhCCHHHHHHHHHhCCCCc---cccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccc--cccccccch
Q 019685           31 RVSRTSLILWHAHQNDAAAVRKLLEEDQSLV---HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNA--QDRWKNTPL  105 (337)
Q Consensus        31 ~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~v---n~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~--~d~~g~t~l  105 (337)
                      ..++|||++  |+.+|+.+++++|++.|+++   +..+.+ +||||+||..||.++|++|+++|++++.  +|..|.|||
T Consensus       126 ~~~~tpL~~--Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL  202 (376)
T 2aja_A          126 AENYQAFRL--AAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAF  202 (376)
T ss_dssp             HHHHHHHHH--HHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHH
T ss_pred             cCCCCHHHH--HHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHH
Confidence            345677755  99999999999999999752   222223 9999999999999999999999999988  899999999


Q ss_pred             hhhh-hhhhhhHHHHHHhhcC
Q 019685          106 ADAE-GAKKFNMMELLNAHGG  125 (337)
Q Consensus       106 ~~A~-~~~~~~~v~~L~~~~a  125 (337)
                      |+|+ ..|+.+++++|+..++
T Consensus       203 ~~Aa~~~G~~eiv~~Ll~~ga  223 (376)
T 2aja_A          203 RWAAVGRGHHNVINFLLDCPV  223 (376)
T ss_dssp             HHHHSTTCCHHHHHHHTTSHH
T ss_pred             HHHHHHCCCHHHHHHHHhCCC
Confidence            9999 9999999999988654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=5.9e-13  Score=115.63  Aligned_cols=143  Identities=13%  Similarity=0.056  Sum_probs=108.3

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      .|.....++.|+.+.||++...++.+++|.........   ...+.+|+.+++.+. +..+++++++....+..|+|||+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            35555667778888999998778899999886422111   135778999998885 67788999998888889999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-----------------------------------------  275 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----------------------------------------  275 (337)
                      ++|.+|.+.+.     +......++.+++.+|..||+..                                         
T Consensus        92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            99999877531     22233477889999999999810                                         


Q ss_pred             ----------------CCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          276 ----------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       276 ----------------~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                                      ..++|+|++|.||++  +....+.|+||+.+....
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~lIDwe~a~~gd  215 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSGRAD  215 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEE--ETTEEEEECCCTTCEEEE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEE--ECCcEEEEEEchhcccCC
Confidence                            228999999999999  444456799999886543

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.38  E-value=5.6e-14  Score=128.39  Aligned_cols=100  Identities=14%  Similarity=0.076  Sum_probs=79.3

Q ss_pred             hhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCC---ccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCC---ccccc
Q 019685           25 KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD---VNAQD   98 (337)
Q Consensus        25 ~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~---vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~---~~~~d   98 (337)
                      ....++.+++|||++  |+..|..+++++|++.|+.   .+..+..|.||||+||..||.++|++|+++|++   .+..+
T Consensus        84 ~l~~~g~~~~T~Lh~--Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~  161 (376)
T 2aja_A           84 DAHKKGIKSEVICFV--AAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQA  161 (376)
T ss_dssp             HHHHHTCCHHHHHHH--HHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSH
T ss_pred             HHHHcCCCcCCHHHH--HHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCC
Confidence            445566667788865  8888999999999999882   223445688999999999999999999999986   34444


Q ss_pred             cccccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685           99 RWKNTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                      .. .||||.|+..|+.+++++|+.++++.
T Consensus       162 ~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~  189 (376)
T 2aja_A          162 EN-YHAFRLAAENGHLHVLNRLCELAPTE  189 (376)
T ss_dssp             HH-HHHHHHHHHTTCHHHHHHHHHSCGGG
T ss_pred             CC-CCHHHHHHHCCCHHHHHHHHHcCCcc
Confidence            44 99999999999999999999998763

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.38  E-value=3.7e-13  Score=100.89  Aligned_cols=72  Identities=28%  Similarity=0.256  Sum_probs=62.8

Q ss_pred             ccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCC
Q 019685           61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNG  132 (337)
Q Consensus        61 vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~  132 (337)
                      .+..|.+|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..++.+++++|+.++++.+..+.
T Consensus        17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~   88 (110)
T 2zgd_A           17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDK   88 (110)
T ss_dssp             -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccc
Confidence            455678999999999999999999999999999999999999999999999999999999999987665443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.27  E-value=2.7e-11  Score=110.11  Aligned_cols=144  Identities=17%  Similarity=0.196  Sum_probs=104.5

Q ss_pred             cceecccCceeEEEEEECCceEEEEEec--CCCCchHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEEeC---CceEEEE
Q 019685          162 SAIIGKGSFGEILKAYWRGTPVAIKRIL--PSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTER---KPLMLIT  234 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~g~~vavK~l~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~---~~~~lv~  234 (337)
                      .+.|+.|.++.||+....+..+++|+..  ....  ......+.+|+.+++.+.  +..+++++..+.+.   +..|+||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3578899999999998888889998765  3211  112346778999999887  45578888887766   4489999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE----------------------------------------  274 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~----------------------------------------  274 (337)
                      ||++|..+.+..  ...+++.+...++.+++..|..||+.                                        
T Consensus       121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999997774311  12467888888999999999999972                                        


Q ss_pred             ----------------CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          275 ----------------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       275 ----------------~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                                      ...++|+|++|.||++..+....+.|+||+.+..-
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                            13489999999999993322233689999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.17  E-value=5.5e-11  Score=102.66  Aligned_cols=129  Identities=19%  Similarity=0.147  Sum_probs=92.5

Q ss_pred             cccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCC--eeeeeeeEEeCCceEEEEeecCCCCH
Q 019685          166 GKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN--IVQFLGAVTERKPLMLITEYLRGGDL  242 (337)
Q Consensus       166 g~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~--Iv~~~~~~~~~~~~~lv~e~~~~~~L  242 (337)
                      +.|..+.||++... |..+++|......      ...+..|+.+++.+.+.+  +++++++....+..++||||++|.+|
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l  102 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL  102 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence            35556899998765 5679999875431      134567888888876433  66788888877789999999999887


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------------
Q 019685          243 HKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-----------------------------------------------  275 (337)
Q Consensus       243 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----------------------------------------------  275 (337)
                      .  ..   ..+   ...++.+++..|..||+..                                               
T Consensus       103 ~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          103 L--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             T--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             C--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            4  11   112   2256677777788887642                                               


Q ss_pred             ---------CCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          276 ---------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       276 ---------~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                               ..++|+|++|.||++  +.++.+.|+||+.+....
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~--~~~~~~~liD~~~a~~g~  216 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMV--ENGRFSGFIDCGRLGVAD  216 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEE--ETTEEEEECCCTTCEEEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEE--ECCcEEEEEcchhcccCC
Confidence                     118999999999999  554556799999986643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.68  E-value=6.2e-08  Score=85.69  Aligned_cols=137  Identities=20%  Similarity=0.179  Sum_probs=96.8

Q ss_pred             ceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCC--eeeeeeeEEeCC---ceEEEEee
Q 019685          163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPN--IVQFLGAVTERK---PLMLITEY  236 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--Iv~~~~~~~~~~---~~~lv~e~  236 (337)
                      +.++.|....||+.   +..+++|+....     .....+.+|+.+++.+. +..  +.+++.......   ..|+||++
T Consensus        26 ~~~~~G~~n~v~~v---~~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           26 EISGEGNDCIAYEI---NRDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CEEEECSSEEEEES---TTSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             EecCCCCcceEEEE---CCEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            35889999999886   367888875321     33467888999998874 332  445554433332   34889999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-----------------------------------------  275 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----------------------------------------  275 (337)
                      ++|.++.+...  ..++..+...++.+++..|..||+..                                         
T Consensus        98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99988875432  24677777888888888888888511                                         


Q ss_pred             ---------------CCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          276 ---------------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       276 ---------------~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                                     ..++|+|++|.||++..+....+.|+||+.+..-
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                           1379999999999994322456789999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=6.7e-07  Score=79.13  Aligned_cols=136  Identities=20%  Similarity=0.172  Sum_probs=90.8

Q ss_pred             ceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCC---CeeeeeeeEE-eCCceEEEEeecC
Q 019685          163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP---NIVQFLGAVT-ERKPLMLITEYLR  238 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~---~Iv~~~~~~~-~~~~~~lv~e~~~  238 (337)
                      ..++.|....||+.   +..+++|+-..     ......+..|+.++..+.+.   .+.+++.+.. ..+..|++||+++
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eecCCCcceeEEEE---CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            45778888889987   78888887421     23346788999999998742   3566666653 3456789999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP-------------------------------------------  275 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-------------------------------------------  275 (337)
                      |.++.+..-  ..++..+...++.++...|..||+..                                           
T Consensus        97 G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           97 GQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             SEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             CeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            988765321  12344444444444544444444321                                           


Q ss_pred             ---------------CCcEeeCCCCCCEEEecCC---CCc-EEEEeccCceeee
Q 019685          276 ---------------NVIIHRDLKPRNVLLVNSS---ADH-LKVGDFGLSKLIK  310 (337)
Q Consensus       276 ---------------~~ivHrdlkp~Nil~~~~~---~~~-~kl~DFgla~~~~  310 (337)
                                     ..++|+|++|.||++  +.   ++. +.|+||+.+..-.
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~--~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLT--NLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEE--CTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEE--ecCCCCCceEEEEehhhcCCCC
Confidence                           236999999999999  44   344 4899999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.53  E-value=1.4e-06  Score=75.33  Aligned_cols=134  Identities=21%  Similarity=0.244  Sum_probs=93.0

Q ss_pred             ecccCce-eEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          165 IGKGSFG-EILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       165 lg~G~~g-~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      +..|..+ .||+....  +..+++|.-...      ....+.+|...|+.+. +--+.+++.++.+.+..|+|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4445544 58886654  567888976432      2456778999988875 444778888888888999999999998


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 019685          241 DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP---------------------------------------------  275 (337)
Q Consensus       241 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---------------------------------------------  275 (337)
                      ++.+.....    ......+..++...|.-||+..                                             
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887765431    2223345556666666666320                                             


Q ss_pred             -----------CCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          276 -----------NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       276 -----------~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                                 ..++|+|+.|.|||+  +..+.+-|+||+.+..-.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~--~~~~~~~viDwe~a~~gd  225 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIF--DEGKLIGCIDVGRVGIAD  225 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCEEEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEE--ECCeEEEEEECcccccCC
Confidence                       027899999999999  555556799999987543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.27  E-value=1.1e-06  Score=79.25  Aligned_cols=77  Identities=9%  Similarity=0.034  Sum_probs=50.9

Q ss_pred             cee-cccCceeEEEEEEC--------CceEEEEEecCCC---CchHHHHHHHHHHHHHHHhCC-C--CCeeeeeeeEEeC
Q 019685          163 AII-GKGSFGEILKAYWR--------GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLR-H--PNIVQFLGAVTER  227 (337)
Q Consensus       163 ~~l-g~G~~g~V~~~~~~--------g~~vavK~l~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~~Iv~~~~~~~~~  227 (337)
                      +.| +.|....+|+....        +..+++|......   ...   ...+.+|+.+++.+. +  -.+.+++.+..+.
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            467 77888899987765        6778888764322   000   134566777777765 2  3567777776554


Q ss_pred             ---CceEEEEeecCCCCH
Q 019685          228 ---KPLMLITEYLRGGDL  242 (337)
Q Consensus       228 ---~~~~lv~e~~~~~~L  242 (337)
                         +..|+|||+++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               346899999988654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.18  E-value=5e-06  Score=76.22  Aligned_cols=76  Identities=20%  Similarity=0.281  Sum_probs=47.9

Q ss_pred             ceecccCceeEEEEEE--CCceEEEEEecCCCC-chH---HHHHHHHHHHHHHHhCCC--C-CeeeeeeeEEeCCceEEE
Q 019685          163 AIIGKGSFGEILKAYW--RGTPVAIKRILPSLS-DDR---LVIQDFRHEVNLLVKLRH--P-NIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~--~g~~vavK~l~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~Iv~~~~~~~~~~~~~lv  233 (337)
                      +.||.|.++.||++..  .++.+++|...+... ...   ....++..|..+++.+..  + .+++++.+  +....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            4789999999999954  467899998754321 000   112445678888877642  3 34556543  34556899


Q ss_pred             EeecCCC
Q 019685          234 TEYLRGG  240 (337)
Q Consensus       234 ~e~~~~~  240 (337)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.12  E-value=3.8e-05  Score=68.46  Aligned_cols=73  Identities=15%  Similarity=0.164  Sum_probs=40.8

Q ss_pred             ceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC--CCCeeeeee------eEEeCCceEEEE
Q 019685          163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLG------AVTERKPLMLIT  234 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~------~~~~~~~~~lv~  234 (337)
                      ..|+.|..+.||+....+..+++|.....    .   .....|..++..+.  .-.+++++.      +....+..+++|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            35656678899998877667999988652    1   22233444444332  112334432      123456789999


Q ss_pred             eecCCCCH
Q 019685          235 EYLRGGDL  242 (337)
Q Consensus       235 e~~~~~~L  242 (337)
                      +|++|..+
T Consensus       111 ~~i~G~~~  118 (346)
T 2q83_A          111 DWIEGRPF  118 (346)
T ss_dssp             ECCCCBCC
T ss_pred             EeecCccC
Confidence            99998643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.90  E-value=7e-05  Score=69.11  Aligned_cols=75  Identities=15%  Similarity=0.156  Sum_probs=44.3

Q ss_pred             ceecccCceeEEEEEECCceEEEEEecCCCC---ch-H--HHHHHHHHHHHHHH-hCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLS---DD-R--LVIQDFRHEVNLLV-KLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~---~~-~--~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +.||.|..+.||++...++.++||...+...   .. .  .....+..|+..+. ......+++++.+.  .+..++|||
T Consensus        40 ~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~e  117 (420)
T 2pyw_A           40 KEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGMR  117 (420)
T ss_dssp             EECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEEC
T ss_pred             EEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEEe
Confidence            4688898999999977778899995432111   00 0  01122233333222 22234566777654  566799999


Q ss_pred             ec-CC
Q 019685          236 YL-RG  239 (337)
Q Consensus       236 ~~-~~  239 (337)
                      ++ ++
T Consensus       118 ~l~~g  122 (420)
T 2pyw_A          118 YLEPP  122 (420)
T ss_dssp             CCCTT
T ss_pred             ecCCc
Confidence            99 76

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.78  E-value=0.00011  Score=64.94  Aligned_cols=75  Identities=21%  Similarity=0.118  Sum_probs=58.5

Q ss_pred             cceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEeCCceEEEEeecC
Q 019685          162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      .+.|+.|.+..+|+....+..+++|.....      ....+..|+..|+.+.   ...+++++......+..|+|||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            356888999999998877888999976532      1356778888887774   3568888888777788999999999


Q ss_pred             CCCH
Q 019685          239 GGDL  242 (337)
Q Consensus       239 ~~~L  242 (337)
                      +..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.43  E-value=0.00041  Score=61.70  Aligned_cols=31  Identities=35%  Similarity=0.484  Sum_probs=25.9

Q ss_pred             CcEeeCCCCCCEEEecCCC----CcEEEEeccCceee
Q 019685          277 VIIHRDLKPRNVLLVNSSA----DHLKVGDFGLSKLI  309 (337)
Q Consensus       277 ~ivHrdlkp~Nil~~~~~~----~~~kl~DFgla~~~  309 (337)
                      .++|+|+.+.||++  +.+    +.+.|+||+.+..-
T Consensus       184 ~lvHgD~~~~Nil~--~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLW--LPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEE--CTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEe--ccCcCCCCCeEEEeCCCcCcC
Confidence            49999999999999  442    57899999988654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.31  E-value=0.0014  Score=57.27  Aligned_cols=71  Identities=8%  Similarity=0.004  Sum_probs=41.5

Q ss_pred             cceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEeec-CC
Q 019685          162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYL-RG  239 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~-~~  239 (337)
                      .+.|+.|....+|+.    ..+++|+.......    ......|+.+++.+. +.-..+++...  ...-++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            457888888999998    67888877542111    011234666666554 21124555443  33357899999 66


Q ss_pred             CCH
Q 019685          240 GDL  242 (337)
Q Consensus       240 ~~L  242 (337)
                      .++
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            444

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.29  E-value=0.0021  Score=55.88  Aligned_cols=74  Identities=20%  Similarity=0.109  Sum_probs=50.7

Q ss_pred             ccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-C--CCeeeeeeeEEeCCceEEEEee
Q 019685          161 SSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H--PNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       161 ~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      ....+|.|..+.||+.... |+.+++|+-.......   ...+..|+..|+.+. .  --+++++...    .-+++||+
T Consensus        19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            3467899999999999875 8899999765433222   145677888888774 2  2345555432    24789999


Q ss_pred             cCCCC
Q 019685          237 LRGGD  241 (337)
Q Consensus       237 ~~~~~  241 (337)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            87654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.27  E-value=0.00063  Score=60.05  Aligned_cols=140  Identities=17%  Similarity=0.114  Sum_probs=74.8

Q ss_pred             ceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-C-CCeeeeeee------EEeCCceEEEE
Q 019685          163 AIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H-PNIVQFLGA------VTERKPLMLIT  234 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h-~~Iv~~~~~------~~~~~~~~lv~  234 (337)
                      +.|+.|....+|+....+..+++|.......     ...+..|+.++..+. + -.+.+++..      ....+..++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEECC---EEEEEEEESSCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eccCCCcccceEEEEeCCccEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            4577788888999887766889998865311     123445666666553 1 113333321      12235678999


Q ss_pred             eecCCCCHH-----------HH---HHhc-CCC--------C---HHHHHH------------HHHHHHHHHHHHHcC--
Q 019685          235 EYLRGGDLH-----------KY---LKEK-GAL--------S---PSTAVN------------FALDIARGMAYLHNE--  274 (337)
Q Consensus       235 e~~~~~~L~-----------~~---l~~~-~~~--------~---~~~~~~------------~~~~i~~~l~~lH~~--  274 (337)
                      ++++|..+.           ..   ++.. ..+        .   +.....            +...+...+.++...  
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            999885431           11   1111 011        1   111000            001133445555421  


Q ss_pred             ---CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          275 ---PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       275 ---~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                         ...++|+|+.+.|||+  +.++.+.|+||+.+..-
T Consensus       183 ~~~~~~liHgDl~~~Nil~--~~~~~~~lIDf~~a~~g  218 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFF--LGDELSGLIDFYFACND  218 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCEEE
T ss_pred             ccCCcccCCCCCCccCEEE--eCCceEEEecchhccCc
Confidence               1238999999999999  44444579999988653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.02  E-value=0.005  Score=54.34  Aligned_cols=73  Identities=7%  Similarity=0.018  Sum_probs=44.3

Q ss_pred             eecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-C-CCeeeeeee-----EEeCCceEEEEe
Q 019685          164 IIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-H-PNIVQFLGA-----VTERKPLMLITE  235 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h-~~Iv~~~~~-----~~~~~~~~lv~e  235 (337)
                      .++ |....||+.... |+.+++|...+....    ...+..|..++..+. + -.+++++..     ....+..+++|+
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            455 667789987654 567999988643222    134555777766664 1 124444432     122455688999


Q ss_pred             ecCCCC
Q 019685          236 YLRGGD  241 (337)
Q Consensus       236 ~~~~~~  241 (337)
                      +++|..
T Consensus       108 ~i~G~~  113 (328)
T 1zyl_A          108 SVGGRQ  113 (328)
T ss_dssp             CCCCEE
T ss_pred             ecCCCC
Confidence            998743

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.90  E-value=0.0056  Score=56.46  Aligned_cols=69  Identities=12%  Similarity=0.113  Sum_probs=44.5

Q ss_pred             ceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEE
Q 019685          163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +.|+.|-...+|++...         +..+++|+....  ..   ...+..|..+++.+. +.-.+++++.+.  +  .+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            46777778899998864         467888877432  11   133446888877775 333356666543  2  38


Q ss_pred             EEeecCCC
Q 019685          233 ITEYLRGG  240 (337)
Q Consensus       233 v~e~~~~~  240 (337)
                      |+||++|.
T Consensus       150 v~e~l~G~  157 (429)
T 1nw1_A          150 LEEYIPSR  157 (429)
T ss_dssp             EECCCCEE
T ss_pred             EEEEeCCc
Confidence            99999863

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.79  E-value=0.0091  Score=55.50  Aligned_cols=71  Identities=18%  Similarity=0.125  Sum_probs=44.2

Q ss_pred             ceecccCceeEEEEEECC--ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEeCCceEEEEeecCC
Q 019685          163 AIIGKGSFGEILKAYWRG--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLMLITEYLRG  239 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g--~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~lv~e~~~~  239 (337)
                      +.|+.|-...+|++...+  ..+++|+........    -...+|..++..+...+ .+++++.+.  +  .+|+||++|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            467777778899998876  788888764322110    11146888888876433 356776662  2  359999987


Q ss_pred             CC
Q 019685          240 GD  241 (337)
Q Consensus       240 ~~  241 (337)
                      .+
T Consensus       186 ~~  187 (458)
T 2qg7_A          186 YA  187 (458)
T ss_dssp             EE
T ss_pred             cc
Confidence            43

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.75  E-value=0.0035  Score=56.82  Aligned_cols=138  Identities=19%  Similarity=0.222  Sum_probs=76.4

Q ss_pred             eecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEE
Q 019685          164 IIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       164 ~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      .|..|-...+|++...         ++.+++|+.-.. ..   ......+|..+++.+. +.-..++++.+..    .+|
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            5655666778988763         367888875221 11   1244567888887775 3334566665543    289


Q ss_pred             EeecCCCCHH--------------HHHHh---c----C-CCC--HHHHHHHHHHHHH-------------------HHHH
Q 019685          234 TEYLRGGDLH--------------KYLKE---K----G-ALS--PSTAVNFALDIAR-------------------GMAY  270 (337)
Q Consensus       234 ~e~~~~~~L~--------------~~l~~---~----~-~~~--~~~~~~~~~~i~~-------------------~l~~  270 (337)
                      |||++|..|.              +.+.+   .    + ...  +.++.++..++..                   .+.+
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            9999875432              11111   1    0 111  3445555544322                   2333


Q ss_pred             H----HcC--CCCcEeeCCCCCCEEEecC--CCCcEEEEeccCceee
Q 019685          271 L----HNE--PNVIIHRDLKPRNVLLVNS--SADHLKVGDFGLSKLI  309 (337)
Q Consensus       271 l----H~~--~~~ivHrdlkp~Nil~~~~--~~~~~kl~DFgla~~~  309 (337)
                      |    ...  ...++|+|+.+.||++..+  ..+.+.|+||..+..-
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence            3    221  1238999999999999433  1368999999988754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.58  E-value=0.027  Score=50.05  Aligned_cols=32  Identities=25%  Similarity=0.434  Sum_probs=26.7

Q ss_pred             CcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       277 ~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      .++|+|+.+.||++  +.++.+.|+||+.+....
T Consensus       207 ~~~HgD~~~~N~l~--~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          207 VLCHSDIHAGNVLV--GNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             EEECSCCCGGGEEE--CGGGCEEECCCSSCEEEC
T ss_pred             eeEeCCCCcCCEEE--eCCCeEEEEECCCCeeCC
Confidence            48999999999999  655679999998876543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.49  E-value=0.0068  Score=54.55  Aligned_cols=71  Identities=15%  Similarity=0.128  Sum_probs=40.3

Q ss_pred             ceecccCceeEEEEEECC----------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceE
Q 019685          163 AIIGKGSFGEILKAYWRG----------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~g----------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~  231 (337)
                      ..|+.|....+|+....+          ..+++|+.......    ......|..+++.+. +.-++++++..  .  -+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~  110 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG  110 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence            356677777899987654          67888876432111    012245777777665 32244666543  2  37


Q ss_pred             EEEeecCCCC
Q 019685          232 LITEYLRGGD  241 (337)
Q Consensus       232 lv~e~~~~~~  241 (337)
                      ++|||++|..
T Consensus       111 ~v~e~i~G~~  120 (369)
T 3c5i_A          111 RIEEWLYGDP  120 (369)
T ss_dssp             EEEECCCSEE
T ss_pred             EEEEEecCCc
Confidence            8999998743

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.73  E-value=0.085  Score=48.37  Aligned_cols=71  Identities=11%  Similarity=0.079  Sum_probs=43.0

Q ss_pred             ceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEE
Q 019685          163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +.+..|-...+|+....         +..+++++.......    .-+..+|..+++.+. +.-..++++.+  .  -++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~  147 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF--P--EGR  147 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence            35656666789998876         578888876432111    112245777776664 33345556533  2  278


Q ss_pred             EEeecCCCC
Q 019685          233 ITEYLRGGD  241 (337)
Q Consensus       233 v~e~~~~~~  241 (337)
                      |+||++|..
T Consensus       148 I~efI~G~~  156 (424)
T 3mes_A          148 IEEFIDGEP  156 (424)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEeCCcc
Confidence            999999854

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.29  E-value=1.8  Score=35.57  Aligned_cols=86  Identities=8%  Similarity=0.026  Sum_probs=60.4

Q ss_pred             CCCCeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHcCCCCcEeeCCCCCCEEEe
Q 019685          213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMA-YLHNEPNVIIHRDLKPRNVLLV  291 (337)
Q Consensus       213 ~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~ivHrdlkp~Nil~~  291 (337)
                      .||++  -..+-.+.+.+.+.++.-+++-=+..++   .++..+.++++.+|+.-.. ++++    -+|--|.|+||++ 
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~f-  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLMF-  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEEE-
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEEE-
Confidence            47777  3333456666777776543333233343   4788889999999888766 5544    5788899999999 


Q ss_pred             cCCCCcEEEEeccCceee
Q 019685          292 NSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       292 ~~~~~~~kl~DFgla~~~  309 (337)
                       +.++.++|.-.|+-..+
T Consensus       118 -~~~~~p~i~hRGi~~~l  134 (219)
T 4ano_A          118 -NRALEPFFLHVGVKESL  134 (219)
T ss_dssp             -CTTCCEEESCCEETTTB
T ss_pred             -eCCCcEEEEEcCCcccC
Confidence             88899999988875444

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.96  E-value=0.72  Score=41.76  Aligned_cols=32  Identities=31%  Similarity=0.426  Sum_probs=26.1

Q ss_pred             cEeeCCCCCCEEEec----CCCCcEEEEeccCceee
Q 019685          278 IIHRDLKPRNVLLVN----SSADHLKVGDFGLSKLI  309 (337)
Q Consensus       278 ivHrdlkp~Nil~~~----~~~~~~kl~DFgla~~~  309 (337)
                      ++|+|+.+.|||+.+    +....+.++||.+|..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            569999999999953    34567999999998664

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.65  E-value=1.3  Score=36.20  Aligned_cols=87  Identities=9%  Similarity=0.135  Sum_probs=61.1

Q ss_pred             CCCCCeeeeeeeEEeCCceEEEEeecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEE
Q 019685          212 LRHPNIVQFLGAVTERKPLMLITEYLR-GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLL  290 (337)
Q Consensus       212 l~h~~Iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~  290 (337)
                      ..||+.+.. .+-.+.+.+.+.++.-+ +.+... +   ..++....++++.+|+.-..++++    -+|--|.|+||++
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f  112 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF  112 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence            357877765 45555666666666433 223322 2   246788889999999988766654    4788899999999


Q ss_pred             ecCCCCcEEEEeccCceee
Q 019685          291 VNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       291 ~~~~~~~~kl~DFgla~~~  309 (337)
                        +.++.+++.-.|+-..+
T Consensus       113 --~~~~~p~i~~RGik~~l  129 (215)
T 4ann_A          113 --TRDGLPIAKTRGLQNVV  129 (215)
T ss_dssp             --CTTSCEEESCCEETTTB
T ss_pred             --cCCCCEEEEEccCccCC
Confidence              89999999988875444

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	337
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-41
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-41
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-41
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-39
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-39
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-37
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-35
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-28
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-16
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	1e-11
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	3e-10
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-09
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	3e-09
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-07
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	1e-06
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-15
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	1e-12
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	1e-11
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	7e-08
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	1e-05
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	3e-05
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	1e-12
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	7e-08
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	9e-05
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	1e-11
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	1e-07
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	1e-04
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	6e-11
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	2e-08
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	2e-06
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	3e-05
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	8e-10
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	8e-08
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-04
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	0.002
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	9e-10
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-09
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	8e-09
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-06
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	0.001
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	1e-09
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	4e-08
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	2e-04
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	8e-04
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	8e-09
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	6e-08
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	5e-07
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	1e-05
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	4e-08
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	8e-05
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	3e-04
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	0.001
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	2e-07
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	2e-06
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	9e-05
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	1e-06
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-06
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	1e-05
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	1e-05
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	3e-05
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	2e-05
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	2e-05
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	0.002
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	2e-04
d1dcqa1	154	d.211.1.1 (A:369-522) Pyk2-associated protein beta	5e-04
d1bi7b_	125	d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 8e-47
 Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 12/183 (6%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           DWEI   ++       IG GSFG + K  W G  VA+K +  +    +  +Q F++EV +
Sbjct: 2   DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQ-QLQAFKNEVGV 57

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
           L K RH NI+ F+G  T    L ++T++  G  L+ +L   +        ++ A   A+G
Sbjct: 58  LRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC 327
           M YLH +   IIHRDLK  N+ L       +K+GDFGL+ +    +    ++    +GS 
Sbjct: 117 MDYLHAKS--IIHRDLKSNNIFL--HEDLTVKIGDFGLATVKSRWSGS--HQFEQLSGSI 170

Query: 328 EYL 330
            ++
Sbjct: 171 LWM 173

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (386), Expect = 1e-44
 Identities = 57/168 (33%), Positives = 77/168 (45%), Gaps = 7/168 (4%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           ++ DP +L FS    IG GSFG +  A        VAIK++  S        QD   EV 
Sbjct: 9   FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
            L KLRHPN +Q+ G         L+ EY  G         K  L             +G
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           +AYLH+    +IHRD+K  N+LL  S    +K+GDFG + ++   NS 
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAPANSF 171

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-44
 Identities = 64/184 (34%), Positives = 95/184 (51%), Gaps = 16/184 (8%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           W ++  EL       IGKG FG+++   +RG  VA+K I      +    Q F  E +++
Sbjct: 2   WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVM 54

Query: 210 VKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIAR 266
            +LRH N+VQ LG + E K  L ++TEY+  G L  YL+ +G   L     + F+LD+  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGS 326
            M YL       +HRDL  RNVL+  S  +  KV DFGL+K     ++ D  K+  +  +
Sbjct: 115 AMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLTKEA--SSTQDTGKLPVKWTA 168

Query: 327 CEYL 330
            E L
Sbjct: 169 PEAL 172

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 3e-44
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 17/185 (9%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +WE+    L       +G G FGE+   Y+   T VA+K +        +    F  E N
Sbjct: 7   EWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEAN 60

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSPSTAVNFALDIA 265
           L+ +L+H  +V+    VT+ +P+ +ITEY+  G L  +LK      L+ +  ++ A  IA
Sbjct: 61  LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
            GMA++       IHRDL+  N+L+ ++     K+ DFGL++LI     ++     G   
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDT--LSCKIADFGLARLI---EDNEYTAREGAKF 172

Query: 326 SCEYL 330
             ++ 
Sbjct: 173 PIKWT 177

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-44
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 13/175 (7%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF   + +G G+ G + K   +  G  +A K I   L     +      E+ +L +   P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECNSP 64

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            IV F GA      + +  E++ GG L + LK+ G +        ++ + +G+ YL  + 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK- 123

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           + I+HRD+KP N+L+ +     +K+ DFG+S  +               G+  Y+
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLIDS------MANSFVGTRSYM 170

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (377), Expect = 7e-43
 Identities = 44/201 (21%), Positives = 89/201 (44%), Gaps = 16/201 (7%)

Query: 133 SHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILP 190
             + P+PV     +  D         +     +G G+FG + +   +  G     K I  
Sbjct: 13  KKYVPQPVEVKQGSVYD--------YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 64

Query: 191 SLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG 250
               D+      ++E++++ +L HP ++    A  ++  ++LI E+L GG+L   +  + 
Sbjct: 65  PYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121

Query: 251 -ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
             +S +  +N+      G+ ++H   + I+H D+KP N++     A  +K+ DFGL+  +
Sbjct: 122 YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179

Query: 310 KVQNSHDVYKMTGETGSCEYL 330
                  V   T E  + E +
Sbjct: 180 NPDEIVKVTTATAEFAAPEIV 200

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 2e-42
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 16/183 (8%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           W ++    DF     +GKG FG +  A  +     +A+K +  +  +   V    R EV 
Sbjct: 3   WALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
           +   LRHPNI++  G   +   + LI EY   G +++ L++           +  ++A  
Sbjct: 59  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 118

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC 327
           ++Y H+    +IHRD+KP N+LL   SA  LK+ DFG S          +       G+ 
Sbjct: 119 LSYCHS--KRVIHRDIKPENLLL--GSAGELKIADFGWSVHAPSSRRTTL------CGTL 168

Query: 328 EYL 330
           +YL
Sbjct: 169 DYL 171

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 7e-42
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLS 193
           P  LP    WE   + L F     +G G+FG++++A             VA+K + PS  
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66

Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG-- 250
                 +    E+ +L  L  H NIV  LGA T   P ++ITEY   GDL  +L+ K   
Sbjct: 67  LTE--REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 251 ----------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSS 294
                           AL     ++F+  +A+GMA+L ++    IHRDL  RN+LL +  
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG- 181

Query: 295 ADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
               K+ DFGL++ IK  +++ V       
Sbjct: 182 -RITKICDFGLARDIKNDSNYVVKGNARLP 210

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  146 bits (370), Expect = 8e-42
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 12/196 (6%)

Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD 195
           +  P P+  K D  +D     +     +G G+FG + +   R  G   A K ++     D
Sbjct: 11  QYYPQPVEIKHDHVLD----HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66

Query: 196 RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSP 254
           +   +  R E+  +  LRHP +V    A  +   +++I E++ GG+L + +  E   +S 
Sbjct: 67  K---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123

Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
             AV +   + +G+ ++H   N  +H DLKP N++     ++ LK+ DFGL+  +  + S
Sbjct: 124 DEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181

Query: 315 HDVYKMTGETGSCEYL 330
             V   T E  + E  
Sbjct: 182 VKVTTGTAEFAAPEVA 197

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-41
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 39/215 (18%)

Query: 141 PPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLS 193
                    WE     L+F    ++G G+FG+++ A   G         VA+K +     
Sbjct: 23  FREYEYDLKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80

Query: 194 DDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK--- 249
                 +    E+ ++ +L  H NIV  LGA T   P+ LI EY   GDL  YL+ K   
Sbjct: 81  SSER--EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138

Query: 250 --------------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVL 289
                                 L+    + FA  +A+GM +L  +    +HRDL  RNVL
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVL 196

Query: 290 LVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGET 324
           +  +    +K+ DFGL++ I   +++ V       
Sbjct: 197 V--THGKVVKICDFGLARDIMSDSNYVVRGNARLP 229

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (362), Expect = 3e-41
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 17/194 (8%)

Query: 140 VPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRL 197
           + P  PN   WE++ +++       +G G +GE+ +  W+     VA+K +     +D +
Sbjct: 2   MDPSSPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTM 55

Query: 198 VIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL--KEKGALSPS 255
            +++F  E  ++ +++HPN+VQ LG  T   P  +ITE++  G+L  YL    +  +S  
Sbjct: 56  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV 115

Query: 256 TAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
             +  A  I+  M YL  +    IHRDL  RN L+       +KV DFGLS+L+      
Sbjct: 116 VLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHLVKVADFGLSRLM---TGD 168

Query: 316 DVYKMTGETGSCEY 329
                 G     ++
Sbjct: 169 TYTAHAGAKFPIKW 182

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 3e-41
 Identities = 46/182 (25%), Positives = 85/182 (46%), Gaps = 15/182 (8%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNL 208
           +++P +  +     +G G+FG++ KA  +      A K I     ++    +D+  E+++
Sbjct: 7   DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDI 62

Query: 209 LVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARG 267
           L    HPNIV+ L A      L ++ E+  GG +   + + +  L+ S            
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSC 327
           + YLH+  N IIHRDLK  N+L   +    +K+ DFG+S     +N+  + +     G+ 
Sbjct: 123 LNYLHD--NKIIHRDLKAGNILF--TLDGDIKLADFGVSA----KNTRTIQRRDSFIGTP 174

Query: 328 EY 329
            +
Sbjct: 175 YW 176

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 4e-41
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 10/175 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           D+     +G+G++GE+  A  R     VA+K +    + D    ++ + E+ +   L H 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHE 63

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           N+V+F G   E     L  EY  GG+L   ++    +    A  F   +  G+ YLH   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-- 121

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             I HRD+KP N+LL     D+LK+ DFGL+ + +  N   +  +    G+  Y+
Sbjct: 122 IGITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRERL--LNKMCGTLPYV 172

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 6e-41
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 8/160 (5%)

Query: 164 IIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            IG+GSF  + K     T   VA   +           Q F+ E  +L  L+HPNIV+F 
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 222 GA----VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNV 277
            +    V  +K ++L+TE +  G L  YLK    +      ++   I +G+ +LH     
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134

Query: 278 IIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
           IIHRDLK  N+ +   +   +K+GD GL+ L +   +  V
Sbjct: 135 IIHRDLKCDNIFITGPT-GSVKIGDLGLATLKRASFAKAV 173

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 7e-41
 Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 15/181 (8%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           IDP +L F     +G G FG +    WR    VAIK I     +  +   +F  E  +++
Sbjct: 1   IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMM 54

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMA 269
            L H  +VQ  G  T+++P+ +ITEY+  G L  YL + +        +    D+   M 
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEY 329
           YL ++    +HRDL  RN L+  +    +KV DFGLS+ +      +     G      +
Sbjct: 115 YLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRW 167

Query: 330 L 330
            
Sbjct: 168 S 168

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-40
 Identities = 50/176 (28%), Positives = 72/176 (40%), Gaps = 17/176 (9%)

Query: 165 IGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV 224
           IGKG FGE+ +  WRG  VA+K                  E+   V LRH NI+ F+ A 
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF----REAEIYQTVMLRHENILGFIAAD 66

Query: 225 TER----KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------ 274
            +       L L+++Y   G L  YL     ++    +  AL  A G+A+LH E      
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
              I HRDLK +N+L+         + D GL+                  G+  Y+
Sbjct: 126 KPAIAHRDLKSKNILV--KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 7e-40
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 11/170 (6%)

Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G+FG + K Y++       VA+K +    +D  L   +   E N++ +L +P IV+ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-KDELLAEANVMQQLDNPYIVRM 73

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIH 280
           +G + E +  ML+ E    G L+KYL++   +     +     ++ GM YL       +H
Sbjct: 74  IG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVH 130

Query: 281 RDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           RDL  RNVLL   +  + K+ DFGLSK ++   ++   +  G     ++ 
Sbjct: 131 RDLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWY 177

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-39
 Identities = 54/188 (28%), Positives = 94/188 (50%), Gaps = 18/188 (9%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFR 203
           D+EI    ++      IG+G FG++ +  +         VAIK      SD   V + F 
Sbjct: 1   DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFL 56

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY-LKEKGALSPSTAVNFAL 262
            E   + +  HP+IV+ +G +TE  P+ +I E    G+L  +    K +L  ++ + +A 
Sbjct: 57  QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            ++  +AYL ++    +HRD+  RNVL+  SS D +K+GDFGLS+ +        YK + 
Sbjct: 116 QLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGDFGLSRYM---EDSTYYKASK 168

Query: 323 ETGSCEYL 330
                +++
Sbjct: 169 GKLPIKWM 176

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-39
 Identities = 33/169 (19%), Positives = 75/169 (44%), Gaps = 9/169 (5%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           +G+G FG + +            K +    +D  L     + E+++L   RH NI+    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHE 68

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
           +    + L++I E++ G D+ + +      L+    V++   +   + +LH+    I H 
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHF 126

Query: 282 DLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           D++P N++     +  +K+ +FG ++ +K  ++  +     E  + E  
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 15/189 (7%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-----PVAIKRILPSLSDDRLVIQDFR 203
             EID S +      +IG G FGE+   + +        VAIK +    ++ +   +DF 
Sbjct: 20  AKEIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFL 75

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFAL 262
            E +++ +  HPN++   G VT+  P+M+ITE++  G L  +L++  G  +    V    
Sbjct: 76  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY-KMT 321
            IA GM YL +     +HRDL  RN+L+  +S    KV DFGLS+ ++   S   Y    
Sbjct: 136 GIAAGMKYLADMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191

Query: 322 GETGSCEYL 330
           G      + 
Sbjct: 192 GGKIPIRWT 200

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-39
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 13/171 (7%)

Query: 165 IGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQF 220
           +G G+FG + +  +R       VAIK +           ++   E  ++ +L +P IV+ 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRL 74

Query: 221 LGAVTERKPLMLITEYLRGGDLHKYL-KEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
           +G V + + LML+ E   GG LHK+L  ++  +  S        ++ GM YL  +    +
Sbjct: 75  IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FV 131

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           HRDL  RNVLLVN    + K+ DFGLSK +   +S+   +  G     ++ 
Sbjct: 132 HRDLAARNVLLVNR--HYAKISDFGLSKALGADDSYYTARSAG-KWPLKWY 179

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 5e-39
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 8/175 (4%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    I+G+GSF  ++ A         AIK +          +     E +++ +L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
             V+      + + L     Y + G+L KY+++ G+   +    +  +I   + YLH   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-- 126

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             IIHRDLKP N+LL  +   H+++ DFG +K++  ++     +     G+ +Y+
Sbjct: 127 KGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ--ARANSFVGTAQYV 177

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 6e-39
 Identities = 61/183 (33%), Positives = 86/183 (46%), Gaps = 14/183 (7%)

Query: 152 IDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           IDPSEL F     IG G FG +   YW     VAIK I     +  +  +DF  E  +++
Sbjct: 2   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMM 55

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGAL-SPSTAVNFALDIARGMA 269
           KL HP +VQ  G   E+ P+ L+ E++  G L  YL+ +  L +  T +   LD+  GMA
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115

Query: 270 YLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG--SC 327
           YL      +IHRDL  RN L+       +KV DFG+++ +                  S 
Sbjct: 116 YLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 328 EYL 330
           E  
Sbjct: 172 EVF 174

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-39
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 15/185 (8%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           D+     IG GS+G   K   +  G  +  K +      +    Q    EVNLL +L+HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKHP 63

Query: 216 NIVQFLGAVTER--KPLMLITEYLRGGDLHKYL----KEKGALSPSTAVNFALDIARGMA 269
           NIV++   + +R    L ++ EY  GGDL   +    KE+  L     +     +   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 270 YLH---NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH-DVYKMTGETG 325
             H   +  + ++HRDLKP NV L      ++K+GDFGL++++    S    +  T    
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 326 SCEYL 330
           S E +
Sbjct: 182 SPEQM 186

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (346), Expect = 9e-39
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 12/170 (7%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
           ++G G+F E++ A  +     VAIK I     + +       +E+ +L K++HPNIV   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPNIVALD 73

Query: 222 GAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
                   L LI + + GG+L   + EKG  +   A      +   + YLH+    I+HR
Sbjct: 74  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD--LGIVHR 131

Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           DLKP N+L  +   D  + + DFGLSK+    +      ++   G+  Y+
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-----VLSTACGTPGYV 176

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-37
 Identities = 62/196 (31%), Positives = 90/196 (45%), Gaps = 18/196 (9%)

Query: 138 KPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-PVAIKRILPSLSDDR 196
           KP    L  K  WEI    L       +G+G FGE+    W GT  VAIK + P      
Sbjct: 1   KPQTQGLA-KDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP- 56

Query: 197 LVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGA--LSP 254
              + F  E  ++ KLRH  +VQ    V+  +P+ ++TEY+  G L  +LK +    L  
Sbjct: 57  ---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRL 112

Query: 255 STAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS 314
              V+ A  IA GMAY+       +HRDL+  N+L+        KV DFGL++LI     
Sbjct: 113 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVADFGLARLI---ED 165

Query: 315 HDVYKMTGETGSCEYL 330
           ++     G     ++ 
Sbjct: 166 NEYTARQGAKFPIKWT 181

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-37
 Identities = 63/188 (33%), Positives = 96/188 (51%), Gaps = 16/188 (8%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFR 203
            EI PS    +   +IG G FGE+ K   + +      PVAIK +    ++ +    DF 
Sbjct: 2   TEIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFL 57

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFAL 262
            E  ++ +  H NI++  G +++ KP+M+ITEY+  G L K+L+EK G  S    V    
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            IA GM YL N     +HRDL  RN+L+  +S    KV DFGLS++++  +    Y  +G
Sbjct: 118 GIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRVLE-DDPEATYTTSG 172

Query: 323 ETGSCEYL 330
                 + 
Sbjct: 173 GKIPIRWT 180

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 5e-37
 Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 12/179 (6%)

Query: 158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL 212
           D      +G GSFG + +  W     +   VA+K + P +      + DF  EVN +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKY-LKEKGALSPSTAVNFALDIARGMAYL 271
            H N+++  G V    P+ ++TE    G L     K +G     T   +A+ +A GM YL
Sbjct: 69  DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            ++    IHRDL  RN+LL  ++ D +K+GDFGL + +   + H V           + 
Sbjct: 128 ESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWC 181

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  132 bits (332), Expect = 5e-37
 Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 13/182 (7%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRI------LPSLSDDRLVIQDFRHEVNLL 209
           ++    I+G+G    + +   +      A+K I        S  + + + +    EV++L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 210 VKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGM 268
            K+  HPNI+Q            L+ + ++ G+L  YL EK  LS          +   +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 269 AYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCE 328
             LH     I+HRDLKP N+LL      ++K+ DFG S  +           T    + E
Sbjct: 124 CALHK--LNIVHRDLKPENILL--DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179

Query: 329 YL 330
            +
Sbjct: 180 II 181

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 2e-36
 Identities = 42/180 (23%), Positives = 81/180 (45%), Gaps = 15/180 (8%)

Query: 153 DPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV 210
           DP +  ++    IG+G+ G +  A     G  VAI+++       +   +   +E+ ++ 
Sbjct: 17  DPKK-KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMR 72

Query: 211 KLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           + ++PNIV +L +      L ++ EYL GG L   + E              +  + + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEF 131

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           LH+    +IHRD+K  N+LL       +K+ DFG    I    + +  K +   G+  ++
Sbjct: 132 LHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWM 183

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  131 bits (331), Expect = 4e-36
 Identities = 50/184 (27%), Positives = 79/184 (42%), Gaps = 10/184 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN---LLVKL 212
           DFS   IIG+G FGE+        G   A+K +       +       +E     L+   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 213 RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLH 272
             P IV    A      L  I + + GGDLH +L + G  S +    +A +I  G+ ++H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 273 NEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVS 332
           N    +++RDLKP N+LL      H+++ D GL+     +  H     T    + E L  
Sbjct: 125 N--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179

Query: 333 NCSF 336
             ++
Sbjct: 180 GVAY 183

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 5e-36
 Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 29/201 (14%)

Query: 151 EIDPSELDFSSSAIIGKGSFGEILKAYWRGT----PVAIKRILPSLSDDRLVIQDFRHEV 206
            +D +++ F    +IG+G+FG++LKA  +        AIKR+    S D    +DF  E+
Sbjct: 6   VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGEL 61

Query: 207 NLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK---------------- 249
            +L KL  HPNI+  LGA   R  L L  EY   G+L  +L++                 
Sbjct: 62  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121

Query: 250 GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI 309
             LS    ++FA D+ARGM YL  +    IHRDL  RN+L+        K+ DFGLS+  
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENYVAKIADFGLSRGQ 177

Query: 310 KVQNSHDVYKMTGETGSCEYL 330
           +V     + ++     + E L
Sbjct: 178 EVYVKKTMGRLPVRWMAIESL 198

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (325), Expect = 8e-36
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 41/212 (19%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQD 201
             E   + +++     IG+G+FG + +A           T VA+K +    S D  +  D
Sbjct: 7   SLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQAD 62

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------- 250
           F+ E  L+ +  +PNIV+ LG     KP+ L+ EY+  GDL+++L+              
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
                         LS +  +  A  +A GMAYL       +HRDL  RN L+       
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLV--GENMV 178

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEY 329
           +K+ DFGLS+ I   + +       +     +
Sbjct: 179 VKIADFGLSRNIYSADYYKA--DGNDAIPIRW 208

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-35
 Identities = 49/176 (27%), Positives = 83/176 (47%), Gaps = 11/176 (6%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT--PVAIKRILPSLSDDRLVIQDFRHEVNLL-VKLRH 214
           DF    ++GKGSFG++  A ++ T    AIK +   +      ++    E  +L +   H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           P +         ++ L  + EYL GGDL  +++       S A  +A +I  G+ +LH+ 
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS- 121

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
              I++RDLK  N+L       H+K+ DFG+ K    +N     K     G+ +Y+
Sbjct: 122 -KGIVYRDLKLDNIL--LDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYI 170

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  127 bits (321), Expect = 2e-35
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 13/185 (7%)

Query: 154 PSEL--DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLL 209
           PS L   +    I+G G   E+  A        VA+K +   L+ D      FR E    
Sbjct: 2   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61

Query: 210 VKLRHPNIVQFLGAVTERKP----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIA 265
             L HP IV          P      ++ EY+ G  L   +  +G ++P  A+    D  
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 266 RGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
           + + + H     IIHRD+KP N+++  S+ + +KV DFG+++ I   + + V +     G
Sbjct: 122 QALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIA-DSGNSVTQTAAVIG 176

Query: 326 SCEYL 330
           + +YL
Sbjct: 177 TAQYL 181

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 4e-35
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 14/205 (6%)

Query: 134 HFEPKPVPPPLPNKC-DWEIDPSELDFSSSAIIGKGSFGEILKAYW-----RGTPVAIKR 187
           H +   + P L        I PS L    + +IG+G FG +          +    A+K 
Sbjct: 3   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62

Query: 188 ILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK-PLMLITEYLRGGDLHKYL 246
           +          +  F  E  ++    HPN++  LG     +   +++  Y++ GDL  ++
Sbjct: 63  LNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 247 K-EKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 305
           + E    +    + F L +A+GM +L ++    +HRDL  RN +L       +KV DFGL
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVADFGL 176

Query: 306 SKLIKVQNSHDVYKMTGETGSCEYL 330
           ++ +  +    V+  TG     +++
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWM 201

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 8e-35
 Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 14/179 (7%)

Query: 158 DFSSSAIIGKGSFGEILKAYWRGT------PVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           +F    ++G G+FG + K  W         PVAIK +  + S      ++   E  ++  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMAS 67

Query: 212 LRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYL 271
           + +P++ + LG        ++      G  L    + K  +     +N+ + IA+GM YL
Sbjct: 68  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 272 HNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
            +    ++HRDL  RNVL+   +  H+K+ DFGL+KL+  +     Y   G     +++
Sbjct: 128 EDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWM 180

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-34
 Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 20/177 (11%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQF 220
           ++G G  G++L+ + +      A+K +              R EV L  +  + P+IV+ 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRI 70

Query: 221 LGA----VTERKPLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNE 274
           +         RK L+++ E L GG+L   ++++G  A +   A      I   + YLH+ 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 275 PNVIIHRDLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
              I HRD+KP N+L  +   +  LK+ DFG +K     NS      T    + E L
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-34
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 27/199 (13%)

Query: 149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQD 201
           +WE+   ++  S    +G+GSFG + +   +        T VAIK +  + S       +
Sbjct: 14  EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IE 69

Query: 202 FRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG----------A 251
           F +E +++ +    ++V+ LG V++ +P ++I E +  GDL  YL+              
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 252 LSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV 311
            S S  +  A +IA GMAYL+      +HRDL  RN ++  +    +K+GDFG+++ I  
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV--AEDFTVKIGDFGMTRDIYE 185

Query: 312 QNSHDVYKMTGETGSCEYL 330
            + +   K         ++
Sbjct: 186 TDYY--RKGGKGLLPVRWM 202

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 5e-34
 Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 9/173 (5%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSL---SDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
           +G G F  + K   +  G   A K I       S   +  +D   EV++L +++HPN++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
                  +  ++LI E + GG+L  +L EK +L+   A  F   I  G+ YLH+    I 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS--LQIA 135

Query: 280 HRDLKPRNVLLV--NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           H DLKP N++L+  N     +K+ DFGL+  I   N       T E  + E +
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 4e-33
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 36/213 (16%)

Query: 144 LPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT---------PVAIKRILPSLSD 194
           LP    WE+    L       +G+G+FG+++ A   G           VA+K +    ++
Sbjct: 2   LPEDPRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59

Query: 195 DRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG--- 250
               + D   E+ ++  + +H NI+  LGA T+  PL +I EY   G+L +YL+ +    
Sbjct: 60  KD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117

Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
                         LS    V+ A  +ARGM YL ++    IHRDL  RNVL+  +  + 
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV--TEDNV 173

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           +K+ DFGL++ I   +     K T      +++
Sbjct: 174 MKIADFGLARDI--HHIDYYKKTTNGRLPVKWM 204

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (305), Expect = 1e-32
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 6/155 (3%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF     +G GSFG +     R  G   A+K +   +      ++    E  +L  + HP
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            I++  G   + + + +I +Y+ GG+L   L++        A  +A ++   + YLH++ 
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK 310
             II+RDLKP N+LL      H+K+ DFG +K + 
Sbjct: 125 --IIYRDLKPENILL--DKNGHIKITDFGFAKYVP 155

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 3e-32
 Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 16/178 (8%)

Query: 150 WEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +++ P    +++ + IG+G++G +  AY       VAIK+I  S  + +   Q    E+ 
Sbjct: 4   FDVGP---RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58

Query: 208 LLVKLRHPNIVQFLGAV----TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALD 263
           +L++ RH NI+     +     E+   + +  +L G DL+K LK +  LS      F   
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117

Query: 264 IARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
           I RG+ Y+H+    ++HRDLKP N+LL  ++   LK+ DFGL+++    + H  +   
Sbjct: 118 ILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVADPDHDHTGFLTE 171

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 4e-32
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 36/213 (16%)

Query: 144 LP-NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGT-------PVAIKRILPSLSDD 195
           LP +   WE     L       +G+G+FG++++A   G         VA+K +    +  
Sbjct: 1   LPYDASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 58

Query: 196 RLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE-RKPLMLITEYLRGGDLHKYLKEKG--- 250
               +    E+ +L+    H N+V  LGA T+   PLM+I E+ + G+L  YL+ K    
Sbjct: 59  E--HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116

Query: 251 -------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH 297
                         L+    + ++  +A+GM +L +     IHRDL  RN+LL  S  + 
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL--SEKNV 172

Query: 298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           +K+ DFGL++ I      D  +        +++
Sbjct: 173 VKICDFGLARDI--YKDPDYVRKGDARLPLKWM 203

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 6e-32
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 10/175 (5%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           DF    ++GKG+FG+++    +  G   A+K +   +   +  +     E  +L   RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +     A      L  + EY  GG+L  +L  +   +   A  +  +I   + YLH+  
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
             +++RD+K  N++L      H+K+ DFGL K      +     M    G+ EYL
Sbjct: 126 --VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYL 172

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 1e-31
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 11/162 (6%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD---FRHEVNLLVKLR--HPN 216
           ++G G FG +          PVAIK +      D   + +      EV LL K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 217 IVQFLGAVTERKPLMLITEYLRGG-DLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
           +++ L         +LI E      DL  ++ E+GAL    A +F   +   + + HN  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
             ++HRD+K  N+L+ + +   LK+ DFG   L+K     D 
Sbjct: 131 --VLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDF 169

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-31
 Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 21/194 (10%)

Query: 154 PSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK 211
           P E+ ++ + +IG GSFG + +A     G  VAIK++L          +    E+ ++ K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRK 69

Query: 212 LRHPNIVQFLGAVTERKP------LMLITEYLRGG---DLHKYLKEKGALSPSTAVNFAL 262
           L H NIV+                L L+ +Y+          Y + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129

Query: 263 DIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTG 322
            + R +AY+H+    I HRD+KP+N+LL +     LK+ DFG +K +     +  Y  + 
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186

Query: 323 ETGSCEYLVSNCSF 336
              + E +     +
Sbjct: 187 YYRAPELIFGATDY 200

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 6e-31
 Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 15/176 (8%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G+FGE+ KA  R  G  VA+K++L     +   I     E+ +L  L+H N+V  + 
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIE 76

Query: 223 AVTERKP--------LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
               +          + L+ ++                + S        +  G+ Y+H  
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
              I+HRD+K  NVL+       LK+ DFGL++   +  +    + T    +  Y 
Sbjct: 137 K--ILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  116 bits (290), Expect = 6e-31
 Identities = 47/157 (29%), Positives = 84/157 (53%), Gaps = 6/157 (3%)

Query: 165 IGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA 223
           IG+G++G + KA    G   A+K+I     D+  +      E+++L +L+H NIV+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHSNIVKLYDV 68

Query: 224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDL 283
           +  +K L+L+ E+L           +G L   TA +F L +  G+AY H+    ++HRDL
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDL 126

Query: 284 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
           KP+N+L+  +    LK+ DFGL++   +      +++
Sbjct: 127 KPQNLLI--NREGELKIADFGLARAFGIPVRKYTHEI 161

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-30
 Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 12/171 (7%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSL--SDDRLVIQDFRHEVNLLVKLRHPNIVQ 219
            +G+G F  + KA  +     VAIK+I           + +    E+ LL +L HPNI+ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVII 279
            L A   +  + L+ +++              L+PS    + L   +G+ YLH   + I+
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWIL 122

Query: 280 HRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
           HRDLKP N+LL       LK+ DFGL+K             T +  +  Y 
Sbjct: 123 HRDLKPNNLLL--DENGVLKLADFGLAKSF----GSPNRAYTHQVVTRWYR 167

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  114 bits (287), Expect = 5e-30
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 6/152 (3%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
            F     +G GSFG ++    +  G   A+K +          I+   +E  +L  +  P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 216 NIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
            +V+   +  +   L ++ EY+ GG++  +L+  G  S   A  +A  I     YLH+  
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-- 159

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK 307
             +I+RDLKP N+L+      +++V DFG +K
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAK 189

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (275), Expect = 1e-28
 Identities = 38/173 (21%), Positives = 63/173 (36%), Gaps = 14/173 (8%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG GSFG+I        G  VAIK         +        E  +   ++    +  + 
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGVGIPTIR 69

Query: 223 AV-TERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
               E    +++ E L       +       S  T +  A  +   + Y+H+     IHR
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--KNFIHR 127

Query: 282 DLKPRNVLLVNSSAD-HLKVGDFGLSKLIKVQNSHDV---YKMTGETGSCEYL 330
           D+KP N L+        + + DFGL+K  +   +H      +    TG+  Y 
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 6e-28
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 7/153 (4%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+G++G + KA  R     VA+KR+     DD  V      E+ LL +L+H NIV+   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRD 282
            +   K L L+ E+        +    G L P    +F   + +G+ + H+    ++HRD
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRD 126

Query: 283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
           LKP+N+L+  +    LK+ +FGL++   +    
Sbjct: 127 LKPQNLLI--NRNGELKLANFGLARAFGIPVRC 157

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-27
 Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 8/161 (4%)

Query: 158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHP 215
           +F     IG+G++G + KA  +  G  VA+K+I      +  V      E++LL +L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHP 61

Query: 216 NIVQFLGAVTERKPLMLITEYL-RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE 274
           NIV+ L  +     L L+ E+L +             +      ++   + +G+A+ H+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120

Query: 275 PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH 315
            + ++HRDLKP+N+L+  ++   +K+ DFGL++   V    
Sbjct: 121 -HRVLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPVRT 158

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 3e-27
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 14/178 (7%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
            K  WE+      +     +G G++G +  A     G  VAIK++      +    +   
Sbjct: 10  TKTAWEVRA---VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAY 65

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL----RGGDLHKYLKEKGALSPSTAVN 259
            E+ LL  +RH N++  L   T  + L   T++       G     L +   L       
Sbjct: 66  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125

Query: 260 FALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV 317
               + +G+ Y+H     IIHRDLKP N+ +  +    LK+ DFGL++    + +  V
Sbjct: 126 LVYQMLKGLRYIHA--AGIIHRDLKPGNLAV--NEDCELKILDFGLARQADSEMTGYV 179

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 1e-26
 Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 11/175 (6%)

Query: 158 DFSSSAIIGKGSFGEILKAY-----WRGTPVAIKRILPS-LSDDRLVIQDFRHEVNLLVK 211
           +F    ++G G++G++           G   A+K +  + +       +  R E  +L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 212 LRH-PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAY 270
           +R  P +V    A      L LI +Y+ GG+L  +L ++   +      +  +I   + +
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144

Query: 271 LHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETG 325
           LH     II+RD+K  N+LL   S  H+ + DFGLSK      +   Y   G   
Sbjct: 145 LHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  105 bits (262), Expect = 1e-26
 Identities = 37/191 (19%), Positives = 81/191 (42%), Gaps = 23/191 (12%)

Query: 150 WEIDPSELDFSSS------AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQD 201
           W+ +   +++ +         +G+G + E+ +A        V +K + P         + 
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KK 75

Query: 202 FRHEVNLLVKLR-HPNIVQFLGAVTER--KPLMLITEYLRGGDLHKYLKEKGALSPSTAV 258
            + E+ +L  LR  PNI+     V +   +   L+ E++   D  +  +    L+     
Sbjct: 76  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIR 132

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
            +  +I + + Y H+    I+HRD+KP NV++ +     L++ D+GL++       ++V 
Sbjct: 133 FYMYEILKALDYCHS--MGIMHRDVKPHNVMI-DHEHRKLRLIDWGLAEFYHPGQEYNVR 189

Query: 319 KMTGETGSCEY 329
             +      E 
Sbjct: 190 VASRYFKGPEL 200

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  102 bits (254), Expect = 9e-26
 Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 16/175 (9%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLG 222
           IG+GSFG I +         VAIK   P  SD        R E      L     +  + 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVY 67

Query: 223 AVTERKPLMLITEYLRGGDLHKYLKEKGA-LSPSTAVNFALDIARGMAYLHNEPNVIIHR 281
              +     ++   L G  L   L   G   S  T    A  +   +  +H     +++R
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--KSLVYR 125

Query: 282 DLKPRNVLL---VNSSADHLKVGDFGLSKLIKVQNSHDV---YKMTGETGSCEYL 330
           D+KP N L+    + +A+ + V DFG+ K  +   +       +    +G+  Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 1e-24
 Identities = 44/177 (24%), Positives = 85/177 (48%), Gaps = 15/177 (8%)

Query: 165 IGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFR--HEVNLLVKLRHPNIVQ 219
           IG+G++G++ KA      G  VA+KR+     ++ + +   R    +  L    HPN+V+
Sbjct: 15  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 220 FLGAVTERKP-----LMLITEYLRGGDL-HKYLKEKGALSPSTAVNFALDIARGMAYLHN 273
                T  +      L L+ E++      +     +  +   T  +    + RG+ +LH+
Sbjct: 75  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134

Query: 274 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYL 330
               ++HRDLKP+N+L+  +S+  +K+ DFGL+++   Q +     +T    + E L
Sbjct: 135 HR--VVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.9 bits (240), Expect = 2e-23
 Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 16/180 (8%)

Query: 146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFR 203
           NK  WE+      + + + +G G++G +  A+    G  VA+K++           +   
Sbjct: 10  NKTIWEVPE---RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTY 65

Query: 204 HEVNLLVKLRHPNIVQFLGAVTERKPLM-----LITEYLRGGDLHKYLKEKGALSPSTAV 258
            E+ LL  ++H N++  L   T  + L       +  +L G D    + +   L+     
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQ 124

Query: 259 NFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY 318
                I RG+ Y+H+    IIHRDLKP N+    +    LK+ DFGL++    + +  V 
Sbjct: 125 FLIYQILRGLKYIHS--ADIIHRDLKPSNLA--VNEDCELKILDFGLARHTDDEMTGYVA 180

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.6 bits (234), Expect = 1e-22
 Identities = 41/166 (24%), Positives = 66/166 (39%), Gaps = 16/166 (9%)

Query: 164 IIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            IG G+ G +  AY       VAIK++     +     +    E+ L+  + H NI+  L
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHKNIISLL 82

Query: 222 GAVT------ERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEP 275
              T      E + + L+ E +          E               +  G+ +LH+  
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAG 139

Query: 276 NVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
              IHRDLKP N+++   S   LK+ DFGL++          Y +T
Sbjct: 140 I--IHRDLKPSNIVV--KSDCTLKILDFGLARTAGTSFMMTPYVVT 181

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.9 bits (191), Expect = 1e-17
 Identities = 26/173 (15%), Positives = 58/173 (33%), Gaps = 32/173 (18%)

Query: 164 IIGKGSFGEILKAY-WRGTPVAIKRILPSLSDDR---------------LVIQDFRHEVN 207
           ++G+G    +   Y  +     +K      +  +               L I+  R+E  
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 208 LLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARG 267
            L KL+   + +            ++ E +   +L++                   I   
Sbjct: 67  ALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILEE 115

Query: 268 MAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKM 320
           +A  ++    I+H DL   NVL+   S + + + DF  S  +  +   ++ + 
Sbjct: 116 VAKFYH--RGIVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEGWREILER 163

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.3 bits (189), Expect = 2e-16
 Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 3/180 (1%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
           +       V+ LL+   S  +  +    TPLH+A+  G  +VAK L++  A VNA+ +  
Sbjct: 8   SFMGHLPIVKNLLQRGAS-PNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDD 66

Query: 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSS 161
            TPL  A      NM++LL  +         +   P  +     +         +    +
Sbjct: 67  QTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQA 126

Query: 162 SAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
              + K  F  +  A   G     + +L   +      ++    +++ V   + +IV+ L
Sbjct: 127 --CMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLL 184

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.1 bits (152), Expect = 1e-11
 Identities = 23/82 (28%), Positives = 38/82 (46%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A       + K L + Q+ V+A+     +PLH A+  G  D+   L++ GA  N   
Sbjct: 301 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 360

Query: 99  RWKNTPLADAEGAKKFNMMELL 120
               TPLA A+     ++ ++L
Sbjct: 361 SDGTTPLAIAKRLGYISVTDVL 382

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.4 bits (140), Expect = 3e-10
 Identities = 19/55 (34%), Positives = 27/55 (49%)

Query: 70  TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           TPLHVAS  G + + K L++ GA  N  +    TPL  A  A    + + L  + 
Sbjct: 2   TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNK 56

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (134), Expect = 2e-09
 Identities = 26/99 (26%), Positives = 42/99 (42%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A +     V +LL E  +  +A   +  TPLHVA  H  +D+ K L+  G   ++  
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
               TPL  A    +  +   L  +GG +  ++     P
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTP 234

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (132), Expect = 3e-09
 Identities = 34/200 (17%), Positives = 73/200 (36%), Gaps = 2/200 (1%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A + +   V + L +     +A      TPLH+A+  G  ++   L+   A+ N  +
Sbjct: 202 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 261

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSELD 158
           +   TPL          + ++L  HG +        + P  V           +      
Sbjct: 262 KSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVAS--HYGNIKLVKFLLQH 319

Query: 159 FSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIV 218
            +      K  +  + +A  +G    +  +L + +    V  D    + +  +L + ++ 
Sbjct: 320 QADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVT 379

Query: 219 QFLGAVTERKPLMLITEYLR 238
             L  VT+    +L+++  R
Sbjct: 380 DVLKVVTDETSFVLVSDKHR 399

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (118), Expect = 2e-07
 Identities = 25/86 (29%), Positives = 38/86 (44%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
             A +         L E ++          TPLHVA+ +G + VA+ L+E  A  NA  +
Sbjct: 104 HIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGK 163

Query: 100 WKNTPLADAEGAKKFNMMELLNAHGG 125
              TPL  A      ++++LL   GG
Sbjct: 164 NGLTPLHVAVHHNNLDIVKLLLPRGG 189

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (112), Expect = 1e-06
 Identities = 26/99 (26%), Positives = 42/99 (42%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A +     V K L ++++ V+A+  D++TPLH A+  G  ++ K L+E  A+ N   
Sbjct: 37  LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 96

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP 137
              +TPL  A        +  L              F P
Sbjct: 97  TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 74.3 bits (181), Expect = 2e-15
 Identities = 31/175 (17%), Positives = 59/175 (33%), Gaps = 24/175 (13%)

Query: 165 IGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN------ 216
           +G G F  +  A      T VA+K +      D++  +    E+ LL ++   +      
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 217 -----IVQFLGAVTERKP-----LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIAR 266
                I++ L     + P     +M+               E   +        +  +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 267 GMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMT 321
           G+ Y+H     IIH D+KP NVL+         +    ++ L       + Y  +
Sbjct: 137 GLDYMHRRCG-IIHTDIKPENVLM-EIVDSPENLIQIKIADLGNACWYDEHYTNS 189

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.0 bits (157), Expect = 1e-12
 Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 1/71 (1%)

Query: 28  EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
            +    +T LIL          V++LLE++   ++  D D +T L +A       +A+ L
Sbjct: 214 VRGERGKTPLILAVEK-KHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELL 272

Query: 88  IEYGADVNAQD 98
            + GA  +  D
Sbjct: 273 CKRGASTDCGD 283

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.9 bits (149), Expect = 1e-11
 Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 1/86 (1%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQD 98
             +  +D  A+  LL +  + V+ R    +TPL +A     + + + L+E    ++N  D
Sbjct: 191 LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD 250

Query: 99  RWKNTPLADAEGAKKFNMMELLNAHG 124
               T L  A   K   + ELL   G
Sbjct: 251 SDGKTALLLAVELKLKKIAELLCKRG 276

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (120), Expect = 7e-08
 Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 4/92 (4%)

Query: 38  ILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVA----SLHGWIDVAKCLIEYGAD 93
           ++  A +     ++ LL+E  + V+A D   R  L  A           +   L+++GAD
Sbjct: 152 LMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGAD 211

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
           VN +     TPL  A   K   +++ L     
Sbjct: 212 VNVRGERGKTPLILAVEKKHLGLVQRLLEQEH 243

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (102), Expect = 1e-05
 Identities = 24/95 (25%), Positives = 41/95 (43%)

Query: 30  ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
           A V    L++      D   V++LLE   ++    +    TPLH A      D+ + L+ 
Sbjct: 1   AAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLR 60

Query: 90  YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
           +GAD   + +   TP   A  A    +++L  + G
Sbjct: 61  HGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKG 95

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (99), Expect = 3e-05
 Identities = 18/64 (28%), Positives = 26/64 (40%), Gaps = 1/64 (1%)

Query: 61  VHARDYDNRTPLHVASLHGWIDVAKCLI-EYGADVNAQDRWKNTPLADAEGAKKFNMMEL 119
                    T L  A+  G ++V K L+ E GADVNA D      L  A  +   + +E 
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200

Query: 120 LNAH 123
           +   
Sbjct: 201 ITHL 204

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 64.8 bits (156), Expect = 1e-12
 Identities = 23/82 (28%), Positives = 42/82 (51%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
           + A  ++   V+ L+ E  S    +D D +TP+ +A+  G I+V   LI+ GA V A D 
Sbjct: 193 YAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDA 252

Query: 100 WKNTPLADAEGAKKFNMMELLN 121
             +T    A+     N++++ +
Sbjct: 253 TDHTARQLAQANNHHNIVDIFD 274

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 50.5 bits (119), Expect = 7e-08
 Identities = 23/78 (29%), Positives = 35/78 (44%), Gaps = 9/78 (11%)

Query: 36  SLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL-------- 87
           S I  H     + A+ + +   +S+       NRT LH  + +   + ++ L        
Sbjct: 2   SPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKEC 60

Query: 88  IEYGADVNAQDRWKNTPL 105
           I  GADVNA D  +NTPL
Sbjct: 61  IAAGADVNAMDCDENTPL 78

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 41.3 bits (95), Expect = 9e-05
 Identities = 9/52 (17%), Positives = 17/52 (32%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
           +  A Q     V   L +  + V A D  + T   +A  +   ++       
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRC 276

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 62.0 bits (149), Expect = 1e-11
 Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 2/85 (2%)

Query: 28  EKARVSRTSLILWHAHQNDAAAVRKLLEED--QSLVHARDYDNRTPLHVASLHGWIDVAK 85
           +     + S       +   + +  L  +    ++++A+D +  T L++A+  G I +  
Sbjct: 217 QSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVD 276

Query: 86  CLIEYGADVNAQDRWKNTPLADAEG 110
            L++YGAD    ++    P+    G
Sbjct: 277 ALLDYGADPFIANKSGLRPVDFGAG 301

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 50.0 bits (118), Expect = 1e-07
 Identities = 11/44 (25%), Positives = 21/44 (47%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA 108
           D    TPLH  +    +++ K L+++G++    D    + L  A
Sbjct: 104 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKA 147

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 41.2 bits (95), Expect = 1e-04
 Identities = 12/98 (12%), Positives = 33/98 (33%), Gaps = 3/98 (3%)

Query: 30  ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLI- 88
              S  +     A       +  ++++    + +   +  +  +  +      + + L  
Sbjct: 185 IITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDL 244

Query: 89  --EYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
                  +NAQD   +T L  A      ++++ L  +G
Sbjct: 245 KWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYG 282

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 60.1 bits (144), Expect = 6e-11
 Identities = 22/71 (30%), Positives = 34/71 (47%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A       V KLL + +  V+ +DYD  TPLH A+  G  +  + L+E   D+ A +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262

Query: 99  RWKNTPLADAE 109
           +   T    A+
Sbjct: 263 KVGQTAFDVAD 273

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 52.8 bits (125), Expect = 2e-08
 Identities = 20/121 (16%), Positives = 38/121 (31%), Gaps = 8/121 (6%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHAR--------DYDNRTPLHVASLHGWIDVAKCLIEY 90
           +  A Q     +++ +  +  L             +D+      A   G  +    L+E 
Sbjct: 3   MADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLER 62

Query: 91  GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
           GAD+N  +    T L  A      +M++ L  +G      +   + P             
Sbjct: 63  GADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIA 122

Query: 151 E 151
           E
Sbjct: 123 E 123

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 46.3 bits (108), Expect = 2e-06
 Identities = 22/85 (25%), Positives = 31/85 (36%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
               +      R+ L               T LHVA+  G+ +V K LI+   DVN +D 
Sbjct: 171 KEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDY 230

Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
              TPL  A    K     +L  + 
Sbjct: 231 DGWTPLHAAAHWGKEEACRILVENL 255

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 42.4 bits (98), Expect = 3e-05
 Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 1/107 (0%)

Query: 25  KQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVA 84
           ++K K +    ++ L      D   V +LLE     ++  + D  T LH A +   +D+ 
Sbjct: 31  RKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD-INYANVDGLTALHQACIDDNVDMV 89

Query: 85  KCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQN 131
           K L+E GA++N  D     PL  A      ++ E L + G      N
Sbjct: 90  KFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVN 136

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 56.8 bits (136), Expect = 8e-10
 Identities = 14/101 (13%), Positives = 27/101 (26%), Gaps = 5/101 (4%)

Query: 28  EKARVSRTSLIL--WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
           +K   S     +       +    +  LL  D+  V     +N     +A+ +G + V  
Sbjct: 85  KKGIKSEVICFVAAITGCSSALDTLCLLLTSDEI-VKVIQAENYQAFRLAAENGHLHVLN 143

Query: 86  CLIEYGADVNAQDR--WKNTPLADAEGAKKFNMMELLNAHG 124
            L E                    A      +++  L    
Sbjct: 144 RLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELA 184

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 51.0 bits (121), Expect = 8e-08
 Identities = 10/80 (12%), Positives = 21/80 (26%), Gaps = 3/80 (3%)

Query: 48  AAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKC---LIEYGADVNAQDRWKNTP 104
           A   +  ++  S  H +   +     VA++ G          L+     V          
Sbjct: 70  AHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQA 129

Query: 105 LADAEGAKKFNMMELLNAHG 124
              A      +++  L    
Sbjct: 130 FRLAAENGHLHVLNRLCELA 149

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 40.6 bits (94), Expect = 1e-04
 Identities = 12/86 (13%), Positives = 21/86 (24%), Gaps = 5/86 (5%)

Query: 15  CKGGATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLE----EDQSLVHARDYDNRT 70
              G      K +          ++    +     +R LL     +  +       D   
Sbjct: 260 NPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319

Query: 71  PLHVASLHGWIDVAKCLIEYGADVNA 96
            L +A   G       L+     V A
Sbjct: 320 LLRLALRLGNQGACALLLSIP-SVLA 344

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 37.6 bits (86), Expect = 0.002
 Identities = 15/87 (17%), Positives = 26/87 (29%), Gaps = 4/87 (4%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVN---AQ 97
           A       + +L E   + + A    +N     +A+ +G + V   L E          Q
Sbjct: 134 AENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQ 193

Query: 98  DRWKNTPLADAEGAKKFNMMELLNAHG 124
                     A G    N++  L    
Sbjct: 194 AENYYAFRWAAVGRGHHNVINFLLDCP 220

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (133), Expect = 9e-10
 Identities = 22/85 (25%), Positives = 40/85 (47%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L  A       + K L    + V+A + +  TPLH A+     ++A  L+E GA+ +A+D
Sbjct: 74  LHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 133

Query: 99  RWKNTPLADAEGAKKFNMMELLNAH 123
            ++ T +  A       M+ +L  +
Sbjct: 134 HYEATAMHRAAAKGNLKMIHILLYY 158

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (129), Expect = 3e-09
 Identities = 18/72 (25%), Positives = 36/72 (50%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           +  A       +  +L   ++  + +D +  TPLH+A     ++ AK L+  GA +  ++
Sbjct: 140 MHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIEN 199

Query: 99  RWKNTPLADAEG 110
           + + TPL  A+G
Sbjct: 200 KEEKTPLQVAKG 211

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.0 bits (126), Expect = 8e-09
 Identities = 25/121 (20%), Positives = 42/121 (34%), Gaps = 33/121 (27%)

Query: 37  LILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG----------------- 79
           ++   A+      +++ +  D+SL    D D+RT LH A   G                 
Sbjct: 6   MVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVND 65

Query: 80  ----------------WIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAH 123
                             ++ K L+  GA VNA ++   TPL  A    +  +  +L   
Sbjct: 66  KDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEG 125

Query: 124 G 124
           G
Sbjct: 126 G 126

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (106), Expect = 3e-06
 Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 2/91 (2%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
            T L  + A +N       LLE   +   A+D+   T +H A+  G + +   L+ Y A 
Sbjct: 104 CTPLH-YAASKNRHEIAVMLLEGGAN-PDAKDHYEATAMHRAAAKGNLKMIHILLYYKAS 161

Query: 94  VNAQDRWKNTPLADAEGAKKFNMMELLNAHG 124
            N QD   NTPL  A   ++    +LL + G
Sbjct: 162 TNIQDTEGNTPLHLACDEERVEEAKLLVSQG 192

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.3 bits (85), Expect = 0.001
 Identities = 13/51 (25%), Positives = 23/51 (45%), Gaps = 1/51 (1%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
           L  A   +     KLL    + ++  + + +TPL VA   G   + K ++E
Sbjct: 173 LHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (132), Expect = 1e-09
 Identities = 22/70 (31%), Positives = 41/70 (58%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD 98
           L HA +N++ ++ +LL +  + V+A+ Y   + LH AS  G + + + L+  GAD + ++
Sbjct: 148 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 207

Query: 99  RWKNTPLADA 108
              +TPL  A
Sbjct: 208 CHNDTPLMVA 217

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.0 bits (120), Expect = 4e-08
 Identities = 13/55 (23%), Positives = 25/55 (45%), Gaps = 4/55 (7%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFNMM 117
           D  TPLH+A + G +     L+      G +++  +  + TPL  A      +++
Sbjct: 2   DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVV 56

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (91), Expect = 2e-04
 Identities = 11/47 (23%), Positives = 18/47 (38%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAK 85
           L  A       + + L    +    ++  N TPL VA     ID+ +
Sbjct: 181 LHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILR 227

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (86), Expect = 8e-04
 Identities = 29/194 (14%), Positives = 59/194 (30%), Gaps = 7/194 (3%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEY 90
            T L      Q +  AV +L+   Q     +   +   +TPLH+A +     V + L+  
Sbjct: 4   DTPLH-IAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTA 62

Query: 91  GADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
           GA   A DR   T    A   +    +  L            +          +    + 
Sbjct: 63  GASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTEC 122

Query: 151 EIDPSELDF---SSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVN 207
           +     L        A+  K     ++ A    +   ++ +L   ++    +      ++
Sbjct: 123 QETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALH 182

Query: 208 LLVKLRHPNIVQFL 221
                    +V+ L
Sbjct: 183 SASGRGLLPLVRTL 196

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 53.2 bits (126), Expect = 8e-09
 Identities = 27/85 (31%), Positives = 34/85 (40%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
                 DA  VR L +    L        RTPLH+A       V + L++ GAD  A+  
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMY 223

Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
              TPL  A       +  LL AHG
Sbjct: 224 GGRTPLGSALLRPNPILARLLRAHG 248

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 50.9 bits (120), Expect = 6e-08
 Identities = 12/47 (25%), Positives = 19/47 (40%), Gaps = 3/47 (6%)

Query: 65  DYDNRTPLHVASLHGWIDVAKCLIEYGAD---VNAQDRWKNTPLADA 108
             D  T LH+A +H        L+ + A    ++ Q+    T L  A
Sbjct: 6   TEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLA 52

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 48.2 bits (113), Expect = 5e-07
 Identities = 19/56 (33%), Positives = 27/56 (48%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVN 95
             A +  AA+V +LL +  +   AR Y  RTPL  A L     +A+ L  +GA   
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEP 252

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 43.5 bits (101), Expect = 1e-05
 Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 3/94 (3%)

Query: 34  RTSLILWHAHQNDAAAVRKLLEE--DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
            T+L            +  LL        +  ++   +T LH+A++ G     + L   G
Sbjct: 10  DTALH-LAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAG 68

Query: 92  ADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGG 125
           A V   +R  +T L  A   +      +L     
Sbjct: 69  AGVLVAERGGHTALHLACRVRAHTCACVLLQPRP 102

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 50.9 bits (120), Expect = 4e-08
 Identities = 14/58 (24%), Positives = 27/58 (46%)

Query: 64  RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLN 121
           +D  + TPL +A+  G  + +K L++  A+    D     P   A      +++ LL+
Sbjct: 152 QDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 8e-05
 Identities = 12/49 (24%), Positives = 22/49 (44%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
           L+ A +  +    K L ++ +     D+ +R P  VAS     D+ + L
Sbjct: 160 LFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL 208

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.4 bits (90), Expect = 3e-04
 Identities = 18/85 (21%), Positives = 34/85 (40%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
             A +     + + L    + ++A D   +T LH A+     +    L+ + A+ +AQD 
Sbjct: 95  ILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDD 154

Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
              TPL  A     +   + L  + 
Sbjct: 155 KDETPLFLAAREGSYEASKALLDNF 179

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.5 bits (85), Expect = 0.001
 Identities = 18/51 (35%), Positives = 25/51 (49%)

Query: 50  VRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
           +  LL +   L    D    T LH+A+     D AK L++ GAD N+QD  
Sbjct: 5   ISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNT 55

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (114), Expect = 2e-07
 Identities = 17/88 (19%), Positives = 30/88 (34%), Gaps = 4/88 (4%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEY----GADVNAQDRWKNTPLADAEGAKKFNMMELLNA 122
           D  + LH+A +H    +   +I       A +N Q+  + TPL  A    +  + E L  
Sbjct: 1   DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLG 60

Query: 123 HGGLSYGQNGSHFEPKPVPPPLPNKCDW 150
            G     ++     P  +          
Sbjct: 61  AGCDPELRDFRGNTPLHLACEQGCLASV 88

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.0 bits (107), Expect = 2e-06
 Identities = 17/85 (20%), Positives = 28/85 (32%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR 99
             +       V  L+     +      + RT LH+A      D+   L++ GADVN    
Sbjct: 117 LASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTY 176

Query: 100 WKNTPLADAEGAKKFNMMELLNAHG 124
              +P     G     + + L    
Sbjct: 177 QGYSPYQLTWGRPSTRIQQQLGQLT 201

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 9e-05
 Identities = 3/32 (9%), Positives = 10/32 (31%)

Query: 62  HARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
           +   Y   +P  +        + + L +   +
Sbjct: 172 NRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 46.4 bits (108), Expect = 1e-06
 Identities = 9/82 (10%), Positives = 23/82 (28%), Gaps = 1/82 (1%)

Query: 70  TPLHVASLHGWIDVAKCLIE-YGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSY 128
            PLH A +       + L+    + +  +D+    PL  +   +   +   L +      
Sbjct: 2   YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61

Query: 129 GQNGSHFEPKPVPPPLPNKCDW 150
             +              +  + 
Sbjct: 62  LDDYPDDSGWTPFHIACSVGNL 83

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 46.4 bits (108), Expect = 2e-06
 Identities = 34/224 (15%), Positives = 73/224 (32%), Gaps = 18/224 (8%)

Query: 42  AHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK 101
             +N+   V++LL    SL+  +D D R PLH +      ++   L+    +VN  D   
Sbjct: 8   CMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPD 67

Query: 102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKPVPPPLPNKCDWEIDPSE-LDFS 160
           ++       A     +E++ +        + +    + V            + S+ L  +
Sbjct: 68  DSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIEN 127

Query: 161 SSAIIGKGSFGEI-LKAYWRGTPVAIKRILPSLSDDRLVIQDFRHE--VNLLVKLRHPNI 217
            +++  K  F +I L        + +  +L  L    +  QD +    +   +   H + 
Sbjct: 128 GASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDA 187

Query: 218 VQFL----GAVTERK------PLMLITEYLRGGDLHKYLKEKGA 251
              L    GA  +           +         + K+      
Sbjct: 188 AVLLVEKYGAEYDLVDNKGAKAEDVALNE----QVKKFFLNNVV 227

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 43.3 bits (100), Expect = 1e-05
 Identities = 9/54 (16%), Positives = 14/54 (25%), Gaps = 3/54 (5%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGAD 93
               +    A   L+E+  +     D        VA       V K  +    D
Sbjct: 178 HALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.6 bits (98), Expect = 1e-05
 Identities = 8/33 (24%), Positives = 16/33 (48%)

Query: 70  TPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN 102
             L  A+  G ++    L++   +VNAQ+ +  
Sbjct: 3   NELASAAARGDLEQLTSLLQNNVNVNAQNGFGR 35

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 3e-05
 Identities = 12/52 (23%), Positives = 21/52 (40%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG 91
             A +     V  L++   S V  R++   T   +A L+G  +V   +   G
Sbjct: 105 LAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG 156

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 41.8 bits (96), Expect = 2e-05
 Identities = 12/49 (24%), Positives = 25/49 (51%)

Query: 39  LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL 87
           L  A +++   V +LL +  + VH +    +T   ++  +G  D+A+ L
Sbjct: 104 LHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 41.8 bits (96), Expect = 2e-05
 Identities = 16/155 (10%), Positives = 41/155 (26%), Gaps = 3/155 (1%)

Query: 67  DNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGL 126
           D    L  A+  G  D  + L+  GA         +     A+         LL A    
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFTTDWLGTSPLHLAAQYGHFSTTEVLLRAGVSR 60

Query: 127 SYGQNGSHFEPKPVPPPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIK 186
                                    +     D ++  ++       +  A        ++
Sbjct: 61  DARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLK---MTALHWATEHNHQEVVE 117

Query: 187 RILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL 221
            ++   +D     +  +   ++ +   + ++ + L
Sbjct: 118 LLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 36.0 bits (81), Expect = 0.002
 Identities = 19/59 (32%), Positives = 32/59 (54%)

Query: 62  HARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL 120
           +A+D    T LH A+ H   +V + LI+YGADV+ Q ++  T    +      ++ E+L
Sbjct: 94  NAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 2e-04
 Identities = 12/50 (24%), Positives = 17/50 (34%)

Query: 40  WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE 89
            H    +           +S +H RD    TPL +A   G  D+   L  
Sbjct: 105 IHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 38.0 bits (87), Expect = 5e-04
 Identities = 6/38 (15%), Positives = 12/38 (31%), Gaps = 1/38 (2%)

Query: 62  HARDYDNRTPLHVASLHGWIDVAKCLIEYGAD-VNAQD 98
              +    TPL +A         + L +  +   N+  
Sbjct: 108 EIANESGETPLDIAKRLKHEHCEELLTQALSGRFNSHV 145

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.3 bits (79), Expect = 0.002
 Identities = 9/31 (29%), Positives = 17/31 (54%)

Query: 70  TPLHVASLHGWIDVAKCLIEYGADVNAQDRW 100
             L  A+  G ++  + L+E GA+ NA + +
Sbjct: 5   DWLATAAARGRVEEVRALLEAGANPNAPNSY 35

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	337
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.84
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.82
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.82
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.8
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.78
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.78
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.75
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.74
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.73
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.71
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.7
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.7
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.7
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.68
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.67
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.67
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.66
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.66
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.65
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.64
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.64
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.63
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.62
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.62
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.61
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.6
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.59
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.58
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.58
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.57
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.57
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.56
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.54
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.53
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.52
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.5
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.49
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.48
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.57
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.91
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.69
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.43
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.31

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=294.89  Aligned_cols=169  Identities=30%  Similarity=0.499  Sum_probs=150.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|..+  ++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            7899999999999999999986  78899999865433223334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||++|+|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+|+.....   
T Consensus        87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill--~~~~~~kl~DFG~a~~~~~~---  159 (263)
T d2j4za1          87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLL--GSAGELKIADFGWSVHAPSS---  159 (263)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEECCCCSCSCCCCC---
T ss_pred             ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeecccccee--cCCCCEeecccceeeecCCC---
Confidence            9999999999998889999999999999999999999988  9999999999999  88889999999999876543   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|||||++.
T Consensus       160 ---~~~~~~Gt~~Y~APE~~~  177 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPPEMIE  177 (263)
T ss_dssp             ---CCEETTEEGGGCCHHHHT
T ss_pred             ---cccccCCCCcccCHHHHc
Confidence               234568999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=294.89  Aligned_cols=171  Identities=29%  Similarity=0.472  Sum_probs=148.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|.++  |+.||+|++......  ...+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            6889999999999999999986  789999998764332  234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||++|+|.+++...+.+++.+++.++.||+.||.|||++|  |+||||||+|||+  +.++.+||+|||+|+.+...+..
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl--~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLL--DERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--CTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEE--CCCCCEEEccchhheeeccCCcc
Confidence            9999999999987778999999999999999999999988  9999999999999  78889999999999987654321


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|||||++.
T Consensus       160 --~~~~~~~GT~~Y~APE~~~  178 (271)
T d1nvra_         160 --RLLNKMCGTLPYVAPELLK  178 (271)
T ss_dssp             --CCBCCCCSCGGGSCTHHHH
T ss_pred             --ccccceeeCcCccCHhHhc
Confidence              1245678999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-40  Score=291.38  Aligned_cols=182  Identities=31%  Similarity=0.597  Sum_probs=156.6

Q ss_pred             CCCCCCCCcccCCCCcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeee
Q 019685          142 PPLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQ  219 (337)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~  219 (337)
                      |..|....|+|+.+  +|+..+.||+|+||.||+|.++  ++.||||++......    .+.+.+|+.++++++||||++
T Consensus         4 p~~p~~~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~   77 (287)
T d1opja_           4 PSSPNYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQ   77 (287)
T ss_dssp             TTSTTCCTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCCCcccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEec
Confidence            44556677988765  5677789999999999999985  778999998765433    357889999999999999999


Q ss_pred             eeeeEEeCCceEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCc
Q 019685          220 FLGAVTERKPLMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADH  297 (337)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~  297 (337)
                      +++++.+.+.+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.
T Consensus        78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl--~~~~~  153 (287)
T d1opja_          78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV--GENHL  153 (287)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGC
T ss_pred             CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEE--CCCCc
Confidence            999999999999999999999999999764  46899999999999999999999987  9999999999999  78889


Q ss_pred             EEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          298 LKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       298 ~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +||+|||+|+.......   .......||+.|||||++.
T Consensus       154 ~Kl~DFG~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~  189 (287)
T d1opja_         154 VKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLA  189 (287)
T ss_dssp             EEECCCCCTTTCCSSSS---EEETTEEECGGGCCHHHHH
T ss_pred             EEEccccceeecCCCCc---eeeccccccccccChHHHc
Confidence            99999999987754422   2345567999999999863

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-40  Score=288.91  Aligned_cols=167  Identities=25%  Similarity=0.429  Sum_probs=148.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||.||+|..+  |+.||+|++.......   .+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            6889999999999999999975  8899999986544333   3678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||++|+|.+++.. ..+++.++..++.||+.||.|||++|  |+||||||+|||+  +.++.+||+|||+|+.+..... 
T Consensus        98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl--~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1          98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSTTC-
T ss_pred             ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEE--CCCCcEeeccchhheeeccccc-
Confidence            9999999998865 46999999999999999999999988  9999999999999  7888999999999998764432 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......||+.|||||++.
T Consensus       172 ---~~~~~~gt~~Y~aPE~~~  189 (293)
T d1yhwa1         172 ---KRSTMVGTPYWMAPEVVT  189 (293)
T ss_dssp             ---CBCCCCSCGGGCCHHHHS
T ss_pred             ---cccccccCCCccChhhhc
Confidence               345667999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-40  Score=292.55  Aligned_cols=167  Identities=32%  Similarity=0.440  Sum_probs=151.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|...  ++.||||++...........+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888899999999999999975  78899999987766666677889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||.+|+|..++.....+++.+++.++.||+.||.|||++|  ||||||||+|||+  +.++.+||+|||+|+....    
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl--~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILL--SEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEE--ETTTEEEECCCTTCBSSSS----
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEE--CCCCCEEEeecccccccCC----
Confidence            9999999888877888999999999999999999999988  9999999999999  7788999999999986543    


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....||+.|||||++.
T Consensus       168 ----~~~~~GT~~Y~APE~~~  184 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVIL  184 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHT
T ss_pred             ----CCccccCccccCHHHHh
Confidence                23467999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=291.96  Aligned_cols=173  Identities=26%  Similarity=0.463  Sum_probs=148.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|.++  ++.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            6899999999999999999985  78999999865432222334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++|+|.+++...+.+++..++.++.|++.||.|||+++  ||||||||+|||+  +.++.+||+|||+|+.+......
T Consensus        89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll--~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCCTTCEECC-----
T ss_pred             ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCcccccc--CCCceEEecccccceecccCCcc
Confidence            9999999999998889999999999999999999999988  9999999999999  88889999999999987643221


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|||||++.
T Consensus       165 --~~~~~~~GT~~Y~APE~~~  183 (288)
T d1uu3a_         165 --ARANSFVGTAQYVSPELLT  183 (288)
T ss_dssp             -------CCCCGGGCCHHHHH
T ss_pred             --cccccccCCccccCceeec
Confidence              1234567999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-40  Score=286.83  Aligned_cols=177  Identities=33%  Similarity=0.547  Sum_probs=144.9

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK  228 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  228 (337)
                      +|+++..  +|+..+.||+|+||.||+|.+++ .||||++....... ...+.+.+|+.++++++||||+++++++. .+
T Consensus         2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~   76 (276)
T d1uwha_           2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-AP   76 (276)
T ss_dssp             CCBCCTT--CCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             Ccccccc--cEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence            6887765  45667899999999999998765 59999987654433 34678999999999999999999999865 45


Q ss_pred             ceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          229 PLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      .+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++  ||||||||+|||+  +.++.+||+|||+|+
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl--~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFL--HEDLTVKIGDFGLAT  152 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--ETTSSEEECCCCCSC
T ss_pred             EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEE--cCCCCEEEcccccee
Confidence            689999999999999999764 56999999999999999999999987  9999999999999  778899999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ........  .......||+.|||||++.
T Consensus       153 ~~~~~~~~--~~~~~~~gt~~y~APE~l~  179 (276)
T d1uwha_         153 VKSRWSGS--HQFEQLSGSILWMAPEVIR  179 (276)
T ss_dssp             C--------------CCCCGGGCCHHHHT
T ss_pred             eccccCCc--ccccccccCcccCCHHHHh
Confidence            77543221  2345678999999999874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=283.20  Aligned_cols=169  Identities=28%  Similarity=0.467  Sum_probs=145.0

Q ss_pred             ccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe----CCceEE
Q 019685          159 FSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE----RKPLML  232 (337)
Q Consensus       159 ~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~----~~~~~l  232 (337)
                      |...+.||+|+||.||+|.++  +..||+|.+...... ....+.+.+|++++++++||||+++++++..    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            356678999999999999986  678999998765443 3345778999999999999999999999865    345899


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla~~~~~  311 (337)
                      ||||+++|+|.+++.....+++.+++.++.||+.||.|||+++.+|+||||||+|||+  + .++.+||+|||+|+....
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl--~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE--SSTTSCEEECCTTGGGGCCT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhcee--eCCCCCEEEeecCcceeccC
Confidence            9999999999999998888999999999999999999999976669999999999999  5 367899999999986543


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .      ......||+.|||||++.
T Consensus       168 ~------~~~~~~GT~~Y~aPE~~~  186 (270)
T d1t4ha_         168 S------FAKAVIGTPEFMAPEMYE  186 (270)
T ss_dssp             T------SBEESCSSCCCCCGGGGG
T ss_pred             C------ccCCcccCccccCHHHhC
Confidence            3      234568999999999863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-40  Score=294.37  Aligned_cols=171  Identities=26%  Similarity=0.422  Sum_probs=152.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|..+  |+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            6889999999999999999975  88999999975432222335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ||++|+|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||+  +.+|.+||+|||+|+....... 
T Consensus        86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl--~~~g~vkl~DFG~a~~~~~~~~-  160 (337)
T d1o6la_          86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCSCCTTC-
T ss_pred             ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEe--cCCCCEEEeecccccccccCCc-
Confidence            9999999999999889999999999999999999999988  9999999999999  8889999999999987654332 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         .....+||+.|||||++.
T Consensus       161 ---~~~~~~GT~~Y~aPE~~~  178 (337)
T d1o6la_         161 ---TMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             ---CBCCCEECGGGCCGGGGS
T ss_pred             ---ccccceeCHHHhhhhhcc
Confidence               345678999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-40  Score=287.94  Aligned_cols=168  Identities=26%  Similarity=0.428  Sum_probs=147.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|++.+.||+|+||.||+|.++  ++.||+|++......   ..+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            4788899999999999999985  778999998765333   23678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||++|+|.+++.+ .+.+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+|+.......
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll--~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECHHHHH
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeE--CCCCCEEEEechhhhccCCCcc
Confidence            9999999999875 456999999999999999999999988  9999999999999  7888999999999987654321


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|||||++.
T Consensus       166 ----~~~~~~Gt~~y~APE~l~  183 (288)
T d2jfla1         166 ----RRDSFIGTPYWMAPEVVM  183 (288)
T ss_dssp             ----HHTCCCSCCTTCCHHHHT
T ss_pred             ----cccccccccccCCHHHHh
Confidence                234678999999999873

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-40  Score=294.70  Aligned_cols=169  Identities=26%  Similarity=0.442  Sum_probs=148.7

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEE
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      ..+|+..+.||+|+||.||+|.+.  |+.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            347899999999999999999985  789999998765332  2346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE-PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||.|||++ +  |+||||||+|||+  +.++++||+|||+|+.+...
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl--~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILV--NSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEE--CTTCCEEECCCCCCHHHHHH
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeE--CCCCCEEEeeCCCccccCCC
Confidence            99999999999999888899999999999999999999974 7  9999999999999  88899999999999876543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                            ...+..||+.|||||++.
T Consensus       159 ------~~~~~~GT~~Y~APEvl~  176 (322)
T d1s9ja_         159 ------MANSFVGTRSYMSPERLQ  176 (322)
T ss_dssp             ------TC---CCSSCCCCHHHHH
T ss_pred             ------ccccccCCccccCchHHc
Confidence                  234568999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=283.52  Aligned_cols=172  Identities=28%  Similarity=0.473  Sum_probs=136.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--CCceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--RKPLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~~~lv  233 (337)
                      +|++.+.||+|+||.||+|..+  |+.||+|.+...... ....+.+.+|+.++++++||||+++++++.+  .+.+|+|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6888999999999999999986  789999999776544 3345778999999999999999999999864  4568999


Q ss_pred             EeecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC---CCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          234 TEYLRGGDLHKYLKE----KGALSPSTAVNFALDIARGMAYLHNEP---NVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      ||||++|+|.+++..    ...+++..++.++.||+.||.|||+++   ++|+||||||+|||+  +.++.+||+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll--~~~~~vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE--CTTSCEEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc--CCCCcEEEeeccce
Confidence            999999999999864    456999999999999999999999854   349999999999999  88899999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.+.....    ......||+.|||||++.
T Consensus       162 ~~~~~~~~----~~~~~~gt~~Y~APE~l~  187 (269)
T d2java1         162 RILNHDTS----FAKAFVGTPYYMSPEQMN  187 (269)
T ss_dssp             HHC---------------CCCSCCCHHHHT
T ss_pred             eecccCCC----ccccCCCCcccCCHHHHc
Confidence            88764422    245678999999999874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-39  Score=288.63  Aligned_cols=168  Identities=27%  Similarity=0.499  Sum_probs=150.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|..+  |+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            7899999999999999999975  88999999865432222335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+++|+|.+++.....+++..+..++.||+.||.|||+++  |+||||||+|||+  +.+|.+||+|||+|+.....   
T Consensus        85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl--~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILL--DKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTSCEEECCCSSCEECSSC---
T ss_pred             ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeE--cCCCCEEEecCccceEeccc---
Confidence            9999999999998889999999999999999999999988  9999999999999  88899999999999876543   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....||+.|||||++.
T Consensus       158 ----~~~~~Gt~~Y~APE~l~  174 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVS  174 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHT
T ss_pred             ----cccccCcccccCHHHHc
Confidence                34578999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.7e-39  Score=288.42  Aligned_cols=169  Identities=24%  Similarity=0.507  Sum_probs=149.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|..+  |+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            7999999999999999999985  8899999996543   2334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||++|+|.+++.. .+.+++.++..++.||+.||.|||++|  ||||||||+|||+..+..+.+||+|||+|+.+.... 
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999954 457999999999999999999999988  999999999999965556899999999998876543 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|||||++.
T Consensus       181 ----~~~~~~gT~~Y~aPEv~~  198 (350)
T d1koaa2         181 ----SVKVTTGTAEFAAPEVAE  198 (350)
T ss_dssp             ----CEEEECSCTTTCCHHHHH
T ss_pred             ----ccceecCcccccCHHHHc
Confidence                234567999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-39  Score=280.58  Aligned_cols=176  Identities=30%  Similarity=0.535  Sum_probs=149.6

Q ss_pred             CCCcccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          147 KCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      ..+|+|+..  +|+..+.||+|+||.||+|.++ ++.||||.+......    .+.+.+|+.++++++||||+++++++.
T Consensus         5 ~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           5 EDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             TCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            467888754  6777889999999999999997 568999999764433    256899999999999999999999875


Q ss_pred             eCCceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                       .+.+|+||||+++|+|.+++..  ...+++.+++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+||
T Consensus        79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll--~~~~~~Kl~DF  153 (272)
T d1qpca_          79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV--SDTLSCKIADF  153 (272)
T ss_dssp             -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTSCEEECCC
T ss_pred             -cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheee--ecccceeeccc
Confidence             4568999999999999998753  235999999999999999999999987  9999999999999  88899999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+|+.+.....   .......||+.|||||++.
T Consensus       154 Gla~~~~~~~~---~~~~~~~gt~~y~APE~~~  183 (272)
T d1qpca_         154 GLARLIEDNEY---TAREGAKFPIKWTAPEAIN  183 (272)
T ss_dssp             TTCEECSSSCE---ECCTTCCCCTTTSCHHHHH
T ss_pred             cceEEccCCcc---ccccccCCcccccChHHHh
Confidence            99998764321   2345678999999999863

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-39  Score=286.48  Aligned_cols=170  Identities=28%  Similarity=0.467  Sum_probs=133.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      .|+..+.||+|+||.||+|..+  ++.||||.+.+.....  ....+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4889999999999999999986  7889999997654332  23567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||++|+|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+.. +.++.+||+|||+|+...... 
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            9999999999998888999999999999999999999988  999999999999943 346789999999998765432 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|||||++.
T Consensus       165 ----~~~~~~GT~~y~APE~~~  182 (307)
T d1a06a_         165 ----VLSTACGTPGYVAPEVLA  182 (307)
T ss_dssp             ------------CTTSCHHHHT
T ss_pred             ----eeeeeeeCccccCcHHHc
Confidence                234567999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=276.42  Aligned_cols=168  Identities=32%  Similarity=0.583  Sum_probs=136.3

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||+|.+. ++.||||++......    .+++.+|+.++++++||||+++++++...+.+|+||||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            5777889999999999999986 667999998764433    25788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++|+|.+++... ..+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+|+....... 
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~-  156 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQY-  156 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEE--CGGGCEEECSCC-----------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheee--cCCCCeEecccchheeccCCCc-
Confidence            9999999998754 56899999999999999999999987  9999999999999  7888999999999987764422 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|||||++.
T Consensus       157 --~~~~~~~gt~~y~aPE~l~  175 (263)
T d1sm2a_         157 --TSSTGTKFPVKWASPEVFS  175 (263)
T ss_dssp             ----------CTTSCCHHHHT
T ss_pred             --eeecceecCcccCChHHhc
Confidence              1234567999999999874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-38  Score=278.53  Aligned_cols=170  Identities=29%  Similarity=0.501  Sum_probs=149.2

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCch---HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD---RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~---~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|+..+.||+|+||.||+|.++  |+.||||++.+.....   ....+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            6899999999999999999986  8899999986543321   1234778899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC----cEEEEeccCcee
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD----HLKVGDFGLSKL  308 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~----~~kl~DFgla~~  308 (337)
                      |||||++|+|.+++...+.+++..++.++.||+.||.|||+++  |+||||||+|||+  +..+    .+||+|||+|+.
T Consensus        91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill--~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--SCSSSSSCCEEECCCTTCEE
T ss_pred             EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEE--ecCCCcccceEecchhhhhh
Confidence            9999999999999998889999999999999999999999988  9999999999999  4444    599999999988


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....     ......||+.|||||++.
T Consensus       167 ~~~~~-----~~~~~~~t~~y~APE~~~  189 (293)
T d1jksa_         167 IDFGN-----EFKNIFGTPEFVAPEIVN  189 (293)
T ss_dssp             CTTSC-----BCSCCCCCGGGCCHHHHT
T ss_pred             cCCCc-----cccccCCCCcccCHHHHc
Confidence            75442     245678999999999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-38  Score=287.24  Aligned_cols=168  Identities=27%  Similarity=0.421  Sum_probs=150.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|.++  |+.||||++.+.........+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            7999999999999999999985  88999999865332222334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      |+.+|+|.+++...+.+++.+++.++.||+.||.|||+++  ||||||||+|||+  +.++.+||+|||+|+.+...   
T Consensus       122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl--~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTSCEEECCCTTCEECSSC---
T ss_pred             cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHccc--CCCCCEEeeeceeeeecccc---
Confidence            9999999999998889999999999999999999999988  9999999999999  88899999999999887543   


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          .....||+.|||||++.
T Consensus       195 ----~~~~~Gt~~Y~APE~~~  211 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIIL  211 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHT
T ss_pred             ----cccccCccccCCHHHHc
Confidence                34567999999999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.6e-38  Score=285.52  Aligned_cols=169  Identities=22%  Similarity=0.449  Sum_probs=148.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|..+  |+.||||++.....   .....+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            5899999999999999999985  88999999876432   234677899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||++|+|.+++...+ .+++.+++.++.||+.||.|||++|  |+||||||+|||+.....+.+||+|||+|+.+.... 
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            999999999876544 6999999999999999999999988  999999999999954467899999999999876543 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|||||++.
T Consensus       184 ----~~~~~~gt~~y~aPE~~~  201 (352)
T d1koba_         184 ----IVKVTTATAEFAAPEIVD  201 (352)
T ss_dssp             ----CEEEECSSGGGCCHHHHT
T ss_pred             ----ceeeccCcccccCHHHHc
Confidence                245567999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-38  Score=275.40  Aligned_cols=166  Identities=28%  Similarity=0.517  Sum_probs=138.0

Q ss_pred             ceecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeecC
Q 019685          163 AIIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYLR  238 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~  238 (337)
                      +.||+|+||.||+|.++    ++.||||.+..... +....+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            47999999999999864    35799999865443 33445789999999999999999999999864 56799999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccccee
Q 019685          239 GGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVY  318 (337)
Q Consensus       239 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~  318 (337)
                      +|+|.+++.....+++.++..++.||+.||.|||+++  ||||||||+|||+  +..+.+||+|||+|+.+...... ..
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill--~~~~~~kl~DFGla~~~~~~~~~-~~  165 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL--VTQHYAKISDFGLSKALRADENY-YK  165 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--EETTEEEECCCTTCEECCTTCSE-EE
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcc--cccCcccccchhhhhhccccccc-cc
Confidence            9999999998888999999999999999999999987  9999999999999  77889999999999887654321 11


Q ss_pred             eeeCCcccccccccccc
Q 019685          319 KMTGETGSCEYLVSNCS  335 (337)
Q Consensus       319 ~~~~~~gt~~y~aPE~l  335 (337)
                      ......||+.|||||++
T Consensus       166 ~~~~~~gt~~y~APE~l  182 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECI  182 (277)
T ss_dssp             C----CCCGGGCCHHHH
T ss_pred             cccccCCCceecCchhh
Confidence            23456799999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.5e-38  Score=287.07  Aligned_cols=169  Identities=29%  Similarity=0.409  Sum_probs=145.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHH---HHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDF---RHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~---~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|++.+.||+|+||.||+|...  |+.||||++.+...........+   ..|+.+++.++||||+++++++.+.+.+|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            7889999999999999999985  88999999864322211112223   345777788889999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecc
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||||+++|+|.+++.....+++..+..++.||+.||.|||+++  ||||||||+|||+  +..+.+||+|||+|+.+...
T Consensus        85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl--~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILL--DEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CSSSCEEECCCTTCEECSSS
T ss_pred             EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEE--cCCCcEEEeeeceeeecCCC
Confidence            9999999999999998888999999999999999999999988  9999999999999  88899999999999877543


Q ss_pred             cccceeeeeCCccccccccccccc
Q 019685          313 NSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                            ......||+.|||||++.
T Consensus       161 ------~~~~~~GT~~y~APE~~~  178 (364)
T d1omwa3         161 ------KPHASVGTHGYMAPEVLQ  178 (364)
T ss_dssp             ------CCCSCCSCGGGCCHHHHS
T ss_pred             ------cccccccccccchhHHhh
Confidence                  234568999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-37  Score=271.36  Aligned_cols=170  Identities=26%  Similarity=0.421  Sum_probs=151.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCch------HHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCC
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD------RLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERK  228 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~  228 (337)
                      +|+..+.||+|+||+||+|+..  ++.||||++.+.....      ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            7889999999999999999984  7899999987654321      233456889999999997 999999999999999


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+||||||+++|+|.+++..++.+++.+++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill--~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILL--DDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CTTCCEEECCCTTCEE
T ss_pred             ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEE--cCCCCeEEccchheeE
Confidence            99999999999999999998889999999999999999999999988  9999999999999  8889999999999998


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +....     ......||+.|+|||++.
T Consensus       160 ~~~~~-----~~~~~~gt~~y~~PE~~~  182 (277)
T d1phka_         160 LDPGE-----KLREVCGTPSYLAPEIIE  182 (277)
T ss_dssp             CCTTC-----CBCCCCSCGGGCCHHHHH
T ss_pred             ccCCC-----ceeeeeccCCCCCHHHhh
Confidence            76542     235567999999999863

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-38  Score=281.28  Aligned_cols=179  Identities=30%  Similarity=0.519  Sum_probs=146.6

Q ss_pred             CCcccCCCCcCccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeee
Q 019685          148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQ  219 (337)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~  219 (337)
                      ..|+++.+  +|+..+.||+|+||.||+|.+.+       ..||+|.+.....  ......+.+|+.++.++ +|||||+
T Consensus        30 ~kwei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~  105 (325)
T d1rjba_          30 LKWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVN  105 (325)
T ss_dssp             GGGBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeE
Confidence            34666654  57778899999999999998752       2588898865432  22346788999999988 7999999


Q ss_pred             eeeeEEeCCceEEEEeecCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHcCCC
Q 019685          220 FLGAVTERKPLMLITEYLRGGDLHKYLKEKG-----------------------ALSPSTAVNFALDIARGMAYLHNEPN  276 (337)
Q Consensus       220 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lH~~~~  276 (337)
                      +++++.+.+.+|+|||||++|+|.++|....                       .+++.+++.++.||+.||.|||+++ 
T Consensus       106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-  184 (325)
T d1rjba_         106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-  184 (325)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             EEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            9999999999999999999999999997542                       3789999999999999999999987 


Q ss_pred             CcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       277 ~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                       ||||||||+|||+  +.++.+||+|||+|+.......  .....+..||+.|||||++.
T Consensus       185 -IiHRDlKp~Nill--~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~  239 (325)
T d1rjba_         185 -CVHRDLAARNVLV--THGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLF  239 (325)
T ss_dssp             -EEETTCSGGGEEE--ETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHH
T ss_pred             -eeeccCchhcccc--ccCCeEEEeeccccccccCCCc--eeeeccccCCCccCChHHHc
Confidence             9999999999999  7888999999999987665432  12344567899999999873

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-38  Score=276.67  Aligned_cols=173  Identities=31%  Similarity=0.528  Sum_probs=134.0

Q ss_pred             CccccceecccCceeEEEEEEC--Cc---eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GT---PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~---~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|+..+.||+|+||.||+|.++  ++   .||||.+.....  ....+.+.+|+.+|++++|||||++++++...+.+|+
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            5777889999999999999975  32   478887755433  3445789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      |||||++|+|.+++... +.+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+|+.+..
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl--~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILV--NSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCC--------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEE--CCCCcEEECCcccceEccC
Confidence            99999999999998864 56999999999999999999999987  9999999999999  8889999999999998765


Q ss_pred             ccccce-eeeeCCccccccccccccc
Q 019685          312 QNSHDV-YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~-~~~~~~~gt~~y~aPE~l~  336 (337)
                      ...... .......||+.|||||++.
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~  206 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQ  206 (299)
T ss_dssp             ---------------CGGGSCHHHHH
T ss_pred             CCCcceeeecccccCCccccCHHHHh
Confidence            432211 1234456899999999863

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=273.25  Aligned_cols=176  Identities=35%  Similarity=0.587  Sum_probs=140.2

Q ss_pred             cCCCCcCccccceecccCceeEEEEEECC------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEE
Q 019685          152 IDPSELDFSSSAIIGKGSFGEILKAYWRG------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVT  225 (337)
Q Consensus       152 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~g------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~  225 (337)
                      |+++  +|+..++||+|+||.||+|.+++      ..||||.+.....  ......+.+|+.++++++||||+++++++.
T Consensus         4 i~~~--~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           4 IHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             CCTT--TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCHH--HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            4444  47778899999999999998753      3699999865443  234467899999999999999999999999


Q ss_pred             eCCceEEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEecc
Q 019685          226 ERKPLMLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFG  304 (337)
Q Consensus       226 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFg  304 (337)
                      +.+.+++||||+.++++.+++... ..+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl--~~~~~~Kl~DFG  155 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV--NSNLVCKVSDFG  155 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCC
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEE--CCCCeEEEcccc
Confidence            999999999999999999988764 56999999999999999999999987  9999999999999  888999999999


Q ss_pred             CceeeecccccceeeeeCCccccccccccccc
Q 019685          305 LSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       305 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +|+.+...... ........||+.|||||++.
T Consensus       156 la~~~~~~~~~-~~~~~~~~gt~~Y~APE~l~  186 (283)
T d1mqba_         156 LSRVLEDDPEA-TYTTSGGKIPIRWTAPEAIS  186 (283)
T ss_dssp             C------------------CCCGGGSCHHHHH
T ss_pred             hhhcccCCCcc-ceEeccCCCCccccCHHHHc
Confidence            99887644221 12345567899999999863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-37  Score=271.24  Aligned_cols=170  Identities=28%  Similarity=0.511  Sum_probs=142.4

Q ss_pred             Cccccc-eecccCceeEEEEEEC----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSA-IIGKGSFGEILKAYWR----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~-~lg~G~~g~V~~~~~~----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|...+ .||+|+||.||+|.++    +..||||.+....  .....+++.+|+.++++++||||+++++++.. +.+|+
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            455555 4999999999999874    3469999986543  33456789999999999999999999998865 56899


Q ss_pred             EEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      ||||+++|+|.+++.. +..+++.++..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+|+.+..
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL--VNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--EETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheee--ccCCceeeccchhhhcccc
Confidence            9999999999999865 457999999999999999999999987  9999999999999  6778999999999998765


Q ss_pred             ccccceeeeeCCcccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .... ........||+.|||||++
T Consensus       162 ~~~~-~~~~~~~~gt~~y~aPE~~  184 (285)
T d1u59a_         162 DDSY-YTARSAGKWPLKWYAPECI  184 (285)
T ss_dssp             CSCE-ECCCCSSCCCGGGCCHHHH
T ss_pred             cccc-cccccccccCccccChHHH
Confidence            4321 1123456799999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-38  Score=278.51  Aligned_cols=171  Identities=28%  Similarity=0.459  Sum_probs=147.4

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHH-hCCCCCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLV-KLRHPNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|++.+.||+|+||+||+|..+  ++.||||++.+.........+.+..|..++. .++||||+++++++.+.+.+|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            6888999999999999999985  8899999996532222222355666777654 689999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          235 EYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||+++|+|.+++...+.+++.++..++.||+.||.|||+++  |+||||||+|||+  +..+.+||+|||+++.......
T Consensus        83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~--~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEE--CTTSCEEECCCTTCBCCCCTTC
T ss_pred             eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceee--cCCCceeccccchhhhcccccc
Confidence            99999999999999889999999999999999999999988  9999999999999  8889999999999987654322


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|||||++.
T Consensus       159 ----~~~~~~gt~~y~aPE~~~  176 (320)
T d1xjda_         159 ----KTNTFCGTPDYIAPEILL  176 (320)
T ss_dssp             ----CBCCCCSCGGGCCHHHHT
T ss_pred             ----cccccCCCCCcCCHHHHc
Confidence                345578999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-37  Score=266.59  Aligned_cols=168  Identities=29%  Similarity=0.541  Sum_probs=147.3

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||+|.++ ++.||||.+.+.....    +.+.+|+.++++++||||+++++++.+.+.+++||||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            6777889999999999999997 5589999997654432    5788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          237 LRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       237 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      +++|+|.+++.. ...+++..+.+++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.+..... 
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill--~~~~~~kl~DfG~a~~~~~~~~-  155 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV--NDQGVVKVSDFGLSRYVLDDEY-  155 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEE--CTTCCEEECCCSSCCBCSSSSC-
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEE--cCCCcEEECcchhheeccCCCc-
Confidence            999999999765 456999999999999999999999987  9999999999999  7888999999999987654422 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                        .......||+.|||||++.
T Consensus       156 --~~~~~~~~t~~y~aPE~~~  174 (258)
T d1k2pa_         156 --TSSVGSKFPVRWSPPEVLM  174 (258)
T ss_dssp             --CCCCCSCCCGGGCCHHHHH
T ss_pred             --eeecccCCCCCcCCcHHhc
Confidence              2345577999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-37  Score=271.66  Aligned_cols=177  Identities=32%  Similarity=0.556  Sum_probs=143.8

Q ss_pred             CCCCcccCCCCcCccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeE
Q 019685          146 NKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAV  224 (337)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~  224 (337)
                      .+.+|+|+..  +|++.+.||+|+||.||+|.++ ++.||||.+......    .+.+.+|+.++++++|||||++++++
T Consensus         8 ~~~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~   81 (285)
T d1fmka3           8 AKDAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVV   81 (285)
T ss_dssp             STTCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCcceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEE
Confidence            3567888755  6888899999999999999987 457999998765443    26789999999999999999999998


Q ss_pred             EeCCceEEEEeecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          225 TERKPLMLITEYLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       225 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                      . .+.+|+||||+++|+|..++..  ...+++.+++.++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|
T Consensus        82 ~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll--~~~~~~kl~D  156 (285)
T d1fmka3          82 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV--GENLVCKVAD  156 (285)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CGGGCEEECC
T ss_pred             e-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEE--CCCCcEEEcc
Confidence            5 4568999999999999998854  456999999999999999999999987  9999999999999  7788999999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+|+.+.....   .......||+.|+|||++.
T Consensus       157 fGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~  187 (285)
T d1fmka3         157 FGLARLIEDNEY---TARQGAKFPIKWTAPEAAL  187 (285)
T ss_dssp             CCTTC-----------------CCGGGSCHHHHH
T ss_pred             cchhhhccCCCc---eeeccccccccccChHHHh
Confidence            999987754321   2345567999999999873

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.9e-37  Score=270.42  Aligned_cols=174  Identities=26%  Similarity=0.451  Sum_probs=144.8

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC----ceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~  231 (337)
                      +|++.+.||+|+||.||+|.+.  |+.||||++.+....+......+.+|+.+++.++||||+++++++....    .+|
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence            5889999999999999999975  8899999998877766667788999999999999999999999987654    389


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      +||||+++++|.+++...+.+++.+++.++.||+.||.|||++|  |+||||||+|||+  +..+.++|+|||+++....
T Consensus        88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll--~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI--SATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTSCEEECCCTTCEECC-
T ss_pred             EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCccccc--Cccccceeehhhhhhhhcc
Confidence            99999999999999998889999999999999999999999988  9999999999999  7788999999999987654


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .... ........||+.|||||++.
T Consensus       164 ~~~~-~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         164 SGNS-VTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             ----------------TTCCHHHHT
T ss_pred             cccc-ccccccccCcccccCHHHHc
Confidence            3221 12345678999999999874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-37  Score=274.78  Aligned_cols=168  Identities=18%  Similarity=0.337  Sum_probs=147.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|.++  ++.||+|.+.....    ....+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            5888999999999999999985  78899999976432    23567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||++|+|.+++...+ .+++.+++.++.||+.||.|||++|  |+||||||+|||+..+..+.+||+|||+++...... 
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            999999999998655 6999999999999999999999988  999999999999955566789999999998775432 


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                          ......||+.|+|||++.
T Consensus       159 ----~~~~~~~t~~y~ape~~~  176 (321)
T d1tkia_         159 ----NFRLLFTAPEYYAPEVHQ  176 (321)
T ss_dssp             ----EEEEEESCGGGSCHHHHT
T ss_pred             ----cccccccccccccchhcc
Confidence                244567999999999863

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-37  Score=273.43  Aligned_cols=167  Identities=30%  Similarity=0.437  Sum_probs=139.7

Q ss_pred             cceecccCceeEEEEEEC--CceEEEEEecCCCCch--HHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEeec
Q 019685          162 SAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDD--RLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEYL  237 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~--~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~  237 (337)
                      .++||+|+||+||+|.++  |+.||||++.......  ....+.+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999975  7899999986543221  112356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccce
Q 019685          238 RGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDV  317 (337)
Q Consensus       238 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~  317 (337)
                      .++++..++.....+++.++..++.||+.||.|||++|  |+||||||+|||+  +..+.+||+|||+|+.......   
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli--~~~~~~KL~DFG~a~~~~~~~~---  155 (299)
T d1ua2a_          83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNR---  155 (299)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCCGGGSTTTSCCC---
T ss_pred             cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEe--cCCCccccccCccccccCCCcc---
Confidence            98877777666677999999999999999999999988  9999999999999  8889999999999987654322   


Q ss_pred             eeeeCCccccccccccccc
Q 019685          318 YKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       318 ~~~~~~~gt~~y~aPE~l~  336 (337)
                       ......||+.|||||++.
T Consensus       156 -~~~~~~gt~~y~aPE~~~  173 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLF  173 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHT
T ss_pred             -cccceecChhhccHHHHc
Confidence             345568999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-36  Score=264.01  Aligned_cols=176  Identities=30%  Similarity=0.533  Sum_probs=135.7

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEEC-----CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeee
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-----GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGA  223 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~  223 (337)
                      +|+|+.+  +|+..+.||+|+||.||+|.+.     +..||+|.+....  .....+.+.+|+.++++++||||++++++
T Consensus         1 ~~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~   76 (273)
T d1mp8a_           1 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGV   76 (273)
T ss_dssp             CCBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CCCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4777655  6888899999999999999875     2357788775433  34445789999999999999999999999


Q ss_pred             EEeCCceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEe
Q 019685          224 VTERKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGD  302 (337)
Q Consensus       224 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~D  302 (337)
                      +. .+.+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++  |+||||||+||++  +..+.+||+|
T Consensus        77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll--~~~~~~Kl~D  151 (273)
T d1mp8a_          77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV--SSNDCVKLGD  151 (273)
T ss_dssp             EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--EETTEEEECC
T ss_pred             Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheee--cCCCcEEEcc
Confidence            85 4678999999999999998765 456999999999999999999999987  9999999999999  7778999999


Q ss_pred             ccCceeeecccccceeeeeCCccccccccccccc
Q 019685          303 FGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       303 Fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ||+|+.......   .......||+.|||||++.
T Consensus       152 fG~a~~~~~~~~---~~~~~~~gt~~y~apE~l~  182 (273)
T d1mp8a_         152 FGLSRYMEDSTY---YKASKGKLPIKWMAPESIN  182 (273)
T ss_dssp             ----------------------CCGGGCCHHHHH
T ss_pred             chhheeccCCcc---eeccceecCcccchhhHhc
Confidence            999987654322   1334567899999999863

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=263.45  Aligned_cols=169  Identities=34%  Similarity=0.614  Sum_probs=138.2

Q ss_pred             cccCCCCcCccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-CC
Q 019685          150 WEIDPSELDFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RK  228 (337)
Q Consensus       150 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~  228 (337)
                      |+|+..+  |+..+.||+|+||.||+|.++|..||||++....     ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus         2 w~i~~~~--~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMKE--LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGGG--EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHH--eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            7777764  5667899999999999999999999999986542     23678899999999999999999998854 46


Q ss_pred             ceEEEEeecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCc
Q 019685          229 PLMLITEYLRGGDLHKYLKEKG--ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLS  306 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla  306 (337)
                      .+|+||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||++
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~--~~~~~~kl~dfg~s  150 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV--SEDNVAKVSDFGLT  150 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTSCEEECCCCC-
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhhee--cCCCCEeecccccc
Confidence            7899999999999999997543  4899999999999999999999977  9999999999999  88899999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +.....       .....+|+.|||||++.
T Consensus       151 ~~~~~~-------~~~~~~~~~y~aPE~l~  173 (262)
T d1byga_         151 KEASST-------QDTGKLPVKWTAPEALR  173 (262)
T ss_dssp             ------------------CCTTTSCHHHHH
T ss_pred             eecCCC-------CccccccccCCChHHHh
Confidence            875432       23456899999999863

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-36  Score=268.62  Aligned_cols=164  Identities=27%  Similarity=0.470  Sum_probs=138.4

Q ss_pred             Ccccc-ceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHh-CCCCCeeeeeeeEEe----CCc
Q 019685          158 DFSSS-AIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK-LRHPNIVQFLGAVTE----RKP  229 (337)
Q Consensus       158 ~~~~~-~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~-l~h~~Iv~~~~~~~~----~~~  229 (337)
                      +|.+. +.||+|+||.||+|.+.  ++.||||++...        ..+.+|+.++.+ .+||||+++++++.+    ...
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            67765 46999999999999975  789999998542        446679988654 579999999999875    456


Q ss_pred             eEEEEeecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecC-CCCcEEEEeccCc
Q 019685          230 LMLITEYLRGGDLHKYLKEK--GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNS-SADHLKVGDFGLS  306 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~-~~~~~kl~DFgla  306 (337)
                      +|+|||||+||+|.++|...  ..+++.+++.++.||+.||.|||++|  |+||||||+|||+..+ ..+.+||+|||+|
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccccccee
Confidence            89999999999999999864  36999999999999999999999988  9999999999999432 3568999999999


Q ss_pred             eeeecccccceeeeeCCccccccccccccc
Q 019685          307 KLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      +......     ......||+.|||||++.
T Consensus       162 ~~~~~~~-----~~~~~~gt~~y~aPE~~~  186 (335)
T d2ozaa1         162 KETTSHN-----SLTTPCYTPYYVAPEVLG  186 (335)
T ss_dssp             EECCCCC-----CCCCCSCCCSSCCCCCCC
T ss_pred             eeccCCC-----ccccccCCcccCCcHHHc
Confidence            8876543     245678999999999873

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-36  Score=265.95  Aligned_cols=171  Identities=26%  Similarity=0.371  Sum_probs=144.2

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchH---HHHHHHHHHHHHHHhCC--CCCeeeeeeeEEeCCc
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDR---LVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKP  229 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~  229 (337)
                      .+|++.+.||+|+||.||+|.+.  |+.||||.+.+......   ....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            47899999999999999999985  78999999865432211   11133567999999987  8999999999999999


Q ss_pred             eEEEEeecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          230 LMLITEYLRG-GDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       230 ~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .|+||||+.+ +++.+++.....+++.+++.++.||+.||.|||+++  |+||||||+|||++. ..+.+||+|||+|+.
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~-~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDL-NRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEET-TTTEEEECCCTTCEE
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEec-CCCeEEECcccccee
Confidence            9999999975 688899988889999999999999999999999988  999999999999932 346899999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....      ......||+.|||||++.
T Consensus       161 ~~~~------~~~~~~GT~~y~aPE~~~  182 (273)
T d1xwsa_         161 LKDT------VYTDFDGTRVYSPPEWIR  182 (273)
T ss_dssp             CCSS------CBCCCCSCGGGSCHHHHH
T ss_pred             cccc------cccccccCCCcCCHHHHc
Confidence            5433      235678999999999863

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-36  Score=264.21  Aligned_cols=171  Identities=29%  Similarity=0.437  Sum_probs=138.4

Q ss_pred             CccccceecccCceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC----ceEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLMLI  233 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~lv  233 (337)
                      +|...+.||+|+||.||+|.++|+.||||++....    ........|+..+.+++||||+++++++.+.+    .+|+|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            56677899999999999999999999999985431    11122334555667789999999999987654    58999


Q ss_pred             EeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC------CCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          234 TEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNE------PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       234 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      |||+++|+|.+++++. .+++...+.++.|++.||.|+|+.      ..+||||||||+|||+  +.++.+||+|||+++
T Consensus        80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl--~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred             EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE--cCCCCeEEEecCccc
Confidence            9999999999999764 689999999999999999999973      1249999999999999  888999999999999


Q ss_pred             eeecccccceeeeeCCcccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCS  335 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l  335 (337)
                      .................||+.|||||++
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~  184 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVL  184 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHH
T ss_pred             cccCCCcceeccccceecccCcCChhhc
Confidence            8876543222234567899999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-36  Score=260.53  Aligned_cols=174  Identities=30%  Similarity=0.541  Sum_probs=134.7

Q ss_pred             cCccccceecccCceeEEEEEEC---C--ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceE
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR---G--TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLM  231 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~---g--~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~  231 (337)
                      .+|+..+.||+|+||.||+|.+.   +  ..||||++.+.........+++.+|+.++++++||||+++++++.+ +.++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            46888999999999999999864   2  2689999877665555666889999999999999999999999975 4679


Q ss_pred             EEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          232 LITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +||||++++++.+++.. .+.+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+.
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll--~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLL--ATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEE--EETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhcc--ccccceeeccchhhhhcc
Confidence            99999999999998765 456999999999999999999999987  9999999999999  667899999999999875


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..... ........||+.|+|||++.
T Consensus       163 ~~~~~-~~~~~~~~~~~~~~aPE~~~  187 (273)
T d1u46a_         163 QNDDH-YVMQEHRKVPFAWCAPESLK  187 (273)
T ss_dssp             C-CCE-EEC-----CCGGGCCHHHHH
T ss_pred             cCCCc-ceecCccccCcccCCHHHHh
Confidence            44321 12234556899999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-35  Score=262.77  Aligned_cols=171  Identities=32%  Similarity=0.518  Sum_probs=145.1

Q ss_pred             CccccceecccCceeEEEEEECC-------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWRG-------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~g-------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      +|+..+.||+|+||.||+|.+++       +.||||++.....  ....+++.+|+.++++++||||+++++++...+..
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            68889999999999999998754       5799999865432  34457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCC
Q 019685          231 MLITEYLRGGDLHKYLKEKG------------------------ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPR  286 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~  286 (337)
                      +++|||+++|+|.+++....                        .+++.+++.++.||+.||.|||+++  ||||||||+
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~  169 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATR  169 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEccc
Confidence            99999999999999996432                        3788899999999999999999987  999999999


Q ss_pred             CEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          287 NVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       287 Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+  +.++.+||+|||+|+.+...+..  .......||+.|||||++.
T Consensus       170 NILl--d~~~~~Kl~DFGls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  215 (301)
T d1lufa_         170 NCLV--GENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIF  215 (301)
T ss_dssp             GEEE--CGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHH
T ss_pred             ceEE--CCCCcEEEccchhheeccCCccc--cccCCCCcCcCcCCHHHHc
Confidence            9999  78889999999999876544321  1334567999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-36  Score=263.98  Aligned_cols=179  Identities=28%  Similarity=0.523  Sum_probs=137.0

Q ss_pred             CCcccCCCCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeee
Q 019685          148 CDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQ  219 (337)
Q Consensus       148 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~  219 (337)
                      ..|+++.+  +|+..+.||+|+||.||+|.+.       ++.||||.+.....  ....+.+.+|...+.++ +|+||+.
T Consensus         6 ~~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~   81 (299)
T d1ywna1           6 SKWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVN   81 (299)
T ss_dssp             HHHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEE
Confidence            35666643  6788899999999999999874       35799999865433  23346677788877776 5899999


Q ss_pred             eeeeEEeC-CceEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeC
Q 019685          220 FLGAVTER-KPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRD  282 (337)
Q Consensus       220 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrd  282 (337)
                      +++++... ..+++|||||++|+|.+++...                ..+++.+++.++.||+.||.|||+++  |||||
T Consensus        82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrD  159 (299)
T d1ywna1          82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  159 (299)
T ss_dssp             EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCc
Confidence            99987654 4689999999999999999753                23789999999999999999999987  99999


Q ss_pred             CCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          283 LKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       283 lkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||+|||+  +.++.+||+|||+|+........  .......||+.|||||++.
T Consensus       160 lKp~NILl--~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~  209 (299)
T d1ywna1         160 LAARNILL--SEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIF  209 (299)
T ss_dssp             CCGGGEEE--CGGGCEEECC------CCSCTTS--CCTTSCCCGGGGCCHHHHH
T ss_pred             CCccceeE--CCCCcEEEccCcchhhccccccc--cccCceeeCccccchhHhh
Confidence            99999999  78889999999999876543321  1234567999999999863

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-35  Score=262.58  Aligned_cols=184  Identities=33%  Similarity=0.526  Sum_probs=154.1

Q ss_pred             CCCCCCCcccCCCCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CC
Q 019685          143 PLPNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH  214 (337)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h  214 (337)
                      .+|....|+++..  +|+..+.||+|+||.||+|.+.       ++.||||.+.+...  ......+.+|+.+++.+ +|
T Consensus        11 ~~~~~~~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~H   86 (311)
T d1t46a_          11 QLPYDHKWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNH   86 (311)
T ss_dssp             TSCCCGGGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCC
T ss_pred             cCCCcccccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCC
Confidence            3444446887765  6666889999999999999863       35799999976543  33456788999999998 59


Q ss_pred             CCeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCC
Q 019685          215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEKG------------------ALSPSTAVNFALDIARGMAYLHNEPN  276 (337)
Q Consensus       215 ~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~i~~~l~~lH~~~~  276 (337)
                      |||+++++++.+...+|++||||++|+|.+++....                  .+++..+..++.||+.||.|||+++ 
T Consensus        87 pnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-  165 (311)
T d1t46a_          87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-  165 (311)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             CCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            999999999999999999999999999999997532                  4889999999999999999999988 


Q ss_pred             CcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       277 ~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                       ||||||||+||++  +..+.+||+|||+++.......  ........||+.|||||++.
T Consensus       166 -ivHrDLKp~NIl~--~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~  220 (311)
T d1t46a_         166 -CIHRDLAARNILL--THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIF  220 (311)
T ss_dssp             -CCCSCCSGGGEEE--ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHH
T ss_pred             -eeecccccccccc--cccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhc
Confidence             9999999999999  7788999999999987654322  22445678999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-36  Score=264.11  Aligned_cols=169  Identities=30%  Similarity=0.525  Sum_probs=141.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|++.+.||+|+||.||+|.+.  |+.||||++...... ....+.+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6888999999999999999985  889999999654322 2234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccc
Q 019685          236 YLRGGDLHKYLKE--KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQN  313 (337)
Q Consensus       236 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~  313 (337)
                      |+.+ ++.+++..  ...+++.++..++.||+.||.|||+++  ||||||||+|||+  +.++.+||+|||+|+......
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~--~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheee--cccCcceeccCCcceeccCCc
Confidence            9976 55555543  456999999999999999999999988  9999999999999  888899999999998765432


Q ss_pred             ccceeeeeCCccccccccccccc
Q 019685          314 SHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       314 ~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .    ......||+.|+|||++.
T Consensus       157 ~----~~~~~~gt~~y~apE~~~  175 (298)
T d1gz8a_         157 R----TYTHEVVTLWYRAPEILL  175 (298)
T ss_dssp             B----CTTCCBCCCTTCCHHHHT
T ss_pred             c----cceeecccceeeehhhhc
Confidence            2    345568999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-35  Score=263.26  Aligned_cols=171  Identities=29%  Similarity=0.603  Sum_probs=137.7

Q ss_pred             cCccccceecccCceeEEEEEEC--Cc----eEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCce
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GT----PVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPL  230 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~----~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  230 (337)
                      .+|+..+.||+|+||.||+|.+.  |+    .||+|.+.....  ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            36899999999999999999875  33    588888764322  22346789999999999999999999999764 57


Q ss_pred             EEEEeecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          231 MLITEYLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      ++++|++.+++|.+++... ..+++..++.++.||+.||.|||+++  ||||||||+|||+  +.++.+||+|||+|+.+
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll--~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLV--KTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--EETTEEEECCCSHHHHT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhccee--CCCCCeEeeccccceec
Confidence            8889999999999988764 56999999999999999999999987  9999999999999  77789999999999887


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......  .......||+.|||||++.
T Consensus       162 ~~~~~~--~~~~~~~gt~~y~APE~l~  186 (317)
T d1xkka_         162 GAEEKE--YHAEGGKVPIKWMALESIL  186 (317)
T ss_dssp             TTTCC----------CCTTTSCHHHHH
T ss_pred             cccccc--ccccccccCccccChHHHh
Confidence            544321  1234557999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-35  Score=259.93  Aligned_cols=178  Identities=29%  Similarity=0.479  Sum_probs=150.7

Q ss_pred             CcccCCCCcCccccceecccCceeEEEEEEC-------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeee
Q 019685          149 DWEIDPSELDFSSSAIIGKGSFGEILKAYWR-------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFL  221 (337)
Q Consensus       149 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~  221 (337)
                      .|+|++.  +|+..+.||+|+||.||+|.++       ++.||||++.....  ......+.+|+.++++++||||++++
T Consensus        14 ~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             TTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            6888865  6677889999999999999874       46799999875432  33456789999999999999999999


Q ss_pred             eeEEeCCceEEEEeecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEe
Q 019685          222 GAVTERKPLMLITEYLRGGDLHKYLKEK----------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLV  291 (337)
Q Consensus       222 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~  291 (337)
                      +++......++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++  |+||||||+|||+ 
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLl-  166 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV-  166 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE-
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceee-
Confidence            9999999999999999999999998642          23688999999999999999999987  9999999999999 


Q ss_pred             cCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          292 NSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       292 ~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                       +.++++||+|||+|+.+.....  ........||+.|||||.+.
T Consensus       167 -d~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~  208 (308)
T d1p4oa_         167 -AEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLK  208 (308)
T ss_dssp             -CTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHH
T ss_pred             -cCCceEEEeecccceeccCCcc--eeeccceecccccCCHHHHc
Confidence             8889999999999987654422  12335567999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-35  Score=259.27  Aligned_cols=182  Identities=32%  Similarity=0.569  Sum_probs=147.1

Q ss_pred             CCCCCcccCCCCcCccccceecccCceeEEEEEECC---------ceEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CC
Q 019685          145 PNKCDWEIDPSELDFSSSAIIGKGSFGEILKAYWRG---------TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RH  214 (337)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~g---------~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h  214 (337)
                      |....|+|+.+  +|++.+.||+|+||.||+|...+         ..||||.+.+...  ......+.+|...+.++ +|
T Consensus         3 ~~~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~H   78 (299)
T d1fgka_           3 PEDPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKH   78 (299)
T ss_dssp             CCCTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCC
T ss_pred             CcCCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCC
Confidence            44455877666  67778899999999999998642         3689999876543  23456788888888887 79


Q ss_pred             CCeeeeeeeEEeCCceEEEEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 019685          215 PNIVQFLGAVTERKPLMLITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVI  278 (337)
Q Consensus       215 ~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~i  278 (337)
                      |||+++++++.+.+.+++||||+++|+|.++|...                ..+++.+++.++.||+.||.|||+++  |
T Consensus        79 pnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--i  156 (299)
T d1fgka_          79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--C  156 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             CeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--E
Confidence            99999999999999999999999999999999754                24899999999999999999999987  9


Q ss_pred             EeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          279 IHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       279 vHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |||||||+|||+  +.++.+||+|||+++........  .......||+.|||||++.
T Consensus       157 vHrDiKp~NiLl--~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~  210 (299)
T d1fgka_         157 IHRDLAARNVLV--TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALF  210 (299)
T ss_dssp             CCSCCSGGGEEE--CTTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHH
T ss_pred             Eeeeecccceee--cCCCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhc
Confidence            999999999999  88889999999999887654322  1345567999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-35  Score=260.29  Aligned_cols=168  Identities=38%  Similarity=0.582  Sum_probs=138.4

Q ss_pred             CccccceecccCceeEEEEEEC--Cc--eEEEEEecCCCCchHHHHHHHHHHHHHHHhC-CCCCeeeeeeeEEeCCceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GT--PVAIKRILPSLSDDRLVIQDFRHEVNLLVKL-RHPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~--~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +|+..++||+|+||.||+|.++  +.  .||||.+.....  ....+.+.+|+.+++++ +||||+++++++.+.+.+|+
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            5677889999999999999985  33  467777754332  22346789999999998 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC
Q 019685          233 ITEYLRGGDLHKYLKEK----------------GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD  296 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~  296 (337)
                      ||||+++|+|.++|...                ..+++..+..++.||+.||.|||+.+  |+||||||+|||+  +..+
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~--~~~~  164 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV--GENY  164 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE--CGGG
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEE--cCCC
Confidence            99999999999999643                46899999999999999999999987  9999999999999  7888


Q ss_pred             cEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          297 HLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       297 ~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+||+|||+|+......     ......||+.|+|||++.
T Consensus       165 ~~kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~  199 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLN  199 (309)
T ss_dssp             CEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHH
T ss_pred             ceEEccccccccccccc-----cccceecCCcccchHHhc
Confidence            99999999998665432     234557999999999873

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.5e-35  Score=259.29  Aligned_cols=170  Identities=30%  Similarity=0.481  Sum_probs=143.8

Q ss_pred             CccccceecccCceeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEee
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITEY  236 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~  236 (337)
                      +|+..+.||+|+||.||+|.++ |+.||||++...... ....+.+.+|+.++++++||||+++++++...+..+++||+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6888999999999999999986 789999999665432 22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccccc
Q 019685          237 LRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD  316 (337)
Q Consensus       237 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~~  316 (337)
                      +.++.+..+....+.+++..+..++.||+.||+|||+.+  ||||||||+|||+  +.++.+||+|||+|........  
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll--~~~~~~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeE--cCCCCEEecccccceecccCcc--
Confidence            988777777666778999999999999999999999987  9999999999999  7889999999999987654321  


Q ss_pred             eeeeeCCccccccccccccc
Q 019685          317 VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       317 ~~~~~~~~gt~~y~aPE~l~  336 (337)
                        ......|++.|+|||++.
T Consensus       156 --~~~~~~~~~~y~~pE~~~  173 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLM  173 (286)
T ss_dssp             --------CCCTTCCHHHHT
T ss_pred             --ccceecccchhhhHHHHh
Confidence              345567999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=257.32  Aligned_cols=169  Identities=24%  Similarity=0.463  Sum_probs=141.6

Q ss_pred             cceecccCceeEEEEEECC-----ceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe-CCceEEEEe
Q 019685          162 SAIIGKGSFGEILKAYWRG-----TPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE-RKPLMLITE  235 (337)
Q Consensus       162 ~~~lg~G~~g~V~~~~~~g-----~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~~~~~lv~e  235 (337)
                      .++||+|+||+||+|.+..     ..||||.+...  ......+++.+|+.++++++||||+++++++.. ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            5689999999999999742     25889988643  234456889999999999999999999999765 457999999


Q ss_pred             ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeecccc
Q 019685          236 YLRGGDLHKYLKEK-GALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNS  314 (337)
Q Consensus       236 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~  314 (337)
                      ||++++|.+++... ..+++..++.++.|++.||.|||+.+  |+||||||+|||+  +..+.+||+|||+++.......
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl--~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE--CTTCCEEECSSGGGCCTTTTTC
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeE--CCCCCEEEecccchhhcccccc
Confidence            99999999998754 45788899999999999999999987  9999999999999  8888999999999988765433


Q ss_pred             cceeeeeCCccccccccccccc
Q 019685          315 HDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       315 ~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..........||+.|+|||++.
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~  207 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQ  207 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHH
T ss_pred             ccceecccccccccccChHHHh
Confidence            2222344567999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-33  Score=255.37  Aligned_cols=171  Identities=30%  Similarity=0.489  Sum_probs=140.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC----ceE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK----PLM  231 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~----~~~  231 (337)
                      +|+..+.||+|+||.||+|..+  |+.||||++.+..  .....+.+.+|+.+|+.++||||+++++++....    ..+
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            5999999999999999999975  8899999996543  3344577889999999999999999999986543    234


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeec
Q 019685          232 LITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKV  311 (337)
Q Consensus       232 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~  311 (337)
                      ++++++.+++|.+++.. ..+++.+++.++.||+.||.|||++|  ||||||||+|||+  +..+.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl--~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLL--NTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEE--CCCCCEEEcccCceeeccC
Confidence            55566778999999965 46999999999999999999999988  9999999999999  7888999999999988765


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..... .......||+.|+|||++.
T Consensus       162 ~~~~~-~~~~~~~gt~~y~aPE~l~  185 (345)
T d1pmea_         162 DHDHT-GFLTEYVATRWYRAPEIML  185 (345)
T ss_dssp             GGCBC-CTTCCCCSCGGGCCGGGTT
T ss_pred             CCccc-eeeccccccceechHHHhh
Confidence            43221 1245677999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-34  Score=257.21  Aligned_cols=165  Identities=29%  Similarity=0.397  Sum_probs=136.2

Q ss_pred             CcCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC------
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER------  227 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~------  227 (337)
                      +.+|+..++||+|+||+||+|.+.  |+.||||++......       ..+|+.++++++||||+++++++...      
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            447899999999999999999985  889999999664322       23699999999999999999998543      


Q ss_pred             CceEEEEeecCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCC-cEEEEec
Q 019685          228 KPLMLITEYLRGGDLHKYL---KEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSAD-HLKVGDF  303 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~-~~kl~DF  303 (337)
                      ..+|+||||++++.+..+.   .....+++.+++.++.||+.||+|||++|  |+||||||+|||+  +.++ .+||+||
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl--~~~~~~~kl~DF  167 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLL--DPDTAVLKLCDF  167 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEE--CTTTCCEEECCC
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEE--ecCCCceeEecc
Confidence            3479999999875433332   23456999999999999999999999988  9999999999999  6554 8999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++.+....     ......||+.|+|||+++
T Consensus       168 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~  195 (350)
T d1q5ka_         168 GSAKQLVRGE-----PNVSYICSRYYRAPELIF  195 (350)
T ss_dssp             TTCEECCTTS-----CCCSCCSCTTSCCHHHHT
T ss_pred             cchhhccCCc-----ccccccccccccChHHhh
Confidence            9998876543     235568999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-34  Score=255.55  Aligned_cols=174  Identities=24%  Similarity=0.389  Sum_probs=140.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe--------C
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE--------R  227 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--------~  227 (337)
                      +|++.+.||+|+||+||+|.+.  |+.||||++....... .....+.+|+.+|+.++||||+++++++..        .
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            7999999999999999999985  8899999986543322 233667889999999999999999998754        3


Q ss_pred             CceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCce
Q 019685          228 KPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSK  307 (337)
Q Consensus       228 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~  307 (337)
                      +.+|++|||+.++.+.........+++..++.++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl--~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLI--TRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheee--cCCCcEEeeecceee
Confidence            468999999988666655555667999999999999999999999988  9999999999999  888999999999998


Q ss_pred             eeecccccceeeeeCCccccccccccccc
Q 019685          308 LIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       308 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .+...............||+.|+|||+++
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~  194 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLL  194 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHT
T ss_pred             ecccccccccccccceecCHHHhhHHHHc
Confidence            77654332222345567999999999874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=254.70  Aligned_cols=166  Identities=28%  Similarity=0.488  Sum_probs=138.3

Q ss_pred             cCccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCC------
Q 019685          157 LDFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERK------  228 (337)
Q Consensus       157 ~~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~------  228 (337)
                      .+|++.+.||+|+||.||+|.++  |+.||||++.+... .....+.+.+|+.+|+.++||||+++++++...+      
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            47999999999999999999986  88999999976544 3345678889999999999999999999997654      


Q ss_pred             ceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          229 PLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       229 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      .+|+||||+ +.+|..+++ ...+++..++.++.||+.||.|||++|  |+||||||+|||+  +.++.+||+|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~--~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV--NEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE--CTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhc--ccccccccccccceec
Confidence            479999999 557877765 457999999999999999999999988  9999999999999  8889999999999987


Q ss_pred             eecccccceeeeeCCccccccccccccc
Q 019685          309 IKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       309 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....       .....||+.|+|||+++
T Consensus       171 ~~~~-------~~~~~~t~~y~aPE~~~  191 (346)
T d1cm8a_         171 ADSE-------MTGYVVTRWYRAPEVIL  191 (346)
T ss_dssp             CCSS-------CCSSCSCGGGCCTHHHH
T ss_pred             cCCc-------cccccccccccCHHHHc
Confidence            6532       35678999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-33  Score=247.25  Aligned_cols=170  Identities=28%  Similarity=0.464  Sum_probs=150.1

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeCCceEEEEe
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTERKPLMLITE  235 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e  235 (337)
                      +|+..+.||+|+||+||+|.+.  ++.||||++...... ......+.+|+.+++.++||||+++++++......++++|
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            6888999999999999999985  778999999665433 3345788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeeeccccc
Q 019685          236 YLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSH  315 (337)
Q Consensus       236 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~~~~~~  315 (337)
                      ++.+++|..++...+.+++..+..++.|++.||+|||+++  |+||||||+|||+  +..+.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli--~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--CTTCCEEECCCTTCEECCSCCS-
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCccccc--ccCCceeeeecchhhcccCCCc-
Confidence            9999999999888888999999999999999999999987  9999999999999  7788999999999988765432 


Q ss_pred             ceeeeeCCccccccccccccc
Q 019685          316 DVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       316 ~~~~~~~~~gt~~y~aPE~l~  336 (337)
                         ......+++.|+|||++.
T Consensus       157 ---~~~~~~~~~~~~~pe~~~  174 (292)
T d1unla_         157 ---CYSAEVVTLWYRPPDVLF  174 (292)
T ss_dssp             ---CCCSCCSCGGGCCHHHHT
T ss_pred             ---cceeeccccchhhhhHhc
Confidence               234556889999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-33  Score=253.46  Aligned_cols=161  Identities=22%  Similarity=0.416  Sum_probs=138.6

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeC--CceEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTER--KPLML  232 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~--~~~~l  232 (337)
                      +|++.+.||+|+||+||+|...  ++.||||++.+..      .+.+.+|+.+|+.++ ||||+++++++...  ..+++
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            6999999999999999999985  8899999986432      256788999999996 99999999998754  56999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCC-CcEEEEeccCceeeec
Q 019685          233 ITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSA-DHLKVGDFGLSKLIKV  311 (337)
Q Consensus       233 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~-~~~kl~DFgla~~~~~  311 (337)
                      ||||+.+++|..+.   +.+++.+++.++.||+.||.|||++|  |+||||||+|||+  +.+ +.+||+|||+|+....
T Consensus       110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi--~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE--ETTTTEEEECCGGGCEECCT
T ss_pred             EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEE--cCCCCeeeecccccceeccC
Confidence            99999999997764   46999999999999999999999988  9999999999999  543 4699999999987764


Q ss_pred             ccccceeeeeCCccccccccccccc
Q 019685          312 QNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       312 ~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..     ......||+.|+|||++.
T Consensus       183 ~~-----~~~~~~~t~~y~aPE~~~  202 (328)
T d3bqca1         183 GQ-----EYNVRVASRYFKGPELLV  202 (328)
T ss_dssp             TC-----CCCSCCSCGGGCCHHHHT
T ss_pred             CC-----cccccccCccccCccccc
Confidence            42     245667999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.3e-33  Score=244.92  Aligned_cols=171  Identities=24%  Similarity=0.311  Sum_probs=142.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|++.+.||+|+||.||+|.+.  |+.||||++......     ..+.+|++.+..++| +||+.+++++......++||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            6889999999999999999975  789999988654322     345678899999985 89999999999999999999


Q ss_pred             eecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec---CCCCcEEEEeccCceeee
Q 019685          235 EYLRGGDLHKYLKEKG-ALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN---SSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       235 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~---~~~~~~kl~DFgla~~~~  310 (337)
                      ||+ +++|.+++...+ .+++.++..++.|++.||.|||++|  |+||||||+|||+..   ...+.+||+|||+|+...
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            999 679999987654 6999999999999999999999988  999999999999943   135689999999999876


Q ss_pred             cccccc---eeeeeCCccccccccccccc
Q 019685          311 VQNSHD---VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~---~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ......   ........||+.|||||++.
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~  186 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHL  186 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             cCccccceeecccCceEEchhhcCHHHhc
Confidence            442211   11244567999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-34  Score=252.20  Aligned_cols=171  Identities=27%  Similarity=0.460  Sum_probs=136.1

Q ss_pred             CcCccccceecccCceeEEEEEEC---CceEEEEEecCCCCchHHHHHHHHHHHHHHHh---CCCCCeeeeeeeEEe---
Q 019685          156 ELDFSSSAIIGKGSFGEILKAYWR---GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVK---LRHPNIVQFLGAVTE---  226 (337)
Q Consensus       156 ~~~~~~~~~lg~G~~g~V~~~~~~---g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~---l~h~~Iv~~~~~~~~---  226 (337)
                      +.+|++.+.||+|+||.||+|.+.   ++.||||++........ ....+.+|+.+++.   ++||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            458999999999999999999974   45789999865432211 11234456666555   489999999999853   


Q ss_pred             --CCceEEEEeecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          227 --RKPLMLITEYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       227 --~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                        ...++++|||+.++++...... ...+++..++.++.||+.||.|||+++  ||||||||+|||+  +..+.+||+||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi--~~~~~~kl~df  160 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV--TSSGQIKLADF  160 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECSC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEE--cCCCCeeecch
Confidence              3468999999988766554443 346899999999999999999999988  9999999999999  88889999999


Q ss_pred             cCceeeecccccceeeeeCCccccccccccccc
Q 019685          304 GLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       304 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      |+++......     ......||+.|||||++.
T Consensus       161 g~~~~~~~~~-----~~~~~~gT~~Y~APE~~~  188 (305)
T d1blxa_         161 GLARIYSFQM-----ALTSVVVTLWYRAPEVLL  188 (305)
T ss_dssp             CSCCCCCGGG-----GGCCCCCCCTTCCHHHHT
T ss_pred             hhhhhhcccc-----cCCCcccChhhcCcchhc
Confidence            9998765442     345678999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-34  Score=254.09  Aligned_cols=172  Identities=26%  Similarity=0.411  Sum_probs=148.2

Q ss_pred             CccccceecccCceeEEEEEE-----CCceEEEEEecCCCCc-hHHHHHHHHHHHHHHHhCCC-CCeeeeeeeEEeCCce
Q 019685          158 DFSSSAIIGKGSFGEILKAYW-----RGTPVAIKRILPSLSD-DRLVIQDFRHEVNLLVKLRH-PNIVQFLGAVTERKPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~~~~~  230 (337)
                      +|++.+.||+|+||.||+|..     +|+.||||.+.+.... +....+.+.+|+.++++++| |||+++++++.+...+
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            689999999999999999986     3678999998654321 11123567789999999976 8999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +++|||+.+++|.+++...+.+++..+..++.||+.||.|||+++  |+||||||+|||+  +.++.+||+|||+++.+.
T Consensus       105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill--~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILL--DSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTSCEEESCSSEEEECC
T ss_pred             eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceee--cCCCCEEEeeccchhhhc
Confidence            999999999999999998888999999999999999999999987  9999999999999  788999999999998876


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      .....   ......|++.|+|||.+.
T Consensus       181 ~~~~~---~~~~~~g~~~~~~pe~~~  203 (322)
T d1vzoa_         181 ADETE---RAYDFCGTIEYMAPDIVR  203 (322)
T ss_dssp             GGGGG---GGCGGGSCCTTCCHHHHT
T ss_pred             ccccc---cccccccccccchhHHhh
Confidence            54321   245567999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=4.1e-32  Score=240.06  Aligned_cols=171  Identities=24%  Similarity=0.308  Sum_probs=137.3

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCC-eeeeeeeEEeCCceEEEE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPN-IVQFLGAVTERKPLMLIT  234 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~-Iv~~~~~~~~~~~~~lv~  234 (337)
                      +|++.+.||+|+||.||+|.+.  |+.||||++......     ..+..|+.+++.++|++ |+.+.+++...+..++||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            5889999999999999999975  789999988664332     34678999999998665 555566667788899999


Q ss_pred             eecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEec-CCCCcEEEEeccCceeeecc
Q 019685          235 EYLRGGDLHKYLKE-KGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVN-SSADHLKVGDFGLSKLIKVQ  312 (337)
Q Consensus       235 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~-~~~~~~kl~DFgla~~~~~~  312 (337)
                      ||+. +++.+.+.. ...+++..+..++.|++.||.|||+++  |+||||||+|||+.. +....+||+|||+|+.+...
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          83 ELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             ECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             EEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9995 477666654 557999999999999999999999988  999999999999832 34557999999999987654


Q ss_pred             cccc---eeeeeCCccccccccccccc
Q 019685          313 NSHD---VYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       313 ~~~~---~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....   ........||+.|||||++.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~  186 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHL  186 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHT
T ss_pred             ccccceeccccCCcCCCccccCHHHHh
Confidence            3211   11335668999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-32  Score=246.48  Aligned_cols=166  Identities=27%  Similarity=0.455  Sum_probs=138.7

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEeC-----Cce
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTER-----KPL  230 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~  230 (337)
                      +|++.+.||+|+||.||+|.+.  |+.||||++.+.... ....+.+.+|+.+++.++||||+++++++...     ...
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            6999999999999999999975  889999999765443 33456788999999999999999999998643     234


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceeee
Q 019685          231 MLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIK  310 (337)
Q Consensus       231 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~~  310 (337)
                      +++++++.+++|.+++.. +.+++.+++.++.||+.||.|||++|  |+||||||+|||+  +.++.+|++|||++....
T Consensus        98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi--~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV--NEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE--CTTCCEEECCC----CCT
T ss_pred             EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccc--cccccccccccchhcccC
Confidence            666777889999999854 56999999999999999999999988  9999999999999  888999999999997654


Q ss_pred             cccccceeeeeCCccccccccccccc
Q 019685          311 VQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       311 ~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ..       .....||+.|+|||++.
T Consensus       173 ~~-------~~~~~g~~~y~apE~~~  191 (348)
T d2gfsa1         173 DE-------MTGYVATRWYRAPEIML  191 (348)
T ss_dssp             GG-------GSSSCHHHHTSCHHHHT
T ss_pred             cc-------cccccccccccCchhhc
Confidence            32       35678999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.5e-32  Score=246.09  Aligned_cols=166  Identities=26%  Similarity=0.369  Sum_probs=131.0

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCeeeeeeeEEe------CCc
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNIVQFLGAVTE------RKP  229 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~------~~~  229 (337)
                      +|++.+.||+|+||+||+|.+.  |+.||||++...... .....++.+|+.++++++||||+++++++..      ...
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6899999999999999999986  889999999766543 3445678899999999999999999999864      357


Q ss_pred             eEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          230 LMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       230 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                      +|+||||+.+ ++.+.+  ...+++..++.++.||+.||.|||++|  |+||||||+|||+  +.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~--~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVV--KSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE--CTTCCEEECCCCC----
T ss_pred             eEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCcccccc--ccccceeeechhhhhcc
Confidence            8999999976 555544  346899999999999999999999988  9999999999999  88889999999999876


Q ss_pred             ecccccceeeeeCCccccccccccccc
Q 019685          310 KVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       310 ~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                      ....     ......||+.|+|||++.
T Consensus       170 ~~~~-----~~~~~~~t~~y~aPE~l~  191 (355)
T d2b1pa1         170 GTSF-----MMTPYVVTRYYRAPEVIL  191 (355)
T ss_dssp             ----------------CCTTCCHHHHT
T ss_pred             cccc-----ccccccccccccChhhhc
Confidence            5432     345567999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.93  E-value=1.5e-26  Score=209.36  Aligned_cols=166  Identities=20%  Similarity=0.312  Sum_probs=128.5

Q ss_pred             CccccceecccCceeEEEEEEC--CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-----------CCCeeeeeeeE
Q 019685          158 DFSSSAIIGKGSFGEILKAYWR--GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-----------HPNIVQFLGAV  224 (337)
Q Consensus       158 ~~~~~~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~Iv~~~~~~  224 (337)
                      +|++.+.||+|+||+||+|...  |+.||||++.+.    ....+.+.+|+.+++.+.           |+||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            5999999999999999999975  889999999654    223456778888887764           57899999887


Q ss_pred             EeC--CceEEEEeecCCCCH-HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHc-CCCCcEeeCCCCCCEEEecCCC---
Q 019685          225 TER--KPLMLITEYLRGGDL-HKYLK--EKGALSPSTAVNFALDIARGMAYLHN-EPNVIIHRDLKPRNVLLVNSSA---  295 (337)
Q Consensus       225 ~~~--~~~~lv~e~~~~~~L-~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrdlkp~Nil~~~~~~---  295 (337)
                      ...  ...+++++++..+.. .....  ....+++..+..++.||+.||.|||+ +|  |+||||||+|||+..+..   
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence            543  456677776655433 33332  23568999999999999999999998 67  999999999999943322   


Q ss_pred             -CcEEEEeccCceeeecccccceeeeeCCccccccccccccc
Q 019685          296 -DHLKVGDFGLSKLIKVQNSHDVYKMTGETGSCEYLVSNCSF  336 (337)
Q Consensus       296 -~~~kl~DFgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  336 (337)
                       ..+|++|||.+......       .....||+.|+|||++.
T Consensus       168 ~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~  202 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLL  202 (362)
T ss_dssp             EEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHH
T ss_pred             cceeeEeecccccccccc-------cccccccccccChhhcc
Confidence             14999999999765432       34567999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=1.1e-23  Score=173.20  Aligned_cols=137  Identities=19%  Similarity=0.210  Sum_probs=105.8

Q ss_pred             cccceecccCceeEEEEEEC-CceEEEEEecCCCCc---------------hHHHHHHHHHHHHHHHhCCCCCeeeeeee
Q 019685          160 SSSAIIGKGSFGEILKAYWR-GTPVAIKRILPSLSD---------------DRLVIQDFRHEVNLLVKLRHPNIVQFLGA  223 (337)
Q Consensus       160 ~~~~~lg~G~~g~V~~~~~~-g~~vavK~l~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~  223 (337)
                      .+++.||+|+||.||+|... |+.||||++......               ..........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45689999999999999864 889999987542111               01122345578889999999999988765


Q ss_pred             EEeCCceEEEEeecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCCCcEeeCCCCCCEEEecCCCCcEEEEec
Q 019685          224 VTERKPLMLITEYLRGGDLHKYLKEKGALSPSTAVNFALDIARGMAYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDF  303 (337)
Q Consensus       224 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrdlkp~Nil~~~~~~~~~kl~DF  303 (337)
                      .    ..+++|||+++..+.+       ++...+..++.|++.+|.|||++|  |+||||||+|||+  +. +.++|+||
T Consensus        83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv--~~-~~~~liDF  146 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV--SE-EGIWIIDF  146 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE--ET-TEEEECCC
T ss_pred             c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheee--eC-CCEEEEEC
Confidence            3    2379999998865432       455667789999999999999988  9999999999999  43 35999999


Q ss_pred             cCceeeecc
Q 019685          304 GLSKLIKVQ  312 (337)
Q Consensus       304 gla~~~~~~  312 (337)
                      |+|.....+
T Consensus       147 G~a~~~~~~  155 (191)
T d1zara2         147 PQSVEVGEE  155 (191)
T ss_dssp             TTCEETTST
T ss_pred             CCcccCCCC
Confidence            999776533

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.84  E-value=1.2e-21  Score=147.95  Aligned_cols=102  Identities=24%  Similarity=0.236  Sum_probs=93.5

Q ss_pred             chhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhh
Q 019685           35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF  114 (337)
Q Consensus        35 ~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~  114 (337)
                      |||++  |+++|..+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..++.
T Consensus         4 tpL~~--A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~   81 (118)
T d1myoa_           4 KEFMW--ALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHV   81 (118)
T ss_dssp             HHHHH--HHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCC
T ss_pred             hHHHH--HHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCch
Confidence            57755  8888888999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHhhcCCCCCCCCCCCCCC
Q 019685          115 NMMELLNAHGGLSYGQNGSHFEPK  138 (337)
Q Consensus       115 ~~v~~L~~~~a~~~~~~~~~~~~~  138 (337)
                      +++++|+++|++.+..+....+|.
T Consensus        82 ~~v~~Ll~~Gad~~~~d~~G~t~l  105 (118)
T d1myoa_          82 SCVKLLLSKGADKTVKGPDGLTAL  105 (118)
T ss_dssp             HHHHHHHTTCCCSSSSSSSTCCCC
T ss_pred             hhhhhhhcccccceeeCCCCCCHH
Confidence            999999999998887766655543

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.82  E-value=1e-20  Score=149.37  Aligned_cols=95  Identities=21%  Similarity=0.181  Sum_probs=87.4

Q ss_pred             hccCCchhHHHHHhh---CCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchh
Q 019685           30 ARVSRTSLILWHAHQ---NDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA  106 (337)
Q Consensus        30 ~~~~~~~~~~~~a~~---~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~  106 (337)
                      +..|+||||+  |+.   .+..+++++|++.|+++|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||||
T Consensus        42 ~~~g~t~Lh~--A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~  119 (154)
T d1dcqa1          42 HEPDETALHL--AVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLD  119 (154)
T ss_dssp             SSTTCBHHHH--HHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred             CCCCCchHHH--HHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHH
Confidence            5678999966  553   46788999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhHHHHHHhhcCC
Q 019685          107 DAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       107 ~A~~~~~~~~v~~L~~~~a~  126 (337)
                      +|+..++.+++++|.+.++.
T Consensus       120 ~A~~~~~~~i~~~L~~~~~~  139 (154)
T d1dcqa1         120 IAKRLKHEHCEELLTQALSG  139 (154)
T ss_dssp             HHHHTTCHHHHHHHHHHHTT
T ss_pred             HHHHcCCHHHHHHHHHhCCC
Confidence            99999999999999998764

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=1.5e-20  Score=144.38  Aligned_cols=93  Identities=20%  Similarity=0.263  Sum_probs=84.5

Q ss_pred             HHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHH
Q 019685           39 LWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMME  118 (337)
Q Consensus        39 ~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~  118 (337)
                      ++.|+..|..+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..++.++++
T Consensus         5 L~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~   84 (130)
T d1ycsb1           5 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCK   84 (130)
T ss_dssp             HHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHH
Confidence            34466666677888888999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCC
Q 019685          119 LLNAHGGLSYGQN  131 (337)
Q Consensus       119 ~L~~~~a~~~~~~  131 (337)
                      +|+++|++.+..+
T Consensus        85 ~Ll~~ga~v~~~~   97 (130)
T d1ycsb1          85 FLVESGAAVFAMT   97 (130)
T ss_dssp             HHHHTTCCTTCCC
T ss_pred             HHHHcCCCccccc
Confidence            9999998876443

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.80  E-value=6e-21  Score=144.07  Aligned_cols=88  Identities=20%  Similarity=0.219  Sum_probs=82.3

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+++++.+|..|+||+++  |+..+..+++++|++.|+++|.+|.+|+||||+|+.+|+.+++++|+++|||+|.+|..
T Consensus        23 ~~g~d~n~~~~~g~t~lh~--A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~d~~  100 (118)
T d1myoa_          23 AKGEDVNRTLEGGRKPLHY--AADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPD  100 (118)
T ss_dssp             TTTCCCCCCSSSSCCTTHH--HHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSSSSS
T ss_pred             Hhhhccccccccccccccc--cccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceeeCCC
Confidence            4577889999999999976  88888889999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhhhhh
Q 019685          101 KNTPLADAEG  110 (337)
Q Consensus       101 g~t~l~~A~~  110 (337)
                      |.||||+|..
T Consensus       101 G~t~l~~a~~  110 (118)
T d1myoa_         101 GLTALEATDN  110 (118)
T ss_dssp             TCCCCCTCSS
T ss_pred             CCCHHHHHhH
Confidence            9999999854

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4.5e-20  Score=140.67  Aligned_cols=99  Identities=21%  Similarity=0.289  Sum_probs=88.9

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCC-cHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNR-TPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~-tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ..+++++.+|..|+|+++.  |+ .++.+++++|++.|+++|.+|..|. ||||+||..|+.+++++|+++|+++|.+|.
T Consensus        24 ~~gad~n~~~~~g~t~l~~--a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~  100 (125)
T d1bi7b_          24 EAGANPNAPNSYGRRPIQV--MM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDA  100 (125)
T ss_dssp             TTTCCTTCCCSSSCCTTTS--SC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCT
T ss_pred             HcCCccccccccccccccc--cc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccC
Confidence            4577889999999998853  55 5678889999999999999998876 699999999999999999999999999999


Q ss_pred             ccccchhhhhhhhhhhHHHHHHh
Q 019685          100 WKNTPLADAEGAKKFNMMELLNA  122 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~  122 (337)
                      .|+||||+|+..|+.+++++|+.
T Consensus       101 ~G~T~l~~A~~~g~~~~v~~Lls  123 (125)
T d1bi7b_         101 WGRLPVDLAEELGHRDVARYLRA  123 (125)
T ss_dssp             TCCCHHHHHHHHTCHHHHHHHSS
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHh
Confidence            99999999999999999999875

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=6.5e-20  Score=140.73  Aligned_cols=103  Identities=24%  Similarity=0.143  Sum_probs=91.5

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ...+++++.+|.+|+|||++  |+..+..+++++|++.|+++|.+|.+|+||||+|+.+|+.+++++|+++||++|.++.
T Consensus        21 l~~g~d~n~~d~~g~t~Lh~--A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~~~~   98 (130)
T d1ycsb1          21 IYEVDDPSLPNDEGITALHN--AVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTY   98 (130)
T ss_dssp             TSTTSSCCCCCTTSCCHHHH--HHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCS
T ss_pred             HHcCCCcccccccccccccc--ccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCcccccC
Confidence            45678999999999999966  8888899999999999999999999999999999999999999999999999998764


Q ss_pred             -ccccchhhh--hhhhhhhHHHHHHhhc
Q 019685          100 -WKNTPLADA--EGAKKFNMMELLNAHG  124 (337)
Q Consensus       100 -~g~t~l~~A--~~~~~~~~v~~L~~~~  124 (337)
                       .+.||++.+  ...|+.+++++|....
T Consensus        99 ~~~~~~~~~~~a~~~g~~eiv~~L~~~~  126 (130)
T d1ycsb1          99 SDMQTAADKCEEMEEGYTQCSQFLYGVQ  126 (130)
T ss_dssp             SSCCCHHHHCCSSSTTCCCHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHcChHHHHHHHHhHH
Confidence             588876554  5778899999998654

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.75  E-value=8.4e-19  Score=149.65  Aligned_cols=105  Identities=26%  Similarity=0.216  Sum_probs=96.6

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccc-cCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccc
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHA-RDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQD   98 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~-~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d   98 (337)
                      ...+.+++.+|..|+|||++  |+..+..+++++|++.+++.+. .+..|.||||+||..|+.+++++|+++||++|.+|
T Consensus       145 ~~~~~~in~~d~~g~TpLh~--A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d  222 (255)
T d1oy3d_         145 EDWRLQLEAENYDGHTPLHV--AVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARM  222 (255)
T ss_dssp             CCGGGGTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             hhcCcccccccccCcccccc--cccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCC
Confidence            45567888999999999865  8888899999999999998875 46789999999999999999999999999999999


Q ss_pred             cccccchhhhhhhhhhhHHHHHHhhcCC
Q 019685           99 RWKNTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      ..|.||||+|+..++.+++++|+++||.
T Consensus       223 ~~g~t~L~~A~~~~~~~i~~~Ll~~Ga~  250 (255)
T d1oy3d_         223 YGGRTPLGSALLRPNPILARLLRAHGAP  250 (255)
T ss_dssp             TTSCCHHHHHHTSSCHHHHHHHHHTTCC
T ss_pred             CCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence            9999999999999999999999999984

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=2.3e-18  Score=144.35  Aligned_cols=113  Identities=24%  Similarity=0.249  Sum_probs=102.6

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+.+++.+|..|+|||++  |+..+..+++++|++.|++++.+|.+|.||||+|+..++.+++++|++.|+++|.+|..|
T Consensus        92 ~~~d~~~~d~~g~tpL~~--A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g  169 (223)
T d1uoha_          92 KGAQVNAVNQNGCTPLHY--AASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEG  169 (223)
T ss_dssp             TTCCTTCCCTTCCCHHHH--HHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTC
T ss_pred             cCceeEeeCCCCCchhhH--HHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCC
Confidence            455778899999999966  888888899999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      +||||.|+..++.+++++|+++|++++..+....+
T Consensus       170 ~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~t  204 (223)
T d1uoha_         170 NTPLHLACDEERVEEAKLLVSQGASIYIENKEEKT  204 (223)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCC
T ss_pred             CceeccccccCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence            99999999999999999999999988766544443

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=2.7e-18  Score=141.95  Aligned_cols=96  Identities=20%  Similarity=0.239  Sum_probs=88.8

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      +.+++.++..|+|+++.  ++..+...+++.|+..+.++|..|..|.||||+||.+|+.+++++||++|||+|.+|..|+
T Consensus       113 ~~~~~~~~~~~~t~l~~--~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g~  190 (209)
T d1ot8a_         113 DADINAADNSGKTALHW--AAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDR  190 (209)
T ss_dssp             TCCTTCBCTTSCBHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             cccccccCCCCCCcchh--hcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCCC
Confidence            44567788999998855  7788888888999999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhhHHHHH
Q 019685          103 TPLADAEGAKKFNMMELL  120 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L  120 (337)
                      ||||+|+..++.+++++|
T Consensus       191 Tpl~~A~~~~~~~iv~lL  208 (209)
T d1ot8a_         191 LPRDVASERLHHDIVRLL  208 (209)
T ss_dssp             CHHHHHHHTTCHHHHHHH
T ss_pred             CHHHHHHHcCCHHHHhhc
Confidence            999999999999999987

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=3.2e-18  Score=130.15  Aligned_cols=96  Identities=22%  Similarity=0.188  Sum_probs=84.5

Q ss_pred             chhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc-cchhhhhhhhh
Q 019685           35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN-TPLADAEGAKK  113 (337)
Q Consensus        35 ~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~-t~l~~A~~~~~  113 (337)
                      ++|+  .|+..|+.+++++|++.|+++|.+|.+|.||||+|+ .|+.+++++|+++|+++|.+|..+. ||||+|+..++
T Consensus         5 ~~L~--~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~   81 (125)
T d1bi7b_           5 DWLA--TAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF   81 (125)
T ss_dssp             THHH--HHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred             hHHH--HHHHCCCHHHHHHHHHcCCccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence            4454  477777788999999999999999999999999774 7999999999999999999999876 69999999999


Q ss_pred             hhHHHHHHhhcCCCCCCCCC
Q 019685          114 FNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       114 ~~~v~~L~~~~a~~~~~~~~  133 (337)
                      .+++++|+++|++.+..+..
T Consensus        82 ~~~v~~Ll~~ga~~~~~d~~  101 (125)
T d1bi7b_          82 LDTLVVLHRAGARLDVRDAW  101 (125)
T ss_dssp             HHHHHHHHHHTCCSSCCCTT
T ss_pred             ccccccccccccccccccCC
Confidence            99999999999877655443

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=1.1e-17  Score=132.10  Aligned_cols=107  Identities=21%  Similarity=0.247  Sum_probs=68.6

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      +++++.+|..|+|||++  |+.++. ++++.|++.+.++|..+..|.+||++|+..++.+++++++++|+++|.+|..|+
T Consensus        26 ~~~~n~~d~~g~t~L~~--A~~~~~-~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~  102 (156)
T d1bd8a_          26 LVHPDALNRFGKTALQV--MMFGST-AIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGA  102 (156)
T ss_dssp             CCCTTCCCTTSCCHHHH--SCTTCH-HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSC
T ss_pred             CCCCCccCCCCCccccc--cccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccCCCC
Confidence            44566666777777643  555444 444555566667777666777777777777777777777777777777777777


Q ss_pred             cchhhhhhhhhhhHHHHHHhhcCCCCCCCCC
Q 019685          103 TPLADAEGAKKFNMMELLNAHGGLSYGQNGS  133 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~  133 (337)
                      ||||+|+..++.+++++|. .+++.+..+..
T Consensus       103 t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~  132 (156)
T d1bd8a_         103 LPIHLAVQEGHTAVVSFLA-AESDLHRRDAR  132 (156)
T ss_dssp             CHHHHHHHHTCHHHHHHHH-TTSCTTCCCTT
T ss_pred             eeecccccccccccccccc-ccccccccCCC
Confidence            7777777777777776665 45554444433

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.70  E-value=8.7e-18  Score=143.23  Aligned_cols=94  Identities=20%  Similarity=0.115  Sum_probs=87.5

Q ss_pred             hccCCchhHHHHHhhCCHHHHHHHHHhCCCC---ccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchh
Q 019685           30 ARVSRTSLILWHAHQNDAAAVRKLLEEDQSL---VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA  106 (337)
Q Consensus        30 ~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~---vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~  106 (337)
                      +++|+||||+  |+..+..+++++|++.|++   +|.+|..|.||||+||..|+.+++++|+++||+++.+|..|.||||
T Consensus         6 ~~~G~t~Lh~--A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~   83 (255)
T d1oy3d_           6 TEDGDTALHL--AVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALH   83 (255)
T ss_dssp             CTTCCCHHHH--HHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHH
T ss_pred             CcCCCCHHHH--HHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhh
Confidence            5789999966  9999999999999999887   7788999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhHHHHHHhhcC
Q 019685          107 DAEGAKKFNMMELLNAHGG  125 (337)
Q Consensus       107 ~A~~~~~~~~v~~L~~~~a  125 (337)
                      .|+..++.+++++++....
T Consensus        84 ~A~~~~~~~~~~~Ll~~~~  102 (255)
T d1oy3d_          84 LACRVRAHTCACVLLQPRP  102 (255)
T ss_dssp             HHTTTTCHHHHHHHSSSCC
T ss_pred             hhhccCchHHHHHHHhhcc
Confidence            9999999999999987654

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=1.2e-17  Score=139.90  Aligned_cols=98  Identities=19%  Similarity=0.234  Sum_probs=90.3

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWK  101 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g  101 (337)
                      .+++++.+|..|.|||+.  |+..+...+.++|.+.+.++|.+|.+|+||||+||..|+.+++++|+++|||++.+|.+|
T Consensus       125 ~g~d~~~~~~~~~t~L~~--a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g  202 (223)
T d1uoha_         125 GGANPDAKDHYEATAMHR--AAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEE  202 (223)
T ss_dssp             TTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTS
T ss_pred             CCCCCCCcCCCCCccchh--hhhcCCcchhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCC
Confidence            466788999999999855  888888889999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHh
Q 019685          102 NTPLADAEGAKKFNMMELLNA  122 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~  122 (337)
                      +||||+|. .++.++++.|++
T Consensus       203 ~tpl~~A~-~~~~~i~~~Ll~  222 (223)
T d1uoha_         203 KTPLQVAK-GGLGLILKRMVE  222 (223)
T ss_dssp             CCHHHHCC-TTHHHHHHHHHC
T ss_pred             CCHHHHHH-CCCHHHHhcccC
Confidence            99999985 688889988874

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=3.5e-17  Score=141.44  Aligned_cols=109  Identities=23%  Similarity=0.230  Sum_probs=95.8

Q ss_pred             chhhhhhhhccCCchhHHH--HHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHH-cCCCccccc
Q 019685           22 SADKQKEKARVSRTSLILW--HAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQD   98 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~--~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~-~ga~~~~~d   98 (337)
                      .+++++.++..+.+++...  ++..++...++++|++.|+++|.+|..|.||||+|+..|+.+++++||+ .|+++|.+|
T Consensus       171 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d  250 (285)
T d1wdya_         171 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD  250 (285)
T ss_dssp             SCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCC
T ss_pred             cCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCC
Confidence            3567777888887766542  2445778889999999999999999999999999999999999999997 499999999


Q ss_pred             cccccchhhhhhhhhhhHHHHHHhhcCCCCCC
Q 019685           99 RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQ  130 (337)
Q Consensus        99 ~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~  130 (337)
                      .+|.||||+|+..++.+++++|+++||+++..
T Consensus       251 ~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~  282 (285)
T d1wdya_         251 SDGKTALLLAVELKLKKIAELLCKRGASTDCG  282 (285)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCS
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcc
Confidence            99999999999999999999999999987644

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.67  E-value=2.8e-18  Score=153.47  Aligned_cols=104  Identities=13%  Similarity=0.088  Sum_probs=87.6

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHH---HHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRK---LLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQ   97 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~---lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~   97 (337)
                      ....+++.++..|.|+|++  ||++|+.++++   +|++.|++||.+|.+|+||||+||.+||.++|++|+++|++++..
T Consensus        78 ~~~~~~~~~~~~~~t~L~~--Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~  155 (346)
T d2ajaa1          78 QLWSDAHKKGIKSEVICFV--AAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMA  155 (346)
T ss_dssp             THHHHHHHHTCCHHHHHHH--HHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHH
T ss_pred             hhhhHHHhccCCCCcHHHH--HHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCcccc
Confidence            4456778889999999876  77777665544   478999999999999999999999999999999999999999987


Q ss_pred             c--cccccchhhhhhhhhhhHHHHHHhhcCC
Q 019685           98 D--RWKNTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus        98 d--~~g~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      +  ..|+||||+|+..|+.+++++|+..++.
T Consensus       156 ~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~  186 (346)
T d2ajaa1         156 MIQAENYHAFRLAAENGHLHVLNRLCELAPT  186 (346)
T ss_dssp             HHSHHHHHHHHHHHHTTCHHHHHHHHHSCGG
T ss_pred             ccccCCCChhHHHHHHhhHHHHHHHHHcCCc
Confidence            6  4699999999999999999999988754

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=3.5e-17  Score=148.75  Aligned_cols=98  Identities=26%  Similarity=0.290  Sum_probs=88.7

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      +++++..+..+.|||+.  ++..+..++++++++.|+++|.+|.+|.||||+|+.+|+.++|++|+++|||+|.+|..|+
T Consensus       287 g~~~~~~~~~~~t~L~~--~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~  364 (408)
T d1n11a_         287 GVMVDATTRMGYTPLHV--ASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGT  364 (408)
T ss_dssp             TCCTTCCCSSCCCHHHH--HHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSC
T ss_pred             CCccccccccccccchh--hcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence            55667777788888865  7777788888999999999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhhHHHHHHh
Q 019685          103 TPLADAEGAKKFNMMELLNA  122 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~  122 (337)
                      ||||+|+..|+.+++++|..
T Consensus       365 t~L~~A~~~~~~~iv~~L~~  384 (408)
T d1n11a_         365 TPLAIAKRLGYISVTDVLKV  384 (408)
T ss_dssp             CHHHHHHHTTCHHHHHHHHH
T ss_pred             CHHHHHHHcCCHHHHHHHHH
Confidence            99999999999999987753

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.66  E-value=1.6e-17  Score=143.03  Aligned_cols=106  Identities=25%  Similarity=0.241  Sum_probs=88.0

Q ss_pred             CCCCCCCchhhhhhhh-ccCCchhHHHHHhhCCHHHHHHHH--------HhCCCCccccCCCCCcHHHHHHHcCCHHHHH
Q 019685           15 CKGGATSSADKQKEKA-RVSRTSLILWHAHQNDAAAVRKLL--------EEDQSLVHARDYDNRTPLHVASLHGWIDVAK   85 (337)
Q Consensus        15 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~a~~~~~~~~~~lL--------~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~   85 (337)
                      +.......+  +|..| +.|+||||+  |+.+|+.+++++|        ++.|+|||.+|.+|+||||+|+.+|+.++++
T Consensus        16 ~~~~l~~~~--~n~~~~~~g~T~Lh~--A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~   91 (277)
T d2fo1e1          16 ITEPITRES--VNIIDPRHNRTVLHW--IASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVA   91 (277)
T ss_dssp             CCSCCSTTT--TTTCCCSSCCCHHHH--HHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHH
T ss_pred             HHHHHHhcC--CCcCCCCCCccHHHH--HHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeeccccccccccccc
Confidence            444444433  44455 469999966  8887777666554        5789999999999999999999999999999


Q ss_pred             HHHHcCCCccccccccccchhhhhhhhhhhHHHHHHhhc
Q 019685           86 CLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHG  124 (337)
Q Consensus        86 ~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~  124 (337)
                      +|+++|||+|.+|.+|.|||+.|...++..+...+....
T Consensus        92 ~Ll~~Gad~n~~~~~g~t~l~~a~~~~~~~~~~~l~~~~  130 (277)
T d2fo1e1          92 YLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNST  130 (277)
T ss_dssp             HHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSH
T ss_pred             cccccccccccccccccccccchhhhcchhhhhhhhhcc
Confidence            999999999999999999999999999999888876543

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.66  E-value=5.2e-17  Score=136.05  Aligned_cols=98  Identities=22%  Similarity=0.138  Sum_probs=80.6

Q ss_pred             hhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCC-CCccccCCCCCcHHHHHHHcCCHHHHHHHHH-cCCCcccccccc
Q 019685           24 DKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQ-SLVHARDYDNRTPLHVASLHGWIDVAKCLIE-YGADVNAQDRWK  101 (337)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~-~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~-~ga~~~~~d~~g  101 (337)
                      .+.+.+|..|+||+++  |+..+..+++++|++.+ .++|.+|.+|+||||+|+..|+.++|++|++ .|||+|.+|..|
T Consensus       129 ~~~~~~~~~g~t~l~~--a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g  206 (229)
T d1ixva_         129 ASVRIKDKFNQIPLHR--AASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKG  206 (229)
T ss_dssp             CCSCCCCTTSCCHHHH--HHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTS
T ss_pred             ccccccCCCCCCccch--hhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCC
Confidence            3445567788888855  77666777777787776 6889999999999999999999999999996 599999999999


Q ss_pred             ccchhhhhhhhhhhHHHHHHhhcCC
Q 019685          102 NTPLADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       102 ~t~l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      +||||+|+.   .+++++|++.|++
T Consensus       207 ~t~l~~A~~---~~~~~~Ll~~g~d  228 (229)
T d1ixva_         207 AKAEDVALN---EQVKKFFLNNVVD  228 (229)
T ss_dssp             CCTGGGCSC---HHHHHHHHHHCCC
T ss_pred             CCHHHHHhh---HHHHHHHHHcCCC
Confidence            999999874   4688899988875

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=8e-17  Score=146.31  Aligned_cols=93  Identities=29%  Similarity=0.281  Sum_probs=86.5

Q ss_pred             chhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhh
Q 019685           35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKF  114 (337)
Q Consensus        35 ~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~  114 (337)
                      ||||+  ||..|..+++++|++.|++||..|..|+||||+||..|+.+++++||++||++|.+|..|+|||++|+..++.
T Consensus         2 TpL~~--Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~   79 (408)
T d1n11a_           2 TPLHV--ASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHT   79 (408)
T ss_dssp             CHHHH--HHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCH
T ss_pred             ChHHH--HHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCH
Confidence            78866  8888889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHhhcCCCCC
Q 019685          115 NMMELLNAHGGLSYG  129 (337)
Q Consensus       115 ~~v~~L~~~~a~~~~  129 (337)
                      +++++|+........
T Consensus        80 ~~~~~Ll~~~~~~~~   94 (408)
T d1n11a_          80 NMVKLLLENNANPNL   94 (408)
T ss_dssp             HHHHHHHHHTCCTTC
T ss_pred             HHHHHHHHhhhcccc
Confidence            999999988765443

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.64  E-value=1.2e-16  Score=139.98  Aligned_cols=111  Identities=19%  Similarity=0.059  Sum_probs=89.6

Q ss_pred             hhhhh-hccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCC-------HHHHHHH---------
Q 019685           25 KQKEK-ARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGW-------IDVAKCL---------   87 (337)
Q Consensus        25 ~~~~~-~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~-------~~~~~~L---------   87 (337)
                      ++|.+ |.+|+||||+  |+..++.+++++|++.|++++.+|..|+||||+||..++       .+++++|         
T Consensus        98 dvn~~~D~~G~T~LH~--Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~  175 (301)
T d1sw6a_          98 NLNIPVDEHGNTPLHW--LTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDS  175 (301)
T ss_dssp             CSCSCCSTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECT
T ss_pred             CcCcCcCCCCCCHHHH--HHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhccc
Confidence            45544 7889999965  888888999999999999999999999999999998654       2333332         


Q ss_pred             ---------------------------------HHcCCC-------------------------------------cccc
Q 019685           88 ---------------------------------IEYGAD-------------------------------------VNAQ   97 (337)
Q Consensus        88 ---------------------------------l~~ga~-------------------------------------~~~~   97 (337)
                                                       ++.+..                                     +|.+
T Consensus       176 ~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~  255 (301)
T d1sw6a_         176 MNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQ  255 (301)
T ss_dssp             TCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCC
T ss_pred             ccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCC
Confidence                                             222211                                     6888


Q ss_pred             ccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCC
Q 019685           98 DRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEP  137 (337)
Q Consensus        98 d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~  137 (337)
                      |..|+||||+|+..++.+++++|+++|++++..+....+|
T Consensus       256 D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tp  295 (301)
T d1sw6a_         256 DSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP  295 (301)
T ss_dssp             CTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            9999999999999999999999999999988777665544

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.64  E-value=1.2e-16  Score=138.68  Aligned_cols=89  Identities=28%  Similarity=0.379  Sum_probs=78.1

Q ss_pred             hhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhh
Q 019685           28 EKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLAD  107 (337)
Q Consensus        28 ~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~  107 (337)
                      ..+..|.|||+.  |+..+..+++++|++.|+++|.+|.+|+||||+||..|+.++|++|+++|||+|.+|..|+||||+
T Consensus       194 ~~~~~g~t~L~~--a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~~  271 (291)
T d1s70b_         194 RHAKSGGTALHV--AAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDV  271 (291)
T ss_dssp             CCTTTCCCHHHH--HHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTS
T ss_pred             cccCCCCChhhH--HHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHH
Confidence            345678899865  777788888999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhHHHHHHh
Q 019685          108 AEGAKKFNMMELLNA  122 (337)
Q Consensus       108 A~~~~~~~~v~~L~~  122 (337)
                      |+.    +++++|..
T Consensus       272 A~e----~~~~~L~~  282 (291)
T d1s70b_         272 ADE----DILGYLEE  282 (291)
T ss_dssp             CCS----GGGHHHHH
T ss_pred             HHH----HHHHHHHH
Confidence            975    45555443

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.63  E-value=2.9e-16  Score=123.42  Aligned_cols=97  Identities=14%  Similarity=0.061  Sum_probs=79.9

Q ss_pred             HHHHhhCCHHHHHHHHHhCCCCcccc------CCCCCcHHHHHHHc---CCHHHHHHHHHcCCCccccccccccchhhhh
Q 019685           39 LWHAHQNDAAAVRKLLEEDQSLVHAR------DYDNRTPLHVASLH---GWIDVAKCLIEYGADVNAQDRWKNTPLADAE  109 (337)
Q Consensus        39 ~~~a~~~~~~~~~~lL~~~~~~vn~~------~~~g~tpLh~A~~~---g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~  109 (337)
                      +.++..++...+.+++ ..|+|++..      +..|+||||+|+..   |+.+++++|+++|+++|.+|..|+||||+|+
T Consensus        11 ~~Av~~~dl~~l~~~~-~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~   89 (154)
T d1dcqa1          11 CEAVKTRDIFGLLQAY-ADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCC   89 (154)
T ss_dssp             HHHHHTTCHHHHHHHH-HTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHH
T ss_pred             HHHHHhCCHHHHHHHH-HcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhcccccccc
Confidence            3444556666665555 778877754      77899999999974   6899999999999999999999999999999


Q ss_pred             hhhhhhHHHHHHhhcCCCCCCCCCCCC
Q 019685          110 GAKKFNMMELLNAHGGLSYGQNGSHFE  136 (337)
Q Consensus       110 ~~~~~~~v~~L~~~~a~~~~~~~~~~~  136 (337)
                      ..++.+++++|+.+|++.+..+....+
T Consensus        90 ~~~~~~~v~~Ll~~gad~~~~d~~g~t  116 (154)
T d1dcqa1          90 LTDNAECLKLLLRGKASIEIANESGET  116 (154)
T ss_dssp             HTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             ccccccccccccccCccccccCCCCCC
Confidence            999999999999999987766544443

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=5.5e-16  Score=122.14  Aligned_cols=100  Identities=20%  Similarity=0.224  Sum_probs=91.0

Q ss_pred             CchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccc
Q 019685           21 SSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRW  100 (337)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~  100 (337)
                      ..+.+++.++..+.+|++.  ++..+..++.+++++.|+++|.+|.+|.||||+||..|+.+++++|+ .|++++.+|..
T Consensus        56 ~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~  132 (156)
T d1bd8a_          56 KQGASPNVQDTSGTSPVHD--AARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDAR  132 (156)
T ss_dssp             HTTCCTTCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTT
T ss_pred             ccccccccccccccccccc--ccccccccccccccccccccccccCCCCeeecccccccccccccccc-ccccccccCCC
Confidence            3456788888889998865  88888899999999999999999999999999999999999999887 78999999999


Q ss_pred             cccchhhhhhhhhhhHHHHHHhh
Q 019685          101 KNTPLADAEGAKKFNMMELLNAH  123 (337)
Q Consensus       101 g~t~l~~A~~~~~~~~v~~L~~~  123 (337)
                      |+||||+|+..++.+++++|+++
T Consensus       133 G~TpL~~A~~~g~~~iv~~Ll~h  155 (156)
T d1bd8a_         133 GLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             SCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             CCCHHHHHHHcCCHHHHHHHHhh
Confidence            99999999999999999999865

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.62  E-value=3.4e-16  Score=122.65  Aligned_cols=74  Identities=30%  Similarity=0.395  Sum_probs=67.8

Q ss_pred             HHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHH
Q 019685           47 AAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELL  120 (337)
Q Consensus        47 ~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L  120 (337)
                      ..+.+++|...+++++.+|.+|+||||+||..|+.+++++|+++|+|+|.+|..|.||||+|+..++.+++++|
T Consensus        79 ~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL  152 (153)
T d1awcb_          79 HANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL  152 (153)
T ss_dssp             CHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             cceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHHHcCCHHHHHhC
Confidence            44567788888999999999999999999999999999999999999999999999999999999999999877

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.61  E-value=9.1e-16  Score=131.82  Aligned_cols=99  Identities=27%  Similarity=0.378  Sum_probs=85.6

Q ss_pred             hhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccc
Q 019685           23 ADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKN  102 (337)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~  102 (337)
                      ....+..+..|+|++++ ++..++...+..++...+.+++.+|..|+||||+||..|+.+++++|+++|||+|.+|.+|+
T Consensus       177 ~~~~~~~~~~g~t~L~~-~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~  255 (277)
T d2fo1e1         177 AARKDSEKYKGRTALHY-AAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDH  255 (277)
T ss_dssp             GGGTSSSSCCCCCTHHH-HHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSC
T ss_pred             cccccccccCCCCcccc-ccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCC
Confidence            33455667789999965 44455555555667788999999999999999999999999999999999999999999999


Q ss_pred             cchhhhhhhhhhhHHHHHHh
Q 019685          103 TPLADAEGAKKFNMMELLNA  122 (337)
Q Consensus       103 t~l~~A~~~~~~~~v~~L~~  122 (337)
                      ||||+|+..++.+++++|.+
T Consensus       256 T~L~~A~~~~~~~iv~lL~~  275 (277)
T d2fo1e1         256 TARQLAQANNHHNIVDIFDR  275 (277)
T ss_dssp             CHHHHHHHTTCHHHHHHHHT
T ss_pred             CHHHHHHHcCCHHHHHHHHH
Confidence            99999999999999999975

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.60  E-value=7.7e-16  Score=120.60  Aligned_cols=98  Identities=27%  Similarity=0.291  Sum_probs=75.0

Q ss_pred             chhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcC---------------------------------CH
Q 019685           35 TSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHG---------------------------------WI   81 (337)
Q Consensus        35 ~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g---------------------------------~~   81 (337)
                      |||+.  |+..|..+++++|+++|++++ .|..|+||||+|+..+                                 +.
T Consensus         4 t~L~~--Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (153)
T d1awcb_           4 KKLLE--AARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHA   80 (153)
T ss_dssp             HHHHH--HHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCH
T ss_pred             HHHHH--HHHCCCHHHHHHHHHcCCCcc-cccCCCccccccccccccccccccccccccccccccccccccccccccccc
Confidence            55543  555555666666666676665 4666777777776554                                 44


Q ss_pred             HHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCC
Q 019685           82 DVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHF  135 (337)
Q Consensus        82 ~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~  135 (337)
                      +++++|+.+|++++.+|..|+||||+|+..++.+++++|+++|++++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~  134 (153)
T d1awcb_          81 NIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCK  134 (153)
T ss_dssp             HHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             eeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCC
Confidence            688899999999999999999999999999999999999999998765554433

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.59  E-value=2.9e-17  Score=146.86  Aligned_cols=107  Identities=18%  Similarity=0.049  Sum_probs=91.5

Q ss_pred             CCCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC--CCCCcHHHHHHHcCCHHHHHHHHHcCCCc--
Q 019685           19 ATSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD--YDNRTPLHVASLHGWIDVAKCLIEYGADV--   94 (337)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~--~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~--   94 (337)
                      ....+++++.+|.+|+|||++  ||.+|+.+++++|++.|++++..+  .+|+||||+||.+||.++|++|++.|++.  
T Consensus       112 L~~~~~~in~~~~~g~taL~~--Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~  189 (346)
T d2ajaa1         112 LLTSDEIVKVIQAENYQAFRL--AAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEAT  189 (346)
T ss_dssp             C--CCSSCC--CHHHHHHHHH--HHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHH
T ss_pred             HHhCCCcccccCCCCCCHHHH--HHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCcccc
Confidence            456788999999999999977  999999999999999999999876  46999999999999999999999999865  


Q ss_pred             -cccccccccchhhhhhhhhhhHHHHHHhhcCCC
Q 019685           95 -NAQDRWKNTPLADAEGAKKFNMMELLNAHGGLS  127 (337)
Q Consensus        95 -~~~d~~g~t~l~~A~~~~~~~~v~~L~~~~a~~  127 (337)
                       +..+..+.||++.|+..|+.+++++|++.+++.
T Consensus       190 ~~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~  223 (346)
T d2ajaa1         190 AMIQAENYYAFRWAAVGRGHHNVINFLLDCPVML  223 (346)
T ss_dssp             HHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHHH
T ss_pred             cccccCCCcchhhHHhhcCHHHHHHHHHhCCCCc
Confidence             455667788889999999999999999887643

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=2.1e-15  Score=125.72  Aligned_cols=99  Identities=24%  Similarity=0.177  Sum_probs=85.5

Q ss_pred             hhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccC-CCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccc
Q 019685           26 QKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARD-YDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTP  104 (337)
Q Consensus        26 ~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~-~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~  104 (337)
                      .......+.||++.  |+..+..+++.+|+..|+.++..+ .+|.||||+|+..|+.+++++|+++|||+|.+|..|+||
T Consensus       104 ~~~~~~~~~t~l~~--a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tp  181 (221)
T d1iknd_         104 LKATNYNGHTCLHL--ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSP  181 (221)
T ss_dssp             GGCCCTTCCCHHHH--HHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCG
T ss_pred             ccccccccchhhhH--HhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCH
Confidence            33344557788855  777888888888889999888765 679999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhhHHHHHHhhcCC
Q 019685          105 LADAEGAKKFNMMELLNAHGGL  126 (337)
Q Consensus       105 l~~A~~~~~~~~v~~L~~~~a~  126 (337)
                      ||+|+..++.+++++|.+....
T Consensus       182 l~~A~~~~~~~~~~~l~~~~~~  203 (221)
T d1iknd_         182 YQLTWGRPSTRIQQQLGQLTLE  203 (221)
T ss_dssp             GGGCTTSSCHHHHHHHHTTSCG
T ss_pred             HHHHHHCCCHHHHHHHHHcCCc
Confidence            9999999999999999887653

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.58  E-value=2.8e-15  Score=123.38  Aligned_cols=112  Identities=21%  Similarity=0.142  Sum_probs=96.2

Q ss_pred             Cchhhhhh-hhccCCchhHHHHHhhCCHHHHHHHHHhCCCCcc-------------------------------------
Q 019685           21 SSADKQKE-KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVH-------------------------------------   62 (337)
Q Consensus        21 ~~~~~~~~-~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn-------------------------------------   62 (337)
                      +.|++++. .|++|.|||++  |+..|+.+++++|++.|+++|                                     
T Consensus        10 ~~g~din~~~d~~G~t~L~~--A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   87 (209)
T d1ot8a_          10 AQGAELNATMDKTGETSLHL--AARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNARM   87 (209)
T ss_dssp             HHHHHHHHHHHHHCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCCC
T ss_pred             HCCCCcCcCcCCCCCCHHHH--HHHcCCHHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccc
Confidence            56889987 58999999966  888888888888888776554                                     


Q ss_pred             ------------------------------ccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhh
Q 019685           63 ------------------------------ARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAK  112 (337)
Q Consensus        63 ------------------------------~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~  112 (337)
                                                    ..+..|+||||+|+..+..++++.|++.++++|.+|..|.||||+|+..|
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g  167 (209)
T d1ot8a_          88 HDGTTPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREG  167 (209)
T ss_dssp             TTCCCHHHHHHHTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTT
T ss_pred             ccccccccccccccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhcccc
Confidence                                          46677889999999999999999999999999999999999999999999


Q ss_pred             hhhHHHHHHhhcCCCCCCCCCC
Q 019685          113 KFNMMELLNAHGGLSYGQNGSH  134 (337)
Q Consensus       113 ~~~~v~~L~~~~a~~~~~~~~~  134 (337)
                      +.+++++|+++|++++..+...
T Consensus       168 ~~~~v~~Ll~~gad~n~~d~~g  189 (209)
T d1ot8a_         168 SYEASKALLDNFANREITDHMD  189 (209)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTS
T ss_pred             HHHHHHHHHHCCCCCCCcCCCC
Confidence            9999999999998876554433

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=1.1e-15  Score=127.41  Aligned_cols=118  Identities=24%  Similarity=0.253  Sum_probs=95.0

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHH------------
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCL------------   87 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~L------------   87 (337)
                      ...++++|.+|.+|+||||+  |+..+..+++++|++.|++++..|.+|+||||+|+..|+.+++++|            
T Consensus        26 ~~~~~~in~~d~~g~TpLh~--A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~~  103 (221)
T d1iknd_          26 KGDLAFLNFQNNLQQTPLHL--AVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSI  103 (221)
T ss_dssp             ---CCCCCCCCTTCCCHHHH--HHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCG
T ss_pred             HhCCCCcccCCCCCCccccc--cccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccc
Confidence            35678899999999999976  8888889999999999999999999999998888877776666555            


Q ss_pred             ---------------------------HHcCCCccccc-cccccchhhhhhhhhhhHHHHHHhhcCCCCCCCCCCCCCCC
Q 019685           88 ---------------------------IEYGADVNAQD-RWKNTPLADAEGAKKFNMMELLNAHGGLSYGQNGSHFEPKP  139 (337)
Q Consensus        88 ---------------------------l~~ga~~~~~d-~~g~t~l~~A~~~~~~~~v~~L~~~~a~~~~~~~~~~~~~~  139 (337)
                                                 +..|++++.++ ..|.||||.|+..++.+++++|+.+|++++..+....+|..
T Consensus       104 ~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~  183 (221)
T d1iknd_         104 LKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQ  183 (221)
T ss_dssp             GGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGG
T ss_pred             ccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHH
Confidence                                       45566666554 56899999999999999999999999988877766665543

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=2.1e-15  Score=124.38  Aligned_cols=88  Identities=26%  Similarity=0.423  Sum_probs=80.0

Q ss_pred             hhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhh
Q 019685           29 KARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADA  108 (337)
Q Consensus        29 ~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A  108 (337)
                      .+..+.++++.  |+..+...+.+.+++.|.+++.+|..|.||||+|+..|+.+++++|+++|||+|.+|..|+||||+|
T Consensus       140 ~~~~~~~~l~~--a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A  217 (228)
T d1k1aa_         140 DIKSGRSPLIH--AVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVA  217 (228)
T ss_dssp             CTTTCCCHHHH--HHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTC
T ss_pred             cccchhhHHHH--HHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence            33467777754  8888888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhHHH
Q 019685          109 EGAKKFNMME  118 (337)
Q Consensus       109 ~~~~~~~~v~  118 (337)
                      +..++.++++
T Consensus       218 ~~~~~~divk  227 (228)
T d1k1aa_         218 RSRRVIDILR  227 (228)
T ss_dssp             SSHHHHHHHT
T ss_pred             HhCCCccccC
Confidence            9999988774

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.56  E-value=2e-15  Score=130.91  Aligned_cols=95  Identities=23%  Similarity=0.254  Sum_probs=84.5

Q ss_pred             cCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhh
Q 019685           32 VSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGA  111 (337)
Q Consensus        32 ~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~  111 (337)
                      ++.|+|+.  ||..|+.+++++|+++|+|||.+|.+|+||||+|+..|+.+++++|+++|++.+..+..+.|||+.|+..
T Consensus        39 ~~~t~l~~--A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~  116 (291)
T d1s70b_          39 DDGAVFLA--ACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASC  116 (291)
T ss_dssp             CHHHHHHH--HHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHH
T ss_pred             CCchHHHH--HHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeecccccccccccccccccccccccc
Confidence            34466643  6666777777888899999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhHHHHHHhhcCCCC
Q 019685          112 KKFNMMELLNAHGGLSY  128 (337)
Q Consensus       112 ~~~~~v~~L~~~~a~~~  128 (337)
                      ++.++++.+..+++...
T Consensus       117 ~~~~~~~~l~~~~~~~~  133 (291)
T d1s70b_         117 GYLDIAEYLISQGAHVG  133 (291)
T ss_dssp             TCHHHHHHHHHTTCCTT
T ss_pred             cccchhhcccccCcccc
Confidence            99999999999887544

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=4.8e-15  Score=116.34  Aligned_cols=113  Identities=21%  Similarity=0.212  Sum_probs=92.7

Q ss_pred             CCchhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           20 TSSADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      ...+++++.+|..|+|||+  +|+. ++.+++++|++.|++++..+..|.|||+.|+..++.+.++.|++.+.+++..|.
T Consensus        21 l~~g~d~n~~d~~g~TpL~--~A~~-~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~   97 (156)
T d1ihba_          21 LQNNVNVNAQNGFGRTALQ--VMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDN   97 (156)
T ss_dssp             TTSCCCTTCCCTTSCCHHH--HCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHCCCCcCccCCccccccc--cccc-ccccccccccccccccccccccCccccccccccccccccccccccccccccccc
Confidence            3567889999999999985  3665 457788889999999999999999999999999999999999999988888889


Q ss_pred             ccccchhhhhhhhhhhHHHHHHhhcC-CCCCCCCCCC
Q 019685          100 WKNTPLADAEGAKKFNMMELLNAHGG-LSYGQNGSHF  135 (337)
Q Consensus       100 ~g~t~l~~A~~~~~~~~v~~L~~~~a-~~~~~~~~~~  135 (337)
                      .|.+|++.|+..++.+++++|+.+++ +....+....
T Consensus        98 ~~~~~l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~~g~  134 (156)
T d1ihba_          98 EGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGD  134 (156)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSC
T ss_pred             ccccccccccccccccccccccccccccccccCCCCC
Confidence            99999999988888899988888776 3443343333

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=1.1e-14  Score=114.22  Aligned_cols=95  Identities=20%  Similarity=0.125  Sum_probs=82.6

Q ss_pred             HHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhhhhhhhHHHH
Q 019685           40 WHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEGAKKFNMMEL  119 (337)
Q Consensus        40 ~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~v~~  119 (337)
                      |.|+..|..+++++|+++|+|+|.+|.+|+||||+|+ .|+.|++++|+++|++++.++..+.+|++.++..++...+..
T Consensus         6 h~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~   84 (156)
T d1ihba_           6 ASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQT   84 (156)
T ss_dssp             HHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCcccccccccccccccccc
Confidence            4477778888888888999999999999999999886 789999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCCCCCCC
Q 019685          120 LNAHGGLSYGQNGSHF  135 (337)
Q Consensus       120 L~~~~a~~~~~~~~~~  135 (337)
                      +...+...+..+....
T Consensus        85 l~~~~~~~~~~~~~~~  100 (156)
T d1ihba_          85 LLEFQADVNIEDNEGN  100 (156)
T ss_dssp             HHHTTCCTTCCCTTSC
T ss_pred             cccccccccccccccc
Confidence            9988877665544433

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=2.2e-14  Score=118.03  Aligned_cols=93  Identities=20%  Similarity=0.148  Sum_probs=81.9

Q ss_pred             ccCCchhHHHHHhhCCHHHHHHHHH----hCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchh
Q 019685           31 RVSRTSLILWHAHQNDAAAVRKLLE----EDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLA  106 (337)
Q Consensus        31 ~~~~~~~~~~~a~~~~~~~~~~lL~----~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~  106 (337)
                      ++|+||||+  |+..++.++++.|+    +.|+++|.+|.+|+||||+||..|+.+++++|+++|++++..+..+.++++
T Consensus         1 ~dG~TpLh~--A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~   78 (228)
T d1k1aa_           1 EDGDTPLHI--AVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAH   78 (228)
T ss_dssp             CTTCCHHHH--HHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred             CCCccHHHH--HHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhcccccccccccccccccccccccccccccc
Confidence            469999976  77777777666665    589999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhHHHHHHhhcC
Q 019685          107 DAEGAKKFNMMELLNAHGG  125 (337)
Q Consensus       107 ~A~~~~~~~~v~~L~~~~a  125 (337)
                      .|....+..+++.+.....
T Consensus        79 ~a~~~~~~~~~~~~~~~~~   97 (228)
T d1k1aa_          79 LACEHRSPTCLRALLDSAA   97 (228)
T ss_dssp             HHHHTTCHHHHHHHHHHSC
T ss_pred             cccccccccchhhhhhccc
Confidence            9999999988887766543

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.50  E-value=3.7e-14  Score=118.22  Aligned_cols=109  Identities=26%  Similarity=0.194  Sum_probs=93.7

Q ss_pred             hhhhccCCchhHHHHHhhCCHHHHHHHHHhCCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcC-CCccccccccccch
Q 019685           27 KEKARVSRTSLILWHAHQNDAAAVRKLLEEDQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYG-ADVNAQDRWKNTPL  105 (337)
Q Consensus        27 ~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~g-a~~~~~d~~g~t~l  105 (337)
                      ...+..+.|+++.  ++..+..++.++|+..|.+++.+|.+|+||||+|+..|+.+++++|++.| .++|.+|.+|+|||
T Consensus        99 ~~~~~~~~~~l~~--~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpL  176 (229)
T d1ixva_          99 NKITNQGVTCLHL--AVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPL  176 (229)
T ss_dssp             TCCCTTSCCHHHH--HHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHH
T ss_pred             ccccccccccccc--ccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCch
Confidence            3344556677755  77788889999999999999999999999999999999999999999997 68999999999999


Q ss_pred             hhhhhhhhhhHHHHHHh-hcCCCCCCCCCCCCC
Q 019685          106 ADAEGAKKFNMMELLNA-HGGLSYGQNGSHFEP  137 (337)
Q Consensus       106 ~~A~~~~~~~~v~~L~~-~~a~~~~~~~~~~~~  137 (337)
                      |+|+..++.+++++|+. .|++++..+....+|
T Consensus       177 h~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~  209 (229)
T d1ixva_         177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKA  209 (229)
T ss_dssp             HHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCT
T ss_pred             hhhcccccHHHHHHHHHhcCCCCCCcCCCCCCH
Confidence            99999999999999985 588877666554443

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=8.6e-15  Score=126.13  Aligned_cols=76  Identities=22%  Similarity=0.257  Sum_probs=67.6

Q ss_pred             chhhhhhhhccCCchhHHHHHhhCCHHHHHHHHHh-CCCCccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccc
Q 019685           22 SADKQKEKARVSRTSLILWHAHQNDAAAVRKLLEE-DQSLVHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDR   99 (337)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~lL~~-~~~~vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~   99 (337)
                      .+++++.+|..|+|||+.  |+..+..+++++|++ .|++||.+|.+|.||||+|+..|+.|+|++||++|||+|++|.
T Consensus       208 ~ga~~n~~~~~g~t~L~~--a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~  284 (285)
T d1wdya_         208 HGADVNVRGERGKTPLIL--AVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL  284 (285)
T ss_dssp             TTCCSSCCCTTSCCHHHH--HHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred             CCCCCCccCCCCCCccch--hhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence            456778889999999865  777777788888876 6999999999999999999999999999999999999999884

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.48  E-value=1.8e-14  Score=125.84  Aligned_cols=50  Identities=28%  Similarity=0.434  Sum_probs=48.1

Q ss_pred             ccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccccccccchhhhhh
Q 019685           61 VHARDYDNRTPLHVASLHGWIDVAKCLIEYGADVNAQDRWKNTPLADAEG  110 (337)
Q Consensus        61 vn~~~~~g~tpLh~A~~~g~~~~~~~Ll~~ga~~~~~d~~g~t~l~~A~~  110 (337)
                      ||.+|.+|+||||+||..|+.++|++|+++|||+|.+|+.|+|||++|++
T Consensus       252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~~  301 (301)
T d1sw6a_         252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGAG  301 (301)
T ss_dssp             TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTCC
T ss_pred             ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcCC
Confidence            68889999999999999999999999999999999999999999999974

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.57  E-value=1.4e-07  Score=79.29  Aligned_cols=131  Identities=15%  Similarity=0.080  Sum_probs=85.7

Q ss_pred             CceeEEEEEECCceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEEEEeecCCCCHHHHHH
Q 019685          169 SFGEILKAYWRGTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLMLITEYLRGGDLHKYLK  247 (337)
Q Consensus       169 ~~g~V~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  247 (337)
                      +.+.||+....++.+++|+........   ...+.+|...+..+. +--+.+++.+....+..++||++++|.++.+...
T Consensus        26 s~~~v~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~  102 (263)
T d1j7la_          26 SPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE  102 (263)
T ss_dssp             SSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred             CCCcEEEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence            346899988778888999875432221   134566777777664 4446778888888888999999999977755431


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------------------
Q 019685          248 EKGALSPSTAVNFALDIARGMAYLHNE-----------------------------------------------------  274 (337)
Q Consensus       248 ~~~~~~~~~~~~~~~~i~~~l~~lH~~-----------------------------------------------------  274 (337)
                      .     ......++.++...+..||+.                                                     
T Consensus       103 ~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  177 (263)
T d1j7la_         103 D-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE  177 (263)
T ss_dssp             T-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred             c-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence            1     111122334444444444421                                                     


Q ss_pred             ----CCCcEeeCCCCCCEEEecCCCCcEEEEeccCceee
Q 019685          275 ----PNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLI  309 (337)
Q Consensus       275 ----~~~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~~  309 (337)
                          ...++|+|+.|.|||+  +.++.+-|+||+.+..-
T Consensus       178 ~~~~~~~l~HgD~~~~Nil~--~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         178 KPEEELVFSHGDLGDSNIFV--KDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             CCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCEEE
T ss_pred             CCcCCcEEEEeeccCcceee--cCCceEEEeechhcccC
Confidence                0127899999999999  55445569999988654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.94  E-value=1.8e-05  Score=65.45  Aligned_cols=72  Identities=19%  Similarity=0.150  Sum_probs=48.1

Q ss_pred             ecccCc-eeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC--CCCeeeeeeeEEeCCceEEEEeecCCC
Q 019685          165 IGKGSF-GEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR--HPNIVQFLGAVTERKPLMLITEYLRGG  240 (337)
Q Consensus       165 lg~G~~-g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~--h~~Iv~~~~~~~~~~~~~lv~e~~~~~  240 (337)
                      +..|.. +.||+.... +..+++|.......      ..+..|...++.+.  .-.+.+++.+..+.+..+++|++++|.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            344443 578988776 44578887655432      23455666666554  234677888878888899999999875


Q ss_pred             CH
Q 019685          241 DL  242 (337)
Q Consensus       241 ~L  242 (337)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            54

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.91  E-value=1.7e-05  Score=70.49  Aligned_cols=77  Identities=18%  Similarity=0.226  Sum_probs=46.8

Q ss_pred             ceecccCceeEEEEEEC--CceEEEEEecCCC----CchHHHHHHHHHHHHHHHhCC---CCCeeeeeeeEEeCCceEEE
Q 019685          163 AIIGKGSFGEILKAYWR--GTPVAIKRILPSL----SDDRLVIQDFRHEVNLLVKLR---HPNIVQFLGAVTERKPLMLI  233 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~--g~~vavK~l~~~~----~~~~~~~~~~~~E~~~l~~l~---h~~Iv~~~~~~~~~~~~~lv  233 (337)
                      +.||.|....||+....  ++.+++|.-.+..    ...+....+...|...++.+.   ...+++++.+  +....+++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46888999999998754  6789999754311    000111233455777776553   2346666654  44556899


Q ss_pred             EeecCCCC
Q 019685          234 TEYLRGGD  241 (337)
Q Consensus       234 ~e~~~~~~  241 (337)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.69  E-value=0.003  Score=53.83  Aligned_cols=65  Identities=8%  Similarity=0.072  Sum_probs=40.2

Q ss_pred             eeEEEEEEC-CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCCCCCe--eeeee-----eEEeCCceEEEEeecCC
Q 019685          171 GEILKAYWR-GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLRHPNI--VQFLG-----AVTERKPLMLITEYLRG  239 (337)
Q Consensus       171 g~V~~~~~~-g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~h~~I--v~~~~-----~~~~~~~~~lv~e~~~~  239 (337)
                      -.||++... |..+++|+.++.....    +.+..|...+..|....|  +..+.     .+...+..+.+++++.|
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            579998864 7889999987654322    445567777766542111  11111     23445667889998876

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.43  E-value=0.0093  Score=52.08  Aligned_cols=70  Identities=11%  Similarity=0.120  Sum_probs=43.6

Q ss_pred             ceecccCceeEEEEEEC---------CceEEEEEecCCCCchHHHHHHHHHHHHHHHhCC-CCCeeeeeeeEEeCCceEE
Q 019685          163 AIIGKGSFGEILKAYWR---------GTPVAIKRILPSLSDDRLVIQDFRHEVNLLVKLR-HPNIVQFLGAVTERKPLML  232 (337)
Q Consensus       163 ~~lg~G~~g~V~~~~~~---------g~~vavK~l~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~l  232 (337)
                      +.|+.|-.-.+|++...         .+.+++++.- .. ...   ....+|..+++.+. +.-.+++++++..    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            46766777789998764         2346666553 21 111   23456888887775 4445677776642    68


Q ss_pred             EEeecCCCC
Q 019685          233 ITEYLRGGD  241 (337)
Q Consensus       233 v~e~~~~~~  241 (337)
                      |+||++|..
T Consensus       119 I~efi~g~~  127 (395)
T d1nw1a_         119 LEEYIPSRP  127 (395)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEecccc
Confidence            899998743

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.31  E-value=0.087  Score=43.86  Aligned_cols=30  Identities=27%  Similarity=0.259  Sum_probs=25.2

Q ss_pred             CcEeeCCCCCCEEEecCCCCcEEEEeccCcee
Q 019685          277 VIIHRDLKPRNVLLVNSSADHLKVGDFGLSKL  308 (337)
Q Consensus       277 ~ivHrdlkp~Nil~~~~~~~~~kl~DFgla~~  308 (337)
                      ++||+|+.+.||++  +.+...-|+||+.+..
T Consensus       184 giIHgDl~~dNvl~--~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFF--LGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhc--ccccceeEeccccccc
Confidence            39999999999999  5555568999998854